PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tang, SQ; Gong, YC; Edwards, EA				Tang, Shuiquan; Gong, Yunchen; Edwards, Elizabeth A.			Semi-Automatic In Silico Gap Closure Enabled De Novo Assembly of Two Dehalobacter Genomes from Metagenomic Data	PLOS ONE			English	Article							SEQUENCE	Typically, the assembly and closure of a complete bacterial genome requires substantial additional effort spent in a wet lab for gap resolution and genome polishing. Assembly is further confounded by subspecies polymorphism when starting from metagenome sequence data. In this paper, we describe an in silico gap-resolution strategy that can substantially improve assembly. This strategy resolves assembly gaps in scaffolds using pre-assembled contigs, followed by verification with read mapping. It is capable of resolving assembly gaps caused by repetitive elements and subspecies polymorphisms. Using this strategy, we realized the de novo assembly of the first two Dehalobacter genomes from the metagenomes of two anaerobic mixed microbial cultures capable of reductive dechlorination of chlorinated ethanes and chloroform. Only four additional PCR reactions were required even though the initial assembly with Newbler v. 2.5 produced 101 contigs within 9 scaffolds belonging to two Dehalobacter strains. By applying this strategy to the re-assembly of a recently published genome of Bacteroides, we demonstrate its potential utility for other sequencing projects, both metagenomic and genomic.	[Tang, Shuiquan; Edwards, Elizabeth A.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Gong, Yunchen] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	Edwards, EA (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	elizabeth.edwards@utoronto.ca	Edwards, Elizabeth/GXV-2307-2022	Edwards, Elizabeth/0000-0002-8071-338X	Government of Canada through Genome Canada; Ontario Genomics Institute [2009-OGI-ABC-1405]; Government of Ontario through the ORF-GL2 program; United States Department of Defense through the Strategic Environmental Research and Development Program (SERDP) [W912HQ-07-C-0036, ER-1586]; Government of Ontario; Natural Sciences and Engineering Research Council of Canada (NSERC PGS B)	Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Government of Ontario through the ORF-GL2 program; United States Department of Defense through the Strategic Environmental Research and Development Program (SERDP); Government of Ontario; Natural Sciences and Engineering Research Council of Canada (NSERC PGS B)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Metagenome sequencing of the ACT-3 culture was provided by the U.S. Deparment of Energy Joint Genome Institute through the Community Sequencing Program (CSP 2010). Support was provided by the Government of Canada through Genome Canada and the Ontario Genomics Institute (2009-OGI-ABC-1405). Support was also provided by the Government of Ontario through the ORF-GL2 program and the United States Department of Defense through the Strategic Environmental Research and Development Program (SERDP) under contract W912HQ-07-C-0036 (project ER-1586). S. T. received awards from the Government of Ontario through the Ontario Graduate Scholarships in Science and Technology (OGSST) and the Natural Sciences and Engineering Research Council of Canada (NSERC PGS B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Drummond A. J., 2011, GENEIOUS V5 4 2; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gronow S, 2011, STAND GENOMIC SCI, V4, P191, DOI 10.4056/sigs.1704212; Grostern A, 2010, ENVIRON MICROBIOL, V12, P1053, DOI 10.1111/j.1462-2920.2009.02150.x; Grostern A, 2006, APPL ENVIRON MICROB, V72, P7849, DOI 10.1128/AEM.01269-06; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Koren S, 2011, BIOINFORMATICS, V27, P2964, DOI 10.1093/bioinformatics/btr520; Lapidus A, 2008, ADV GENOME BIOL TECH; Laserson J, 2011, J COMPUT BIOL, V18, P429, DOI 10.1089/cmb.2010.0244; Mardis E, 2002, GENOME RES, V12, P669, DOI 10.1101/gr.032102; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Simmons SL, 2008, PLOS BIOL, V6, P1427, DOI 10.1371/journal.pbio.0060177; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tang S, 2012, IDENTIFICATION UNPUB; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	26	29	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52038	10.1371/journal.pone.0052038	http://dx.doi.org/10.1371/journal.pone.0052038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284863	gold, Green Submitted, Green Published			2022-12-25	WOS:000313158800024
J	Corser, CA; McLenachan, PA; Pierson, MJ; Harrison, GLA; Penny, D				Corser, Chris A.; McLenachan, Patricia A.; Pierson, Melanie J.; Harrison, G. L. Abby; Penny, David			The Q2 Mitochondrial Haplogroup in Oceania	PLOS ONE			English	Article							Y-CHROMOSOME; FOUNDING POPULATION; GENOME VARIATION; NEW-ZEALAND; MTDNA; PACIFIC; ISLAND; HISTORY; ORIGIN; TREES	Many details surrounding the origins of the peoples of Oceania remain to be resolved, and as a step towards this we report seven new complete mitochondrial genomes from the Q2a haplogroup, from Papua New Guinea, Fiji and Kiribati. This brings the total to eleven Q2 genomes now available. The Q haplogroup (that includes Q2) is an old and diverse lineage in Near Oceania, and is reasonably common; within our sample set of 430, 97 are of the Q haplogroup. However, only 8 are Q2, and we report 7 here. The tree with all complete Q genomes is proven to be minimal. The dating estimate for the origin of Q2 (around 35 Kya) reinforces the understanding that humans have been in Near Oceania for tens of thousands of years; nevertheless the Polynesian maternal haplogroups remain distinctive. A major focus now, with regard to Polynesian ancestry, is to address the differences and timing of the 'Melanesian' contribution to the maternal and paternal lineages as people moved further and further into Remote Oceania. Input from other fields such as anthropology, history and linguistics is required for a better understanding and interpretation of the genetic data.	[Corser, Chris A.; McLenachan, Patricia A.; Harrison, G. L. Abby; Penny, David] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand; [Pierson, Melanie J.] Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; [Harrison, G. L. Abby] Univ Oxford, Oxford, England	Massey University; University of Auckland; University of Oxford	Penny, D (corresponding author), Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.	D.Penny@massey.ac.nz			Wellcome Trust [AL061746 Goding]; Royal Society of NZ	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society of NZ(Royal Society of New Zealand)	The Wellcome Trust funded the project under a Collaborative Research Initiative Grant 'AL061746 Goding', 16th Feb 2001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CAC acknowledges a Teacher Fellowship from the Royal Society of NZ. We thank Patrick Biggs and Bennet McComish for assembling a Q2a mitochondrial genome from output from the Solexa DNA Sequencer, and Angela McGraughan for completing the PD047 genome.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Cox MP, 2008, HUM BIOL, V80, P335, DOI 10.3378/1534-6617-80.4.335; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; Derrick RA., 1950, HIST FIJI; Friedlaender J, 2005, MOL BIOL EVOL, V22, P1506, DOI 10.1093/molbev/msi142; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Hage P, 2003, CURR ANTHROPOL, V44, pS121, DOI 10.1086/379272; Harrison A, 2011, VIRUSES-BASEL, V3, P83, DOI 10.3390/v3020083; Harrison GL, 2008, THESIS; HENDY MD, 1978, J THEOR BIOL, V71, P441, DOI 10.1016/0022-5193(78)90171-6; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Holland BR, 2005, MOL BIOL EVOL, V22, P235, DOI 10.1093/molbev/msi010; Holland BR, 2004, MOL BIOL EVOL, V21, P1459, DOI 10.1093/molbev/msh145; Howe KR, 2006, VAKA MOANA VOYAGES O; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; Hurles ME, 2003, TRENDS ECOL EVOL, V18, P531, DOI 10.1016/S0169-5347(03)00245-3; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jordan FM, 2009, P ROY SOC B-BIOL SCI, V276, P1957, DOI 10.1098/rspb.2009.0088; Kayser M, 2008, MOL BIOL EVOL, V25, P1362, DOI 10.1093/molbev/msn078; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kirch PV, 2000, ON THE ROAD OF THE W; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Lum JK, 1998, AM J HUM GENET, V63, P613, DOI 10.1086/301949; McComish BJ, 2010, GENOME BIOL EVOL, V2, P410, DOI 10.1093/gbe/evq029; Miles JAR, 1997, INFECTIOUS DISEASES; Mona S, 2009, MOL BIOL EVOL, V26, P1865, DOI 10.1093/molbev/msp097; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Murray-McIntosh RP, 1998, P NATL ACAD SCI USA, V95, P9047, DOI 10.1073/pnas.95.15.9047; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; PAWLEY A, 1993, ANNU REV ANTHROPOL, V22, P425; Penny D, 2002, J POLYNESIAN SOC, V111, P207; PENNY D, 1991, PHYLOGENETIC ANALYSIS OF DNA SEQUENCES, P155; Pierson MJ, 2006, MOL BIOL EVOL, V23, P1966, DOI 10.1093/molbev/msl063; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Scott MW, 2007, THE SEVERED SNAKE MA; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Steel M, 2004, APPL MATH LETT, V17, P785, DOI 10.1016/j.aml.2004.06.006; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Tuffley C, 2012, MOL BIOL EVOL, V29, P3703, DOI 10.1093/molbev/mss172; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Whyte ALH, 2005, HUM BIOL, V77, P157, DOI 10.1353/hub.2005.0045; Wollstein A, 2010, CURR BIOL, V20, P1983, DOI 10.1016/j.cub.2010.10.040; Wyeth EH, 2005, ARTHRITIS RHEUM-US, V52, pS582; Wyeth EH, 2007, THESIS	60	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52022	10.1371/journal.pone.0052022	http://dx.doi.org/10.1371/journal.pone.0052022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284859	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500079
J	Kallijarvi, J; Stratoulias, V; Virtanen, K; Hietakangas, V; Heino, TI; Saarma, M				Kallijarvi, Jukka; Stratoulias, Vassilis; Virtanen, Kristel; Hietakangas, Ville; Heino, Tapio I.; Saarma, Mart			Characterization of Drosophila GDNF Receptor-Like and Evidence for Its Evolutionarily Conserved Interaction with Neural Cell Adhesion Molecule (NCAM)/FasII	PLOS ONE			English	Article							FAMILY; EXPRESSION; NEURTURIN; HYBRIDIZATION; BINDING; PROTEIN; LIGAND; RNA	Background: Glial cell line-derived neurotrophic factor (GDNF) family ligands are secreted growth factors distantly related to the TGF-beta superfamily. In mammals, they bind to the GDNF family receptor alpha (Gfr alpha) and signal through the Ret receptor tyrosine kinase. In order to gain insight into the evolution of the Ret-Gfr-Gdnf signaling system, we have cloned and characterized the first invertebrate Gfr-like cDNA (DmGfrl) from Drosophila melanogaster and generated a DmGfrl mutant allele. Results: We found that DmGfrl encodes a large GPI-anchored membrane protein with four GFR-like domains. In line with the fact that insects lack GDNF ligands, DmGfrl mediated neither Drosophila Ret phosphorylation nor mammalian RET phosphorylation. In situ hybridization analysis revealed that DmGfrl is expressed in the central and peripheral nervous systems throughout Drosophila development, but, surprisingly, DmGfrl and DmRet expression patterns were largely non-overlapping. We generated a DmGfrl null allele by genomic FLP deletion and found that both DmGfrl null females and males are viable but display fertility defects. The female fertility defect manifested as dorsal appendage malformation, small size and reduced viability of eggs laid by mutant females. In male flies DmGfrl interacted genetically with the Drosophila Ncam (neural cell adhesion molecule) homolog FasII to regulate fertility. Conclusion: Our results suggest that Ret and Gfrl did not function as an in cis receptor-coreceptor pair before the emergence of GDNF family ligands, and that the Ncam-Gfr interaction predated the in cis Ret-Gfr interaction in evolution. The fertility defects that we describe in DmGfrl null flies suggest that GDNF receptor-like has an evolutionarily ancient role in regulating male fertility and a previously unrecognized role in regulating oogenesis. Significance: These results shed light on the evolutionary aspects of the structure, expression and function of Ret-Gfr alpha and Ncam-Gfr alpha signaling complexes.	[Kallijarvi, Jukka; Virtanen, Kristel; Hietakangas, Ville; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Helsinki, Finland; [Stratoulias, Vassilis; Heino, Tapio I.] Univ Helsinki, Dept Biosci, Viikki Bioctr, Helsinki, Finland	University of Helsinki; University of Helsinki	Kallijarvi, J (corresponding author), Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Viikinkaari 9, Helsinki, Finland.	jukka.kallijarvi@helsinki.fi	Kallijarvi, Jukka/AAV-5091-2021; Stratoulias, Vassilis/P-6724-2018; Stratoulias, Vassilis/M-7074-2019	Kallijarvi, Jukka/0000-0003-3773-7025; Stratoulias, Vassilis/0000-0002-9724-6589; Stratoulias, Vassilis/0000-0002-9724-6589; Hietakangas, Ville/0000-0002-9900-7549	Academy of Finland [1121015]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (grant 1121015) as a part of JK's post-doctoral researcher's project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G, 2003, DEVELOPMENT, V130, P2397, DOI 10.1242/dev.00460; Airaksinen MS, 2006, BRAIN BEHAV EVOLUT, V68, P181, DOI 10.1159/000094087; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Golden JP, 1998, J COMP NEUROL, V398, P139, DOI 10.1002/(SICI)1096-9861(19980817)398:1<139::AID-CNE9>3.0.CO;2-2; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Hahn M, 2001, P NATL ACAD SCI USA, V98, P1053, DOI 10.1073/pnas.021558598; Hatinen T, 2007, MOL CELL NEUROSCI, V34, P155, DOI 10.1016/j.mcn.2006.10.009; Hidalgo A, 2006, BRAIN BEHAV EVOLUT, V68, P173, DOI 10.1159/000094086; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Parker JS, 2001, PROTEINS, V45, P71, DOI 10.1002/prot.1125; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Read RD, 2005, GENETICS, V171, P1057, DOI 10.1534/genetics.104.038018; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Schwientek T, 2007, PROTEOMICS, V7, P3264, DOI 10.1002/pmic.200600793; SUGAYA R, 1994, MECH DEVELOP, V45, P139, DOI 10.1016/0925-4773(94)90027-2; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002; White IJ, 2000, J CELL SCI, V113, P721; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	35	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51997	10.1371/journal.pone.0051997	http://dx.doi.org/10.1371/journal.pone.0051997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284846	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500074
J	Mathieu, E; Lamirault, G; Toquet, C; Lhommet, P; Rederstorff, E; Sourice, S; Biteau, K; Hulin, P; Forest, V; Weiss, P; Guicheux, J; Lemarchand, P				Mathieu, Eva; Lamirault, Guillaume; Toquet, Claire; Lhommet, Pierre; Rederstorff, Emilie; Sourice, Sophie; Biteau, Kevin; Hulin, Philippe; Forest, Virginie; Weiss, Pierre; Guicheux, Jerome; Lemarchand, Patricia			Intramyocardial Delivery of Mesenchymal Stem Cell-Seeded Hydrogel Preserves Cardiac Function and Attenuates Ventricular Remodeling after Myocardial Infarction	PLOS ONE			English	Article							HYDROXYPROPYL METHYLCELLULOSE; 3-DIMENSIONAL CULTURE; SKELETAL MYOBLASTS; GENERAL-PROPERTIES; TRANSPLANTATION; HEART; ECHOCARDIOGRAPHY; INJECTION; SURVIVAL; MATRIX	Background: To improve the efficacy of bone marrow-derived mesenchymal stem cell (MSC) therapy targeted to infarcted myocardium, we investigated whether a self-setting silanized hydroxypropyl methylcellulose (Si-HPMC) hydrogel seeded with MSC (MSC+hydrogel) could preserve cardiac function and attenuate left ventricular (LV) remodeling during an 8-week follow-up study in a rat model of myocardial infarction (MI). Methodology/Principal Finding: Si-HPMC hydrogel alone, MSC alone or MSC+hydrogel were injected into the myocardium immediately after coronary artery ligation in female Lewis rats. Animals in the MSC+hydrogel group showed an increase in cardiac function up to 28 days after MI and a mid-term prevention of cardiac function alteration at day 56. Histological analyses indicated that the injection of MSC+hydrogel induced a decrease in MI size and an increase in scar thickness and ultimately limited the transmural extent of MI. These findings show that intramyocardial injection of MSC+hydrogel induced short-term recovery of ventricular function and mid-term attenuation of remodeling after MI. Conclusion/Significance: These beneficial effects may be related to the specific scaffolding properties of the Si-HPMC hydrogel that may provide the ability to support MSC injection and engraftment within myocardium.	[Mathieu, Eva; Lamirault, Guillaume; Lhommet, Pierre; Biteau, Kevin; Forest, Virginie; Lemarchand, Patricia] CNRS, Inst Thorax, INSERM, UMR1087,UMR6291, Nantes, France; [Mathieu, Eva; Lamirault, Guillaume; Lhommet, Pierre; Rederstorff, Emilie; Sourice, Sophie; Biteau, Kevin; Hulin, Philippe; Forest, Virginie; Weiss, Pierre; Guicheux, Jerome; Lemarchand, Patricia] Univ Nantes, Nantes, France; [Toquet, Claire] CHU Nantes, Serv Anat Pathol, EA Biometadys, F-44035 Nantes 01, France; [Rederstorff, Emilie; Sourice, Sophie; Weiss, Pierre; Guicheux, Jerome] INSERM, U791, Lab Osteoarticular & Dent Tissue Engn, Grp STEP Skeletal Tissue Engn & Physiopathol, Nantes, France; [Hulin, Philippe] Nantes Univ MicroPICell, Cellular & Tissular Imaging Core Facil, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite; CHU de Nantes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lemarchand, P (corresponding author), CNRS, Inst Thorax, INSERM, UMR1087,UMR6291, Nantes, France.	patricia.lemarchand@univ-nantes.fr	WEISS, Pierre/AAE-9260-2020; Weiss, Pierre/P-1372-2014; Lamirault, Guillaume/G-3699-2010; lemarchand, patricia/C-3247-2011; guicheux, Jerome/F-7767-2013	WEISS, Pierre/0000-0002-6159-8590; Weiss, Pierre/0000-0002-6159-8590; Lamirault, Guillaume/0000-0001-6490-1279; lemarchand, patricia/0000-0002-5330-2008; guicheux, Jerome/0000-0003-2754-3024	National Institute for Health and Medical Research; Fondation de l'Avenir pour la recherche medicale appliquee [ET0 570]; French Ministry of Research and Technology	National Institute for Health and Medical Research(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation de l'Avenir pour la recherche medicale appliquee; French Ministry of Research and Technology	This work was supported by grants from the National Institute for Health and Medical Research and "Fondation de l'Avenir pour la recherche medicale appliquee, ET0 570". Eva Mathieu received a fellowship from the French Ministry of Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA; BOOR PJ, 1985, AM J PATHOL, V121, P39; Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053; Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0; Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937; Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003; Elnakish MT, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/646038; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fatimi A, 2008, BIOMATERIALS, V29, P533, DOI 10.1016/j.biomaterials.2007.10.032; Fatimi A, 2009, ACTA BIOMATER, V5, P3423, DOI 10.1016/j.actbio.2009.05.030; Fernandes S, 2006, CARDIOVASC RES, V69, P348, DOI 10.1016/j.cardiores.2005.10.003; FOLLAND ED, 1979, CIRCULATION, V60, P760, DOI 10.1161/01.CIR.60.4.760; Imanishi Y, 2008, J MOL CELL CARDIOL, V44, P662, DOI 10.1016/j.yjmcc.2007.11.001; Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kanashiro-Takeuchi RM, 2010, P NATL ACAD SCI USA, V107, P2604, DOI 10.1073/pnas.0914138107; Karaoz E, 2009, HISTOCHEM CELL BIOL, V132, P533, DOI 10.1007/s00418-009-0629-6; Laib S, 2009, BIOMATERIALS, V30, P1568, DOI 10.1016/j.biomaterials.2008.11.031; Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEHOCZKY J, 1964, ARCH PATHOL, V78, P37; Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010; Li LL, 2008, TRANSPL INT, V21, P1181, DOI 10.1111/j.1432-2277.2008.00742.x; Maurel A, 2005, TRANSPLANTATION, V80, P660, DOI 10.1097/01.tp.0000172178.35488.31; Merceron C, 2011, CELL TRANSPLANT, V20, P1575, DOI 10.3727/096368910X557191; Mias C, 2008, STEM CELLS, V26, P1749, DOI 10.1634/stemcells.2007-1000; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Niagara MI, 2007, CIRC RES, V100, P545, DOI 10.1161/01.RES.0000258460.41160.ef; Poulsen SH, 2001, DAN MED BULL, V48, P199; Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001; Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571; Savoye C, 2006, AM J CARDIOL, V98, P1144, DOI 10.1016/j.amjcard.2006.06.011; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Sherman Warren, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS57, DOI 10.1038/ncpcardio0446; Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Trojani C, 2005, BIOMATERIALS, V26, P5509, DOI 10.1016/j.biomaterials.2005.02.001; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Verma A, 2008, JACC-CARDIOVASC IMAG, V1, P582, DOI 10.1016/j.jcmg.2008.05.012; Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867; Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057; Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI [10.1089/ten.teb.2009.0352, 10.1089/ten.TEB.2009.0352]; Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040; Ye ZY, 2011, ADV DRUG DELIVER REV, V63, P688, DOI 10.1016/j.addr.2011.02.007; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhang XL, 2010, EXP BIOL MED, V235, P1505, DOI 10.1258/ebm.2010.010175	58	65	69	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51991	10.1371/journal.pone.0051991	http://dx.doi.org/10.1371/journal.pone.0051991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284842	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500072
J	Menalled, LB; Kudwa, AE; Miller, S; Fitzpatrick, J; Watson-Johnson, J; Keating, N; Ruiz, M; Mushlin, R; Alosio, W; McConnell, K; Connor, D; Murphy, C; Oakeshott, S; Kwan, M; Beltran, J; Ghavami, A; Brunner, D; Park, LC; Ramboz, S; Howland, D				Menalled, Liliana B.; Kudwa, Andrea E.; Miller, Sam; Fitzpatrick, Jon; Watson-Johnson, Judy; Keating, Nicole; Ruiz, Melinda; Mushlin, Richard; Alosio, William; McConnell, Kristi; Connor, David; Murphy, Carol; Oakeshott, Steve; Kwan, Mei; Beltran, Jose; Ghavami, Afshin; Brunner, Dani; Park, Larry C.; Ramboz, Sylvie; Howland, David			Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington's Disease: zQ175	PLOS ONE			English	Article							MESSENGER-RNA; MUTANT HUNTINGTIN; GENE-EXPRESSION; STRIATAL NEURONS; TRANSGENIC MICE; PRECISION GRIP; EARLY MOTOR; REPEAT; ONSET; LENGTH	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder characterized by motor, cognitive and psychiatric manifestations. Since the mutation responsible for the disease was identified as an unstable expansion of CAG repeats in the gene encoding the huntingtin protein in 1993, numerous mouse models of HD have been generated to study disease pathogenesis and evaluate potential therapeutic approaches. Of these, knock-in models best mimic the human condition from a genetic perspective since they express the mutation in the appropriate genetic and protein context. Behaviorally, however, while some abnormal phenotypes have been detected in knock-in mouse models, a model with an earlier and more robust phenotype than the existing models is required. We describe here for the first time a new mouse line, the zQ175 knock-in mouse, derived from a spontaneous expansion of the CAG copy number in our CAG 140 knock-in colony [1]. Given the inverse relationship typically observed between age of HD onset and length of CAG repeat, since this new mouse line carries a significantly higher CAG repeat length it was expected to be more significantly impaired than the parent line. Using a battery of behavioral tests we evaluated both heterozygous and homozygous zQ175 mice. Homozygous mice showed motor and grip strength abnormalities with an early onset (8 and 4 weeks of age, respectively), which were followed by deficits in rotarod and climbing activity at 30 weeks of age and by cognitive deficits at around 1 year of age. Of particular interest for translational work, we also found clear behavioral deficits in heterozygous mice from around 4.5 months of age, especially in the dark phase of the diurnal cycle. Decreased body weight was observed in both heterozygotes and homozygotes, along with significantly reduced survival in the homozygotes. In addition, we detected an early and significant decrease of striatal gene markers from 12 weeks of age. These data suggest that the zQ175 knock-in line could be a suitable model for the evaluation of therapeutic approaches and early events in the pathogenesis of HD.	[Park, Larry C.; Howland, David] CHDI Management CHDI Fdn, Princeton, NJ USA; [Menalled, Liliana B.; Kudwa, Andrea E.; Miller, Sam; Fitzpatrick, Jon; Watson-Johnson, Judy; Keating, Nicole; Ruiz, Melinda; Mushlin, Richard; Alosio, William; Connor, David; Murphy, Carol; Oakeshott, Steve; Kwan, Mei; Beltran, Jose; Ghavami, Afshin; Brunner, Dani; Ramboz, Sylvie] PsychoGenics Inc, Tarrytown, NY USA		Howland, D (corresponding author), CHDI Management CHDI Fdn, Princeton, NJ USA.	David.Howland@CHDIFoundation.org			CHDI Foundation	CHDI Foundation	CHDI Foundation is a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. The research described was conducted by PsychoGenics under a fee-for-service agreement for CHDI Foundation in collaboration with and funded by CHDI Foundation. The funder, through CHDI Management, fully participated in study design, data collection and analysis, the decision to publish, and preparation of the manuscript. CHDI Foundation has recently provided financial support to the Public Library of Science for PLOS Currents: Huntington Disease.	ALBIN RL, 1991, ANN NEUROL, V30, P542, DOI 10.1002/ana.410300406; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Augood SJ, 1997, ANN NEUROL, V42, P215, DOI 10.1002/ana.410420213; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Brooks S, 2010, BRAIN RES B; Brooks SP, 2006, BRAIN RES BULL, V69, P452, DOI 10.1016/j.brainresbull.2006.02.011; Chan EYW, 2002, HUM MOL GENET, V11, P1939, DOI 10.1093/hmg/11.17.1939; Denovan-Wright EM, 2000, NEUROSCIENCE, V98, P705, DOI 10.1016/S0306-4522(00)00157-3; Fellows S, 1997, NEUROSCI LETT, V226, P103, DOI 10.1016/S0304-3940(97)00264-4; Gordon AM, 2000, EXP NEUROL, V163, P136, DOI 10.1006/exnr.2000.7348; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hebb ALO, 2004, NEUROSCIENCE, V123, P967, DOI 10.1016/j.neuroscience.2003.11.009; Heng MY, 2007, J NEUROSCI, V27, P8989, DOI 10.1523/JNEUROSCI.1830-07.2007; Heng MY, 2010, HUM MOL GENET, V19, P3702, DOI 10.1093/hmg/ddq285; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Hickey MA, 2003, CYTOGENET GENOME RES, V100, P276, DOI 10.1159/000072863; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Hu H, 2004, EUR J NEUROSCI, V20, P3351, DOI 10.1111/j.1460-9568.2004.03796.x; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lione LA, 1999, J NEUROSCI, V19, P10428; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McCaw EA, 2004, EUR J BIOCHEM, V271, P4909, DOI 10.1111/j.1432-1033.2004.04460.x; Menalled L, 2000, EXP NEUROL, V162, P328, DOI 10.1006/exnr.1999.7327; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled LB, 2002, TRENDS PHARMACOL SCI, V23, P32, DOI 10.1016/S0165-6147(00)01884-8; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Morton AJ, 2006, NAT METHODS, V3, P767, DOI 10.1038/nmeth1006-767; Murphy C, IMPAIRMENTS SI UNPUB; RICHFIELD EK, 1995, ANN NEUROL, V37, P335, DOI 10.1002/ana.410370309; Rising AC, 2011, EXP NEUROL, V228, P173, DOI 10.1016/j.expneurol.2010.12.017; ROOS RAC, 1993, J NEUROL NEUROSUR PS, V56, P98, DOI 10.1136/jnnp.56.1.98; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Squitieri F, 2003, BRAIN, V126, P946, DOI 10.1093/brain/awg077; Trembath MK, 2010, MOVEMENT DISORD, V25, P1444, DOI 10.1002/mds.23108; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004	45	248	255	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e49838	10.1371/journal.pone.0049838	http://dx.doi.org/10.1371/journal.pone.0049838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284626	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500009
J	Silva, MCPE; Dias, ACF; van Elsas, JD; Salles, JF				Pereira e Silva, Michele C.; Franco Dias, Armando Cavalcante; van Elsas, Jan Dirk; Salles, Joana Falcao			Spatial and Temporal Variation of Archaeal, Bacterial and Fungal Communities in Agricultural Soils	PLOS ONE			English	Article							MICROBIAL COMMUNITY; BETA-DIVERSITY; KINGDOM CRENARCHAEOTA; PROKARYOTIC DIVERSITY; PHYLOGENETIC ANALYSIS; GRADIENT; PH; RHIZOSPHERE; ABUNDANCE; DYNAMICS	Background: Soil microbial communities are in constant change at many different temporal and spatial scales. However, the importance of these changes to the turnover of the soil microbial communities has been rarely studied simultaneously in space and time. Methodology/Principal Findings: In this study, we explored the temporal and spatial responses of soil bacterial, archaeal and fungal beta-diversities to abiotic parameters. Taking into account data from a 3-year sampling period, we analyzed the abundances and community structures of Archaea, Bacteria and Fungi along with key soil chemical parameters. We questioned how these abiotic variables influence the turnover of bacterial, archaeal and fungal communities and how they impact the long-term patterns of changes of the aforementioned soil communities. Interestingly, we found that the bacterial and fungal b-diversities are quite stable over time, whereas archaeal diversity showed significantly higher fluctuations. These fluctuations were reflected in temporal turnover caused by soil management through addition of N-fertilizers. Conclusions: Our study showed that management practices applied to agricultural soils might not significantly affect the bacterial and fungal communities, but cause slow and long-term changes in the abundance and structure of the archaeal community. Moreover, the results suggest that, to different extents, abiotic and biotic factors determine the community assembly of archaeal, bacterial and fungal communities.	[Pereira e Silva, Michele C.; van Elsas, Jan Dirk; Salles, Joana Falcao] Univ Groningen, Ctr Life Sci, Dept Microbial Ecol, Groningen, Netherlands; [Franco Dias, Armando Cavalcante] Univ Sao Paulo, Dept Soil Sci, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil	University of Groningen; Universidade de Sao Paulo	Silva, MCPE (corresponding author), Univ Groningen, Ctr Life Sci, Dept Microbial Ecol, Groningen, Netherlands.	m.silva@rug.nl	Dias, Armando Cavalcante Franco/F-5878-2012; de Cassia Pereira e Silva, Michele/D-3918-2016; Dias, Armando Cavalcante Franco/O-1477-2019; Falcao Salles, Joana/A-7313-2008; Pereira e Silva, Michele de Cássia/H-6958-2013; Salles, Joana Falcao/AAG-7070-2020	Dias, Armando Cavalcante Franco/0000-0002-2651-6270; de Cassia Pereira e Silva, Michele/0000-0002-6426-8474; Dias, Armando Cavalcante Franco/0000-0002-2651-6270; Falcao Salles, Joana/0000-0003-4317-7263; Salles, Joana Falcao/0000-0003-4317-7263	NWO-ERGO Programme	NWO-ERGO Programme	This work was supported by the NWO-ERGO Programme and was part of a collaborative project with Utrecht University, Utrecht, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA HG, 1953, AUST J ZOOL, V1, P174, DOI 10.1071/ZO9530174; Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; Bach HJ, 2002, J MICROBIOL METH, V49, P235, DOI 10.1016/S0167-7012(01)00370-0; Baez S, 2006, ECOLOGY, V87, P2746, DOI 10.1890/0012-9658(2006)87[2746:BROPCS]2.0.CO;2; Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P997, DOI 10.1016/S0038-0717(02)00033-0; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Bano N, 2004, APPL ENVIRON MICROB, V70, P781, DOI 10.1128/AEM.70.2.781-789.2004; Bardgett Richard D., 2005, P100, DOI 10.1017/CBO9780511541926.007; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bengtson P, 2012, APPL ENVIRON MICROB, V78, P5906, DOI 10.1128/AEM.01476-12; Bomberg M, 2007, MICROB ECOL, V54, P406, DOI 10.1007/s00248-007-9232-3; Bossuyt H, 2001, APPL SOIL ECOL, V16, P195, DOI 10.1016/S0929-1393(00)00116-5; Brons JK, 2008, APPL ENVIRON MICROB, V74, P2717, DOI 10.1128/AEM.02195-07; Buckley DH, 1998, APPL ENVIRON MICROB, V64, P4333; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Flohre A, 2011, ECOL APPL, V21, P1772, DOI 10.1890/10-0645.1; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jung J, 2011, RES MICROBIOL, V162, P1018, DOI 10.1016/j.resmic.2011.07.007; Jurgens G, 1997, APPL ENVIRON MICROB, V63, P803, DOI 10.1128/AEM.63.2.803-805.1997; Kampichler C, 2005, PEDOBIOLOGIA, V49, P41, DOI 10.1016/j.pedobi.2004.07.011; Kemnitz D, 2007, FEMS MICROBIOL ECOL, V60, P442, DOI 10.1111/j.1574-6941.2007.00310.x; King AJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1055; Kropf S, 2004, J STAT PLAN INFER, V125, P31, DOI 10.1016/j.jspi.2003.07.021; Langenheder S, 2012, ISME J, V6, P1107, DOI 10.1038/ismej.2011.177; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lehtovirta LE, 2009, FEMS MICROBIOL ECOL, V70, P367, DOI 10.1111/j.1574-6941.2009.00748.x; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Leps J, 2003, MULTIVARIATE ANAL EC; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Lindstrom ES, 2012, ENV MICROBIOL REP, V4, P1, DOI 10.1111/j.1758-2229.2011.00257.x; Lipson DA, 2002, MICROB ECOL, V43, P307, DOI 10.1007/s00248-001-1057-x; Magurran AE, 2010, PHILOS T R SOC B, V365, P3593, DOI 10.1098/rstb.2010.0296; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; Nevarez L, 2009, INT J FOOD MICROBIOL, V130, P166, DOI 10.1016/j.ijfoodmicro.2009.01.013; Nicol GW, 2004, ENVIRON MICROBIOL, V6, P861, DOI 10.1111/j.1462-2920.2004.00627.x; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; RADEMAKER JLW, 1999, MOL MICROBIAL ECOLOG, P1; Rasche F, 2011, ISME J, V5, P389, DOI 10.1038/ismej.2010.138; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Thibault KM, 2004, ECOLOGY, V85, P2649, DOI 10.1890/04-0321; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; UEDA T, 1995, EUR J SOIL SCI, V46, P415, DOI 10.1111/j.1365-2389.1995.tb01337.x; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wang JJ, 2008, ENVIRON MICROBIOL, V10, P2537, DOI 10.1111/j.1462-2920.2008.01678.x; WHEELER KA, 1991, INT J FOOD MICROBIOL, V12, P141, DOI 10.1016/0168-1605(91)90063-U; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019950	75	41	42	1	185	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51554	10.1371/journal.pone.0051554	http://dx.doi.org/10.1371/journal.pone.0051554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284712	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500033
J	Thriemer, K; Ley, BB; Ame, SS; Deen, JL; Pak, GD; Chang, NY; Hashim, R; Schmied, WH; Busch, CJL; Nixon, S; Morrissey, A; Puri, MK; Ochiai, RL; Wierzba, T; Clemens, JD; Ali, M; Jiddawi, MS; von Seidlein, L; Ali, SM				Thriemer, Kamala; Ley, Benedikt B.; Ame, Shaali S.; Deen, Jaqueline L.; Pak, Gi Deok; Chang, Na Yoon; Hashim, Ramadhan; Schmied, Wolfgang Hellmut; Busch, Clara Jana-Lui; Nixon, Shanette; Morrissey, Anne; Puri, Mahesh K.; Ochiai, R. Leon; Wierzba, Thomas; Clemens, John D.; Ali, Mohammad; Jiddawi, Mohammad S.; von Seidlein, Lorenz; Ali, Said M.			Clinical and Epidemiological Features of Typhoid Fever in Pemba, Zanzibar: Assessment of the Performance of the WHO Case Definitions	PLOS ONE			English	Article							DIAGNOSIS; CHILDREN; SALMONELLOSIS; TANZANIA	Background: The gold standard for diagnosis of typhoid fever is blood culture (BC). Because blood culture is often not available in impoverished settings it would be helpful to have alternative diagnostic approaches. We therefore investigated the usefulness of clinical signs, WHO case definition and Widal test for the diagnosis of typhoid fever. Methodology/Principal Findings: Participants with a body temperature >= 37.5 degrees C or a history of fever were enrolled over 17 to 22 months in three hospitals on Pemba Island, Tanzania. Clinical signs and symptoms of participants upon presentation as well as blood and serum for BC and Widal testing were collected. Clinical signs and symptoms of typhoid fever cases were compared to other cases of invasive bacterial diseases and BC negative participants. The relationship of typhoid fever cases with rainfall, temperature, and religious festivals was explored. The performance of the WHO case definitions for suspected and probable typhoid fever and a local cut off titre for the Widal test was assessed. 79 of 2209 participants had invasive bacterial disease. 46 isolates were identified as typhoid fever. Apart from a longer duration of fever prior to admission clinical signs and symptoms were not significantly different among patients with typhoid fever than from other febrile patients. We did not detect any significant seasonal patterns nor correlation with rainfall or festivals. The sensitivity and specificity of the WHO case definition for suspected and probable typhoid fever were 82.6% and 41.3% and 36.3 and 99.7% respectively. Sensitivity and specificity of the Widal test was 47.8% and 99.4 both forfor O-agglutinin and H-agglutinin at a cut-off titre of 1:80. Conclusions/Significance: Typhoid fever prevalence rates on Pemba are high and its clinical signs and symptoms are nonspecific. The sensitivity of the Widal test is low and the WHO case definition performed better than the Widal test.	[Thriemer, Kamala; Ley, Benedikt B.; Deen, Jaqueline L.; Pak, Gi Deok; Chang, Na Yoon; Hashim, Ramadhan; Schmied, Wolfgang Hellmut; Busch, Clara Jana-Lui; Puri, Mahesh K.; Ochiai, R. Leon; Wierzba, Thomas; Clemens, John D.; Ali, Mohammad] Int Vaccine Inst, Seoul, South Korea; [Thriemer, Kamala] Inst Trop Med, B-2000 Antwerp, Belgium; [Ley, Benedikt B.] Univ Vienna, Bioctr, Vienna, Austria; [Ame, Shaali S.; Ali, Said M.] Publ Hlth Lab Pemba, Ivo De Carneri, Chake Chake, Tanzania; [Ame, Shaali S.; Jiddawi, Mohammad S.; Ali, Said M.] Minist Hlth & Social Welf, Zanzibar, Tanzania; [Deen, Jaqueline L.; von Seidlein, Lorenz] Menzies Sch Hlth Res, Casuarina, NT, Australia; [Nixon, Shanette; Morrissey, Anne] Duke Univ, KCMC Collaborat, Moshi, Tanzania	International Vaccine Institute; Institute of Tropical Medicine (ITM); University of Vienna; Charles Darwin University; Menzies School of Health Research; Duke University	Thriemer, K (corresponding author), Int Vaccine Inst, Seoul, South Korea.	kthriemer@itg.be	Schmied, Wolfgang/AAU-9961-2020; Ali, Mohammad/E-2365-2017	Schmied, Wolfgang/0000-0001-7625-0995; Ali, Mohammad/0000-0003-1410-388X; Thriemer, Kamala/0000-0001-7536-7497; Ochiai, Leon/0000-0002-5079-6786; Ley, Benedikt/0000-0002-5734-0845	Swedish International Development Cooperation Agency (SIDA)	Swedish International Development Cooperation Agency (SIDA)	This work has been supported by a grant from the Swedish International Development Cooperation Agency (SIDA) to the International Vaccine Institute (IVI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutta ZA, 1996, ANN TROP PAEDIATR, V16, P299, DOI 10.1080/02724936.1996.11747842; Crump JA, 2012, CLIN INFECT DIS, V54, P1107, DOI 10.1093/cid/cis024; Hosoglu S, 2006, T ROY SOC TROP MED H, V100, P1068, DOI 10.1016/j.trstmh.2005.12.007; Keddy KH, 2011, B WORLD HEALTH ORGAN, V89, P640, DOI 10.2471/BLT.11.087627; Ley B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-147; Ley B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-180; Mindy J., 2003, MANUAL LAB IDENTIFIC; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Thriemer Kamala, 2012, BMC Res Notes, V5, P113, DOI 10.1186/1756-0500-5-113; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; World Health Organization, 2012, WHOIVB1202	12	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51823	10.1371/journal.pone.0051823	http://dx.doi.org/10.1371/journal.pone.0051823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284780	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500051
J	Flavel, SC; Koch, JD; White, JM; Todd, G				Flavel, Stanley C.; Koch, Jenna D.; White, Jason M.; Todd, Gabrielle			Illicit Stimulant Use in Humans Is Associated with a Long-Term Increase in Tremor	PLOS ONE			English	Article							MDMA ECSTASY; RAT-BRAIN; (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; CLINICAL-PHARMACOLOGY; DOPAMINE TRANSPORTER; PARKINSONS-DISEASE; MOVEMENT-DISORDERS; COCAINE; NEURONS	Use of illicit stimulants such as methamphetamine, cocaine, and ecstasy is a significant health problem. The United Nations Office on Drugs and Crime estimates that 14-57 million people use stimulants each year. Chronic use of illicit stimulants can cause neurotoxicity in animals and humans but the long-term functional consequences are not well understood. Stimulant users self-report problems with tremor whilst abstinent. Thus, the aim of the current study was to investigate the long-term effect of stimulant use on human tremor during rest and movement. We hypothesized that individuals with a history of stimulant use would exhibit abnormally large tremor during rest and movement. Tremor was assessed in abstinent ecstasy users (n = 9; 22 +/- 3 yrs) and abstinent users of amphetamine-like drugs (n = 7; 33 +/- 9 yrs) and in two control groups: non-drug users (n = 23; 27 +/- 8 yrs) and cannabis users (n = 12; 24 +/- 7 yrs). Tremor was measured with an accelerometer attached to the index finger at rest (30 s) and during flexion and extension of the index finger (30 s). Acceleration traces were analyzed with fast-Fourier transform. During movement, tremor amplitude was significantly greater in ecstasy users than in non-drug users (frequency range 3.9-13.3 Hz; P<0.05), but was unaffected in cannabis users or users of amphetamine-like drugs. The peak frequency of tremor did not significantly differ between groups nor did resting tremor. In conclusion, abstinent ecstasy users exhibit an abnormally large tremor during movement. Further work is required to determine if the abnormality translates to increased risk of movement disorders in this population.	[Flavel, Stanley C.; Koch, Jenna D.; White, Jason M.; Todd, Gabrielle] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [White, Jason M.; Todd, Gabrielle] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia	University of South Australia; University of South Australia	Todd, G (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	gabrielle.todd@unisa.edu.au	Todd, Gabrielle/K-7122-2012; White, Jason M/A-2795-2011	Todd, Gabrielle/0000-0002-2465-6026; White, Jason M/0000-0001-6750-1078	Clive and Vera Ramaciotti Foundation [2974/2010]; National Health and Medical Research Council of Australia [627003]; University of South Australia	Clive and Vera Ramaciotti Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of South Australia	This work was supported by the Clive and Vera Ramaciotti Foundation (Establishment Grant, ID 2974/2010), National Health and Medical Research Council of Australia (GT holds a Career Development Award; ID 627003), and University of South Australia (GT holds a RsearchSA Fellowship, SF held an Australian Postgraduate Award, and JK held a South Australia Rural Health Scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2005, STAT DRUG US AUSTR 2, V62, P1; AIHW, 2011, 2010 NAT DRUG STRAT, P1; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; BAUER LO, 1993, PSYCHIAT RES, V47, P69, DOI 10.1016/0165-1781(93)90056-M; Beck A.T., 1996, PSYCHOL ASSESS, DOI DOI 10.1037/T00742-000; BENOWITZ NL, 1993, PHARMACOL TOXICOL, V72, P3, DOI 10.1111/j.1600-0773.1993.tb01331.x; Benton AL, 1983, MULTILINGUAL APHASIA; Bousman CA, 2010, J INT NEUROPSYCH SOC, V16, P1047, DOI 10.1017/S1355617710000846; Buchert R, 2003, J NUCL MED, V44, P375; Callaghan RC, 2010, MOVEMENT DISORD, V25, P2333, DOI 10.1002/mds.23263; CARDOSO F, 1993, NEUROL CLIN, V11, P625, DOI 10.1016/S0733-8619(18)30143-9; CARDOSO FEC, 1993, MOVEMENT DISORD, V8, P175, DOI 10.1002/mds.870080210; Catalano G, 1997, SOUTH MED J, V90, P1050, DOI 10.1097/00007611-199710000-00017; COMMINS DL, 1987, J PHARMACOL EXP THER, V241, P338; Cosentino C, 2004, MOVEMENT DISORD, V19, P1386, DOI 10.1002/mds.20306; Dafters RI, 1999, PSYCHOPHARMACOLOGY, V145, P82, DOI 10.1007/s002130051035; Demirkiran M, 1996, CLIN NEUROPHARMACOL, V19, P157, DOI 10.1097/00002826-199619020-00004; Diaz-Martinez A, 1998, CLIN THER, V20, P467, DOI 10.1016/S0149-2918(98)80056-8; Downes Michael A, 2005, Emerg Med Australas, V17, P277; Esteban B, 2001, PSYCHOPHARMACOLOGY, V154, P251, DOI 10.1007/s002130000645; FACTOR SA, 1988, ANN NEUROL, V23, P423, DOI 10.1002/ana.410230431; Farmer SF, 1998, J PHYSIOL-LONDON, V509, P3, DOI 10.1111/j.1469-7793.1998.003bo.x; FISCHER C, 1995, J NEUROSCI, V15, P5476; FREEMAN JS, 1993, J NEUROL NEUROSUR PS, V56, P1078, DOI 10.1136/jnnp.56.10.1078; Frei E, 2001, HUM BRAIN MAPP, V14, P152, DOI 10.1002/hbm.1049; Greco PG, 2003, EUR J PHARMACOL, V479, P117, DOI 10.1016/j.ejphar.2003.08.062; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V80, P732, DOI 10.2466/pms.1995.80.3.732; Hallett M, 1998, MOVEMENT DISORD, V13, P43; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; Jones DC, 2005, J PHARMACOL EXP THER, V313, P422, DOI 10.1124/jpet.104.077628; KEARCOLWELL JJ, 1978, J CLIN PSYCHOL, V34, P437, DOI 10.1002/1097-4679(197804)34:2<437::AID-JCLP2270340239>3.0.CO;2-K; Kish SJ, 2010, J PSYCHOPHARMACOL, V24, P281, DOI 10.1177/0269881108097724; Lew R, 1996, J PHARMACOL EXP THER, V276, P855; LUNDH H, 1981, J NEUROL NEUROSUR PS, V44, P728, DOI 10.1136/jnnp.44.8.728; Lyons KE, 2008, CNS DRUGS, V22, P1037, DOI 10.2165/0023210-200822120-00006; McAuley JH, 2000, BRAIN, V123, P1545, DOI 10.1093/brain/123.8.1545; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; MCCANN UD, 1994, NEUROPSYCHOPHARMACOL, V10, P129, DOI 10.1038/npp.1994.15; Morefield KM, 2011, ADDICTION, V106, P1293, DOI 10.1111/j.1360-0443.2011.03399.x; Mrazik M, 2010, ARCH CLIN NEUROPSYCH, V25, P236, DOI 10.1093/arclin/acq006; Mueller M, 2011, SYNAPSE, V65, P983, DOI 10.1002/syn.20925; Parrott AC, 2002, HUM PSYCHOPHARM CLIN, V17, P309, DOI 10.1002/hup.415; PASCUALLEONE A, 1990, NEUROLOGY, V40, P999, DOI 10.1212/WNL.40.6.999; PRIORI A, 1995, MOVEMENT DISORD, V10, P353, DOI 10.1002/mds.870100323; Raethjen J, 2001, J NEUROL NEUROSUR PS, V70, P78, DOI 10.1136/jnnp.70.1.78; Reneman L, 2002, NEUROPSYCHOPHARMACOL, V26, P387, DOI 10.1016/S0893-133X(01)00366-9; RICAURTE GA, 1992, J PHARMACOL EXP THER, V261, P616; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rothwell JC, 1998, MOVEMENT DISORD, V13, P24; SCHMIDT CJ, 1987, BIOCHEM PHARMACOL, V36, P4095, DOI 10.1016/0006-2952(87)90566-1; Scholey AB, 2004, ADDICT BEHAV, V29, P743, DOI 10.1016/j.addbeh.2004.02.022; Selvaraj S, 2009, BRIT J PSYCHIAT, V194, P355, DOI 10.1192/bjp.bp.108.050344; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Thompson G.B., 1992, PSYCHOL ASSESSMENT, V4, P363; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Toomey R, 2003, ARCH GEN PSYCHIAT, V60, P303, DOI 10.1001/archpsyc.60.3.303; VALLBO AB, 1993, J PHYSIOL-LONDON, V469, P673, DOI 10.1113/jphysiol.1993.sp019837; Vickers D, 1972, Perception, V1, P263, DOI 10.1068/p010263; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Yamamoto Bryan K., 2005, Critical Reviews in Neurobiology, V17, P87	63	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52025	10.1371/journal.pone.0052025	http://dx.doi.org/10.1371/journal.pone.0052025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272201	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000312483300049
J	Nimitphong, H; Holick, MF; Fried, SK; Lee, MJ				Nimitphong, Hataikarn; Holick, Michael F.; Fried, Susan K.; Lee, Mi-Jeong			25-Hydroxyvitamin D-3 and 1,25-Dihydroxyvitamin D-3 Promote the Differentiation of Human Subcutaneous Preadipocytes	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; ENERGY-EXPENDITURE; GENE-EXPRESSION; IDENTIFICATION; ADIPOGENESIS; FAT; OBESITY; METABOLISM; CELLS	1,25(OH)(2)D-3 inhibits adipogenesis in mouse 3T3-L1 adipocytes, but little is known about its effects or local metabolism in human adipose tissue. We showed that vitamin D receptor (VDR) and 1 alpha-hydroxylase (CYP27B1), the enzyme that activates 25(OH)D-3 to 1,25(OH)(2)D-3, were expressed in human adipose tissues, primary preadipocytes and newly-differentiated adipocytes. Preadipocytes and newly-differentiated adipocytes were responsive to 1,25(OH)(2)D-3, as indicated by a markedly increased expression of CYP24A1, a primary VDR target. 1,25(OH)(2)D-3 enhanced adipogenesis as determined by increased expression of adipogenic markers and triglyceride accumulation (50% to 150%). The magnitude of the effect was greater in the absence of thiazolidinediones. 1,25(OH)(2)D-3 was equally effective when added after the removal of differentiation cocktail on day 3, but it had no effect when added only during the induction period (day 0-3), suggesting that 1,25(OH)(2)D-3 promoted maturation. 25(OH)D-3 also stimulated CYP24A1 expression and adipogenesis, most likely through its conversion to 1,25(OH)(2)D-3. Consistent with this possibility, incubation of preadipocytes with 25(OH)D-3 led to 1,25(OH)(2)D-3 accumulation in the media. 1,25(OH)(2)D-3 also enhanced adipogenesis in primary mouse preadipocytes. We conclude that vitamin D status may regulate human adipose tissue growth and remodeling.	[Nimitphong, Hataikarn; Holick, Michael F.; Fried, Susan K.; Lee, Mi-Jeong] Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Nimitphong, Hataikarn] Ramathibodi Hosp, Dept Med, Sect Endocrinol & Metab, Bangkok, Thailand	Boston University; Mahidol University	Lee, MJ (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA.	mijlee@bu.edu	Lee, Mi-Jeong/ABE-1084-2020; Lee, Mi-Jeong/GXV-9843-2022	Lee, Mi-Jeong/0000-0002-8171-7913; Lee, Mi-Jeong/0000-0002-8171-7913; Holick, Michael/0000-0001-6023-9062; Fried, Susan K./0000-0003-1101-9332	National Institutes of Health [DK-52398, DK-080448, P30 DK-046200]; Ramathibodi Hospital, Mahidol University, Thailand; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052398, R01DK080448, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ramathibodi Hospital, Mahidol University, Thailand; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (DK-52398, DK-080448, and P30 DK-046200). HN was supported by a research fellowship training grant from Ramathibodi Hospital, Mahidol University, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Ching S, 2011, J CELL BIOCHEM, V112, P3393, DOI 10.1002/jcb.23273; DeLuca HF, 2011, ARCH BIOCHEM BIOPHYS, V505, P226, DOI 10.1016/j.abb.2010.10.012; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Hauner H, 2000, METH MOL B, V155, P239; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2622, DOI 10.1210/en.139.5.2622; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Lahnalampi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012991; Lee MJ, 2012, OBESITY SILVER SPRIN, DOI [10.1038/ oby.2012.116, DOI 10.1038/0BY.2012.116]; Lenders CM, 2009, AM J CLIN NUTR, V90, P459, DOI 10.3945/ajcn.2008.27275; Li J, 2008, J STEROID BIOCHEM, V112, P122, DOI 10.1016/j.jsbmb.2008.09.006; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Lorente-Cebrian S, 2012, EUR J NUTR, V51, P335, DOI 10.1007/s00394-011-0218-z; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; Mitri J, 2011, AM J CLIN NUTR, V94, P486, DOI 10.3945/ajcn.111.011684; Monkawa T, 2000, KIDNEY INT, V58, P559, DOI 10.1046/j.1523-1755.2000.00202.x; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Overbergh L, 2000, CLIN EXP IMMUNOL, V120, P139, DOI 10.1046/j.1365-2249.2000.01204.x; Samuel S, 2008, NUTR REV, V66, pS116, DOI 10.1111/j.1753-4887.2008.00094.x; Shi H, 2001, FASEB J, V15, P2751, DOI 10.1096/fj.01-0584fje; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Valina-Toth ALB, 2010, CLIN ENDOCRINOL, V72, P595, DOI 10.1111/j.1365-2265.2009.03676.x; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wong KE, 2011, J BIOL CHEM, V286, P33804, DOI 10.1074/jbc.M111.257568; Wong KE, 2009, AM J PHYSIOL-ENDOC M, V296, pE820, DOI 10.1152/ajpendo.90763.2008; Wood RJ, 2008, NUTR REV, V66, P40, DOI 10.1111/j.1753-4887.2007.00004.x; Yang HN, 2011, BIOMATERIALS, V32, P5924, DOI 10.1016/j.biomaterials.2011.04.072; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Zehnder D, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133621	37	97	99	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52171	10.1371/journal.pone.0052171	http://dx.doi.org/10.1371/journal.pone.0052171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272223	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300067
J	Ninomiya, T; Sawamura, H; Inoue, K; Takada, M				Ninomiya, Taihei; Sawamura, Hiromasa; Inoue, Ken-ichi; Takada, Masahiko			Multisynaptic Inputs from the Medial Temporal Lobe to V4 in Macaques	PLOS ONE			English	Article							RETROGRADE TRANSNEURONAL TRANSPORT; CENTRAL-NERVOUS-SYSTEM; AREA V4; ENTORHINAL CORTEX; RHESUS-MONKEY; HIPPOCAMPAL-FORMATION; CORTICAL CONNECTIONS; VISUAL-CORTEX; PARAHIPPOCAMPAL CORTICES; RECIPROCAL CONNECTIONS	Retrograde transsynaptic transport of rabies virus was employed to undertake the top-down projections from the medial temporal lobe (MTL) to visual area V4 of the occipitotemporal visual pathway in Japanese monkeys (Macaca fuscata). On day 3 after rabies injections into V4, neuronal labeling was observed prominently in the temporal lobe areas that have direct connections with V4, including area TF of the parahippocampal cortex. Furthermore, conspicuous neuron labeling appeared disynaptically in area TH of the parahippocampal cortex, and areas 35 and 36 of the perirhinal cortex. The labeled neurons were located predominantly in deep layers. On day 4 after the rabies injections, labeled neurons were found in the hippocampal formation, along with massive labeling in the parahippocampal and perirhinal cortices. In the hippocampal formation, the densest neuron labeling was seen in layer 5 of the entorhinal cortex, and a small but certain number of neurons were labeled in other regions, such as the subicular complex and CA1 and CA3 of the hippocampus proper. The present results indicate that V4 receives major input from the hippocampus proper via the entorhinal cortex, as well as "short-cut'' pathways that bypass the entorhinal cortex. These multisynaptic pathways may define an anatomical basis for hippocampal-cortical interactions involving lower visual areas. The multisynaptic input from the MTL to V4 is likely to provide mnemonic information about object recognition that is accomplished through the occipitotemporal pathway.	[Ninomiya, Taihei; Sawamura, Hiromasa; Inoue, Ken-ichi; Takada, Masahiko] Tokyo Metropolitan Inst Neurosci, Dept Syst Neurosci, Fuchu, Tokyo 183, Japan; [Ninomiya, Taihei; Inoue, Ken-ichi; Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan; [Sawamura, Hiromasa] Univ Tokyo, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Kyoto University; University of Tokyo	Ninomiya, T (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Syst Neurosci, Fuchu, Tokyo 183, Japan.	ninomiya@pri.kyoto-u.ac.jp	Inoue, Ken-ichi/K-4103-2015	Inoue, Ken-ichi/0000-0002-5683-5280	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20019011, 19790162, 22790202]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas-Integrative Brain Research (20019011) to H. S., as well as Young Scientists (B) (19790162) and (22790202) to H. S. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARAL DG, 1987, J COMP NEUROL, V264, P326, DOI 10.1002/cne.902640305; AMARAL DG, 1983, BRAIN RES, V275, P263, DOI 10.1016/0006-8993(83)90987-3; Blatt GJ, 1998, J COMP NEUROL, V392, P92, DOI 10.1002/(SICI)1096-9861(19980302)392:1<92::AID-CNE7>3.0.CO;2-K; Bonda E, 2000, EUR J NEUROSCI, V12, P1971, DOI 10.1046/j.1460-9568.2000.00082.x; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; DeWeerd P, 1996, VISUAL NEUROSCI, V13, P529, DOI 10.1017/S0952523800008208; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Felleman DJ, 1997, J NEUROSCI, V17, P3185; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; Girard P, 2002, CEREB CORTEX, V12, P1146, DOI 10.1093/cercor/12.11.1146; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; LEVAY S, 1990, EXP BRAIN RES, V82, P77; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; Merigan WH, 1998, VISUAL NEUROSCI, V15, P359, DOI 10.1017/S0952523898152112; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Miyachi S, 2005, J NEUROSCI, V25, P2547, DOI 10.1523/JNEUROSCI.4186-04.2005; Nassi JJ, 2006, NEURON, V50, P319, DOI 10.1016/j.neuron.2006.03.019; Nassi JJ, 2006, J NEUROSCI, V26, P12789, DOI 10.1523/JNEUROSCI.4044-06.2006; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Ninomiya T, 2011, CEREB CORTEX, V21, P2797, DOI 10.1093/cercor/bhr078; Orban GA, 2008, PHYSIOL REV, V88, P59, DOI 10.1152/physrev.00008.2007; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pistorio AL, 2006, J NEUROSCI METH, V153, P135, DOI 10.1016/j.jneumeth.2005.10.014; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; Rainer G, 2004, PLOS BIOL, V2, P275, DOI 10.1371/journal.pbio.0020044; Rosene D. L., 1987, CEREB CORTEX, V6, P345, DOI DOI 10.1007/978-1-4615-6616-8_9; SAUNDERS RC, 1988, J COMP NEUROL, V271, P153, DOI 10.1002/cne.902710202; SAUNDERS RC, 1988, J COMP NEUROL, V271, P185, DOI 10.1002/cne.902710203; SCHILLER PH, 1995, NATURE, V376, P342, DOI 10.1038/376342a0; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Suzuki WA, 2003, J COMP NEUROL, V463, P67, DOI 10.1002/cne.10744; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Tokuno H, 1998, NEUROSCI RES, V31, P251, DOI 10.1016/S0168-0102(98)00041-8; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ungerleider LG, 2008, CEREB CORTEX, V18, P477, DOI 10.1093/cercor/bhm061; von Bonin G., 1947, NEOCORTEX MACACA MUL; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Xiao YP, 1999, CEREB CORTEX, V9, P792, DOI 10.1093/cercor/9.8.792; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yukie M, 2000, J COMP NEUROL, V423, P282, DOI 10.1002/1096-9861(20000724)423:2<282::AID-CNE7>3.0.CO;2-Z; ZEKI S, 1983, PROC R SOC SER B-BIO, V217, P449, DOI 10.1098/rspb.1983.0020; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52115	10.1371/journal.pone.0052115	http://dx.doi.org/10.1371/journal.pone.0052115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272220	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300065
J	Varga, A; Marcus, AP; Himoto, M; Iwai, S; Szuts, D				Varga, Agnes; Marcus, Adam P.; Himoto, Masayuki; Iwai, Shigenori; Szuets, David			Analysis of CPD Ultraviolet Lesion Bypass in Chicken DT40 Cells: Polymerase eta and PCNA Ubiquitylation Play Identical Roles	PLOS ONE			English	Article							YEAST DNA-POLYMERASE; CYCLOBUTANE PYRIMIDINE DIMERS; DAMAGE TOLERANCE PATHWAY; REV1 PROTEIN INTERACTS; THYMINE-THYMINE DIMER; TRANSLESION SYNTHESIS; ERROR-FREE; 2-POLYMERASE MECHANISMS; POSTREPLICATION REPAIR; INDUCED MUTAGENESIS	Translesion synthesis (TLS) provides a mechanism of copying damaged templates during DNA replication. This potentially mutagenic process may operate either at the replication fork or at post-replicative gaps. We used the example of T-T cyclobutane pyrimidine dimer (CPD) bypass to determine the influence of polymerase recruitment via PCNA ubiquitylation versus the REV1 protein on the efficiency and mutagenic outcome of TLS. Using mutant chicken DT40 cell lines we show that, on this numerically most important UV lesion, defects in polymerase eta or in PCNA ubiquitylation similarly result in the long-term failure of lesion bypass with persistent strand gaps opposite the lesion, and the elevation of mutations amongst successful TLS events. Our data suggest that PCNA ubiquitylation promotes CPD bypass mainly by recruiting polymerase eta, resulting in the majority of CPD lesions bypassed in an error-free manner. In contrast, we find that polymerase zeta is responsible for the majority of CPD-dependent mutations, but has no essential function in the completion of bypass. These findings point to a hierarchy of access of the different TLS polymerases to the lesion, suggesting a temporal order of their recruitment. The similarity of REV1 and REV3 mutant phenotypes confirms that the involvement of polymerase zeta in TLS is largely determined by its recruitment to DNA by REV1. Our data demonstrate the influence of the TLS polymerase recruitment mechanism on the success and accuracy of bypass.	[Varga, Agnes; Szuets, David] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Marcus, Adam P.] Univ London, Div Biomed Sci, London, England; [Himoto, Masayuki; Iwai, Shigenori] Osaka Univ, Div Chem, Grad Sch Engn Sci, Osaka, Japan	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of London; Osaka University	Szuts, D (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.	szuts@enzim.hu	Szuts, David/N-1149-2016	Szuts, David/0000-0001-7985-0136; Nagy, Agnes/0000-0002-7639-0987	St George's, University of London; Hungarian Academy of Sciences [LP2011-015]	St George's, University of London; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by St George's, University of London, and by the Hungarian Academy of Sciences (Momentum grant LP2011-015 to D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; BANERJEE SK, 1988, P NATL ACAD SCI USA, V85, P8141, DOI 10.1073/pnas.85.21.8141; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Chen CC, 2006, DNA REPAIR, V5, P1475, DOI 10.1016/j.dnarep.2006.07.007; Crevel G, 2012, J CELL SCI, V125, P965, DOI 10.1242/jcs.094409; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Diamant N, 2012, NUCLEIC ACIDS RES, V40, P170, DOI 10.1093/nar/gkr596; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Elvers I, 2011, NUCLEIC ACIDS RES, V39, P7049, DOI 10.1093/nar/gkr420; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Guo DY, 2001, NUCLEIC ACIDS RES, V29, P2875, DOI 10.1093/nar/29.13.2875; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; Hirota K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001151; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Ikehata H, 2008, J INVEST DERMATOL, V128, P2289, DOI 10.1038/jid.2008.61; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Jansen JG, 2009, DNA REPAIR, V8, P1444, DOI 10.1016/j.dnarep.2009.09.006; Jansen JG, 2009, MOL CELL BIOL, V29, P3113, DOI 10.1128/MCB.00071-09; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2012, P NATL ACAD SCI US; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; LEHMANN AR, 1972, J MOL BIOL, V66, P319, DOI 10.1016/0022-2836(72)90418-4; LEMONTT JF, 1971, GENETICS, V68, P21; Livneh Z, 2010, CELL CYCLE, V9, P729, DOI 10.4161/cc.9.4.10727; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; MURATA T, 1990, NUCLEIC ACIDS RES, V18, P7279, DOI 10.1093/nar/18.24.7279; Narita T, 2010, GENES CELLS, V15, P1228, DOI 10.1111/j.1365-2443.2010.01457.x; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ozgenc AI, 2005, J BACTERIOL, V187, P1974, DOI 10.1128/JB.187.6.1974-1984.2005; Parker JL, 2007, NUCLEIC ACIDS RES, V35, P881, DOI 10.1093/nar/gkl1102; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; RAO BS, 1988, NUCLEIC ACIDS RES, V16, P4171, DOI 10.1093/nar/16.9.4171; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Sale JE, 2009, PHILOS T R SOC B, V364, P595, DOI 10.1098/rstb.2008.0197; Servant L, 2002, J BIOL CHEM, V277, P50046, DOI 10.1074/jbc.M207101200; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stone JE, 2011, DNA REPAIR, V10, P826, DOI 10.1016/j.dnarep.2011.04.032; Szuts D, 2008, NUCLEIC ACIDS RES, V36, P6767, DOI 10.1093/nar/gkn651; Takeda DY, 2005, GENE DEV, V19, P2827, DOI 10.1101/gad.1369805; Temviriyanukul P, 2012, DNA REPAIR, V11, P550, DOI 10.1016/j.dnarep.2012.03.007; Thomas NE, 2006, J INVEST DERMATOL, V126, P1693, DOI 10.1038/sj.jid.5700458; Tissier A, 2004, DNA REPAIR, V3, P1503, DOI 10.1016/j.dnarep.2004.06.015; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2011, FEBS LETT, V585, P2861, DOI 10.1016/j.febslet.2011.05.028; Unk I, 2010, DNA REPAIR AMST; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200; Ziv O, 2009, P NATL ACAD SCI USA, V106, P11552, DOI 10.1073/pnas.0812548106	68	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52472	10.1371/journal.pone.0052472	http://dx.doi.org/10.1371/journal.pone.0052472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272247	Green Submitted, gold, Green Published			2022-12-25	WOS:000312483300089
J	Barakat, KH; Jordheim, LP; Perez-Pineiro, R; Wishart, D; Dumontet, C; Tuszynski, JA				Barakat, Khaled H.; Jordheim, Lars P.; Perez-Pineiro, Rolando; Wishart, David; Dumontet, Charles; Tuszynski, Jack A.			Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; ACCOMMODATING RECEPTOR FLEXIBILITY; COMPLEMENTATION GROUP-A; DRUG-LIKE INHIBITORS; MOLECULAR-DYNAMICS; DNA-REPAIR; CISPLATIN; ERCC1; XPA; EXPRESSION	Background: Nucleotide excision repair (NER) removes many types of DNA lesions including those induced by UV radiation and platinum-based therapy. Resistance to platinum-based therapy correlates with high expression of ERCC1, a major element of the NER machinery. The interaction between ERCC1 and XPA is essential for a successful NER function. Therefore, one way to regulate NER is by inhibiting the activity of ERCC1 and XPA. Methodology/Principal Findings: Here we continued our earlier efforts aimed at the identification and characterization of novel inhibitors of the ERCC1-XPA interaction. We used a refined virtual screening approach combined with a biochemical and biological evaluation of the compounds for their ability to interact with ERCC1 and to sensitize cells to UV radiation. Our findings reveal a new validated ERCC1-XPA inhibitor that significantly sensitized colon cancer cells to UV radiation indicating a strong inhibition of the ERCC1-XPA interaction. Conclusions: NER is a major factor in acquiring resistance to platinum-based therapy. Regulating the NER pathway has the potential of improving the efficacy of platinum treatments. One approach that we followed is to inhibit the essential interaction between the two NER elements, ERCC1 and XPA. Here, we performed virtual screening against the ERCC1-XPA interaction and identified novel inhibitors that block the XPA-ERCC1 binding. The identified inhibitors significantly sensitized colon cancer cells to UV radiation indicating a strong inhibition of the ERCC1-XPA interaction. Citation: Barakat KH, Jordheim LP, Perez-Pineiro R, Wishart D, Dumontet C, et al. (2012) Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction. PLoS ONE 7(12): e51329. doi:10.1371/journal.pone.0051329	[Barakat, Khaled H.; Tuszynski, Jack A.] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Barakat, Khaled H.] Fayoum Univ, Dept Engn Math & Phys, Al Fayyum, Egypt; [Jordheim, Lars P.; Dumontet, Charles] Univ Lyon, Lyon, France; [Jordheim, Lars P.; Dumontet, Charles] Ctr Rech Cancerol Lyon, INSERM, U1052, Lyon, France; [Jordheim, Lars P.; Dumontet, Charles] Ctr Rech Cancerol Lyon, CNRS, UMR 5286, Lyon, France; [Tuszynski, Jack A.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Perez-Pineiro, Rolando; Wishart, David] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Wishart, David] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada	University of Alberta; Egyptian Knowledge Bank (EKB); Fayoum University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; University of Alberta; University of Alberta; University of Alberta	Tuszynski, JA (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB, Canada.	jackt@ualberta.ca	Wishart, David Scott/ABI-3181-2020; Tuszynski, Jack/AAA-2073-2020; Jordheim, Lars Petter/X-7228-2019; Pineiro, Rolando Perez/O-7117-2018	Tuszynski, Jack/0000-0001-9976-0429; Jordheim, Lars Petter/0000-0003-3948-7090; Pineiro, Rolando Perez/0000-0001-6107-1898; Wishart, David S/0000-0002-3207-2434; Barakat, Khaled/0000-0002-3567-7279; Dumontet, Charles/0000-0003-1875-134X	Allard Foundation	Allard Foundation	The only source of funding for this project was the Allard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan R, 2001, CURR OPIN CHEM BIOL, V5, P375, DOI 10.1016/S1367-5931(00)00217-9; Amaro RE, 2008, P NATL ACAD SCI USA, V105, P17278, DOI 10.1073/pnas.0805820105; Babakhani A, 2009, COMPUT BIOL CHEM, V33, P160, DOI 10.1016/j.compbiolchem.2008.12.002; Barakat K., 2010, 17 CAN S THEOR CHEM; Barakat K, 2011, DNA REPAIR PATHWAYS; Barakat K.H., 2011, HDB RES COMPUTATIONA; Barakat K, 2010, J MOL GRAPH MODEL, V28, P555, DOI 10.1016/j.jmgm.2009.12.003; Barakat KH, 2009, J MOL GRAPH MODEL, V28, P113, DOI 10.1016/j.jmgm.2009.04.009; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Bellmunt J, 2007, ANN ONCOL, V18, P522, DOI 10.1093/annonc/mdl435; Bennett MJ, 2010, CHEM BIOL, V17, P725, DOI 10.1016/j.chembiol.2010.05.019; Bodenreider C, 2009, ANAL BIOCHEM, V395, P195, DOI 10.1016/j.ab.2009.08.013; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cummings M, 2006, BIOCHEM PHARMACOL, V72, P166, DOI 10.1016/j.bcp.2006.04.025; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Durrant JD, 2010, J MED CHEM, V53, P5025, DOI 10.1021/jm100456a; Durrant JD, 2010, COMPUT BIOL CHEM, V34, P97, DOI 10.1016/j.compbiolchem.2010.03.005; Handra-Luca A, 2007, CLIN CANCER RES, V13, P3855, DOI 10.1158/1078-0432.CCR-07-0252; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jiang H, 1999, CANCER RES, V59, P4529; Jordheim LP, 2005, MOL CANCER THER, V4, P1268, DOI 10.1158/1535-7163.MCT-05-0121; Jun HJ, 2008, BRIT J CANCER, V99, P167, DOI 10.1038/sj.bjc.6604464; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Koberle B, 1999, CURR BIOL, V9, P273, DOI 10.1016/S0960-9822(99)80118-3; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lin JH, 2003, BIOPOLYMERS, V68, P47, DOI 10.1002/bip.10218; Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162; MARKOWITZ M, 2006, 16 INT AIDS C TOR CA; Metzger R, 1998, J CLIN ONCOL, V16, P309, DOI 10.1200/JCO.1998.16.1.309; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nagao A, 2008, BIOCHEM BIOPH RES CO, V370, P301, DOI 10.1016/j.bbrc.2008.03.078; Ni HH, 2001, J MED CHEM, V44, P3043, DOI 10.1021/jm010205y; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Philippopoulos M, 1999, PROTEINS, V36, P87, DOI 10.1002/(SICI)1097-0134(19990701)36:1<87::AID-PROT8>3.0.CO;2-R; Rosenberg E, 2001, CANCER RES, V61, P764; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Routier S, 2005, J MED CHEM, V48, P1401, DOI 10.1021/jm049213f; Routier S, 2001, TETRAHEDRON LETT, V42, P7025, DOI 10.1016/S0040-4039(01)01308-9; Sarasin A, 1999, MUTAT RES-FUND MOL M, V428, P5, DOI 10.1016/S1383-5742(99)00025-3; Schames JR, 2004, J MED CHEM, V47, P1879, DOI 10.1021/jm0341913; Schneider G, 2002, DRUG DISCOV TODAY, V7, P64, DOI 10.1016/S1359-6446(01)02091-8; Shahzad MMK, 2009, DRUG RESIST UPDATE, V12, P148, DOI 10.1016/j.drup.2009.09.001; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; SHOICHET BK, 1993, SCIENCE, V259, P1445, DOI 10.1126/science.8451640; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; WELCOMME N, 1978, ANN PHARM FR, V36, P135; Welsh C, 2004, INT J CANCER, V110, P352, DOI 10.1002/ijc.20134; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q	54	52	52	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51329	10.1371/journal.pone.0051329	http://dx.doi.org/10.1371/journal.pone.0051329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272099	Green Submitted, gold, Green Published			2022-12-25	WOS:000312386800042
J	Dean, D; Turingan, RS; Thomann, HU; Zolotova, A; Rothschild, J; Joseph, SJ; Read, TD; Tan, E; Selden, RF				Dean, Deborah; Turingan, Rosemary S.; Thomann, Hans-Ulrich; Zolotova, Anna; Rothschild, James; Joseph, Sandeep J.; Read, Timothy D.; Tan, Eugene; Selden, Richard F.			A Multiplexed Microfluidic PCR Assay for Sensitive and Specific Point-of-Care Detection of Chlamydia trachomatis	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ACID AMPLIFICATION TESTS; CHAIN-REACTION ASSAY; AMPLICOR-PCR; SEX WORKERS; SCREENING-TESTS; HIGH PREVALENCE; CELL-CULTURE; PERFORMANCE; DIAGNOSIS	Background: Chlamydia trachomatis (Ct) is the most common cause of bacterial sexually transmitted diseases (STD) worldwide. While commercial nucleic acid amplification tests (NAAT) are available for Ct, none are rapid or inexpensive enough to be used at the point-of-care (POC). Towards the first Ct POC NAAT, we developed a microfluidic assay that simultaneously interrogates nine Ct loci in 20 minutes. Methodology and Principal Findings: Endocervical samples were selected from 263 women at high risk for Ct STDs (similar to 35% prevalence). A head-to-head comparison was performed with the Roche-Amplicor NAAT. 129 (49.0%) and 88 (33.5%) samples were positive by multiplex and Amplicor assays, respectively. Sequencing resolved 71 discrepant samples, confirming 53 of 53 positive multiplex samples and 12 of 18 positive Amplicor samples. The sensitivity and specificity were 91.5% and 100%, and 62.4% and 95.9%, respectively, for multiplex and Amplicor assays. Positive and negative predictive values were 100% and 91%, and 94.1% and 68.6%, respectively. Conclusions: This is the first rapid multiplex approach to Ct detection, and the assay was also found to be superior to a commercial NAAT. In effect, nine simultaneous reactions significantly increased sensitivity and specificity. Our assay can potentially increase Ct detection in globally diverse clinical settings at the POC. Citation: Dean D, Turingan RS, Thomann H-U, Zolotova A, Rothschild J, et al. (2012) A Multiplexed Microfluidic PCR Assay for Sensitive and Specific Point-of-Care Detection of Chlamydia trachomatis. PLoS ONE 7(12): e51685. doi: 10.1371/journal.pone.0051685	[Turingan, Rosemary S.; Thomann, Hans-Ulrich; Zolotova, Anna; Tan, Eugene; Selden, Richard F.] NetBio, Waltham, MA USA; [Dean, Deborah; Rothschild, James] Childrens Hosp, Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Dean, Deborah; Rothschild, James] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Dean, Deborah; Rothschild, James] Univ Calif San Francisco, Joint Grad Program Bioengn, Berkeley, CA USA; [Joseph, Sandeep J.; Read, Timothy D.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Joseph, Sandeep J.; Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Emory University; Emory University	Selden, RF (corresponding author), NetBio, Waltham, MA USA.	richard.selden@netbio.com		Joseph, Sandeep/0000-0003-0697-2487; Read, Timothy/0000-0001-8966-9680	Small Business Innovation Research Program Award from the National Institute of Allergy and Infectious Diseases [R43AI084206]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098843, R43AI084206] Funding Source: NIH RePORTER	Small Business Innovation Research Program Award from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by a Small Business Innovation Research Program Award to NetBio (R43AI084206 to DD, TDR and RFS) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TRENDS REP SEX TRANS; Bandea CI, 2009, J CLIN MICROBIOL, V47, P215, DOI 10.1128/JCM.01338-08; BASS CA, 1993, J CLIN MICROBIOL, V31, P2648, DOI 10.1128/JCM.31.10.2648-2653.1993; BAUWENS JE, 1993, J CLIN MICROBIOL, V31, P3023, DOI 10.1128/JCM.31.11.3023-3027.1993; BIANCHI A, 1994, SEX TRANSM DIS, V21, P196, DOI 10.1097/00007435-199407000-00003; CATRY MA, 1995, GENITOURIN MED, V71, P247; Centers for Disease Control and Prevention, 2009, EXP CONS M SUMM REP; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Desai VK, 2003, SEX TRANSM INFECT, V79, P111, DOI 10.1136/sti.79.2.111; Dukers-Muijrers NHTM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034108; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gaydos CA, 2010, J CLIN MICROBIOL, V48, P3236, DOI 10.1128/JCM.01019-10; Gaydos CA, 2005, INFECT DIS CLIN N AM, V19, P367, DOI 10.1016/j.idc.2005.03.006; Gaydos CA, 2004, J CLIN MICROBIOL, V42, P3041, DOI 10.1128/JCM.42.7.3041-3045.2004; Giese H, 2009, J FORENSIC SCI, V54, P1287, DOI 10.1111/j.1556-4029.2009.01200.x; Gill P, 2001, CROAT MED J, V42, P229; Joseph SJ, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-28; Kim AA, 2005, SEX TRANSM DIS, V32, P745, DOI 10.1097/01.olq.0000175384.44106.be; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mahilum-Tapay L, 2007, BMJ-BRIT MED J, V335, P1190, DOI 10.1136/bmj.39402.463854.AE; MAHONY JB, 1994, J CLIN MICROBIOL, V32, P2490, DOI 10.1128/JCM.32.10.2490-2493.1994; McClelland RS, 2005, J INFECT DIS, V191, P333, DOI 10.1086/427262; Moller JK, 2010, J CLIN MICROBIOL, V48, P440, DOI 10.1128/JCM.01446-09; Mulcahy GM, 1998, CLIN CHEM, V44, P1575; Nessa K, 2005, SEX TRANSM DIS, V32, P13, DOI 10.1097/01.olq.0000148298.26228.74; Parra-Sanchez M, 2012, DIAGNOSTIC MICROBIOL; Pasternack R, 1996, J CLIN MICROBIOL, V34, P995, DOI 10.1128/JCM.34.4.995-998.1996; Peeling RW, 2006, SEX TRANSM INFECT, V82, P425, DOI 10.1136/sti.2005.017251; Peterson EM, 1997, J CLIN MICROBIOL, V35, P957, DOI 10.1128/JCM.35.4.957-959.1997; Read TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010595; Sabido M, 2009, J CLIN MICROBIOL, V47, P475, DOI 10.1128/JCM.01975-08; Saison F, 2007, J CLIN MICROBIOL, V45, P4011, DOI 10.1128/JCM.01343-07; Satterwhite C. L., 2011, Morbidity and Mortality Weekly Report, V60, P370; Schachter J, 2008, SEX TRANSM DIS, V35, P637, DOI 10.1097/OLQ.0b013e31817bdd7e; Schwebke JR, 1997, SEX TRANSM DIS, V24, P181, DOI 10.1097/00007435-199704000-00001; SKULNICK M, 1991, J CLIN MICROBIOL, V29, P2086, DOI 10.1128/JCM.29.9.2086-2088.1991; Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11; Toye B, 1996, J CLIN MICROBIOL, V34, P1396, DOI 10.1128/JCM.34.6.1396-1400.1996; Unemo M, 2007, Euro Surveill, V12, pE5; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Watson EJ, 2002, J MED MICROBIOL, V51, P1021, DOI 10.1099/0022-1317-51-12-1021; Yin YP, 2006, SEX TRANSM INFECT, V82, pV33, DOI 10.1136/sti.2006.022475	42	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51685	10.1371/journal.pone.0051685	http://dx.doi.org/10.1371/journal.pone.0051685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272140	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800064
J	Wang, S; Diao, N; Lu, CY; Wu, J; Gao, Y; Chen, JZ; Zhou, ZM; Huang, HQ; Shao, LY; Jin, JL; Weng, XH; Zhang, Y; Zhang, WH				Wang, Sen; Diao, Ni; Lu, Chanyi; Wu, Jing; Gao, Yan; Chen, Jiazhen; Zhou, Zumo; Huang, Heqing; Shao, Lingyun; Jin, Jialin; Weng, Xinhua; Zhang, Ying; Zhang, Wenhong			Evaluation of the Diagnostic Potential of IP-10 and IL-2 as Biomarkers for the Diagnosis of Active and Latent Tuberculosis in a BCG-Vaccinated Population	PLOS ONE			English	Article							GAMMA-INDUCIBLE PROTEIN-10; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; WHOLE-BLOOD; IFN-GAMMA; RELEASE ASSAYS; T-CELLS; INFECTION; RESPONSES; CHILDREN	Background: The Mycobacterium tuberculosis (Mtb)-specific T-cell interferon gamma release assays (IGRAs) are useful in detecting Mtb infection but perform poorly at distinguishing active tuberculosis disease (ATB) and latent tuberculosis infection (LTBI). This study is aimed at evaluating additional cytokines as biomarkers besides interferon-gamma (IFN-gamma) to improve the identification of ATB and LTBI. Methodology/Principal Findings: Sixty-six patients with ATB, 73 household contacts (HHC) of ATB patients and 76 healthy controls (HC) were recruited to undergo QuantiFERON TB GOLD in-tube assay (QFT) and the enzyme-linked immunosorbent assay (ELISA) where the release of IFN-gamma, IFN-gamma inducible protein 10 (IP-10), Interleukin 2 (IL-2) and Tumor Necrosis Factor-alpha (TNF-alpha) was determined in the whole blood with or without antigen-stimulation. The positive rates of the QFT, IP-10 and IL-2 tests were 86.4%, 89.4% and 86.4% for the ATB group with no difference between them (p > 0.05). However, QFT in combination with IP-10 and IL-2 significantly increased the detection rate to 95.5% in the ATB group (p = 0.03) and the indeterminate rate of all samples decreased from 2.3% (5/215) to 0.4% (1/215). The un-stimulated level of IP-10 was significantly higher in the HHC than the ATB and HC groups. The IP-10 responses were strongly associated with extended Mtb exposure time and the degree of smear-positivity of the index cases. The IL-2/IFN-gamma ratio in the antigen-stimulated plasma could discriminate LTBI from ATB with a sensitivity of 77.2% and a specificity of 87.2%. Conclusion: The increased Mtb-specific antigen-stimulated expression of IP-10 and IL-2 may be useful for detecting both ATB and LTBI. Combining the QFT with IP-10 and IL-2 could increase the detection accuracy of active TB over the QFT alone. Citation: Wang S, Diao N, Lu C, Wu J, Gao Y, et al. (2012) Evaluation of the Diagnostic Potential of IP-10 and IL-2 as Biomarkers for the Diagnosis of Active and Latent Tuberculosis in a BCG-Vaccinated Population. PLoS ONE 7(12): e51338. doi:10.1371/journal.pone.0051338	[Wang, Sen; Diao, Ni; Lu, Chanyi; Wu, Jing; Gao, Yan; Chen, Jiazhen; Shao, Lingyun; Jin, Jialin; Weng, Xinhua; Zhang, Ying; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Zhou, Zumo; Huang, Heqing] Peoples Hosp Zhuji, Zhuji, Zhejiang, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Zhang, Ying; Zhang, Wenhong] Fudan Univ, Shanghai Med Coll, MOE Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Zhang, Ying; Zhang, Wenhong] Fudan Univ, Shanghai Med Coll, MOH, Shanghai 200433, Peoples R China; [Zhang, Wenhong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fudan University; Fudan University; Fudan University	Zhang, WH (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China.	yzhang@jhsph.edu; zhangwenhong@fudan.edu.cn	Wu, Jing/GQI-1843-2022	Wu, Jing/0000-0002-1224-0912	Key Technologies Research and Development Program for Infectious Diseases of China [2013ZX10003001-002]; Shanghai Science and Technology Development Funds [10XD1400900, 10QA1401100]; National Natural Science Foundation of China [30901277]; Key Project of Science and Technology of Shanghai [10411955000]	Key Technologies Research and Development Program for Infectious Diseases of China; Shanghai Science and Technology Development Funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai	This work was supported by research grants from the Key Technologies Research and Development Program for Infectious Diseases of China (2013ZX10003001-002), Shanghai Science and Technology Development Funds (10XD1400900, 10QA1401100), National Natural Science Foundation of China (30901277) and the Key Project of Science and Technology of Shanghai (10411955000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039228; Alessandri AL, 2006, INFLAMM RES, V55, P528, DOI 10.1007/s00011-006-5136-9; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Bibova I, 2012, DIAGN MICR INFEC DIS, V72, P68, DOI 10.1016/j.diagmicrobio.2011.09.024; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chakera A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-143; Chen DY, 2011, INT J TUBERC LUNG D, V15, P192; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Kasprowicz VO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020606; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kellar KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026545; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; Lighter-Fisher J, 2010, INT J TUBERC LUNG D, V14, P1548; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Luetkemeyer AF, 2007, AM J RESP CRIT CARE, V175, P737, DOI 10.1164/rccm.200608-1088OC; Matulis G, 2008, ANN RHEUM DIS, V67, P84, DOI 10.1136/ard.2007.070789; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pedersen P A, 1990, Ugeskr Laeger, V152, P828; Petrucci R, 2008, PEDIATR INFECT DIS J, V27, P1073, DOI 10.1097/INF.0b013e31817d05a3; Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Suter-Riniker F, 2011, CLIN VACCINE IMMUNOL; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	45	56	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51338	10.1371/journal.pone.0051338	http://dx.doi.org/10.1371/journal.pone.0051338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272100	Green Submitted, gold, Green Published			2022-12-25	WOS:000312386800043
J	Winther, SO; Thiesson, HC; Poulsen, LN; Chehri, M; Agerskov, H; Tepel, M				Winther, Stine O.; Thiesson, Helle C.; Poulsen, Lene N.; Chehri, Mahtab; Agerskov, Hanne; Tepel, Martin			The Renal Arterial Resistive Index and Stage of Chronic Kidney Disease in Patients with Renal Allograft	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; VASCULAR-RESISTANCE; ULTRASOUND; SURVIVAL; EQUATION	Objective: The study investigated the optimal threshold value of renal arterial resistive index as assessed by Doppler ultrasonography determining chronic kidney disease stage 4 or higher in patients with renal allograft. Methods: In a cross-sectional study the renal arterial resistive index were obtained in interlobar arteries by Doppler ultrasonography in 78 patients with renal allograft. The stage of chronic kidney disease was determined by the estimated glomerular filtration rate equation. Results: The median renal arterial resistive index was 0.61 (interquartile range, 0.56 to 0.66). We observed a significant association between renal arterial resistive index above the upper quartile and chronic kidney disease stage 4 or higher (relative risk, 4.64; 95% confidence interval, 1.71 to 12.55; p = 0.003 by Fisher's exact test). Multivariate logistic regression analysis showed that renal arterial resistive indices (p = 0.02) and time since transplantation (p = 0.04), but not age, gender, or blood pressure were significantly associated with chronic kidney disease stage 4 or higher. Conclusion: A renal arterial resistive index higher than 0.66 may determine the threshold value of chronic kidney disease stage 4 or higher in patients with renal allograft. Citation: Winther SO, Thiesson HC, Poulsen LN, Chehri M, Agerskov H, et al. (2012) The Renal Arterial Resistive Index and Stage of Chronic Kidney Disease in Patients with Renal Allograft. PLoS ONE 7(12): e51772. doi:10.1371/journal.pone.0051772	[Winther, Stine O.; Thiesson, Helle C.; Poulsen, Lene N.; Chehri, Mahtab; Agerskov, Hanne; Tepel, Martin] Odense Univ Hosp, Dept Nephrol, DK-5000 Odense, Denmark; [Tepel, Martin] Univ So Denmark, Inst Mol Med Cardiovasc & Renal Res, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Tepel, M (corresponding author), Odense Univ Hosp, Dept Nephrol, DK-5000 Odense, Denmark.	mtepel@health.sdu.dk	Tepel, Martin/GRS-9581-2022	Tepel, Martin/0000-0002-0086-0997; Agerskov, Hanne/0000-0002-3271-0686	European Union (Interreg 4A) [62-1.2-10]	European Union (Interreg 4A)	This study was supported by European Union (Interreg 4A, number 62-1.2-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlouli A, 2009, UROL J, V6, P194; de Vries APJ, 2006, AM J TRANSPLANT, V6, P364, DOI 10.1111/j.1600-6143.2005.01192.x; Doi Y, 2012, HYPERTENSION, V60, P770, DOI 10.1161/HYPERTENSIONAHA.112.196717; Gaston RS, 2011, CURR OPIN ORGAN TRAN, V16, P594, DOI 10.1097/MOT.0b013e32834c23a7; Gerhart MK, 2010, NEPHROL DIAL TRANSPL, V25, P1294, DOI 10.1093/ndt/gfp631; Ikee R, 2005, AM J KIDNEY DIS, V46, P603, DOI 10.1053/j.ajkd.2005.06.006; Krol R, 2011, TRANSPL P, V43, P2926, DOI 10.1016/j.transproceed.2011.08.019; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin ZY, 2002, ABDOM IMAGING, V28, P230, DOI 10.1007/s00261-002-0024-4; Loock MT, 2010, CLIN J AM SOC NEPHRO, V5, P1867, DOI 10.2215/CJN.01210210; Marcantoni C, 2007, J NEPHROL, V20, P518; McArthur C, 2011, RADIOLOGY, V259, P278, DOI 10.1148/radiol.10101329; MOSTBECK GH, 1991, J ULTRAS MED, V10, P189, DOI 10.7863/jum.1991.10.4.189; Radermacher J, 2003, NEW ENGL J MED, V349, P115, DOI 10.1056/NEJMoa022602; Schnell D, 2012, INTENS CARE MED, V38, P1751, DOI 10.1007/s00134-012-2692-z; Tublin ME, 1999, RADIOLOGY, V213, P258, DOI 10.1148/radiology.213.1.r99oc19258; White CA, 2010, CLIN CHEM, V56, P474, DOI 10.1373/clinchem.2009.135111	17	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51772	10.1371/journal.pone.0051772	http://dx.doi.org/10.1371/journal.pone.0051772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272164	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800080
J	Xue, WY; Ruprecht, C; Street, N; Hematy, K; Chang, C; Frommer, WB; Persson, S; Niittyla, T				Xue, Weiya; Ruprecht, Colin; Street, Nathaniel; Hematy, Kian; Chang, Christine; Frommer, Wolf B.; Persson, Staffan; Niittyla, Totte			Paramutation-Like Interaction of T-DNA Loci in Arabidopsis	PLOS ONE			English	Article							ORIENTED CELL EXPANSION; METHYLATION PATTERNS; EPIGENETIC INHERITANCE; CYTOSINE METHYLATION; DEFENSE RESPONSES; ANCHORED PROTEIN; RNA-POLYMERASE; R1 LOCUS; ZEA-MAYS; MAIZE	In paramutation, epigenetic information is transferred from one allele to another to create a gene expression state which is stably inherited over generations. Typically, paramutation describes a phenomenon where one allele of a gene down-regulates the expression of another allele. Paramutation has been described in several eukaryotes and is best understood in plants. Here we describe an unexpected paramutation-like trans SALK T-DNA interaction in Arabidopsis. Unlike most of the previously described paramutations, which led to gene silencing, the trans SALK T-DNA interaction caused an increase in the transcript levels of the endogenous gene (COBRA) where the T-DNA was inserted. This increased COBRA expression state was stably inherited for several generations and led to the partial suppression of the cobra phenotype. DNA methylation was implicated in this trans SALK T-DNA interaction since mutation of the DNA methyltransferase 1 in the suppressed cobra caused a reversal of the suppression. In addition, null mutants of the DNA demethylase ROS1 caused a similar COBRA transcript increase in the cobra SALK T-DNA mutant as the trans T-DNA interaction. Our results provide a new example of a paramutation-like trans T-DNA interaction in Arabidopsis, and establish a convenient hypocotyl elongation assay to study this phenomenon. The results also alert to the possibility of unexpected endogenous transcript increase when two T-DNAs are combined in the same genetic background. Citation: Xue W, Ruprecht C, Street N, Hematy K, Chang C, et al. (2012) Paramutation-Like Interaction of T-DNA Loci in Arabidopsis. PLoS ONE 7(12): e51651. doi:10.1371/journal.pone.0051651	[Xue, Weiya; Niittyla, Totte] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Ruprecht, Colin; Persson, Staffan] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Street, Nathaniel] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Hematy, Kian] INRA AgroParisTech, Inst Jean Pierre Bourgin, Versailles, France; [Chang, Christine; Frommer, Wolf B.; Niittyla, Totte] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA USA	Swedish University of Agricultural Sciences; Umea University; Max Planck Society; Umea University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Carnegie Institution for Science	Niittyla, T (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden.	totte.niittyla@slu.se	xue, weiya/L-5834-2015; Hématy, Kian/AAD-8989-2021; Frommer, Wolf B/K-5042-2017; Persson, Staffan/S-8399-2016; Street, Nathaniel Robert/B-3920-2008; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Persson, Staffan/0000-0002-6377-5132; Street, Nathaniel Robert/0000-0001-6031-005X; Frommer, Wolf B/0000-0001-6465-0115; Niittyla, Totte/0000-0001-8029-1503; Ruprecht, Colin/0000-0003-4362-2208; Hematy, Kian/0000-0002-3933-3852	Swedish research agency FORMAS; Human Frontier Science Program and Bio4Energy; Swedish Programme for renewable energy	Swedish research agency FORMAS; Human Frontier Science Program and Bio4Energy; Swedish Programme for renewable energy	This work was supported by grants from the Swedish research agency FORMAS, the Human Frontier Science Program and Bio4Energy, the Swedish Programme for renewable energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Baubec T, 2009, PLANT J, V57, P542, DOI 10.1111/j.1365-313X.2008.03699.x; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chandler VL, 2004, NAT REV GENET, V5, P532, DOI 10.1038/nrg1378; COE EH, 1966, GENETICS, V53, P1035; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Dische Z, 1962, METHODS CARBOHYDRATE, P478; Erhard KF, 2011, CURR OPIN PLANT BIOL, V14, P210, DOI 10.1016/j.pbi.2011.02.005; Erhard KF, 2009, SCIENCE, V323, P1201, DOI 10.1126/science.1164508; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Gao YB, 2013, MOL PLANT, V6, P539, DOI 10.1093/mp/sss093; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Haring M, 2010, PLANT J, V63, P366, DOI 10.1111/j.1365-313X.2010.04245.x; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hong SM, 2010, PLANT CELL PHYSL, V51, P1964; Kankel MW, 2003, GENETICS, V163, P1109; Ko JH, 2006, J EXP BOT, V57, P2923, DOI 10.1093/jxb/erl052; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATZKE MA, 1989, EMBO J, V8, P643, DOI 10.1002/j.1460-2075.1989.tb03421.x; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; PATTERSON GI, 1995, GENETICS, V140, P1389; Penterman J, 2007, PLANT PHYSIOL, V145, P1549, DOI 10.1104/pp.107.107730; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Sidorenko L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000725; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Urdvardi MK, 2008, PLANT CELL, V20, P1736; Walker EL, 1998, GENETICS, V148, P1973; Walker EL, 2001, GENETICS, V159, P1201; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	44	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51651	10.1371/journal.pone.0051651	http://dx.doi.org/10.1371/journal.pone.0051651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272131	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800059
J	Qin, B; Chen, TT; Cao, AZ; Wang, HY; Xing, LP; Ling, HQ; Wang, DW; Yu, CM; Xiao, J; Ji, JH; Chen, XL; Chen, PD; Liu, DJ; Wang, XE				Qin, Bi; Chen, Tingting; Cao, Aizhong; Wang, Haiyan; Xing, Liping; Ling, Hongqing; Wang, Daowen; Yu, Chunmei; Xiao, Jin; Ji, Jianhui; Chen, Xueluan; Chen, Peidu; Liu, Dajun; Wang, Xiue			Cloning of a Conserved Receptor-Like Protein Kinase Gene and Its Use as a Functional Marker for Homoeologous Group-2 Chromosomes of the Triticeae Species	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; DISEASE RESISTANCE; DIFFERENTIAL EXPRESSION; HEXAPLOID WHEAT; RICE; ARABIDOPSIS; FAMILY; EVOLUTION; GENOMES; CANCER	Receptor-like kinases (RLKs) play broad biological roles in plants. We report on a conserved receptor-like protein kinase (RPK) gene from wheat and other Triticeae species. The TaRPK1 was isolated from the Triticum aestivum cv. Prins - Triticum timopheevii introgression line IGVI-465 carrying the powdery mildew resistance gene Pm6. The TaRPK1 was mapped to homoeologous chromosomes 2A (TaRPK1-2A), 2D (TaRPK1-2D) and the Pm6-carrier chromosome 2G (TaRPK1-2G) of IGVI-465. Under the tested conditions, only the TaRPK1-2G allele was actively transcribed, producing two distinct transcripts via alternative splicing. The predicted 424-amino acid protein of TaRPK1-2G contained a signal peptide, a transmembrane domain and an intracellular serine/threonine kinase domain, but lacked a typical extracellular domain. The expression of TaRPK1-2G gene was up-regulated upon the infection by Blumeria graminis f.sp. tritici (Bgt) and treatment with methyl jasmonate (MeJA), but down-regulated in response to treatments of SA and ABA. Over-expression of TaRPK1-2G in the powdery mildew susceptible wheat variety Prins by a transient expression assay showed that it slightly reduced the haustorium index of the infected Bgt. These data indicated that TaRPK1-2G participated in the defense response to Bgt infection and in the JA signaling pathway. Phylogenetic analysis indicated that TaRPK1-2G was highly conserved among plant species, and the amino acid sequence similarity of TaRPK1-2G among grass species was more than 86%. Based on its conservation, the RPK gene-based STS primers were designed, and used to amplify the RPK orthologs from the homoeologous group-2 chromosomes of all the tested Triticeae species, such as chromosome 2G of T. timopheevii, 2R of Secale cereale, 2H of Hordeum vulgare, 2S of Aegilops speltoides, 2S(l) of Ae. longissima, 2M(g) of Ae. geniculata, 2S(p) and 2U(p) of Ae. peregrina. The developed STS markers serve as conserved functional markers for the identification of homoeologous group-2 chromosomes of the Triticeae species. Citation: Qin B, Chen T, Cao A, Wang H, Xing L, et al. (2012) Cloning of a Conserved Receptor-Like Protein Kinase Gene and Its Use as a Functional Marker for Homoeologous Group-2 Chromosomes of the Triticeae Species. PLoS ONE 7(12): e49718. doi:10.1371/journal.pone.0049718	[Qin, Bi; Chen, Tingting; Cao, Aizhong; Wang, Haiyan; Xing, Liping; Xiao, Jin; Ji, Jianhui; Chen, Xueluan; Chen, Peidu; Liu, Dajun; Wang, Xiue] Nanjing Agr Univ, Cytogenet Inst, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Ling, Hongqing; Wang, Daowen; Yu, Chunmei] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Qin, Bi] Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Key Lab Biol & Genet Resources Rubber Tree, Danzhou, Hainan, Peoples R China	Nanjing Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Wang, XE (corresponding author), Nanjing Agr Univ, Cytogenet Inst, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	xiuew@njau.edu.cn	Ling, Hong-Qing/ABC-9451-2020	wang, dao wen/0000-0002-6230-8735	Chinese High Tech Program of China [2011AA1001]; Natural Science Foundation of Jiangsu Province [BK2006720]; Important National Science and Technology Specific Projects of Transgenic Research [2011ZX08002-001]; Program of Introducing Talents of Discipline [B08025]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Ministry of Science and Technology of China [2011BAD07B02-2]	Chinese High Tech Program of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Important National Science and Technology Specific Projects of Transgenic Research; Program of Introducing Talents of Discipline; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by grants from the Chinese High Tech Program of China (No. 2011AA1001), the Natural Science Foundation of Jiangsu Province (No. BK2006720), Important National Science and Technology Specific Projects of Transgenic Research (No. 2011ZX08002-001), the Program of Introducing Talents of Discipline to Universities (No. B08025) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). Research in Daowen Wang's group is supported in part by a grant (2011BAD07B02-2) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2006, HUM MOL GENET, V15, P777, DOI 10.1093/hmg/ddi492; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Dong LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013548; Egawa C, 2006, GENES GENET SYST, V81, P77, DOI 10.1266/ggs.81.77; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Feuillet C, 1998, PLANT MOL BIOL, V37, P943, DOI 10.1023/A:1006062016593; Feuillet C, 1997, PLANT J, V11, P45, DOI 10.1046/j.1365-313X.1997.11010045.x; Feuillet C, 2001, PLANT PHYSIOL, V125, P1304, DOI 10.1104/pp.125.3.1304; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; [郭志爱 GUO Zhi-Ai], 2009, [作物学报, Acta Agronomica Sinica], V35, P1764; Ji JH, 2008, EUPHYTICA, V163, P159, DOI 10.1007/s10681-007-9578-0; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li Qiang, 2005, Yichuan, V27, P808; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Park YJ, 2004, MOL CELLS, V17, P492; Qin B, 2011, THEOR APPL GENET, V123, P207, DOI 10.1007/s00122-011-1577-9; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Shirasu K, 1999, PLANT J, V17, P293, DOI 10.1046/j.1365-313X.1999.00376.x; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Soleymanlou N, 2005, CELL DEATH DIFFER, V12, P441, DOI 10.1038/sj.cdd.4401593; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Song YZ, 1995, NATURE, V373, P536; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tan EK, 2005, NEUROGENETICS, V6, P179, DOI 10.1007/s10048-005-0001-5; Tao W, 2000, THEOR APPL GENET, V100, P564, DOI 10.1007/s001220050074; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Torii KU, 2000, ADV BOT RES, V32, P225, DOI 10.1016/S0065-2296(00)32026-2; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; WALKER JC, 1993, PLANT J, V3, P451, DOI 10.1046/j.1365-313X.1993.t01-23-00999.x; WALKER JC, 1994, PLANT MOL BIOL, V26, P1599, DOI 10.1007/BF00016492; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474; Zhang XC, 2007, PLANT PHYSIOL, V145, P1577, DOI 10.1104/pp.107.108720; Zhou HB, 2007, PLANT J, V52, P420, DOI 10.1111/j.1365-313X.2007.03246.x	43	4	4	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e49718	10.1371/journal.pone.0049718	http://dx.doi.org/10.1371/journal.pone.0049718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272050	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600004
J	Tristan, A; Rasigade, JP; Ruizendaal, E; Laurent, F; Bes, M; Meugnier, H; Lina, G; Etienne, J; Celard, M; Tattevin, P; Monecke, S; Le Moing, V; Vandenesch, F				Tristan, Anne; Rasigade, Jean-Philippe; Ruizendaal, Esmee; Laurent, Frederic; Bes, Michele; Meugnier, Helene; Lina, Gerard; Etienne, Jerome; Celard, Marie; Tattevin, Pierre; Monecke, Stefan; Le Moing, Vincent; Vandenesch, Francois		French AEPEI Study Grp Infective E	Rise of CC398 Lineage of Staphylococcus aureus among Infective Endocarditis Isolates Revealed by Two Consecutive Population-Based Studies in France	PLOS ONE			English	Article							METHICILLIN-RESISTANT; MORTALITY; GENOTYPE; CRITERIA; CLFA	Staphylococcus aureus isolates from two prospective studies on infective endocarditis (IE) conducted in 1999 and 2008 and isolated from non-IE bacteremia collected in 2006 were spa-typed and their virulence factors were analyzed with a microarray. Both populations were genetically diverse, with no virulence factors or genotypes significantly more associated with the IE isolates compared with the non-IE isolates. The population structure of the IE isolates did not change much between 1999 and 2008, with the exception of the appearance of CC398 methicillin-susceptible Staphylococcus aureus (MSSA) isolates responsible for 5.6% of all cases in 2008. In 1999, this lineage was responsible for no cases. The increasing prevalence of S. aureus in IE is apparently not the result of a major change in staphylococcal population structure over time, with the exception of the emerging CC398 MSSA lineage. Citation: Tristan A, Rasigade J-P, Ruizendaal E, Laurent F, Bes M, et al. (2012) Rise of CC398 Lineage of Staphylococcus aureus among Infective Endocarditis Isolates Revealed by Two Consecutive Population-Based Studies in France. PLoS ONE 7(12): e51172. doi:10.1371/journal.pone.0051172	[Tristan, Anne; Rasigade, Jean-Philippe; Ruizendaal, Esmee; Laurent, Frederic; Bes, Michele; Meugnier, Helene; Lina, Gerard; Etienne, Jerome; Celard, Marie; Vandenesch, Francois] Hosp Civils Lyon, Ctr Natl Reference Staphylocoques, Bron, France; [Tristan, Anne; Rasigade, Jean-Philippe; Laurent, Frederic; Bes, Michele; Lina, Gerard; Etienne, Jerome; Vandenesch, Francois] Univ Lyon, Domaine Buire, Lyon, France; [Tristan, Anne; Rasigade, Jean-Philippe; Laurent, Frederic; Bes, Michele; Lina, Gerard; Etienne, Jerome; Vandenesch, Francois] INSERM, U851, Bacterial Pathogenesis & Innate Immun Lab, F-69008 Lyon, France; [Tattevin, Pierre] Pontchaillou Univ Hosp, Infect Dis & Intens Care Unit, Rennes, France; [Monecke, Stefan] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Le Moing, Vincent] Hop Gui de Chauliac, Dept Malad Infect & Trop, Montpellier, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Technische Universitat Dresden; Universite de Montpellier; CHU de Montpellier	Tristan, A (corresponding author), Hosp Civils Lyon, Ctr Natl Reference Staphylocoques, Bron, France.	anne.tristan@univ-lyon1.fr	Laurent, Frederic/M-4719-2014; Rasigade, Jean-Philippe/L-9320-2014; Lina, Gerard J/L-9352-2014; TRISTAN, Anne/GSN-8306-2022; ETIENNE, Jerome/C-5471-2014; Ruizendaal, Esmée/AAG-6157-2020; Tristan, Anne/L-9464-2014; Vandenesch, Francois/C-7209-2014; Rasigade, Jean-Philippe/AAE-1667-2021; LAURENT, Frederic/AGM-0706-2022	Rasigade, Jean-Philippe/0000-0002-8264-0452; TRISTAN, Anne/0000-0001-9471-2655; ETIENNE, Jerome/0000-0002-3348-3315; Vandenesch, Francois/0000-0001-9412-7106; Lina, Gerard/0000-0002-9236-7998; Le Moing, Vincent/0000-0002-9529-2792; laurent, frederic/0000-0003-0609-9091	Programme Hospitalier de Recherche Clinique (clinical research program); French Ministry of Health	Programme Hospitalier de Recherche Clinique (clinical research program); French Ministry of Health	The study was supported by a Programme Hospitalier de Recherche Clinique (clinical research program) funded by the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Chang FY, 2003, MEDICINE, V82, P322, DOI 10.1097/01.md.0000091185.93122.40; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; Entenza JM, 2005, INFECT IMMUN, V73, P990, DOI 10.1128/IAI.73.2.990-998.2005; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hienz SA, 1996, J INFECT DIS, V174, P83, DOI 10.1093/infdis/174.1.83; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Kaasch AJ, 2011, CLIN INFECT DIS, V53, P1, DOI 10.1093/cid/cir320; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rijnders MIA, 2009, J CLIN MICROBIOL, V47, P4090, DOI 10.1128/JCM.00820-09; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; Thuny F, 2010, EUR HEART J, V31, P1826, DOI 10.1093/eurheartj/ehq154; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09	31	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51172	10.1371/journal.pone.0051172	http://dx.doi.org/10.1371/journal.pone.0051172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272091	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600019
J	Wang, N; Zhou, Y; Jiang, L; Li, DH; Yang, JW; Zhang, CY; Zen, K				Wang, Nan; Zhou, Yang; Jiang, Lei; Li, Donghai; Yang, Junwei; Zhang, Chen-Yu; Zen, Ke			Urinary MicroRNA-10a and MicroRNA-30d Serve as Novel, Sensitive and Specific Biomarkers for Kidney Injury	PLOS ONE			English	Article							CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; IDENTIFICATION; EXPRESSION; DIAGNOSIS; DISEASE; TARGETS; CANCER; SERUM	The steadily increasing incidence of kidney injury is a significant threat to human health. The current tools available for the early detection of kidney injury, however, have limited sensitivity or specificity. Thus, the development of novel biomarkers to detect early kidney injury is of high importance. Employing mouse renal ischemia-reperfusion and streptozotocin (STZ)-induced renal injury as acute and chronic kidney injury model, respectively, we assessed the alteration of microRNA (miRNA) in mouse urine, serum and kidney tissue by TaqMan probe-based qRT-PCR assay. Our results demonstrated that kidney-enriched microRNA-10a (miR-10a) and microRNA-30d (miR-30d) were readily detected in mouse urine and the levels of urinary miR-10a and miR-30d were positively correlated with the degree of kidney injury induced by renal ischemia-reperfusion or STZ diabetes. In contrast, no such alteration of miR-10a and miR-30d levels was observed in mouse serum after kidney injury. Compared with the blood urea nitrogen (BUN) assay, the test for urinary miR-10a and miR-30d levels was more sensitive for the detection of acute kidney injury. Furthermore, the substantial elevation of the urinary miR-10a and miR-30d levels was also observed in focal segmental glomerulosclerosis (FSGS) patients compared to healthy donors. In conclusion, the present study collectively demonstrates that urinary miR-10a and miR-30d represent a novel noninvasive, sensitive, specific and potentially high-throughput method for detecting renal injury. Citation: Wang N, Zhou Y, Jiang L, Li D, Yang J, et al. (2012) Urinary MicroRNA-10a and MicroRNA-30d Serve as Novel, Sensitive and Specific Biomarkers for Kidney Injury. PLoS ONE 7(12): e51140. doi:10.1371/journal.pone.0051140	[Wang, Nan; Li, Donghai; Zhang, Chen-Yu; Zen, Ke] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Zhou, Yang; Jiang, Lei; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Res Ctr Nephrol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn; cyzhang@nju.edu.cn; kzen@nju.edu.cn			National Basic Research Program of China (973 Program) [2012CB517603, 2011CB504803]; National Natural Science Foundation of China [30988003, 30890044, 30800946, 30871019, 30890032, 31071232, 31000323, 90608010, 90813035]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (No. 2012CB517603, 2011CB504803), the grants from the National Natural Science Foundation of China (Nos. 30988003, 30890044, 30800946, 30871019, 30890032, 31071232, 31000323, 90608010 and 90813035), and the Natural Science Foundation of Jiangsu Province (BK2011013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chow FY, 2006, KIDNEY INT, V69, P73, DOI 10.1038/sj.ki.5000014; Contu R, 2010, CIRC RES, V107, P573, DOI 10.1161/CIRCRESAHA.110.227983; Dieterle F, 2008, CURR OPIN DRUG DISC, V11, P60; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Hewitt SM, 2004, J AM SOC NEPHROL, V15, P1677, DOI 10.1097/01.ASN.0000129114.92265.32; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Ho J, 2011, J AM SOC NEPHROL, V22, P1053, DOI 10.1681/ASN.2010080841; Jiang T, 2010, DIABETES, V59, P850, DOI 10.2337/db09-1342; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Kumar S, 2009, J AM SOC NEPHROL, V20, P2412, DOI 10.1681/ASN.2008080868; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li N, 2012, CANCER RES, V72, P154, DOI 10.1158/0008-5472.CAN-11-2484; Lorenzen JM, 2011, AM J TRANSPLANT, V11, P2221, DOI 10.1111/j.1600-6143.2011.03679.x; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Wang G, 2012, LUPUS, V21, P1190; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Westhuyzen J, 2003, NEPHROL DIAL TRANSPL, V18, P543, DOI 10.1093/ndt/18.3.543; Xue XC, 2011, J IMMUNOL, V187, P5879, DOI 10.4049/jimmunol.1100535; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215	35	61	78	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51140	10.1371/journal.pone.0051140	http://dx.doi.org/10.1371/journal.pone.0051140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272089	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386600018
J	Dahl, JU; Radon, C; Buhning, M; Nimtz, M; Leichert, LI; Denis, Y; Jourlin-Castelli, C; Iobbi-Nivol, C; Mejean, V; Leimkuhler, S				Dahl, Jan-Ulrik; Radon, Christin; Buehning, Martin; Nimtz, Manfred; Leichert, Lars I.; Denis, Yann; Jourlin-Castelli, Cecile; Iobbi-Nivol, Chantal; Mejean, Vincent; Leimkuehler, Silke			The Sulfur Carrier Protein TusA Has a Pleiotropic Role in Escherichia coli That Also Affects Molybdenum Cofactor Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; MOLYBDOPTERIN SYNTHASE; CONVERTING FACTOR; SULFITE OXIDASE; EXPRESSION; GENE; IDENTIFICATION; FNR; REDUCTASE; PATHWAYS	The Escherichia coli L-cysteine desulfurase IscS mobilizes sulfur from L-cysteine for the synthesis of several biomolecules such as iron-sulfur (FeS) clusters, molybdopterin, thiamin, lipoic acid, biotin, and the thiolation of tRNAs. The sulfur transfer from IscS to various biomolecules is mediated by different interaction partners (e.g. TusA for thiomodification of tRNAs, IscU for FeS cluster biogenesis, and ThiI for thiamine biosynthesis/tRNA thiolation), which bind at different sites of IscS. Transcriptomic and proteomic studies of a Delta tusA strain showed that the expression of genes of the moaABCDE operon coding for proteins involved in molybdenum cofactor biosynthesis is increased under aerobic and anaerobic conditions. Additionally, under anaerobic conditions the expression of genes encoding hydrogenase 3 and several molybdoenzymes such as nitrate reductase were also increased. On the contrary, the activity of all molydoenzymes analyzed was significantly reduced in the Delta tusA mutant. Characterization of the Delta tusA strain under aerobic conditions showed an overall low molybdopterin content and an accumulation of cyclic pyranopterin monophosphate. Under anaerobic conditions the activity of nitrate reductase was reduced by only 50%, showing that TusA is not essential for molybdenum cofactor biosynthesis. We present a model in which we propose that the direction of sulfur transfer for each sulfur-containing biomolecule is regulated by the availability of the interaction partner of IscS. We propose that in the absence of TusA, more IscS is available for FeS cluster biosynthesis and that the overproduction of FeS clusters leads to a modified expression of several genes.	[Dahl, Jan-Ulrik; Radon, Christin; Buehning, Martin; Leimkuehler, Silke] Univ Potsdam, Dept Mol Enzymol, Inst Biochem & Biol, D-14476 Golm, Germany; [Nimtz, Manfred] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Leichert, Lars I.] Ruhr Univ Bochum, Med Proteom Ctr, Redox Prote Grp, D-44780 Bochum, Germany; [Denis, Yann] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee FR3479, F-13402 Marseille 20, France; [Jourlin-Castelli, Cecile; Iobbi-Nivol, Chantal; Mejean, Vincent] Aix Marseille Univ, CNRS, Lab Chim Bacterienne UMR7283, F-13402 Marseille 20, France	University of Potsdam; Helmholtz Association; Helmholtz-Center for Infection Research; Ruhr University Bochum; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Leimkuhler, S (corresponding author), Univ Potsdam, Dept Mol Enzymol, Inst Biochem & Biol, D-14476 Golm, Germany.	sleim@uni-potsdam.de	Dahl, Jan-Ulrik/J-1893-2019; Leichert, Lars I./B-4762-2009; Dahl, Jan-Ulrik/J-4970-2017	Dahl, Jan-Ulrik/0000-0001-8597-7416; Leichert, Lars I./0000-0002-5666-9681; Dahl, Jan-Ulrik/0000-0002-4164-6129; Leimkuhler, Silke/0000-0003-3238-2122; Mejean, Vincent/0000-0001-6533-5846; Jourlin-Castelli, Cecile/0000-0001-8581-2590	Deutsche Forschungsgemeinschaft [LE1171/5-3]; DAAD (German Academic Exchange Program)-PROCOPE program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD (German Academic Exchange Program)-PROCOPE program(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Deutsche Forschungsgemeinschaft Grant LE1171/5-3 (to S.L.). The exchange of researchers among the laboratories involved in the work was funded by the DAAD (German Academic Exchange Program)-PROCOPE program (to C.I.-N. and S.L.).	Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Dahl JU, 2011, J BIOL CHEM, V286, P35801, DOI 10.1074/jbc.M111.282368; Dietzel U, 2009, J BIOL CHEM, V284, P8759, DOI 10.1074/jbc.M808114200; Dos Santos PC, 2007, J BACTERIOL, V189, P2854, DOI 10.1128/JB.01734-06; ERASO JM, 1992, J BACTERIOL, V174, P5101, DOI 10.1128/JB.174.15.5101-5109.1992; Flint DH, 1996, J BIOL CHEM, V271, P16068; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garrett RM, 1996, J BIOL CHEM, V271, P7387, DOI 10.1074/jbc.271.13.7387; Genest O, 2006, FEMS MICROBIOL LETT, V265, P51, DOI 10.1111/j.1574-6968.2006.00468.x; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hidese R, 2011, APPL MICROBIOL BIOT, V91, P47, DOI 10.1007/s00253-011-3336-x; Hilton JC, 1996, ARCH BIOCHEM BIOPHYS, V325, P139, DOI 10.1006/abbi.1996.0017; Iannuzzi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021992; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; IobbiNivol C, 1996, BBA-PROTEIN STRUCT M, V1294, P77, DOI 10.1016/0167-4838(95)00271-5; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Katoh E, 2000, J MOL BIOL, V304, P219, DOI 10.1006/jmbi.2000.4170; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Maynard ND, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.101; Moore LJ, 2001, J BIOL CHEM, V276, P45744, DOI 10.1074/jbc.M106569200; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Neumann M, 2007, BIOCHEMISTRY-US, V46, P9586, DOI 10.1021/bi700630p; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Neumann M, 2009, FEBS J, V276, P2762, DOI 10.1111/j.1742-4658.2009.07000.x; PITTERLE DM, 1989, J BACTERIOL, V171, P3373, DOI 10.1128/jb.171.6.3373-3378.1989; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rajagopalan KV, 1996, ESCHERICHIA COLI SAL, P674; Reinhart F, 2008, J BACTERIOL, V190, P879, DOI 10.1128/JB.01374-07; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schmitz J, 2007, BIOCHEMISTRY-US, V46, P909, DOI 10.1021/bi062011w; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; SYLVERS LA, 1993, BIOCHEMISTRY-US, V32, P3836, DOI 10.1021/bi00066a002; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; UNDEN G, 1995, ARCH MICROBIOL, V164, P81; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Yamashino T, 1998, J BACTERIOL, V180, P2257, DOI 10.1128/JB.180.8.2257-2261.1998; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172	54	46	48	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5426	5442		10.1074/jbc.M112.431569	http://dx.doi.org/10.1074/jbc.M112.431569			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23281480	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000315342500018
J	Kummarapurugu, AB; Fischer, BM; Zheng, S; Milne, GL; Ghio, AJ; Potts-Kant, EN; Foster, WM; Soderblom, EJ; Dubois, LG; Moseley, MA; Thompson, JW; Voynow, JA				Kummarapurugu, Apparao B.; Fischer, Bernard M.; Zheng, Shuo; Milne, Ginger L.; Ghio, Andrew J.; Potts-Kant, Erin N.; Foster, W. Michael; Soderblom, Erik J.; Dubois, Laura G.; Moseley, M. Arthur; Thompson, J. Will; Voynow, Judith A.			NADPH: Quinone Oxidoreductase 1 Regulates Host Susceptibility to Ozone via Isoprostane Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BRONCHIAL EPITHELIAL-CELLS; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; IN-VITRO; IL-8 EXPRESSION; ALPHA KINASE; CYSTEINE 179; TNF-ALPHA; IKK-BETA	NADPH: quinone oxidoreductase 1 (NQO1) is recognized as a major susceptibility gene for ozone-induced pulmonary toxicity. In the absence of NQO1 as can occur by genetic mutation, the human airway is protected from harmful effects of ozone. We recently reported that NQO1-null mice are protected from airway hyperresponsiveness and pulmonary inflammation following ozone exposure. However, NQO1 regenerates intracellular antioxidants and therefore should protect the individual from oxidative stress. To explain this paradox, we tested whether in the absence of NQO1 ozone exposure results in increased generation of A(2)-isoprostane, a cyclopentenone isoprostane that blunts inflammation. Using GC-MS, we found that NQO1-null mice had greater lung tissue levels of D-2- and E-2-isoprostanes, the precursors of J(2)- and A(2)-isoprostanes, both at base line and following ozone exposure compared with congenic wild-type mice. We confirmed in primary cultures of normal human bronchial epithelial cells that A(2)-isoprostane inhibited ozone-induced NF-kappa B activation and IL-8 regulation. Furthermore, we determined that A(2)-isoprostane covalently modified the active Cys(179) domain in inhibitory kappa B kinase in the presence of ozone in vitro, thus establishing the biochemical basis for A(2)-isoprostane inhibition of NF-kappa B. Our results demonstrate that host factors may regulate pulmonary susceptibility to ozone by regulating the generation of A(2)-isoprostanes in the lung. These observations provide the biochemical basis for the epidemiologic observation that NQO1 regulates pulmonary susceptibility to ozone.	[Kummarapurugu, Apparao B.; Fischer, Bernard M.; Zheng, Shuo; Voynow, Judith A.] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Pulm & Sleep Med, Durham, NC 27710 USA; [Potts-Kant, Erin N.; Foster, W. Michael] Duke Univ, Med Ctr, Div Pulm Med, Dept Med, Durham, NC 27710 USA; [Soderblom, Erik J.; Dubois, Laura G.; Moseley, M. Arthur; Thompson, J. Will] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Milne, Ginger L.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Milne, Ginger L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Ghio, Andrew J.] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA	Duke University; Duke University; Duke University; Vanderbilt University; Vanderbilt University; United States Environmental Protection Agency	Voynow, JA (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Pediat Pulm & Sleep Med, Box 102360, Durham, NC 27710 USA.	voyno001@mc.duke.edu	Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X	National Institutes of Health [R01 ES016836]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 ES016836.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; [Anonymous], 1996, Am J Respir Crit Care Med, V153, P477; AWAD JA, 1993, J BIOL CHEM, V268, P4161; Bayram H, 2001, J ALLERGY CLIN IMMUN, V107, P287, DOI 10.1067/mai.2001.111141; Bergamaschi E, 2001, AM J RESP CRIT CARE, V163, P1426, DOI 10.1164/ajrccm.163.6.2006056; Chen C, 2007, EUR RESPIR J, V30, P677, DOI 10.1183/09031936.00160806; Corradi M, 2002, TOXICOL LETT, V134, P219, DOI 10.1016/S0378-4274(02)00169-8; David GL, 2003, AM J RESP CRIT CARE, V168, P1199, DOI 10.1164/rccm.200305-684OC; DEVLIN RB, 1994, AM J PHYSIOL, V266, pL612, DOI 10.1152/ajplung.1994.266.6.L612; Fakhrzadeh L, 2004, AM J PHYSIOL-LUNG C, V287, pL279, DOI 10.1152/ajplung.00348.2003; Farias SE, 2008, J LIPID RES, V49, P1990, DOI 10.1194/jlr.M800200-JLR200; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Foster WM, 2000, J APPL PHYSIOL, V89, P1804, DOI 10.1152/jappl.2000.89.5.1804; Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984; Harikumar KB, 2009, BLOOD, V113, P2003, DOI 10.1182/blood-2008-04-151944; Janssen LJ, 2001, AM J PHYSIOL-LUNG C, V280, pL1067, DOI 10.1152/ajplung.2001.280.6.L1067; Janssen LJ, 2005, ANTIOXID REDOX SIGN, V7, P244, DOI 10.1089/ars.2005.7.244; Janssen-Heininger Yvonne M W, 2009, Proc Am Thorac Soc, V6, P249, DOI 10.1513/pats.200806-054RM; Jaspers I, 1997, AM J PHYSIOL-LUNG C, V272, pL504, DOI 10.1152/ajplung.1997.272.3.L504; Kafoury RM, 2007, ENVIRON TOXICOL, V22, P159, DOI 10.1002/tox.20246; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Krunkosky TM, 2003, FREE RADICAL BIO MED, V35, P1158, DOI 10.1016/S0891-5849(03)00498-2; Lappas M, 2007, FREE RADICAL BIO MED, V42, P1791, DOI 10.1016/j.freeradbiomed.2007.03.009; LEIKAUF GD, 1995, ENVIRON HEALTH PERSP, V103, P91, DOI 10.2307/3432455; Milne GL, 2005, BIOMARKERS, V10, pS10, DOI 10.1080/13547500500216546; Milne GL, 2005, ANTIOXID REDOX SIGN, V7, P210, DOI 10.1089/ars.2005.7.210; Morrow JD, 1998, ARCH BIOCHEM BIOPHYS, V353, P160, DOI 10.1006/abbi.1998.0645; Musiek ES, 2005, LIPIDS, V40, P987, DOI 10.1007/s11745-005-1460-7; Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200; Nichols BG, 2001, TOXICOL SCI, V60, P356, DOI 10.1093/toxsci/60.2.356; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Peden DB, 2005, J ALLERGY CLIN IMMUN, V115, P213, DOI 10.1016/j.jaci.2004.12.003; PRYOR WA, 1995, FREE RADICAL BIO MED, V19, P935, DOI 10.1016/0891-5849(95)02033-7; Reich EE, 2001, AM J PATHOL, V158, P293, DOI 10.1016/S0002-9440(10)63968-5; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Ross D, 2004, METHOD ENZYMOL, V382, P115; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rusznak C, 1996, EUR RESPIR J, V9, P2298, DOI 10.1183/09031936.96.09112298; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Siegel D, 1998, CLIN CANCER RES, V4, P2065; Son PS, 2010, CARCINOGENESIS, V31, P1442, DOI 10.1093/carcin/bgq099; Trasande L, 2005, J ALLERGY CLIN IMMUN, V115, P689, DOI 10.1016/j.jaci.2005.01.056; Valacchi G, 2005, ANTIOXID REDOX SIGN, V7, P25, DOI 10.1089/ars.2005.7.25; Voynow JA, 2004, AM J PHYSIOL-LUNG C, V287, pL1293, DOI 10.1152/ajplung.00140.2004; Voynow JA, 2009, AM J RESP CELL MOL, V41, P107, DOI 10.1165/rcmb.2008-0381OC; Zheng S, 2007, FREE RADICAL BIO MED, V42, P1398, DOI 10.1016/j.freeradbiomed.2007.01.040	47	5	5	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4681	4691		10.1074/jbc.M112.438440	http://dx.doi.org/10.1074/jbc.M112.438440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23275341	hybrid, Green Published			2022-12-25	WOS:000315340400017
J	Golla, K; Cherukuvada, B; Ahmed, F; Kondapi, AK				Golla, Kishore; Cherukuvada, Bhaskar; Ahmed, Farhan; Kondapi, Anand K.			Efficacy, Safety and Anticancer Activity of Protein Nanoparticle-Based Delivery of Doxorubicin through Intravenous Administration in Rats	PLOS ONE			English	Article							SOLID LIPID NANOPARTICLES; PRIMARY LIVER-CANCER; HEPATOCELLULAR-CARCINOMA; TISSUE DISTRIBUTION; NON-STEALTH; PHARMACOKINETICS; DRUG; CHEMOEMBOLIZATION; POLYMERSOMES; IRON	Background and Aims: Doxorubicin is a potent anticancer drug and a major limiting factor that hinders therapeutic use as its high levels of systemic circulation often associated with various off-target effects, particularly cardiotoxicity. The present study focuses on evaluation of the efficacy of doxorubicin when it is loaded into the protein nanoparticles and delivered intravenously in rats bearing Hepatocellular carcinoma (HCC). The proteins selected as carrier were Apotransferrin and Lactoferrin, since the receptors for these two proteins are known to be over expressed on cancer cells due to their iron transport capacity. Methods: Doxorubicin loaded apotransferrin (Apodoxonano) and lactoferrin nanoparticles (Lactodoxonano) were prepared by sol-oil chemistry. HCC in the rats was induced by 100 mg/l of diethylnitrosamine (DENA) in drinking water for 8 weeks. Rats received 5 doses of 2 mg/kg drug equivalent nanoparticles through intravenous administration. Pharmacokinetics and toxicity of nanoformulations was evaluated in healthy rats and anticancer activity was studied in DENA treated rats. The anticancer activity was evaluated through counting of the liver nodules, H & E analysis and by estimating the expression levels of angiogenic and antitumor markers. Results: In rats treated with nanoformulations, the numbers of liver nodules were found to be significantly reduced. They showed highest drug accumulation in liver (22.4 and 19.5 mu g/g). Both nanoformulations showed higher localization compared to doxorubicin (Doxo) when delivered in the absence of a carrier. Higher amounts of Doxo (195 mu g/g) were removed through kidney, while Apodoxonano and Lactodoxonano showed only a minimal amount of removal (<40 mu g/g), suggesting the extended bioavailability of Doxo when delivered through nanoformulation. Safety analysis shows minimal cardiotoxicity due to lower drug accumulation in heart in the case of nanoformulation. Conclusion: Drug delivery through nanoformulations not only minimizes the cardiotoxicity of doxorubicin but also enhances the efficacy and bioavailability of the drug in a target-specific manner.	[Cherukuvada, Bhaskar; Ahmed, Farhan; Kondapi, Anand K.] Univ Hyderabad, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Golla, Kishore; Kondapi, Anand K.] Univ Hyderabad, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Golla, Kishore; Kondapi, Anand K.] Univ Hyderabad, Ctr Nanotechnol, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad; University of Hyderabad	Kondapi, AK (corresponding author), Univ Hyderabad, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India.	akondapi@gmail.com		Ahmed, Farhan/0000-0002-3420-5405	Department of Science and Technology, Government of India; Department of Biotechnology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work is carried out in a research project funded by the Department of Science and Technology, and Department of Biotechnology, Government of India through research projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1973, P NATL ACAD SCI USA, V70, P1968, DOI 10.1073/pnas.70.7.1968; Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012; Al-Abd AM, 2010, J CONTROL RELEASE, V142, P101, DOI 10.1016/j.jconrel.2009.10.003; Alhareth K, 2012, EUR J PHARM BIOPHARM, V81, P453, DOI 10.1016/j.ejpb.2012.03.009; Ayen WY, 2012, PHARM RES; Bae S, 2012, BIOMATERIALS, V33, P1536, DOI 10.1016/j.biomaterials.2011.10.050; Borbath I, 2010, CHEM-BIOL INTERACT, V183, P238, DOI 10.1016/j.cbi.2009.10.011; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cao H, 2011, HEPATOLOGY, V54, P1819, DOI 10.1002/hep.24572; CHIANNILKULACHAI N, 1990, CANCER CHEMOTH PHARM, V26, P122, DOI 10.1007/BF02897257; CHIANNILKULCHAI N, 1989, SELECT CANCER THER, V5, P1, DOI 10.1089/sct.1989.5.1; COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034; COLOMBO M, 1989, LANCET, V2, P1006; FALKSON G, 1978, CANCER, V42, P2149, DOI 10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5; Fiume L, 2005, J HEPATOL, V43, P645, DOI 10.1016/j.jhep.2005.02.045; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Fundaro A, 2000, PHARMACOL RES, V42, P337, DOI 10.1006/phrs.2000.0695; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon AA, 2001, CANCER INVEST, V19, P424, DOI 10.1081/CNV-100103136; Hamad I, 2008, EXPERT OPIN DRUG DEL, V5, P205, DOI 10.1517/17425247.5.2.205; Holmstrom P, 2006, LIVER INT, V26, P976, DOI 10.1111/j.1478-3231.2006.01316.x; Kataoka K, 2000, J CONTROL RELEASE, V64, P143, DOI 10.1016/S0168-3659(99)00133-9; Krishna ADS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007240; Li XM, 2009, INT J PHARMACEUT, V373, P116, DOI 10.1016/j.ijpharm.2009.01.023; Lin HL, 2000, CANCER-AM CANCER SOC, V89, P983, DOI 10.1002/1097-0142(20000901)89:5<983::AID-CNCR7>3.3.CO;2-7; Lin RY, 2005, BIOMATERIALS, V26, P4476, DOI 10.1016/j.biomaterials.2004.11.014; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; MORGAN EH, 1986, BIOCHEM J, V237, P163, DOI 10.1042/bj2370163; OKADA S, 1993, ONCOLOGY, V50, P22; Pang ZQ, 2008, J CONTROL RELEASE, V128, P120, DOI 10.1016/j.jconrel.2008.03.007; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Schneider Y., 1984, NATO ASI SERIES LIFE, DOI [10.1007/978-1-4684-4862-7_1, DOI 10.1007/978-1-4684-4862-7_1]; Sharma AK, 1999, J MOL BIOL, V289, P303, DOI 10.1006/jmbi.1999.2767; Sheela A, 2003, METHOD ENZYMOL, V391, P71; Shuai XT, 2004, J CONTROL RELEASE, V98, P415, DOI 10.1016/j.jconrel.2004.06.003; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Tseng HH, 2009, J CANCER RES CLIN, V135, P1413, DOI 10.1007/s00432-009-0585-5; Upadhyay KK, 2010, BIOMATERIALS, V31, P2882, DOI 10.1016/j.biomaterials.2009.12.043; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; Varela M, 2007, J HEPATOL, V46, P474, DOI 10.1016/j.jhep.2006.10.020; VERDUN C, 1990, CANCER CHEMOTH PHARM, V26, P13, DOI 10.1007/BF02940287; Wong HL, 2006, J CONTROL RELEASE, V116, P275, DOI 10.1016/j.jconrel.2006.09.007; Xu JP, 2005, J CONTROL RELEASE, V107, P502, DOI 10.1016/j.jconrel.2005.06.013; Xu ZH, 2009, BIOMATERIALS, V30, P226, DOI 10.1016/j.biomaterials.2008.09.014; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yokoyama M, 1998, J CONTROL RELEASE, V50, P79, DOI 10.1016/S0168-3659(97)00115-6; Yoo HS, 2001, J CONTROL RELEASE, V70, P63, DOI 10.1016/S0168-3659(00)00340-0; Zara GP, 2002, J DRUG TARGET, V10, P327, DOI 10.1080/10611860290031868; Zara GP, 1999, PHARMACOL RES, V40, P281, DOI 10.1006/phrs.1999.0509; Zhang J, 2007, NANOMED-NANOTECHNOL, V3, P258, DOI 10.1016/j.nano.2007.08.002; Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248	52	46	47	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51960	10.1371/journal.pone.0051960	http://dx.doi.org/10.1371/journal.pone.0051960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284832	Green Submitted, gold, Green Published			2022-12-25	WOS:000313158800017
J	Heikkinen, T; Lehtimaki, K; Vartiainen, N; Puolivali, J; Hendricks, SJ; Glaser, JR; Bradaia, A; Wadel, K; Touller, C; Kontkanen, O; Yrjanheikki, JM; Buisson, B; Howland, D; Beaumont, V; Munoz-Sanjuan, I; Park, LC				Heikkinen, Taneli; Lehtimaki, Kimmo; Vartiainen, Nina; Puolivali, Jukka; Hendricks, Susan J.; Glaser, Jack R.; Bradaia, Amyaouch; Wadel, Kristian; Touller, Chrystelle; Kontkanen, Outi; Yrjanheikki, Juha M.; Buisson, Bruno; Howland, David; Beaumont, Vahri; Munoz-Sanjuan, Ignacio; Park, Larry C.			Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease	PLOS ONE			English	Article							STRIATAL NEURONAL LOSS; SPINY NEURONS; CORTICOSTRIATAL PATHWAY; TRINUCLEOTIDE REPEAT; BASAL GANGLIA; EARLY MOTOR; CAG REPEAT; BLOOD-FLOW; HD GENE; H-1 MRS	Huntington's disease (HD) is an autosomal neurodegenerative disorder, characterized by severe behavioral, cognitive, and motor deficits. Since the discovery of the huntingtin gene (HTT) mutation that causes the disease, several mouse lines have been developed using different gene constructs of Htt. Recently, a new model, the zQ175 knock-in (KI) mouse, was developed (see description by Menalled et al, [1]) in an attempt to have the Htt gene in a context and causing a phenotype that more closely mimics HD in humans. Here we confirm the behavioral phenotypes reported by Menalled et al [1], and extend the characterization to include brain volumetry, striatal metabolite concentration, and early neurophysiological changes. The overall reproducibility of the behavioral phenotype across the two independent laboratories demonstrates the utility of this new model. Further, important features reminiscent of human HD pathology are observed in zQ175 mice: compared to wild-type neurons, electrophysiological recordings from acute brain slices reveal that medium spiny neurons from zQ175 mice display a progressive hyperexcitability; glutamatergic transmission in the striatum is severely attenuated; decreased striatal and cortical volumes from 3 and 4 months of age in homo-and heterozygous mice, respectively, with whole brain volumes only decreased in homozygotes. MR spectroscopy reveals decreased concentrations of N-acetylaspartate and increased concentrations of glutamine, taurine and creatine + phosphocreatine in the striatum of 12-month old homozygotes, the latter also measured in 12-month-old heterozygotes. Motor, behavioral, and cognitive deficits in homozygotes occur concurrently with the structural and metabolic changes observed. In sum, the zQ175 KI model has robust behavioral, electrophysiological, and histopathological features that may be valuable in both furthering our understanding of HD-like pathophyisology and the evaluation of potential therapeutic strategies to slow the progression of disease.	[Howland, David; Beaumont, Vahri; Munoz-Sanjuan, Ignacio; Park, Larry C.] CHDI Management CHDI Fdn, Los Angeles, CA USA; [Heikkinen, Taneli; Lehtimaki, Kimmo; Vartiainen, Nina; Puolivali, Jukka; Kontkanen, Outi; Yrjanheikki, Juha M.] Charles River Discovery Res Serv, Kuopio, Finland; [Hendricks, Susan J.; Glaser, Jack R.] MBF Labs, Williston, VA USA; [Bradaia, Amyaouch; Wadel, Kristian; Touller, Chrystelle; Buisson, Bruno] Neuroserv SARL, Aix En Provence, France		Park, LC (corresponding author), CHDI Management CHDI Fdn, Los Angeles, CA USA.	larry.park@chdifoundation.org	Lehtimäki, Kimmo K/A-6018-2009	Lehtimäki, Kimmo K/0000-0003-2750-8229; Beaumont, Vahri/0000-0002-6488-2175; BRADAIA, Amyaouch/0000-0001-9664-4641	CHDI Foundation	CHDI Foundation	CHDI Foundation is a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. The research described was conducted by Charles River under a fee-for-service agreement for CHDI Foundation in collaboration with and funded by CHDI Foundation. The funder, through CHDI Management, fully participated in study design, data collection and analysis, the decision to publish, and preparation of the manuscript. CHDI Foundation has recently provided financial support to the Public Library of Science for PLoS Currents: Huntington Disease.	Ariano MA, 2005, J NEUROPHYSIOL, V93, P2565, DOI 10.1152/jn.00791.2004; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Aylward EH, 1998, NEUROLOGY, V50, P252, DOI 10.1212/WNL.50.1.252; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; Cayzac S, 2011, P NATL ACAD SCI USA, V108, P9280, DOI 10.1073/pnas.1016190108; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Cepeda C, 2010, ASN NEURO, V2, DOI 10.1042/AN20090058; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Doig NM, 2010, J NEUROSCI, V30, P14610, DOI 10.1523/JNEUROSCI.1623-10.2010; Dorner JL, 2009, BRAIN RES, V1290, P111, DOI 10.1016/j.brainres.2009.07.019; Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hamilton JM, 2003, NEUROPSYCHOLOGIA, V41, P614, DOI 10.1016/S0028-3932(02)00218-X; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Harris GJ, 1999, BRAIN, V122, P1667, DOI 10.1093/brain/122.9.1667; Harris GJ, 1996, ARCH NEUROL-CHICAGO, V53, P316, DOI 10.1001/archneur.1996.00550040044013; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Hoang TQ, 1998, NEUROLOGY, V50, P1033, DOI 10.1212/WNL.50.4.1033; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Lawrence AD, 1998, TRENDS COGN SCI, V2, P379, DOI 10.1016/S1364-6613(98)01231-5; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled LB, 2012, PLOS ONE IN PRESS; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Miller BR, 2008, J NEUROPHYSIOL, V100, P2205, DOI 10.1152/jn.90606.2008; Miller BR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00026; Miller BR, 2010, NEUROBIOL DIS, V37, P106, DOI 10.1016/j.nbd.2009.09.013; Milnerwood AJ, 2007, J PHYSIOL-LONDON, V585, P817, DOI 10.1113/jphysiol.2007.142448; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; NORREMOLLE A, 1993, HUM MOL GENET, V2, P1475, DOI 10.1093/hmg/2.9.1475; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Ramaswamy S, 2007, ILAR J, V48, P356, DOI 10.1093/ilar.48.4.356; Ramaswamy S, 2009, NEUROBIOL DIS, V34, P40, DOI 10.1016/j.nbd.2008.12.005; Raymond LA, 2011, NEUROSCIENCE, V198, P252, DOI 10.1016/j.neuroscience.2011.08.052; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rosas HD, 2001, NEUROLOGY, V57, P1025, DOI 10.1212/WNL.57.6.1025; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sanchez-Pernaute R, 1999, NEUROLOGY, V53, P806, DOI 10.1212/WNL.53.4.806; Schmitz C, 2000, J CHEM NEUROANAT, V20, P93, DOI 10.1016/S0891-0618(00)00066-1; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Sturrock A, 2010, NEUROLOGY, V75, P1702, DOI 10.1212/WNL.0b013e3181fc27e4; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tkac I, 2007, J NEUROCHEM, V100, P1397, DOI 10.1111/j.1471-4159.2006.04323.x; Traficante A, 2007, NEUROREPORT, V18, P1997, DOI 10.1097/WNR.0b013e3282f262ca; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Weir DW, 2011, LANCET NEUROL, V10, P573, DOI 10.1016/S1474-4422(11)70070-9; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004	55	152	154	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e50717	10.1371/journal.pone.0050717	http://dx.doi.org/10.1371/journal.pone.0050717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284644	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500015
J	Hofgaard, PO; Jodal, HC; Bommert, K; Huard, B; Caers, J; Carlsen, H; Schwarzer, R; Schunemann, N; Jundt, F; Lindeberg, MM; Bogen, B				Hofgaard, Peter O.; Jodal, Henriette C.; Bommert, Kurt; Huard, Bertrand; Caers, Jo; Carlsen, Harald; Schwarzer, Rolf; Schuenemann, Nicole; Jundt, Franziska; Lindeberg, Mona M.; Bogen, Bjarne			A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease	PLOS ONE			English	Article							CD4(+) T-CELLS; TUMOR-SPECIFIC ANTIGEN; PLASMA-CELLS; B-CELL; C57BL/KALWRIJ MOUSE; BONE-DISEASE; SCID MICE; IDIOTYPE; DIFFERENTIATION; RESISTANCE	Multiple myeloma (MM) is a lethal human cancer characterized by a clonal expansion of malignant plasma cells in bone marrow. Mouse models of human MM are technically challenging and do not always recapitulate human disease. Therefore, new mouse models for MM are needed. Mineral-oil induced plasmacytomas (MOPC) develop in the peritoneal cavity of oil-injected BALB/c mice. However, MOPC typically grow extramedullary and are considered poor models of human MM. Here we describe an in vivo-selected MOPC315 variant, called MOPC315.BM, which can be maintained in vitro. When injected i.v. into BALB/c mice, MOPC315.BM cells exhibit tropism for bone marrow. As few as 10(4) MOPC315.BM cells injected i.v. induced paraplegia, a sign of spinal cord compression, in all mice within 3-4 weeks. MOPC315.BM cells were stably transfected with either firefly luciferase (MOPC315.BM.Luc) or DsRed (MOPC315.BM.DsRed) for studies using noninvasive imaging. MOPC315.BM.Luc cells were detected in the tibiofemoral region already 1 hour after i.v. injection. Bone foci developed progressively, and as of day 5, MM cells were detected in multiple sites in the axial skeleton. Additionally, the spleen (a hematopoietic organ in the mouse) was invariably affected. Luminescent signals correlated with serum myeloma protein concentration, allowing for easy tracking of tumor load with noninvasive imaging. Affected mice developed osteolytic lesions. The MOPC315.BM model employs a common strain of immunocompetent mice (BALB/c) and replicates many characteristics of human MM. The model should be suitable for studies of bone marrow tropism, development of osteolytic lesions, drug testing, and immunotherapy in MM.	[Hofgaard, Peter O.; Jodal, Henriette C.; Lindeberg, Mona M.; Bogen, Bjarne] Univ Oslo, Ctr Immune Regulat, Inst Immunol, Oslo, Norway; [Hofgaard, Peter O.; Jodal, Henriette C.; Lindeberg, Mona M.; Bogen, Bjarne] Oslo Univ Hosp, Oslo, Norway; [Bommert, Kurt] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Bommert, Kurt] Univ Hosp Wurzburg, Dept Internal Med 2, Div Haematol & Med Oncol, Wurzburg, Germany; [Huard, Bertrand] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland; [Huard, Bertrand] Univ Geneva, Med Ctr, Dept Pathol Immunol, CH-1211 Geneva, Switzerland; [Caers, Jo] Univ Liege, Dept Hematol, Liege, Belgium; [Carlsen, Harald] Univ Oslo, Inst Nutr Res, Oslo, Norway; [Schwarzer, Rolf; Schuenemann, Nicole; Jundt, Franziska] Charite, Dept Hematol Oncol & Tumor Immunol, Campus Virchow Clin, Mol Krebsforschungszentrum, D-13353 Berlin, Germany; [Jundt, Franziska] Max Delbruck Ctr Mol Med, Berlin, Germany	University of Oslo; University of Oslo; University of Wurzburg; University of Wurzburg; University of Geneva; University of Geneva; University of Liege; University of Oslo; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bogen, B (corresponding author), Univ Oslo, Ctr Immune Regulat, Inst Immunol, Oslo, Norway.	bjarne.bogen@medisin.uio.no	huard, bertrand/L-8011-2013; Jundt, Franziska/E-9748-2014; Bommert, Kurt/G-9247-2011	huard, bertrand/0000-0003-1358-6576; Jundt, Franziska/0000-0002-8661-7110; Schwarzer, Rolf/0000-0002-8934-8788; Jodal, Henriette Cecilie/0000-0001-6957-9469; Carlsen, Harald/0000-0001-5123-5756; Caers, Jo/0000-0002-3175-1195	Norwegian Cancer Society [420042 71237-PR-2006-0303]; Multiple Myeloma Research Foundation; Deutsche Forschungsgemeinschaft [CRU216, TRR54/B6]; FNRS Belgium; Deutsche Krebshilfe [108658]	Norwegian Cancer Society(Norwegian Cancer Society); Multiple Myeloma Research Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FNRS Belgium(Fonds de la Recherche Scientifique - FNRS); Deutsche Krebshilfe(Deutsche Krebshilfe)	The work was supported by grants from The Norwegian Cancer Society (420042 71237-PR-2006-0303) (http://www.kreftforeningen.no), the Multiple Myeloma Research Foundation (http://www.themmrf.org/), Deutsche Forschungsgemeinschaft (http://www.dfg.de/) CRU216 (KB) and TRR54/B6 (FJ), FNRS Belgium (http://www1.frs-fnrs.be/) (JC), and from the Deutsche Krebshilfe 108658 (http://www.krebshilfe.de) (FJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KC, 2007, EXP HEMATOL, V35, P155, DOI 10.1016/j.exphem.2007.01.024; BAKKUS MHC, 1994, BRIT J HAEMATOL, V87, P68, DOI 10.1111/j.1365-2141.1994.tb04872.x; BOGEN B, 1995, EUR J IMMUNOL, V25, P3079, DOI 10.1002/eji.1830251114; Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Cheung WC, 2004, J CLIN INVEST, V113, P1763, DOI 10.1172/JCI200420369; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Corthay A, 2009, CANCER RES, V69, P5901, DOI 10.1158/0008-5472.CAN-08-4816; DALEY MJ, 1978, J IMMUNOL METHODS, V24, P47, DOI 10.1016/0022-1759(78)90085-6; Dellacasagrande J, 2003, SCAND J IMMUNOL, V57, P534, DOI 10.1046/j.1365-3083.2003.01263.x; Dembic Z, 2000, P NATL ACAD SCI USA, V97, P2697, DOI 10.1073/pnas.050579897; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; EISEN HN, 1968, BIOCHEMISTRY-US, V7, P4126, DOI 10.1021/bi00851a048; FEOZUPPARDI FJ, 1992, BLOOD, V80, P2843; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Haabeth OAW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1239; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hjorth-Hansen H, 1999, J BONE MINER RES, V14, P256, DOI 10.1359/jbmr.1999.14.2.256; HUANG YW, 1993, CANCER RES, V53, P1392; KOBAYASHI H, 1962, J NATL CANCER I, V28, P649; LAURITZSEN GF, 1993, CELL IMMUNOL, V148, P177, DOI 10.1006/cimm.1993.1100; LAURITZSEN GF, 1994, P NATL ACAD SCI USA, V91, P5700, DOI 10.1073/pnas.91.12.5700; LYNCH RG, 1972, P NATL ACAD SCI USA, V69, P1540, DOI 10.1073/pnas.69.6.1540; MANNING LS, 1992, BRIT J CANCER, V66, P1088, DOI 10.1038/bjc.1992.415; MELLSTEDT H, 1974, CLIN EXP IMMUNOL, V17, P371; Menu E, 2004, BLOOD CELL MOL DIS, V33, P111, DOI 10.1016/j.bcmd.2004.04.012; Mitsiades CS, 2007, HEMATOL ONCOL CLIN N, V21, P1051, DOI 10.1016/j.hoc.2007.08.003; Miyakawa Y, 2004, BIOCHEM BIOPH RES CO, V313, P258, DOI 10.1016/j.bbrc.2003.11.120; Mori Y, 2004, BLOOD, V104, P2149, DOI 10.1182/blood-2004-01-0236; Nachtrab F, 2008, NUCL SCI S 2008 NSS, P532; O'Connor BP, 2003, IMMUNOL REV, V194, P61, DOI 10.1034/j.1600-065X.2003.00055.x; Oyajobi BO, 2007, MOL CANCER THER, V6, P1701, DOI 10.1158/1535-7163.MCT-07-0121; Pilarski LM, 2000, BLOOD, V95, P1056, DOI 10.1182/blood.V95.3.1056.003k26_1056_1065; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; POTTER M, 1972, PHYSIOL REV, V52, P631, DOI 10.1152/physrev.1972.52.3.631; POTTER M, 1957, P SOC EXP BIOL MED, V94, P327; RADL J, 1979, J IMMUNOL, V122, P609; RADL J, 1988, AM J PATHOL, V132, P593; Radl J, 1999, PATHOL BIOL, V47, P109; ROHRER JW, 1977, J IMMUNOL, V119, P861; Salamon M, 2008, NUCL INSTRUMENTS M A, P591; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; Szczepek AJ, 1998, BLOOD, V92, P2844, DOI 10.1182/blood.V92.8.2844.420k17_2844_2855; Tsunenari T, 1997, BLOOD, V90, P2437; Vanderkerken K, 1997, BRIT J CANCER, V76, P451, DOI 10.1038/bjc.1997.409; Vanderkerken K, 2003, IMMUNOL REV, V194, P196, DOI 10.1034/j.1600-065X.2003.00035.x; Vanderkerken K, 2000, BRIT J CANCER, V82, P953, DOI 10.1054/bjoc.1999.1024; Vanderkerken K, 1996, BRIT J CANCER, V73, P1463, DOI 10.1038/bjc.1996.277; WILTSHAW E, 1976, MEDICINE, V55, P217, DOI 10.1097/00005792-197605000-00002; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913	52	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51892	10.1371/journal.pone.0051892	http://dx.doi.org/10.1371/journal.pone.0051892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284805	Green Published, Green Accepted, gold			2022-12-25	WOS:000312794500063
J	Odrowaz, Z; Sharrocks, AD				Odrowaz, Zaneta; Sharrocks, Andrew D.			The ETS Transcription Factors ELK1 and GABPA Regulate Different Gene Networks to Control MCF10A Breast Epithelial Cell Migration	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; CYCLE PROGRESSION; IN-VIVO; CYTOKINESIS; EXPRESSION; KINESIN; FAMILY	Members of the ETS transcription factor family often target the same binding regions and hence have the potential to regulate the same genes and downstream biological processes. However, individual family members also preferentially bind to other genomic regions, thus providing the potential for controlling distinct transcriptional programmes and generating specific biological effects. The ETS transcription factor ELK1 controls cell migration in breast epithelial cells through targeting a cohort of genes, independently from another family member GABPA, and therefore achieves biological specificity. Here, we demonstrate that GABPA also controls cell migration in breast epithelial cells. However, GABPA controls the expression of a different network of target genes to ELK1. Both direct and indirect target genes for GABPA are identified and amongst the direct targets we confirm the importance of RAC1 and KIF20A for cell migration. Therefore, although ELK1 and GABPA ultimately control the same biological process, they do so by regulating different cohorts of target genes associated with cytoskeletal functions and cell migration control.	[Odrowaz, Zaneta; Sharrocks, Andrew D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Sharrocks, AD (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	a.d.sharrocks@manchester.ac.uk	Sharrocks, Andrew/J-6756-2013		Wellcome Trust; Royal Society-Wolfson	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society-Wolfson(Royal Society of London)	This work was supported by grants from the Wellcome Trust, and a Royal Society-Wolfson award to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Carstanjen D, 2005, J IMMUNOL, V174, P4613, DOI 10.4049/jimmunol.174.8.4613; Crook MF, 2008, FASEB J, V22, P225, DOI 10.1096/fj.07-8573com; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fontijn RD, 2001, MOL CELL BIOL, V21, P2944, DOI 10.1128/MCB.21.8.2944-2955.2001; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Yu SY, 2011, BLOOD, V117, P2166, DOI 10.1182/blood-2010-09-306563; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102	20	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e49892	10.1371/journal.pone.0049892	http://dx.doi.org/10.1371/journal.pone.0049892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284628	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500010
J	Johannesen, J; Foissac, X; Kehrli, P; Maixner, M				Johannesen, Jes; Foissac, Xavier; Kehrli, Patrik; Maixner, Michael			Impact of Vector Dispersal and Host-Plant Fidelity on the Dissemination of an Emerging Plant Pathogen	PLOS ONE			English	Article							HYALESTHES-OBSOLETUS; GRAPEVINE YELLOWS; STOLBUR PHYTOPLASMA; BOIS NOIR; BORRELIA-BURGDORFERI; FLAVESCENCE-DOREE; CONIFER PATHOGEN; DISEASE; DIVERSITY; DYNAMICS	Dissemination of vector-transmitted pathogens depend on the survival and dispersal of the vector and the vector's ability to transmit the pathogen, while the host range of vector and pathogen determine the breath of transmission possibilities. In this study, we address how the interaction between dispersal and plant fidelities of a pathogen (stolbur phytoplasma tuf-a) and its vector (Hyalesthes obsoletus: Cixiidae) affect the emergence of the pathogen. Using genetic markers, we analysed the geographic origin and range expansion of both organisms in Western Europe and, specifically, whether the pathogen's dissemination in the northern range is caused by resident vectors widening their host-plant use from field bindweed to stinging nettle, and subsequent host specialisation. We found evidence for common origins of pathogen and vector south of the European Alps. Genetic patterns in vector populations show signals of secondary range expansion in Western Europe leading to dissemination of tuf-a pathogens, which might be newly acquired and of hybrid origin. Hence, the emergence of stolbur tuf-a in the northern range was explained by secondary immigration of vectors carrying stinging nettle-specialised tuf-a, not by widening the host-plant spectrum of resident vectors with pathogen transmission from field bindweed to stinging nettle nor by primary co-migration from the resident vector's historical area of origin. The introduction of tuf-a to stinging nettle in the northern range was therefore independent of vector's host-plant specialisation but the rapid pathogen dissemination depended on the vector's host shift, whereas the general dissemination elsewhere was linked to plant specialisation of the pathogen but not of the vector.	[Johannesen, Jes] Johannes Gutenberg Univ Mainz, Inst Zool, Saarstr 21, D-6500 Mainz, Germany; [Foissac, Xavier] INRA, Fruit Biol & Pathol UMR1332, Villenave Dornon, France; [Foissac, Xavier] Univ Bordeaux Segalen, Fruit Biol & Pathol UMR1332, Villenave Dornon, France; [Kehrli, Patrik] Stn Rech Agroscope Changins Wadenswil ACW, Nyon, Switzerland; [Maixner, Michael] Julius Kuhn Inst, Inst Plant Protect Fruit Crops & Viticulture, Bernkastel Kues, Germany	Johannes Gutenberg University of Mainz; INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Swiss Federal Research Station Agroscope; Julius Kuhn-Institut	Johannesen, J (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Saarstr 21, D-6500 Mainz, Germany.	jesjo@uni-mainz.de	Foissac, Xavier/ABI-7227-2020; Foissac, Xavier/B-7662-2015	Foissac, Xavier/0000-0002-2170-5793; Foissac, Xavier/0000-0002-2170-5793; Kehrli, Patrik/0000-0003-0937-0561	Stiftung Rheinland-Pfalz fur Innovation [0861]	Stiftung Rheinland-Pfalz fur Innovation	This research was funded by "Stiftung Rheinland-Pfalz fur Innovation,'' grant number 0861 (http://www.stiftung-innovation.rlp.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini E, 2011, PETRIA, V21, P85; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4001, DOI 10.1128/AEM.02323-06; Bai XD, 2004, FEMS MICROBIOL LETT, V235, P249, DOI [10.1111/j.1574-6968.2004.tb09596.x, 10.1016/j.femsle.2004.04.043]; Bertaccini A, 2007, B INSECTOLOGY, VLX; Bertaccini A, 2011, 2 INT PHYT WORK GROU, VLXIV; BLATTNY C., 1954, Phytopathologische Zeitschrift, V22, P381; Bojnansky V, 1955, POLNOHOSPODARSTVO, V2, P326; Boudon-Padieu E, 2008, P INT MULT C U DIJ, P1; Brasier CM, 2001, BIOSCIENCE, V51, P123, DOI 10.1641/0006-3568(2001)051[0123:REOIPP]2.0.CO;2; Bressan A, 2007, ANN APPL BIOL, V150, P331, DOI 10.1111/j.1744-7348.2007.00134.x; Brinkerhoff RJ, 2011, FRONT ECOL ENVIRON, V9, P103, DOI 10.1890/090062; Chen HY, 2005, J MED ENTOMOL, V42, P899, DOI 10.1603/0022-2585(2005)042[0899:EASDOL]2.0.CO;2; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Cimerman A, 2009, APPL ENVIRON MICROB, V75, P2951, DOI 10.1128/AEM.02613-08; Cimerman A, 2006, APPL ENVIRON MICROB, V72, P3274, DOI 10.1128/AEM.72.5.3274-3283.2006; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Credi R., 2006, 15 M ICVG STELL S AF, P182; Daire X, 1997, EUR J PLANT PATHOL, V103, P507, DOI 10.1023/A:1008641411025; Ember I, 2011, EUR J PLANT PATHOL, V130, P367, DOI 10.1007/s10658-011-9759-5; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabiszewski AM, 2010, ECOL APPL, V20, P582, DOI 10.1890/08-0820.1; Fabre A, 2011, GENE, V472, P37, DOI 10.1016/j.gene.2010.10.012; Fialova R, 2009, J PLANT PATHOL, V91, P411; Filippin L, 2009, PLANT PATHOL, V58, P826, DOI 10.1111/j.1365-3059.2009.02092.x; Firrao G, 2004, INT J SYST EVOL MICR, V54, P1243, DOI 10.1099/ijs.0.02854-0; FOS A, 1992, PLANT DIS, V76, P1092, DOI 10.1094/PD-76-1092; Fu YX, 1997, GENETICS, V147, P915; Gladieux P, 2011, MOL ECOL, V20, P4521, DOI 10.1111/j.1365-294X.2011.05288.x; Herschler A, 1937, DTSCH WEIN BAU, V16, P177; Hoch H., 1985, Marburger Entomologische Publikationen, V2, P1; Hogenhout SA, 2003, TRENDS MICROBIOL, V11, P264, DOI 10.1016/S0966-842X(03)00120-3; Humphrey PT, 2010, EVOLUTION, V64, P2653, DOI 10.1111/j.1558-5646.2010.01001.x; Imo M, 2011, EUR J ENTOMOL, V108, P161, DOI 10.14411/eje.2011.019; Johannesen J, 2008, ENTOMOL EXP APPL, V126, P217, DOI 10.1111/j.1570-7458.2007.00655.x; Kast WK, 2008, 1 EUR BOIS WORKSH 20; Kehrli P., 2011, IOBC/WPRS Bulletin, V67, P3; Kessler S, 2011, ENTOMOL EXP APPL, V139, P60, DOI 10.1111/j.1570-7458.2011.01107.x; Kuntzmann P., 2008, IOBC/WPRS Bulletin, V36, P127; Langer M, 2004, VITIS, V43, P191; Lee IM, 1998, INT J SYST BACTERIOL, V48, P1153, DOI 10.1099/00207713-48-4-1153; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Lessio F, 2007, J PLANT PATHOL, V89, P97; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maixner M, 2000, VITIS, V39, P83; MAIXNER M, 1995, EUR J PLANT PATHOL, V101, P241, DOI 10.1007/BF01874780; Maixner M., 2011, PETRIA, V21, P95; Maixner M, 2009, P 16 M ICVG DIJ FRAN, P141; Maixner M, 2007, B INSECTOL, V60, P399; Malembic-Maher S, 2010, 18 INT C INT ORG MYC, P52; Mannelli A, 2012, FEMS MICROBIOL REV, V36, P837, DOI 10.1111/j.1574-6976.2011.00312.x; Marin M, 2009, FOREST PATHOL, V39, P249, DOI 10.1111/j.1439-0329.2009.00585.x; Mendgen K., 1971, Weinberg und Keller, V18, P345; Nunney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015488; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sergel R., 1986, ABHANDLUGEN NATURWIS, V25, P81; Sforza R, 1998, J PHYTOPATHOL, V146, P549, DOI 10.1111/j.1439-0434.1998.tb04753.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Swofford D.L., 1999, PHYLOGENETIC ANAL US; TAJIMA F, 1989, GENETICS, V123, P585; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Thompson J. N., 2005, INTERSPEC INTERACT; Tsui CKM, 2012, MOL ECOL, V21, P71, DOI 10.1111/j.1365-294X.2011.05366.x; van Putten WF, 2007, INT J PLANT SCI, V168, P421, DOI 10.1086/511050; Wagner W., 1939, Jahrbuch des Nassauischen Vereins fuer Naturkunde, V86, P77; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039	68	49	50	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51809	10.1371/journal.pone.0051809	http://dx.doi.org/10.1371/journal.pone.0051809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284774	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300046
J	Tegel, W; Elburg, R; Hakelberg, D; Stauble, H; Buntgen, U				Tegel, Willy; Elburg, Rengert; Hakelberg, Dietrich; Staeuble, Harald; Buentgen, Ulf			Early Neolithic Water Wells Reveal the World's Oldest Wood Architecture	PLOS ONE			English	Article							CENTRAL-EUROPE; HOLOCENE	The European Neolithization similar to 6000-4000 BC represents a pivotal change in human history when farming spread and the mobile style of life of the hunter-foragers was superseded by the agrarian culture. Permanent settlement structures and agricultural production systems required fundamental innovations in technology, subsistence, and resource utilization. Motivation, course, and timing of this transformation, however, remain debatable. Here we present annually resolved and absolutely dated dendroarchaeological information from four wooden water wells of the early Neolithic period that were excavated in Eastern Germany. A total of 151 oak timbers preserved in a waterlogged environment were dated between 5469 and 5098 BC and reveal unexpectedly refined carpentry skills. The recently discovered water wells enable for the first time a detailed insight into the earliest wood architecture and display the technological capabilities of humans similar to 7000 years ago. The timbered well constructions made of old oak trees feature an unopened tree-ring archive from which annually resolved and absolutely dated environmental data can be culled. Our results question the principle of continuous evolutionary development in prehistoric technology, and contradict the common belief that metal was necessary for complex timber constructions. Early Neolithic craftsmanship now suggests that the first farmers were also the first carpenters.	[Tegel, Willy; Hakelberg, Dietrich] Univ Freiburg, Inst Forest Growth IWW, D-79106 Freiburg, Germany; [Elburg, Rengert; Staeuble, Harald] Archaeol Heritage Off Saxony, Dresden, Germany; [Buentgen, Ulf] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Buentgen, Ulf] Oeschger Ctr Climate Change Res, Bern, Switzerland	University of Freiburg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern	Tegel, W (corresponding author), Univ Freiburg, Inst Forest Growth IWW, Hugstetter Str 55, D-79106 Freiburg, Germany.	tegel@dendro.de	Tegel, Willy/M-8187-2014; buentgen, ulf/J-6952-2013	Petraglia, Michael/0000-0003-2522-5727; Tegel, Willy/0000-0003-4707-2848; Elburg, Rengert/0000-0001-5595-8900	German Research Foundation [SP 437/16-1]	German Research Foundation(German Research Foundation (DFG))	WT and DH received funding from the German Research Foundation, project #SP 437/16-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold B, 1995, PIROGUES MONOXYLES E, V1; Barker G, 2011, NATURE, V473, P163, DOI 10.1038/473163a; Becker B., 1978, DENDROCHRONOLOGY EUR, V51, P59; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Clark P, 2004, DOVER BRONZE AGE BOA, P124; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Haase D, 2007, QUATERNARY SCI REV, V26, P1301, DOI 10.1016/j.quascirev.2007.02.003; Herbig C, 2012, SCHRIFTEN, V18, P147; Hodder I., 1990, DOMESTICATION EUROPE; HOFFMANN P, 1990, ADV CHEM SER, P35; Kalis AJ, 2003, QUATERNARY SCI REV, V22, P33, DOI 10.1016/S0277-3791(02)00181-6; Kreuz A.M., 1990, ERSTEN BAUERN MITTEL; Kreuz A, 2011, VEG HIST ARCHAEOBOT, V20, P333, DOI 10.1007/s00334-011-0294-2; Lobisser WFA, 1998, BRUNNEN JUNGSTEINZEI, P177; Luley H, 1992, URGESCHICHTLICHER HA; Luning J., 2000, UNIVERSITATSFORSCHUN, V58; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Mazurie de Keroualin K, 2003, GENESE DIFFUSION AGR; Mitchell FJG, 2005, J ECOL, V93, P168, DOI 10.1111/j.1365-2745.2004.00964.x; Modderman P.J.R., 1988, BER RIJKSD OUDHEIDKD, V38, P63; Petrequin P., 1993, ECOLOGIE OUTIL HACHE; Ramminger B, 2007, WIRTSCHAFTSARCHALOGI; Renfrew C., 2007, PREHISTORY MAKING HU; Renssen H, 2009, NAT GEOSCI, V2, P410, DOI 10.1038/NGEO513; Schiffer M.B., 1987, FORMATION PROCESSES; Spurk M, 2002, HOLOCENE, V12, P707, DOI 10.1191/0959683602hl583rp; Spurk M, 1998, RADIOCARBON, V40, P1107, DOI 10.1017/S0033822200019159; Stauble H, 1995, RADIOCARBON, V37, P227, DOI 10.1017/S003382220003068X; Stauble H., 2005, HAUSER ABSOLUTE DATI; Stehli P, 1982, SIEDLUNGEN KULTUR LI, P271; Thorpe I.J.N., 1996, ORIGINS AGR EUROPE; Wanner H, 2008, QUATERNARY SCI REV, V27, P1791, DOI 10.1016/j.quascirev.2008.06.013; Weisdorf JL, 2005, J ECON SURV, V19, P561, DOI 10.1111/j.0950-0804.2005.00259.x; Whittle A., 1996, EUROPE NEOLITHIC CRE; Zvelebil M., 2004, LBK DIALOGUES STUDIE, P183	36	72	75	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51374	10.1371/journal.pone.0051374	http://dx.doi.org/10.1371/journal.pone.0051374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284685	Green Submitted, Green Published, gold			2022-12-25	WOS:000312694300021
J	Friedman, J; Korman, M				Friedman, Jason; Korman, Maria			Kinematic Strategies Underlying Improvement in the Acquisition of a Sequential Finger Task with Self-Generated vs. Cued Repetition Training	PLOS ONE			English	Article							MOVEMENT SEQUENCES; MOTOR SEQUENCE; TIME-COURSE; SLEEP; SKILL; CONSOLIDATION; FEEDBACK; PERFORMANCE; CORTEX; MODEL	Many motor skills, such as typing, consist of articulating simple movements into novel sequences that are executed faster and smoother with practice. Dynamics of re-organization of these movement sequences with multi-session training and its dependence on the amount of self-regulation of pace during training is not yet fully understood. In this study, participants practiced a sequence of key presses. Training sessions consisted of either externally (Cued) or self-initiated (Uncued) training. Long-term improvements in performance speed were mainly due to reducing gaps between finger movements in both groups, but Uncued training induced higher gains. The underlying kinematic strategies producing these changes and the representation of the trained sequence differed significantly across subjects, although net gains in speed were similar. The differences in long-term memory due to the type of training and the variation in strategies between subjects, suggest that the different neural mechanisms may subserve the improvements observed in overall performance.	[Friedman, Jason] Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia; [Friedman, Jason] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia; [Korman, Maria] Univ Haifa, Fac Social Welf & Hlth Sci, Dept Occupat Therapy, IL-31999 Haifa, Israel	Macquarie University; Macquarie University; University of Haifa	Friedman, J (corresponding author), Tel Aviv Univ, Dept Phys Therapy, IL-69978 Tel Aviv, Israel.	jason@post.tau.ac.il	Korman, Maria/GWQ-3314-2022; Friedman, Jason/B-4690-2008	Korman, Maria/0000-0003-1895-0189; Friedman, Jason/0000-0001-8845-5082	Macquarie University	Macquarie University	This research has been supported in part by a Macquarie University Safety Net Grant to Friedman. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschersleben G, 2004, SCI PSYCH S, P117; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Blackburn CS, 2000, J ACOUST SOC AM, V107, P1659, DOI 10.1121/1.428450; Blischke K, 2008, J HUM KINET, V20, P23, DOI 10.2478/v10078-008-0015-9; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown RM, 2007, NAT NEUROSCI, V10, P148, DOI 10.1038/nn1836; Chiviacowsky S, 2005, RES Q EXERCISE SPORT, V76, P42; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Engel KC, 1997, EXP BRAIN RES, V113, P189, DOI 10.1007/BF02450317; Goebl W, 2008, EXP BRAIN RES, V186, P471, DOI 10.1007/s00221-007-1252-1; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Huet M, 2009, HUM MOVEMENT SCI, V28, P450, DOI 10.1016/j.humov.2008.12.004; Janelle CM, 1997, RES Q EXERCISE SPORT, V68, P269, DOI 10.1080/02701367.1997.10608008; Jerde TE, 2003, J NEUROSCI, V23, P2383; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Keetch KM, 2007, RES Q EXERCISE SPORT, V78, P476; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; Lewis PA, 2011, NEUROPSYCHOLOGIA, V49, P115, DOI 10.1016/j.neuropsychologia.2010.10.025; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; Nudo RJ, 1996, J NEUROSCI, V16, P785; O'Reilly JX, 2008, J NEUROPHYSIOL, V99, P2731, DOI 10.1152/jn.01141.2007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orban P, 2011, NEUROSCIENCE, V179, P94, DOI 10.1016/j.neuroscience.2011.01.040; Panzer S, 2006, J MOTOR BEHAV, V38, P60, DOI 10.3200/JMBR.38.1.60-70; Rozanov S, 2010, BRAIN RES, V1331, P80, DOI 10.1016/j.brainres.2010.03.019; SOECHTING JF, 1992, J NEUROPHYSIOL, V67, P1275, DOI 10.1152/jn.1992.67.5.1275; Sosnik R, 2004, EXP BRAIN RES, V156, P422, DOI 10.1007/s00221-003-1799-4; TERZUOLO CA, 1980, NEUROSCIENCE, V5, P1085, DOI 10.1016/0306-4522(80)90188-8; Verwey WB, 2003, PSYCHOL RES-PSYCH FO, V67, P106, DOI 10.1007/s00426-002-0120-7; Verwey WB, 2003, J MOTOR BEHAV, V35, P171, DOI 10.1080/00222890309602131; Viviani P., 1983, LANGUAGE PRODUCTION, V2, P103; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; WRIGHT CE, 1993, ACTA PSYCHOL, V82, P5, DOI 10.1016/0001-6918(93)90003-A; Wrisberg CA, 2002, PERCEPT MOTOR SKILL, V94, P792, DOI 10.2466/PMS.94.2.792-794; Wulf G, 2005, RES Q EXERCISE SPORT, V76, P107	42	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52063	10.1371/journal.pone.0052063	http://dx.doi.org/10.1371/journal.pone.0052063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272210	gold, Green Submitted, Green Published			2022-12-25	WOS:000312483300056
J	Miljkovic, D; Stare, T; Mozetic, I; Podpecan, V; Petek, M; Witek, K; Dermastia, M; Lavrac, N; Gruden, K				Miljkovic, Dragana; Stare, Tjasa; Mozetic, Igor; Podpecan, Vid; Petek, Marko; Witek, Kamil; Dermastia, Marina; Lavrac, Nada; Gruden, Kristina			Signalling Network Construction for Modelling Plant Defence Response	PLOS ONE			English	Article							SALICYLIC-ACID; TRANSCRIPTION FACTORS; SYSTEMS BIOLOGY; CROSS-TALK; JASMONATE; INFORMATION; PATHWAY; NONEXPRESSOR; ACTIVATION; EXTRACTION	Plant defence signalling response against various pathogens, including viruses, is a complex phenomenon. In resistant interaction a plant cell perceives the pathogen signal, transduces it within the cell and performs a reprogramming of the cell metabolism leading to the pathogen replication arrest. This work focuses on signalling pathways crucial for the plant defence response, i.e., the salicylic acid, jasmonic acid and ethylene signal transduction pathways, in the Arabidopsis thaliana model plant. The initial signalling network topology was constructed manually by defining the representation formalism, encoding the information from public databases and literature, and composing a pathway diagram. The manually constructed network structure consists of 175 components and 387 reactions. In order to complement the network topology with possibly missing relations, a new approach to automated information extraction from biological literature was developed. This approach, named Bio3graph, allows for automated extraction of biological relations from the literature, resulting in a set of (component1, reaction, component2) triplets and composing a graph structure which can be visualised, compared to the manually constructed topology and examined by the experts. Using a plant defence response vocabulary of components and reaction types, Bio3graph was applied to a set of 9,586 relevant full text articles, resulting in 137 newly detected reactions between the components. Finally, the manually constructed topology and the new reactions were merged to form a network structure consisting of 175 components and 524 reactions. The resulting pathway diagram of plant defence signalling represents a valuable source for further computational modelling and interpretation of omics data. The developed Bio3graph approach, implemented as an executable language processing and graph visualisation workflow, is publically available at http://ropot.ijs.si/bio3graph/and can be utilised for modelling other biological systems, given that an adequate vocabulary is provided.	[Miljkovic, Dragana; Mozetic, Igor; Podpecan, Vid; Lavrac, Nada] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia; [Miljkovic, Dragana; Podpecan, Vid] Jozef Stefan Int Postgrad Sch, Ljubljana, Slovenia; [Lavrac, Nada] Univ Nova Gorica, Sch Engn & Management, Nova Gorica, Slovenia; [Stare, Tjasa; Petek, Marko; Dermastia, Marina; Gruden, Kristina] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia; [Witek, Kamil] Sainsbury Lab, Norwich, Norfolk, England; [Witek, Kamil] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Nova Gorica; National Institute of Biology - Slovenia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Miljkovic, D (corresponding author), Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia.	dragana.miljkovic@ijs.si	Gruden, kristina/AAI-6439-2020; Petek, Marko/L-6692-2019	Petek, Marko/0000-0003-3644-7827; Mozetic, Igor/0000-0002-5466-0608; gruden, kristina/0000-0001-5906-8569	Slovenian Research Agency [P4 0165, J4-2228, J4-4165, P2-0103]; AD Futura Scholarship	Slovenian Research Agency(Slovenian Research Agency - Slovenia); AD Futura Scholarship	This work was supported by the Slovenian Research Agency grants P4 0165, J4-2228, J4-4165 and P2-0103 and AD Futura Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiadou S, 2010, TRENDS BIOTECHNOL, V28, P381, DOI 10.1016/j.tibtech.2010.04.005; BARNES J, 1986, NATURE, V324, P446, DOI 10.1038/324446a0; Bird S., 2009, NATURAL LANGUAGE PRO; Blaschke C, 2001, Genome Inform, V12, P123; Blaschke C, 2002, IEEE INTELL SYST, V17, P14, DOI 10.1109/MIS.2002.999215; Blaschke C, 1999, Proc Int Conf Intell Syst Mol Biol, P60; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Carr JP, 2010, ADV VIRUS RES, V76, P57, DOI 10.1016/S0065-3527(10)76003-6; Chandra-Shekara AC, 2004, PLANT J, V40, P647, DOI 10.1111/j.1365-313X.2004.02241.x; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Chen HM, 2009, PLANT CELL, V21, P2527, DOI 10.1105/tpc.108.065193; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Cohen KB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040020; Corney DPA, 2004, BIOINFORMATICS, V20, P3206, DOI 10.1093/bioinformatics/bth386; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Devoto A, 2005, PHYSIOL PLANTARUM, V123, P161, DOI 10.1111/j.1399-3054.2004.00418.x; Eronen L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-119; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Genoud T, 2001, PLANT PHYSIOL, V126, P1430, DOI 10.1104/pp.126.4.1430; Gfeller A, 2010, SCI SIGNAL, V3; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Ibdah M, 2009, PLANT PHYSIOL, V150, P416, DOI 10.1104/pp.109.135848; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Kestler HA, 2008, BIOESSAYS, V30, P1110, DOI 10.1002/bies.20834; Kiss T, 2006, COMPUT LINGUIST, V32, P485, DOI 10.1162/coli.2006.32.4.485; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kohler J, 2006, BIOINFORMATICS, V22, P1383, DOI 10.1093/bioinformatics/btl081; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Krallinger M, 2009, NUCLEIC ACIDS RES, V37, pW160, DOI 10.1093/nar/gkp484; Krummenacker M, 2005, BIOINFORMATICS, V21, P3454, DOI 10.1093/bioinformatics/bti546; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Leon-Reyes A, 2010, MOL PLANT MICROBE IN, V23, P187, DOI 10.1094/MPMI-23-2-0187; Leon-Reyes A, 2009, PLANT PHYSIOL, V149, P1797, DOI 10.1104/pp.108.133926; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Maier F, 2011, MOL PLANT PATHOL, V12, P73, DOI 10.1111/j.1364-3703.2010.00653.x; Moore JW, 2011, PLANT CELL, V23, P2809, DOI 10.1105/tpc.111.087346; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Olmedo G, 2006, P NATL ACAD SCI USA, V103, P13286, DOI 10.1073/pnas.0605528103; Ono T, 2001, BIOINFORMATICS, V17, P155, DOI 10.1093/bioinformatics/17.2.155; Pieterse CMJ, 2001, AGBIOTECHNET, V3, P1; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Podpecan V, 2012, COMPUT J, V55, P82, DOI 10.1093/comjnl/bxr077; Raza S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-36; Raza S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-63; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Rhee SY, 2006, BIOTECH AGR FOREST, V57, P141; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Sato M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001011; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Sevon P, 2006, LECT NOTES COMPUT SC, V4075, P35; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Somssich IE, 1998, TRENDS PLANT SCI, V3, P86, DOI 10.1016/S1360-1385(98)01199-6; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stepanova Anna N, 2005, Sci STKE, V2005, pcm4, DOI 10.1126/stke.2762005cm4; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tsesmetzis N, 2008, PLANT CELL, V20, P1426, DOI 10.1105/tpc.108.057976; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; Tsuruoka Y, 2005, P C HUMAN LANGUAGE T, P467, DOI DOI 10.3115/1220575.1220634; van Wees SCM, 2000, P NATL ACAD SCI USA, V97, P8711, DOI 10.1073/pnas.130425197; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Zander M, 2010, PLANT J, V61, P200, DOI 10.1111/j.1365-313X.2009.04044.x; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042	71	17	22	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51822	10.1371/journal.pone.0051822	http://dx.doi.org/10.1371/journal.pone.0051822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272172	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300032
J	Regazzetti, C; Dumas, K; Le Marchand-Brustel, Y; Peraldi, P; Tanti, JF; Giorgetti-Peraldi, S				Regazzetti, Claire; Dumas, Karine; Le Marchand-Brustel, Yannick; Peraldi, Pascal; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie			Regulated in Development and DNA Damage Responses-1 (REDD1) Protein Contributes to Insulin Signaling Pathway in Adipocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SKELETAL-MUSCLE; MTORC1 REPRESSOR; ENERGY STRESS; EXPRESSION; HYPOXIA; GROWTH; INHIBITION; PHOSPHORYLATION; TARGET	REDD1 (Regulated in development and DNA damage response 1) is a hypoxia and stress response gene and is a negative regulator of mTORC1. Since mTORC1 is involved in the negative feedback loop of insulin signaling, we have studied the role of REDD1 on insulin signaling pathway and its regulation by insulin. In human and murine adipocytes, insulin transiently stimulates REDD1 expression through a MEK dependent pathway. In HEK-293 cells, expression of a constitutive active form of MEK stabilizes REDD1 and protects REDD1 from proteasomal degradation mediated by CUL4A-DDB1 ubiquitin ligase complex. In 3T3-L1 adipocytes, silencing of REDD1 with siRNA induces an increase of mTORC1 activity as well as an inhibition of insulin signaling pathway and lipogenesis. Rapamycin, a mTORC1 inhibitor, restores the insulin signaling after downregulation of REDD1 expression. This observation suggests that REDD1 positively regulates insulin signaling through the inhibition of mTORC1 activity. In conclusion, our results demonstrate that insulin increases REDD1 expression, and that REDD1 participates in the biological response to insulin.	[Regazzetti, Claire; Dumas, Karine; Le Marchand-Brustel, Yannick; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie] Mediterranean Res Ctr Mol Med, INSERM, U1065, Team Cellular & Mol Physiopathol Obes & Diabet, Nice, France; [Peraldi, Pascal] Fac Med Nice, INSERM, UMR 1091, UMR CNRS 7277, F-06034 Nice, France; [Regazzetti, Claire; Dumas, Karine; Le Marchand-Brustel, Yannick; Peraldi, Pascal; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie] Univ Nice Sophia Antipolis, UFR Med, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Giorgetti-Peraldi, S (corresponding author), Mediterranean Res Ctr Mol Med, INSERM, U1065, Team Cellular & Mol Physiopathol Obes & Diabet, Nice, France.	peraldis@unice.fr	Peraldi, Pascal/O-4592-2016	Peraldi, Pascal/0000-0003-0205-9252; Giorgetti-Peraldi, Sophie/0000-0002-2751-2618; Regazzetti, Claire/0000-0002-8094-5885; Tanti, Jean-Francois/0000-0003-1782-1318	INSERM, France; Societe Francophone du Diabete, Agence Nationale de la Recherche [ANR-09-GENO-036]; Association for Research on Diabetes (Paris, France); University of Nice-Sophia Antipolis; Region Provence- Alpes-Cote-d'Azur; Conseil General des Alpes Maritimes; European Commission [LSHM-CT-2005-018734]; Ministere de la recherche et de l'education; Societe Francophone du Diabete	INSERM, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Societe Francophone du Diabete, Agence Nationale de la Recherche(French National Research Agency (ANR)); Association for Research on Diabetes (Paris, France); University of Nice-Sophia Antipolis; Region Provence- Alpes-Cote-d'Azur(Region Provence-Alpes-Cote d'Azur); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministere de la recherche et de l'education; Societe Francophone du Diabete	This work was supported by INSERM, France, Societe Francophone du Diabete, Agence Nationale de la Recherche (ANR-09-GENO-036), the Association for Research on Diabetes (Paris, France), the University of Nice-Sophia Antipolis, Region Provence- Alpes-Cote-d'Azur, Conseil General des Alpes Maritimes. This work is part of the project "Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome'' (HEPADIP), which is supported by the European Commission as an integrated Project under the 6th Framework Program, Contract LSHM-CT-2005-018734. C. R. is a recipient of a fellowship from Ministere de la recherche et de l'education (2008-2011) and Societe Francophone du Diabete (2011-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-101; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Catania C, 2011, INT J OBESITY, V35, P751, DOI 10.1038/ijo.2010.208; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Favier FB, 2010, AM J PHYSIOL-REG I, V298, pR1659, DOI 10.1152/ajpregu.00550.2009; Frost RA, 2009, J CELL BIOCHEM, V108, P1192, DOI 10.1002/jcb.22349; Goenaga D, 2009, MOL ENDOCRINOL, V23, P1043, DOI 10.1210/me.2008-0360; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Kimball SR, 2012, BIOCHEM BIOPH RES CO, V427, P485, DOI 10.1016/j.bbrc.2012.09.074; Laplante M, 2012, CELL METAB, V16, P202, DOI 10.1016/j.cmet.2012.07.008; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; McGhee NK, 2009, J NUTR, V139, P828, DOI 10.3945/jn.108.099846; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Plaisant M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016798; Regazzetti C, 2010, J BIOL CHEM, V285, P5157, DOI 10.1074/jbc.M109.047688; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Ren SC, 2012, J MOL MED, V90, P1121, DOI 10.1007/s00109-012-0885-0; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schneider A, 2008, NEOPLASIA, V10, P1295, DOI 10.1593/neo.08586; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Siddle Kenneth, 2012, Front Endocrinol (Lausanne), V3, P34, DOI 10.3389/fendo.2012.00034; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Tanti JF, 1996, J BIOL CHEM, V271, P25227, DOI 10.1074/jbc.271.41.25227; Vega-Rubin-de-Celis S, 2010, BIOCHEMISTRY-US, V49, P2491, DOI 10.1021/bi902135e; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	40	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52154	10.1371/journal.pone.0052154	http://dx.doi.org/10.1371/journal.pone.0052154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272222	gold, Green Submitted, Green Published			2022-12-25	WOS:000312483300066
J	Krolewski, RC; Packard, A; Jang, W; Wildner, H; Schwob, JE				Krolewski, Richard C.; Packard, Adam; Jang, Woochan; Wildner, Hendrik; Schwob, James E.			Ascl1 (Mash1) Knockout Perturbs Differentiation of Nonneuronal Cells in Olfactory Epithelium	PLOS ONE			English	Article							GLOBOSE BASAL-CELLS; PROGENITOR-CELL; ELECTRON-MICROSCOPY; NOTCH1 EXPRESSION; NEURON LINEAGE; HES GENES; MOUSE; NEUROGENESIS; PROLIFERATION; REGENERATION	The embryonic olfactory epithelium (OE) generates only a very few olfactory sensory neurons when the basic helix-loop-helix transcription factor, ASCL1 (previously known as MASH1) is eliminated by gene mutation. We have closely examined the structure and composition of the OE of knockout mice and found that the absence of neurons dramatically affects the differentiation of multiple other epithelial cell types as well. The most prominent effect is observed within the two known populations of stem and progenitor cells of the epithelium. The emergence of horizontal basal cells, a multipotent progenitor population in the adult epithelium, is anomalous in the Ascl1 knockout mice. The differentiation of globose basal cells, another multipotent progenitor population in the adult OE, is also aberrant. All of the persisting globose basal cells are marked by SOX2 expression, suggesting a prominent role for SOX2 in progenitors upstream of Ascl1. However, NOTCH1-expressing basal cells are absent from the knockout; since NOTCH1 signaling normally acts to suppress Ascl1 via HES1 and drives sustentacular (Sus) cell differentiation during adult epithelial regeneration, its absence suggests reciprocity between neurogenesis and the differentiation of Sus cells. Indeed, the Sus cells of the mutant mice express a markedly lower level of HES1, strengthening that notion of reciprocity. Duct/gland development appears normal. Finally, the expression of cKIT by basal cells is also undetectable, except in those small patches where neurogenesis escapes the effects of Ascl1 knockout and neurons are born. Thus, persistent neurogenic failure distorts the differentiation of multiple other cell types in the olfactory epithelium.	[Krolewski, Richard C.; Packard, Adam; Jang, Woochan; Schwob, James E.] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Krolewski, Richard C.; Packard, Adam] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Cellular Mol & Dev Biol, Boston, MA 02111 USA; [Wildner, Hendrik] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland	Tufts University; Tufts University; University of Zurich	Schwob, JE (corresponding author), Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA.	jim.schwob@tufts.edu		Krolewski, Richard/0000-0001-5974-079X	National Institutes of Health (NIH) [RO1 DC002167, F30 DC010276]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F30DC010276, R01DC002167] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health (NIH) to JES (RO1 DC002167) and to RCK (F30 DC010276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Cai J, 2009, DEV BIOL, V326, P420, DOI 10.1016/j.ydbio.2008.11.021; Cau E, 2000, DEVELOPMENT, V127, P2323; Cau E, 1997, DEVELOPMENT, V124, P1611; Cau E, 2002, DEVELOPMENT, V129, P1871; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; CUSCHIERI A, 1975, J ANAT, V119, P277; CUSCHIERI A, 1975, J ANAT, V119, P471; Dahl L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002025; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Guo Z, 2007, 220092007 SOC NEUR; Guo Z, 2010, J COMP NEUROL, V518, P4395, DOI 10.1002/cne.22463; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; Ishida T, 2008, NEUROSCI LETT, V441, P277, DOI 10.1016/j.neulet.2008.06.045; Ito T, 2000, DEVELOPMENT, V127, P3913; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Kawauchi S, 2009, DEVELOPMENT, V136, P1453, DOI 10.1242/dev.034967; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Lukin K, 2008, SEMIN IMMUNOL, V20, P221, DOI 10.1016/j.smim.2008.07.004; Manglapus GL, 2004, J COMP NEUROL, V479, P216, DOI 10.1002/cne.20316; Murdoch B, 2008, J NEUROSCI, V28, P4271, DOI 10.1523/JNEUROSCI.5566-07.2008; Murray RGE, 2003, ASM NEWS, V69, P1; Noda M, 1981, BIOMEDICAL RES S, P449; Orita Y, 2006, ACTA OTO-LARYNGOL, V126, P498, DOI 10.1080/00016480500437419; Packard A, 2011, J COMP NEUROL, V519, P3580, DOI 10.1002/cne.22726; Packard A, 2011, J NEUROSCI, V31, P8748, DOI 10.1523/JNEUROSCI.0681-11.2011; Rodriguez S, 2008, DEV BIOL, V314, P40, DOI 10.1016/j.ydbio.2007.10.056; Schwarting GA, 2007, J MOL HISTOL, V38, P543, DOI 10.1007/s10735-007-9110-9; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Schwob JE, 2008, OLFACTION TASTE, P591; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Shou JY, 2000, DEVELOPMENT, V127, P5403; SMART IHM, 1971, J ANAT, V109, P243; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Weiler E, 1997, J NEUROSCI, V17, P3610; Weiler E, 1998, GLIA, V22, P315, DOI 10.1002/(SICI)1098-1136(199804)22:4<315::AID-GLIA1>3.0.CO;2-2; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Wildner H, 2006, DEVELOPMENT, V133, P2105, DOI 10.1242/dev.02345; WILSON POG, 1988, BRIT J EXP PATHOL, V69, P91	47	31	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51737	10.1371/journal.pone.0051737	http://dx.doi.org/10.1371/journal.pone.0051737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284756	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000312435900051
J	Li, GS; Li, HD; Yang, J; Zhang, WQ; Hou, ZS; Li, QC; Zhang, Y				Li, Gui-Shuang; Li, Hai-De; Yang, Jie; Zhang, Wen-Quan; Hou, Zong-Shen; Li, Qing-Chen; Zhang, Yun			Feasibility and Safety of Transthoracic Echocardiography-Guided Transcatheter Closure of Atrial Septal Defects with Deficient Superior-Anterior Rims	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; PERCUTANEOUS CLOSURE; OCCLUDER; UPDATE; ADULTS	Although previous studies showed that transthoracic echocardiography (TTE) can be used to guide transcatheter closure of atrial septal defect (ASD), whether TTE can be used to guide transcatheter closure of secundum ASD with a deficient superior-anterior rim is unknown and this critical issue was addressed in the present study. A total of 280 patients with secundum ASD who underwent transcatheter ASD closure were recruited and divided into groups A and B depending on ASD superior-anterior rim >4 mm (n = 118) or <= 4 mm (n = 162). TTE was used to guide Amplatzer-type septal occluder (ASO) positioning and assess residual shunt. Procedure success was defined as no, trivial and small residual shunt immediately after the procedure as assessed by color Doppler flow imaging. Group A and group B did not differ in complication rate (8.55% vs. 7.55%), procedure success rate (98.3% vs. 95.0%) or complete closure rate immediately after the procedure (89.7% vs. 89.3%) or at 6-month follow-up (98.3% vs. 96.8%). The mean procedure and fluoroscopy time in group B were much longer than those in group A. In conclusion, the absence of a sufficient superior-anterior rim in patients undergoing percutaneous closure of secundum-type ASDs using fluoroscopic and TTE guidance is associated with slightly greater device malposition and migration as well as increased procedural and fluoroscopic times, but the overall complication rate did not differ with TTE guidance when compared to historical controls that used TEE guidance.	[Li, Gui-Shuang; Hou, Zong-Shen; Li, Qing-Chen; Zhang, Yun] Shandong Univ, Qilu Hosp, Dept Cardiol, Chinese Minist Educ,Key Lab Cardiovasc Remodeling, Jinan 250100, Shandong, Peoples R China; [Li, Gui-Shuang; Hou, Zong-Shen; Li, Qing-Chen; Zhang, Yun] Shandong Univ, Qilu Hosp, Dept Cardiol, Chinese Minist Hlth, Jinan 250100, Shandong, Peoples R China; [Li, Hai-De] Yishui Peoples Hosp, Yishui, Shandong, Peoples R China; [Yang, Jie] Shandong Univ, Qilu Hosp, Dept Pediat, Jinan 250100, Shandong, Peoples R China; [Zhang, Wen-Quan] Dezhou Peoples Hosp, Dezhou, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Zhang, Y (corresponding author), Shandong Univ, Qilu Hosp, Dept Cardiol, Chinese Minist Educ,Key Lab Cardiovasc Remodeling, Jinan 250100, Shandong, Peoples R China.	zhangyun@sdu.edu.cn			National 973 Basic Research Program of China [2012CB518603, 2011CB503906]; tackle key problems in science and technology of Shandong Province [2010GSF10232]; National High-tech Research and Development Program of China [2012AA02A510]; Program of Introducing Talents of Discipline to Universities [B07035]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]; State Key Program of National Natural Science of China [60831003]	National 973 Basic Research Program of China(National Basic Research Program of China); tackle key problems in science and technology of Shandong Province; National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 973 Basic Research Program of China (No. 2012CB518603, 2011CB503906), the tackle key problems in science and technology of Shandong Province (No. 2010GSF10232), the National High-tech Research and Development Program of China (No. 2012AA02A510), the Program of Introducing Talents of Discipline to Universities (No. B07035), the State Program of National Natural Science Foundation of China for Innovative Research Group (No. 81021001), and the State Key Program of National Natural Science of China (No. 60831003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres NA, 2005, J AM SOC ECHOCARDIOG, V18, P91, DOI 10.1016/j.echo.2004.11.004; BOUTIN C, 1993, CIRCULATION, V88, P621, DOI 10.1161/01.CIR.88.2.621; Cao QL, 2000, EUR HEART J, V21, P941, DOI 10.1053/euhj.1999.1909; Cheitlin MD, 2003, J AM SOC ECHOCARDIOG, V16, P1091, DOI 10.1016/S0894-7317(03)00685-0; Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4; Du ZD, 2002, AM J CARDIOL, V90, P865, DOI 10.1016/S0002-9149(02)02709-1; Fischer G, 2003, HEART, V89, P199, DOI 10.1136/heart.89.2.199; Hijazi ZM, 2001, CATHETER CARDIO INTE, V52, P194, DOI 10.1002/1522-726X(200102)52:2<194::AID-CCD1046>3.3.CO;2-W; Huang CF, 2007, J FORMOS MED ASSOC, V106, P986, DOI 10.1016/S0929-6646(08)60073-X; Li GS, 2008, CHINESE MED J-PEKING, V121, P973, DOI 10.1097/00029330-200806010-00003; Li GS, 2009, ULTRASOUND MED BIOL, V35, P58, DOI 10.1016/j.ultrasmedbio.2008.06.008; Lin SM, 2003, ANESTH ANALG, V96, P1584, DOI 10.1213/01.ANE.0000062651.59656.B4; Podnar T, 2001, CATHETER CARDIO INTE, V53, P386, DOI 10.1002/ccd.1187; Rastogi N, 2009, PEDIATR CARDIOL, V30, P888, DOI 10.1007/s00246-009-9452-z; Therrien J, 2001, CAN J CARDIOL, V17, P940; Wang JK, 2004, AM HEART J, V148, P511, DOI 10.1016/j.ahj.2004.01.030; [朱鲜阳 Zhu Xianyang], 2011, [介入放射学杂志, Journal of Interventional Radiology], V20, P3	17	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51117	10.1371/journal.pone.0051117	http://dx.doi.org/10.1371/journal.pone.0051117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284660	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900012
J	Singh, MM; Howard, A; Irwin, ME; Gao, Y; Lu, XL; Multani, A; Chandra, J				Singh, Melissa M.; Howard, Adrienne; Irwin, Mary E.; Gao, Yin; Lu, Xiaolin; Multani, Asha; Chandra, Joya			Expression and Activity of Fyn Mediate Proliferation and Blastic Features of Chronic Myelogenous Leukemia	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; SRC-FAMILY KINASES; PROTEIN-TYROSINE KINASES; BCR-ABL; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; MOUSE OOCYTES; UP-REGULATION; TUMOR-CELLS; C-SRC	The BCR-ABL1 oncogene is a tyrosine kinase that activates many signaling pathways, resulting in the induction of chronic myeloid leukemia (CML). Kinase inhibitors, such as imatinib, have been developed for the treatment of CML; however, the terminal, blast crisis phase of the disease remains a clinical challenge. Blast crisis CML is difficult to treat due to resistance to tyrosine kinase inhibitors, increased genomic instability and acquired secondary mutations. Our recent studies uncovered a role for Fyn in promoting BCR-ABL1 mediated cell growth and sensitivity to imatinib. Here we demonstrate that Fyn contributes to BCR-ABL1 induced genomic instability, a feature of blast crisis CML. Bone marrow cells and mouse embryonic fibroblasts derived from Fyn knockout mice transduced with BCR-ABL1 display slowed growth and clonogenic potential as compared to Fyn wild-type BCR-ABL1 expressing counterparts. K562 cells overexpressing constitutively active Fyn kinase were larger in size and displayed an accumulation of genomic abnormalities such as chromosomal aberrations and polyploidy. Importantly, loss of Fyn protected mouse embryonic fibroblast cells from increased number of chromosomal aberrations and fragments induced by BCR-ABL1. Together, these results reveal a novel role for Fyn in regulating events required for genomic maintenance and suggest that Fyn kinase activity plays a role in the progression of CML to blast crisis.	[Singh, Melissa M.; Howard, Adrienne; Irwin, Mary E.; Gao, Yin; Lu, Xiaolin; Chandra, Joya] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA; [Multani, Asha] Univ Texas MD Anderson Canc Ctr, Mol Cytogenet Core Facil, Houston, TX 77030 USA; [Howard, Adrienne; Chandra, Joya] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Chandra, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA.	jchandra@mdanderson.org	lu, xl/HDO-8340-2022; Chandra, Joya/ABC-7869-2021	Chandra, Joya/0000-0002-2077-9715	National Institutes of Health [R01CA115811, F32CA150610, F32CA171905]; MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [F32CA171905, P30CA016672, F32CA150610, R01CA115811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson's Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported by the National Institutes of Health through R01CA115811 (to JC), F32CA150610 (to MMS), F32CA171905 (to MEI) and MD Anderson's Cancer Center Support Grant (CA016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALITALO R, 1990, LEUKEMIA RES, V14, P501, DOI 10.1016/0145-2126(90)90002-Q; Ban KC, 2008, BLOOD, V111, P2904, DOI 10.1182/blood-2007-05-091769; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Bihani T, 2004, CELL CYCLE, V3, P1201; Bihani T, 2007, J BIOL CHEM, V282, P2666, DOI 10.1074/jbc.M608127200; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; DAVIDSON D, 1994, J BIOL CHEM, V269, P10956; Dingemans AMC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-152; Doggrell SA, 2005, EXPERT OPIN INV DRUG, V14, P89, DOI 10.1517/13543784.14.1.89; Doki N, 2012, INT J HEMATOL, V95, P167, DOI 10.1007/s12185-011-0994-5; Fenouille N, 2010, CANCER RES, V70, P9659, DOI 10.1158/0008-5472.CAN-10-2034; Fibach E, 2005, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.im22f07s69, DOI 10.1002/0471142735.IM22F07S69]; Fusaki N, 1997, J BIOL CHEM, V272, P6214, DOI 10.1074/jbc.272.10.6214; Gao Y, 2009, J BIOL CHEM, V284, P7114, DOI 10.1074/jbc.M804801200; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; Gorre ME, 2002, BLOOD, V100, P3041, DOI 10.1182/blood-2002-05-1361; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Grosso S, 2009, MOL CANCER THER, V8, P1924, DOI 10.1158/1535-7163.MCT-09-0168; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Juric D, 2007, J CLIN ONCOL, V25, P1341, DOI 10.1200/JCO.2006.09.3534; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Kukharskyy V, 2004, EXP CELL RES, V298, P218, DOI 10.1016/j.yexcr.2004.04.016; Lam LT, 2000, J BIOL CHEM, V275, P19676, DOI 10.1074/jbc.M002866200; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Levi M, 2010, MOL CELL ENDOCRINOL, V314, P228, DOI 10.1016/j.mce.2009.08.027; Levi M, 2010, REPRODUCTION, V140, P827, DOI 10.1530/REP-10-0312; Levi M, 2010, CELL CYCLE, V9, P1577, DOI 10.4161/cc.9.8.11299; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; McGinnis LK, 2009, DEV BIOL, V327, P280, DOI 10.1016/j.ydbio.2008.11.038; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; NOWELL PC, 1961, JNCI-J NATL CANCER I, V27, P1013; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Payne CM, 2008, CLIN EXP GASTROENTER, V1, P19; Penserga ETP, 2007, ONCOGENE, V26, P11, DOI 10.1038/sj.onc.1209756; Phipps DJ, 1997, BLOOD, V90, P3603, DOI 10.1182/blood.V90.9.3603; Quackenbush RC, 2000, BLOOD, V95, P2913, DOI 10.1182/blood.V95.9.2913.009k32_2913_2921; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Roginskaya V, 1999, LEUKEMIA, V13, P855, DOI 10.1038/sj.leu.2401429; ROWLEY JD, 1980, CLIN HAEMATOL, V9, P55; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; SEIDELDUGAN C, 1992, MOL CELL BIOL, V12, P1835, DOI 10.1128/MCB.12.4.1835; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sette C, 2002, EMBO J, V21, P5386, DOI 10.1093/emboj/cdf553; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Shet AS, 2002, LEUKEMIA, V16, P1402, DOI 10.1038/sj.leu.2402577; Skorski T, 2002, NAT REV CANCER, V2, P351, DOI 10.1038/nrc799; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Talmor A, 1998, DEV BIOL, V194, P38, DOI 10.1006/dbio.1997.8816; TENHOEVE J, 1994, BLOOD, V84, P1731; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	67	25	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51611	10.1371/journal.pone.0051611	http://dx.doi.org/10.1371/journal.pone.0051611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284724	Green Submitted, gold, Green Published			2022-12-25	WOS:000312435900033
J	Ando, T; Sato, S; Toyooka, T; Kobayashi, H; Nawashiro, H; Ashida, H; Obara, M				Ando, Takahiro; Sato, Shunichi; Toyooka, Terushige; Kobayashi, Hiroaki; Nawashiro, Hiroshi; Ashida, Hiroshi; Obara, Minoru			Photomechanical Wave-Driven Delivery of siRNAs Targeting Intermediate Filament Proteins Promotes Functional Recovery after Spinal Cord Injury in Rats	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; SMALL INTERFERING RNA; INDUCED STRESS WAVES; IMPROVES NEURONAL SURVIVAL; ADENOVIRAL GENE-TRANSFER; GROWTH IN-VITRO; REACTIVE ASTROCYTES; NEURITE GROWTH; AXONAL GROWTH; GLIAL SCAR	The formation of glial scars after spinal cord injury (SCI) is one of the factors inhibiting axonal regeneration. Glial scars are mainly composed of reactive astrocytes overexpressing intermediate filament (IF) proteins such as glial fibrillary acidic protein (GFAP) and vimentin. In the current study, we delivered small interfering RNAs (siRNAs) targeting these IF proteins to SCI model rats using photomechanical waves (PMWs), and examined the restoration of motor function in the rats. PMWs are generated by irradiating a light-absorbing material with 532-nm nanosecond laser pulses from a Q-switched Nd:YAG laser. PMWs can site-selectively increase the permeability of the cell membrane for molecular delivery. Rat spinal cord was injured using a weight-drop device and the siRNA(s) solutions were intrathecally injected into the vicinity of the exposed SCI, to which PMWs were applied. We first confirmed the substantial uptake of fluorescence-labeled siRNA by deep glial cells; then we delivered siRNAs targeting GFAP and vimentin into the lesion. The treatment led to a significant improvement in locomotive function from five days post-injury in rats that underwent PMW-mediated siRNA delivery. This was attributable to the moderate silencing of the IF proteins and the subsequent decrease in the cavity area in the injured spinal tissue. Citation: Ando T, Sato S, Toyooka T, Kobayashi H, Nawashiro H, et al. (2012) Photomechanical Wave-Driven Delivery of siRNAs Targeting Intermediate Filament Proteins Promotes Functional Recovery after Spinal Cord Injury in Rats. PLoS ONE 7(12): e51744. doi:10.1371/journal.pone.0051744	[Sato, Shunichi; Ashida, Hiroshi] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 359, Japan; [Ando, Takahiro; Obara, Minoru] Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 223, Japan; [Toyooka, Terushige; Kobayashi, Hiroaki; Nawashiro, Hiroshi] Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan; Keio University; National Defense Medical College - Japan	Sato, S (corresponding author), Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 359, Japan.	shunsato@ndmc.ac.jp	Ando, Takahiro/H-5209-2019; Ando, Takahiro/R-8374-2019		National Defense Medical College; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [10J04881] Funding Source: KAKEN	National Defense Medical College; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for the Special Research Program of the National Defense Medical College and a Grant-in-Aid for Research Fellows of the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif AA, 2006, J NEUROSCI RES, V84, P553, DOI 10.1002/jnr.20968; Aizawa K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253325; Ando T, 2012, APPL PHYS A IN PRESS; Ando T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3642014; Ando T, 2012, ULTRASOUND MED BIOL, V38, P75, DOI 10.1016/j.ultrasmedbio.2011.10.020; Ando T, 2009, APPL SURF SCI, V255, P9898, DOI 10.1016/j.apsusc.2009.04.115; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; Desclaux M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006227; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Doukas AG, 2004, ADV DRUG DELIVER REV, V56, P559, DOI 10.1016/j.addr.2003.10.031; Duck F.A., 1990, MED PHYS, V18; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; FABBRO R, 1990, J APPL PHYS, V68, P775, DOI 10.1063/1.346783; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; Hyun JK, 2009, J NEUROTRAUM, V26, P1773, DOI [10.1089/neu.2007.0485, 10.1089/neu.2007-0485]; Kinouchi N, 2008, GENE THER, V15, P1126, DOI 10.1038/gt.2008.24; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Kondoh T, 2000, NEUROL MED-CHIR, V40, P618, DOI 10.2176/nmc.40.618; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Koshiyama K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.018105; Kurita A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3628313; Lauer U, 1997, GENE THER, V4, P710, DOI 10.1038/sj.gt.3300462; Lee S, 1996, ULTRASOUND MED BIOL, V22, P1285, DOI 10.1016/S0301-5629(96)00149-4; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Li SD, 2007, J CONTROL RELEASE, V123, P181, DOI 10.1016/j.jconrel.2007.09.004; Mannes AJ, 1998, BRAIN RES, V793, P1, DOI 10.1016/S0006-8993(97)01422-4; Menet V, 2000, GLIA, V31, P267, DOI 10.1002/1098-1136(200009)31:3<267::AID-GLIA80>3.0.CO;2-N; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Menet V, 2001, J NEUROSCI, V21, P6147; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Nakajima H, 2005, NEUROSCI LETT, V385, P30, DOI 10.1016/j.neulet.2005.05.012; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Ogura M, 2004, LASER SURG MED, V34, P242, DOI 10.1002/lsm.20024; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pettigrew DB, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-8; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; Romero MI, 1998, GENE THER, V5, P1612, DOI 10.1038/sj.gt.3300774; Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005; Sato S, 2011, OPT LETT, V36, P4545, DOI 10.1364/OL.36.004545; Satoh Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2128432; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Shimamura M, 2005, J GENE MED, V7, P1468, DOI 10.1002/jgm.793; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Takahashi M, 2007, J CONTROL RELEASE, V117, P267, DOI 10.1016/j.jconrel.2006.10.026; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Takeshita F, 2006, CANCER SCI, V97, P689, DOI 10.1111/j.1349-7006.2006.00234.x; Tang W, 2006, PLANT SCI, V171, P375, DOI 10.1016/j.plantsci.2006.04.005; Teng Q, 2005, GENE THER, V12, P108, DOI 10.1038/sj.gt.3302400; Terakawa M, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2160407; Terakawa M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2745313; Tillakaratne NJK, 2010, NEUROSCIENCE, V166, P23, DOI 10.1016/j.neuroscience.2009.12.010; Toyooka T, 2011, J NEUROTRAUM, V28, P607, DOI 10.1089/neu.2010.1520; von Meyenburg J, 1998, EXP NEUROL, V154, P583, DOI 10.1006/exnr.1998.6912; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Xie F, 2008, EXP NEUROL, V209, P302, DOI 10.1016/j.expneurol.2007.07.005; Yao CP, 2008, IEEE T NANOBIOSCI, V7, P111, DOI 10.1109/TNB.2008.2000742; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; You SW, 2003, RESTOR NEUROL NEUROS, V21, P39	78	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51744	10.1371/journal.pone.0051744	http://dx.doi.org/10.1371/journal.pone.0051744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272155	Green Submitted, gold, Green Published			2022-12-25	WOS:000312386800076
J	Carmona, SJ; Sartor, PA; Leguizamon, MS; Campetella, OE; Aguero, F				Carmona, Santiago J.; Sartor, Paula A.; Leguizamon, Maria S.; Campetella, Oscar E.; Agueero, Fernan			Diagnostic Peptide Discovery: Prioritization of Pathogen Diagnostic Markers Using Multiple Features	PLOS ONE			English	Article							B-CELL EPITOPES; TRYPANOSOMA-CRUZI; TANDEM REPEATS; ANTIGENIC DETERMINANTS; ENHANCE IMMUNOGENICITY; PROTEIN; PREDICTION; INFECTION; SELECTION; IMMUNODOMINANT	The availability of complete pathogen genomes has renewed interest in the development of diagnostics for infectious diseases. Synthetic peptide microarrays provide a rapid, high-throughput platform for immunological testing of potential B-cell epitopes. However, their current capacity prevent the experimental screening of complete "peptidomes". Therefore, computational approaches for prediction and/or prioritization of diagnostically relevant peptides are required. In this work we describe a computational method to assess a defined set of molecular properties for each potential diagnostic target in a reference genome. Properties such as sub-cellular localization or expression level were evaluated for the whole protein. At a higher resolution (short peptides), we assessed a set of local properties, such as repetitive motifs, disorder (structured vs natively unstructured regions), trans-membrane spans, genetic polymorphisms (conserved vs. divergent regions), predicted B-cell epitopes, and sequence similarity against human proteins and other potential cross-reacting species (e.g. other pathogens endemic in overlapping geographical locations). A scoring function based on these different features was developed, and used to rank all peptides from a large eukaryotic pathogen proteome. We applied this method to the identification of candidate diagnostic peptides in the protozoan Trypanosoma cruzi, the causative agent of Chagas disease. We measured the performance of the method by analyzing the enrichment of validated antigens in the high-scoring top of the ranking. Based on this measure, our integrative method outperformed alternative prioritizations based on individual properties (such as B-cell epitope predictors alone). Using this method we ranked similar to 10 million 12-mer overlapping peptides derived from the complete T. cruzi proteome. Experimental screening of 190 high-scoring peptides allowed the identification of 37 novel epitopes with diagnostic potential, while none of the low scoring peptides showed significant reactivity. Many of the metrics employed are dependent on standard bioinformatic tools and data, so the method can be easily extended to other pathogen genomes. Citation: Carmona SJ, Sartor PA, Leguizamon MS, Campetella OE, Aguero F (2012) Diagnostic Peptide Discovery: Prioritization of Pathogen Diagnostic Markers Using Multiple Features. PLoS ONE 7(12): e50748. doi:10.1371/journal.pone.0050748	[Carmona, Santiago J.; Leguizamon, Maria S.; Campetella, Oscar E.; Agueero, Fernan] Univ Nacl San Martin, Inst Tecnol Chascomus IIB INTECH, Inst Invest Biotecnol, Consejo Invest Cientif & Tecn UNSAM CONICET, San Martin, Buenos Aires, Argentina; [Sartor, Paula A.; Leguizamon, Maria S.] Univ Buenos Aires, Fac Med, Inst Microbiol & Parasitol Med, Buenos Aires, DF, Argentina	University of Buenos Aires	Aguero, F (corresponding author), Univ Nacl San Martin, Inst Tecnol Chascomus IIB INTECH, Inst Invest Biotecnol, Consejo Invest Cientif & Tecn UNSAM CONICET, San Martin, Buenos Aires, Argentina.	fernan@unsam.edu.ar	Carmona, Santiago J/E-9356-2015; Aguero, Fernan/F-5606-2013	Carmona, Santiago J/0000-0002-2495-0671; Aguero, Fernan/0000-0003-1331-5741; Campetella, Oscar/0000-0002-7018-375X	University of San Martin [PROG07F/1]; Special Programme for Research and Training in Tropical Diseases (WHO/World Bank/UNDP/UNICEF)	University of San Martin; Special Programme for Research and Training in Tropical Diseases (WHO/World Bank/UNDP/UNICEF)	This work was supported by grants from the University of San Martin (PROG07F/1) to Dr. Campetella and Dr. Aguero, and the Special Programme for Research and Training in Tropical Diseases (WHO/World Bank/UNDP/UNICEF) to Dr. Aguero. Dr. Carmona and Dr. Sartor are fellows of the National Research Council of Argentina (CONICET). Dr. Leguizamon, Dr. Campetella, and Dr. Aguero are members of the Research Career of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AA, 2009, NUCLEIC ACIDS RES, V37, pD544, DOI 10.1093/nar/gkn874; AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9; Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1; Alvarez P, 2001, INFECT IMMUN, V69, P7946, DOI 10.1128/IAI.69.12.7946-7949.2001; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Andresen Heiko, 2009, V509, P123, DOI 10.1007/978-1-59745-372-1_8; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; BURNS JM, 1992, P NATL ACAD SCI USA, V89, P1239, DOI 10.1073/pnas.89.4.1239; BUSCHIAZZO A, 1992, MOL BIOCHEM PARASIT, V54, P125, DOI 10.1016/0166-6851(92)90105-S; CAZZULO JJ, 1992, FASEB J, V6, P3259, DOI 10.1096/fasebj.6.14.1426764; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; FOLGORI A, 1994, EMBO J, V13, P2236, DOI 10.1002/j.1460-2075.1994.tb06501.x; Gaseitsiwe S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003840; Goto Y, 2008, INFECT IMMUN, V76, P3967, DOI 10.1128/IAI.00604-08; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Horn D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-2; Houghton RL, 1999, J INFECT DIS, V179, P1226, DOI 10.1086/314723; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kanduc Darja, 2010, Self Nonself, V1, P255, DOI 10.4161/self.1.3.11897; Kjerrulf M, 1997, MOL IMMUNOL, V34, P599, DOI 10.1016/S0161-5890(97)00078-3; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kronegg J, 1999, DETECTION PREDICTION; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liang L, 2011, J PROTEOME RES, V10, P4813, DOI 10.1021/pr200619r; Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381; List C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000771; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; Ludin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017546; Maksimov P, 2012, CLIN VACCINE IMMUNOL, V19, P865, DOI 10.1128/CVI.00119-12; Mollick Joseph A, 2003, Cancer Immun, V3, P3; Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Peeling RW, 2011, INFECT DIS CLIN N AM, V25, P693, DOI 10.1016/j.idc.2011.06.002; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PELLEQUER JL, 1991, METHOD ENZYMOL, V203, P176; Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723; Pereira CM, 1998, FEMS MICROBIOL LETT, V164, P125, DOI 10.1111/j.1574-6968.1998.tb13077.x; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; Torres D, 2006, INFECT IMMUN, V74, P4932, DOI 10.1128/IAI.00442-06; Toseland Christopher P, 2005, Immunome Res, V1, P4, DOI 10.1186/1745-7580-1-4; Vanniasinkam T, 2001, J CLIN MICROBIOL, V39, P1633, DOI 10.1128/JCM.39.4.1633-1637.2001; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Yankai Z, 2006, BIOCHEM BIOPH RES CO, V345, P1365, DOI 10.1016/j.bbrc.2006.05.022; ZHENG BJ, 1993, VACCINE, V11, P1191, DOI 10.1016/0264-410X(93)90042-V	63	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50748	10.1371/journal.pone.0050748	http://dx.doi.org/10.1371/journal.pone.0050748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272069	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800015
J	Pinamonti, G; Marro, J; Torres, JJ				Pinamonti, Giovanni; Marro, J.; Torres, Joaquin J.			Stochastic Resonance Crossovers in Complex Networks	PLOS ONE			English	Article							NOISE; INFORMATION; MODELS; FREQUENCY; SYSTEMS	Here we numerically study the emergence of stochastic resonance as a mild phenomenon and how this transforms into an amazing enhancement of the signal-to-noise ratio at several levels of a disturbing ambient noise. The setting is a cooperative, interacting complex system modelled as an Ising-Hopfield network in which the intensity of mutual interactions or "synapses" varies with time in such a way that it accounts for, e.g., a kind of fatigue reported to occur in the cortex. This induces nonequilibrium phase transitions whose rising comes associated to various mechanisms producing two types of resonance. The model thus clarifies the details of the signal transmission and the causes of correlation among noise and signal. We also describe short-time persistent memory states, and conclude on the limited relevance of the network wiring topology. Our results, in qualitative agreement with the observation of excellent transmission of weak signals in the brain when competing with both intrinsic and external noise, are expected to be of wide validity and may have technological application. We also present here a first contact between the model behavior and psychotechnical data. Citation: Pinamonti G, Marro J, Torres JJ (2012) Stochastic Resonance Crossovers in Complex Networks. PLoS ONE 7(12): e51170. doi:10.1371/journal.pone.0051170	[Torres, Joaquin J.] Univ Granada, Inst Carlos Theoret & Computat Phys 1, Granada, Spain; Univ Granada, Dept Electromagnetism & Matter Phys, Granada, Spain	University of Granada; University of Granada	Torres, JJ (corresponding author), Univ Granada, Inst Carlos Theoret & Computat Phys 1, Granada, Spain.	jtorres@onsager.ugr.es	Torres, Joaquín J./C-1385-2012; Torres, Joaquín J./AAE-6228-2019	Torres, Joaquín J./0000-0001-6175-9676; 	Andalusian Regional Government "Junta de Andalucia" [FQM-01505]; Spanish Science and Innovation Ministry MICINN-FEDER [FIS2009-08451]; Spanish Science and Innovation Ministry MICINN-GREIB [GREIB.PT_2011_19]	Andalusian Regional Government "Junta de Andalucia"(Junta de Andalucia); Spanish Science and Innovation Ministry MICINN-FEDER; Spanish Science and Innovation Ministry MICINN-GREIB	The work was supported by the following: Andalusian Regional Government "Junta de Andalucia," project number FQM-01505; Spanish Science and Innovation Ministry MICINN-FEDER, project number FIS2009-08451; and Spanish Science and Innovation Ministry MICINN-GREIB, project number GREIB.PT_2011_19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit DJ, 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; [Anonymous], 2009, EUR PHYS J B, V69, P1; Barbi M, 2005, BIOSYSTEMS, V79, P61, DOI 10.1016/j.biosystems.2004.09.003; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Brey JJ, 1996, PHYS LETT A, V216, P240, DOI 10.1016/0375-9601(96)00291-5; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Cortes JM, 2006, NEURAL COMPUT, V18, P614, DOI 10.1162/089976606775623342; de Franciscis S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041105; de Franciscis S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036114; Dimov II, 2012, QUANT FINANC, V12, P567, DOI 10.1080/14697688.2012.664931; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Fulinski A, 2000, J STAT PHYS, V101, P483, DOI 10.1023/A:1026463523619; GAMMAITONI L, 1989, PHYS REV LETT, V62, P349, DOI 10.1103/PhysRevLett.62.349; Ghosh PK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.020601; Golyandina N., 2001, ANAL TIME SERIES STR, DOI DOI 10.1201/9781420035841; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hong H, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021102; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izus GG, 1998, PHYS REV E, V58, P93, DOI 10.1103/PhysRevE.58.93; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Johnson S, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46006; JUNG P, 1995, PHYS REV LETT, V74, P2130, DOI 10.1103/PhysRevLett.74.2130; Kim BJ, 2001, EUROPHYS LETT, V56, P333, DOI 10.1209/epl/i2001-00524-7; Krawiecki A, 2008, ACTA PHYS POL B, V39, P1103; Krawiecki A, 2003, PHYSICA A, V317, P597, DOI 10.1016/S0378-4371(02)01375-4; Krawiecki A, 2009, EUR PHYS J B, V69, P81, DOI 10.1140/epjb/e2009-00082-x; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Lugo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002860; Marro J, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/02/P02017; Marro J., 1999, NONEQUILIBRIUM PHASE, DOI 10.1017/CBO9780511524288; McDonnell M.D., 2008, STOCH RES SUPR, DOI DOI 10.1017/CBO9780511535239; MCNAMARA B, 1989, PHYS REV A, V39, P4854, DOI 10.1103/PhysRevA.39.4854; Mejias JF, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48008; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Munakata T, 2005, J PHYS SOC JPN, V74, P2094, DOI 10.1143/JPSJ.74.2094; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Radicchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029910; Sagues F, 2007, PHYS TODAY, V79, P829; Sato AH, 2006, PHYSICA A, V369, P753, DOI 10.1016/j.physa.2006.02.009; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Snieder R, 2010, PHYS TODAY, V63, P44, DOI 10.1063/1.3490500; Tessone CJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.194101; Torres JJ, 2007, NEURAL COMPUT, V19, P2739, DOI 10.1162/neco.2007.19.10.2739; Torres JJ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053014; Torres JJ, 2008, NEURAL NETWORKS, V21, P1272, DOI 10.1016/j.neunet.2008.07.002; Torres JJ, 2004, NEUROCOMPUTING, V58, P229, DOI 10.1016/j.neucom.2004.01.048; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tuckwell HC, 2012, ARXIV1202249; Vilar JMG, 1997, PHYS REV LETT, V78, P2882, DOI 10.1103/PhysRevLett.78.2882; Weaver RL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.134301; Yasuda H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118103; Zhang JQ, 2008, SCI CHINA SER G, V51, P492, DOI 10.1007/s11433-008-0061-2	60	15	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51170	10.1371/journal.pone.0051170	http://dx.doi.org/10.1371/journal.pone.0051170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272090	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800028
J	Sarzynski, MA; Jacobson, P; Rankinen, T; Carlsson, B; Sjostrom, L; Bouchard, C; Carlsson, LMS				Sarzynski, Mark A.; Jacobson, Peter; Rankinen, Tuomo; Carlsson, Bjorn; Sjostrom, Lars; Bouchard, Claude; Carlsson, Lena M. S.			Changes in Uric Acid Levels following Bariatric Surgery Are Not Associated with SLC2A9 Variants in the Swedish Obese Subjects Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SERUM URATE; METABOLIC SYNDROME; BLOOD-PRESSURE; WEIGHT CHANGE; RISK-FACTORS; EXCRETION; FAMILY; GOUT; DETERMINANT	Context and Objective: Obesity and SLC2A9 genotype are strong determinants of uric acid levels. However, data on SLC2A9 variants and weight loss induced changes in uric acid levels are missing. We examined whether the changes in uric acid levels two- and ten-years after weight loss induced by bariatric surgery were associated with SLC2A9 single nucleotide polymorphisms (SNPs) in the Swedish Obese Subjects study. Methods: SNPs (N = 14) identified by genome-wide association studies and exonic SNPs in the SLC2A9 gene locus were genotyped. Cross-sectional associations were tested before (N = 1806), two (N = 1664) and ten years (N = 1201) after bariatric surgery. Changes in uric acid were compared between baseline and Year 2 (N = 1660) and years 2 and 10 (N = 1172). A multiple testing corrected threshold of P = 0.007 was used for statistical significance. Results: Overall, 11 of the 14 tested SLC2A9 SNPs were significantly associated with cross-sectional uric acid levels at all three time points, with rs13113918 showing the strongest association at each time point (R-2 = 3.725.2%, 3.9 x 10-(22)<= p <= 7.7 x 10(-11)). One SNP (rs737267) showed a significant association (R-2 = 0.60%, P = 0.002) with change in uric acid levels from baseline to Year 2, as common allele homozygotes (C/C, N = 957) showed a larger decrease in uric acid (-61.4 mu mol/L) compared to minor allele carriers (A/X: -51.7 mu mol/L, N = 702). No SNPs were associated with changes in uric acid from years 2 to 10. Conclusions: SNPs in the SLC2A9 locus contribute significantly to uric acid levels in obese individuals, and the associations persist even after considerable weight loss due to bariatric surgery. However, we found little evidence for an interaction between genotype and weight change on the response of uric acid to bariatric surgery over ten years. Thus, the fluctuations in uric acid levels among the surgery group appear to be driven by the weight losses and gains, independent of SLC2A9 genotypes. Citation: Sarzynski MA, Jacobson P, Rankinen T, Carlsson B, Sjostrom L, et al. (2012) Changes in Uric Acid Levels following Bariatric Surgery Are Not Associated with SLC2A9 Variants in the Swedish Obese Subjects Study. PLoS ONE 7(12): e51658. doi: 10.1371/journal.pone.0051658	[Jacobson, Peter; Carlsson, Bjorn; Sjostrom, Lars; Carlsson, Lena M. S.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Sarzynski, Mark A.; Rankinen, Tuomo; Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA USA	University of Gothenburg; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Carlsson, LMS (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden.	lena.carlsson@medic.gu.se	Bouchard, Claude/AAE-2035-2019; Bouchard, Claude/A-7637-2009; Sarzynski, Mark/A-9798-2014; Rankinen, Tuomo/N-1984-2017; Carlsson, Lena/F-7570-2018	Bouchard, Claude/0000-0002-0048-491X; Carlsson, Lena/0000-0003-4145-6242; Jacobson, Peter/0000-0002-1769-1827	Coypu Foundation; Swedish Research Council [K2010-55X-11285-13]; Swedish foundation for Strategic Research; Swedish Diabetes Foundation; Swedish federal government under the LUA/ALF agreement; John W. Barton Sr. Chair in Genetics and Nutrition; Hoffmann LaRoche; sanofi-aventis; Johnson Johnson; AstraZeneca; Biovitrum; Bristol-Myers Squibb; GlaxoSmithKline; Lenimen; Merck; Novo Nordisk; Servier	Coypu Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Diabetes Foundation; Swedish federal government under the LUA/ALF agreement; John W. Barton Sr. Chair in Genetics and Nutrition; Hoffmann LaRoche(Hoffmann-La Roche); sanofi-aventis(Sanofi-Aventis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); AstraZeneca(AstraZeneca); Biovitrum; Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Lenimen; Merck(Merck & Company); Novo Nordisk(Novo Nordisk); Servier(Servier)	This work was supported by grants from the Coypu Foundation to the Human Genomics Laboratory at Pennington Biomedical Research Center, the Swedish Research Council (K2010-55X-11285-13), the Swedish foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research, the Swedish Diabetes Foundation, and the Swedish federal government under the LUA/ALF agreement. C. Bouchard is partially supported by the John W. Barton Sr. Chair in Genetics and Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: P. Jacobson reported receiving research grants from Hoffmann LaRoche. B. Carlsson reported being employed by and holding stocks in AstraZeneca. L. Sjostrom reported obtaining unrestricted Swedish Obese Subjects grants from sanofi-aventis and Johnson & Johnson since 2007; receiving lecture and consulting fees from AstraZeneca, Biovitrum, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Lenimen, Merck, Novo Nordisk, Hoffmann LaRoche, sanofi-aventis, and Servier; and holding stocks in Lenimen and being chairman of its board. C. Bouchard reported receiving consulting fees from the Weight Watchers Scientific Advisory Board and is a member of the Scientific Advisory Board of Pathway Genomics. L. Carlsson reported serving as a consultant for AstraZeneca and holding stocks in Sahltech. The other authors have nothing to disclose. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Charles BA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-17; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dessein PH, 2000, ANN RHEUM DIS, V59, P539, DOI 10.1136/ard.59.7.539; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; HEYDEN S, 1985, J CHRON DIS, V38, P281, DOI 10.1016/0021-9681(85)90073-6; Ishizaka N, 2010, J RHEUMATOL, V37, P410, DOI 10.3899/jrheum.090736; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Luyckx FH, 1998, DIABETES METAB, V24, P355; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014; RAO DC, 1982, HUM GENET, V60, P257, DOI 10.1007/BF00303013; Rathmann W, 2007, EUR J EPIDEMIOL, V22, P439, DOI 10.1007/s10654-007-9132-3; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Neto AS, 2011, ARQ BRAS ENDOCRINOL, V55, P38, DOI 10.1590/S0004-27302011000100005; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Takahashi S, 1997, METABOLISM, V46, P1162, DOI 10.1016/S0026-0495(97)90210-9; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; WHITFIELD JB, 1983, ACTA GENET MED GEMEL, V32, P117, DOI 10.1017/S0001566000006401; Wilk JB, 2000, HUM GENET, V106, P355, DOI 10.1007/s004390051050; YAMASHITA S, 1986, INT J OBESITY, V10, P255	35	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51658	10.1371/journal.pone.0051658	http://dx.doi.org/10.1371/journal.pone.0051658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272134	Green Submitted, gold, Green Published			2022-12-25	WOS:000312386800061
J	Acevedo, P; Melo-Ferreira, J; Real, R; Alves, PC				Acevedo, Pelayo; Melo-Ferreira, Jose; Real, Raimundo; Celio Alves, Paulo			Past, Present and Future Distributions of an Iberian Endemic, Lepus granatensis: Ecological and Evolutionary Clues from Species Distribution Models	PLOS ONE			English	Article							CLIMATE-CHANGE; ENVIRONMENTAL SUITABILITY; REPRODUCTIVE-BIOLOGY; HABITAT SUITABILITY; MITOCHONDRIAL-DNA; NICHE OVERLAP; HARE; POPULATION; TIMIDUS; INTROGRESSION	The application of species distribution models (SDMs) in ecology and conservation biology is increasing and assuming an important role, mainly because they can be used to hindcast past and predict current and future species distributions. However, the accuracy of SDMs depends on the quality of the data and on appropriate theoretical frameworks. In this study, comprehensive data on the current distribution of the Iberian hare (Lepus granatensis) were used to i) determine the species' ecogeographical constraints, ii) hindcast a climatic model for the last glacial maximum (LGM), relating it to inferences derived from molecular studies, and iii) calibrate a model to assess the species future distribution trends (up to 2080). Our results showed that the climatic factor (in its pure effect and when it is combined with the land-cover factor) is the most important descriptor of the current distribution of the Iberian hare. In addition, the model's output was a reliable index of the local probability of species occurrence, which is a valuable tool to guide species management decisions and conservation planning. Climatic potential obtained for the LGM was combined with molecular data and the results suggest that several glacial refugia may have existed for the species within the major Iberian refugium. Finally, a high probability of occurrence of the Iberian hare in the current species range and a northward expansion were predicted for future. Given its current environmental envelope and evolutionary history, we discuss the macroecology of the Iberian hare and its sensitivity to climate change.	[Acevedo, Pelayo; Real, Raimundo] Univ Malaga, Biogeog Div & Conservat Res Team, E-29071 Malaga, Spain; [Acevedo, Pelayo; Melo-Ferreira, Jose; Celio Alves, Paulo] Univ Porto, InBio Lab Associado, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Acevedo, Pelayo] CSIC UCLM JCCM, Inst Invest Recursos Cineget, Ciudad Real, Spain; [Celio Alves, Paulo] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Celio Alves, Paulo] Univ Montana, Coll Forestry & Conservat, Wildlife Biol Program, Missoula, MT 59812 USA	Universidad de Malaga; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidade do Porto; University of Montana System; University of Montana	Acevedo, P (corresponding author), UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Campus Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain.	pelayo.acevedo@cresa.uab.cat	Melo-Ferreira, José/E-9784-2010; Acevedo, Pelayo/L-6737-2013; ALVES, Paulo Célio/B-5448-2009; Real, Raimundo/E-6559-2010	Melo-Ferreira, José/0000-0003-4473-1908; Acevedo, Pelayo/0000-0002-3509-7696; ALVES, Paulo Célio/0000-0003-4797-0939; Real, Raimundo/0000-0002-6642-1284	Vicerrectorado de Investigacion of the University of Malaga; Spanish Government [CGL2009-11316/BOS]; "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa'' of the Generalitat de Catalunya; European Community; Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/43264/2008]; European Social Fund; FCT [PTDC/BIA-EVF/111931/2009, PTDC/BIA-EVF/115069/2009]; FEDER	Vicerrectorado de Investigacion of the University of Malaga; Spanish Government(Spanish GovernmentEuropean Commission); "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa'' of the Generalitat de Catalunya(Generalitat de Catalunya); European Community(European Commission); Portuguese Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission)	P.A. was supported by the Vicerrectorado de Investigacion of the University of Malaga and partially by the project CGL2009-11316/BOS of the Spanish Government and FEDER. Currently, P.A. holds a Beatriu de Pinos fellowship funded by "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa'' of the Generalitat de Catalunya, and the COFUND Programme - Marie Curie Actions under 7th Marc Programme of the European Community. J.M.- F. was funded from the SFRH/BPD/43264/2008 post-doctoral grant by by Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) and the European Social Fund. Financial support was partially obtained from the Research Projects PTDC/BIA-EVF/111931/2009 and PTDC/BIA-EVF/115069/2009, by FCT and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2009, ANN ZOOL FENN, V46, P39, DOI 10.5735/086.046.0105; Acevedo P, 2007, ACTA OECOL, V31, P174, DOI 10.1016/j.actao.2006.09.003; Acevedo P, 2012, GLOBAL CHANGE BIOL, V18, P1509, DOI 10.1111/j.1365-2486.2012.02655.x; Acevedo P, 2011, LANDSCAPE ECOL, V26, P19, DOI 10.1007/s10980-010-9538-2; Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; Acevedo P, 2010, DIVERS DISTRIB, V16, P515, DOI 10.1111/j.1472-4642.2010.00662.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almeida J, 2004, QUANT GEO G, V13, P127; Altuna J., 1970, MUNIBE SOC CIENCIAS, V22, P165; Alves PC, 2003, MOL PHYLOGENET EVOL, V27, P70, DOI 10.1016/S1055-7903(02)00417-7; Alves PC, 2002, MAMM BIOL, V67, P358, DOI 10.1078/1616-5047-00051; Alzaga V, 2008, BEHAV ECOL SOCIOBIOL, V62, P769, DOI 10.1007/s00265-007-0502-3; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Barbosa AM, 2010, CONSERV BIOL, V24, P1378, DOI 10.1111/j.1523-1739.2010.01517.x; Barbosa AM, 2009, ECOL MODEL, V220, P747, DOI 10.1016/j.ecolmodel.2008.12.004; Bicheron P., 2008, GLOBCOVER 2005 PRODU; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Brambilla M, 2012, J ANIM ECOL, V81, P781, DOI 10.1111/j.1365-2656.2012.01970.x; Brambilla M, 2010, BIOL CONSERV, V143, P2770, DOI 10.1016/j.biocon.2010.07.025; Brambilla M, 2009, BIOL CONSERV, V142, P2033, DOI 10.1016/j.biocon.2009.03.033; Brunet M, 2007, GENERACION ESCENARIO; Carro F, 2010, LIBEBRE IBERICA; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; Delibes-Mateos M, 2007, BIOL CONSERV, V137, P149, DOI 10.1016/j.biocon.2007.01.024; ESRI, 2011, ARCGIS DESKT REL 10; Estrada A, 2011, BIOL CONSERV, V144, P1120, DOI 10.1016/j.biocon.2010.12.031; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farfan MA, 2012, J ZOOL, V286, P258, DOI 10.1111/j.1469-7998.2011.00873.x; Farfan MA, 2004, ACTA THERIOL, V49, P319, DOI 10.1007/BF03192531; Fouquet A, 2010, BIOL CONSERV, V143, P1375, DOI 10.1016/j.biocon.2010.03.012; Franklin J, 2009, MAPPING SPECIES DIST; Gao XJ, 2008, GLOBAL PLANET CHANGE, V62, P195, DOI 10.1016/j.gloplacha.2008.02.002; Gortazar C, 2007, WILDLIFE BIOL, V13, P244, DOI 10.2981/0909-6396(2007)13[244:ALSOBH]2.0.CO;2; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Illan JG, 2010, GLOBAL ECOL BIOGEOGR, V19, P159, DOI 10.1111/j.1466-8238.2009.00507.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Knowles LL, 2010, MOL ECOL, V19, P3727, DOI 10.1111/j.1365-294X.2010.04702.x; LAZO A, 1992, Z SAUGETIERKD, V57, P373; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Levinsky I, 2007, BIODIVERS CONSERV, V16, P3803, DOI 10.1007/s10531-007-9181-7; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121; Marquez AL, 2011, CLIMATIC CHANGE, V1-23; Melo-Ferreira J, 2007, MOL ECOL, V16, P605, DOI 10.1111/j.1365-294X.2006.03166.x; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Melo-Ferreira J, 2012, SYST BIOL, V61, P367, DOI 10.1093/sysbio/syr114; Melo-Ferreira J, 2009, MOL ECOL, V18, P2643, DOI 10.1111/j.1365-294X.2009.04221.x; Melo-Ferreira J, 2011, EVOLUTION, V65, P1956, DOI 10.1111/j.1558-5646.2011.01261.x; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Munoz AR, 2005, DIVERS DISTRIB, V11, P477, DOI 10.1111/j.1366-9516.2005.00188.x; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Pauperio J, 2008, EUR J WILDLIFE RES, V54, P571, DOI 10.1007/s10344-008-0181-z; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Real R, 2003, J BIOGEOGR, V30, P939, DOI 10.1046/j.1365-2699.2003.00871.x; Real R, 2009, DIVERS DISTRIB, V15, P390, DOI 10.1111/j.1472-4642.2008.00546.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rivas-Martinez S., 2004, BIOCLIMATIC MAP EURO; Sanchez-Fernandez D, 2011, DIVERS DISTRIB, V17, P163, DOI 10.1111/j.1472-4642.2010.00716.x; Smith AT, 2008, IUCN 2011 IUCN RED L; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x; Tapia L, 2010, ACTA THERIOL, V55, P73, DOI 10.4098/j.at.0001-7051.018.2009; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Tuanmu MN, 2011, J BIOGEOGR, V38, P1510, DOI 10.1111/j.1365-2699.2011.02479.x; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Vargas JM, 2007, WILDLIFE RES, V34, P498, DOI 10.1071/WR06012; Vaughn CC, 2000, ECOGRAPHY, V23, P11, DOI 10.1034/j.1600-0587.2000.230102.x; Wilson CD, 2011, BIOL CONSERV, V144, P821, DOI 10.1016/j.biocon.2010.11.014; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	86	24	24	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51529	10.1371/journal.pone.0051529	http://dx.doi.org/10.1371/journal.pone.0051529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272115	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386600029
J	Crawford, DC; Jiang, XP; Taylor, A; Moulder, KL; Mennerick, S				Crawford, Devon C.; Jiang, Xiaoping; Taylor, Amanda; Moulder, Krista L.; Mennerick, Steven			Differential Requirement for Protein Synthesis in Presynaptic Unmuting and Muting in Hippocampal Glutamate Terminals	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ACTIVE ZONE; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; POSTSYNAPTIC MECHANISMS; TRANSCRIPTION FACTOR; GENE-TRANSCRIPTION; PHORBOL ESTERS; GRANULE CELLS; LATE-PHASE	Synaptic function and plasticity are crucial for information processing within the nervous system. In glutamatergic hippocampal neurons, presynaptic function is silenced, or muted, after strong or prolonged depolarization. This muting is neuroprotective, but the underlying mechanisms responsible for muting and its reversal, unmuting, remain to be clarified. Using cultured rat hippocampal neurons, we found that muting induction did not require protein synthesis; however, slow forms of unmuting that depend on protein kinase A (PKA), including reversal of depolarization-induced muting and forskolin-induced unmuting of basally mute synapses, required protein synthesis. In contrast, fast unmuting of basally mute synapses by phorbol esters was protein synthesis-independent. Further studies of recovery from depolarization-induced muting revealed that protein levels of Rim1 and Munc13-1, which mediate vesicle priming, correlated with the functional status of presynaptic terminals. Additionally, this form of unmuting was prevented by both transcription and translation inhibitors, so proteins are likely synthesized de novo after removal of depolarization. Phosphorylated cyclic adenosine monophosphate response element-binding protein (pCREB), a nuclear transcription factor, was elevated after recovery from depolarization-induced muting, consistent with a model in which PKA-dependent mechanisms, possibly including pCREB-activated transcription, mediate slow unmuting. In summary, we found that protein synthesis was required for slower, PKA-dependent unmuting of presynaptic terminals, but it was not required for muting or a fast form of unmuting. These results clarify some of the molecular mechanisms responsible for synaptic plasticity in hippocampal neurons and emphasize the multiple mechanisms by which presynaptic function is modulated. Citation: Crawford DC, Jiang X, Taylor A, Moulder KL, Mennerick S (2012) Differential Requirement for Protein Synthesis in Presynaptic Unmuting and Muting in Hippocampal Glutamate Terminals. PLoS ONE 7(12): e51930. doi:10.1371/journal.pone.0051930	[Crawford, Devon C.; Jiang, Xiaoping; Taylor, Amanda; Moulder, Krista L.; Mennerick, Steven] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Crawford, Devon C.] Washington Univ, Sch Med, Grad Program Neurosci, St Louis, MO 63110 USA; [Mennerick, Steven] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Mennerick, Steven] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	menneris@psychiatry.wustl.edu	Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664; Crawford, Devon/0000-0002-9354-4976	National Institutes of Health [NS066611, DA015948, MH078823, NS52823]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS066611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA015948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The studies were supported by the National Institutes of Health grants NS066611 (DCC), DA015948 (KLM), MH078823 (SM), and NS52823 (SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Andrews-Zwilling YS, 2006, J BIOL CHEM, V281, P19720, DOI 10.1074/jbc.M601421200; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Chang CY, 2010, J NEUROSCI, V30, P10048, DOI 10.1523/JNEUROSCI.1159-10.2010; Chavis P, 1998, NEURON, V20, P773, DOI 10.1016/S0896-6273(00)81015-6; Crawford DC, 2012, NEUROSCIENTIST, V18, P216, DOI 10.1177/1073858411418525; Crawford DC, 2011, J NEUROSCI, V31, P979, DOI 10.1523/JNEUROSCI.4960-10.2011; Crawford DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008166; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; DUBINSKY JM, 1990, J NEUROBIOL, V21, P414, DOI 10.1002/neu.480210304; DUFFY C, 1981, SCIENCE, V212, P1148, DOI 10.1126/science.7233208; Duncan RR, 1999, J BIOL CHEM, V274, P27347, DOI 10.1074/jbc.274.39.27347; GERBER G, 1989, J NEUROSCI, V9, P3606; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Hogins J, 2011, NEUROBIOL DIS, V43, P516, DOI 10.1016/j.nbd.2011.05.005; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jancic D, 2009, CEREB CORTEX, V19, P2535, DOI 10.1093/cercor/bhp004; Jiang XP, 2010, J NEUROSCI, V30, P1798, DOI 10.1523/JNEUROSCI.4965-09.2010; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kaeser PS, 2012, P NATL ACAD SCI USA, V109, P11830, DOI 10.1073/pnas.1209318109; Kaneko M, 2004, J NEUROSCI, V24, P5202, DOI 10.1523/JNEUROSCI.0999-04.2004; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Khodthong C, 2011, CELL METAB, V14, P254, DOI 10.1016/j.cmet.2011.07.002; Kohara K, 2001, NEUROSCI RES, V41, P79, DOI 10.1016/S0168-0102(01)00267-X; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Moulder KL, 2004, NEURON, V42, P423, DOI 10.1016/S0896-6273(04)00184-9; Moulder KL, 2003, J NEUROSCI, V23, P1825; Moulder KL, 2010, J VIS EXP, V35, pe1676; Moulder KL, 2008, J NEUROSCI, V28, P5159, DOI 10.1523/JNEUROSCI.5317-07.2008; Moulder KL, 2006, J NEUROSCI, V26, P6618, DOI 10.1523/JNEUROSCI.5498-05.2006; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Sajikumar S, 2005, CURR OPIN NEUROBIOL, V15, P607, DOI 10.1016/j.conb.2005.08.009; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sokolova IV, 2006, J NEUROPHYSIOL, V95, P2570, DOI 10.1152/jn.00617.2005; STANTON PK, 1984, J NEUROSCI, V4, P3080; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011	63	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51930	10.1371/journal.pone.0051930	http://dx.doi.org/10.1371/journal.pone.0051930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272190	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386600049
J	Wakao, S; Kitada, M; Kuroda, Y; Ogura, F; Murakami, T; Niwa, A; Dezawa, M				Wakao, Shohei; Kitada, Masaaki; Kuroda, Yasumasa; Ogura, Fumitaka; Murakami, Toru; Niwa, Akira; Dezawa, Mari			Morphologic and Gene Expression Criteria for Identifying Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HUMAN FIBROBLASTS; HUMAN BLASTOCYSTS; DEFINED FACTORS; LINES; DIFFERENTIATION; MOUSE; SOX2; PRECURSORS; INDUCTION	Induced pluripotent stem (iPS) cells can be generated from somatic cells by the forced expression of four factors, Oct3/4, Sox2, Klf4, and c-Myc. While a great variety of colonies grow during induction, only a few of them develop into iPS cells. Researchers currently use visual observation to identify iPS cells and select colonies resembling embryonic stem (ES) cells, and there are no established objective criteria. Therefore, we exhaustively analyzed the morphology and gene expression of all the colonies generated from human fibroblasts after transfection with four retroviral vectors encoding individual factors (192 and 203 colonies in two experiments) and with a single polycistronic retroviral vector encoding all four factors (199 and 192 colonies in two experiments). Here we demonstrate that the morphologic features of emerged colonies can be categorized based on six parameters, and all generated colonies that could be passaged were classified into seven subtypes in colonies transfected with four retroviral vectors and six subtypes with a single polycistronic retroviral vector, both including iPS cell colonies. The essential qualifications for iPS cells were: cells with a single nucleolus; nucleus to nucleolus (N/Nls) ratio similar to 2.19: cell size similar to 43.5 mu m(2) : a nucleus to cytoplasm (N/C) ratio similar to 0.87: cell density in a colony similar to 5900 cells/mm(2) : and number of cell layer single. Most importantly, gene expression analysis revealed for the first time that endogenous Sox2 and Cdx2 were expressed specifically in iPS cells, whereas Oct3/4 and Nanog, popularly used markers for identifying iPS cells, are expressed in colonies other than iPS cells, suggesting that Sox2 and Cdx2 are reliable markers for identifying iPS cells. Our findings indicate that morphologic parameters and the expression of endogenous Sox2 and Cdx2 can be used to accurately identify iPS cells. Citation: Wakao S, Kitada M, Kuroda Y, Ogura F, Murakami T, et al. (2012) Morphologic and Gene Expression Criteria for Identifying Human Induced Pluripotent Stem Cells. PLoS ONE 7(12): e48677. doi:10.1371/journal.pone.0048677	[Wakao, Shohei; Kitada, Masaaki; Ogura, Fumitaka; Murakami, Toru; Dezawa, Mari] Tohoku Univ, Dept Stem Cell Biol & Histol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Kuroda, Yasumasa; Dezawa, Mari] Tohoku Univ, Grad Sch Med, Dept Anat & Anthropol, Sendai, Miyagi 980, Japan; [Niwa, Akira] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan	Tohoku University; Tohoku University; Kyoto University	Wakao, S (corresponding author), Tohoku Univ, Dept Stem Cell Biol & Histol, Grad Sch Med, Sendai, Miyagi 980, Japan.	wakao@med.tohoku.ac.jp; mdezawa@med.tohoku.ac.jp	Kitada, Masaaki/I-1591-2017	Kitada, Masaaki/0000-0002-4103-9767	Ministry of Education, Culture Sports, Science, and Technology, Japan [23390060]; Grants-in-Aid for Scientific Research [22790181, 23659145] Funding Source: KAKEN	Ministry of Education, Culture Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (23390060) from the Ministry of Education, Culture Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Khoo MLM, 2005, BIOL REPROD, V73, P1147, DOI 10.1095/biolreprod.104.036673; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Spassky N, 2000, GLIA, V29, P143, DOI 10.1002/(SICI)1098-1136(20000115)29:2<143::AID-GLIA7>3.3.CO;2-4; Spassky N, 1998, J NEUROSCI, V18, P8331; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; Ware CB, 2006, STEM CELLS, V24, P2677, DOI 10.1634/stemcells.2005-0452; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zappone MV, 2000, DEVELOPMENT, V127, P2367	26	33	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e48677	10.1371/journal.pone.0048677	http://dx.doi.org/10.1371/journal.pone.0048677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272044	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386600002
J	Pacheco-Quinto, J; Eckman, EA				Pacheco-Quinto, Javier; Eckman, Elizabeth A.			Endothelin-converting Enzymes Degrade Intracellular beta-Amyloid Produced within the Endosomal/Lysosomal Pathway and Autophagosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NONPEPTIDIC INHIBITORS; CELLULAR UPTAKE; PEPTIDE; PROTEIN; PHOSPHORAMIDON; ACCUMULATION; ENDOSOMES; METALLOPROTEASE; PHARMACOLOGY	Impairments in A beta removal are increasingly being considered as a possible cause for the abnormal A beta build-up typical of Alzheimer disease. Of particular interest is a pool of A beta that accumulates intraneuronally and may contribute to neuronal toxicity. The mechanism for intraneuronal accumulation, however, is not well understood and is commonly attributed to impaired removal of extracellular A beta by neurons. Based on the intracellular distribution of the well established A beta degrading enzymes, ECE-1 and ECE-2, we tested whether impairments in their catalytic activity could lead to intracellular A beta accumulation. Using SH-SY5Y cells overexpressing wild-type amyloid precursor protein and pharmacological inhibition of endogenous ECE activity, we found that ECEs participate in the degradation of at least two distinct pools of A beta; one destined for secretion and the other being produced and degraded within the endosomal-autophagic-lysosomal pathways. Although ECE-1 regulates both pools of A beta, ECE-2 regulates mainly the intracellular pool of the peptide. Consistent with this result, ECE-2 was found to co-localize with markers of the endosomal/lysosomal pathway but not with a trans-Golgi network marker. Furthermore, ECE-2 was detected in autophagic vesicles in cells treated with chloroquine. Under these conditions, ECE inhibition produced significantly higher elevations in intracellular A beta than chloroquine treatment alone. This study highlights the existence of A beta clearance mechanisms by ECEs at intracellular sites of production. Alterations in ECE activity may be considered as a cause for increased intraneuronal A beta in Alzheimer disease.	[Pacheco-Quinto, Javier; Eckman, Elizabeth A.] MidAtlantic Neonatol Associates, Biomed Res Inst New Jersey, Morristown, NJ 07960 USA; Atlantic Hlth Sys, Morristown, NJ 07960 USA	Atlantic Health System	Eckman, EA (corresponding author), Biomed Res Inst New Jersey, 140 E Hanover Ave, Cedar Knolls, NJ 07927 USA.	elizabeth.eckman@atlantichealth.org	Eckman, Elizabeth/AAL-7316-2021	Eckman, Elizabeth/0000-0002-5391-4960	NINDS, National Institutes of Health Grant [R01 NS073512]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073512] Funding Source: NIH RePORTER	NINDS, National Institutes of Health Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grant R01 NS073512 (to E. A. E.).	Abramowski D, 2012, J NEUROSCI, V32, P1273, DOI 10.1523/JNEUROSCI.4586-11.2012; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cattaruzza F, 2009, BRIT J PHARMACOL, V156, P730, DOI 10.1111/j.1476-5381.2008.00039.x; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; De Lombaert S, 2000, J MED CHEM, V43, P488, DOI 10.1021/jm990507o; DELOMBAERT S, 1995, BIOORG MED CHEM LETT, V5, P151, DOI 10.1016/0960-894X(94)00475-U; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Fauq AH, 2004, SYNTHETIC COMMUN, V34, P775, DOI 10.1081/SCC-120028350; FULLER SJ, 1995, BIOCHEMISTRY-US, V34, P8091, DOI 10.1021/bi00025a015; Glenner G G, 1984, Appl Pathol, V2, P357; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; GRUNDKEIQBAL I, 1989, P NATL ACAD SCI USA, V86, P2853, DOI 10.1073/pnas.86.8.2853; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haugabook SJ, 2001, J NEUROSCI METH, V108, P171, DOI 10.1016/S0165-0270(01)00388-0; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Ida N, 1996, FEBS LETT, V394, P174, DOI 10.1016/0014-5793(96)00948-9; Ikeda S, 2002, BIOCHEM BIOPH RES CO, V293, P421, DOI 10.1016/S0006-291X(02)00252-8; Jeng AY, 2000, J CARDIOVASC PHARM, V36, pS36; KUKKOLA PJ, 1995, J CARDIOVASC PHARM, V26, pS65; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lunemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115; Muller L, 2003, J BIOL CHEM, V278, P545, DOI 10.1074/jbc.M208949200; Nixon Ralph A, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a008839; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Pacheco-Quinto J., 2012, J ALZHEIMERS DIS; Pasternak SH, 2004, J ALZHEIMERS DIS, V6, P53; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Steinerman JR, 2008, ARCH NEUROL-CHICAGO, V65, P906, DOI 10.1001/archneur.65.7.906; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Turner AJ, 1996, BIOCHEM PHARMACOL, V51, P91, DOI 10.1016/0006-2952(95)02036-5; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	47	67	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5606	5615		10.1074/jbc.M112.422964	http://dx.doi.org/10.1074/jbc.M112.422964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23283972	hybrid, Green Published			2022-12-25	WOS:000315342500034
J	Yao, PP; Qian, L; Xia, Y; Xu, F; Yang, ZN; Xie, RH; Li, X; Liang, WF; Huang, XX; Zhu, ZY; Zhu, HP				Yao, Ping-Ping; Qian, Lei; Xia, Yong; Xu, Fang; Yang, Zhang-Nv; Xie, Rong-Hui; Li, Xiao; Liang, Wei-Feng; Huang, Xiao-Xiao; Zhu, Zhi-Yong; Zhu, Han-Ping			Enterovirus 71-Induced Neurological Disorders in Young Gerbils, Meriones unguiculatus: Development and Application of a Neurological Disease Model	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; 71 INFECTION; MOUTH-DISEASE; NEWBORN MICE; OUTBREAK; CHILDREN; TAIWAN; LETHAL; HAND; FOOT	A reliable disease model mimicking Enterovirus 71 (EV71) infection in humans is essential for understanding pathogenesis and for developing a safe and effective vaccine. Commonly used rodent models including mouse or rat models are not suitable for vaccine evaluation because the rodents are resistant to EV71 infection after they reach the age of 6 days. In this study, 21-day-old gerbils inoculated intraperitoneally (IP) with a non mouse-adapted EV71 strain developed neurological lesion-related signs including hind limb paralysis, slowness, ataxia and lethargy similar to those of central nervous system (CNS) infection of EV71 in humans. The infected gerbils eventually died of the neurological lesions and EV71 could be isolated from lung, liver, spleen, kidney, heart, spinal cord, brain cortex, brainstem and skeletal muscle. Significantly high virus replication was detected in spinal cord, brainstem and skeletal muscle by cellular analysis, real-time quantitative PCR (RT-PCR) and immunohistochemical staining. Histopathologic changes such as neuronal degeneration, neuronal loss and neuronophagia were observed in spinal cord, brain cortex, brainstem, and skeletal muscle along with necrotizing myositis and splenic atrophy. Gerbils that received two doses of inactive whole-virus vaccine showed no EV71-specific symptoms after challenged with EV71. In contrast, gerbils that received mock vaccination died of EV71-induced neuropathology after challenged with EV71. The result indicates that gerbils can serve as a reliable disease model for evaluating safety and efficacy of EV71 vaccine.	[Yao, Ping-Ping; Qian, Lei; Xia, Yong; Xu, Fang; Yang, Zhang-Nv; Xie, Rong-Hui; Zhu, Zhi-Yong; Zhu, Han-Ping] Zhejiang Prov Ctr Dis Prevent & Control, Key Lab Vaccine Hemorrhag Fever Renal Syndrome, Hangzhou, Zhejiang, Peoples R China; [Li, Xiao] First Municipal Hosp Hangzhou, Dept Pathol, Hangzhou, Zhejiang, Peoples R China; [Liang, Wei-Feng; Huang, Xiao-Xiao] Hangzhou Sixth Peoples Hosp, Hangzhou, Zhejiang, Peoples R China		Zhu, HP (corresponding author), Zhejiang Prov Ctr Dis Prevent & Control, Key Lab Vaccine Hemorrhag Fever Renal Syndrome, Hangzhou, Zhejiang, Peoples R China.	hanpingzhu@yahoo.com.cn			Natural Science Foundation of Zhejiang Province [Y3100701]; Medical and Technological Project of Zhejiang Province [2010KYB027]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Medical and Technological Project of Zhejiang Province	The work was granted by Natural Science Foundation of Zhejiang Province (Y3100701) and Medical and Technological Project of Zhejiang Province (2010KYB027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bek EJ, 2011, VACCINE, V29, P4829, DOI 10.1016/j.vaccine.2011.04.070; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chen CY, 2001, AM J NEURORADIOL, V22, P200; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Chung CY, 2010, VACCINE, V28, P6951, DOI 10.1016/j.vaccine.2010.08.052; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; CROSS J H, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P183; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; HSIUNG GD, 1994, HSIUNGS DIAGNOSTIC V, P119; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Ito Y, 1997, J CLIN MICROBIOL, V35, P1710, DOI 10.1128/JCM.35.7.1710-1714.1997; Khong WX, 2011, J VIROL, V85, P3067, DOI 10.1128/JVI.01779-10; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Nagata N, 2002, J MED VIROL, V67, P207, DOI 10.1002/jmv.2209; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yu CK, 2000, J BIOMED SCI, V7, P523, DOI 10.1007/BF02253368; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhu ZY, 1986, VIROLOGICA SINICA, V1, P19	34	24	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51996	10.1371/journal.pone.0051996	http://dx.doi.org/10.1371/journal.pone.0051996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284845	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800020
J	Suetta, C; Frandsen, U; Jensen, L; Jensen, MM; Jespersen, JG; Hvid, LG; Bayer, M; Petersson, SJ; Schroder, HD; Andersen, JL; Heinemeier, KM; Aagaard, P; Schjerling, P; Kjaer, M				Suetta, Charlotte; Frandsen, Ulrik; Jensen, Line; Jensen, Mette Munk; Jespersen, Jakob G.; Hvid, Lars G.; Bayer, Monika; Petersson, Stine J.; Schroder, Henrik D.; Andersen, Jesper L.; Heinemeier, Katja M.; Aagaard, Per; Schjerling, Peter; Kjaer, Michael			Aging Affects the Transcriptional Regulation of Human Skeletal Muscle Disuse Atrophy	PLOS ONE			English	Article							HUMAN QUADRICEPS MUSCLE; NF-KAPPA-B; UBIQUITIN LIGASES; PROTEIN-SYNTHESIS; GENE-EXPRESSION; MESSENGER-RNA; LIMB IMMOBILIZATION; PROTEASOME PATHWAY; APOPTOSIS; RAT	Important insights concerning the molecular basis of skeletal muscle disuse-atrophy and aging related muscle loss have been obtained in cell culture and animal models, but these regulatory signaling pathways have not previously been studied in aging human muscle. In the present study, muscle atrophy was induced by immobilization in healthy old and young individuals to study the time-course and transcriptional factors underlying human skeletal muscle atrophy. The results reveal that irrespectively of age, mRNA expression levels of MuRF-1 and Atrogin-1 increased in the very initial phase (2-4 days) of human disuse-muscle atrophy along with a marked reduction in PGC-1 alpha and PGC-1 beta (1-4 days) and a similar to 10% decrease in myofiber size (4 days). Further, an age-specific decrease in Akt and S6 phosphorylation was observed in young muscle within the first days (1-4 days) of immobilization. In contrast, Akt phosphorylation was unchanged in old muscle after 2 days and increased after 4 days of immobilization. Further, an age-specific down-regulation of MuRF-1 and Atrogin-1 expression levels was observed following 2 weeks of immobilization, along with a slowing atrophy response in aged skeletal muscle. Neither the immediate loss of muscle mass, nor the subsequent age-differentiated signaling responses could be explained by changes in inflammatory mediators, apoptosis markers or autophagy indicators. Collectively, these findings indicate that the time-course and regulation of human skeletal muscle atrophy is age dependent, leading to an attenuated loss in aging skeletal muscle when exposed to longer periods of immobility-induced disuse.	[Suetta, Charlotte; Jensen, Line; Jespersen, Jakob G.; Bayer, Monika; Andersen, Jesper L.; Heinemeier, Katja M.; Schjerling, Peter; Kjaer, Michael] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Inst Sports Med, Copenhagen, Denmark; [Suetta, Charlotte; Jensen, Line; Jespersen, Jakob G.; Bayer, Monika; Andersen, Jesper L.; Heinemeier, Katja M.; Schjerling, Peter; Kjaer, Michael] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Ctr Healthy Aging, Copenhagen, Denmark; [Frandsen, Ulrik; Jensen, Line; Jensen, Mette Munk; Hvid, Lars G.; Aagaard, Per] Univ So Denmark, Inst Exercise Physiol & Clin Biomech, Odense, Denmark; [Petersson, Stine J.; Schroder, Henrik D.] Odense Univ Hosp, Dept Clin Pathol, DK-5000 Odense, Denmark; [Suetta, Charlotte] Univ Copenhagen, Glostrup Hosp, Dept Clin Physiol & Nucl Med, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen	Suetta, C (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Inst Sports Med, Copenhagen, Denmark.	csuetta@gmail.com	Schjerling, Peter/F-6194-2011; Schrøder, Henrik Daa/E-2077-2013; Bayer, Monika/ABE-4909-2020; Andersen, Jesper L/W-6813-2019; Kjaer, Michael/W-6842-2019; suetta, charlotte/AAK-1257-2020	Schjerling, Peter/0000-0001-7138-3211; Schrøder, Henrik Daa/0000-0001-7588-235X; Kjaer, Michael/0000-0002-4582-8755; Dalgaard, Line Barner/0000-0001-7676-5323; Aagaard, Per/0000-0002-9773-7361; G Hvid, Lars/0000-0003-3233-0429	Danish National Research Council; Danish Rheumatology Association, Faculty of Health Sciences, University of Copenhagen; Danish Ministry of Culture, MYOAGE [223576]; European Commission; Nordea Foundation; Lundbeck Foundation	Danish National Research Council(Danmarks Grundforskningsfond); Danish Rheumatology Association, Faculty of Health Sciences, University of Copenhagen; Danish Ministry of Culture, MYOAGE; European Commission(European CommissionEuropean Commission Joint Research Centre); Nordea Foundation; Lundbeck Foundation(Lundbeckfonden)	The study was supported by grants from the Danish National Research Council, the Danish Rheumatology Association, Faculty of Health Sciences, University of Copenhagen, The Danish Ministry of Culture, MYOAGE (nr. 223576) funded by the European Commission under FP7, The Nordea Foundation and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Alway SE, 2001, EXP PHYSIOL, V86, P509, DOI 10.1113/eph8602235; Bar-Shai M, 2005, ANN NY ACAD SCI, V1057, P431, DOI 10.1196/annals.1356.034; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; Bloomfield SA, 1997, MED SCI SPORT EXER, V29, P197, DOI 10.1097/00005768-199702000-00006; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BOOTH FW, 1979, J APPL PHYSIOL, V47, P974, DOI 10.1152/jappl.1979.47.5.974; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Bruunsgaard H, 2003, AM J MED, V115, P278, DOI 10.1016/S0002-9343(03)00329-2; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Bruusgaard JC, 2008, J CLIN INVEST, V118, P1450, DOI 10.1172/JCI34022; Calura E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-630; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; de Boer MD, 2007, J PHYSIOL-LONDON, V585, P241, DOI 10.1113/jphysiol.2007.142828; Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001; Dupont-Versteegden EE, 2005, EXP GERONTOL, V40, P473, DOI 10.1016/j.exger.2005.04.003; Dupont-Versteegden EE, 2006, AM J PHYSIOL-REG I, V291, pR1730, DOI 10.1152/ajpregu.00176.2006; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; FURUNO K, 1990, J BIOL CHEM, V265, P8550; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Guerra B, 2011, J APPL PHYSIOL, V110, P1708, DOI 10.1152/japplphysiol.00091.2011; Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Hvid L, 2010, J APPL PHYSIOL, V109, P1628, DOI 10.1152/japplphysiol.00637.2010; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Kimball SR, 2004, AM J PHYSIOL-ENDOC M, V287, pE772, DOI 10.1152/ajpendo.00535.2003; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Leger B, 2008, REJUV RES, V11, P163, DOI 10.1089/rej.2007.0588; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malmgren LT, 2001, OTOLARYNG HEAD NECK, V125, P34, DOI 10.1067/mhn.2001.116449; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782; Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005; Marzetti E, 2009, MECH AGEING DEV, V130, P272, DOI 10.1016/j.mad.2008.12.008; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Pistilli EE, 2006, J GERONTOL A-BIOL, V61, P245, DOI 10.1093/gerona/61.3.245; Pistilli EE, 2006, APOPTOSIS, V11, P2115, DOI 10.1007/s10495-006-0194-6; Raffaello A, 2006, PHYSIOL GENOMICS, V25, P60, DOI 10.1152/physiolgenomics.00051.2005; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC338, DOI 10.1152/ajpcell.00239.2004; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Strasser H, 2000, J UROLOGY, V164, P1781, DOI 10.1016/S0022-5347(05)67106-6; Suetta C, 2009, J APPL PHYSIOL, V107, P1172, DOI 10.1152/japplphysiol.00290.2009; Suetta C, 2008, J APPL PHYSIOL, V105, P180, DOI 10.1152/japplphysiol.01354.2007; THOMASON DB, 1989, AM J PHYSIOL, V257, pR300, DOI 10.1152/ajpregu.1989.257.2.R300; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; WATSON PA, 1984, AM J PHYSIOL, V247, pC39, DOI 10.1152/ajpcell.1984.247.1.C39; Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8; Zhao JH, 2008, AUTOPHAGY, V4, P378, DOI 10.4161/auto.5633; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	68	111	111	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51238	10.1371/journal.pone.0051238	http://dx.doi.org/10.1371/journal.pone.0051238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284670	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300016
J	Koo, HJ; Gang, DR				Koo, Hyun Jo; Gang, David R.			Suites of Terpene Synthases Explain Differential Terpenoid Production in Ginger and Turmeric Tissues	PLOS ONE			English	Article							ZINGIBER-ZERUMBET SMITH; CURCUMA-LONGA; FUNCTIONAL-CHARACTERIZATION; GLANDULAR TRICHOMES; SESQUITERPENE SYNTHASES; BY-PRODUCT; BIOSYNTHESIS; OFFICINALE; CLONING; OIL	The essential oils of ginger (Zingiber officinale) and turmeric (Curcuma longa) contain a large variety of terpenoids, some of which possess anticancer, antiulcer, and antioxidant properties. Despite their importance, only four terpene synthases have been identified from the Zingiberaceae family: (+)-germacrene D synthase and (S)-beta-bisabolene synthase from ginger rhizome, and alpha-humulene synthase and beta-eudesmol synthase from shampoo ginger (Zingiber zerumbet) rhizome. We report the identification of 25 mono-and 18 sesquiterpene synthases from ginger and turmeric, with 13 and 11, respectively, being functionally characterized. Novel terpene synthases, (-)-caryolan-1-ol synthase and alpha-zingiberene/beta-sesquiphellandrene synthase, which is responsible for formation of the major sesquiterpenoids in ginger and turmeric rhizomes, were also discovered. These suites of enzymes are responsible for formation of the majority of the terpenoids present in these two plants. Structures of several were modeled, and a comparison of sets of paralogs suggests how the terpene synthases in ginger and turmeric evolved. The most abundant and most important sesquiterpenoids in turmeric rhizomes, (+)-alpha-turmerone and (+)-beta-turmerone, are produced from (-)-alpha-zingiberene and (-)-beta-sesquiphellandrene, respectively, via alpha-zingiberene/beta-sesquiphellandrene oxidase and a still unidentified dehydrogenase.	Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; Univ Arizona, Inst Bio5, Tucson, AZ USA	University of Arizona; University of Arizona	Gang, DR (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	gangd@wsu.edu			US National Science Foundation [DBI-0227618]	US National Science Foundation(National Science Foundation (NSF))	This research was funded by a grant from the US National Science Foundation to DRG (grant #DBI-0227618; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 1995, IDENTIFICATION ESSEN; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; de Kraker JW, 1998, PLANT PHYSIOL, V117, P1381, DOI 10.1104/pp.117.4.1381; Ficker CE, 2003, MYCOSES, V46, P29, DOI 10.1046/j.1439-0507.2003.00838.x; Fischer MJC, 2011, BIOTECHNOL BIOENG, V108, P1883, DOI 10.1002/bit.23129; Fujisawa M, 2010, PLANTA, V232, P121, DOI 10.1007/s00425-010-1137-6; Garms S, 2012, PHYTOCHEMISTRY, V75, P6, DOI 10.1016/j.phytochem.2011.12.009; Gennadios HA, 2009, BIOCHEMISTRY-US, V48, P6175, DOI 10.1021/bi900483b; Gopfert JC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-86; Golding BT, 1992, J CHEM SOC P1, V1, P1519; Habib SHM, 2008, CLINICS, V63, P807, DOI 10.1590/S1807-59322008000600017; Hiserodt R, 1996, J CHROMATOGR A, V740, P51, DOI 10.1016/0021-9673(96)00103-3; Hyatt DC, 2007, P NATL ACAD SCI USA, V104, P5360, DOI 10.1073/pnas.0700915104; Jayaprakasha GK, 2002, Z NATURFORSCH C, V57, P828; Jeong CH, 2009, CANCER RES, V69, P5584, DOI 10.1158/0008-5472.CAN-09-0491; Jiang HL, 2006, PHYTOCHEMISTRY, V67, P1673, DOI 10.1016/j.phytochem.2005.08.001; Jianjun Q, 2008, THORAC CARDIOV SURG, V56, P103, DOI 10.1055/s-2007-965708; Jurenka JS, 2009, ALTERN MED REV, V14, P141; KISO Y, 1983, PHYTOCHEMISTRY, V22, P596, DOI 10.1016/0031-9422(83)83057-X; Kreiser W, 1999, HELV CHIM ACTA, V82, P1427, DOI 10.1002/(SICI)1522-2675(19990908)82:9<1427::AID-HLCA1427>3.0.CO;2-S; Kundu JK, 2009, FORUM NUTR, V61, P182, DOI 10.1159/000212750; Lee HS, 2006, BIORESOURCE TECHNOL, V97, P1372, DOI 10.1016/j.biortech.2005.07.006; Lee Y, 2009, BMB REP, V42, P96, DOI 10.5483/BMBRep.2009.42.2.096; Leong-Skornickova J, 2007, ANN BOT-LONDON, V100, P505, DOI 10.1093/aob/mcm144; Lopez P, 2005, J AGR FOOD CHEM, V53, P6939, DOI 10.1021/jf050709v; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Nakano C, 2011, J BIOL CHEM, P21; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Nigam N, 2009, CANCER CHEMOTH PHARM, V24, P24; Nishiyama T, 2005, J AGR FOOD CHEM, V53, P959, DOI 10.1021/jf0483873; Oswald M, 2007, FEMS YEAST RES, V7, P413, DOI 10.1111/j.1567-1364.2006.00172.x; Picaud S, 2006, ARCH BIOCHEM BIOPHYS, V452, P17, DOI 10.1016/j.abb.2006.06.007; Ponnamperuma K, 1996, ARCH BIOCHEM BIOPHYS, V329, P9, DOI 10.1006/abbi.1996.0185; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Shukla Y, 2007, FOOD CHEM TOXICOL, V45, P683, DOI 10.1016/j.fct.2006.11.002; Wang G, 2005, CELL MOL LIFE SCI, V62, P881, DOI 10.1007/s00018-005-5017-3; Wang GD, 2008, PLANT PHYSIOL, V148, P1254, DOI 10.1104/pp.108.125187; YAMAHARA J, 1992, YAKUGAKU ZASSHI, V112, P645, DOI 10.1248/yakushi1947.112.9_645; YAMAHARA J, 1988, J ETHNOPHARMACOL, V23, P299, DOI 10.1016/0378-8741(88)90009-8; Yu F, 2008, FEBS LETT, V582, P565, DOI 10.1016/j.febslet.2008.01.020; Yu FN, 2008, PLANTA, V227, P1291, DOI 10.1007/s00425-008-0700-x; Zhuang XF, 2012, PLANT J, V69, P70, DOI 10.1111/j.1365-313X.2011.04771.x	44	30	33	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51481	10.1371/journal.pone.0051481	http://dx.doi.org/10.1371/journal.pone.0051481			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272109	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300017
J	Naf, S; Escote, X; Yanez, RE; Ballesteros, M; Simon, I; Gil, P; Megia, A; Vendrell, J				Naef, Silvia; Escote, Xavier; Elena Yanez, Rosa; Ballesteros, Monica; Simon, Inmaculada; Gil, Pilar; Megia, Ana; Vendrell, Joan			Zinc-alpha 2-Glycoprotein Is Unrelated to Gestational Diabetes: Anthropometric and Metabolic Determinants in Pregnant Women and Their Offspring	PLOS ONE			English	Article							LIPID-MOBILIZING FACTOR; SERUM ZINC-ALPHA-2-GLYCOPROTEIN; ADIPONECTIN; ZINC-ALPHA(2)-GLYCOPROTEIN; ADIPOKINE; GLUCOSE; WEIGHT; FAT; ZAG	Context: Zinc-alpha 2-Glycoprotein (ZAG) is an adipokine with lipolytic action and is positively associated with adiponectin in adipose tissue. We hypothesize that ZAG may be related with hydrocarbonate metabolism disturbances observed in gestational diabetes mellitus (GDM). Objective: The aim of this study was to analyze serum ZAG concentration and its relationship with carbohydrate metabolism in pregnant women and its influence on fetal growth. Design: 207 pregnant women (130 with normal glucose tolerance (NGT) and 77 with GDM) recruited in the early third trimester and their offspring were studied. Cord blood was obtained at delivery and neonatal anthropometry was assessed in the first 48 hours. ZAG was determined in maternal serum and cord blood. Results: ZAG concentration was lower in cord blood than in maternal serum, but similar concentration was observed in NGT and GDM pregnant women. Also similar levels were found between offspring of NGT and GDM women. In the bivariate analysis, maternal ZAG (mZAG) was positively correlated with adiponectin and HDL cholesterol, and negatively correlated with insulin and triglyceride concentrations, and HOMA index. On the other hand, cord blood ZAG (cbZAG) was positively correlated with fat-free mass, birth weight and gestational age at delivery. After adjusting for confounding variables, gestational age at delivery and HDL cholesterol emerged as the sole determinants of cord blood ZAG and maternal ZAG concentrations, respectively. Conclusion: mZAG was not associated with glucose metabolism during pregnancy. ZAG concentration was lower in cord blood compared with maternal serum. cbZAG was independently correlated with gestational age at delivery, suggesting a role during the accelerated fetal growth during latter pregnancy.	[Naef, Silvia; Escote, Xavier; Elena Yanez, Rosa; Simon, Inmaculada; Gil, Pilar; Megia, Ana; Vendrell, Joan] Univ Rovira & Virgili, IISPV, Endocrinol & Diabet Unit, Hosp Univ Tarragona Joan 23, Tarragona, Spain; [Naef, Silvia; Escote, Xavier; Elena Yanez, Rosa; Simon, Inmaculada; Gil, Pilar; Megia, Ana; Vendrell, Joan] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Ballesteros, Monica] Univ Rovira & Virgili, Obstet & Gynecol Serv, IISPV, Hosp Univ Tarragona Joan 23, Tarragona, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Naf, S (corresponding author), Univ Rovira & Virgili, IISPV, Endocrinol & Diabet Unit, Hosp Univ Tarragona Joan 23, Tarragona, Spain.	snafco@hotmail.com	Vendrell, Joan j/V-4034-2018; Escote, Xavier/AAC-6335-2019; Escote, Xavier/G-3440-2015; Escoté, Xavier/AAH-2973-2020; Gil, Pilar Rivera/W-6910-2019; Megia, Ana/W-5556-2019	Vendrell, Joan j/0000-0002-6994-6115; Escote, Xavier/0000-0003-1172-3995; Escote, Xavier/0000-0003-1172-3995; Gil, Pilar Rivera/0000-0002-6587-7538; Megia, Ana/0000-0002-5101-9452	Universitat Rovira I Virgili [Exp.2010 FIB01004]; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBERDEM is an initiative of the Instituto de Salud Carlos III [CB07708/0012]	Universitat Rovira I Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBERDEM is an initiative of the Instituto de Salud Carlos III	REY is supported by a fellowship Ajut predoctoral per a la contractacio de personal investigador novell (Exp.2010 FIB01004) from Universitat Rovira I Virgili. AM is grateful to the Institut d'Investigacio Sanitaria Pere Virgili (IISPV) for the 2010 grant: "Programa d'ajuts per el desenvolupament de la recerca". CIBERDEM is an initiative of the Instituto de Salud Carlos III (CB07708/0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; Ballesteros M, 2011, DIABETES CARE, V34, P2418, DOI 10.2337/dc11-0788; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Catalano PM, 1999, AM J OBSTET GYNECOL, V180, P903, DOI 10.1016/S0002-9378(99)70662-9; Ceperuelo-Mallafre V, 2009, J CLIN ENDOCR METAB, V94, P5062, DOI 10.1210/jc.2009-0764; DAUNCEY MJ, 1977, ARCH DIS CHILD, V52, P223, DOI 10.1136/adc.52.3.223; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Gong FY, 2009, INT J OBESITY, V33, P1023, DOI 10.1038/ijo.2009.141; HARRIS M, 1979, DIABETES, V28, P1039; Hirai K, 1998, CANCER RES, V58, P2359; Marrades MP, 2008, J PHYSIOL BIOCHEM, V64, P61, DOI 10.1007/BF03168235; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazaki-Tovi S, 2009, J PERINAT MED, V37, P637, DOI 10.1515/JPM.2009.101; Mracek T, 2010, CLIN ENDOCRINOL, V72, P334, DOI 10.1111/j.1365-2265.2009.03658.x; Ortega-Senovilla H, 2011, DIABETES CARE, V34, P2061, DOI 10.2337/dc11-0715; Retnakaran R, 2007, DIABETIC MED, V24, P245, DOI 10.1111/j.1464-5491.2007.02077.x; Russell ST, 2002, BRIT J CANCER, V86, P424, DOI 10.1038/sj.bjc.6600086; Russell ST, 2010, ENDOCRINOLOGY, V151, P948, DOI 10.1210/en.2009-0827; Selva DM, 2009, J CLIN ENDOCR METAB, V94, P4499, DOI 10.1210/jc.2009-0758; Sociedad espanola de ginecologia y obstetricia, 2006, AV DIABETOL, V22, P73; Stejskal D, 2008, CLIN BIOCHEM, V41, P313, DOI 10.1016/j.clinbiochem.2007.11.010; Stepan H, 2012, J ENDOCRINOL INVEST, V35, P562, DOI 10.3275/7877; TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221, DOI 10.1177/39.9.1918940; Tsangaris GT, 2006, IN VIVO, V20, P479; Yeung DCY, 2009, J CLIN ENDOCR METAB, V94, P2531, DOI 10.1210/jc.2009-0058; Yilmaz Y, 2011, CLIN CHEM LAB MED, V49, P93, DOI 10.1515/CCLM.2011.022	28	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e47601	10.1371/journal.pone.0047601	http://dx.doi.org/10.1371/journal.pone.0047601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272038	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300002
J	Yamazaki, S; Maruyama, A; Okada, K; Matsumoto, M; Morita, A; Seya, T				Yamazaki, Sayuri; Maruyama, Akira; Okada, Kohei; Matsumoto, Misako; Morita, Akimichi; Seya, Tsukasa			Dendritic Cells from Oral Cavity Induce Foxp3(+) Regulatory T Cells upon Antigen Stimulation	PLOS ONE			English	Article							RETINOIC-ACID; LANGERHANS CELLS; TGF-BETA; RECEPTOR; DIFFERENTIATION; HOMEOSTASIS; ACTIVATION; MICROBIOTA; TOLERANCE; EXPANSION	Evidence is accumulating that dendritic cells (DCs) from the intestines have the capacity to induce Foxp3(+) CD4(+) regulatory T cells (T-regs) and regulate immunity versus tolerance in the intestines. However, the contribution of DCs to controlling immunity versus tolerance in the oral cavity has not been addressed. Here, we report that DCs from the oral cavity induce Foxp3(+) T-regs as well as DCs from intestine. We found that oral-cavity-draining cervical lymph nodes contained higher frequencies of Foxp3(+) T-regs and ROR-gamma t(+) CD4(+) T cells than other lymph nodes. The high frequency of Foxp3(+) T-regs in the oral-cavity-draining cervical lymph nodes was not dependent on the Toll like receptor (TLR) adaptor molecules, Myd88 and TICAM-1 (TRIF). In contrast, the high frequency of ROR-gamma t(+) CD4(+) T cells relies on Myd88 and TICAM-1. In vitro data showed that CD11c(+) DCs from oral-cavity-draining cervical lymph nodes have the capacity to induce Foxp3(+) T-regs in the presence of antigen. These data suggest that, as well as in the intestinal environment, antigen-presenting DCs may play a vital role in maintaining tolerance by inducing Foxp3(+) T-regs in the oral cavity.	[Yamazaki, Sayuri; Maruyama, Akira; Okada, Kohei; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Yamazaki, Sayuri; Morita, Akimichi] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi, Japan	Hokkaido University; Nagoya City University	Yamazaki, S (corresponding author), Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Sapporo, Hokkaido, Japan.	yamazas@med.nagoya-cu.ac.jp; seya-tu@pop.med.hokudai.ac.jp	Seya, Tsukasa/A-4336-2012		Japan Society for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; MEXT; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Grants-in-Aid for Scientific Research [24659214] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by a Grant-in-Aid for challenging Exploratory Research (SY) and a Grant-in-Aid for Scientific Research B (SY) from Japan Society for the Promotion of Science, the Mochida Memorial Foundation for Medical and Pharmaceutical Research (SY) and Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced Research) and the Ministry of Health, Labor, and Welfare of Japan. Specified financial supports by a MEXT Grant-in-Project 'the Carcinogenic Spiral' and the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) are gratefully acknowledged. These funding bodies had no role in study design, data collection or analysis, the decision to publish, or preparation of the manuscript.	Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Azukizawa H, 2011, EUR J IMMUNOL, V41, P1420, DOI 10.1002/eji.201040930; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; de Aguero MG, 2012, J CLIN INVEST, V122, P1700, DOI 10.1172/JCI59725; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hanabuchi S, 2010, J IMMUNOL, V184, P2999, DOI 10.4049/jimmunol.0804106; Hand T, 2010, CURR OPIN IMMUNOL, V22, P63, DOI 10.1016/j.coi.2010.01.008; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Lieberman SM, 2012, EUR J IMMUNOL, V42, P1429, DOI 10.1002/eji.201142286; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Naik S, 2012, SCIENCE; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Onodera T, 2009, J IMMUNOL, V183, P5608, DOI 10.4049/jimmunol.0804116; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Yamazaki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018833; Yamazaki S, 2009, J DERMATOL SCI, V54, P69, DOI 10.1016/j.jdermsci.2009.02.001; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075	48	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51665	10.1371/journal.pone.0051665	http://dx.doi.org/10.1371/journal.pone.0051665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272135	Green Published, gold			2022-12-25	WOS:000312483300021
J	Bretler, DM; Hansen, PR; Lindhardsen, J; Ahlehoff, O; Andersson, C; Jensen, TB; Raunso, J; Torp-Pedersen, C; Gislason, GH				Bretler, Ditte-Marie; Hansen, Peter Riis; Lindhardsen, Jesper; Ahlehoff, Ole; Andersson, Charlotte; Jensen, Thomas Bo; Raunso, Jakob; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar			Hormone Replacement Therapy and Risk of New-Onset Atrial Fibrillation after Myocardial Infarction - A Nationwide Cohort Study	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; CARDIOVASCULAR EVENTS; POSTMENOPAUSAL WOMEN; MORTALITY; POPULATION; FLUTTER; PREVALENCE; VALIDATION; PREVENTION; DIAGNOSIS	Objectives: Our aim was to assess the association between use of hormone replacement therapy (HRT) and risk of new-onset atrial fibrillation (AF) after myocardial infarction. Design, Setting and Participants: We used Danish nationwide registers of hospitalizations and prescriptions to identify all women admitted with myocardial infarction in the period 1997 to 2009 and with no known diagnosis of AF. Their use of overall HRT and HRT categories was assessed. Multivariable Cox proportional hazards analysis was used to calculate the risk of new-onset AF first year after discharge, comparing use of HRT to no use. Main Outcome Measures: New-onset atrial fibrillation. Results: In the period 1997 to 2009, 32 925 women were discharged alive after MI. In the first year after MI, new-onset AF was diagnosed in 1381 women (4.2%). Unadjusted incidence rates of AF decreased with use of HRT (incidence rate 37.4 for use of overall HRT and 53.7 for no use). Overall HRT was associated with a decreased risk of AF (HR 0.82, 95% confidence interval [CI] 0.68-1.00). The lowest risk of AF was found in women >= 80 years old for use of overall HRT and vaginal estrogen (HR 0.63, CI 0.42-0.94, and HR 0.58, CI 0.34-0.99, respectively). Decreased risk of AF with use of overall HRT and HRT categories was also found in other age groups. Conclusions: Use of HRT is associated with a decreased risk of new-onset AF in women with myocardial infarction first year after discharge. The underlying mechanisms remain to be determined. Unmeasured confounding might be one of them.	[Bretler, Ditte-Marie; Hansen, Peter Riis; Lindhardsen, Jesper; Ahlehoff, Ole; Andersson, Charlotte; Jensen, Thomas Bo; Raunso, Jakob; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Torp-Pedersen, Christian] Univ Copenhagen, Panum Inst, Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Raunso, Jakob] Univ Copenhagen, Hosp Holbaek, Dept Internal Med, Holbaek, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Holbaek Hospital; University of Copenhagen	Bretler, DM (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark.	dimabr01@geh.regionh.dk	Torp-Pedersen, Christian/E-5931-2013; Gislason, Gunnar/B-7561-2009; Andersson, Charlotte/P-4849-2014; Hansen, Peter Riis/AAR-7659-2020; Jensen, Thomas Bo/H-9518-2019	Gislason, Gunnar/0000-0002-0548-402X; Jensen, Thomas Bo/0000-0002-8920-9374; Hansen, Peter Riis/0000-0002-9056-535X	Danish Heart Foundation [08-4-R65-A1904-B844-22440F]; Lundbeck Foundation [R31-A2566]; Novo Nordisk Foundation	Danish Heart Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	DMB was supported by the Danish Heart Foundation [grant 08-4-R65-A1904-B844-22440F], and the Lundbeck Foundation [grant R31-A2566]. Dr. Gislason has received a research grant from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili F, 1998, AM J CARDIOL, V82, P215, DOI 10.1016/S0002-9149(98)00314-2; Andersson P, 2012, J INTERN MED, V272, P170, DOI 10.1111/j.1365-2796.2012.02519.x; Aronson D, 2011, AM J CARDIOL, V107, P1738, DOI 10.1016/j.amjcard.2011.02.334; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Berry JD, 2010, AM J CARDIOL, V105, P844, DOI 10.1016/j.amjcard.2009.11.039; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Bretler DM, 2011, BRIT J CLIN PHARMACO, V71, P105, DOI 10.1111/j.1365-2125.2010.03790.x; Cavasin MA, 2003, AM J PHYSIOL-HEART C, V284, pH1560, DOI 10.1152/ajpheart.01087.2002; Christiansen CF, 2009, ARCH INTERN MED, V169, P1677, DOI 10.1001/archinternmed.2009.297; Cirillo DJ, 2005, JAMA-J AM MED ASSOC, V293, P330, DOI 10.1001/jama.293.3.330; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Ekholm O, 2009, SCAND J PUBLIC HEALT, V37, P758, DOI 10.1177/1403494809341095; Ettinger B, 2011, MENOPAUSE; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Frost L, 2007, AM J MED, V120, P47, DOI 10.1016/j.amjmed.2005.12.027; Gaist D, 1997, DAN MED BULL, V44, P445; Gislason GH, 2006, EUR HEART J, V27, P1153, DOI 10.1093/eurheartj/ehi705; Gorodeski EZ, 2010, MENOPAUSE, V17, P443, DOI 10.1097/gme.0b013e3181d0edaa; Guazzi M, 2009, HEART, V95, P102, DOI 10.1136/hrt.2007.135277; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Humphries KH, 2001, CIRCULATION, V103, P2365; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Jabre P, 2011, CIRCULATION, V123, P2094, DOI 10.1161/CIRCULATIONAHA.110.990192; Jons C, 2010, EUR J ECHOCARDIOGR, V11, P602, DOI 10.1093/ejechocard/jeq024; Karim R, 2010, MENOPAUSE, V17, P785, DOI 10.1097/gme.0b013e3181cc50b2; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Lokkegaard EL, 2004, ACTA OBSTET GYN SCAN, V83, P476, DOI 10.1111/j.0001-6349.2004.00376.x; Lokkegaard E, 2007, ACTA OBSTET GYN SCAN, V86, P1342, DOI 10.1080/00016340701505523; Maalouf NM, 2010, ARCH INTERN MED, V170, P1678, DOI 10.1001/archinternmed.2010.342; Macchia A, 2008, EUR J CLIN PHARMACOL, V64, P627, DOI 10.1007/s00228-008-0464-z; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Magnani JW, 2012, AM HEART J, V163, P729, DOI 10.1016/j.ahj.2012.01.010; Margolis DJ, 2002, LANCET, V359, P675, DOI 10.1016/S0140-6736(02)07806-6; Mitchell GF, 2007, JAMA-J AM MED ASSOC, V297, P709, DOI 10.1001/jama.297.7.709; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P146, DOI 10.1002/pds.2073; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schmidt M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3450; Shinmura K, 2008, CARDIOVASC RES, V79, P387, DOI 10.1093/cvr/cvn086; Smith PJW, 2000, CIRCULATION, V102, P2983; Tang JY, 2011, J NATL CANCER I, V103, P1469, DOI 10.1093/jnci/djr333; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; van Eickels M, 2003, J AM COLL CARDIOL, V41, P2084, DOI 10.1016/S0735-1097(03)00423-6; Vermeulen MJ, 2007, J CLIN EPIDEMIOL, V60, P971, DOI 10.1016/j.jclinepi.2006.12.009; Vestergaard P, 2010, CALCIFIED TISSUE INT, V86, P335, DOI 10.1007/s00223-010-9349-0; Zanger D, 2000, J AM COLL CARDIOL, V36, P1797, DOI 10.1016/S0735-1097(00)00952-9	49	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51580	10.1371/journal.pone.0051580	http://dx.doi.org/10.1371/journal.pone.0051580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284717	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900029
J	Vishwakarma, V; Pati, NB; Chandel, HS; Sahoo, SS; Saha, B; Suar, M				Vishwakarma, Vikalp; Pati, Niladri Bhusan; Chandel, Himanshu Singh; Sahoo, Sushree Sangeeta; Saha, Bhaskar; Suar, Mrutyunjay			Evaluation of Salmonella enterica Serovar Typhimurium TTSS-2 Deficient fur Mutant as Safe Live-Attenuated Vaccine Candidate for Immunocompromised Mice	PLOS ONE			English	Article							III SECRETION SYSTEM; IN-VIVO; COLITIS MODEL; MOUSE MODEL; T-CELLS; INFECTION; ENTERITIDIS; PROTECTION; STRAIN; HOST	Salmonella enterica serovar Typhimurium has been extensively exploited as live attenuated vaccines (LAV) which generally confers better protection than killed or subunit vaccines. However, many LAV are limited by their inherent ability to access systemic organs in many of the vaccinated hosts, especially those which are immunocompromised. We evaluated the efficacy of a live-attenuated SPI2-deficient (Delta ssaV) S. Typhimurium vaccine candidate (MT13) that additionally devoids the ferric uptake regulator (fur). We used specific pathogen free (SPF) streptomycin-pretreated mouse colitis model that included healthy C57BL/6 and immunocompromised iNos(-/-), IL10(-/-) and CD40L(-/-) in the background of C57BL/6 mice to assess the efficacy of developed vaccine candidate. In our study, the S. Typhimurium MT13 strain was established as a safe vaccine candidate to be administered in immunocompromised mice as it was found to be systemically attenuated without conferring significant pathological signs and growth defect within the host. In bacterial challenge experiment, the MT13-vaccinated C57BL/6 mice were protected from subsequent wild-type S. Typhimurium infection by inducing proficient mucosal immunity. The MT13 strain elicited efficient O-antigen specific mucosal secretory IgA associated protective response which was comparable with its parental ssaV mutant. Vaccination with MT13 also showed proficient T-cell activation in host mice; which has direct relation with pathogen clearance from host tissues. Collectively, these data implicate the possible application of SPI-2 deficient fur mutant (MT13) as a novel live attenuated vaccine strain with adept immunogenicity and improved safety, even in immunocompromised hosts. Further, this vaccine candidate can be employed to express heterologous antigens targeted against several other diseases, especially related to enterocolitic pathogens.	[Vishwakarma, Vikalp; Pati, Niladri Bhusan; Sahoo, Sushree Sangeeta; Suar, Mrutyunjay] KIIT Univ, Sch Biotechnol, Bhubaneswar, Odisha, India; [Chandel, Himanshu Singh; Saha, Bhaskar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Kalinga Institute of Industrial Technology (KIIT); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Suar, M (corresponding author), KIIT Univ, Sch Biotechnol, Bhubaneswar, Odisha, India.	msbiotek@yahoo.com	Sahoo, Sushree/AAA-8361-2022	Suar, Mrutyunjay/0000-0003-4815-5477; VISHWAKARMA, VIKALP/0000-0001-5555-2126	Department of Biotechnology, Ministry of Science and Technology, New Delhi, India [BT/PR14489/Med/29/207/2010]	Department of Biotechnology, Ministry of Science and Technology, New Delhi, India(Department of Biotechnology (DBT) India)	This study was funded by the Department of Biotechnology, Ministry of Science and Technology, New Delhi, India (grant BT/PR14489/Med/29/207/2010) to MS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APTER FM, 1993, INFECT IMMUN, V61, P5279, DOI 10.1128/IAI.61.12.5279-5285.1993; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Campoy S, 2002, MICROBIOL-SGM, V148, P1039, DOI 10.1099/00221287-148-4-1039; CHUTTANI C S, 1973, Bulletin of the World Health Organization, V48, P754; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; EISENSTEIN TK, 1984, J INFECT DIS, V150, P425, DOI 10.1093/infdis/150.3.425; El Ghany MA, 2007, INFECT IMMUN, V75, P1835, DOI 10.1128/IAI.01655-06; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Endt K, 2012, ANTIMICROB AGENTS CH, V56, P2295, DOI 10.1128/AAC.05819-11; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Fierer J, 2012, INFECT IMMUN, V80, P3360, DOI 10.1128/IAI.00404-12; Fraillery D, 2007, CLIN VACCINE IMMUNOL, V14, P1285, DOI 10.1128/CVI.00164-07; Garmory HS, 2002, FEMS MICROBIOL REV, V26, P339, DOI 10.1016/S0168-6445(02)00113-4; GAUTREAUX MD, 1994, INFECT IMMUN, V62, P2874, DOI 10.1128/IAI.62.7.2874-2884.1994; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; Gunn BM, 2010, CLIN VACCINE IMMUNOL, V17, P354, DOI 10.1128/CVI.00412-09; Hall HK, 1996, J BACTERIOL, V178, P5683, DOI 10.1128/jb.178.19.5683-5691.1996; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hegazy WAH, 2012, FUTURE MICROBIOL, V7, P111, DOI [10.2217/FMB.11.144, 10.2217/fmb.11.144]; Husseiny MI, 2005, INFECT IMMUN, V73, P1598, DOI 10.1128/IAI.73.3.1598-1605.2005; Hutchings AB, 2004, J VIROL, V78, P947, DOI 10.1128/JVI.78.2.947-957.2004; Johanns TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001043; Johnson M, 2011, INT J MED MICROBIOL, V301, P44, DOI 10.1016/j.ijmm.2010.05.003; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; Konjufca V, 2006, INFECT IMMUN, V74, P6785, DOI 10.1128/IAI.00851-06; Ku YW, 2005, INFECT IMMUN, V73, P8194, DOI 10.1128/IAI.73.12.8194-8203.2005; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Li YH, 2009, P NATL ACAD SCI USA, V106, P593, DOI 10.1073/pnas.0811697106; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; MILLER SI, 1990, RES MICROBIOL, V141, P817, DOI 10.1016/0923-2508(90)90115-7; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; Nagarajan AG, 2009, VACCINE, V27, P2804, DOI 10.1016/j.vaccine.2009.02.092; Negi VD, 2007, VACCINE, V25, P5315, DOI 10.1016/j.vaccine.2007.05.015; Roland KL, 2005, CURR OPIN MOL THER, V7, P62; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; Rychlik I, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-268; Santander J, 2012, INFECT IMMUN, V80, P2689, DOI 10.1128/IAI.00013-12; Spreng S, 2006, METHODS, V38, P133, DOI 10.1016/j.ymeth.2005.09.012; Suar M, 2006, INFECT IMMUN, V74, P632, DOI 10.1128/IAI.74.1.632-644.2006; Suar M, 2009, INFECT IMMUN, V77, P3569, DOI 10.1128/IAI.00511-09; Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711; Troxell B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-236; Troxell B, 2011, J BACTERIOL, V193, P497, DOI 10.1128/JB.00942-10; TSOLIS RM, 1995, J BACTERIOL, V177, P4628, DOI 10.1128/jb.177.16.4628-4637.1995; Vishwakarma V, 2012, INFECT IMMUN, V80, P3236, DOI 10.1128/IAI.00180-12; Yoo, 2007, J MICROBIOL BIOTECHN, V17, P1452; Yrlid U, 2001, INFECT IMMUN, V69, P5726, DOI 10.1128/IAI.69.9.5726-5735.2001	53	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52043	10.1371/journal.pone.0052043	http://dx.doi.org/10.1371/journal.pone.0052043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284865	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900072
J	Choi, JS; Baek, HM; Kim, S; Kim, MJ; Youk, JH; Moon, HJ; Kim, EK; Han, KH; Kim, DH; Kim, SI; Koo, JS				Choi, Ji Soo; Baek, Hyeon-Man; Kim, Suhkmann; Kim, Min Jung; Youk, Ji Hyun; Moon, Hee Jung; Kim, Eun-Kyung; Han, Kyung Hwa; Kim, Dong-Hyun; Kim, Seung Il; Koo, Ja Seung			HR-MAS MR Spectroscopy of Breast Cancer Tissue Obtained with Core Needle Biopsy: Correlation with Prognostic Factors	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CHOLINE KINASE-ACTIVITY; NEOADJUVANT CHEMOTHERAPY; NMR-SPECTROSCOPY; LESIONS; METABOLISM; DIAGNOSIS; WOMEN; MAMMOGRAPHY; MARKERS	The purpose of this study was to examine the correlation between high-resolution magic angle spinning (HR-MAS) magnetic resonance (MR) spectroscopy using core needle biopsy (CNB) specimens and histologic prognostic factors currently used in breast cancer patients. After institutional review board approval and informed consent were obtained for this study, CNB specimens were collected from 36 malignant lesions in 34 patients. Concentrations and metabolic ratios of various choline metabolites were estimated by HR-MAS MR spectroscopy using CNB specimens. HR-MAS spectroscopic values were compared according to histopathologic variables [tumor size, lymph node metastasis, histologic grade, status of estrogens receptor (ER), progesterone receptor (PR), HER2 (a receptor for human epidermal growth factor), and Ki-67, and triple negativity]. Multivariate analysis was performed with Orthogonal Projections to Latent Structure-Discriminant Analysis (OPLS-DA). HR-MAS MR spectroscopy quantified and discriminated choline metabolites in all CNB specimens of the 36 breast cancers. Several metabolite markers [free choline (Cho), phosphocholine (PC), creatine (Cr), taurine, myo-inositol, scyllo-inositol, total choline (tCho), glycine, Cho/Cr, tCho/Cr, PC/Cr] on HR-MAS MR spectroscopy were found to correlate with histologic prognostic factors [ER, PR, HER2, histologic grade, triple negativity, Ki-67, poor prognosis]. OPLS-DA multivariate models were generally able to discriminate the status of histologic prognostic factors (ER, PR, HER2, Ki-67) and prognosis groups. Our study suggests that HR-MAS MR spectroscopy using CNB specimens can predict tumor aggressiveness prior to surgery in breast cancer patients. In addition, it may be helpful in the detection of reliable markers for breast cancer characterization.	[Choi, Ji Soo; Kim, Min Jung; Youk, Ji Hyun; Moon, Hee Jung; Kim, Eun-Kyung] Yonsei Univ, Coll Med, Dept Radiol, Res Inst Radiol Sci, Seoul, South Korea; [Choi, Ji Soo] Natl Canc Ctr, Dept Radiol, Goyang Si, Gyeonggi Do, South Korea; [Baek, Hyeon-Man] Korea Basic Sci Inst, Div Magnet Resonance, Taejon, South Korea; [Kim, Suhkmann] Pusan Natl Univ, Chem Inst Funct Mat, Pusan, South Korea; [Kim, Suhkmann] Pusan Natl Univ, Dept Chem, Pusan, South Korea; [Han, Kyung Hwa] Yonsei Univ, Coll Med, Dept Res Affair, Seoul, South Korea; [Kim, Dong-Hyun] Yonsei Univ, Coll Elect & Elect Engn, Seoul 120749, South Korea; [Kim, Seung Il] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Koo, Ja Seung] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); Korea Basic Science Institute (KBSI); Pusan National University; Pusan National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, MJ (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Res Inst Radiol Sci, Seoul, South Korea.	mines@yuhs.ac	Kim, Eun-Kyung/E-5211-2017; Kim, Dong-Hyun/G-5096-2012	Kim, Eun-Kyung/0000-0002-3368-5013; koo, ja seung/0000-0003-4546-4709; Han, Kyunghwa/0000-0002-5687-7237; Moon, Hee Jung/0000-0002-5643-5885	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [A110700]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (A110700). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; American Cancer Society Inc, 2011, BREAST CANC FACTS FI; Bassett LW, 2007, RADIOL CLIN N AM, V45, P881, DOI 10.1016/j.rcl.2007.06.010; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Beckonert O, 2003, NMR BIOMED, V16, P1, DOI 10.1002/nbm.797; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Berg WA, 2007, RADIOL CLIN N AM, V45, P895, DOI 10.1016/j.rcl.2007.06.001; Birdsall T C, 1998, Altern Med Rev, V3, P128; Bolan PJ, 2003, MAGNET RESON MED, V50, P1134, DOI 10.1002/mrm.10654; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Bruening W, 2010, ANN INTERN MED, V152, P238, DOI 10.7326/0003-4819-152-1-201001050-00190; Cao MD, 2012, NMR BIOMED, V25, P369, DOI 10.1002/nbm.1762; Cecil KM, 2001, BREAST CANCER RES TR, V68, P45, DOI 10.1023/A:1017911211090; Chen JH, 2011, NMR BIOMED, V24, P316, DOI 10.1002/nbm.1595; Cheng LL, 1998, CANCER RES, V58, P1825; Cheng LL, 1998, J MAGN RESON, V135, P194, DOI 10.1006/jmre.1998.1578; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Dorrius MD, 2011, RADIOLOGY, V259, P695, DOI 10.1148/radiol.11101855; Duffy MJ, 2006, CLIN CHEM, V52, P345, DOI 10.1373/clinchem.2005.059832; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Giskeodegard GF, 2010, J PROTEOME RES, V9, P972, DOI 10.1021/pr9008783; Glunde K, 2006, EXPERT REV MOL DIAGN, V6, P821, DOI 10.1586/14737159.6.6.821; GREEN TR, 1991, BIOCHIM BIOPHYS ACTA, V1073, P91, DOI 10.1016/0304-4165(91)90187-L; GRIBBESTAD IS, 1993, ANTICANCER RES, V13, P1973; Gribbestad IS, 1999, ANTICANCER RES, V19, P1737; Gruber S, 2011, RADIOLOGY, V261, P752, DOI 10.1148/radiol.11102096; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Katz-Brull R, 2002, CANCER RES, V62, P1966; Koo JS, 2009, J KOREAN MED SCI, V24, P1150, DOI 10.3346/jkms.2009.24.6.1150; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Le-Petross HT, 2011, CANCER-AM CANCER SOC, V117, P3900, DOI 10.1002/cncr.25971; Lehman CD, 2007, NEW ENGL J MED, V356, P1295, DOI 10.1056/NEJMoa065447; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025563; Moran J, 2000, PFLUG ARCH EUR J PHY, V439, P271, DOI 10.1007/s004240050940; Mountford CE, 2001, BRIT J SURG, V88, P1234, DOI 10.1046/j.0007-1323.2001.01864.x; Nakagami K, 1999, JPN J CANCER RES, V90, P1212, DOI 10.1111/j.1349-7006.1999.tb00698.x; Natarajan K, 2000, ADV ENZYME REGUL, V40, P271, DOI 10.1016/S0065-2571(99)00026-6; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Roebuck JR, 1998, RADIOLOGY, V209, P269, DOI 10.1148/radiology.209.1.9769842; Sands CJ, 2009, ANAL CHEM, V81, P6458, DOI 10.1021/ac900828p; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shin HJ, 2012, AM J ROENTGENOL, V198, pW488, DOI 10.2214/AJR.11.7292; SINGER S, 1995, CANCER RES, V55, P5140; Sitter B, 2002, NMR BIOMED, V15, P327, DOI 10.1002/nbm.775; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; Sitter B, 2010, NMR BIOMED, V23, P424, DOI 10.1002/nbm.1478; Taylor JL, 2003, MAGNET RESON MED, V50, P627, DOI 10.1002/mrm.10562; Tozaki M, 2010, J MAGN RESON IMAGING, V31, P895, DOI 10.1002/jmri.22118; Wen H, 2010, J HEPATOL, V52, P228, DOI 10.1016/j.jhep.2009.11.002	49	31	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51712	10.1371/journal.pone.0051712	http://dx.doi.org/10.1371/journal.pone.0051712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272149	Green Published, gold			2022-12-25	WOS:000312386800070
J	Park, HY; Jun, CD; Jeon, SJ; Choi, SS; Kim, HR; Choi, DB; Kwak, S; Lee, HS; Cheong, JS; So, HS; Lee, YJ; Park, DS				Park, Hyun Young; Jun, Chang-Duk; Jeon, Se-Jeong; Choi, See-Sung; Kim, Hak-Ryul; Choi, Dan-Bee; Kwak, Seongae; Lee, Hak-Seung; Cheong, Jin Sung; So, Hong-Seob; Lee, Young-Jin; Park, Do-Sim			Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; EXPRESSION; ATHEROSCLEROSIS; INFLAMMATION; MACROPHAGES; POPULATION; BIOMARKER; DISEASE; INJURY	Background and Purpose: YKL-40 is associated with various neurological disorders. However, circulatory YKL-40 levels early after onset of acute ischemic stroke (AIS) have not been systematically assessed. We aimed to identify the temporal changes and clinical usefulness of measuring serum YKL-40 immediately following AIS. Methods: Serum YKL-40 and C-reactive protein (CRP) levels were monitored over time in AIS patients (n = 105) and compared with those of stroke-free controls (n = 34). Infarct volume and stroke severity (National Institutes of Health Stroke Scale; NIHSS) were measured within 48 hours of symptom onset, and functional outcome (modified Rankin Scale; mRS) was measured 3 months after AIS. Results: Within 12 hours of symptom onset, levels of YKL-40 (251 vs. 41 ng/mL) and CRP (1.50 vs. 0.96 mu g/mL) were elevated in AIS patients compared to controls. The power of YKL-40 for discriminating AIS patients from controls was superior to that of CRP (area under the curve 0.84 vs. 0.64) and YKL-40 (r = 0.26, P<0.001) but not CRP levels were correlated with mRS. On day 2 of admission (D2), YKL-40 levels correlated with infarct volume and NIHSS. High YKL-40 levels predicted poor functional outcome (odds ratio 5.73, P = 0.03). YKL-40 levels peaked on D2 and declined on D3, whereas CRP levels were highest on D3. Conclusions: Our results demonstrate serial changes in serum YKL-40 levels immediately following AIS and provide the first evidence that it is a valid indicator of AIS extent and an early predictor of functional outcome.	[Choi, Dan-Bee; Kwak, Seongae; Lee, Young-Jin; Park, Do-Sim] Wonkwang Univ, Sch Med, Dept Lab Med, Iksan, South Korea; [Park, Hyun Young; Lee, Hak-Seung] Wonkwang Univ, Sch Med, Dept Neurol, Iksan, South Korea; [Jun, Chang-Duk] GIST, Sch Life Sci, Kwangju, South Korea; [Jeon, Se-Jeong; Choi, See-Sung; Cheong, Jin Sung] Wonkwang Univ, Sch Med, Dept Radiol, Iksan, South Korea; [Kim, Hak-Ryul] Wonkwang Univ, Sch Med, Dept Internal Med, Iksan, South Korea; [So, Hong-Seob] Wonkwang Univ, Sch Med, Dept Microbiol, Iksan, South Korea; [So, Hong-Seob; Park, Do-Sim] Wonkwang Univ, Inst Wonkwang Clin Med, Sch Med, Iksan, South Korea; [So, Hong-Seob; Park, Do-Sim] Wonkwang Univ, Inst Wonkwang Med Sci, Ctr Metab Funct Regulat, Iksan, South Korea	Wonkwang University; Wonkwang University; Gwangju Institute of Science & Technology (GIST); Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University	Park, DS (corresponding author), Wonkwang Univ, Sch Med, Dept Lab Med, Iksan, South Korea.	emailds@hanmail.net	Park, Do-Sim/B-6594-2013; Park, Do-Sim/P-1529-2019; Park, Do-Sim/CAF-2588-2022	Park, Do-Sim/0000-0002-6001-4223; Park, Do-Sim/0000-0002-6001-4223; 	National Research Foundation of Korea (NRF); Korean government (MEST) [2011-0030718]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0030718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bonneh-Barkay D, 2012, BRAIN PATHOL, V22, P530, DOI 10.1111/j.1750-3639.2011.00550.x; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Coull BM, 2007, STROKE, V38, P631, DOI 10.1161/01.STR.0000255945.89287.23; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; den Hertog HM, 2009, J NEUROL, V256, P2003, DOI 10.1007/s00415-009-5228-x; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Idicula TT, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-18; Kastrup J, 2012, IMMUNOBIOLOGY, V217, P483, DOI 10.1016/j.imbio.2011.04.007; Kjaergaard AD, 2010, ANN NEUROL, V68, P672, DOI 10.1002/ana.22220; Michelsen AE, 2010, ATHEROSCLEROSIS, V211, P589, DOI 10.1016/j.atherosclerosis.2010.02.035; Ormstad H, 2011, J NEUROL, V258, P677, DOI 10.1007/s00415-011-6006-0; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Song IU, 2009, CEREBROVASC DIS, V28, P545, DOI 10.1159/000247597; van Everdingen KJ, 1998, STROKE, V29, P1783, DOI 10.1161/01.STR.29.9.1783; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Waje-Andreassen U, 2005, ACTA NEUROL SCAND, V111, P360, DOI 10.1111/j.1600-0404.2005.00416.x; Winbeck K, 2002, STROKE, V33, P2459, DOI 10.1161/01.STR.0000029828.51413.82; Youn CS, 2012, AM J EMERG MED, V30, P124, DOI 10.1016/j.ajem.2010.11.006	23	11	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51722	10.1371/journal.pone.0051722	http://dx.doi.org/10.1371/journal.pone.0051722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272150	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800071
J	Sommer, CA; Christodoulou, C; Gianotti-Sommer, A; Shen, SS; Sailaja, BS; Hezroni, H; Spira, A; Meshorer, E; Kotton, DN; Mostoslavsky, G				Sommer, Cesar A.; Christodoulou, Constantina; Gianotti-Sommer, Andreia; Shen, Steven S.; Sailaja, Badi Sri; Hezroni, Hadas; Spira, Avrum; Meshorer, Eran; Kotton, Darrell N.; Mostoslavsky, Gustavo			Residual Expression of Reprogramming Factors Affects the Transcriptional Program and Epigenetic Signatures of Induced Pluripotent Stem Cells	PLOS ONE			English	Article							C-MYC; IPS CELLS; GENERATION; MOUSE; DIFFERENTIATION; ACTIVATION; INDUCTION; COMPLEX; ES	Delivery of the transcription factors Oct4, Klf4, Sox2 and c-Myc via integrating viral vectors has been widely employed to generate induced pluripotent stem cell (iPSC) lines from both normal and disease-specific somatic tissues, providing an invaluable resource for medical research and drug development. Residual reprogramming transgene expression from integrated viruses nevertheless alters the biological properties of iPSCs and has been associated with a reduced developmental competence both in vivo and in vitro. We performed transcriptional profiling of mouse iPSC lines before and after excision of a polycistronic lentiviral reprogramming vector to systematically define the overall impact of persistent transgene expression on the molecular features of iPSCs. We demonstrate that residual expression of the Yamanaka factors prevents iPSCs from acquiring the transcriptional program exhibited by embryonic stem cells (ESCs) and that the expression profiles of iPSCs generated with and without c-Myc are indistinguishable. After vector excision, we find 36% of iPSC clones show normal methylation of the Gtl2 region, an imprinted locus that marks ESC-equivalent iPSC lines. Furthermore, we show that the reprogramming factor Klf4 binds to the promoter region of Gtl2. Regardless of Gtl2 methylation status, we find similar endodermal and hepatocyte differentiation potential comparing syngeneic Gtl2(ON) vs Gtl2(OFF) iPSC clones. Our findings provide new insights into the reprogramming process and emphasize the importance of generating iPSCs free of any residual transgene expression.	[Christodoulou, Constantina; Kotton, Darrell N.] Boston Univ, Ctr Pulm, Boston, MA 02215 USA; [Sommer, Cesar A.; Gianotti-Sommer, Andreia; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Dept Med, Gastroenterol Sect, Boston, MA 02118 USA; [Shen, Steven S.; Spira, Avrum] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA 02118 USA; [Sailaja, Badi Sri; Hezroni, Hadas; Meshorer, Eran] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel; [Kotton, Darrell N.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Hebrew University of Jerusalem; Boston University	Kotton, DN (corresponding author), Boston Univ, Ctr Pulm, Boston, MA 02215 USA.	dkotton@bu.edu; gmostosl@bu.edu	Sommer, Cesar A/H-9187-2013	Kotton, Darrell/0000-0002-9604-8476; Mostoslavsky, Gustavo/0000-0002-0784-2169; Spira, Avrum/0000-0003-1467-0489; Meshorer, Eran/0000-0003-4777-986X; Sailaja, Badi Sri/0000-0003-4488-738X; Christodoulou, Constantina/0000-0001-5371-2210	NIH [PO1 HL047049-16A1, 1RC2HL101535-01, 1R01 HL095993-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101535, P01HL047049, R01HL095993] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	GM and DNK are supported by NIH PO1 HL047049-16A1, 1RC2HL101535-01, and 1R01 HL095993-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki R, 2011, STEM CELLS, V29, P1362, DOI 10.1002/stem.685; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Christodoulou C, 2011, J CLIN INVEST, V121, P2313, DOI 10.1172/JCI43853; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; Hezroni H, 2011, J BIOL CHEM; Hezroni H, 2011, NUCLEUS-PHILA, V2, P300, DOI 10.4161/nucl.2.4.16767; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Martinez-Fernandez A, 2010, J CARDIOVASC TRANSL, V3, P13, DOI 10.1007/s12265-009-9150-5; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Sommer CA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt26; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Unternaehrer JJ, 2011, PHILOS T R SOC B, V366, P2274, DOI 10.1098/rstb.2011.0017; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	52	35	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51711	10.1371/journal.pone.0051711	http://dx.doi.org/10.1371/journal.pone.0051711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272148	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800069
J	Haga, C; Kondo, N; Suzuki, K; Sato, M; Ando, D; Yokomichi, H; Tanaka, T; Yamagata, Z				Haga, Chiyori; Kondo, Naoki; Suzuki, Kohta; Sato, Miri; Ando, Daisuke; Yokomichi, Hiroshi; Tanaka, Taichiro; Yamagata, Zentaro			Developmental Trajectories of Body Mass Index Among Japanese Children and Impact of Maternal Factors during Pregnancy	PLOS ONE			English	Article							CHILDHOOD OBESITY; GENDER-DIFFERENCES; RISK-FACTORS; SMOKING; ASSOCIATION; ADOLESCENTS; OVERWEIGHT; ADULTHOOD; ASTHMA; GROWTH	Background: The aims of this study were to 1) determine the distinct patterns of body mass index (BMI) trajectories in Japanese children, and 2) elucidate the maternal factors during pregnancy, which contribute to the determination of those patterns. Methodology/Principal Findings: All of the children (1,644 individuals) born in Koshu City, Japan, between 1991 and 1998 were followed in a longitudinal study exploring the subjects' BMI. The BMI was calculated 11 times for each child between birth and 12 years of age. Exploratory latent class growth analyses were conducted to identify trajectory patterns of the BMI z-scores. The distribution of BMI trajectories were best characterized by a five-group model for boys and a six-group model for girls. The groups were named "stable thin," "stable average," "stable high average," "progressive overweight," and "progressive obesity" in both sexes; girls were allocated to an additional group called "progressive average." Multinomial logistic regression found that maternal weight, smoking, and skipping breakfast during pregnancy were associated with children included in the progressive obesity pattern rather than the stable average pattern. These associations were stronger for boys than for girls. Conclusions/Significance: Multiple developmental patterns in Japanese boys and girls were identified, some of which have not been identified in Western countries. Maternal BMI and some unfavorable behaviors during early pregnancy may impact a child's pattern of body mass development. Further studies to explain the gender and regional differences that were identified are warranted, as these may be important for early life prevention of weight-associated health problems. Citation: Haga C, Kondo N, Suzuki K, Sato M, Ando D, et al. (2012) Developmental Trajectories of Body Mass Index Among Japanese Children and Impact of Maternal Factors during Pregnancy. PLoS ONE 7(12): e51896. doi: 10.1371/journal.pone.0051896	[Haga, Chiyori; Kondo, Naoki; Suzuki, Kohta; Sato, Miri; Yokomichi, Hiroshi; Yamagata, Zentaro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Yamanashi, Japan; [Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Dept Hlth Econ & Epidemiol Res, Tokyo, Japan; [Ando, Daisuke] Natl Def Acad, Dept Phys Educ, Kanagawa, Japan; [Tanaka, Taichiro] Toho Univ, Fac Med, Dept Environm & Occupat Hlth, Tokyo, Japan	University of Yamanashi; University of Tokyo; National Defence Academy - Japan; Toho University	Haga, C (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Yamanashi, Japan.	chiyorih@yamanashi.ac.jp; zenymgt@yamanashi.ac.jp	Kondo, Naoki/K-3898-2012; Yokomichi, Hiroshi/B-2816-2013; Kondo, Naoki/ABC-5865-2020	Kondo, Naoki/0000-0002-6425-6844; Yokomichi, Hiroshi/0000-0001-7369-155X; Kondo, Naoki/0000-0002-6425-6844	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [24792544, 22119504, 23390173]; Grants-in-Aid for Scientific Research [24790614, 23390173, 24792544] Funding Source: KAKEN	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) 24792544, 22119504, 23390173 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. (http://www.jsps.go.jp/j-grantsinaid/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alati R, 2006, EPIDEMIOLOGY, V17, P138, DOI 10.1097/01.ede.0000198148.02347.33; Bao Weihang, 1994, Archives of Internal Medicine, V154, P1842, DOI 10.1001/archinte.154.16.1842; Baschat AA, 2011, ULTRASOUND OBST GYN, V37, P501, DOI 10.1002/uog.9008; Costello J, 2007, MEASUREMENT DESIGN L; Dietz WH, 2000, LANCET, V356, P2027, DOI 10.1016/S0140-6736(00)03396-1; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Figueroa-Munoz JI, 2001, THORAX, V56, P133, DOI 10.1136/thorax.56.2.133; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Galloway T, 2007, AM J HUM BIOL, V19, P774, DOI 10.1002/ajhb.20637; Gorog K, 2011, MATERN CHILD HLTH J, V15, P985, DOI 10.1007/s10995-009-0543-5; Hejazi Samar, 2009, Health Rep, V20, P63; Hoekstra T, 2011, LONGITUD LIFE COURSE, V2, P319; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2010, TRAJ GROUP BASED MOD; Kass ER, 1995, J AM STAT ASSOC, V90, P928; Kim S, 2003, J NUTR, V133, P3476, DOI 10.1093/jn/133.11.3476; Kirchengast S, 2008, COLLEGIUM ANTROPOL, V32, P1079; Lewy VD, 2001, J PEDIATR-US, V138, P38, DOI 10.1067/mpd.2001.109603; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Li JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011896; Lorson BA, 2009, J AM DIET ASSOC, V109, P474, DOI 10.1016/j.jada.2008.11.022; Ludwig DS, 2001, JAMA-J AM MED ASSOC, V286, P1427, DOI 10.1001/jama.286.12.1427; Malina MR, 1991, DEV PHYS; Mizutani T, 2007, OBESITY, V15, P3133, DOI 10.1038/oby.2007.373; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; National Obesity Observatory, 2009, INT COMP OBESITY PRE; Papalia D. E., 2009, HUMAN DEV; Parizkova J., 2005, CHILDHOOD OBESITY PR, V2nd ed., DOI [10.1201/9781420038965, DOI 10.1201/9781420038965]; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; SMOAK CG, 1987, AM J EPIDEMIOL, V125, P364, DOI 10.1093/oxfordjournals.aje.a114543; Suzuki K, 2012, J EPIDEMIOL; Suzuki K, 2010, INT J OBES LOND; Suzuki K, 2009, J EPIDEMIOL, V19, P136, DOI 10.2188/jea.JE20081012; Takayanagi K, 1993, Clin Perform Qual Health Care, V1, P29; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; US Department of Health and Human Services & US Department of Agriculture, 2010, DIET GUID AM 2010; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; WHO, 2006, WHO CHILD GROWTH STA	43	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51896	10.1371/journal.pone.0051896	http://dx.doi.org/10.1371/journal.pone.0051896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272187	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600047
J	Garcia-Yague, AJ; Rada, P; Rojo, AI; Lastres-Becker, I; Cuadrado, A				Juan Garcia-Yaguee, Angel; Rada, Patricia; Rojo, Ana I.; Lastres-Becker, Isabel; Cuadrado, Antonio			Nuclear Import and Export Signals Control the Subcellular Localization of Nurr1 Protein in Response to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; DOPAMINERGIC-NEURONS; NGFI-B; GENE-EXPRESSION; NR4A2; IDENTIFICATION; PHENOTYPE; TRANSPORT; PATHWAY; HETERODIMERIZATION	Orphan receptor Nurr1 participates in the acquisition and maintenance of the dopaminergic cell phenotype, modulation of inflammation, and cytoprotection, but little is known about its regulation. In this study, we report that Nurr1 contains a bipartite nuclear localization signal (NLS) within its DNA binding domain and two leucine-rich nuclear export signals (NES) in its ligand binding domain. Together, these signals regulate Nurr1 shuttling in and out of the nucleus. Immunofluorescence and immunoblot analysis revealed that Nurr1 is mostly nuclear. A Nurr1 mutant lacking the NLS failed to enter the nucleus. The Nurr1 NLS sequence, when fused to green fluorescent protein, led to nuclear accumulation of this chimeric protein, indicating that this sequence was sufficient to direct nuclear localization of Nurr1. Furthermore, two NES were characterized in the ligand binding domain, whose deletion caused Nurr1 to accumulate predominantly in the nucleus. The Nurr1 NES was sensitive to CRM1 and could function as an independent export signal when fused to green fluorescent protein. Sodium arsenite, an agent that induces oxidative stress, promoted nuclear export of ectopically expressed Nurr1 in HEK293T cells, and the antioxidant N-acetylcysteine rescued from this effect. Similarly, in dopaminergic MN9D cells, arsenite induced the export of endogenous Nurr1, resulting in the loss of expression of Nurr1-dependent genes. This study illustrates that Nurr1 shuttling between the cytosol and nucleus is controlled by specific nuclear import and export signals and that oxidative stress can unbalance the distribution of Nurr1 to favor its cytosolic accumulation.	[Juan Garcia-Yaguee, Angel; Rada, Patricia; Rojo, Ana I.; Lastres-Becker, Isabel; Cuadrado, Antonio] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Juan Garcia-Yaguee, Angel; Rada, Patricia; Lastres-Becker, Isabel; Cuadrado, Antonio] CSIC, Dept Quim, Madrid, Spain; [Juan Garcia-Yaguee, Angel; Rada, Patricia; Lastres-Becker, Isabel; Cuadrado, Antonio] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Juan Garcia-Yaguee, Angel; Rada, Patricia; Lastres-Becker, Isabel; Cuadrado, Antonio] Univ Autonoma Madrid, CSIC UAM, Madrid, Spain; [Juan Garcia-Yaguee, Angel; Rada, Patricia; Lastres-Becker, Isabel; Cuadrado, Antonio] Inst Invest Sanitaria La Paz IDIPAZ, Madrid, Spain; [Rojo, Ana I.] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol, Madrid, Spain	CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Complutense University of Madrid	Lastres-Becker, I (corresponding author), UAM CSIC, Inst Invest Biomed Alberto Sols, C Arturo Duperier 4, Madrid 28029, Spain.	ilbecker@iib.uam.es; antonio.cuadrado@uam.es	Rada, Patricia/G-7300-2015; García Yagüe, Ángel Juan/AER-0203-2022; Lastres-Becker, Isabel/R-3403-2018; Becker, Isabel Lastres/AAB-6788-2019; Rojo, Ana I/AAA-5203-2019	Rada, Patricia/0000-0002-6731-2098; García Yagüe, Ángel Juan/0000-0002-7876-0638; Lastres-Becker, Isabel/0000-0002-4968-2175; Becker, Isabel Lastres/0000-0002-4968-2175; Cuadrado, Antonio/0000-0002-3444-9012; Rojo, Ana I/0000-0002-0312-5867; Cuadrado, Antonio/0000-0002-4039-7140	Spanish Ministry of Science and Innovation [SAF2010-172218]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported in part by Grant SAF2010-172218 from the Spanish Ministry of Science and Innovation.; Recipient of a Ramon y Cajal Contract provided by the Spanish Ministry of Science and Innovation. To whom correspondence may be addressed: Instituto de Investigaciones Biomedicas "Alberto Sols" UAM-CSIC, c/Arturo Duperier 4, 28029 Madrid, Spain. Tel.: 34-915854383; Fax: 34-915854401; E-mail: ilbecker@ iib.uam.es.	Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; Alavian KN, 2008, MOVEMENT DISORD, V23, P319, DOI 10.1002/mds.21640; Arenas E, 2005, ANN NY ACAD SCI, V1049, P51, DOI 10.1196/annals.1334.007; Bassett MH, 2004, MOL ENDOCRINOL, V18, P279, DOI 10.1210/me.2003-0005; Bensinger SJ, 2009, CELL, V137, P26, DOI 10.1016/j.cell.2009.03.024; Buervenich S, 2000, AM J MED GENET, V96, P808, DOI 10.1002/1096-8628(20001204)96:6<808::AID-AJMG23>3.0.CO;2-E; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Carpentier R, 2008, J NEUROCHEM, V104, P777, DOI 10.1111/j.1471-4159.2007.05055.x; Codina A, 2004, J BIOL CHEM, V279, P53338, DOI 10.1074/jbc.M409096200; Debernard KAB, 2012, NEUROCHEM INT, V61, P79, DOI 10.1016/j.neuint.2012.04.002; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grimes DA, 2006, MOVEMENT DISORD, V21, P906, DOI 10.1002/mds.20820; Guttler T, 2011, EMBO J, V30, P3457, DOI 10.1038/emboj.2011.287; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Holla VR, 2011, J BIOL CHEM, V286, P30003, DOI 10.1074/jbc.M110.184697; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Inamoto T, 2010, CANCER-AM CANCER SOC, V116, P340, DOI 10.1002/cncr.24737; Jacobsen KX, 2008, NEUROBIOL DIS, V29, P117, DOI 10.1016/j.nbd.2007.08.003; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Jo AY, 2009, STEM CELLS, V27, P2238, DOI 10.1002/stem.146; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Lammi J, 2007, BIOCHEM BIOPH RES CO, V359, P391, DOI 10.1016/j.bbrc.2007.05.122; Lastres-Becker I, 2012, HUM MOL GENET, V21, P3173, DOI 10.1093/hmg/dds143; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Li WG, 2006, J BIOL CHEM, V281, P27251, DOI 10.1074/jbc.M602746200; Li XL, 2009, CARCINOGENESIS, V30, P1606, DOI 10.1093/carcin/bgp161; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; No H, 2010, NEUROCHEM INT, V56, P620, DOI 10.1016/j.neuint.2010.01.005; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Pirih FQ, 2004, J BIOL CHEM, V279, P53167, DOI 10.1074/jbc.M405677200; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Sacchetti P, 2002, J BIOL CHEM, V277, P35088, DOI 10.1074/jbc.M205816200; Sacchetti P, 2006, NUCLEIC ACIDS RES, V34, P5515, DOI 10.1093/nar/gkl712; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sun Z, 2012, ONCOGENE, V31, P2653, DOI 10.1038/onc.2011.448; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Watanabe T., 2012, ARCH TOXICOL, V85, P577; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Wingate AD, 2006, BIOCHEM SOC T, V34, P1107, DOI 10.1042/BST0341107; Wu YM, 2005, ENDOCRINOLOGY, V146, P237, DOI 10.1210/en.2004-0889; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang T, 2007, NEUROSCI LETT, V423, P118, DOI 10.1016/j.neulet.2007.06.041; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	51	50	52	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5506	5517		10.1074/jbc.M112.439190	http://dx.doi.org/10.1074/jbc.M112.439190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23283970	Green Published, hybrid			2022-12-25	WOS:000315342500025
J	Mittal, N				Mittal, Nikhil			Cell Surface Concentrations and Concentration Ranges for Testing In Vitro Autocrine Loops and Small Molecules	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSPORT; BIOMARKER; SURVIVAL; ASSAYS; LIGAND; SERUM; MODEL	A common assumption made when performing in vitro cellular assays is that the concentration of substances in the culture system is uniform. However, since the cells that internalize and secrete substances reside at the bottom of the well, it is conceivable that a concentration gradient could arise across the fluid layer. Importantly, the concentration of a substance in the vicinity of a cell, which is the concentration of interest, cannot be measured via existing methods. In this work a simple strategy for estimating the concentration of a chemical species at the surface of a cell is presented. Finally, this result is used to outline a method for determining the appropriate concentration ranges for testing in vitro autocrine loops and small molecules.	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Mittal, N (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.	nvmittal@partners.org		Mittal, Nikhil/0000-0002-2360-7134				Aziz N, 1999, CLIN DIAGN LAB IMMUN, V6, P89, DOI 10.1128/CDLI.6.1.89-95.1999; Batsilas L, 2003, BIOPHYS J, V85, P3659, DOI 10.1016/S0006-3495(03)74783-3; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chaigneau C, 2007, CLIN CHEM LAB MED, V45, P1390, DOI 10.1515/CCLM.2007.160; Ellison D, 2009, MOL BIOSYST, V5, P1004, DOI 10.1039/b905602e; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; He L, 2003, BIOTECHNOL PROGR, V19, P544; KNAUER DJ, 1984, J BIOL CHEM, V259, P5623; Lengelle J, 2008, CYTOKINE, V44, P275, DOI 10.1016/j.cyto.2008.08.010; Li F, 2006, INT FREQ CONTR S EXP, P538; Monine MI, 2005, BIOPHYS J, V88, P2384, DOI 10.1529/biophysj.104.051425; Netti PA, 2000, CANCER RES, V60, P2497; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; THAVASU PW, 1992, J IMMUNOL METHODS, V153, P115, DOI 10.1016/0022-1759(92)90313-I; Vander AJ, 2001, HUMAN PHYSL MECH BOD, Vxviii; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777	18	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51796	10.1371/journal.pone.0051796	http://dx.doi.org/10.1371/journal.pone.0051796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284769	gold, Green Published			2022-12-25	WOS:000313051500014
J	Fitzpatrick, R; Thums, M; Bell, I; Meekan, MG; Stevens, JD; Barnett, A				Fitzpatrick, Richard; Thums, Michele; Bell, Ian; Meekan, Mark G.; Stevens, John D.; Barnett, Adam			A Comparison of the Seasonal Movements of Tiger Sharks and Green Turtles Provides Insight into Their Predator-Prey Relationship	PLOS ONE			English	Article							FRENCH FRIGATE SHOALS; GALEOCERDO-CUVIER; HABITAT USE; FORAGING BEHAVIOR; APEX PREDATOR; SITE FIDELITY; PATTERNS; ECOLOGY; RISK; DIET	During the reproductive season, sea turtles use a restricted area in the vicinity of their nesting beaches, making them vulnerable to predation. At Raine Island (Australia), the highest density green turtle Chelonia mydas rookery in the world, tiger sharks Galeocerdo cuvier have been observed to feed on green turtles, and it has been suggested that they may specialise on such air-breathing prey. However there is little information with which to examine this hypothesis. We compared the spatial and temporal components of movement behaviour of these two potentially interacting species in order to provide insight into the predator-prey relationship. Specifically, we tested the hypothesis that tiger shark movements are more concentrated at Raine Island during the green turtle nesting season than outside the turtle nesting season when turtles are not concentrated at Raine Island. Turtles showed area-restricted search behaviour around Raine Island for similar to 3-4 months during the nesting period (November-February). This was followed by direct movement (transit) to putative foraging grounds mostly in the Torres Straight where they switched to area-restricted search mode again, and remained resident for the remainder of the deployment (53-304 days). In contrast, tiger sharks displayed high spatial and temporal variation in movement behaviour which was not closely linked to the movement behaviour of green turtles or recognised turtle foraging grounds. On average, tiger sharks were concentrated around Raine Island throughout the year. While information on diet is required to determine whether tiger sharks are turtle specialists our results support the hypothesis that they target this predictable and plentiful prey during turtle nesting season, but they might not focus on this less predictable food source outside the nesting season.	[Barnett, Adam] Deakin Univ, Sch Life & Environm Sci, Melbourne, Vic, Australia; [Fitzpatrick, Richard] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Fitzpatrick, Richard; Barnett, Adam] Reef Channel, Cairns, Qld, Australia; [Thums, Michele; Meekan, Mark G.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Thums, Michele] Univ Western Australia, Sch Environm Syst Engn, Crawley, WA, Australia; [Thums, Michele; Meekan, Mark G.] Univ Western Australia, Australian Inst Marine Sci, Crawley, WA, Australia; [Bell, Ian] Queensland Dept Environm & Heritage Protect, Townsville, Qld, Australia; [Stevens, John D.] CSIRO, Marine & Atmospher Res, Hobart, Tas, Australia; [Barnett, Adam] Univ Tasmania, Fisheries Aquaculture & Coasts Ctr, Inst Marine & Antarct Studies, Hobart, Tas, Australia	Deakin University; James Cook University; University of Western Australia; University of Western Australia; Australian Institute of Marine Science; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Barnett, A (corresponding author), Deakin Univ, Sch Life & Environm Sci, Melbourne, Vic, Australia.	adam.barnett@utas.edu.au	Thums, Michele/A-3850-2013	Thums, Michele/0000-0002-8669-8440; Meekan, Mark/0000-0002-3067-9427; , Adam/0000-0001-7430-8428	Digital Dimensions, Australia; commercial source, Digital Dimensions	Digital Dimensions, Australia; commercial source, Digital Dimensions	Funding was supplied by Digital Dimensions, Australia, through the production of documentaries related to shark research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was from a commercial source, Digital Dimensions. RF and AB are affiliated with a commercial company The Reef Channel. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abrantes KG, 2011, MAR ECOL PROG SER, V442, P133, DOI 10.3354/meps09395; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Estes JA, 1996, PREDATION DIVERSITY, P857; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hays GC, 2007, J EXP MAR BIOL ECOL, V349, P52, DOI 10.1016/j.jembe.2007.04.016; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2008, J EXP MAR BIOL ECOL, V356, P43, DOI 10.1016/j.jembe.2007.12.013; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2003, J THEOR BIOL, V223, P79, DOI 10.1016/S0022-5193(03)00073-0; Heithaus MR, 2002, MAR BIOL, V140, P237, DOI 10.1007/s00227-001-0711-7; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Laroche RK, 2008, ANIM BEHAV, V76, P1901, DOI 10.1016/j.anbehav.2008.06.025; Laundre JW, 2010, ECOLOGY, V91, P2995, DOI 10.1890/08-2345.1; Limpus CJ, 2008, BIOL REV MARINE TURT; Limpus Colin J., 2003, Memoirs of the Queensland Museum, V49, P349; Lowe Christopher G., 2006, Atoll Research Bulletin, P281; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Papastamatiou YP, 2010, J EXP MAR BIOL ECOL, V386, P94, DOI 10.1016/j.jembe.2010.02.009; Pinheiro J, 2012, LINEAR NONLINEAR MIX; Plummer M., 2003, P 3 INT WORKSH DISTR; R Development Core Team, 2012, R LANG ENV STAT COMP; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Wirsing AJ, 2011, FRONT ECOL ENVIRON, V9, P335, DOI 10.1890/090226; Wirsing AJ, 2010, ANIM BEHAV, V79, P531, DOI 10.1016/j.anbehav.2009.12.014; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022	41	51	52	2	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51927	10.1371/journal.pone.0051927	http://dx.doi.org/10.1371/journal.pone.0051927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284819	Green Published, Green Accepted, gold			2022-12-25	WOS:000312694300059
J	Fudickar, AM; Partecke, J				Fudickar, Adam M.; Partecke, Jesko			The Flight Apparatus of Migratory and Sedentary Individuals of a Partially Migratory Songbird Species	PLOS ONE			English	Article							BIRDS; ECOMORPHOLOGY; EVOLUTION; BEHAVIOR; WINGS	Variations in the geometry of the external flight apparatus of birds are beneficial for different behaviors. Long-distance flight is less costly with more pointed wings and shorter tails; however these traits decrease maneuverability at low speeds. Selection has led to interspecific differences in these and other flight apparatuses in relation to migration distance. If these principles are general, how are the external flight apparatus within a partially migratory bird species shaped in which individuals either migrate or stay at their breeding grounds? We resolved this question by comparing the wing pointedness and tail length (relative to wing length) of migrant and resident European blackbirds (Turdus merula) breeding in the same population. We predicted that migrant blackbirds would have more pointed wings and shorter tails than residents. Contrary to our predictions, there were no differences between migrants and residents in either measure. Our results indicate that morphological differences between migrants and residents in this partially migratory population may be constrained.	[Fudickar, Adam M.; Partecke, Jesko] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Fudickar, Adam M.] Univ Konstanz, Dept Biol, Constance, Germany	Max Planck Society; University of Konstanz	Fudickar, AM (corresponding author), Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany.	afudickar@gmail.com		Fudickar, Adam/0000-0001-5517-7063	Max-Planck-Society; International Max Planck Research School for Organismal Biology	Max-Planck-Society(Max Planck Society); International Max Planck Research School for Organismal Biology	The Max-Planck-Society provided funding for the project. AMF was also supported by the International Max Planck Research School for Organismal Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, ECONOMIST 0326; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; BERTHOLD P, 1982, EXPERIENTIA, V38, P805, DOI 10.1007/BF01972282; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Fiedler W, 2005, ANN NY ACAD SCI, V1046, P253, DOI 10.1196/annals.1343.022; Fitzpatrick S, 1998, J AVIAN BIOL, V29, P248, DOI 10.2307/3677107; Forschler MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018732; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; Gerson AR, 2011, SCIENCE, V333, P1434, DOI 10.1126/science.1210449; Hatchwell BJ, 1996, J APPL ECOL, V33, P1114, DOI 10.2307/2404691; Kays R, 2011, COMPUT J, V54, P1931, DOI 10.1093/comjnl/bxr072; Kipp F.A., 1959, VOGELWARTE, V20, P77; MARCHETTI K, 1995, J AVIAN BIOL, V26, P177, DOI 10.2307/3677316; Mitchell GW, 2012, J ANIM ECOL, V81, P1024, DOI 10.1111/j.1365-2656.2012.01978.x; Naef-Daenzer B, 2007, J AVIAN BIOL, V38, P404, DOI 10.1111/j.2007.0908-8857.03863.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Partecke J, 2007, ECOLOGY, V88, P882, DOI 10.1890/06-1105; Piersma T, 1998, J AVIAN BIOL, V29, P511, DOI 10.2307/3677170; Ramenofsky M, 2007, BIOSCIENCE, V57, P135, DOI 10.1641/B570208; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; SCHWABL H, 1983, J ORNITHOL, V124, P101, DOI 10.1007/BF01640158; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Svensson L., 1992, IDENTIFICATION GUIDE; Thomas ALR, 1996, J THEOR BIOL, V183, P237, DOI 10.1006/jtbi.1996.0217; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; WINKLER H, 1992, IBIS, V134, P21	27	14	15	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51920	10.1371/journal.pone.0051920	http://dx.doi.org/10.1371/journal.pone.0051920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284817	Green Submitted, gold, Green Published			2022-12-25	WOS:000312694300057
J	Stimpert, AK; Peavey, LE; Friedlaender, AS; Nowacek, DP				Stimpert, Alison K.; Peavey, Lindsey E.; Friedlaender, Ari S.; Nowacek, Douglas P.			Humpback Whale Song and Foraging Behavior on an Antarctic Feeding Ground	PLOS ONE			English	Article							EASTERN NORTH PACIFIC; MEGAPTERA-NOVAEANGLIAE; ACOUSTIC DETECTIONS; HAWAIIAN; WESTERN; KINEMATICS; MIGRATION; WATERS	Reports of humpback whale (Megaptera novaeangliae) song chorusing occurring outside the breeding grounds are becoming more common, but song structure and underwater behavior of individual singers on feeding grounds and migration routes remain unknown. Here, ten humpback whales in the Western Antarctic Peninsula were tagged in May 2010 with non-invasive, suction-cup attached tags to study foraging ecology and acoustic behavior. Background song was identified on all ten records, but additionally, acoustic records of two whales showed intense and continuous singing, with a level of organization and structure approaching that of typical breeding ground song. The songs, produced either by the tagged animals or close associates, shared phrase types and theme structure with one another, and some song bouts lasted close to an hour. Dive behavior of tagged animals during the time of sound production showed song occurring during periods of active diving, sometimes to depths greater than 100 m. One tag record also contained song in the presence of feeding lunges identified from the behavioral sensors, indicating that mating displays occur in areas worthy of foraging. These data show behavioral flexibility as the humpbacks manage competing needs to continue to feed and to prepare for the breeding season during late fall. This may also signify an ability to engage in breeding activities outside of the traditional, warm water breeding ground locations.	[Stimpert, Alison K.] USN, Dept Oceanog, Postgrad Sch, Monterey, CA 93943 USA; [Peavey, Lindsey E.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Friedlaender, Ari S.; Nowacek, Douglas P.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Nowacek, Douglas P.] Duke Univ, Marine Lab, Pratt Sch Engn, Beaufort, NC 28516 USA	United States Department of Defense; United States Navy; Naval Postgraduate School; University of California System; University of California Santa Barbara; Duke University; Duke University	Stimpert, AK (corresponding author), USN, Dept Oceanog, Postgrad Sch, Monterey, CA 93943 USA.	akstimpe@nps.edu		Stimpert, Alison/0000-0002-9400-0305; Peavey Reeves, Lindsey/0000-0003-4900-5921	National Science Foundation [ANT-07-39483]; Acoustical Society of America	National Science Foundation(National Science Foundation (NSF)); Acoustical Society of America	This material is based upon work supported by the National Science Foundation under Grant No. ANT-07-39483. The authors also gratefully acknowledge funding support from the F. V. Hunt Fellowship of the Acoustical Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; BAKER CS, 1984, CAN J ZOOL, V62, P1922, DOI 10.1139/z84-282; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Charif RA, 2001, MAR MAMMAL SCI, V17, P751, DOI 10.1111/j.1748-7692.2001.tb01297.x; Cholewiak DM, 2008, THESIS CORNELL U; CLAPHAM PJ, 1990, MAR MAMMAL SCI, V6, P155, DOI 10.1111/j.1748-7692.1990.tb00238.x; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Darling JD, 2006, BEHAVIOUR, V143, P1051, DOI 10.1163/156853906778607381; Darling JD, 2005, MAR MAMMAL SCI, V21, P557, DOI 10.1111/j.1748-7692.2005.tb01249.x; Darling JD, 2001, MAR MAMMAL SCI, V17, P570, DOI 10.1111/j.1748-7692.2001.tb01005.x; Alves LCPD, 2009, MAR MAMMAL SCI, V25, P416, DOI 10.1111/j.1748-7692.2008.00249.x; Dunlop RA, 2007, J ACOUST SOC AM, V122, P2893, DOI 10.1121/1.2783115; FRANKEL AS, 1995, CAN J ZOOL, V73, P1134, DOI 10.1139/z95-135; Frazer LN, 2000, IEEE J OCEANIC ENG, V25, P160, DOI 10.1109/48.820748; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; HELWEG DA, 1994, ETHOLOGY, V98, P298, DOI 10.1111/j.1439-0310.1994.tb01078.x; HELWEG DA, 1992, MARINE MAMMAL SENSORY SYSTEMS, P459; Jensen FH, 2009, MAR ECOL PROG SER, V395, P161, DOI 10.3354/meps08204; Johnson M, 2009, MAR ECOL PROG SER, V395, P55, DOI 10.3354/meps08255; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; MCSWEENEY DJ, 1989, MAR MAMMAL SCI, V5, P139, DOI 10.1111/j.1748-7692.1989.tb00328.x; MEDRANO L, 1994, CAN J ZOOL, V72, P1771, DOI 10.1139/z94-239; MILLS HG, 2005, J ACOUST SOC AM, V117, P2525; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Norris TF, 1999, J ACOUST SOC AM, V106, P506, DOI 10.1121/1.427071; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; Parks S. E., 2011, Endangered Species Research, V15, P63, DOI 10.3354/esr00368; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Reidenberg JS, 2007, ANAT REC, V290, P745, DOI 10.1002/ar.20544; Robbins Jooke, 2011, Endangered Species Research, V13, P117, DOI 10.3354/esr00328; Schneider JN, 2010, THESIS U BUFFALO; Simon M, 2012, J EXP BIOL, V215, P3786, DOI 10.1242/jeb.071092; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Smith JN, 2008, ANIM BEHAV, V76, P467, DOI 10.1016/j.anbehav.2008.02.013; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Stevick PT, 2011, BIOL LETTERS, V7, P299, DOI 10.1098/rsbl.2010.0717; Stimpert AK, 2010, THESIS U HAWAII MANO; Stimpert AK, 2011, J ACOUST SOC AM, V129, P476, DOI 10.1121/1.3504708; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; Tyson RB, 2012, MAR ECOL PROG SER, V457, P209, DOI 10.3354/meps09708; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; WEINRICH M, 1995, MAR MAMMAL SCI, V11, P251, DOI 10.1111/j.1748-7692.1995.tb00524.x; WEINRICH MT, 1992, ANIM BEHAV, V44, P1059, DOI 10.1016/S0003-3472(05)80318-5; WHITEHEAD H, 1983, CAN J ZOOL, V61, P1391, DOI 10.1139/z83-186; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631; Wright TF, 2010, ETHOL ECOL EVOL, V22, P393, DOI 10.1080/03949370.2010.505580; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	54	53	55	0	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51214	10.1371/journal.pone.0051214	http://dx.doi.org/10.1371/journal.pone.0051214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284666	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300015
J	Baltazar, GC; Guha, S; Lu, WN; Lim, J; Boesze-Battaglia, K; Laties, AM; Tyagi, P; Kompella, UB; Mitchell, CH				Baltazar, Gabriel C.; Guha, Sonia; Lu, Wennan; Lim, Jason; Boesze-Battaglia, Kathleen; Laties, Alan M.; Tyagi, Puneet; Kompella, Uday B.; Mitchell, Claire H.			Acidic Nanoparticles Are Trafficked to Lysosomes and Restore an Acidic Lysosomal pH and Degradative Function to Compromised ARPE-19 Cells	PLOS ONE			English	Article							ROD OUTER SEGMENTS; PIGMENT-EPITHELIUM; GENE DELIVERY; RPE CELLS; ACIDIFICATION; PHAGOCYTOSIS; INHIBITION; PURIFICATION; STIMULATION; BINDING	Lysosomal enzymes function optimally in acidic environments, and elevation of lysosomal pH can impede their ability to degrade material delivered to lysosomes through autophagy or phagocytosis. We hypothesize that abnormal lysosomal pH is a key aspect in diseases of accumulation and that restoring lysosomal pH will improve cell function. The propensity of nanoparticles to end up in the lysosome makes them an ideal method of delivering drugs to lysosomes. This study asked whether acidic nanoparticles could traffic to lysosomes, lower lysosomal pH and enhance lysosomal degradation by the cultured human retinal pigmented epithelial cell line ARPE-19. Acidic nanoparticles composed of poly (DL-lactide-co-glycolide) (PLGA) 502 H, PLGA 503 H and poly (DL-lactide) (PLA) colocalized to lysosomes of ARPE-19 cells within 60 min. PLGA 503 H and PLA lowered lysosomal pH in cells compromised by the alkalinizing agent chloroquine when measured 1 hr. after treatment, with acidification still observed 12 days later. PLA enhanced binding of Bodipy-pepstatin-A to the active site of cathepsin D in compromised cells. PLA also reduced the cellular levels of opsin and the lipofuscin-like autofluorescence associated with photoreceptor outer segments. These observations suggest the acidification produced by the nanoparticles was functionally effective. In summary, acid nanoparticles lead to a rapid and sustained lowering of lysosomal pH and improved degradative activity.	[Baltazar, Gabriel C.; Guha, Sonia; Lu, Wennan; Lim, Jason; Mitchell, Claire H.] Univ Penn, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Boesze-Battaglia, Kathleen] Univ Penn, Dept Biochem, Philadelphia, PA USA; [Laties, Alan M.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Mitchell, Claire H.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Tyagi, Puneet; Kompella, Uday B.] Univ Colorado Denver, Aurora, CO USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Mitchell, CH (corresponding author), Univ Penn, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA.	chm@exchange.upenn.edu		Guha, Sonia/0000-0002-7585-8381	National Institutes of Health [NIH EY013434, EY015537, EY018705, EY017045]; Vision Research Core Grant [EY001583]; Research to Prevent Blindness; Paul and Evanina Bell Mackall Foundation Trust; Beckman Institute for Macular Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026365] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001583, R01EY015537, R21EY018705, R01EY010420, R01EY013434, R29EY010420, R24EY017045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vision Research Core Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Paul and Evanina Bell Mackall Foundation Trust; Beckman Institute for Macular Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by National Institutes of Health grants NIH EY013434 and EY015537 (CHM), EY018705 (KBB), EY017045 (AML), Vision Research Core Grant EY001583 (CHM and AML), Research to Prevent Blindness (AML), the Paul and Evanina Bell Mackall Foundation Trust (AML), and the Beckman Institute for Macular Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEIS D, 1994, EUR J BIOCHEM, V219, P905, DOI 10.1111/j.1432-1033.1994.tb18572.x; Baltazar G, 2010, INVEST OPHTH VIS SCI, V51; Baltazar G, 2011, INVEST OPHTH VIS SCI, V52, P3216; Barrett A, 1977, PROTINASES MAMMALIAN, P220; Bejjani R, 2005, MOL VIS, V11, P124; Blanchette CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006056; Bourges JL, 2003, INVEST OPHTH VIS SCI, V44, P3562, DOI 10.1167/iovs.02-1068; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Chen PM, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-10; Chen Y, 1999, J BIOL CHEM, V274, P18364, DOI 10.1074/jbc.274.26.18364; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; DEGUCHI J, 1994, INVEST OPHTH VIS SCI, V35, P568; Diebold Y, 2010, PROG RETIN EYE RES, V29, P596, DOI 10.1016/j.preteyeres.2010.08.002; Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744; Elner Victor M, 2002, Trans Am Ophthalmol Soc, V100, P301; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Guha S, 2012, J NEUROCHEM, V122, P823, DOI 10.1111/j.1471-4159.2012.07804.x; HALL MO, 1987, EXP EYE RES, V45, P907, DOI 10.1016/S0014-4835(87)80105-7; HALL MO, 1993, INVEST OPHTH VIS SCI, V34, P2392; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HAYASAKA S, 1977, EXP EYE RES, V25, P317, DOI 10.1016/0014-4835(77)90099-9; HAYASAKA S, 1975, J BIOCHEM-TOKYO, V78, P1365, DOI 10.1093/oxfordjournals.jbchem.a131034; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Kompella UB, 2007, NANOMED-NANOTECHNOL, V3, P342, DOI 10.1016/j.nano.2007.10.034; KROGSTAD DJ, 1987, AM J TROP MED HYG, V36, P213, DOI 10.4269/ajtmh.1987.36.213; LAVAIL MM, 1976, EXP EYE RES, V23, P277, DOI 10.1016/0014-4835(76)90209-8; Li W, 2011, BIOMATERIALS, V32, P4030, DOI 10.1016/j.biomaterials.2011.02.008; Liu J, 2008, INVEST OPHTH VIS SCI, V49, P772, DOI 10.1167/iovs.07-0675; Liu J, 2012, AM J PHYSIOL-CELL PH, V303, pC160, DOI 10.1152/ajpcell.00278.2011; Lu W, 2007, J PHARMACOL EXP THER, V323, P157, DOI 10.1124/jpet.107.124545; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Peters S, 2006, OPHTHAL RES, V38, P83, DOI 10.1159/000090268; Prow TW, 2008, NANOMED-NANOTECHNOL, V4, P340, DOI 10.1016/j.nano.2008.06.003; Roizenblatt R, 2006, J NEUROSCI METH, V153, P154, DOI 10.1016/j.jneumeth.2005.10.001; SIAKOTOS AN, 1978, INVEST OPHTH VIS SCI, V17, P618; Singh SR, 2009, GENE THER, V16, P645, DOI 10.1038/gt.2008.185; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021; Zhao Y, 2004, MACROMOL BIOSCI, V4, P901, DOI 10.1002/mabi.200400072	40	88	91	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e49635	10.1371/journal.pone.0049635	http://dx.doi.org/10.1371/journal.pone.0049635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272048	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300007
J	Garzon, I; Carriel, V; Marin-Fernandez, AB; Oliveira, AC; Garrido-Gomez, J; Campos, A; Sanchez-Quevedo, MD; Alaminos, M				Garzon, Ingrid; Carriel, Victor; Belen Marin-Fernandez, Ana; Celeste Oliveira, Ana; Garrido-Gomez, Juan; Campos, Antonio; del Carmen Sanchez-Quevedo, Maria; Alaminos, Miguel			A Combined Approach for the Assessment of Cell Viability and Cell Functionality of Human Fibrochondrocytes for Use in Tissue Engineering	PLOS ONE			English	Article							X-RAY-MICROANALYSIS; TEMPOROMANDIBULAR-JOINT DISC; ELEMENTAL CONCENTRATIONS; ARTICULAR-CARTILAGE; ENDOTHELIAL-CELLS; STEM-CELLS; CHONDROCYTES; DIFFERENTIATION; DISORDERS; THERAPY	Temporo-mandibular joint disc disorders are highly prevalent in adult populations. Autologous chondrocyte implantation is a well-established method for the treatment of several chondral defects. However, very few studies have been carried out using human fibrous chondrocytes from the temporo-mandibular joint (TMJ). One of the main drawbacks associated to chondrocyte cell culture is the possibility that chondrocyte cells kept in culture tend to de-differentiate and to lose cell viability under in in-vitro conditions. In this work, we have isolated human temporo-mandibular joint fibrochondrocytes (TMJF) from human disc and we have used a highly-sensitive technique to determine cell viability, cell proliferation and gene expression of nine consecutive cell passages to determine the most appropriate cell passage for use in tissue engineering and future clinical use. Our results revealed that the most potentially viable and functional cell passages were P5-P6, in which an adequate equilibrium between cell viability and the capability to synthesize all major extracellular matrix components exists. The combined action of pro-apoptotic (TRAF5, PHLDA1) and anti-apoptotic genes (SON, HTT, FAIM2) may explain the differential cell viability levels that we found in this study. These results suggest that TMJF should be used at P5-P6 for cell therapy protocols.	[Garzon, Ingrid; Carriel, Victor; Celeste Oliveira, Ana; Garrido-Gomez, Juan; Campos, Antonio; del Carmen Sanchez-Quevedo, Maria; Alaminos, Miguel] Univ Granada, Dept Histol, Tissue Engn Grp, Granada, Spain; [Belen Marin-Fernandez, Ana] Univ Hosp Virgen de las Nieves, Div Oral & Maxillofacial Surg, Granada, Spain; [Garrido-Gomez, Juan] Univ Hosp San Cecilio, Div Trauma & Orthoped Surg, Granada, Spain	University of Granada; Hospital Universitario Virgen de las Nieves; Hospital Universitario San Cecilio	Alaminos, M (corresponding author), Univ Granada, Dept Histol, Tissue Engn Grp, Granada, Spain.	malaminos@ugr.es	ARAYA, VICTOR CARRIEL/H-9425-2018; Oliveira, Ana Carolina/GRF-1435-2022; ALAMINOS, MIGUEL/N-9960-2016	ARAYA, VICTOR CARRIEL/0000-0002-8114-5644; ALAMINOS, MIGUEL/0000-0003-4876-2672; Campos, A/0000-0003-4061-8182	University of Granada-Campus de Excelencia Internacional, Subprograma de I+D+I y Transferencia; Spanish Ministry of Economy and Competitiveness (INNPACTO program) [IPT-300000-2010-017]; European Regional Development Fund, European Union	University of Granada-Campus de Excelencia Internacional, Subprograma de I+D+I y Transferencia; Spanish Ministry of Economy and Competitiveness (INNPACTO program); European Regional Development Fund, European Union	This work was supported by University of Granada-Campus de Excelencia Internacional, Subprograma de I+D+I y Transferencia and by the Spanish Ministry of Economy and Competitiveness, grant IPT-300000-2010-017 (INNPACTO program), co-financed by the European Regional Development Fund, European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Alaminos M, 2008, EXP EYE RES, V86, P758, DOI 10.1016/j.exer.2008.02.003; Alaminos M, 2007, J CELL PHYSIOL, V211, P692, DOI 10.1002/jcp.20976; Allen KD, 2007, TISSUE ENG, V13, P101, DOI 10.1089/ten.2006.0094; Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65; Almarza AJ, 2011, ANN BIOMED ENG, V39, P2479, DOI 10.1007/s10439-011-0364-8; Anderson DEJ, 2009, ARCH ORAL BIOL, V54, P138, DOI 10.1016/j.archoralbio.2008.09.018; Anderson DEJ, 2008, ANN BIOMED ENG, V36, P1992, DOI 10.1007/s10439-008-9572-2; BOEKESTEIN A, 1985, HISTOCHEMISTRY, V82, P257, DOI 10.1007/BF00501402; Dai JW, 2011, MED HYPOTHESES, V77, P132, DOI 10.1016/j.mehy.2011.03.045; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Di Francesco A, 1998, ARCH BIOCHEM BIOPHYS, V360, P149, DOI 10.1006/abbi.1998.0937; Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050; Garzon I, 2012, TISSUE ENG PART C-ME, V18, P408, DOI [10.1089/ten.tec.2011.0508, 10.1089/ten.TEC.2011.0508]; Hayes AJ, 2007, J HISTOCHEM CYTOCHEM, V55, P853, DOI 10.1369/jhc.7A7210.2007; Hecht JT, 2005, DIFFERENTIATION, V73, P212, DOI 10.1111/j.1432-0436.2005.00025.x; Johns DE, 2008, J DENT RES, V87, P548; Kalpakci KN, 2011, ACTA BIOMATER, V7, P1710, DOI 10.1016/j.actbio.2010.12.015; Landesberg R, 1996, ARCH ORAL BIOL, V41, P761, DOI 10.1016/S0003-9969(96)00068-4; Lee NK, 2002, J BIOCHEM MOL BIOL, V35, P61; Maenpaa K, 2010, J R SOC INTERFACE, V7, P177, DOI 10.1098/rsif.2009.0117; Moioli EK, 2007, ADV DRUG DELIVER REV, V59, P308, DOI 10.1016/j.addr.2007.03.019; Peterson L, 2000, CLIN ORTHOP RELAT R, P212, DOI 10.1097/00003086-200005000-00020; Rangone H, 2004, PATHOL BIOL, V52, P338, DOI 10.1016/j.patbio.2003.06.004; Richardson JB, 1999, J BONE JOINT SURG BR, V81B, P1064, DOI 10.1302/0301-620X.81B6.9343; Rodriguez-Morata A, 2008, ANN VASC SURG, V22, P440, DOI 10.1016/j.avsg.2008.03.004; Roomans Godfried M., 2002, European Cells & Materials, V3, P1; Salido M, 2004, CELL BIOL INT, V28, P397, DOI 10.1016/j.cellbi.2004.03.008; SANCHEZQUEVEDO MC, 1989, BONE MINER, V6, P323, DOI 10.1016/0169-6009(89)90037-8; Shukla S, 2011, APOPTOSIS, V16, P162, DOI 10.1007/s10495-010-0556-y; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; WARLEY A, 1990, J MICROSC-OXFORD, V157, P135, DOI 10.1111/j.1365-2818.1990.tb02954.x; WARLEY A, 1994, CELL BIOL INT, V18, P915, DOI 10.1006/cbir.1994.1131; Xia Z, 2012, CELL TISSUE BANK	34	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51961	10.1371/journal.pone.0051961	http://dx.doi.org/10.1371/journal.pone.0051961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272194	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300043
J	Glombiewski, JA; Nestoriuc, Y; Rief, W; Glaesmer, H; Braehler, E				Glombiewski, Julia A.; Nestoriuc, Yvonne; Rief, Winfried; Glaesmer, Heide; Braehler, Elmar			Medication Adherence in the General Population	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; DRUG-THERAPY; NONADHERENCE; MEDICINES; BELIEFS; PERSISTENCE; PREDICTORS	Background: Adherence to medication is low in specific populations who need chronic medication. However, adherence to medication is also of interest in a more general fashion, independent of specific populations or side effects of particular drugs. If clinicians and researchers expect patients to show close to full adherence, it is relevant to know how likely the achievement of this goal is. Population based rates can provide an estimate of efforts needed to achieve near complete adherence in patient populations. The objective of the study was to collect normative data for medication nonadherence in the general population. Methods and Findings: We assessed 2,512 persons (a representative sample of German population). Adherence was measured by Rief Adherence Index. We also assessed current medication intake and side effects. We found that at least 33% of Germans repeatedly fail to follow their doctor's recommendations regarding pharmacological treatments and only 25% of Germans describe themselves as fully adherent. Nonadherence to medication occurs more often in younger patients with higher socioeconomic status taking short-term medications than in older patients with chronic conditions. Experience with medication side effects was the most prominent predictor of nonadherence. Conclusions: The major strengths of our study are a representative sample and a novel approach to assess adherence. Nonadherece seems to be commonplace in the general population. Therefore adherence cannot be expected per se but needs special efforts on behalf of prescribers and public health initiatives. Nonadherence to medication should not only be considered as a drug-specific behaviour problem, but as a behaviour pattern that is independent of the prescribed medication.	[Glombiewski, Julia A.; Nestoriuc, Yvonne; Rief, Winfried] Univ Marburg, Dept Clin Psychol & Psychotherapy, Marburg, Germany; [Glaesmer, Heide; Braehler, Elmar] Univ Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany; [Nestoriuc, Yvonne] Univ Hamburg, Dept Clin Psychol & Psychotherapy, Hamburg, Germany	Philipps University Marburg; Leipzig University; University of Hamburg	Glombiewski, JA (corresponding author), Univ Marburg, Dept Clin Psychol & Psychotherapy, Marburg, Germany.	glombiew@staff.uni-marburg.de	Rief, Winfried/ABD-4994-2021; Braehler, Elmar/C-6535-2009	Rief, Winfried/0000-0002-7019-2250; Braehler, Elmar/0000-0002-2648-2728; Nestoriuc, Yvonne/0000-0003-2191-0495				Bardel A, 2007, EUR J CLIN PHARMACOL, V63, P307, DOI 10.1007/s00228-006-0246-4; BARSKY AJ, 1990, J PSYCHIAT RES, V24, P323, DOI 10.1016/0022-3956(90)90004-A; Bates TR, 2009, EXPERT OPIN PHARMACO, V10, P2973, DOI 10.1517/14656560903376186; Briesacher BA, 2008, PHARMACOTHERAPY, V28, P437, DOI 10.1592/phco.28.4.437; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Cooper V, 2009, AIDS CARE, V21, P520, DOI 10.1080/09540120802301824; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Curkendall S, 2005, VALUE HEALTH, V8, P360, DOI 10.1016/S1098-3015(10)62959-2; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Frankenfield DL, 2010, J HEALTH CARE POOR U, V21, P518, DOI 10.1353/hpu.0.0314; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Horne R, 2007, JAIDS-J ACQ IMM DEF, V45, P334; Ingersoll KS, 2008, J BEHAV MED, V31, P213, DOI 10.1007/s10865-007-9147-y; Jackson C, 2006, PATIENT EDUC COUNS, V61, P212, DOI 10.1016/j.pec.2005.03.010; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Nestoriuc Y, 2010, ARTHRIT CARE RES, V62, P791, DOI 10.1002/acr.20160; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Rief W, 2011, PHARMACOEPIDEM DR S, V20, P405, DOI 10.1002/pds.2067; Sandelowski M, 2009, AIDS CARE, V21, P953, DOI 10.1080/09540120802626212; Simoni Jane M, 2008, Curr Infect Dis Rep, V10, P515, DOI 10.1007/s11908-008-0083-y; Steiner JF, 2010, MED CARE, V48, P193, DOI 10.1097/MLR.0b013e3181d51ddf; van Bruggen R, 2009, PHARMACOEPIDEM DR S, V18, P983, DOI 10.1002/pds.1810; World Health Organization, 2003, ADHERENCE LONG TERM; Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728, DOI 10.18553/jmcp.2009.15.9.728; Ziller V, 2009, ANN ONCOL, V20, P431, DOI 10.1093/annonc/mdn646	27	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50537	10.1371/journal.pone.0050537	http://dx.doi.org/10.1371/journal.pone.0050537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272064	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300009
J	Lorgis, L; Gudjoncik, A; Richard, C; Mock, L; Buffet, P; Brunel, P; Janin-Manificat, L; Beer, JC; Brunet, D; Touzery, C; Rochette, L; Cottin, Y; Zeller, M				Lorgis, Luc; Gudjoncik, Aurelie; Richard, Carole; Mock, Laurent; Buffet, Philippe; Brunel, Philippe; Janin-Manificat, Luc; Beer, Jean-Claude; Brunet, Damien; Touzery, Claude; Rochette, Luc; Cottin, Yves; Zeller, Marianne			Pre-Infarction Angina and Outcomes in Non-ST-Segment Elevation Myocardial Infarction: Data from the RICO Survey	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; SUSTAINED VENTRICULAR-ARRHYTHMIAS; PREINFARCTION ANGINA; GLOBAL REGISTRY; HOSPITAL OUTCOMES; ELDERLY-PATIENTS; PROTECTION; PECTORIS; ANGIOPLASTY; THROMBOLYSIS	Background: The presence of pre-infarction angina (PIA) has been shown to confer cardioprotection after ST-segment elevation myocardial infarction (STEMI). However, the clinical impact of PIA in non-ST-segment elevation myocardial infarction (NSTEMI) remains to be determined. Methods and Results: From the obseRvatoire des Infarctus de Cote d'Or (RICO) survey, 1541 consecutive patients admitted in intensive care unit with a first NSTEMI were included. Patients who experienced chest pain <7 days before the episode leading to admission were defined as having PIA and were compared with patients without PIA. Incidence of in-hospital ventricular arrhythmias (VAs), heart failure and 30-day mortality were collected. Among the 1541 patients included in the study, 693 (45%) patients presented PIA. PIA was associated with a lower creatine kinase peak, as a reflection of infarct size (231(109-520) vs. 322(148-844) IU/L, p<0.001) when compared with the group without PIA. Patients with PIA developed fewer VAs, by 3 fold (1.6% vs. 4.0%, p = 0.008) and heart failure (18.0% vs. 22.4%, p = 0.040) during the hospital stay. Overall, there was a decrease in early CV events by 26% in patients with PIA (19.2% vs. 25.9%, p = 0.002). By multivariate analysis, PIA remained independently associated with less VAs. Conclusion: From this large contemporary prospective study, our work showed that PIA is very frequent in patients admitted for a first NSTEMI, and is associated with a better prognosis, including reduced infarct size and in hospital VAs. Accordingly, protecting the myocardium by ischemic or pharmacological conditioning not only in STEMI, but in all type of MI merits further attention.	[Lorgis, Luc; Gudjoncik, Aurelie; Richard, Carole; Rochette, Luc; Cottin, Yves; Zeller, Marianne] SFR Sante Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, INSERM, U866, Dijon, France; [Lorgis, Luc; Gudjoncik, Aurelie; Richard, Carole; Buffet, Philippe; Beer, Jean-Claude; Touzery, Claude; Cottin, Yves] Univ Hosp, Dept Cardiol, Dijon, France; [Mock, Laurent; Brunel, Philippe; Brunet, Damien] Clin Fontaine Les Dijon, Dept Cardiol, Fontaine Les Dijon, France; [Janin-Manificat, Luc] CH Beaune, Dept Cardiol, Beaune, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne	Zeller, M (corresponding author), SFR Sante Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, INSERM, U866, Dijon, France.	marianne.zeller@u-bourgogne.fr	COTTIN, YVES/ABA-4622-2020	Rochette, Luc/0000-0001-9973-8803	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Conseil Regional de Bourgogne; Federation Francaise de Cardiologie; Union Regionale des Caisses d'Assurance Maladie de Bourgogne (URCAM); Agence Regionale de Sante (ARS) de Bourgogne	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Federation Francaise de Cardiologie; Union Regionale des Caisses d'Assurance Maladie de Bourgogne (URCAM); Agence Regionale de Sante (ARS) de Bourgogne(Region Bourgogne-Franche-Comte)	This work was supported by the University Hospital of Dijon, Association de Cardiologie de Bourgogne, Conseil Regional de Bourgogne, Federation Francaise de Cardiologie, and by grants from the Union Regionale des Caisses d'Assurance Maladie de Bourgogne (URCAM), and the Agence Regionale de Sante (ARS) de Bourgogne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete P, 2003, AM J CLIN NUTR, V78, P796, DOI 10.1093/ajcn/78.4.796; Abete P, 1997, J AM COLL CARDIOL, V30, P947, DOI 10.1016/S0735-1097(97)00256-8; Airaksinen KEJ, 1997, J AM COLL CARDIOL, V29, P1035, DOI 10.1016/S0735-1097(97)00042-9; Al-Khatib SM, 2002, CIRCULATION, V106, P309, DOI 10.1161/01.CIR.0000022692.49934.E3; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Ambrosio G, 2010, EUR HEART J, V31, P430, DOI 10.1093/eurheartj/ehp457; Andreotti F, 1996, NEW ENGL J MED, V334, P7, DOI 10.1056/NEJM199601043340102; Avezum A, 2008, AM J CARDIOL, V102, P1577, DOI 10.1016/j.amjcard.2008.08.009; Bahr RD, 2000, AM HEART J, V140, P126, DOI 10.1067/mhj.2000.106641; Banerjee S, 1999, AM J PHYSIOL-HEART C, V277, pH2488, DOI 10.1152/ajpheart.1999.277.6.H2488; Bjorck L, 2010, ARCH INTERN MED, V170, P1375, DOI 10.1001/archinternmed.2010.203; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Braunwald E, 1996, NEW ENGL J MED, V334, P51, DOI 10.1056/NEJM199601043340113; Brieger D, 2009, HEART, V95, P888, DOI 10.1136/hrt.2008.153387; Cambou JP, 2007, ARCH MAL COEUR VAISS, V100, P524; Colonna P, 2002, AM HEART J, V144, P796, DOI 10.1067/mhj.2002.123835; Edwards RJ, 2002, HEART, V88, P604, DOI 10.1136/heart.88.6.604; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Gheeraert PJ, 2001, J AM COLL CARDIOL, V38, P1369, DOI 10.1016/S0735-1097(01)01561-3; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Iglesias-Garriz I, 2005, REV ESP CARDIOL, V58, P484, DOI 10.1157/13074842; Ishihara M, 2005, AM J CARDIOL, V95, P622, DOI 10.1016/j.amjcard.2004.11.009; Ishihara M, 2001, J AM COLL CARDIOL, V38, P1007, DOI 10.1016/S0735-1097(01)01477-2; Itoh T, 2006, AM J CARDIOL, V97, P1157, DOI 10.1016/j.amjcard.2005.11.032; Jimenez-Navarro M, 2001, REV ESP CARDIOL, V54, P1161, DOI 10.1016/S0300-8932(01)76474-3; Jimenez-Navarro M, 2001, AM J CARDIOL, V87, P11; Kloner RA, 1998, CIRCULATION, V97, P1848, DOI 10.1161/01.CIR.97.18.1848; Kloner RA, 1998, CIRCULATION, V97, P1042, DOI 10.1161/01.CIR.97.11.1042; KLONER RA, 1995, CIRCULATION, V91, P37, DOI 10.1161/01.CIR.91.1.37; Kloner RA, 1998, J THROMB THROMBOLYS, V6, P89, DOI 10.1023/A:1008833101817; Leesar MA, 2001, CIRCULATION, V103, P2935, DOI 10.1161/01.CIR.103.24.2935; LIU GS, 1991, CIRCULATION, V84, P350, DOI 10.1161/01.CIR.84.1.350; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Newby KH, 1998, CIRCULATION, V98, P2567, DOI 10.1161/01.CIR.98.23.2567; Noda T, 1999, J AM COLL CARDIOL, V34, P1966, DOI 10.1016/S0735-1097(99)00462-3; Okishige K, 1996, J AM COLL CARDIOL, V28, P70, DOI 10.1016/0735-1097(96)00119-2; Ovize M, 1995, AM J PHYSIOL, V269, P72; Papadopoulos CE, 2003, INT J CARDIOL, V92, P209, DOI 10.1016/S0167-5273(03)00087-1; Pasceri V, 1996, CIRCULATION, V94, P1850, DOI 10.1161/01.CIR.94.8.1850; Pomerantz BJ, 2000, J SURG RES, V90, P191, DOI 10.1006/jsre.2000.5889; Spencer FA, 2002, AM J CARDIOL, V90, P1056, DOI 10.1016/S0002-9149(02)02769-8; Takahashi T, 2002, AM J CARDIOL, V90, P465, DOI 10.1016/S0002-9149(02)02515-8; Takeuchi T, 2011, CIRC J, V75, P1192, DOI 10.1253/circj.CJ-10-0906; Tomoda H, 1999, AM J CARDIOL, V84, P621, DOI 10.1016/S0002-9149(99)00405-1; VEGH A, 1992, CARDIOVASC RES, V26, P487, DOI 10.1093/cvr/26.5.487; Wu ZK, 2002, CIRCULATION, V106, P3091, DOI 10.1161/01.CIR.0000041430.32233.5B; YELLON DM, 1995, J MOL CELL CARDIOL, V27, P1023, DOI 10.1016/0022-2828(95)90071-3; Zeller M, 2005, ARCH INTERN MED, V165, P1192, DOI 10.1001/archinte.165.10.1192	48	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e48513	10.1371/journal.pone.0048513	http://dx.doi.org/10.1371/journal.pone.0048513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272043	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300005
J	Singh, O; Chan, JY; Lin, K; Heng, CCT; Chowbay, B				Singh, Onkar; Chan, Jason Yongsheng; Lin, Keegan; Heng, Charles Chuah Thuan; Chowbay, Balram			SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemiae	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CHRONIC MYELOGENOUS LEUKEMIA; STANDARD-DOSE IMATINIB; GENETIC POLYMORPHISMS; MOLECULAR RESPONSES; PLASMA-LEVELS; CML PATIENTS; TROUGH CONCENTRATION; CANCER-PATIENTS; ASSOCIATION	Objective: This study aimed to explore the influence of SLC22A1, PXR, ABCG2, ABCB1 and CYP3A5*3 genetic polymorphisms on imatinib mesylate (IM) pharmacokinetics in Asian patients with chronic myeloid leukemia (CML). Patients and Methods: Healthy subjects belonging to three Asian populations (Chinese, Malay, Indian; n = 70 each) and CML patients (n = 38) were enrolled in a prospective pharmacogenetics study. Imatinib trough (C-0h) and clearance (CL) were determined in the patients at steady state. Haplowalk method was applied to infer the haplotypes and generalized linear model (GLM) to estimate haplotypic effects on IM pharmacokinetics. Association of haplotype copy numbers with IM pharmacokinetics was defined by Mann-Whitney U test. Results: Global haplotype score statistics revealed a SLC22A1 sub-haplotypic region encompassing three polymorphisms (rs3798168, rs628031 and IVS7+850C>T), to be significantly associated with IM clearance (p = 0.013). Haplotype-specific GLM estimated that the haplotypes AGT and CGC were both associated with 22% decrease in clearance compared to CAC [CL (*10(-2) L/hr/mg): CAC vs AGT: 4.03 vs 3.16, p = 0.017; CAC vs CGC: 4.03 vs 3.15, p = 0.017]. Patients harboring 2 copies of AGT or CGC haplotypes had 33.4% lower clearance and 50% higher C-0h than patients carrying 0 or 1 copy [CL(*10(-2) L/hr/mg): 2.19 vs 3.29, p = 0.026; C-0h (*10(-6) 1/ml): 4.76 vs 3.17, p = 0.013, respectively]. Further subgroup analysis revealed SLC22A1 and ABCB1 haplotypic combinations to be significantly associated with clearance and C-0h (p = 0.002 and 0.009, respectively). Conclusion: This exploratory study suggests that SLC22A1-ABCB1 haplotypes may influence IM pharmacokinetics in Asian CML patients. Citation: Singh O, Chan JY, Lin K, Heng CCT, Chowbay B (2012) SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia. PLoS ONE 7(12): e51771. doi:10.1371/journal.pone.0051771	[Singh, Onkar; Chan, Jason Yongsheng; Lin, Keegan; Chowbay, Balram] Natl Canc Ctr Singapore, Lab Clin Pharmacol, Div Med Sci, Humphrey Oei Inst Canc Res, Singapore, Singapore; [Heng, Charles Chuah Thuan] Singapore Gen Hosp, Dept Haematol, Singapore 0316, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital	Chowbay, B (corresponding author), Natl Canc Ctr Singapore, Lab Clin Pharmacol, Div Med Sci, Humphrey Oei Inst Canc Res, Singapore, Singapore.	ctebal@nccs.com.sg	Chan, Jason Yongsheng/AAC-4863-2020	Chan, Jason Yongsheng/0000-0002-4801-3703	NMRC Institutional Grant [NMCCE10123, NMPPG11122]; Singhealth Research Fund [SRFIM07103]	NMRC Institutional Grant; Singhealth Research Fund(SingHealth)	This project was supported by funds from the NMRC Institutional Grant (NMCCE10123 and NMPPG11122) and the Singhealth Research Fund (SRFIM07103) [http://www.nmrc.gov.sg/content/nmrc_internet/home.html, http://research.singhealth.com.sg/Pages/home.aspx]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awidi A, 2010, LEUKEMIA RES, V34, P1573, DOI 10.1016/j.leukres.2010.07.014; Balram C, 2003, EUR J CLIN PHARMACOL, V59, P123, DOI 10.1007/s00228-003-0594-2; Bazeos A, 2010, LEUKEMIA, V24, P1243, DOI 10.1038/leu.2010.86; Chen LG, 2010, J PHARMACOL EXP THER, V335, P42, DOI 10.1124/jpet.110.170159; Chowbay B, 2003, PHARMACOGENETICS, V13, P89, DOI 10.1097/00008571-200302000-00005; Cortes JE, 2009, LEUKEMIA, V23, P1537, DOI 10.1038/leu.2009.88; Crossman LC, 2005, BLOOD, V106, P1133, DOI 10.1182/blood-2005-02-0694; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dulucq S, 2008, BLOOD, V112, P2024, DOI 10.1182/blood-2008-03-147744; Faber E, 2012, ANN HEMATOL, V91, P923, DOI 10.1007/s00277-011-1394-x; Forrest DL, 2009, LEUKEMIA RES, V33, P271, DOI 10.1016/j.leukres.2008.07.015; Gardner ER, 2006, CLIN PHARMACOL THER, V80, P192, DOI 10.1016/j.clpt.2006.05.003; Gurney H, 2007, CLIN PHARMACOL THER, V82, P33, DOI 10.1038/sj.clpt.6100201; Haouala A, 2011, BLOOD, V117, pE75, DOI 10.1182/blood-2010-07-294330; Hu S, 2008, CLIN CANCER RES, V14, P3141, DOI 10.1158/1078-0432.CCR-07-4913; Hughes Timothy, 2006, Hematology Am Soc Hematol Educ Program, P211, DOI 10.1182/asheducation-2006.1.211; Hughes TP, 2010, BLOOD, V116, P3758, DOI 10.1182/blood-2010-03-273979; Jada SR, 2007, CANCER SCI, V98, P1461, DOI 10.1111/j.1349-7006.2007.00541.x; Karami S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007013; Kim DH, 2009, CLIN CANCER RES, V15, P4750, DOI 10.1158/1078-0432.CCR-09-0145; Koren-Michowitz M, 2012, HEMATOL ONCOL; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Li QB, 2010, ACTA PHARMACOL SIN, V31, P999, DOI 10.1038/aps.2010.79; Maffioli M, 2011, LEUKEMIA RES, V35, P1014, DOI 10.1016/j.leukres.2010.12.004; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Nardinelli L, 2012, ACTA HAEMATOL-BASEL, V127, P228, DOI 10.1159/000336610; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Oostendorp RL, 2007, BIOMED CHROMATOGR, V21, P747, DOI 10.1002/bmc.816; Picard S, 2007, BLOOD, V109, P3496, DOI 10.1182/blood-2006-07-036012; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Quintes-Cardama A, 2009, CANCER CONTROL, V16, P122, DOI 10.1177/107327480901600204; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sandanaraj E, 2008, CLIN CANCER RES, V14, P7116, DOI 10.1158/1078-0432.CCR-08-0411; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Scherag A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013967; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Sohn SK, 2011, LEUKEMIA LYMPHOMA, V52, P1024, DOI 10.3109/10428194.2011.563885; Takahashi N, 2010, CLIN PHARMACOL THER, V88, P809, DOI 10.1038/clpt.2010.186; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; van Erp NR, 2007, CLIN CANCER RES, V13, P7394, DOI 10.1158/1078-0432.CCR-07-0346; Velpandian T, 2004, J CHROMATOGR B, V804, P431, DOI 10.1016/j.jchromb.2004.01.032; Wang YF, 2008, BRIT J CLIN PHARMACO, V65, P885, DOI 10.1111/j.1365-2125.2008.03150.x; White DL, 2010, LEUKEMIA, V24, P1962, DOI 10.1038/leu.2010.188; White DL, 2007, BLOOD, V110, P4064, DOI 10.1182/blood-2007-06-093617; Yamakawa Y, 2011, THER DRUG MONIT, V33, P244, DOI 10.1097/FTD.0b013e31820beb02; Zhang L, 1998, ANNU REV PHARMACOL, V38, P431, DOI 10.1146/annurev.pharmtox.38.1.431; Zhang WW, 2009, J CLIN ONCOL, V27, P3642, DOI 10.1200/JCO.2008.19.4076; Zhong JS, 2012, ACTA HAEMATOL-BASEL, V127, P221, DOI 10.1159/000336244; Zhou QY, 2005, BRIT J CLIN PHARMACO, V59, P415, DOI 10.1111/j.1365-2125.2004.02330.x	50	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51771	10.1371/journal.pone.0051771	http://dx.doi.org/10.1371/journal.pone.0051771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272163	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300027
J	Huuskonen, A; Lappalainen, J; Oksala, N; Santtila, M; Hakkinen, K; Kyrolainen, H; Atalay, M				Huuskonen, Antti; Lappalainen, Jani; Oksala, Niku; Santtila, Matti; Hakkinen, Keijo; Kyrolainen, Heikki; Atalay, Mustafa			Aerobic Fitness Does Not Modify the Effect of FTO Variation on Body Composition Traits	PLOS ONE			English	Article							LEPTIN RECEPTOR GENE; PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; G-2548A POLYMORPHISM; OBESITY; ASSOCIATION; WEIGHT; WOMEN; MASS; DETERMINANTS	Purpose: Poor physical fitness and obesity are risk factors for all cause morbidity and mortality. We aimed to clarify whether common genetic variants of key energy intake determinants in leptin (LEP), leptin receptor (LEPR), and fat mass and obesity-associated (FTO) are associated with aerobic and neuromuscular performance, and whether aerobic fitness can alter the effect of these genotypes on body composition. Methods: 846 healthy Finnish males of Caucasian origin were genotyped for FTO (rs8050136), LEP (rs7799039) and LEPR (rs8179183 and rs1137101) single nucleotide polymorphisms (SNPs), and studied for associations with maximal oxygen consumption, body fat percent, serum leptin levels, waist circumference and maximal force of leg extensor muscles. Results: Genotype AA of the FTO SNP rs8050136 associated with higher BMI and greater waist circumference compared to the genotype CC. In general linear model, no significant interaction for FTO genotype-relative VO(2)max (mL.kg(-1).min(-1)) or FTO genotype-absolute VO(2)max (L.min(-1)) on BMI or waist circumference was found. Main effects of aerobic performance on body composition traits were significant (p < 0.001). Logistic regression modelling found no significant interaction between aerobic fitness and FTO genotype. LEP SNP rs7799039, LEPR SNPs rs8179183 and rs1137101 did not associate with any of the measured variables, and no significant interactions of LEP or LEPR genotype with aerobic fitness were observed. In addition, none of the studied SNPs associated with aerobic or neuromuscular performance. Conclusions: Aerobic fitness may not modify the effect of FTO variation on body composition traits. However, relative aerobic capacity associates with lower BMI and waist circumference regardless of the FTO genotype. FTO, LEP and LEPR genotypes unlikely associate with physical performance.	[Huuskonen, Antti; Lappalainen, Jani; Oksala, Niku; Atalay, Mustafa] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Oksala, Niku] Tampere Univ Hosp, Dept Surg, Tampere, Finland; [Santtila, Matti] Finnish Def Forces, Personnel Div, Helsinki, Finland; [Hakkinen, Keijo; Kyrolainen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, Jyvaskyla, Finland	University of Eastern Finland; Tampere University; Tampere University Hospital; University of Jyvaskyla	Huuskonen, A (corresponding author), Univ Eastern Finland, Inst Biomed, Kuopio, Finland.	antti.huuskonen@fimnet.fi		Kyrolainen, Heikki/0000-0003-3822-1733	Research Council for Physical Education and Sports; Finnish Ministry of Education; TBGS Graduate School; Yrjo Jahnsson Foundation; Scientific Advisory Board of Defense, Finland; COST actions [B35, BM0602]	Research Council for Physical Education and Sports; Finnish Ministry of Education; TBGS Graduate School; Yrjo Jahnsson Foundation; Scientific Advisory Board of Defense, Finland; COST actions(European Cooperation in Science and Technology (COST))	This work was funded by the Research Council for Physical Education and Sports, Finnish Ministry of Education, TBGS Graduate School, Yrjo Jahnsson Foundation, the Scientific Advisory Board of Defense, Finland and COST actions B35 and BM0602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2010, AM HEART J, V160, P1163, DOI 10.1016/j.ahj.2010.08.002; Ben Ali S, 2009, ARCH MED RES, V40, P186, DOI 10.1016/j.arcmed.2009.02.008; Berentzen T, 2008, J CLIN ENDOCR METAB, V93, P2904, DOI 10.1210/jc.2008-0007; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Bouchard C, 2008, OBESITY, V16, pS5, DOI 10.1038/oby.2008.528; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Demura Shinichi, 2004, Journal of Physiological Anthropology and Applied Human Science, V23, P93, DOI 10.2114/jpa.23.93; Fairbrother UL, 2007, J BONE MINER RES, V22, P544, DOI 10.1359/jbmr.070114; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Furusawa T, 2010, HUM GENET, V127, P287, DOI 10.1007/s00439-009-0768-9; Hakkinen A, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-15; Hoffstedt J, 2002, HORM METAB RES, V34, P355, DOI 10.1055/s-2002-33466; Huuskonen A, 2010, CELL BIOCHEM FUNCT, V28, P306, DOI 10.1002/cbf.1658; Huygens W, 2004, CAN J APPL PHYSIOL, V29, P186, DOI 10.1139/h04-014; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Laukkanen JA, 2009, AM J CARDIOL, V103, P1598, DOI 10.1016/j.amjcard.2009.01.371; Loos RJF, 2006, INT J OBESITY, V30, P183, DOI 10.1038/sj.ijo.0803127; Mammes O, 2000, ANN HUM GENET, V64, P391, DOI 10.1017/S0003480000008277; Mangge H, 2011, J OBES, V2011, DOI 10.1155/2011/186368; Masuo K, 2008, HYPERTENS RES, V31, P1093, DOI 10.1291/hypres.31.1093; McPherson R, 2007, CAN J CARDIOL, V23, p23A, DOI 10.1016/S0828-282X(07)71002-4; Mergen H, 2007, ENDOCR J, V54, P89, DOI 10.1507/endocrj.K06-023; Mitchell JA, 2010, OBESITY, V18, P641, DOI 10.1038/oby.2009.311; Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Pyrzak B, 2009, EUR J MED RES, V14, P201, DOI 10.1186/2047-783X-14-S4-201; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shapiro A, 2008, DIABETES, V57, P614, DOI 10.2337/db07-0863; Silver K, 1997, DIABETES, V46, P1898, DOI 10.2337/diab.46.11.1898; Sui XM, 2010, MED SCI SPORT EXER, V42, P872, DOI 10.1249/MSS.0b013e3181c47b65; Uitenbroek D, 2004, SAMPLE SIZE SISA 201; van Rossum CTM, 2003, OBES RES, V11, P377, DOI 10.1038/oby.2003.51; Wang TN, 2006, OBESITY, V14, P183, DOI 10.1038/oby.2006.23; Wauters M, 2002, OBES RES, V10, P394, DOI 10.1038/oby.2002.54; Zhang Y, 2010, NUTR METAB CARDIOVAS, V20, P386, DOI 10.1016/j.numecd.2010.02.001; Zimmermann E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015958	39	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51635	10.1371/journal.pone.0051635	http://dx.doi.org/10.1371/journal.pone.0051635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284729	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900036
J	Lorenzen, JM; Martino, F; Scheffner, I; Brocker, V; Leitolf, H; Haller, H; Gwinner, W				Lorenzen, Johan M.; Martino, Filippo; Scheffner, Irina; Broecker, Verena; Leitolf, Holger; Haller, Hermann; Gwinner, Wilfried			Fetuin, Matrix-Gla Protein and Osteopontin in Calcification of Renal Allografts	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TYRAMINE AMPLIFICATION TECHNIQUE; VASCULAR CALCIFICATION; CARDIOVASCULAR MORTALITY; CLINICAL-IMPLICATIONS; PROTOCOL BIOPSIES; EPITHELIAL-CELLS; STONES; URINE; GENE	Background: Calcification of renal allografts is common in the first year after transplantation and is related to hyperparathyroidism. It is associated with an impaired long-term function of the graft (Am J Transplant 5:1934-41, 2005). Aim of this study is to examine the role of the anti-calcifying/calcifying factors in the pathophysiology of renal allograft calcification. Methods: We analyzed protocol allograft biopsies, blood and urine samples of 31 patients with and 27 patients without allograft calcification taken at 6 weeks, 3 and 6 months after transplantation. Patient demographical data, cold ischemia time, initial graft function and donor characteristics were comparable between the two groups. Biopsies were stained for osteopontin, fetuin, and matrix-gla-protein. Serum and urine electrolytes, matrix-gla-protein, fetuin, Vitamin D and intact parathyroid hormone in serum and osteopontin (OPN) in urine were examined. Results: Serum levels of fetuin and matrix-Gla protein as well as urinary levels of OPN showed specific time dependent changes (6 weeks vs. 3 months vs. 6 months; all p<0.0001). In patients with calcifications, urinary levels of OPN were decreased by 55% at 6 weeks and increased thereafter, showing 54% higher levels at 6 months compared to patients without calcification (6 weeks: p<0.01, 6 months: p<0.05). Local protein expression of fetuin-A, matrix-Gla protein and OPN in the graft was specifically increased around calcified plaques, without differences in the mRNA tissue expression. Conclusion: Anticalcifying factors show significant changes in the early phase after renal transplantation, which may be important for the prevention of allograft calcification. The differences in OPN indicate an involvement of this factor in the regulation of calcification.	[Lorenzen, Johan M.; Martino, Filippo; Scheffner, Irina; Haller, Hermann; Gwinner, Wilfried] Hannover Med Sch, Div Nephrol & Hypertens, Dept Med, Hannover, Germany; [Broecker, Verena] Hannover Med Sch, Dept Pathol, Hannover, Germany; [Leitolf, Holger] Hannover Med Sch, Div Endocrinol, Dept Med, Hannover, Germany; [Lorenzen, Johan M.; Martino, Filippo] Hannover Med Sch, IMTTS, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Gwinner, W (corresponding author), Hannover Med Sch, Div Nephrol & Hypertens, Dept Med, Hannover, Germany.	Gwinner.Wilfried@mh-hannover.de		Lorenzen, Johan/0000-0002-9132-948X	German Ministry for Education and Research (IFB-Tx); German Research Foundation [DFG LO 1736/1-1]	German Ministry for Education and Research (IFB-Tx); German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant of the German Ministry for Education and Research (IFB-Tx to W.G. and J.L.) as well as the German Research Foundation (DFG LO 1736/1-1 to JL). The German Research Foundation funded the cost of Open Access publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselman M, 2003, J AM SOC NEPHROL, V14, P3155, DOI 10.1097/01.ASN.0000099380.18995.F7; Brancaccio D, 2005, AM J NEPHROL, V25, P548, DOI 10.1159/000088809; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; CONN KM, 1985, BONE, V6, P33, DOI 10.1016/8756-3282(85)90404-1; Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.0590062290.x; FRASER JD, 1988, J BIOL CHEM, V263, P11033; Gao B, 2007, J UROLOGY, V177, P2361, DOI 10.1016/j.juro.2007.01.118; Gwinner W, 2008, AM J TRANSPLANT, V8, P1684, DOI 10.1111/j.1600-6143.2008.02293.x; Gwinner W, 2005, AM J TRANSPLANT, V5, P1934, DOI 10.1111/j.1600-6143.2005.00938.x; Jahnen-Dechent W, 2005, ANONYMOUS BIOMINERAL, P243; Jahnen-Dechent W, 2004, ANONYMOUS BIOMINERAL, P243; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; LIESKE JC, 1995, AM J PHYSIOL-RENAL, V268, pF604, DOI 10.1152/ajprenal.1995.268.4.F604; Lorenzen J, 2008, J AM SOC NEPHROL, V19, P884, DOI 10.1681/ASN.2007040486; Lorenzen J, 2010, EUR J CLIN INVEST, V40, P294, DOI 10.1111/j.1365-2362.2010.02271.x; Lorenzen JM, 2010, ATHEROSCLEROSIS, V209, P184, DOI 10.1016/j.atherosclerosis.2009.09.009; Mazzaferro S, 2007, AM J NEPHROL, V27, P75, DOI 10.1159/000099095; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x; Mengel M, 1999, HISTOCHEM J, V31, P195, DOI 10.1023/A:1003554217994; Moe SM, 2005, KIDNEY INT, V67, P2295, DOI 10.1111/j.1523-1755.2005.00333.x; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Parks JH, 2004, KIDNEY INT, V66, P777, DOI 10.1111/j.1523-1755.2004.00803.x; Schlieper G, 2007, SEMIN DIALYSIS, V20, P113, DOI 10.1111/j.1525-139X.2007.00257.x; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Spronk HMH, 2001, BIOCHEM BIOPH RES CO, V289, P485, DOI 10.1006/bbrc.2001.5996; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; Stubbs J, 2007, SEMIN DIALYSIS, V20, P302, DOI 10.1111/j.1525-139X.2007.00308.x; Verhulst A, 2005, KIDNEY INT, V68, P1643, DOI 10.1111/j.1523-1755.2005.00584.x; Vivek KR, 2003, J UROLOGY, V170, P221, DOI 10.1097/01.ju.0000059540.36463.9f; vonWasielewski R, 1997, J HISTOCHEM CYTOCHEM, V45, P1455, DOI 10.1177/002215549704501102; Yasui T, 1999, UROL RES, V27, P225, DOI 10.1007/s002400050114	32	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52039	10.1371/journal.pone.0052039	http://dx.doi.org/10.1371/journal.pone.0052039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284864	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900071
J	Sandoval, D; Barrera, JG; Stefater, MA; Sisley, S; Woods, SC; D'Alessio, DD; Seeley, RJ				Sandoval, Darleen; Barrera, Jason G.; Stefater, Margaret A.; Sisley, Stephanie; Woods, Stephen C.; D'Alessio, David D.; Seeley, Randy J.			The Anorectic Effect of GLP-1 in Rats Is Nutrient Dependent	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; FOOD-INTAKE; BODY-WEIGHT; RECEPTOR ACTIVATION; GLUCOSE; HYPERGLYCEMIA; INFUSION; MEDIATE; GLUCOPRIVATION; SUPPRESSION	GLP-1-induced insulin secretion from the beta-cell is dependent upon glucose availability. The purpose of the current study was to determine whether CNS GLP-1 signaling is also glucose-dependent. We found that fasting blunted the ability of 3rd cerebroventricularly (i3vt)-administered GLP-1 to reduce food intake. However, fasted animals maintained the anorexic response to melanotan II, a melanocortin receptor agonist, indicating a specific effect of fasting on GLP-1 action. We also found that i3vt administration of leptin, which is also decreased with fasting, was not able to potentiate GLP-1 action in fasted animals. However, we did find that CNS glucose sensing is important in GLP-1 action. Specifically, we found that i3vt injection of 2DG, a drug that blocks cellular glucose utilization, and AICAR which activates AMPK, both blocked GLP-1-induced reductions in food intake. To examine the role of glucokinase, an important CNS glucose sensor, we studied glucokinase-heterozygous knockout mice, but found that they responded normally to peripherally administered GLP-1 and exendin-4. Interestingly, oral, but not i3vt or IP glucose potentiated GLP-1's anorectic action. Thus, CNS and peripheral fuel sensing are both important in GLP-1-induced reductions in food intake.	[Sandoval, Darleen; Barrera, Jason G.; Stefater, Margaret A.; Sisley, Stephanie; D'Alessio, David D.; Seeley, Randy J.] Univ Cincinnati, Div Endocrinol & Metab, Cincinnati, OH 45221 USA; [Woods, Stephen C.] Univ Cincinnati, Dept Psychiat, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Sandoval, D (corresponding author), Univ Cincinnati, Div Endocrinol & Metab, Cincinnati, OH 45221 USA.	darleen.sandoval@uc.edu	Sisley, Stephanie/AGP-7748-2022	Sisley, Stephanie/0000-0003-2900-7014; Seeley, Randy/0000-0002-3721-5625	National Institutes of Health [DK75365, DK54080, DK54890, DK056863, DK 017844]; Ethicon Endo-Surgeries; Roche; Mannkind; Ethicon Endosurgery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054890, P01DK056863, R01DK054080, R01DK017844, K01DK075365, R01DK082480, R01DK057900, R37DK017844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ethicon Endo-Surgeries; Roche(Roche Holding); Mannkind; Ethicon Endosurgery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK75365 to D.S., DK54080, DK54890 and DK056863 to R.J.S. and DK 017844 to S.C.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and we have the following conflicts: Drs. Sandoval, Seeley, Woods, and D'Alessio receive funding from Ethicon Endo-Surgeries. Dr. Seeley currently has stock/stock options with Zafgen and consults for Zafgen, Eli Lilly and Ethicon Endo-Surgeries. Dr. Sandoval has received grant support from Roche, Mannkind, and Ethicon Endosurgery. Dr. D'Alessio has grant funding from Mannkind. The remaining authors disclose no conflicts. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. None of the above research funding was used to support this study.	Amato A, 2010, NEUROGASTROENT MOTIL, V22, P664; Barrera JG, 2009, DIABETES; DALESSIO D, 1993, DIGESTION, V54, P377; DAVIS JD, 1981, SCIENCE, V212, P81, DOI 10.1126/science.7193909; DunnMeynell AA, 1997, BRAIN RES, V748, P100, DOI 10.1016/S0006-8993(96)01280-2; Gielkens HAJ, 1998, METABOLISM, V47, P321, DOI 10.1016/S0026-0495(98)90264-5; Gilbert M, 2003, DIABETES, V52, P277, DOI 10.2337/diabetes.52.2.277; Grill HJ, 2004, AM J PHYSIOL-REG I, V287, pR1190, DOI 10.1152/ajpregu.00163.2004; Hayes MR, 2011, CELL METAB, V13, P320, DOI 10.1016/j.cmet.2011.02.001; Hayes MR, 2009, ENDOCRINOLOGY, V150, P2654, DOI 10.1210/en.2008-1479; Hudson B, 2004, PHYSIOL BEHAV, V82, P241, DOI 10.1016/j.physbeh.2004.03.032; Kanoski SE, 2011, ENDOCRINOLOGY, V152, P3103, DOI 10.1210/en.2011-0174; Kinzig KP, 2002, J NEUROSCI, V22, P10470; Knauf C, 2008, DIABETES, V57, P2603, DOI 10.2337/db07-1788; KREYMANN B, 1987, LANCET, V2, P1300; KURATA K, 1986, PHYSIOL BEHAV, V37, P615, DOI 10.1016/0031-9384(86)90295-7; MAYER J, 1955, ANN NY ACAD SCI, V63, P15, DOI 10.1111/j.1749-6632.1955.tb36543.x; McMahon LR, 1998, AM J PHYSIOL-REG I, V274, pR23, DOI 10.1152/ajpregu.1998.274.1.R23; Meier JJ, 2002, EUR J PHARMACOL, V440, P269, DOI 10.1016/S0014-2999(02)01434-6; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; QUALMANN C, 1995, SCAND J GASTROENTERO, V30, P892, DOI 10.3109/00365529509101597; RITTER RC, 1980, AM J PHYSIOL, V238, pE141, DOI 10.1152/ajpendo.1980.238.2.E141; Russell AW, 2001, DIABETIC MED, V18, P718, DOI 10.1046/j.1464-5491.2001.00545.x; Sanders NM, 2001, DIABETES, V50, pA53; Schick RR, 2003, AM J PHYSIOL-REG I, V284, pR1427, DOI 10.1152/ajpregu.00479.2002; Seeley RJ, 2002, AM J PHYSIOL-REG I, V283, pR46, DOI 10.1152/ajpregu.00021.2002; Tang-Christensen M, 1998, DIABETES, V47, P530, DOI 10.2337/diabetes.47.4.530; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Vahl TP, 2007, ENDOCRINOLOGY, V148, P4965, DOI 10.1210/en.2006-0153; vanDijk G, 1996, AM J PHYSIOL-REG I, V271, pR1096, DOI 10.1152/ajpregu.1996.271.4.R1096; vanDijk G, 1997, NATURE, V385, P214, DOI 10.1038/385214a0; Washington MC, 2010, BRAIN RES, V1344, P124, DOI 10.1016/j.brainres.2010.05.002; WEIR GC, 1989, DIABETES, V38, P338, DOI 10.2337/diabetes.38.3.338; Williams DL, 2006, DIABETES, V55, P3387, DOI 10.2337/db06-0558; WOODS SC, 1984, AM J PHYSIOL, V247, pR393, DOI 10.1152/ajpregu.1984.247.2.R393	38	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51870	10.1371/journal.pone.0051870	http://dx.doi.org/10.1371/journal.pone.0051870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284795	Green Submitted, gold, Green Published			2022-12-25	WOS:000312435900060
J	Wang, EM; Aslanzadeh, V; Papa, F; Zhu, HY; de la Grange, P; Cambi, F				Wang, Erming; Aslanzadeh, Vahid; Papa, Filomena; Zhu, Haiyan; de la Grange, Pierre; Cambi, Franca			Global Profiling of Alternative Splicing Events and Gene Expression Regulated by hnRNPH/F	PLOS ONE			English	Article							TRANSCRIPTIONAL CONTROL; HUMAN TISSUES; G RUNS; BINDING; OLIGODENDROCYTES; PROTEIN; MOUSE; DIFFERENTIATION; MECHANISMS; COMPLEXES	In this study, we have investigated the global impact of heterogeneous nuclear Ribonuclear Protein (hnRNP) H/F-mediated regulation of splicing events and gene expression in oligodendrocytes. We have performed a genome-wide transcriptomic analysis at the gene and exon levels in Oli-neu cells treated with siRNA that targets hnRNPH/F compared to untreated cells using Affymetrix Exon Array. Gene expression levels and regulated exons were identified with the GenoSplice EASANA algorithm. Bioinformatics analyses were performed to determine the structural properties of G tracts that correlate with the function of hnRNPH/F as enhancers vs. repressors of exon inclusion. Different types of alternatively spliced events are regulated by hnRNPH/F. Intronic G tracts density, length and proximity to the 59 splice site correlate with the hnRNPH/F enhancer function. Additionally, 6% of genes are differently expressed upon knock down of hnRNPH/F. Genes that regulate the transition of oligodendrocyte progenitor cells to oligodendrocytes are differentially expressed in hnRNPH/F depleted Oli-neu cells, resulting in a decrease of negative regulators and an increase of differentiation-inducing regulators. The changes were confirmed in developing oligodendrocytes in vivo. This is the first genome wide analysis of splicing events and gene expression regulated by hnRNPH/F in oligodendrocytes and the first report that hnRNPH/F regulate genes that are involved in the transition from oligodendrocyte progenitor cells to oligodendrocytes.	[Wang, Erming; Papa, Filomena; Zhu, Haiyan; Cambi, Franca] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Aslanzadeh, Vahid] Univ Zanjan, Dept Biotechnol, Res Inst Physiol & Biotechnol, Zanjan, Iran; [de la Grange, Pierre] Hop St Louis, GenoSplice Technol, Paris, France	University of Kentucky; University Zanjan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Cambi, F (corresponding author), Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA.	franca.cambi@uky.edu	zhu, xueqiong/U-1320-2019	Aslanzadeh, Vahid/0000-0002-4500-1627; de la Grange, Pierre/0000-0001-6361-1878	National Institutes of Health/National Institute of Neurological Disorders and Stroke [RO1NS053905, ARRA R01NS053905-03S]; University of Kentucky Research Foundation; NIH Shared Instrument Program [S10 RR026827-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053905] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Kentucky Research Foundation; NIH Shared Instrument Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work as supported by the following funding agencies: National Institutes of Health/National Institute of Neurological Disorders and Stroke (RO1NS053905 and ARRA R01NS053905-03S) and Microarray Pilot grant from the University of Kentucky Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Gene Yeo for critical reading of the manuscript. We thank the personnel at the Microarray Core facility for the excellent technical support in performing the exon arrays studies and Ms. Jennifer Strange for excellent technical assistance with the FACS isolation of OL. The FACS sorting facility at the University of Kentucky is in part supported by NIH Shared Instrument Program (S10 RR026827-01A1).	Alkan SA, 2006, BIOCHEM J, V393, P361, DOI 10.1042/BJ20050538; Belachew S, 2002, J NEUROSCI, V22, P8553; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; Dominguez C, 2010, NAT STRUCT MOL BIOL, V17, P853, DOI 10.1038/nsmb.1814; Hicks MJ, 2010, MOL CELL BIOL, V30, P1878, DOI 10.1128/MCB.01071-09; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZX, 2011, HUM MOL GENET, V20, P1084, DOI 10.1093/hmg/ddq553; Maggipinto M, 2004, J NEUROSCI RES, V75, P614, DOI 10.1002/jnr.20014; Marcucci R, 2007, NUCLEIC ACIDS RES, V35, P132, DOI 10.1093/nar/gkl965; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Reed R, 2000, CURR OPIN CELL BIOL, V12, P340, DOI 10.1016/S0955-0674(00)00097-1; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; Tang XM, 1998, J CELL BIOCHEM, V68, P128, DOI 10.1002/(SICI)1097-4644(19980101)68:1<128::AID-JCB13>3.0.CO;2-D; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wang EM, 2012, J NEUROSCI RES, V90, P1701, DOI 10.1002/jnr.23055; Wang E, 2011, J BIOL CHEM, V286, P4059, DOI 10.1074/jbc.M110.199927; Wang EM, 2009, J BIOL CHEM, V284, P11194, DOI 10.1074/jbc.M809373200; Wang E, 2008, EXP NEUROL, V214, P322, DOI 10.1016/j.expneurol.2008.09.001; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wegner M, 2000, GLIA, V29, P118, DOI 10.1002/(SICI)1098-1136(20000115)29:2<118::AID-GLIA4>3.0.CO;2-Q; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Yao WG, 2008, GROWTH HORM IGF RES, V18, P517, DOI 10.1016/j.ghir.2008.04.006; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zhu H, 2012, GLIA, V60, P69, DOI 10.1002/glia.21248; Zhu H, 2011, QKI PLP PATHWAY CONT	43	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51266	10.1371/journal.pone.0051266	http://dx.doi.org/10.1371/journal.pone.0051266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284676	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900018
J	Jordan, LKB; Lindeman, KC; Spieler, RE				Jordan, Lance K. B.; Lindeman, Kenyon C.; Spieler, Richard E.			Depth-Variable Settlement Patterns and Predation Influence on Newly Settled Reef Fishes (Haemulon spp., Haemulidae)	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ONE-TREE-REEF; CORAL-REEF; HABITAT COMPLEXITY; SEAGRASS BEDS; ARTIFICIAL REEFS; POSTSETTLEMENT SURVIVORSHIP; NEARSHORE HARDBOTTOM; RECRUITMENT PATTERNS; ASSEMBLAGE STRUCTURE	During early demersal ontogeny, many marine fishes display complex habitat-use patterns. Grunts of the speciose genus Haemulon are among the most abundant fishes on western North Atlantic coral reefs, with most species settling to shallow habitats (<= 12 m). To gain understanding into cross-shelf distributional patterns exhibited by newly settled stages of grunts <2 cm total length), we examined: 1) depth-specific distributions of congeners at settlement among sites at 8 m, 12 m, and 21 m, and 2) depth-variable predation pressure on newly settled individuals (species pooled). Of the six species identified from collections of newly settled specimens (n = 2125), Haemulon aurolineatum (tomtate), H. flavolineatum (French grunt), and H. striatum (striped grunt) comprised 98% of the total abundance; with the first two species present at all sites. Prevalence of H. aurolineatum and H. flavolineatum decreased substantially from the 8-m site to the two deeper sites. In contrast, H. striatum was absent from the 8-m site and exhibited its highest frequency at the 21-m site. Comparison of newly settled grunt delta density for all species on caged (predator exclusion) and control artificial reefs at the shallowest site (8-m) revealed no difference, while the 12-m and 21-m sites exhibited significantly greater delta densities on the caged treatment. This result, along with significantly higher abundances of co-occurring piscivorous fishes at the deeper sites, indicated lower predation pressure at the 8-m site. This study suggests habitat-use patterns of newly settled stages of some coral reef fishes that undergo ontogenetic shifts are a function of depth-variable predation pressure while, for at least one deeper-water species, proximity to adult habitat appears to be an important factor affecting settlement distribution. Citation: Jordan LKB, Lindeman KC, Spieler RE (2012) Depth-Variable Settlement Patterns and Predation Influence on Newly Settled Reef Fishes (Haemulon spp., Haemulidae). PLoS ONE 7(12): e50897. doi:10.1371/journal.pone.0050897	[Jordan, Lance K. B.; Spieler, Richard E.] Nova SE Univ, Natl Coral Reef Inst, Oceanog Ctr, Dania, FL 33004 USA; [Lindeman, Kenyon C.] Florida Inst Technol, Dept Educ & Interdisciplinary Studies, Melbourne, FL 32901 USA	Nova Southeastern University; Florida Institute of Technology	Jordan, LKB (corresponding author), Nova SE Univ, Natl Coral Reef Inst, Oceanog Ctr, Dania, FL 33004 USA.	Lance@microwavetelemetry.com		Lindeman, Ken/0000-0003-4098-4158	National Oceanic and Atmospheric Administration Coastal Ocean Program	National Oceanic and Atmospheric Administration Coastal Ocean Program(National Oceanic Atmospheric Admin (NOAA) - USA)	This manuscript is a result of research partially funded by the National Oceanic and Atmospheric Administration Coastal Ocean Program under an award to Nova Southeastern University for the National Coral Reef Institute (NCRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams AJ, 2002, MAR ECOL PROG SER, V228, P213, DOI 10.3354/meps228213; Adams AJ, 2004, B MAR SCI, V75, P93; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Appeldoorn RS, 2009, CARIBB J SCI, V45, P304; Arena PT, 2007, HYDROBIOLOGIA, V580, P157, DOI 10.1007/s10750-006-0456-x; Ault JS, 2008, ENVIRON CONSERV, V35, P221, DOI 10.1017/S0376892908005043; Banks K. W, 2008, CORAL REEFS US, P125; Baron RM, 2004, ESTUAR COAST SHELF S, V60, P431, DOI 10.1016/j.ecss.2004.02.002; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Beets J, 1997, MAR ECOL PROG SER, V148, P11, DOI 10.3354/meps148011; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bohnsack J.A., 1991, P412; BOHNSACK JA, 1989, B MAR SCI, V44, P631; BOHNSACK JA, 1994, B MAR SCI, V55, P796; BROTHERS E B, 1981, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V178, P369; CARR MH, 1995, MAR ECOL PROG SER, V124, P31, DOI 10.3354/meps124031; Chittaro PM, 2005, ENVIRON BIOL FISH, V72, P175, DOI 10.1007/s10641-004-9077-2; Claro Rodolfo, 2001, P194; Connell SD, 1998, CORAL REEFS, V17, P49, DOI 10.1007/s003380050094; Connell SD, 1996, MAR BIOL, V126, P347, DOI 10.1007/BF00347459; Connell SD, 1997, J EXP MAR BIOL ECOL, V213, P181, DOI 10.1016/S0022-0981(96)02773-6; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; D'Alessandro E, 2007, MAR ECOL PROG SER, V331, P85, DOI 10.3354/meps331085; Dahlgren CP, 2000, ECOLOGY, V81, P2227; de la Moriniere EC, 2004, MAR BIOL, V144, P139, DOI 10.1007/s00227-003-1167-8; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; Dorenbosch M, 2009, MAR ECOL PROG SER, V379, P181, DOI 10.3354/meps07896; Eklund A.M., 1997, P 8 INT COR REEF S, V2, P1139; Ferro F, 2005, SEFSC532 NOAA NMFS, P73; Fisher RA, 1925, STAT METHODS RES WOR, P318; Fletcher D, 2005, ENVIRON ECOL STAT, V12, P45, DOI 10.1007/s10651-005-6817-1; Gaston K.J., 1994, RARITY, P205; Gilliam DS, 2008, 08 ENV PROT DEP BIOL, P105; Gilliam DS, 1999, THESIS NOVA SE U FT, P111; Grol MGG, 2008, MAR ECOL PROG SER, V366, P137, DOI 10.3354/meps07509; HAMNER WM, 1988, B MAR SCI, V42, P459; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Heck K.L. Jr, 1991, P281; HELFMAN GS, 1982, ANIM BEHAV, V30, P317, DOI 10.1016/S0003-3472(82)80042-0; Hill RL, 2002, THESIS U PUERTO RICO, P152; Hixon M.A., 1991, P475; HIXON MA, 1989, B MAR SCI, V44, P666; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; HIXON MA, 1991, THEOR POPUL BIOL, V39, P178, DOI 10.1016/0040-5809(91)90035-E; Holmes TH, 2011, ANIM BEHAV, V81, P543, DOI 10.1016/j.anbehav.2010.11.019; Horinouchi M, 2009, MAR ECOL PROG SER, V377, P43, DOI 10.3354/meps07869; Huijbers CM, 2008, J EXP MAR BIOL ECOL, V357, P134, DOI 10.1016/j.jembe.2008.01.004; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jordan LKB, 2005, J EXP MAR BIOL ECOL, V326, P170, DOI 10.1016/j.jembe.2005.05.023; Jordan LKB, 2004, PROCEEDINGS OF THE FIFTY-FIFTH ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P322; Kingsford MJ, 2002, B MAR SCI, V70, P309; Laegdsgaard P, 2001, J EXP MAR BIOL ECOL, V257, P229, DOI 10.1016/S0022-0981(00)00331-2; Levin P, 1997, OECOLOGIA, V112, P55, DOI 10.1007/s004420050283; LIMOUZYPARIS C, 1994, B MAR SCI, V54, P857; LINDEMAN KC, 1986, B MAR SCI, V39, P673; Lindeman KC, 1999, FISH B-NOAA, V97, P508; Lindeman KC, 2000, B MAR SCI, V66, P929; Lindeman KC, 2006, GUIDE EARLY STAGES A, P1597; Lindeman Kenneth C., 2001, Proceedings of the Gulf and Caribbean Fisheries Institute, V52, P732; Lindeman Kenyon C., 1998, Proceedings of the Gulf and Caribbean Fisheries Institute, V50, P385; LIVINGSTON RJ, 1982, MAR ECOL PROG SER, V7, P1, DOI 10.3354/meps007001; LO NCH, 1992, CAN J FISH AQUAT SCI, V49, P2515, DOI 10.1139/f92-278; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Marnane MJ, 2002, MAR ECOL PROG SER, V231, P261, DOI 10.3354/meps231261; McFarland W.N., 1980, Proceedings of the Gulf and Caribbean Fisheries Institute, V32, P132; MCFARLAND WN, 1985, FISH B-NOAA, V83, P413; MCIVOR CC, 1988, ECOLOGY, V69, P1341, DOI 10.2307/1941632; Meekan MG, 1996, MAR ECOL PROG SER, V137, P25, DOI 10.3354/meps137025; Milinski M, 1986, BEHAV TELEOST FISHES, P285; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nagelkerken I, 2001, MAR ECOL PROG SER, V214, P225, DOI 10.3354/meps214225; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; OGDEN JC, 1977, MAR BIOL, V42, P273, DOI 10.1007/BF00397751; PARRISH JD, 1989, MAR ECOL PROG SER, V58, P143, DOI 10.3354/meps058143; PETRANKA JW, 1983, COPEIA, P624, DOI 10.2307/1444326; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; Power M.E., 1987, P333; Power RM, 2003, P GULF CARIB FISH I, V54, P401; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Rice J., 1995, MATH STAT DATA ANAL, P597; Rocha LA, 2008, MOL PHYLOGENET EVOL, V48, P918, DOI 10.1016/j.ympev.2008.05.024; Seber G., 1982, ESTIMATION ANIMAL AB, P654; Serafy JE, 2007, B MAR SCI, V80, P609; Sherman RL, 2002, ICES J MAR SCI, V59, pS196, DOI 10.1006/jmsc.2001.1163; Sherman RL, 2000, THESIS NOVA SE U FT, P173; SHULMAN MJ, 1983, ECOLOGY, V64, P1508, DOI 10.2307/1937505; SHULMAN MJ, 1987, MAR ECOL PROG SER, V39, P233, DOI 10.3354/meps039233; SHULMAN MJ, 1985, ECOLOGY, V66, P1056, DOI 10.2307/1940565; SHULMAN MJ, 1984, J EXP MAR BIOL ECOL, V74, P85, DOI 10.1016/0022-0981(84)90039-X; SHULMAN MJ, 1985, J EXP MAR BIOL ECOL, V89, P205, DOI 10.1016/0022-0981(85)90127-3; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Spina AP, 2000, ENVIRON BIOL FISH, V57, P393, DOI 10.1023/A:1007682010268; STARCK WALTER A., 1966, ICHTHYOL AQUARIUM J, V38, P313; Theilacker G.H., 1974, P287; Victor B.C., 1991, P231; Vigliola L, 2002, OECOLOGIA, V131, P89, DOI 10.1007/s00442-001-0866-4; Wahl DH, 1995, CAN J FISH AQUAT SCI, V52, P2312, DOI 10.1139/f95-823; Walker BK, 2009, J COASTAL RES, V25, P39, DOI [10.2112/S153-005.1, 10.2112/SI53-005.1]; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141	104	5	5	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50897	10.1371/journal.pone.0050897	http://dx.doi.org/10.1371/journal.pone.0050897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272077	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800020
J	Silachev, DN; Isaev, NK; Pevzner, IB; Zorova, LD; Stelmashook, EV; Novikova, SV; Plotnikov, EY; Skulachev, VP; Zorov, DB				Silachev, Denis N.; Isaev, Nikolay K.; Pevzner, Irina B.; Zorova, Ljubava D.; Stelmashook, Elena V.; Novikova, Svetlana V.; Plotnikov, Egor Y.; Skulachev, Vladimir P.; Zorov, Dmitry B.			The Mitochondria-Targeted Antioxidants and Remote Kidney Preconditioning Ameliorate Brain Damage through Kidney-to-Brain Cross-Talk	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; GLYCOGEN-SYNTHASE KINASE-3-BETA; N-ACETYL-CYSTEINE; PLASTOQUINONE DERIVATIVES; INTERRUPT EXECUTION; HIF-ALPHA; ERYTHROPOIETIN; ISCHEMIA; REPERFUSION; TOOLS	Background: Many ischemia-induced neurological pathologies including stroke are associated with high oxidative stress. Mitochondria-targeted antioxidants could rescue the ischemic organ by providing specific delivery of antioxidant molecules to the mitochondrion, which potentially suffers from oxidative stress more than non-mitochondrial cellular compartments. Besides direct antioxidative activity, these compounds are believed to activate numerous protective pathways. Endogenous anti-ischemic defense may involve the very powerful neuroprotective agent erythropoietin, which is mainly produced by the kidney in a redox-dependent manner, indicating an important role of the kidney in regulation of brain ischemic damage. The goal of this study is to track the relations between the kidney and the brain in terms of the amplification of defense mechanisms during SkQR1 treatment and remote renal preconditioning and provide evidence that the kidney can generate signals inducing a tolerance to oxidative stress-associated brain pathologies. Methodology/Principal Findings: We used the cationic plastoquinone derivative, SkQR1, as a mitochondria-targeted antioxidant to alleviate the deleterious consequences of stroke. A single injection of SkQR1 before cerebral ischemia in a dose-dependent manner reduces infarction and improves functional recovery. Concomitantly, an increase in the levels of erythropoietin in urine and phosphorylated glycogen synthase kinase-3 beta (GSK-3 beta) in the brain was detected 24 h after SkQR1 injection. However, protective effects of SkQR1 were not observed in rats with bilateral nephrectomy and in those treated with the nephrotoxic antibiotic gentamicin, indicating the protective role of humoral factor(s) which are released from functional kidneys. Renal preconditioning also induced brain protection in rats accompanied by an increased erythropoietin level in urine and kidney tissue and P-GSK-3 beta in brain. Co-cultivation of SkQR1-treated kidney cells with cortical neurons resulted in enchanced phosphorylation of GSK-3 beta in neuronal cells. Conclusion: The results indicate that renal preconditioning and SkQR1-induced brain protection may be mediated through the release of EPO from the kidney.	[Silachev, Denis N.; Isaev, Nikolay K.; Plotnikov, Egor Y.; Skulachev, Vladimir P.; Zorov, Dmitry B.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Silachev, Denis N.; Isaev, Nikolay K.; Pevzner, Irina B.; Zorova, Ljubava D.; Stelmashook, Elena V.; Novikova, Svetlana V.; Plotnikov, Egor Y.; Skulachev, Vladimir P.; Zorov, Dmitry B.] Moscow MV Lomonosov State Univ, Mitoengn Res Inst, Moscow, Russia; [Isaev, Nikolay K.; Stelmashook, Elena V.; Novikova, Svetlana V.] Russian Acad Med Sci, Res Ctr Neurol, Moscow, Russia; [Pevzner, Irina B.; Skulachev, Vladimir P.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Zorova, Ljubava D.] Moscow MV Lomonosov State Univ, Ctr Int Laser, Moscow 119899, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Research Center of Neurology; Russian Academy of Medical Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University	Zorov, DB (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	zorov@genebee.msu.su	Plotnikov, Egor Y/F-8592-2019; Zorova, Ljubava/AAC-7286-2022; Zorov, Dmitry B./AAB-1738-2019; Silachev, Denis/ABE-8515-2020; Stelmashook, Elena V/B-4442-2012; Isaev, Nikolay K/B-4194-2012; Zorova, Ljubava D/J-3554-2017; Silachev, Denis N/C-9464-2012; Pevzner, Irina B/S-6178-2018	Plotnikov, Egor Y/0000-0003-2838-3704; Zorova, Ljubava/0000-0001-9046-712X; Zorov, Dmitry B./0000-0003-0863-8490; Zorova, Ljubava D/0000-0001-9046-712X; Skulachev, Vladimir/0000-0001-5141-7517; Stelmashook, Elena/0000-0003-2533-7673; Silachev, Denis/0000-0003-0581-9755; Isaev, Nickolay/0000-0001-8427-1163	Research Institute of Mitoengineering; RFBR [12-04-00025, 11-04-00771, 11-04-01307]; Russian Federation [MK-729.2012.4]	Research Institute of Mitoengineering; RFBR(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation)	This study was supported by the Research Institute of Mitoengineering; RFBR grants, 12-04-00025, 11-04-00771 and 11-04-01307; Grant of the President of the Russian Federation MK-729.2012.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com; Anisimov VN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1329, DOI 10.1134/S0006297908120055; Antonenko YN, 2008, J MEMBRANE BIOL, V222, P141, DOI 10.1007/s00232-008-9108-6; Antonenko YN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1273, DOI 10.1134/S0006297908120018; Bakeeva LE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1288, DOI 10.1134/S000629790812002X; BARONE FC, 1991, BRAIN RES BULL, V26, P285, DOI 10.1016/0361-9230(91)90240-K; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Bergmann MW, 2011, EUR J HEART FAIL, V13, P560, DOI 10.1093/eurjhf/hfr002; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Canbolat O, 1998, RESP PHYSIOL, V114, P175, DOI 10.1016/S0034-5687(98)00080-2; Cocheme HM, 2007, MITOCHONDRION, V7, pS94, DOI 10.1016/j.mito.2007.02.007; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diwan V, 2008, J CARDIOVASC PHARM, V51, P126, DOI 10.1097/FJC.0b013e31815d88c9; Diwan V, 2008, MOL CELL BIOCHEM, V315, P195, DOI 10.1007/s11010-008-9808-3; Ehrenreich H, 2011, MOL MED, V17, P1306, DOI 10.2119/molmed.2011.00259; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Hagen T, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/436981; Hildebrandt W, 2002, BLOOD, V99, P1552, DOI 10.1182/blood.V99.5.1552; Hobbs CE, 2008, PEDIATR INT, V50, P481, DOI 10.1111/j.1442-200X.2008.02705.x; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; HUNTER AJ, 1995, TRENDS PHARMACOL SCI, V16, P123, DOI 10.1016/S0165-6147(00)88999-3; [Исаев Н.К. Isaev N.K.], 2012, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V77, P1201; Ishida T, 1997, SHOCK, V8, P86, DOI 10.1097/00024382-199708000-00003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jelkmann W, 1997, KIDNEY INT, V51, P497, DOI 10.1038/ki.1997.69; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Ludman AJ, 2011, HEART, V97, P1560, DOI 10.1136/hrt.2011.223867; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCCLANAHAN TB, 1993, FASEB J, V7, pA118; Miura T, 2010, CARDIOVASC RES, V88, P7, DOI 10.1093/cvr/cvq206; Momeni M, 2011, EUR J APPL PHYSIOL, V111, P2681, DOI 10.1007/s00421-011-1893-4; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Neroev VV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1317, DOI 10.1134/S0006297908120043; Neumcke I, 1999, ENDOCRINOLOGY, V140, P641, DOI 10.1210/en.140.2.641; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Paliege A, 2010, KIDNEY INT, V77, P312, DOI 10.1038/ki.2009.460; Plotnikov EY, 2007, KIDNEY INT, V72, P1493, DOI 10.1038/sj.ki.5002568; Plotnikov EY, 2011, BBA-MOL BASIS DIS, V1812, P77, DOI 10.1016/j.bbadis.2010.09.008; Plotnikov EY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P145, DOI 10.1134/S0006297910020045; Prunier F, 2012, AM HEART J, V163, P200, DOI 10.1016/j.ahj.2011.11.005; Quiroz JA, 2010, NEUROPSYCHOBIOLOGY, V62, P50, DOI 10.1159/000314310; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Silachev DN, 2009, B EXP BIOL MED+, V147, P269, DOI 10.1007/s10517-009-0489-z; Skulachev MV, 2011, CURR DRUG TARGETS, V12, P800; Skulachev VP, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1385, DOI 10.1134/S0006297907120139; Skulachev VP, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1400, DOI 10.1134/S0006297909120165; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Zembron-Lacny A, 2009, PHYSIOL RES, V58, P855, DOI 10.33549/physiolres.931590	55	37	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51553	10.1371/journal.pone.0051553	http://dx.doi.org/10.1371/journal.pone.0051553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272118	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800053
J	Singh, PP; Lucchi, NW; Blackstock, A; Udhayakumar, V; Singh, N				Singh, Puspendra P.; Lucchi, Naomi W.; Blackstock, Anna; Udhayakumar, Venkatachalam; Singh, Neeru			Intervillous Macrophage Migration Inhibitory Factor Is Associated with Adverse Birth Outcomes in a Study Population in Central India	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; RAPID DIAGNOSTIC-TEST; PLACENTAL MALARIA; INFECTED ERYTHROCYTES; PREGNANCY OUTCOMES; UP-REGULATION; FACTOR MIF; BLOOD; EXPRESSION; CYTOKINES	Macrophage migration inhibitory factor (MIF) is a pluripotent factor produced by a variety of cells. It plays an important biological role in the regulation of pregnancy and has been shown to influence malaria pathogenesis. In this study, the levels of MIF in the peripheral, cord and placental intervillous blood (IVB) plasma collected from women residing in a malaria endemic region of Central India was determined and its association with malaria in pregnancy and birth outcomes was investigated. MIF levels were significantly different in IVB, peripheral, and cord plasma, with IVB plasma having the highest MIF levels and peripheral plasma having the lowest. Placental malaria positive women had significantly higher IVB plasma MIF levels than placental malaria negative women, but this relationship was not seen in peripheral or cord plasma MIF levels. In addition, the odds of stillbirth and low birth weight deliveries for the uppermost placental MIF quartile (irrespective of placental malaria status) was significantly higher than that of the lowest placental MIF quartile, supporting the hypothesis that elevated concentrations of placental MIF may be associated with an increased risk of adverse birth outcome. Citation: Singh PP, Lucchi NW, Blackstock A, Udhayakumar V, Singh N (2012) Intervillous Macrophage Migration Inhibitory Factor Is Associated with Adverse Birth Outcomes in a Study Population in Central India. PLoS ONE 7(12): e51678. doi:10.1371/journal.pone.0051678	[Singh, Puspendra P.; Singh, Neeru] Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India; [Singh, Puspendra P.; Singh, Neeru] Natl Inst Malaria Res Field Unit, Jabalpur, Madhya Pradesh, India; [Lucchi, Naomi W.; Blackstock, Anna; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Blackstock, Anna] Atlanta Res & Educ Fdn, VA Med Ctr, Decatur, GA USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Singh, N (corresponding author), Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India.	neeru.singh@gmail.com	Singh, Pushpendra P./P-6421-2018; Singh, Puspendra/R-5135-2019; Singh, Puspendra/P-1772-2017; Singh, Puspendra/F-5751-2012	Singh, Pushpendra P./0000-0003-3813-4322; Singh, Puspendra/0000-0003-2616-9309; Lucchi, Naomi/0000-0001-8789-8041	Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, Govt. of India, New Delhi	Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, Govt. of India, New Delhi	The study was funded by Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, Govt. of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Awandare GA, 2006, CLIN IMMUNOL, V119, P219, DOI 10.1016/j.clim.2005.12.003; Beeson JG, 2002, INFECT IMMUN, V70, P5412, DOI 10.1128/IAI.70.10.5412-5415.2002; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Bharti PK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-126; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; Cardaropoli S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/639342; Carli C, 2009, ENDOCRINOLOGY, V150, P3128, DOI 10.1210/en.2008-1088; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P631, DOI 10.1128/CDLI.10.4.631-636.2003; Chaisavaneeyakorn S, 2002, J INFECT DIS, V186, P1371, DOI 10.1086/344322; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V18, P405, DOI 10.1080/14767050500361703; Chaiyaroj SC, 2004, ACTA TROP, V89, P319, DOI 10.1016/j.actatropica.2003.10.010; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Diamond-Smith Nadia, 2009, Malar J, V8, P24, DOI 10.1186/1475-2875-8-24; Fievet N, 2001, J INFECT DIS, V183, P1530, DOI 10.1086/320201; Fried M, 1998, J IMMUNOL, V160, P2523; GALBRAITH RM, 1980, T ROY SOC TROP MED H, V74, P61, DOI 10.1016/0035-9203(80)90012-7; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Hamer DH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-210; Kochar Dhanpat K., 1998, Indian Journal of Malariology, V35, P123; Leopardi O, 1996, PATHOL RES PRACT, V192, P892, DOI 10.1016/S0344-0338(96)80068-9; Letta F, 2002, AM J REPROD IMMUNOL, V48, P404, DOI 10.1034/j.1600-0897.2002.01152.x; Lucchi NW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-42; Martiney JA, 2000, INFECT IMMUN, V68, P2259, DOI 10.1128/IAI.68.4.2259-2267.2000; McGready R, 2004, AM J TROP MED HYG, V70, P398, DOI 10.4269/ajtmh.2004.70.398; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Moore JM, 1999, J INFECT DIS, V179, P1218, DOI 10.1086/314737; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Nair Latika S., 1993, Indian Journal of Malariology, V30, P207; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Pearce BD, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.066; RANDALL CL, 1987, ALCOHOL CLIN EXP RES, V11, P32, DOI 10.1111/j.1530-0277.1987.tb01256.x; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Sakamoto Y, 2005, J REPROD IMMUNOL, V66, P161, DOI 10.1016/j.jri.2005.04.005; Singh N, 2003, ANN TROP MED PARASIT, V97, P875, DOI 10.1179/000349803225002688; Singh N, 1999, B WORLD HEALTH ORGAN, V77, P567; Singh N, 2000, ANN TROP MED PARASIT, V94, P421, DOI 10.1080/00034983.2000.11813560; Singh Neeru, 1996, Indian Journal of Malariology, V33, P41; Singh Neeru, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P10; Singh Neeru, 1995, Indian Journal of Malariology, V32, P6; Swope MD, 1999, REV PHYSIOL BIOCH P, V139, P1, DOI 10.1007/BFb0033647; Todros T, 2005, EUR J OBSTET GYN R B, V123, P162, DOI 10.1016/j.ejogrb.2005.03.014; URQUHART AD, 1994, CLIN INFECT DIS, V19, P117, DOI 10.1093/clinids/19.1.117; Young A, 2002, BIOL REPROD, V66, P445, DOI 10.1095/biolreprod66.2.445	44	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51678	10.1371/journal.pone.0051678	http://dx.doi.org/10.1371/journal.pone.0051678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272137	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386600035
J	Schmedt, T; Chen, YM; Nguyen, TT; Li, SM; Bonanno, JA; Jurkunas, UV				Schmedt, Thore; Chen, Yuming; Nguyen, Tracy T.; Li, Shimin; Bonanno, Joseph A.; Jurkunas, Ula V.			Telomerase Immortalization of Human Corneal Endothelial Cells Yields Functional Hexagonal Monolayers	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; CELLULAR SENESCENCE; MOLECULAR-MECHANISMS; CL-/HCO3-EXCHANGE; EPITHELIAL-CELLS; NEURAL CREST; EXPRESSION; TRANSPORT; LIFE; DONORS	Human corneal endothelial cells (HCEnCs) form a monolayer of hexagonal cells whose main function is to maintain corneal clarity by regulating corneal hydration. HCEnCs are derived from neural crest and are arrested in the post-mitotic state. Thus cell loss due to aging or corneal endothelial disorders leads to corneal edema and blindness-the leading indication for corneal transplantation. Here we show the existence of morphologically distinct subpopulations of HCEnCs that are interspersed among primary cells and exhibit enhanced self-renewal competence and lack of phenotypic signs of cellular senescence. Colonies of these uniform and hexagonal HCEnCs (HCEnC-21) were selectively isolated and demonstrated high proliferative potential that was dependent on endogenous upregulation of telomerase and cyclin D/CDK4. Further transduction of HCEnC-21 with telomerase yielded a highly proliferative corneal endothelial cell line (HCEnT-21T) that was devoid of oncogenic transformation and retained critical corneal endothelial cell characteristics and functionality. This study will significantly impact the fields of corneal cell biology and regenerative medicine.	[Schmedt, Thore; Chen, Yuming; Jurkunas, Ula V.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol,Schepens Eye Res Inst, Boston, MA 02115 USA; [Nguyen, Tracy T.; Li, Shimin; Bonanno, Joseph A.] Indiana Univ, Sch Optometry, Bloomington, IN USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Indiana University System; Indiana University Bloomington	Jurkunas, UV (corresponding author), Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol,Schepens Eye Res Inst, Boston, MA 02115 USA.	ula.jurkunas@schepens.harvard.edu			National Institutes of Health/National Eye Institute [R01EY020581]; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [R01EY020581, P30EY019008] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health/National Eye Institute R01EY020581 and Massachusetts Lions Eye Research Fund grants to UVJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Azizi B, 2011, INVEST OPHTH VIS SCI, V52, P9291, DOI 10.1167/iovs.11-8312; BARRY PA, 1995, INVEST OPHTH VIS SCI, V36, P1115; Baumer Y, 2010, CELL MOL LIFE SCI, V67, P2451, DOI 10.1007/s00018-010-0349-z; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2010, J MEMBRANE BIOL, V234, P125, DOI 10.1007/s00232-010-9240-y; Bednarz J, 2000, ACTA OPHTHALMOL SCAN, V78, P130, DOI 10.1034/j.1600-0420.2000.078002130.x; Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bonanno JA, 1998, INVEST OPHTH VIS SCI, V39, P2713; BONANNO JA, 1992, INVEST OPHTH VIS SCI, V33, P3068; Bonanno JA, 2012, EXP EYE RES, V95, P2, DOI 10.1016/j.exer.2011.06.004; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Choudhary Bibha, 2012, Front Biosci (Schol Ed), V4, P16; CRISTOFALO VJ, 1988, EXP GERONTOL, V23, P297, DOI 10.1016/0531-5565(88)90032-0; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Egan CA, 1998, INVEST OPHTH VIS SCI, V39, P648; Enomoto K, 2006, INVEST OPHTH VIS SCI, V47, P4330, DOI 10.1167/iovs.05-1581; FISCELLA M, 1993, ONCOGENE, V8, P1519; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huang B, 2003, ARCH OPHTHALMOL-CHIC, V121, P840, DOI 10.1001/archopht.121.6.840; Huang L, 2010, INVEST OPHTH VIS SCI, V51, P3943, DOI 10.1167/iovs.09-4970; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; JAUNIN P, 1993, J CELL BIOL, V123, P1751, DOI 10.1083/jcb.123.6.1751; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Joyce Nancy C, 2004, Cornea, V23, pS8, DOI 10.1097/01.ico.0000136666.63870.18; Joyce NC, 2005, EXP EYE RES, V81, P629, DOI 10.1016/j.exer.2005.06.012; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Joyce NC, 1998, INVEST OPHTH VIS SCI, V39, P2572; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645; KLYCE SD, 1981, J PHYSIOL-LONDON, V321, P49, DOI 10.1113/jphysiol.1981.sp013971; Lee JG, 2012, INVEST OPHTH VIS SCI, V53, P1530, DOI 10.1167/iovs.11-9102; Lee KM, 2004, CYTOTECHNOLOGY, V45, P33, DOI 10.1007/s10616-004-5123-3; Levy SG, 1996, CURR EYE RES, V15, P45, DOI 10.3109/02713689609017610; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu SH, 2010, INVEST OPHTH VIS SCI, V51, P3993, DOI 10.1167/iovs.09-5108; Nguyen TT, 2011, INVEST OPHTH VIS SCI, V52, P8086, DOI 10.1167/iovs.11-8086; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Roy NS, 2007, NAT PROTOC, V2, P2815, DOI 10.1038/nprot.2007.402; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Sheerin AN, 2012, AGING CELL, V11, P234, DOI 10.1111/j.1474-9726.2011.00776.x; Shivanna M, 2009, EXP EYE RES, V89, P950, DOI 10.1016/j.exer.2009.08.004; Srinivas SP, 2010, OPTOMETRY VISION SCI, V87, P239, DOI 10.1097/OPX.0b013e3181d39464; Wetzel P, 2001, J PHYSIOL-LONDON, V531, P743, DOI 10.1111/j.1469-7793.2001.0743h.x; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2112; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yokoi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029677; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	52	61	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51427	10.1371/journal.pone.0051427	http://dx.doi.org/10.1371/journal.pone.0051427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284695	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800011
J	Xu, J; Nonogaki, M; Madhira, R; Ma, HY; Hermanson, O; Kioussi, C; Gross, MK				Xu, Jun; Nonogaki, Mariko; Madhira, Ravi; Ma, Hsiao-Yen; Hermanson, Ola; Kioussi, Chrissa; Gross, Michael K.			Population-Specific Regulation of Chmp2b by Lbx1 during Onset of Synaptogenesis in Lateral Association Interneurons	PLOS ONE			English	Article							MOUSE SPINAL-CORD; EARLY REFLEX PATHWAY; ESCRT-III COMPLEX; FRONTOTEMPORAL DEMENTIA; MULTIVESICULAR BODIES; TRANSCRIPTIONAL NETWORK; SYNAPTIC JUNCTIONS; NERVOUS-SYSTEM; GOLGI ANALYSIS; MOTOR-NEURONS	Chmp2b is closely related to Vps2, a key component of the yeast protein complex that creates the intralumenal vesicles of multivesicular bodies. Dominant negative mutations in Chmp2b cause autophagosome accumulation and neurodegenerative disease. Loss of Chmp2b causes failure of dendritic spine maturation in cultured neurons. The homeobox gene Lbx1 plays an essential role in specifying postmitotic dorsal interneuron populations during late pattern formation in the neural tube. We have discovered that Chmp2b is one of the most highly regulated cell-autonomous targets of Lbx1 in the embryonic mouse neural tube. Chmp2b was expressed and depended on Lbx1 in only two of the five nascent, Lbx1-expressing, postmitotic, dorsal interneuron populations. It was also expressed in neural tube cell populations that lacked Lbx1 protein. The observed population-specific expression of Chmp2b indicated that only certain population-specific combinations of sequence specific transcription factors allow Chmp2b expression. The cell populations that expressed Chmp2b corresponded, in time and location, to neurons that make the first synapses of the spinal cord. Chmp2b protein was transported into neurites within the motor-and association-neuropils, where the first synapses are known to form between E11.5 and E12.5 in mouse neural tubes. Selective, developmentally-specified gene expression of Chmp2b may therefore be used to endow particular neuronal populations with the ability to mature dendritic spines. Such a mechanism could explain how mammalian embryos reproducibly establish the disynaptic cutaneous reflex only between particular cell populations.	[Xu, Jun; Nonogaki, Mariko; Madhira, Ravi; Ma, Hsiao-Yen; Kioussi, Chrissa; Gross, Michael K.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Hermanson, Ola] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Oregon State University; Karolinska Institutet	Gross, MK (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	michael.gross@oregonstate.edu	, Ola/AAF-5126-2021; Xu, Jun/K-1233-2016	Xu, Jun/0000-0003-4221-5563; Kioussi, Chrissa/0000-0001-8226-9908; Nonogaki, Mariko/0000-0001-9893-719X; Hermanson, Ola/0000-0001-9320-7921	National Institutes of Health-NIAMS [AR054406]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER	National Institutes of Health-NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by National Institutes of Health-NIAMS grant AR054406 to Chrissa Kioussi. URL of the funder: http://www.niams.nih.gov/default.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belly A, 2010, J CELL SCI, V123, P2943, DOI 10.1242/jcs.068817; Bolouri H, 2002, BIOESSAYS, V24, P1118, DOI 10.1002/bies.10189; Bolouri H, 2002, DEV BIOL, V246, P2, DOI 10.1006/dbio.2002.0617; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; Davidson E.H., 2006, REGULATORY GENOME; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2003, P NATL ACAD SCI USA, V100, P1475, DOI 10.1073/pnas.0437746100; Ferrari R, 2010, ALZHEIMER DIS ASS DI; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Froud KE, 2011, AUSTR NEUR SOC ANN M; Ghanim M, 2010, J NEUROL, V257, P2032, DOI 10.1007/s00415-010-5655-8; Ghazi-Noori S, 2012, BRAIN, V135, P819, DOI 10.1093/brain/aws006; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Gross MK, 2000, DEVELOPMENT, V127, P413; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; HENRIKSON CK, 1974, J NEUROCYTOL, V3, P659, DOI 10.1007/BF01097190; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Istrail S, 2007, DEV BIOL, V310, P187, DOI 10.1016/j.ydbio.2007.08.009; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kioussi C, 2006, P NATL ACAD SCI USA, V103, P18621, DOI 10.1073/pnas.0609055103; Kioussi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002179; Kriks S, 2005, DEVELOPMENT, V132, P2991, DOI 10.1242/dev.01878; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Li SG, 2010, GENESIS, V48, P667, DOI 10.1002/dvg.20669; Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; MATUS A, 1986, NEUROSCIENCE, V17, P371, DOI 10.1016/0306-4522(86)90253-8; Miesegaes GR, 2009, DEV BIOL, V327, P339, DOI 10.1016/j.ydbio.2008.12.016; Mizuguchi R, 2006, NAT NEUROSCI, V9, P770, DOI 10.1038/nn1706; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Ozaki S, 1997, J COMP NEUROL, V380, P215; PARKINSON N, 2006, NEUROLOGY; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rizzu P, 2006, AM J MED GENET B, V141B, P944, DOI 10.1002/ajmg.b.30410; Saueressig H, 1999, DEVELOPMENT, V126, P4201; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; van der Zee J, 2008, HUM MOL GENET, V17, P313, DOI 10.1093/hmg/ddm309; VAUGHN JE, 1978, J NEUROCYTOL, V7, P337, DOI 10.1007/BF01176998; VAUGHN JE, 1974, J CELL BIOL, V60, P664, DOI 10.1083/jcb.60.3.664; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; VAUGHN JE, 1973, J COMP NEUROL, V148, P177, DOI 10.1002/cne.901480205; VAUGHN JE, 1977, J COMP NEUROL, V175, P79, DOI 10.1002/cne.901750106; VAUGHN JE, 1975, J COMP NEUROL, V161, P541, DOI 10.1002/cne.901610405; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; WENTWORTH LE, 1984, J COMP NEUROL, V222, P81, DOI 10.1002/cne.902220108; WENTWORTH LE, 1984, J COMP NEUROL, V222, P96, DOI 10.1002/cne.902220109; Wildner H, 2006, DEVELOPMENT, V133, P2105, DOI 10.1242/dev.02345; Willis W.D., 2004, SENSORY MECH SPINAL, V207, P1067, DOI [10.1126/science.207.4435.1067.b, DOI 10.1126/SCIENCE.207.4435.1067.B]; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	65	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e48573	10.1371/journal.pone.0048573	http://dx.doi.org/10.1371/journal.pone.0048573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284619	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800002
J	Nwugo, CC; Arivett, BA; Zimbler, DL; Gaddy, JA; Richards, AM; Actis, LA				Nwugo, Chika C.; Arivett, Brock A.; Zimbler, Daniel L.; Gaddy, Jennifer A.; Richards, Ashley M.; Actis, Luis A.			Effect of Ethanol on Differential Protein Production and Expression of Potential Virulence Functions in the Opportunistic Pathogen Acinetobacter baumannii	PLOS ONE			English	Article							INDOLE-3-ACETIC-ACID BIOSYNTHESIS; 5-HYDROXYINDOLEACETIC ACID; NECROTIZING FASCIITIS; INDOLEACETIC-ACID; BIOFILM FORMATION; ABIOTIC SURFACES; GENE-EXPRESSION; TRYPTOPHAN; IDENTIFICATION; STRAINS	Acinetobacter baumannii persists in the medical environment and causes severe human nosocomial infections. Previous studies showed that low-level ethanol exposure increases the virulence of A. baumannii ATCC 17978. To better understand the mechanisms involved in this response, 2-D gel electrophoresis combined with mass spectrometry was used to investigate differential protein production in bacteria cultured in the presence or absence of ethanol. This approach showed that the presence of ethanol significantly induces and represses the production of 22 and 12 proteins, respectively. Although over 25% of the ethanol-induced proteins were stress-response related, the overall bacterial viability was uncompromised when cultured under these conditions. Production of proteins involved in lipid and carbohydrate anabolism was increased in the presence of ethanol, a response that correlates with increased carbohydrate biofilm content, enhanced biofilm formation on abiotic surfaces and decrease bacterial motility on semi-solid surfaces. The presence of ethanol also induced the acidification of bacterial cultures and the production of indole-3-acetic acid (IAA), a ubiquitous plant hormone that signals bacterial stress-tolerance and promotes plant-bacteria interactions. These responses could be responsible for the significantly enhanced virulence of A. baumannii ATCC 17978 cells cultured in the presence of ethanol when tested with the Galleria mellonella experimental infection model. Taken together, these observations provide new insights into the effect of ethanol in bacterial virulence. This alcohol predisposes the human host to infections by A. baumannii and could favor the survival and adaptation of this pathogen to medical settings and adverse host environments.	[Nwugo, Chika C.; Arivett, Brock A.; Zimbler, Daniel L.; Gaddy, Jennifer A.; Richards, Ashley M.; Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA	University System of Ohio; Miami University	Actis, LA (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	actisla@muohio.edu	Arivett, Brock/T-2569-2018	Arivett, Brock/0000-0002-1291-3814	NSF [0420479, CHE0839233]; Miami University;  [AI070174]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070174] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Miami University; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from Public Health AI070174 and NSF 0420479 grant awards (to LAA) and Miami University research funds. The MALDI-TOF data were collected using instrumentation purchased with NSF grant award CHE0839233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Anstey NM, 2002, J CLIN MICROBIOL, V40, P685, DOI 10.1128/JCM.40.2.685-686.2002; Bailey KL, 2009, ALCOHOL CLIN EXP RES, V33, P499, DOI 10.1111/j.1530-0277.2008.00862.x; Basse CW, 1996, EUR J BIOCHEM, V242, P648, DOI 10.1111/j.1432-1033.1996.0648r.x; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bianco C, 2006, MICROBIOL-SGM, V152, P2421, DOI 10.1099/mic.0.28765-0; Bianco C, 2006, ARCH MICROBIOL, V185, P373, DOI 10.1007/s00203-006-0103-y; Brachelente C, 2007, VET DERMATOL, V18, P432, DOI 10.1111/j.1365-3164.2007.00624.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Centers for Disease Control and Prevention, 2004, MMWR MORB MORTAL WKL, V53, P1063; Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024; Chaplin M.F., 1986, MASS SPECTROM, P1; Charnot-Katsikas A, 2009, J CLIN MICROBIOL, V47, P258, DOI 10.1128/JCM.01250-08; Chen Hsin-Pai, 2005, Journal of Microbiology Immunology and Infection, V38, P127; Chen MZ, 2001, CHEST, V120, P1072, DOI 10.1378/chest.120.4.1072; CHILCOTE DD, 1972, CLIN CHEM, V18, P1376; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Corradino B, 2010, INT J LOW EXTR WOUND, V9, P152, DOI 10.1177/1534734610389598; Dallo SF, 2012, SCI WORLD J, DOI 10.1100/2012/128705; Davis KA, 2005, EMERG INFECT DIS, V11, P1218, DOI 10.3201/1108.050103; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Edwards J, 2007, J MED MICROBIOL, V56, P1595, DOI 10.1099/jmm.0.47442-0; Erridge C, 2007, J MED MICROBIOL, V56, P165, DOI 10.1099/jmm.0.46823-0; Fernandez-Reyes M, 2009, PROTEOMICS, V9, P1632, DOI 10.1002/pmic.200800434; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Goodarzi H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.33; Guerrero DM, 2010, SURG INFECT, V11, P49, DOI 10.1089/sur.2009.022; Guillet G, 2000, PLANT PHYSIOL, V122, P933, DOI 10.1104/pp.122.3.933; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hood MI, 2010, ANTIMICROB AGENTS CH, V54, P1029, DOI 10.1128/AAC.00963-09; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; INGRAM LO, 1984, ADV MICROB PHYSIOL, V25, P253; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Kampf G, 2004, CLIN MICROBIOL REV, V17, P863, DOI 10.1128/CMR.17.4.863-893.2004; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; KOGA J, 1994, BBA-PROTEIN STRUCT M, V1209, P241, DOI 10.1016/0167-4838(94)90191-0; KOGA J, 1992, J BIOL CHEM, V267, P15823; KORNBERG HL, 1966, BIOCHEM J, V99, P1; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Lin GH, 2012, ANTON LEEUW INT J G, V101, P881, DOI 10.1007/s10482-012-9704-4; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; MORITA I, 1990, J CHROMATOGR-BIOMED, V526, P367, DOI 10.1016/S0378-4347(00)82520-7; Murray CK, 2006, MIL MED, V171, P821, DOI 10.7205/MILMED.171.9.821; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nwugo CC, 2011, J PROTEOMICS, V74, P44, DOI 10.1016/j.jprot.2010.07.010; OBERHANSLI T, 1991, J GEN MICROBIOL, V137, P2273, DOI 10.1099/00221287-137-10-2273; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pirog T. P., 2002, Mikrobiologiya, V71, P222; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; RABIN RS, 1993, J BACTERIOL, V175, P3259, DOI 10.1128/jb.175.11.3259-3268.1993; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Sambrook J., 2001, MOL CLONING LAB MANU; SANDLIN RC, 1995, INFECT IMMUN, V63, P229, DOI 10.1128/IAI.63.1.229-237.1995; SLAUCH JM, 1989, J MOL BIOL, V210, P281, DOI 10.1016/0022-2836(89)90330-6; Smani Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033073; Smith MG, 2004, MOL CELL BIOL, V24, P3874, DOI 10.1128/MCB.24.9.3874-3884.2004; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Ramirez MS, 2010, J CLIN MICROBIOL, V48, P1488, DOI 10.1128/JCM.01264-09; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; STRUELENS MJ, 1993, J HOSP INFECT, V25, P15, DOI 10.1016/0195-6701(93)90005-K; SUGINO H, 1992, J BACTERIOL, V174, P2485, DOI 10.1128/jb.174.8.2485-2492.1992; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Thomas JG, 1997, PROTEIN EXPRES PURIF, V11, P289, DOI 10.1006/prep.1997.0796; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; van den Broek PJ, 2006, CLIN MICROBIOL INFEC, V12, P837, DOI 10.1111/j.1469-0691.2006.01510.x; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; YAMAMOTO S, 1994, ARCH MICROBIOL, V162, P249, DOI 10.1007/BF00301846; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; YOUNG SN, 1981, J NEUROL NEUROSUR PS, V44, P323, DOI 10.1136/jnnp.44.4.323	82	45	45	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51936	10.1371/journal.pone.0051936	http://dx.doi.org/10.1371/journal.pone.0051936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284824	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500067
J	Prochnow, N; Abdulazim, A; Kurtenbach, S; Wildforster, V; Dvoriantchikova, G; Hanske, J; Petrasch-Parwez, E; Shestopalov, VI; Dermietzel, R; Manahan-Vaughan, D; Zoidl, G				Prochnow, Nora; Abdulazim, Amr; Kurtenbach, Stefan; Wildfoerster, Verena; Dvoriantchikova, Galina; Hanske, Julian; Petrasch-Parwez, Elisabeth; Shestopalov, Valery I.; Dermietzel, Rolf; Manahan-Vaughan, Denise; Zoidl, Georg			Pannexin1 Stabilizes Synaptic Plasticity and Is Needed for Learning	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; HIPPOCAMPAL AREA CA1; RECOGNITION MEMORY; OBJECT RECOGNITION; ATP RELEASE; 1 CHANNELS; HEMICHANNELS; RATS; ACTIVATION; ASTROCYTES	Pannexin 1 (Panx1) represents a class of vertebrate membrane channels, bearing significant sequence homology with the invertebrate gap junction proteins, the innexins and more distant similarities in the membrane topologies and pharmacological sensitivities with gap junction proteins of the connexin family. In the nervous system, cooperation among pannexin channels, adenosine receptors, and K-ATP channels modulating neuronal excitability via ATP and adenosine has been recognized, but little is known about the significance in vivo. However, the localization of Panx1 at postsynaptic sites in hippocampal neurons and astrocytes in close proximity together with the fundamental role of ATP and adenosine for CNS metabolism and cell signaling underscore the potential relevance of this channel to synaptic plasticity and higher brain functions. Here, we report increased excitability and potently enhanced early and persistent LTP responses in the CA1 region of acute slice preparations from adult Panx1(-/-) mice. Adenosine application and N-methyl-D-aspartate receptor (NMDAR)-blocking normalized this phenotype, suggesting that absence of Panx1 causes chronic extracellular ATP/adenosine depletion, thus facilitating postsynaptic NMDAR activation. Compensatory transcriptional up-regulation of metabotropic glutamate receptor 4 (grm4) accompanies these adaptive changes. The physiological modification, promoted by loss of Panx1, led to distinct behavioral alterations, enhancing anxiety and impairing object recognition and spatial learning in Panx1(-/-) mice. We conclude that ATP release through Panx1 channels plays a critical role in maintaining synaptic strength and plasticity in CA1 neurons of the adult hippocampus. This result provides the rationale for in-depth analysis of Panx1 function and adenosine based therapies in CNS disorders.	[Prochnow, Nora; Abdulazim, Amr; Wildfoerster, Verena; Hanske, Julian; Petrasch-Parwez, Elisabeth; Dermietzel, Rolf; Manahan-Vaughan, Denise; Zoidl, Georg] Ruhr Univ Bochum, Fac Med, Bochum, Germany; [Kurtenbach, Stefan] Ruhr Univ Bochum, Fac Biol & Biotechnol, Bochum, Germany; [Dvoriantchikova, Galina; Shestopalov, Valery I.] Univ Miami, Sch Med, Bascom Palmer Eye Res Inst, Miami, FL USA; [Zoidl, Georg] York Univ, Fac Hlth, Toronto, ON M3J 2R7, Canada	Ruhr University Bochum; Ruhr University Bochum; Bascom Palmer Eye Institute; University of Miami; York University - Canada	Zoidl, G (corresponding author), Ruhr Univ Bochum, Fac Med, Univ Str 150, Bochum, Germany.	gzoidl@yorku.ca	Shestopalov, Valery/AAE-9838-2020; Kurtenbach, Stefan/H-3786-2019	Kurtenbach, Stefan/0000-0002-7445-596X; Manahan-Vaughan, Denise/0000-0002-9283-9609; Shestopalov, Valery/0000-0002-1568-6637	FoRUM start up grant [F570-05]; Sophia and Fritz Heinemann Foundation; National Institutes of Health [EY017991, EY021517]; Canada Research Chair Molecular and Cellular Neuroscience/CIHR; NSERC; NATIONAL EYE INSTITUTE [R01EY021517, R21EY017991] Funding Source: NIH RePORTER	FoRUM start up grant; Sophia and Fritz Heinemann Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair Molecular and Cellular Neuroscience/CIHR; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by FoRUM start up grant F570-05; Sophia and Fritz Heinemann Foundation (N.P.); National Institutes of Health grants EY017991 and EY021517 (V.I.S.); and Canada Research Chair Molecular and Cellular Neuroscience/CIHR, NSERC (G.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dahl G, 2012, BRAIN RES; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dvoriantchikova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031991; Garre JM, 2010, P NATL ACAD SCI USA, V107, P22659, DOI 10.1073/pnas.1013793107; GEREAU RW, 1995, J NEUROSCI, V15, P6879; Goh JJ, 2012, CEREBRAL CORTEX; Grover LM, 2009, LEARN MEMORY, V16, P69, DOI 10.1101/lm.1179109; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hamil NE, 2012, EPILEPSIA, V53, P177, DOI 10.1111/j.1528-1167.2011.03340.x; Hohnadel E, 2007, NEUROPHARMACOLOGY, V52, P542, DOI 10.1016/j.neuropharm.2006.08.025; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Iglesias R, 2009, CELL COMMUN ADHES, V16, P131, DOI 10.3109/15419061003642618; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Iwabuchi S, 2011, NEUROCHEM INT, V58, P376, DOI 10.1016/j.neuint.2010.12.013; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Kienitz MC, 2011, J BIOL CHEM, V286, P290, DOI 10.1074/jbc.M110.163477; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Manahan-Vaughan D, 2008, HIPPOCAMPUS, V18, P125, DOI 10.1002/hipo.20367; Mohammad-Zadeh M, 2009, NEUROSCIENCE, V158, P1632, DOI 10.1016/j.neuroscience.2008.11.008; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Penuela S, 2012, J BIOL CHEM; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Prochnow N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019437; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; Santiago MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025178; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schneider M, 2005, EXP NEUROL, V195, P185, DOI 10.1016/j.expneurol.2005.04.014; Schneider M, 2002, BEHAV PHARMACOL, V13, P29, DOI 10.1097/00008877-200202000-00003; Sperlagh B, 2011, CURR TOP MED CHEM, V11, P1034, DOI 10.2174/156802611795347564; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951; Vianna EPM, 2005, EPILEPSIA, V46, P166, DOI 10.1111/j.1528-1167.2005.01027.x; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061	49	89	89	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51767	10.1371/journal.pone.0051767	http://dx.doi.org/10.1371/journal.pone.0051767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284764	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500045
J	Ramirez-Latorre, JA				Ramirez-Latorre, Jose A.			Functional Upregulation of Ca2+ -Activated K+ Channels in the Development of Substantia Nigra Dopamine Neurons	PLOS ONE			English	Article							PARS COMPACTA NEURONS; POTASSIUM CHANNELS; CALCIUM-CHANNELS; HIGH-FREQUENCY; BASAL GANGLIA; BK CHANNELS; POSTNATAL-DEVELOPMENT; RAT; CONDUCTANCE; EXPRESSION	Many connections in the basal ganglia are made around birth when animals are exposed to a host of new affective, cognitive, and sensori-motor stimuli. It is thought that dopamine modulates cortico-striatal synapses that result in the strengthening of those connections that lead to desired outcomes. We propose that there must be a time before which stimuli cannot be processed into functional connections, otherwise it would imply an effective link between stimulus, response, and reward in uterus. Consistent with these ideas, we present evidence that early in development dopamine neurons are electrically immature and do not produce high-frequency firing in response to salient stimuli. We ask first, what makes dopamine neurons immature? and second, what are the implications of this immaturity for the basal ganglia? As an answer to the first question, we find that at birth the outward current is small (3nS-V), insensitive to Ca2+, TEA, BK, and SK blockers. Rapidly after birth, the outward current increases to 15nS-V and becomes sensitive to Ca2+, TEA, BK, and SK blockers. We make a detailed analysis of the kinetics of the components of the outward currents and produce a model for BK and SK channels that we use to reproduce the outward current, and to infer the geometrical arrangement of BK and Ca2+ channels in clusters. In the first cluster, T-type Ca2+ and BK channels are coupled within distances of similar to 20 nm (200 parallel to). The second cluster consists of L-type Ca2+ and BK channels that are spread over distances of at least 60 nm. As for the second question, we propose that early in development, the mechanism of action selection is in a "locked-in" state that would prevent dopamine neurons from reinforcing cortico-striatal synapses that do not have a functional experiential-based value.	[Ramirez-Latorre, Jose A.] Columbia Univ, Ctr Neurobiol, New York, NY USA	Columbia University	Ramirez-Latorre, JA (corresponding author), Univ Rosario, Fac Med, Grp Neurociencias NEUROS, Bogota, Colombia.	jose.ramirezl@urosario.edu.co			Colciencias; Limback Foundation	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Limback Foundation	Funding provided by Colciencias and a Limback Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, NEUROSCIENCE, V161, P95, DOI 10.1016/j.neuroscience.2009.03.022; ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ben-Ari Y, 2010, TRENDS NEUROSCI, V33, P485, DOI 10.1016/j.tins.2010.08.005; Blythe SN, 2007, J NEUROPHYSIOL, V97, P2837, DOI 10.1152/jn.01157.2006; Blythe SN, 2009, J NEUROSCI, V29, P15531, DOI 10.1523/JNEUROSCI.2961-09.2009; Cameron JS, 2001, P NATL ACAD SCI USA, V98, P2832, DOI 10.1073/pnas.041394098; CARDOZO DL, 1995, J NEUROPHYSIOL, V74, P1137, DOI 10.1152/jn.1995.74.3.1137; Carlsson T, 2011, J NEUROCHEM, V117, P1066, DOI 10.1111/j.1471-4159.2011.07284.x; CHERGUI K, 1993, EUR J NEUROSCI, V5, P137, DOI 10.1111/j.1460-9568.1993.tb00479.x; Cohen BN, 2012, NEUROSCIENCE, V200, P31, DOI 10.1016/j.neuroscience.2011.10.047; Cueni L, 2009, PFLUG ARCH EUR J PHY, V457, P1161, DOI 10.1007/s00424-008-0582-6; Cui GH, 2004, J NEUROSCI, V24, P11079, DOI 10.1523/JNEUROSCI.2713-04.2004; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Durante P, 2004, J NEUROPHYSIOL, V91, P1450, DOI 10.1152/jn.01015.2003; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; Faber ESL, 2003, J PHYSIOL-LONDON, V552, P483, DOI 10.1113/jphysiol.2003.050120; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Ferrari DC, 2012, FRONTIERS IN CELLULA, V6, P1; Franciolini F, 2001, PFLUG ARCH EUR J PHY, V441, P629, DOI 10.1007/s004240000471; GARRIS PA, 1994, J NEUROSCI, V14, P6084; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; GRACE AA, 1984, J NEUROSCI, V4, P2877; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; HAINSWORTH AH, 1991, NEUROSCIENCE, V43, P81, DOI 10.1016/0306-4522(91)90419-O; HARRIS NC, 1989, NEUROSCIENCE, V31, P355, DOI 10.1016/0306-4522(89)90379-5; Hicks GA, 1998, J PHYSIOL-LONDON, V508, P721, DOI 10.1111/j.1469-7793.1998.721bp.x; Hille B, 1984, IONIC CHANNELS EXCIT; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Imlach WL, 2008, J PHARMACOL EXP THER, V327, P657, DOI 10.1124/jpet.108.143933; Iribe Y, 1999, J NEUROPHYSIOL, V82, P925, DOI 10.1152/jn.1999.82.2.925; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; KANG Y, 1993, NEUROSCI RES, V18, P209, DOI 10.1016/0168-0102(93)90056-V; Katayama J, 2003, NEUROSCI RES, V45, P101, DOI 10.1016/S0168-0102(02)00202-X; LACEY MG, 1989, J NEUROSCI, V9, P1233; Lee CR, 2009, J NEURAL TRANSM-SUPP, P71, DOI 10.1007/978-3-211-92660-4_6; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Lee US, 2009, J PHYSIOL-LONDON, V587, P1481, DOI 10.1113/jphysiol.2009.169243; Liu JX, 2008, MOL PHARMACOL, V74, P628, DOI 10.1124/mol.108.048694; Lobb CJ, 2011, J NEUROPHYSIOL, V105, P2501, DOI 10.1152/jn.01076.2010; Lokwan SJA, 1999, NEUROSCIENCE, V92, P245, DOI 10.1016/S0306-4522(98)00748-9; MacDonald SHF, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-37; MANLEY LD, 1992, J NEUROCHEM, V58, P1491, DOI 10.1111/j.1471-4159.1992.tb11369.x; MARCHAND R, 1983, NEUROSCIENCE, V9, P373, DOI 10.1016/0306-4522(83)90300-7; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MCGUIGAN JAS, 1991, CAN J PHYSIOL PHARM, V69, P1733, DOI 10.1139/y91-257; Meyer D, 1997, DEVELOPMENT, V124, P3575; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Olsen ML, 2005, J NEUROSCI RES, V81, P179, DOI 10.1002/jnr.20543; Pouvreau S, 2004, J PHYSIOL-LONDON, V555, P365, DOI 10.1113/jphysiol.2003.055285; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Pyott SJ, 2004, J NEUROSCI, V24, P9469, DOI 10.1523/JNEUROSCI.3162-04.2004; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; SHERMAN A, 1990, BIOPHYS J, V58, P985, DOI 10.1016/S0006-3495(90)82443-7; Shi WX, 2009, J NEURAL TRANSM-SUPP, P103, DOI 10.1007/978-3-211-92660-4_8; SHULTS CW, 1990, NEUROSCIENCE, V38, P427, DOI 10.1016/0306-4522(90)90039-7; Smith GD, 2001, METH NE FRO NEUROSCI, P49; Smith GD, 1996, BIOPHYS J, V70, P2527, DOI 10.1016/S0006-3495(96)79824-7; Smith Y, 1998, NEUROSCIENCE, V86, P353; SOLARO CR, 1995, J NEUROSCI, V15, P6110; Su WT, 2010, NEUROSCI LETT, V471, P1, DOI 10.1016/j.neulet.2009.12.058; Sun XL, 2003, J NEUROSCI, V23, P3639; TEPPER JM, 1994, NEUROSCIENCE, V60, P469, DOI 10.1016/0306-4522(94)90258-5; TEPPER JM, 1990, DEV BRAIN RES, V54, P21, DOI 10.1016/0165-3806(90)90061-3; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; TRENT F, 1991, EUR J PHARMACOL, V204, P265, DOI 10.1016/0014-2999(91)90851-G; Vandael DH, 2010, MOL NEUROBIOL, V42, P185, DOI 10.1007/s12035-010-8151-3; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; Watmuff B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031999; WISGIRDA ME, 1994, P NATL ACAD SCI USA, V91, P2858, DOI 10.1073/pnas.91.7.2858; Wolfart J, 2002, J NEUROSCI, V22, P3404; YUNG WH, 1991, J PHYSIOL-LONDON, V436, P643, DOI 10.1113/jphysiol.1991.sp018571; Yurek DM, 2004, BRAIN RES, V1028, P116, DOI 10.1016/j.brainres.2004.08.066; Zhang L, 2006, MED HYPOTHESES, V67, P41, DOI 10.1016/j.mehy.2005.09.055	80	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51610	10.1371/journal.pone.0051610	http://dx.doi.org/10.1371/journal.pone.0051610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284723	Green Accepted, gold, Green Published			2022-12-25	WOS:000312794500036
J	Subramanian, H; Gupta, K; Ali, H				Subramanian, Hariharan; Gupta, Kshitij; Ali, Hydar			Roles for NHERF1 and NHERF2 on the Regulation of C3a Receptor Signaling in Human Mast Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; RENAL PHOSPHATE-TRANSPORT; NA+/H+-EXCHANGER; PARATHYROID-HORMONE; CHEMOKINE PRODUCTION; FACTOR-I; PLASMA-MEMBRANE; PDZ DOMAINS; KINASE; PHOSPHORYLATION	Background: The anaphylatoxin C3a binds to the G protein coupled receptor (GPCR, C3aR) and activates divergent signaling pathways to induce degranulation and cytokine production in human mast cells. Adapter proteins such as the Na+/H+ exchange regulatory factor (NHERF1 and NHERF2) have been implicated in regulating functions of certain GPCRs by binding to the class I PDZ (PSD-95/Dlg/Zo1) motifs present on their cytoplasmic tails. Although C3aR possesses a class I PDZ motif, the possibility that it interacts with NHERF proteins to modulate signaling in human mast cells has not been determined. Methodology/Principal Findings: Using reverse transcription PCR and Western blotting, we found that NHERF1 and NHERF2 are expressed in human mast cell lines (HMC-1, LAD2) and CD34(+)-derived primary human mast cells. Surprisingly, however, C3aR did not associate with these adapter proteins. To assess the roles of NHERFs on signaling downstream of C3aR, we used lentiviral shRNA to stably knockdown the expression of these proteins in human mast cells. Silencing the expression of NHERF1 and NHERF2 had no effect on C3aR desensitization, agonist-induced receptor internalization, ERK/Akt phosphorylation or chemotaxis. However, loss of NHERF1 and NHERF2 resulted in significant inhibition of C3a-induced mast cell degranulation, NF-kappa B activation and chemokine production. Conclusion/Significance: This study demonstrates that although C3aR possesses a class I PDZ motif, it does not associate with NHERF1 and NHERF2. Surprisingly, these proteins provide stimulatory signals for C3a-induced degranulation, NF-kappa B activation and chemokine generation in human mast cells. These findings reveal a new level of complexity for the functional regulation of C3aR by NHERFs in human mast cells.	[Subramanian, Hariharan; Gupta, Kshitij; Ali, Hydar] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ali, H (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA.	alih@upenn.edu	Subramanian, Hariharan/AHC-5755-2022		National Institutes of Health [AI-080852]; American Heart Association [12POST9260009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant to HA from the National Institutes of Health (AI-080852) and a grant to HS from the American Heart Association (12POST9260009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2001, J IMMUNOL, V167, P3559, DOI 10.4049/jimmunol.167.7.3559; Ali H, 2000, J IMMUNOL, V165, P7215, DOI 10.4049/jimmunol.165.12.7215; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Becamel Carine, 2002, Biological Procedures Online, V4, P94, DOI 10.1251/bpo39; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Capuano P, 2007, AM J PHYSIOL-CELL PH, V292, pC927, DOI 10.1152/ajpcell.00126.2006; CIVITELLI R, 1989, J IMMUNOL, V143, P4000; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Fukuoka Y, 2008, J IMMUNOL, V180, P6307, DOI 10.4049/jimmunol.180.9.6307; Guo Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022559; Gupta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046369; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hammad MM, 2010, J BIOL CHEM, V285, P34653, DOI 10.1074/jbc.M110.106591; Hartmann K, 1997, BLOOD, V89, P2863, DOI 10.1182/blood.V89.8.2863; Huang P, 2004, J BIOL CHEM, V279, P25002, DOI 10.1074/jbc.M313366200; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Molina JR, 2010, CANCER RES, V70, P6697, DOI 10.1158/0008-5472.CAN-10-1271; Nemeth ZH, 2002, AM J PHYSIOL-CELL PH, V283, pC396, DOI 10.1152/ajpcell.00491.2001; Nemeth ZH, 2001, BBA-MOL CELL RES, V1539, P233, DOI 10.1016/S0167-4889(01)00111-2; Nilsson G, 1996, J IMMUNOL, V157, P1693; ORLINSKA U, 1995, IMMUNOPHARMACOLOGY, V30, P41, DOI 10.1016/0162-3109(95)00006-F; Radinger M., 2011, CURR PROTOC IMMUNOL; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Rivera J, 2008, CURR ALLERGY ASTHM R, V8, P14, DOI 10.1007/s11882-008-0004-z; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Schafer B, 2013, J ALLERGY CLIN IMMUN, V131, P541, DOI 10.1016/j.jaci.2012.05.009; Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Subramanian H, 2011, MOL PHARMACOL, V79, P1005, DOI 10.1124/mol.111.071472; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; Weinman EJ, 2010, J BIOL CHEM, V285, P13454, DOI 10.1074/jbc.M109.094359; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wu YN, 2012, J BIOL CHEM, V287, P5744, DOI 10.1074/jbc.M111.315762; Yun CC, 2005, AM J PHYSIOL-CELL PH, V289, pC2, DOI 10.1152/ajpcell.00610.2004; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	53	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51355	10.1371/journal.pone.0051355	http://dx.doi.org/10.1371/journal.pone.0051355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284683	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500026
J	Trindade, BC; Sorgi, CA; Nicolete, LDD; Malta, TM; Pinto, MT; Takayanagui, OM; Covas, DT; Martins, OA; Kashima, S; Faccioli, LH				Trindade, Bruno Caetano; Sorgi, Carlos Arterio; de Figueiredo Nicolete, Larissa Deadame; Malta, Tathiane Maistro; Pinto, Mariana Tomazini; Takayanagui, Osvaldo Massaiti; Covas, Dimas Tadeu; Martins Filho, Olindo Assis; Kashima, Simone; Faccioli, Lucia Helena			Leukotrienes Are Upregulated and Associated with Human T-Lymphotropic Virus Type 1 (HTLV-1)-Associated Neuroinflammatory Disease	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; PROVIRAL LOAD; CEREBROSPINAL-FLUID; CYSTEINYL-LEUKOTRIENES; HAM/TSP PATIENTS; INFECTION; RECEPTORS; RELEASE; TUBERCULOSIS	Leukotrienes (LTs) are lipid mediators involved in several inflammatory disorders. We investigated the LT pathway in human T-lymphotropic virus type 1 (HTLV-1) infection by evaluating LT levels in HTLV-1-infected patients classified according to the clinical status as asymptomatic carriers (HACs) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients. Bioactive LTB4 and CysLTs were both increased in the plasma and in the supernatant of peripheral blood mononuclear cell cultures of HTLV-1-infected when compared to non-infected. Interestingly, CysLT concentrations were increased in HAM/TSP patients. Also, the concentration of plasma LTB4 and LTC4 positively correlated with the HTLV-1 proviral load in HTLV-1-infected individuals. The gene expression levels of LT receptors were differentially modulated in CD4(+) and CD8(+) T cells of HTLV-1-infected patients. Analysis of the overall plasma signature of immune mediators demonstrated that LT and chemokine amounts were elevated during HTLV-1 infection. Importantly, in addition to CysLTs, IP-10 was also identified as a biomarker for HAM/TSP activity. These data suggest that LTs are likely to be associated with HTLV-1 infection and HAM/TSP development, suggesting their putative use for clinical monitoring.	[Trindade, Bruno Caetano; Sorgi, Carlos Arterio; Faccioli, Lucia Helena] Univ Sao Paulo, Lab Inflamacao & Imunol Parasitoses, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil; [Trindade, Bruno Caetano; Martins Filho, Olindo Assis] Fundacao Oswaldo Cruz, Lab Biomarcadores Diagnost & Monitoracao, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [de Figueiredo Nicolete, Larissa Deadame; Malta, Tathiane Maistro; Pinto, Mariana Tomazini; Covas, Dimas Tadeu; Kashima, Simone] Inst Nacl Ciencia & Tecnol Celulas Tronco & Terap, Sao Paulo, Brazil; [Takayanagui, Osvaldo Massaiti] Univ Sao Paulo, Dept Neurociencias & Ciencias Comportamento, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Covas, Dimas Tadeu] Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Universidade de Sao Paulo	Faccioli, LH (corresponding author), Univ Sao Paulo, Lab Inflamacao & Imunol Parasitoses, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil.	faccioli@fcfrp.usp.br	Faccioli, Lúcia Helena/AGH-5297-2022; Martins-Filho, Olindo Assis/ABE-6278-2021; Covas, Dimas/AAL-8499-2021; Pinto, Mariana/B-6129-2017; Malta, Tathiane/N-1686-2013; Lucia, Faccioli/G-8976-2015; Sorgi, Carlos Artério/AAA-6284-2020; Covas, Dimas T/C-5431-2013; Kashima, Simone/G-4876-2012; Takayanagui, Osvaldo M/C-8159-2013; Sorgi, Carlos Arterio/ABE-4246-2020; Sorgi, Carlos/O-2839-2017	Faccioli, Lúcia Helena/0000-0002-4999-8305; Martins-Filho, Olindo Assis/0000-0002-5494-4889; Pinto, Mariana/0000-0002-5176-7776; Malta, Tathiane/0000-0003-1129-5791; Lucia, Faccioli/0000-0002-4999-8305; Sorgi, Carlos Artério/0000-0001-7528-9935; Covas, Dimas T/0000-0002-7364-2595; Kashima, Simone/0000-0002-1487-0141; Takayanagui, Osvaldo M/0000-0002-8190-0275; Sorgi, Carlos/0000-0001-7528-9935	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao Hemocentro de Ribeirao Preto; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Hemocentro de Ribeirao Preto; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Fundacao Hemocentro de Ribeirao Preto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Virginia Mara de Deus Wagatsuma and Evandra Strazza Rodrigues, from the Hemocentro Foundation of Ribeirao Preto, for their technical assistance. LHF, OAMF, DTC and OMT are thankful to CNPq for the PQ fellowship Program.	AHMADZADEH N, 1991, INFLAMMATION, V15, P497, DOI 10.1007/BF00923346; Best I, 2006, CLIN EXP IMMUNOL, V146, P226, DOI 10.1111/j.1365-2249.2006.03208.x; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333; Capra V, 2007, MED RES REV, V27, P469, DOI 10.1002/med.20071; Carvalho EM, 2001, J ACQ IMMUN DEF SYND, V27, P1, DOI 10.1097/00126334-200105010-00001; CLAESSON HE, 1992, INT J IMMUNOPHARMACO, V14, P441, DOI 10.1016/0192-0561(92)90174-J; Coffey MJ, 1999, BLOOD, V94, P3897, DOI 10.1182/blood.V94.11.3897.423k12_3897_3905; Cooper Sarah A, 2009, Pract Neurol, V9, P16, DOI 10.1136/jnnp.2008.167155; de Souza JG, 2011, J CLIN VIROL, V50, P13, DOI 10.1016/j.jcv.2010.09.007; Flamand L, 2004, J INFECT DIS, V189, P2001, DOI 10.1086/386374; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; Flamand N, 2007, CELL MOL LIFE SCI, V64, P2657, DOI 10.1007/s00018-007-7228-2; FROLDI M, 1992, J NEUROIMMUNOL, V38, P155, DOI 10.1016/0165-5728(92)90100-Y; Gaudreault E, 2008, J IMMUNOL, V180, P6211, DOI 10.4049/jimmunol.180.9.6211; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; GOUT O, 1990, NEW ENGL J MED, V322, P383, DOI 10.1056/NEJM199002083220607; Guerreiro JB, 2006, CLIN EXP IMMUNOL, V145, P296, DOI 10.1111/j.1365-2249.2006.03150.x; Haddad R, 2011, AIDS RES HUM RETROV, V27, P283, DOI 10.1089/aid.2010.0165; Ichiyama T, 2005, CLIN EXP ALLERGY, V35, P1214, DOI 10.1111/j.1365-2222.2005.02323.x; Izumo S, 2010, NEUROPATHOLOGY, V30, P480, DOI 10.1111/j.1440-1789.2010.01135.x; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Keating SM, 2011, AIDS, V25, P1823, DOI 10.1097/QAD.0b013e3283489d1f; Kihara Y, 2010, BIOCHEM BIOPH RES CO, V394, P673, DOI 10.1016/j.bbrc.2010.03.049; LEWIS RA, 1984, J CLIN INVEST, V73, P889, DOI 10.1172/JCI111312; Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439; Machado ER, 2005, J IMMUNOL, V175, P3892, DOI 10.4049/jimmunol.175.6.3892; Matsuo M, 1996, PEDIATR NEUROL, V14, P121, DOI 10.1016/0887-8994(96)83272-3; Matsuzaki T, 2001, J NEUROVIROL, V7, P228; Medeiros AI, 2004, INFECT IMMUN, V72, P1637, DOI 10.1128/IAI.72.3.1637-1644.2004; Medeiros AI, 2008, J IMMUNOL, V181, P8544, DOI 10.4049/jimmunol.181.12.8544; Moriuchi M, 2001, J VIROL, V75, P192, DOI 10.1128/JVI.75.1.192-198.2001; Nassar GM, 1997, KIDNEY INT, V51, P1520, DOI 10.1038/ki.1997.209; NEU I, 1992, ACTA NEUROL SCAND, V86, P586, DOI 10.1111/j.1600-0404.1992.tb05491.x; Okubo M, 2010, GLIA, V58, P599, DOI 10.1002/glia.20948; Okunishi K, 2011, BBA-GEN SUBJECTS, V1810, P1096, DOI 10.1016/j.bbagen.2011.02.005; Olindo S, 2005, J NEUROL SCI, V237, P53, DOI 10.1016/j.jns.2005.05.010; Peres CM, 2007, MICROBES INFECT, V9, P483, DOI 10.1016/j.micinf.2007.01.006; Peres-Buzalaf C, 2011, PROSTAG LEUKOTR ESS, V85, P75, DOI 10.1016/j.plefa.2011.04.024; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; POULIOT M, 1994, J IMMUNOL, V152, P851; Santos SB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-7; Takenouchi N, 2003, J NEUROVIROL, V9, P29, DOI 10.1080/13550280390173418; Toulza F, 2010, J IMMUNOL, V185, P183, DOI 10.4049/jimmunol.0903846; Umehara F, 2003, GANN MONOGR CANC RES, P141; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; Wang LF, 2011, J IMMUNOL, V187, P2336, DOI 10.4049/jimmunol.1100333; Watanabe T, 1997, INT J HEMATOL, V66, P257; Yoshikawa K, 2011, PROSTAG LEUKOTR ESS, V85, P43, DOI 10.1016/j.plefa.2011.04.022	49	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51873	10.1371/journal.pone.0051873	http://dx.doi.org/10.1371/journal.pone.0051873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284797	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500058
J	Grisa, L; Leonel, ML; Goncalves, MIR; Pletsch, F; Sade, ER; Custodio, G; Zagonel, IPS; Longui, CA; Figueiredo, BC				Grisa, Leila; Leonel, Maria L.; Goncalves, Maria I. R.; Pletsch, Francisco; Sade, Elis R.; Custodio, Gislaine; Zagonel, Ivete P. S.; Longui, Carlos A.; Figueiredo, Bonald C.			Impact of Early Postnatal Androgen Exposure on Voice Development	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; SPEAKING FUNDAMENTAL-FREQUENCY; ADRENOCORTICAL TUMORS; XENOPUS-LAEVIS; TESTOSTERONE GEL; MUTATION; LARYNX; VOCALIZATIONS; DEFICIENCY; CHILDHOOD	Background: The impact of early postnatal androgen exposure on female laryngeal tissue may depend on certain characteristics of this exposure. We assessed the impact of the dose, duration, and timing of early androgen exposure on the vocal development of female subjects who had been treated for adrenocortical tumor (ACT) in childhood. Methods: The long-term effects of androgen exposure on the fundamental vocal frequency (F0), vocal pitch, and final height and the presence of virilizing signs were examined in 9 adult (age, 18.4 to 33.5 years) and 10 adolescent (13.6 to 17.8 years) female ACT patients. We also compared the current values with values obtained 0.9 years to 7.4 years after these subjects had undergone ACT surgery, a period during which they had shown normal androgen levels. Results: Of the 19 subjects, 17 (89%) had been diagnosed with ACT before 4 years of age, 1 (5%) at 8.16 years, and 1 (5%) at 10.75 years. Androgen exposure (2 to 30 months) was sufficiently strong to cause pubic hair growth in all subjects and clitoromegaly in 74% (14/19) of the subjects, but did not reduce their height from the target value. Although androgen exposure induced a remarkable reduction in F0 (132 Hz) and moderate pitch virilization in 1 subject and partial F0 virilization, resulting in F0 of 165 and 169 Hz, in 2 subjects, the majority had normal F0 ranging from 189 to 245 Hz. Conclusions: Female laryngeal tissue is less sensitive to androgen exposure between birth and adrenarche than during other periods. Differential larynx sensitivity to androgen exposure in childhood and F0 irreversibility in adulthood are age-, concentration-, duration-, and timing-dependent events that may also be affected by exposure to inhibitory or stimulatory hormones. Further studies are required to better characterize each of these factors.	[Grisa, Leila; Sade, Elis R.; Custodio, Gislaine; Zagonel, Ivete P. S.; Figueiredo, Bonald C.] Inst Pesquisa Pele Pequeno Principe, Curitiba, Parana, Brazil; [Grisa, Leila; Sade, Elis R.; Figueiredo, Bonald C.] Hosp Pequeno Principe, Curitiba, Parana, Brazil; [Grisa, Leila; Zagonel, Ivete P. S.; Figueiredo, Bonald C.] Fac Pequeno Principe, Curitiba, Parana, Brazil; [Leonel, Maria L.] Inst Voz Maringa, Maringa, Parana, Brazil; [Goncalves, Maria I. R.] Univ Fed Sao Paulo, Dept Fonoaudiol, Sao Paulo, Brazil; [Pletsch, Francisco] Clin Voz, Curitiba, Parana, Brazil; [Longui, Carlos A.] Irmandade Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil; [Figueiredo, Bonald C.] Univ Fed Parana, Dept Saude Comunitaria, BR-80060000 Curitiba, Parana, Brazil	Hospital Pequeno Principe; Hospital Pequeno Principe; Hospital Pequeno Principe; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Parana	Figueiredo, BC (corresponding author), Inst Pesquisa Pele Pequeno Principe, Curitiba, Parana, Brazil.	bonaldf@pelepequenoprincipe.org.br	Longui, Carlos A/B-8112-2013; Gonçalves, Maria I R/N-8916-2017; de Figueiredo, Bonald Cavalcante/AAD-6672-2021	de Figueiredo, Bonald Cavalcante/0000-0002-1051-2056	Brazilian State of Parana Secretary of Science, Technology and Higher Education (SETI); Brazilian National Council for Research and Development (CNPq), (Curitiba, Brazil); Raul Carneiro Hospital Association for Childhood Protection (AHPIRC); American Lebanese Syrian Associated Charities (ALSAC); SETI; AHPIRC; CNPq; ALSAC	Brazilian State of Parana Secretary of Science, Technology and Higher Education (SETI); Brazilian National Council for Research and Development (CNPq), (Curitiba, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Raul Carneiro Hospital Association for Childhood Protection (AHPIRC); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); SETI; AHPIRC; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ALSAC(American Lebanese Syrian Associated Charities (ALSAC))	This project was funded by grants from the Brazilian State of Parana Secretary of Science, Technology and Higher Education (SETI, 2008), the Brazilian National Council for Research and Development (CNPq, 2009), (Curitiba, Brazil), the Raul Carneiro Hospital Association for Childhood Protection (AHPIRC), and the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SETI funded equipments and transportation of all participants; AHPIRC funded all laryngological exams; CNPq and ALSAC provided additional support for the ACT project (materials, statistical analysis and scholarship).	Abitbol J, 1999, J VOICE, V13, P424, DOI 10.1016/S0892-1997(99)80048-4; Behlau M., 2001, VOZ LIVRO ESPECIALIS, VI; Behlau M, 1998, REV SOC BRAS FONOAUD, V2, P56; Brachet C, 2005, EUR J PEDIATR, V164, P646, DOI 10.1007/s00431-005-1714-z; Carlson AD, 1999, J STEROID BIOCHEM, V69, P19, DOI 10.1016/S0960-0760(99)00059-X; Custodio G, 2012, MOL CELL ENDOCRINOL, V351, P44, DOI 10.1016/j.mce.2011.10.019; Custodio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018015; Damrose EJ, 2009, AURIS NASUS LARYNX, V36, P110, DOI 10.1016/j.anl.2008.03.002; de Ronde W, 2009, HUM REPROD, V24, P425, DOI 10.1093/humrep/den372; Figueiredo BC, 2006, J MED GENET, V43, P91, DOI 10.1136/jmg.2004.030551; Figueiredo BC, 2005, J CLIN ENDOCR METAB, V90, P615, DOI 10.1210/jc.2004-0942; Figueiredo BC, 1999, J CLIN ENDOCR METAB, V84, P1116, DOI 10.1210/jc.84.3.1116; Gonçalves Maria Inês Rebelo, 2009, Braz. j. otorhinolaryngol., V75, P680; HOLLIEN H, 1972, J SPEECH HEAR RES, V15, P155, DOI 10.1044/jshr.1501.155; HOLLIEN H, 1994, J ACOUST SOC AM, V96, P2646, DOI 10.1121/1.411275; KROOK MIP, 1988, FOLIA PHONIATR, V40, P82, DOI 10.1159/000265888; Leonel MLL, 2003, THESIS U TUIUTI PARA; Longui CA, 2004, J MED GENET, V41, P354, DOI 10.1136/jmg.2004.018978; Longui CA, 2006, ENDOCRINOLOGIA PEDIA, P31; Michalkiewicz E, 2004, J CLIN ONCOL, V22, P838, DOI 10.1200/JCO.2004.08.085; Moore C, 2005, J CLIN ENDOCR METAB, V90, P4128, DOI 10.1210/jc.2004-2558; Nygren U, 2009, CLIN ENDOCRINOL, V70, P18, DOI 10.1111/j.1365-2265.2008.03347.x; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Patel A, 2010, INT J PEDIATR ENDOCR, DOI 10.1155/2010/867471; Pattie MA, 1998, J VOICE, V12, P366, DOI 10.1016/S0892-1997(98)80027-1; Pianovski MAD, 2006, PEDIATR BLOOD CANCER, V47, P56, DOI 10.1002/pbc.20624; PInho SMR, 2001, TOPICOS VOZ, P19; Plack C.J., 2005, PITCH NEURAL CODING, DOI [10.1007/0-387-28958-5, DOI 10.1007/0-387-28958-5]; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Ruel TD, 1998, J COMP PHYSIOL A, V182, P35; SASSOON DA, 1987, J NEUROSCI, V7, P3198; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; STOICHEFF ML, 1981, J SPEECH HEAR RES, V24, P437, DOI 10.1044/jshr.2403.437; TOBIAS ML, 1987, J NEUROSCI, V7, P3191; TOBIAS ML, 1988, J NEUROSCI, V8, P2422; Wasserman JD, 2012, MOL CELL ENDOCRINOL, V351, P101, DOI 10.1016/j.mce.2011.09.010; Wit JM, 2002, J PEDIATR ENDOCR MET, V15, P1229; Yamaguchi A, 2000, J NEUROSCI, V20, P1559; Yamaguchi A, 2010, DEV NEUROBIOL, V70, P862, DOI 10.1002/dneu.20822	39	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e50242	10.1371/journal.pone.0050242	http://dx.doi.org/10.1371/journal.pone.0050242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284635	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300010
J	Hwang, YC; Ahn, HY; Lee, WJ; Park, CY; Park, SW				Hwang, You-Cheol; Ahn, Hong-Yup; Lee, Woo Je; Park, Cheol-Young; Park, Sung-Woo			An Equation to Estimate the Concentration of Serum Apolipoprotein B	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; MYOCARDIAL-INFARCTION; RISK; MANAGEMENT; DISEASE; EVENTS; PLASMA; LIPIDS	Background: Several large prospective studies have demonstrated that apolipoprotein B (apoB) has greater value in predicting cardiovascular risk than any other lipid measurements. Currently, however, serum apoB levels are not routinely measured, because of the additional cost. The aim of this study was to develop an equation to estimate apoB from conventional lipid measurements including total cholesterol, HDL cholesterol, and triglycerides. Methods: Data from a total of 78,127 subjects (47,057 men and 31,070 women), aged 15 to 88 years (mean age 41.8 years) were reviewed to develop an apoB equation. Additional datasets from the same institution and the NHANES obtained in 2007-2008 were used for internal (n = 73,445) and external validation (n = 3,097), respectively. Results: We developed an apoB equation based on a linear regression model that contains total cholesterol, triglycerides, and HDL cholesterol as terms (model 1). To more precisely estimate the serum apoB level, we adjusted mode1 1 using a cutoff serum triglyceride value of 270 mg/dl (model 2). Model 2 showed more randomly distributed residuals in patients with diabetes, atherogenic dyslipidemia, and those taking lipid-lowering agents than model 1. The residuals in the development, internal validation, and external validation datasets were also randomly distributed around 0 with no clear trends. Conclusion: The new equation we developed to estimate serum apoB concentrations is accurate and can be used in diverse subgroups of patients including those with diabetes, atherogenic dyslipidemia, and those taking lipid-lowering agents.	[Park, Cheol-Young; Park, Sung-Woo] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab,Kangbuk Samsung Hosp, Seoul, South Korea; [Hwang, You-Cheol] Kyung Hee Univ, Div Endocrinol & Metab, Dept Med, Sch Med,Kyung Hee Univ Hosp Gangdong, Seoul, South Korea; [Ahn, Hong-Yup] Dongguk Univ Seoul, Dept Stat, Seoul, South Korea; [Lee, Woo Je] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University; Kyung Hee University Hospital; Dongguk University; University of Ulsan	Park, CY (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab,Kangbuk Samsung Hosp, Seoul, South Korea.	cydoctor@chol.com	Hwang, You-Cheol/AAA-4616-2022; Ahn, Hongyup/M-5043-2017; Park, Cheol-Young/C-6690-2018	Ahn, Hongyup/0000-0001-8149-6981; Park, Cheol-Young/0000-0002-9415-9965; Hwang, You-Cheol/0000-0003-4033-7874				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Kastelein JJP, 2008, CIRCULATION, V117, P3002, DOI 10.1161/CIRCULATIONAHA.107.713438; Marcovina S, 2006, J INTERN MED, V259, P437, DOI 10.1111/j.1365-2796.2006.01648.x; MCNAMARA JR, 1990, CLIN CHEM, V36, P36; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Sniderman AD, 2003, CLIN BIOCHEM, V36, P499, DOI 10.1016/S0009-9120(03)00117-6; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2	15	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51607	10.1371/journal.pone.0051607	http://dx.doi.org/10.1371/journal.pone.0051607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284722	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300032
J	Sears, BF; Schlunk, AD; Rohr, JR				Sears, Brittany F.; Schlunk, Andrea D.; Rohr, Jason R.			Do Parasitic Trematode Cercariae Demonstrate a Preference for Susceptible Host Species?	PLOS ONE			English	Article							DISEASE; INFECTION; PATTERNS; DIGENEA; MALFORMATIONS; RECOGNITION; STRATEGIES; RESISTANCE; MIRACIDIA; TADPOLES	Many parasites are motile and exhibit behavioural preferences for certain host species. Because hosts can vary in their susceptibility to infections, parasites might benefit from preferentially detecting and infecting the most susceptible host, but this mechanistic hypothesis for host-choice has rarely been tested. We evaluated whether cercariae (larval trematode parasites) prefer the most susceptible host species by simultaneously presenting cercariae with four species of tadpole hosts. Cercariae consistently preferred hosts in the following order: Anaxyrus (=Bufo) terrestris (southern toad), Hyla squirella (squirrel tree frog), Lithobates (=Rana) sphenocephala (southern leopard frog), and Osteopilus septentrionalis (Cuban tree frog). These host species varied in susceptibility to cercariae in an order similar to their attractiveness with a correlation that approached significance. Host attractiveness to parasites also varied consistently and significantly among individuals within a host species. If heritable, this individual-level host variation would represent the raw material upon which selection could act, which could promote a Red Queen "arms race" between host cues and parasite detection of those cues. If, in general, motile parasites prefer to infect the most susceptible host species, this phenomenon could explain aggregated distributions of parasites among hosts and contribute to parasite transmission rates and the evolution of virulence. Parasite preferences for hosts belie the common assumption of disease models that parasites seek and infect hosts at random.	[Sears, Brittany F.; Schlunk, Andrea D.; Rohr, Jason R.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Sears, BF (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	bsears@mail.usf.edu	Rohr, Jason R./AAJ-5856-2021	Sears, Brittany/0000-0002-8515-8573	University of South Florida	University of South Florida	BFS was supported by a University of South Florida Presidential Fellowship (http://www.grad.usf.edu/presidential-fellowships.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARUS V, 1967, Vestnik Ceskoslovenske Spolecnosti Zoologicke, V31, P1; Burkett-Cadena ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017681; BYRD ELON E., 1938, JOUR PARASITOL, V24, P379, DOI 10.2307/3272115; BYRD ELON E., 1935, TRANS AMER MICROSC SOC, V54, P196, DOI 10.2307/3222133; Campbell RA, 1997, FOLIA PARASIT, V44, P199; Center NPWR, 1997, CHECKL AMPH SPEC ID; COHEN LM, 1980, J PARASITOL, V66, P362, DOI 10.2307/3280843; COMBES C, 1994, PARASITOLOGY, V109, pS3, DOI 10.1017/S0031182000085048; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dybdahl MF, 2004, J EVOLUTION BIOL, V17, P967, DOI 10.1111/j.1420-9101.2004.00759.x; FEILER W, 1988, PARASITOLOGY, V96, P493, DOI 10.1017/S0031182000080136; FLAJNIK MF, 1987, IMMUNOL TODAY, V8, P58, DOI 10.1016/0167-5699(87)90240-4; FLIER J, 1980, SCIENCE, V208, P503, DOI 10.1126/science.6245447; Fried B, 1997, PARASITOL RES, V83, P666, DOI 10.1007/s004360050316; Gosner K. L., 1960, Herpetologica, V16, P183; HAAS W, 1995, PARASITOL TODAY, V11, P468, DOI 10.1016/0169-4758(95)80066-2; Haas W, 2003, ZOOLOGY, V106, P349, DOI 10.1078/0944-2006-00125; HAAS W, 1994, J PARASITOL, V80, P345, DOI 10.2307/3283401; Haberl B, 2000, PARASITOLOGY, V120, P479, DOI 10.1017/S0031182099005697; Hanken J., 1981, Functional Photography, V16, P22; Heinicke MP, 2011, BIOL LETTERS, V7, P407, DOI 10.1098/rsbl.2010.1131; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Johnson PTJ, 2009, J ANIM ECOL, V78, P191, DOI 10.1111/j.1365-2656.2008.01455.x; Koehler AV, 2011, PARASITOLOGY, V138, P100, DOI 10.1017/S0031182010001022; Krist AC, 2000, PARASITOLOGY, V121, P395, DOI 10.1017/S0031182099006538; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lannoo Michael, 2005, P349; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Mouritsen KN, 2001, INT J PARASITOL, V31, P1417, DOI 10.1016/S0020-7519(01)00247-8; Olson PD, 2003, INT J PARASITOL, V33, P733, DOI 10.1016/S0020-7519(03)00049-3; Raffel TR, 2011, OECOLOGIA, V165, P1031, DOI 10.1007/s00442-010-1776-0; Raffel TR, 2008, TRENDS ECOL EVOL, V23, P610, DOI 10.1016/j.tree.2008.06.015; Reichard M, 2010, EVOLUTION, V64, P3047, DOI 10.1111/j.1558-5646.2010.01032.x; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Rohr JR, 2010, FUNCT ECOL, V24, P1110, DOI 10.1111/j.1365-2435.2010.01709.x; Santoro M, 2011, DIS AQUAT ORGAN, V95, P233, DOI 10.3354/dao02365; Schell S. C., 1970, KNOW TREMATODES; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Simpson JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007861; SMITHGILL SJ, 1979, AM NAT, V113, P563, DOI 10.1086/283413; StatSoft, 2009, STATISTICA; TALBOT S. BENTON, 1934, TRANS AMER MICROSC SOC, V53, P40, DOI 10.2307/3222335; TALBOT S. BENTON, 1933, PARASITOLOGY, V25, P518, DOI 10.1017/S0031182000019764; Taylor CN, 2004, CAN J ZOOL, V82, P701, DOI [10.1139/z04-037, 10.1139/Z04-037]; THOMAS J. D., 1965, J ZOOL PROC ZOOL SOC LONDON, V146, P413; Todd BD, 2007, AM NAT, V170, P793, DOI 10.1086/521958; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Venesky MD, 2012, OECOLOGIA, V169, P23, DOI 10.1007/s00442-011-2171-1; Wassersug R.J., 1973, P273; Wilson WD, 2005, J PARASITOL, V91, P1040, DOI 10.1645/GE-465R.1	50	19	19	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51012	10.1371/journal.pone.0051012	http://dx.doi.org/10.1371/journal.pone.0051012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272084	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300015
J	Wang, WP; Tzeng, TY; Wang, JY; Lee, DC; Lin, YH; Wu, PC; Chen, YP; Chiu, IM; Chi, YH				Wang, Wan-Ping; Tzeng, Tsai-Yu; Wang, Jing-Ya; Lee, Don-Ching; Lin, Yu-Hsiang; Wu, Pei-Chun; Chen, Yen-Po; Chiu, Ing-Ming; Chi, Ya-Hui			The EP300, KDM5A, KDM6A and KDM6B Chromatin Regulators Cooperate with KLF4 in the Transcriptional Activation of POU5F1	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; OCT4; GENE; DIFFERENTIATION; EXPRESSION; INDUCTION; P300; SOX2; DEDIFFERENTIATION	POU5F1 is essential for maintaining pluripotency in embryonic stem cells (ESCs). It has been reported that the constitutive activation of POU5F1 is sustained by the core transcriptional regulatory circuitry in ESCs; however, the means by which POU5F1 is epigenetically regulated remains enigmatic. In this study a fluorescence-based reporter system was used to monitor the interplay of 5 reprogramming-associated TFs and 17 chromatin regulators in the transcription of POU5F1. We show the existence of a stoichiometric effect for SOX2, POU5F1, NANOG, MYC and KLF4, in regulating POU5F1 transcription. Chromatin regulators EP300, KDM5A, KDM6A and KDM6B cooperate with KLF4 in promoting the transcription of POU5F1. Moreover, inhibiting HDAC activities induced the expression of Pou5f1 in mouse neural stem cells (NSCs) in a spatial-and temporal-dependent manner. Quantitative chromatin immunoprecipitation-PCR (ChIP-qPCR) shows that treatment with valproic acid (VPA) increases the recruitment of Kdm5a and Kdm6a to proximal promoter (PP) and proximal enhancer (PE) of Pou5f1 whereas enrichment of Ep300 and Kdm6b was seen in PP but not PE of Pou5f1 promoter. These findings reveal the interplay between the chromatin regulators and histone modifications in the expression of POU5F1.	[Wang, Wan-Ping; Wang, Jing-Ya; Lee, Don-Ching; Chen, Yen-Po; Chiu, Ing-Ming; Chi, Ya-Hui] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Tzeng, Tsai-Yu; Lin, Yu-Hsiang; Wu, Pei-Chun] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 112, Taiwan; [Chen, Yen-Po] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Chi, Ya-Hui] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; National Tsing Hua University; China Medical University Taiwan	Chi, YH (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	ychi@nhri.org.tw	Chi, Ya-Hui/ABE-8550-2020; Chiu, Ing-Ming/B-1534-2008; Chi, Ya-Hui/B-1080-2010	Chi, Ya-Hui/0000-0002-9216-0938; Tzeng, Tsai-Yu/0000-0001-7334-6270	National Health Research Institutes [(NHRI) 98A1-CSPP11-014, NHRI 99A1-CSPP11-014]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	Work in the authors' laboratories was supported by grants to YHC (National Health Research Institutes (NHRI) 98A1-CSPP11-014, NHRI 99A1-CSPP11-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Gao Y, 2010, MOL REPROD DEV, V77, P540, DOI 10.1002/mrd.21180; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Ho R, 2011, J CELL PHYSIOL, V226, P868, DOI 10.1002/jcp.22450; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kellner S, 2010, HISTOL HISTOPATHOL, V25, P405, DOI 10.14670/HH-25.405; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee DC, 2009, MOL CELL NEUROSCI, V41, P348, DOI 10.1016/j.mcn.2009.04.010; Lowry WE, 2008, NAT BIOTECHNOL, V26, P1246, DOI 10.1038/nbt1108-1246; Mansour AA, 2012, NATURE; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Sun GQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/835968; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yu IT, 2009, NEUROPHARMACOLOGY, V56, P473, DOI 10.1016/j.neuropharm.2008.09.019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200	48	9	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52556	10.1371/journal.pone.0052556	http://dx.doi.org/10.1371/journal.pone.0052556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272250	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300092
J	Johnson, S; Issac, B; Zhao, SP; Bisht, M; Celiku, O; Tofilon, P; Camphausen, K; Shankavaram, U				Johnson, Seth; Issac, Biju; Zhao, Shuping; Bisht, Mohit; Celiku, Orieta; Tofilon, Philip; Camphausen, Kevin; Shankavaram, Uma			StRAP: An Integrated Resource for Profiling High-Throughput Cancer Genomic Data from Stress Response Studies	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; RADIATION-THERAPY; PLATFORMS; RADIOTHERAPY; BIOLOGY; SYSTEMS; TOOL	The increasing availability and maturity of DNA microarray technology has led to an explosion of cancer profiling studies for identifying cancer biomarkers, and predicting treatment response. Uncovering complex relationships, however, remains the most challenging task as it requires compiling and efficiently querying data from various sources. Here, we describe the Stress Response Array Profiler (StRAP), an open-source, web-based resource for storage, profiling, visualization, and sharing of cancer genomic data. StRAP houses multi-cancer microarray data with major emphasis on radiotherapy studies, and takes a systems biology approach towards the integration, comparison, and cross-validation of multiple cancer profiling studies. The database is a comprehensive platform for comparative analysis of gene expression data. For effective use of arrays, we provide user-friendly and interactive visualization tools that can display the data and query results. StRAP is web-based, platform-independent, and freely accessible at http://strap.nci.nih.gov/.	[Johnson, Seth; Zhao, Shuping; Bisht, Mohit; Celiku, Orieta; Tofilon, Philip; Camphausen, Kevin; Shankavaram, Uma] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Johnson, Seth; Zhao, Shuping] SAIC Frederick Inc, Natl Canc Inst Frederick, Frederick, MD USA; [Issac, Biju] Univ Miami, Sylvester Comprehens Canc Ctr, Div Bioinformat, Coral Gables, FL 33124 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Miami	Shankavaram, U (corresponding author), NCI, Radiat Oncol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	uma@mail.nih.gov		Issac, Biju/0000-0002-7311-678X; Celiku, Orieta/0000-0002-0500-1032	National Institutes of Health, National Cancer Institute, Center for Cancer Research	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman NS, 2006, GENET RES, V88, P153, DOI 10.1017/S0016672307008476; Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bargaje R, 2010, RNA, V16, P16, DOI 10.1261/rna.1688110; Bevilacqua V, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S9; Burnet NG, 2000, BRIT MED J, V320, P198, DOI 10.1136/bmj.320.7229.198; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chon BH, 2002, ONCOLOGIST, V7, P136, DOI 10.1634/theoncologist.7-2-136; Chon HS, 2011, CANCER CONTROL, V18, P8, DOI 10.1177/107327481101800102; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Mah N, 2004, PHYSIOL GENOMICS, V16, P361, DOI 10.1152/physiolgenomics.00080.2003; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rieger KE, 2004, P NATL ACAD SCI USA, V101, P6635, DOI 10.1073/pnas.0307761101; Rodningen AK, 2005, RADIOTHER ONCOL, V77, P231, DOI 10.1016/j.radonc.2005.09.020; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Stafford P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1133; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang YY, 2009, METHODS MOL BIOL, V573, P259, DOI 10.1007/978-1-60761-247-6_15	27	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51693	10.1371/journal.pone.0051693	http://dx.doi.org/10.1371/journal.pone.0051693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284744	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900045
J	Reniers, G; Armbruster, B				Reniers, Georges; Armbruster, Benjamin			HIV Status Awareness, Partnership Dissolution and HIV Transmission in Generalized Epidemics	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COPD; POPULATION	Objectives: HIV status aware couples with at least one HIV positive partner are characterized by high separation and divorce rates. This phenomenon is often described as a corollary of couples HIV Testing and Counseling (HTC) that ought to be minimized. In this contribution, we demonstrate the implications of partnership dissolution in serodiscordant couples for the propagation of HIV. Methods: We develop a compartmental model to study epidemic outcomes of elevated partnership dissolution rates in serodiscordant couples and parameterize it with estimates from population-based data (Rakai, Uganda). Results: Via its effect on partnership dissolution, every percentage point increase in HIV status awareness reduces HIV incidence in monogamous populations by 0.27 percent for women and 0.63 percent for men. These effects are even larger when the assumption of monogamy can be relaxed, but are moderated by other behavior changes (e. g., increased condom use) in HIV status aware serodiscordant partnerships. When these behavior changes are taken into account, each percentage point increase in HIV status awareness reduces HIV incidence by 0.13 and 0.32 percent for women and men, respectively (assuming monogamy). The partnership dissolution effect exists because it decreases the fraction of serodiscordant couples in the population and prolongs the time that individuals spend outside partnerships. Conclusion: Our model predicts that elevated partnership dissolution rates in HIV status aware serodiscordant couples reduce the spread of HIV. As a consequence, the full impact of couples HTC for HIV prevention is probably larger than recognized to date. Particularly high partnership dissolution rates in female positive serodiscordant couples contribute to the gender imbalance in HIV infections.	[Reniers, Georges] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Reniers, Georges] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England; [Armbruster, Benjamin] Northwestern Univ, Evanston, IL USA	Princeton University; University of London; London School of Hygiene & Tropical Medicine; Northwestern University	Reniers, G (corresponding author), Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.	georges.reniers@lshtm.ac.uk	Armbruster, Benjamin/B-7455-2009	Reniers, Georges/0000-0001-6582-1692	National Institute of Child Health and Human Development (NICHD) Center Grant [R24HD047879]; NICHD [R24 HD066613]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD066613, R24HD066613, R24HD047879] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD) Center Grant; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was made possible with financial support from a National Institute of Child Health and Human Development (NICHD) Center Grant to the Office of Population Research at Princeton University (R24HD047879) and an NICHD grant to the University of Colorado Population Center (R24 HD066613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert P, 2012, THORAX, V67, P701, DOI 10.1136/thoraxjnl-2011-201458; Fletcher MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-612; Foster Talia S, 2006, COPD, V3, P211, DOI 10.1080/15412550601009396; GOLD, GLOB IN CHRON OBSTR; Gruffydd-Jones K, 2011, PRIM CARE RESP J, V20, P199, DOI 10.4104/pcrj.2011.00011; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Kainu A, 2008, CHEST, V134, P387, DOI 10.1378/chest.07-2207; Nakahara N, 2012, INT J CLIN IN PRESS; Nurmagambetov Tursynbek, 2006, COPD, V3, P203, DOI 10.1080/15412550600977320; Procopiou PA, 2010, J MED CHEM, V53, P4522, DOI 10.1021/jm100326d; Salpeter SR, 2004, DRUG AGING, V21, P405, DOI 10.2165/00002512-200421060-00005; Sovani MP, 2004, DRUG SAFETY, V27, P689, DOI 10.2165/00002018-200427100-00001; WILLIAMS EJ, 1949, AUST J SCI RES SER A, V2, P149, DOI 10.1071/CH9490149	13	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e50669	10.1371/journal.pone.0050669	http://dx.doi.org/10.1371/journal.pone.0050669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284641	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000312435900007
J	Vecellio, M; Meraviglia, V; Nanni, S; Barbuti, A; Scavone, A; DiFrancesco, D; Farsetti, A; Pompilio, G; Colombo, GI; Capogrossi, MC; Gaetano, C; Rossini, A				Vecellio, Matteo; Meraviglia, Viviana; Nanni, Simona; Barbuti, Andrea; Scavone, Angela; DiFrancesco, Dario; Farsetti, Antonella; Pompilio, Giulio; Colombo, Gualtiero I.; Capogrossi, Maurizio C.; Gaetano, Carlo; Rossini, Alessandra			In Vitro Epigenetic Reprogramming of Human Cardiac Mesenchymal Stromal Cells into Functionally Competent Cardiovascular Precursors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RETINOIC ACID; BONE-MARROW; PROGENITOR CELLS; CORD BLOOD; DIFFERENTIATION; MOUSE; ACTIVATION; EXPRESSION; CARDIOMYOCYTES	Adult human cardiac mesenchymal-like stromal cells (CStC) represent a relatively accessible cell type useful for therapy. In this light, their conversion into cardiovascular precursors represents a potential successful strategy for cardiac repair. The aim of the present work was to reprogram CStC into functionally competent cardiovascular precursors using epigenetically active small molecules. CStC were exposed to low serum (5% FBS) in the presence of 5 mu M all-trans Retinoic Acid (ATRA), 5 mM Phenyl Butyrate (PB), and 200 mu M diethylenetriamine/nitric oxide (DETA/NO), to create a novel epigenetically active cocktail (EpiC). Upon treatment the expression of markers typical of cardiac resident stem cells such as c-Kit and MDR-1 were up-regulated, together with the expression of a number of cardiovascular-associated genes including KDR, GATA6, Nkx2.5, GATA4, HCN4, NaV1.5, and alpha-MHC. In addition, profiling analysis revealed that a significant number of microRNA involved in cardiomyocyte biology and cell differentiation/proliferation, including miR 133a, 210 and 34a, were up-regulated. Remarkably, almost 45% of EpiC-treated cells exhibited a TTX-sensitive sodium current and, to a lower extent in a few cells, also the pacemaker I-f current. Mechanistically, the exposure to EpiC treatment introduced global histone modifications, characterized by increased levels of H3K4Me3 and H4K16Ac, as well as reduced H4K20Me3 and H3s10P, a pattern compatible with reduced proliferation and chromatin relaxation. Consistently, ChIP experiments performed with H3K4me3 or H3s10P histone modifications revealed the presence of a specific EpiC-dependent pattern in c-Kit, MDR-1, and Nkx2.5 promoter regions, possibly contributing to their modified expression. Taken together, these data indicate that CStC may be epigenetically reprogrammed to acquire molecular and biological properties associated with competent cardiovascular precursors.	[Gaetano, Carlo] Goethe Univ Frankfurt, Dept Cardiol, Div Cardiovasc Epigenet, Frankfurt, Germany; [Vecellio, Matteo; Pompilio, Giulio; Rossini, Alessandra] Univ Milan, Dipartimento Sci Clin & Comunita, Milan, Italy; [Vecellio, Matteo; Meraviglia, Viviana; Pompilio, Giulio] IRCCS, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerativa, Milan, Italy; [Nanni, Simona] Univ Cattolica Sacro Cuore, Ist Patol Med, Rome, Italy; [Barbuti, Andrea; Scavone, Angela; DiFrancesco, Dario] Univ Milan, Dipartimento Biosci, PaceLab, Milan, Italy; [Farsetti, Antonella] Ist Nazl Tumori Regina Elena, Rome, Italy; [Farsetti, Antonella] CNR, Ist Neurobiol & Med Mol, Rome, Italy; [Colombo, Gualtiero I.] IRCCS, Ctr Cardiol Monzino, Lab Immunol & Genom Funz, Milan, Italy; [Capogrossi, Maurizio C.] IRCCS, Ist Dermopat Immacolata, Lab Patol Vasc, Rome, Italy	Goethe University Frankfurt; University of Milan; IRCCS Centro Cardiologico Monzino; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Milan; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Consiglio Nazionale delle Ricerche (CNR); IRCCS Centro Cardiologico Monzino; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Gaetano, C (corresponding author), Goethe Univ Frankfurt, Dept Cardiol, Div Cardiovasc Epigenet, Frankfurt, Germany.	Gaetano@em.uni-frankfurt.de; alessandra.rossini@unimi.it	Vecellio, Matteo Luca/AAA-9143-2022; Pompilio, Giulio/J-6701-2014; Meraviglia, Viviana/J-4823-2016; Colombo, Gualtiero I./B-4737-2010; Rossini, Alessandra/N-8446-2013; Farsetti, Antonella/I-8710-2018; Gaetano, Carlo/P-9997-2019; DiFrancesco, Dario/G-8408-2017; Vecellio, Matteo Luca/HGB-6768-2022; Barbuti, Andrea/N-9805-2013	Vecellio, Matteo Luca/0000-0002-8643-1316; Pompilio, Giulio/0000-0003-2581-5735; Meraviglia, Viviana/0000-0002-9571-0309; Colombo, Gualtiero I./0000-0002-7348-1939; Rossini, Alessandra/0000-0002-0440-1130; Farsetti, Antonella/0000-0002-8603-7925; Gaetano, Carlo/0000-0002-5238-1832; DiFrancesco, Dario/0000-0002-7322-1790; Vecellio, Matteo Luca/0000-0002-8643-1316; Barbuti, Andrea/0000-0002-4521-4913	Italian Ministry of Health (RC); Italian Ministry of Education, University and Research [FIRB-MIUR RBFR087JMZ, FIRB-MIUR RBFR10URHP_001, PRIN-MIUR 2008NY72S, PRIN-MIUR 2008ETWBTW]; LOEWE-CGT centre of excellence	Italian Ministry of Health (RC)(Ministry of Health, Italy); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); LOEWE-CGT centre of excellence	The present study was supported by the Italian Ministry of Health (RC 2010-2011) and by the Italian Ministry of Education, University and Research (FIRB-MIUR RBFR087JMZ to A.R. and A.F; FIRB-MIUR RBFR10URHP_001 to S.N; PRIN-MIUR 2008NY72S to A.F; PRIN-MIUR 2008ETWBTW to DD). C.G. is supported by the LOEWE-CGT centre of excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, ARTERIOSCL THROM VAS, V23, P404, DOI 10.1161/01.ATV.0000059405.51042.A0; Anastasia L, 2010, CELL DEATH DIFFER, V17, P1230, DOI 10.1038/cdd.2010.14; Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Avitabile D, 2011, AM J PHYSIOL-HEART C, V300, pH1875, DOI 10.1152/ajpheart.00523.2010; Barbuti A, 2009, J MOL CELL CARDIOL, V46, P343, DOI 10.1016/j.yjmcc.2008.12.001; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Boettger T, 2012, CIRC RES, V110, P1000, DOI 10.1161/CIRCRESAHA.111.247742; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Cho J, 2009, J BIOL CHEM, V284, P36647, DOI 10.1074/jbc.M109.019109; Cottage CT, 2010, CIRC RES, V106, P891, DOI 10.1161/CIRCRESAHA.109.208629; Das S, 2010, CANCER RES, V70, P7874, DOI 10.1158/0008-5472.CAN-10-1534; Dietze EC, 2003, BIOCHEM BIOPH RES CO, V302, P841, DOI 10.1016/S0006-291X(03)00266-3; Galvez BG, 2008, CELL DEATH DIFFER, V15, P1417, DOI 10.1038/cdd.2008.75; Goto S, 1999, ANAL BIOCHEM, V272, P135, DOI 10.1006/abio.1999.4163; Gu MF, 2000, J BIOL CHEM, V275, P11389, DOI 10.1074/jbc.275.15.11389; Haufe V, 2005, J PHYSIOL-LONDON, V564, P683, DOI 10.1113/jphysiol.2004.079681; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Karamboulas C, 2006, J CELL SCI, V119, P4305, DOI 10.1242/jcs.03185; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Kudo T, 2011, GENES CELLS, V16, P1121, DOI 10.1111/j.1365-2443.2011.01556.x; Li L, 2012, CLIN EXP MED; Liu J, 2011, J CELL MOL MED, V15, P1474, DOI 10.1111/j.1582-4934.2010.01104.x; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Liu SP, 2009, CELL TRANSPLANT, V18, P1039, DOI 10.3727/096368909X471224; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; Majumdar A, 2011, J BIOL CHEM; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Martin-Rendon E, 2008, VOX SANG, V95, P137, DOI 10.1111/j.1423-0410.2008.01076.x; Mattout A, 2011, J MOL CELL BIOL; McManus KJ, 2006, BIOCHEM CELL BIOL, V84, P640, DOI 10.1139/O06-086; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Mujoo K, 2008, P NATL ACAD SCI USA, V105, P18924, DOI 10.1073/pnas.0810230105; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pan J, 2007, VITAM HORM, V75, P257, DOI 10.1016/S0083-6729(06)75010-5; Piccolo FM, 2011, PHILOS T R SOC B, V366, P2260, DOI 10.1098/rstb.2011.0004; Rosati J, 2011, ARTERIOSCL THROM VAS, V31, P898, DOI 10.1161/ATVBAHA.110.214478; Rossini A, 2011, CARDIOVASC RES, V89, P650, DOI 10.1093/cvr/cvq290; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Spallotta F, 2010, STEM CELLS, V28, P431, DOI 10.1002/stem.300; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tjwa M, 2008, CIRC RES, V103, P4, DOI 10.1161/CIRCRESAHA.108.179994; Ventura C, 2007, J BIOL CHEM, V282, P14243, DOI 10.1074/jbc.M609350200; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; Wu SM, 2011, CELL CYCLE, V10, P68, DOI 10.4161/cc.10.1.14363; Yasui K, 2001, CIRC RES, V88, P536, DOI 10.1161/01.RES.88.5.536; Ybarra N, 2011, NITRIC OXIDE-BIOL CH, V24, P25, DOI 10.1016/j.niox.2010.09.008; Zhang QZ, 2011, CELL RES, V21, P579, DOI 10.1038/cr.2010.163	58	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51694	10.1371/journal.pone.0051694	http://dx.doi.org/10.1371/journal.pone.0051694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284745	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900046
J	Albers, DJ; Hripcsak, G; Schmidt, M				Albers, D. J.; Hripcsak, George; Schmidt, Michael			Population Physiology: Leveraging Electronic Health Record Data to Understand Human Endocrine Dynamics	PLOS ONE			English	Article							CONTROL-ORIENTED MODEL; GLUCOSE DYNAMICS; INSULIN; OSCILLATIONS	Studying physiology and pathophysiology over a broad population for long periods of time is difficult primarily because collecting human physiologic data can be intrusive, dangerous, and expensive. One solution is to use data that have been collected for a different purpose. Electronic health record (EHR) data promise to support the development and testing of mechanistic physiologic models on diverse populations and allow correlation with clinical outcomes, but limitations in the data have thus far thwarted such use. For example, using uncontrolled population-scale EHR data to verify the outcome of time dependent behavior of mechanistic, constructive models can be difficult because: (i) aggregation of the population can obscure or generate a signal, (ii) there is often no control population with a well understood health state, and (iii) diversity in how the population is measured can make the data difficult to fit into conventional analysis techniques. This paper shows that it is possible to use EHR data to test a physiological model for a population and over long time scales. Specifically, a methodology is developed and demonstrated for testing a mechanistic, time-dependent, physiological model of serum glucose dynamics with uncontrolled, population-scale, physiological patient data extracted from an EHR repository. It is shown that there is no observable daily variation the normalized mean glucose for any EHR subpopulations. In contrast, a derived value, daily variation in nonlinear correlation quantified by the time-delayed mutual information (TDMI), did reveal the intuitively expected diurnal variation in glucose levels amongst a random population of humans. Moreover, in a population of continuously (tube) fed patients, there was no observable TDMI-based diurnal signal. These TDMI-based signals, via a glucose insulin model, were then connected with human feeding patterns. In particular, a constructive physiological model was shown to correctly predict the difference between the general uncontrolled population and a subpopulation whose feeding was controlled. Citation: Albers DJ, Hripcsak G, Schmidt M (2012) Population Physiology: Leveraging Electronic Health Record Data to Understand Human Endocrine Dynamics. PLoS ONE 7(12): e48058. doi: 10.1371/journal.pone.0048058	[Albers, D. J.; Hripcsak, George] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Schmidt, Michael] Columbia Univ, Dept Neurol, New York, NY USA	Columbia University; Columbia University	Albers, DJ (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.	david.albers@dbmi.columbia.edu			National Library of Medicine - National Institutes of Health grant [RO1 LM06910]; NATIONAL LIBRARY OF MEDICINE [R01LM006910] Funding Source: NIH RePORTER	National Library of Medicine - National Institutes of Health grant; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors would like to acknowledge the financial support provided by National Library of Medicine - National Institutes of Health grant RO1 LM06910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2010, PHILOS T R SOC A, V368, P4893, DOI 10.1098/rsta.2010.0237; Albers DJ, 2012, CHAOS SOLITON FRACT, V45, P853, DOI 10.1016/j.chaos.2012.03.003; Albers DJ, 2012, CHAOS, V22, DOI 10.1063/1.3675621; Albers D. J., 2010, PHYS LETT A; Astrom K. J., 2008, FEEDBACK SYSTEMS INT; Blanco P, 2010, INT J BIOMEDICAL ENG, V1, P1; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Bolander F. F., 2004, MOL ENDOCRINOLOGY; Brunetti P, 2003, ARTIF CELL BLOOD SUB, V31, P127, DOI 10.1081/BIO-120020169; Fabietti PG, 2007, DIABETES TECHNOL THE, V9, P327, DOI 10.1089/dia.2006.0030; Fabietti PG, 2006, MED BIOL ENG COMPUT, V44, P69, DOI 10.1007/s11517-005-0012-2; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Higgins JM, 2010, P NATL ACAD SCI USA, V107, P20587, DOI 10.1073/pnas.1012747107; Hirata Y, 2010, CHAOS, V20, DOI DOI 10.1063/1.3526968; Hripcsak G, 2007, COMPUT BIOL MED, V37, P296, DOI 10.1016/j.compbiomed.2006.02.001; Huising MO, 2010, P NATL ACAD SCI USA, V107, P912, DOI 10.1073/pnas.0913610107; Inscho EW, 2009, HYPERTENSION, V53, P299, DOI 10.1161/HYPERTENSIONAHA.108.119982; Kacsoh B., 2000, ENDOCRINE PHYSL; Kaldor N., 1961, THEORY CAPITAL, P177, DOI DOI 10.1007/978-1-349-08452-4_10; Kantz H., 2003, NONLINEAR TIME SERIE; Karsh BT, 2010, J AM MED INFORM ASSN, V17, P617, DOI 10.1136/jamia.2010.005637; KATZ J, 1984, J CLIN INVEST, V74, P1901, DOI 10.1172/JCI111610; Keener J., 2008, MATH PHYSL, V1; Keener James, 2008, MATH PHYSL; Keller J, 2002, J APPL PHYSIOL, V93, P592, DOI 10.1152/japplphysiol.00807.2001; Keller J, 2001, AM J PHYSIOL-GASTR L, V93, P592; Kirk D, 1988, OPTIMAL CONTROL THEO; Kovatchev Boris P, 2009, J Diabetes Sci Technol, V3, P44; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Levin SA, 2003, B AM MATH SOC, V40, P3; Lorenc A, 1988, Q J ROY METEOR SOC, V112, P1177; Makroglou A, 2006, APPL NUMER MATH, V56, P559, DOI 10.1016/j.apnum.2005.04.023; McQueen D. M., 2000, MECH NEW MILLENNIUM; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Moghissi E, 2009, ENDOCRINE PRACTICE, V15; Moore Gray, 2003, JOINT STAT M; Peschke E, 1998, DIABETOLOGIA, V41, P1085, DOI 10.1007/s001250051034; Sagreiya H, 2010, J BIOMED INFORM, V43, P747, DOI 10.1016/j.jbi.2010.03.014; SCHIFF S. J., 2011, NEURAL CONTROL ENG E; Schmidt J, 2012, CRIT CARE MED; Sedigh-Sarvestan M, 34 ANN INT IN PRESS; Sprott JC, 2003, CHAOS TIME SERIES AN; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; STURIS J, 1991, AM J PHYSIOL, V260, pE801, DOI 10.1152/ajpendo.1991.260.5.E801; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732	45	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e48058	10.1371/journal.pone.0048058	http://dx.doi.org/10.1371/journal.pone.0048058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272040	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800002
J	Vetukuri, RR; Asman, AKM; Tellgren-Roth, C; Jahan, SN; Reimegard, J; Fogelqvist, J; Savenkov, E; Soderbom, F; Avrova, AO; Whisson, SC; Dixelius, C				Vetukuri, Ramesh R.; Asman, Anna K. M.; Tellgren-Roth, Christian; Jahan, Sultana N.; Reimegard, Johan; Fogelqvist, Johan; Savenkov, Eugene; Soderbom, Fredrik; Avrova, Anna O.; Whisson, Stephen C.; Dixelius, Christina			Evidence for Small RNAs Homologous to Effector-Encoding Genes and Transposable Elements in the Oomycete Phytophthora infestans	PLOS ONE			English	Article							LATE BLIGHT RESISTANCE; ENDOGENOUS SIRNAS; STRUCTURAL BASIS; INTERFERING RNA; GENOME; PLANT; PATHOGEN; MICRORNAS; DIVERSE; EVOLUTION	Phytophthora infestans is the oomycete pathogen responsible for the devastating late blight disease on potato and tomato. There is presently an intense research focus on the role(s) of effectors in promoting late blight disease development. However, little is known about how they are regulated, or how diversity in their expression may be generated among different isolates. Here we present data from investigation of RNA silencing processes, characterized by non-coding small RNA molecules (sRNA) of 19-40 nt. From deep sequencing of sRNAs we have identified sRNAs matching numerous RxLR and Crinkler (CRN) effector protein genes in two isolates differing in pathogenicity. Effector gene-derived sRNAs were present in both isolates, but exhibited marked differences in abundance, especially for CRN effectors. Small RNAs in P. infestans grouped into three clear size classes of 21, 25/26 and 32 nt. Small RNAs from all size classes mapped to RxLR effector genes, but notably 21 nt sRNAs were the predominant size class mapping to CRN effector genes. Some effector genes, such as PiAvr3a, to which sRNAs were found, also exhibited differences in transcript accumulation between the two isolates. The P. infestans genome is rich in transposable elements, and the majority of sRNAs of all size classes mapped to these sequences, predominantly to long terminal repeat (LTR) retrotransposons. RNA silencing of Dicer and Argonaute genes provided evidence that generation of 21 nt sRNAs is Dicer-dependent, while accumulation of longer sRNAs was impacted by silencing of Argonaute genes. Additionally, we identified six microRNA (miRNA) candidates from our sequencing data, their precursor sequences from the genome sequence, and target mRNAs. These miRNA candidates have features characteristic of both plant and metazoan miRNAs. Citation: Vetukuri RR, Asman AKM, Tellgren-Roth C, Jahan SN, Reimegard J, et al. (2012) Evidence for Small RNAs Homologous to Effector-Encoding Genes and Transposable Elements in the Oomycete Phytophthora infestans. PLoS ONE 7(12): e51399. doi:10.1371/journal.pone.0051399	[Vetukuri, Ramesh R.; Asman, Anna K. M.; Jahan, Sultana N.; Fogelqvist, Johan; Savenkov, Eugene; Dixelius, Christina] Swedish Univ Agr Sci, Uppsala BioCtr, Dept Plant Biol & Forest Genet, Uppsala, Sweden; [Vetukuri, Ramesh R.; Asman, Anna K. M.; Jahan, Sultana N.; Fogelqvist, Johan; Savenkov, Eugene; Dixelius, Christina] Linnean Ctr Plant Biol, Uppsala, Sweden; [Tellgren-Roth, Christian] Uppsala Univ, Rudbeck Lab, SciLifeLab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Reimegard, Johan] KTH, Sch Biotechnol, SciLife Lab, Solna, Sweden; [Soderbom, Fredrik] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden; [Avrova, Anna O.; Whisson, Stephen C.] James Hutton Inst, Dundee, Scotland	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; SciLifeLab; Uppsala University; Royal Institute of Technology; SciLifeLab; Uppsala University; James Hutton Institute	Vetukuri, RR (corresponding author), Swedish Univ Agr Sci, Uppsala BioCtr, Dept Plant Biol & Forest Genet, Uppsala, Sweden.	Ramesh.Vetukuri@slu.se		Tellgren-Roth, Christian/0000-0003-0502-3693; Savenkov, Eugene/0000-0002-5802-5089	Formas(Forskningsradet for miljo, areella naringar och samhallsbyggande); SJV(sverige jordbruksverket); SLF(Stiftelsen Lantbruksforskning); SLU(Sveriges Lantbruks universitet); Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Biotechnology and Biological Sciences Research Council (BBSRC)	Formas(Forskningsradet for miljo, areella naringar och samhallsbyggande); SJV(sverige jordbruksverket); SLF(Stiftelsen Lantbruksforskning); SLU(Sveriges Lantbruks universitet); Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Formas(Forskningsradet for miljo, areella naringar och samhallsbyggande), SJV(sverige jordbruksverket), SLF(Stiftelsen Lantbruksforskning) and SLU(Sveriges Lantbruks universitet) supported this work. SCW and AOA were supported by grants from the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD) and the Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Ah-Fong AMV, 2008, FUNGAL GENET BIOL, V45, P1197, DOI 10.1016/j.fgb.2008.05.009; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Avrova AO, 2008, CELL MICROBIOL, V10, P2271, DOI 10.1111/j.1462-5822.2008.01206.x; Avrova AO, 2003, FUNGAL GENET BIOL, V40, P4, DOI 10.1016/S1087-1845(03)00063-X; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bozkurt TO, 2011, P NATL ACAD SCI USA, V108, P20832, DOI 10.1073/pnas.1112708109; Braun L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000920; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Cooke D. E. L., 2007, Proceedings of the Tenth Workshop of an European Network for Development of an Integrated Control Strategy of Potato Late Blight, Bologna, Italy, 2-5 May 2007, P145; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; de Haro JP, 2009, EUKARYOT CELL, V8, P1486, DOI 10.1128/EC.00191-09; Dick MW, 2001, MYCOTA, V7, P39; Dolgosheina EV, 2008, RNA, V14, P1508, DOI 10.1261/rna.1052008; Dong SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002353; Flier WG, 2001, PLANT PATHOL, V50, P292, DOI 10.1046/j.1365-3059.2001.00574.x; Fong AMVA, 2003, MOL MICROBIOL, V50, P487, DOI 10.1046/j.1365-2958.2003.03735.x; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grenville-Briggs LJ, 2005, FUNGAL GENET BIOL, V42, P244, DOI 10.1016/j.fgb.2004.11.009; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grouffaud S, 2008, MICROBIOL-SGM, V154, P3743, DOI 10.1099/mic.0.2008/021964-0; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Harper JT, 2005, INT J SYST EVOL MICR, V55, P487, DOI 10.1099/ijs.0.63216-0; Hinas A, 2007, NUCLEIC ACIDS RES, V35, P6714, DOI 10.1093/nar/gkm707; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; Judelson HS, 2007, EUKARYOT CELL, V6, P1200, DOI 10.1128/EC.00311-06; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Kamoun S, 1999, FUNGAL GENET BIOL, V28, P94, DOI 10.1006/fgbi.1999.1166; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Klevebring D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-620; Kojima KK, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-12; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kreuze JF, 2005, J VIROL, V79, P7227, DOI 10.1128/JVI.79.11.7227-7238.2005; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li GC, 2011, MOL PLANT MICROBE IN, V24, P1132, DOI 10.1094/MPMI-11-10-0276; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nicolas FE, 2003, EMBO J, V22, P3983, DOI 10.1093/emboj/cdg384; Norden-Krichmar TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022870; Nunes CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-288; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Tang G, 2004, BIOCH DISSECTION RNA, P223; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Tsui CKM, 2009, MOL PHYLOGENET EVOL, V50, P129, DOI 10.1016/j.ympev.2008.09.027; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; van West P, 1999, MOL CELL, V3, P339, DOI 10.1016/S1097-2765(00)80461-X; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vetukuri RR, 2011, FUNGAL BIOL-UK, V115, P1225, DOI 10.1016/j.funbio.2011.08.007; Vetukuri RR, 2011, MOL PLANT PATHOL, V12, P772, DOI [10.1111/J.1364-3703.2011.00710.X, 10.1111/j.1364-3703.2011.00710.x]; Vleeshouwers VGAA, 2011, ANNU REV PHYTOPATHOL, V49, P507, DOI 10.1146/annurev-phyto-072910-095326; Wang H, 2011, PLANT J, V67, P292, DOI 10.1111/j.1365-313X.2011.04594.x; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Welker NC, 2010, RNA, V16, P893, DOI 10.1261/rna.2122010; Whisson SC, 2005, MOL PLANT PATHOL, V6, P153, DOI 10.1111/J.1364-3703.2005.00272.X; Whisson SC, 2005, FUNGAL GENET BIOL, V42, P351, DOI 10.1016/j.fgb.2005.01.004; Whisson Stephen, 2012, Mob Genet Elements, V2, P110; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Xie FL, 2010, BIOINFORMATICS, V26, P3002, DOI 10.1093/bioinformatics/btq568; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	100	52	57	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51399	10.1371/journal.pone.0051399	http://dx.doi.org/10.1371/journal.pone.0051399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272103	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800044
J	Wisotzkey, RG; Konikoff, CE; Newfeld, SJ				Wisotzkey, Robert G.; Konikoff, Charlotte E.; Newfeld, Stuart J.			Hippo Pathway Phylogenetics Predicts Monoubiquitylation of Salvador and Merlin/Nf2	PLOS ONE			English	Article							TGF-BETA; YAP; UBIQUITINATION; EVOLUTION; FAMILY; DEUBIQUITYLATION; PHOSPHORYLATION; DIVERSIFICATION; IDENTIFICATION; DOMAIN	Recently we employed phylogenetics to predict that the cellular interpretation of TGF-beta signals is modulated by monoubiquitylation cycles affecting the Smad4 signal transducer/tumor suppressor. This prediction was subsequently validated by experiments in flies, frogs and mammalian cells. Here we apply a phylogenetic approach to the Hippo pathway and predict that two of its signal transducers, Salvador and Merlin/Nf2 (also a tumor suppressor) are regulated by monoubiquitylation. This regulatory mechanism does not lead to protein degradation but instead serves as a highly efficient "off/on'' switch when the protein is subsequently deubiquitylated. Overall, our study shows that the creative application of phylogenetics can predict new roles for pathway components and new mechanisms for regulating intercellular signaling pathways.	[Newfeld, Stuart J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA; [Wisotzkey, Robert G.] NextBio, Santa Clara, CA USA; [Konikoff, Charlotte E.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	Arizona State University; Arizona State University-Tempe; University of Washington; University of Washington Seattle	Newfeld, SJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85069 USA.	newfeld@asu.edu	Konikoff, Charlotte/F-2320-2011		National Science Foundation [DBI-0939454]; National Institutes of Health [HG002516]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002516] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	CEK is supported in part by National Science Foundation DBI-0939454. SJN is supported in part by National Institutes of Health HG002516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; [Anonymous], SMAD SIGNAL TRANSDUC; BURGLIN TR, 1991, CELL, V66, P11, DOI 10.1016/0092-8674(91)90132-I; Cai YD, 2012, AMINO ACIDS, V42, P1387, DOI 10.1007/s00726-011-0835-0; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; Dupont S, 2012, FEBS LETT, V586, P1913, DOI 10.1016/j.febslet.2012.03.037; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gray RS, 2009, DEV DYNAM, V238, P2044, DOI 10.1002/dvdy.22028; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hedges S. B., 2009, TIME TREE LIFE; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Jukam D, 2011, DEV CELL, V21, P874, DOI 10.1016/j.devcel.2011.10.004; Konikoff CE, 2008, J MOL EVOL, V67, P323, DOI 10.1007/s00239-008-9159-4; Konikoff CE, 2010, J MOL EVOL, V70, P303, DOI 10.1007/s00239-010-9337-z; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Mrkobrada S, 2006, J MOL BIOL, V362, P430, DOI 10.1016/j.jmb.2006.07.007; Newfeld SJ, 1999, GENETICS, V152, P783; Ponte I, 1998, MOL BIOL EVOL, V15, P702, DOI 10.1093/oxfordjournals.molbev.a025973; Poy F, 2001, NAT STRUCT BIOL, V8, P1053, DOI 10.1038/nsb720; Quijano JC, 2011, GENETICS, V189, P809, DOI 10.1534/genetics.111.133801; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Record CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011905; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sebe-Pedros A, 2012, CELL REP, V1, P13, DOI 10.1016/j.celrep.2011.11.004; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Stinchfield MJ, 2012, DEVELOPMENT, V139, P2721, DOI 10.1242/dev.077206; Takaesu NT, 2006, GENETICS, V174, P1299, DOI 10.1534/genetics.106.064956; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yogesha SD, 2011, PROTEIN SCI, V20, P2113, DOI 10.1002/pro.751; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	43	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51599	10.1371/journal.pone.0051599	http://dx.doi.org/10.1371/journal.pone.0051599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272121	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800055
J	Zakrzewski, P; Medema, MH; Gevorgyan, A; Kierzek, AM; Breitling, R; Takano, E				Zakrzewski, Piotr; Medema, Marnix H.; Gevorgyan, Albert; Kierzek, Andrzej M.; Breitling, Rainer; Takano, Eriko			MultiMetEval: Comparative and Multi-Objective Analysis of Genome-Scale Metabolic Models	PLOS ONE			English	Article							CONSTRAINT-BASED MODELS; STREPTOMYCES-COELICOLOR; IN-SILICO; CLAVULANIC ACID; QUANTITATIVE PREDICTION; HETEROLOGOUS EXPRESSION; CELLULAR-METABOLISM; NETWORK ANALYSIS; COBRA TOOLBOX; GENE-CLUSTER	Comparative metabolic modelling is emerging as a novel field, supported by the development of reliable and standardized approaches for constructing genome-scale metabolic models in high throughput. New software solutions are needed to allow efficient comparative analysis of multiple models in the context of multiple cellular objectives. Here, we present the user-friendly software framework Multi-Metabolic Evaluator (MultiMetEval), built upon SurreyFBA, which allows the user to compose collections of metabolic models that together can be subjected to flux balance analysis. Additionally, MultiMetEval implements functionalities for multi-objective analysis by calculating the Pareto front between two cellular objectives. Using a previously generated dataset of 38 actinobacterial genome-scale metabolic models, we show how these approaches can lead to exciting novel insights. Firstly, after incorporating several pathways for the biosynthesis of natural products into each of these models, comparative flux balance analysis predicted that species like Streptomyces that harbour the highest diversity of secondary metabolite biosynthetic gene clusters in their genomes do not necessarily have the metabolic network topology most suitable for compound overproduction. Secondly, multi-objective analysis of biomass production and natural product biosynthesis in these actinobacteria shows that the well-studied occurrence of discrete metabolic switches during the change of cellular objectives is inherent to their metabolic network architecture. Comparative and multi-objective modelling can lead to insights that could not be obtained by normal flux balance analyses. MultiMetEval provides a powerful platform that makes these analyses straightforward for biologists. Sources and binaries of MultiMetEval are freely available from https://github.com/PiotrZakrzewski/MetEval/downloads. Citation: Zakrzewski P, Medema MH, Gevorgyan A, Kierzek AM, Breitling R, et al. (2012) MultiMetEval: Comparative and Multi-Objective Analysis of Genome-Scale Metabolic Models. PLoS ONE 7(12): e51511. doi:10.1371/journal.pone.0051511	[Zakrzewski, Piotr; Medema, Marnix H.; Breitling, Rainer] Univ Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands; [Zakrzewski, Piotr; Medema, Marnix H.; Takano, Eriko] Univ Groningen, Dept Microbial Physiol, Groningen, Netherlands; [Gevorgyan, Albert; Kierzek, Andrzej M.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Breitling, Rainer] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland	University of Groningen; University of Groningen; University of Surrey; University of Glasgow	Breitling, R (corresponding author), Univ Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands.	rainer.breitling@glasgow.ac.uk; e.takano@rug.nl	Medema, Marnix H./AAR-3138-2021	Medema, Marnix H./0000-0002-2191-2821; Kierzek, Andrzej/0000-0002-2605-9057; Takano, Eriko/0000-0002-6791-3256; Breitling, Rainer/0000-0001-7173-0922	Dutch Technology Foundation (STW), which is the applied science division of the Netherlands Organisation for Scientific Research (NWO); Technology Programme of the Ministry of Economic Affairs [STW 10463]; NWO-Vidi fellowship; Rosalind Franklin Fellowship, University of Groningen	Dutch Technology Foundation (STW), which is the applied science division of the Netherlands Organisation for Scientific Research (NWO); Technology Programme of the Ministry of Economic Affairs; NWO-Vidi fellowship; Rosalind Franklin Fellowship, University of Groningen	This work was supported by the Dutch Technology Foundation (STW), which is the applied science division of the Netherlands Organisation for Scientific Research (NWO), and the Technology Programme of the Ministry of Economic Affairs [STW 10463]. RB is supported by an NWO-Vidi fellowship, and ET by a Rosalind Franklin Fellowship, University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrio JL, 2006, FEMS MICROBIOL REV, V30, P187, DOI 10.1111/j.1574-6976.2005.00009.x; Alam MT, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-202; Alam MT, 2011, FEBS LETT, V585, P2389, DOI 10.1016/j.febslet.2011.06.014; Alexander DC, 2010, APPL ENVIRON MICROB, V76, P6877, DOI 10.1128/AEM.01248-10; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Blank LM, 2005, FEMS YEAST RES, V5, P545, DOI 10.1016/j.femsyr.2004.09.008; Breitling R, 2008, NAT REV MICROBIOL, V6, P156, DOI 10.1038/nrmicro1797; Brooks J. Paul, 2012, Advances in Bioinformatics, V2012, P323472, DOI 10.1155/2012/323472; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Covert MW, 2001, TRENDS BIOCHEM SCI, V26, P179, DOI 10.1016/S0968-0004(00)01754-0; DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Freitag A, 2006, METAB ENG, V8, P653, DOI 10.1016/j.ymben.2006.07.003; Gevorgyan A, 2011, BIOINFORMATICS, V27, P433, DOI 10.1093/bioinformatics/btq679; Gonzalez-Lergier J, 2005, J AM CHEM SOC, V127, P9930, DOI 10.1021/ja051586y; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Ives PR, 1997, MICROBIOL-UK, V143, P3573, DOI 10.1099/00221287-143-11-3573; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; Latendresse M, 2012, BIOINFORMATICS, V28, P388, DOI 10.1093/bioinformatics/btr681; Lee FC, 2010, METAB ENG, V12, P251, DOI 10.1016/j.ymben.2009.12.003; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Marler RT, 2004, STRUCT MULTIDISCIP O, V26, P369, DOI 10.1007/s00158-003-0368-6; Medema MH, 2012, NAT REV MICROBIOL, V10, P191, DOI 10.1038/nrmicro2717; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Medema MH, 2011, MICROB BIOTECHNOL, V4, P300, DOI 10.1111/j.1751-7915.2010.00226.x; Medema MH, 2011, NAT REV MICROBIOL, V9, P131, DOI 10.1038/nrmicro2478; Mithani A, 2011, MOL BIOL EVOL, V28, P483, DOI 10.1093/molbev/msq213; Nagrath D, 2010, METAB ENG, V12, P429, DOI 10.1016/j.ymben.2010.05.003; Nieselt K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-10; Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Paradise EM, 2008, BIOTECHNOL BIOENG, V100, P371, DOI 10.1002/bit.21766; Pfeifer BA, 2001, MICROBIOL MOL BIOL R, V65, P106, DOI 10.1128/MMBR.65.1.106-118.2001; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; ROMERO J, 1986, APPL ENVIRON MICROB, V52, P892, DOI 10.1128/AEM.52.4.892-897.1986; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Scherr N, 2009, CURR OPIN MICROBIOL, V12, P699, DOI 10.1016/j.mib.2009.10.003; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Stevens DC, 2010, APPL ENVIRON MICROB, V76, P2681, DOI 10.1128/AEM.02841-09; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Vo TD, 2004, J BIOL CHEM, V279, P39532, DOI 10.1074/jbc.M403782200; Yanai K, 2006, P NATL ACAD SCI USA, V103, P9661, DOI 10.1073/pnas.0603251103; Zhao XQ, 2010, ARCH MICROBIOL, V192, P289, DOI 10.1007/s00203-010-0548-x	54	27	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51511	10.1371/journal.pone.0051511	http://dx.doi.org/10.1371/journal.pone.0051511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272111	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000312386800049
J	Malti, T; Gummerum, M; Keller, M; Chaparro, MP; Buchmann, M				Malti, Tina; Gummerum, Michaela; Keller, Monika; Chaparro, Maria Paula; Buchmann, Marlis			Early Sympathy and Social Acceptance Predict the Development of Sharing in Children	PLOS ONE			English	Article							BEHAVIOR; COOPERATION; ALTRUISM; COMPETENCE; CHILDHOOD	Sharing is a fascinating activity of the human species and an important basis for the development of fairness, care, and cooperation in human social interaction. Economic research has proposed that sharing, or the willingness to sacrifice own resources for others, has its roots in social emotions such as sympathy. However, only few cross-sectional experiments have investigated children's other-regarding preferences, and the question how social-emotional skills influence the willingness to share valuable resources has not been tested. In the present longitudinal-experimental study, a sample of 175 6-year-old children, their primary caregivers, and their teachers is examined over a 3-year period of time. Data are analyzed by means of growth curve modeling. The findings show that sharing valuable resources strongly increases in children from 6 to 9 years of age. Increases in sharing behavior are associated with the early-developing ability to sympathize with anonymous others. Sharing at 7 years of age is predicted by feelings of social acceptance at 6 years of age. These findings hold after controlling for children's IQ and SES. Girls share more equally than boys at 6 and 7 years of age, however, this gender difference disappears at the age of 9 years. These results indicate that human sharing strongly increases in middle childhood and, that this increase is associated with sympathy towards anonymous others and with feelings of social acceptance. Additionally, sharing develops earlier in girls than in boys. This developmental perspective contributes to new evidence on change in sharing and its social-emotional roots. A better understanding of the factors underlying differences in the development of sharing and pro-social orientations should also provide insights into the development of atypical, anti-social orientations which exhibit social-emotional differences such as aggression and bullying behavior. Citation: Malti T, Gummerum M, Keller M, Chaparro MP, Buchmann M (2012) Early Sympathy and Social Acceptance Predict the Development of Sharing in Children. PLoS ONE 7(12): e52017. doi:10.1371/journal.pone.0052017	[Malti, Tina; Chaparro, Maria Paula] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada; [Gummerum, Michaela] Univ Plymouth, Dept Psychol, Plymouth PL4 8AA, Devon, England; [Keller, Monika] Max Planck Inst Human Dev, Berlin, Germany; [Malti, Tina; Buchmann, Marlis] Univ Zurich, Jacobs Ctr Prod Youth Dev, Zurich, Switzerland	University of Toronto; University Toronto Mississauga; University of Plymouth; Max Planck Society; University of Zurich	Malti, T (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	tina.malti@utoronto.ca			Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was funded by the Swiss National Science Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almas I, 2010, SCIENCE, V328, P1176, DOI 10.1126/science.1187300; Arsenio WF, 2006, HANDBOOK OF MORAL DEVELOPMENT, P581; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Brosnan SF, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00043; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Eisenberg N, 1996, CHILD DEV, V67, P2227, DOI 10.1111/j.1467-8624.1996.tb01854.x; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Eisenberg N, 2006, HANDBOOK OF MORAL DEVELOPMENT, P517; Eisenberg N, 1999, CHILD DEV, V70, P1360, DOI 10.1111/1467-8624.00100; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Eisenberg N., 1987, EMPATHY ITS DEV, P292; Eisenberg N., 1986, ALTRUISTIC COGNITION; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Flavell JH, 2004, MERRILL PALMER QUART, V50, P274, DOI 10.1353/mpq.2004.0018; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gummerum M., 2009, EVOL PSYCHOL-US, V7, DOI [10.1177/147470490900700212, DOI 10.1177/147470490900700212]; Gummerum M, 2008, HUM DEV, V51, P235, DOI 10.1159/000151494; Gummerum M, 2008, CHILD DEV, V79, P562, DOI 10.1111/j.1467-8624.2008.01143.x; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Harbaugh WT, 2000, ECON INQ, V38, P95, DOI 10.1093/ei/38.1.95; Hart CH, 2000, INT J BEHAV DEV, V24, P73, DOI 10.1080/016502500383494; HARTER S, 1984, CHILD DEV, V55, P1969, DOI 10.2307/1129772; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Houser D, 2009, J ECON PSYCHOL, V30, P634, DOI 10.1016/j.joep.2009.05.002; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Knafo A, 2006, DEV PSYCHOL, V42, P771, DOI 10.1037/0012-1649.42.5.771; Knafo A, 2008, EMOTION, V8, P737, DOI 10.1037/a0014179; Leman PJ, 2009, SOC DEV, V18, P711, DOI 10.1111/j.1467-9507.2008.00486.x; [朱莉琪 ZHU LiQi], 2008, [心理学报, Acta Psychologica Sinica], V40, P402; Malti T, 2012, CHILD DEV; Malti T, 2012, J ABNORM CH IN PRESS; Malti T, 2009, CHILD DEV, V80, P442, DOI 10.1111/j.1467-8624.2009.01271.x; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Muthen L.K., 2010, MPLUS USERS GUIDE; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Ongley S., HDB MORAL DEV; Ongley SF, 2012, ROLE MORAL EMO UNPUB; Perren S, 2006, J CHILD PSYCHOL PSYC, V47, P45, DOI 10.1111/j.1469-7610.2005.01445.x; PIACENTINI JC, 1992, J ABNORM CHILD PSYCH, V20, P51, DOI 10.1007/BF00927116; Rubin KH, 2006, HDB CHILD PSYCHOL SO, P571, DOI 10.1002/9780470147658.chpsy0310; RUSHTON JP, 1983, PSYCHOL BULL, V94, P18, DOI 10.1037/0033-2909.94.1.18; Ryan R. M., 2002, HDB SELF DETERMINATI; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Sutter M, 2007, GAME ECON BEHAV, V59, P364, DOI 10.1016/j.geb.2006.07.006; Sutter M, 2007, J ECON PSYCHOL, V28, P69, DOI 10.1016/j.joep.2006.09.001; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Warneken F, 2011, PSYCHOL SCI, V22, P267, DOI 10.1177/0956797610395392; Watson M., 2003, LEARNING TRUST TRANS; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	53	41	44	5	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52017	10.1371/journal.pone.0052017	http://dx.doi.org/10.1371/journal.pone.0052017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AH	23272197	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000312386600052
J	Pascoal, S; Carvalho, G; Creer, S; Mendo, S; Hughes, R				Pascoal, Sonia; Carvalho, Gary; Creer, Simon; Mendo, Sonia; Hughes, Roger			Plastic and Heritable Variation in Shell Thickness of the Intertidal Gastropod Nucella lapillus Associated with Risks of Crab Predation and Wave Action, and Sexual Maturation	PLOS ONE			English	Article							MARINE SNAIL; EVOLUTION; DOGWHELK; GROWTH; PREY; RESPONSES; DEFENSES; ECOTYPES; SHAPE; CUES	The intertidal snail Nucella lapillus generally has thicker shells at sites sheltered from wave action, where crabs are abundant and pose a high risk of predation, than at exposed sites where crabs are rare. We studied two populations showing the opposite trend. We reciprocally transplanted snails between field sites and measured shell length, width and lip thickness of those recaptured 12 months later. Snails transplanted to the sheltered site grew larger than sheltered-site residents, which in turn grew larger than transplants to the exposed site. Relative shell-lip thickness was greater in residents at the exposed site than at the sheltered site. Transplants from shelter to exposure developed relatively thicker shells than their controls and relatively thinner shells from exposure to shelter. Progeny of the two populations were reared for 12 months in a common garden experiment presenting effluent from crabs feeding on broken conspecifics as the treatment and fresh seawater as the control. The crab-effluent treatment decreased foraging activity, concomitantly reducing cumulative somatic growth and reproductive output. Juveniles receiving crab-effluent grew slower in shell length while developing relatively thicker shell lips than controls, the level of response being similar between lineages. F-2 progeny of the exposed-site lineage showed similar trends to the F(1)s; sheltered-site F(2)s were too few for statistical analysis. At sexual maturity, shell-lip thickness was greater in snails receiving crab-effluent than in controls, indicating plasticity, but was also greater in the exposed-site than in the sheltered- site lineage, indicating heritable variation, probably in degree of sexual thickening of the shell lip. Results corroborate hypotheses that 'defensive' shell thickening is a passive consequence of starvation and that heritable and plastic control of defensive shell morphology act synergistically. Shell thickening of juveniles was similar between lineages, contrary to hypotheses predicting differential strengths of plasticity in populations from low- or high-risk habitats. Citation: Pascoal S, Carvalho G, Creer S, Mendo S, Hughes R (2012) Plastic and Heritable Variation in Shell Thickness of the Intertidal Gastropod Nucella lapillus Associated with Risks of Crab Predation and Wave Action, and Sexual Maturation. PLoS ONE 7(12): e52134. doi:10.1371/journal.pone.0052134	[Pascoal, Sonia; Carvalho, Gary; Creer, Simon; Hughes, Roger] Bangor Univ, Sch Biol Sci, Environm Ctr Wales, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales; [Pascoal, Sonia; Mendo, Sonia] Univ Aveiro, CESAM Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal; [Pascoal, Sonia; Mendo, Sonia] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal	Bangor University; Universidade de Aveiro; Universidade de Aveiro	Hughes, R (corresponding author), Bangor Univ, Sch Biol Sci, Environm Ctr Wales, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales.	r.n.hughes@bangor.ac.uk	Mendo, Sonia/E-1095-2011	Mendo, Sonia/0000-0001-5057-5660	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/27711/2006]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) through Ph.D. grant SFRH/BD/27711/2006 awarded to Sonia Pascoal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2006, MAR ENVIRON RES, V62, pS317, DOI 10.1016/j.marenvres.2006.04.011; APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; Bourdeau PE, 2012, J ANIM ECOL, V81, P849, DOI 10.1111/j.1365-2656.2012.01965.x; Bourdeau PE, 2010, P ROY SOC B-BIOL SCI, V277, P455, DOI 10.1098/rspb.2009.1295; Brookes JI, 2007, J EVOLUTION BIOL, V20, P1015, DOI 10.1111/j.1420-9101.2007.01299.x; BURROWS MT, 1989, J MOLLUS STUD, V55, P285, DOI 10.1093/mollus/55.2.285; Carvajal-Rodriguez A, 2005, ONLINE J BIOINFORMAT, V6, P34; CROTHERS J H, 1985, Field Studies, V6, P291; CURREY JD, 1982, J ANIM ECOL, V51, P47, DOI 10.2307/4309; Edgell TC, 2008, EVOLUTION, V62, P1216, DOI 10.1111/j.1558-5646.2008.00350.x; ETTER RJ, 1988, EVOLUTION, V42, P322, DOI 10.1111/j.1558-5646.1988.tb04136.x; Hollander J, 2006, EVOLUTION, V60, P2490; Hollander J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-333; Hughes R.N., 1986, FUNCTIONAL BIOL MARI; HUGHES RN, 1979, J ANIM ECOL, V48, P65, DOI 10.2307/4100; Hughes RN, 2001, ANIM BEHAV, V61, P711, DOI 10.1006/anbe.2000.1640; Johannesson K, 1997, BIOL J LINN SOC, V61, P267; KITCHING JA, 1966, J ANIM ECOL, V35, P113, DOI 10.2307/2693; Moody RM, 2012, J EXP MAR BIOL ECOL, V413, P78, DOI 10.1016/j.jembe.2011.11.029; PALMER AR, 1990, HYDROBIOLOGIA, V193, P155, DOI 10.1007/BF00028074; Pascoal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030289; Rohlf FJ, 2003, SYST BIOL, V52, P66, DOI 10.1080/10635150390132759; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; SEELEY RH, 1986, P NATL ACAD SCI USA, V83, P6897, DOI 10.1073/pnas.83.18.6897; Sepulveda RD, 2012, J MOLLUS STUD, V78, P173, DOI 10.1093/mollus/eyr058; Trussell GC, 2002, ECOLOGY, V83, P1635, DOI 10.2307/3071984; Trussell GC, 2003, ECOLOGY, V84, P629, DOI 10.1890/0012-9658(2003)084[0629:TMEIRI]2.0.CO;2; Trussell GC, 2001, GENETICA, V112, P321, DOI 10.1023/A:1013364527698; Trussell GC, 2011, ECOLOGY, V92, P1799, DOI 10.1890/10-2222.1; VADAS RL, 1994, OECOLOGIA, V100, P439, DOI 10.1007/BF00317866; VERMEIJ GJ, 1982, NATURE, V299, P349, DOI 10.1038/299349a0	31	15	15	3	208	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52134	10.1371/journal.pone.0052134	http://dx.doi.org/10.1371/journal.pone.0052134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272221	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386600056
J	Pivato, M; De Franceschi, G; Tosatto, L; Frare, E; Kumar, D; Aioanei, D; Brucale, M; Tessari, I; Bisaglia, M; Samori, B; de Laureto, PP; Bubacco, L				Pivato, Micaela; De Franceschi, Giorgia; Tosatto, Laura; Frare, Erica; Kumar, Dhruv; Aioanei, Daniel; Brucale, Marco; Tessari, Isabella; Bisaglia, Marco; Samori, Bruno; de laureto, Patrizia Polverino; Bubacco, Luigi			Covalent alpha-Synuclein Dimers: Chemico-Physical and Aggregation Properties	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; AMYLOID FIBRIL FORMATION; PARKINSONS-DISEASE; CORE STRUCTURE; ALZHEIMERS-DISEASE; SOLID-STATE; CONFORMATION; SPECTROSCOPY; ABSORPTION; SEQUENCE	The aggregation of alpha-synuclein into amyloid fibrils constitutes a key step in the onset of Parkinson's disease. Amyloid fibrils of alpha-synuclein are the major component of Lewy bodies, histological hallmarks of the disease. Little is known about the mechanism of aggregation of alpha-synuclein. During this process, alpha-synuclein forms transient intermediates that are considered to be toxic species. The dimerization of alpha-synuclein could represent a rate-limiting step in the aggregation of the protein. Here, we analyzed four covalent dimers of alpha-synuclein, obtained by covalent link of the N-terms, C-terms, tandem cloning of two sequences and tandem juxtaposition in one protein of the 1-104 and 29-140 sequences. Their biophysical properties in solution were determined by CD, FT-IR and NMR spectroscopies. SDS-induced folding was also studied. The fibrils formation was analyzed by ThT and polarization fluorescence assays. Their morphology was investigated by TEM and AFM-based quantitative morphometric analysis. All dimers were found to be devoid of ordered secondary structure under physiological conditions and undergo alpha-helical transition upon interaction with SDS. All protein species are able to form amyloid-like fibrils. The reciprocal orientation of the alpha-synuclein monomers in the dimeric constructs affects the kinetics of the aggregation process and a scale of relative amyloidogenic propensity was determined. Structural investigations by FT IR spectroscopy, and proteolytic mapping of the fibril core did not evidence remarkable difference among the species, whereas morphological analyses showed that fibrils formed by dimers display a lower and diversified level of organization in comparison with alpha-synuclein fibrils. This study demonstrates that although alpha-synuclein dimerization does not imply the acquisition of a preferred conformation by the participating monomers, it can strongly affect the aggregation properties of the molecules. The results presented highlight a substantial role of the relative orientation of the individual monomer in the definition of the fibril higher structural levels. Citation: Pivato M, De Franceschi G, Tosatto L, Frare E, Kumar D, et al. (2012) Covalent alpha-Synuclein Dimers: Chemico-Physical and Aggregation Properties. PLoS ONE 7(12): e50027. doi:10.1371/journal.pone.0050027	[Pivato, Micaela; De Franceschi, Giorgia; Frare, Erica; de laureto, Patrizia Polverino] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Tosatto, Laura; Tessari, Isabella; Bisaglia, Marco; Bubacco, Luigi] Univ Padua, Dept Biol, Padua, Italy; [Kumar, Dhruv; Aioanei, Daniel; Samori, Bruno] Univ Bologna, Dept Biochem, I-40126 Bologna, Italy; [Brucale, Marco] CNR, Inst Nanostruct Mat ISMN, Rome, Italy	University of Padua; University of Padua; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR)	de Laureto, PP (corresponding author), Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy.	patrizia.polverinodelaureto@unipd.it; luigi.bubacco@unipd.it	Kumar, Dhruv/AAF-7440-2019; Tessari, Isabella/K-7847-2016; kumar, Dhruv/C-1090-2011; Tosatto, Laura/K-1746-2014; Bubacco, Luigi/B-5602-2012; Brucale, Marco/G-2455-2018	Kumar, Dhruv/0000-0003-2586-9397; Tessari, Isabella/0000-0002-5823-645X; kumar, Dhruv/0000-0003-2586-9397; Tosatto, Laura/0000-0002-5966-8131; Bubacco, Luigi/0000-0001-7927-9208; BRUCALE, MARCO/0000-0001-7244-4389	Progetti di Ricerca di Interesse Nazionale (PRIN) [2008SYP7]	Progetti di Ricerca di Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	IT, MB and LB were supported by Progetti di Ricerca di Interesse Nazionale (PRIN) 2008 (Prot. 2008SYP79). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adochitei A, 2011, REV ROUM CHIM, V56, P783; Aioanei D, 2012, LAZY SHORTEST PATH C; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cookson MR, 2009, MOL NEURODEGENER, V4, P114; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; de Laureto PP, 2003, J MOL BIOL, V334, P129, DOI 10.1016/j.jmb.2003.09.024; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x; FABIAN H, 1993, APPL SPECTROSC, V47, P1513, DOI 10.1366/0003702934067469; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferreon ACM, 2007, BIOCHEMISTRY-US, V46, P4499, DOI 10.1021/bi602461y; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Frare E, 2006, J MOL BIOL, V361, P551, DOI 10.1016/j.jmb.2006.06.055; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Karyagina I, 2011, BIOPHYS J, V101, pL1, DOI 10.1016/j.bpj.2011.05.052; Kloepper KD, 2007, J PHYS CHEM B, V111, P13353, DOI 10.1021/jp077036z; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Luk KC, 2007, BIOCHEMISTRY-US, V46, P12522, DOI 10.1021/bi701128c; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Oberg KA, 2004, EUR J BIOCHEM, V271, P2937, DOI 10.1111/j.1432-1033.2004.04220.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Takahashi T, 2002, BRAIN RES, V938, P73, DOI 10.1016/S0006-8993(02)02498-8; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; van Raaij ME, 2008, BIOPHYS J, V95, P4871, DOI 10.1529/biophysj.107.127464; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wang W, 2011, P NATL ACAD SCI USA, V109, P2336; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wellner N, 1996, BIOCHEM J, V319, P741, DOI 10.1042/bj3190741; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang F, 2008, BIOCHEM BIOPH RES CO, V368, P388, DOI 10.1016/j.bbrc.2008.01.091; Zhou WB, 2004, J BIOL CHEM, V279, P10128, DOI 10.1074/jbc.M307563200; Zhou W, 2008, J BIOL CHEM, V283, P9863, DOI 10.1074/jbc.M710232200	58	29	29	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50027	10.1371/journal.pone.0050027	http://dx.doi.org/10.1371/journal.pone.0050027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272053	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600006
J	Kekesi, KA; Juhasz, G; Simor, A; Gulyassy, P; Szego, EM; Hunyadi-Gulyas, E; Darula, Z; Medzihradszky, KF; Palkovits, M; Penke, B; Czurko, A				Kekesi, Katalin Adrienna; Juhasz, Gabor; Simor, Attila; Gulyassy, Peter; Szego, Eva Monika; Hunyadi-Gulyas, Eva; Darula, Zsuzsanna; Medzihradszky, Katalin F.; Palkovits, Miklos; Penke, Botond; Czurko, Andras			Altered Functional Protein Networks in the Prefrontal Cortex and Amygdala of Victims of Suicide	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; ANTERIOR CINGULATE CORTEX; CALCIUM-BINDING PROTEINS; GENE-EXPRESSION ANALYSIS; OF-THE-LITERATURE; BIPOLAR DISORDER; GEL-ELECTROPHORESIS; PROTEOMIC ANALYSIS; FRONTAL-CORTEX; HUMAN BRAIN	Probing molecular brain mechanisms related to increased suicide risk is an important issue in biological psychiatry research. Gene expression studies on post mortem brains indicate extensive changes prior to a successful suicide attempt; however, proteomic studies are scarce. Thus, we performed a DIGE proteomic analysis of post mortem tissue samples from the prefrontal cortex and amygdala of suicide victims to identify protein changes and biomarker candidates of suicide. Among our matched spots we found 46 and 16 significant differences in the prefrontal cortex and amygdala, respectively; by using the industry standard t test and 1.3 fold change as cut off for significance. Because of the risk of false discoveries (FDR) in these data, we also made FDR adjustment by calculating the q-values for all the t tests performed and by using 0.06 and 0.4 as alpha thresholds we reduced the number of significant spots to 27 and 9 respectively. From these we identified 59 proteins in the cortex and 11 proteins in the amygdala. These proteins are related to biological functions and structures such as metabolism, the redox system, the cytoskeleton, synaptic function, and proteolysis. Thirteen of these proteins (CBR1, DPYSL2, EFHD2, FKBP4, GFAP, GLUL, HSPA8, NEFL, NEFM, PGAM1, PRDX6, SELENBP1 and VIM,) have already been suggested to be biomarkers of psychiatric disorders at protein or genome level. We also pointed out 9 proteins that changed in both the amygdala and the cortex, and from these, GFAP, INA, NEFL, NEFM and TUBA1 are interacting cytoskeletal proteins that have a functional connection to glutamate, GABA, and serotonin receptors. Moreover, ACTB, CTSD and GFAP displayed opposite changes in the two examined brain structures that might be a suitable characteristic for brain imaging studies. The opposite changes of ACTB, CTSD and GFAP in the two brain structures were validated by western blot analysis. Citation: Kekesi KA, Juhasz G, Simor A, Gulyassy P, Szego EM, et al. (2012) Altered Functional Protein Networks in the Prefrontal Cortex and Amygdala of Victims of Suicide. PLoS ONE 7(12): e50532. doi:10.1371/journal.pone.0050532	[Kekesi, Katalin Adrienna; Juhasz, Gabor; Simor, Attila; Gulyassy, Peter; Szego, Eva Monika; Czurko, Andras] Eotvos Lorand Univ, Inst Biol, Lab Prote, Budapest, Hungary; [Kekesi, Katalin Adrienna] Eotvos Lorand Univ, Dept Physiol & Neurobiol, Budapest, Hungary; [Hunyadi-Gulyas, Eva; Darula, Zsuzsanna; Medzihradszky, Katalin F.] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Prote Res Grp, H-6701 Szeged, Hungary; [Medzihradszky, Katalin F.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Palkovits, Miklos] Semmelweis Univ, Hungarian Acad Sci, Neuromorphol Res Grp, H-1085 Budapest, Hungary; [Penke, Botond; Czurko, Andras] Univ Szeged, Dept Med Chem, Szeged, Hungary	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of California System; University of California San Francisco; Hungarian Academy of Sciences; Semmelweis University; Szeged University	Kekesi, KA (corresponding author), Eotvos Lorand Univ, Inst Biol, Lab Prote, Budapest, Hungary.	kakekesi@dec001.geobio.elte.hu	Simor, Attila/R-8071-2018; Palkovits, Miklos/F-2707-2013; Kékesi, Katalin Adrienna A/H-3484-2017; Czurkó, András/H-5500-2019; Juhász, Gábor/I-7781-2017	Palkovits, Miklos/0000-0003-0578-0387; Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Juhász, Gábor/0000-0002-0849-6931; Szego, Eva Monika/0000-0002-2629-2131; Hunyadi-Gulyas, Eva/0000-0003-2089-1499; Czurko, Andras/0000-0002-1985-7296	FP-7 Health EC [201 159]; Social Renewal Operational Programme [TAMOP-4.2.2/08/1, TAMOP 4.2.1./B-09/1/KMR-2010-0003]; Economic Competitiveness Operational Programme [GVOP-3.2.1.-2004-04-0309]; NKTH EGISPSYCH grant	FP-7 Health EC; Social Renewal Operational Programme; Economic Competitiveness Operational Programme; NKTH EGISPSYCH grant	This work was supported by the FP-7 Health EC project 201 159 (Memoload), the Social Renewal Operational Programme (TAMOP-4.2.2/08/1) to G. Juhasz, K.F. Medzihradszky and B. Penke; the Economic Competitiveness Operational Programme (GVOP-3.2.1.-2004-04-0309) to G. Juhasz, the Social Renewal Operational Programme (TAMOP 4.2.1./B-09/1/KMR-2010-0003) to G. Juhasz, A. Czurko and K. A. Kekesi and NKTH EGISPSYCH grant to B. Penke, G. Juhasz and A. Czurko. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarian S, 2008, BIOL PSYCHIAT, V64, P643, DOI 10.1016/j.biopsych.2008.06.013; Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Altshuler LL, 2010, BIPOLAR DISORD, V12, P541, DOI 10.1111/j.1399-5618.2010.00838.x; Arai R, 2007, PROTEINS, V67, P732, DOI 10.1002/prot.21299; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Arnold SE, 2001, ARCH GEN PSYCHIAT, V58, P829, DOI 10.1001/archpsyc.58.9.829; Banay-Schwartz M, 1998, NEUROCHEM RES, V23, P953, DOI 10.1023/A:1021028304481; Beasley CL, 2002, BIOL PSYCHIAT, V52, P708, DOI 10.1016/S0006-3223(02)01360-4; Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; Behan AT, 2009, MOL PSYCHIATR, V14, P601, DOI 10.1038/mp.2008.7; Ben-Efraim YJ, 2012, MOL PSYCHIA IN PRESS; Ben-Shachar D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000817; Bernard R, 2011, MOL PSYCHIATR, V16, P634, DOI 10.1038/mp.2010.44; BERNSTEIN HG, 1992, ACTA HISTOCHEM, P19; Berth M, 2007, APPL MICROBIOL BIOT, V76, P1223, DOI 10.1007/s00253-007-1128-0; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Brown LA, 2010, DEPRESS ANXIETY, V27, P310, DOI 10.1002/da.20609; Buckland PR, 2004, BBA-MOL BASIS DIS, V1690, P238, DOI 10.1016/j.bbadis.2004.06.023; Burbaeva GS, 2003, WORLD J BIOL PSYCHIA, V4, P177, DOI 10.1080/15622970310029916; Byne W, 2008, SCHIZOPHR RES, V98, P118, DOI 10.1016/j.schres.2007.09.034; Carter CJ, 2007, SCHIZOPHRENIA BULL, V33, P1343, DOI 10.1093/schbul/sbm007; Casini A, 2003, BIOORG MED CHEM LETT, V13, P2765, DOI 10.1016/S0960-894X(03)00507-9; Clark D, 2007, PROTEOM CLIN APPL, V1, P157, DOI 10.1002/prca.200600541; Coryell W, 2007, PSYCHIAT RES, V150, P187, DOI 10.1016/j.psychres.2006.01.021; Crecelius A, 2008, PROTEOMICS, V8, P1276, DOI 10.1002/pmic.200700728; Crow TJ, 2007, AM J PSYCHIAT, V164, P13, DOI 10.1176/appi.ajp.164.1.13; Dong E, 2007, P NATL ACAD SCI USA, V104, P4676, DOI 10.1073/pnas.0700529104; Du LS, 2001, J AFFECT DISORDERS, V65, P37, DOI 10.1016/S0165-0327(00)00274-3; Dwivedi Y, 2009, INT J NEUROPSYCHOPH, V12, P1337, DOI 10.1017/S1461145709990575; Ehlers MD, 1998, J NEUROSCI, V18, P720; English JA, 2009, PROTEOMICS, V9, P3368, DOI 10.1002/pmic.200900015; Ernst C, 2009, PROG NEUROBIOL, V89, P315, DOI 10.1016/j.pneurobio.2009.09.001; Falcone T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011089; Gall D, 2005, PROG BRAIN RES, V148, P321, DOI 10.1016/S0079-6123(04)48025-X; Garbett Krassimira, 2008, Neuropsychopharmacol Hung, V10, P9; Gardner A, 2008, CNS SPECTRUMS, V13, P805, DOI 10.1017/S1092852900013936; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Gollan JK, 2005, DEV PSYCHOPATHOL, V17, P1151, DOI 10.1017/S0954579405050546; Gonda X, 2011, J PSYCHOPHARMACOL, V25, P857, DOI 10.1177/0269881110376693; Grover D, 2009, AM J MED GENET B, V150B, P977, DOI 10.1002/ajmg.b.30927; Gudmundsson P, 2010, PSYCHIAT RES, V176, P174, DOI 10.1016/j.psychres.2008.11.012; Gvion Y, 2011, ARCH SUICIDE RES, V15, P93, DOI 10.1080/13811118.2011.565265; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Heinz A, 2007, BIOL PSYCHIAT, V61, P1011, DOI 10.1016/j.biopsych.2006.08.019; Hercher C, 2009, J PSYCHIATR RES, V43, P947, DOI 10.1016/j.jpsychires.2009.01.006; Huang JTJ, 2008, MOL PSYCHIATR, V13, P1118, DOI 10.1038/sj.mp.4002108; Hunter AM, 2010, ACTA PSYCHIAT SCAND, V122, P461, DOI 10.1111/j.1600-0447.2010.01560.x; Ikeda M, 2008, HUM MOL GENET, V17, P3212, DOI 10.1093/hmg/ddn217; Ji BH, 2009, J PROTEOME RES, V8, P3633, DOI 10.1021/pr800876z; Jia YB, 2004, EUR PSYCHIAT, V19, P377, DOI 10.1016/j.eurpsy.2004.07.006; Jimenez-Trevino L, 2011, ACTAS ESP PSIQUIATRI, V39, P61; Johnston-Wilson NL, 2000, MOL PSYCHIATR, V5, P142, DOI 10.1038/sj.mp.4000696; Kanazawa T, 2008, AM J MED GENET B, V147B, P686, DOI 10.1002/ajmg.b.30664; Kanazawa T, 2009, SCHIZOPHR RES, V113, P268, DOI 10.1016/j.schres.2009.06.011; KANEKO M, 1993, NEUROSCI LETT, V157, P195, DOI 10.1016/0304-3940(93)90735-4; Karolewicz B, 2009, INT J NEUROPSYCHOPH, V12, P143, DOI 10.1017/S1461145708008985; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Karp NA, 2007, MOL CELL PROTEOMICS, V6, P1354, DOI 10.1074/mcp.M600274-MCP200; Kasper S, 2010, WORLD J BIOL PSYCHIA, V11, P36, DOI 10.3109/15622970701691503; Kekesi KA, 2006, CELL MOL NEUROBIOL, V26, P833, DOI 10.1007/s10571-006-9103-3; Kim S, 2010, MOL PSYCHIATR, V15, P326, DOI 10.1038/mp.2008.99; Klempan TA, 2009, MOL PSYCHIATR, V14, P175, DOI 10.1038/sj.mp.4002110; Knittel D, 2008, AM J FOREN MED PATH, V29, P238, DOI 10.1097/PAF.0b013e3181834540; Kodydkova J, 2009, CLIN BIOCHEM, V42, P1368, DOI 10.1016/j.clinbiochem.2009.06.006; Koene S, 2009, J AFFECT DISORDERS, V114, P327, DOI 10.1016/j.jad.2008.06.023; Kroes RA, 2006, NEUROSCIENCE, V137, P37, DOI 10.1016/j.neuroscience.2005.08.076; KUGLER P, 1993, INT REV CYTOL, V147, P285, DOI 10.1016/S0074-7696(08)60771-8; Lewis DA, 2002, NEUROPSYCHOPHARMACOL, V26, P143, DOI 10.1016/S0893-133X(01)00393-1; Liu Q, 2009, EUR NEUROPSYCHOPHARM, V19, P796, DOI 10.1016/j.euroneuro.2009.06.010; Lopez JL, 2007, J CHROMATOGR B, V849, P190, DOI 10.1016/j.jchromb.2006.11.049; Magno LAV, 2010, GENES BRAIN BEHAV, V9, P411, DOI 10.1111/j.1601-183X.2010.00571.x; Malkesman O, 2009, TRENDS PHARMACOL SCI, V30, P165, DOI 10.1016/j.tips.2009.01.004; Mann JJ, 2009, BIOL PSYCHIAT, V65, P556, DOI 10.1016/j.biopsych.2008.11.021; Mann JJ, 2001, NEUROPSYCHOPHARMACOL, V24, P467, DOI 10.1016/S0893-133X(00)00228-1; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Martins-de-Souza D, 2010, J PSYCHIATR RES, V44, P1176, DOI 10.1016/j.jpsychires.2010.04.014; Martins-De-Souza D, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-17; Matsuzawa D, 2009, AM J MED GENET B, V150B, P86, DOI 10.1002/ajmg.b.30776; Matthews PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038211; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGuffin P, 2010, EUR PSYCHIAT, V25, P275, DOI 10.1016/j.eurpsy.2009.12.012; McHugh PC, 2010, J PSYCHOPHARMACOL, V24, P1243, DOI 10.1177/0269881109102786; McHugh PC, 2008, J NEUROSCI RES, V86, P306, DOI 10.1002/jnr.21482; Meerwijk EL, 2010, PERSPECT PSYCHIATR C, V46, P65, DOI 10.1111/j.1744-6163.2009.00239.x; Miguel-Hidalgo JJ, 2010, J AFFECT DISORDERS, V127, P230, DOI 10.1016/j.jad.2010.06.003; Monoranu CM, 2009, NEUROPATH APPL NEURO, V35, P329, DOI 10.1111/j.1365-2990.2008.01003a.x; Musazzi L, 2010, J PSYCHIATR RES, V44, P511, DOI 10.1016/j.jpsychires.2009.11.008; Musselman DL, 1996, AM J PSYCHIAT, V153, P1313; Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118; Neves FS, 2010, J AFFECT DISORDERS, V125, P98, DOI 10.1016/j.jad.2009.12.026; Newton SS, 2004, MOL BRAIN RES, V129, P185, DOI 10.1016/j.molbrainres.2004.06.032; Nordentoft M, 2007, DAN MED BULL, V54, P306; Novikova SI, 2006, NEUROBIOL DIS, V23, P61, DOI 10.1016/j.nbd.2006.02.002; Oquendo MA, 2003, ARCH GEN PSYCHIAT, V60, P14, DOI 10.1001/archpsyc.60.1.14; Panula P, 2010, NEUROBIOL DIS, V40, P46, DOI 10.1016/j.nbd.2010.05.010; Paulson L, 2007, J NEURAL TRANSM, V114, P885, DOI 10.1007/s00702-007-0626-7; Paulson L, 2004, PROTEOMICS, V4, P819, DOI 10.1002/pmic.200300622; Pennington K, 2008, MOL PSYCHIATR, V13, P1102, DOI 10.1038/sj.mp.4002098; Pennington K, 2008, PROTEOMICS, V8, P5097, DOI 10.1002/pmic.200800415; Poulter MO, 2008, BIOL PSYCHIAT, V64, P645, DOI 10.1016/j.biopsych.2008.05.028; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Rapoport SI, 2009, BRAIN RES REV, V61, P185, DOI 10.1016/j.brainresrev.2009.06.003; Robinson AA, 2009, PROTEOMICS, V9, P4433, DOI 10.1002/pmic.200900287; ROY A, 1989, ARCH GEN PSYCHIAT, V46, P609; SALLANONMOULIN M, 1994, MOL BRAIN RES, V22, P113, DOI 10.1016/0169-328X(94)90038-8; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Scaini G, 2010, BRAIN RES BULL, V82, P224, DOI 10.1016/j.brainresbull.2010.03.006; Schlicht K, 2007, J PSYCHIATR RES, V41, P493, DOI 10.1016/j.jpsychires.2006.04.006; Schmitt A, 2007, J NEURAL TRANSM, V114, P527, DOI 10.1007/s00702-006-0601-8; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Sillaber I, 2008, PSYCHOPHARMACOLOGY, V200, P557, DOI 10.1007/s00213-008-1232-6; Sivagnanasundaram S, 2007, PROTEOM CLIN APPL, V1, P1291, DOI 10.1002/prca.200700230; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Smalla KH, 2008, MOL PSYCHIATR, V13, P878, DOI 10.1038/mp.2008.60; Steffek AE, 2008, SCHIZOPHR RES, V103, P71, DOI 10.1016/j.schres.2008.04.032; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki G, 2009, HUM MOL GENET, V18, P1652, DOI 10.1093/hmg/ddp086; Szego EM, 2010, PSYCHONEUROENDOCRINO, V35, P807, DOI 10.1016/j.psyneuen.2009.11.006; Szego EM, 2010, EUR NEUROPSYCHOPHARM, V20, P96, DOI 10.1016/j.euroneuro.2009.11.003; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Takahashi S, 2008, SCHIZOPHR RES, V104, P153, DOI 10.1016/j.schres.2008.05.028; Tatro ET, 2009, BRAIN RES, V1286, P1, DOI 10.1016/j.brainres.2009.06.036; Tatro ET, 2009, J NEUROIMMUNE PHARM, V4, P218, DOI 10.1007/s11481-009-9146-6; Taurines R, 2011, J PSYCHOPHARMACOL, V25, P151, DOI 10.1177/0269881109106931; Taylor K, 2000, SCHIZOPHR RES, V44, P245, DOI 10.1016/S0920-9964(99)00194-2; Taylor PJ, 2011, PSYCHOL BULL, V137, P391, DOI 10.1037/a0022935; Tonge R, 2001, PROTEOMICS, V1, P377; Toyooka K, 1999, AM J MED GENET, V88, P164, DOI 10.1002/(SICI)1096-8628(19990416)88:2<164::AID-AJMG13>3.0.CO;2-3; Vaccarino V, 2008, BIOL PSYCHIAT, V64, P476, DOI 10.1016/j.biopsych.2008.04.023; Vawter MP, 2004, NEUROCHEM RES, V29, P1245, DOI 10.1023/B:NERE.0000023611.99452.47; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59; Yanagi M, 2005, J HUM GENET, V50, P210, DOI 10.1007/s10038-005-0241-0; Yang CH, 2012, J NEUROSCI, V32, P7550, DOI 10.1523/JNEUROSCI.5902-11.2012; Yuan PX, 2010, J AFFECT DISORDERS, V124, P164, DOI 10.1016/j.jad.2009.10.017	143	46	46	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50532	10.1371/journal.pone.0050532	http://dx.doi.org/10.1371/journal.pone.0050532			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23272063	Green Published, gold, Green Accepted			2022-12-25	WOS:000312589700016
J	Bourgeois, S; Bounoure, L; Christensen, EI; Ramakrishnan, SK; Houillier, P; Devuyst, O; Wagner, CA				Bourgeois, Soline; Bounoure, Lisa; Christensen, Erik I.; Ramakrishnan, Suresh K.; Houillier, Pascal; Devuyst, Olivier; Wagner, Carsten A.			Haploinsufficiency of the Ammonia Transporter Rhcg Predisposes to Chronic Acidosis Rhcg IS CRITICAL FOR APICAL AND BASOLATERAL AMMONIA TRANSPORT IN THE MOUSE COLLECTING DUCT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; C GLYCOPROTEIN; B GLYCOPROTEIN; KIDNEY; NH4+; RHBG; EXPRESSION; EXCRETION; BASE; K+	Ammonia secretion by the collecting duct (CD) is critical for acid-base homeostasis and, when defective, causes distal renal tubular acidosis (dRTA). The Rhesus protein RhCG mediates NH3 transport as evident from cell-free and cellular models as well as from Rhcg-null mice. Here, we investigated in a Rhcg mouse model the metabolic effects of Rhcg haploinsufficiency, the role of Rhcg in basolateral NH3 transport, and the mechanisms of adaptation to the lack of Rhcg. Both Rhcg(+/+) and Rhcg(+/-) mice were able to handle an acute acid load, whereas Rhcg(-/-) mice developed severe metabolic acidosis with reduced ammonuria and high mortality. However, chronic acid loading revealed that Rhcg(+/-) mice did not fully recover, showing lower blood HCO3- concentration and more alkaline urine. Microperfusion studies demonstrated that transepithelial NH3 permeability was reduced by 80 and 40%, respectively, in CDs from Rhcg(-/-) and Rhcg(+/-) mice compared with controls. Basolateral membrane permeability to NH3 was reduced in CDs from Rhcg(-/-) mice consistent with basolateral Rhcg localization. Rhcg(-/-) responded to acid loading with normal expression of enzymes and transporters involved in proximal tubular ammoniagenesis but reduced abundance of the NKCC2 transporter responsible for medullary accumulation of ammonium. Consequently, tissue ammonium content was decreased. These data demonstrate a role for apical and basolateral Rhcg in transepithelial NH3 transport and uncover an incomplete dRTA pheno-type in Rhcg(+/-) mice. Haploinsufficiency or reduced expression of RhCG may underlie human forms of (in)complete dRTA.	[Bourgeois, Soline; Bounoure, Lisa; Devuyst, Olivier; Wagner, Carsten A.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Bourgeois, Soline; Bounoure, Lisa; Devuyst, Olivier; Wagner, Carsten A.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Christensen, Erik I.] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Ramakrishnan, Suresh K.; Houillier, Pascal] Ctr Rech Cordeliers, INSERM, UMRS872, F-75270 Paris, France; [Ramakrishnan, Suresh K.] Univ Paris 06, Fac Med, F-75015 Paris, France; [Houillier, Pascal] Univ Paris 05, F-75015 Paris, France; [Houillier, Pascal] Hop Europeen Georges Pompidou, AP HP, Dept Physiol, F-75015 Paris, France	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	Wagnerca@access.uzh.ch	Houillier, Pascal/AAD-4903-2019	Houillier, Pascal/0000-0003-4953-6917; Devuyst, Olivier/0000-0003-3744-4767	Swiss National Science Foundation [3100A0-122217, 31003A_138143]; 7th European Union Framework Project EUNEFRON; Danish Medical Research Council; The Novo Nordisk Foundation; Swiss National Centre of Competence in Research; Erasmus Mundus External Cooperation Window Lot 15, India	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 7th European Union Framework Project EUNEFRON; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Novo Nordisk Foundation(Novo Nordisk Foundation); Swiss National Centre of Competence in Research; Erasmus Mundus External Cooperation Window Lot 15, India	This work was supported in part by Grants 3100A0-122217 and 31003A_138143 from the Swiss National Science Foundation (to C. A. W.), the 7th European Union Framework Project EUNEFRON (to P. H., E. I. C., O. D., and C. A. W.), the Danish Medical Research Council, The Novo Nordisk Foundation (to E. I. C.), and the Swiss National Centre of Competence in Research (to O. D. and C. A. W.).; Supported by Erasmus Mundus External Cooperation Window Lot 15, India.	Batlle D. C., 1985, RENAL TUBULAR DISORD, P281; BERTHELOT MPE, 1959, REP CHEM APPL, V1, P284, DOI DOI 10.1056/NEJMOA1708131; Bishop JM, 2010, AM J PHYSIOL-RENAL, V299, pF1065, DOI 10.1152/ajprenal.00277.2010; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; BLEICH M, 1995, PFLUG ARCH EUR J PHY, V429, P345, DOI 10.1007/BF00374149; Brown ACN, 2009, AM J PHYSIOL-RENAL, V296, pF1279, DOI 10.1152/ajprenal.00013.2009; Chambrey R, 2005, AM J PHYSIOL-RENAL, V289, pF1281, DOI 10.1152/ajprenal.00172.2005; CHRISTENSEN EI, 1995, EUR J CELL BIOL, V66, P349; CURTHOYS NP, 1976, ARCH BIOCHEM BIOPHYS, V172, P162, DOI 10.1016/0003-9861(76)90062-X; DUBOSE TD, 1991, J AM SOC NEPHROL, V1, P1193; Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D; FLESSNER MF, 1992, AM J PHYSIOL, V262, pF1, DOI 10.1152/ajprenal.1992.262.1.F1; GOOD DW, 1994, ANNU REV PHYSIOL, V56, P623, DOI 10.1146/annurev.ph.56.030194.003203; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Hafner P, 2008, AM J PHYSIOL-CELL PH, V295, pC1658, DOI 10.1152/ajpcell.00419.2008; Hamm LL, 2008, SELDIN GIEBISCHS KID, P1539; Han KH, 2010, AM J PHYSIOL-RENAL, V299, pF187, DOI 10.1152/ajprenal.00607.2009; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; JONES ER, 1984, J CLIN INVEST, V74, P992, DOI 10.1172/JCI111520; JORGENSEN K, 1957, SCAND J CLIN LAB INV, V9, P287, DOI 10.3109/00365515709079972; KIKERI D, 1989, NATURE, V339, P478, DOI 10.1038/339478a0; Kim H. Y., 2009, AM J PHYSIOL-RENAL, V296, pF1364; Kim HY, 2009, AM J PHYSIOL-RENAL, V296, pF543, DOI 10.1152/ajprenal.90637.2008; Lee HW, 2009, AM J PHYSIOL-RENAL, V296, pF1364, DOI 10.1152/ajprenal.90667.2008; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Milton AE, 1998, AM J PHYSIOL-RENAL, V274, pF1086, DOI 10.1152/ajprenal.1998.274.6.F1086; Mouro-Chanteloup I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008921; NUTBOURNE D, 1961, CLIN SCI, V20, P263; PACKER RK, 1991, J AM SOC NEPHROL, V2, P77; Prabhakar SS, 2004, KIDNEY INT, V66, P1742, DOI 10.1111/j.1523-1755.2004.00951.x; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SEATON B, 1984, MED LAB SCI, V41, P327; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wagner CA, 2011, KIDNEY INT, V79, P154, DOI 10.1038/ki.2010.386; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Wall SM, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134827; Wall SM, 2002, AM J PHYSIOL-RENAL, V282, pF91, DOI 10.1152/ajprenal.0141.2001; WALL SM, 1994, AM J PHYSIOL-RENAL, V267, pF660, DOI 10.1152/ajprenal.1994.267.4.F660; WATTS BA, 1994, J BIOL CHEM, V269, P20250; Weiner ID, 2011, AM J PHYSIOL-RENAL, V300, pF11, DOI 10.1152/ajprenal.00554.2010; Zhelyaskov VR, 2000, KIDNEY INT, V57, P1764, DOI 10.1046/j.1523-1755.2000.00022.x	43	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5518	5529		10.1074/jbc.M112.441782	http://dx.doi.org/10.1074/jbc.M112.441782			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23281477	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000315342500026
J	Prindle, MJ; Schmitt, MW; Parmeggiani, F; Loeb, LA				Prindle, Marc J.; Schmitt, Michael W.; Parmeggiani, Fabio; Loeb, Lawrence A.			A Substitution in the Fingers Domain of DNA Polymerase delta Reduces Fidelity by Altering Nucleotide Discrimination in the Catalytic Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROOFREADING EXONUCLEASE; MOTIF-A; REPLICATION; ANTIMUTATOR; MUTANTS; EPSILON; BACTERIOPHAGE-T4; MUTATIONS; INCREASE	DNA polymerase delta (Pol delta) is one of the major replicative DNA polymerases in eukaryotic cells, catalyzing lagging strand synthesis as well as playing a role in many DNA repair pathways. The catalytic site for polymerization consists of a palm domain and mobile fingers domain that opens and closes each catalytic cycle. We explored the effect of amino acid substitutions in a region of the highly conserved sequence motif B in the fingers domain on replication fidelity. A novel substitution, A699Q, results in a marked increase in mutation rate at the yeast CAN1 locus, and is synthetic lethal with both proofreading deficiency and mismatch repair deficiency. Modeling the A699Q mutation onto the crystal structure of Saccharomyces cerevisiae Pol delta template reveals four potential contacts for A699Q but not for A699. We substituted alanine for each of these residues and determined that an interaction with multiple residues of the N-terminal domain is responsible for the mutator phenotype. The corresponding mutation in purified human Pol delta results in a similar 30-fold increase in mutation frequency when copying gapped DNA templates. Sequence analysis indicates that the most characteristic mutation is a guanine-to-adenine (G to A) transition. The increase in deoxythymidine 5'-triphosphate-G mispairs was confirmed by performing steady state single nucleotide addition studies. Our combined data support a model in which the Ala-to-Gln substitution in the fingers domain of Pol delta results in an interaction with the N-terminal domain that affects the base selectivity of the enzyme.	[Prindle, Marc J.; Schmitt, Michael W.; Loeb, Lawrence A.] Univ Washington, Joseph Gottstein Mem Lab, Dept Pathol, Seattle, WA 98195 USA; [Parmeggiani, Fabio; Loeb, Lawrence A.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Loeb, LA (corresponding author), Univ Washington, Sch Med, Box 357705, Seattle, WA 98195 USA.	laloeb@uw.edu	Parmeggiani, Fabio/P-3661-2019; Parmeggiani, Fabio/B-9344-2016	Parmeggiani, Fabio/0000-0001-8548-1090; Parmeggiani, Fabio/0000-0001-8548-1090	National Institutes of Health [CA15802, CA102029, POLCA77852]; Human Frontier Science Program long term fellowship; NATIONAL CANCER INSTITUTE [R01CA102029, P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program long term fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA15802, CA102029, and POLCA77852.; A recipient of a Human Frontier Science Program long term fellowship.	Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; Daee DL, 2010, P NATL ACAD SCI USA, V107, P157, DOI 10.1073/pnas.0907526106; Fazlieva R, 2009, NUCLEIC ACIDS RES, V37, P2854, DOI 10.1093/nar/gkp155; Flohr T, 1999, INT J CANCER, V80, P919, DOI 10.1002/(SICI)1097-0215(19990315)80:6<919::AID-IJC19>3.0.CO;2-U; Fortune JM, 2005, J BIOL CHEM, V280, P29980, DOI 10.1074/jbc.M505236200; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Herr AJ, 2011, CRIT REV BIOCHEM MOL, V46, P548, DOI 10.3109/10409238.2011.620941; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; JOYCE CM, 1995, J BACTERIOL, V177, P6321, DOI 10.1128/jb.177.22.6321-6329.1995; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Larrea AA, 2010, P NATL ACAD SCI USA, V107, P17674, DOI 10.1073/pnas.1010178107; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Loh E, 2007, J BIOL CHEM, V282, P12201, DOI 10.1074/jbc.M611294200; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; Ogawa M, 2003, J BIOL CHEM, V278, P19071, DOI 10.1074/jbc.M208605200; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pavlov YI, 2001, GENETICS, V159, P47; Prindle MJ, 2012, ENVIRON MOL MUTAGEN, V53, P666, DOI 10.1002/em.21745; REHAKRANTZ LJ, 1994, J BIOL CHEM, V269, P5635; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Schaaper RM, 1998, GENETICS, V148, P1579; Schmitt MW, 2009, BIOCHIMIE, V91, P1163, DOI 10.1016/j.biochi.2009.06.007; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Suzuki M, 1997, J BIOL CHEM, V272, P11228; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Yang GW, 2002, BIOCHEMISTRY-US, V41, P2526, DOI 10.1021/bi0119924	31	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5572	5580		10.1074/jbc.M112.436410	http://dx.doi.org/10.1074/jbc.M112.436410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23283971	Green Published, hybrid			2022-12-25	WOS:000315342500031
J	Tong, X; Zhang, DQ; Buelow, K; Guha, A; Arthurs, B; Brady, HJM; Yin, L				Tong, Xin; Zhang, Deqiang; Buelow, Katie; Guha, Anirvan; Arthurs, Blake; Brady, Hugh J. M.; Yin, Lei			Recruitment of Histone Methyltransferase G9a Mediates Transcriptional Repression of Fgf21 Gene by E4BP4 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 21; REV-ERB-ALPHA; PPAR-ALPHA; CIRCADIAN EXPRESSION; HEPATIC EXPRESSION; METABOLIC SYNDROME; CLOCK; OBESITY; METHYLATION; FIBROBLAST-GROWTH-FACTOR-21	The liver responds to fasting-refeeding cycles by reprogramming expression of metabolic genes. Fasting potently induces one of the key hepatic hormones, fibroblast growth factor 21 (FGF21), to promote lipolysis, fatty acid oxidation, and ketogenesis, whereas refeeding suppresses its expression. We previously reported that the basic leucine zipper transcription factor E4BP4 (E4 binding protein 4) represses Fgf21 expression and disrupts its circadian oscillations in cultured hepatocytes. However, the epigenetic mechanism for E4BP4-dependent suppression of Fgf21 has not yet been addressed. Here we present evidence that histone methyltransferase G9a mediates E4BP4-dependent repression of Fgf21 during refeeding by promoting repressive histone modification. We find that Fgf21 expression is up-regulated in E4bp4 knock-out mouse liver. We demonstrate that the G9a-specific inhibitor BIX01294 abolishes suppression of the Fgf21 promoter activity by E4BP4, whereas overexpression of E4bp4 leads to increased levels of dimethylation of histone 3 lysine 9 (H3K9me2) around the Fgf21 promoter region. Furthermore, we also show that E4BP4 interacts with G9a, and knockdown of G9a blocks repression of Fgf21 promoter activity and expression in cells overexpressing E4bp4. A G9a mutant lacking catalytic activity, due to deletion of the SET domain, fails to inhibit the Fgf21 promoter activity. Importantly, acute hepatic knockdown by adenoviral shRNA targeting G9a abolishes Fgf21 repression by refeeding, concomitant with decreased levels of H3K9me2 around the Fgf21 promoter region. In summary, we show that G9a mediates E4BP4-dependent suppression of hepatic Fgf21 by enhancing histone methylation (H3K9me2) of the Fgf21 promoter.	[Tong, Xin; Zhang, Deqiang; Buelow, Katie; Guha, Anirvan; Arthurs, Blake; Yin, Lei] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Brady, Hugh J. M.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Immunol & Infect Sect, London SW7 2AZ, England	University of Michigan System; University of Michigan; Imperial College London	Yin, L (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	leiyin@umich.edu	Zhang, Deqiang/J-9199-2016	TONG, XIN/0000-0002-4832-8940; Guha, Anirvan/0000-0001-6018-1438; Buelow, Katie/0000-0002-2616-1756; Brady, Hugh/0000-0002-3152-067X	National Institutes of Health [K99/R00 DK 077449]; Michigan Diabetes Research Center [P600K020572]; Michigan Obesity and Nutrition Research Center [DK089503]; MRC [G0901737] Funding Source: UKRI; Medical Research Council [G0901737] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK077449, P30DK089503, P30DK020572, P60DK020572, R25DK088752, R00DK077449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research Center; Michigan Obesity and Nutrition Research Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant K99/R00 DK 077449 (to L.Y.). Part of this work was also supported by a pilot grants (to L.Y.) from the Michigan Diabetes Research Center (P600K020572) and Michigan Obesity and Nutrition Research Center (DK089503).	Adams AC, 2010, J BIOL CHEM, V285, P14078, DOI 10.1074/jbc.C110.107375; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Cowell IG, 1996, NUCLEIC ACIDS RES, V24, P3607, DOI 10.1093/nar/24.18.3607; Cowell IG, 2002, BIOESSAYS, V24, P1023, DOI 10.1002/bies.10176; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Esteve PO, 2005, NUCLEIC ACIDS RES, V33, P3211, DOI 10.1093/nar/gki635; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Oishi K, 2008, FEBS LETT, V582, P3639, DOI 10.1016/j.febslet.2008.09.046; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Takahashi S, 2010, J ATHEROSCLER THROMB, V17, P73, DOI 10.5551/jat.2410; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Uebanso T, 2012, J NUTR BIOCHEM, V23, P785, DOI 10.1016/j.jnutbio.2011.03.023; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Vila-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; ZHANG W, 1995, MOL CELL BIOL, V15, P6055; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	63	28	28	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5417	5425		10.1074/jbc.M112.433482	http://dx.doi.org/10.1074/jbc.M112.433482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23283977	hybrid, Green Published			2022-12-25	WOS:000315342500017
J	Anguille, S; Lion, E; Tel, J; de Vries, IJM; Coudere, K; Fromm, PD; Van Tendeloo, VF; Smits, EL; Berneman, ZN				Anguille, Sebastien; Lion, Eva; Tel, Jurjen; de Vries, I. Jolanda M.; Coudere, Karen; Fromm, Phillip D.; Van Tendeloo, Viggo F.; Smits, Evelien L.; Berneman, Zwi N.			Interleukin-15-Induced CD56(+) Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CD8(+) T-CELLS; IN-VITRO; GRANZYME-B; INTERFERON-ALPHA; IFN-GAMMA; NK; CYTOTOXICITY; ACTIVATION; EXPRESSION	Dendritic cells (DCs) are the quintessential antigen-presenting cells of the human immune system and play a prime role in coordinating innate and adaptive immune responses, explaining the strong and still growing interest in their application for cancer immunotherapy. Much current research in the field of DC-based immunotherapy focuses on optimizing the culture conditions for in vitro DC generation in order to assure that DCs with the best possible immunogenic qualities are being used for immunotherapy. In this context, monocyte-derived DCs that are alternatively induced by interleukin-15 (IL-15 DCs) have attracted recent attention due to their superior immunostimulatory characteristics. In this study, we show that IL-15 DCs, in addition to potent tumor antigen-presenting function, possess tumoricidal potential and thus qualify for the designation of killer DCs. Notwithstanding marked expression of the natural killer (NK) cell marker CD56 on a subset of IL-15 DCs, we found no evidence of a further phenotypic overlap between IL-15 DCs and NK cells. Allostimulation and antigen presentation assays confirmed that IL-15 DCs should be regarded as bona fide myeloid DCs not only from the phenotypic but also from the functional point of view. Concerning their cytotoxic activity, we demonstrate that IL-15 DCs are able to induce apoptotic cell death of the human K562 tumor cell line, while sparing tumor antigen-specific T cells. The cytotoxicity of IL-15 DCs is predominantly mediated by granzyme B and, to a small extent, by tumor necrosis factor-alpha (TNF-alpha)-related apoptosis-inducing ligand (TRAIL) but is independent of perforin, Fas ligand and TNF-alpha. In conclusion, our data provide evidence of a previously unappreciated role for IL-15 in the differentiation of human monocytes towards killer DCs. The observation that IL-15 DCs have killer DC capacity lends further support to their implementation in DC-based immunotherapy protocols.	[Anguille, Sebastien; Lion, Eva; Coudere, Karen; Van Tendeloo, Viggo F.; Smits, Evelien L.; Berneman, Zwi N.] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol, B-2020 Antwerp, Belgium; [Anguille, Sebastien; Smits, Evelien L.; Berneman, Zwi N.] Univ Antwerp Hosp, Ctr Cell Therapy & Regenerat Med, Antwerp, Belgium; [Tel, Jurjen; de Vries, I. Jolanda M.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Tel, Jurjen; de Vries, I. Jolanda M.] Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands; [Fromm, Phillip D.] ANZAC Res Inst, Dendrit Cell Biol & Therapeut Grp, Sydney, NSW, Australia	University of Antwerp; University of Antwerp; Radboud University Nijmegen; Radboud University Nijmegen; University of Sydney; ANZAC Research Institute	Anguille, S (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol, B-2020 Antwerp, Belgium.	sebastien.anguille@uza.be	Smits, Evelien/A-3520-2014; Tel, Jurjen/A-2712-2016; de Vries, Jolanda I.J.M./F-5563-2010; Research Institute, ANZAC/CAE-9030-2022; Van Tendeloo, Viggo FI/A-1233-2010; Ekanayake, Kanchana/P-8817-2016	Smits, Evelien/0000-0001-9255-3435; Tel, Jurjen/0000-0002-7213-3422; de Vries, Jolanda I.J.M./0000-0002-8653-4040; Van Tendeloo, Viggo FI/0000-0003-3217-9917; Berneman, Zwi/0000-0002-9133-4588; Lion, Eva/0000-0002-2420-0301	Research Foundation Flanders (FWO Vlaanderen); Belgian Foundation against Cancer (Stichting tegen Kanker); Methusalem program of the Flemish Government; Interuniversity Attraction Pole program (IAP) of the Belgian Government [P6/41]; Belgian Hercules Foundation; Belgian Foundation against Cancer; Belgian public utility foundation VOCATIO; Emmanuel van der Schueren Fellowship of the Flemish League against Cancer (Vlaamse Liga tegen Kanker); Netherlands Organization for Scientific Research (NWO ZonMW); Institute for the Promotion of Innovation through Science and Technology (IWT)	Research Foundation Flanders (FWO Vlaanderen)(FWO); Belgian Foundation against Cancer (Stichting tegen Kanker); Methusalem program of the Flemish Government; Interuniversity Attraction Pole program (IAP) of the Belgian Government; Belgian Hercules Foundation; Belgian Foundation against Cancer; Belgian public utility foundation VOCATIO; Emmanuel van der Schueren Fellowship of the Flemish League against Cancer (Vlaamse Liga tegen Kanker); Netherlands Organization for Scientific Research (NWO ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Institute for the Promotion of Innovation through Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported in part by research grants of the Research Foundation Flanders (FWO Vlaanderen, www.fwo.be), the Belgian Foundation against Cancer (Stichting tegen Kanker, www.kanker.be), the Methusalem program of the Flemish Government attributed to Prof Herman Goossens (University of Antwerp, Belgium), the Interuniversity Attraction Pole program (IAP # P6/41) of the Belgian Government and the Belgian Hercules Foundation (www.herculesstichting.be). SA is a PhD fellow of the Research Foundation Flanders and received financial support from the Belgian Foundation against Cancer and the Belgian public utility foundation VOCATIO (www.vocatio.be). EL holds an Emmanuel van der Schueren Fellowship of the Flemish League against Cancer (Vlaamse Liga tegen Kanker, www.tegenkanker.be). JT was supported by a grant from The Netherlands Organization for Scientific Research (NWO ZonMW, www.zonmw.nl). YW is funded by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology (IWT, www.iwt.be). NC and ELS are post-doctoral fellows of the Research Foundation Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AAZ, 2008, CLIN CANCER RES, V14, P4232, DOI 10.1158/1078-0432.CCR-07-4912; Anguille S, 2012, LEUKEMIA, V26, P2186, DOI 10.1038/leu.2012.145; Anguille S, 2011, LEUKEMIA, V25, P739, DOI 10.1038/leu.2010.324; Anguille S, 2012, B CANCER, V99, P635, DOI 10.1684/bdc.2012.1587; Anguille S, 2012, CYTOTHERAPY, V14, P647, DOI 10.3109/14653249.2012.693744; Anguille S, 2011, HUM VACCINES, V7, P579, DOI 10.4161/hv.7.5.14652; Anguille S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-109; Barblu L, 2012, J INFECT DIS, V206, P790, DOI 10.1093/infdis/jis384; Bigley V, 2010, BLOOD, V116, P2859, DOI 10.1182/blood-2010-05-285676; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Caminschi I, 2007, J EXP MED, V204, P2579, DOI 10.1084/jem.20071351; Chan CW, 2008, CELL DEATH DIFFER, V15, P58, DOI 10.1038/sj.cdd.4402235; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Chapoval AI, 2000, BLOOD, V95, P2346, DOI 10.1182/blood.V95.7.2346.007k05_2346_2351; Chauvin C, 2008, J IMMUNOL, V181, P11, DOI 10.4049/jimmunol.181.1.11; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; Cookson S, 2003, BLOOD, V102, P2195, DOI 10.1182/blood-2003-01-0232; Correia MP, 2011, IMMUNOBIOLOGY, V216, P604, DOI 10.1016/j.imbio.2010.09.012; Drobits B, 2012, J CLIN INVEST, V122, P575, DOI 10.1172/JCI61034; Dubsky P, 2007, EUR J IMMUNOL, V37, P1678, DOI 10.1002/eji.200636329; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Hanna J, 2004, J CLIN INVEST, V114, P1612, DOI 10.1172/JCI200422787; Harris KM, 2011, J LEUKOCYTE BIOL, V90, P727, DOI 10.1189/jlb.0311132; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kalb ML, 2012, J IMMUNOL, V188, P1583, DOI 10.4049/jimmunol.1102437; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Koski GK, 2012, J IMMUNOTHER, V35, P54, DOI 10.1097/CJI.0b013e318235f512; LaCasse CJ, 2011, J IMMUNOL, V187, P6310, DOI 10.4049/jimmunol.1101812; LANIER LL, 1994, J IMMUNOL, V153, P2417; LANIER LL, 1989, J EXP MED, V169, P2233, DOI 10.1084/jem.169.6.2233; Larmonier N, 2010, CANCER IMMUNOL IMMUN, V59, P1, DOI 10.1007/s00262-009-0736-1; Lion E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020952; Luckey U, 2011, J CLIN INVEST, V121, P3860, DOI 10.1172/JCI45963; Manna PP, 2013, CYTOKINE, V61, P118, DOI 10.1016/j.cyto.2012.09.004; Manna PP, 2002, J LEUKOCYTE BIOL, V72, P312; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Milush JM, 2009, BLOOD, V114, P4823, DOI 10.1182/blood-2009-04-216374; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Papewalis C, 2008, J IMMUNOL, V180, P1462, DOI 10.4049/jimmunol.180.3.1462; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; Pillarisetty VG, 2005, J IMMUNOL, V174, P2612, DOI 10.4049/jimmunol.174.5.2612; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Pittet MJ, 2000, J IMMUNOL, V164, P1148, DOI 10.4049/jimmunol.164.3.1148; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; ROBERTSON MJ, 1990, J IMMUNOL, V145, P3194; Santin AD, 2001, CLIN CANCER RES, V7, p804S; Schmitz M, 2005, J IMMUNOL, V174, P4127, DOI 10.4049/jimmunol.174.7.4127; Smits ELJM, 2009, HUM GENE THER, V20, P1106, DOI 10.1089/hum.2009.145; Spits H, 2007, IMMUNITY, V26, P11, DOI 10.1016/j.immuni.2007.01.004; Stary G, 2007, J EXP MED, V204, P1441, DOI 10.1084/jem.20070021; STEINMAN RM, 1980, IMMUNOL REV, V53, P127, DOI 10.1111/j.1600-065X.1980.tb01042.x; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Tel J, 2012, BLOOD, V120, P3936, DOI 10.1182/blood-2012-06-435941; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; Urban EM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-50; Vidalain PO, 2001, J IMMUNOL, V167, P3765, DOI 10.4049/jimmunol.167.7.3765; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Walzer T, 2007, CURR OPIN IMMUNOL, V19, P365, DOI 10.1016/j.coi.2007.04.004; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Wesa AK, 2008, CELL DEATH DIFFER, V15, P51, DOI 10.1038/sj.cdd.4402243	64	46	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51851	10.1371/journal.pone.0051851	http://dx.doi.org/10.1371/journal.pone.0051851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284789	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500015
J	Marseille, E; Giganti, MJ; Mwango, A; Chisembele-Taylor, A; Mulenga, L; Over, M; Kahn, JG; Stringer, JSA				Marseille, Elliot; Giganti, Mark J.; Mwango, Albert; Chisembele-Taylor, Angela; Mulenga, Lloyd; Over, Mead; Kahn, James G.; Stringer, Jeffrey S. A.			Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia	PLOS ONE			English	Article							SOUTH-AFRICA; CARE; HIV; MORTALITY; COUNTRIES; CHILDREN; OUTCOMES; HEALTH; UGANDA	Background: We estimated the unit costs and cost-effectiveness of a government ART program in 45 sites in Zambia supported by the Centre for Infectious Disease Research Zambia (CIDRZ). Methods: We estimated per person-year costs at the facility level, and support costs incurred above the facility level and used multiple regression to estimate variation in these costs. To estimate ART effectiveness, we compared mortality in this Zambian population to that of a cohort of rural Ugandan HIV patients receiving co-trimoxazole (CTX) prophylaxis. We used micro-costing techniques to estimate incremental unit costs, and calculated cost-effectiveness ratios with a computer model which projected results to 10 years. Results: The program cost $69.7 million for 125,436 person-years of ART, or $556 per ART-year. Compared to CTX prophylaxis alone, the program averted 33.3 deaths or 244.5 disability adjusted life-years (DALYs) per 100 person-years of ART. In the base-case analysis, the net cost per DALY averted was $833 compared to CTX alone. More than two-thirds of the variation in average incremental total and on-site cost per patient-year of treatment is explained by eight determinants, including the complexity of the patient-case load, the degree of adherence among the patients, and institutional characteristics including, experience, scale, scope, setting and sector. Conclusions and Significance: The 45 sites exhibited substantial variation in unit costs and cost-effectiveness and are in the mid-range of cost-effectiveness when compared to other ART programs studied in southern Africa. Early treatment initiation, large scale, and hospital setting, are associated with statistically significantly lower costs, while others (rural location, private sector) are associated with shifting cost from on- to off-site. This study shows that ART programs can be significantly less costly or more cost-effective when they exploit economies of scale and scope, and initiate patients at higher CD4 counts.	[Marseille, Elliot] Hlth Strategies Int, Oakland, CA 94609 USA; [Giganti, Mark J.; Chisembele-Taylor, Angela; Mulenga, Lloyd; Stringer, Jeffrey S. A.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Over, Mead] Ctr Global Dev, Washington, DC USA; [Mwango, Albert] Zambian Minist Hlth, Lusaka, Zambia; [Kahn, James G.] Super Models Global Hlth, Oakland, CA USA; [Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Marseille, E (corresponding author), Hlth Strategies Int, Oakland, CA 94609 USA.	emarseille@comcast.net	Stringer, Jeffrey S. A./AAU-2342-2021	Stringer, Jeffrey/0000-0002-9590-7216	U.S. Centers for Disease Control and Prevention [U62/CCU12354]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The program that this work describes is supported through a multi-country grant from the U.S. Centers for Disease Control and Prevention (U62/CCU12354). The corresponding author had full access to all data in the study and takes final responsibility for the decision to submit the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funding agencies.	[AVERTing HIV AIDS], 2011, PRESIDENTS EMERGENCY; Babigumira JB, 2009, PHARMACOECONOMICS, V27, P963, DOI 10.2165/11318230-000000000-00000; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Bikilla AD, 2009, COST EFF RESOUR ALLO, V7, P6, DOI DOI 10.1186/1478-7547-7-6; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Boulle A, 2002, SAMJ S AFR MED J, V92, P811; Cleary S, 2004, COST EFFECTIVENESS O; Cleary S, 2004, RESOURCE REQUIREMENT; Dezii C M, 2001, Manag Care, V10, P42; Donald PR, 2009, NEW ENGL J MED, V360, P2393, DOI 10.1056/NEJMp0903806; Drummond M.F., 1997, METHODS FOR THE ECON; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Galaty D, 2004, SCALING UP ANTIRETRO; Geffen N, 2003, REPORT ISSUED BY CEN; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Govender V, 2000, REPORT FROM PHR AND; Government of the Republic of Zambia, 2010, ZAMBIA COUNTRY REPOR; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; Hounton SH, 2008, AIDS CARE, V20, P582, DOI 10.1080/09540120701868303; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kevany S, 2009, SAMJ S AFR MED J, V99, P320; Kombe G, 2003, APPLICATION OF THE A; Kombe G, 2005, THE HUMAN AND FINANC; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; Marseille E, 2009, APPL HEALTH ECON HEA, V7, P229, DOI 10.2165/11318740-000000000-00000; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Morgan MG, 1990, UNCERTAINTY A GUIDE; Sikka R, 2005, AM J MANAG CARE, V11, P453; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), 2011, PEPFAR OPERATIONAL P; The World Bank, 1993, WORLD DEVELOPMENT RE; UNAIDS, 2008, 2008 REPORT ON THE G; UNAIDS/World Health Organization, 2008, EPIDEMIOLOGICAL FACT; World Health Organization, 2007, MATERNAL MORTALITY I; World Health Organization, 2009, RAPID ADVICE ANTIRET; Zwillich T, 2009, LANCET, V373, P1325, DOI 10.1016/S0140-6736(09)60755-8	37	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51993	10.1371/journal.pone.0051993	http://dx.doi.org/10.1371/journal.pone.0051993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284843	Green Published, gold			2022-12-25	WOS:000312794500073
J	Senter, E; Sheikh, S; Dotu, I; Ponty, Y; Clote, P				Senter, Evan; Sheikh, Saad; Dotu, Ivan; Ponty, Yann; Clote, Peter			Using the Fast Fourier Transform to Accelerate the Computational Search for RNA Conformational Switches	PLOS ONE			English	Article							SECONDARY STRUCTURE; STRUCTURAL NEIGHBORS; SAMPLING ALGORITHM; ENERGY LANDSCAPE; RIBOSWITCHES; PATHWAYS; DESIGN; IDENTIFICATION	Using complex roots of unity and the Fast Fourier Transform, we design a new thermodynamics-based algorithm, FFTbor, that computes the Boltzmann probability that secondary structures differ by k base pairs from an arbitrary initial structure of a given RNA sequence. The algorithm, which runs in quartic time O(n(4)) and quadratic space O(n(2)), is used to determine the correlation between kinetic folding speed and the ruggedness of the energy landscape, and to predict the location of riboswitch expression platform candidates. A web server is available at http://bioinformatics.bc.edu/clotelab/FFTbor/.	[Senter, Evan; Dotu, Ivan; Clote, Peter] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Sheikh, Saad] Univ Florida, Dept Comp Sci, Gainesville, FL USA; [Ponty, Yann] Ecole Polytech, Lab Informat, Palaiseau, France	Boston College; State University System of Florida; University of Florida; Institut Polytechnique de Paris	Clote, P (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	clote@bc.edu	Ponty, Yann/AAC-7046-2020	Ponty, Yann/0000-0002-7615-3930; Dotu, Ivan/0000-0002-0438-9557	National Science Foundation [DMS-1016618, DMS-0817971]; Division Of Mathematical Sciences [1016618] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Source of funding provided by National Science Foundation grants DMS-1016618 and DMS-0817971 to PC, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, P33; ALTSCHUL SF, 1985, MOL BIOL EVOL, V2, P526; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andronescu M, 2004, J MOL BIOL, V336, P607, DOI 10.1016/j.jmb.2003.12.041; Bengert P, 2004, NUCLEIC ACIDS RES, V32, pW154, DOI 10.1093/nar/gkh352; Bergig Oriel, 2004, In Silico Biology, V4, P593; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Busch A, 2006, BIOINFORMATICS, V22, P1823, DOI 10.1093/bioinformatics/btl194; Chang TH, 2009, RNA, V15, P1426, DOI 10.1261/rna.1623809; Clote P, 2005, BIOINFORMATICS, V21, P4140, DOI 10.1093/bioinformatics/bti669; Clote P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S5-S6; Cormen T, 1990, ALGORITHMS; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Dotu I, 2010, NUCLEIC ACIDS RES, V38, P1711, DOI 10.1093/nar/gkp1054; Flamm C, 2000, RNA, V6, P325, DOI 10.1017/S1355838200992161; Flamm C, 2001, RNA, V7, P254, DOI 10.1017/S1355838201000863; Freyhult E, 2007, BIOINFORMATICS, V23, P2054, DOI 10.1093/bioinformatics/btm314; Freyhult Eva, 2005, Appl Bioinformatics, V4, P53, DOI 10.2165/00822942-200504010-00006; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Higham NJ, 2004, IMA J NUMER ANAL, V24, P547, DOI 10.1093/imanum/24.4.547; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Knight TF, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100028; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Nawrocki EP, 2009, INFERNAL 1 0 INFEREN; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Singh P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-325; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Waldispuhl J, 2011, J COMPUT BIOL, V18, P1465, DOI 10.1089/cmb.2011.0181; Waldispuhl J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000124; Waldminghaus T, 2008, BIOL CHEM, V389, P1319, DOI 10.1515/BC.2008.150; Wolynes PG, 2005, PHILOS T R SOC A, V363, P453, DOI 10.1098/rsta.2004.1502; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633; Zar JH, 1999, BIOSTATISTICAL ANAL	40	17	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e50506	10.1371/journal.pone.0050506	http://dx.doi.org/10.1371/journal.pone.0050506			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284639	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300011
J	Ge, HY; Ni, SS; Wang, XA; Xu, N; Liu, Y; Wang, X; Wang, LY; Song, DL; Song, YL; Bai, CX				Ge, Haiyan; Ni, Songshi; Wang, Xingan; Xu, Nuo; Liu, Ying; Wang, Xun; Wang, Lingyan; Song, Dongli; Song, Yuanlin; Bai, Chunxue			Dexamethasone Reduces Sensitivity to Cisplatin by Blunting p53-Dependent Cellular Senescence in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							NF-KAPPA-B; DNA-DAMAGE; GROWTH-INHIBITION; INDUCED APOPTOSIS; RESISTANCE; CHEMOTHERAPY; ACTIVATION; THERAPY; P53; GEMCITABINE	Introduction: Dexamethasone (DEX) co-treatment has proved beneficial in NSCLC patients, improving clinical symptoms by the reduction of side effects after chemotherapy. However, recent studies have shown that DEX could render cancer cells more insensitive to cytotoxic drug therapy, but it is not known whether DEX co-treatment could influence therapy-induced senescence (TIS), and unknown whether it is in a p53-dependent or p53-independent manner. Methods: We examined in different human NSCLC cell lines and detected cellular senescence after cisplatin (DDP) treatment in the presence or absence of DEX. The in vivo effect of the combination of DEX and DDP was assessed by tumor growth experiments using human lung cancer cell lines growing as xenograft tumors in nude mice. Results: Co-treatment with DEX during chemotherapy in NSCLC resulted in increased tumor cell viability and inhibition of TIS compared with DDP treated group. DEX co-treatment cells exhibited the decrease of DNA damage signaling pathway proteins, the lower expression of p53 and p21(CIP1), the lower cellular secretory program and down-regulation of NF-kappa B and its signaling cascade. DEX also significantly reduced DDP sensitivity in vivo. Conclusions: Our results underscore that DEX reduces chemotherapy sensitivity by blunting therapy induced cellular senescence after chemotherapy in NSCLC, which may, at least in part, in a p53-dependent manner. These data therefore raise concerns about the widespread combined use of gluocorticoids (GCs) with antineoplastic drugs in the clinical management of cancer patients.	[Ge, Haiyan; Wang, Xingan; Xu, Nuo; Wang, Xun; Wang, Lingyan; Song, Dongli; Song, Yuanlin; Bai, Chunxue] Fudan Univ, Dept Pulm Med, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Ge, Haiyan; Ni, Songshi; Liu, Ying] Nantong Univ, Dept Resp Med, Affiliated Hosp, Nantong, Peoples R China	Fudan University; Nantong University	Bai, CX (corresponding author), Fudan Univ, Dept Pulm Med, Zhongshan Hosp, Shanghai 200433, Peoples R China.	bai.chunxue@zs-hospital.sh.cn		Bai, Chunxue/0000-0001-5798-3130	3rd program of National Project "973''; 3rd program of National Project "985''; National Natural Key Science foundation of China [30930090]; National Natural Science Foundation of China [30971306/H0107]	3rd program of National Project "973''; 3rd program of National Project "985''; National Natural Key Science foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the 3rd program of National Project "973'' (to Chunxue Bai), 3rd program of National Project "985'' (to Chunxue Bai), National Natural Key Science foundation of China (30930090) (to Chunxue Bai), and National Natural Science Foundation of China (30971306/H0107) (to Songshi Ni) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Arriagada R, 2010, J CLIN ONCOL, V28, P35, DOI 10.1200/JCO.2009.23.2272; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen YX, 2010, ENDOCR-RELAT CANCER, V17, P39, DOI 10.1677/ERC-08-0296; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Ewald JA, 2009, J BIOMOL SCREEN, V14, P853, DOI 10.1177/1087057109340314; Fan WM, 2004, CURR MED CHEM, V11, P403, DOI 10.2174/0929867043455990; Gassler N, 2005, BRIT J CANCER, V92, P1084, DOI 10.1038/sj.bjc.6602453; Helbig L, 2011, J BIOL CHEM, V286, P12991, DOI 10.1074/jbc.M110.190645; Herr I, 2003, CANCER RES, V63, P3112; Hesketh PJ, 2012, SUPPORT CARE CANCER, V20, P653, DOI 10.1007/s00520-011-1312-8; Isbister GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038739; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin X, 2012, MOL CANC RES; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee YK, 2012, ARCH DERMATOL RES, V304, P73, DOI 10.1007/s00403-011-1176-2; Madsen SH, 2011, STEROIDS, V76, P1474, DOI 10.1016/j.steroids.2011.07.018; Meng L, 2011, ONCOGENE, V30, P1716, DOI 10.1038/onc.2010.550; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; O'Prey J, 2010, CELL CYCLE, V9, P947, DOI 10.4161/cc.9.5.10872; Qian YH, 2009, BBA-MOL CELL RES, V1793, P764, DOI 10.1016/j.bbamcr.2009.01.017; Raabe EH, 2011, CLIN CANCER RES, V17, P3590, DOI 10.1158/1078-0432.CCR-10-3349; Rebbaa A, 2006, CELL DEATH DIFFER, V13, P1960, DOI 10.1038/sj.cdd.4401895; Rho JK, 2007, CANCER RES, V67, P1163, DOI 10.1158/0008-5472.CAN-06-2037; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rossetto D, 2010, CLIN CANCER RES, V16, P4543, DOI 10.1158/1078-0432.CCR-10-0513; Rovillain E, 2011, ONCOGENE, V30, P2356, DOI 10.1038/onc.2010.611; Rutz HP, 2002, LANCET, V360, P1969, DOI 10.1016/S0140-6736(02)11922-2; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012; Schneider G, 2011, BBA-REV CANCER, V1815, P90, DOI 10.1016/j.bbcan.2010.10.003; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; Song JH, 2011, CANCER RES, V71, P506, DOI 10.1158/0008-5472.CAN-10-1977; Sui MH, 2006, INT J CANCER, V119, P712, DOI 10.1002/ijc.21743; Sumikawa T, 2008, INT J ONCOL, V32, P683; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Tan XL, 2011, CLIN CANCER RES, V17, P5801, DOI 10.1158/1078-0432.CCR-11-1133; Villalonga-Planells R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018588; Wagenblast J, 2009, ONCOL REP, V22, P171, DOI 10.3892/or_00000421; Wang H, 2004, CLIN CANCER RES, V10, P1633, DOI 10.1158/1078-0432.CCR-0829-3; Wang Q, 2011, INT J CANCER, V128, P1546, DOI 10.1002/ijc.25482; Weichhart T, 2011, BLOOD, V117, P4273, DOI 10.1182/blood-2010-09-310888; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Xu N, 2012, ACTA PHARMACOL SIN, V33, P675, DOI 10.1038/aps.2011.188; Yang N, 2011, HEPATO-GASTROENTEROL, V58, P1730, DOI 10.5754/hge11153; Zhang C, 2006, CANCER BIOL THER, V5, P59, DOI 10.4161/cbt.5.1.2272; Zhang CW, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-61; Zhang Y, 2012, J CELL PHYSIOL, V227, P35, DOI 10.1002/jcp.22722	53	30	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51821	10.1371/journal.pone.0051821	http://dx.doi.org/10.1371/journal.pone.0051821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272171	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300031
J	Kao, YC; Jiang, SJ; Pan, WA; Wang, KC; Chen, PK; Wei, HJ; Chen, WS; Chang, BI; Shi, GY; Wu, HL				Kao, Yuan-Chung; Jiang, Shinn-Jong; Pan, Wen-An; Wang, Kuan-Chieh; Chen, Po-Ku; Wei, Hsi-Ju; Chen, Wei-Sheng; Chang, Bi-Ing; Shi, Guey-Yueh; Wu, Hua-Lin			The Epidermal Growth Factor-like Domain of CD93 Is a Potent Angiogenic Factor	PLOS ONE			English	Article							LECTIN-LIKE RECEPTOR; ENDOTHELIAL-CELLS; C1Q-MEDIATED ENHANCEMENT; AA4 ANTIGEN; IN-VITRO; C1QR(P); PHAGOCYTOSIS; SURFACE; THROMBOMODULIN; EXPRESSION	Human CD93, an epidermal growth factor (EGF)-like domain containing transmembrane protein, is predominantly expressed in the vascular endothelium. Studies have shown that AA4, the homolog of CD93 in mice, may mediate cell migration and angiogenesis in endothelial cells. Soluble CD93 has been detected in the plasma of healthy individuals. However, the role of soluble CD93 in the endothelium remains unclear. Recombinant soluble CD93 proteins with EGF-like domains (rCD93D123, with domains 1, 2, and 3; and rCD93D23, with domains 2 and 3) were generated to determine their functions in angiogenesis. We found that rCD93D23 was more potent than rCD93D123 in stimulating the proliferation and migration of human umbilical vein endothelial cells (HUVECs). Production of matrix-metalloproteinase 2 increased after the HUVECs were treated with rCD93D23. Further, in a tube formation assay, rCD93D23 induced cell differentiation of HUVECs through phosphoinositide 3-kinase/Akt/endothelial nitric oxide synthase and extracellular signal-regulated kinases-1/2 signaling. Moreover, rCD93D23 promoted blood vessel formation in a Matrigel-plug assay and an oxygen-induced retinopathy model in vivo. Our findings suggest that the soluble EGF-like domain containing CD93 protein is a novel angiogenic factor acting on the endothelium.	[Kao, Yuan-Chung; Jiang, Shinn-Jong; Pan, Wen-An; Wang, Kuan-Chieh; Chen, Po-Ku; Wei, Hsi-Ju; Chen, Wei-Sheng; Chang, Bi-Ing; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Kao, Yuan-Chung; Jiang, Shinn-Jong; Pan, Wen-An; Wang, Kuan-Chieh; Chen, Po-Ku; Wei, Hsi-Ju; Chen, Wei-Sheng; Chang, Bi-Ing; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Cardiovasc Res Ctr, Tainan 70101, Taiwan; [Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Shi, GY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan.	gyshi@mail.ncku.edu.tw; halnwu@mail.ncku.edu.tw			National Science Council [NSC99-2323-B-006-003]; National Cheng Kung University through the Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Cheng Kung University through the Ministry of Education, Taiwan	This work was supported by the National Science Council grant NSC99-2323-B-006-003 and a grant from the "Aim for the Top University Plan" of the National Cheng Kung University through the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlson SS, 2005, J IMMUNOL, V175, P1239, DOI 10.4049/jimmunol.175.2.1239; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chung BH, 2009, PHYTOTHER RES; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Danet GH, 2002, P NATL ACAD SCI USA, V99, P10441, DOI 10.1073/pnas.162104799; Dean YD, 2000, J BIOL CHEM, V275, P34382, DOI 10.1074/jbc.M006229200; Dean YD, 2001, EUR J IMMUNOL, V31, P1370, DOI 10.1002/1521-4141(200105)31:5<1370::AID-IMMU1370>3.0.CO;2-B; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; Fonseca MI, 2001, J LEUKOCYTE BIOL, V70, P793; Garg P, 2011, AM J PHYSIOL-LUNG C, V301, pL79, DOI 10.1152/ajplung.00287.2010; Greenlee MC, 2009, INFLAMM RES, V58, P909, DOI 10.1007/s00011-009-0064-0; GUAN E, 1994, J IMMUNOL, V152, P4005; Ikewaki N, 2007, MICROBIOL IMMUNOL, V51, P1189, DOI 10.1111/j.1348-0421.2007.tb04014.x; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kanno Y, 2006, J THROMB HAEMOST, V4, P1602, DOI 10.1111/j.1538-7836.2006.01978.x; Koch AE, 2000, ANN RHEUM DIS, V59, P65, DOI 10.1136/ard.59.suppl_1.i65; KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0; Kuo CH, 2012, BLOOD, V119, P1302, DOI 10.1182/blood-2011-08-376038; Larsen AK, 2011, PHARMACOL THERAPEUT, V131, P80, DOI 10.1016/j.pharmthera.2011.03.012; Lee OH, 2000, BRIT J CANCER, V82, P385; Maharjan S, 2011, EUR J PHARMACOL, V657, P35, DOI 10.1016/j.ejphar.2011.01.040; Malarstig A, 2011, J INTERN MED, V270, P229, DOI 10.1111/j.1365-2796.2011.02364.x; McGreal EP, 2002, J IMMUNOL, V168, P5222, DOI 10.4049/jimmunol.168.10.5222; Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7; Nepomuceno RR, 1998, J IMMUNOL, V160, P1929; Nepomuceno RR, 1999, J IMMUNOL, V162, P3583; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; Park CC, 2001, J IMMUNOL, V167, P1644, DOI 10.4049/jimmunol.167.3.1644; Park M, 2003, J CELL PHYSIOL, V196, P512, DOI 10.1002/jcp.10332; PASSANITI A, 1992, LAB INVEST, V67, P519; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267; Shi CS, 2005, CIRCULATION, V111, P1627, DOI 10.1161/01.CIR.0000160364.05405.B5; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648	35	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51647	10.1371/journal.pone.0051647	http://dx.doi.org/10.1371/journal.pone.0051647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272129	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300020
J	Barnwal, RP; Agarwal, G; Chary, KVR				Barnwal, Ravi Pratap; Agarwal, Geetika; Chary, Kandala V. R.			Guanidine-HCl Dependent Structural Unfolding of M-Crystallin: Fluctuating Native State Like Topologies and Intermolecular Association	PLOS ONE			English	Article							AMINO-ACID-RESIDUES; BACKBONE DYNAMICS; LENS CRYSTALLINS; SECONDARY STRUCTURE; PROTEIN RESPONSE; NMR-SPECTROSCOPY; DENATURED STATE; PRION PROTEIN; CA2+ BINDING; DISEASE	Numerous experimental techniques and computational studies, proposed in recent times, have revolutionized the understanding of protein-folding paradigm. The complete understanding of protein folding and intermediates are of medical relevance, as the aggregation of misfolding proteins underlies various diseases, including some neurodegenerative disorders. Here, we describe the unfolding of M-crystallin, a beta gamma-crystallin homologue protein from archaea, from its native state to its denatured state using multidimensional NMR and other biophysical techniques. The protein, which was earlier characterized to be a predominantly beta-sheet protein in its native state, shows different structural propensities (alpha and beta), under different denaturing conditions. In 2 M GdmCl, the protein starts showing two distinct sets of peaks, with one arising from a partially unfolded state and the other from a completely folded state. The native secondary structural elements start disappearing as the denaturant concentration approaches 4 M. Subsequently, the protein is completely unfolded when the denaturant concentration is 6 M. The N-15 relaxation data (T-1/T-2), heteronuclear H-1-N-15 Overhauser effects (nOes), NOESY data, and other biophysical data taken together indicate that the protein shows a consistent, gradual change in its structural and motional preferences with increasing GdmCl concentration.	[Barnwal, Ravi Pratap; Agarwal, Geetika; Chary, Kandala V. R.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Barnwal, RP (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	barnwal@u.washington.edu; chary@tifr.res.in	Barnwal, Ravi Pratap/G-7191-2012	Barnwal, Ravi Pratap/0000-0003-3156-5357	Department of Science and Technology; Department of Biotechnology; Council of Scientific and Industrial Research; Tata Institute of Fundamental Research, Mumbai	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Tata Institute of Fundamental Research, Mumbai	The facilities provided by the National Facility for High Field NMR, and the support of the Department of Science and Technology, Department of Biotechnology, Council of Scientific and Industrial Research, and Tata Institute of Fundamental Research, Mumbai, are greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstedt K, 2004, J MOL BIOL, V342, P619, DOI 10.1016/j.jmb.2004.07.024; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Barnwal RP, 2011, PROTEINS, V79, P569, DOI 10.1002/prot.22905; Barnwal RP, 2009, BIOMOL NMR ASSIGN, V3, P107, DOI 10.1007/s12104-009-9152-x; Barnwal RP, 2008, J BIOMOL NMR, V42, P149, DOI 10.1007/s10858-008-9273-z; Barnwal RP, 2008, J BIOMOL NMR, V41, P191, DOI 10.1007/s10858-008-9254-2; Barnwal RP, 2007, J BIOMOL NMR, V39, P259, DOI 10.1007/s10858-007-9200-8; Barnwal RP, 2009, J MOL BIOL, V386, P675, DOI 10.1016/j.jmb.2008.12.058; Barnwal RP, 2008, CURR SCI, V94, P5; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Benedek GB, 1997, INVEST OPHTH VIS SCI, V38, P1911; Bevington PR, 2003, DATA REDUCTION ERROR, Vxi; Bezsonova I, 2007, J AM CHEM SOC, V129, P1826, DOI 10.1021/ja065173o; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chary K. V. R., 2008, NMR BIOL SYSTEMS MOL; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 1998, NAT STRUCT BIOL, V5, P499, DOI 10.1038/739; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eliezer D, 2000, BIOCHEMISTRY-US, V39, P2894, DOI 10.1021/bi992545f; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Felitsky DJ, 2008, P NATL ACAD SCI USA, V105, P6278, DOI 10.1073/pnas.0710641105; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Gerum C, 2009, ANGEW CHEM INT EDIT, V48, P9452, DOI 10.1002/anie.200903771; Gong H, 2008, P NATL ACAD SCI USA, V105, P3321, DOI 10.1073/pnas.0712240105; Hung HC, 2003, B MATH BIOL, V65, P553, DOI 10.1016/S0092-8240(03)00024-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kazmirski SL, 1998, J MOL BIOL, V277, P487, DOI 10.1006/jmbi.1998.1634; Kazmirski SL, 1998, J MOL BIOL, V284, P793, DOI 10.1006/jmbi.1998.2192; Kazmirski SL, 2001, P NATL ACAD SCI USA, V98, P4349, DOI 10.1073/pnas.071054398; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; KORDEL J, 1992, BIOCHEMISTRY-US, V31, P4856; Kretschmar W, 1999, J MOL BIOL, V289, P701, DOI 10.1006/jmbi.1999.2833; Kudo T, 2002, ANN NY ACAD SCI, V977, P349, DOI 10.1111/j.1749-6632.2002.tb04837.x; Kumar A, 2006, BIOPHYS J, V90, P2498, DOI 10.1529/biophysj.105.071746; Kumar A, 2006, J MOL BIOL, V361, P180, DOI 10.1016/j.jmb.2006.06.003; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; Lundstrom P, 2005, P NATL ACAD SCI USA, V102, P16984, DOI 10.1073/pnas.0504361102; Ma B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.100; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; Mishra A, 2012, J MOL BIOL, V415, P75, DOI 10.1016/j.jmb.2011.10.037; Mok KH, 2007, NATURE, V447, P106, DOI 10.1038/nature05728; Patel S, 2004, BIOCHEMISTRY-US, V43, P1724, DOI 10.1021/bi0347104; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Santucci R, 2008, MINI-REV MED CHEM, V8, P57, DOI 10.2174/138955708783331522; Scheibel T, 2006, HANDB EXP PHARM, V172, P199; Scriven P, 2007, J MOL MED, V85, P331, DOI 10.1007/s00109-006-0150-5; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Silva JL, 2006, BBA-PROTEINS PROTEOM, V1764, P443, DOI 10.1016/j.bbapap.2005.11.012; Sinha D, 2012, TRANSGENIC RES, V21, P1033, DOI 10.1007/s11248-012-9608-0; Slavotinek AM, 2001, TRENDS GENET, V17, P528, DOI 10.1016/S0168-9525(01)02413-1; Solomon B, 2002, CURR MED CHEM, V9, P1737; Suman SK, 2011, J BIOL CHEM, V286, P43891, DOI 10.1074/jbc.M111.247890; Wenk M, 1998, EUR J BIOCHEM, V255, P604, DOI 10.1046/j.1432-1327.1998.2550604.x; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISTOW G, 1990, J MOL EVOL, V30, P140, DOI 10.1007/BF02099940; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	62	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e42948	10.1371/journal.pone.0042948	http://dx.doi.org/10.1371/journal.pone.0042948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284604	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900001
J	Gautrey, HL; Tyson-Capper, AJ				Gautrey, Hannah L.; Tyson-Capper, Alison J.			Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells	PLOS ONE			English	Article							SPLICING FACTOR SF2/ASF; HUMAN BREAST-CANCER; TRANSLATIONAL CONTROL; APOPTOSIS; IDENTIFICATION; PROTOONCOGENE; EXPRESSION; OLIGONUCLEOTIDES; PROLIFERATION; CARCINOMA	Up-regulation of the apoptosis-regulatory gene Mcl-1 (myeloid cell leukemia-1) occurs in different cancer types and is linked with drug resistance to cancer therapies. It is well known that Mcl-1 pre-mRNA undergoes alternative splicing events to produce two functionally distinct proteins, Mcl-1S (pro-apoptotic) and Mcl-lL (anti-apoptotic); the latter isoform is predominant in different cancers including breast and ovarian cancer cells. In the present study we report that the RNA-binding protein (RBP) and proto-oncogene SRSF1 (serine and arginine-rich splicing factor 1) influences splicing of Mcl-1 in both MCF-7 and MDA-MB-231 breast cancer cells and JAR choriocarcinoma cells; we also show for the first time that another RBP SRSF5 affects splicing of Mcl-1 in the MCF-7 cells. Moreover, we report that SRSF1 is involved in other aspects of Mcl-1 regulation with knockdown of SRSF1, by RNAi, resulting in a significant decrease in Mcl-1 protein levels in MCF-7 cells but an increase in JAR cells, respectively, by potentially affecting protein stability and translation of Mcl-l. The key findings from this study highlight the importance of the cellular context of different cancer cells for the function of multifunctional RBPs like SRSF1 and have implications for therapeutic approaches employed to target Mcl-1.	[Gautrey, Hannah L.; Tyson-Capper, Alison J.] Newcastle Univ, Inst Cellular Med, Fac Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Tyson-Capper, AJ (corresponding author), Newcastle Univ, Inst Cellular Med, Fac Med Sci, Framlington Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Alison.Tyson-Capper@ncl.ac.uk			JGW Patterson Foundation; Newcastle Healthcare Charity (RVI/NGH); Newcastle upon Tyne Hospitals NHS Charity	JGW Patterson Foundation; Newcastle Healthcare Charity (RVI/NGH); Newcastle upon Tyne Hospitals NHS Charity	This work was supported by a grant awarded from the JGW Patterson Foundation and supplementary funding from the Newcastle Healthcare Charity (RVI/NGH) and Newcastle upon Tyne Hospitals NHS Charity (FH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Benjamin CW, 1998, MOL PHARMACOL, V53, P446, DOI 10.1124/mol.53.3.446; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Bushell M, 2008, MOL CELL, V30, P262, DOI 10.1016/j.molcel.2008.04.007; Chetoui N, 2008, MOL CANCER RES, V6, P42, DOI 10.1158/1541-7786.MCR-07-0080; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Goncalves V, 2009, HUM MOL GENET, V18, P3696, DOI 10.1093/hmg/ddp317; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Huang CS, 2007, CLIN CHIM ACTA, V384, P69, DOI 10.1016/j.cca.2007.06.001; Jia R, 2010, INT J BIOL SCI, V6, P806; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Mitchell C, 2010, CANCER BIOL THER, V10, P907, DOI 10.4161/cbt.10.9.13273; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Olshavsky NA, 2010, CANCER RES, V70, P3975, DOI 10.1158/0008-5472.CAN-09-3468; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shieh JJ, 2009, J INVEST DERMATOL, V129, P2497, DOI 10.1038/jid.2009.83; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Venables JP, 2008, CANCER RES, V68, P9525, DOI 10.1158/0008-5472.CAN-08-1769; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	36	60	65	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51497	10.1371/journal.pone.0051497	http://dx.doi.org/10.1371/journal.pone.0051497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284704	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900025
J	Neron, S; Roy, A; Dumont, N				Neron, Sonia; Roy, Annie; Dumont, Nellie			Large-Scale In Vitro Expansion of Polyclonal Human Switched-Memory B Lymphocytes	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; EPSTEIN-BARR-VIRUS; CD40 STIMULATION; T-CELLS; INTRAVENOUS IMMUNOGLOBULIN; THERAPEUTIC ANTIBODIES; CANCER-IMMUNOTHERAPY; LIGAND; IGG; SUBPOPULATIONS	Polyclonal preparations of therapeutic immunoglobulins, namely intravenous immunoglobulins (IVIg), are essential in the treatment of immunodeficiency and are increasingly used for the treatment of autoimmune and inflammatory diseases. Currently, patients' accessibility to IVIg depends exclusively upon volunteer blood donations followed by the fractionation of pooled human plasma obtained from thousands of individuals. Presently, there are no in vitro cell culture procedures allowing the preparation of polyclonal human antibodies. All in vitro human therapeutic antibodies that are currently generated are based on monoclonal antibodies, which are mostly issued from genetic engineering or single cell antibody technologies. Here, we describe an in vitro cell culture system, using CD40-CD154 interactions, that leads to a 1x10(6)-fold expansion of switched memory B lymphocytes in approximately 50 days. These expanded cells secrete polyclonal IgG, which distribution into IgG(1), IgG(2), IgG(3) and IgG(4) is similar to that of normal human serum. Such in vitro generated IgG showed relatively low self-reactivity since they interacted moderately with only 24 human antigens among a total of 9484 targets. Furthermore, up to one liter of IgG secreting cells can be produced in about 40 days. This experimental model, providing large-scale expansion of human B lymphocytes, represents a critical step toward the in vitro production of polyclonal human IgG and a new method for the ex vivo expansion of B cells for therapeutic purposes.	[Neron, Sonia; Roy, Annie; Dumont, Nellie] Hema Quebec, Ingn Cellulaire, Rech & Dev, Quebec City, PQ, Canada; [Neron, Sonia] Univ Laval, Fac Sci & Genie, Dept Biochim & Microbiol, Quebec City, PQ G1K 7P4, Canada	Hema-Quebec; Laval University	Neron, S (corresponding author), Hema Quebec, Ingn Cellulaire, Rech & Dev, Quebec City, PQ, Canada.	sonia.neron@hema-quebec.qc.ca						Al Tabaa Y, 2009, BLOOD, V113, P604, DOI 10.1182/blood-2008-02-136903; Ballow M, 2009, CLIN EXP IMMUNOL, V158, P14, DOI [10.1111/j.1365-2249.2009.04023.X, 10.1111/j.1365-2249.2009.04023.x]; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Beerli RR, 2010, MABS, P2; Bussone G, 2009, PROTEOMICS, V9, P2253, DOI 10.1002/pmic.200800819; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Deneys V, 2001, J IMMUNOL METHODS, V253, P23, DOI 10.1016/S0022-1759(01)00338-6; Ducas E, 2009, J IMMUNOL METHODS, V344, P133, DOI 10.1016/j.jim.2009.03.009; Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.X, 10.1111/j.1365-2249.2009.04022.x]; Elovaara I, 2010, ACTA NEUROL SCAND, V122, P309, DOI 10.1111/j.1600-0404.2009.01317.x; Fecteau JF, 2009, IMMUNOLOGY, V128, pe353, DOI 10.1111/j.1365-2567.2008.02976.x; Fecteau JF, 2003, J IMMUNOL, V171, P4621, DOI 10.4049/jimmunol.171.9.4621; Frandsen TP, 2011, BIOTECHNOL BIOENG, V108, P2171, DOI 10.1002/bit.23166; HAMILTON RG, 1987, CLIN CHEM, V33, P1707; Johansson C, 2005, CLIN EXP IMMUNOL, V141, P279, DOI 10.1111/j.1365-2249.2005.02843.x; Kondo E, 2009, CLIN EXP IMMUNOL, V155, P249, DOI 10.1111/j.1365-2249.2008.03820.x; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lapointe R, 2003, CANCER RES, V63, P2836; Neron S, 1996, IMMUNOL INVEST, V25, P79; Neron S, 2006, INT IMMUNOL, V18, P375, DOI 10.1093/intimm/dxh377; Neron S, 2005, IMMUNOLOGY, V116, P454, DOI 10.1111/j.1365-2567.2005.02244.x; Neron S, 2011, ADV MED BIOL, P145; Neron S, 2012, BIOCH ANAL BIOCH S, pS8, DOI [10.4172/2161-1009.S4178-4001, DOI 10.4172/2161-1009.S4178-4001]; Neron S, 2007, TRANSFUSION, V47, P1042, DOI 10.1111/j.1537-2995.2007.01233.x; Neron S, 2011, ARCH IMMUNOL THER EX, V59, P25, DOI 10.1007/s00005-010-0108-8; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Radosevich M, 2010, VOX SANG, V98, P12, DOI 10.1111/j.1423-0410.2009.01226.x; Robak T, 2011, ASH ANN M, V118, P527; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Roughan JE, 2010, J VIROL, V84, P1158, DOI 10.1128/JVI.01780-09; Roughan JE, 2009, J VIROL, V83, P3968, DOI 10.1128/JVI.02609-08; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; Schultze JL, 2004, TRENDS IMMUNOL, V25, P659, DOI 10.1016/j.it.2004.09.016; Souza TA, 2007, J IMMUNOL, V179, P3153, DOI 10.4049/jimmunol.179.5.3153; Tiller T, 2011, NEW BIOTECHNOL, V28, P453, DOI 10.1016/j.nbt.2011.03.014; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Waltz E, 2006, NAT BIOTECHNOL, V24, P1181, DOI 10.1038/nbt1006-1181; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wiesner M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001464; Wu C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-370; Zheng J, 2010, CELL MOL IMMUNOL, V7, P44, DOI 10.1038/cmi.2009.103	44	11	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51946	10.1371/journal.pone.0051946	http://dx.doi.org/10.1371/journal.pone.0051946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284827	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900065
J	McLernon, DJ; Dillon, JF; Sullivan, FM; Roderick, P; Rosenberg, WM; Ryder, SD; Donnan, PT				McLernon, David J.; Dillon, John F.; Sullivan, Frank M.; Roderick, Paul; Rosenberg, William M.; Ryder, Stephen D.; Donnan, Peter T.			The Utility of Liver Function Tests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI)	PLOS ONE			English	Article							RECORD-LINKAGE; DISEASE; MODEL; RISK; SURVIVAL; POPULATION; EPIDEMIOLOGY; VALIDATION; PROGNOSIS; METFORMIN	Background: Although liver function tests (LFTs) are routinely measured in primary care, raised levels in patients with no obvious liver disease may trigger a range of subsequent expensive and unnecessary management plans. The aim of this study was to develop and validate a prediction model to guide decision-making by general practitioners, which estimates risk of one year all-cause mortality in patients with no obvious liver disease. Methods: In this population-based historical cohort study, biochemistry data from patients in Tayside, Scotland, with LFTs performed in primary care were record-linked to secondary care and prescription databases to ascertain baseline characteristics, and to mortality data. Using this derivation cohort a survival model was developed to predict mortality. The model was assessed for calibration, discrimination (using the C-statistic) and performance, and validated using a separate cohort of Scottish primary care practices. Results: From the derivation cohort (n = 95 977), 2.7% died within one year. Predictors of mortality included: age; male gender; social deprivation; history of cancer, renal disease, stroke, ischaemic heart disease or respiratory disease; statin use; and LFTs (albumin, transaminase, alkaline phosphatase, bilirubin, and gamma-glutamyltransferase). The C-statistic for the final model was 0.82 (95% CI 0.80-0.84), and was similar in the validation cohort (n = 11 653) 0.86 (0.79-0.90). As an example of performance, for a 10% predicted probability cut-off, sensitivity = 52.8%, specificity = 94.0%, PPV = 21.0%, NPV = 98.5%. For the model without LFTs the respective values were 43.8%, 92.8%, 15.6%, 98.1%. Conclusions: The Algorithm for Liver Function Investigations (ALFI) is the first model to successfully estimate the probability of all-cause mortality in patients with no apparent liver disease having LFTs in primary care. While LFTs added to the model's discrimination and sensitivity, the clinical utility of ALFI remains to be established since LFTs did not improve an already high NPV for short term mortality and only modestly improved a very low PPV. Citation: McLernon DJ, Dillon JF, Sullivan FM, Roderick P, Rosenberg WM, et al. (2012) The Utility of Liver Function Tests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI). PLoS ONE 7(12): e50965. doi:10.1371/journal.pone.0050965	[McLernon, David J.] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland; [Dillon, John F.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Sullivan, Frank M.; Donnan, Peter T.] Univ Dundee, Med Res Inst, Div Populat Hlth Sci, Dundee, Scotland; [Roderick, Paul] Univ Southampton, Fac Med, Acad Unit Primary Care & Populat Sci, Southampton SO9 5NH, Hants, England; [Rosenberg, William M.] UCL, Div Med, Ctr Hepatol, London, England; [Rosenberg, William M.] UCL, ULCH UCL NIHR Biomed Res Ctr, London, England; [Ryder, Stephen D.] Nottingham Univ Hosp NHS Trust, Dept Gastroenterol, Nottingham, England; [Ryder, Stephen D.] Biomed Res Unit, Nottingham, England	University of Aberdeen; University of Dundee; University of Dundee; University of Southampton; University of London; University College London; University of London; University College London; Nottingham University Hospital NHS Trust	McLernon, DJ (corresponding author), Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland.	d.mclernon@abdn.ac.uk	Rosenberg, William/ABA-1071-2021; McLernon, David/D-5167-2012; Sullivan, Frank/L-8286-2019	Rosenberg, William/0000-0002-2732-2304; McLernon, David/0000-0001-8905-2429; Sullivan, Frank/0000-0002-6623-4964; Donnan, Peter/0000-0001-7828-0610; Ryder, Stephen David/0000-0001-9649-4444; Dillon, John/0000-0002-2164-4476	National Health Service Research & Development Programme Health Technology Assessment Programme [03/38/02]; Backett Weir Russell Career Development Fellowship; UK National Health Service Research & Development Programme Health Technology Assessment Programme; National Institute for Health Research [03/38/02] Funding Source: researchfish	National Health Service Research & Development Programme Health Technology Assessment Programme; Backett Weir Russell Career Development Fellowship; UK National Health Service Research & Development Programme Health Technology Assessment Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the National Health Service Research & Development Programme Health Technology Assessment Programme (project number 03/38/02) and the Backett Weir Russell Career Development Fellowship. Department of Health Disclaimer: The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: DJM (while employed by the University of Dundee), PTD, JFD, and FMS declare financial support to their institutions for the submitted work from the UK National Health Service Research & Development Programme Health Technology Assessment Programme. DJM declares financial support to his institution for the submitted work from the Backett Weir Russell Career Development Fellowship. SR received reimbursement of travel costs to attend study meetings from the UK National Health Service Research & Development Programme Health Technology Assessment Programme grant. PR and WMR have no competing interests to declare.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Armstrong MJ, 2012, J HEPATOL, V56, P234, DOI 10.1016/j.jhep.2011.03.020; CARSTAIRS V, 1989, COMMUNITY MED, V11, P210, DOI 10.1093/oxfordjournals.pubmed.a042469; Chambless LE, 2011, STAT MED, V30, P22, DOI 10.1002/sim.4026; Clinical Practice Research Datalink, 2012, WELCOME TO THE CLINI; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Donnan PT, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13250; Donnan PT, 2008, ARCH INTERN MED, V168, P1416, DOI 10.1001/archinte.168.13.1416; Donnan PT, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-54; Donnan PT, 2004, BRIT MED J, V328, P1297, DOI 10.1136/bmj.328.7451.1297; Donnan PT, 2009, HEALTH TECHNOL ASSES, V13, pix; Dorans K, 2009, NAT MED, V15, P226, DOI 10.1038/nm0309-226a; Evans JMM, 1999, BRIT J CLIN PHARMACO, V47, P105, DOI 10.1046/j.1365-2125.1999.00853.x; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; McLernon DJ, 2009, FAM PRACT, V26, P251, DOI 10.1093/fampra/cmp025; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Morris AD, 1997, BMJ-BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524; NHS National Services Scotland, 2012, SMR01 GENERAL ACUTE; NHS National Services Scotland, 2011, GENERAL PRACTICE PRA; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Roderick P, 2004, BMJ-BRIT MED J, V328, P987, DOI 10.1136/bmj.328.7446.987; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Rubin DB, 2004, MULTIPLE IMPUTATION; Schalk BWM, 2006, AM J EPIDEMIOL, V164, P969, DOI 10.1093/aje/kwj312; Sherwood P, 2001, BRIT MED J, V322, P276, DOI 10.1136/bmj.322.7281.276; SORENSEN HT, 1991, DAN MED BULL, V38, P420; Soriano S, 2007, CLIN NEPHROL, V67, P352; Steinke DT, 2002, J BIOMED INFORM, V35, P186, DOI 10.1016/S1532-0464(02)00526-9; Steinke DT, 2002, GUT, V50, P100, DOI 10.1136/gut.50.1.100; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Steyerberg E., 2009, CLIN PREDICTION MODE; Swierczynski J, 2009, OBES SURG, V19, P883, DOI 10.1007/s11695-008-9521-z; Theal RM, 1996, AM FAM PHYSICIAN, V53, P2111; University of Aberdeen, PRIMARY CARE CLINICA; University of Dundee, 2012, HEALTH INFORMATICS C; Zhang ZJ, 2012, J CLIN ENDOCR METAB, V97, P2347, DOI 10.1210/jc.2012-1267; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50965	10.1371/journal.pone.0050965	http://dx.doi.org/10.1371/journal.pone.0050965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272082	Green Accepted, Green Published, gold			2022-12-25	WOS:000312386800023
J	Tu, HF; Liu, CJ; Chang, CL; Wang, PW; Kao, SY; Yang, CC; Yu, EH; Lin, SC; Chang, KW				Tu, Hsi-Feng; Liu, Chung-Ji; Chang, Che-Lun; Wang, Pei-Wen; Kao, Shou-Yen; Yang, Cheng-Chieh; Yu, En-Hao; Lin, Shu-Chun; Chang, Kuo-Wei			The Association between Genetic Polymorphism and the Processing Efficiency of miR-149 Affects the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							GASTRIC-CANCER; MICRORNA; EXPRESSION; RISK; APOPTOSIS; SURVIVAL; LIN28; URIDYLATION; VARIANTS; TONGUE	MicroRNAs (miRNAs) play important roles in modulating the neoplastic process of cancers including head and neck squamous cell carcinoma (HNSCC). A genetic polymorphism (rs2292832, C.T) has been recently identified in the precursor of miR-149; nevertheless its clinicopathological implications remain obscure. In this study, we showed that miR-149 is down-regulated in HNSCC compared to normal mucosa and this is associated with a poorer patient survival. In addition, HNSCC patients with the T/T genotype have more advanced tumors and a worse prognosis. Multivariate analysis indicated that patients carried the T/T genotype have a 2.81-fold (95% CI: 1.58-4.97) increased risk of nodal metastasis and 1.66-fold (95% CI: 1.05-2.60) increased risk of mortality compared to other groups. T/T genotype also predicted the worse prognosis of buccal mucosa carcinoma subset of HNSCC. In vitro analysis indicated that exogenous miR-149 expression reduces the migration of HNSCC cells. Moreover, HNSCC cell subclones carrying the pri-mir-149 sequence containing the T variant show a low processing efficacy when converting the pre-mir-149 to mature miR-149. These findings suggest that miR-149 suppresses tumor cell mobility, and that the pre-mir-149 polymorphism may affect the processing of miR-149, resulting in a change in the abundance of the mature form miRNA, which, in turn, modulates tumor progression and patient survival. Citation: Tu H-F, Liu C-J, Chang C-L, Wang P-W, Kao S-Y, et al. (2012) The Association between Genetic Polymorphism and the Processing Efficiency of miR-149 Affects the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. PLoS ONE 7(12): e51606. doi:10.1371/journal.pone.0051606	[Kao, Shou-Yen; Yang, Cheng-Chieh; Lin, Shu-Chun; Chang, Kuo-Wei] Taipei Vet Gen Hosp, Dept Stomatol, Taipei, Taiwan; [Wang, Pei-Wen; Lin, Shu-Chun] Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan; [Tu, Hsi-Feng; Liu, Chung-Ji; Kao, Shou-Yen; Yang, Cheng-Chieh; Yu, En-Hao; Lin, Shu-Chun; Chang, Kuo-Wei] Natl Yang Ming Univ, Dept Dent, Taipei 112, Taiwan; [Tu, Hsi-Feng; Yu, En-Hao] Natl Yang Ming Univ Hosp, Dept Dent, Ilan, Taiwan; [Liu, Chung-Ji; Chang, Che-Lun] MacKay Mem Hosp, Dept Oral & Maxillofacial Surg, Taipei, Taiwan; [Liu, Chung-Ji] MacKay Med Coll, New Taipei City, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Medical College	Lin, SC (corresponding author), Taipei Vet Gen Hosp, Dept Stomatol, Taipei, Taiwan.	sclin@ym.edu.tw; ckcw@ym.edu.tw			National Yang Ming University Hospital [RD2010-003]; National Science Council in Taiwan [NSC98-2314-B-010-017-MY2, NSC-99-2628-B-195-002-MY3, NSC-99-2628-B-010-012-MY3]	National Yang Ming University Hospital; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from National Yang Ming University Hospital (RD2010-003) and National Science Council (NSC98-2314-B-010-017-MY2; NSC-99-2628-B-195-002-MY3, NSC-99-2628-B-010-012-MY3) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; [Anonymous], 2011, MOL CARCINOG; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030585; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hoffman AE, 2009, CANC RES; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hung PS, 2008, J PERIODONTAL RES, V43, P673, DOI 10.1111/j.1600-0765.2007.01070.x; Hung PS, 2012, ORAL ONCOL, V48, P404, DOI 10.1016/j.oraloncology.2011.11.019; Jeong Chang-hee, 2009, Journal of Periodontal & Implant Science, V39, P253; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Li D, 2011, OMICS, V15, P673, DOI 10.1089/omi.2011.0064; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031615; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu CJ, 2004, J ORAL PATHOL MED, V33, P327, DOI 10.1111/j.1600-0714.2004.00092.x; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Lo WL, 2011, J PATHOL, V223, P482, DOI 10.1002/path.2826; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sharan RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042759; Shieh TM, 2007, CLIN CANCER RES, V13, P4378, DOI 10.1158/1078-0432.CCR-06-2685; Vinci S, 2011, CLIN CHEM LAB MED; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x	42	45	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51606	10.1371/journal.pone.0051606	http://dx.doi.org/10.1371/journal.pone.0051606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272122	Green Submitted, gold, Green Published			2022-12-25	WOS:000312386800056
J	Odafe, S; Torpey, K; Khamofu, H; Ogbanufe, O; Oladele, EA; Kuti, O; Adedokun, O; Badru, T; Okechukwu, E; Chabikuli, O				Odafe, Solomon; Torpey, Kwasi; Khamofu, Hadiza; Ogbanufe, Obinna; Oladele, Edward A.; Kuti, Oluwatosin; Adedokun, Oluwasanmi; Badru, Titilope; Okechukwu, Emeka; Chabikuli, Otto			The Pattern of Attrition from an Antiretroviral Treatment Program in Nigeria	PLOS ONE			English	Article							SOUTH-AFRICA; THERAPY; OUTCOMES; MORTALITY; ADULTS; CHALLENGES; TENOFOVIR; CHILDREN; SERVICE; INCOME	Objective: To evaluate the rate and factors associated with attrition of patients receiving ART in tertiary and secondary hospitals in Nigeria. Methods and Findings: We reviewed patient level data collected between 2007 and 2010 from 11 hospitals across Nigeria. Kaplan-Meier product-limit and Cox regression were used to determine probability of retention in care and risk factors for attrition respectively. Of 6,408 patients in the cohort, 3,839 (59.9%) were females, median age of study population was 33years (IQR: 27-40) and 4,415 (69%) were from secondary health facilities. The NRTI backbone was Stavudine (D4T) in 3708 (57.9%) and Zidovudine (ZDV) in 2613 (40.8%) of patients. Patients lost to follow up accounted for 62.7% of all attrition followed by treatment stops (25.3%) and deaths (12.0%). Attrition was 14.1 (N = 624) and 15.1% (N = 300) in secondary and tertiary hospitals respectively (p = 0.169) in the first 12 months on follow up. During the 13 to 24 months follow up period, attrition was 10.7% (N = 407) and 19.6% (N = 332) in secondary and tertiary facilities respectively (p<0.001). Median time to lost to follow up was 11.1 (IQR: 6.1 to 18.5) months in secondary compared with 13.6 (IQR: 9.9 to 17.0) months in tertiary sites (p = 0.002). At 24 months follow up, male gender [AHR 1.18, 95% CI: 1.01-1.37, P = 0.038]; WHO clinical stage III [AHR 1.30, 95%CI: 1.03-1.66, P = 0.03] and clinical stage IV [AHR 1.90, 95%CI: 1.20-3.02, p = 0.007] and care in a tertiary hospital [AHR 2.21, 95% CI: 1.83-2.67, p<0.001], were associated with attrition. Conclusion: Attrition could potentially be reduced by decentralizing patients on ART after the first 12 months on therapy to lower level facilities, earlier initiation on treatment and strengthening adherence counseling amongst males. Citation: Odafe S, Torpey K, Khamofu H, Ogbanufe O, Oladele EA, et al. (2012) The Pattern of Attrition from an Antiretroviral Treatment Program in Nigeria. PLoS ONE 7(12): e51254. doi:10.1371/journal.pone.0051254	[Odafe, Solomon; Torpey, Kwasi; Khamofu, Hadiza; Ogbanufe, Obinna; Oladele, Edward A.; Kuti, Oluwatosin] Prevent Care & Treatment Dept, Abuja, Nigeria; [Adedokun, Oluwasanmi; Badru, Titilope] Monitoring & Evaluat Dept, Abuja, Nigeria; [Okechukwu, Emeka] HIV AIDS TB Unit USAID Nigeria, Abuja, Nigeria; [Chabikuli, Otto] Med Univ Southern Africa, Dept Family Med, Medusa, South Africa	Sefako Makgatho Health Sciences University	Odafe, S (corresponding author), Prevent Care & Treatment Dept, Abuja, Nigeria.	sfodafe@gmail.com	Okechukwu, Emeka Franklin/AAH-1130-2020; Fazli, Ghazal/AAE-8320-2022; Odafe, Solomon/AAJ-2390-2020	Oladele, Edward Adekola/0000-0003-4999-1397; Adedokun, Oluwasanmi/0000-0002-4678-9735; Torpey, Kwasi/0000-0003-1628-2922	FHI360's Global HIV/AIDS Initiative in Nigeria; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) [620-A-00-04-00122-00]	FHI360's Global HIV/AIDS Initiative in Nigeria; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this paper was provided by FHI360's Global HIV/AIDS Initiative in Nigeria with funds from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) Cooperative Agreement No. 620-A-00-04-00122-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brennan A, 2011, AIDS, V25, P1603, DOI 10.1097/QAD.0b013e32834957da; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Castelnuovo B, 2011, JAIDS-J ACQ IMM DEF, V56, P59, DOI 10.1097/QAI.0b013e3181f5bd03; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; Chi BH, 2010, JAIDS-J ACQ IMM DEF, V54, P63, DOI 10.1097/QAI.0b013e3181c6c65c; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Federal Ministry of Health (FMoH), 2007, NAT GUID HIV AIDS TR, P32; Federal Ministry of Health (FMoH), 2004, HLTH PLANN RES STAT; Federal Ministry of Health (FMoH), 2007, NAT GUID PAED HIV AI, p116to120; [Federal Ministry of Health (FMOH) National AIDS/STI Control Programme (NASCP)], 2007, INTRODUCTION, P12; Mateo MG, 2012, EXPERT OPIN DRUG SAF, V11, P473, DOI 10.1517/14740338.2012.676639; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Minga A, 2010, AIDS RES HUM RETROV, V26, P991, DOI 10.1089/aid.2009.0309; National Agency for the Control of AIDS (NACA), 2007, STRAT PLANN RES, P20; National agency for the control of AIDS (NACA), 2010, POL STRAT, P82; O'Brien DP, 2006, AIDS, V20, P1955, DOI 10.1097/01.aids.0000247117.66585.ce; Odafe S, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17424; Ratsela A, 2010, J INFECT DIS, V202, P1529, DOI 10.1086/656718; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rouet F, 2006, AIDS, V20, P2315, DOI 10.1097/QAD.0b013e328010943b; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tayler-Smith K, 2011, TROPICAL MED INT HLT, P16; UNAIDS, 2009, HIV AIDS EST NIG; UNAIDS, 2009, EP FACTSH; Unge C, 2008, AIDS CARE, V20, P146, DOI 10.1080/09540120701513677; Van Damme W, 2006, AIDS, V20, P653, DOI 10.1097/01.aids.0000216364.44409.b1; VERDUGO RM, 2007, FARM HOSP, V31, P200; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; WHO UNAIDS UNICEF, 2010, URB HEARTION, P4; World Health Organization (WHO) HIV/AIDS, 2006, PAT MON GUID HIV CAR, P30	40	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51254	10.1371/journal.pone.0051254	http://dx.doi.org/10.1371/journal.pone.0051254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272094	Green Submitted, gold, Green Published			2022-12-25	WOS:000312386600021
J	Xue, FM; Zhang, HP; Hao, HJ; Shi, ZY; Zhou, C; Feng, BS; Yang, PC				Xue, Fu-Min; Zhang, Huan-Ping; Hao, Hui-Jie; Shi, Zhao-Yang; Zhou, Chuan; Feng, Baisui; Yang, Ping-Chang			CD98 Positive Eosinophils Contribute to T Helper 1 Pattern Inflammation	PLOS ONE			English	Article							BOWEL-DISEASE; EPITHELIAL CD98; GALECTIN-3; ACTIVATION; MECHANISMS; ASTHMA; CELLS	Background and Aims: The pathogenesis of inflammatory bowel disease (IBD) has not been fully understood yet. Eosinophils (Eo) are one type of the major proinflammatory cells of the chronic inflammation in the intestine. CD98 is involved in the pathogenesis of a number of inflammations. This study aims to elucidate the role of CD98(+) Eos in the initiation of intestinal inflammation. Methods: The colon biopsies were collected from 60 patients with IBD. The expression of CD98 in the biopsies was examined by immunohistochemistry. The serum levels of the flagellin (FGN) antibody and Eo-derived mediators in the culture supernatants were assessed by enzyme-linked immunosorbent assay. The role of FGN on Eo activation was examined in a cell culture model. The role of FGN in the induction of colitis was observed in a mouse model. Results: Compared to normal controls, the frequency of CD98(+) Eos was markedly increased in the IBD colon mucosa. FGN were detected in the colon biopsies and in the sera of IBD patients. Exposure to FGN induced the expression of galectin 3 (the ligand of CD98) in dendritic cells. The exposure to galectin 3 activated the CD98(+) Eos. After treatment with FGN intrarectally, mice with eosinophilia showed severe inflammation in the colon. Conclusions: The interaction of galectin 3 and CD98 can induce Eos to release chemical mediators that contributes to the initiation of the intestinal inflammation.	[Zhang, Huan-Ping; Yang, Ping-Chang] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Xue, Fu-Min; Hao, Hui-Jie; Shi, Zhao-Yang; Zhou, Chuan; Feng, Baisui] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 1, Zhengzhou, Peoples R China	McMaster University; Zhengzhou University	Yang, PC (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	yangp@mcmaster.ca	Yang, Ping-Chang/K-4669-2019		Natural Science Foundation of China [81070288]; Canadian Institutes of Health Research [191063, 220058, 177843]; Natural Sciences, Engineering Research Council of Canada (NSERC) [371268]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences, Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by grants from the Natural Science Foundation of China (#81070288), the Canadian Institutes of Health Research (#191063, #220058 and #177843), Natural Sciences, Engineering Research Council of Canada (NSERC, #371268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broide DH, 2011, J ALLERGY CLIN IMMUN, V127, P689, DOI 10.1016/j.jaci.2011.01.027; Chiu CG, 2010, AM J PATHOL, V176, P2067, DOI 10.2353/ajpath.2010.090353; Dalton P, 2007, FEBS J, V274, P2715, DOI 10.1111/j.1742-4658.2007.05806.x; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Hang TTN, 2011, J CLIN INVEST, V121, P1733, DOI 10.1172/JCI44631; Kargili AE, 2004, RHEUMATOL INT, V24, P321, DOI 10.1007/s00296-004-0469-6; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Kucharzik T, 2005, LAB INVEST, V85, P932, DOI 10.1038/labinvest.3700289; Lamouse-Smith Esi S N, 2006, Curr Gastroenterol Rep, V8, P390, DOI 10.1007/s11894-006-0024-6; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Motomura Y, 2010, AM J PHYSIOL-GASTR L, V299, pG1354, DOI 10.1152/ajpgi.00324.2010; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Peterson CGB, 2002, AM J GASTROENTEROL, V97, P1755; Podolsky DK, 2003, J GASTROENTEROL, V38, P63; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P1008, DOI 10.1056/NEJM199110033251406; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Qiu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022004; Rao SP, 2007, J IMMUNOL, V179, P7800, DOI 10.4049/jimmunol.179.11.7800; Taha Y, 2001, DIGEST DIS SCI, V46, P888, DOI 10.1023/A:1010781224158; van Stijn CMW, 2009, MOL IMMUNOL, V46, P3292, DOI 10.1016/j.molimm.2009.07.026; von Wattenwyl F, 2001, EUR J GASTROEN HEPAT, V13, P721, DOI 10.1097/00042737-200106000-00018; Woodruff SA, 2011, J PEDIATR GASTR NUTR, V52, P650, DOI 10.1097/MPG.0b013e3182128512; Yan YT, 2008, BBA-GEN SUBJECTS, V1780, P1087, DOI 10.1016/j.bbagen.2008.06.007; Yanavitski Marat, 2011, Curr Heart Fail Rep, V8, P206, DOI 10.1007/s11897-011-0065-5	24	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51830	10.1371/journal.pone.0051830	http://dx.doi.org/10.1371/journal.pone.0051830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272174	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600042
J	Nakano, T; Miyamoto-Matsubara, M; Shoulkamy, MI; Salem, AMH; Pack, SP; Ishimi, Y; Ide, H				Nakano, Toshiaki; Miyamoto-Matsubara, Mayumi; Shoulkamy, Mahmoud I.; Salem, Amir M. H.; Pack, Seung Pil; Ishimi, Yukio; Ide, Hiroshi			Translocation and Stability of Replicative DNA Helicases upon Encountering DNA-Protein Cross-links	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ESCHERICHIA-COLI; HEXAMERIC HELICASE; STERIC EXCLUSION; BINDING-ACTIVITY; MCM HELICASE; UNWIND DNA; DUPLEX DNA; T-ANTIGEN; MECHANISM	DNA-protein cross-links (DPCs) are formed when cells are exposed to various DNA-damaging agents. Because DPCs are extremely large, steric hindrance conferred by DPCs is likely to affect many aspects of DNA transactions. In DNA replication, DPCs are first encountered by the replicative helicase that moves at the head of the replisome. However, little is known about how replicative helicases respond to covalently immobilized protein roadblocks. In the present study we elucidated the effect of DPCs on the DNA unwinding reaction of hexameric replicative helicases in vitro using defined DPC substrates. DPCs on the translocating strand but not on the nontranslocating strand impeded the progression of the helicases including the phage T7 gene 4 protein, simian virus 40 large T antigen, Escherichia coli DnaB protein, and human minichromosome maintenance Mcm467 subcomplex. The impediment varied with the size of the cross-linked proteins, with a threshold size for clearance of 5.0-14.1 kDa. These results indicate that the central channel of the dynamically translocating hexameric ring helicases can accommodate only small proteins and that all of the helicases tested use the steric exclusion mechanism to unwind duplex DNA. These results further suggest that DPCs on the translocating and nontranslocating strands constitute helicase and polymerase blocks, respectively. The helicases stalled by DPC had limited stability and dissociated from DNA with a half-life of 15-36 min. The implications of the results are discussed in relation to the distinct stabilities of replisomes that encounter tight but reversible DNA-protein complexes and irreversible DPC roadblocks.	[Nakano, Toshiaki; Miyamoto-Matsubara, Mayumi; Shoulkamy, Mahmoud I.; Ide, Hiroshi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Salem, Amir M. H.] Natl Res Ctr, Dept Pathol, Cairo 12311, Egypt; [Pack, Seung Pil] Korea Univ, Dept Biotechnol & Bioinformat, Jochiwon 339700, Sejong, South Korea; [Ishimi, Yukio] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan	Hiroshima University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Korea University; Ibaraki University	Ide, H (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan.	ideh@hiroshima-u.ac.jp	Shoulkamy, Mahmoud Ibrahim/AAV-9934-2020; Ide, Hiroshi/G-9042-2019; Salem, Amir/J-7562-2016	Shoulkamy, Mahmoud Ibrahim/0000-0002-4736-1212; Nakano, Toshiaki/0000-0002-5274-2909; Salem, Amir/0000-0001-5852-1501	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Marine Biomaterials Research Center grant from the Marine Biotechnology Program; Ministry of Land, Transport, and Maritime Affairs, Korea	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Marine Biomaterials Research Center grant from the Marine Biotechnology Program; Ministry of Land, Transport, and Maritime Affairs, Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea)	This work was supported in part by a grant-in-aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. I.), a grant-in-aid for Young Scientists (B) from the Japan Society for the Promotion of Science (to T. N.), and a Marine Biomaterials Research Center grant from the Marine Biotechnology Program funded by the Ministry of Land, Transport, and Maritime Affairs, Korea (to S. P. P.).	Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Chen HJC, 2008, CHEMBIOCHEM, V9, P1074, DOI 10.1002/cbic.200700686; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costa A, 2009, CRIT REV BIOCHEM MOL, V44, P326, DOI 10.1080/10409230903186012; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; ISHIMI Y, 1993, P NATL ACAD SCI USA, V90, P5399, DOI 10.1073/pnas.90.12.5399; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Jiao JF, 2003, J VIROL, V77, P12720, DOI 10.1128/JVI.77.23.12720-12728.2003; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Kumari A, 2010, J BIOL CHEM, V285, P21313, DOI 10.1074/jbc.M109.078964; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; McGlynn P, 2008, J MOL BIOL, V381, P249, DOI 10.1016/j.jmb.2008.05.053; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Nakano T, 2005, NUCLEIC ACIDS RES, V33, P2181, DOI 10.1093/nar/gki513; Nakano T, 2003, J BIOL CHEM, V278, P25264, DOI 10.1074/jbc.M212847200; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2012, J BIOL CHEM, V287, P6562, DOI 10.1074/jbc.M111.318410; Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174; Novakova O, 2003, NUCLEIC ACIDS RES, V31, P6450, DOI 10.1093/nar/gkg863; Numata Y, 2010, J BIOCHEM, V147, P917, DOI 10.1093/jb/mvq028; Pack SP, 2005, NUCLEIC ACIDS RES, V33, P5771, DOI 10.1093/nar/gki865; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Possoz C, 2006, EMBO J, V25, P2596, DOI 10.1038/sj.emboj.7601155; Salem AMH, 2009, J BACTERIOL, V191, P5657, DOI 10.1128/JB.00417-09; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Shin JH, 2007, J BIOL CHEM, V282, P4908, DOI 10.1074/jbc.M606847200; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Shoulkamy MI, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks601; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Veaute X, 2000, MUTAT RES-DNA REPAIR, V459, P19, DOI 10.1016/S0921-8777(99)00052-X; YANCEYWRONA JE, 1992, NUCLEIC ACIDS RES, V20, P6713, DOI 10.1093/nar/20.24.6713; Yong YQ, 1996, CHEM RES TOXICOL, V9, P179, DOI 10.1021/tx950112h	61	47	47	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4649	4658		10.1074/jbc.M112.419358	http://dx.doi.org/10.1074/jbc.M112.419358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283980	Green Published, hybrid			2022-12-25	WOS:000315340400014
J	Hallin, S; Welsh, A; Stenstrom, J; Hallet, S; Enwall, K; Bru, D; Philippot, L				Hallin, Sara; Welsh, Allana; Stenstrom, John; Hallet, Stephanie; Enwall, Karin; Bru, David; Philippot, Laurent			Soil Functional Operating Range Linked to Microbial Biodiversity and Community Composition Using Denitrifiers as Model Guild	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; ECOSYSTEM FUNCTION; NITROUS-OXIDE; DIVERSITY; BACTERIA; PRODUCTIVITY; ECOLOGY; FERTILIZATION; PHYLOGENIES; GRADIENTS	Soil microorganisms are key players in biogeochemical cycles. Yet, there is no consistent view on the significance of microbial biodiversity for soil ecosystem functioning. According to the insurance hypothesis, declines in ecosystem functioning due to reduced biodiversity are more likely to occur under fluctuating, extreme or rapidly changing environmental conditions. Here, we compare the functional operating range, a new concept defined as the complete range of environmental conditions under which soil microbial communities are able to maintain their functions, between four naturally assembled soil communities from a long-term fertilization experiment. A functional trait approach was adopted with denitrifiers involved in nitrogen cycling as our model soil community. Using short-term temperature and salt gradients, we show that the functional operating range was broader and process rates were higher when the soil community was phylogenetically more diverse. However, key bacterial genotypes played an important role for maintaining denitrification as an ecosystem functioning under certain conditions.	[Hallin, Sara; Welsh, Allana; Stenstrom, John; Enwall, Karin] Swedish Univ Agr Sci, Dept Microbiol, S-75007 Uppsala, Sweden; [Hallet, Stephanie; Bru, David; Philippot, Laurent] INRA, UMR Agroecol, F-21034 Dijon, France	Swedish University of Agricultural Sciences; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Hallin, S (corresponding author), Swedish Univ Agr Sci, Dept Microbiol, Box 7025, S-75007 Uppsala, Sweden.	Sara.Hallin@slu.se	Hallin, Sara/H-4648-2012; Stenström, John/GYA-6846-2022; Bru, David/A-9702-2016; Philippot, Laurent/G-5598-2011	Hallin, Sara/0000-0002-9069-9024; Philippot, Laurent/0000-0003-3461-4492; Bru, David/0000-0002-1011-017X	Environment and Agronomy research division; International Relations Department of the INRA; Department of Microbiology of the Swedish University of Agricultural Sciences in Uppsala; Swedish Research Council Formas [2007-1197]; European Commission [FP7-264465]	Environment and Agronomy research division; International Relations Department of the INRA; Department of Microbiology of the Swedish University of Agricultural Sciences in Uppsala; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); European Commission(European CommissionEuropean Commission Joint Research Centre)	The Environment and Agronomy research division and the International Relations Department of the INRA and the Department of Microbiology of the Swedish University of Agricultural Sciences in Uppsala are gratefully acknowledged for supporting and hosting L. Philippot's sabbatical in Sweden. The Swedish Research Council Formas (contract 2007-1197) and the European Commission within EcoFINDERS project (FP7-264465) are acknowledged for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Craig MacLean R, 2005, ECOL LETT, V8, P38, DOI 10.1111/j.1461-0248.2004.00689.x; Dandie CE, 2007, SYST APPL MICROBIOL, V30, P128, DOI 10.1016/j.syapm.2006.05.002; EXCOFFIER L, 1992, GENETICS, V131, P479; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; GABEL RA, 1973, ANESTHESIOLOGY, V38, P75, DOI 10.1097/00000542-197301000-00019; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Gu LH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002119; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hol WHG, 2010, ECOL LETT, V13, P292, DOI 10.1111/j.1461-0248.2009.01424.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jones CM, 2008, MOL BIOL EVOL, V25, P1955, DOI 10.1093/molbev/msn146; Jousset A, 2011, ECOL LETT, V14, P537, DOI 10.1111/j.1461-0248.2011.01613.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Lamb EG, 2011, GLOBAL CHANGE BIOL, V17, P3187, DOI 10.1111/j.1365-2486.2011.02431.x; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Mao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024750; Mounier E, 2004, ENVIRON MICROBIOL, V6, P301, DOI 10.1111/j.1462-2920.2004.00571.x; O'Mullan GD, 2005, APPL ENVIRON MICROB, V71, P697, DOI 10.1128/AEM.71.2.697-705.2005; Orcutt FS, 1937, SOIL SCI, V44, P203, DOI 10.1097/00010694-193709000-00003; Oren A, 2011, ENVIRON MICROBIOL, V13, P1908, DOI 10.1111/j.1462-2920.2010.02365.x; Pell M, 1996, SOIL BIOL BIOCHEM, V28, P393, DOI 10.1016/0038-0717(95)00149-2; Petric I, 2011, J MICROBIOL METH, V84, P454, DOI 10.1016/j.mimet.2011.01.016; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Philippot L, 2005, CURR OPIN MICROBIOL, V8, P234, DOI 10.1016/j.mib.2005.04.003; Philippot L, 2007, ADV AGRON, V96, P249, DOI 10.1016/S0065-2113(07)96003-4; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tuomi M, 2008, ECOL MODEL, V211, P182, DOI 10.1016/j.ecolmodel.2007.09.003; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wawrik B, 2005, APPL ENVIRON MICROB, V71, P6776, DOI 10.1128/AEM.71.11.6776-6783.2005; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x; Wilson SD, 2002, ECOLOGY, V83, P492, DOI 10.1890/0012-9658(2002)083[0492:QVIOFS]2.0.CO;2; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	50	19	19	0	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51962	10.1371/journal.pone.0051962	http://dx.doi.org/10.1371/journal.pone.0051962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284833	Green Published, gold			2022-12-25	WOS:000312794500069
J	Dixon, ML; Christoff, K				Dixon, Matthew L.; Christoff, Kalina			The Decision to Engage Cognitive Control Is Driven by Expected Reward-Value: Neural and Behavioral Evidence	PLOS ONE			English	Article							PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; SELF-CONTROL; REPETITION SUPPRESSION; MOTIVATIONAL CONTEXT; SYSTEMS; UNCERTAINTY; CINGULATE; UNDERLIE; NEURONS	Cognitive control is a fundamental skill reflecting the active use of task-rules to guide behavior and suppress inappropriate automatic responses. Prior work has traditionally used paradigms in which subjects are told when to engage cognitive control. Thus, surprisingly little is known about the factors that influence individuals' initial decision of whether or not to act in a reflective, rule-based manner. To examine this, we took three classic cognitive control tasks (Stroop, Wisconsin Card Sorting Task, Go/No-Go task) and created novel 'free-choice' versions in which human subjects were free to select an automatic, pre-potent action, or an action requiring rule-based cognitive control, and earned varying amounts of money based on their choices. Our findings demonstrated that subjects' decision to engage cognitive control was driven by an explicit representation of monetary rewards expected to be obtained from rule-use. Subjects rarely engaged cognitive control when the expected outcome was of equal or lesser value as compared to the value of the automatic response, but frequently engaged cognitive control when it was expected to yield a larger monetary outcome. Additionally, we exploited fMRI-adaptation to show that the lateral prefrontal cortex (LPFC) represents associations between rules and expected reward outcomes. Together, these findings suggest that individuals are more likely to act in a reflective, rule-based manner when they expect that it will result in a desired outcome. Thus, choosing to exert cognitive control is not simply a matter of reason and willpower, but rather, conforms to standard mechanisms of value-based decision making. Finally, in contrast to current models of LPFC function, our results suggest that the LPFC plays a direct role in representing motivational incentives.	[Dixon, Matthew L.; Christoff, Kalina] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Christoff, Kalina] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Dixon, ML (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	mattdixon@psych.ubc.ca		Dixon, Matthew/0000-0001-8033-8113	Natural Sciences and Engineering Council of Canada [05-5918]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Council of Canada, grant # 05-5918 (to KC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2012, NEURON, V73, P595, DOI 10.1016/j.neuron.2011.12.025; Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P115, DOI 10.1111/j.1751-9004.2007.00001.x; Baumgartner T, 2011, NAT NEUROSCI, V14, P1468, DOI 10.1038/nn.2933; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; BUCKLESS FA, 1990, ACCOUNT REV, V65, P933; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; De Baene W, 2011, HUM BRAIN MAPP; de Gardelle V, 2012, CEREB CORTEX; Diekhof EK, 2010, J NEUROSCI, V30, P1488, DOI 10.1523/JNEUROSCI.4690-09.2010; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Fujita K, 2011, PERS SOC PSYCHOL REV; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Histed MH, 2009, NEURON, V63, P244, DOI 10.1016/j.neuron.2009.06.019; Hofmann W, 2009, PERSPECT PSYCHOL SCI, V4, P162, DOI 10.1111/j.1745-6924.2009.01116.x; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kahnt T, 2011, J NEUROSCI, V31, P14624, DOI 10.1523/JNEUROSCI.3412-11.2011; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Li JA, 2011, P NATL ACAD SCI USA, V108, P55, DOI 10.1073/pnas.1014938108; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Lundqvist D., 1998, KAROLINSKA DIRECTED; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Martinez A., 1998, 24 CVC; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Muller NG, 2012, CEREB CORTEX; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Race EA, 2009, J COGNITIVE NEUROSCI, V21, P1766, DOI 10.1162/jocn.2009.21132; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rosnow RL, 1996, PSYCHOL SCI, V7, P253, DOI 10.1111/j.1467-9280.1996.tb00369.x; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Salimpoor VN, 2010, J COGNITIVE NEUROSCI, V22, P790, DOI 10.1162/jocn.2009.21234; Savine AC, 2010, J NEUROSCI, V30, P10294, DOI 10.1523/JNEUROSCI.2052-10.2010; Seo H, 2007, CEREB CORTEX, V17, pI110, DOI 10.1093/cercor/bhm064; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Tobler PN, 2009, P NATL ACAD SCI USA, V106, P7185, DOI 10.1073/pnas.0809599106; Turk-Browne NB, 2007, CEREB CORTEX, V17, P425, DOI 10.1093/cercor/bhj159; Venkatraman V, 2009, NEURON, V62, P593, DOI 10.1016/j.neuron.2009.04.007; Vuilleumier P, 2005, J COGNITIVE NEUROSCI, V17, P1245, DOI 10.1162/0898929055002409; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Watanabe M, 2002, J NEUROSCI, V22, P2391, DOI 10.1523/JNEUROSCI.22-06-02391.2002; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Watanabe M, 2007, CEREB CORTEX, V17, pI101, DOI 10.1093/cercor/bhm067; Weber BJ, 2008, BRAIN RES, V1234, P104, DOI 10.1016/j.brainres.2008.07.105; Yeterian EH, 2012, CORTEX, V48, P58, DOI 10.1016/j.cortex.2011.03.004	68	72	73	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51637	10.1371/journal.pone.0051637	http://dx.doi.org/10.1371/journal.pone.0051637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284730	Green Submitted, Green Published, gold			2022-12-25	WOS:000312694300034
J	Pauli, JN; Peery, MZ				Pauli, Jonathan N.; Peery, M. Zachariah			Unexpected Strong Polygyny in the Brown-Throated Three-Toed Sloth	PLOS ONE			English	Article							MATING SYSTEM; MICROSATELLITE ANALYSIS; MULTIPLE PATERNITY; COMPUTER-PROGRAM; BRADYPUS; ECOLOGY; BIRDS	Promiscuous mating strategies are much more common than previously appreciated. So much so, that several authors have proposed that promiscuity is the "rule" rather than the exception in vertebrate mating systems. Decreasing species mobility and increasing habitat fragmentation have both been suggested to reduce the "polygyny potential" of the environment and promote other mating strategies like promiscuity in females. We explored the social and genetic mating system for one of the most sedentary extant mammals, the brown-throated three-toed sloth (Bradypus variegatus), within a highly fragmented Neotropical habitat. Surprisingly, we found that three-toed sloths were strongly polygynous, with males excluding male competitors from their core ranges, and exhibiting strong reproductive skew. Indeed, only 25% of all resident adult males sired offspring and one individual sired half of all sampled juveniles. Paradoxically, a sedentary life-history strategy seems to facilitate polygyny in fragmented landscapes because multiple females can persist within small patches of habitat, and be monopolized by a single male. Our work demonstrates that strong polygyny can arise in systems in which the polygyny potential should be extremely low, and other strategies, including promiscuity, would be favoured. Mating systems can be influenced by a multitude of factor and are dynamic, varying among taxa, over time, and across habitats; consequently, mating systems remain difficult to predict based on general ecological principles.	[Pauli, Jonathan N.; Peery, M. Zachariah] Univ Wisconsin Madison, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pauli, JN (corresponding author), Univ Wisconsin Madison, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	jnpauli@wisc.edu			Milwaukee Public Museum; University of Wisconsin-Madison; American Society of Mammalogists; Department of Forest and Wildlife Ecology at the University of Wisconsin-Madison	Milwaukee Public Museum; University of Wisconsin-Madison; American Society of Mammalogists; Department of Forest and Wildlife Ecology at the University of Wisconsin-Madison	Funding was provided by the Milwaukee Public Museum, the University of Wisconsin-Madison, and through a fellowship awarded by the American Society of Mammalogists. Publication costs were paid for by the Department of Forest and Wildlife Ecology at the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley JC, 2010, J HERED, V101, P368, DOI 10.1093/jhered/esp114; Bishop JM, 2007, BIOL LETTERS, V3, P176, DOI 10.1098/rsbl.2006.0607; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Crawford JC, 2008, J MAMMAL, V89, P575, DOI 10.1644/07-MAMM-A-251R1.1; DAVIES NB, 1984, J ANIM ECOL, V53, P895, DOI 10.2307/4666; DeYoung RW, 2002, J MAMMAL, V83, P884, DOI 10.1644/1545-1542(2002)083&lt;0884:MPIWTD&gt;2.0.CO;2; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Flatz R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033654; GREENE HW, 1989, BIOTROPICA, V21, P369, DOI 10.2307/2388289; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hoffman JI, 2003, EVOLUTION, V57, P1917; Holdridge LR, 1967, LIFE ZONE ECOLOGY; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kays RW, 2000, MOL ECOL, V9, P743, DOI 10.1046/j.1365-294x.2000.00921.x; Lara-Ruiz P, 2005, J ZOOL, V267, P63, DOI 10.1017/S0952836905007259; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McEachern MB, 2009, ANIM BEHAV, V77, P449, DOI 10.1016/j.anbehav.2008.10.024; Millspaugh JJ., 2001, RADIO TRACKING ANIMA; Moss WE, 2012, CONSERV GENET RESOUR, V4, P1037, DOI 10.1007/s12686-012-9701-y; Munroe KE, 2011, BEHAV ECOL SOCIOBIOL, V65, P1811, DOI 10.1007/s00265-011-1189-z; NAGY KA, 1980, J MAMMAL, V61, P465, DOI 10.2307/1379840; Patzenhauerova H, 2010, BEHAV ECOL SOCIOBIOL, V64, P757, DOI 10.1007/s00265-009-0893-4; Peery MZ, 2012, ANIM BEHAV, V84, P555, DOI 10.1016/j.anbehav.2012.06.007; R Core Team, 2012, R LANG ENV STAT COMP; Reynolds JD, 1996, TRENDS ECOL EVOL, V11, pA68, DOI 10.1016/0169-5347(96)81045-7; Say L, 2003, MOL ECOL, V12, P2793, DOI 10.1046/j.1365-294X.2003.01945.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Taube E, 2001, MAMMAL REV, V31, P173, DOI 10.1046/j.1365-2907.2001.00085.x; Vanpe C, 2009, BIOL J LINN SOC, V97, P128, DOI 10.1111/j.1095-8312.2009.01196.x; Vaughan C, 2007, BIODIVERS CONSERV, V16, P2293, DOI 10.1007/s10531-007-9191-5; WAAGE JK, 1976, SCIENCE, V193, P157, DOI 10.1126/science.193.4248.157; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; WOODROFFE R, 1995, J ZOOL, V235, P237	37	25	28	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51389	10.1371/journal.pone.0051389	http://dx.doi.org/10.1371/journal.pone.0051389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284687	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300023
J	Li, X; Feng, YF; Wang, CT; Li, GC; Lei, W; Zhang, ZY; Wang, L				Li, Xiang; Feng, Ya-Fei; Wang, Cheng-Tao; Li, Guo-Chen; Lei, Wei; Zhang, Zhi-Yong; Wang, Lin			Evaluation of Biological Properties of Electron Beam Melted Ti6Al4V Implant with Biomimetic Coating In Vitro and In Vivo	PLOS ONE			English	Article							POROUS TITANIUM IMPLANTS; CALCIUM-PHOSPHATE; APATITE FORMATION; ORTHOPEDIC APPLICATIONS; TI-6AL-4V STRUCTURES; TREATED TITANIUM; BONE INGROWTH; SURFACE; FABRICATION; SCAFFOLD	Background: High strength porous titanium implants are widely used for the reconstruction of craniofacial defects because of their similar mechanical properties to those of bone. The recent introduction of electron beam melting (EBM) technique allows a direct digitally enabled fabrication of patient specific porous titanium implants, whereas both their in vitro and in vivo biological performance need further investigation. Methods: In the present study, we fabricated porous Ti6Al4V implants with controlled porous structure by EBM process, analyzed their mechanical properties, and conducted the surface modification with biomimetic approach. The bioactivities of EBM porous titanium in vitro and in vivo were evaluated between implants with and without biomimetic apatite coating. Results: The physical property of the porous implants, containing the compressive strength being 163 - 286 MPa and the Young's modulus being 14.5-38.5 GPa, is similar to cortical bone. The in vitro culture of osteoblasts on the porous Ti6Al4V implants has shown a favorable circumstance for cell attachment and proliferation as well as cell morphology and spreading, which were comparable with the implants coating with bone-like apatite. In vivo, histological analysis has obtained a rapid ingrowth of bone tissue from calvarial margins toward the center of bone defect in 12 weeks. We observed similar increasing rate of bone ingrowth and percentage of bone formation within coated and uncoated implants, all of which achieved a successful bridging of the defect in 12 weeks after the implantation. Conclusions: This study demonstrated that the EBM porous Ti6Al4V implant not only reduced the stress-shielding but also exerted appropriate osteoconductive properties, as well as the apatite coated group. The results opened up the possibility of using purely porous titanium alloy scaffolds to reconstruct specific bone defects in the maxillofacial and orthopedic fields.	[Feng, Ya-Fei; Lei, Wei; Zhang, Zhi-Yong; Wang, Lin] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China; [Li, Xiang; Wang, Cheng-Tao] Shanghai Jiao Tong Univ, Sch Mech Engn, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China; [Li, Guo-Chen] Fourth Mil Med Univ, Dept Orthopaed, Tangdu Hosp, Xian 710032, Peoples R China; [Zhang, Zhi-Yong] Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Sch Med, Shanghai 200030, Peoples R China	Air Force Military Medical University; Shanghai Jiao Tong University; Air Force Military Medical University; Shanghai Jiao Tong University	Zhang, ZY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.	mr.zhiyong@gmail.com; wanglinxj@fmmu.edu.cn	zhang, zhiyong/G-3227-2010; Wang, Lin/J-8805-2018	zhang, zhiyong/0000-0001-7903-1544; Wang, Lin/0000-0001-5937-6318; Lei, Wei/0000-0002-7346-6915	XIJING ZHUTUI Foundation [XJZT10M07]; National Key Technology RD Program [2012BAI18B07]; Ph.D. Programs Foundation of the Ministry of Education of China [20100073120051]; Research Project of State Key Laboratory of Mechanical System and Vibration [MSV201114]	XIJING ZHUTUI Foundation; National Key Technology RD Program(National Key Technology R&D Program); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Research Project of State Key Laboratory of Mechanical System and Vibration	The authors would like to thank Contract Grant Sponsor: XIJING ZHUTUI Foundation (XJZT10M07), the Project supported by National Key Technology R&D Program (2012BAI18B07), the Ph.D. Programs Foundation of the Ministry of Education of China (Grant No. 20100073120051) and the Research Project of State Key Laboratory of Mechanical System and Vibration (Grant No. MSV201114) for their support to this work. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.0.CO;2-J; Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9; Aparecida AH, 2009, J MATER SCI-MATER M, V20, P1215, DOI 10.1007/s10856-008-3682-0; Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057; Ben-Nissan B, 2004, BIOMATERIALS, V25, P4971, DOI 10.1016/j.biomaterials.2004.02.006; Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109; Fujibayashi S, 2011, EUR SPINE J, V20, P1486, DOI 10.1007/s00586-011-1728-3; Goransson A, 2003, BIOMATERIALS, V24, P197, DOI 10.1016/S0142-9612(02)00277-6; Goyenvalle E, 2006, BIOMATERIALS, V27, P1119, DOI 10.1016/j.biomaterials.2005.07.039; HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407; Hansson S, 1999, J BIOMECH, V32, P829, DOI 10.1016/S0021-9290(99)00058-5; Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013; Hollander DA, 2006, BIOMATERIALS, V27, P955, DOI 10.1016/j.biomaterials.2005.07.041; Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5; Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.005; Jalota S, 2007, MAT SCI ENG C-BIO S, V27, P432, DOI 10.1016/j.msec.2006.05.052; Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009; Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3; Kim HM, 1997, J BIOMED MATER RES, V38, P121; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008; Kroger H, 1998, CLIN ORTHOP RELAT R, P66; Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9; Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020; Li JP, 2007, BIOMATERIALS, V28, P4209, DOI 10.1016/j.biomaterials.2007.05.042; Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033; Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048; Li X, 2009, MATER LETT, V63, P403, DOI 10.1016/j.matlet.2008.10.065; Lopez-Heredia MA, 2008, J BIOMED MATER RES A, V85A, P664, DOI 10.1002/jbm.a.31468; Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021; Ma J, 2003, BIOMATERIALS, V24, P3505, DOI 10.1016/S0142-9612(03)00203-5; Nebe JB, 2008, ACTA BIOMATER, V4, P1985, DOI 10.1016/j.actbio.2008.05.028; Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4; O'Hare P, 2010, BIOMATERIALS, V31, P515, DOI 10.1016/j.biomaterials.2009.09.067; Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006; PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1; Ponader S, 2008, J BIOMED MATER RES A, V84A, P1111, DOI 10.1002/jbm.a.31540; Ponader S, 2010, J BIOMED MATER RES A, V92A, P56, DOI 10.1002/jbm.a.32337; Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002; Sader MS, 2005, CLIN ORAL IMPLAN RES, V16, P667, DOI 10.1111/j.1600-0501.2005.01135.x; Sugita Y, 2011, BIOMATERIALS, V32, P8374, DOI 10.1016/j.biomaterials.2011.07.077; Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019; Thomsen P, 2009, J BIOMED MATER RES B, V90B, P35, DOI 10.1002/jbm.b.31250; Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014; Zhao LZ, 2010, J BIOMED MATER RES A, V92A, P432, DOI 10.1002/jbm.a.32348	45	47	57	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52049	10.1371/journal.pone.0052049	http://dx.doi.org/10.1371/journal.pone.0052049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272208	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300054
J	Castelnuovo, B; Kiragga, A; Afayo, V; Ncube, M; Orama, R; Magero, S; Okwi, P; Manabe, YC; Kambugu, A				Castelnuovo, Barbara; Kiragga, Agnes; Afayo, Victor; Ncube, Malisa; Orama, Richard; Magero, Stephen; Okwi, Peter; Manabe, Yukari C.; Kambugu, Andrew			Implementation of Provider-Based Electronic Medical Records and Improvement of the Quality of Data in a Large HIV Program in Sub-Saharan Africa	PLOS ONE			English	Article							PATIENT FLOW; SETTINGS; KAMPALA; UGANDA; SYSTEM; CARE	Introduction: Starting in June 2010 the Infectious Diseases Institute (IDI) clinic (a large urban HIV out-patient facility) switched to provider-based Electronic Medical Records (EMR) from paper EMR entered in the database by data-entry clerks. Standardized clinics forms were eliminated but providers still fill free text clinical notes in physical patients' files. The objective of this study was to compare the rate of errors in the database before and after the introduction of the provider-based EMR. Methods and Findings: Data in the database pre and post provider-based EMR was compared with the information in the patients' files and classified as correct, incorrect, and missing. We calculated the proportion of incorrect, missing and total error for key variables (toxicities, opportunistic infections, reasons for treatment change and interruption). Proportions of total errors were compared using chi-square test. A survey of the users of the EMR was also conducted. We compared data from 2,382 visits (from 100 individuals) of a retrospective validation conducted in 2007 with 34,957 visits (from 10,920 individuals) of a prospective validation conducted in April-August 2011. The total proportion of errors decreased from 66.5% in 2007 to 2.1% in 2011 for opportunistic infections, from 51.9% to 3.5% for ART toxicity, from 82.8% to 12.5% for reasons for ART interruption and from 94.1% to 0.9% for reasons for ART switch (all P < 0.0001). The survey showed that 83% of the providers agreed that provider-based EMR led to improvement of clinical care, 80% reported improved access to patients' records, and 80% appreciated the automation of providers' tasks. Conclusions: The introduction of provider-based EMR improved the quality of data collected with a significant reduction in missing and incorrect information. The majority of providers and clients expressed satisfaction with the new system. We recommend the use of provider-based EMR in large HIV programs in Sub-Saharan Africa.	[Castelnuovo, Barbara; Kiragga, Agnes; Afayo, Victor; Ncube, Malisa; Orama, Richard; Magero, Stephen; Okwi, Peter; Manabe, Yukari C.; Kambugu, Andrew] Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA	Johns Hopkins University	Castelnuovo, B (corresponding author), Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	bcastelnuovo@idi.co.ug			International epidemiologic Database to Evaluate AIDS (IeDEA)	International epidemiologic Database to Evaluate AIDS (IeDEA)	This work was partially funded by the International epidemiologic Database to Evaluate AIDS (IeDEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Allen Christian, 2006, AMIA Annu Symp Proc, P840; Amoroso CL, 2010, STUD HEALTH TECHNOL, V160, P337, DOI 10.3233/978-1-60750-588-4-337; Castelnuovo B, 2009, INT J STD AIDS, V20, P123, DOI 10.1258/ijsa.2008.008174; Cebul RD, 2011, NEW ENGL J MED, V365, P825, DOI 10.1056/NEJMsa1102519; Colebunders R, 2007, AIDS CARE, V19, P149, DOI 10.1080/09540120600762078; Douglas G P, 2005, AMIA Annu Symp Proc, P942; Douglas GP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000319; Duda SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033908; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fraser Hamish S F, 2006, AMIA Annu Symp Proc, P264; Fraser HSF, 2004, BMJ-BRIT MED J, V329, P1142, DOI 10.1136/bmj.329.7475.1142; Gearing Pauline, 2006, J Healthc Inf Manag, V20, P40; Harries AD, 2007, B WORLD HEALTH ORGAN, V85, P152, DOI 10.2471/BLT.06.032060; HORBAR JD, 1995, CONTROL CLIN TRIALS, V16, P51, DOI 10.1016/0197-2456(94)00019-Y; Kiragga AN, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-3; Payne TH, 2010, J AM MED INFORM ASSN, V17, P108, DOI 10.1197/jamia.M3173; Rotich JK, 2003, J AM MED INFORM ASSN, V10, P295, DOI 10.1197/jamia.M1301; Simba Daudi O, 2004, Afr Health Sci, V4, P194; Smith CJ, 2004, HIV MED, V5, P88, DOI 10.1111/j.1468-1293.2004.00191.x; Waters E, 2010, STUD HEALTH TECHNOL, V160, P96, DOI 10.3233/978-1-60750-588-4-96; Williams Faustine, 2008, Inform Prim Care, V16, P139	21	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51631	10.1371/journal.pone.0051631	http://dx.doi.org/10.1371/journal.pone.0051631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055RZ	23284728	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900035
J	Duncan, C; Chauvenet, ALM; McRae, LM; Pettorelli, N				Duncan, Clare; Chauvenet, Alienor L. M.; McRae, Louise M.; Pettorelli, Nathalie			Predicting the Future Impact of Droughts on Ungulate Populations in Arid and Semi-Arid Environments	PLOS ONE			English	Article							ELEPHANT LOXODONTA-AFRICANA; NATIONAL-PARK; CLIMATE-CHANGE; DYNAMICS; RAINFALL; DECLINE; VULNERABILITY; SERENGETI; MORTALITY; ECOSYSTEM	Droughts can have a severe impact on the dynamics of animal populations, particularly in semi-arid and arid environments where herbivore populations are strongly limited by resource availability. Increased drought intensity under projected climate change scenarios can be expected to reduce the viability of such populations, yet this impact has seldom been quantified. In this study, we aim to fill this gap and assess how the predicted worsening of droughts over the 21st century is likely to impact the population dynamics of twelve ungulate species occurring in arid and semi-arid habitats. Our results provide support to the hypotheses that more sedentary, grazing and mixed feeding species will be put at high risk from future increases in drought intensity, suggesting that management intervention under these conditions should be targeted towards species possessing these traits. Predictive population models for all sedentary, grazing or mixed feeding species in our study show that their probability of extinction dramatically increases under future emissions scenarios, and that this extinction risk is greater for smaller populations than larger ones. Our study highlights the importance of quantifying the current and future impacts of increasing extreme natural events on populations and species in order to improve our ability to mitigate predicted biodiversity loss under climate change.	[Duncan, Clare; Chauvenet, Alienor L. M.; McRae, Louise M.; Pettorelli, Nathalie] Zool Soc London, Inst Zool, London NW1 4RY, England; [Chauvenet, Alienor L. M.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England	Zoological Society of London; Imperial College London	Pettorelli, N (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	Nathalie.Pettorelli@ioz.ac.uk	Duncan, Clare/V-6005-2019; Chauvenet, Alienor/L-9135-2015; Pettorelli, Nathalie/AAW-8438-2021	Duncan, Clare/0000-0001-5315-2997; Chauvenet, Alienor/0000-0002-3743-7375; 				[Anonymous], 2012, MAN RISKS EXTR EV DI; ARMBRUSTER P, 1993, CONSERV BIOL, V7, P602, DOI 10.1046/j.1523-1739.1993.07030602.x; Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; BENSHAHAR R, 1993, J TROP ECOL, V9, P249, DOI 10.1017/S0266467400007252; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Bouche P, 2012, BIOTECHNOL AGRON SOC, V16, P77; Brockett BH, 2002, S AFR J WILDL RES, V32, P121; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chege G, 2008, LEWA WILDLIFE CONSER; Clutton-Brock T.H., 1988, P1; Collen B, 2011, PHILOS T R SOC B, V366, P2577, DOI 10.1098/rstb.2011.0015; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; de Leeuw J, 2001, BIOL CONSERV, V100, P297, DOI 10.1016/S0006-3207(01)00034-9; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; DUNHAM KM, 1994, J ZOOL, V234, P489, DOI 10.1111/j.1469-7998.1994.tb04862.x; EMSLIE R, 2011, IUCN RED LIST THREAT; Epps CW, 2004, CONSERV BIOL, V18, P102, DOI 10.1111/j.1523-1739.2004.00023.x; Erasmus BFN, 2002, GLOBAL CHANGE BIOL, V8, P679, DOI 10.1046/j.1365-2486.2002.00502.x; Foden W., 2008, 2008 REV IUCN RED LI, P77; Foley C, 2008, BIOL LETTERS, V4, P541, DOI 10.1098/rsbl.2008.0370; Gasaway WC, 1996, CAN J ZOOL, V74, P1556, DOI 10.1139/z96-170; Gaylard A., 2003, KRUGER EXPERIENCE EC, P171; Georgiadis N, 2003, J APPL ECOL, V40, P125, DOI 10.1046/j.1365-2664.2003.00796.x; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Heim RR, 2002, B AM METEOROL SOC, V83, P1149, DOI 10.1175/1520-0477-83.8.1149; Heim RR, 2000, ROUTLEDGE HAZARDS DI, P159; HILLMAN J C, 1977, East African Wildlife Journal, V15, P1, DOI 10.1111/j.1365-2028.1977.tb00374.x; Illius AW, 2000, OIKOS, V89, P283, DOI 10.1034/j.1600-0706.2000.890209.x; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN SSC ANTELOPE SPECIALIST GROUP, 2008, IUCN RED LIST THREAT; Jachmann H., 2001, ESTIMATING ABUNDANCE, DOI 10.1007/978-1-4615-1381-0; Jolles AE, 2005, ECOLOGY, V86, P2358, DOI 10.1890/05-0038; Joly DO, 2004, CAN J ZOOL, V82, P1165, DOI 10.1139/Z04-072; Kay RNB, 1997, J ARID ENVIRON, V37, P683, DOI 10.1006/jare.1997.0299; Keyantash J, 2002, B AM METEOROL SOC, V83, P1167, DOI 10.1175/1520-0477(2002)083&lt;1191:TQODAE&gt;2.3.CO;2; Knight MH, 1995, AFR J ECOL, V33, P377, DOI 10.1111/j.1365-2028.1995.tb01047.x; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Loveridge AJ, 2006, J ZOOL, V270, P523, DOI 10.1111/j.1469-7998.2006.00181.x; MAGIN CD, 1989, AFR J ECOL, V27, P297, DOI 10.1111/j.1365-2028.1989.tb01023.x; Mallon D. P., 2008, IUCN RED LIST THREAT; Mbaiwa J.E., 2006, INT J WILDERNESS, V12, P41; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Novellie P, 2008, IUCN RED LIST THREAT; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Ogutu JO, 2012, BIODIVERS CONSERV, V21, P1033, DOI 10.1007/s10531-012-0239-9; Olech W, 2008, IUCN RED LIST THREAT; Owen-Smith N, 2006, ECOL MONOGR, V76, P73, DOI 10.1890/04-1101; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; OwenSmith N, 1996, S AFR J WILDL RES, V26, P107; Palmer W.C., 1965, 45 WEATH BUR; Ponce VM, 2000, J HYDROL ENG, V5, P222, DOI 10.1061/(ASCE)1084-0699(2000)5:2(222); Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Rubel F, 2010, METEOROL Z, V19, P135, DOI 10.1127/0941-2948/2010/0430; RUTHERFORD MC, 1980, S AFR J SCI, V76, P53; Saltz D, 2002, ZEBRA ASSESS HORSES; Saltz D, 2006, CONSERV BIOL, V20, P1402, DOI 10.1111/j.1523-1739.2006.00486.x; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Society A.M., 1997, B AM METEOROL SOC, V78, P847; South African National Parks, 2008, S AFR NAT PARKS DAT; Spinage C. A., 1982, TERRITORIAL ANTELOPE, P350; Team RDC, 2012, R LANG ENV STAT COMP; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; UNEP/CMS, 2006, MIGR SPEC CLIM CHANG; VanDierendonck MC, 1996, CONSERV BIOL, V10, P728, DOI 10.1046/j.1523-1739.1996.10030728.x; Verlinden A, 1998, AFR J ECOL, V36, P117; WALKER BH, 1987, J APPL ECOL, V24, P381, DOI 10.2307/2403882; Wells N, 2004, J CLIMATE, V17, P2335, DOI [10.1175/1520-0442(2004)017<2335:ASPDSI>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;2335:ASPDSI&gt;2.0.CO;2]; Wilson DE, 2011, HOOFED MAMMALS, V2; WWF/ZSL, 2012, LIV PLAN DAT; YOUNG TP, 1994, CONSERV BIOL, V8, P410, DOI 10.1046/j.1523-1739.1994.08020410.x	77	41	43	0	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51490	10.1371/journal.pone.0051490	http://dx.doi.org/10.1371/journal.pone.0051490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284700	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900023
J	Sampath, H; Vartanian, V; Rollins, MR; Sakumi, K; Nakabeppu, Y; Lloyd, RS				Sampath, Harini; Vartanian, Vladimir; Rollins, M. Rick; Sakumi, Kunihiko; Nakabeppu, Yusaku; Lloyd, R. Stephen			8-Oxoguanine DNA Glycosylase (OGG1) Deficiency Increases Susceptibility to Obesity and Metabolic Dysfunction	PLOS ONE			English	Article							OXIDATIVE DAMAGE; SER326CYS POLYMORPHISM; GENE-EXPRESSION; REPAIR ENZYME; PPAR-GAMMA; CANCER; LUNG; ACCUMULATION; KNOCKOUT; DISEASE	Oxidative damage to DNA is mainly repaired via base excision repair, a pathway that is catalyzed by DNA glycosylases such as 8-oxoguanine DNA glycosylase (OGG1). While OGG1 has been implicated in maintaining genomic integrity and preventing tumorigenesis, we report a novel role for OGG1 in altering cellular and whole body energy homeostasis. OGG1-deficient (Ogg1(-/-)) mice have increased adiposity and hepatic steatosis following exposure to a high-fat diet (HFD), compared to wild-type (WT) animals. Ogg1(-/-) animals also have higher plasma insulin levels and impaired glucose tolerance upon HFD feeding, relative to WT counterparts. Analysis of energy expenditure revealed that HFD-fed Ogg1(-/-) mice have a higher resting VCO2 and consequently, an increased respiratory quotient during the resting phase, indicating a preference for carbohydrate metabolism over fat oxidation in these mice. Additionally, microarray and quantitative PCR analyses revealed that key genes of fatty acid oxidation, including carnitine palmitoyl transferase-1, and the integral transcriptional co-activator Pgc-1 alpha were significantly downregulated in Ogg1(-/-) livers. Multiple genes involved in TCA cycle metabolism were also significantly reduced in livers of Ogg1(-/-) mice. Furthermore, hepatic glycogen stores were diminished, and fasting plasma ketones were significantly reduced in Ogg1(-/-) mice. Collectively, these data indicate that OGG1 deficiency alters cellular substrate metabolism, favoring a fat sparing phenotype, that results in increased susceptibility to obesity and related pathologies in Ogg1(-/-) mice.	[Sakumi, Kunihiko; Nakabeppu, Yusaku] Kyushu Univ, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan; [Sakumi, Kunihiko; Nakabeppu, Yusaku] Kyushu Univ, Res Ctr Nucleotide Pool, Fukuoka 812, Japan; [Sampath, Harini; Vartanian, Vladimir; Rollins, M. Rick; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Dept Mol & Med Genet, Portland, OR 97201 USA	Kyushu University; Kyushu University; Oregon Health & Science University	Nakabeppu, Y (corresponding author), Kyushu Univ, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan.	yusaku@bioreg.kyushu-u.ac.jp; lloydst@ohsu.edu	Nakabeppu, Yusaku/A-8902-2011; Sakumi, Kunihiko/G-4808-2011	Nakabeppu, Yusaku/0000-0002-6739-242X; Lloyd, R. Stephen/0000-0001-7273-372X	American Heart Association [11POST7480004]; National Institutes of Health (NIH) [R01 DK075974]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075974] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22221004] Funding Source: KAKEN	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by American Heart Association Postdoctoral grant 11POST7480004 (HS) and National Institutes of Health (NIH) R01 DK075974 (RSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, TOXICOLOGY, V221, P179, DOI 10.1016/j.tox.2006.01.004; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cardozo-Pelaez F, 2005, GENE EXPRESSION, V12, P315, DOI 10.3727/000000005783992007; Casorelli I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012070; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; Daimon M, 2009, BIOCHEM BIOPH RES CO, V386, P26, DOI 10.1016/j.bbrc.2009.05.119; Dezor M, 2011, FOLIA NEUROPATHOL, V49, P123; Dorszewska J, 2009, DNA CELL BIOL, V28, P579, DOI 10.1089/dna.2009.0926; Feilchenfeldt J, 2004, CANCER LETT, V203, P25, DOI 10.1016/j.canlet.2003.08.024; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Fukae J, 2005, ACTA NEUROPATHOL, V109, P256, DOI 10.1007/s00401-004-0937-9; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Iida T, 2002, ACTA NEUROPATHOL, V103, P20, DOI 10.1007/s004010100418; Jiang WG, 2003, INT J CANCER, V106, P752, DOI 10.1002/ijc.11302; Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7; Kim HJ, 2011, ACTA BIOCH BIOPH SIN, V43, P589, DOI 10.1093/abbs/gmr053; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Klungland A, 2007, DNA REPAIR, V6, P481, DOI 10.1016/j.dnarep.2006.10.012; Li GP, 2012, FREE RADICAL BIO MED, V52, P392, DOI 10.1016/j.freeradbiomed.2011.10.490; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191; Nemec AA, 2010, SEMIN CANCER BIOL, V20, P320, DOI 10.1016/j.semcancer.2010.10.010; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Okasaka T, 2009, J HUM GENET, V54, P739, DOI 10.1038/jhg.2009.108; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Radak Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6; Radak Z, 2011, FREE RADICAL BIO MED, V51, P417, DOI 10.1016/j.freeradbiomed.2011.04.018; Radak Z, 2010, FREE RADICAL BIO MED, V49, P587, DOI 10.1016/j.freeradbiomed.2010.05.008; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sakumi K, 2003, CANCER RES, V63, P902; Sampath H, 2012, FREE RADICAL RES, V46, P460, DOI 10.3109/10715762.2012.655730; Sampath H, 2011, AM J PHYSIOL-ENDOC M, V300, pE724, DOI 10.1152/ajpendo.00387.2010; Shao C, 2008, FREE RADICAL BIO MED, V45, P813, DOI 10.1016/j.freeradbiomed.2008.06.003; Thameem F, 2010, HUM HERED, V70, P97, DOI 10.1159/000291964; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405; Torisu K, 2005, J BIOCHEM, V138, P763, DOI 10.1093/jb/mvi168; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Watkins G, 2004, ONCOL REP, V12, P483; Wood LJ, 2006, BIOL RES NURS, V8, P157, DOI 10.1177/1099800406290932	46	87	89	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51697	10.1371/journal.pone.0051697	http://dx.doi.org/10.1371/journal.pone.0051697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284747	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900047
J	Tiwari, BM; Kannan, N; Vemu, L; Raghunand, TR				Tiwari, Bhavana Mishra; Kannan, Nisha; Vemu, Lakshmi; Raghunand, Tirumalai R.			The Mycobacterium tuberculosis PE Proteins Rv0285 and Rv1386 Modulate Innate Immunity and Mediate Bacillary Survival in Macrophages	PLOS ONE			English	Article							MULTIGENE FAMILY; PGRS PROTEINS; EXPRESSION; SMEGMATIS; IL-10; GENE; LOCALIZATION; APOPTOSIS; NECROSIS; COMPLEX	The unique PE/PPE multigene family of proteins occupies almost 10% of the coding sequence of Mycobacterium tuberculosis (M.tb), the causative agent of human tuberculosis. Although some members of this family have been shown to be involved in pathways essential to M.tb pathogenesis, their precise physiological functions remain largely undefined. Here, we investigate the roles of the conserved members of the 'PE only' subfamily Rv0285 (PE5) and Rv1386 (PE15) in mediating host-pathogen interactions. Recombinant Mycobacterium smegmatis strains expressing PE5 and PE15 showed enhanced survival vs controls in J774.1 and THP-1 macrophages - this increase in viable counts was correlated with a reduction in transcript levels of inducible nitric oxide synthase. An up-regulation of anti- and down-regulation of pro-inflammatory cytokine levels was also observed in infected macrophages implying an immuno-modulatory function for these proteins. Induction of IL-10 production upon infection of THP-1 macrophages was associated with increased phosphorylation of the MAP Kinases p38 and ERK1/2, which was abolished in the presence of the pharmacological inhibitors SB203580 and PD98059. The PE5-PPE4 and PE15-PPE20 gene pairs were observed to be co-operonic in M.tb, hinting at an additional level of complexity in the functioning of these proteins. We conclude that M.tb exploits the PE proteins to evade the host immune response by altering the Th1 and Th2 type balance thereby favouring in vivo bacillary survival.	[Tiwari, Bhavana Mishra; Kannan, Nisha; Raghunand, Tirumalai R.] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Vemu, Lakshmi] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Nizam's Institute of Medical Sciences	Raghunand, TR (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	raghu@ccmb.res.in		Tiwari, Dr. Bhavana/0000-0002-3772-7487	Department of Science and Technology, Government of India [SR/SO/HS-115/2009]; Council of Scientific and Industrial Research (CSIR), Government of India; CSIR; CCMB	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); CCMB	This work was supported by the Department of Science and Technology, Government of India (SR/SO/HS-115/2009 (to TRR) and the Council of Scientific and Industrial Research (CSIR), Government of India. BMT was supported by a Junior Research Fellowship from the CSIR. NK was supported by a fellowship from CCMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Campuzano J, 2007, VACCINE, V25, P3722, DOI 10.1016/j.vaccine.2006.12.042; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chaitra MG, 2005, VACCINE, V23, P1265, DOI 10.1016/j.vaccine.2004.08.046; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daim S, 2011, J MED MICROBIOL, V60, P582, DOI 10.1099/jmm.0.026047-0; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Dheenadhayalan V, 2006, J BACTERIOL, V188, P3721, DOI 10.1128/JB.188.10.3721-3725.2006; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Huang Y, 2010, MOL CELL BIOCHEM, V340, P223, DOI 10.1007/s11010-010-0421-x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Singh PP, 2008, MICROBIOL-SGM, V154, P3469, DOI 10.1099/mic.0.2008/019968-0; Spratt JM, 2005, PLASMID, V53, P269, DOI 10.1016/j.plasmid.2004.11.002; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205	51	74	77	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51686	10.1371/journal.pone.0051686	http://dx.doi.org/10.1371/journal.pone.0051686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284742	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900043
J	Zhang, YJ; Duan, L; Zhang, H; Biswal, BB; Lu, CM; Zhu, CZ				Zhang, Yu-Jin; Duan, Lian; Zhang, Han; Biswal, Bharat B.; Lu, Chun-Ming; Zhu, Chao-Zhe			Determination of Dominant Frequency of Resting-State Brain Interaction within One Functional System	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; INTRINSIC CONNECTIVITY NETWORKS; CEREBRAL HEMODYNAMICS; CORTICAL NETWORKS; BOLD SIGNAL; OSCILLATIONS; FMRI; FLUCTUATIONS; DYNAMICS; SYNCHRONIZATION	Accumulating evidence has revealed that the resting-state functional connectivity (RSFC) is frequency specific and functional system dependent. Determination of dominant frequency of RSFC (RSFCdf) within a functional system, therefore, is of importance for further understanding the brain interaction and accurately assessing the RSFC within the system. Given the unique advantages over other imaging techniques, functional near-infrared spectroscopy (fNIRS) holds distinct merits for RSFCdf determination. However, an obstacle that hinders fNIRS from potential RSFCdf investigation is the interference of various global noises in fNIRS data which could bring spurious connectivity at the frequencies unrelated to spontaneous neural activity. In this study, we first quantitatively evaluated the interferences of multiple systemic physiological noises and the motion artifact by using simulated data. We then proposed a functional system dependent and frequency specific analysis method to solve the problem by introducing anatomical priori information on the functional system of interest. Both the simulated and real resting-state fNIRS experiments showed that the proposed method outperforms the traditional one by effectively eliminating the negative effects of the global noises and significantly improving the accuracy of the RSFCdf estimation. The present study thus provides an effective approach to RSFCdf determination for its further potential applications in basic and clinical neurosciences.	[Zhang, Yu-Jin; Duan, Lian; Zhang, Han; Lu, Chun-Ming; Zhu, Chao-Zhe] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Biswal, Bharat B.] Univ Med & Dent New Jersey, Dept Radiol, Newark, NJ 07103 USA	Beijing Normal University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhu, CZ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	czzhu@bnu.edu.cn	Chaozhe, Zhu/AAK-7737-2020	Chaozhe, Zhu/0000-0002-9247-9607; Zhang, Han/0000-0002-6645-8810; Duan, Lian/0000-0002-9215-5194	Natural Science Foundation of China [30970773]; Program for New Century Excellent Talents in University [NCET-11-0046]; Engagement Fund of Outstanding Doctoral Dissertation of Beijing Normal University [2009044]; Fundamental Research Funds for the Central Universities; National Natural Science Foundation of China [31221003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Engagement Fund of Outstanding Doctoral Dissertation of Beijing Normal University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China, grant number 30970773 (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm); Program for New Century Excellent Talents in University, grant number NCET-11-0046 (http://www.dost.moe.edu.cn/xzzx/rcxmgsxz/20120411142542); Engagement Fund of Outstanding Doctoral Dissertation of Beijing Normal University, grant number 2009044 (http://graduate.bnu.edu.cn/NewsList.aspx?ColumnId = 179#); Fundamental Research Funds for the Central Universities. This work is also supported by the National Natural Science Foundation of China, grant number 31221003 (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Homae F, 2010, J NEUROSCI, V30, P4877, DOI 10.1523/JNEUROSCI.5618-09.2010; Hoshi Y, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804911; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Jann K, 2010, NEUROIMAGE, V51, P365, DOI 10.1016/j.neuroimage.2010.02.024; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Lu CM, 2010, J NEUROSCI METH, V186, P242, DOI 10.1016/j.jneumeth.2009.11.010; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mesquita RC, 2010, BIOMED OPT EXPRESS, V1, P324, DOI 10.1364/BOE.1.000324; Minagawa-Kawai Y, 2008, DEV NEUROBIOL, V68, P712, DOI 10.1002/dneu.20618; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Robertson FC, 2010, IEEE T BIO-MED ENG, V57, P1377, DOI 10.1109/TBME.2009.2038667; Saager R, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940587; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Sasai S, 2011, NEUROIMAGE, P1053; Sasai S, 2010, 16 ANN M ORG HUM BRA; Sato H, 2004, NEUROIMAGE, V21, P1554, DOI 10.1016/j.neuroimage.2003.12.017; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Tong YJ, 2010, NEUROIMAGE, V53, P553, DOI 10.1016/j.neuroimage.2010.06.049; van Buuren M, 2009, HUM BRAIN MAPP, V30, P3031, DOI 10.1002/hbm.20729; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; White BR, 2009, NEUROIMAGE, V47, P148, DOI 10.1016/j.neuroimage.2009.03.058; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Zhang H., 2010, NEUROIMAGE; Zhang H, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3591020; Zhang H, 2011, NEUROIMAGE, V55, P607, DOI 10.1016/j.neuroimage.2010.12.007; Zhang H, 2010, NEUROIMAGE, V51, P1414, DOI 10.1016/j.neuroimage.2010.03.039; Zhang Q, 2009, NEUROIMAGE, V45, P788, DOI 10.1016/j.neuroimage.2008.12.048; Zhang YJ, 2010, 16 ANN M ORG HUM BRA; Zhang YJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3462973	52	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51584	10.1371/journal.pone.0051584	http://dx.doi.org/10.1371/journal.pone.0051584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284719	gold, Green Submitted, Green Published			2022-12-25	WOS:000312435900031
J	Chargui, A; Cesaro, A; Mimouna, S; Fareh, M; Brest, P; Naquet, P; Darfeuille-Michaud, A; Hebuterne, X; Mograbi, B; Vouret-Craviari, V; Hofman, P				Chargui, Abderrahman; Cesaro, Annabelle; Mimouna, Sanda; Fareh, Mohamed; Brest, Patrick; Naquet, Philippe; Darfeuille-Michaud, Arlette; Hebuterne, Xavier; Mograbi, Baharia; Vouret-Craviari, Valerie; Hofman, Paul			Subversion of Autophagy in Adherent Invasive Escherichia coli-Infected Neutrophils Induces Inflammation and Cell Death	PLOS ONE			English	Article							CROHNS-DISEASE; ILEAL MUCOSA; MACROPHAGES; PATHWAYS; MANIPULATION; IMMUNITY; STRAINS; PLB-985	Invading bacteria are recognized, captured and killed by a specialized form of autophagy, called xenophagy. Recently, defects in xenophagy in Crohn's disease (CD) have been implicated in the pathogenesis of human chronic inflammatory diseases of uncertain etiology of the gastrointestinal tract. We show here that pathogenic adherent-invasive Escherichia coli (AIEC) isolated from CD patients are able to adhere and invade neutrophils, which represent the first line of defense against bacteria. Of particular interest, AIEC infection of neutrophil-like PLB-985 cells blocked autophagy at the autolysosomal step, which allowed intracellular survival of bacteria and exacerbated interleukin-8 (IL-8) production. Interestingly, this block in autophagy correlated with the induction of autophagic cell death. Likewise, stimulation of autophagy by nutrient starvation or rapamycin treatment reduced intracellular AIEC survival and IL-8 production. Finally, treatment with an inhibitor of autophagy decreased cell death of AIEC-infected neutrophil-like PLB-985 cells. In conclusion, excessive autophagy in AIEC infection triggered cell death of neutrophils.	[Chargui, Abderrahman; Cesaro, Annabelle; Mimouna, Sanda; Brest, Patrick; Hebuterne, Xavier; Mograbi, Baharia; Vouret-Craviari, Valerie; Hofman, Paul] Inst Res Canc & Aging, Nice, France; [Chargui, Abderrahman; Cesaro, Annabelle; Mimouna, Sanda; Brest, Patrick; Hebuterne, Xavier; Mograbi, Baharia; Vouret-Craviari, Valerie; Hofman, Paul] CNRS, INSERM, U1081, UMR7284,Team 3, F-06034 Nice, France; [Chargui, Abderrahman; Cesaro, Annabelle; Mimouna, Sanda; Fareh, Mohamed; Brest, Patrick; Hebuterne, Xavier; Mograbi, Baharia; Vouret-Craviari, Valerie; Hofman, Paul] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Chargui, Abderrahman; Cesaro, Annabelle; Mimouna, Sanda; Brest, Patrick; Hebuterne, Xavier; Mograbi, Baharia; Vouret-Craviari, Valerie; Hofman, Paul] Equipe Labellisee Fdn Assoc Rech Canc, Villejuif, France; [Fareh, Mohamed] Fac Med Nice, INSERM, U898, F-06034 Nice, France; [Naquet, Philippe] Ctr Imunol Marseille Luminy, UMR 631, Marseille, France; [Darfeuille-Michaud, Arlette] INSERM, U1071, Clermont Ferrand, France; [Darfeuille-Michaud, Arlette] INRA, USC2018, Clermont Ferrand, France; [Hebuterne, Xavier] CHU Nice, Hop Archet, Dept Gastroenterol, Nice, France; [Hofman, Paul] Pasteur Hosp, CHU Nice, Lab Clin & Expt Pathol & Human Biobank, Human Biobank, Nice, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; CHU Nice; CHU Nice	Mograbi, B (corresponding author), Inst Res Canc & Aging, Nice, France.	mograbi@unice.fr; vouret@unice.fr; hofman.p@chu-nice.fr	Hofman, Paul/P-7654-2018; Mograbi, Baharia/N-5531-2018; Cesaro, Annabelle/AAX-3177-2020; brest, patrick/B-7311-2012; Mograbi, Baharia/Q-7953-2019	Hofman, Paul/0000-0003-0431-9353; brest, patrick/0000-0002-1252-4747; Mograbi, Baharia/0000-0002-1025-3429; Fareh, Mohamed/0000-0001-9551-8213	Infectiopole Sud PACA; Association Francois Aupetit; Institut National de la Sante et de la Recherche Medicale; Agence de l'Environnement et de la Maitrise de l'Energie [08 62 C 0044]; Agence regionale sante Provence Alpes Cote d'Azur and Direction regionale de l'Environnement, de l'amenagement et du logement [6.3.3.3]	Infectiopole Sud PACA; Association Francois Aupetit; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence de l'Environnement et de la Maitrise de l'Energie; Agence regionale sante Provence Alpes Cote d'Azur and Direction regionale de l'Environnement, de l'amenagement et du logement	Funding provided by Infectiopole Sud PACA (A. Chargui: postdoctoral fellowship), Association Francois Aupetit, "Institut National de la Sante et de la Recherche Medicale'', "Agence de l'Environnement et de la Maitrise de l'Energie'' (A B and A. Cesaro: convention ADEME no 08 62 C 0044), "Agence regionale sante Provence Alpes Cote d'Azur and Direction regionale de l'Environnement, de l'amenagement et du logement'' (A B: plan regional sante environnement PRSE PACA no6.3.3.3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Brest P, 2010, CURR MOL MED, V10, P486, DOI 10.2174/156652410791608252; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Cesaro A, 2010, AM J PHYSIOL-GASTR L, V299, pG32, DOI 10.1152/ajpgi.00282.2009; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hausmann M, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/574568; Hofman P, 1996, AM J PHYSIOL-CELL PH, V271, pC312, DOI 10.1152/ajpcell.1996.271.1.C312; Hofman PM, 2010, WORLD J GASTROENTERO, V16, P5790, DOI 10.3748/wjg.v16.i46.5790; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kumar Y, 2009, CELL HOST MICROBE, V5, P593, DOI 10.1016/j.chom.2009.05.014; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lapaquette P, 2012, CELL MICROBIOL; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Maianski NA, 2003, BLOOD, V101, P1987, DOI 10.1182/blood-2002-02-0522; MALCOLM ID, 1979, ARCH INTERN MED, V139, P675, DOI 10.1001/archinte.139.6.675; Mihalache CC, 2011, J IMMUNOL, V186, P6532, DOI 10.4049/jimmunol.1004055; Mimouna S, 2011, GUT MICROBES, V2, P335, DOI [10.4161/gmic.18771, 10.4161/gmic.2.6.18771]; Mitroulis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029318; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Panyasrivanit M, 2011, VIROLOGY, V418, P74, DOI 10.1016/j.virol.2011.07.010; Pedruzzi E, 2002, BRIT J HAEMATOL, V117, P719, DOI 10.1046/j.1365-2141.2002.03521.x; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Raso T, 2011, CURR MICROBIOL, V63, P131, DOI 10.1007/s00284-011-9947-8; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Semiramoth N, 2009, J LEUKOCYTE BIOL, V85, P310, DOI 10.1189/jlb.0608350; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; TUCKER KA, 1987, BLOOD, V70, P372; von Gunten S, 2005, BLOOD, V106, P1423, DOI 10.1182/blood-2004-10-4112	43	49	53	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51727	10.1371/journal.pone.0051727	http://dx.doi.org/10.1371/journal.pone.0051727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272151	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800072
J	Taylor, AE; Kuper, H; Varma, RD; Wells, JC; Bell, JD; Radhakrishna, KV; Kulkarni, B; Kinra, S; Timpson, NJ; Ebrahim, S; Smith, GD; Ben-Shlomo, Y				Taylor, Amy E.; Kuper, Hannah; Varma, Ravi D.; Wells, Jonathan C.; Bell, Jimmy D.; Radhakrishna, K. V.; Kulkarni, Bharati; Kinra, Sanjay; Timpson, Nicholas J.; Ebrahim, Shah; Smith, George Davey; Ben-Shlomo, Yoav			Validation of Dual Energy X-Ray Absorptiometry Measures of Abdominal Fat by Comparison with Magnetic Resonance Imaging in an Indian Population	PLOS ONE			English	Article							TOTAL-BODY FAT; ADIPOSE-TISSUE; 4-COMPARTMENT MODEL; COMPUTED-TOMOGRAPHY; INSULIN-RESISTANCE; ASIAN INDIANS; VISCERAL FAT; SOFT-TISSUE; DXA; WOMEN	Objective: Abdominal adiposity is an important risk factor for diabetes and cardiovascular disease in Indians. Dual energy Xray absorptiometry (DXA) can be used to determine abdominal fat depots, being more accessible and less costly than gold standard measures such as magnetic resonance imaging (MRI). DXA has not been fully validated for use in South Asians. Here, we determined the accuracy of DXA for measurement of abdominal fat in an Indian population by comparison with MRI. Design: 146 males and females (age range 18-74, BMI range 15-46 kg/m(2)) from Hyderabad, India underwent whole body DXA scans on a Hologic Discovery A scanner, from which fat mass in two abdominal regions was calculated, from the L1 to L4 vertebrae (L1L4) and from the L2 to L4 vertebrae (L2L4). Abdominal MRI scans (axial T1-weighted spin echo images) were taken, from which adipose tissue volumes were calculated for the same regions. Results: Intra-class correlation coefficients between DXA and MRI measures of abdominal fat were high (0.98 for both regions). Although at the level of the individual, differences between DXA and MRI could be large (95% of DXA measures were between 0.8 and 1.4 times MRI measures), at the sample level, DXA only slightly overestimated MRI measures of abdominal fat mass (mean difference in L1L4 region: 2% (95% CI: 0%, 5%), mean difference in L2L4 region: 4% (95% CI: 1%, 7%)). There was evidence of a proportional bias in the association between DXA and MRI (correlation between difference and mean 20.3), with overestimation by DXA greater in individuals with less abdominal fat (mean bias in leaner half of sample was 6% for L1L4 (95% CI: 2, 11%) and 7% for L2L4 (95% CI: 3,12%). Conclusions: DXA measures of abdominal fat are suitable for use in Indian populations and provide a good indication of abdominal adiposity at the population level. Citation: Taylor AE, Kuper H, Varma RD, Wells JC, Bell JD, et al. (2012) Validation of Dual Energy X-Ray Absorptiometry Measures of Abdominal Fat by Comparison with Magnetic Resonance Imaging in an Indian Population. PLoS ONE 7(12): e51042. doi:10.1371/journal.pone.0051042	[Taylor, Amy E.; Timpson, Nicholas J.; Smith, George Davey] Univ Bristol, Sch Social & Community Med, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England; [Kuper, Hannah] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Varma, Ravi D.] Krishna Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Wells, Jonathan C.] Childrens Nutr Res Ctr, Inst Child Hlth, London, England; [Bell, Jimmy D.] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Metab & Mol Imaging Grp, London, England; [Radhakrishna, K. V.; Kulkarni, Bharati] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India; [Kinra, Sanjay; Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Ebrahim, Shah] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India	University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Imperial College London; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India	Taylor, AE (corresponding author), Univ Bristol, Sch Social & Community Med, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England.	amy.taylor@bristol.ac.uk	Ben-Shlomo, Yoav/ABD-2004-2021; Fox, Laura J/C-6249-2016; Kulkarni, Bharati/ABB-3188-2020; Kulkarni, Bharati/C-9036-2011; Wells, Jonathan/A-4604-2009; Attrill, Lauren/V-1688-2018; Timpson, Nicholas John/O-7548-2015; Davey Smith, George/A-7407-2013	Ben-Shlomo, Yoav/0000-0001-6648-3007; Kulkarni, Bharati/0000-0003-0636-318X; Kulkarni, Bharati/0000-0003-0636-318X; Wells, Jonathan/0000-0003-0411-8025; Timpson, Nicholas John/0000-0002-7141-9189; Davey Smith, George/0000-0002-1407-8314; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Bell, Jimmy/0000-0003-3804-1281; s, hema/0000-0002-3440-9475	Wellcome Trust Grant [WT083707MA]; Wellcome Trust PhD Studentship [WT083431MA]; UK Medical Research Council [G0600705]; MRC; National Institute of Nutrition; Medical Research Council [MC_U120061305, G0600705] Funding Source: researchfish; MRC [G0600705, MC_U120061305] Funding Source: UKRI	Wellcome Trust Grant(Wellcome Trust); Wellcome Trust PhD Studentship(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Nutrition; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Hyderabad DXA Study was funded by a Wellcome Trust Grant (WT083707MA). Amy Taylor is funded by a 4 year Wellcome Trust PhD Studentship (WT083431MA). The MRC Centre for Causal Analyses in Translational Epidemiology (CAiTE) receives funds from the UK Medical Research Council (G0600705). The MRC Clinical Sciences Centre acknowledges funding from the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the participants of the Hyderabad DXA Study and the field staff at the National Institute of Nutrition who carried out the data collection for the Hyderabad DXA Study. We are grateful to the National Institute of Nutrition for supporting the running of the Hyderabad DXA Study. We would also like to thank employees at the Krishna Institute of Medical Sciences who performed the MRI scans.	Andreoli A, 2009, RADIOL MED, V114, P286, DOI 10.1007/s11547-009-0369-7; Anjana M, 2004, DIABETES CARE, V27, P2948, DOI 10.2337/diacare.27.12.2948; Benfield LL, 2009, INT J BODY COMPOSITI, V7, P131; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Browning LM, 2011, OBESITY FACTS, V4, P9, DOI 10.1159/000324546; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; Despres JP, 1996, HUMAN BODY COMPOSITI, P149; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; ENTENMAN C, 1958, J APPL PHYSIOL, V13, P129, DOI 10.1152/jappl.1958.13.1.129; Glickman SG, 2004, J APPL PHYSIOL, V97, P509, DOI 10.1152/japplphysiol.01234.2003; Goel K, 2008, OBESITY, V16, P451, DOI 10.1038/oby.2007.55; International Atomic Energy Agency, 2012, RAD PROT DXA PREGN; JENSEN MD, 1995, AM J CLIN NUTR, V61, P274, DOI 10.1093/ajcn/61.2.274; Kamel EG, 1999, INT J OBESITY, V23, P686, DOI 10.1038/sj.ijo.0800904; Kinra S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a605; LaForgia J, 2009, OBESITY, V17, P821, DOI 10.1038/oby.2008.595; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; Litaker MS, 2003, OBES RES, V11, P1545, DOI 10.1038/oby.2003.206; Lyngdoh T, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-2; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Misra A, 2009, METAB SYNDR RELAT D, V7, P497, DOI 10.1089/met.2009.0024; Nelson TL, 2008, DIABETES-METAB RES, V24, P33, DOI 10.1002/dmrr.747; O'Connor DP, 2011, MED SCI SPORT EXER, V43, P1785, DOI 10.1249/MSS.0b013e318216d90f; Paradisi G, 1999, DIABETES CARE, V22, P1310, DOI 10.2337/diacare.22.8.1310; ROSS R, 1992, J APPL PHYSIOL, V72, P787, DOI 10.1152/jappl.1992.72.2.787; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; Sakai Y, 2006, J CLIN DENSITOM, V9, P191, DOI 10.1016/j.jocd.2006.03.008; Scherzer R, 2008, AM J CLIN NUTR, V88, P1088, DOI 10.1093/ajcn/88.4.1088; Shen W, 2003, OBES RES, V11, P5, DOI 10.1038/oby.2003.3; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; SOHLSTROM A, 1993, AM J CLIN NUTR, V58, P830, DOI 10.1093/ajcn/58.6.830; Sopher AB, 2004, PEDIATRICS, V113, P1285, DOI 10.1542/peds.113.5.1285; SVENDSEN OL, 1993, INT J OBESITY, V17, P45; Thomas EL, 2003, INT J OBESITY, V27, P211, DOI 10.1038/sj.ijo.802229; Thomas EL, 1998, J APPL PHYSIOL, V85, P1778, DOI 10.1152/jappl.1998.85.5.1778; THOMAS LW, 1962, Q J EXP PHYSIOL CMS, V47, P179, DOI 10.1113/expphysiol.1962.sp001589; Thomsen TK, 1998, EUR J SURG, V164, P133; TOTHILL P, 1994, EUR J CLIN NUTR, V48, P781; Tothill P, 2000, ANN NY ACAD SCI, V904, P63; Tothill P, 1998, APPL RADIAT ISOTOPES, V49, P457, DOI 10.1016/S0969-8043(97)00053-5; Van der Ploeg GE, 2003, J APPL PHYSIOL, V94, P499, DOI 10.1152/japplphysiol.00436.2002; VANLOAN MD, 1995, MED SCI SPORT EXER, V27, P587; Williams JE, 2006, AM J CLIN NUTR, V83, P1047, DOI 10.1093/ajcn/83.5.1047	45	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51042	10.1371/journal.pone.0051042	http://dx.doi.org/10.1371/journal.pone.0051042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272086	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000312386800025
J	Kordes, C; Sawitza, I; Gotze, S; Haussinger, D				Kordes, Claus; Sawitza, Iris; Goetze, Silke; Haeussinger, Dieter			Stellate Cells from Rat Pancreas Are Stem Cells and Can Contribute to Liver Regeneration	PLOS ONE			English	Article							FAT-STORING CELLS; PROGENITOR CELLS; IN-VITRO; NESTIN EXPRESSION; EPITHELIAL-CELLS; OVAL CELLS; ADULT-RAT; DIFFERENTIATION; LINEAGE; ISLETS	The identity of pancreatic stem/progenitor cells is still under discussion. They were suggested to derive from the pancreatic ductal epithelium and/or islets. Here we report that rat pancreatic stellate cells (PSC), which are thought to contribute to pancreatic fibrosis, have stem cell characteristics. PSC reside in islets and between acini and display a gene expression pattern similar to umbilical cord blood stem cells and mesenchymal stem cells. Cytokine treatment of isolated PSC induced the expression of typical hepatocyte markers. The PSC-derived hepatocyte-like cells expressed endodermal proteins such as bile salt export pump along with the mesodermal protein vimentin. The transplantation of culture-activated PSC from enhanced green fluorescent protein-expressing rats into wild type rats after partial hepatectomy in the presence of 2-acetylaminofluorene revealed that PSC were able to reconstitute large areas of the host liver through differentiation into hepatocytes and cholangiocytes. This developmental fate of transplanted PSC was confirmed by fluorescence in situ hybridization of chromosome Y after gender-mismatched transplantation of male PSC into female rats. Transplanted PSC displayed long-lasting survival, whereas muscle fibroblasts were unable to integrate into the host liver. The differentiation potential of PSC was further verified by the transplantation of clonally expanded PSC. PSC clones maintained the expression of stellate cell and stem cell markers and preserved their differentiation potential, which indicated self-renewal potential of PSC. These findings demonstrate that PSC have stem cell characteristics and can contribute to the regeneration of injured organs through differentiation across tissue boundaries. Citation: Kordes C, Sawitza I, Gotze S, Haussinger D (2012) Stellate Cells from Rat Pancreas Are Stem Cells and Can Contribute to Liver Regeneration. PLoS ONE 7(12): e51878. doi: 10.1371/journal.pone.0051878	[Kordes, Claus; Sawitza, Iris; Goetze, Silke; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Kordes, Claus/AFM-1775-2022	Kordes, Claus/0000-0003-0782-1998	German Research Foundation through the Collaborative Research Center CRC [974]; Research Commission of the Medical Faculty of the Heinrich Heine University Dusseldorf	German Research Foundation through the Collaborative Research Center CRC; Research Commission of the Medical Faculty of the Heinrich Heine University Dusseldorf	This work was supported by the German Research Foundation through the Collaborative Research Center CRC 974 ("Communication and Systems Relevance during Liver Injury and Regeneration") and the Research Commission of the Medical Faculty of the Heinrich Heine University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bani-Yaghoub M, 2007, DEV DYNAM, V236, P696, DOI 10.1002/dvdy.21072; BISGAARD HC, 1991, J CELL PHYSIOL, V147, P333, DOI 10.1002/jcp.1041470220; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; FITZGERALD PJ, 1952, NATURE, V170, P929, DOI 10.1038/170929b0; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; GARD AL, 1985, J NEUROIMMUNOL, V8, P359, DOI 10.1016/S0165-5728(85)80073-4; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5; Higgins GM, 1931, ARCH PATHOL, V12, P186; IKEJIRI N, 1990, Kurume Medical Journal, V37, P67, DOI 10.2739/kurumemedj.37.67; Karanu FN, 2003, LEUKEMIA, V17, P1366, DOI 10.1038/sj.leu.2402973; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Kubitz R, 2004, GASTROENTEROLOGY, V126, P541, DOI 10.1053/j.gastro.2003.11.003; Lange C, 2005, TRANSPL P, V37, P276, DOI 10.1016/j.transproceed.2004.11.087; Lardon J, 2002, HISTOCHEM CELL BIOL, V117, P535, DOI 10.1007/s00418-002-0412-4; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Niki T, 1999, HEPATOLOGY, V29, P520, DOI 10.1002/hep.510290232; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; POUR P, 1978, AM J PATHOL, V90, P295; Ramiya VK, 2000, NAT MED, V6, P278; Rao MS, 1996, GENE EXPRESSION, V6, P15; RAO MS, 1989, AM J PATHOL, V134, P1069; REDDY JK, 1991, DIGEST DIS SCI, V36, P502, DOI 10.1007/BF01298883; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; TATEMATSU M, 1984, AM J PATHOL, V114, P418; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Uyama N, 2006, GUT, V55, P1276, DOI 10.1136/gut.2005.078865; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; YOKOI Y, 1984, HEPATOLOGY, V4, P709, DOI 10.1002/hep.1840040425; Zhang QH, 2007, DNA CELL BIOL, V26, P497, DOI 10.1089/dna.2006.0562; Zhao LN, 2007, J MOL HISTOL, V38, P53, DOI 10.1007/s10735-007-9078-5; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	39	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51878	10.1371/journal.pone.0051878	http://dx.doi.org/10.1371/journal.pone.0051878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272184	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386600046
J	So, LM; Yea, SS; Oak, JS; Lu, MR; Manmadhan, A; Ke, QH; Janes, MR; Kessler, LV; Kucharski, JM; Li, LS; Martin, MB; Ren, PD; Jessen, KA; Liu, Y; Rommel, C; Fruman, DA				So, Lomon; Yea, Sung Su; Oak, Jean S.; Lu, Mengrou; Manmadhan, Arun; Ke, Qiao Han; Janes, Matthew R.; Kessler, Linda V.; Kucharski, Jeff M.; Li, Lian-Sheng; Martin, Michael B.; Ren, Pingda; Jessen, Katti A.; Liu, Yi; Rommel, Christian; Fruman, David A.			Selective Inhibition of Phosphoinositide 3-Kinase p110 alpha Preserves Lymphocyte Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL; T-CELLS; P110-DELTA ISOFORM; PI3K INHIBITOR; KINASE; ANTIGEN; GROWTH; IMMUNOTHERAPY; MECHANISMS; MUTATIONS	Class IA phosphoinositide 3-kinase (PI3K) is essential for clonal expansion, differentiation, and effector function of B and T lymphocytes. The p110 delta catalytic isoform of PI3K is highly expressed in lymphocytes and plays a prominent role in B and T cell responses. Another class IA PI3K catalytic isoform, p110 alpha, is a promising drug target in cancer but little is known about its function in lymphocytes. Here we used highly selective inhibitors to probe the function of p110 alpha in lymphocyte responses in vitro and in vivo. p110 alpha inhibition partially reduced B cell receptor (BCR)-dependent AKT activation and proliferation, and diminished survival supported by the cytokines BAFF and IL-4. Selective p110 delta inhibition suppressed B cell responses much more strongly, yet maximal suppression was achieved by targeting multiple PI3K isoforms. In mouse and human T cells, inhibition of single class IA isoforms had little effect on proliferation, whereas pan-class I inhibition did suppress T cell expansion. In mice, selective p110 alpha inhibition using the investigational agent MLN1117 (previously known as INK1117) did not disrupt the marginal zone B cell compartment and did not block T cell-dependent germinal center formation. In contrast, the selective p110 delta inhibitor IC87114 strongly suppressed germinal center formation and reduced marginal zone B cell numbers, similar to a pan-class I inhibitor. These findings show that although acute p110 alpha inhibition partially diminishes AKT activation, selective p110 alpha inhibitors are likely to be less immunosuppressive in vivo compared with p110 delta or pan-class I inhibitors.	[So, Lomon; Yea, Sung Su; Oak, Jean S.; Lu, Mengrou; Manmadhan, Arun; Ke, Qiao Han; Fruman, David A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [So, Lomon; Yea, Sung Su; Oak, Jean S.; Lu, Mengrou; Manmadhan, Arun; Ke, Qiao Han; Fruman, David A.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA; [Yea, Sung Su] Inje Univ, Dept Biochem, Coll Med, Pusan 614735, South Korea; [Janes, Matthew R.; Kessler, Linda V.; Kucharski, Jeff M.; Li, Lian-Sheng; Martin, Michael B.; Ren, Pingda; Jessen, Katti A.; Liu, Yi; Rommel, Christian] Intellikine Inc, La Jolla, CA 92037 USA; [Janes, Matthew R.; Kessler, Linda V.; Kucharski, Jeff M.; Li, Lian-Sheng; Martin, Michael B.; Jessen, Katti A.] Takeda Calif Inc, San Diego, CA 92121 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Inje University; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc	Fruman, DA (corresponding author), 3242 McGaugh Hall, Irvine, CA 92697 USA.	dfruman@uci.edu		Manmadhan, Arun/0000-0001-9500-8184	Intellikine, Inc.; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	Intellikine, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a sponsored research agreement from Intellikine, Inc. (to D. A. F.).	Agarwal R, 2010, CURR OPIN INVEST DR, V11, P615; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Donahue AC, 2007, EUR J IMMUNOL, V37, P2923, DOI 10.1002/eji.200737281; Durand CA, 2009, J IMMUNOL, V183, P5673, DOI 10.4049/jimmunol.0900432; Edgar KA, 2010, CANCER RES, V70, P1164, DOI 10.1158/0008-5472.CAN-09-2525; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Fruman DA, 2011, CANCER DISCOV, V1, P562, DOI 10.1158/2159-8290.CD-11-0249; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jessen K, 2011, MOL CANC THER, V10; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Marshall NA, 2012, CANCER RES, V72, P581, DOI 10.1158/0008-5472.CAN-11-0307; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; Okkenhaug K, 2010, CURR TOP MICROBIOL, V346, P57, DOI 10.1007/82_2010_45; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Ramadani F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001104; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Rewcastle GW, 2011, J MED CHEM, V54, P7105, DOI 10.1021/jm200688y; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; So L, 2012, BIOCHEM J, V442, P465, DOI 10.1042/BJ20112092; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Sun MH, 2010, P NATL ACAD SCI USA, V107, P15547, DOI 10.1073/pnas.1009652107; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Zhang TT, 2008, J ALLERGY CLIN IMMUN, V122, P811, DOI 10.1016/j.jaci.2008.08.008	42	53	54	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5718	5731		10.1074/jbc.M112.379446	http://dx.doi.org/10.1074/jbc.M112.379446			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23275335	Green Published, hybrid			2022-12-25	WOS:000315342500044
J	Peltier, E; Peltier, C; Tahar, S; Alliot-Lugaz, E; Cazals, Y				Peltier, Elisabeth; Peltier, Cedric; Tahar, Stephanie; Alliot-Lugaz, Evelyne; Cazals, Yves			Long-Term Tinnitus Suppression with Linear Octave Frequency Transposition Hearing Aids	PLOS ONE			English	Article							MECHANISMS; REGION	Over the last three years of hearing aid dispensing, it was observed that among 74 subjects fitted with a linear octave frequency transposition (LOFT) hearing aid, 60 reported partial or complete tinnitus suppression during day and night, an effect still lasting after several months or years of daily use. We report in more details on 38 subjects from whom we obtained quantified measures of tinnitus suppression through visual analog scaling and several additional psychoacoustic and audiometric measures. The long-term suppression seems independent of subject age, and of duration and subjective localization of tinnitus. A small but significant correlation was found with audiogram losses but not with high frequency loss slope. Long-term tinnitus suppression was observed for different etiologies, but with a low success rate for sudden deafness. It should be noted that a majority of subjects (23) had a history of noise exposure. Tinnitus suppression started after a few days of LOFT hearing aid use and reached a maximum after a few weeks of daily use. For nine subjects different amounts of frequency shifting were tried and found more or less successful for long-term tinnitus suppression, no correlation was found with tinnitus pitch. When the use of the LOFT hearing aid was stopped tinnitus reappeared within a day, and after re-using the LOFT aid it disappeared again within a day. For about one third of the 38 subjects a classical amplification or a non linear frequency compression aid was also tried, and no such tinnitus suppression was observed. Besides improvements in audiometric sensitivity to high frequencies and in speech discrimination scores, LOFT can be considered as a remarkable opportunity to suppress tinnitus over a long time scale. From a pathophysiological viewpoint these observations seem to fit with a possible re-attribution of activity to previously deprived cerebral areas corresponding to high frequency coding.	[Cazals, Yves] Aix Marseille Univ, Lab Neurosci Integrat & Adaptat, CNRS, UMR Federat Rech Cerveau Comportement Cognit 7260, Marseille, France; [Peltier, Elisabeth; Peltier, Cedric; Tahar, Stephanie; Alliot-Lugaz, Evelyne] Lab Chelles Surdite, Chelles, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cazals, Y (corresponding author), Aix Marseille Univ, Lab Neurosci Integrat & Adaptat, CNRS, UMR Federat Rech Cerveau Comportement Cognit 7260, Marseille, France.	yves.cazals@univ-amu.fr						Anari M, 1999, SCAND AUDIOL, V28, P219, DOI 10.1080/010503999424653; ATHERLEY GR, 1968, J ACOUST SOC AM, V44, P1503, DOI 10.1121/1.1911288; BERGMAN A, 1990, AUDITORY SCENE ANAL; Cazals Y, 1983, Rev Laryngol Otol Rhinol (Bord), V104, P433; Del Bo L, 2007, PROG BRAIN RES, V166, P341, DOI 10.1016/S0079-6123(07)66032-4; Del Bo L, 2008, OTOLARYNG HEAD NECK, V139, P391, DOI 10.1016/j.otohns.2008.06.019; Diesch E, 2010, NEUROIMAGE, V50, P1545, DOI 10.1016/j.neuroimage.2010.01.067; Dutt SN, 2002, J LARYNGOL OTOL, V116, P2, DOI 10.1258/0022215021911275; Eggermont JJ, 2012, HEAR RES; Fullgrabe C, 2010, INT J AUDIOL, V49, P420, DOI 10.3109/14992020903505521; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); HENRY JA, 1999, P 6 INT TINN SEM, P51; Hobson J, 2010, COCHRANE DB SYST REV, V12; Holmes S, 2009, J CLIN NURS, V18, P2927, DOI 10.1111/j.1365-2702.2009.02909.x; Jastreboff PJ, 1996, AM J OTOL, V17, P236; McDermott HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022358; Moffat G, 2009, HEARING RES, V254, P82, DOI 10.1016/j.heares.2009.04.016; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Robinson JD, 2009, INT J AUDIOL, V48, P384, DOI 10.1080/14992020902803138; Simpson Andrea, 2009, Trends Amplif, V13, P87, DOI 10.1177/1084713809336421; Terry A M, 1983, Br J Audiol, V17, P245, DOI 10.3109/03005368309081485; Trotrer MI, 2008, J LARYNGOL OTOL, V122, P1052, DOI 10.1017/S002221510800203X; Tucker DA, 2005, OTOLARYNG HEAD NECK, V132, P20, DOI 10.1016/j.otohns.2005.08.016; VERNON J, 1990, AM J OTOLARYNG, V11, P44, DOI 10.1016/0196-0709(90)90169-V; Vickers DA, 2001, J ACOUST SOC AM, V110, P1164, DOI 10.1121/1.1381534; Wegel RL, 1931, ARCHIV OTOLARYNGOL, V14, P158	27	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51915	10.1371/journal.pone.0051915	http://dx.doi.org/10.1371/journal.pone.0051915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284815	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500066
J	Schneider, A; Ruppert, M; Hendrich, O; Giang, T; Ogueta, M; Hampel, S; Vollbach, M; Buschges, A; Scholz, H				Schneider, Andrea; Ruppert, Manuela; Hendrich, Oliver; Giang, Thomas; Ogueta, Maite; Hampel, Stefanie; Vollbach, Marvin; Bueschges, Ansgar; Scholz, Henrike			Neuronal Basis of Innate Olfactory Attraction to Ethanol in Drosophila	PLOS ONE			English	Article							OCTOPAMINERGIC NEURONS; CENTRAL COMPLEX; FRUIT-FLY; MELANOGASTER; BEHAVIOR; FLIES; STIMULATION; MECHANISMS; DOPAMINE; TYRAMINE	The decision to move towards a mating partner or a food source is essential for life. The mechanisms underlying these behaviors are not well understood. Here, we investigated the role of octopamine - the invertebrate analogue of noradrenaline - in innate olfactory attraction to ethanol. We confirmed that preference is caused via an olfactory stimulus by dissecting the function of the olfactory co-receptor Orco (formally known as OR83b). Orco function is not required for ethanol recognition per se, however it plays a role in context dependent recognition of ethanol. Odor-evoked ethanol preference requires the function of Tbh (Tyramine beta hydroxalyse), the rate-limiting enzyme of octopamine synthesis. In addition, neuronal activity in a subset of octopaminergic neurons is necessary for olfactory ethanol preference. Notably, a specific neuronal activation pattern of tyraminergic/octopaminergic neurons elicit preference and is therefore sufficient to induce preference. In contrast, dopamine dependent increase in locomotor activity is not sufficient for olfactory ethanol preference. Consistent with the role of noradrenaline in mammalian drug induced rewards, we provide evidence that in adult Drosophila the octopaminergic neurotransmitter functions as a reinforcer and that the molecular dissection of the innate attraction to ethanol uncovers the basic properties of a response selection system.	[Schneider, Andrea; Ruppert, Manuela; Hendrich, Oliver; Giang, Thomas; Vollbach, Marvin; Bueschges, Ansgar; Scholz, Henrike] Univ Cologne, Bioctr, Inst Zool, Dept Anim Physiol Neurobiol, D-50931 Cologne, Germany; [Ogueta, Maite] Inst Neurociencias Castilla & Leon, Dept Biol Celular & Patol, Salamanca, Spain; [Hampel, Stefanie] Howard Hughes Med Inst, Ashburn, VA USA	University of Cologne; Howard Hughes Medical Institute	Scholz, H (corresponding author), Univ Cologne, Bioctr, Inst Zool, Dept Anim Physiol Neurobiol, D-50931 Cologne, Germany.	henrike.scholz@uni-koeln.de	Scholz, Henrike/ABE-1063-2020	Ogueta, Maite/0000-0002-4777-8317; Hendrich, Oliver/0000-0003-1185-520X; Hampel, Stefanie/0000-0001-8287-549X	DFG [656/4-1, 656/7-1]	DFG(German Research Foundation (DFG))	This work was supported by the DFG 656/4-1 and DFG656/7-1 to H.S. (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Bellmann D, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00027; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Buschges A, 2011, CURR BIOL, V21, pR513, DOI 10.1016/j.cub.2011.05.029; BULTHOFF H, 1982, BIOL CYBERN, V45, P63, DOI 10.1007/BF00387215; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Busto GU, 2010, PHYSIOLOGY, V25, P338, DOI 10.1152/physiol.00026.2010; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Dierks A, 2008, J INSECT PHYSIOL, V54, P1363, DOI 10.1016/j.jinsphys.2008.07.008; Farooqui T, 2003, J NEUROSCI, V23, P5370; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Glanzman DL, 2011, P NATL ACAD SCI USA, V108, P14711, DOI 10.1073/pnas.1111230108; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Kononenko NL, 2009, J COMP NEUROL, V512, P433, DOI 10.1002/cne.21911; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; MCKENZIE JA, 1972, OECOLOGIA, V10, P373, DOI 10.1007/BF00345738; Monastirioti M, 1996, J NEUROSCI, V16, P3900; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Ogueta M, 2010, CHEM SENSES, V35, P813, DOI 10.1093/chemse/bjq084; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Pophof B, 2000, J COMP PHYSIOL A, V186, P307, DOI 10.1007/s003590050431; REDGRAVE P, 1981, BRIT MED BULL, V37, P141, DOI 10.1093/oxfordjournals.bmb.a071691; Scholz H, 2005, J NEUROBIOL, V63, P199, DOI 10.1002/neu.20127; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; Sinakevitch I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014536; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Weinshenker D, 2007, NEUROPSYCHOPHARMACOL, V32, P1433, DOI 10.1038/sj.npp.1301263; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	44	34	34	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52007	10.1371/journal.pone.0052007	http://dx.doi.org/10.1371/journal.pone.0052007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284851	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500077
J	Yong-Gonzales, V; Hang, LE; Castellucci, F; Branzei, D; Zhao, XL				Yong-Gonzales, Vladimir; Hang, Lisa E.; Castellucci, Federica; Branzei, Dana; Zhao, Xiaolan			The Smc5-Smc6 Complex Regulates Recombination at Centromeric Regions and Affects Kinetochore Protein Sumoylation during Normal Growth	PLOS ONE			English	Article							DAMAGED REPLICATION FORKS; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; SMC5/6 COMPLEX; SUMO LIGASE; CHROMOSOME TRANSMISSION; CHECKPOINT RESPONSES; SPINDLE ELONGATION; GLOBAL ANALYSIS; YEAST	The Smc5-Smc6 complex in Saccharomyces cerevisiae is both essential for growth and important for coping with genotoxic stress. While it facilitates damage tolerance throughout the genome under genotoxin treatment, its function during unperturbed growth is mainly documented for repetitive DNA sequence maintenance. Here we provide physical and genetic evidence showing that the Smc5-Smc6 complex regulates recombination at non-repetitive loci such as centromeres in the absence of DNA damaging agents. Mutating Smc6 results in the accumulation of recombination intermediates at centromeres and other unique sequences as assayed by 2D gel analysis. In addition, smc6 mutant cells exhibit increased levels of Rad52 foci that co-localize with centromere markers. A rad52 mutation that decreases centromeric, but not overall, levels of Rad52 foci in smc6 mutants suppresses the nocodazole sensitivity of these cells, suggesting that the Smc6-mediated regulation of recombination at centromeric regions impacts centromere-related functions. In addition to influencing recombination, the SUMO ligase subunit of the Smc5-Smc6 complex promotes the sumoylation of two kinetochore proteins and affects mitotic spindles. These results suggest that the Smc5-Smc6 complex regulates both recombination and kinetochore sumoylation to facilitate chromosomal maintenance during growth.	[Yong-Gonzales, Vladimir; Hang, Lisa E.; Zhao, Xiaolan] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Hang, Lisa E.] Weill Cornell Grad Sch Med Sci, Program Biochem, New York, NY USA; [Hang, Lisa E.] Weill Cornell Grad Sch Med Sci, Cell Biol Program, New York, NY USA; [Hang, Lisa E.] Weill Cornell Grad Sch Med Sci, Program Mol Biol, New York, NY USA; [Castellucci, Federica; Branzei, Dana] FIRC Inst Mol Oncol, IFOM, Milan, Italy	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; IFOM - FIRC Institute of Molecular Oncology	Zhao, XL (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.	zhaox1@mskcc.org	Branzei, Dana/A-2806-2015; Branzei, Dana/GOG-9093-2022	Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888; Zhao, Xiaolan/0000-0002-8302-6905	National Institute of General Medical Science [R01 GM080670]; American Cancer Society [RSG-12-013-01-CCG]; Associazione Italiana per la Ricerca sul Cancro [IG 10637]; ERC [242928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080670] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Science grant R01 GM080670 and American Cancer Society Research Scholar Grant RSG-12-013-01-CCG to X. Zhao and by the Associazione Italiana per la Ricerca sul Cancro grant IG 10637 and the ERC grant 242928 to D. Branzei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Bermudez-Lopez M, 2010, NUCLEIC ACIDS RES, V38, P6502, DOI 10.1093/nar/gkq546; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Bustard DE, 2012, J BIOL CHEM, V287, P11374, DOI 10.1074/jbc.M111.336263; Chavez A, 2010, J BIOL CHEM, V285, P11922, DOI 10.1074/jbc.M109.041277; Chen YH, 2009, P NATL ACAD SCI USA, V106, P21252, DOI 10.1073/pnas.0908258106; Choi KY, 2010, MOL BIOL CELL, V21, P2306, DOI 10.1091/mbc.E10-01-0050; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Fousteri MI, 2000, EMBO J, V19, P1691, DOI 10.1093/emboj/19.7.1691; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hu B, 2005, MOL MICROBIOL, V55, P1735, DOI 10.1111/j.1365-2958.2005.04531.x; Hwang JY, 2008, DNA REPAIR, V7, P1426, DOI 10.1016/j.dnarep.2008.05.006; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Kotwaliwale C, 2006, CELL, V127, P1105, DOI 10.1016/j.cell.2006.11.032; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Montpetit B, 2006, J CELL BIOL, V174, P653, DOI 10.1083/jcb.200605019; Mortensen UH, 2002, GENETICS, V161, P549; Mukhopadhyay D, 2010, CELL CYCLE, V9, P3194, DOI 10.4161/cc.9.16.12619; MURRAY JM, 1994, MOL CELL BIOL, V14, P4878, DOI 10.1128/MCB.14.7.4878; Noel JF, 2011, DNA REPAIR, V10, P271, DOI 10.1016/j.dnarep.2010.11.010; Onoda F, 2004, DNA REPAIR, V3, P429, DOI 10.1016/j.dnarep.2003.12.007; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; SPENCER F, 1990, GENETICS, V124, P237; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Takahashi Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000215; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Wehrkamp-Richter S, 2012, NUCL ACIDS RES; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Widlund PO, 2006, MOL BIOL CELL, V17, P1065, DOI 10.1091/mbc.E05-07-0640; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	53	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51540	10.1371/journal.pone.0051540	http://dx.doi.org/10.1371/journal.pone.0051540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284708	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500032
J	Chen, MH; Huang, J; Chen, WM; Larson, MG; Fox, CS; Vasan, RS; Seshadri, S; O'Donnell, CJ; Yang, Q				Chen, Ming-Huei; Huang, Jie; Chen, Wei-Min; Larson, Martin G.; Fox, Caroline S.; Vasan, Ramachandran S.; Seshadri, Sudha; O'Donnell, Christopher J.; Yang, Qiong			Using Family-Based Imputation in Genome-Wide Association Studies with Large Complex Pedigrees: The Framingham Heart Study	PLOS ONE			English	Article							GENETIC-LOCI; ALZHEIMER-DISEASE; URIC-ACID; FIBRINOGEN; VARIANTS; DESIGN; RISK; MAPS	Imputation has been widely used in genome-wide association studies (GWAS) to infer genotypes of un-genotyped variants based on the linkage disequilibrium in external reference panels such as the HapMap and 1000 Genomes. However, imputation has only rarely been performed based on family relationships to infer genotypes of un-genotyped individuals. Using 8998 Framingham Heart Study (FHS) participants genotyped with Affymetrix 550K SNPs, we imputed genotypes of same set of SNPs for additional 3121 participants, most of whom were never genotyped due to lack of DNA sample. Prior to imputation, 122 pedigrees were too large to be handled by the imputation software Merlin. Therefore, we developed a novel pedigree splitting algorithm that can maximize the number of genotyped relatives for imputing each un-genotyped individual, while keeping new sub-pedigrees under a pre-specified size. In GWAS of four phenotypes available in FHS (Alzheimer disease, circulating levels of fibrinogen, high-density lipoprotein cholesterol, and uric acid), we compared results using genotyped individuals only with results using both genotyped and imputed individuals. We studied the impact of applying different imputation quality filtering thresholds on the association results and did not found a universal threshold that always resulted in a more significant p-value for previously identified loci. However most of these loci had a lower p-value when we only included imputed genotypes with with >= 60% SNP- and >= 50% person-specific imputation certainty. In summary, we developed a novel algorithm for splitting large pedigrees for imputation and found a plausible imputation quality filtering threshold based on FHS. Further examination may be required to generalize this threshold to other studies.	[Chen, Ming-Huei; Larson, Martin G.; Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Chen, Ming-Huei; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Chen, Ming-Huei; Huang, Jie; Larson, Martin G.; Fox, Caroline S.; Vasan, Ramachandran S.; Seshadri, Sudha; O'Donnell, Christopher J.; Yang, Qiong] NHLBI, Framingham Heart Study, Framingham, MA USA; [Huang, Jie] Wellcome Trust Sanger Inst, Cambridge, England; [Chen, Wei-Min] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol Hypertens & Diabet, Boston, MA USA; [O'Donnell, Christopher J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Div Cardiol, Boston, MA USA	Boston University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wellcome Trust Sanger Institute; University of Virginia; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Yang, Q (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	qyang@bu.edu	Ramachandran, Vasan/Y-2527-2019; Yang, Qiong/G-5438-2014	Ramachandran, Vasan/0000-0001-7357-5970; Larson, Martin/0000-0002-9631-1254; Seshadri, Sudha/0000-0001-6135-2622; Yang, Qiong/0000-0002-3658-1375; Chen, Ming-Huei/0000-0003-3551-8726	National Heart, Lung, and Blood Institute [N01-HC-25195]; Affymetrix, Inc [N02-HL-6-4278]; NIH [R01 NS017950-28, R01-HL093328-01]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center;  [R01HL093328];  [R01HL093029];  [R01NS017950]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093328, R01HL093029, ZIAHL006094, ZIAHL006002, ZIAHL006175, R01HL064278, ZIAHL006173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008122] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors were supported in part by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Con-tract No. N01-HC-25195) and grant numbers R01HL093328, R01HL093029, R01NS017950 and R01HL093029. The research was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195), its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278) and NIH grants R01 NS017950-28 and R01-HL093328-01. A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; CROWLEY LV, 1964, CLIN CHEM, V10, P838; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dehghan A, 2009, CIRC-CARDIOVASC GENE, V2, P125, DOI 10.1161/CIRCGENETICS.108.825224; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Srivastava M, 1990, REGRESSION ANAL THEO; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365	23	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51589	10.1371/journal.pone.0051589	http://dx.doi.org/10.1371/journal.pone.0051589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284720	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900032
J	Feng, XB; Wang, DD; Chen, JJ; Lu, L; Hua, BZ; Li, X; Tsao, BP; Sun, LY				Feng, Xuebing; Wang, Dandan; Chen, Jingjing; Lu, Lin; Hua, Bingzhu; Li, Xia; Tsao, Betty P.; Sun, Lingyun			Inhibition of Aberrant Circulating Tfh Cell Proportions by Corticosteroids in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							FOLLICULAR-HELPER-CELLS; CENTER B-CELL; T-CELLS; DISEASE; IL-21; MICE; GLUCOCORTICOIDS; INTERLEUKIN-21; MECHANISMS; EXPRESSION	Objective: To observe the proportion of peripheral T follicular helper (Tfh) cells in patients with systemic lupus erythematosus (SLE) and to assess the role of steroids on Tfh cells from SLE patients. Methods: Peripheral blood mononuclear cells (PBMCs) from 42 SLE patients and 22 matched healthy subjects were collected to assess proportions of circulating CXCR5(+)PD1(+)/CD4(+) T cells (Tfh), CD4(+)CCR6(+) T cells (Th17-like) and CD19(+)CD138(+) plasma cells by flow cytometry. 8 of the patients had their blood redrawn within one week after receiving methylprednisolone pulse treatment. Disease activity was evaluated by SLE disease activity index. To test the effect of IL-21 and corticosteroids on Tfh cells in vitro, PBMCs harvested from another 15 SLE patients were cultured with medium, IL-21, or IL-21+ dexamethasone for 24 hours and 72 hours. PBMCs from an independent 23 SLE patients were cultured with different concentrations of dexamethasone for 24 hours. Results: Compared to normal controls, percentages of circulating Tfh cells, but not Th17 cells, were elevated in SLE patients and correlated with disease activity. Proportions of Tfh cells in SLE patients were positively correlated with those of plasma cells and serum levels of antinuclear antibodies. After methylprednisolone pulse treatment, both percentages and absolute numbers of circulating Tfh cells were significantly decreased. In vitro cultures showed an increase of Tfh cell proportion after IL-21 stimulation that was totally abolished by the addition of dexamethasone. Both 0.5 and 1 mu M dexamethasone decreased Tfh cells dose dependently (overall p = 0.013). Conclusions: We demonstrated that elevated circulating Tfh cell proportions in SLE patients correlated with their disease activities, and circulating levels of plasma cells and ANA. Corticosteroids treatment down-regulated aberrant circulating Tfh cell proportions both in vivo and in vitro, making Tfh cells a new treatment target for SLE patients.	[Feng, Xuebing; Wang, Dandan; Chen, Jingjing; Lu, Lin; Hua, Bingzhu; Li, Xia; Sun, Lingyun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China; [Tsao, Betty P.] Univ Calif Los Angeles, David Geffen Sch Med, Div Rheumatol, Los Angeles, CA 90095 USA	Nanjing University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Feng, XB (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China.	fengxuebing@hotmail.com; lingyunsun2001@yahoo.com.cn	chen, JJ/HGB-6029-2022	Tsao, Betty/0000-0001-7938-5975; Feng, Xuebing/0000-0002-9837-9690	National Natural Science Foundation of China [30972735, 81172846]; Jiangsu Province's Key Provincial Talents Program, "Six Talent Summit" Program; Nanjing Medical Science and Technique Development Foundation; NIAMS NIH [RO1 43814]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Key Provincial Talents Program, "Six Talent Summit" Program; Nanjing Medical Science and Technique Development Foundation; NIAMS NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Natural Science Foundation of China (grant number 30972735, 81172846), Jiangsu Province's Key Provincial Talents Program, "Six Talent Summit" Program and Nanjing Medical Science and Technique Development Foundation. B.P.T. was supported by RO1 43814 from the the NIAMS NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunno A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/823085; Appel H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3370; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cepika AM, 2010, SCAND J IMMUNOL, V72, P434, DOI 10.1111/j.1365-3083.2010.02450.x; Deenick EK, 2011, IMMUNOLOGY, V134, P361, DOI 10.1111/j.1365-2567.2011.03487.x; Dolff S, 2011, ARTHRITIS RES THER, V13, pR157, DOI DOI 10.1186/AR3474; Fagerli UM, 2011, ONCOGENE, V30, P3198, DOI 10.1038/onc.2011.79; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021698; Feng XB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2972; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Harrison OJ, 2008, IMMUNOL LETT, V121, P13, DOI 10.1016/j.imlet.2008.07.011; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; King JK, 2007, BEST PRACT RES CL RH, V21, P971, DOI 10.1016/j.berh.2007.09.002; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Lucas JA, 2008, J IMMUNOL, V181, P2513, DOI 10.4049/jimmunol.181.4.2513; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Maranville JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002162; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Patakas A, 2011, IMMUNOL LETT, V138, P38, DOI 10.1016/j.imlet.2011.03.002; Prado C, 2011, RHEUMATOLOGY, V50, P1794, DOI 10.1093/rheumatology/ker227; Recher M, 2012, BLOOD, V119, P2819, DOI 10.1182/blood-2011-09-379412; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Shah K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2964; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Terrier B, 2012, J RHEUMATOL, V39, P1819, DOI 10.3899/jrheum.120468; Nguyen V, 2012, J IMMUNOL, V189, P1081, DOI 10.4049/jimmunol.1200318; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Zeller GC, 2006, J AM SOC NEPHROL, V17, P122, DOI 10.1681/ASN.2005080802; Zhang WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022659	33	76	82	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51982	10.1371/journal.pone.0051982	http://dx.doi.org/10.1371/journal.pone.0051982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284839	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900068
J	Klancnik, A; Mozina, SS; Zhang, QJ				Klancnik, Anja; Mozina, Sonja Smole; Zhang, Qijing			Anti-Campylobacter Activities and Resistance Mechanisms of Natural Phenolic Compounds in Campylobacter	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMP; ANTIMICROBIAL ACTIVITY; ERYTHROMYCIN RESISTANCE; ANTIBIOTIC-RESISTANCE; MACROLIDE RESISTANCE; CMER FUNCTIONS; CMEABC; JEJUNI; IDENTIFICATION; FOOD	Background: Campylobacter is a major foodborne pathogen and alternative antimicrobials are needed to prevent or decrease Campylobacter contamination in foods or food producing animals. The objectives of this study are to define the anti-Campylobacter activities of natural phenolic compounds of plant origin and to determine the roles of bacterial drug efflux systems in the resistance to these natural phenolics in Campylobacter jejuni. Methodology/Principal Findings: Anti-Campylobacter activities were evaluated by an MIC assay using microdilution coupled with ATP measurement. Mutants of the cmeB and cmeF efflux genes and the cmeR transcriptional repressor gene were compared with the wild-type strain for their susceptibilities to phenolics in the absence and presence of efflux-pump inhibitors (EPIs). The phenolic compounds produced significant, but variable activities against both antibiotic-susceptible and antibiotic resistant Campylobacter. The highest anti-Campylobacter activity was seen with carnosic and rosmarinic acids in their pure forms or in enriched plant extracts. Inactivation of cmeB rendered C. jejuni significantly more susceptible to the phenolic compounds, while mutation of cmeF or cmeR only produced a moderate effect on the MICs. Consistent with the results from the efflux pump mutants, EPIs, especially phenylalanine-arginine beta-naphthylamide and NMP, significantly reduced the MICs of the tested phenolic compounds. Further reduction of MICs by the EPIs was also observed in the cmeB and cmeF mutants, suggesting that other efflux systems are also involved in Campylobacter resistance to phenolic compounds. Conclusion/Significance: Natural phenolic compounds of plant origin have good anti-Campylobacter activities and can be further developed for potential use in controlling Campylobacter. The drug efflux systems in Campylobacter contribute significantly to its resistance to the phenolics and EPIs potentiate the anti-Campylobacter activities of plant phenolic compounds.	[Zhang, Qijing] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [Klancnik, Anja; Mozina, Sonja Smole] Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Ljubljana, Slovenia	Iowa State University; University of Ljubljana	Zhang, QJ (corresponding author), Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	zhang123@iastate.edu	Klančnik, Anja/I-4571-2012; Zhang, Qijing/B-7530-2012	Klančnik, Anja/0000-0003-1632-5785; 	Ministry of Higher Education, Science and Technology of the Republic of Slovenia [Z1-2190]; BI-SLO-USA; National Institutes of Health [R01DK063008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063008] Funding Source: NIH RePORTER	Ministry of Higher Education, Science and Technology of the Republic of Slovenia; BI-SLO-USA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Ministry of Higher Education, Science and Technology of the Republic of Slovenia for the Z1-2190 Post-doctoral project of A.K., the bilateral project between Slovenia and the U.S.A. (BI-SLO-USA 2011/12), and the National Institutes of Health grant R01DK063008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar F, 2008, EFSA J, V721, P1; Akiba M, 2006, J ANTIMICROB CHEMOTH, V57, P52, DOI 10.1093/jac/dki419; Altekruse SF, 2003, J AM VET MED ASSOC, V223, P445, DOI 10.2460/javma.2003.223.445; Baydar NG, 2004, FOOD CONTROL, V15, P335, DOI 10.1016/S0956-7135(03)00083-5; Cagliero C, 2005, J ANTIMICROB CHEMOTH, V56, P948, DOI 10.1093/jac/dki292; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Gibreel A, 2005, ANTIMICROB AGENTS CH, V49, P2753, DOI 10.1128/AAC.49.7.2753-2759.2005; Guo BQ, 2008, J BACTERIOL, V190, P1879, DOI 10.1128/JB.01796-07; Guo BQ, 2010, FOODBORNE PATHOG DIS, V7, P77, DOI 10.1089/fpd.2009.0354; Hannula M, 2008, J MED MICROBIOL, V57, P851, DOI 10.1099/jmm.0.47823-0; Hemaiswarya S, 2008, PHYTOMEDICINE, V15, P639, DOI 10.1016/j.phymed.2008.06.008; Horiuchi K, 2007, BIOL PHARM BULL, V30, P287, DOI 10.1248/bpb.30.287; Katalinic V, 2013, INT J FOOD PROP, V16, P45, DOI 10.1080/10942912.2010.526274; Katalinic V, 2010, FOOD CHEM, V119, P715, DOI 10.1016/j.foodchem.2009.07.019; Klancnik A, 2010, J MICROBIOL METH, V81, P121, DOI 10.1016/j.mimet.2010.02.004; Klancnik A, 2009, J FOOD PROTECT, V72, P1744, DOI 10.4315/0362-028X-72.8.1744; Kurek A, 2011, POL J MICROBIOL, V60, P3, DOI 10.33073/pjm-2011-001; Kurincic M, 2007, INT J FOOD MICROBIOL, V120, P186, DOI 10.1016/j.ijfoodmicro.2007.03.012; Kurincic M, 2012, MICROBIAL D IN PRESS; Lin J, 2005, ANTIMICROB AGENTS CH, V49, P1067, DOI 10.1128/AAC.49.3.1067-1075.2005; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin J, 2005, J BACTERIOL, V187, P7417, DOI 10.1128/JB.187.21.7417-7424.2005; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Mavri A, 2012, CHEM BIODIVERS, V9, P1545, DOI 10.1002/cbdv.201100337; Moore JE, 2006, MICROBES INFECT, V8, P1955, DOI 10.1016/j.micinf.2005.12.030; Moreno S, 2006, FREE RADICAL RES, V40, P223, DOI 10.1080/10715760500473834; Mozina SS, 2011, TRENDS FOOD SCI TECH, V22, P91, DOI 10.1016/j.tifs.2010.09.003; Murphy C, 2006, J APPL MICROBIOL, V100, P623, DOI 10.1111/j.1365-2672.2006.02903.x; Park SF, 2002, INT J FOOD MICROBIOL, V74, P177, DOI 10.1016/S0168-1605(01)00678-X; Payot S, 2004, INT J ANTIMICROB AG, V23, P468, DOI 10.1016/j.ijantimicag.2003.12.008; Pumbwe L, 2002, FEMS MICROBIOL LETT, V206, P185, DOI 10.1111/j.1574-6968.2002.tb11007.x; Puupponen-Pimia R, 2005, J APPL MICROBIOL, V98, P991, DOI 10.1111/j.1365-2672.2005.02547.x; Si WD, 2006, J CHROMATOGR A, V1125, P204, DOI 10.1016/j.chroma.2006.05.061; Taguri T, 2004, BIOL PHARM BULL, V27, P1965, DOI 10.1248/bpb.27.1965; WANG Y, 1990, J BACTERIOL, V172, P949, DOI 10.1128/JB.172.2.949-955.1990; Zorman T, 2002, FOOD TECHNOL BIOTECH, V40, P177	37	37	37	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51800	10.1371/journal.pone.0051800	http://dx.doi.org/10.1371/journal.pone.0051800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284770	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900054
J	Rasheed-Depardieu, C; Parent, C; Crevecoeur, M; Parelle, J; Tatin-Froux, F; Le Provost, G; Capelli, N				Rasheed-Depardieu, Claire; Parent, Claire; Crevecoeur, Michele; Parelle, Julien; Tatin-Froux, Fabienne; Le Provost, Gregoire; Capelli, Nicolas			Identification and Expression of Nine Oak Aquaporin Genes in the Primary Root Axis of Two Oak Species, Quercus petraea and Quercus robur	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEINS; PLASMA-MEMBRANE AQUAPORINS; WATER-TRANSPORT; ARABIDOPSIS; CHANNEL; MAIZE; FAMILY; RICE; CELL; QUANTIFICATION	Aquaporins (AQPs) belong to the Major Intrinsic Protein family that conducts water and other small solutes across biological membranes. This study aimed to identify and characterize AQP genes in the primary root axis of two oak species, Quercus petraea and Quercus robur. Nine putative AQP genes were cloned, and their expression was profiled in different developmental root zones by real-time PCR. A detailed examination of the predicted amino acid sequences and subsequent phylogenetic analysis showed that the isolated AQPs could be divided into two subfamilies, which included six plasma membrane intrinsic proteins (PIPs) and three tonoplast intrinsic proteins (TIPs). We characterized the anatomical features of the roots and defined three developmental root zones: the immature, transition and mature zones. Expression analysis of the AQPs was performed according to these root developmental stages. Our results showed that the expression of PIP2;3 and TIP1 was significantly higher in Quercus petraea compared with Quercus robur in the three root zones. However, PIP2;1 and TIP2;1 were found to be differentially expressed in the mature zone of the two oak species. Of the nine AQP genes identified and analyzed, we highlighted four genes that might facilitate a deeper understanding of how these two closely related tree species adapted to different environments.	[Rasheed-Depardieu, Claire; Parent, Claire; Parelle, Julien; Tatin-Froux, Fabienne; Capelli, Nicolas] Univ Franche Comte, UMR Chronoenvironm 6249, F-25030 Besancon, France; [Crevecoeur, Michele] Univ Geneva, Dept Bot & Biol Vegetale, Geneva, Switzerland; [Le Provost, Gregoire] INRA, UMR BIOGECO 1202, Cestas, France; [Le Provost, Gregoire] Univ Bordeaux, UMR BIOGECO 1202, Talence, France	Universite de Franche-Comte; University of Geneva; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Capelli, N (corresponding author), Univ Franche Comte, UMR Chronoenvironm 6249, F-25030 Besancon, France.	nicolas.capelli@univ-fcomte.fr		Parelle, Julien/0000-0002-9209-3755; TATIN-FROUX, Fabienne/0000-0001-8663-305X	French research ministry; University of Franche-Comte; regional council of Franche-Comte	French research ministry(Ministry of Research, France); University of Franche-Comte; regional council of Franche-Comte(Region Bourgogne-Franche-Comte)	This work was supported by a doctoral fellowship from the French research ministry to C. Rasheed-Depardieu. The authors are also indebted to the University of Franche-Comte and the regional council of Franche-Comte for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Almeida-Rodriguez AM, 2011, PLANT CELL ENVIRON, V34, P1318, DOI 10.1111/j.1365-3040.2011.02331.x; Audigeos D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-202; Ayadi M, 2011, PLANT PHYSIOL BIOCH, V49, P1029, DOI 10.1016/j.plaphy.2011.06.002; Bansal A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-27; Barrieu F, 1998, PLANT PHYSIOL, V117, P1153, DOI 10.1104/pp.117.4.1153; Beebo A, 2009, PLANT MOL BIOL, V70, P193, DOI 10.1007/s11103-009-9465-2; Besse M, 2011, J EXP BOT, V62, P4127, DOI 10.1093/jxb/err175; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Bramley H, 2009, PLANT PHYSIOL, V150, P348, DOI 10.1104/pp.108.134098; BREDA N, 1993, ANN SCI FOREST, V50, P571, DOI 10.1051/forest:19930606; BRUNDRETT MC, 1988, PROTOPLASMA, V146, P133, DOI 10.1007/BF01405922; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 1998, PLANT PHYSIOL, V117, P1143, DOI 10.1104/pp.117.4.1143; Enstone DE, 2005, PLANT CELL ENVIRON, V28, P444, DOI 10.1111/j.1365-3040.2005.01286.x; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Fouquet R, 2008, PLANT CELL REP, V27, P1541, DOI 10.1007/s00299-008-0566-1; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Gattolin S, 2010, BIOCHEM SOC T, V38, P769, DOI 10.1042/BST0380769; Gattolin S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-133; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Hachez C, 2006, PLANT MOL BIOL, V62, P305, DOI 10.1007/s11103-006-9022-1; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kaldenhoff R, 1998, PLANT J, V14, P121, DOI 10.1046/j.1365-313X.1998.00111.x; Knipfer T, 2011, J EXP BOT, V62, P717, DOI 10.1093/jxb/erq312; Krishnamurthy P, 2011, J EXP BOT, V62, P4215, DOI 10.1093/jxb/err135; Lagree V, 1999, J BIOL CHEM, V274, P6817, DOI 10.1074/jbc.274.11.6817; Le Provost G, 2012, TREE PHYSIOL, V32, P119, DOI 10.1093/treephys/tpr123; Leitao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033219; LEVY G, 1992, FOREST ECOL MANAG, V55, P51, DOI 10.1016/0378-1127(92)90091-M; Ma S, 2004, PLANT J, V40, P845, DOI 10.1111/j.1365-313X.2004.02265.x; MAGGIO A, 1995, PLANT PHYSIOL, V109, P331, DOI 10.1104/pp.109.1.331; Mariette S, 2002, SILVAE GENET, V51, P72; Maurel C, 1997, P NATL ACAD SCI USA, V94, P7103, DOI 10.1073/pnas.94.13.7103; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Nardini A, 1999, ANN FOR SCI, V56, P371, DOI 10.1051/forest:19990502; Parent C, 2011, PLANT CELL ENVIRON, V34, P1113, DOI 10.1111/j.1365-3040.2011.02309.x; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Soukup A, 2004, BIOL PLANTARUM, V48, P481, DOI 10.1023/B:BIOP.0000047141.49470.77; Steudle E, 1996, PLANT SOIL, V187, P67, DOI 10.1007/BF00011658; Steudle E, 1996, J EXP BOT, V47, P387, DOI 10.1093/jxb/47.3.387; Steudle E, 2000, PLANT SOIL, V226, P45, DOI 10.1023/A:1026439226716; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueno S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-650; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Verdaguer D, 1997, CAN J BOT, V75, P769, DOI 10.1139/b97-087; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415; Yamada K, 2011, PLANT BIOTECHNOL-NAR, V28, P509, DOI 10.5511/plantbiotechnology.11.0922a; YAMADA S, 1995, PLANT CELL, V7, P1129, DOI 10.1105/tpc.7.8.1129; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang MH, 2010, J BIOL CHEM, V285, P41982, DOI 10.1074/jbc.M110.101790; Zhao CX, 2008, COLLOID SURFACE B, V62, P163, DOI 10.1016/j.colsurfb.2007.10.015	64	9	9	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51838	10.1371/journal.pone.0051838	http://dx.doi.org/10.1371/journal.pone.0051838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284785	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900057
J	Lige, B; Romano, JD; Sampels, V; Sonda, S; Joiner, KA; Coppens, I				Lige, Bao; Romano, Julia D.; Sampels, Vera; Sonda, Sabrina; Joiner, Keith A.; Coppens, Isabelle			Introduction of Caveolae Structural Proteins into the Protozoan Toxoplasma Results in the Formation of Heterologous Caveolae but Not Caveolar Endocytosis	PLOS ONE			English	Article							TRANSCRIPT RELEASE FACTOR; PLASMA-MEMBRANE; POLYMERASE-I; LIPID RAFTS; CHOLESTEROL-BINDING; MAMMALIAN CAVEOLIN; VESICLE FORMATION; DENSE GRANULES; GENE FAMILY; EXPRESSION	Present on the plasma membrane of most metazoans, caveolae are specialized microdomains implicated in several endocytic and trafficking mechanisms. Caveolins and the more recently discovered cavins are the major protein components of caveolae. Previous studies reported that caveolar invaginations can be induced de novo on the surface of caveolae-negative mammalian cells upon heterologous expression of caveolin-1. However, it remains undocumented whether other components in the transfected cells participate in caveolae formation. To address this issue, we have exploited the protozoan Toxoplasma as a heterologous expression system to provide insights into the minimal requirements for caveogenesis and caveolar endocytosis. Upon expression of caveolin-1, Toxoplasma accumulates prototypical exocytic caveolae 'precursors' in the cytoplasm. Toxoplasma expressing caveolin-1 alone, or in conjunction with cavin-1, neither develops surface-located caveolae nor internalizes caveolar ligands. These data suggest that the formation of functional caveolae at the plasma membrane in Toxoplasma and, by inference in all non-mammalian cells, requires effectors other than caveolin-1 and cavin-1. Interestingly, Toxoplasma co-expressing caveolin-1 and cavin-1 displays an impressive spiraled network of membranes containing the two proteins, in the cytoplasm. This suggests a synergistic activity of caveolin-1 and cavin-1 in the morphogenesis and remodeling of membranes, as illustrated for Toxoplasma. Citation: Lige B, Romano JD, Sampels V, Sonda S, Joiner KA, et al. (2012) Introduction of Caveolae Structural Proteins into the Protozoan Toxoplasma Results in the Formation of Heterologous Caveolae but Not Caveolar Endocytosis. PLoS ONE 7(12): e51773. doi:10.1371/journal.pone.0051773	[Lige, Bao; Romano, Julia D.; Sampels, Vera; Coppens, Isabelle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA; [Sonda, Sabrina] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Joiner, Keith A.] Univ Arizona, Coll Med, Arizona Hlth Sci Ctr, Tucson, AZ USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Zurich; University of Arizona; University of Arizona Health Sciences	Coppens, I (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	icoppens@jhsph.edu	Joiner, Keith/AAH-1059-2021	Joiner, Keith/0000-0003-3062-823X; Romano, Julia/0000-0001-8956-7377	National Institutes of Health [AI060767]; American Heart Association [0230079N, 0755368U]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this research was provided by the National Institutes of Health (AI060767) and the American Heart Association (0230079N and 0755368U). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Assossou O, 2003, FEMS MICROBIOL LETT, V224, P161, DOI 10.1016/S0378-1097(03)00479-8; Azzouz N, 2002, INT J PARASITOL, V32, P677, DOI 10.1016/S0020-7519(02)00009-7; Bai L, 2011, CELL RES, V21, P1088, DOI 10.1038/cr.2011.56; Chaturvedi S, 1999, J BIOL CHEM, V274, P2424, DOI 10.1074/jbc.274.4.2424; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Coppens I, 2003, MOL BIOL CELL, V14, P3804, DOI 10.1091/mbc.E02-12-0830; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engelman JA, 1998, FEBS LETT, V429, P330, DOI 10.1016/S0014-5793(98)00619-X; Field MC, 2007, ADV EXP MED BIOL, V607, P84; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; FOUSSARD F, 1991, PARASITOLOGY, V102, P367, DOI 10.1017/S0031182000064313; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Hatanaka M, 1998, BIOCHEM BIOPH RES CO, V253, P382, DOI 10.1006/bbrc.1998.9744; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ikonen E, 2004, BIOCHEM SOC T, V32, P121, DOI 10.1042/BST0320121; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Karsten V, 1998, J CELL BIOL, V141, P1323, DOI 10.1083/jcb.141.6.1323; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Kiss AL, 2012, ADV EXP MED BIOL, V729, P14, DOI 10.1007/978-1-4614-1222-9_2; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; Li SW, 1996, J BIOL CHEM, V271, P28647, DOI 10.1074/jbc.271.45.28647; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lige B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002410; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nam HW, 2009, KOREAN J PARASITOL, V47, pS29, DOI 10.3347/kjp.2009.47.S.S29; PALADE GE, 1953, J APPL PHYS, V24, P1424; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Parkar NS, 2009, ANTIOXID REDOX SIGN, V11, P1301, DOI 10.1089/ARS.2008.2397; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parussini F, 2010, MOL MICROBIOL, V76, P1340, DOI 10.1111/j.1365-2958.2010.07181.x; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Quittnat F, 2004, MOL BIOCHEM PARASIT, V138, P107, DOI 10.1016/j.molbiopara.2004.08.004; Robibaro B, 2001, INT J PARASITOL, V31, P1343, DOI 10.1016/S0020-7519(01)00252-1; Rodighiero C, 2001, J BIOL CHEM, V276, P36939, DOI 10.1074/jbc.M104245200; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Simionescu M, 2009, CELL TISSUE RES, V335, P27, DOI 10.1007/s00441-008-0688-3; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sonda S, 2005, ANTIMICROB AGENTS CH, V49, P1794, DOI 10.1128/AAC.49.5.1794-1801.2005; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Tang ZL, 1997, J BIOL CHEM, V272, P2437, DOI 10.1074/jbc.272.4.2437; Uittenbogaard A, 2000, J BIOL CHEM, V275, P25595, DOI 10.1074/jbc.M003401200; Verkade P, 2000, J CELL BIOL, V148, P727, DOI 10.1083/jcb.148.4.727; Verma P, 2010, MOL BIOL CELL, V21, P2226, DOI 10.1091/mbc.E09-05-0417; Walser PJ, 2012, CELL, V150, P752, DOI 10.1016/j.cell.2012.06.042; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305	71	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51773	10.1371/journal.pone.0051773	http://dx.doi.org/10.1371/journal.pone.0051773			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272165	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800081
J	Zheng, SX; Ren, HY; Li, WH; Lan, ZC				Zheng, Shuxia; Ren, Haiyan; Li, Wenhuai; Lan, Zhichun			Scale-Dependent Effects of Grazing on Plant C: N: P Stoichiometry and Linkages to Ecosystem Functioning in the Inner Mongolia Grassland	PLOS ONE			English	Article							TYPICAL STEPPE; SOIL; TERRESTRIAL; VEGETATION; RESPONSES; TRAITS; CARBON; MINERALIZATION; BIODIVERSITY; MANAGEMENT	Background: Livestock grazing is the most prevalent land use of grasslands worldwide. The effects of grazing on plant C, N, P contents and stoichiometry across hierarchical levels, however, have rarely been studied; particularly whether the effects are mediated by resource availability and the underpinning mechanisms remain largely unclear. Methodology/Principal Findings: Using a multi-organization-level approach, we examined the effects of grazing on the C, N, and P contents and stoichiometry in plant tissues (leaves and roots) and linkages to ecosystem functioning across three vegetation types (meadow, meadow steppe, and typical steppe) in the Inner Mongolia grassland, China. Our results showed that the effects of grazing on the C, N, and P contents and stoichiometry in leaves and roots differed substantially among vegetation types and across different hierarchical levels (species, functional group, and vegetation type levels). The magnitude of positive effects of grazing on leaf N and P contents increased progressively along the hierarchy of organizational levels in the meadow, whereas its negative effect on leaf N content decreased considerably along hierarchical levels in both the typical and meadow steppes. Grazing increased N and P allocation to aboveground in the meadow, while greater N and P allocation to belowground was found in the typical and meadow steppes. The differences in soil properties, plant trait-based resource use strategies, tolerance or defense strategies to grazing, and shifts in functional group composition are likely to be the key mechanisms for the observed patterns among vegetation types. Conclusions/Significance: Our findings suggest that the enhanced vegetation-type-level N contents by grazing and species compensatory feedbacks may be insufficient to prevent widespread declines in primary productivity in the Inner Mongolia grassland. Hence, it is essential to reduce the currently high stocking rates and restore the vast degraded steppes for sustainable development of arid and semiarid grasslands. Citation: Zheng S, Ren H, Li W, Lan Z (2012) Scale-Dependent Effects of Grazing on Plant C: N: P Stoichiometry and Linkages to Ecosystem Functioning in the Inner Mongolia Grassland. PLoS ONE 7(12): e51750. doi:10.1371/journal.pone.0051750	[Zheng, Shuxia; Ren, Haiyan; Li, Wenhuai; Lan, Zhichun] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Zheng, SX (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	zsx@ibcas.ac.cn	Li, Wenhuai/A-1268-2015	Li, Wenhuai/0000-0002-1113-2020	State Key Basic Research Development Program of China [2009CB421102]; National Natural Science Foundation of China [30900193]	State Key Basic Research Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the State Key Basic Research Development Program of China (2009CB421102) and the National Natural Science Foundation of China (30900193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Augustine DJ, 2006, ECOSYSTEMS, V9, P1242, DOI 10.1007/s10021-005-0020-y; Bagchi S, 2010, ECOL LETT, V13, P959, DOI 10.1111/j.1461-0248.2010.01486.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF., 2000, ACTA PHYTOECOLOGICA, V24, P667, DOI DOI 10.3321/J.ISSN:1005-264X.2000.06.005; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; BRYANT JP, 1991, ANNU REV ECOL SYST, V22, P431, DOI 10.1146/annurev.es.22.110191.002243; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Craine JM, 2001, OIKOS, V93, P274, DOI 10.1034/j.1600-0706.2001.930210.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Frank DA, 1998, ECOLOGY, V79, P2229, DOI 10.1890/0012-9658(1998)079[2229:UVLCOS]2.0.CO;2; Frank DA, 2005, OECOLOGIA, V143, P629, DOI 10.1007/s00442-005-0019-2; Frank DA, 1997, ECOLOGY, V78, P2238, DOI 10.1890/0012-9658(1997)078[2238:EONGOG]2.0.CO;2; Franzluebbers AJ, 2000, SOIL BIOL BIOCHEM, V32, P469, DOI 10.1016/S0038-0717(99)00176-5; Golluscio RA, 2009, ECOSYSTEMS, V12, P686, DOI 10.1007/s10021-009-9252-6; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; HOLLAND EA, 1990, ECOLOGY, V71, P1040, DOI 10.2307/1937372; Holland JN, 1996, OECOLOGIA, V107, P87, DOI 10.1007/BF00582238; Jiang GM, 2006, AMBIO, V35, P269, DOI 10.1579/06-S-158.1; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; McCully ME, 1999, ANNU REV PLANT PHYS, V50, P695, DOI 10.1146/annurev.arplant.50.1.695; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; MCNAUGHTON SJ, 1985, ECOLOGY, V66, P1617, DOI 10.2307/1938024; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Pan QM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020078; PASTOR J, 1992, AM NAT, V139, P690, DOI 10.1086/285353; Pastor J, 2006, LARGE HERBIVORE ECOL, P289, DOI DOI 10.1017/CO09780511617461; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; Sasaki T, 2008, J ECOL, V96, P145, DOI 10.1111/j.1365-2745.2007.01315.x; Semmartin M, 2004, OIKOS, V107, P148, DOI 10.1111/j.0030-1299.2004.13153.x; Shan YM, 2011, SOIL BIOL BIOCHEM, V43, P1943, DOI 10.1016/j.soilbio.2011.06.002; Tian H, 2009, EUR J SOIL BIOL, V45, P321, DOI 10.1016/j.ejsobi.2009.05.003; TILMAN D, 1988; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; White R., 2000, PILOT ANAL GLOBAL EC; Wu HH, 2011, PLANT SOIL, V340, P127, DOI 10.1007/s11104-010-0575-z; Zheng SX, 2010, BIOGEOSCIENCES, V7, P1117, DOI 10.5194/bg-7-1117-2010; Zheng SX, 2011, PLANT SOIL, V340, P141, DOI 10.1007/s11104-010-0369-3; Zhou ZY, 2011, PLANT SOIL, V341, P257, DOI 10.1007/s11104-010-0641-6	55	43	47	4	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51750	10.1371/journal.pone.0051750	http://dx.doi.org/10.1371/journal.pone.0051750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272158	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800078
J	Benamrouz, S; Guyot, K; Gazzola, S; Mouray, A; Chassat, T; Delaire, B; Chabe, M; Gosset, P; Viscogliosi, E; Dei-Cas, E; Creusy, C; Conseil, V; Certad, G				Benamrouz, Sadia; Guyot, Karine; Gazzola, Sophie; Mouray, Anthony; Chassat, Thierry; Delaire, Baptiste; Chabe, Magali; Gosset, Pierre; Viscogliosi, Eric; Dei-Cas, Eduardo; Creusy, Colette; Conseil, Valerie; Certad, Gabriela			Cryptosporidium parvum Infection in SCID Mice Infected with Only One Oocyst: qPCR Assessment of Parasite Replication in Tissues and Development of Digestive Cancer	PLOS ONE			English	Article							FULMINANT CRYPTOSPORIDIOSIS; MOUSE; ADENOCARCINOMA; INTENSITY; STRAIN; CATTLE; MODEL; ASSAY	Dexamethasone (Dex) treated Severe Combined Immunodeficiency (SCID) mice were previously described as developing digestive adenocarcinoma after massive infection with Cryptosporidium parvum as soon as 45 days post-infection (P. I.). We aimed to determine the minimum number of oocysts capable of inducing infection and thereby gastrointestinal tumors in this model. Mice were challenged with calibrated oocyst suspensions containing intended doses of: 1, 10, 100 or 10(5) oocysts of C. parvum Iowa strain. All administered doses were infective for animals but increasing the oocyst challenge lead to an increase in mice infectivity (P = 0.01). Oocyst shedding was detected at 7 days P. I. after inoculation with more than 10 oocysts, and after 15 days in mice challenged with one oocyst. In groups challenged with lower inocula, parasite growth phase was significantly higher (P = 0.005) compared to mice inoculated with higher doses. After 45 days P. I. all groups of mice had a mean of oocyst shedding superior to 10,000 oocyst/g of feces. The most impressive observation of this study was the demonstration that C. parvum-induced digestive adenocarcinoma could be caused by infection with low doses of Cryptosporidium, even with only one oocyst: in mice inoculated with low doses, neoplastic lesions were detected as early as 45 days P. I. both in the stomach and ileo-caecal region, and these lesions could evolve in an invasive adenocarcinoma. These findings show a great amplification effect of parasites in mouse tissues after challenge with low doses as confirmed by quantitative PCR. The ability of C. parvum to infect mice with one oocyst and to develop digestive adenocarcinoma suggests that other mammalian species including humans could be also susceptible to this process, especially when they are severely immunocompromised. Citation: Benamrouz S, Guyot K, Gazzola S, Mouray A, Chassat T, et al. (2012) Cryptosporidium parvum Infection in SCID Mice Infected with Only One Oocyst: qPCR Assessment of Parasite Replication in Tissues and Development of Digestive Cancer. PLoS ONE 7(12): e51232. doi:10.1371/journal.pone.0051232	[Benamrouz, Sadia; Guyot, Karine; Gazzola, Sophie; Chabe, Magali; Viscogliosi, Eric; Dei-Cas, Eduardo; Conseil, Valerie; Certad, Gabriela] Univ Lille N France, CNRS,UMR 8402, Inst Pasteur Lille,INSERM,U1019, Ctr Infect & Immun Lille,Lab Biol & Divers Pathog, Lille, France; [Benamrouz, Sadia; Conseil, Valerie] Univ Lille N France, Fac Libre Sci & Technol Lille, Lab Environm & Sante, Lille, France; [Mouray, Anthony; Chassat, Thierry] Inst Pasteur, Plateforme Expt & Hautes Technol Anim, F-59019 Lille, France; [Delaire, Baptiste; Gosset, Pierre; Creusy, Colette] Univ Lille N France, Grp Hosp Univ Catholique Lille, Serv Anat & Cytol Pathol, Lille, France; [Chabe, Magali] Univ Lille N France, Fac Pharm, Lille, France; [Dei-Cas, Eduardo] Univ Lille N France, Fac Med, Lille, France; [Dei-Cas, Eduardo] Ctr Hosp Reg & Univ Lille, Ctr Biol & Pathol, Lab Parasitol Mycol, F-59037 Lille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite Catholique de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Certad, G (corresponding author), Univ Lille N France, CNRS,UMR 8402, Inst Pasteur Lille,INSERM,U1019, Ctr Infect & Immun Lille,Lab Biol & Divers Pathog, Lille, France.	gabriela.certad@pasteur-lille.fr	B, S/HGC-3038-2022; Chabe, Magali/H-6045-2017	B, S/0000-0003-1791-4389; Viscogliosi, Eric/0000-0002-5805-7179; Chabe, Magali/0000-0002-6732-6772	Catholic Institute of Lille (ICL); Ministry of Research, France [EA3609/4547]; Federative Institute of Research (Institut Pasteur de Lille) [142]; French National Research Agency [ANR-09-ALIA-009, ANR-10-ALIA-004]	Catholic Institute of Lille (ICL); Ministry of Research, France(Ministry of Research, France); Federative Institute of Research (Institut Pasteur de Lille); French National Research Agency(French National Research Agency (ANR))	Specific support was provided by Catholic Institute of Lille (ICL) including a grant for Sadia Benamrouz. This work was supported by the Ministry of Research, France (EA3609/4547 Universite de Lille 2), Federative Institute of Research 142 (Institut Pasteur de Lille), and the French National Research Agency (grants No. ANR-09-ALIA-009 and ANR-10-ALIA-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat EM, 1997, J EUKARYOT MICROBIOL, V44, p41S, DOI 10.1111/j.1550-7408.1997.tb05765.x; Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Marcon GEB, 2011, MEM I OSWALDO CRUZ, V106, P85, DOI 10.1590/S0074-02762011000100014; Bulckaen H, 2008, AM J PHYSIOL-HEART C, V294, pH1562, DOI 10.1152/ajpheart.00241.2007; Certad G, 2012, APPL ENVIRON MICROB, V78, P1746, DOI 10.1128/AEM.06457-11; Certad G, 2010, INT J PARASITOL, V40, P1469, DOI 10.1016/j.ijpara.2010.07.007; Certad G, 2010, AM J TROP MED HYG, V82, P257, DOI 10.4269/ajtmh.2010.09-0309; Certad Gabriela, 2007, Infect Agent Cancer, V2, P22, DOI 10.1186/1750-9378-2-22; Chappell CL, 1996, J INFECT DIS, V173, P232, DOI 10.1093/infdis/173.1.232; Chappell CL, 2006, AM J TROP MED HYG, V75, P851, DOI 10.4269/ajtmh.2006.75.851; Chen ZG, 2011, VET PARASITOL, V181, P113, DOI 10.1016/j.vetpar.2011.04.037; DOLAN TT, 1984, INT J PARASITOL, V14, P89, DOI 10.1016/0020-7519(84)90017-1; Fontaine M, 2002, FEMS MICROBIOL LETT, V214, P13, DOI 10.1111/j.1574-6968.2002.tb11318.x; Guyot K, 2000, WATER SCI TECHNOL, V41, P189, DOI 10.2166/wst.2000.0132; HAAS CN, 1994, P AM WAT WORKS ASS 1, P517; Huang K, 2003, J PARASITOL, V89, P620, DOI 10.1645/0022-3395(2003)089[0620:DOPIII]2.0.CO;2; Levine N. D., 1973, PROTOZOAN PARASITES, P156; MAHONEY DF, 1979, INT J PARASITOL, V9, P297, DOI 10.1016/0020-7519(79)90078-X; Ramirez NE, 2004, MICROBES INFECT, V6, P773, DOI 10.1016/j.micinf.2004.02.021; Rochelle PA, 2002, APPL ENVIRON MICROB, V68, P3809, DOI 10.1128/AEM.68.8.3809-3817.2002; Shebl FM, 2012, AIDS RES HUM RETROVI; Sulzyc-Bielicka Violetta, 2012, Pol Przegl Chir, V84, P348, DOI 10.2478/v10035-012-0058-4; Yang RC, 2011, VET PARASITOL, V179, P22, DOI 10.1016/j.vetpar.2011.02.011; Yang SG, 2000, J PARASITOL, V86, P884, DOI 10.1645/0022-3395(2000)086[0884:IOICAM]2.0.CO;2; Yoder JS, 2010, EXP PARASITOL, V124, P31, DOI 10.1016/j.exppara.2009.09.020	25	39	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51232	10.1371/journal.pone.0051232	http://dx.doi.org/10.1371/journal.pone.0051232			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272093	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600020
J	Peltan, A; Briggs, L; Matthews, G; Sweeney, ST; Smith, DF				Peltan, Adam; Briggs, Laura; Matthews, Gareth; Sweeney, Sean T.; Smith, Deborah F.			Identification of Drosophila Gene Products Required for Phagocytosis of Leishmania donovani	PLOS ONE			English	Article							WIDE RNAI ANALYSIS; BREFELDIN-A; GUANINE-NUCLEOTIDE; AMASTIGOTE STAGES; CELL-LINES; IN-VIVO; GENOME; REVEALS; ENTRY; INTERFERENCE	The identity and function of host factors required for efficient phagocytosis and intracellular maintenance of the protozoan parasite Leishmania donovani are poorly understood. Utilising the phagocytic capability of Drosophila S2 cells, together with available tools for modulating gene expression by RNAi, we have developed an experimental system in which to identify host proteins of this type on a genome-wide scale. We have shown that L. donovani amastigotes can be phagocytosed by S2 cells, in which they replicate and are maintained in a compartment with features characteristic of mammalian phagolysosomes. Screening with dsRNAs from 1920 conserved metazoan genes has identified transcripts that, when reduced in expression, cause either increased or decreased phagocytosis. Focussing on genes in the latter class, RNA-imediated knockdown of the small GTPase Rab5, the prenylated SNARE protein YKT6, one sub-unit of serine palmitoyltransferase (spt2/lace), the Rac1-associated protein Sra1 and the actin cytoskeleton regulatory protein, SCAR, all lead to a significant reduction in parasite phagocytosis. A role for the lace mammalian homologue in amastigote uptake by mammalian macrophages has been verified using the serine palmitoyltransferase inhibitor, myriocin. These observations suggest that this experimental approach has the potential to identify a large number of host effectors required for efficient parasite uptake and maintenance.	[Peltan, Adam; Matthews, Gareth; Smith, Deborah F.] Univ York, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Peltan, Adam; Briggs, Laura; Sweeney, Sean T.; Smith, Deborah F.] Univ York, Hull York Med Sch, Dept Biol, York YO10 5DD, N Yorkshire, England	University of York - UK; University of Hull; University of York - UK	Smith, DF (corresponding author), Univ York, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England.	deborah.smith@york.ac.uk	Matthews, Gareth/GZK-6840-2022	Sweeney, Sean/0000-0003-2673-9578; Matthews, Gareth/0000-0001-8353-4806	UK BBSRC; UK EPSRC; UK MRC [G0400580]; Wellcome Trust [077503]; MRC [G0400580] Funding Source: UKRI; Medical Research Council [G0400580] Funding Source: researchfish	UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK BBSRC (pre-doctoral studentship to AP), the UK EPSRC (vacation studentship to GM), the UK MRC (project grant G0400580 to LB and STS) and the Wellcome Trust (programme grant 077503 to DFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; ASHFORD RW, 1992, PARASITOL TODAY, V8, P104, DOI 10.1016/0169-4758(92)90249-2; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHANNON JY, 1984, IMMUNOLOGY, V53, P345; Chappuis F, 2007, NAT REV MICRO; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203; Courret N, 2002, J CELL SCI, V115, P2303; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Duclos S, 2000, J CELL SCI, V113, P3531; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Elwell C, 2005, CELL MICROBIOL, V7, P725, DOI 10.1111/j.1462-5822.2005.00508.x; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Flockhart I, 2006, NUCLEIC ACIDS RES, V34, pD489, DOI 10.1093/nar/gkj114; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; GUY RA, 1993, INFECT IMMUN, V61, P1553, DOI 10.1128/IAI.61.4.1553-1558.1993; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Isgandarova S, 2007, J BIOL CHEM, V282, P30466, DOI 10.1074/jbc.M704117200; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Kwiatkowska K, 2003, J CELL SCI, V116, P537, DOI 10.1242/jcs.00254; LANG T, 1994, J CELL SCI, V107, P2137; Lodge R, 2006, EUR J IMMUNOL, V36, P2735, DOI 10.1002/eji.200636089; Love DC, 1998, EXP PARASITOL, V88, P161, DOI 10.1006/expr.1998.4232; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Maganto-Garcia E, 2008, TRAFFIC, V9, P1299, DOI 10.1111/j.1600-0854.2008.00760.x; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x; Meister M, 2004, CURR OPIN IMMUNOL, V16, P10, DOI 10.1016/j.coi.2003.11.002; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Morehead J, 2002, INFECT IMMUN, V70, P4571, DOI 10.1128/IAI.70.8.4571-4580.2002; Nagy A, 2003, NAT GENET, V33, P276, DOI 10.1038/ng1115; Niedergang F, 2005, CURR TOP MICROBIOL, V291, P43; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Phillips R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000813; Prina E, 2004, J CELL SCI, V117, P315, DOI 10.1242/jcs.00860; Qin QM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000110; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Siqueira-Neto JL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000675; St-Denis A, 1999, J IMMUNOL, V163, P5505; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x	70	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51831	10.1371/journal.pone.0051831	http://dx.doi.org/10.1371/journal.pone.0051831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272175	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386600043
J	Vinyard, DJ; Gimpel, J; Ananyev, GM; Cornejo, MA; Golden, SS; Mayfield, SP; Dismukes, GC				Vinyard, David J.; Gimpel, Javier; Ananyev, Gennady M.; Cornejo, Mario A.; Golden, Susan S.; Mayfield, Stephen P.; Dismukes, G. Charles			Natural Variants of Photosystem II Subunit D1 Tune Photochemical Fitness to Solar Intensity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC O2 EVOLUTION; HIGH LIGHT-INTENSITY; PSBA GENES; THERMOSYNECHOCOCCUS-ELONGATUS; DISTINCT FORMS; DIFFERENTIAL EXPRESSION; ELECTRON-TRANSFER; OXYGEN EVOLUTION; WATER OXIDATION; UV-B	Photosystem II (PSII) is composed of six core polypeptides that make up the minimal unit capable of performing the primary photochemistry of light-driven charge separation and water oxidation in all oxygenic phototrophs. The D1 subunit of this complex contains most of the ligating amino acid residues for the Mn4CaO5 core of the water-oxidizing complex (WOC). Most cyanobacteria have 3-5 copies of the psbA gene coding for at least two isoforms of D1, whereas algae and plants have only one isoform. Synechococcus elongatus PCC 7942 contains two D1 isoforms; D1:1 is expressed under low light conditions, and D1:2 is up-regulated in high light or stress conditions. Using a heterologous psbA expression system in the green alga Chlamydomonas reinhardtii, we have measured growth rate, WOC cycle efficiency, and O-2 yield as a function of D1:1, D1:2, or the native algal D1 isoform. D1:1-PSII cells outcompete D1:2-PSII cells and accumulate more biomass in light-limiting conditions. However, D1:2-PSII cells easily outcompete D1:1-PSII cells at high light intensities. The native C. reinhardtii-PSII WOC cycles less efficiently at all light intensities and produces less O-2 than either cyanobacterial D1 isoform. D1:2-PSII makes more O-2 per saturating flash than D1:1-PSII, but it exhibits lower WOC cycling efficiency at low light intensities due to a 40% faster charge recombination rate in the S-3 state. These functional advantages of D1:1-PSII and D1:2-PSII at low and high light regimes, respectively, can be explained by differences in predicted redox potentials of PSII electron acceptors that control kinetic performance.	[Vinyard, David J.; Ananyev, Gennady M.; Dismukes, G. Charles] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Vinyard, David J.; Ananyev, Gennady M.; Cornejo, Mario A.; Dismukes, G. Charles] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Vinyard, David J.] Princeton Univ, Dept Chem, Princeton, NJ 08540 USA; [Gimpel, Javier; Golden, Susan S.; Mayfield, Stephen P.] Univ Calif San Diego, San Diego Ctr Algae Biotechnol, Div Biol Sci, La Jolla, CA 92093 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Princeton University; University of California System; University of California San Diego	Dismukes, GC (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	dismukes@rci.rutgers.edu		Gimpel, Javier/0000-0002-8671-9627; Vinyard, David/0000-0002-8058-5998	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-10ER16195]; Air Force Office of Scientific Research Grant [FA9550-10-1-0052]; Department of Energy [DE-EE0003373]; Consortium for Algal Biofuels Commercialization (CAB-COMM); Department of Defense, Army Research Office, National Defense Science and Engineering Graduate Fellowship [32CFR168a]; National Science Foundation Graduate Research Fellowship [DGE-0937373]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Air Force Office of Scientific Research Grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Department of Energy(United States Department of Energy (DOE)); Consortium for Algal Biofuels Commercialization (CAB-COMM); Department of Defense, Army Research Office, National Defense Science and Engineering Graduate Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported in part by Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FG02-10ER16195 (to G.C.D.), Air Force Office of Scientific Research Grant FA9550-10-1-0052, and Department of Energy Grant DE-EE0003373, Consortium for Algal Biofuels Commercialization (CAB-COMM) (to S.P.M. and S.S.G.).; Supported by the Department of Defense, Army Research Office, National Defense Science and Engineering Graduate Fellowship 32CFR168a and National Science Foundation Graduate Research Fellowship DGE-0937373.	Ananyev G, 2005, PHOTOSYNTH RES, V84, P355, DOI 10.1007/s11120-004-7081-1; Ananyev GM, 1996, BIOCHEMISTRY-US, V35, P4102, DOI 10.1021/bi952667h; BABCOCK GT, 1983, BIOCHIM BIOPHYS ACTA, V723, P276, DOI 10.1016/0005-2728(83)90127-5; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Boussac A, 2011, BBA-BIOENERGETICS, V1807, P119, DOI 10.1016/j.bbabio.2010.10.004; BOUYOUB A, 1993, PLANT MOL BIOL, V21, P249, DOI 10.1007/BF00019941; BUSER CA, 1992, BIOCHEMISTRY-US, V31, P11449, DOI 10.1021/bi00161a025; BUSTOS SA, 1990, J BACTERIOL, V172, P1998, DOI 10.1128/jb.172.4.1998-2004.1990; Campbell D, 1998, P NATL ACAD SCI USA, V95, P364, DOI 10.1073/pnas.95.1.364; CAMPBELL D, 1995, EMBO J, V14, P5457, DOI 10.1002/j.1460-2075.1995.tb00232.x; Chen GY, 2012, BIOCHEMISTRY-US, V51, P138, DOI 10.1021/bi200627j; Chen R., 2010, J BOT, V2010; CLARKE AK, 1993, P NATL ACAD SCI USA, V90, P9973, DOI 10.1073/pnas.90.21.9973; CLARKE AK, 1993, P NATL ACAD SCI USA, V90, P11985, DOI 10.1073/pnas.90.24.11985; DELRIEU MJ, 1987, BIOCHIM BIOPHYS ACTA, V892, P163, DOI 10.1016/0005-2728(87)90171-X; Dyer B. D., 2003, FIELD GUIDE BACTERIA, P232; FORBUSH B, 1971, PHOTOCHEM PHOTOBIOL, V14, P307, DOI 10.1111/j.1751-1097.1971.tb06175.x; Gokhale Z., 2009, CHLAMYDOMONAS SOURCE, P573; GOLDEN SS, 1986, EMBO J, V5, P2789, DOI 10.1002/j.1460-2075.1986.tb04569.x; Hughes JL, 2010, BBA-BIOENERGETICS, V1797, P11, DOI 10.1016/j.bbabio.2009.07.007; Johnson S.G., 2011, NLOPT NONLINEAR OPTI; Joliot P., 1975, BIOENERG PHOTOSYNTH, P387; Kato Y, 2012, BBA-BIOENERGETICS, V1817, P1998, DOI 10.1016/j.bbabio.2012.06.006; Kato Y, 2009, P NATL ACAD SCI USA, V106, P17365, DOI 10.1073/pnas.0905388106; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kolling DRJ, 2009, BIOCHEMISTRY-US, V48, P1381, DOI 10.1021/bi801774f; KULKARNI RD, 1994, J BACTERIOL, V176, P959, DOI 10.1128/JB.176.4.959-965.1994; Kulkarni RD, 1995, PHOTOSYNTH RES, V46, P435, DOI 10.1007/BF00032298; LAVOREL J, 1976, J THEOR BIOL, V57, P171, DOI 10.1016/S0022-5193(76)80011-2; Loll B, 2008, BIOL CHEM, V389, P609, DOI 10.1515/BC.2008.058; Manuell AL, 2007, PLANT BIOTECHNOL J, V5, P402, DOI 10.1111/j.1467-7652.2007.00249.x; Mason CB, 2006, NAT PROTOC, V1, P2227, DOI 10.1038/nprot.2006.348; MAYFIELD SP, 1994, J CELL BIOL, V127, P1537, DOI 10.1083/jcb.127.6.1537; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; Merry SAP, 1998, BIOCHEMISTRY-US, V37, P17439, DOI 10.1021/bi980502d; MESSINGER J, 1993, BIOCHEMISTRY-US, V32, P7658, DOI 10.1021/bi00081a009; MOHAMED A, 1993, MOL GEN GENET, V238, P161, DOI 10.1007/BF00279543; Morton BR, 1996, J MOL EVOL, V43, P28, DOI 10.1007/BF02352296; Muh F, 2011, FRONT BIOSCI-LANDMRK, V16, P3072, DOI 10.2741/3900; Mulo P, 2009, CELL MOL LIFE SCI, V66, P3697, DOI 10.1007/s00018-009-0103-6; Ogami S, 2012, BBA-BIOENERGETICS, V1817, P1322, DOI 10.1016/j.bbabio.2012.01.015; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Powell M.J.D., 2009, BOBYQA ALGORITHM BOU; Prasil O, 1996, PHOTOSYNTH RES, V48, P395, DOI 10.1007/BF00029472; Rasala BA, 2011, PLANT BIOTECHNOL J, V9, P674, DOI 10.1111/j.1467-7652.2011.00620.x; Raven, 2007, AQUATIC PHOTOSYNTHES, P81; Rutherford AW, 2012, FEBS LETT, V586, P603, DOI 10.1016/j.febslet.2011.12.039; Sander J, 2010, J BIOL CHEM, V285, P29851, DOI 10.1074/jbc.M110.127142; Sane PV, 2002, J BIOL CHEM, V277, P32739, DOI 10.1074/jbc.M200444200; SCHAEFER MR, 1989, J BIOL CHEM, V264, P7412; SCHAEFER MR, 1989, J BACTERIOL, V171, P3973, DOI 10.1128/jb.171.7.3973-3981.1989; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; SCHUSTER G, 1988, EUR J BIOCHEM, V177, P403, DOI 10.1111/j.1432-1033.1988.tb14389.x; Shibamoto T, 2009, BIOCHEMISTRY-US, V48, P10682, DOI 10.1021/bi901691j; SHIM HS, 1990, PHOTOSYNTH RES, V26, P223, DOI 10.1007/BF00033135; Shinkarev VP, 2005, BIOPHYS J, V88, P412, DOI 10.1529/biophysj.104.050898; Shinopoulos KE, 2012, BBA-BIOENERGETICS, V1817, P66, DOI 10.1016/j.bbabio.2011.08.002; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Sippola K, 1999, PLANT MOL BIOL, V41, P425, DOI 10.1023/A:1006347808475; Stambler N, 2007, ALGAE CYANOBACTERIA, P81; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; Sugiura M, 2010, J BIOL CHEM, V285, P30008, DOI 10.1074/jbc.M110.136945; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1491, DOI 10.1016/j.bbabio.2010.03.022; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Tichy M, 2003, BBA-BIOENERGETICS, V1605, P55, DOI 10.1016/S0005-2728(03)00064-1; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VASS I, 1991, BIOCHEMISTRY-US, V30, P830, DOI 10.1021/bi00217a037; Vass I, 2009, TRENDS PLANT SCI, V14, P200, DOI 10.1016/j.tplants.2009.01.009; WHITMARSH J, 1978, BIOCHIM BIOPHYS ACTA, V501, P83, DOI 10.1016/0005-2728(78)90097-X; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	71	27	28	1	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5451	5462		10.1074/jbc.M112.394668	http://dx.doi.org/10.1074/jbc.M112.394668			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271739	Green Published, hybrid			2022-12-25	WOS:000315342500020
J	Harris, B; Klein, R; Jerosch-Herold, M; Hoffman, EA; Ahmed, FS; Jacobs, DR; Klein, BEK; Wong, TY; Lima, JAC; Cotch, MF; Barr, G				Harris, Bianca; Klein, Ronald; Jerosch-Herold, Michael; Hoffman, Eric A.; Ahmed, Firas S.; Jacobs, David R., Jr.; Klein, Barbara E. K.; Wong, Tien Y.; Lima, Joao A. C.; Cotch, Mary Frances; Barr, Graham			The Association of Systemic Microvascular Changes with Lung Function and Lung Density: A Cross-Sectional Study	PLOS ONE			English	Article							RETINAL VASCULAR CALIBER; AIR-FLOW OBSTRUCTION; ATHEROSCLEROSIS MESA; CARDIOVASCULAR MORTALITY; MYOCARDIAL-PERFUSION; ALBUMIN EXCRETION; MEDIATED DILATION; REFERENCE VALUES; RISK-FACTORS; EX-SMOKERS	Smoking causes endothelial dysfunction and systemic microvascular disease with resultant end-organ damage in the kidneys, eyes and heart. Little is known about microvascular changes in smoking-related lung disease. We tested if microvascular changes in the retina, kidneys and heart were associated with obstructive spirometry and low lung density on computed tomography. The Multi-Ethnic Study of Atherosclerosis recruited participants age 45-84 years without clinical cardiovascular disease. Measures of microvascular function included retinal arteriolar and venular caliber, urine albumin-to-creatinine ratio and, in a subset, myocardial blood flow on magnetic resonance imaging. Spirometry was measured following ATS/ERS guidelines. Low attenuation areas (LAA) were measured on lung fields of cardiac computed tomograms. Regression models adjusted for pulmonary and cardiac risk factors, medications and body size. Among 3,397 participants, retinal venular caliber was inversely associated with forced expiratory volume in one second (FEV1) (P<0.001) and FEV1/forced vital capacity (FVC) ratio (P = 0.04). Albumin-to-creatinine ratio was inversely associated with FEV1 (P = 0.002) but not FEV1/FVC. Myocardial blood flow (n = 126) was associated with lower FEV1 (P = 0.02), lower FEV1/FVC (P = 0.001) and greater percentage LAA (P = 0.04). Associations were of greater magnitude among smokers. Low lung function was associated with microvascular changes in the retina, kidneys and heart, and low lung density was associated with impaired myocardial microvascular perfusion. These cross-sectional results suggest that microvascular damage with end-organ dysfunction in all circulations may pertain to the lung, that lung dysfunction may contribute to systemic microvascular disease, or that there may be a shared predisposition.	[Harris, Bianca; Ahmed, Firas S.; Barr, Graham] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA; [Klein, Ronald; Klein, Barbara E. K.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Jerosch-Herold, Michael] Univ Minnesota, Sch Med, Dept Radiol, Minneapolis, MN 55455 USA; [Jerosch-Herold, Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Ahmed, Firas S.] Columbia Univ, Coll Phys & Surg, Dept Radiol, New York, NY USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway; [Wong, Tien Y.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Wong, Tien Y.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore; [Lima, Joao A. C.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Lima, Joao A. C.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; [Barr, Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Iowa; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo; Centre for Eye Research Australia; University of Melbourne; National University of Singapore; Singapore National Eye Center; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Columbia University	Barr, G (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA.	rgb9@columbia.edu	Wong, Tien Yin/AAC-9724-2020; Jerosch-Herold, Michael/R-9824-2019	Wong, Tien Yin/0000-0002-8448-1264; Klein, Ronald/0000-0002-4428-6237; Cotch, Mary Frances/0000-0002-2046-4350; Hoffman, Eric/0000-0001-8456-9437; Jacobs, David/0000-0002-7232-0543	National Institutes of Health [R01-HL077612, R01-HL093081, R01-HL075476]; Vida Diagnostics;  [N01-HC95159-HC95169];  [UL1-TR000040]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000403] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077612, R01HL093081, R01HL075476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vida Diagnostics; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institutes of Health R01-HL077612, R01-HL093081, and R01-HL075476. MESA is supported by N01-HC95159-HC95169 and UL1-TR000040. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by federal sources, an interest in Vida Diagnostics (EA Hoffman) and a gift of a fish oil supplement, Omax3, provided by Cenestra Health for a federally funded randomized clinical trial (RG Barr). These conflicts-of-interest do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alford SK, 2010, P NATL ACAD SCI USA, V107, P7485, DOI 10.1073/pnas.0913880107; Bakke PS, 2011, EUR RESPIR J, V38, P1261, DOI 10.1183/09031936.00193809; Barr RG, 2012, EUR RESPIR J, V39, P846, DOI 10.1183/09031936.00165410; Barr RG, 2007, AM J RESP CRIT CARE, V176, P1200, DOI 10.1164/rccm.200707-980OC; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Calabrese C, 2006, RESP MED, V100, P1415, DOI 10.1016/j.rmed.2005.11.009; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Casanova C, 2010, AM J RESP CRIT CARE, V182, P1004, DOI 10.1164/rccm.201003-0360OC; Chandra D, 2012, CHEST, V142, P655, DOI 10.1378/chest.11-1456; Chester AH, 1998, CARDIOVASC RES, V38, P814, DOI 10.1016/S0008-6363(98)00054-6; COXSON HO, 1995, J APPL PHYSIOL, V79, P1525, DOI 10.1152/jappl.1995.79.5.1525; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; Di Stefano A, 1998, AM J RESP CRIT CARE, V158, P1277, DOI 10.1164/ajrccm.158.4.9802078; Eickhoff P, 2008, AM J RESP CRIT CARE, V178, P1211, DOI 10.1164/rccm.200709-1412OC; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Giordano RJ, 2008, J BIOL CHEM, V283, P29447, DOI 10.1074/jbc.M804595200; Gooding KM, 2010, DIABETOLOGIA, V53, P2029, DOI 10.1007/s00125-010-1805-x; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hashimoto M, 2005, CHEST, V127, P965, DOI 10.1378/chest.127.3.965; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hoffman EA, 2009, ACAD RADIOL, V16, P689, DOI 10.1016/j.acra.2008.12.024; Hu SY, 2001, IEEE T MED IMAGING, V20, P490, DOI 10.1109/42.929615; Jerosch-Herold M, 2002, MED PHYS, V29, P886, DOI 10.1118/1.1473135; Kramer H, 2005, HYPERTENSION, V46, P38, DOI 10.1161/01.HYP.0000171189.48911.18; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; MEHROTRA PP, 1983, J AM COLL CARDIOL, V2, P233, DOI 10.1016/S0735-1097(83)80158-2; Mendes ES, 2006, CHEST, V129, P893, DOI 10.1378/chest.129.4.893; Michaud SE, 2006, J MOL CELL CARDIOL, V41, P275, DOI 10.1016/j.yjmcc.2006.05.004; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; Nana-Sinkam SP, 2007, AM J RESP CRIT CARE, V175, P676, DOI 10.1164/rccm.200605-724OC; Nguyen TT, 2010, STROKE, V41, P1343, DOI 10.1161/STROKEAHA.110.581017; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Ozer T, 2006, EUR J RADIOL, V57, P63, DOI 10.1016/j.ejrad.2005.06.010; Panting JR, 2002, NEW ENGL J MED, V346, P1948, DOI 10.1056/NEJMoa012369; Pesci A, 1998, EUR RESPIR J, V12, P380, DOI 10.1183/09031936.98.12020380; Polatli M, 2008, J THROMB THROMBOLYS, V26, P97, DOI 10.1007/s11239-007-0073-1; Reddy S, 2005, ABSTRACT PRESENTED A; Rennard Stephen I, 2008, Proc Am Thorac Soc, V5, P878, DOI 10.1513/pats.200804-035QC; Rodriguez J, 2010, ANN INTERN MED, V152, P201, DOI 10.7326/0003-4819-152-4-201002160-00004; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schweitzer KS, 2011, AM J PHYSIOL-LUNG C, V301, pL836, DOI 10.1152/ajplung.00385.2010; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Sharma J, 2012, AM J PHYSIOL-LUNG C, V302, pL47, DOI 10.1152/ajplung.00179.2011; Soltani A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-105; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Takahashi T, 2012, THORAX, V67, P1067, DOI 10.1136/thoraxjnl-2011-201395; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; Wang L, 2006, J AM COLL CARDIOL, V47, P565, DOI 10.1016/j.jacc.2005.09.036; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zanini A, 2009, THORAX, V64, P1019, DOI 10.1136/thx.2009.114629	62	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e50224	10.1371/journal.pone.0050224	http://dx.doi.org/10.1371/journal.pone.0050224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284634	Green Published, gold			2022-12-25	WOS:000312794500012
J	Tsai, YC; Riess, O; Soehn, AS; Nguyen, HP				Tsai, Yu-Chun; Riess, Olaf; Soehn, Anne S.; Huu Phuc Nguyen			The Guanine Nucleotide Exchange Factor Kalirin-7 Is a Novel Synphilin-1 Interacting Protein and Modifies Synphilin-1 Aggregate Transport and Formation	PLOS ONE			English	Article							HUNTINGTIN-ASSOCIATED PROTEIN-1; LEWY-BODY FORMATION; REGULATES AGGRESOME FORMATION; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; SPINE MORPHOGENESIS; MUTANT HUNTINGTIN; IN-VIVO; INCLUSIONS; HDAC6	Synphilin-1 has been identified as an interaction partner of alpha-synuclein, a key protein in the pathogenesis of Parkinson disease (PD). To further explore novel binding partners of synphilin-1, a yeast two hybrid screening was performed and kalirin-7 was identified as a novel interactor. We then investigated the effect of kalirin-7 on synphilin-1 aggregate formation. Coexpression of kalirin-7 and synphilin-1 caused a dramatic relocation of synphilin-1 cytoplasmic small inclusions to a single prominent, perinuclear inclusion. These perinuclear inclusions were characterized as being aggresomes according to their colocalization with microtubule organization center markers, and their formation was microtubule-dependent. Furthermore, kalirin-7 increased the susceptibility of synphilin-1 inclusions to be degraded as demonstrated by live cell imaging and quantification of aggregates. However, the kalirin-7-mediated synphilin-1 aggresome response was not dependent on the GEF activity of kalirin-7 since various dominant negative small GTPases could not inhibit the formation of aggresomes. Interestingly, the aggresome response was blocked by HDAC6 catalytic mutants and the HDAC inhibitor trichostatin A (TSA). Moreover, kalirin-7 decreased the level of acetylated alpha-tubulin in response to TSA, which suggests an effect of kalirin-7 on HDAC6-mediated protein transportation and aggresome formation. In summary, this is the first report demonstrating that kalirin-7 leads to the recruitment of synphilin-1 into aggresomes in a HDAC6-dependent manner and also links kalirin-7 to microtubule dynamics.	[Tsai, Yu-Chun; Riess, Olaf; Soehn, Anne S.; Huu Phuc Nguyen] Univ Tubingen, Dept Med Genet, Tubingen, Germany	Eberhard Karls University of Tubingen	Nguyen, HP (corresponding author), Univ Tubingen, Dept Med Genet, Tubingen, Germany.	hoa.nguyen@med.uni-tuebingen.de	Nguyen, Huu Phuc/HDO-3462-2022; Nguyen, Huu Phuc/F-5390-2015	Nguyen, Huu Phuc/0000-0001-6139-788X; Nguyen, Huu Phuc/0000-0001-6139-788X	DFG [RI 682/10-1]; European Union [20235]; Landesgraduiertenforderungsgesetz (LGFG) Baden-Wurttemberg	DFG(German Research Foundation (DFG)); European Union(European Commission); Landesgraduiertenforderungsgesetz (LGFG) Baden-Wurttemberg	This work was supported by the DFG (grant number RI 682/10-1). YCT was a fellow of the Early Stage Training Network NEUROTRAIN (funded by the European Union research program FP6-Mobility 20235) and she has received a stipend according to the Landesgraduiertenforderungsgesetz (LGFG) Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Bobrowska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020696; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Cahill ME, 2009, P NATL ACAD SCI USA, V106, P13058, DOI 10.1073/pnas.0904636106; Chakrabarti K, 2005, MOL CELL BIOL, V25, P5106, DOI 10.1128/MCB.25.12.5106-5118.2005; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Colomer V, 1997, HUM MOL GENET, V6, P1519, DOI 10.1093/hmg/6.9.1519; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ito T, 2003, J BIOL CHEM, V278, P29106, DOI 10.1074/jbc.M302763200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnson RC, 2000, J BIOL CHEM, V275, P19324, DOI 10.1074/jbc.M000676200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Krug T, 2010, HUM GENET, V127, P513, DOI 10.1007/s00439-010-0790-y; Kruger R, 2004, CELL TISSUE RES, V318, P195, DOI 10.1007/s00441-004-0953-z; Lee G, 2002, J NEUROCHEM, V83, P346, DOI 10.1046/j.1471-4159.2002.01136.x; Lee HJ, 1990, NEURONAL PROPERTIES, P1779; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Ma XM, 2008, J NEUROSCI, V28, P711, DOI 10.1523/JNEUROSCI.5283-07.2008; Ma XM, 2008, J NEUROSCI, V28, P12368, DOI 10.1523/JNEUROSCI.4269-08.2008; Marx FP, 2003, HUM MOL GENET, V12, P1223, DOI 10.1093/hmg/ddg134; Marx FP, 2007, FASEB J, V21, P1759, DOI 10.1096/fj.06-6734com; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; May V, 2002, J NEUROSCI, V22, P6980; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Murray IVJ, 2003, ACTA NEUROPATHOL, V105, P177, DOI 10.1007/s00401-002-0629-2; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; O'Farrell C, 2001, MOL BRAIN RES, V97, P94, DOI 10.1016/S0169-328X(01)00292-3; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ratovitski EA, 1999, J BIOL CHEM, V274, P993, DOI 10.1074/jbc.274.2.993; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Schiller MR, 2008, EXP CELL RES, V314, P2674, DOI 10.1016/j.yexcr.2008.05.011; Schiller MR, 2005, EXP CELL RES, V307, P402, DOI 10.1016/j.yexcr.2005.03.024; Segev N, 2011, SEMIN CELL DEV BIOL, V22, P1, DOI 10.1016/j.semcdb.2010.12.004; Soehn AS, 2010, NEUROGENETICS, V11, P203, DOI 10.1007/s10048-009-0215-z; Takahashi T, 2006, FEBS LETT, V580, P4479, DOI 10.1016/j.febslet.2006.07.019; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Verhey KJ, 2007, CELL CYCLE; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Viswanathan J, 2011, TRAFFIC, V12, P330, DOI 10.1111/j.1600-0854.2010.01149.x; Wang LY, 2007, AM J HUM GENET, V80, P650, DOI 10.1086/512981; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Xie YY, 2010, FASEB J, V24, P196, DOI 10.1096/fj.09-133082; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Youn H, 2007, J ALZHEIMERS DIS, V12, P271; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	84	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51999	10.1371/journal.pone.0051999	http://dx.doi.org/10.1371/journal.pone.0051999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284848	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500076
J	Wang, F; He, L; Dai, WQ; Xu, YP; Wu, D; Lin, CL; Wu, SM; Cheng, P; Zhang, Y; Shen, M; Wang, CF; Lu, J; Zhou, YQ; Xu, XF; Xu, L; Guo, CY				Wang, Fan; He, Lei; Dai, Wei-Qi; Xu, Ya-Ping; Wu, Dong; Lin, Chun-Lei; Wu, Shu-Mei; Cheng, Ping; Zhang, Yan; Shen, Miao; Wang, Chen-Feng; Lu, Jie; Zhou, Ying-Qun; Xu, Xuan-Fu; Xu, Ling; Guo, Chuan-Yong			Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In Vivo	PLOS ONE			English	Article							TUMOR-CELLS; WNT; OVEREXPRESSION; METASTASIS; MUTATIONS; CA2+	The anti-tumor antibiotic salinomycin (Sal) was recently identified as a selective inhibitor of breast cancer stem cells; however, the effect of Sal on hepatocellular carcinoma (HCC) is not clear. This study aimed to determine the anti-tumor efficacy and mechanism of Sal on HCC. HCC cell lines (HepG2, SMMC-7721, and BEL-7402) were treated with Sal. Cell doubling time was determinated by drawing growth curve, cell viability was evaluated using the Cell Counting Kit 8. The fraction of CD133(+) cell subpopulations was assessed by flow cytometry. We found that Sal inhibits proliferation and decreases PCNA levels as well as the proportion of HCC CD133(+) cell subpopulations in HCC cells. Cell cycle was analyzed using flow cytometry and showed that Sal caused cell cycle arrest of the various HCC cell lines in different phases. Cell apoptosis was evaluated using flow cytometry and Hoechst 33342 staining. Sal induced apoptosis as characterized by an increase in the Bax/Bcl-2 ratio. Several signaling pathways were selected for further mechanistic analyses using real time-PCR and Western blot assays. Compared to control, beta-catenin expression is significantly down-regulated upon Sal addition. The Ca2+ concentration in HCC cells was examined by flow cytometry and higher Ca2+ concentrations were observed in Sal treatment groups. The anti-tumor effect of Sal was further verified in vivo using the hepatoma orthotopic tumor model and the data obtained showed that the size of liver tumors in Sal-treated groups decreased compared to controls. Immunohistochemistry and TUNEL staining also demonstrated that Sal inhibits proliferation and induces apoptosis in vivo. Finally, the role of Sal on in vivo Wnt/beta-catenin signaling was evaluated by Western blot and immunohistochemistry. This study demonstrates Sal inhibits proliferation and induces apoptosis of HCC cells in vitro and in vivo and one potential mechanism is inhibition of Wnt/beta-catenin signaling via increased intracellular Ca2+ levels.	[Wang, Fan; He, Lei; Dai, Wei-Qi; Xu, Ya-Ping; Wu, Dong; Lin, Chun-Lei; Wu, Shu-Mei; Cheng, Ping; Zhang, Yan; Shen, Miao; Wang, Chen-Feng; Lu, Jie; Zhou, Ying-Qun; Xu, Xuan-Fu; Xu, Ling; Guo, Chuan-Yong] Tongji Univ Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai, Peoples R China	Tongji University	Xu, L (corresponding author), Tongji Univ Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai, Peoples R China.	xuling606@sina.com; guochuanyong@hotmail.com		Guo, Chuanyong/0000-0002-6527-4673	National Natural Science Foundation of China [81101579]; Shanghai Science and Technology Innovation Plan of Action for international cooperation projects [11430702400]; China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund [20100021]; Shanghai Health Bureau issues [2011287]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Innovation Plan of Action for international cooperation projects; China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund; Shanghai Health Bureau issues	This work was supported by the National Natural Science Foundation of China (no. 81101579), the Shanghai Science and Technology Innovation Plan of Action for international cooperation projects (no. 11430702400), the China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund (no. 20100021), and the Shanghai Health Bureau issues (No. 2011287). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cui J, 2001, J CANCER RES CLIN, V127, P577, DOI 10.1007/s004320100259; Devereux TR, 2001, MOL CARCINOGEN, V31, P68, DOI 10.1002/mc.1041; Dong TT, 2011, ANN SURG ONCOL, V18, P1797, DOI 10.1245/s10434-011-1561-2; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hou Y, 2012, CELL RES, V22, P259, DOI 10.1038/cr.2011.139; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim KY, 2011, BIOCHEM BIOPH RES CO, V413, P80, DOI 10.1016/j.bbrc.2011.08.054; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kudo M, 2011, DIGEST DIS, V29, P289, DOI 10.1159/000327562; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lee S, 2003, CURR OPIN GENET DEV, V13, P90, DOI 10.1016/S0959-437X(02)00014-X; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Maye P, 2004, J BIOL CHEM, V279, P24659, DOI 10.1074/jbc.M311724200; MITANI M, 1975, BIOCHEM BIOPH RES CO, V66, P1231, DOI 10.1016/0006-291X(75)90490-8; MIYAZAKI Y, 1974, J ANTIBIOT, V27, P814, DOI 10.7164/antibiotics.27.814; NAITO S, 1986, CANCER RES, V46, P4109; Park CH, 2005, CARCINOGENESIS, V26, P1929, DOI 10.1093/carcin/bgi145; Piao LS, 2012, CANCER LETT, V315, P129, DOI 10.1016/j.canlet.2011.10.012; Ryder SD, 2003, GUT, V52, pIII1, DOI 10.1136/gut.52.suppl_3.iii1; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Story Phillipa, 2004, N Z Med J, V117, pU799; Wang LY, 2011, HEPATO-GASTROENTEROL, V58, P1757; Wong CM, 2001, CANCER-AM CANCER SOC, V92, P136, DOI 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	30	89	97	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e50638	10.1371/journal.pone.0050638	http://dx.doi.org/10.1371/journal.pone.0050638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284640	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500014
J	Chen, R; Chang, GB; Zhang, Y; Dai, AQ; Ma, T; Li, JC; Zhai, F; Hua, DK; Xia, MX; Chen, GH				Chen, Rong; Chang, Guobin; Zhang, Ying; Dai, Aiqin; Ma, Teng; Li, Jianchao; Zhai, Fei; Hua, Dengke; Xia, Mingxiu; Chen, Guohong			Cloning of the Quail PIWI Gene and Characterization of PIWI Binding to Small RNAs	PLOS ONE			English	Article							GERMLINE STEM-CELLS; MICRORNA EXPRESSION; CHICKEN-EMBRYO; DROSOPHILA; PATHWAY; FAMILY; SPERMATOGENESIS; IDENTIFICATION; PROTEIN; TESTES	The PIWI protein regulates gene expression at the epigenetic and post-transcriptional level with a variety of endogenous small non-coding RNAs. In poultry, the biological function of the PIWI protein and PIWI binding to small RNAs had not been determined. The present study cloned and analyzed the sequences of the PIWIL1 protein. We also characterized PIWIL1 binding to small RNAs from adult quail testis, where the PIWIL1 protein is specifically expressed. Small RNAs showed a strong peak at 24-27 nt in the testicular RNA library, mapped primarily to repeat sequences and were similar to rasiRNAs. MicroRNAs (miRNAs) were abundant in the ovarian RNA library at a peak of 22 nt.	[Chen, Rong; Chang, Guobin; Zhang, Ying; Dai, Aiqin; Ma, Teng; Li, Jianchao; Zhai, Fei; Hua, Dengke; Xia, Mingxiu; Chen, Guohong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Peoples R China	Yangzhou University	Chen, GH (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Peoples R China.	ghchen@yzu.edu.cn			National Natural Science Foundation of China [31172199]; Natural Science Foundation of Jiangsu Province [BK2009190]; priority academic program development of Jiangsu Higher Education Institutions; National High Technology Research and Development Program [2011AA100305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); priority academic program development of Jiangsu Higher Education Institutions; National High Technology Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (31172199) (http://159.226.244.22/portal/Proj_List.asp), the Natural Science Foundation of Jiangsu Province (BK2009190), and the priority academic program development of Jiangsu Higher Education Institutions(http://202.119.175.131/pages/xkmd.aspx). This study was also supported by National High Technology Research and Development Program (2011AA100305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bannister SC, 2009, BIOL REPROD, V81, P165, DOI 10.1095/biolreprod.108.074005; Barh D, 2010, CURR ONCOL, V17, P70; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chang GB, 2011, THAI J VET MED, V41, P193; Chen Rong, 2011, Scientia Agricultura Sinica, V44, P1727; Cox DN, 2000, DEVELOPMENT, V127, P503; Cutting AD, 2012, CHROMOSOME RES, V20, P201, DOI 10.1007/s10577-011-9263-y; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lian J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-13; Lin HF, 1997, DEVELOPMENT, V124, P2463; LIN M, 1992, CELL TISSUE RES, V267, P591, DOI 10.1007/BF00319382; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Tian F, 2012, GENOMICS, V99, P152, DOI 10.1016/j.ygeno.2011.11.004; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang XG, 2012, POULTRY SCI, V91, P139, DOI 10.3382/ps.2011-01656; Xu HT, 2006, FEBS LETT, V580, P3610, DOI 10.1016/j.febslet.2006.05.044; Yang H, 2012, MOL CELL BIOCHEM, V360, P347, DOI 10.1007/s11010-011-1074-0; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954	34	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51724	10.1371/journal.pone.0051724	http://dx.doi.org/10.1371/journal.pone.0051724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284755	Green Submitted, Green Published, gold			2022-12-25	WOS:000312694300037
J	Huerga, H; Varaine, F; Okwaro, E; Bastard, M; Ardizzoni, E; Sitienei, J; Chakaya, J; Bonnet, M				Huerga, Helena; Varaine, Francis; Okwaro, Eric; Bastard, Mathieu; Ardizzoni, Elisa; Sitienei, Joseph; Chakaya, Jeremiah; Bonnet, Maryline			Performance of the 2007 WHO Algorithm to Diagnose Smear-Negative Pulmonary Tuberculosis in a HIV Prevalent Setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; FLUORESCENCE MICROSCOPY; COST-EFFECTIVENESS; CULTURE; IMPLEMENTATION; INFECTION; COUNTRY; PEOPLE; UGANDA; MEDIA	Background: The 2007 WHO algorithm for diagnosis of smear-negative pulmonary tuberculosis (PTB) including Mycobacterium tuberculosis (MTB) culture was evaluated in a HIV prevalent area of Kenya. Methods: PTB smear-negative adult suspects were included in a prospective diagnostic study (2009-2011). In addition, program data (2008-2009) were retrospectively analysed. At the first consultation, clinical examination, chest X-ray, and sputum culture (Thin-Layer-Agar and Lowenstein-Jensen) were performed. Patients not started on TB treatment were clinically re-assessed after antibiotic course. The algorithm performance was calculated using culture as reference standard. Results: 380 patients were included prospectively and 406 analyzed retrospectively. Culture was positive for MTB in 17.5% (61/348) and 21.8% (72/330) of cases. Sensitivity of the clinical-radiological algorithm was 55.0% and 31.9% in the prospective study and the program data analysis, respectively. Specificity, positive and negative predictive values were 72.9%, 29.7% and 88.6% in the prospective study and 79.8%, 30.7% and 80.8% in the program data analysis. Performing culture increased the number of confirmed TB patients started on treatment by 43.3% in the prospective study and by 44.4% in the program data analysis. Median time to treatment of confirmed TB patients was 6 days in the prospective study and 27 days in the retrospective study. Inter-reader agreement for X-ray interpretation between the study clinician and a radiologist was low (Kappa coefficient = 0.11, 95%CI: 0.09-0.12). In a multivariate logistic analysis, past TB history, number of symptoms and signs at the clinical exam were independently associated with risk of overtreatment. Conclusion: The clinical-radiological algorithm is suboptimal to diagnose smear-negative PTB. Culture increases significantly the proportion of confirmed TB cases started on treatment. Better access to rapid MTB culture and development of new diagnostic tests is necessary.	[Huerga, Helena; Bastard, Mathieu; Bonnet, Maryline] Epictr, Dept Clin Res, Paris, France; [Varaine, Francis; Ardizzoni, Elisa] Med Sans Frontieres, Dept Med, Paris, France; [Okwaro, Eric] Med Sans Frontieres, Dist Hosp Lab, Homa Bay, Kenya; [Ardizzoni, Elisa] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Sitienei, Joseph] Minist Hlth, Div Leprosy TB & Lung Dis, Nairobi, Kenya; [Chakaya, Jeremiah] Kenya Govt Med Res Ctr, Ctr Resp Dis Res, Nairobi, Kenya	Doctors Without Borders; Sanofi-Aventis; Sanofi France; Institute of Tropical Medicine (ITM); Kenya Medical Research Institute	Huerga, H (corresponding author), Epictr, Dept Clin Res, Paris, France.	helena.huerga@epicentre.msf.org			Medecins Sans Frontieres	Medecins Sans Frontieres	This work was supported by Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, some of the co-investigators and authors of this study work for this institution.	Bah B, 2002, INT J TUBERC LUNG D, V6, P592; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hepple P, 2011, INT J TUBERC LUNG D, V15, P405; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; Koole O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018502; Kudjawu Y, 2006, INT J TUBERC LUNG D, V10, P441; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Martin A, 2009, J CLIN MICROBIOL, V47, P2632, DOI 10.1128/JCM.00264-09; Martin A, 2009, J MICROBIOL METH, V78, P107, DOI 10.1016/j.mimet.2009.05.001; Mejia GI, 1999, INT J TUBERC LUNG D, V3, P138; Mejía Gloria Isabel, 2004, Biomed., V24, P52; Ministry of Public Health and Sanitation, 2009, GUID MAN LEPR TUB; Mueller DH, 2008, INT J TUBERC LUNG D, V12, P1196; Nackers F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032140; Pardini M, 2007, J CLIN MICROBIOL, V45, P575, DOI 10.1128/JCM.01985-06; Rishi S, 2007, Indian J Med Microbiol, V25, P383; Robledo JA, 2006, INT J TUBERC LUNG D, V10, P613; Saranchuk P, 2007, SAMJ S AFR MED J, V97, P517; Satti L, 2010, INT J TUBERC LUNG D, V14, P1354; Siddiqi K, 2006, TROP MED INT HEALTH, V11, P323, DOI 10.1111/j.1365-3156.2006.01559.x; Soto A, 2009, INT J INFECT DIS, V13, P40, DOI 10.1016/j.ijid.2008.03.023; Soto A, 2011, TROP MED INT HEALTH, V16, P424, DOI 10.1111/j.1365-3156.2010.02715.x; Swai Hedwiga F, 2011, BMC Res Notes, V4, P475, DOI 10.1186/1756-0500-4-475; Tamhane A, 2009, INT J TUBERC LUNG D, V13, P347; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; Walley J, 2011, JAIDS-J ACQ IMM DEF, V57, pE93, DOI 10.1097/QAI.0b013e3182243a8c; WHO, 1998, LAB SERV TUB CONTR 2; WHO, 2012, TUB DIAGN XPERT MTB; WHO, 2007, IMPR DIAGN TREATM SM; Wilkinson D, 2000, INT J TUBERC LUNG D, V4, P513; Wilson D, 2011, INT J TUBERC LUNG D, V15, P919, DOI 10.5588/ijtld.10.0440; World Health Organization, 2010, REP CONCL REC STRAT	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51336	10.1371/journal.pone.0051336	http://dx.doi.org/10.1371/journal.pone.0051336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284681	Green Submitted, Green Published, gold			2022-12-25	WOS:000312694300019
J	O'Gorman, EJ; Hone, DWE				O'Gorman, Eoin J.; Hone, David W. E.			Body Size Distribution of the Dinosaurs	PLOS ONE			English	Article							GROWTH-RATES; EVOLUTION; SAUROPOD; MASS; MAMMALS; WEIGHT; LENGTH; ALLOMETRIES; DIVERSITY; PATTERNS	The distribution of species body size is critically important for determining resource use within a group or clade. It is widely known that non-avian dinosaurs were the largest creatures to roam the Earth. There is, however, little understanding of how maximum species body size was distributed among the dinosaurs. Do they share a similar distribution to modern day vertebrate groups in spite of their large size, or did they exhibit fundamentally different distributions due to unique evolutionary pressures and adaptations? Here, we address this question by comparing the distribution of maximum species body size for dinosaurs to an extensive set of extant and extinct vertebrate groups. We also examine the body size distribution of dinosaurs by various sub-groups, time periods and formations. We find that dinosaurs exhibit a strong skew towards larger species, in direct contrast to modern day vertebrates. This pattern is not solely an artefact of bias in the fossil record, as demonstrated by contrasting distributions in two major extinct groups and supports the hypothesis that dinosaurs exhibited a fundamentally different life history strategy to other terrestrial vertebrates. A disparity in the size distribution of the herbivorous Ornithischia and Sauropodomorpha and the largely carnivorous Theropoda suggests that this pattern may have been a product of a divergence in evolutionary strategies: herbivorous dinosaurs rapidly evolved large size to escape predation by carnivores and maximise digestive efficiency; carnivores had sufficient resources among juvenile dinosaurs and non-dinosaurian prey to achieve optimal success at smaller body size.	[O'Gorman, Eoin J.; Hone, David W. E.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [O'Gorman, Eoin J.; Hone, David W. E.] Univ Coll Dublin, Sch Biol & Environm Sci, Sci Ctr W, Dublin 2, Ireland	University of London; Queen Mary University London; University College Dublin	O'Gorman, EJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	e.ogorman@qmul.ac.uk; d.hone@qmul.ac.uk	O'Gorman, Eoin J/I-6744-2012; Benton, Michael J/A-5639-2008	O'Gorman, Eoin J/0000-0003-4507-5690; Benton, Michael J/0000-0002-4323-1824	North American Electric Reliability Corporation [NE/I009280/1]	North American Electric Reliability Corporation	EJO was funded by the Irish Research Council for Science Engineering and Technology's EMPOWER initiative when this work was carried out and is now a North American Electric Reliability Corporation funded Postdoctoral Research Fellow on grant NE/I009280/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; ALROY J, 2008, PALEOBIOLOGY DATABAS, V3; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Bakker VJ, 2000, ECOLOGY, V81, P3530, DOI 10.1890/0012-9658(2000)081[3530:SDPIBS]2.0.CO;2; BARTHOLOMAI A, 1981, Memoirs of the Queensland Museum, V20, P319; Bates KT, 2009, PALAEONTOL ELECTRON, V12; BLACKBURN TM, 1994, OIKOS, V70, P127, DOI 10.2307/3545707; Bonaparte J.F., 1990, NATURAL HIST MUSEUM, V416, P1; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Brochu CA, 2003, J VERTEBR PALEONTOL, V22; Brown CM, PALAEOGEOGRAPHY PALA; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Buffetaut E, 2002, C R PALEVOL, V1, P103, DOI 10.1016/S1631-0683(02)00019-2; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; CARPENTER K, 1984, CAN J EARTH SCI, V21, P1491, DOI 10.1139/e84-154; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Carrano MT, 2005, AMNIOTE PALEOBIOLOGY, P225; CAUGHLEY G, 1987, OECOLOGIA, V74, P319, DOI 10.1007/BF00379377; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Chrtstiansen P, 1999, J VERTEBR PALEONTOL, V19, P666, DOI 10.1080/02724634.1999.10011180; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Codron D, 2012, BIOL LETTERS, V8, P620, DOI 10.1098/rsbl.2012.0240; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Coria RA, 1996, J VERTEBR PALEONTOL, V16, P445, DOI 10.1080/02724634.1996.10011333; Currie PJ, 1993, PEOPLES REPUBLIC CHI, V30, P2037; DEMMENT MW, 1982, AFR J ECOL, V20, P43, DOI 10.1111/j.1365-2028.1982.tb01082.x; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dong Zhiming, 1990, P255; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Elgin RA, PTEROSAURIA IN PRESS; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; Froese R., 2012, FISHBASE; Galton P. M., 1997, COMPLETE DINOSAUR, P291; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Gardezi T, 1999, AM NAT, V153, P110, DOI 10.1086/303150; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; GASTON KJ, 1995, IBIS, V137, P237, DOI 10.1111/j.1474-919X.1995.tb03245.x; Gatton P. M., 1970, J. Paleont., V44, P464; Gilmore CW., 1920, B US NATL MUSEUM, V110, P1, DOI [10.5479/si.03629236.110.i, DOI 10.5479/SI.03629236.110.I]; Godefroit Pascal, 1998, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V68, P3; Greer AE, 2001, J HERPETOL, V35, P383, DOI 10.2307/1565956; Guyer C., 2011, COSAM COLLECTIONS RE; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Henderson DM, 2004, P ROY SOC B-BIOL SCI, V271, pS180, DOI 10.1098/rsbl.2003.0136; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Henderson DM, 2006, J VERTEBR PALEONTOL, V26, P907, DOI 10.1671/0272-4634(2006)26[907:BGCOMS]2.0.CO;2; Hoare JM, 2006, ANIM CONSERV, V9, P456, DOI 10.1111/j.1469-1795.2006.00061.x; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Hone DWE, 2010, LETHAIA, V43, P232, DOI 10.1111/j.1502-3931.2009.00187.x; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Joanes DN, 1998, J ROY STAT SOC D-STA, V47, P183; Jones KE, 1997, FUNCT ECOL, V11, P751, DOI 10.1046/j.1365-2435.1997.00149.x; Kindlmann P, 1999, AM NAT, V153, P445, DOI 10.1086/303180; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; KOCH CF, 1978, PALEOBIOLOGY, V4, P367, DOI 10.1017/S0094837300006060; Kozlowski J, 2002, FUNCT ECOL, V16, P419, DOI 10.1046/j.1365-2435.2002.00646.x; Kozlowski J, 1997, AM NAT, V149, P352; Kurzanov S.M., 1987, T SOVMESTNOI SOVETSK, V31, P1; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Mallison H, 2010, SWISS J GEOSCIENCE, V103; Manly BFJ, 1996, ECOLOGY, V77, P81, DOI 10.2307/2265657; MAURER BA, 1992, EVOLUTION, V46, P939, DOI 10.1111/j.1558-5646.1992.tb00611.x; Maurer BA, 1998, EVOL ECOL, V12, P925, DOI 10.1023/A:1006512121434; MAURER BA, 1988, ECOLOGY, V69, P1923, DOI 10.2307/1941169; MAZZETTA G. V., 2004, HIST BIOL, V16, P1; McIntosh John S., 1997, P264; McKinney M.L., 1990, P75; Meiri S, 2010, J ZOOL, V281, P218, DOI 10.1111/j.1469-7998.2010.00696.x; Meiri S, 2008, GLOBAL ECOL BIOGEOGR, V17, P724, DOI 10.1111/j.1466-8238.2008.00414.x; Moore JA, 2007, BIOL CONSERV, V135, P181, DOI 10.1016/j.biocon.2006.10.029; MORSE DR, 1985, NATURE, V314, P731, DOI 10.1038/314731a0; NORMAN D B, 1980, Institut Royal des Sciences Naturelles de Belgique Memoires, P1; Ostrom J.H., 1986, Zitteliana, V14, P111; Paul G., 1988, PREDATORY DINOSAURS; Paul Gregory S., 1997, P129; Paul GS, 1990, ENCY DINOSAURS, P58; PECZKIS J, 1994, J VERTEBR PALEONTOL, V14, P520; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; POUGH FH, 1980, AM NAT, V115, P92, DOI 10.1086/283547; Riggs ES, 1903, AM J SCI, V15, P299; SALGADO L, 1991, Ameghiniana, V28, P333; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sereno P.C., 1990, P203, DOI 10.1017/CBO9780511608377.018; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; SERENO PC, 1994, SCIENCE, V266, P267, DOI 10.1126/science.266.5183.267; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Siemann E, 1999, ECOLOGY, V80, P2788, DOI 10.2307/177258; SILVERMAN BW, 1981, J ROY STAT SOC B MET, V43, P97; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Sookias RB, P ROYAL SOC LONDON B; Speakman JR, 2011, INTEGR COMP BIOL, V51, pE130; Symonds MRE, 1999, FUNCT ECOL, V13, P508, DOI 10.1046/j.1365-2435.1999.00340.x; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Van Heerden J, 1997, COMPLETE DINOSAUR, P330; Varricchio DJ, 2011, HIST BIOL, V23, P91, DOI 10.1080/08912963.2010.500379; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Yates Adam M., 2004, Postilla, V230, P1; Zhou S.W, 1984, MIDDLE JURASSIC DINO	108	55	56	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51925	10.1371/journal.pone.0051925	http://dx.doi.org/10.1371/journal.pone.0051925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284818	Green Published, gold, Green Accepted			2022-12-25	WOS:000312694300058
J	Pena-Gomez, C; Sole-Padulles, C; Clemente, IC; Junque, C; Bargallo, N; Bosch, B; Molinuevo, JL; Valls-Sole, J; Pascual-Leone, A; Bartres-Faz, D				Pena-Gomez, Cleofe; Sole-Padulles, Cristina; Clemente, Imma C.; Junque, Carme; Bargallo, Nuria; Bosch, Beatriz; Luis Molinuevo, Jose; Valls-Sole, Josep; Pascual-Leone, Alvaro; Bartres-Faz, David			APOE Status Modulates the Changes in Network Connectivity Induced by Brain Stimulation in Non-Demented Elders	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INDEPENDENT COMPONENT ANALYSIS; DEFAULT-MODE NETWORK; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; LIFE-SPAN; CEREBRAL-CORTEX; FUNCTIONAL MRI; CORTICAL PLASTICITY; MEMORY DYSFUNCTION	Behavioral consequences of a brain insult represent an interaction between the injury and the capacity of the rest of the brain to adapt to it. We provide experimental support for the notion that genetic factors play a critical role in such adaptation. We induced a controlled brain disruption using repetitive transcranial magnetic stimulation (rTMS) and show that APOE status determines its impact on distributed brain networks as assessed by functional MRI (fMRI). Twenty non-demented elders exhibiting mild memory dysfunction underwent two fMRI studies during face-name encoding tasks (before and after rTMS). Baseline task performance was associated with activation of a network of brain regions in prefrontal, parietal, medial temporal and visual associative areas. APOE epsilon 4 bearers exhibited this pattern in two separate independent components, whereas epsilon 4-non carriers presented a single partially overlapping network. Following rTMS all subjects showed slight ameliorations in memory performance, regardless of APOE status. However, after rTMS APOE epsilon 4-carriers showed significant changes in brain network activation, expressing strikingly similar spatial configuration as the one observed in the non-carrier group prior to stimulation. Similarly, activity in areas of the default-mode network (DMN) was found in a single component among the epsilon 4-non bearers, whereas among carriers it appeared disaggregated in three distinct spatiotemporal components that changed to an integrated single component after rTMS. Our findings demonstrate that genetic background play a fundamental role in the brain responses to focal insults, conditioning expression of distinct brain networks to sustain similar cognitive performance.	[Pena-Gomez, Cleofe; Clemente, Imma C.; Junque, Carme; Bartres-Faz, David] Univ Barcelona, Dept Psiquiatria & Psicobiol Clin, Barcelona, Catalonia, Spain; [Sole-Padulles, Cristina; Bosch, Beatriz; Luis Molinuevo, Jose] Hosp Clin Barcelona, Serv Neurol, Unitat Alzheimer & Altres Trastorns Cognitius, Barcelona, Catalonia, Spain; [Clemente, Imma C.; Bartres-Faz, David] Inst Recerca Cervell Cognicio & Conducta, Barcelona, Catalonia, Spain; [Junque, Carme; Bargallo, Nuria; Bosch, Beatriz; Luis Molinuevo, Jose] Inst Invest Biomed August Pi & Sunyer, Barcelona, Catalonia, Spain; [Bargallo, Nuria] Ctr Diagnost Imatge, Serv Radiol, Seccio Neuroradiol, Barcelona, Catalonia, Spain; [Valls-Sole, Josep] Hosp Clin Barcelona, Serv Neuroradiol, Lab Explorac Neurofunc, Barcelona, Catalonia, Spain; [Pascual-Leone, Alvaro] Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [Pascual-Leone, Alvaro] Harvard Univ, Sch Med, Boston, MA USA	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Bartres-Faz, D (corresponding author), Univ Barcelona, Dept Psiquiatria & Psicobiol Clin, Barcelona, Catalonia, Spain.	dbartres@ub.edu	Solé-Padullés, Cristina/K-6984-2017; Bartres-Faz, David/C-8997-2011; Clemente, I Concepcion/H-5399-2013; Bargallo, Nuria/G-6854-2016; Junque, Carme/B-4400-2011; Pascual-Leone, Alvaro/AAC-5101-2019; Molinuevo, Jose Luis/HCH-3881-2022	Solé-Padullés, Cristina/0000-0002-6653-1053; Bartres-Faz, David/0000-0001-6020-4118; Clemente, I Concepcion/0000-0003-0728-0925; Bargallo, Nuria/0000-0001-6284-5402; Junque, Carme/0000-0002-6381-3063; Pascual-Leone, Alvaro/0000-0001-8975-0382; Molinuevo, Jose Luis/0000-0003-0485-6001; Bosch, Beatriz/0000-0002-6094-0024	Spanish Ministerio de Educacion y Ciencia [SAF2007-66270]; Spanish Ministerio de Ciencia e Innovacion [SAF2009-07489]; Generalitat de Catalunya [2009SGR941]; Ajuts al Personal Investigador en Formacio APIF-UB grant from the University of Barcelona; CONSOLIDER-Ingenio program [CSD2010-00045]; National Institutes of Health [K24 RR018875, RO1-NS 20068, R01-EB 005047]; Harvard Clinical and Translational Science Center, from the National Center for Research Resources [UL1 RR025758-]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, K24RR018875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005047] Funding Source: NIH RePORTER	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Ajuts al Personal Investigador en Formacio APIF-UB grant from the University of Barcelona; CONSOLIDER-Ingenio program(Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Clinical and Translational Science Center, from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Partially funded by a Spanish Ministerio de Educacion y Ciencia research project award (SAF2007-66270) and the Spanish Ministerio de Ciencia e Innovacion (SAF2009-07489) to DB-F and fundings from the Generalitat de Catalunya to the Neuropsychology Research Group (2009SGR941). CP-G was funded by a Ajuts al Personal Investigador en Formacio APIF-UB grant from the University of Barcelona. JLM was funded through a CONSOLIDER-Ingenio program 2010: CSD2010-00045). APL was supported in part by grants from the National Institutes of Health (K24 RR018875, RO1-NS 20068, R01-EB 005047), and Grant Number UL1 RR025758- Harvard Clinical and Translational Science Center, from the National Center for Research Resources. The funders had no role in study design, data colllection and analysis, decision to publish, or preparation of the manuscript.	Abele M, 1997, BRAIN, V120, P2141, DOI 10.1093/brain/120.12.2141; Adamson MM, 2011, NEUROPSYCHOLOGIA, V49, P2448, DOI 10.1016/j.neuropsychologia.2011.04.022; Bartres-Faz D, 2008, NEUROBIOL AGING, V29, P1644, DOI 10.1016/j.neurobiolaging.2007.04.021; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Dennis NA, 2010, ALZHEIMERS DEMENT, V6, P303, DOI 10.1016/j.jalz.2009.07.003; Filippini N, 2011, NEUROIMAGE, V54, P602, DOI 10.1016/j.neuroimage.2010.08.009; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fleisher AS, 2005, ARCH NEUROL-CHICAGO, V62, P1881, DOI 10.1001/archneur.62.12.1881; Fox MD, 2012, NEUROIMAGE; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Han SD, 2007, NEUROBIOL AGING, V28, P238, DOI 10.1016/j.neurobiolaging.2005.12.013; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; He BJ, 2007, CURR OPIN NEUROL, V20, P655, DOI 10.1097/WCO.0b013e3282f1c720; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Lind J, 2006, BRAIN, V129, P1240, DOI 10.1093/brain/awl054; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Meyer-Lindenberg A, 2009, HUM BRAIN MAPP, V30, P1938, DOI 10.1002/hbm.20639; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Palop JJ, 2010, NEUROMOL MED, V12, P48, DOI 10.1007/s12017-009-8097-7; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Park J, 2012, J NEUROSCI, V32, P2154, DOI 10.1523/JNEUROSCI.4494-11.2012; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P302, DOI 10.1007/s10548-011-0196-8; Persson J, 2008, NEUROPSYCHOLOGIA, V46, P1679, DOI 10.1016/j.neuropsychologia.2008.01.026; Petrella JR, 2008, RADIOLOGY, V246, P20, DOI 10.1148/radiol.2461061994; Pihlajamaki M, 2010, ALZ DIS ASSOC DIS, V24, P28, DOI 10.1097/WAD.0b013e3181a785c9; Popp J, 2010, J ALZHEIMERS DIS, V22, P459, DOI 10.3233/JAD-2010-100561; Prakash RS, 2012, BEHAV BRAIN RES, V230, P192, DOI 10.1016/j.bbr.2012.01.058; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rami L, 2012, J ALZHEIMERS DIS; Rasetti R, 2011, CURR OPIN GENET DEV, V21, P340, DOI 10.1016/j.gde.2011.02.003; RISSANEN J, 1983, ANN STAT, V11, P416, DOI 10.1214/aos/1176346150; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Sala-Llonch R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00152; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schwenkreis P, 2002, BRAIN, V125, P301, DOI 10.1093/brain/awf023; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith CD, 2002, NEUROLOGY, V58, P1197, DOI 10.1212/WNL.58.8.1197; Sole-Padulles C, 2006, CEREB CORTEX, V16, P1487, DOI 10.1093/cercor/bhj083; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; Sperling RA, 2001, HUM BRAIN MAPP, V14, P129, DOI 10.1002/hbm.1047; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2010, RESTOR NEUROL NEUROS, V28, P425, DOI 10.3233/RNN-2010-0553; Sternang O, 2011, BIOL PSYCHIAT, V70, P109, DOI 10.1016/j.biopsych.2011.05.023; Trachtenberg AJ, 2012, NEUROBIOL AGING, V33, P323, DOI 10.1016/j.neurobiolaging.2010.03.009; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Walsh V, 2003, TMS COGNITIVE SCI NE; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Wierenga CE, 2010, NEUROIMAGE, V51, P1222, DOI 10.1016/j.neuroimage.2010.03.021; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Winner B, 2004, ARCH NEUROL-CHICAGO, V61, P117, DOI 10.1001/archneur.61.1.117; Zanardi R, 2007, EUR NEUROPSYCHOPHARM, V17, P651, DOI 10.1016/j.euroneuro.2007.03.008; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004	77	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51833	10.1371/journal.pone.0051833	http://dx.doi.org/10.1371/journal.pone.0051833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284783	gold, Green Submitted, Green Published			2022-12-25	WOS:000312694300049
J	Shechter, A; Lesperance, P; Kin, NMKNY; Boivin, DB				Shechter, Ari; Lesperance, Paul; Kin, N. M. K. Ng Ying; Boivin, Diane B.			Pilot Investigation of the Circadian Plasma Melatonin Rhythm across the Menstrual Cycle in a Small Group of Women with Premenstrual Dysphoric Disorder	PLOS ONE			English	Article							BRIGHT-LIGHT; SLEEP-DEPRIVATION; CLOCK GENES; PHASE; MOOD; SEROTONIN; THERAPY; AMPLITUDE; CORTISOL; RECEPTOR	Women with premenstrual dysphoric disorder (PMDD) experience mood deterioration and altered circadian rhythms during the luteal phase (LP) of their menstrual cycles. Disturbed circadian rhythms may be involved in the development of clinical mood states, though this relationship is not fully characterized in PMDD. We therefore conducted an extensive chronobiological characterization of the melatonin rhythm in a small group of PMDD women and female controls. In this pilot study, participants included five women with PMDD and five age-matched controls with no evidence of menstrual-related mood disorders. Participants underwent two 24-hour laboratory visits, during the follicular phase (FP) and LP of the menstrual cycle, consisting of intensive physiological monitoring under "unmasked", time-isolation conditions. Measures included visual analogue scale for mood, ovarian hormones, and 24-hour plasma melatonin. Mood significantly (P <=.03) worsened during LP in PMDD compared to FP and controls. Progesterone was significantly (P=.025) increased during LP compared to FP, with no between-group differences. Compared to controls, PMDD women had significantly (P<.05) decreased melatonin at circadian phases spanning the biological night during both menstrual phases and reduced amplitude of its circadian rhythm during LP. PMDD women also had reduced area under the curve of melatonin during LP compared to FP. PMDD women showed affected circadian melatonin rhythms, with reduced nocturnal secretion and amplitude during the symptomatic phase compared to controls. Despite our small sample size, these pilot findings support a role for disturbed circadian rhythms in affective disorders. Possible associations with disrupted serotonergic transmission are proposed.	[Shechter, Ari; Boivin, Diane B.] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Ctr Study & Treatment Circadian Rhythms, Montreal, PQ, Canada; [Lesperance, Paul] Univ Montreal, Dept Psychiat, Ctr Hosp Univ Montre, Montreal, PQ H3C 3J7, Canada; [Kin, N. M. K. Ng Ying] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Div Clin Res, Montreal, PQ, Canada	McGill University; Universite de Montreal; McGill University	Boivin, DB (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Ctr Study & Treatment Circadian Rhythms, Montreal, PQ, Canada.	diane.boivin@douglas.mcgill.ca	Shechter, Ari/GXM-8324-2022	Shechter, Ari/0000-0001-8243-0247	Canadian Institutes of Health Research; Fonds de la recherche en sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was supported by an operating grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). DBB was supported by a scholarship from the Fonds de la recherche en sante du Quebec (http://www.frsq.gouv.qc.ca/en/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDEGUNDE M, 1985, INT J NEUROSCI, V26, P9, DOI 10.3109/00207458508985598; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; ARMITAGE R, 2005, PRINCIPLES PRACTICE, P1266; ASHBY CR, 1988, BIOL PSYCHIAT, V24, P225, DOI 10.1016/0006-3223(88)90277-6; AXELROD J, 1974, SCIENCE, V184, P1341, DOI 10.1126/science.184.4144.1341; Baker FC, 2007, SLEEP, V30, P1283, DOI 10.1093/sleep/30.10.1283; Boivin DB, 1997, ARCH GEN PSYCHIAT, V54, P145; Boivin DB, 2000, J PSYCHIATR NEUROSCI, V25, P446; BROWN EN, 1992, J BIOL RHYTHM, V7, P177, DOI 10.1177/074873049200700301; BRZEZINSKI AA, 1990, OBSTET GYNECOL, V76, P296; Cain SW, 2010, J BIOL RHYTHM, V25, P288, DOI 10.1177/0748730410374943; CHILDS PA, 1995, BRIT J PSYCHIAT, V166, P196, DOI 10.1192/bjp.166.2.196; Clemett DA, 2000, NEUROPHARMACOLOGY, V39, P123, DOI 10.1016/S0028-3908(99)00086-6; De Berardis Domenico, 2007, Ther Clin Risk Manag, V3, P585; de Bodinat C, 2010, NAT REV DRUG DISCOV, V9, P628, DOI 10.1038/nrd3140; DEACON S, 1994, NEUROSCI LETT, V167, P191, DOI 10.1016/0304-3940(94)91059-6; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; GOLDEN RN, 1988, ARCH GEN PSYCHIAT, V45, P150; HARDIN TA, 1991, J PSYCHIAT RES, V25, P75, DOI 10.1016/0022-3956(91)90001-Q; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; James FO, 2007, CHRONOBIOL INT, V24, P1009, DOI 10.1080/07420520701800736; James FO, 2007, SLEEP, V30, P1427, DOI 10.1093/sleep/30.11.1427; JEWETT ME, 1994, J BIOL RHYTHM, V9, P295, DOI 10.1177/074873049400900310; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Kruijver FPM, 2002, NEUROENDOCRINOLOGY, V75, P296, DOI 10.1159/000057339; Lam RW, 1999, PSYCHIAT RES, V86, P185, DOI 10.1016/S0165-1781(99)00043-8; Lamont EW, 2010, ISR J PSYCHIATR REL, V47, P27; Landen M, 2003, DEPRESS ANXIETY, V17, P122, DOI 10.1002/da.10089; Lopez-Gimenez JF, 2001, SYNAPSE, V42, P12, DOI 10.1002/syn.1095; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; Miguez JM, 1995, J NEUROENDOCRINOL, V7, P949, DOI 10.1111/j.1365-2826.1995.tb00740.x; Parry BL, 2008, PSYCHIAT RES, V161, P76, DOI 10.1016/j.psychres.2007.11.017; PARRY BL, 1987, AM J PSYCHIAT, V144, P808; PARRY BL, 1989, AM J PSYCHIAT, V146, P1215; Parry BL, 1997, J BIOL RHYTHM, V12, P47, DOI 10.1177/074873049701200107; PARRY BL, 1995, AM J PSYCHIAT, V152, P404; PARRY BL, 1993, AM J PSYCHIAT, V150, P1417; Parry BL, 1997, J BIOL RHYTHM, V12, P443, DOI 10.1177/074873049701200506; PARRY BL, 1990, ARCH GEN PSYCHIAT, V47, P1139; Parry BL, 2001, CNS DRUGS, V15, P277, DOI 10.2165/00023210-200115040-00003; Parry BL, 2001, NEUROPSYCHOPHARMACOL, V25, pS102, DOI 10.1016/S0893-133X(01)00340-2; Rahman SA, 2010, EUR ARCH PSY CLIN N, V260, P327, DOI 10.1007/s00406-009-0080-7; RAPKIN AJ, 1987, OBSTET GYNECOL, V70, P533; Rapkin AJ, 1997, OBSTET GYNECOL, V90, P709, DOI 10.1016/S0029-7844(97)00417-1; Shah NR, 2008, OBSTET GYNECOL, V111, P1175, DOI 10.1097/AOG.0b013e31816fd73b; Shanahan TL, 1999, J BIOL RHYTHM, V14, P237, DOI 10.1177/074873099129000560; SHANAHAN TL, 1991, J CLIN ENDOCR METAB, V73, P227, DOI 10.1210/jcem-73-2-227; Shechter A, 2012, SLEEP MED, V13, P1071, DOI 10.1016/j.sleep.2012.05.012; Shechter A, 2010, SLEEP, V33, P647, DOI 10.1093/sleep/33.5.647; Shechter A, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/259345; SKENE DJ, 1994, BRIT J CLIN PHARMACO, V37, P181, DOI 10.1111/j.1365-2125.1994.tb04258.x; Steinberg S, 1999, BIOL PSYCHIAT, V45, P313, DOI 10.1016/S0006-3223(98)00005-5; Steiner M, 1999, J AFFECT DISORDERS, V53, P269, DOI 10.1016/S0165-0327(98)00121-9; STEINER M, 1995, NEW ENGL J MED, V332, P1529, DOI 10.1056/NEJM199506083322301; Steiner M, 2000, J PSYCHIATR NEUROSCI, V25, P459; THOMPSON C, 1985, BRIT J PSYCHIAT, V147, P389, DOI 10.1192/bjp.147.4.389; VACAS MI, 1979, NEUROENDOCRINOLOGY, V29, P84, DOI 10.1159/000122909	60	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51929	10.1371/journal.pone.0051929	http://dx.doi.org/10.1371/journal.pone.0051929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284821	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300061
J	Abraham, NM; Guerin, D; Bhaukaurally, K; Carleton, A				Abraham, Nixon M.; Guerin, Delphine; Bhaukaurally, Khaleel; Carleton, Alan			Similar Odor Discrimination Behavior in Head-Restrained and Freely Moving Mice	PLOS ONE			English	Article							NEURAL CIRCUITRY; TRANSGENIC MICE; OLFACTORY-BULB; VISUAL-CORTEX; ACCURACY; SNIFF; SPEED; REPRESENTATIONS; ACTIVATION; NEURONS	A major challenge in neuroscience is relating neuronal activity to animal behavior. In olfaction limited techniques are available for these correlation studies in freely moving animals. To solve this problem, we developed an olfactory behavioral assay in head-restrained mice where we can monitor behavioral responses with high temporal precision. Mice were trained on a go/no-go operant conditioning paradigm to discriminate simple monomolecular odorants, as well as complex odorants such as binary mixtures of monomolecular odorants or natural odorants. Mice learned to discriminate both simple and complex odors in a few hundred trials with high accuracy. We then compared the discrimination performance of head-restrained mice to the performance observed in freely moving mice. Discrimination accuracies were comparable in both behavioral paradigms. In addition, discrimination times were measured while the animals performed well. In both tasks, mice discriminated simple odors in a few hundred milliseconds and took additional time to discriminate the complex mixtures. In conclusion, mice showed similar and efficient discrimination behavior while head-restrained compared with freely moving mice. Therefore, the head-restrained paradigm offers a relevant approach to monitor neuronal activity while animals are actively engaged in olfactory discrimination behaviors. Citation: Abraham NM, Guerin D, Bhaukaurally K, Carleton A (2012) Similar Odor Discrimination Behavior in Head-Restrained and Freely Moving Mice. PLoS ONE 7(12): e51789. doi:10.1371/journal.pone.0051789	[Abraham, Nixon M.; Guerin, Delphine; Bhaukaurally, Khaleel; Carleton, Alan] Univ Geneva, Sch Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Abraham, Nixon M.; Guerin, Delphine; Bhaukaurally, Khaleel; Carleton, Alan] Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland	University of Geneva; University of Geneva	Abraham, NM (corresponding author), Univ Geneva, Sch Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	nixon.abraham@unige.ch; alan.carleton@unige.ch	Abraham, Nixon/R-8381-2016; Carleton, Alan/C-9721-2010	Abraham, Nixon/0000-0001-8523-716X; Carleton, Alan/0000-0001-5633-9159	University of Geneva; Swiss National Science Foundation [PP0033_119169, PP00P3_139189, 51AU40_125759]; National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases''; European Research Council [ERC-2009-StG-243344-NEUROCHEMS]; Novartis foundation for medical research; Carlos & Elsie de Reuter foundation; Ernst & Lucie Schmidheiny foundation; European Molecular Biology Organization	University of Geneva; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases''(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); Novartis foundation for medical research; Carlos & Elsie de Reuter foundation; Ernst & Lucie Schmidheiny foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This research was supported by the University of Geneva, the Swiss National Science Foundation (SNF professor grant numbers: PP0033_119169 and PP00P3_139189), the National Center of Competence in Research (NCCR) "SYNAPSY - The Synaptic Bases of Mental Diseases'' financed by the Swiss National Science Foundation (no 51AU40_125759), the European Research Council (contract number ERC-2009-StG-243344-NEUROCHEMS), the Novartis foundation for medical research, the Carlos & Elsie de Reuter foundation, the Ernst & Lucie Schmidheiny foundation and the European Molecular Biology Organization (A.C. young investigator program, N.A. long-term postdoctoral fellowship program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bathellier B, 2007, NEUROIMAGE, V34, P1020, DOI 10.1016/j.neuroimage.2006.10.038; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Frederick DE, 2011, BEHAV NEUROSCI, V125, P588, DOI 10.1037/a0024371; Friedrich RW, 2006, TRENDS NEUROSCI, V29, P40, DOI 10.1016/j.tins.2005.10.004; Gschwend O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030155; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kerr JND, 2012, CURR OPIN NEUROBIOL, V22, P45, DOI 10.1016/j.conb.2011.12.002; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Kurt S, 2010, P NATL ACAD SCI USA, V107, P8481, DOI 10.1073/pnas.0912357107; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; Lepousez G, 2011, JOVE-J VIS EXP, DOI 10.3791/3380; Lin JY, 2012, PROG BRAIN RES, V196, P29, DOI 10.1016/B978-0-444-59426-6.00002-1; Luce R. D, 1986, OXFORD PSYCHOL SERIE, V8; Mainen ZF, 2006, CURR OPIN NEUROBIOL, V16, P429, DOI 10.1016/j.conb.2006.06.003; Morita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020437; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Populin LC, 2011, J NEUROPHYSIOL, V106, P2000, DOI 10.1152/jn.00331.2011; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Vincis R, 2012, NAT NEUROSCI, V15, P537, DOI 10.1038/nn.3057; Wesson DW, 2009, J NEUROPHYSIOL, V101, P1089, DOI 10.1152/jn.90981.2008; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	44	29	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51789	10.1371/journal.pone.0051789	http://dx.doi.org/10.1371/journal.pone.0051789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272168	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300029
J	Basu, D; Reyes-Mugica, M; Rebbaa, A				Basu, Dipanjan; Reyes-Mugica, Miguel; Rebbaa, Abdelhadi			Role of the Beta Catenin Destruction Complex in Mediating Chemotherapy-Induced Senescence-Associated Secretory Phenotype	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DRUG-RESISTANCE; ANTITUMOR-ACTIVITY; CANCER-TREATMENT; TUMOR-CELLS; INHIBITION; WNT; ACTIVATION; EXPRESSION; PROLIFERATION	Cellular senescence is considered as a tumor suppressive mechanism. Recent evidence indicates however that senescent cells secrete various growth factors and cytokines, some of which may paradoxically promote cancer progression. This phenomenon termed senescence-associated secretory phenotype (SASP) must be inhibited in order for anti-proliferative agents to be effective. The present study was designed to determine whether the beta-catenin destruction complex (BCDC), known to integrate the action of various growth factors and cytokines, would represent a suitable target to inhibit the activity of SASP components. For this, we carried out experiments to determine the effect of drug-induced senescence on secretion of SASP, beta-catenin transactivation, and the relationship between these processes. Moreover, genetic and pharmacological approaches were used to define the implication of BCDC in mediating the effects of SASP components on cell migration and resistance to drugs. The findings indicate that drug-induced senescence was associated with expression of various Wnt ligands in addition to previously known SASP components. Beta catenin transactivation and expression of genes implicated in epithelial-mesenchymal transition (EMT) also increased in response to drug-induced SASP. These effects were prevented by Pyrvinium, a recently described activator of BCDC. Pyrvinium also suppressed the effects of SASP on cell migration and resistance to doxorubicin. Together, these findings provide insights on the potential role of BCDC in mediating the effects of drug-induced SASP on cancer cell invasion and resistance to therapy, and suggest that targeting this pathway may represent an effective approach to enhance the activity of current and prospective anti-cancer therapeutics.	[Rebbaa, Abdelhadi] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rebbaa, A (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	abr25@pitt.edu	Basu, Dipanjan/J-8043-2019; Reyes-Mugica, Miguel/C-2483-2008	Basu, Dipanjan/0000-0002-3083-2954; Reyes-Mugica, Miguel/0000-0001-5698-3702	University of Pittsburgh	University of Pittsburgh(University of Pittsburgh)	This work was supported by startup funds from the University of Pittsburgh. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Canino C, 2011, ONCOGENE; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Chang BD, 1999, CANCER RES, V59, P3761; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kendziorra E, 2011, CARCINOGENESIS, V32, P1824, DOI 10.1093/carcin/bgr222; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Laberge RM, 2012, CANCER MICROENVIRON, V5, P39, DOI 10.1007/s12307-011-0069-4; Laberge RM, 2012, AGING CELL; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim JC, 2008, J NEUROCHEM, V106, P1855, DOI 10.1111/j.1471-4159.2008.05537.x; Lyden D, 2011, CANC METASTASIS BIOL; Mirkin BL, 2005, ONCOGENE, V24, P4965, DOI 10.1038/sj.onc.1208671; Pazolli E, 2012, CANCER RES, V72, P2251, DOI 10.1158/0008-5472.CAN-11-3386; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Rebbaa A, 2001, MOL MED, V7, P393, DOI 10.1007/BF03402185; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Roninson IB, 2003, CANCER RES, V63, P2705; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Tenbaum SP, 2012, NAT MED; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951; Zheng X, 2004, CANCER RES, V64, P1773, DOI 10.1158/0008-5472.CAN-03-0820	40	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52188	10.1371/journal.pone.0052188	http://dx.doi.org/10.1371/journal.pone.0052188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272224	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300068
J	Lee, S; Lee, I; Jung, Y; McConkey, D; Czerniak, B				Lee, Sangkyou; Lee, Ilkyun; Jung, Yoonsuh; McConkey, David; Czerniak, Bogdan			In-Frame cDNA Library Combined with Protein Complementation Assay Identifies ARL11-Binding Partners	PLOS ONE			English	Article							PHOSPHOGLYCERATE MUTASE; BLADDER CARCINOGENESIS; 13-CIS-RETINOIC ACID; 2-HYBRID SYSTEM; FLUORESCENT PROTEINS; MESSENGER-RNAS; INTERACTOME; INHIBITION; CARCINOMA; CANCER	The cDNA expression libraries that produce correct proteins are essential in facilitating the identification of protein-protein interactions. The 5'-untranslated regions (UTRs) that are present in the majority of mammalian and non-mammalian genes are predicted to alter the expression of correct proteins from cDNA libraries. We developed a novel cDNA expression library from which 5'-UTRs were removed using a mixture of polymerase chain reaction primers that complement the Kozak sequences we refer to as an "in-frame cDNA library.'' We used this library with the protein complementation assay to identify two novel binding partners for ras-related ADP-ribosylation factor-like 11 (ARL11), cellular retinoic acid binding protein 2 (CRABP2), and phosphoglycerate mutase 1 (PGAM1). Thus, the in-frame cDNA library without 5'-UTRs we describe here increases the chance of correctly identifying protein interactions and will have wide applications in both mammalian and non-mammalian detection systems.	[Lee, Sangkyou; Lee, Ilkyun; Czerniak, Bogdan] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Jung, Yoonsuh] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [McConkey, David] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Czerniak, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	bczernia@mdanderson.org	Jung, Yoonsuh/A-1782-2015	Jung, Yoonsuh/0000-0002-1743-5049	National Institute of Health [R01 CA 151489]; GU SPORE Grant [P50 CA91846]; NATIONAL CANCER INSTITUTE [R01CA151489, P30CA016672, P50CA091846] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GU SPORE Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health Grants R01 CA 151489 (BC) and GU SPORE Grant P50 CA91846 (Project 1, BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; BECCI PJ, 1978, CANCER RES, V38, P4463; Bonetta L, 2010, NATURE, V468, P851, DOI [10.1038/468851a, 10.1038/468854a, 10.1038/468852a]; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Chen GA, 2003, P NATL ACAD SCI USA, V100, P13537, DOI 10.1073/pnas.2233850100; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Dube DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015648; Durany N, 2000, BRIT J CANCER, V82, P20; Evans DRH, 2004, BIOTECHNIQUES, V37, P840, DOI 10.2144/04375PT02; Fang MZ, 2004, CARCINOGENESIS, V25, P865, DOI 10.1093/carcin/bgh097; GRUBBS CJ, 1977, SCIENCE, V198, P743, DOI 10.1126/science.910158; Gupta A, 2006, CANCER RES, V66, P8100, DOI 10.1158/0008-5472.CAN-05-4519; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Huang WD, 2001, BIOTECHNIQUES, V30, P94, DOI 10.2144/01301st06; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee S, 2007, P NATL ACAD SCI USA, V104, P13732, DOI 10.1073/pnas.0701771104; Lemmens I, 2010, J PROTEOMICS, V73, P1415, DOI 10.1016/j.jprot.2010.02.001; LIPPMAN SM, 1987, CANCER TREAT REP, V71, P391; Majewski T, 2008, LAB INVEST, V88, P694, DOI 10.1038/labinvest.2008.27; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Ren FL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-81; Sabichi Anita L., 1998, Current Opinion in Oncology, V10, P479, DOI 10.1097/00001622-199809000-00019; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; SPORN MB, 1977, SCIENCE, V195, P487, DOI 10.1126/science.835006; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; THOMPSON HJ, 1981, CANCER RES, V41, P933; Turhani D, 2006, ELECTROPHORESIS, V27, P1417, DOI 10.1002/elps.200500510; Tyagi S, 2000, BIOCHEM BIOPH RES CO, V277, P589, DOI 10.1006/bbrc.2000.3720; Usuba T, 2001, INT J CANCER, V94, P662, DOI 10.1002/ijc.1524; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	36	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52290	10.1371/journal.pone.0052290	http://dx.doi.org/10.1371/journal.pone.0052290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272234	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300076
J	Schemann, M; Kugler, EM; Buhner, S; Eastwood, C; Donovan, J; Jiang, W; Grundy, D				Schemann, Michael; Kugler, Eva Maria; Buhner, Sabine; Eastwood, Christopher; Donovan, Jemma; Jiang, Wen; Grundy, David			The Mast Cell Degranulator Compound 48/80 Directly Activates Neurons	PLOS ONE			English	Article							HISTAMINE-RELEASE; ENTERIC NEURONS; RAT-BRAIN; IN-VIVO; RECEPTORS; CALCIUM; AXIS; H-1	Background: Compound 48/80 is widely used in animal and tissue models as a "selective'' mast cell activator. With this study we demonstrate that compound 48/80 also directly activates enteric neurons and visceral afferents. Methodology/Principal Findings: We used in vivo recordings from extrinsic intestinal afferents together with Ca++ imaging from primary cultures of DRG and nodose neurons. Enteric neuronal activation was examined by Ca++ and voltage sensitive dye imaging in isolated gut preparations and primary cultures of enteric neurons. Intraluminal application of compound 48/80 evoked marked afferent firing which desensitized on subsequent administration. In egg albumen-sensitized animals, intraluminal antigen evoked a similar pattern of afferent activation which also desensitized on subsequent exposure to antigen. In cross-desensitization experiments prior administration of compound 48/80 failed to influence the mast cell mediated response. Application of 1 and 10 mu g/ml compound 48/80 evoked spike discharge and Ca++ transients in enteric neurons. The same nerve activating effect was observed in primary cultures of DRG and nodose ganglion cells. Enteric neuron cultures were devoid of mast cells confirmed by negative staining for c-kit or toluidine blue. In addition, in cultured enteric neurons the excitatory action of compound 48/80 was preserved in the presence of histamine H-1 and H-2 antagonists. The mast cell stabilizer cromolyn attenuated compound 48/80 and nicotine evoked Ca++ transients in mast cell-free enteric neuron cultures. Conclusions/Significance: The results showed direct excitatory action of compound 48/80 on enteric neurons and visceral afferents. Therefore, functional changes measured in tissue or animal models may involve a mast cell independent effect of compound 48/80 and cromolyn.	[Schemann, Michael; Kugler, Eva Maria; Buhner, Sabine] Tech Univ Munich, Freising Weihenstephan, Germany; [Eastwood, Christopher; Donovan, Jemma; Jiang, Wen; Grundy, David] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	Technical University of Munich; University of Sheffield	Schemann, M (corresponding author), Tech Univ Munich, Freising Weihenstephan, Germany.	schemann@wzw.tum.de		Grundy, David/0000-0003-3974-7390; Schemann, Michael/0000-0003-1007-9843	DFG [Sche 267/9-1]	DFG(German Research Foundation (DFG))	This study was supported by DFG grant Sche 267/9-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Bischoff SC, 2009, SEMIN IMMUNOPATHOL, V31, P185, DOI 10.1007/s00281-009-0165-4; Breunig E, 2007, J PHYSIOL-LONDON, V583, P731, DOI 10.1113/jphysiol.2007.139352; Buhner S, 2012, BBA-MOL BASIS DIS, V1822, P85, DOI 10.1016/j.bbadis.2011.06.004; Chiang G, 2000, J UROLOGY, V164, P2119, DOI 10.1016/S0022-5347(05)66981-9; De Jonge F, 2004, AM J PHYSIOL-GASTR L, V287, pG178, DOI 10.1152/ajpgi.00528.2003; DJALDETTI M, 1979, NOUV REV FR HEMATOL, V21, P185; EGLEZOS A, 1992, ARCH INT PHARMACOD T, V315, P96; Giebel J, 1995, EUR J MORPHOL, V33, P359; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; HEPPNER TJ, 1992, EUR J PHARMACOL, V213, P427, DOI 10.1016/0014-2999(92)90632-E; JANISZEWSKI J, 1990, BRAIN BEHAV IMMUN, V4, P139, DOI 10.1016/0889-1591(90)90016-J; Janssen LJ, 1998, EUR RESPIR J, V12, P50, DOI 10.1183/09031936.98.12010050; Jiang W, 2000, GASTROENTEROLOGY, V119, P1267, DOI 10.1053/gast.2000.19461; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Katayama G, 2005, INFLAMM RES, V54, P370, DOI 10.1007/s00011-005-1369-2; Kaur R, 2009, ARCH PHARM RES, V32, P1775, DOI 10.1007/s12272-009-2216-8; Koszegi Z, 2006, J BIOCHEM BIOPH METH, V69, P227, DOI 10.1016/j.jbbm.2006.03.009; Kovacs P, 2006, J NEUROIMMUNOL, V171, P1, DOI 10.1016/j.jneuroim.2005.07.026; Kubes P, 1996, CARDIOVASC RES, V32, P699, DOI 10.1016/S0008-6363(96)00118-6; Kugler EM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00133; Law JKY, 2011, BBA-GEN SUBJECTS, V1810, P867, DOI 10.1016/j.bbagen.2011.05.007; Levy D, 2012, BRAIN BEHAV IMMUN, V26, P311, DOI 10.1016/j.bbi.2011.09.016; LOVENBERG TW, 1988, J PHARMACOL EXP THER, V247, P562; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Michel K, 2011, J PHYSIOL-LONDON, V589, P5941, DOI 10.1113/jphysiol.2011.219550; MOUSLI M, 1990, TRENDS PHARMACOL SCI, V11, P358, DOI 10.1016/0165-6147(90)90179-C; Palomaki VAB, 2006, BRIT J PHARMACOL, V147, P596, DOI 10.1038/sj.bjp.0706671; Paterson WG, 2007, GUT, V56, P1347, DOI 10.1136/gut.2006.115881; PATON WDM, 1951, BRIT J PHARM CHEMOTH, V6, P499, DOI 10.1111/j.1476-5381.1951.tb00661.x; Quinson N, 2001, CELL TISSUE RES, V305, P3, DOI 10.1007/s004410100395; ROTHSCHILD AM, 1970, BRIT J PHARMACOL, V38, P253, DOI 10.1111/j.1476-5381.1970.tb10354.x; TAKEUCHI K, 1985, AGENTS ACTIONS, V17, P10, DOI 10.1007/BF01966673; Theoharides TC, 2000, BRIT J PHARMACOL, V131, P1039, DOI 10.1038/sj.bjp.0703672	34	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52104	10.1371/journal.pone.0052104	http://dx.doi.org/10.1371/journal.pone.0052104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272218	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000312483300064
J	Smith, SJ; Wilson, M; Ward, JH; Rahman, CV; Peet, AC; Macarthur, DC; Rose, FRAJ; Grundy, RG; Rahman, R				Smith, Stuart J.; Wilson, Martin; Ward, Jennifer H.; Rahman, Cheryl V.; Peet, Andrew C.; Macarthur, Donald C.; Rose, Felicity R. A. J.; Grundy, Richard G.; Rahman, Ruman			Recapitulation of Tumor Heterogeneity and Molecular Signatures in a 3D Brain Cancer Model with Decreased Sensitivity to Histone Deacetylase Inhibition	PLOS ONE			English	Article							ROTATING-WALL VESSEL; GLIOBLASTOMA STEM-CELLS; IN-VITRO; ENDOTHELIAL-CELLS; INITIATING CELLS; PEDIATRIC GLIOBLASTOMA; CYTOSINE-ARABINOSIDE; MALIGNANT GLIOMAS; DRUG-EVALUATION; TISSUE MODELS	Introduction: Physiologically relevant pre-clinical ex vivo models recapitulating CNS tumor micro-environmental complexity will aid development of biologically-targeted agents. We present comprehensive characterization of tumor aggregates generated using the 3D Rotary Cell Culture System (RCCS). Methods: CNS cancer cell lines were grown in conventional 2D cultures and the RCCS and comparison with a cohort of 53 pediatric high grade gliomas conducted by genome wide gene expression and microRNA arrays, coupled with immunohistochemistry, ex vivo magnetic resonance spectroscopy and drug sensitivity evaluation using the histone deacetylase inhibitor, Vorinostat. Results: Macroscopic RCCS aggregates recapitulated the heterogeneous morphology of brain tumors with a distinct proliferating rim, necrotic core and oxygen tension gradient. Gene expression and microRNA analyses revealed significant differences with 3D expression intermediate to 2D cultures and primary brain tumors. Metabolic profiling revealed differential profiles, with an increase in tumor specific metabolites in 3D. To evaluate the potential of the RCCS as a drug testing tool, we determined the efficacy of Vorinostat against aggregates of U87 and KNS42 glioblastoma cells. Both lines demonstrated markedly reduced sensitivity when assaying in 3D culture conditions compared to classical 2D drug screen approaches. Conclusions: Our comprehensive characterization demonstrates that 3D RCCS culture of high grade brain tumor cells has profound effects on the genetic, epigenetic and metabolic profiles of cultured cells, with these cells residing as an intermediate phenotype between that of 2D cultures and primary tumors. There is a discrepancy between 2D culture and tumor molecular profiles, and RCCS partially re-capitulates tissue specific features, allowing drug testing in a more relevant ex vivo system.	[Smith, Stuart J.; Ward, Jennifer H.; Grundy, Richard G.; Rahman, Ruman] Univ Nottingham, Sch Clin Sci, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England; [Wilson, Martin; Peet, Andrew C.] Univ Birmingham, Sch Med, Div Reprod & Child Hlth, Birmingham, W Midlands, England; [Rahman, Cheryl V.; Rose, Felicity R. A. J.] Univ Nottingham, Sch Pharm, Div Drug Delivery & Tissue Engn, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Macarthur, Donald C.] Univ Nottingham Hosp, Dept Neurosurg, Nottingham NG7 2UH, England	University of Nottingham; University of Birmingham; University of Nottingham; University of Nottingham	Grundy, RG (corresponding author), Univ Nottingham, Sch Clin Sci, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England.	richard.grundy@nottingham.ac.uk; ruman.rahman@nottingham.ac.uk	Rahman, Ruman/FFR-5799-2022; Wilson, Martin/ABA-7210-2021	Rahman, Ruman/0000-0002-6541-9983; Wilson, Martin/0000-0002-2089-3956; Ward, Jennifer/0000-0002-3906-0858; Smith, Stuart/0000-0002-4556-2707; Rose, Felicity/0000-0001-6640-8840; Peet, Andrew/0000-0002-4846-5152	Samantha Dickson Brain Tumor Trust; Gentleman's Night Out Charity; Joseph Foote Brain Tumour Trust; The Brain Tumour Charity [17/86] Funding Source: researchfish	Samantha Dickson Brain Tumor Trust; Gentleman's Night Out Charity; Joseph Foote Brain Tumour Trust; The Brain Tumour Charity	This work was supported by the Samantha Dickson Brain Tumor Trust, the Gentleman's Night Out Charity and the Joseph Foote Brain Tumour Trust. RR is a Nottingham Advanced Research Fellow and SJS is a National Institute for Health Research/UoN Clinical Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKER H, 1987, BRIT J CANCER, V56, P325, DOI 10.1038/bjc.1987.197; Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Bielen A, 2011, MOL CANCER THER, V10, P1407, DOI 10.1158/1535-7163.MCT-11-0205; Biggs T, 2011, J BIOMOL SCREEN, V16, P805, DOI 10.1177/1087057111414895; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Buchwald M, 2009, CANCER LETT, V280, P160, DOI 10.1016/j.canlet.2009.02.028; Buffa FM, 2001, INT J RADIAT ONCOL, V49, P1109, DOI 10.1016/S0360-3016(00)01533-9; Burdett E, 2010, TISSUE ENG PART B-RE, V16, P351, DOI [10.1089/ten.teb.2009.0676, 10.1089/ten.TEB.2009.0676]; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campbell JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025661; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; Davies NP, 2010, NMR BIOMED, V23, P80, DOI 10.1002/nbm.1432; de Antonellis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024584; Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; Faute MAD, 2002, CLIN EXP METASTAS, V19, P161, DOI 10.1023/A:1014594825502; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fotovati A, 2011, CANCER RES, V71, P5569, DOI 10.1158/0008-5472.CAN-10-2805; Fouladi M, 2010, J CLIN ONCOL, V28, P3623, DOI 10.1200/JCO.2009.25.9119; Frankel A, 1997, CANCER RES, V57, P2388; Galan-Moya EM, 2011, EMBO REP, V12, P470, DOI 10.1038/embor.2011.39; Galanis E, 2009, J CLIN ONCOL, V27, P2052, DOI 10.1200/JCO.2008.19.0694; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gierse JK, 2005, J PHARMACOL EXP THER, V312, P1206, DOI 10.1124/jpet.104.076877; GRANT DS, 1992, J CELL PHYSIOL, V153, P614, DOI 10.1002/jcp.1041530324; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hassan SB, 2001, ANTI-CANCER DRUG, V12, P33, DOI 10.1097/00001813-200101000-00005; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hicks KO, 2001, J PHARMACOL EXP THER, V297, P1088; Hutmacher DW, 2009, J CELL MOL MED, V13, P1417, DOI 10.1111/j.1582-4934.2009.00853.x; Ingthorsson Saevar, 2010, BMC Res Notes, V3, P184, DOI 10.1186/1756-0500-3-184; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Kim C, 2012, LAB CHIP, V12, P4135, DOI 10.1039/c2lc40570a; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Laguinge LM, 2004, CANCER RES, V64, P2643, DOI 10.1158/0008-5472.CAN-03-3663; Lamfers ML, 2004, CURR OPIN MOL THER, V6, P403; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Lee C, 2012, STEM CELLS, V30, P1064, DOI 10.1002/stem.1081; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Milde T, 2011, ACTA NEUROPATHOL, V122, P637, DOI 10.1007/s00401-011-0866-3; Nicholson KM, 1997, EUR J CANCER, V33, P1291, DOI 10.1016/S0959-8049(97)00114-7; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Olin MR, 2011, CANCER RES, V71, P6583, DOI 10.1158/0008-5472.CAN-11-1166; Oshiro S, 2007, ANTICANCER RES, V27, P3757; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Pellegrini M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009064; Perche F, 2012, CANCER BIOL THER, V13, P1205, DOI 10.4161/cbt.21353; Phillips WT, 2012, NEURO-ONCOLOGY, V14, P416, DOI 10.1093/neuonc/nos060; Rahman R, 2010, MOL CANCER THER, V9, P2568, DOI 10.1158/1535-7163.MCT-10-0272; Richon VM, 2002, CLIN CANCER RES, V8, P662; Schnell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030429; Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744; Schwerk C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030069; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Silvestrini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031567; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skardal A, 2010, BIOMATERIALS, V31, P8426, DOI 10.1016/j.biomaterials.2010.07.047; Smith BH, 2011, CANCER RES, V71, P716, DOI 10.1158/0008-5472.CAN-10-2254; Smith SJ, 2012, ACTA NEUROPATHOL, V124, P99, DOI 10.1007/s00401-012-0952-1; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; STEWART DJ, 1984, J NEURO-ONCOL, V2, P29, DOI 10.1007/BF00165155; Suggitt M, 2005, CLIN CANCER RES, V11, P971; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Svensson KJ, 2011, P NATL ACAD SCI USA, V108, P13147, DOI 10.1073/pnas.1104261108; Swinnen LJ, 2008, J NEURO-ONCOL, V86, P353, DOI 10.1007/s11060-007-9483-3; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Venkatesh HS, 2012, NEURO-ONCOLOGY, V14, P315, DOI 10.1093/neuonc/nor209; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Weinstein JN, 2002, CURR OPIN PHARMACOL, V2, P361, DOI 10.1016/S1471-4892(02)00185-6; Wilson M, 2011, MAGN RESON MED, V65, P1, DOI 10.1002/mrm.22579; YUHAS JM, 1977, CANCER RES, V37, P3639	87	33	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52335	10.1371/journal.pone.0052335	http://dx.doi.org/10.1371/journal.pone.0052335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272238	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300080
J	Shukla, M; Minda, R; Singh, H; Tirumani, S; Chary, KVR; Rao, BJ				Shukla, Manish; Minda, Renu; Singh, Himanshu; Tirumani, Srikanth; Chary, Kandala V. R.; Rao, Basuthkar J.			UVI31+Is a DNA Endonuclease That Dynamically Localizes to Chloroplast Pyrenoids in C. reinhardtii	PLOS ONE			English	Article							UV-INDUCIBLE GENE; CHLAMYDOMONAS-REINHARDTII; SCHIZOSACCHAROMYCES-POMBE; ESCHERICHIA-COLI; CELL-DIVISION; GREEN-ALGAE; BOLA; PROTEIN; IDENTIFICATION; EXPRESSION	UVI31+ is an evolutionarily conserved BolA family protein. In this study we examine the presence, localization and possible functions of this protein in the context of a unicellular alga, Chlamydomonas reinhardtii. UVI31+ in C. reinhardtii exhibits DNA endonuclease activity and is induced upon UV stress. Further, UVI31+ that normally localizes to the cell wall and pyrenoid regions gets redistributed into punctate foci within the whole chloroplast, away from the pyrenoid, upon UV stress. The observed induction upon UV-stress as well as the endonuclease activity suggests plausible role of this protein in DNA repair. We have also observed that UV31+ is induced in C. reinhardtii grown in dark conditions, whereby the protein localization is enhanced in the pyrenoid. Biomolecular interaction between the purified pyrenoids and UVI31+ studied by NMR demonstrates the involvement of the disordered loop domain of the protein in its interaction.	[Shukla, Manish; Minda, Renu; Tirumani, Srikanth; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Singh, Himanshu; Chary, Kandala V. R.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR)	Rao, BJ (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	bjrao@tifr.res.in	Singh, Himanshu/M-6619-2019; Minda, Renu/M-5476-2016	Singh, Himanshu/0000-0002-2819-6282; Minda, Renu/0000-0002-2359-9146	Department of Atomic Energy at TIFR; Department of Science and Technology (DST); Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR); Tata Institute of Fundamental Research, Mumbai, India	Department of Atomic Energy at TIFR; Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Tata Institute of Fundamental Research, Mumbai, India	This work was funded by Department of Atomic Energy at TIFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The facilities provided by National Facility for High Field NMR at TIFR supported by Department of Science and Technology (DST), Department of Biotechnology (DBT), Council of Scientific and Industrial Research (CSIR) and Tata Institute of Fundamental Research, Mumbai, India are gratefully acknowledged. We also acknowledge Dr. Ishita Mehta for a critical reading of the manuscript. BJR and KVRC thank DST for their JC Bose Fellowships.	Adnan M, 2010, MOL CELL BIOCHEM, V342, P207, DOI 10.1007/s11010-010-0485-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Silva WLD, 2005, GENET MOL BIOL, V28, P814, DOI 10.1590/S1415-47572005000500025; Freire P, 2009, J MOL BIOL, V385, P1345, DOI 10.1016/j.jmb.2008.12.026; GIBBS SP, 1962, J ULTRA MOL STRUCT R, V7, P247, DOI 10.1016/S0022-5320(62)90021-7; Grafi G, 1995, PLANT MOL BIOL, V29, P703, DOI 10.1007/BF00041161; Harris EH, 2009, CHLAMYDOMONAS LAB; Hsia KC, 2005, CURR OPIN STRUC BIOL, V15, P126, DOI 10.1016/j.sbi.2005.01.015; IMAM SH, 1985, J CELL BIOL, V101, P1599, DOI 10.1083/jcb.101.4.1599; Kasai T, 2004, PROTEIN SCI, V13, P545, DOI 10.1110/ps.03401004; Kim MJ, 2002, MOL CELLS, V14, P425; Kim SH, 1997, ENVIRON MOL MUTAGEN, V30, P72, DOI 10.1002/(SICI)1098-2280(1997)30:1<72::AID-EM10>3.0.CO;2-N; Koch B, 2006, FEMS MICROBIOL LETT, V262, P48, DOI 10.1111/j.1574-6968.2006.00359.x; KUCHITSU K, 1988, PROTOPLASMA, V144, P17, DOI 10.1007/BF01320276; LEE JK, 1994, BIOCHEM BIOPH RES CO, V202, P1113, DOI 10.1006/bbrc.1994.2043; Lin S, 1997, MAR BIOL, V127, P521, DOI 10.1007/s002270050041; Lou YC, 2009, NUCLEIC ACIDS RES, V37, P2381, DOI 10.1093/nar/gkp097; MIYAMURA S, 1991, PROTOPLASMA, V161, P192, DOI 10.1007/BF01322731; Moharikar S, 2006, J PHYCOL, V42, P423, DOI 10.1111/j.1529-8817.2006.00207.x; Moharikar S, 2007, J BIOSCIENCES, V32, P261, DOI 10.1007/s12038-007-0026-z; Nikaido SS, 2000, PHOTOCHEM PHOTOBIOL, V71, P758, DOI 10.1562/0031-8655(2000)071<0758:DACVIS>2.0.CO;2; Rangarajan ES, 2001, FEMS MICROBIOL REV, V25, P583, DOI 10.1111/j.1574-6976.2001.tb00593.x; Rout AK, 2010, BIOMOL NMR ASSIGN, V4, P171, DOI 10.1007/s12104-010-9239-4; SANDERS MA, 1995, METHOD CELL BIOL, V47, P163, DOI 10.1016/S0091-679X(08)60805-5; Santos JM, 1999, MOL MICROBIOL, V32, P789, DOI 10.1046/j.1365-2958.1999.01397.x; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Selenko P, 2007, J STRUCT BIOL, V158, P244, DOI 10.1016/j.jsb.2007.04.001; Uniacke J, 2008, J CELL BIOL, V182, P641, DOI 10.1083/jcb.200805125; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Zhou YB, 2008, MOL CELL BIOCHEM, V317, P61, DOI 10.1007/s11010-008-9809-2	31	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51913	10.1371/journal.pone.0051913	http://dx.doi.org/10.1371/journal.pone.0051913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284814	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900064
J	Kazakoff, SH; Imelfort, M; Edwards, D; Koehorst, J; Biswas, B; Batley, J; Scott, PT; Gresshoff, PM				Kazakoff, Stephen H.; Imelfort, Michael; Edwards, David; Koehorst, Jasper; Biswas, Bandana; Batley, Jacqueline; Scott, Paul T.; Gresshoff, Peter M.			Capturing the Biofuel Wellhead and Powerhouse: The Chloroplast and Mitochondrial Genomes of the Leguminous Feedstock Tree Pongamia pinnata	PLOS ONE			English	Article							PLANT; STABILITY	Pongamia pinnata (syn. Millettia pinnata) is a novel, fast-growing arboreal legume that bears prolific quantities of oil-rich seeds suitable for the production of biodiesel and aviation biofuel. Here, we have used Illumina (R) 'Second Generation DNA Sequencing (2GS)' and a new short-read de novo assembler, SaSSY, to assemble and annotate the Pongamia chloroplast (152,968 bp; cpDNA) and mitochondrial (425,718 bp; mtDNA) genomes. We also show that SaSSY can be used to accurately assemble 2GS data, by re-assembling the Lotus japonicus cpDNA and in the process assemble its mtDNA (380,861 bp). The Pongamia cpDNA contains 77 unique protein-coding genes and is almost 60% gene-dense. It contains a 50 kb inversion common to other legumes, as well as a novel 6.5 kb inversion that is responsible for the non-disruptive, re-orientation of five protein-coding genes. Additionally, two copies of an inverted repeat firmly place the species outside the subclade of the Fabaceae lacking the inverted repeat. The Pongamia and L. japonicus mtDNA contain just 33 and 31 unique protein-coding genes, respectively, and like other angiosperm mtDNA, have expanded intergenic and multiple repeat regions. Through comparative analysis with Vigna radiata we measured the average synonymous and non-synonymous divergence of all three legume mitochondrial (1.59% and 2.40%, respectively) and chloroplast (8.37% and 8.99%, respectively) protein-coding genes. Finally, we explored the relatedness of Pongamia within the Fabaceae and showed the utility of the organellar genome sequences by mapping transcriptomic data to identify up- and down-regulated stress-responsive gene candidates and confirm in silico predicted RNA editing sites. Citation: Kazakoff SH, Imelfort M, Edwards D, Koehorst J, Biswas B, et al. (2012) Capturing the Biofuel Wellhead and Powerhouse: The Chloroplast and Mitochondrial Genomes of the Leguminous Feedstock Tree Pongamia pinnata. PLoS ONE 7(12): e51687. doi:10.1371/journal.pone.0051687	[Kazakoff, Stephen H.; Koehorst, Jasper; Biswas, Bandana; Batley, Jacqueline; Scott, Paul T.; Gresshoff, Peter M.] Univ Queensland, Australian Res Council Ctr Excellence Integrat Le, Brisbane, Qld, Australia; [Imelfort, Michael] Univ Queensland, Adv Water Management Ctr, Brisbane, Qld, Australia; [Edwards, David] Univ Queensland, Australian Ctr Plant Funct Genom, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Gresshoff, PM (corresponding author), Univ Queensland, Australian Res Council Ctr Excellence Integrat Le, Brisbane, Qld, Australia.	p.gresshoff@uq.edu.au	Batley, Jacqueline/A-5723-2008; Edwards, David/H-3710-2015; Koehorst, Jasper Jan/Z-1697-2019	Batley, Jacqueline/0000-0002-5391-5824; Edwards, David/0000-0001-7599-6760; Koehorst, Jasper Jan/0000-0001-8172-8981	BioEnergy Plantation Australia; Australian Research Council Centre of Excellence grant; BES Pty Ltd	BioEnergy Plantation Australia; Australian Research Council Centre of Excellence grant(Australian Research Council); BES Pty Ltd	The authors thank BioEnergy Plantation Australia for research support in Pongamia, BES Pty Ltd. for university liaison. Research was also funded by an Australian Research Council Centre of Excellence grant to PMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This reasearch was funded in part by BioEnergy Plantation Australia and BES Pty Ltd. BioEnergy Plantation Australia is developing critical technology platforms for the genetic, genomic and biotechnology application to the legume tree Pongamia pinnata. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Bally J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025289; Biswas B, 2011, J PLANT PHYSL, DOI [10.1016/j.jclepro.2009.04.004, DOI 10.1016/J.JCLEPRO.2009.04.004]; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Doyle JJ, 1996, MOL PHYLOGENET EVOL, V5, P429, DOI 10.1006/mpev.1996.0038; Du PF, 2008, J THEOR BIOL, V253, P579, DOI 10.1016/j.jtbi.2008.04.006; Du PF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-135; Gottipati R, 2011, J FUEL CHEM TECHNOL, DOI [10.1016/S1872-5813(11)60021-2, DOI 10.1016/S1872-5813(11)60021-2]; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Kato T, 2000, DNA RES, V7, P323, DOI 10.1093/dnares/7.6.323; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murphy HT, 2012, BIOENERG RES, V5, P778, DOI 10.1007/s12155-012-9190-6; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Scott PT, 2008, BIOENERG RES, V1, P2, DOI 10.1007/s12155-008-9003-0; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wojiechowski MF, 2004, AM J BOT, DOI [10.3732/ajb.91.11.1846, DOI 10.3732/AJB.91.11.1846]; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	37	55	57	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51687	10.1371/journal.pone.0051687	http://dx.doi.org/10.1371/journal.pone.0051687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272141	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800065
J	Mahs, A; Ischebeck, T; Heilig, Y; Stenzel, I; Hempel, F; Seiler, S; Heilmann, I				Maehs, Anette; Ischebeck, Till; Heilig, Yvonne; Stenzel, Irene; Hempel, Franziska; Seiler, Stephan; Heilmann, Ingo			The Essential Phosphoinositide Kinase MSS-4 Is Required for Polar Hyphal Morphogenesis, Localizing to Sites of Growth and Cell Fusion in Neurospora crassa	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASES; INOSITOL PHOSPHOLIPID KINASE; POLLEN-TUBE GROWTH; PLASMA-MEMBRANE; DEPENDENT ENDOCYTOSIS; GENOME SEQUENCE; TIP GROWTH; ARABIDOPSIS; PROTEIN; YEAST	Fungal hyphae and plant pollen tubes are among the most highly polarized cells known and pose extraordinary requirements on their cell polarity machinery. Cellular morphogenesis is driven through the phospholipid-dependent organization at the apical plasma membrane. We characterized the contribution of phosphoinositides (PIs) in hyphal growth of the filamentous ascomycete Neurospora crassa. MSS-4 is an essential gene and its deletion resulted in spherically growing cells that ultimately lyse. Two conditional mss-4-mutants exhibited altered hyphal morphology and aberrant branching at restrictive conditions that were complemented by expression of wild type MSS-4. Recombinant MSS-4 was characterized as a phosphatidylinositolmonophosphate-kinase phosphorylating phosphatidylinositol 4-phosphate (PtdIns4P) to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2). PtdIns3P was also used as a substrate. Sequencing of two conditional mss-4 alleles identified a single substitution of a highly conserved Y750 to N. The biochemical characterization of recombinant protein variants revealed Y750 as critical for PI4P 5-kinase activity of MSS-4 and of plant PI4P 5-kinases. The conditional growth defects of mss-4 mutants were caused by severely reduced activity of MSS-4(Y750N), enabling the formation of only trace amounts of PtdIns(4,5)P-2. In N. crassa hyphae, PtdIns(4,5)P-2 localized predominantly in the plasma membrane of hyphae and along septa. Fluorescence-tagged MSS-4 formed a subapical collar at hyphal tips, localized to constricting septa and accumulated at contact points of fusing N. crassa germlings, indicating MSS-4 is responsible for the formation of relevant pools of PtdIns(4,5)P-2 that control polar and directional growth and septation. N. crassa MSS-4 differs from yeast, plant and mammalian PI4P 5-kinases by containing additional protein domains. The N-terminal domain of N. crassa MSS-4 was required for correct membrane association. The data presented for N. crassa MSS-4 and its roles in hyphal growth are discussed with a comparative perspective on PI-control of polar tip growth in different organismic kingdoms.	[Heilig, Yvonne; Seiler, Stephan] Univ Gottingen, Inst Microbiol & Genet, Gottingen, Germany; [Maehs, Anette; Ischebeck, Till; Stenzel, Irene; Hempel, Franziska; Heilmann, Ingo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Gottingen, Germany	University of Gottingen; University of Gottingen	Seiler, S (corresponding author), Univ Freiburg, Inst Biol Mol Plant Physiol 2, Hugstetter Str 55, D-79106 Freiburg, Germany.	stephan.seiler@biologie.uni-freiburg.de; ingo.heilmann@biochemtech.uni-halle.de	Ischebeck, Till/AAM-4327-2020	Ischebeck, Till/0000-0003-0737-3822	German Research Foundation (DFG) through the Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB) [He3424/1, SE1054/3-2, GSC 226/1]; Neurospora program grant [PO1 GM068087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087] Funding Source: NIH RePORTER	German Research Foundation (DFG) through the Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB)(German Research Foundation (DFG)); Neurospora program grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the German Research Foundation (DFG) [Emmy-Noether grant He3424/1 to I.H., grant SE1054/3-2 to S.S. and grant GSC 226/1 through the Gottingen Graduate School for Neurosciences and Molecular Biosciences (GGNB)]. The authors acknowledge the FGSC and the Neurospora program grant PO1 GM068087 for continuous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand A, 2009, CURR OPIN MICROBIOL, V12, P350, DOI 10.1016/j.mib.2009.05.007; Camacho L, 2009, J CELL SCI, V122, P4383, DOI 10.1242/jcs.053488; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; Cho MH, 1995, METHODS CELL BIOL, V49, P543, DOI 10.1016/S0091-679X(08)61479-X; Cole RA, 2006, CURR OPIN PLANT BIOL, V9, P579, DOI 10.1016/j.pbi.2006.09.014; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Dettmann A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002950; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Dowd PE, 2006, PLANT CELL, V18, P1438, DOI 10.1105/tpc.106.041582; Drobak BK, 1999, INT REV CYTOL, V189, P95, DOI 10.1016/S0074-7696(08)61386-8; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Echauri-Espinosa RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038237; Elge S, 2001, PLANT J, V26, P561, DOI 10.1046/j.1365-313x.2001.01051.x; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Fischer U, 2004, CURR OPIN PLANT BIOL, V7, P670, DOI 10.1016/j.pbi.2004.09.007; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Harris SD, 2011, MOL MICROBIOL, V79, P1123, DOI 10.1111/j.1365-2958.2010.07525.x; Heilmann I, 2009, TRENDS PLANT SCI, V14, P171, DOI 10.1016/j.tplants.2008.12.002; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Hur HS, 2006, J MICROBIOL, V44, P523; Ischebeck T, 2011, PLANT J, V65, P453, DOI 10.1111/j.1365-313X.2010.04435.x; Ischebeck T, 2010, MOL PLANT, V3, P870, DOI 10.1093/mp/ssq031; Ischebeck T, 2010, PROTOPLASMA, V240, P13, DOI 10.1007/s00709-009-0093-0; Ischebeck T, 2008, PLANT CELL, V20, P3312, DOI 10.1105/tpc.108.059568; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Konig S, 2008, ANAL BIOCHEM, V378, P197, DOI 10.1016/j.ab.2008.03.052; Kost B, 1999, J CELL BIOL, V145, P317, DOI 10.1083/jcb.145.2.317; Kunz J, 2002, J BIOL CHEM, V277, P5611, DOI 10.1074/jbc.M110775200; Kusano H, 2008, PLANT CELL, V20, P367, DOI 10.1105/tpc.107.056119; Maerz S, 2012, MOL CELL BIOL, V32, P2083, DOI 10.1128/MCB.06263-11; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Markham JE, 2011, PLANT CELL, V23, P2362, DOI 10.1105/tpc.110.080473; Martin SW, 2004, EUKARYOT CELL, V3, P675, DOI 10.1128/EC.3.3.675-684.2004; McCaffrey LM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001370; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Mei Y, 2012, CELL RES, V22, P581, DOI 10.1038/cr.2011.150; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Mueller-Roeber B, 2002, PLANT PHYSIOL, V130, P22, DOI 10.1104/pp.004770; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Orlando K, 2008, J BIOL CHEM, V283, P14205, DOI 10.1074/jbc.M708178200; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Perera IY, 2005, FEBS LETT, V579, P3427, DOI 10.1016/j.febslet.2005.05.018; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Read Nick D., 2012, Fungal Biology Reviews, V26, P1, DOI 10.1016/j.fbr.2012.02.003; Read ND, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P260; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Seiler S, 2006, MOL BIOL CELL, V17, P4080, DOI 10.1091/mbc.E06-01-0072; Seiler S, 2010, MOL MICROBIOL, V78, P1058, DOI 10.1111/j.1365-2958.2010.07392.x; Sousa E, 2008, PLANT CELL, V20, P3050, DOI 10.1105/tpc.108.058826; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; STENZEL I, 2012, FRONT PLANT SCI, V2, pNIL93, DOI DOI 10.3389/fpls.2011.00114; Stenzel I, 2008, PLANT CELL, V20, P124, DOI 10.1105/tpc.107.052852; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Takeshita N, 2012, MOL MICROBIOL, V83, P1136, DOI 10.1111/j.1365-2958.2012.07996.x; Thole JM, 2008, CURR OPIN PLANT BIOL, V11, P620, DOI 10.1016/j.pbi.2008.10.010; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Zhao Y, 2010, PLANT CELL, V22, P4031, DOI 10.1105/tpc.110.076760; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007	71	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51454	10.1371/journal.pone.0051454	http://dx.doi.org/10.1371/journal.pone.0051454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272106	Green Published, gold			2022-12-25	WOS:000312386600026
J	van Helden, MJG; Zaiss, DMW; Sijts, AJAM				van Helden, Mary J. G.; Zaiss, Dietmar M. W.; Sijts, Alice J. A. M.			CCR2 Defines a Distinct Population of NK Cells and Mediates Their Migration during Influenza Virus Infection in Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; BACTERIAL-INFECTION; CHEMOKINE RECEPTORS; BONE-MARROW; IN-VIVO; IMMUNE-RESPONSES; DENDRITIC CELLS; LYMPH-NODES; EXPRESSION; TRAFFICKING	Natural killer (NK) cells are innate lymphocytes that play an important role in control of viral infections. We recently showed that intranasal infection of mice with influenza virus induced the accumulation of NK cells in the airways. NK cells however did not proliferate in the airways or in the draining lymph node, but in the bone marrow mainly. As also monocyte-precursors undergo vigorous proliferation in the bone marrow (BM) during infections and then egress CCR2-dependently, we decided to determine the role of CCR2 in NK cell migration during intranasal influenza virus infection. We show that a unique population of NK cells in the BM expressed CCR2 and that monocyte chemotactic protein-1 (MCP-1), one of the CCR2 ligands, was produced in the airways of influenza virus infected mice. Analysis of BM chimeric mice reconstituted with a mix of wild-type (wt) and CCR2-deficient BM cells showed that upon influenza virus infection, a significantly lower proportion of CCR2-deficient than wt NK cells was recovered from the bronchoalveolar lavage (BAL). Taken together, our data demonstrate that during influenza virus infection a proportion of NK cells migrate in a CCR2-dependent fashion. Citation: van Helden MJG, Zaiss DMW, Sijts AJAM (2012) CCR2 Defines a Distinct Population of NK Cells and Mediates Their Migration during Influenza Virus Infection in Mice. PLoS ONE 7(12): e52027. doi:10.1371/journal.pone.0052027	[van Helden, Mary J. G.; Zaiss, Dietmar M. W.; Sijts, Alice J. A. M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University	Zaiss, DMW (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	d.zaiss@uu.nl; e.j.a.m.sijts@uu.nl		Sijts, Alice/0000-0003-3815-4788; Zaiss, Dietmar M.W./0000-0003-3596-7062	Top Institute Pharma grant [T4-214]; Wellcome Trust grant [WT085733MA]	Top Institute Pharma grant; Wellcome Trust grant(Wellcome Trust)	Top Institute Pharma grant T4-214, URL: http://www.tipharma.com/and Wellcome Trust grant WT085733MA, URL: http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Andrews DM, 2010, IMMUNOL CELL BIOL, V88, P107, DOI 10.1038/icb.2009.94; Babic M, 2010, J EXP MED, V207, P2663, DOI 10.1084/jem.20100921; Bernardini G, 2008, BLOOD, V111, P3626, DOI 10.1182/blood-2007-08-106203; Bernardini G, 2012, IMMUNOL LETT, V145, P39, DOI 10.1016/j.imlet.2012.04.014; Brandstadter JD, 2011, J INNATE IMMUN, V3, P274, DOI 10.1159/000324176; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Hanna J, 2005, BLOOD, V106, P3465, DOI 10.1182/blood-2005-03-0855; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Inngjerdingen M, 2000, J IMMUNOL, V164, P4048, DOI 10.4049/jimmunol.164.8.4048; Inngjerdingen M, 2001, BLOOD, V97, P367, DOI 10.1182/blood.V97.2.367; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Morrison BE, 2003, J CLIN INVEST, V112, P1862, DOI 10.1172/JCI200318125; Polakos NK, 2007, J IMMUNOL, V179, P201, DOI 10.4049/jimmunol.179.1.201; Polentarutti N, 1997, J IMMUNOL, V158, P2689; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Sciume G, 2011, BLOOD, V117, P4467, DOI 10.1182/blood-2010-07-297101; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shi C, 2010, J IMMUNOL, V184, P6266, DOI 10.4049/jimmunol.0904160; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; van Helden MJG, 2012, J IMMUNOL, V189, P2333, DOI 10.4049/jimmunol.1200008; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Walzer T, 2011, TRENDS IMMUNOL, V32, P486, DOI 10.1016/j.it.2011.05.002; Zaiss DMW, 2008, INFECT IMMUN, V76, P1207, DOI 10.1128/IAI.01134-07	40	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52027	10.1371/journal.pone.0052027	http://dx.doi.org/10.1371/journal.pone.0052027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272202	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386600053
J	Benedetti, IM; de Lorenzo, V; Silva-Rocha, R				Maria Benedetti, Ilaria; de Lorenzo, Victor; Silva-Rocha, Rafael			Quantitative, Non-Disruptive Monitoring of Transcription in Single Cells with a Broad-Host Range GFP-luxCDABE Dual Reporter System	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; COPY-NUMBER; ESCHERICHIA-COLI; PROMOTER; VECTORS; PLASMID; CLONING; NOISE; TECHNOLOGIES; NETWORKS	A dual promoter probe system based on a tandem bi-cistronic GFP-luxCDABE reporter cassette is described and implemented. This system is assembled in two synthetic, modular, broad-host range plasmids based on pBBR1 and RK2 origins of replication, allowing its utilization in an extensive number of gram-negative bacteria. We analyze the performance of this dual cassette in two hosts, Escherichia coli and Pseudomonas putida, by examining the induction properties of the lacI(9)-Ptrc expression system in the first host and the Pb promoter of the benzoate degradation pathway in the second host. By quantifying the bioluminescence signal produced through the expression of the lux genes, we explore the dynamic range of induction for the two systems (Ptrc-based and Pb-based) in response to the two inducers. In addition, by quantifying the fluorescence signals produced by GFP expression, we were able to monitor the single-cell expression profile and to explore stochasticity of the same two promoters by flow cytometry. The results provided here demonstrate the power of the dual GFP-luxCDABE cassette as a new, single-step tool to assess promoter properties at both the population and single-cell levels in gram-negative bacteria.	[Maria Benedetti, Ilaria; de Lorenzo, Victor; Silva-Rocha, Rafael] CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Canto Blanco, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	de Lorenzo, V (corresponding author), CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Canto Blanco, Spain.	vdlorenzo@cnb.csic.es	Silva-Rocha, Rafael/H-4929-2012	Silva-Rocha, Rafael/0000-0001-6319-631X; de Lorenzo, Victor/0000-0002-6041-2731	BIO program of the Spanish Ministry of Economy and Competitiveness; FEDER CONSOLIDER-INGENIO program of the Spanish Ministry of Economy and Competitiveness; MICROME Contract of the EU; ST-FLOW Contract of the EU; ERANET-IB Program; Autonomous Community of Madrid (PROMPT); La-Caixa International PhD fellowship; MCINN [BES-2008-009823]	BIO program of the Spanish Ministry of Economy and Competitiveness; FEDER CONSOLIDER-INGENIO program of the Spanish Ministry of Economy and Competitiveness; MICROME Contract of the EU; ST-FLOW Contract of the EU; ERANET-IB Program; Autonomous Community of Madrid (PROMPT); La-Caixa International PhD fellowship(La Caixa Foundation); MCINN(European Commission)	This work was supported by the BIO and FEDER CONSOLIDER-INGENIO programs of the Spanish Ministry of Economy and Competitiveness, the MICROME and ST-FLOW Contracts of the EU, the ERANET-IB Program and funding from the Autonomous Community of Madrid (PROMPT). IB was supported by La-Caixa International PhD fellowship. RS-R was the holder of FPI PhD stipend BES-2008-009823) of the MCINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; ANTOINE R, 1992, MOL MICROBIOL, V6, P1785, DOI 10.1111/j.1365-2958.1992.tb01351.x; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Balleza E, 2009, FEMS MICROBIOL REV, V33, P133, DOI 10.1111/j.1574-6976.2008.00145.x; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Cowles CE, 2000, J BACTERIOL, V182, P6339, DOI 10.1128/JB.182.22.6339-6346.2000; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Keasling JD, 1999, TRENDS BIOTECHNOL, V17, P452, DOI 10.1016/S0167-7799(99)01376-1; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Khlebnikov A, 2002, BIOTECHNOL PROGR, V18, P672, DOI 10.1021/bp010141k; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kinkhabwala A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002030; Lale R, 2011, METHODS MOL BIOL, V765, P327, DOI 10.1007/978-1-61779-197-0_19; Lin B, 2012, CURR OPIN CHEM BIOL, V16, P307, DOI 10.1016/j.cbpa.2012.04.012; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Miller WG, 1997, GENE, V191, P149, DOI 10.1016/S0378-1119(97)00051-6; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; Silva-Rocha R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034675; Silva-Rocha R, 2012, MOL BIOSYST, V8, P1950, DOI 10.1039/c2mb25030f; Silva-Rocha R, 2011, MOL BIOSYST, V7, P2389, DOI 10.1039/c1mb05094j; Silva-Rocha R, 2010, ANNU REV MICROBIOL, V64, P257, DOI 10.1146/annurev.micro.091208.073229; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; THOMAS CM, 1984, EMBO J, V3, P57, DOI 10.1002/j.1460-2075.1984.tb01761.x; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; Unge A, 1999, APPL ENVIRON MICROB, V65, P813; Unge A, 2001, MICROBIAL ECOL, V41, P290; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x	50	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52000	10.1371/journal.pone.0052000	http://dx.doi.org/10.1371/journal.pone.0052000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284849	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500019
J	Ballou, B; Andreko, SK; Osuna-Highley, E; McRaven, M; Catalone, T; Bruchez, MP; Hope, TJ; Labib, ME				Ballou, Byron; Andreko, Susan K.; Osuna-Highley, Elvira; McRaven, Michael; Catalone, Tina; Bruchez, Marcel P.; Hope, Thomas J.; Labib, Mohamed E.			Nanoparticle Transport from Mouse Vagina to Adjacent Lymph Nodes	PLOS ONE			English	Article							BIODEGRADABLE POLYMER NANOPARTICLES; QUANTUM DOTS; HUMAN MUCUS; IN-VITRO; MICROBICIDES; DELIVERY; TRANSMISSION; MICE; INFLAMMATION; IMMUNIZATION	To test the feasibility of localized intravaginal therapy directed to neighboring lymph nodes, the transport of quantum dots across the vaginal wall was investigated. Quantum dots instilled into the mouse vagina were transported across the vaginal mucosa into draining lymph nodes, but not into distant nodes. Most of the particles were transported to the lumbar nodes; far fewer were transported to the inguinal nodes. A low level of transport was evident at 4 hr after intravaginal instillation, and transport peaked at about 36 hr after instillation. Transport was greatly enhanced by prior vaginal instillation of Nonoxynol-9. Hundreds of micrograms of nanoparticles/kg tissue (ppb) were found in the lumbar lymph nodes at 36 hr post-instillation. Our results imply that targeted transport of microbicides or immunogens from the vagina to local lymph organs is feasible. They also offer an in vivo model for assessing the toxicity of compounds intended for intravaginal use.	[Ballou, Byron; Andreko, Susan K.; Osuna-Highley, Elvira; Bruchez, Marcel P.] Carnegie Mellon Univ, MBIC, Pittsburgh, PA 15213 USA; [Osuna-Highley, Elvira] Carnegie Mellon Univ, ICES, Pittsburgh, PA 15213 USA; [McRaven, Michael; Hope, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Catalone, Tina] De Sales Univ, Dept Nat Sci, Ctr Valley, Pittsburgh, PA USA; [Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Labib, Mohamed E.] Adv Biodevices, Princeton, NJ USA	Carnegie Mellon University; Carnegie Mellon University; Northwestern University; Feinberg School of Medicine; Carnegie Mellon University; Carnegie Mellon University	Ballou, B (corresponding author), Carnegie Mellon Univ, MBIC, Pittsburgh, PA 15213 USA.	bbal@andrew.cmu.edu	Bruchez, Marcel P/C-2271-2009	Bruchez, Marcel P/0000-0002-7370-4848	National Institutes of Health [R21 AI82738, R33-AI082738-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI082738, R21AI082738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health awards R21 AI82738 and R33-AI082738-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Ayehunie S, 2011, TOXICOLOGY, V279, P130, DOI 10.1016/j.tox.2010.10.001; Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y; Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j; Bostick Roberd M, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3313; Catalone BJ, 2004, ANTIMICROB AGENTS CH, V48, P1837, DOI 10.1128/AAC.48.5.1837-1847.2004; Chakraborty SK, 2007, NANO LETT, V7, P2618, DOI 10.1021/nl0709930; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Cu Y, 2011, J CONTROL RELEASE, V156, P258, DOI 10.1016/j.jconrel.2011.06.036; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Czerkinsky C, 2012, CURR TOP MICROBIOL, V354, P1, DOI 10.1007/82_2010_112; Czerkinsky C, 2010, MUCOSAL IMMUNOL, V3, P545, DOI 10.1038/mi.2010.55; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Efimova OI, 2009, B EXP BIOL MED+, V147, P3, DOI 10.1007/s10517-009-0463-9; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fogel P, 2009, EVALUATION UNMIXING, P1; Fraillery D, 2009, VACCINE, V27, P2326, DOI 10.1016/j.vaccine.2009.02.029; Genovesio A, 2006, IEEE T IMAGE PROCESS, V15, P1062, DOI 10.1109/TIP.2006.872323; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Ham AS, 2009, PHARM RES-DORDR, V26, P502, DOI 10.1007/s11095-008-9765-2; Hama Y, 2007, J INVEST DERMATOL, V127, P2351, DOI 10.1038/sj.jid.5700892; Hama Y, 2007, BREAST CANCER RES TR, V103, P23, DOI 10.1007/s10549-006-9347-0; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Ibata B, 1997, BIOL REPROD, V56, P537, DOI 10.1095/biolreprod56.2.537; Inoue Y, 2010, J FLUORESC, V20, P599, DOI 10.1007/s10895-009-0593-5; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; King NJC, 1998, J IMMUNOL, V160, P1173; Lagerholm B Christoffer, 2007, Methods Mol Biol, V374, P105; Lagerholm BC, 2004, NANO LETT, V4, P2019, DOI 10.1021/nl049295v; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lindqvist M, 2010, MUCOSAL ADJUVANTS TH; Mallipeddi R, 2010, EXPERT OPIN DRUG DEL, V7, P37, DOI 10.1517/17425240903338055; Milligan GN, 2002, SEX TRANSM DIS, V29, P597, DOI 10.1097/00007435-200210000-00006; Moench TR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-331; PARR MB, 1990, J REPROD IMMUNOL, V17, P101, DOI 10.1016/0165-0378(90)90029-6; Parungo CP, 2007, ANN SURG ONCOL, V14, P286, DOI 10.1245/s10434-006-9044-6; Parungo CP, 2005, CHEST, V127, P1799, DOI 10.1378/chest.127.5.1799; Parungo CP, 2005, J THORAC CARDIOV SUR, V129, P844, DOI 10.1016/j.jtcvs.2004.08.001; Paskaleva BS, 2010, INT GEOSCI REMOTE SE, P2198, DOI 10.1109/IGARSS.2010.5648869; Robe A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-111; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; Sherwood JK, 1996, BIOL REPROD, V54, P264, DOI 10.1095/biolreprod54.1.264; Soltesz EG, 2005, ANN THORAC SURG, V79, P269, DOI 10.1016/j.athoracsur.2004.06.055; Tang BC, 2009, P NATL ACAD SCI USA, V106, P19268, DOI 10.1073/pnas.0905998106; Vargas G, 2009, J INFECT DIS, V199, P1546, DOI 10.1086/598221; Vieira OV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002913; Vinegoni C, 2009, OPT LETT, V34, P319, DOI 10.1364/OL.34.000319; Whaley KJ, 2010, ANTIVIR RES, V88, pS55, DOI 10.1016/j.antiviral.2010.09.006; Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]	54	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51995	10.1371/journal.pone.0051995	http://dx.doi.org/10.1371/journal.pone.0051995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284844	gold, Green Submitted, Green Published			2022-12-25	WOS:000313158800019
J	Oldham, AL; Duncan, KE				Oldham, Athenia L.; Duncan, Kathleen E.			Similar Gene Estimates from Circular and Linear Standards in Quantitative PCR Analyses Using the Prokaryotic 16S rRNA Gene as a Model	PLOS ONE			English	Article							REAL-TIME PCR; MICROBIAL-COMMUNITIES; AMPLIFICATION; SAMPLES; QUANTIFICATION; COPY	Quantitative PCR (qPCR) is one of the most widely used tools for quantifying absolute numbers of microbial gene copies in test samples. A recent publication showed that circular plasmid DNA standards grossly overestimated numbers of a target gene by as much as 8-fold in a eukaryotic system using quantitative PCR (qPCR) analysis. Overestimation of microbial numbers is a serious concern in industrial settings where qPCR estimates form the basis for quality control or mitigation decisions. Unlike eukaryotes, bacteria and archaea most commonly have circular genomes and plasmids and therefore may not be subject to the same levels of overestimation. Therefore, the feasibility of using circular DNA plasmids as standards for 16S rRNA gene estimates was assayed using these two prokaryotic systems, with the practical advantage being rapid standard preparation for ongoing qPCR analyses. Full-length 16S rRNA gene sequences from Thermovirga lienii and Archaeoglobus fulgidus were cloned and used to generate standards for bacterial and archaeal qPCR reactions, respectively. Estimates of 16S rRNA gene copies were made based on circular and linearized DNA conformations using two genomes from each domain: Desulfovibrio vulgaris, Pseudomonas aeruginosa, Archaeoglobus fulgidus, and Methanocaldocococcus jannaschii. The ratio of estimated to predicted 16S rRNA gene copies ranged from 0.5 to 2.2-fold in bacterial systems and 0.5 to 1.0-fold in archaeal systems, demonstrating that circular plasmid standards did not lead to the gross over-estimates previously reported for eukaryotic systems.	[Oldham, Athenia L.; Duncan, Kathleen E.] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Oldham, Athenia L.; Duncan, Kathleen E.] Univ Oklahoma, Inst Energy & Environm, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Duncan, KE (corresponding author), Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.	kathleen.e.duncan-1@ou.edu			Office of Naval Research [N000141010946]	Office of Naval Research(Office of Naval Research)	This study was supported by grant N000141010946 from the Office of Naval Research (www.onr.navy.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2009, FEMS MICROBIOL ECOL, V69, P301, DOI 10.1111/j.1574-6941.2009.00714.x; Duncan KE, 2009, ENVIRON SCI TECHNOL, V43, P7977, DOI 10.1021/es9013932; Filion M, 2012, QUANTITATIVE REAL-TIME PCR IN APPLIED MICROBIOLOGY, P1; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hays F, 2003, METHOD MOL BIOL, P1; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029101; Lloyd KG, 2006, APPL ENVIRON MICROB, V72, P7218, DOI 10.1128/AEM.00886-06; McKew BA, 2010, HDB HYDROCARBON LIPI, P3995, DOI [10.1007/978-3-540-77587-4_311, DOI 10.1007/978-3-540-77587-4_311]; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Smith CJ, 2006, ENVIRON MICROBIOL, V8, P804, DOI 10.1111/j.1462-2920.2005.00963.x; Smits THM, 2004, J MICROBIOL METH, V57, P369, DOI 10.1016/j.mimet.2004.02.003; Stevenson BS, 2011, ENVIRON MICROBIOL, V13, P1078, DOI 10.1111/j.1462-2920.2010.02413.x; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	19	16	16	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51931	10.1371/journal.pone.0051931	http://dx.doi.org/10.1371/journal.pone.0051931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284822	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300062
J	Kaur, S; Prabha, V				Kaur, Siftjit; Prabha, Vijay			Infertility as a Consequence of Spermagglutinating Staphylococcus aureus Colonization in Genital Tract of Female Mice	PLOS ONE			English	Article							MICROBICIDES; CHEMOKINES; INFECTION	Various studies have shown Staphylococcus aureus to be one of the most prevalent organism in male and female genital tract but most practitioners dismiss it as mere contamination which is assumed to be of no significance. However, it is now suggested that the presence of this organism should not be ignored, as incubation of spermatozoa with S. aureus results in reduced sperm motility. Although S. aureus has been reported to cause immobilization of spermatozoa, however, its role in infertility has yet to be elucidated. The present study was designed to establish a spermagglutinating strain of S. aureus isolated from the cervix of a woman with unexplained infertility, in mouse and evaluate its effect on fertility outcome. Female Balb/c mice were inoculated intravaginally with different doses of S. aureus (10(4), 10(6) or 10(8) cfu/20 mu l) for 10 consecutive days. Microbial colonization monitored every 3rd day by vaginal cultures, revealed that strain could efficiently colonize mouse vagina. Mating on day 12, with proven breeder males led to 100% decrease in fertility as compared to control. Even a single dose of 10(6) or 10(8) cfu could lead to vaginal colonization which persisted for 10 days followed by gradual clearing till 21 days, vaginal cultures were negative thereafter. Female mice mated on day 7 (culture positive), were rendered infertile, however, the mice mated on day 22 (culture negative), retained fertility and delivered pups indicating its role in provoking infertility. Further, except infertility, no other clinical manifestation could be seen apparently or histologically. However, when a non-spermagglutinating/immobilizing standard strain of S. aureus MTCC6625 was inoculated intravaginally at 10(8) cfu for 10 days followed by mating on day 12, fertility was observed in all the female mice. This supports the hypothesis that infertility observed in the former groups was as a result of colonization with spermagglutinating strain of S. aureus.	[Kaur, Siftjit; Prabha, Vijay] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University	Prabha, V (corresponding author), Panjab Univ, Dept Microbiol, Chandigarh 160014, India.	satishvijay11@yahoo.com		Prabha, Vijay/0000-0002-7654-2215	University Grants Commission, New Delhi, India	University Grants Commission, New Delhi, India(University Grants Commission, India)	The present work was funded by University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranha CC, 2008, CYTOKINE, V43, P63, DOI 10.1016/j.cyto.2008.04.005; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Cunningham KA, 2008, BIOL REPROD, V79, P180, DOI 10.1095/biolreprod.108.067835; Ekhaise FO, 2008, WORLD J MED SCI, V3, P28; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Gdoura R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-129; Golshani M, 2006, IRAN J PUBLIC HEALTH, V35, P81; Ibadin OK, 2008, MALAYS J MICROBIOL, V4, P65, DOI 10.21161/mjm.12108; Jiang J., 1996, CHIN J ANDROL, V10, P196; Kaur S, 2010, AM J BIOMED SCI, V2, P91; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; Milligan GN, 2002, SEX TRANSM DIS, V29, P597, DOI 10.1097/00007435-200210000-00006; Momoh A, 2012, E3 J MED RES, V1, P17; Momoh A. R. M., 2011, Journal of Microbiology and Biotechnology Research, V1, P66; Moretti E, 2009, J ASSIST REPROD GEN, V26, P47, DOI 10.1007/s10815-008-9283-5; Ohri M, 2005, FERTIL STERIL, V84, P1539, DOI 10.1016/j.fertnstert.2005.05.030; Saavedra M, 1999, INFECT IMMUN, V67, P5820, DOI 10.1128/IAI.67.11.5820-5826.1999; Shalika S, 1996, HUM REPROD, V11, P2789; Villegas J, 2005, APOPTOSIS, V10, P105, DOI 10.1007/s10495-005-6065-8	19	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52325	10.1371/journal.pone.0052325	http://dx.doi.org/10.1371/journal.pone.0052325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272237	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300079
J	Lin, S; Kim, J; Lee, MJ; Roche, L; Yang, NL; Tsao, PS; Rockson, SG				Lin, Shin; Kim, Jeanna; Lee, Mi-Joung; Roche, Leslie; Yang, Nancy L.; Tsao, Philip S.; Rockson, Stanley G.			Prospective Transcriptomic Pathway Analysis of Human Lymphatic Vascular Insufficiency: Identification and Validation of a Circulating Biomarker Panel	PLOS ONE			English	Article							GENE-EXPRESSION; LYMPHEDEMA; LYMPHANGIOGENESIS; PATTERNS; CELL; ATHEROSCLEROSIS; ADIPOGENESIS; REGENERATION; DIAGNOSIS; FIBROSIS	Background: In our previous transcriptional profiling of a murine model, we have identified a remarkably small number of specific pathways with altered expression in lymphedema. In this investigation, we utilized microarray-based transcriptomics of human skin for an unbiased a priori prospective candidate identification, with subsequent validation of these candidates through direct serum assay. The resulting multi-analyte biomarker panel sensitively should sensitively discriminate human lymphedema subjects from normal individuals. Methods and Findings: We enrolled 63 lymphedema subjects and 27 normals in our attempt to discover protein analytes that can distinguish diseased individuals from controls. To minimize technical and biologically irrelevant variation, we first identified potential candidates by performing transcriptional microarray analysis on paired diseased and normal skin specimens sampled from the same individuals. We focused our attention on genes with corresponding protein products that are secreted and took these candidates forward to a protein multiplex assay applied to diseased and normal subjects. We developed a logistic regression-based model on an eventual group of six proteins and validated our system on a separate cohort of study subjects. The area under the receiver operating characteristic curve was calculated to be 0.87 (95% CI : 0.75 to 0.97). Conclusions: We have developed an accurate bioassay utilizing proteins representing four central pathogenetic modalities of the disease: lymphangiogenesis, inflammation, fibrosis, and lipid metabolism, suggesting that these proteins are directly related to the pathogenesis of the tissue pathology in lymphatic vascular insufficiency. Further studies are warranted to determine whether this newly-identified biomarker panel will possess utility as an instrument for in vitro diagnosis of early and latent disease; the ultimate applicability to risk stratification, quantitation of disease burden, and response to therapy can easily be envisioned.	[Lin, Shin; Kim, Jeanna; Lee, Mi-Joung; Roche, Leslie; Yang, Nancy L.; Tsao, Philip S.; Rockson, Stanley G.] Stanford Univ, Stanford Ctr Lymphat & Venous Disorders, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA	Stanford University	Rockson, SG (corresponding author), Stanford Univ, Stanford Ctr Lymphat & Venous Disorders, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA.	rockson@stanford.edu		Lin, Shin/0000-0003-0118-0413; rockson, stanley/0000-0003-1253-474X	NIH [1RC1HL100344-01, 1F32HL110473-01]; University of Sydney; Cancer Institute NSW; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL110473, RC1HL100344] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Sydney(University of Sydney); Cancer Institute NSW; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an NIH grant (1RC1HL100344-01) to S. G. R. S. L. is supported by NIH grant 1F32HL110473-01. M.J.L. was a postdoctoral research fellow funded by the University of Sydney and the Cancer Institute NSW. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, Lymphat Res Biol, V5, P217, DOI 10.1089/lrb.2007.5401; Ardigo D, 2007, PHYSIOL GENOMICS, V31, P402, DOI 10.1152/physiolgenomics.00104.2007; Aschen S, 2012, PLAST RECONSTR SURG, V129, P838, DOI 10.1097/PRS.0b013e3182450b47; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Avraham T, 2009, PLAST RECONSTR SURG, V124, P438, DOI 10.1097/PRS.0b013e3181adcf4b; Boschetti E, 2012, PROTEOM CLIN APPL, V6, P22, DOI 10.1002/prca.201100039; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Cheung L, 2006, BIODRUGS, V20, P363, DOI 10.2165/00063030-200620060-00007; Choi I, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006445; Choi I, 2012, CIRCULATION, V125, P872, DOI 10.1161/CIRCULATIONAHA.111.030296; Cooke JP, 2012, CIRCULATION, V125, P853, DOI 10.1161/CIRCULATIONAHA.111.083477; de Boer T, 2007, GENESPRING GENESPRIN; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Gergich NLS, 2008, CANCER-AM CANCER SOC, V112, P2809, DOI 10.1002/cncr.23494; Herd-Smith A, 2001, CANCER-AM CANCER SOC, V92, P1783, DOI 10.1002/1097-0142(20011001)92:7<1783::AID-CNCR1694>3.0.CO;2-G; Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002; Hwang JH, 2011, BIOMATERIALS, V32, P4415, DOI 10.1016/j.biomaterials.2011.02.051; Jin Da Pan, 2009, Lymphatic Research and Biology, V7, P47, DOI 10.1089/lrb.2009.0002; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Lahteenvuo M, 2011, CIRCULATION, V123, P613, DOI 10.1161/CIRCULATIONAHA.110.965384; Lopez E, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-35; Nakamura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008380; National Heart Lung and Blood Institute, 2007, NIH WORK GROUP M LYM; OLSZEWSKI WL, 1993, TROP MED PARASITOL, V44, P40; Paquet A, 2010, ARRAYWUALITY ASSESSI; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rockson S G, 2008, Lymphat Res Biol, V6, P1, DOI 10.1089/lrb.2008.6101; Rockson SG, 1998, CANCER, V83, P2814; Rockson Stanley G., 2006, Lymphatic Research and Biology, V4, P42, DOI 10.1089/lrb.2006.4.42; Rockson SG, 2010, VASC MED, V15, P223, DOI 10.1177/1358863X10364553; Schneider M, 2006, PLOS MED, V3, P970, DOI 10.1371/journal.pmed.0030264; Shin WS, 2008, ANN NY ACAD SCI, V1131, P50, DOI 10.1196/annals.1413.005; Shin William S, 2003, Lymphat Res Biol, V1, P159, DOI 10.1089/153968503321642642; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sitzia J, 1995, Eur J Cancer Care (Engl), V4, P11; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spin JM, 2004, PHYSIOL GENOMICS, V19, P292, DOI 10.1152/physiolgenomics.00148.2004; Tabibiazar R, 2006, PHYSIOL GENOMICS, V25, P194, DOI 10.1152/physiolgenomics.00240.2005; Tabibiazar R, 2005, PHYSIOL GENOMICS, V22, P213, DOI 10.1152/physiolgenomics.00001.2005; Tabibiazar R, 2005, ARTERIOSCL THROM VAS, V25, P302, DOI 10.1161/01.ATV.0000151372.86863.a5; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Team R. D. C, 2011, R LANG ENV STAT COMP; Ward LC, 2011, LYMPHAT RES BIOL, V9, P43, DOI 10.1089/lrb.2010.0024; Ward LC, 2011, LYMPHAT RES BIOL, V9, P47, DOI 10.1089/lrb.2010.0014; Ward Leigh C., 2006, Lymphatic Research and Biology, V4, P51, DOI 10.1089/lrb.2006.4.51; Yang YH, 2009, MARRAY EXPLORATORY A; Zampell JC, 2012, PLAST RECONSTR SURG, V129, P825, DOI 10.1097/PRS.0b013e3182450b2d; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC392, DOI 10.1152/ajpcell.00306.2011; Zampell JC, 2011, AM J PHYSIOL-CELL PH, V300, pC1107, DOI 10.1152/ajpcell.00378.2010	49	28	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52021	10.1371/journal.pone.0052021	http://dx.doi.org/10.1371/journal.pone.0052021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272198	Green Submitted, gold, Green Published			2022-12-25	WOS:000312483300046
J	Liu, J; Wang, QC; Wang, F; Duan, X; Dai, XX; Wang, T; Liu, HL; Cui, XS; Kim, NH; Sun, SC				Liu, Jun; Wang, Qiao-Chu; Wang, Fei; Duan, Xing; Dai, Xiao-Xin; Wang, Teng; Liu, Hong-Lin; Cui, Xiang-Shun; Kim, Nam-Hyung; Sun, Shao-Chen			Nucleation Promoting Factors Regulate the Expression and Localization of Arp2/3 Complex during Meiosis of Mouse Oocytes	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; BINDING-ACTIVITY; WASP FAMILY; F-ACTIN; WAVE2; JMY; CORTACTIN; N-WASP/WAVE2; ACTIVATION; MEMBRANE	The actin nucleation factor Arp2/3 complex is a main regulator of actin assembly and is involved in multiple processes like cell migration and adhesion, endocytosis, and the establishment of cell polarity in mitosis. Our previous work showed that the Arp2/3 complex was involved in the actin-mediated mammalian oocyte asymmetric division. However, the regulatory mechanisms and signaling pathway of Arp2/3 complex in meiosis is still unclear. In the present work, we identified that the nucleation promoting factors (NPFs) JMY and WAVE2 were necessary for the expression and localization of Arp2/3 complex in mouse oocytes. RNAi of both caused the degradation of actin cap intensity, indicating the roles of NPFs in the formation of actin cap. Moreover, JMY and WAVE2 RNAi decreased the expression of ARP2, a key component of Arp2/3 complex. However, knock down of Arp2/3 complex by Arpc2 and Arpc3 siRNA microinjection did not affect the expression and localization of JMY and WAVE2. Our results indicate that the NPFs, JMY and WAVE2, are upstream regulators of Arp2/3 complex in mammalian oocyte asymmetric division.	[Liu, Jun; Wang, Qiao-Chu; Wang, Fei; Duan, Xing; Dai, Xiao-Xin; Wang, Teng; Liu, Hong-Lin; Sun, Shao-Chen] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Chonju, Chungbuk, South Korea	Nanjing Agricultural University; Chungbuk National University	Sun, SC (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	sunsc@njau.edu.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	Fundamental Research Funds for the Central Universities [KYRC201202]; Nanjing Agricultural University, China [804051]; Biogreen 21 Program, RDA, Republic of Korea [PJ0090802012, PJ009098]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Nanjing Agricultural University, China; Biogreen 21 Program, RDA, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Fundamental Research Funds for the Central Universities (KYRC201202) and a research grant (804051) from Nanjing Agricultural University in 2012, China; and the Biogreen 21 Program (PJ0090802012, PJ009098), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127; Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; Brunet S, 2011, HUM REPROD UPDATE, V17, P68, DOI 10.1093/humupd/dmq044; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carabeo RA, 2007, CELL MICROBIOL, V9, P2278, DOI 10.1111/j.1462-5822.2007.00958.x; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Dahl JP, 2003, J NEUROSCI, V23, P3343; Deng MQ, 2003, DEV BIOL, V257, P166, DOI 10.1016/S0012-1606(03)00045-9; Firat-Karalar EN, 2011, MOL BIOL CELL, V22, P4563, DOI 10.1091/mbc.E11-06-0585; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Kutsuna H, 2004, AM J PHYSIOL-CELL PH, V286, pC55, DOI 10.1152/ajpcell.00131.2003; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Schaerer-Brodbeck C, 2000, MOL BIOL CELL, V11, P1113, DOI 10.1091/mbc.11.4.1113; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Suetsugu S, 2001, J CELL SCI, V114, P4533; Suetsugu S, 2001, BIOCHEM BIOPH RES CO, V282, P739, DOI 10.1006/bbrc.2001.4619; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Sun SC, 2011, CELL CYCLE, V10, P1853, DOI 10.4161/cc.10.11.15796; Sun SC, 2011, MOL HUM REPROD, V17, P296, DOI 10.1093/molehr/gar006; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; VANBLERKOM J, 1986, J EMBRYOL EXP MORPH, V93, P213; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	47	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52277	10.1371/journal.pone.0052277	http://dx.doi.org/10.1371/journal.pone.0052277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272233	Green Submitted, gold, Green Published			2022-12-25	WOS:000312483300075
J	Makarova, O; Contaldo, N; Paltrinieri, S; Kawube, G; Bertaccini, A; Nicolaisen, M				Makarova, Olga; Contaldo, Nicoletta; Paltrinieri, Samanta; Kawube, Geofrey; Bertaccini, Assunta; Nicolaisen, Mogens			DNA Barcoding for Identification of 'Candidatus Phytoplasmas' Using a Fragment of the Elongation Factor Tu Gene	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ASTER YELLOWS; NUCLEOTIDE SUBSTITUTIONS; FINER DIFFERENTIATION; X-DISEASE; SEQUENCE; CLASSIFICATION; STRAINS; DIVERSITY; GRAPEVINE	Background: Phytoplasmas are bacterial phytopathogens responsible for significant losses in agricultural production worldwide. Several molecular markers are available for identification of groups or strains of phytoplasmas. However, they often cannot be used for identification of phytoplasmas from different groups simultaneously or are too long for routine diagnostics. DNA barcoding recently emerged as a convenient tool for species identification. Here, the development of a universal DNA barcode based on the elongation factor Tu (tuf) gene for phytoplasma identification is reported. Methodology/Principal Findings: We designed a new set of primers and amplified a 420-444 bp fragment of tuf from all 91 phytoplasmas strains tested (16S rRNA groups -I through -VII, -IX through -XII, -XV, and -XX). Comparison of NJ trees constructed from the tuf barcode and a 1.2 kbp fragment of the 16S ribosomal gene revealed that the tuf tree is highly congruent with the 16S rRNA tree and had higher inter-and intra-group sequence divergence. Mean K2P inter-/intra-group divergences of the tuf barcode did not overlap and had approximately one order of magnitude difference for most groups, suggesting the presence of a DNA barcoding gap. The use of the tuf barcode allowed separation of main ribosomal groups and most of their subgroups. Phytoplasma tuf barcodes were deposited in the NCBI GenBank and Q-bank databases. Conclusions/Significance: This study demonstrates that DNA barcoding principles can be applied for identification of phytoplasmas. Our findings suggest that the tuf barcode performs as well or better than a 1.2 kbp fragment of the 16S rRNA gene and thus provides an easy procedure for phytoplasma identification. The obtained sequences were used to create a publicly available reference database that can be used by plant health services and researchers for online phytoplasma identification.	[Makarova, Olga; Kawube, Geofrey; Nicolaisen, Mogens] Aarhus Univ, AU Sci & Technol, Dept Agroecol, Slagelse, Denmark; [Contaldo, Nicoletta; Paltrinieri, Samanta; Bertaccini, Assunta] Univ Bologna, DipSA Plant Pathol, Bologna, Italy	Aarhus University; University of Bologna	Makarova, O (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	olga.makarova@fu-berlin.de; mogens.nicolaisen@agrsci.dk	Nicolaisen, Mogens/B-6896-2008; Contaldo, Nicoletta/GRJ-0150-2022	Nicolaisen, Mogens/0000-0002-0407-2488; CONTALDO, NICOLETTA/0000-0003-2398-4850; Makarova, Olga/0000-0003-4767-9711; Bertaccini, Assunta/0000-0002-5650-1512	7th Framework Program project "Development of a new diagnostic tool using DNA barcoding to identify quarantine organisms in support of plant health'' [FP7-KBBE-2008-2B]	7th Framework Program project "Development of a new diagnostic tool using DNA barcoding to identify quarantine organisms in support of plant health''	This project was financially supported by the 7th Framework Program project "Development of a new diagnostic tool using DNA barcoding to identify quarantine organisms in support of plant health'' FP7-KBBE-2008-2B (http://cordis.europa.eu/projects/rcn/91249_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4001, DOI 10.1128/AEM.02323-06; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bertaccini A, 2010, PHYTOPLASMA COLLECTI; Bertaccini A, 2007, FRONT BIOSCI-LANDMRK, V12, P673, DOI 10.2741/2092; Besansky NJ, 2003, TRENDS PARASITOL, V19, P545, DOI 10.1016/j.pt.2003.09.015; Bonants P., 2010, Bulletin OEPP, V40, P30, DOI 10.1111/j.1365-2338.2009.02350.x; Botti S, 2003, J APPL MICROBIOL, V94, P103, DOI 10.1046/j.1365-2672.2003.01809.x; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; DENG SJ, 1991, J MICROBIOL METH, V14, P53, DOI 10.1016/0167-7012(91)90007-D; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; GIBB KS, 1995, PHYTOPATHOLOGY, V85, P169, DOI 10.1094/Phyto-85-169; Gundersen D. E., 1996, Phytopathologia Mediterranea, V35, P144; Gundersen DE, 1996, INT J SYST BACTERIOL, V46, P64, DOI 10.1099/00207713-46-1-64; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hodgetts J, 2008, INT J SYST EVOL MICR, V58, P1826, DOI 10.1099/ijs.0.65668-0; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Khan AJ, 2002, PHYTOPATHOLOGY, V92, P1038, DOI 10.1094/PHYTO.2002.92.10.1038; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kube M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-306; Lee IM, 2010, INT J SYST EVOL MICR, V60, P2887, DOI 10.1099/ijs.0.019695-0; Lee IM, 2006, MOL CELL PROBE, V20, P87, DOI 10.1016/j.mcp.2005.10.001; Lee IM, 1998, INT J SYST BACTERIOL, V48, P1153, DOI 10.1099/00207713-48-4-1153; Liefting LW, 1996, APPL ENVIRON MICROB, V62, P3133, DOI 10.1128/AEM.62.9.3133-3139.1996; Marcone C, 2000, INT J SYST EVOL MICR, V50, P1703, DOI 10.1099/00207713-50-5-1703; Martini M, 2007, INT J SYST EVOL MICR, V57, P2037, DOI 10.1099/ijs.0.65013-0; Martini M, 2002, MOL CELL PROBE, V16, P197, DOI 10.1006/mcpr.2002.0410; Mitrovic J, 2011, B INSECTOL, V64, pS17; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; PRINCE JP, 1993, PHYTOPATHOLOGY, V83, P1130, DOI 10.1094/Phyto-83-1130; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider Bernd, 1995, P369, DOI 10.1016/B978-012583805-4/50040-6; Streten C, 2005, PLANT PATHOL, V54, P8, DOI 10.1111/j.1365-3059.2005.01113.x; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; The International Research Programme for Comparative Mycoplasmology Phytoplasma/Spiroplasma Working Team - Phytoplasma Taxonomy Group, 2004, International Journal of Systematic and Evolutionary Microbiology, V54, P1243, DOI 10.1099/ijs.0.02854-0; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Wei W, 2007, INT J SYST EVOL MICR, V57, P1855, DOI 10.1099/ijs.0.65000-0	43	44	48	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52092	10.1371/journal.pone.0052092	http://dx.doi.org/10.1371/journal.pone.0052092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272216	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300062
J	Song, YN; Geng, JS; Liu, T; Zhong, ZB; Liu, Y; Xia, BS; Ji, HF; Li, XM; Zhang, GQ; Ren, YL; Li, ZG; Pang, D				Song, Yan-Ni; Geng, Jing-Shu; Liu, Tong; Zhong, Zhen-Bin; Liu, Yang; Xia, Bing-Shu; Ji, Hong-Fei; Li, Xiao-Mei; Zhang, Guo-Qiang; Ren, Yan-Lv; Li, Zhi-Gao; Pang, Da			Long CAG Repeat Sequence and Protein Expression of Androgen Receptor Considered as Prognostic Indicators in Male Breast Carcinoma	PLOS ONE			English	Article							CANCER; GENE	Background: The androgen receptor (AR) expression and the CAG repeat length within the AR gene appear to be involved in the carcinogenesis of male breast carcinoma (MBC). Although phenotypic differences have been observed between MBC and normal control group in AR gene, there is lack of correlation analysis between AR expression and CAG repeat length in MBC. The purpose of the study was to investigate the prognostic value of CAG repeat lengths and AR protein expression. Methods: 81 tumor tissues were used for immunostaining for AR expression and CAG repeat length determination and 80 normal controls were analyzed with CAG repeat length in AR gene. The CAG repeat length and AR expression were analyzed in relation to clinicopathological factors and prognostic indicators. Results: AR gene in many MBCs has long CAG repeat sequence compared with that in control group (P = 0.001) and controls are more likely to exhibit short CAG repeat sequence than MBCs. There was statistically significant difference in long CAG repeat sequence between AR status for MBC patients (P = 0.004). The presence of long CAG repeat sequence and AR-positive expression were associated with shorter survival of MBC patients (CAG repeat: P = 0.050 for 5y-OS; P = 0.035 for 5yDFS AR status: P = 0.048 for 5y-OS; P = 0.029 for 5y-DFS, respectively). Conclusion: The CAG repeat length within the AR gene might be one useful molecular biomarker to identify males at increased risk of breast cancer development. The presence of long CAG repeat sequence and AR protein expression were in relation to survival of MBC patients. The CAG repeat length and AR expression were two independent prognostic indicators in MBC patients.	[Song, Yan-Ni; Liu, Tong; Zhong, Zhen-Bin; Liu, Yang; Xia, Bing-Shu; Zhang, Guo-Qiang; Ren, Yan-Lv; Li, Zhi-Gao; Pang, Da] Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China; [Geng, Jing-Shu; Li, Xiao-Mei] Harbin Med Univ, Affiliated Hosp 3, Dept Pathol, Harbin, Peoples R China; [Ji, Hong-Fei; Pang, Da] Heilongjiang Inst Canc Res, Dept Genom, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Li, ZG (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China.	drzhigaoli@126.com; pangdasir@163.com		LIU, TONG/0000-0001-9234-1328; LI, ZHIGAO/0000-0002-4169-143X				Anderson WF, 2010, J CLIN ONCOL, V28, P232, DOI 10.1200/JCO.2009.23.8162; Choong CS, 1996, MOL ENDOCRINOL, V10, P1527, DOI 10.1210/me.10.12.1527; Cox DG, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1602; de Toro MMM, 1998, J STEROID BIOCHEM, V67, P333, DOI 10.1016/S0960-0760(98)00124-1; Ferro P, 2002, MOL CELL ENDOCRINOL, V193, P109, DOI 10.1016/S0303-7207(02)00104-1; Gilbert SF, 2011, BREAST CANCER RES TR, V129, P575, DOI 10.1007/s10549-011-1510-6; Giordano SH, 2002, ANN INTERN MED, V137, P678, DOI 10.7326/0003-4819-137-8-200210150-00013; Kidwai N, 2004, BREAST CANCER RES, V6, pR18, DOI 10.1186/bcr733; LOBACCARO JM, 1993, HUM MOL GENET, V2, P1799, DOI 10.1093/hmg/2.11.1799; MacLean HE, 2004, BREAST CANCER RES TR, V88, P239, DOI 10.1007/s10549-004-0781-6; SOREIDE JA, 1992, EUR J SURG ONCOL, V18, P112; Syrjakoski K, 2003, BREAST CANCER RES TR, V77, P167, DOI 10.1023/A:1021369508561; Wang-Rodriguez J, 2002, MODERN PATHOL, V15, P853, DOI 10.1097/01.MP.0000022251.61944.1D; Young IE, 2000, J MED GENET, V37, P139, DOI 10.1136/jmg.37.2.139	14	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52271	10.1371/journal.pone.0052271	http://dx.doi.org/10.1371/journal.pone.0052271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272232	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800157
J	Xu, XH; Sun, HY; Zhang, YH; Wu, W; Chen, KH; Liu, Y; Deng, CY; Yu, XY; Jin, MW; Li, GR				Xu, Xiao-Hui; Sun, Hai-Ying; Zhang, Yan-Hui; Wu, Wei; Chen, Kui-Hao; Liu, Yi; Deng, Chun-Yu; Yu, Xi-Yong; Jin, Man-Wen; Li, Gui-Rong			Allitridi Inhibits Multiple Cardiac Potassium Channels Expressed in HEK 293 Cells	PLOS ONE			English	Article							GARLIC ALLIUM-SATIVUM; TRANSIENT OUTWARD CURRENT; KV4.3 K+ CHANNEL; J WAVE SYNDROMES; DIALLYL TRISULFIDE; CANCER CELLS; CARDIOPROTECTIVE ACTIONS; CARDIOVASCULAR-DISEASE; ATRIAL-FIBRILLATION; DOWN-REGULATION	Allitridi (diallyl trisulfide) is an active compound (volatile oil) from garlic. The previous studies reported that allitridi had antiarrhythmic effect. The potential ionic mechanisms are, however, not understood. The present study was designed to determine the effects of allitridi on cardiac potassium channels expressed in HEK 293 cells using a whole-cell patch voltage-clamp technique and mutagenesis. It was found that allitridi inhibited hKv4.3 channels (IC50 = 11.4 mu M) by binding to the open channel, shifting availability potential to hyperpolarization, and accelerating closed-state inactivation of the channel. The hKv4.3 mutants T366A, T367A, V392A, and I395A showed a reduced response to allitridi with IC(50)s of 35.5 mu M, 44.7 mu M, 23.7 mu M, and 42.4 mu M. In addition, allitridi decreased hKv1.5, hERG, hKCNQ1/hKCNE1 channels stably expressed in HEK 293 cells with IC(50)s of 40.2 mu M, 19.6 mu M and 17.7 mu M. However, it slightly inhibited hKir2.1 current (100 mu M, inhibited by 9.8% at -120 mV). Our results demonstrate for the first time that allitridi preferably blocks hKv4.3 current by binding to the open channel at T366 and T367 of P-loop helix, and at V392 and I395 of S6 domain. It has a weak inhibition of hKv1.5, hERG, and hKCNQ1/hKCNE1 currents. These effects may account for its anti-arrhythmic effect observed in experimental animal models.	[Xu, Xiao-Hui; Chen, Kui-Hao; Liu, Yi; Jin, Man-Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Peoples R China; [Sun, Hai-Ying; Zhang, Yan-Hui; Wu, Wei; Li, Gui-Rong] Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Deng, Chun-Yu; Yu, Xi-Yong] Guangdong Gen Hosp, Res Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Gui-Rong] Univ Hong Kong, Dept Physiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	Huazhong University of Science & Technology; University of Hong Kong; Guangdong Academy of Medical Sciences & Guangdong General Hospital; University of Hong Kong	Jin, MW (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Peoples R China.	mwjin@mail.tjmu.edu.cn; grli@hkucc.hku.hk	Zhang, Yanhui/L-5680-2017; Li, Gui-Rong/C-4341-2009; , 李贵荣（沧海一粟）/AAZ-4335-2020	Zhang, Yanhui/0000-0002-2179-2065; , 李贵荣（沧海一粟）/0000-0002-9437-2280	Sun Chieh Yeh Heart Foundation of Hong Kong	Sun Chieh Yeh Heart Foundation of Hong Kong	This work was supported in part by a grant from the Sun Chieh Yeh Heart Foundation of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Antony ML, 2011, INDIAN J EXP BIOL, V49, P805; Antzelevitch C, 2012, CIRC J, V76, P1054, DOI 10.1253/circj.CJ-12-0284; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; Bai CX, 2005, CIRCULATION, V112, P1701, DOI 10.1161/CIRCULATIONAHA.104.523217; Calvo-Gomez O, 2004, J CHROMATOGR A, V1036, P91, DOI 10.1016/j.chroma.2004.02.072; [程伟 Cheng Wei], 2002, [中国中医基础医学杂志, Chinese Journal of Basic Medicine in Traditional Chinese Medicine], V8, P35; Decher N, 2006, MOL PHARMACOL, V70, P1204, DOI 10.1124/mol.106.026203; Deng CY, 2011, CLIN EXP PHARMACOL P, V38, P323, DOI 10.1111/j.1440-1681.2011.05511.x; Di Diego JM, 2002, CIRCULATION, V106, P2004, DOI 10.1161/01.CIR.0000032002.22105.7A; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Dong MQ, 2006, J MEMBRANE BIOL, V210, P183, DOI 10.1007/s00232-006-0006-5; Dong MQ, 2010, BBA-BIOMEMBRANES, V1798, P995, DOI 10.1016/j.bbamem.2010.01.010; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Ginter E, 2010, BRATISL MED J, V111, P452; Giudicessi JR, 2012, HUM MUTAT, V33, P989, DOI 10.1002/humu.22058; ISENSEE H, 1993, ARZNEIMITTEL-FORSCH, V43-1, P94; Jeong I, 2011, BRIT J PHARMACOL, V163, P510, DOI 10.1111/j.1476-5381.2011.01210.x; Lan H, 2004, ACTA PHARMACOL SIN, V25, P219; Li GR, 2000, AM J PHYSIOL-HEART C, V279, pH130, DOI 10.1152/ajpheart.2000.279.1.H130; LI GR, 1995, AM J PHYSIOL-HEART C, V269, pH463, DOI 10.1152/ajpheart.1995.269.2.H463; Li GR, 2003, CARDIOVASC RES, V58, P89, DOI 10.1016/S0008-6363(02)00859-3; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Li GR, 2008, CIRCULATION, V117, P2449, DOI 10.1161/CIRCULATIONAHA.108.769554; Li GR, 2010, ADV PHARMACOL, V59, P93, DOI 10.1016/S1054-3589(10)59004-5; LIU DW, 1993, CIRC RES, V72, P671, DOI 10.1161/01.RES.72.3.671; Liu S, 2010, FEMS MICROBIOL LETT, V303, P183, DOI 10.1111/j.1574-6968.2009.01877.x; Lu XN, 2011, APPL ENVIRON MICROB, V77, P5257, DOI 10.1128/AEM.02845-10; MARTIN N, 1994, J ETHNOPHARMACOL, V43, P1, DOI 10.1016/0378-8741(94)90109-0; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Mukherjee S, 2009, J AGR FOOD CHEM, V57, P7137, DOI 10.1021/jf901301w; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; Predmore BL, 2012, AM J PHYSL HEART CIR; RAABGRAHAM KF, 1994, NEUROREPORT, V5, P2501, DOI 10.1097/00001756-199412000-00024; Rahman K, 2006, J NUTR, V136, p736S, DOI 10.1093/jn/136.3.736S; Rahman K, 2001, J NUTR, V131, p977S, DOI 10.1093/jn/131.3.977S; Ried K, 2010, MATURITAS, V67, P144, DOI 10.1016/j.maturitas.2010.06.001; RIETZ B, 1993, MOL CELL BIOCHEM, V119, P143, DOI 10.1007/BF00926865; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Seki T, 2008, ASIA PAC J CLIN NUTR, V17, P249; Sener G, 2007, MOL NUTR FOOD RES, V51, P1345, DOI 10.1002/mnfr.200700078; Shukla Y, 2007, CANCER LETT, V247, P167, DOI 10.1016/j.canlet.2006.05.009; SNYDERS DJ, 1995, CIRC RES, V77, P575, DOI 10.1161/01.RES.77.3.575; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; Sungnoon R, 2008, NUTRITION, V24, P711, DOI 10.1016/j.nut.2008.03.003; Sungnoon R, 2008, INT J CARDIOL, V126, P143, DOI 10.1016/j.ijcard.2007.01.083; Tang Q, 2007, BIOCHEM PHARMACOL, V74, P1596, DOI 10.1016/j.bcp.2007.07.042; Wang HC, 2012, NUTR CANC; Wang YB, 2010, PHYTOMEDICINE, V17, P363, DOI 10.1016/j.phymed.2009.07.019; Wu HJ, 2011, J MOL CELL CARDIOL, V51, P966, DOI 10.1016/j.yjmcc.2011.08.022; Xiao D, 2006, CARCINOGENESIS, V27, P533, DOI 10.1093/carcin/bgi228; Xiao D, 2006, NUTR CANCER, V55, P94, DOI 10.1207/s15327914nc5501_12; Xing Y, 2011, J ETHNOPHARMACOL; Zhang DY, 2008, CELL SIGNAL, V20, P1815, DOI 10.1016/j.cellsig.2008.06.006; Zhang DY, 2009, PFLUG ARCH EUR J PHY, V457, P1275, DOI 10.1007/s00424-008-0608-0; Zhang YH, 2012, CARDIOVASC RES, V93, P424, DOI 10.1093/cvr/cvr347	58	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51550	10.1371/journal.pone.0051550	http://dx.doi.org/10.1371/journal.pone.0051550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272117	Green Published, gold			2022-12-25	WOS:000312386800052
J	Ambrosini, E; Ciavarro, M; Pelle, G; Perrucci, MG; Galati, G; Fattori, P; Galletti, C; Committeri, G				Ambrosini, Ettore; Ciavarro, Marco; Pelle, Gina; Perrucci, Mauro Gianni; Galati, Gaspare; Fattori, Patrizia; Galletti, Claudio; Committeri, Giorgia			Behavioral Investigation on the Frames of Reference Involved in Visuomotor Transformations during Peripheral Arm Reaching	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; SPATIAL REPRESENTATIONS; EFFECTOR INFORMATION; VISUAL SPACE; OPTIC ATAXIA; EYE; HAND; INTEGRATION; TARGETS; ERRORS	Background: Several psychophysical experiments found evidence for the involvement of gaze-centered and/or body-centered coordinates in arm-movement planning and execution. Here we aimed at investigating the frames of reference involved in the visuomotor transformations for reaching towards visual targets in space by taking target eccentricity and performing hand into account. Methodology/Principal Findings: We examined several performance measures while subjects reached, in complete darkness, memorized targets situated at different locations relative to the gaze and/or to the body, thus distinguishing between an eye-centered and a body-centered frame of reference involved in the computation of the movement vector. The errors seem to be mainly affected by the visual hemifield of the target, independently from its location relative to the body, with an overestimation error in the horizontal reaching dimension (retinal exaggeration effect). The use of several target locations within the perifoveal visual field allowed us to reveal a novel finding, that is, a positive linear correlation between horizontal overestimation errors and target retinal eccentricity. In addition, we found an independent influence of the performing hand on the visuomotor transformation process, with each hand misreaching towards the ipsilateral side. Conclusions: While supporting the existence of an internal mechanism of target-effector integration in multiple frames of reference, the present data, especially the linear overshoot at small target eccentricities, clearly indicate the primary role of gaze-centered coding of target location in the visuomotor transformation for reaching.	[Ambrosini, Ettore; Pelle, Gina; Perrucci, Mauro Gianni; Committeri, Giorgia] Univ G dAnnunzio, Dept Neurosci & Imaging, Lab Neuropsychol & Cognit Neurosci, Chieti, Italy; [Ambrosini, Ettore; Ciavarro, Marco; Pelle, Gina; Perrucci, Mauro Gianni; Committeri, Giorgia] Fdn G dAnnunzio, Inst Adv Biomed Technol ITAB, Chieti, Italy; [Ciavarro, Marco; Fattori, Patrizia; Galletti, Claudio] Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy; [Ciavarro, Marco; Fattori, Patrizia; Galletti, Claudio] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Galati, Gaspare] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Galati, Gaspare] Fdn Santa Lucia, Neuropsychol Lab, Rome, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Bologna; University of Bologna; Sapienza University Rome; IRCCS Santa Lucia	Committeri, G (corresponding author), Univ G dAnnunzio, Dept Neurosci & Imaging, Lab Neuropsychol & Cognit Neurosci, Chieti, Italy.	gcommitteri@unich.it	Fattori, Patrizia/Q-8947-2017; Perrucci, Mauro Gianni/J-8446-2016; Galati, Gaspare/F-3277-2011; Committeri, Giorgia/AAC-1035-2022; Ambrosini, Ettore/AAH-5525-2019; Ciavarro, Marco/AAA-7142-2022; Ambrosini, Ettore/K-5882-2016	Fattori, Patrizia/0000-0002-0079-3755; Perrucci, Mauro Gianni/0000-0002-5725-1623; Galati, Gaspare/0000-0002-0640-4247; Ambrosini, Ettore/0000-0002-1439-5491; Ciavarro, Marco/0000-0001-6611-6266; Ambrosini, Ettore/0000-0002-1439-5491; GALLETTI, CLAUDIO/0000-0001-8927-3408	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2006055034_002, 2006055034_001]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) to GC (prot. 2006055034_002) and CG (prot. 2006055034_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATISTA A, 2005, HETEROGENEOUS COORDI; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; Bernier PM, 2010, NEURON, V68, P776, DOI 10.1016/j.neuron.2010.11.002; Beurze SM, 2007, J NEUROPHYSIOL, V97, P188, DOI 10.1152/jn.00456.2006; Beurze SM, 2006, J NEUROPHYSIOL, V96, P352, DOI 10.1152/jn.01362.2005; Blangero A, 2009, NEUROPSYCHOLOGIA, V47, P1500, DOI 10.1016/j.neuropsychologia.2008.11.030; Blohm G, 2007, J VIS, V7, P1; BOCK O, 1986, EXP BRAIN RES, V64, P476, DOI 10.1007/BF00340484; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; Carrozzo M, 1999, EXP BRAIN RES, V129, P201, DOI 10.1007/s002210050890; Chang SWC, 2010, P NATL ACAD SCI USA, V107, P7951, DOI 10.1073/pnas.0913209107; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Crawford J D, 2003, Strabismus, V11, P33, DOI 10.1076/stra.11.1.33.14094; Dijkerman HC, 2006, NEUROPSYCHOLOGIA, V44, P2766, DOI 10.1016/j.neuropsychologia.2005.10.018; ENRIGHT JT, 1995, VISION RES, V35, P1611, DOI 10.1016/0042-6989(94)00260-S; Fiehler K, 2010, EXP BRAIN RES, V203, P485, DOI 10.1007/s00221-010-2251-1; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Galati G, 2011, EUR J NEUROSCI, V34, P1871, DOI 10.1111/j.1460-9568.2011.07885.x; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Harrar V, 2009, EXP BRAIN RES, V198, P403, DOI 10.1007/s00221-009-1884-4; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2002, PROG BRAIN RES, V140, P329; Henriques DYP, 2000, EXP BRAIN RES, V132, P179, DOI 10.1007/s002210000340; Jones SAH, 2010, EXP BRAIN RES, V204, P373, DOI 10.1007/s00221-009-2079-8; Khan AZ, 2007, J VISION, V7, DOI 10.1167/7.5.8; Khan AZ, 2005, CEREB CORTEX, V15, P1547, DOI 10.1093/cercor/bhi033; Khan AZ, 2005, NAT NEUROSCI, V8, P418, DOI 10.1038/nn1425; Marzocchi N, 2008, EUR J NEUROSCI, V27, P775, DOI 10.1111/j.1460-9568.2008.06021.x; McGuire LMM, 2011, J NEUROSCI, V31, P6661, DOI 10.1523/JNEUROSCI.2921-10.2011; McIntyre J, 1998, J NEUROSCI, V18, P8423, DOI 10.1523/JNEUROSCI.18-20-08423.1998; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Medendorp WP, 2002, NEUROREPORT, V13, P633, DOI 10.1097/00001756-200204160-00019; Neely KA, 2008, EXP BRAIN RES, V186, P375, DOI 10.1007/s00221-007-1238-z; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Poljac E, 2005, EXP BRAIN RES, V163, P457, DOI 10.1007/s00221-004-2201-x; Poljac E, 2003, EXP BRAIN RES, V151, P501, DOI 10.1007/s00221-003-1498-1; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Sorrento GU, 2008, J NEUROPHYSIOL, V99, P2968, DOI 10.1152/jn.90225.2008; Vindras P, 1998, J NEUROPHYSIOL, V79, P3290, DOI 10.1152/jn.1998.79.6.3290	49	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51856	10.1371/journal.pone.0051856	http://dx.doi.org/10.1371/journal.pone.0051856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272180	Green Submitted, gold, Green Published			2022-12-25	WOS:000312386600045
J	Camp, E; Dietrich, S; Munsterberg, A				Camp, Esther; Dietrich, Susanne; Muensterberg, Andrea			Fate Mapping Identifies the Origin of SHF/AHF Progenitors in the Chick Primitive Streak	PLOS ONE			English	Article							HEART FIELD; PHARYNGEAL MESODERM; MOVEMENT PATTERNS; EMBRYONIC ORIGINS; OUTFLOW TRACT; MOUSE HEART; CELLS; MUSCLES; TUBE; DIFFERENTIATION	Heart development depends on the spatio-temporally regulated contribution of progenitor cells from the primary, secondary and anterior heart fields. Primary heart field (PHF) cells are first recruited to form a linear heart tube; later, they contribute to the inflow myocardium of the four-chambered heart. Subsequently cells from the secondary (SHF) and anterior heart fields (AHF) are added to the heart tube and contribute to both the inflow and outflow myocardium. In amniotes, progenitors of the linear heart tube have been mapped to the anterior-middle region of the early primitive streak. After ingression, these cells are located within bilateral heart fields in the lateral plate mesoderm. On the other hand SHF/AHF field progenitors are situated anterior to the linear heart tube, however, the origin and location of these progenitors prior to the development of the heart tube remains elusive. Thus, an unresolved question in the process of cardiac development is where SHF/AHF progenitors originate from during gastrulation and whether they come from a region in the primitive streak distinct from that which generates the PHF. To determine the origin and location of SHF/AHF progenitors we used vital dye injection and tissue grafting experiments to map the location and ingression site of outflow myocardium progenitors in early primitive streak stage chicken embryos. Cells giving rise to the AHF ingressed from a rostral region of the primitive streak, termed region 'A'. During development these cells were located in the cranial paraxial mesoderm and in the pharyngeal mesoderm. Furthermore we identified region 'B', located posterior to 'A', which gave rise to progenitors that contributed to the primary heart tube and the outflow tract. Our studies identify two regions in the early primitive streak, one which generates cells of the AHF and a second from which cardiac progenitors of the PHF and SHF emerge. Citation: Camp E, Dietrich S, Munsterberg A (2012) Fate Mapping Identifies the Origin of SHF/AHF Progenitors in the Chick Primitive Streak. PLoS ONE 7(12): e51948. doi:10.1371/journal.pone.0051948	[Camp, Esther; Muensterberg, Andrea] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Dietrich, Susanne] Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England	University of East Anglia; University of Portsmouth	Munsterberg, A (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	a.munsterberg@uea.ac.uk	Munsterberg, Andrea E/E-2205-2011; Dietrich, Susanne/M-6515-2015	Munsterberg, Andrea E/0000-0002-4577-4240; Dietrich, Susanne/0000-0001-8688-8992	British Heart Foundation [PG/08/105/26150]	British Heart Foundation(British Heart Foundation)	EC was funded by a British Heart Foundation project grant (PG/08/105/26150) http://www.bhf.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Issa R, 2004, DEV BIOL, V272, P281, DOI 10.1016/j.ydbio.2004.05.016; Abu-Issa R, 2008, DEV BIOL, V319, P223, DOI 10.1016/j.ydbio.2008.04.014; Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Camp E, 2012, FRONTIERS BIOSCIENCE, V17, P2416; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377; Cui C, 2009, DEV BIOL, V332, P212, DOI 10.1016/j.ydbio.2009.05.570; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; DEHAAN R. L., 1965, ORGANOGENESIS, P377; DELACRUZ MV, 1989, J ANAT, V165, P121; DELACRUZ MV, 1977, J ANAT, V123, P661; GARCIAMARTINEZ V, 1993, DEV BIOL, V159, P706, DOI 10.1006/dbio.1993.1276; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hochgreb T, 2003, DEVELOPMENT, V130, P5363, DOI 10.1242/dev.00750; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Lescroart F, 2010, DEVELOPMENT, V137, P3269, DOI 10.1242/dev.050674; LINASK KK, 1992, DEV BIOL, V151, P213, DOI 10.1016/0012-1606(92)90228-9; LITTLE CD, 1995, EXPERIENTIA, V51, P873, DOI 10.1007/BF01921738; Lopez-Sanchez C, 2005, J MORPHOL, V264, P105, DOI 10.1002/jmor.10323; Lopez-Sanchez C, 2009, INT J DEV BIOL, V53, P1445, DOI 10.1387/ijdb.072417cl; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Nagai H, 2011, GENESIS, V49, P46, DOI 10.1002/dvg.20690; Nathan E, 2008, DEVELOPMENT, V135, P647, DOI 10.1242/dev.007989; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Rawles Mary E., 1943, PHYSIOL ZOOL, V16, P22; Redkar A, 2001, DEVELOPMENT, V128, P2269; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; ROSENQUIST GC, 1970, DEV BIOL, V22, P461, DOI 10.1016/0012-1606(70)90163-6; Scott IC, 2012, CURR TOP DEV BIOL, V100, P1, DOI 10.1016/B978-0-12-387786-4.00001-4; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Tam P.P.L., 1999, HEART DEV, DOI [10.1016/b978-012329860-7/50003-9, DOI 10.1016/B978-012329860-7/50003-9]; Tirosh-Finkel L, 2006, DEVELOPMENT, V133, P1943, DOI 10.1242/dev.02365; Tzahor E, 2003, GENE DEV, V17, P3087, DOI 10.1101/gad.1154103; Tzahor E, 2011, CARDIOVASC RES, V91, P196, DOI 10.1093/cvr/cvr116; Varner VD, 2012, DEVELOPMENT, V139, P1680, DOI 10.1242/dev.073486; Wachtler F, 1986, Bibl Anat, P24; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Xavier-Neto J, 2001, GENESIS, V31, P97, DOI 10.1002/gene.10009; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Yuan SP, 2000, ANAT REC, V260, P204, DOI 10.1002/1097-0185(20001001)260:2<204::AID-AR90>3.0.CO;2-5; Yue Q, 2008, DEVELOPMENT, V135, P1029, DOI 10.1242/dev.015321	46	19	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51948	10.1371/journal.pone.0051948	http://dx.doi.org/10.1371/journal.pone.0051948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272192	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386600051
J	Karkare, S; Chung, TTH; Collin, F; Mitchenall, LA; McKay, AR; Greive, SJ; Meyer, JJM; Lall, N; Maxwell, A				Karkare, Shantanu; Chung, Terence T. H.; Collin, Frederic; Mitchenall, Lesley A.; McKay, Adam R.; Greive, Sandra J.; Meyer, Jacobus J. M.; Lall, Namrita; Maxwell, Anthony			The Naphthoquinone Diospyrin Is an Inhibitor of DNA Gyrase with a Novel Mechanism of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II-ALPHA; N-TERMINAL FRAGMENT; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; NALIDIXIC-ACID; DRUG-RESISTANT; DOMAIN; IV	Tuberculosis and other bacterial diseases represent a significant threat to human health. The DNA topoisomerases are excellent targets for chemotherapy, and DNA gyrase in particular is a well-validated target for antibacterial agents. Naphthoquinones (e.g. diospyrin and 7-methyljuglone) have been shown to have therapeutic potential, particularly against Mycobacterium tuberculosis. We have found that these compounds are inhibitors of the supercoiling reaction catalyzed by M. tuberculosis gyrase and other gyrases. Our evidence strongly suggests that the compounds bind to the N-terminal domain of GyrB, which contains the ATPase active site, but are not competitive inhibitors of the ATPase reaction. We propose that naphthoquinones bind to GyrB at a novel site close to the ATPase site. This novel mode of action could be exploited to develop new antibacterial agents.	[Karkare, Shantanu; Chung, Terence T. H.; Collin, Frederic; Mitchenall, Lesley A.; Greive, Sandra J.; Maxwell, Anthony] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [McKay, Adam R.] UCL, Dept Chem, London WC1H 0AJ, England; [Meyer, Jacobus J. M.; Lall, Namrita] Univ Pretoria, Dept Plant Sci, ZA-0002 Pretoria, South Africa	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of London; University College London; University of Pretoria	Maxwell, A (corresponding author), John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	tony.maxwell@jic.ac.uk	Collin, Frederic/N-5579-2015; Lall, Namrita/S-3690-2019; Lall, Namrita/A-2635-2012	Collin, Frederic/0000-0002-6720-5444; Lall, Namrita/0000-0002-3242-3476; Lall, Namrita/0000-0002-3242-3476; Maxwell, Anthony/0000-0002-5756-6430; Mitchenall, Lesley/0000-0002-0063-1991	Early Stage Research Training Scholarship (EU); Biotechnology and Biological Sciences Research Council (UK) [BB/J004561/1]; John Innes Foundation; National Research Foundation of South Africa; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish	Early Stage Research Training Scholarship (EU); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; National Research Foundation of South Africa(National Research Foundation - South Africa); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an Early Stage Research Training Scholarship (EU, FP7), by Grant BB/J004561/1 from the Biotechnology and Biological Sciences Research Council (UK) and the John Innes Foundation, and by the National Research Foundation of South Africa.	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Alt S, 2011, J ANTIMICROB CHEMOTH, V66, P2061, DOI 10.1093/jac/dkr247; Aubry A, 2006, BIOCHEM BIOPH RES CO, V348, P158, DOI 10.1016/j.bbrc.2006.07.017; Bates A. D., 2005, DNA TOPOLOGY; Bender RP, 2007, BIOCHEMISTRY-US, V46, P2856, DOI 10.1021/bi062017l; Bender RP, 2006, BIOCHEMISTRY-US, V45, P10140, DOI 10.1021/bi0524666; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Edwards MJ, 2011, BIOCHEMISTRY-US, V50, P3432, DOI 10.1021/bi101691k; Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123; Flatman RH, 2005, ANTIMICROB AGENTS CH, V49, P1093, DOI 10.1128/AAC.49.3.1093-1100.2005; Fu GS, 2009, NUCLEIC ACIDS RES, V37, P5908, DOI 10.1093/nar/gkp586; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Gormley NA, 1996, BIOCHEMISTRY-US, V35, P5083, DOI 10.1021/bi952888n; Huang YY, 2006, NUCLEIC ACIDS RES, V34, P5650, DOI 10.1093/nar/gkl695; Jacob DA, 2011, BIOCHEMISTRY-US, V50, P5660, DOI 10.1021/bi200438m; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; Kampranis SC, 1999, BIOCHEMISTRY-US, V38, P1967, DOI 10.1021/bi982320p; Kampranis SC, 1998, J BIOL CHEM, V273, P22606, DOI 10.1074/jbc.273.35.22606; Karkare S, 2012, NUCLEIC ACIDS RES, V40, P9774, DOI 10.1093/nar/gks704; KHODURSKY AB, 1995, P NATL ACAD SCI USA, V92, P11801, DOI 10.1073/pnas.92.25.11801; Lall N, 1999, J ETHNOPHARMACOL, V66, P347, DOI 10.1016/S0378-8741(98)00185-8; Lall N, 2001, J ETHNOPHARMACOL, V78, P213, DOI 10.1016/S0378-8741(01)00356-7; Lall N, 2000, J ETHNOPHARMACOL, V72, P313, DOI 10.1016/S0378-8741(00)00231-2; Lewis K, 2006, NAT BIOTECHNOL, V24, P1504, DOI 10.1038/nbt1206-1504; Lindsey RH, 2004, BIOCHEMISTRY-US, V43, P7563, DOI 10.1021/bi049756r; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; Mahapatra A, 2007, BIOORGAN MED CHEM, V15, P7638, DOI 10.1016/j.bmc.2007.08.064; Manjunatha U. H., 2006, Journal of the Indian Institute of Science, V86, P751; Manjunatha UH, 2005, NUCLEIC ACIDS RES, V33, P3085, DOI 10.1093/nar/gki622; Maxwell A, 1999, METH MOL B, V94, P135; Mdluli Khisimuzi, 2007, Infectious Disorders - Drug Targets, V7, P159; Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012; Pan XS, 1996, ANTIMICROB AGENTS CH, V40, P2321, DOI 10.1128/AAC.40.10.2321; Pinto AV, 2009, MOLECULES, V14, P4570, DOI 10.3390/molecules14114570; Ray S, 1998, MOL PHARMACOL, V54, P994, DOI 10.1124/mol.54.6.994; Sibanda T, 2007, AFR J BIOTECHNOL, V6, P2886; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; Ting CY, 2003, BIOCHEM PHARMACOL, V66, P1981, DOI 10.1016/j.bcp.2003.07.003; Tretter EM, 2012, J BIOL CHEM, V287, P18645, DOI 10.1074/jbc.M112.345736; Tretter EM, 2010, PROTEINS, V78, P492, DOI 10.1002/prot.22600; van der Kooy F, 2006, S AFR J BOT, V72, P349, DOI 10.1016/j.sajb.2005.09.009; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wang HM, 2001, BIOCHEMISTRY-US, V40, P3316, DOI 10.1021/bi002786j; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; WILLMOTT CJR, 1993, ANTIMICROB AGENTS CH, V37, P126, DOI 10.1128/AAC.37.1.126; Wright GD, 2011, CHEM COMMUN, V47, P4055, DOI 10.1039/c0cc05111j; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; ZECHIEDRICH EL, 1995, GENE DEV, V9, P2859, DOI 10.1101/gad.9.22.2859	53	53	57	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5149	5156		10.1074/jbc.M112.419069	http://dx.doi.org/10.1074/jbc.M112.419069			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23275348	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000315340400062
J	Tran, H; Bustos, D; Yeh, R; Rubinfeld, B; Lam, C; Shriver, S; Zilberleyb, I; Lee, MW; Phu, L; Sarkar, AA; Zohn, IE; Wertz, IE; Kirkpatrick, DS; Polakis, P				Hoanh Tran; Bustos, Daisy; Yeh, Ronald; Rubinfeld, Bonnee; Lam, Cynthia; Shriver, Stephanie; Zilberleyb, Inna; Lee, Michelle W.; Phu, Lilian; Sarkar, Anjali A.; Zohn, Irene E.; Wertz, Ingrid E.; Kirkpatrick, Donald S.; Polakis, Paul			HectD1 E3 Ligase Modifies Adenomatous Polyposis Coli (APC) with Polyubiquitin to Promote the APC-Axin Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; BETA-CATENIN; TUMOR-SUPPRESSOR; K11-LINKED POLYUBIQUITINATION; NEGATIVE REGULATOR; UBIQUITIN LIGASE; COMPLEX; BINDING; PATHWAY; UBIQUITYLATION	The adenomatous polyposis coli (APC) protein functions as a negative regulator of the Wnt signaling pathway. In this capacity, APC forms a "destruction complex" with Axin, CK1 alpha, and GSK3 beta to foster phosphorylation of the Wnt effector beta-catenin earmarking it for Lys-48-linked polyubiquitylation and proteasomal degradation. APC is conjugated with Lys-63-linked ubiquitin chains when it is bound to Axin, but it is unclear whether this modification promotes the APC-Axin interaction or confers upon APC an alternative function in the destruction complex. Here we identify HectD1 as a candidate E3 ubiquitin ligase that modifies APC with Lys-63 polyubiquitin. Knockdown of HectD1 diminished APC ubiquitylation, disrupted the APC-Axin interaction, and augmented Wnt3a-induced beta-catenin stabilization and signaling. These results indicate that HectD1 promotes the APC-Axin interaction to negatively regulate Wnt signaling.	[Hoanh Tran; Rubinfeld, Bonnee; Polakis, Paul] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA; [Bustos, Daisy; Yeh, Ronald; Lee, Michelle W.; Phu, Lilian; Kirkpatrick, Donald S.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Lam, Cynthia; Wertz, Ingrid E.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Shriver, Stephanie; Zilberleyb, Inna] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Sarkar, Anjali A.; Zohn, Irene E.] Childrens Natl Med Ctr, Ctr Res Neurosci, Washington, DC 20010 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Children's National Health System	Tran, H (corresponding author), Genentech Inc, Dept Canc Targets, 1 DNA Way, San Francisco, CA 94080 USA.	tran.hoanh@gene.com; polakis.paul@gene.com		Rubinfeld, Bonnee/0000-0001-9861-6775; Zohn, Irene/0000-0001-7688-682X; Kirkpatrick, Donald/0000-0003-3091-2804	NICHD NIH HHS [R01 HD058629] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058629] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bai SW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-54; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Borgal L, 2012, J BIOL CHEM, V287, P25370, DOI 10.1074/jbc.M112.385658; Breitman M, 2008, BBA-MOL CELL RES, V1783, P1792, DOI 10.1016/j.bbamcr.2008.04.017; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Castets F, 2000, J BIOL CHEM, V275, P19970, DOI 10.1074/jbc.M909782199; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Emmerich CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002187; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guzzo RM, 2004, J CELL SCI, V117, P2271, DOI 10.1242/jcs.01079; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Tran H, 2012, J BIOL CHEM, V287, P28552, DOI 10.1074/jbc.M112.387878; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sarkar AA, 2012, J CELL BIOL, V196, P789, DOI 10.1083/jcb.201105101; Shi Tong, 2012, BMC Chemical Biology, V12, P4, DOI 10.1186/1472-6769-12-4; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Tauriello DVF, 2010, CELL CYCLE, V9, P3700, DOI 10.4161/cc.9.18.13204; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; Wigley WC, 1999, J CELL BIOL, V145, P481; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zohn IE, 2007, DEV BIOL, V306, P208, DOI 10.1016/j.ydbio.2007.03.018	55	48	48	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3753	3767		10.1074/jbc.M112.415240	http://dx.doi.org/10.1074/jbc.M112.415240			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23277359	hybrid, Green Published			2022-12-25	WOS:000314845000007
J	Liu, X; Sun, XX; Wu, YC; Xie, C; Zhang, WR; Wang, D; Chen, XY; Qu, D; Gan, JH; Chen, H; Jiang, HL; Lan, LF; Yang, CG				Liu, Xing; Sun, Xiaoxu; Wu, Youcong; Xie, Cen; Zhang, Wenru; Wang, Dan; Chen, Xiaoyan; Qu, Di; Gan, Jianhua; Chen, Hao; Jiang, Hualiang; Lan, Lefu; Yang, Cai-Guang			Oxidation-sensing Regulator AbfR Regulates Oxidative Stress Responses, Bacterial Aggregation, and Biofilm Formation in Staphylococcus epidermidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALL TEICHOIC-ACIDS; GLOBAL REGULATOR; REDOX-SWITCH; TRANSCRIPTIONAL REGULATORS; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURES; SULFENIC ACID; DNA-BINDING; MARR FAMILY; MECHANISM	Staphylococcus epidermidis is a notorious human pathogen that is the major cause of infections related to implanted medical devices. Although redox regulation involving reactive oxygen species is now recognized as a critical component of bacterial signaling and regulation, the mechanism by which S. epidermidis senses and responds to oxidative stress remains largely unknown. Here, we report a new oxidation-sensing regulator, AbfR (aggregation and biofilm formation regulator) in S. epidermidis. An environment of oxidative stress mediated by H2O2 or cumene hydroperoxide markedly up-regulates the expression of abfR gene. Similar to Pseudomonas aeruginosa OspR, AbfR is negatively autoregulated and dissociates from promoter DNA in the presence of oxidants. In vivo and in vitro analyses indicate that Cys-13 and Cys-116 are the key functional residues to form an intersubunit disulfide bond upon oxidation in AbfR. We further show that deletion of abfR leads to a significant induction in H2O2 or cumene hydroperoxide resistance, enhanced bacterial aggregation, and reduced biofilm formation. These effects are mediated by derepression of SERP2195 and gpxA-2 that lie immediately downstream of the abfR gene in the same operon. Thus, oxidative stress likely acts as a signal to modulate S. epidermidis key virulence properties through AbfR.	[Liu, Xing; Sun, Xiaoxu; Xie, Cen; Zhang, Wenru; Chen, Xiaoyan; Jiang, Hualiang; Lan, Lefu; Yang, Cai-Guang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Wu, Youcong; Qu, Di] Fudan Univ, Minist Educ, Key Lab Med Mol Virol, Shanghai 200032, Peoples R China; [Wu, Youcong; Qu, Di] Fudan Univ, Minist Hlth, Inst Med Microbiol, Shanghai 200032, Peoples R China; [Wu, Youcong; Qu, Di] Fudan Univ, Inst Biomed Sci, Shanghai Med Sch, Shanghai 200032, Peoples R China; [Wang, Dan; Chen, Hao] Nanjing Univ, Inst Coordinat Chem, Sch Chem & Chem Engn, Nanjing 210093, Jiangsu, Peoples R China; [Wang, Dan; Chen, Hao] Nanjing Univ, State Key Lab Coordinat Chem, Sch Chem & Chem Engn, Nanjing 210093, Jiangsu, Peoples R China; [Gan, Jianhua] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Fudan University; Fudan University; Fudan University; Nanjing University; Nanjing University; Fudan University	Lan, LF (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China.	llan@mail.shcnc.ac.cn; yangcg@mail.shcnc.ac.cn	Qu, Di/AAO-4590-2020; Liu, Xing/AAE-9485-2020	Liu, Xing/0000-0002-3467-7103	National Natural Science Foundation of China [90913010, 21172234, 20972173, 81271791]; Hundred Talent Program of the Chinese Academy of Sciences; National Science and Technology Key New Drug Creation and Manufacturing Program Major Project [2013ZX09507-004]; Natural Science Foundation of Jiangsu Province [BK2010358]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talent Program of the Chinese Academy of Sciences; National Science and Technology Key New Drug Creation and Manufacturing Program Major Project; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China Grants 90913010, 21172234, 20972173, and 81271791; the Hundred Talent Program of the Chinese Academy of Sciences; National Science and Technology Key New Drug Creation and Manufacturing Program Major Project Grant 2013ZX09507-004; and Natural Science Foundation of Jiangsu Province Grant BK2010358.	Aiassa V, 2012, REV ARGENT MICROBIOL, V44, P16, DOI 10.1590/S0325-75412012000100004; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Aoki R, 2012, J BIOL CHEM, V287, P13500, DOI 10.1074/jbc.M112.346205; Atichartpongkul S, 2010, J BACTERIOL, V192, P2093, DOI 10.1128/JB.01510-09; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballal A, 2010, J BACTERIOL, V192, P336, DOI 10.1128/JB.01202-09; Brugarolas P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388611; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Chen H, 2010, EMBO REP, V11, P685, DOI 10.1038/embor.2010.96; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CHRISTENSEN GD, 1990, J INFECT DIS, V161, P1153, DOI 10.1093/infdis/161.6.1153; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Duarte V, 2010, MOL BIOSYST, V6, P316, DOI 10.1039/b915042k; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Glynn AA, 2009, J ORTHOP RES, V27, P627, DOI 10.1002/jor.20758; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Holland LM, 2011, MICROBIOL-SGM, V157, P408, DOI 10.1099/mic.0.042234-0; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Huang RZ, 2012, ACTA PHARMACOL SIN, V33, P418, DOI 10.1038/aps.2011.166; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Ingavale S, 2005, INFECT IMMUN, V73, P1423, DOI 10.1128/IAI.73.3.1423-1431.2005; Ji QJ, 2012, J BIOL CHEM, V287, P21102, DOI 10.1074/jbc.M112.359737; Ji YD, 1999, J BACTERIOL, V181, P6585, DOI 10.1128/JB.181.21.6585-6590.1999; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lan LF, 2010, MOL MICROBIOL, V75, P76, DOI 10.1111/j.1365-2958.2009.06955.x; Lebreton F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002834; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lou Q, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-146; Luong TT, 2003, J BACTERIOL, V185, P3703, DOI 10.1128/JB.185.13.3703-3710.2003; Moore TDE, 1996, J BACTERIOL, V178, P4301, DOI 10.1128/jb.178.14.4301-4305.1996; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palm GJ, 2012, NUCLEIC ACIDS RES, V40, P4178, DOI 10.1093/nar/gkr1316; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0; Schlag S, 2007, J BACTERIOL, V189, P7911, DOI 10.1128/JB.00598-07; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sukchawalit R, 2001, J BACTERIOL, V183, P4405, DOI 10.1128/JB.183.15.4405-4412.2001; Sun F, 2012, P NATL ACAD SCI USA, V109, P15461, DOI 10.1073/pnas.1205952109; Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Uckay I, 2009, ANN MED, V41, P109, DOI 10.1080/07853890802337045; Vazquez-Torres A, 2012, ANTIOXID REDOX SIGN, V17, P1201, DOI 10.1089/ars.2012.4522; Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wu RY, 2003, J BIOL CHEM, V278, P20240, DOI 10.1074/jbc.M300292200; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zianni Michael, 2006, J Biomol Tech, V17, P103; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	67	20	23	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3739	3752		10.1074/jbc.M112.426205	http://dx.doi.org/10.1074/jbc.M112.426205			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23271738	Green Published, hybrid			2022-12-25	WOS:000314845000006
J	Perveen, S; Patel, H; Arif, A; Younis, S; Codipilly, CN; Ahmed, M				Perveen, Shahana; Patel, Hardik; Arif, Arslan; Younis, Sharif; Codipilly, Champa N.; Ahmed, Mohamed			Role of EC-SOD Overexpression in Preserving Pulmonary Angiogenesis Inhibited by Oxidative Stress	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE-DISMUTASE; HUMAN-ENDOTHELIAL-CELLS; INDUCED LUNG INJURY; NITRIC-OXIDE; BRONCHOPULMONARY DYSPLASIA; IMPAIRS ALVEOLARIZATION; DEFICIENT MICE; FREE-RADICALS; NEWBORN MICE; RAT LUNG	Angiogenesis is one of the most important processes for normal lung development. Oxidative stress can impair the pulmonary angiogenesis, leading to chronic lung disease or Bronchopulmonary dysplasia (BPD). Objective: To investigate the protective effects of EC-SOD overexpression on pulmonary angiogenesis on neonates following exposure to acute hyperoxia. Design/Methods: Transgenic (TG) and wild-type (WT) neonatal mice (10 mice per group) were exposed either to air (control group) or 95% O-2 for 7 days starting at birth. After exposure, all animals were sacrificed. ROS concentration was measured in lung homogenates using OxiSelect ROS assay kit. Mean vascular density (MVD) was measured using anti CD34 staining. RNA was extracted and the angiogenesis markers, VEGF, VEGFR1 and VEGFR2 and PECAM-1 were analyzed by RT-q PCR. VGEF protein was measured using Western blots. Endothelial progenitor cells (EPCs) was assayed by flow cytometer. Results: There was a significant reduction of ROS in TG hyperoxic neonate group (156 +/- 14.2) compared to WT hyperoxic animals (255 +/- 35.1). Evaluation of MVD, using anti-CD34, showed marked significant increase of MVD in the TG group following hyperoxic exposure (85 +/- 12) in comparison to the WT hyperoxic group (62 +/- 8.4), (P < 0.05). Among the hyperoxic groups, both RNA and protein of VEGF expression were significantly reduced in the WT animals compared to the TG group (P < 0.05). The same trend was found in VEGFR 1 and 2 which were significantly reduced in WT group compared to the TG group (P < 0.05). There was no significant difference between hyperoxia TG and control group (P > 0.05). PECAM expression was significantly reduced in both hyperoxic compared to normoxic groups (P < 0.05). EPC's showed significant reduction in WT hyperoxic group compared to others (P > 0.05). Conclusions: EC-SOD plays a key role in preserving angiogenesis by scavenging free radicals which has an inhibitory effect on angiogenesis process in neonatal mice lung following exposure to hyperoxia.	[Ahmed, Mohamed] Cohen Childrens Med Ctr New York, Div Neonatal Perinatal Med, Manhasset, NY 11030 USA; N Shore Long Isl Jewish Hlth Syst, Lilling Family Res Lab, Feinstein Inst Med Res, Manhasset, NY USA	Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Northwell Health	Ahmed, M (corresponding author), Cohen Childrens Med Ctr New York, Div Neonatal Perinatal Med, Manhasset, NY 11030 USA.	mahmed2@nshs.edu	Patel, Hardik/L-9000-2013; Perveen, Shahana/Q-2935-2019	Patel, Hardik/0000-0003-3819-4691; PERVEEN, SHAHANA/0000-0001-5750-1787	Department of Pediatrics at Cohen Children's Medical Center NY	Department of Pediatrics at Cohen Children's Medical Center NY	Department of Pediatrics at Cohen Children's Medical Center NY have supported the research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MN, 2003, AM J RESP CRIT CARE, V167, P400, DOI 10.1164/rccm.200202-108OC; Ahmed MN, 2011, EXP LUNG RES, V37, P10, DOI 10.3109/01902148.2010.497893; Balasubramaniam V, 2003, AM J PHYSIOL-LUNG C, V284, pL964, DOI 10.1152/ajplung.00421.2002; Balasubramaniam V, 2007, AM J PHYSIOL-LUNG C, V292, pL1073, DOI 10.1152/ajplung.00347.2006; Balasubramaniam V, 2006, AM J PHYSIOL-LUNG C, V291, pL119, DOI 10.1152/ajplung.00395.2005; Brown KA, 2006, AM J PHYSIOL-HEART C, V290, pH2600, DOI 10.1152/ajpheart.00676.2005; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chakrabarti S, 2010, VASC PHARMACOL, V53, P130, DOI 10.1016/j.vph.2010.05.003; Chen EP, 1996, CIRCULATION, V94, P412; COALSON JJ, 2000, LUNG BIOL HEALTH DIS, V137, P85; CONNOR HD, 1992, TRANSPLANTATION, V54, P199, DOI 10.1097/00007890-199208000-00002; D'Angio CT, 2002, FRONT BIOSCI-LANDMRK, V7, pD1609, DOI 10.2741/angio; DeLisser HM, 2006, J BIOL CHEM, V281, P8724, DOI 10.1074/jbc.M511798200; Ellis LM, 1996, EUR J CANCER, V32A, P2451, DOI 10.1016/S0959-8049(96)00389-9; Fattman CL, 2006, FREE RADICAL BIO MED, V40, P601, DOI 10.1016/j.freeradbiomed.2005.09.030; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Fidler IJ, 1998, CANCER J SCI AM, V4, pS58; FOLZ RJ, 1994, GENOMICS, V22, P162, DOI 10.1006/geno.1994.1357; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Ghio AJ, 2002, AM J PHYSIOL-LUNG C, V283, pL211, DOI 10.1152/ajplung.00409.2001; Heistad DD, 2006, ARTERIOSCL THROM VAS, V26, P689, DOI 10.1161/01.ATV.0000203525.62147.28; Hosford GE, 2003, AM J PHYSIOL-LUNG C, V285, pL161, DOI 10.1152/ajplung.00285.2002; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Jun S, 2010, FREE RADICAL BIO MED, V48, P590, DOI 10.1016/j.freeradbiomed.2009.12.003; Jung O, 2003, CIRC RES, V93, P622, DOI 10.1161/01.RES.0000092140.81594.A8; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; Kliment CR, 2008, ANTIOXID REDOX SIGN, V10, P261, DOI 10.1089/ars.2007.1906; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Levin Edward D., 2005, Current Alzheimer Research, V2, P191; MALMSTROM BG, 1982, ANNU REV BIOCHEM, V51, P21, DOI 10.1146/annurev.bi.51.070182.000321; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MATSUBARA T, 1986, J IMMUNOL, V137, P3295; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; McGrath-Morrow SA, 2005, AM J RESP CELL MOL, V32, P420, DOI 10.1165/rcmb.2004-0287OC; Mokres LM, 2010, AM J PHYSIOL-LUNG C, V298, pL23, DOI 10.1152/ajplung.00251.2009; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; OURY TD, 1992, P NATL ACAD SCI USA, V89, P9715, DOI 10.1073/pnas.89.20.9715; Rabinovitch M, 2002, NAT MED, V8, P664, DOI 10.1038/nm0702-664; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sheng H, 2000, EXP NEUROL, V163, P392, DOI 10.1006/exnr.2000.7363; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; TERADA LS, 1991, J CELL PHYSIOL, V148, P191, DOI 10.1002/jcp.1041480202; Terada LS, 1996, AM J PHYSIOL-HEART C, V270, pH945, DOI 10.1152/ajpheart.1996.270.3.H945; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; ZWEIER JL, 1994, AM J PHYSIOL, V266, pC700, DOI 10.1152/ajpcell.1994.266.3.C700	51	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51945	10.1371/journal.pone.0051945	http://dx.doi.org/10.1371/journal.pone.0051945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284826	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500068
J	Takamura, H; Koyama, Y; Matsuzaki, S; Yamada, K; Hattori, T; Miyata, S; Takemoto, K; Tohyama, M; Katayama, T				Takamura, Hironori; Koyama, Yoshihisa; Matsuzaki, Shinsuke; Yamada, Kohei; Hattori, Tsuyoshi; Miyata, Shingo; Takemoto, Kana; Tohyama, Masaya; Katayama, Taiichi			TRAP1 Controls Mitochondrial Fusion/Fission Balance through Drp1 and Mff Expression	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; OXIDATIVE STRESS; MAMMALIAN-CELLS; PEROXISOMAL FISSION; PARKINSONS-DISEASE; PROTEIN-1 TRAP-1; PROTECTS CELLS; APOPTOSIS; DYNAMICS; FUSION	Mitochondria are dynamic organelles that change in response to extracellular stimuli. These changes are essential for normal mitochondrial/cellular function and are controlled by a tight balance between two antagonistic pathways that promote fusion and fission. Although some molecules have been identified to mediate the mitochondrial fusion and fission process, the underlying mechanisms remain unclear. Tumor necrosis factor receptor-associated protein 1 (TRAP1) is a mitochondrial molecule that regulates a variety of mitochondrial functions. Here, we examined the role of TRAP1 in the regulation of morphology. Stable TRAP1 knockdown cells showed abnormal mitochondrial morphology, and we observed significant decreases in dynamin-related protein 1 (Drp1) and mitochondrial fission factor (Mff), mitochondrial fission proteins. Similar results were obtained by transient knockdown of TRAP1 in two different cell lines, SH-SY5Y neuroblastoma cells and KNS-42 glioma cells. However, TRAP1 knockdown did not affect expression levels of fusion proteins. The reduction in Drp1 and Mff protein levels was rescued following treatment with the proteasome inhibitor MG132. These results suggest that TRAP1 regulates the expression of fission proteins and controls mitochondrial fusion/fission, which affects mitochondrial/cellular function.	[Takamura, Hironori; Matsuzaki, Shinsuke; Yamada, Kohei; Miyata, Shingo; Tohyama, Masaya] Osaka Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Suita, Osaka, Japan; [Takamura, Hironori; Matsuzaki, Shinsuke; Yamada, Kohei; Tohyama, Masaya; Katayama, Taiichi] Osaka Univ, Dept Child Dev & Mol Brain Sci, United Grad Sch Child Dev, Suita, Osaka, Japan; [Koyama, Yoshihisa; Matsuzaki, Shinsuke; Miyata, Shingo; Takemoto, Kana; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka, Japan; [Hattori, Tsuyoshi] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Suita, Osaka, Japan; [Miyata, Shingo; Tohyama, Masaya] Kinki Univ, Div Mol Brain Sci, Res Inst Tradit Oriental Med, Sayama, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Kindai University (Kinki University)	Takamura, H (corresponding author), Osaka Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Suita, Osaka, Japan.	takamura@ugscd.osaka-u.ac.jp			Sakamoto Research Institute of Psychopathology; Japan Society for the Promotion of Science [23791332, 23790224]	Sakamoto Research Institute of Psychopathology; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by the Sakamoto Research Institute of Psychopathology to HT, and by the Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science to HT (No.23791332) and to SM. (No.23790224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amoroso MR, 2012, CELL DEATH DIFFER, V19, P592, DOI 10.1038/cdd.2011.128; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Carette J, 2002, INT J RADIAT BIOL, V78, P183, DOI 10.1080/09553000110097208; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cechetto JD, 2000, EXP CELL RES, V260, P30, DOI 10.1006/excr.2000.4983; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chien WL, 2011, J NEUROCHEM, V117, P643, DOI 10.1111/j.1471-4159.2011.07229.x; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Filosto M, 2011, J NEUROL, V258, P1763, DOI 10.1007/s00415-011-6104-z; Finkel T, 2009, P NATL ACAD SCI USA, V106, P11825, DOI 10.1073/pnas.0906430106; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gesualdi NM, 2007, STRESS, V10, P342, DOI 10.1080/10253890701314863; Hadari YR, 1997, J BIOL CHEM, V272, P657; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Im CN, 2007, J CELL BIOCHEM, V100, P474, DOI 10.1002/jcb.21064; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Kubota K, 2009, J NEUROCHEM, V110, P496, DOI 10.1111/j.1471-4159.2009.06099.x; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200; Mitsumoto A, 2002, FREE RADICAL BIO MED, V32, P22, DOI 10.1016/S0891-5849(01)00755-9; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481; Parone PA, 2006, BBA-MOL CELL RES, V1763, P522, DOI 10.1016/j.bbamcr.2006.04.005; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; SONG HY, 1995, J BIOL CHEM, V270, P3574, DOI 10.1074/jbc.270.8.3574; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Takemoto K, 2011, NEUROCHEM INT, V58, P880, DOI 10.1016/j.neuint.2011.02.015; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Voloboueva LA, 2008, J CEREBR BLOOD F MET, V28, P1009, DOI 10.1038/sj.jcbfm.9600600; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Williamson CL, 2008, AM J PHYSIOL-HEART C, V294, pH249, DOI 10.1152/ajpheart.00775.2007; Xu LJ, 2009, J CEREBR BLOOD F MET, V29, P365, DOI 10.1038/jcbfm.2008.125; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu WD, 2011, HUM MOL GENET, V20, P3227, DOI 10.1093/hmg/ddr235; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418; Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200	70	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51912	10.1371/journal.pone.0051912	http://dx.doi.org/10.1371/journal.pone.0051912			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284813	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500065
J	Yu, LP; Qian, WW; Yin, GY; Ren, YX; Hu, ZY				Yu, Li-Peng; Qian, Wen-Wu; Yin, Guo-Yong; Ren, Yong-Xin; Hu, Zhi-Yi			MRI Assessment of Lumbar Intervertebral Disc Degeneration with Lumbar Degenerative Disease Using the Pfirrmann Grading Systems	PLOS ONE			English	Article							LOW-BACK-PAIN; SIGNAL MODIC CHANGES; MARROW CHANGES; TYPE-2 CHANGES; END-PLATES	Background: To evaluate by MRI intervertebral disc degeneration in patients with lumbar degenerative disease using the Pfirrmann grading system and to determine whether Modic changes correlated with the Pfirrmann grades and modified Pfirrmann grades of disc degeneration. Methods: The clinical data of 108 surgical patients with lumbar degenerative disease were reviewed and their preoperative MR images were analyzed. Disc degeneration was evaluated using the Pfirrmann grading system. Patients were followed up and low back pain was evaluated using the visual analog scale (VAS) and the effect of back pain on the daily quality of life was assessed using Oswestry disability index (ODI). Results: Forty-four cases had normal anatomical appearance (Modic type 0) and their Pfirrmann grades were 3.77 +/- 0.480 and their modified Pfirrmann grades were of 5.81 +/- 1.006. Twenty-seven cases had Modic type I changes and their Pfirrmann grades were 4.79 +/- 0.557 and their modified Pfirrmann grades were 7.00 +/- 0.832. Thirty-six cases exhibited Modic type II changes and their Pfirrmann grades and modified Pfirrmann grades were 4.11 +/- 0.398 and 6.64 +/- 0.867, respectively. One case had Modic type III changes. Kruskal-Wallis test revealed significant difference in modified Pfirrmann grade among Modic type 0, I and II changes (P<0.01) but no significant difference between Modic type I and II changes (P>0.05). Binary regression analysis showed that Modic changes correlated most strongly with disc degeneration. Follow up studies indicated that the VAS and ODI scores were markedly improved postoperatively. However, no difference was noted in VAS and ODI scores among patients with different Modic types. Conclusion: Modic changes correlate with the Pfirrmann and modified Pfirrmann grades of disc degeneration in lumbar degenerative disease. There is no significant correlation between Modic types and surgical outcomes. Citation: Yu L-P, Qian W-W, Yin G-Y, Ren Y-X, Hu Z-Y (2012) MRI Assessment of Lumbar Intervertebral Disc Degeneration with Lumbar Degenerative Disease Using the Pfirrmann Grading Systems. PLoS ONE 7(12): e48074. doi:10.1371/journal.pone.0048074	[Yu, Li-Peng; Yin, Guo-Yong; Ren, Yong-Xin; Hu, Zhi-Yi] Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing, Jiangsu, Peoples R China; [Qian, Wen-Wu] Peoples Hosp, Dept Orthoped Surg, Gaochun, Jiangsu, Peoples R China	Nanjing Medical University	Yin, GY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing, Jiangsu, Peoples R China.	guoyong_submit@sina.com			National Natural and Science Foundation [81071481]	National Natural and Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural and Science Foundation (81071481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert HB, 2008, MED HYPOTHESES, V70, P361, DOI 10.1016/j.mehy.2007.05.014; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511; CROCK HV, 1986, SPINE, V11, P650, DOI 10.1097/00007632-198607000-00028; DEROOS A, 1987, AM J ROENTGENOL, V149, P531, DOI 10.2214/ajr.149.3.531; Djurasovic M, 2012, EUR SPINE J, V21, P1616, DOI 10.1007/s00586-012-2244-9; Emch TM, 2011, SKELETAL RADIOL, V40, P1175, DOI 10.1007/s00256-011-1163-x; Esposito P, 2006, NEUROCHIRURGIE, V52, P315, DOI 10.1016/S0028-3770(06)71225-5; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Jensen RK, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-183; Jensen TS, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-81; Jensen TS, 2010, EUR SPINE J, V19, P129, DOI 10.1007/s00586-009-1184-5; Karchevsky M, 2005, SKELETAL RADIOL, V34, P125, DOI 10.1007/s00256-004-0886-3; Kjaer P, 2005, SPINE, V30, P1173, DOI 10.1097/01.brs.0000162396.97739.76; Kokkonen SM, 2002, SPINE, V27, P2274, DOI 10.1097/00007632-200210150-00017; Marshman LAG, 2007, J NEUROSURG-SPINE, V6, P152, DOI 10.3171/spi.2007.6.2.152; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Ohtori S, 2006, SPINE, V31, P1026, DOI 10.1097/01.brs.0000215027.87102.7c; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; THOMPSON JP, 1990, SPINE, V15, P411, DOI 10.1097/00007632-199005000-00012; TOYONE T, 1994, J BONE JOINT SURG BR, V76B, P757, DOI 10.1302/0301-620X.76B5.8083266; Vital JM, 2003, SPINE, V28, P715; Weishaupt D, 2001, RADIOLOGY, V218, P420, DOI 10.1148/radiology.218.2.r01fe15420	23	49	56	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e48074	10.1371/journal.pone.0048074	http://dx.doi.org/10.1371/journal.pone.0048074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284612	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500003
J	Chiu, YT; Liu, J; Tang, KD; Wong, YC; Khanna, KK; Ling, MT				Chiu, Yung-Tuen; Liu, Ji; Tang, Kaidun; Wong, Yong-Chuan; Khanna, Kum Kum; Ling, Ming-Tat			Inactivation of ATM/ATR DNA Damage Checkpoint Promotes Androgen Induced Chromosomal Instability in Prostate Epithelial Cells	PLOS ONE			English	Article							DEPENDENT DEGRADATION; ATM; ACTIVATION; SENESCENCE; FUSION; KINASE; P53; PHOSPHORYLATION; BARRIER; REPAIR	The ATM/ATR DNA damage checkpoint functions in the maintenance of genetic stability and some missense variants of the ATM gene have been shown to confer a moderate increased risk of prostate cancer. However, whether inactivation of this checkpoint contributes directly to prostate specific cancer predisposition is still unknown. Here, we show that exposure of non-malignant prostate epithelial cells (HPr-1AR) to androgen led to activation of the ATM/ATR DNA damage response and induction of cellular senescence. Notably, knockdown of the ATM gene expression in HPr-1AR cells can promote androgen-induced TMPRSS2: ERG rearrangement, a prostate-specific chromosome translocation frequently found in prostate cancer cells. Intriguingly, unlike the non-malignant prostate epithelial cells, the ATM/ATR DNA damage checkpoint appears to be defective in prostate cancer cells, since androgen treatment only induced a partial activation of the DNA damage response. This mechanism appears to preserve androgen induced autophosphorylation of ATM and phosphorylation of H2AX, lesion processing and repair pathway yet restrain ATM/CHK1/CHK2 and p53 signaling pathway. Our findings demonstrate that ATM/ATR inactivation is a crucial step in promoting androgen-induced genomic instability and prostate carcinogenesis.	[Liu, Ji; Tang, Kaidun; Ling, Ming-Tat] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Chiu, Yung-Tuen] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wong, Yong-Chuan] Univ Hong Kong, Dept Pathol, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Khanna, Kum Kum] Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4006, Australia	Queensland University of Technology (QUT); University of Hong Kong; University of Hong Kong; QIMR Berghofer Medical Research Institute	Ling, MT (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	mingtat.ling@qut.edu.au	Khanna, Kum Kum/I-1747-2013	Khanna, Kum Kum/0000-0001-8650-5381	National Health and Medical Research Council [APP1031221, APP1031228]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council grants (APP1031221 and APP1031228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele S, 2004, BRIT J CANCER, V91, P783, DOI 10.1038/sj.bjc.6602007; Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bastus NC, CANC RES, V70, P9544; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chiu YT, 2009, J MOL BIOL, V385, P446, DOI 10.1016/j.jmb.2008.10.070; Choo CK, 1999, PROSTATE, V40, P150, DOI 10.1002/(SICI)1097-0045(19990801)40:3<150::AID-PROS2>3.0.CO;2-7; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Fan C, 2006, BBA-MOL CELL RES, V1763, P1090, DOI 10.1016/j.bbamcr.2006.08.026; Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Isoda M, 2009, MOL BIOL CELL, V20, P2186, DOI 10.1091/mbc.E09-01-0008; Khanna KK, 2004, J MAMMARY GLAND BIOL, V9, P247, DOI 10.1023/B:JOMG.0000048772.92326.a1; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Ling MT, 2008, J MOL BIOL, V382, P34, DOI 10.1016/j.jmb.2007.06.020; Luk SU, INT J CANC; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Meyer A, 2007, RADIOTHER ONCOL, V83, P283, DOI 10.1016/j.radonc.2007.04.029; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Rickman DS, 2009, CANCER RES, V69, P2734, DOI 10.1158/0008-5472.CAN-08-4926; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; te Poele RH, 2002, CANCER RES, V62, P1876; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tsihlias J, 2000, ONCOGENE, V19, P670, DOI 10.1038/sj.onc.1203369; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	39	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51108	10.1371/journal.pone.0051108	http://dx.doi.org/10.1371/journal.pone.0051108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272087	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300016
J	Tassin, A; Leroy, B; Laoudj-Chenivesse, D; Wauters, A; Vanderplanck, C; Le Bihan, MC; Coppee, F; Wattiez, R; Belayew, A				Tassin, Alexandra; Leroy, Baptiste; Laoudj-Chenivesse, Dalila; Wauters, Armelle; Vanderplanck, Celine; Le Bihan, Marie-Catherine; Coppee, Frederique; Wattiez, Ruddy; Belayew, Alexandra			FSHD Myotubes with Different Phenotypes Exhibit Distinct Proteomes	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; COILED-COIL PROTEIN; NONMUSCLE MYOSIN-II; MYOBLAST FUSION; SKELETAL-MUSCLE; CANDIDATE GENE; NUCLEAR ACTIN; EXPRESSION; D4Z4; LOCUS	Facioscapulohumeral muscular dystrophy (FSHD) is a progressive muscle disorder linked to a contraction of the D4Z4 repeat array in the 4q35 subtelomeric region. This deletion induces epigenetic modifications that affect the expression of several genes located in the vicinity. In each D4Z4 element, we identified the double homeobox 4 (DUX4) gene. DUX4 expresses a transcription factor that plays a major role in the development of FSHD through the initiation of a large gene dysregulation cascade that causes myogenic differentiation defects, atrophy and reduced response to oxidative stress. Because miRNAs variably affect mRNA expression, proteomic approaches are required to define the dysregulated pathways in FSHD. In this study, we optimized a differential isotope protein labeling (ICPL) method combined with shotgun proteomic analysis using a gel-free system (2DLC-MS/MS) to study FSHD myotubes. Primary CD56(+) FSHD myoblasts were found to fuse into myotubes presenting various proportions of an atrophic or a disorganized phenotype. To better understand the FSHD myogenic defect, our improved proteomic procedure was used to compare predominantly atrophic or disorganized myotubes to the same matching healthy control. FSHD atrophic myotubes presented decreased structural and contractile muscle components. This phenotype suggests the occurrence of atrophy-associated proteolysis that likely results from the DUX4-mediated gene dysregulation cascade. The skeletal muscle myosin isoforms were decreased while non-muscle myosin complexes were more abundant. In FSHD disorganized myotubes, myosin isoforms were not reduced, and increased proteins were mostly involved in microtubule network organization and myofibrillar remodeling. A common feature of both FSHD myotube phenotypes was the disturbance of several caveolar proteins, such as PTRF and MURC. Taken together, our data suggest changes in trafficking and in the membrane microdomains of FSHD myotubes. Finally, the adjustment of a nuclear fractionation compatible with mass spectrometry allowed us to highlight alterations of proteins involved in mRNA processing and stability.	[Tassin, Alexandra; Wauters, Armelle; Vanderplanck, Celine; Coppee, Frederique; Belayew, Alexandra] Univ Mons, Mol Biol Lab, Res Inst Hlth Sci & Technol, B-7000 Mons, Belgium; [Leroy, Baptiste; Wattiez, Ruddy] Univ Mons, Dept Prote & Microbiol, Res Inst Hlth Sci & Technol, B-7000 Mons, Belgium; [Laoudj-Chenivesse, Dalila] CHU A Villeneuve, INSERM Physiol & Med Expt Coeur & Muscle U1046, Montpellier, France; [Le Bihan, Marie-Catherine] Univ Paris 06, UM 76, INSERM U974, Inst Myol,CNRS UMR 7215, Paris, France	University of Mons; University of Mons; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Belayew, A (corresponding author), Univ Mons, Mol Biol Lab, Res Inst Hlth Sci & Technol, B-7000 Mons, Belgium.	alexandra.belayew@umons.ac.be	BELAYEW, Alexandra/D-5205-2013	BELAYEW, Alexandra/0000-0001-5115-2424; Leroy, Baptiste/0000-0001-7166-4478; wattiez, ruddy/0000-0003-2071-4310	AFM: Association Francaise contre les Myopathies [13120, 13294]; ABMM : Association Belge contre les Maladies neuro-Musculaires; FNRS (National Fund for Scientific Research, Belgium); FRIA (Fund for Research in Industry and Agriculture) [2007/V 3/5/180-F/3/5/5-IB/CAV-8864]; FSHD Global Research Foundation, Australia	AFM: Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); ABMM : Association Belge contre les Maladies neuro-Musculaires; FNRS (National Fund for Scientific Research, Belgium)(Fonds de la Recherche Scientifique - FNRS); FRIA (Fund for Research in Industry and Agriculture)(Fonds de la Recherche Scientifique - FNRS); FSHD Global Research Foundation, Australia	This study was funded by the AFM: Association Francaise contre les Myopathies (http://www.afm-telethon.fr), grant A.B.#13120, pre-doctoral fellowship A.T.#13294; the ABMM : Association Belge contre les Maladies neuro-Musculaires (http://www.abmm.be), A. T. pre-doctoral fellowship; the FNRS (National Fund for Scientific Research, Belgium) and the FRIA (Fund for Research in Industry and Agriculture) (http://www1.frs-fnrs.be), A. T. post-doctoral fellowship #2007/V 3/5/180-F/3/5/5-IB/CAV-8864, C. V. pre-doctoral fellowships; the FSHD Global Research Foundation, Australia (http://www.fshdglobal.org/), C. V. pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Arashiro P, 2009, P NATL ACAD SCI USA, V106, P6220, DOI 10.1073/pnas.0901573106; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Briand N, 2011, BIOCHIMIE, V93, P71, DOI 10.1016/j.biochi.2010.03.022; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Cheli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020966; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev PV, 2011, BIOPOLYMERS CELL; Dzijak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030529; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Feasson L, 2002, J PHYSIOL-LONDON, V543, P297, DOI 10.1113/jphysiol.2002.018689; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Goudenege S, 2007, PROTEOMICS, V7, P3289, DOI 10.1002/pmic.200700124; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Leroy B, 2010, PROTEOMICS, V10, P2281, DOI 10.1002/pmic.200900286; Mastroleo F, 2009, ISME J, V3, P1402, DOI 10.1038/ismej.2009.74; Mermelstein CS, 2005, CELL TISSUE RES, V319, P289, DOI 10.1007/s00441-004-1004-5; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Oldfors A, 2007, NEUROMUSCULAR DISORD, V17, P355, DOI 10.1016/j.nmd.2007.02.008; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Park I, 2011, BIOCHEM J, V434, P171, DOI 10.1042/BJ20101473; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; Richards M, 2011, HUM GENET, DOI 10.1007/s00439-011-1100-z; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Sakurai T, 2005, FASEB J, V19, P1199, DOI 10.1096/fj.04-3060fje; Shi Y, 2007, PROTEOMICS, V7, P4589, DOI 10.1002/pmic.200700425; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Swailes NT, 2006, J CELL SCI, V119, P3561, DOI 10.1242/jcs.03096; Tagawa M, 2008, AM J PHYSIOL-CELL PH, V295, pC490, DOI 10.1152/ajpcell.00188.2008; Tassin A, 2012, J CELL MOL IN PRESS; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Tupler R, 1999, P NATL ACAD SCI USA, V96, P12650, DOI 10.1073/pnas.96.22.12650; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	57	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51865	10.1371/journal.pone.0051865	http://dx.doi.org/10.1371/journal.pone.0051865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272181	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300036
J	Verrel, J; Lovden, M; Lindenberger, U				Verrel, Julius; Lovden, Martin; Lindenberger, Ulman			Older Adults Show Preserved Equilibrium but Impaired Step Length Control in Motor-Equivalent Stabilization of Gait	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; KINEMATIC VARIABILITY; FOOT PLACEMENT; HUMAN WALKING; COORDINATION; AGE; COVARIATION; PERFORMANCE; TREADMILL; TASKS	Stable walking depends on the coordination of multiple biomechanical degrees of freedom to ensure the dynamic maintenance of whole-body equilibrium as well as continuous forward progression. We investigated adult age-related differences in whole-body coordination underlying stabilization of center of mass (CoM) position and step pattern during locomotion. Sixteen younger (20-30 years) and 16 healthy older men (65-80 years) walked on a motorized treadmill at 80%, 100% and 120% of their self-selected preferred speed. Preferred speeds did not differ between the age groups. Motor-equivalent stabilization of step parameters (step length and width) and CoM position relative to the support (back and front foot) was examined using a generalized covariation analysis. Across age groups, covariation indices were highest for CoM position relative to the front foot, the measure most directly related to body equilibrium. Compared to younger adults, older adults showed lower covariation indices with respect to step length, extending previous findings of age-related differences in motor-equivalent coordination. In contrast, no reliable age differences were found regarding stabilization of step width or any of the CoM parameters. The observed pattern of results may reflect robust prioritization of balance over step pattern regularity, which may be adaptive in the face of age-associated sensorimotor losses and decline of coordinative capacities.	[Verrel, Julius; Lovden, Martin; Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Lovden, Martin] Lund Univ, Dept Psychol, Lund, Sweden; [Lovden, Martin] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Lovden, Martin] Lund Univ, Dept Psychol, Lund, Sweden; [Lovden, Martin] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden	Max Planck Society; Lund University; Karolinska Institutet; Lund University; Karolinska Institutet	Verrel, J (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany.	verrel@mpib-berlin.mpg.de	Lindenberger, Ulman/A-5846-2013	Lindenberger, Ulman/0000-0001-8428-6453; Verrel, Julius/0000-0001-5850-5202	International Max Planck Research School LIFE (The Life Course: Evolutionary and Ontogenetic Dynamics)	International Max Planck Research School LIFE (The Life Course: Evolutionary and Ontogenetic Dynamics)	During this research, JV was supported by a scholarship from the International Max Planck Research School LIFE (The Life Course: Evolutionary and Ontogenetic Dynamics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Bernstein N.A., 1967, COORDINATION REGULAT; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Cusumano JP, 2008, EVIDENCE GOAL EQUIVA; Decker LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041306; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; HOLM S, 1979, SCAND J STAT, V6, P65; Kang HG, 2008, J BIOMECH, V41, P2899, DOI 10.1016/j.jbiomech.2008.08.002; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Lawrence M. A., 2011, EZ EASY ANAL VISUALI; Muller H, 2003, BIOL CYBERN, V89, P22, DOI 10.1007/s00422-003-0399-5; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; R Core Team, 2022, R LANG ENV STAT COMP; REDFERN MS, 1994, J BIOMECH, V27, P1339, DOI 10.1016/0021-9290(94)90043-4; Schellenbach M, 2010, GAIT POSTURE, V31, P295, DOI 10.1016/j.gaitpost.2009.11.008; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schoner G, 1995, ECOL PSYCHOL, V7, P291, DOI 10.1207/s15326969eco0704_5; Seidler RD, 2002, MOTOR CONTROL, V6, P19, DOI 10.1123/mcj.6.1.19; Shim JK, 2004, J APPL PHYSIOL, V97, P213, DOI 10.1152/japplphysiol.00045.2004; Shinohara M, 2004, EXP BRAIN RES, V156, P282, DOI 10.1007/s00221-003-1786-9; Sternad D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000751; Tang PF, 1998, J GERONTOL A-BIOL, V53, pM471, DOI 10.1093/gerona/53A.6.M471; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TOWNSEND MA, 1985, J BIOMECH, V18, P21, DOI 10.1016/0021-9290(85)90042-9; Tseng YW, 2002, MOTOR CONTROL, V6, P183, DOI 10.1123/mcj.6.2.183; Verrel J, 2010, NEUROSCIENCE METHODS, V191, P166; Verrel J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.006; Verrel J, 2011, J NEUROSCI METH, V200, P199, DOI 10.1016/j.jneumeth.2011.04.006; Verrel J, 2010, EXP BRAIN RES, V207, P13, DOI 10.1007/s00221-010-2424-y; Yen JT, 2010, J R SOC INTERFACE, V7, P801, DOI 10.1098/rsif.2009.0296	37	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52024	10.1371/journal.pone.0052024	http://dx.doi.org/10.1371/journal.pone.0052024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272200	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300048
J	Abbasi, A; Bakker, SJL; Corpeleijn, E; van der A, DL; Gansevoort, RT; Gans, ROB; Peelen, LM; van der Schouw, YT; Stolk, RP; Navis, G; Spijkerman, AMW; Beulens, JWJ				Abbasi, Ali; Bakker, Stephan J. L.; Corpeleijn, Eva; van der A, Daphne L.; Gansevoort, Ron T.; Gans, Rijk O. B.; Peelen, Linda M.; van der Schouw, Yvonne T.; Stolk, Ronald P.; Navis, Gerjan; Spijkerman, Annemieke M. W.; Beulens, Joline W. J.			Liver Function Tests and Risk Prediction of Incident Type 2 Diabetes: Evaluation in Two Independent Cohorts	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; CARDIOVASCULAR RISK; METABOLIC SYNDROME; MODELS; BIOMARKERS; VALIDATION; ENZYMES; MARKERS; MEN	Background: Liver function tests might predict the risk of type 2 diabetes. An independent study evaluating utility of these markers compared with an existing prediction model is yet lacking. Methods and Findings: We performed a case-cohort study, including random subcohort (6.5%) from 38,379 participants with 924 incident diabetes cases (the Dutch contribution to the European Prospective Investigation Into Cancer and Nutrition, EPIC-NL, the Netherlands), and another population-based cohort study including 7,952 participants with 503 incident cases (the Prevention of Renal and Vascular End-stage Disease, PREVEND, Groningen, the Netherlands). We examined predictive value of combination of the Liver function tests (gamma-glutamyltransferase, alanine aminotransferase, aspartate aminotransferase and albumin) above validated models for 7.5-year risk of diabetes (the Cooperative Health Research in the Region of Augsburg, the KORA study). Basic model includes age, sex, BMI, smoking, hypertension and parental diabetes. Clinical models additionally include glucose and uric acid (model1) and HbA1c (model2). In both studies, addition of Liver function tests to the basic model improved the prediction (C-statistic by similar to 0.020; NRI by similar to 9.0%; P<0.001). In the EPIC-NL case-cohort study, addition to clinical model1 resulted in statistically significant improvement in the overall population (C-statistic = +0.009; P<0.001; NRI = 8.8%; P<0.001), while addition to clinical model 2 yielded marginal improvement limited to men (C-statistic = +0.007; P = 0.06; NRI = 3.3%; P = 0.04). In the PREVEND cohort study, addition to clinical model 1 resulted in significant improvement in the overall population (C-statistic change = 0.008; P = 0.003; NRI = 3.6%; P = 0.03), with largest improvement in men (C-statistic change = 0.013; P = 0.01; NRI = 5.4%; P = 0.04). In PREVEND, improvement compared to clinical model 2 could not be tested because of lack of HbA1c data. Conclusions: Liver function tests modestly improve prediction for medium-term risk of incident diabetes above basic and extended clinical prediction models, only if no HbA1c is incorporated. If data on HbA1c are available, Liver function tests have little incremental predictive value, although a small benefit may be present in men.	[Abbasi, Ali; Corpeleijn, Eva; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Abbasi, Ali; Bakker, Stephan J. L.; Gansevoort, Ron T.; Gans, Rijk O. B.; Navis, Gerjan] Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Groningen, Netherlands; [Abbasi, Ali; Peelen, Linda M.; van der Schouw, Yvonne T.; Beulens, Joline W. J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der A, Daphne L.] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr & Hlth, Bilthoven, Netherlands; [Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm RIVM, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands	University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Abbasi, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	a.abbasi@umcg.nl	Bakker, Stephan J. L./J-4023-2015; Stolk, Ronald P/B-2341-2013; Abbasi, Ali/N-7707-2013; van der Schouw, Yvonne T./F-8327-2014	Bakker, Stephan J. L./0000-0003-3356-6791; Stolk, Ronald P/0000-0002-0518-1205; van der Schouw, Yvonne T./0000-0002-4605-435X; Beulens, Joline/0000-0002-4181-0937; ABBASI, ALI/0000-0002-6452-4765; Corpeleijn, Eva/0000-0002-2974-3305; Gans, Reinold/0000-0001-5481-2387	Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; project PREDICCt [01C-104-07]; "Europe against Cancer" Programme of the European Commission (SANCO); Dutch Ministry of Health; Dutch Cancer Society; Netherlands Organization for Health Research and Development (ZonMW); World Cancer Research Fund (WCRF)	Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; project PREDICCt; "Europe against Cancer" Programme of the European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Health; Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF))	This work was supported by the Netherlands Heart Foundation, the Dutch Diabetes Research Foundation and the Dutch Kidney Foundation. This research was performed within the framework of the Center for Translational Molecular Medicine (CTMM; www.ctmm.nl); project PREDICCt (grant 01C-104-07). The EPIC-NL study was funded by "Europe against Cancer" Programme of the European Commission (SANCO), the Dutch Ministry of Health, the Dutch Cancer Society, the Netherlands Organization for Health Research and Development (ZonMW), and World Cancer Research Fund (WCRF). The authors thank Statistics Netherlands and the PHARMO Institute for follow-up data on cancer, cardiovascular disease and vital status. None of the study sponsors had a role in the study design, data collection, analysis or interpretation, report writing, or the decision to submit the report for publication.	Abbasi A, 2012, DIABETOLOGIA, V55, P1963, DOI 10.1007/s00125-012-2545-x; Abbasi A, 2011, DIABETOLOGIA, V54, P2463, DOI 10.1007/s00125-011-2216-3; Abbasi A, 2012, EUR J EPIDEMIOL; Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Chao C, 2010, ARCH INTERN MED, V170, P1557, DOI 10.1001/archinternmed.2010.312; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Hanley AJG, 2004, DIABETES, V53, P2623, DOI 10.2337/diabetes.53.10.2623; Herder C, 2011, CLIN PHARMACOL THER, V90, P52, DOI 10.1038/clpt.2011.93; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; McGeechan K, 2008, ARCH INTERN MED, V168, P2304, DOI 10.1001/archinte.168.21.2304; Moons KGM, 2010, CLIN CHEM, V56, P537, DOI 10.1373/clinchem.2009.134155; Nakanishi N, 2004, DIABETES CARE, V27, P1427, DOI 10.2337/diacare.27.6.1427; Paynter NP, 2011, ARCH INTERN MED, V171, P1712, DOI 10.1001/archinternmed.2011.351; Rathmann W, 2010, DIABETIC MED, V27, P1116, DOI 10.1111/j.1464-5491.2010.03065.x; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Shafizadeh TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022863; Sluijs I, 2010, NETH J MED, V68, P333; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Volovics A, 1997, BIOMETRICAL J, V39, P195, DOI 10.1002/bimj.4710390208; Wannamethee SG, 2011, DIABETIC MED, V28, P23, DOI 10.1111/j.1464-5491.2010.03171.x; Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913	33	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51496	10.1371/journal.pone.0051496	http://dx.doi.org/10.1371/journal.pone.0051496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284703	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900024
J	Saeed, M; Ijaz, M; Javed, K; Babri, HA				Saeed, Mehreen; Ijaz, Maliha; Javed, Kashif; Babri, Haroon Atique			Reverse Engineering Boolean Networks: From Bernoulli Mixture Models to Rule Based Systems	PLOS ONE			English	Article								A Boolean network is a graphical model for representing and analyzing the behavior of gene regulatory networks (GRN). In this context, the accurate and efficient reconstruction of a Boolean network is essential for understanding the gene regulation mechanism and the complex relations that exist therein. In this paper we introduce an elegant and efficient algorithm for the reverse engineering of Boolean networks from a time series of multivariate binary data corresponding to gene expression data. We call our method ReBMM, i.e., reverse engineering based on Bernoulli mixture models. The time complexity of most of the existing reverse engineering techniques is quite high and depends upon the indegree of a node in the network. Due to the high complexity of these methods, they can only be applied to sparsely connected networks of small sizes. ReBMM has a time complexity factor, which is independent of the indegree of a node and is quadratic in the number of nodes in the network, a big improvement over other techniques and yet there is little or no compromise in accuracy. We have tested ReBMM on a number of artificial datasets along with simulated data derived from a plant signaling network. We also used this method to reconstruct a network from real experimental observations of microarray data of the yeast cell cycle. Our method provides a natural framework for generating rules from a probabilistic model. It is simple, intuitive and illustrates excellent empirical results.	[Saeed, Mehreen] Natl Univ Comp & Emerging Sci, FAST, Dept Comp Sci, Lahore, Pakistan; [Javed, Kashif; Babri, Haroon Atique] Univ Engn & Technol, Dept Elect Engn, Lahore, Pakistan	University of Engineering & Technology Lahore	Saeed, M (corresponding author), Natl Univ Comp & Emerging Sci, FAST, Dept Comp Sci, Lahore, Pakistan.	mehreen.saeed@nu.edu.pk						Akutsu T, 1999, Pac Symp Biocomput, P17; Akutsu T, 2000, J COMPUT BIOL, V7, P331, DOI 10.1089/106652700750050817; Alpaydin E, 2005, INTRO MACHINE LEARNI; Bishop C.M., 2006, PATTERN RECOGNITION; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Carreira-Perpinan MA, 2000, NEURAL COMPUT, V12, P141, DOI 10.1162/089976600300015925; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; D'haeseleer P, 1999, PACIFIC S BIOCOMPUTI; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dimitrova E, 2011, THEOR COMPUT SCI, V412, P2816, DOI 10.1016/j.tcs.2010.04.034; Duda R.O., 2000, PATTERN CLASSIFICATI; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Friedman N, 2000, P 4 ANN INT C COMP M; Fuente ADL, 2001, 2 INT C SYST BIOL, P213; Guyon I, 2010, JMLR WORKSH C P CAN; Han ZM, 2009, 2009 2ND IEEE INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND INFORMATION TECHNOLOGY, VOL 3, P194, DOI 10.1109/ICCSIT.2009.5234743; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hopfensitz M, 2011, IEEE ACM T COMPUTATI; Ideker T. E., 2000, PAC S BIOC, V5, P302; Jenkins J, 2010, JMLR WORKSH C P CAN; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Lahdesmaki H, 2003, MACH LEARN, V52, P147, DOI 10.1023/A:1023905711304; Li H., 1999, P 20 NAT C ART INT, V20, P807; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Liang S, 1998, Pac Symp Biocomput, P18; Maucher M, 2011, BIOINFORMATICS, V27, P1529, DOI 10.1093/bioinformatics/btr166; MCLACHLAN G, 2000, WILEY SER PROB STAT, P1; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Nam D, 2006, MACH LEARN, V65, P229, DOI 10.1007/s10994-006-9014-z; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pramila T, 2006, GENE DEV, V20; Saeed M, 2010, JMLR WORKSH C P CAN, V6; Shmulevich I, 2002, BIOINFORMATICS, V18, P555, DOI 10.1093/bioinformatics/18.4.555; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Weaver D C, 1999, Pac Symp Biocomput, P112	35	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51006	10.1371/journal.pone.0051006	http://dx.doi.org/10.1371/journal.pone.0051006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284654	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900010
J	Wei, JCC; Hung, KS; Hsu, YW; Wong, RH; Huang, CH; Jan, MS; Wu, SJ; Juan, YS; Chang, WC				Wei, James Cheng-Chung; Hung, Kuo-Sheng; Hsu, Yu-Wen; Wong, Ruey-Hong; Huang, Chun-Huang; Jan, Ming-Shiou; Wu, Shyh-Jong; Juan, Yung-Shun; Chang, Wei-Chiao			Genetic Polymorphisms of Stromal Interaction Molecule 1 Associated with the Erythrocyte Sedimentation Rate and C-Reactive Protein in HLA-B27 Positive Ankylosing Spondylitis Patients	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; DISEASE-ACTIVITY; CANCER-CELLS; ACTIVATION; CHANNELS; STIM1; IMMUNODEFICIENCY; AUTOIMMUNITY; POPULATION; TAIWAN	Ankylosing spondylitis (AS) is a chronic inflammation of the sacroiliac joints, spine and peripheral joints. The development of ankylosing spondylitis is still unclear. Genetics factors such as human leukocyte antigen HLA-B27 and ERAP1 have been widely reported to associate to AS susceptibility. In this study, we enrolled 361 AS patients and selected four tagging single nucleotides polymorphisms (tSNPs) at STIM1 gene. The correlation between STIM1 genetic polymorphisms and AS activity index (BASDAI, BASFI, BAS-G) as well as laboratory parameters of inflammation (erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)) were tested. Our results indicated that HLA-B27 positive AS patients who are carrying the minor allele homozygous G/G genotype of SNP rs3750996 significantly associated with a higher level of ESR in serum. Furthermore, rs3750996/rs3750994 pairwise allele analysis indicated that G-C haplotypes also significantly correlated with higher level of ESR as well as CRP. These findings provide a better understanding of STIM1 genetic contribution to the pathogenesis of AS. Citation: Wei JC-C, Hung K-S, Hsu Y-W, Wong R-H, Huang C-H, et al. (2012) Genetic Polymorphisms of Stromal Interaction Molecule 1 Associated with the Erythrocyte Sedimentation Rate and C-Reactive Protein in HLA-B27 Positive Ankylosing Spondylitis Patients. PLoS ONE 7(12): e49698. doi:10.1371/journal.pone.0049698	[Hsu, Yu-Wen; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Taichung, Taiwan; [Wei, James Cheng-Chung; Huang, Chun-Huang] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hung, Kuo-Sheng] Taipei Med Univ, Wan Fang Med Ctr, Grad Inst Injury Prevent & Control, Ctr Excellence Clin Trial & Res,Dept Neurosurg, Taipei, Taiwan; [Wong, Ruey-Hong] Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Jan, Ming-Shiou] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Wu, Shyh-Jong] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Juan, Yung-Shun] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Urol, Kaohsiung, Taiwan; [Juan, Yung-Shun] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wanfang Hosp, Dept Pharm, Taipei, Taiwan	Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Chung Shan Medical University; Chung Shan Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw	Wei, James Cheng-Chung/AAL-8947-2020	Wei, James Cheng-Chung/0000-0002-1235-0679; Chang, Wei-Chiao/0000-0002-8573-5924				Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; BREWERTON DA, 1973, LANCET, V1, P904; Calin A, 1999, LANCET, V354, P1687, DOI 10.1016/S0140-6736(99)03219-5; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Chou CT, 2001, J IMMUNOL METHODS, V255, P15, DOI 10.1016/S0022-1759(01)00414-8; Chou YH, 2011, J UROLOGY, V185, P1742, DOI 10.1016/j.juro.2010.12.094; de Vries MK, 2009, ARTHRIT RHEUM-ARTHR, V61, P1484, DOI 10.1002/art.24838; Fedida-Metula S, 2012, CARCINOGENESIS, V33, P740, DOI 10.1093/carcin/bgs021; Feske S, 2011, ANN NY ACAD SCI, V1238, P74, DOI 10.1111/j.1749-6632.2011.06240.x; GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927; Guo ZS, 2010, INT J IMMUNOGENET, V37, P33, DOI 10.1111/j.1744-313X.2009.00889.x; Huang WC, 2011, CELL CALCIUM, V50, P27, DOI 10.1016/j.ceca.2011.04.004; Khan MA, 2002, BEST PRACT RES CL RH, V16, P675, DOI 10.1053/BERH.2002.0243; Lee WY, 2010, TISSUE ANTIGENS, V75, P119, DOI 10.1111/j.1399-0039.2009.01411.x; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; McCarl CA, 2010, J IMMUNOL, V185, P5845, DOI 10.4049/jimmunol.1001796; Obermayer-Pietsch BM, 2003, OSTEOPOROSIS INT, V14, P995, DOI 10.1007/s00198-003-1501-5; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ruof J, 1999, J RHEUMATOL, V26, P966; Safrany E, 2009, SCAND J IMMUNOL, V70, P68, DOI 10.1111/j.1365-3083.2009.02265.x; vanderHeijde D, 1997, J RHEUMATOL, V24, P2225; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wang JY, 2012, CELL SIGNAL, V24, P162, DOI 10.1016/j.cellsig.2011.08.017; Wei JCC, 2007, CLIN RHEUMATOL, V26, P1685, DOI 10.1007/s10067-007-0573-6; Wei JCC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020426; Wei JCC, 2004, RHEUMATOLOGY, V43, P839, DOI 10.1093/rheumatology/keh193; Yildirim K, 2004, SOUTH MED J, V97, P350, DOI 10.1097/01.SMJ.0000066946.56322.3C	31	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e49698	10.1371/journal.pone.0049698	http://dx.doi.org/10.1371/journal.pone.0049698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272049	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800007
J	Zhou, SM; Lyons, RA; Brophy, S; Gravenor, MB				Zhou, Shang-Ming; Lyons, Ronan A.; Brophy, Sinead; Gravenor, Mike B.			Constructing Compact Takagi-Sugeno Rule Systems: Identification of Complex Interactions in Epidemiological Data	PLOS ONE			English	Article							AREA-BASED DEPRIVATION; UNIVERSAL APPROXIMATION; EDUCATIONAL-ATTAINMENT; FUZZY; HEALTH; INTERPRETABILITY; CLASSIFIERS; SELECTION	The Takagi-Sugeno (TS) fuzzy rule system is a widely used data mining technique, and is of particular use in the identification of non-linear interactions between variables. However the number of rules increases dramatically when applied to high dimensional data sets (the curse of dimensionality). Few robust methods are available to identify important rules while removing redundant ones, and this results in limited applicability in fields such as epidemiology or bioinformatics where the interaction of many variables must be considered. Here, we develop a new parsimonious TS rule system. We propose three statistics: R, L, and omega-values, to rank the importance of each TS rule, and a forward selection procedure to construct a final model. We use our method to predict how key components of childhood deprivation combine to influence educational achievement outcome. We show that a parsimonious TS model can be constructed, based on a small subset of rules, that provides an accurate description of the relationship between deprivation indices and educational outcomes. The selected rules shed light on the synergistic relationships between the variables, and reveal that the effect of targeting specific domains of deprivation is crucially dependent on the state of the other domains. Policy decisions need to incorporate these interactions, and deprivation indices should not be considered in isolation. The TS rule system provides a basis for such decision making, and has wide applicability for the identification of non-linear interactions in complex biomedical data. Citation: Zhou S-M, Lyons RA, Brophy S, Gravenor MB (2012) Constructing Compact Takagi-Sugeno Rule Systems: Identification of Complex Interactions in Epidemiological Data. PLoS ONE 7(12): e51468. doi:10.1371/journal.pone.0051468	[Zhou, Shang-Ming; Lyons, Ronan A.; Brophy, Sinead; Gravenor, Mike B.] Swansea Univ, Coll Med, Ctr Hlth Informat Res & Evaluat, Swansea, W Glam, Wales	Swansea University	Zhou, SM (corresponding author), Swansea Univ, Coll Med, Ctr Hlth Informat Res & Evaluat, Swansea, W Glam, Wales.	smzhou@ieee.org	Zhou, Shang-Ming/A-8443-2008	Zhou, Shang-Ming/0000-0002-0719-9353; Lyons, Ronan/0000-0001-5225-000X; Brophy, Sinead/0000-0001-7417-2858	Wellcome Trust; ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson D., 1998, INDEPENDENT INQUIRY; Adams P, 2003, J ECONOMETRICS, V112, P3, DOI 10.1016/S0304-4076(02)00145-8; BEZDEK JC, 1995, NEURAL NETWORKS, V8, P729, DOI 10.1016/0893-6080(95)00024-T; Bezdek JC, 1981, PATTERN RECOGNITION, DOI 10.1007/978-1-4757-0450-1; Black SE, 2007, Q J ECON, V122, P409, DOI 10.1162/qjec.122.1.409; Blanc PD, 2006, EUR RESPIR J, V27, P85, DOI 10.1183/09031936.06.00061205; Blanden J, 2004, OXFORD REV ECON POL, V20, P245, DOI 10.1093/oxrep/grh014; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Gan Q, 1999, IEEE T SYST MAN CY B, V29, P559, DOI 10.1109/3477.775275; Gentle J. E., 1998, STATIST COMP, P87; Golub G. H., 1976, TR456 U MAR DEP COMP; Guillaume S, 2001, IEEE T FUZZY SYST, V9, P426, DOI 10.1109/91.928739; GURALNIK JM, 1993, NEW ENGL J MED, V329, P110, DOI 10.1056/NEJM199307083290208; Rey MI, 2011, IEEE INT CONF FUZZY, P1271; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; KANJILAL PP, 1995, IEEE T NEURAL NETWOR, V6, P1061, DOI 10.1109/72.410351; Kiriakidis K., 1999, Proceedings of the 38th IEEE Conference on Decision and Control (Cat. No.99CH36304), P4361, DOI 10.1109/CDC.1999.833228; Laha A, 2001, IEEE T SYST MAN CY B, V31, P881, DOI 10.1109/3477.969492; Li CS, 2006, INT J COMPUT SCI NET, V6, P21; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Malacova E, 2008, AM J EPIDEMIOL, V168, P21, DOI 10.1093/aje/kwn085; MAMDANI EH, 1977, IEEE T COMPUT, V26, P1182, DOI 10.1109/TC.1977.1674779; Picciotto S, 2006, J EPIDEMIOL COMMUN H, V60, P37, DOI 10.1136/jech.2005.037846; Schools Analysis and Research Division D. F. C. S. A. F, 2009, DEPR ED EV PUP ENGL; Setnes M, 2001, IEEE T SYST MAN CY C, V31, P199, DOI 10.1109/5326.941843; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Steenland K, 2004, AM J EPIDEMIOL, V159, P1047, DOI 10.1093/aje/kwh129; Struthers AD, 2000, HEART, V83, P12, DOI 10.1136/heart.83.1.12; Tachibana K, 2002, INT J INTELL SYST, V17, P495, DOI 10.1002/int.10034; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116, DOI 10.1109/TSMC.1985.6313399; Torra V, 2002, INT J INTELL SYST, V17, P531, DOI 10.1002/int.10036; Visweswaran S, 2010, J BIOMED INFORM, V43, P669, DOI 10.1016/j.jbi.2010.04.009; Wang D., 2006, INT J COMPUT COGN, V4, P18; Wang D, 2009, IEEE T FUZZY SYST, V17, P468, DOI 10.1109/TFUZZ.2009.2014940; Wang LX, 1998, FUZZY SET SYST, V93, P223, DOI 10.1016/S0165-0114(96)00197-2; Welsh Statistical Directorate, 2008, TECHNICAL REPORT; Yan SY, 2010, P AMER CONTR CONF, P6472; ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI 10.1016/0020-0255(75)90046-8; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhou SM, 2008, FUZZY SET SYST, V159, P3091, DOI 10.1016/j.fss.2008.05.016; Zhou SM, 2007, IEEE T FUZZY SYST, V15, P398, DOI 10.1109/TFUZZ.2006.882464; Zhou SM, 2009, IEEE T KNOWL DATA EN, V21, P1191, DOI 10.1109/TKDE.2008.208; Zhou SM, 2006, FUZZY SET SYST, V157, P1057, DOI 10.1016/j.fss.2005.08.004	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51468	10.1371/journal.pone.0051468	http://dx.doi.org/10.1371/journal.pone.0051468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23272108	Green Published, gold			2022-12-25	WOS:000312386800047
J	Howman, RA; Charles, AK; Jacques, A; Doherty, DA; Simmer, K; Strunk, T; Richmond, PC; Cole, CH; Burgner, DP				Howman, Rebecca A.; Charles, Adrian K.; Jacques, Angela; Doherty, Dorota A.; Simmer, Karen; Strunk, Tobias; Richmond, Peter C.; Cole, Catherine H.; Burgner, David P.			Inflammatory and Haematological Markers in the Maternal, Umbilical Cord and Infant Circulation in Histological Chorioamnionitis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PRETERM PREMATURE RUPTURE; PROCALCITONIN; INFECTION; BLOOD; SERUM; BIRTH	Background: The relationship between histological chorioamnionitis and haematological and biochemical markers in mothers and infants at delivery, and in infants postnatally, is incompletely characterised. These markers are widely used in the diagnosis of maternal and neonatal infection. Our objective was to investigate the effects of histological chorioamnionitis (HCA) on haematological and biochemical inflammatory markers in mothers and infants at delivery, and in infants post-delivery. Methods: Two hundred and forty seven mothers, delivering 325 infants, were recruited at the only tertiary perinatal centre in Western Australia. Placentae were assessed for evidence of HCA using a semi-quantitative scoring system. Maternal high sensitivity C-reactive protein (hsCRP), procalcitonin, and umbilical cord hsCRP, procalcitonin, white cell count and absolute neutrophil count were measured at delivery. In infants where sepsis was clinically suspected, postnatal CRP, white cell count and absolute neutrophil count were measured up to 48 hours of age. The effect of HCA on maternal, cord and neonatal markers was evaluated by multivariable regression analysis. Results: The median gestational age was 34 weeks and HCA was present in 26 of 247 (10.5%) placentae. Mothers whose pregnancies were complicated by HCA had higher hsCRP (median 26 (range 2-107) versus 5.6 (0-108) mg/L; P<0.001). Histological chorioamnionitis was associated with higher umbilical cord hsCRP (75th percentile 2.91 mg/L (range 0-63.9) versus 75th percentile 0 mg/L (0-45.6); P<0.001) and procalcitonin (median 0.293 (range 0.05-27.37) versus median 0.064 (range 0.01-5.24) ug/L; P<0.001), with a sustained increase in neonatal absolute neutrophil count (median 4.5 (0.1-26.4) x 10(9)/L versus 3.0 (0.1-17.8) x 10(9)/L), and CRP up to 48 hours post-partum (median 10 versus 6.5 mg/L) (P<0.05 for each). Conclusion: Histological chorioamnionitis is associated with modest systemic inflammation in maternal and cord blood. These systemic changes may increase postnatally, potentially undermining their utility in the diagnosis of early-onset neonatal infection.	[Howman, Rebecca A.; Charles, Adrian K.; Simmer, Karen; Strunk, Tobias; Richmond, Peter C.; Cole, Catherine H.; Burgner, David P.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Charles, Adrian K.; Jacques, Angela] Women & Infants Res Fdn, Perth, WA, Australia; [Doherty, Dorota A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Burgner, David P.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Burgner, David P.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	University of Western Australia; University of Western Australia; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Burgner, DP (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	david.burgner@mcri.edu.au	Strunk, Tobias/AIE-3407-2022; Simmer, Karen N/H-5834-2014; Richmond, Peter C/G-3379-2012	Strunk, Tobias/0000-0001-7079-2339; Richmond, Peter C/0000-0001-7562-7228; Burgner, David/0000-0002-8304-4302; Jacques, Angela/0000-0002-0461-681X; Charles, Adrian/0000-0002-3193-1065; Simmer, Karen/0000-0003-4777-9069	Princess Margaret Hospital Foundation; Women and Infant's Research Foundation Western Australia; Clive and Vera Ramaciotti Medical Research Foundation; University of Western Australia; Rebecca Cooper Medical Research Foundation; Channel 7 Telethon; European Society for Paediatric Infectious Diseases; National Health and Medical Research Council Australia [572548]; Deutsche Forschungsgemeinschaft [STR1022/1-1]; National Health and Medical Research Council Clinical Career Development Fellowship; Victorian Government's Operational Infrastructure Support Program	Princess Margaret Hospital Foundation; Women and Infant's Research Foundation Western Australia; Clive and Vera Ramaciotti Medical Research Foundation; University of Western Australia; Rebecca Cooper Medical Research Foundation; Channel 7 Telethon; European Society for Paediatric Infectious Diseases; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical Research Council Clinical Career Development Fellowship; Victorian Government's Operational Infrastructure Support Program	The project was funded by Princess Margaret Hospital Foundation, Women and Infant's Research Foundation Western Australia, Clive and Vera Ramaciotti Medical Research Foundation, University of Western Australia, Rebecca Cooper Medical Research Foundation, Channel 7 Telethon, European Society for Paediatric Infectious Diseases and the National Health and Medical Research Council Australia (Project grant #572548). TS was supported by a Research Fellowship of the Deutsche Forschungsgemeinschaft (STR1022/1-1) and an International Postgraduate Research Scholarship of the University of Western Australia. DPB is supported by a National Health and Medical Research Council Clinical Career Development Fellowship and the research was supported by the Victorian Government's Operational Infrastructure Support Program. BRAHMS (Thermo Fisher Scientific) provided the procalcitonin assays without charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; BARAK M, 1992, ACTA PAEDIATR, V81, P760, DOI 10.1111/j.1651-2227.1992.tb12098.x; Bashiri A, 2006, J PERINAT MED, V34, P5, DOI 10.1515/JPM.2006.001; Becker KL, 2008, CRIT CARE MED, V36, P941, DOI 10.1097/CCM.0B013E318165BABB; Czikk MJ, 2011, CLIN MICROBIOL INFEC, V17, P1304, DOI 10.1111/j.1469-0691.2011.03574.x; De Dooy J, 2003, PEDIATR RES, V54, P113, DOI 10.1203/01.PDR.0000069702.25801.D1; DEVILLIERS WJ, 1990, BRIT J OBSTET GYNAEC, V97, P725, DOI 10.1111/j.1471-0528.1990.tb16247.x; FISK NM, 1987, BRIT J OBSTET GYNAEC, V94, P1159, DOI 10.1111/j.1471-0528.1987.tb02316.x; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Greksova K, 2009, BRATISL MED J, V110, P623; Hecht JL, 2011, PEDIATR RES, V69, P68, DOI 10.1203/PDR.0b013e3181fed334; ISAACS D, 1995, MED J AUSTRALIA, V162, P198, DOI 10.5694/j.1326-5377.1995.tb126024.x; Jackson GL, 2004, PEDIATRICS, V113, P1173, DOI 10.1542/peds.113.5.1173; Janota J, 2001, EUR J CLIN INVEST, V31, P978, DOI 10.1046/j.1365-2362.2001.00912.x; Kordek A, 2008, CLIN CHEM LAB MED, V46, P1143, DOI 10.1515/CCLM.2008.214; Loukovaara MJ, 2003, EUR J OBSTET GYN R B, V110, P26, DOI 10.1016/S0301-2115(03)00084-8; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Miyano A, 1998, PEDIATR DEVEL PATHOL, V1, P513, DOI 10.1007/s100249900070; Nagamatsu T, 2009, HUM REPROD, V24, P3160, DOI 10.1093/humrep/dep308; Nijsten MWN, 2000, CRIT CARE MED, V28, P458, DOI 10.1097/00003246-200002000-00028; Oh KJ, 2011, PLACENTA, V32, P732, DOI 10.1016/j.placenta.2011.07.080; Park CW, 2009, PLACENTA, V30, P56, DOI 10.1016/j.placenta.2008.09.017; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Roberts CL, 1999, MED J AUSTRALIA, V170, P114, DOI 10.5694/j.1326-5377.1999.tb127678.x; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Simon P, 2008, CRIT CARE, V12, DOI 10.1186/cc7124; Skogstrand K, 2008, OBSTET GYNECOL, V111, P1118, DOI 10.1097/AOG.0b013e31817057fb; Smulian JC, 1999, OBSTET GYNECOL, V94, P1000, DOI 10.1016/S0029-7844(99)00416-0; Strunk T, 2012, PEDIATRICS, V129, pE134, DOI 10.1542/peds.2010-3493; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Trochez-Martinez RD, 2007, BJOG-INT J OBSTET GY, V114, P796, DOI 10.1111/j.1471-0528.2007.01385.x; van de Beek C, 2004, HORM BEHAV, V46, P663, DOI 10.1016/j.yhbeh.2004.06.010; van Rossum AMC, 2004, LANCET INFECT DIS, V4, P620, DOI 10.1016/S1473-3099(04)01146-6; Yoon B H, 2003, J Matern Fetal Neonatal Med, V14, P85	35	38	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51836	10.1371/journal.pone.0051836	http://dx.doi.org/10.1371/journal.pone.0051836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272177	Green Published, gold			2022-12-25	WOS:000312386600044
J	Pidkovka, N; Rao, R; Mei, SJ; Gong, Y; Harris, RC; Wang, WH; Capdevila, JH				Pidkovka, Nataliya; Rao, Reena; Mei, Shaojun; Gong, Yan; Harris, Raymond C.; Wang, Wen-Hui; Capdevila, Jorge H.			Epoxyeicosatrienoic Acids (EETs) Regulate Epithelial Sodium Channel Activity by Extracellular Signal-regulated Kinase 1/2 (ERK1/2)-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; COLLECTING DUCT CELLS; ARACHIDONIC-ACID; NA+ CHANNEL; RAT-KIDNEY; LIDDLE-SYNDROME; ENAC; HYPERTENSION; CYTOCHROME-P450; TRANSPORT	The epithelial sodium channel (ENaC) participates in the regulation of plasma sodium and volume, and gain of function mutations in the human channel cause salt-sensitive hypertension. Roles for the arachidonic acid epoxygenase metabolites, the epoxyeicosatrienoic acids (EETs), in ENaC activity have been identified; however, their mechanisms of action remain unknown. In polarizedM1cells, 14,15-EET inhibited amiloridesensitive apical to basolateral sodium transport as effectively as epidermal growth factor (EGF). The EET effects were associated with increased threonine phosphorylation of the ENaC beta and gamma subunits and abolished by inhibitors of (a) mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal regulated kinases 1 and 2 (MEK/ERK1/2) and (b) EGF receptor signaling. CYP2C44 epoxygenase knockdown blunted the sodium transport effects of EGF, and its 14,15-EET metabolite rescued the knockdown phenotype. The relevance of these findings is indicated by (a) the hypertension that results in mice administered cetuximab, an inhibitor of EGF receptor binding, and (b) immunological data showing an association between the pressure effects of cetuximab and reductions in ENaC gamma phosphorylation. These studies (a) identify an ERK1/2dependent mechanism for ENaC inhibition by 14,15-EET, (b) point to ENaC as a proximal target for EET-activated ERK1/2 mitogenic kinases, (c) characterize a mechanistic commonality between EGF and epoxygenase metabolites as ENaC inhibitors, and (d) suggest a CYP2C epoxygenase-mediated pathway for the regulation of distal sodium transport.	[Pidkovka, Nataliya; Mei, Shaojun; Gong, Yan; Harris, Raymond C.; Capdevila, Jorge H.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Rao, Reena] Univ Kansas, Dept Med, Kansas City, KS 66160 USA; [Wang, Wen-Hui] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	Vanderbilt University; University of Kansas; New York Medical College	Capdevila, JH (corresponding author), Vanderbilt Univ, Med Ctr N, Dept Med, Rm S-3223,1161 21st Ave S, Nashville, TN 37232 USA.	jorge.capdevila@vanderbilt.edu			National Institutes of Health from the USPHS [DK038226, DK51265, HL34300]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226, R01DK083525, R01DK051265] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK038226 (to J. H. C. and R. C. H.), DK51265 (to R. H. C.), and HL34300 (to W. H. W.) from the USPHS.	Bubien JK, 2010, J BIOL CHEM, V285, P23527, DOI 10.1074/jbc.R109.025049; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Butterworth MB, 2008, J BIOL CHEM, V283, P35305, DOI 10.1074/jbc.R800044200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Capdevila JH, 2000, J LIPID RES, V41, P163; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; Capidevila JH, 2007, CURR OPIN NEPHROL HY, V16, P465, DOI 10.1097/MNH.0b013e32827ab48c; Chen FM, 2006, BIOORG MED CHEM LETT, V16, P6281, DOI 10.1016/j.bmcl.2006.09.038; Chen JK, 1999, J BIOL CHEM, V274, P4764, DOI 10.1074/jbc.274.8.4764; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; DeLozier TC, 2004, J PHARMACOL EXP THER, V310, P845, DOI 10.1124/jpet.104.067819; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Falin R, 2005, AM J PHYSIOL-CELL PH, V288, pC1003, DOI 10.1152/ajpcell.00213.2004; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P98, DOI 10.1097/MNH.0b013e328332bda4; Harding J, 2005, DRUG TODAY, V41, P107, DOI 10.1358/dot.2005.41.2.882662; HOLTHOFER H, 1987, CELL TISSUE RES, V249, P481; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Hu JC, 2009, J BIOL CHEM, V284, P36334, DOI 10.1074/jbc.M109.032870; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; KORBMACHER C, 1993, J GEN PHYSIOL, V102, P761, DOI 10.1085/jgp.102.4.761; Liu L, 2010, COLORECTAL DIS, V12, P399, DOI 10.1111/j.1463-1318.2009.01916.x; MAKITA K, 1994, J CLIN INVEST, V94, P2414, DOI 10.1172/JCI117608; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Nakhoul NL, 1998, AM J PHYSIOL-RENAL, V275, pF998, DOI 10.1152/ajprenal.1998.275.6.F998; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Rossier BC, 2008, HYPERTENSION, V52, P595, DOI 10.1161/HYPERTENSIONAHA.107.097147; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Schild L, 1996, NEPHROLOGIE, V17, P395; Shen JP, 2003, AM J PHYSIOL-RENAL, V284, pF57, DOI 10.1152/ajprenal.00028.2002; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Shimkets RA, 1998, P NATL ACAD SCI USA, V95, P3301, DOI 10.1073/pnas.95.6.3301; Shushan A, 2007, FERTIL STERIL, V87, P127, DOI 10.1016/j.fertnstert.2006.05.056; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Thomas CP, 2004, CURR OPIN NEPHROL HY, V13, P541, DOI 10.1097/00041552-200409000-00010; VEHASKARI VM, 1989, AM J PHYSIOL, V256, pF803, DOI 10.1152/ajprenal.1989.256.5.F803; Warnock DG, 2001, AM J MED SCI, V322, P302, DOI 10.1097/00000441-200112000-00002; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140; Yang SL, 2009, ARCH BIOCHEM BIOPHYS, V489, P82, DOI 10.1016/j.abb.2009.05.006; Yang WQ, 2008, J PHARMACOL EXP THER, V324, P1019, DOI 10.1124/jpet.107.129577; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402; Zhang YH, 2005, AM J PHYSIOL-CELL PH, V288, pC141, DOI 10.1152/ajpcell.00343.2004	47	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5223	5231		10.1074/jbc.M112.407981	http://dx.doi.org/10.1074/jbc.M112.407981			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283969	Green Published, hybrid			2022-12-25	WOS:000315340400069
J	Vendra, VPR; Chandani, S; Balasubramanian, D				Vendra, Venkata Pulla Rao; Chandani, Sushil; Balasubramanian, Dorairajan			The Mutation V42M Distorts the Compact Packing of the Human Gamma-S-Crystallin Molecule, Resulting in Congenital Cataract	PLOS ONE			English	Article							EYE LENS; AGGREGATION; PROTEINS; STABILITY; BINDING; BOVINE; MUTANT; INTERMEDIATE; SIMULATION; FAMILIES	Background: Human gamma S-crystallin is an important component of the human eye lens nucleus and cortex. The mutation V42M in the molecule causes severe congenital cataract in children. We compare the structure of the mutant protein with that of the wild type in order to understand how structural changes in the mutant relate to the mechanism of opacification. Methods: Both proteins were made using conventional cloning and expression procedures. Secondary and tertiary structural features of the proteins were analyzed using spectral methods. Structural stabilities of the proteins were analyzed using chemical and thermal denaturation methods. Self-aggregation was monitored using extrinsic spectral probes. Molecular modeling was used to compare the structural features of the two proteins. Results: While the wild type and mutant have the same secondary structure, molecular modeling and fluorescence analysis suggest the mutant to have a more open tertiary structure, with a larger hydrophobic surface. Experiments using extrinsic probes reveal that the mutant readily self-aggregates, with the suggestion that the aggregates might be similar to amyloidogenic fibrils. Chemical denaturation indicates that while the wild type exhibits the classic two-state transition, V42M goes through an intermediate state, and has a distinctly lower stability than the wild type. The temperature of thermal unfolding of the mutant is also distinctly lower. Further, the mutant readily precipitates and scatters light more easily than the wild type. Conclusion: The replacement of valine in position 42 by the longer and bulkier methionine in human gamma S-crystallin perturbs the compact beta-sheet core packing topology in the N-terminal domain of the molecule, exposes nonpolar residues thereby increasing the surface hydrophobicity and weakens the stability of the protein, thus promoting self-aggregation leading to light scattering particles. This set of changes in the properties of the mutant offers a molecular insight into the mechanism of opacification.	[Vendra, Venkata Pulla Rao; Balasubramanian, Dorairajan] Hyderabad Eye Res Fdn, Prof Brien Holden Eye Res Ctr, LV Prasad Eye Inst Hyderabad, Hyderabad, Andhra Pradesh, India; [Chandani, Sushil] Novarus Discoveries Pvt Ltd, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute	Balasubramanian, D (corresponding author), Hyderabad Eye Res Fdn, Prof Brien Holden Eye Res Ctr, LV Prasad Eye Inst Hyderabad, Hyderabad, Andhra Pradesh, India.	dbala@lvpei.org		Alimchandani, Sushil/0000-0001-8036-5584	Department of Biotechnology, India [BT/01/COE/06/02/10]; Champalimaud Foundation, Portugal; Hyderabad Eye Research Foundation, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Champalimaud Foundation, Portugal; Hyderabad Eye Research Foundation, India	This research was funded by grants from the Department of Biotechnology, India, (grant number BT/01/COE/06/02/10), Champalimaud Foundation, Portugal, (2008-12) and in-house funding from the Hyderabad Eye Research Foundation, India. The authors have no commercial interests or any financial disclosure to make. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; AUGUSTEYN RC, 1994, BBA-PROTEIN STRUCT M, V1205, P89, DOI 10.1016/0167-4838(94)90096-5; Augusteyn RC, 2010, EXP EYE RES, V90, P643, DOI 10.1016/j.exer.2010.01.013; BRAKENHOFF RH, 1990, J MOL BIOL, V216, P519, DOI 10.1016/0022-2836(90)90380-5; BRITTAIN HG, 1976, J AM CHEM SOC, V98, P8255, DOI 10.1021/ja00441a060; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brubaker WD, 2012, BIOMOL NMR ASSIGN, V6, P63, DOI 10.1007/s12104-011-9326-1; Brubaker WD, 2011, BIOPHYS J, V100, P498, DOI 10.1016/j.bpj.2010.12.3691; CLARK AC, 1993, J BIOL CHEM, V268, P10773; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Devi RR, 2008, MOL VIS, V14, P1157; Foster A, 1997, J CATARACT REFR SURG, V23, P601, DOI 10.1016/S0886-3350(97)80040-5; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; GREENE RF, 1974, J BIOL CHEM, V249, P5388; HEMMINGSEN JM, 1994, PROTEIN SCI, V3, P1927, DOI 10.1002/pro.5560031104; Lee S, 2010, J MOL BIOL, V399, P320, DOI 10.1016/j.jmb.2010.04.003; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Ma ZW, 2009, BIOCHEMISTRY-US, V48, P7334, DOI 10.1021/bi900467a; Macdonald JT, 2005, PROTEIN SCI, V14, P1282, DOI 10.1110/ps.041227805; Mahler B, 2011, J MOL BIOL, V405, P840, DOI 10.1016/j.jmb.2010.11.005; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; Mishra A, 2012, J MOL BIOL, V415, P75, DOI 10.1016/j.jmb.2011.10.037; Purkiss AG, 2002, J BIOL CHEM, V277, P4199, DOI 10.1074/jbc.M110083200; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Shiels A, 2010, MOL VIS, V16, P2007; Sinha D, 1998, Mol Vis, V4, P8; Sinha D, 2001, J BIOL CHEM, V276, P9308, DOI 10.1074/jbc.M010583200; Suman SK, 2011, J BIOL CHEM, V286, P43891, DOI 10.1074/jbc.M111.247890; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; Sun WM, 2011, MOL VIS, V17, P2197; Sutter M, 2007, J FLUORESC, V17, P181, DOI 10.1007/s10895-007-0156-6; Talla V, 2008, INVEST OPHTH VIS SCI, V49, P3483, DOI 10.1167/iovs.07-1114; TARDIEU A, 1988, ANNU REV BIOPHYS BIO, V17, P47; Vanita V, 2009, MOL VIS, V15, P476; Vendra VPR, 2010, MOL VIS, V16, P2822; Wenk M, 2000, BIOPHYS CHEM, V86, P95, DOI 10.1016/S0301-4622(00)00161-7; Wu ZR, 2005, PROTEIN SCI, V14, P3101, DOI 10.1110/ps.051635205	41	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51401	10.1371/journal.pone.0051401	http://dx.doi.org/10.1371/journal.pone.0051401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284690	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800010
J	Yu, RJ; Guo, XL; Zhong, JP; Li, M; Zeng, ZX; Zhang, HH				Yu, Rongjie; Guo, Xiaoling; Zhong, Jiaping; Li, Mei; Zeng, Zhixing; Zhang, Huahua			The N-Terminal HSDCIF Motif Is Required for Cell Surface Trafficking and Dimerization of Family B G Protein Coupled Receptor PAC1	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; SECRETIN RECEPTOR; PHARMACOLOGY; EXPRESSION; OLIGOMERIZATION; RESIDUES; CYSTEINE; VIP	PAC1 is PACAP (pituitary adenylate cyclase-activating polypeptide) preferring receptor belonging to class B G protein coupled receptor (GPCR) mediating the most effects of PACAP. The important role of G protein coupled receptor homo/heteromerization in receptor folding, maturation, trafficking, and cell surface expression has become increasingly evident. The bimolecular fluorescence complementation (BiFC) and bioluminescence resonance energy transfer (BRET) assay were used in this research to confirm the dimerization of PAC1 for the first time. The structure-activity relationship focused on the N-terminal HSDCIF motif, which locates behind the signal sequence and has high homology with PACAP (1-6), was assayed using a receptor mutant with the deletion of the HSDCIF motif. The fluorescence confocal microscope observation showed that the deletion of the HSDCIF motif impaired the cell delivery of PAC1. The results of BiFC, BRET and westernblot indicated that the deletion of HSDCIF motif and the replacement of the Cys residue with Ala in HSDCIF motif resulted in the disruption of receptor dimerization. And the exogenous chemically synthesized oligopeptide HSDCIF (100 nmol/L) not only down-regulated the dimerization of PAC1, induced the internalization of PAC1, but also inhibited the proliferation of CHO cells expressing PAC1 stably and decreased the activity of PACAP on the cell viability. All these data suggested that the N-terminal HSDCIF motif played key role in the trafficking and the dimerization of PAC1, and the exogenous oligopeptide HSDCIF had effects on the cell signaling, trafficking and the dimerization of PAC1.	[Yu, Rongjie; Guo, Xiaoling; Zhong, Jiaping; Li, Mei; Zeng, Zhixing] Jinan Univ, Dept Cell Biol, Inst Cell Biol, Guangzhou, Guangdong, Peoples R China; [Zhang, Huahua] Guangdong Med Coll, Med Genet Lab, Dongguan, Guangdong, Peoples R China	Jinan University; Guangdong Medical University	Yu, RJ (corresponding author), Jinan Univ, Dept Cell Biol, Inst Cell Biol, Guangzhou, Guangdong, Peoples R China.	rongjie_yu1123@163.com	Guo, Xiaoling/AAJ-2958-2020	Yu, Rongjie/0000-0001-9285-5783	National Natural Science Foundation of China [31100545]; Science and Technology Bureau of Guangdong Province [2011B090400024]; Natural Science Foundation of Guangdong Province [S2011010002931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Bureau of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (No. 31100545), the Science and Technology Bureau of Guangdong Province (2011B090400024) and the Natural Science Foundation of Guangdong Province (S2011010002931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINO H, 1995, GENE, V164, P301, DOI 10.1016/0378-1119(95)00391-I; Asmann YW, 2000, MOL PHARMACOL, V58, P911, DOI 10.1124/mol.58.5.911; Boronkai A, 2009, ANN NY ACAD SCI, V1163, P353, DOI 10.1111/j.1749-6632.2008.03630.x; Bourgault S, 2009, CURR MED CHEM, V16, P4462, DOI 10.2174/092986709789712899; Bourgault S, 2009, J MED CHEM, V52, P3308, DOI 10.1021/jm900291j; Couvineau A, 2004, REGUL PEPTIDES, V123, P181, DOI 10.1016/j.regpep.2004.06.025; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2006, MOL PHARMACOL, V69, P363, DOI 10.1124/mol.105.015776; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Hawtin SR, 2006, J BIOL CHEM, V281, P38478, DOI 10.1074/jbc.M607639200; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Laburthe M, 1996, ANN NY ACAD SCI, V805, P94; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Langer I, 2008, BBA-MOL CELL RES, V1783, P1663, DOI 10.1016/j.bbamcr.2008.03.013; Langer I, 2006, BRIT J PHARMACOL, V148, P1051, DOI 10.1038/sj.bjp.0706816; Lee JC, 2010, BRAIN RES, V1351, P32, DOI 10.1016/j.brainres.2010.06.048; Lieu SN, 2006, ANN NY ACAD SCI, V1070, P399, DOI 10.1196/annals.1317.052; Lisenbee CS, 2005, J BIOL CHEM, V280, P12330, DOI 10.1074/jbc.M414016200; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; OKAZAKI K, 1992, FEBS LETT, V298, P49, DOI 10.1016/0014-5793(92)80020-H; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; ROBBERECHT P, 1992, EUR J BIOCHEM, V207, P239, DOI 10.1111/j.1432-1033.1992.tb17043.x; Roed Sarah Norklit, 2012, Front Endocrinol (Lausanne), V3, P62, DOI 10.3389/fendo.2012.00062; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Vaudry D, 2000, PHARMACOL REV, V52, P269; Yu RJ, 2006, PEPTIDES, V27, P1359, DOI 10.1016/j.peptides.2005.11.026; Yu RJ, 2010, NEUROSCI LETT, V480, P73, DOI 10.1016/j.neulet.2010.06.007; Yu RJ, 2010, PEPTIDES, V31, P1062, DOI 10.1016/j.peptides.2010.03.008	34	12	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51811	10.1371/journal.pone.0051811	http://dx.doi.org/10.1371/journal.pone.0051811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284775	Green Submitted, gold, Green Published			2022-12-25	WOS:000313158800015
J	Curtis, AJ; Marshall, CS; Spelman, T; Greig, J; Elliot, JH; Shanks, L; Du Cros, P; Casas, EC; Da Fonseca, MS; O'Brien, DP				Curtis, Andrea J.; Marshall, Catherine S.; Spelman, Tim; Greig, Jane; Elliot, Julian H.; Shanks, Leslie; Du Cros, Philipp; Casas, Esther C.; Da Fonseca, Marcio Silveria; O'Brien, Daniel P.			Incidence of WHO Stage 3 and 4 Conditions following Initiation of Anti-Retroviral Therapy in Resource Limited Settings	PLOS ONE			English	Article							HIV-INFECTED ADULTS; COTRIMOXAZOLE PROPHYLAXIS; OPPORTUNISTIC ILLNESSES; SOUTH-AFRICA; RISK-FACTORS; MORTALITY; COHORT; AIDS; TUBERCULOSIS; CRYPTOCOCCOSIS	Objectives: To determine the incidence of WHO clinical stage 3 and 4 conditions during early anti-retroviral therapy (ART) in resource limited settings (RLS). Design/Setting: A descriptive analysis of routine program data collected prospectively from 25 Medecins Sans Frontieres supported HIV treatment programs in eight countries between 2002 and 2010. Subjects/Participants: 35,349 study participants with median follow-up on ART of 1.33 years (IQR 0.51-2.41). Outcome Measures: Incidence in 100 person-years of WHO stage 3 or 4 conditions during 5 periods after ART initiation. Diagnoses of conditions were made according to WHO criteria and relied upon clinical assessments supported by basic laboratory investigations. Results: The incidence of any WHO clinical stage 3 or 4 condition over 3 years was 40.02 per 100 person-years (31.77 for stage 3 and 8.25 for stage 4). The incidence of stage 3 and 4 conditions fell by over 97% between months 0-3 and months 25-36 (77.81 to 2.40 for stage 3 and 28.70 to 0.64 for stage 4). During months 0-3 pulmonary tuberculosis was the most common condition diagnosed in adults (incidence 22.24 per 100 person-years) and children aged 5-14 years (25.76) and oral candidiasis was the most common in children <5 years (25.79). Overall incidences were higher in Africa compared with Asia (43.98 versus 12.97 for stage 3 and 8.98 versus 7.05 for stage 4 conditions, p < 0.001). Pulmonary tuberculosis, weight loss, oral and oesophageal candidiasis, chronic diarrhoea, HIV wasting syndrome and severe bacterial infections were more common in Africa. Extra-pulmonary tuberculosis, non-tuberculous mycobacterial infection, cryptococcosis, penicilliosis and toxoplasmosis were more common in Asia. Conclusions: The incidence of WHO stage 3 and 4 conditions during the early period after ART initiation in RLS is high, but greatly reduces over time. This is likely due to both the benefits of ART and deaths of the sickest patients occurring shortly after ART initiation. Access to appropriate disease prevention tools prior to ART, and early initiation of ART, are important for their prevention.	[Greig, Jane; Du Cros, Philipp; O'Brien, Daniel P.] Medecins Sans Frontieres, Manson Unit, London, England; [Curtis, Andrea J.; Spelman, Tim; Elliot, Julian H.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Marshall, Catherine S.; Elliot, Julian H.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Spelman, Tim; Elliot, Julian H.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Shanks, Leslie; Casas, Esther C.; Da Fonseca, Marcio Silveria] Medecins Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands; [O'Brien, Daniel P.] Geelong Hosp, Dept Infect Dis, Geelong, Vic, Australia; [O'Brien, Daniel P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Infect Dis, Melbourne, Vic 3050, Australia	Doctors Without Borders; Monash University; Florey Institute of Neuroscience & Mental Health; Burnet Institute; Doctors Without Borders; Geelong Hospital; Royal Melbourne Hospital; University of Melbourne	O'Brien, DP (corresponding author), Medecins Sans Frontieres, Manson Unit, London, England.	daniel.obrien@amsterdam.msf.org	O'Brien, Daniel/ABE-9658-2020	O'Brien, Daniel/0000-0001-5418-3330; du Cros, Philipp/0000-0002-3599-029X; Curtis, Andrea/0000-0003-2407-770X; Greig, Jane/0000-0003-2732-0023	M�decins Sans Fronti�res [OCA_pilot_00_Greig, OCA_ERB_009_20_OBrien] Funding Source: researchfish	M�decins Sans Fronti�res		Abadi J, 1999, CLIN INFECT DIS, V28, P309, DOI 10.1086/515130; [Anonymous], 2011, GUIDELINES FOR INTEN; Buchacz K, 2010, AIDS, V24, P1549, DOI 10.1097/QAD.0b013e32833a3967; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fielding K, 2012, 19TH CONFERENCE ON R; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Gonzalez CE, 1996, PEDIATR INFECT DIS J, V15, P796, DOI 10.1097/00006454-199609000-00012; HOOVER DR, 1991, STAT MED, V10, P1993, DOI 10.1002/sim.4780101212; Ives NJ, 2001, J INFECTION, V42, P134, DOI 10.1053/jinf.2001.0810; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kasprowicz VO, 2011, J INFECT DIS, V204, pS1099, DOI 10.1093/infdis/jir414; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Lynen L, 2006, CLINICAL HIV AIDS CA; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Monforte AD, 2005, ARCH INTERN MED, V165, P416; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Sloan DJ, 2009, CURR OPIN INFECT DIS, V22, P455, DOI 10.1097/QCO.0b013e32832fa214; [UNICEF WHO], 2006, PNEUMONIA THE FORGOT; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2004, SCALING UP ANTIRETRO; World Health Organization, 2006, ANTIRETROVIRAL THERA; World Health Organization, 2011, RAPID ADVICE DIAGNOS; World Health Organization, 2010, ANTIRETROVIRAL THERA; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	29	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52019	10.1371/journal.pone.0052019	http://dx.doi.org/10.1371/journal.pone.0052019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284857	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500078
J	Okumura, M; Kijima, A; Kadota, K; Yokoyama, K; Suzuki, H; Yamamoto, Y				Okumura, Motoki; Kijima, Akifumi; Kadota, Koji; Yokoyama, Keiko; Suzuki, Hiroo; Yamamoto, Yuji			A Critical Interpersonal Distance Switches between Two Coordination Modes in Kendo Matches	PLOS ONE			English	Article							TEAM SPORTS; INSTANTANEOUS FREQUENCY; ECOLOGICAL DYNAMICS; VISUAL COORDINATION; FRACTAL TRANSITION; PHASE-TRANSITIONS; JOINT ACTION; MOVEMENTS; SYSTEMS; CONSTRAINTS	In many competitive sports, players need to quickly and continuously execute movements that co-adapt to various movements executed by their opponents and physical objects. In a martial art such as kendo, players must be able to skillfully change interpersonal distance in order to win. However, very little information about the task and expertise properties of the maneuvers affecting interpersonal distance is available. This study investigated behavioral dynamics underlying opponent tasks by analyzing changes in interpersonal distance made by expert players in kendo matches. Analysis of preferred interpersonal distances indicated that players tended to step toward and away from their opponents based on two distances. The most preferred distance enabled the players to execute both striking and defensive movements immediately. The relative phase analysis of the velocities at which players executed steps toward and away revealed that players developed anti-phase synchronizations at near distances to maintain safe distances from their opponents. Alternatively, players shifted to in-phase synchronization to approach their opponents from far distances. This abrupt phase-transition phenomenon constitutes a characteristic bifurcation dynamics that regularly and instantaneously occurs between in- and anti-phase synchronizations at a critical interpersonal distance. These dynamics are profoundly affected by the task constraints of kendo and the physical constraints of the players. Thus, the current study identifies the clear behavioral dynamics that emerge in a sport setting.	[Okumura, Motoki] Shizuoka Univ, Fac Educ, Shizuoka 4228529, Japan; [Okumura, Motoki] Shizuoka Univ, Grad Sch Educ, Shizuoka 4228529, Japan; [Kijima, Akifumi] Univ Yamanashi, Grad Sch Educ, Kofu, Yamanashi, Japan; [Kadota, Koji] Osaka Univ, Dept Hlth & Sport Sci, Grad Sch Med, Osaka, Japan; [Yokoyama, Keiko] Hokkaido Univ, Div Appl Phys, Fac Engn, Sapporo, Hokkaido 060, Japan; [Yokoyama, Keiko] Japan Soc Promot Sci, Tokyo, Japan; [Suzuki, Hiroo] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi 4648601, Japan; [Yamamoto, Yuji] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan; [Yamamoto, Yuji] Nagoya Univ, Dept Psychol & Human Dev Sci, Nagoya, Aichi 4648601, Japan	Shizuoka University; Shizuoka University; University of Yamanashi; Osaka University; Hokkaido University; Japan Society for the Promotion of Science; Nagoya University; Nagoya University; Nagoya University	Okumura, M (corresponding author), Shizuoka Univ, Fac Educ, Shizuoka 4228529, Japan.	emuokumu@ipc.shizuoka.ac.jp			Japan Society for the Promotion of Science [20240060]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work has been supported in part by Grant-in-Aid for Scientific Research (A) 20240060 from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Araujo D, 2004, SKILL ACQUISITION SP, P409; Araujo D, 2006, PSYCHOL SPORT EXERC, V7, P653, DOI 10.1016/j.psychsport.2006.07.002; Bardy BG, 2002, J EXP PSYCHOL HUMAN, V28, P499, DOI 10.1037//0096-1523.28.3.499; Beek P. J., 2003, EXPERT PERFORMANCE S, P321; BOASHASH B, 1992, P IEEE, V80, P540, DOI 10.1109/5.135378; BOASHASH B, 1992, P IEEE, V80, P520, DOI 10.1109/5.135376; Bourbousson J, 2010, J SPORT SCI, V28, P349, DOI 10.1080/02640410903503640; Bourbousson J, 2010, J SPORT SCI, V28, P339, DOI 10.1080/02640410903503632; Davids K, 2008, DYNAMICS SKILL ACQUI; Dietrich G, 2010, MOTOR CONTROL, V14, P509, DOI 10.1123/mcj.14.4.509; Gohara K, 1999, FRACTALS, V7, P205, DOI 10.1142/S0218348X99000220; Gohara K, 1999, FRACTALS, V7, P313, DOI 10.1142/S0218348X99000311; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H, 1978, SYNERGETICS INTRO NO, DOI [10.1007/978-3-642-96469-5, DOI 10.1007/978-3-642-96469-5]; Haken H., 1983, ADV SYNERGETICS INST; Hall E.T., 1966, HIDDEN DIMENSION, V609; Hediger HP, 1962, SOCIAL LIFE EARLY MA, P34; Higuchi T, 2011, HUM MOVEMENT SCI, V30, P534, DOI 10.1016/j.humov.2010.08.003; Hristovski Robert, 2006, Nonlinear Dynamics Psychol Life Sci, V10, P409; INGLE D, 1977, VISION RES, V17, P1009, DOI 10.1016/0042-6989(77)90003-7; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KELSO JAS, 1981, B PSYCHONOMIC SOC, V18, P63; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kijima A, PLOS ONE IN PRESS; Lames M, 2006, J SPORT SCI MED, V5, P556; LEE DN, 1982, J EXPT PSYCHOL HUMAN, V8, P448, DOI DOI 10.1037/0096-1523.8.3.448; McGarry T, 1999, J SPORT SCI, V17, P297, DOI 10.1080/026404199366019; McGarry T, 2002, J SPORT SCI, V20, P771, DOI 10.1080/026404102320675620; Nishikawa J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036210; Oullier O, 2002, HUM MOVEMENT SCI, V21, P147, DOI 10.1016/S0167-9457(02)00093-3; Palut Y, 2005, J SPORT SCI, V23, P1021, DOI 10.1080/02640410400021682; Passos P, 2006, BEHAV RES METHODS, V38, P683, DOI 10.3758/BF03193901; Passos P, 2011, J MOTOR BEHAV, V43, P155, DOI 10.1080/00222895.2011.552078; Passos P, 2009, J MOTOR BEHAV, V41, P445, DOI 10.3200/35-08-061; Raab, 2009, PERSPECTIVES COGNITI, P157; Ramenzoni VC, 2011, EXP BRAIN RES, V211, P447, DOI 10.1007/s00221-011-2653-8; Rand MK, 2007, EXP BRAIN RES, V181, P447, DOI 10.1007/s00221-007-0945-9; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Schmidt R, 2010, INT J SPORT PSYCHOL, V41, P105; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; SCHMIDT RC, 1994, ECOL PSYCHOL, V6, P159, DOI 10.1207/s15326969eco0603_1; Schmidt RC, 1999, INT J SPORT PSYCHOL, V30, P558; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Travassos B, 2012, PSYCHOL SPORT EXERC, V13, P216, DOI 10.1016/j.psychsport.2011.11.009; Travassos B, 2011, HUM MOVEMENT SCI, V30, P1245, DOI 10.1016/j.humov.2011.04.003; Vilar L, 2012, SPORTS MED, V42, P1, DOI 10.2165/11596520-000000000-00000; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; Yamamoto Y, 2000, HUM MOVEMENT SCI, V19, P341, DOI 10.1016/S0167-9457(00)00018-X; Yokoyama K, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002181	55	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51877	10.1371/journal.pone.0051877	http://dx.doi.org/10.1371/journal.pone.0051877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	060RA	23284799	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500059
J	Park, C; Rubchinsky, LL				Park, Choongseok; Rubchinsky, Leonid L.			Potential Mechanisms for Imperfect Synchronization in Parkinsonian Basal Ganglia	PLOS ONE			English	Article							EXTERNAL GLOBUS-PALLIDUS; SUBTHALAMIC NUCLEUS; PATHOLOGICAL SYNCHRONIZATION; NEURONAL OSCILLATIONS; BETA OSCILLATIONS; DOPAMINE; PATTERNS; DISEASE	Neural activity in the brain of parkinsonian patients is characterized by the intermittently synchronized oscillatory dynamics. This imperfect synchronization, observed in the beta frequency band, is believed to be related to the hypokinetic motor symptoms of the disorder. Our study explores potential mechanisms behind this intermittent synchrony. We study the response of a bursting pallidal neuron to different patterns of synaptic input from subthalamic nucleus (STN) neuron. We show how external globus pallidus (GPe) neuron is sensitive to the phase of the input from the STN cell and can exhibit intermittent phase-locking with the input in the beta band. The temporal properties of this intermittent phase-locking show similarities to the intermittent synchronization observed in experiments. We also study the synchronization of GPe cells to synaptic input from the STN cell with dependence on the dopamine-modulated parameters. Earlier studies showed how the strengthening of dopamine-modulated coupling may lead to transitions from non-synchronized to partially synchronized dynamics, typical in Parkinson's disease. However, dopamine also affects the cellular properties of neurons. We show how the changes in firing patterns of STN neuron due to the lack of dopamine may lead to transition from a lower to a higher coherent state, roughly matching the synchrony levels observed in basal ganglia in normal and parkinsonian states. The intermittent nature of the neural beta band synchrony in Parkinson's disease is achieved in the model due to the interplay of the timing of STN input to pallidum and pallidal neuronal dynamics, resulting in sensitivity of pallidal output to the phase of the arriving STN input. Thus the mechanism considered here (the change in firing pattern of subthalamic neurons through the dopamine-induced change of membrane properties) may be one of the potential mechanisms responsible for the generation of the intermittent synchronization observed in Parkinson's disease.	[Park, Choongseok; Rubchinsky, Leonid L.] Indiana Univ Purdue Univ Indianapolis, Dept Math Sci, Indianapolis, IN USA; [Park, Choongseok; Rubchinsky, Leonid L.] Indiana Univ Purdue Univ Indianapolis, Ctr Math Biosci, Indianapolis, IN USA; [Rubchinsky, Leonid L.] Indiana Univ, Sch Med, Stark Neurosci Res Inst, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Park, C (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.	21cspark@gmail.com	Rubchinsky, Leonid/L-1896-2017	Rubchinsky, Leonid/0000-0002-6596-4594	National Institutes of Health [R01NS067200]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grant R01NS067200 (NSF/NIH CRCNS program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016201; Baufreton J, 2005, FASEB J, V19, P1771, DOI 10.1096/fj.04-3401hyp; Baufreton J, 2003, J NEUROSCI, V23, P816; Best J, 2007, J COMPUT NEUROSCI, V23, P217, DOI 10.1007/s10827-007-0029-7; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Bezard E, 2003, FASEB J, V17, P2337, DOI 10.1096/fj.03-0291fje; Brown P, 2007, CURR OPIN NEUROBIOL, V17, P656, DOI 10.1016/j.conb.2007.12.001; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cragg SJ, 2004, EUR J NEUROSCI, V20, P1788, DOI 10.1111/j.1460-9568.2004.03629.x; Eusebio A, 2009, EXP NEUROL, V217, P1, DOI 10.1016/j.expneurol.2009.02.003; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Hurtado JA, 2005, J NEUROPHYSIOL, V93, P1569, DOI 10.1152/jn.00829.2004; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; Kuhn AA, 2009, EXP NEUROL, V215, P380, DOI 10.1016/j.expneurol.2008.11.008; Loucif AJC, 2008, NEUROPHARMACOLOGY, V55, P94, DOI 10.1016/j.neuropharm.2008.04.025; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; Maran SK, 2011, J COMPUT NEUROSCI; Park C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042901; Park C, 2010, J NEUROPHYSIOL, V103, P2707, DOI 10.1152/jn.00724.2009; Park G, 2012, INTERMITTEN IN PRESS; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020	26	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51530	10.1371/journal.pone.0051530	http://dx.doi.org/10.1371/journal.pone.0051530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284707	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300029
J	Mahadevan, NR; Anufreichik, V; Rodvold, JJ; Chiu, KT; Sepulveda, H; Zanetti, M				Mahadevan, Navin R.; Anufreichik, Veronika; Rodvold, Jeffrey J.; Chiu, Kevin T.; Sepulveda, Homero; Zanetti, Maurizio			Cell-Extrinsic Effects of Tumor ER Stress Imprint Myeloid Dendritic Cells and Impair CD8(+) T Cell Priming	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; SUPPRESSOR-CELLS; IN-SITU; ANTIGEN; INFLAMMATION; ACTIVATION; TOLERANCE; XBP-1	Tumor-infiltrating myeloid cells, such as dendritic cells (BMDC), are key regulators of tumor growth. However, the tumor-derived signals polarizing BMDC to a phenotype that subverts cell-mediated anti-tumor immunity have yet to be fully elucidated. Addressing this unresolved problem we show that the tumor unfolded protein response (UPR) can function in a cell-extrinsic manner via the transmission of ER stress (TERS) to BMDC. TERS-imprinted BMDC upregulate the production of pro-inflammatory, tumorigenic cytokines but also the immunosuppressive enzyme arginase. Importantly, they downregulate cross-presentation of high-affinity antigen and fail to effectively cross-prime CD8(+) T cells, causing T cell activation without proliferation and similarly dominantly suppress cross-priming by bystander BMDC. Lastly, TERS-imprinted BMDC facilitate tumor growth in vivo with fewer tumor-infiltrating CD8(+) T cells. In sum, we demonstrate that tumor-borne ER stress imprints ab initio BMDC to a phenotype that recapitulates several of the inflammatory/suppressive characteristics ascribed to tumor-infiltrating myeloid cells, highlighting the tumor UPR as a critical controller of anti-tumor immunity and a new target for immune modulation in cancer.	[Mahadevan, Navin R.; Anufreichik, Veronika; Rodvold, Jeffrey J.; Chiu, Kevin T.; Zanetti, Maurizio] Univ Calif San Diego, Dept Med, Immunol Lab, La Jolla, CA 92093 USA; [Mahadevan, Navin R.; Anufreichik, Veronika; Rodvold, Jeffrey J.; Chiu, Kevin T.; Zanetti, Maurizio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Sepulveda, Homero] BD Biosci, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Zanetti, M (corresponding author), Univ Calif San Diego, Dept Med, Immunol Lab, La Jolla, CA 92093 USA.	mzanetti@ucsd.edu			UCSD Academic Senate; UCSD MSTP (University of California, San Diego Medical Scientist Training Program); NIDA (National Institute Drug of Abuse) T32 Training Grant [DA007315 07A2]; Frank H. and Eva B. Buck Foundation; UCSD IMSD (University of California, San Diego Initiative for Maximizing Student Diversity) program; NIH [GM083275]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM083275, T32GM007198] Funding Source: NIH RePORTER	UCSD Academic Senate; UCSD MSTP (University of California, San Diego Medical Scientist Training Program); NIDA (National Institute Drug of Abuse) T32 Training Grant; Frank H. and Eva B. Buck Foundation; UCSD IMSD (University of California, San Diego Initiative for Maximizing Student Diversity) program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the UCSD Academic Senate. N.R.M. acknowledges support from the UCSD MSTP (University of California, San Diego Medical Scientist Training Program) and NIDA (National Institute Drug of Abuse) T32 Training Grant DA007315 07A2. J.J.R. acknowledges support from the Frank H. and Eva B. Buck Foundation and the UCSD IMSD (University of California, San Diego Initiative for Maximizing Student Diversity) program, funded by NIH R25 Grant GM083275. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JC, 2000, EUR J IMMUNOL, V30, P3699, DOI 10.1002/1521-4141(200012)30:12<3699::AID-IMMU3699>3.0.CO;2-2; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Caron E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.68; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Daniel C, 2011, ADV IMMUNOL, V112, P177, DOI 10.1016/B978-0-12-387827-4.00005-X; Deeths MJ, 1999, J IMMUNOL, V163, P102; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Filaci G, 2007, J IMMUNOL, V179, P4323, DOI 10.4049/jimmunol.179.7.4323; Franco A, 2010, CELL IMMUNOL, V266, P1, DOI 10.1016/j.cellimm.2010.09.006; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HUARD B, 1994, IMMUNOGENETICS, V39, P213; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Jamora C, 1996, P NATL ACAD SCI USA, V93, P7690, DOI 10.1073/pnas.93.15.7690; Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kruger K, 2001, EUR J IMMUNOL, V31, P138, DOI 10.1002/1521-4141(200101)31:1<138::AID-IMMU138>3.0.CO;2-P; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Liu QY, 2009, J IMMUNOL, V182, P6207, DOI 10.4049/jimmunol.0803926; Luo B, 2012, ONCOGENE; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mahadevan NR, 2011, J IMMUNOL, V187, P4403, DOI 10.4049/jimmunol.1101531; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Mahic M, 2008, EUR J IMMUNOL, V38, P640, DOI 10.1002/eji.200737529; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marzo AL, 1999, J IMMUNOL, V162, P5838; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Park BY, 2004, IMMUNITY, V20, P71, DOI 10.1016/S1074-7613(03)00355-8; Pellicciotta I, 2008, CANCER RES, V68, P8085, DOI 10.1158/0008-5472.CAN-08-1014; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; PREHN RT, 1972, SCIENCE, V176, P170, DOI 10.1126/science.176.4031.170; Redmond WL, 2007, J IMMUNOL, V179, P7244, DOI 10.4049/jimmunol.179.11.7244; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Spiotto MT, 2010, CANCER RES, V70, P78, DOI 10.1158/0008-5472.CAN-09-2747; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wells AD, 2001, J CLIN INVEST, V108, P895, DOI 10.1172/JCI200113220; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	65	92	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51845	10.1371/journal.pone.0051845	http://dx.doi.org/10.1371/journal.pone.0051845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272178	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300034
J	Sotton, B; Guillard, J; Bony, S; Devaux, A; Domaizon, I; Givaudan, N; Crespeau, F; Huet, H; Anneville, O				Sotton, Benoit; Guillard, Jean; Bony, Sylvie; Devaux, Alain; Domaizon, Isabelle; Givaudan, Nicolas; Crespeau, Francois; Huet, Helene; Anneville, Orlane			Impact of Toxic Cyanobacterial Blooms on Eurasian Perch (Perca fluviatilis): Experimental Study and In Situ Observations in a Peri-Alpine Lake	PLOS ONE			English	Article							PLANKTOTHRIX-RUBESCENS; MICROCYSTIN-LR; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR-MECHANISMS; SUBCHRONIC EXPOSURE; OXIDATIVE STRESS; PEPTIDE TOXIN; COMET ASSAY; FISH; WHITEFISH	Due to the importance of young-of-the-year (YOY) perch in the peri-alpine regions where they are consumed, the microcystin (MC) contamination of YOY perch was analysed both in field (Lake Bourget, France) and experimentally using force-feeding protocols with pure MCs. In-situ, schools of YOY perch present in the epilimnion of the lake were never found in direct contact with the P. rubescens blooms that were present in the metalimnion. However, MCs were detected in the muscles and liver of the fish and were thus assumed to reach YOY perch through dietary routes, particularly via the consumption of MC-containing Daphnia. Force-feeding experiment demonstrates the existence of MC detoxification/excretion processes and suggests that in situ, YOY perch could partly detoxify and excrete ingested MCs, thereby limiting the potential negative effects on perch populations under bloom conditions. However, because of chronic exposure these processes could not allow for the complete elimination of MCs. In both experimental and in situ studies, no histological change was observed in YOY perch, indicating that MC concentrations that occurred in Lake Bourget in 2009 were too low to cause histological damage prone to induce mortality. However, Deoxyribonucleic acid (DNA) damages were observed for both the high and low experimental MC doses, suggesting that similar effects could occur in situ and potentially result in perch population disturbance during cyanobacterial blooms. Our results indicate the presence of MCs in wild perch, the consumption of this species coming from Lake Bourget is not contested but more analyses are needed to quantify the risk.	[Sotton, Benoit; Guillard, Jean; Domaizon, Isabelle; Givaudan, Nicolas; Anneville, Orlane] INRA, UMR CARRTEL, Thonon Les Bains, France; [Bony, Sylvie; Devaux, Alain] Univ Lyon, LEHNA, UMR 5023, ENTPE, Vaulx En Velin, France; [Givaudan, Nicolas] Univ Rennes 1, UMR CNRS Ecobio 6553, Rennes, France; [Crespeau, Francois; Huet, Helene] Ecole Natl Vet, Anat Pathol Lab, F-94704 Maisons Alfort, France; [Bony, Sylvie; Devaux, Alain] INRA, USC IGH, ENTPE, Vaulx En Velin, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE	Sotton, B (corresponding author), INRA, UMR CARRTEL, Thonon Les Bains, France.	benoit.sotton@thonon.inra.fr	GUILLARD, Jean/A-2577-2011; Domaizon, Isabelle/A-2517-2011; Guillard, Jean/AAP-9870-2020	GUILLARD, Jean/0000-0003-0116-1167; Domaizon, Isabelle/0000-0001-9785-3082; Guillard, Jean/0000-0003-0116-1167; HUET, Helene/0000-0003-1910-5825	Rhone-Alpes region; ONEMA (Office National de l'Eau et des Milieux Aquatiques); department "Ecologie des forets, Prairies et milieux Aquatiques'' (EFPA) of the "Institut National de la Recherche agronomique'' (INRA)	Rhone-Alpes region(Region Auvergne-Rhone-Alpes); ONEMA (Office National de l'Eau et des Milieux Aquatiques); department "Ecologie des forets, Prairies et milieux Aquatiques'' (EFPA) of the "Institut National de la Recherche agronomique'' (INRA)	B.S.'s PhD is a CIBLE project funded by the Rhone-Alpes region. N.G.'s CDD and experiments were financed by ONEMA (Office National de l'Eau et des Milieux Aquatiques). The in-situ sampling and data analyses were part of "Projet innovant'' funded by the department "Ecologie des forets, Prairies et milieux Aquatiques'' (EFPA) of the "Institut National de la Recherche agronomique'' (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anneville O, 2004, FRESHWATER BIOL, V49, P98, DOI 10.1046/j.1365-2426.2003.01167.x; Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2; Baganz D, 2004, ENVIRON TOXICOL, V19, P564, DOI 10.1002/tox.20063; BOYSE E A, 1964, Methods Med Res, V10, P39; Brancroft JD, 2008, THEORY PRACTICE HIST; Briand JF, 2005, MICROB ECOL, V50, P418, DOI 10.1007/s00248-005-0186-z; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; Carbis CR, 1996, J FISH DIS, V19, P199, DOI 10.1111/j.1365-2761.1996.tb00126.x; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Codd GA, 2005, TOXICOL APPL PHARM, V203, P264, DOI 10.1016/j.taap.2004.02.016; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Craig M, 1996, BIOCHEM CELL BIOL, V74, P569, DOI 10.1139/o96-061; Cuypers Y, 2011, ISME J, V5, P580, DOI 10.1038/ismej.2010.154; D'Alelio D, 2011, FRESHWATER BIOL, V56, P1481, DOI 10.1111/j.1365-2427.2011.02584.x; David J, 1967, B FR PISCIC, V224, P81, DOI DOI 10.1051/KMAE:1967009; Dawson RM, 1998, TOXICON, V36, P953, DOI 10.1016/S0041-0101(97)00102-5; Ernst B, 2005, ENVIRON TOXICOL, V20, P449, DOI 10.1002/tox.20131; Ernst B, 2001, ENVIRON TOXICOL, V16, P483, DOI 10.1002/tox.10006.abs; Ernst B, 2007, AQUAT TOXICOL, V82, P15, DOI 10.1016/j.aquatox.2007.01.007; Ernst B, 2006, AQUAT TOXICOL, V79, P31, DOI 10.1016/j.aquatox.2006.04.013; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; Feuillade J., 1994, ARCH HYDROBIOL, V41, P77; Fischer WJ, 2000, TOXICOL APPL PHARM, V164, P73, DOI 10.1006/taap.1999.8861; Gkelis S, 2006, AQUAT TOXICOL, V78, P32, DOI 10.1016/j.aquatox.2006.02.001; Guillard J, 2006, FISHERIES MANAG ECOL, V13, P319, DOI 10.1111/j.1365-2400.2006.00508.x; Guillard J, 2011, LIMNOL OCEANOGR-METH, V9, P322, DOI 10.4319/lom.2011.9.322; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Ibelings BW, 2005, MICROB ECOL, V49, P487, DOI 10.1007/s00248-004-0014-x; Jacquet S, 2005, HARMFUL ALGAE, V4, P651, DOI 10.1016/j.hal.2003.12.006; Jann-Para G, 2004, TOXICON, V43, P279, DOI 10.1016/j.toxicon.2003.12.005; Jos A, 2005, AQUAT TOXICOL, V72, P261, DOI 10.1016/j.aquatox.2005.01.003; KARAS P, 1992, J FISH BIOL, V41, P217, DOI 10.1111/j.1095-8649.1992.tb02652.x; Leboulanger C, 2002, AQUAT MICROB ECOL, V30, P83, DOI 10.3354/ame030083; Li XY, 2003, TOXICON, V42, P85, DOI 10.1016/S0041-0101(03)00104-1; MACKINTOSH RW, 1995, FEBS LETT, V371, P236, DOI 10.1016/0014-5793(95)00888-G; Malbrouck C, 2003, COMP BIOCHEM PHYS C, V135, P39, DOI 10.1016/S1532-0456(03)00047-4; Malbrouck C, 2006, ENVIRON TOXICOL CHEM, V25, P72, DOI 10.1897/05-029R.1; Mankiewicz-Boczek J, 2011, HARMFUL ALGAE, V10, P356, DOI 10.1016/j.hal.2011.01.001; Masson S, 2001, J PLANKTON RES, V23, P1041, DOI 10.1093/plankt/23.10.1041; McElhiney J, 2005, TOXICOL APPL PHARM, V203, P219, DOI 10.1016/j.taap.2004.06.002; Metcalf JS, 2000, FEMS MICROBIOL LETT, V189, P155, DOI 10.1111/j.1574-6968.2000.tb09222.x; Neffling MR, 2010, ENVIRON POLLUT, V158, P948, DOI 10.1016/j.envpol.2009.10.023; Oberhaus L, 2007, J PHYCOL, V43, P1191, DOI 10.1111/j.1529-8817.2007.00414.x; OLIVE PL, 1993, RADIAT RES, V136, P130, DOI 10.2307/3578650; Paulino S, 2009, HYDROBIOLOGIA, V621, P207, DOI 10.1007/s10750-008-9640-5; Prieto AI, 2006, AQUAT TOXICOL, V77, P314, DOI 10.1016/j.aquatox.2005.12.012; Probst WN, 2009, FISH RES, V96, P133, DOI 10.1016/j.fishres.2008.10.009; RABERGH CMI, 1991, AQUAT TOXICOL, V20, P131, DOI 10.1016/0166-445X(91)90012-X; Repka S, 1997, FRESHWATER BIOL, V38, P675, DOI 10.1046/j.1365-2427.1997.00236.x; Sahin A, 1996, TOXICOLOGY, V106, P123, DOI 10.1016/0300-483X(95)03173-D; Simmonds J., 2005, FISHERIES ACOUSTICS; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smith JL, 2010, ECOTOX ENVIRON SAFE, V73, P757, DOI 10.1016/j.ecoenv.2009.12.003; Smith JL, 2009, TOXICON, V53, P238, DOI 10.1016/j.toxicon.2008.11.007; Sotton B, 2012, ECOTOXICOLOGY, V21, P1788, DOI 10.1007/s10646-012-0913-4; Sotton B, 2011, HARMFUL ALGAE, V10, P749, DOI 10.1016/j.hal.2011.06.006; STRASKRABA M, 1964, LIMNOL OCEANOGR, V9, P268, DOI 10.4319/lo.1964.9.2.0268; Tencalla F, 1997, TOXICON, V35, P583, DOI 10.1016/S0041-0101(96)00153-5; TENCALLA FG, 1994, AQUAT TOXICOL, V30, P215, DOI 10.1016/0166-445X(94)90059-0; Trinchet I, 2011, REPROD TOXICOL, V32, P329, DOI 10.1016/j.reprotox.2011.07.006; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Walsby AE, 2006, NEW PHYTOL, V169, P109, DOI 10.1111/j.1469-8137.2005.01567.x; WANG N, 1994, HYDROBIOLOGIA, V277, P135, DOI 10.1007/BF00007295; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x; Williams DE, 1997, TOXICON, V35, P985, DOI 10.1016/S0041-0101(96)00196-1; Williams DE, 1997, CHEM RES TOXICOL, V10, P463, DOI 10.1021/tx9601519; Wilson AE, 2008, CAN J FISH AQUAT SCI, V65, P1487, DOI 10.1139/F08-067; Zhang DW, 2012, ECOTOXICOLOGY, V21, P244, DOI 10.1007/s10646-011-0783-1; Zhang DW, 2009, SCI TOTAL ENVIRON, V407, P2191, DOI 10.1016/j.scitotenv.2008.12.039	70	11	11	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52243	10.1371/journal.pone.0052243	http://dx.doi.org/10.1371/journal.pone.0052243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272228	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300071
J	Vink, JM; Bartels, M; van Beijsterveldt, TCEM; van Dongen, J; van Beek, JHDA; Distel, MA; de Moor, MHM; Smit, DJA; Minica, CC; Ligthart, L; Geels, LM; Abdellaoui, A; Middeldorp, CM; Hottenga, JJ; Willemsen, G; de Geus, EJC; Boomsma, DI				Vink, Jacqueline M.; Bartels, Meike; van Beijsterveldt, Toos C. E. M.; van Dongen, Jenny; van Beek, Jenny H. D. A.; Distel, Marijn A.; de Moor, Marleen H. M.; Smit, Dirk J. A.; Minica, Camelia C.; Ligthart, Lannie; Geels, Lot M.; Abdellaoui, Abdel; Middeldorp, Christel M.; Hottenga, Jouke Jan; Willemsen, Gonneke; de Geus, Eco J. C.; Boomsma, Dorret I.			Sex Differences in Genetic Architecture of Complex Phenotypes?	PLOS ONE			English	Article							NETHERLANDS TWIN REGISTER; MODEL	We examined sex differences in familial resemblance for a broad range of behavioral, psychiatric and health related phenotypes (122 complex traits) in children and adults. There is a renewed interest in the importance of genotype by sex interaction in, for example, genome-wide association (GWA) studies of complex phenotypes. If different genes play a role across sex, GWA studies should consider the effect of genetic variants separately in men and women, which affects statistical power. Twin and family studies offer an opportunity to compare resemblance between opposite-sex family members to the resemblance between same-sex relatives, thereby presenting a test of quantitative and qualitative sex differences in the genetic architecture of complex traits. We analyzed data on lifestyle, personality, psychiatric disorder, health, growth, development and metabolic traits in dizygotic (DZ) same-sex and opposite-sex twins, as these siblings are perfectly matched for age and prenatal exposures. Sample size varied from slightly over 300 subjects for measures of brain function such as EEG power to over 30,000 subjects for childhood psychopathology and birth weight. For most phenotypes, sample sizes were large, with an average sample size of 9027 individuals. By testing whether the resemblance in DZ opposite-sex pairs is the same as in DZ same-sex pairs, we obtain evidence for genetic qualitative sex-differences in the genetic architecture of complex traits for 4% of phenotypes. We conclude that for most traits that were examined, the current evidence is that same the genes are operating in men and women.	[Vink, Jacqueline M.; Bartels, Meike; van Beijsterveldt, Toos C. E. M.; van Dongen, Jenny; van Beek, Jenny H. D. A.; Distel, Marijn A.; de Moor, Marleen H. M.; Smit, Dirk J. A.; Minica, Camelia C.; Ligthart, Lannie; Geels, Lot M.; Abdellaoui, Abdel; Middeldorp, Christel M.; Hottenga, Jouke Jan; Willemsen, Gonneke; de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Netherlands Twin Register, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Vink, JM (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, Netherlands Twin Register, Amsterdam, Netherlands.	jm.vink@vu.nl	Middeldorp, Christel M/L-7728-2017; de Moor, Marleen/J-7434-2019; de Geus, Eco J.C./M-9318-2015; Boomsma, Dorret I/AAX-4470-2020; Bartels, Meike/D-4492-2014	Middeldorp, Christel M/0000-0002-6218-0428; de Moor, Marleen/0000-0001-7177-5637; de Geus, Eco J.C./0000-0001-6022-2666; Bartels, Meike/0000-0002-9667-7555; Smit, Dirk/0000-0001-8301-8860; Ligthart, Lannie/0000-0002-6570-3319; van Dongen, Jenny/0000-0003-2063-8741; Minica, Camelia/0000-0001-7140-8167; van Beijsterveldt, Toos/0000-0002-6617-4201; Willemsen, Gonneke/0000-0003-3755-0236	Netherlands Organization for Scientific Research (NWO: MagW/ZonMW): Genetic basis of anxiety and depression [904-61-090]; Genetics of individual differences in smoking initiation and persistence [NWO 985-10-002]; Resolving cause and effect in the association between exercise and well-being [904-61-193]; Twin family database for behavior genomics studies [480-04-004]; Twin research focusing on behavior [400-05-717]; Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder [Addiction-31160008]; Genotype/phenotype database for behavior genetic and genetic epidemiological studies [911-09-032]; Spinozapremie [SPI 56-464-14192]; VU University: Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); European Research Council (ERC) Genetics of Mental Illness [230374]; Genetic influences on stability and change in psychopathology from childhood to young adulthood [ZonMW 912-10-020]; ERC [284167]; NWO-VENI [NWO 916-76-125]	Netherlands Organization for Scientific Research (NWO: MagW/ZonMW): Genetic basis of anxiety and depression; Genetics of individual differences in smoking initiation and persistence; Resolving cause and effect in the association between exercise and well-being(Estonian Research Council); Twin family database for behavior genomics studies; Twin research focusing on behavior; Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder; Genotype/phenotype database for behavior genetic and genetic epidemiological studies; Spinozapremie; VU University: Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); European Research Council (ERC) Genetics of Mental Illness(European Research Council (ERC)); Genetic influences on stability and change in psychopathology from childhood to young adulthood; ERC(European Research Council (ERC)European Commission); NWO-VENI(Netherlands Organization for Scientific Research (NWO))	Funding was obtained from the Netherlands Organization for Scientific Research (NWO: MagW/ZonMW): Genetic basis of anxiety and depression (904-61-090); Genetics of individual differences in smoking initiation and persistence (NWO 985-10-002); Resolving cause and effect in the association between exercise and well-being (904-61-193); Twin family database for behavior genomics studies (480-04-004); Twin research focusing on behavior (400-05-717); Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder (Addiction-31160008); Genotype/phenotype database for behavior genetic and genetic epidemiological studies (911-09-032); Spinozapremie (SPI 56-464-14192); the VU University: Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA); the European Research Council (ERC) Genetics of Mental Illness (230374); Genetic influences on stability and change in psychopathology from childhood to young adulthood (ZonMW 912-10-020). JV was supported by ERC starting grant 284167. CMM was supported by NWO-VENI (NWO 916-76-125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels M, 2007, TWIN RES HUM GENET, V10, P3, DOI 10.1375/twin.10.1.3; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Eaves L, 2000, BEHAV GENET, V30, P321, DOI 10.1023/A:1026553518272; EAVES L, 1976, HEREDITY, V36, P205, DOI 10.1038/hdy.1976.25; Eaves LJ, 1997, J CHILD PSYCHOL PSYC, V38, P965, DOI 10.1111/j.1469-7610.1997.tb01614.x; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; Falconer DS, 1996, QUANTITATIVE GENETIC; Falconer DS, 1996, QUANTITATIVE GENETIC; Haberstick BC, 2011, ADDICTION, V106, P215, DOI 10.1111/j.1360-0443.2010.03129.x; Hindorff L, 2012, CATALOG PUBLISHED GE; Jacquard A., 1974, GENETIC STRUCTURE PO; Lynch M., 1998, GENETICS ANAL QUANTI; Meier MH, 2011, J ABNORM PSYCHOL, V120, P377, DOI 10.1037/a0022303; Mook-Kanamori DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039901; Neale M. C., 2006, MX STAT MODELING, V7th; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Randall JC, SEX STRATIFIED GENOM, V270; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Smit DJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036896; Tackett JL, 2011, J AM ACAD CHILD PSY, V50, P818, DOI 10.1016/j.jaac.2011.05.007; van Dongen J, 2012, NAT REV GENET, V13, P640, DOI 10.1038/nrg3243; van Soelen ILC, 2012, TWIN RES HUM GENET, V15, P453, DOI 10.1017/thg.2012.4; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Willemsen G, 2010, TWIN RES HUM GENET, V13, P231, DOI 10.1375/twin.13.3.231	25	55	55	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e47371	10.1371/journal.pone.0047371	http://dx.doi.org/10.1371/journal.pone.0047371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272036	Green Published, gold			2022-12-25	WOS:000312483300001
J	Chao, HH; He, XP; Parker, JS; Zhao, W; Perou, CM				Chao, Hann-Hsiang; He, Xiaping; Parker, Joel S.; Zhao, Wei; Perou, Charles M.			Micro-Scale Genomic DNA Copy Number Aberrations as Another Means of Mutagenesis in Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; MAMMARY EPITHELIAL-CELLS; ONCOGENE AMPLIFICATION; MOLECULAR PORTRAITS; TUMOR-SUPPRESSOR; BASAL-LIKE; INSTABILITY; MUTATIONS; SUBTYPES; BRCA1	Introduction: In breast cancer, the basal-like subtype has high levels of genomic instability relative to other breast cancer subtypes with many basal-like-specific regions of aberration. There is evidence that this genomic instability extends to smaller scale genomic aberrations, as shown by a previously described micro-deletion event in the PTEN gene in the Basal-like SUM149 breast cancer cell line. Methods: We sought to identify if small regions of genomic DNA copy number changes exist by using a high density, gene-centric Comparative Genomic Hybridizations (CGH) array on cell lines and primary tumors. A custom tiling array for CGH (244,000 probes, 200 bp tiling resolution) was created to identify small regions of genomic change, which was focused on previously identified basal-like-specific, and general cancer genes. Tumor genomic DNA from 94 patients and 2 breast cancer cell lines was labeled and hybridized to these arrays. Aberrations were called using SWITCHdna and the smallest 25% of SWITCHdna-defined genomic segments were called micro-aberrations (<64 contiguous probes, similar to 15 kb). Results: Our data showed that primary tumor breast cancer genomes frequently contained many small-scale copy number gains and losses, termed micro-aberrations, most of which are undetectable using typical-density genome-wide aCGH arrays. The basal-like subtype exhibited the highest incidence of these events. These micro-aberrations sometimes altered expression of the involved gene. We confirmed the presence of the PTEN micro-amplification in SUM149 and by mRNA-seq showed that this resulted in loss of expression of all exons downstream of this event. Micro-aberrations disproportionately affected the 59 regions of the affected genes, including the promoter region, and high frequency of micro-aberrations was associated with poor survival. Conclusion: Using a high-probe-density, gene-centric aCGH microarray, we present evidence of small-scale genomic aberrations that can contribute to gene inactivation. These events may contribute to tumor formation through mechanisms not detected using conventional DNA copy number analyses.	[Chao, Hann-Hsiang; He, Xiaping; Parker, Joel S.; Zhao, Wei; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Chao, Hann-Hsiang] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [He, Xiaping; Parker, Joel S.; Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Zhao, Wei] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC USA; [Perou, Charles M.] Univ N Carolina, Carolina Genome Sci Ctr, Chapel Hill, NC USA; [Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Perou, CM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	cperou@med.unc.edu	Parker, Joel/AAG-1108-2019; Perou, Charles M/H-9934-2014	Perou, Charles M/0000-0001-9827-2247	National Cancer Insitute Breast SPORE program [P50-CA58223-09A1]; Breast Cancer Research Foundation;  [RO1-CA138255];  [RO1-CA148761];  [T32-GM008719];  [F30-ES018038]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA148761, R01CA138255, P50CA058223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, F30ES018038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER	National Cancer Insitute Breast SPORE program; Breast Cancer Research Foundation; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Cancer Insitute Breast SPORE program (P50-CA58223-09A1), by RO1-CA138255, RO1-CA148761, T32-GM008719, F30-ES018038, and by the Breast Cancer Research Foundation (http://www.bcrfcure.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; ETHIER SP, 1993, CANCER RES, V53, P627; Fedele CG, 2010, P NATL ACAD SCI US; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hatakeyama H, 2009, J CLIN ONCOL, V27; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Jiang Z, 2010, J CLIN INVEST; Johannsdottir HK, 2006, INT J CANCER, V119, P1052, DOI 10.1002/ijc.21934; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kristensen GB, 2003, ANN ONCOL, V14, P1494, DOI 10.1093/annonc/mdg403; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; R Development Core Team, 2009, R FDN STAT COMP; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Sakakura C, 1999, GENE CHROMOSOME CANC, V24, P299, DOI 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936, DOI 10.1200/JCO.1993.11.10.1936; SESHADRI R, 1989, INT J CANCER, V43, P270, DOI 10.1002/ijc.2910430218; Shen ZY, 2011, J MOL CELL BIOL, V3, P1, DOI 10.1093/jmcb/mjq057; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tran LM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-121; Trope C, 2000, ANN ONCOL, V11, P281, DOI 10.1023/A:1008399414923; Van Loo P, 2010, P NATL ACAD SCI US; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Weigman VJ, 2012, BREAST CANC RES TREA; Wood LD, 2007, SCIENCE; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250	43	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51719	10.1371/journal.pone.0051719	http://dx.doi.org/10.1371/journal.pone.0051719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284754	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900050
J	Distler, MG; Opal, MD; Dulawa, SC; Palmer, AA				Distler, Margaret G.; Opal, Mark D.; Dulawa, Stephanie C.; Palmer, Abraham A.			Assessment of Behaviors Modeling Aspects of Schizophrenia in Csmd1 Mutant Mice	PLOS ONE			English	Article							STARCH SYNTHESIS; ANTISENSE REPRESSION; POTATO PLANTS; PHOSPHOGLUCOMUTASE; CARBON; YIELD	Schizophrenia is a debilitating psychotic disorder that affects up to 1.5% of the population worldwide. Two recent studies in humans identified genome-wide significant associations between schizophrenia and single-nucleotide polymorphisms (SNPs) in an intron of CSMD1. The effect of deleting CSMD1 on mouse behavior is unknown. The present study utilized mice with a mutant Csmd1 allele in which the first exon had been ablated (KO mice). All Csmd1 transcripts that included the first exon were absent in the brains of KO mice, but there was persistent expression of at least one other transcript that does not include the first exon. Wild type (WT), heterozygous (HET), and KO mice were assessed using several well-established behavioral paradigms that model aspects of schizophrenia. Csmd1 KO mice did not differ from wild-type littermates for sensorimotor gating (measured as prepulse inhibition), social interaction, anhedonia (measured by sucrose preference), or sensitivity to the locomotor stimulant effects of the dopaminergic agent d-amphetamine. These data demonstrate that loss of Csmd1 transcripts that include the first exon does not alter multiple well-established behaviors that model aspects of schizophrenia. The SNP most strongly associated with schizophrenia in humans is between exons 3 and 4; therefore, ablation of exon 1 appeared to be a logical animal model. Nevertheless, future studies should consider alternative mouse models including gain-of-function mutations, and loss-of-function mutations that target alternative transcripts of Csmd1.	[Dulawa, Stephanie C.; Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Distler, Margaret G.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Opal, Mark D.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Palmer, Abraham A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Palmer, AA (corresponding author), Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA.	aap@uchicago.edu	Palmer, Abraham/L-2158-2014; Dulawa, Stephanie/M-8070-2016	Palmer, Abraham/0000-0003-3634-0747; Dulawa, Stephanie/0000-0003-1281-782X	NIH [GM07281, GM07839, MH079424, MH079103, DA021336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281, T32GM007839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079424, R01MH079103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants GM07281 (M. G. D.), GM07839 (M.D.O.), MH079424 (S. C. D.), MH079103 (A. A. P.) and DA021336 (A. A. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernie AR, 2002, PLANT PHYSIOL BIOCH, V40, P921, DOI 10.1016/S0981-9428(02)01457-2; Fernie AR, 2002, PLANTA, V214, P510, DOI 10.1007/s004250100644; Fettke J, 2010, NEW PHYTOL, V185, P663, DOI 10.1111/j.1469-8137.2009.03126.x; Geigenberger P, 2001, PLANT PHYSIOL, V125, P1667, DOI 10.1104/pp.125.4.1667; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Jeong JS, 2007, J CHROMATOGR A, V1164, P167, DOI 10.1016/j.chroma.2007.07.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lytovchenko A, 2007, CURR OPIN PLANT BIOL, V10, P227, DOI 10.1016/j.pbi.2007.04.002; Nielsen Kare Lehmann, 2008, V387, P81; Nielsen KL, 2008, NEXT GENERATION SEQU, P229; Regierer B, 2002, NAT BIOTECHNOL, V20, P1256, DOI 10.1038/nbt760; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; Streb S, 2009, PLANT PHYSIOL, V151, P1769, DOI 10.1104/pp.109.144931; Sweetlove LJ, 1999, PLANTA, V209, P330, DOI 10.1007/s004250050640; Tauberger E, 2000, PLANT J, V23, P43, DOI 10.1046/j.1365-313x.2000.00783.x; Tjaden J, 1998, PLANT J, V16, P531, DOI 10.1046/j.1365-313X.1998.00317.x; Vreugdenhil Dick, 2007, pV, DOI 10.1016/B978-044451018-1/50040-3; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	20	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51235	10.1371/journal.pone.0051235	http://dx.doi.org/10.1371/journal.pone.0051235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284669	gold, Green Published			2022-12-25	WOS:000312435900016
J	Li, QX; Wu, HL; Chen, B; Hu, GY; Huang, L; Qin, K; Chen, Y; Yuan, XL; Liao, ZX				Li, Qianxia; Wu, Huanlei; Chen, Bei; Hu, Guangyuan; Huang, Liu; Qin, Kai; Chen, Yu; Yuan, Xianglin; Liao, Zhongxing			SNPs in the TGF-beta Signaling Pathway Are Associated with Increased Risk of Brain Metastasis in Patients with Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							PROPHYLACTIC CRANIAL IRRADIATION; THERAPY-ONCOLOGY-GROUP; GROWTH-FACTOR-BETA; RADIATION-THERAPY; GENETIC-VARIATIONS; ACTIVIN-A; CARCINOMA; CHEMORADIOTHERAPY; FOLLISTATIN; EXPRESSION	Purpose: Brain metastasis (BM) from non-small cell lung cancer (NSCLC) is relatively common, but identifying which patients will develop brain metastasis has been problematic. We hypothesized that genotype variants in the TGF-beta signaling pathway could be a predictive biomarker of brain metastasis. Patients and Methods: We genotyped 33 SNPs from 13 genes in the TGF-beta signaling pathway and evaluated their associations with brain metastasis risk by using DNA from blood samples from 161 patients with NSCLC. Kaplan-Meier analysis was used to assess brain metastasis risk; Cox hazard analyses were used to evaluate the effects of various patient and disease characteristics on the risk of brain metastasis. Results: The median age of the 116 men and 45 women in the study was 58 years; 62 (39%) had stage IIIB or IV disease. Within 24 months after initial diagnosis of lung cancer, brain metastasis was found in 60 patients (37%). Of these 60 patients, 16 had presented with BM at diagnosis. Multivariate analysis showed the GG genotype of SMAD6: rs12913975 and TT genotype of INHBC: rs4760259 to be associated with a significantly higher risk of brain metastasis at 24 months follow-up (hazard ratio [HR] 2.540, 95% confidence interval [CI] 1.204-5.359, P = 0.014; and HR 1.885, 95% CI 1.086-3.273, P = 0.024), compared with the GA or CT/CC genotypes, respectively. When we analyzed combined subgroups, these rates showed higher for those having both the GG genotype of SMAD6: rs12913975 and the TT genotype of INHBC: rs4760259 (HR 2.353, 95% CI 1.390-3.985, P = 0.001). Conclusions: We found the GG genotype of SMAD6: rs12913975 and TT genotype of INHBC: rs4760259 to be associated with risk of brain metastasis in patients with NSCLC. This finding, if confirmed, can help to identify patients at high risk of brain metastasis.	[Li, Qianxia; Wu, Huanlei; Hu, Guangyuan; Huang, Liu; Qin, Kai; Chen, Yu; Yuan, Xianglin] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan 430074, Hubei Province, Peoples R China; [Liao, Zhongxing] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Chen, Bei] Hubei Prov Tumor Hosp, Dept Electrocardiog Room, Wuhan, Hubei Province, Peoples R China	Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center	Yuan, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan 430074, Hubei Province, Peoples R China.	yxl@medmail.com.cn			National Natural Science Foundation [81071832]; Hubei Provincial Health Office [JX5A01]; Wuhan Planning Project of Science and Technology [201161038339-07]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hubei Provincial Health Office; Wuhan Planning Project of Science and Technology	This study was funded by the National Natural Science Foundation ( grant 81071832), a Key Project of Hubei Provincial Health Office grant (JX5A01), and a Wuhan Planning Project of Science and Technology grant (201161038339-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auperin A, 1999, NEW ENGL J MED, V341, P476, DOI 10.1056/NEJM199908123410703; Ball EMA, 2001, DEV BIOL, V238, P1, DOI 10.1006/dbio.2001.0399; Bovi JA, 2012, CURR ONCOL REP, V14, P55, DOI 10.1007/s11912-011-0208-6; Butler CM, 2005, CYTOKINE GROWTH F R, V16, P377, DOI 10.1016/j.cytogfr.2005.04.005; Ceresoli GL, 2002, CANCER, V95, P605, DOI 10.1002/cncr.10687; Cox JD, 1999, INT J RADIAT ONCOL, V43, P505, DOI 10.1016/S0360-3016(98)00429-5; COX JD, 1981, JAMA-J AM MED ASSOC, V245, P469, DOI 10.1001/jama.245.5.469; de Kretser DM, 2002, HUM REPROD UPDATE, V8, P529, DOI 10.1093/humupd/8.6.529; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Gaspar LE, 2000, INT J RADIAT ONCOL, V47, P1001, DOI 10.1016/S0360-3016(00)00547-2; Gore EM, 2011, J CLIN ONCOL, V29, P272, DOI 10.1200/JCO.2010.29.1609; Grinberg-Rashi H, 2009, CLIN CANCER RES, V15, P1755, DOI 10.1158/1078-0432.CCR-08-2124; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; HULLY JR, 1994, HEPATOLOGY, V20, P854, DOI 10.1002/hep.1840200413; Javelaud D, 2008, PIGM CELL MELANOMA R, V21, P123, DOI 10.1111/j.1755-148X.2008.00450.x; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Jones KL, 2004, MOL CELL ENDOCRINOL, V225, P119, DOI 10.1016/j.mce.2004.07.010; Khuri FR, 2001, CANCER EPIDEM BIOMAR, V10, P823; Le Page C, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-4; Lin MB, 2011, CARCINOGENESIS, V32, P1050, DOI 10.1093/carcin/bgr067; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McDowell N, 1999, SEMIN CELL DEV BIOL, V10, P311, DOI 10.1006/scdb.1999.0307; Meert AP, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-5; Mellor SL, 2003, ENDOCRINOLOGY, V144, P4410, DOI 10.1210/en.2003-0225; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Nathoo N, 2005, J CLIN PATHOL, V58, P237, DOI 10.1136/jcp.2003.013623; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Pui Ching-Hon, 2006, Hematology Am Soc Hematol Educ Program, P142; Robnett TJ, 2001, J CLIN ONCOL, V19, P1344, DOI 10.1200/JCO.2001.19.5.1344; RUSSELL AH, 1991, INT J RADIAT ONCOL, V21, P637, DOI 10.1016/0360-3016(91)90681-S; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; Subramanian A, 2002, LANCET ONCOL, V3, P498, DOI 10.1016/S1470-2045(02)00819-7; UMSAWASDI T, 1984, J NEURO-ONCOL, V2, P253; Vejda S, 2003, CARCINOGENESIS, V24, P1801, DOI 10.1093/carcin/bgg154; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Yin JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025559; Yuan XL, 2009, J CLIN ONCOL, V27, P3370, DOI 10.1200/JCO.2008.20.6763	37	19	20	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51713	10.1371/journal.pone.0051713	http://dx.doi.org/10.1371/journal.pone.0051713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284751	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900049
J	Lan, ML; Acharya, MM; Tran, KK; Bahari-Kashani, J; Patel, NH; Strnadel, J; Giedzinski, E; Limoli, CL				Lan, Mary L.; Acharya, Munjal M.; Tran, Katherine K.; Bahari-Kashani, Jessica; Patel, Neal H.; Strnadel, Jan; Giedzinski, Erich; Limoli, Charles L.			Characterizing the Radioresponse of Pluripotent and Multipotent Human Stem Cells	PLOS ONE			English	Article							NEURAL PRECURSOR CELLS; APOPTOSIS; ARREST; STATE	The potential capability of stem cells to restore functionality to diseased or aged tissues has prompted a surge of research, but much work remains to elucidate the response of these cells to genotoxic agents. To more fully understand the impact of irradiation on different stem cell types, the present study has analyzed the radioresponse of human pluripotent and multipotent stem cells. Human embryonic stem (ES) cells, human induced pluripotent (iPS) cells, and iPS-derived human neural stem cells (iPS-hNSCs) cells were irradiated and analyzed for cell survival parameters, differentiation, DNA damage and repair and oxidative stress at various times after exposure. While irradiation led to dose-dependent reductions in survival, the fraction of surviving cells exhibited dose-dependent increases in metabolic activity. Irradiation did not preclude germ layer commitment of ES cells, but did promote neuronal differentiation. ES cells subjected to irradiation exhibited early apoptosis and inhibition of cell cycle progression, but otherwise showed normal repair of DNA double-strand breaks. Cells surviving irradiation also showed acute and persistent increases in reactive oxygen and nitrogen species that were significant at nearly all post-irradiation times analyzed. We suggest that stem cells alter their redox homeostasis to adapt to adverse conditions and that radiation-induced oxidative stress plays a role in regulating the function and fate of stem cells within tissues compromised by radiation injury. Citation: Lan ML, Acharya MM, Tran KK, Bahari-Kashani J, Patel NH, et al. (2012) Characterizing the Radioresponse of Pluripotent and Multipotent Human Stem Cells. PLoS ONE 7(12): e50048. doi:10.1371/journal.pone.0050048	[Lan, Mary L.; Acharya, Munjal M.; Tran, Katherine K.; Bahari-Kashani, Jessica; Patel, Neal H.; Giedzinski, Erich; Limoli, Charles L.] Univ Calif Irvine, Dept Radiat Oncol, Irvine, CA 92717 USA; [Strnadel, Jan] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA	University of California System; University of California Irvine; University of California System; University of California San Diego	Limoli, CL (corresponding author), Univ Calif Irvine, Dept Radiat Oncol, Irvine, CA 92717 USA.	climoli@uci.edu	Strnadel, Jan/Y-5172-2018; Limoli, Charles/AAW-1748-2020	Strnadel, Jan/0000-0002-7233-6537; Limoli, Charles/0000-0002-1321-4142	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS) [R01 NS074388]; California Institute for Regenerative Medicine (CIRM) [RS1-00413]; CIRM Training Grant [TG2-0115]; NASA Grant [NNX09AK25G]; Office of Science (BER) U.S. Department of Energy [DE-FG02-09ER64798]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074388] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); CIRM Training Grant; NASA Grant(National Aeronautics & Space Administration (NASA)); Office of Science (BER) U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS) grant R01 NS074388 (C.L.L.), California Institute for Regenerative Medicine (CIRM) Grant RS1-00413 (C.L.L.), CIRM Training Grant TG2-0115 (M.M.A.), NASA Grant NNX09AK25G (C.L.L.) and Office of Science (BER) U.S. Department of Energy grant no. DE-FG02-09ER64798 (C.L.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya MM, 2010, FREE RADIC BIOL MED; Barani IJ, 2007, INT J RADIAT ONCOL, V68, P324, DOI 10.1016/j.ijrobp.2007.01.033; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Fike JR, 2009, SEMIN RADIAT ONCOL, V19, P122, DOI 10.1016/j.semradonc.2008.12.003; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; Giedzinski E, 2005, RADIAT RES, V164, P540, DOI 10.1667/RR3369.1; Globus RK, 2012, OXID STRESS APPL BAS, P169, DOI 10.1007/978-1-61779-397-4_9; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Jamal M, 2010, CLIN CANCER RES, V16, P6049, DOI 10.1158/1078-0432.CCR-10-2435; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Limoli CL, 2007, RADIAT ENVIRON BIOPH, V46, P167, DOI 10.1007/s00411-006-0077-9; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Pereira A, 2010, PROG NEUROBIOL, V92, P405, DOI 10.1016/j.pneurobio.2010.07.001; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Solozobova V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-46; Tan JH, 2006, CANCER RES, V66, P2320, DOI 10.1158/0008-5472.CAN-05-2700; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Yazlovitskaya EM, 2006, CANCER RES, V66, P11179, DOI 10.1158/0008-5472.CAN-06-2740; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540	26	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50048	10.1371/journal.pone.0050048	http://dx.doi.org/10.1371/journal.pone.0050048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272054	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800011
J	Nedbal, J; Hobson, PS; Fear, DJ; Heintzmann, R; Gould, HJ				Nedbal, Jakub; Hobson, Philip S.; Fear, David J.; Heintzmann, Rainer; Gould, Hannah J.			Comprehensive FISH Probe Design Tool Applied to Imaging Human Immunoglobulin Class Switch Recombination	PLOS ONE			English	Article							IN-SITU; DNA; HYBRIDIZATION; TRANSCRIPTS; INDUCTION; EPIDEMIC; ANTIBODY; ASTHMA; GENE; IGE	We present a web engine boosted fluorescence in-situ hybridization (webFISH) algorithm using a genome-wide sequence similarity search to design target-specific single-copy and repetitive DNA FISH probes. The webFISH algorithm featuring a user-friendly interface (http://www.webfish2.org/) maximizes the coverage of the examined sequences with FISH probes by considering locally repetitive sequences absent from the remainder of the genome. The highly repetitive human immunoglobulin heavy chain sequence was analyzed using webFISH to design three sets of FISH probes. These allowed direct simultaneous detection of class switch recombination in both immunoglobulin-heavy chain alleles in single cells from a population of cultured primary B cells. It directly demonstrated asynchrony of the class switch recombination in the two alleles in structurally preserved nuclei while permitting parallel readout of protein expression by immunofluorescence staining. This novel technique offers the possibility of gaining unprecedented insight into the molecular mechanisms involved in class switch recombination. Citation: Nedbal J, Hobson PS, Fear DJ, Heintzmann R, Gould HJ (2012) Comprehensive FISH Probe Design Tool Applied to Imaging Human Immunoglobulin Class Switch Recombination. PLoS ONE 7(12): e51675. doi:10.1371/journal.pone.0051675	[Nedbal, Jakub; Hobson, Philip S.; Heintzmann, Rainer; Gould, Hannah J.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Nedbal, Jakub; Hobson, Philip S.; Fear, David J.; Gould, Hannah J.] Guys Hosp, MRC, London SE1 9RT, England; [Nedbal, Jakub; Hobson, Philip S.; Fear, David J.; Gould, Hannah J.] Guys Hosp, Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England; [Fear, David J.] Guys Hosp, Div Asthma Allergy & Lung Biol, London SE1 9RT, England; [Heintzmann, Rainer] Inst Photon Technol, Jena, Germany; [Heintzmann, Rainer] Univ Jena, Inst Phys Chem, D-6900 Jena, Germany	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena	Nedbal, J (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	jakub.nedbal@kcl.ac.uk; hannah.gould@kcl.ac.uk	Heintzmann, Rainer/AAY-4849-2020	Heintzmann, Rainer/0000-0002-4950-1936; Gould, Hannah/0000-0003-0411-688X; Fear, David/0000-0003-0239-8385	Medical Research Council; Asthma UK Centre in Allergic Mechanisms of Asthma; Medical Research Council [G0501494]; Biotechnology and Biological Sciences Research Council [BB/H019634/1]; Engineering and Physical Sciences Research Council [EP/F069731/1]; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; BBSRC [BB/H019634/1] Funding Source: UKRI; MRC [G0400106, G0501494] Funding Source: UKRI; Medical Research Council [G0400106, G1000758B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma UK Centre in Allergic Mechanisms of Asthma; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been supported by a Medical Research Council and Asthma UK Centre in Allergic Mechanisms of Asthma PhD studentship to J.N., by the Medical Research Council [grant G0501494, www.mrc.ac.uk] to H.J.G et al.; by Biotechnology and Biological Sciences Research Council [grant BB/H019634/1, www.bbsrc.ac.uk] to D.J.F. and H.J.G.; and by Engineering and Physical Sciences Research Council [grant EP/F069731/1, www.epsrc.ac.uk] to R.H. The authors acknowledge financial support from the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre [www.biomedicalresearchcentre.org] award to Guy's St Thomas' National Health Service Foundation Trust in partnership with King's College London and King's College Hospital National Health Service Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Brown JM, 2010, METHODS MOL BIOL, V659, P33, DOI 10.1007/978-1-60761-789-1_3; Capron A, 1999, MICROBES INFECT, V1, P485, DOI 10.1016/S1286-4579(99)80086-0; Cremer Marion, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4723; Daly J, 2007, EMBO J, V26, P4273, DOI 10.1038/sj.emboj.7601846; Dayal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024571; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; IRSCH J, 1993, EUR J IMMUNOL, V23, P481, DOI 10.1002/eji.1830230227; Isolauri E, 2004, CLIN EXP ALLERGY, V34, P1007, DOI 10.1111/j.1365-2222.2004.01999.x; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Kraan Jaennelle, 2002, Methods Mol Biol, V204, P143, DOI 10.1385/1-59259-300-3:143; LICHTER P, 1990, NATURE, V345, P93, DOI 10.1038/345093a0; Lichter P, 2006, BASIC METHODS MICROS, P223; LIN LC, 1981, P NATL ACAD SCI-BIOL, V78, P504, DOI 10.1073/pnas.78.1.504; Martin-Subero JI, 2006, CANCER RES, V66, P10332, DOI 10.1158/0008-5472.CAN-06-1992; McCloskey N, 1999, EUR J IMMUNOL, V29, P3236, DOI 10.1002/(SICI)1521-4141(199910)29:10<3236::AID-IMMU3236>3.0.CO;2-T; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Navin N, 2006, BIOINFORMATICS, V22, P2437, DOI 10.1093/bioinformatics/btl273; Ozcan E, 2008, J ALLERGY CLIN IMMUN, V122, P1054, DOI 10.1016/j.jaci.2008.10.023; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; PARDUE ML, 1969, P NATL ACAD SCI USA, V64, P600, DOI 10.1073/pnas.64.2.600; Perez-Duran P, 2007, CARCINOGENESIS, V28, P2427, DOI 10.1093/carcin/bgm201; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rozen S, 2000, Methods Mol Biol, V132, P365; RUDKIN GT, 1977, NATURE, V265, P472, DOI 10.1038/265472a0; TAGARRO I, 1994, HUM GENET, V93, P383; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Vaandrager JW, 2000, BLOOD, V96, P1947, DOI 10.1182/blood.V96.5.1947.h8001947_1947_1952; Vaandrager JW, 1998, BLOOD, V92, P2871, DOI 10.1182/blood.V92.8.2871.420k08_2871_2878; Yamada NA, 2010, CYTOGENET GENOME RES, V132; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	32	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51675	10.1371/journal.pone.0051675	http://dx.doi.org/10.1371/journal.pone.0051675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272136	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800062
J	Papadopoulos, P; Gutierrez, L; van der Linden, R; Kong-A-San, J; Maas, A; Drabek, D; Patrinos, GP; Philipsen, S; Grosveld, F				Papadopoulos, Petros; Gutierrez, Laura; van der Linden, Reinier; Kong-A-San, John; Maas, Alex; Drabek, Dubravka; Patrinos, George P.; Philipsen, Sjaak; Grosveld, Frank			A Dual Reporter Mouse Model of the Human beta-Globin Locus: Applications and Limitations	PLOS ONE			English	Article							FETAL-HEMOGLOBIN; TRANSGENIC MICE; GENE; EXPRESSION; CELLS; TRANSCRIPTION; INDUCERS; ADULT; ERYTHROPOIESIS; MATURATION	The human beta-globin locus contains the beta-like globin genes (i.e. fetal gamma-globin and adult beta-globin), which heterotetramerize with alpha-globin subunits to form fetal or adult hemoglobin. Thalassemia is one of the commonest inherited disorders in the world, which results in quantitative defects of the globins, based on a number of genome variations found in the globin gene clusters. Hereditary persistence of fetal hemoglobin (HPFH) also caused by similar types of genomic alterations can compensate for the loss of adult hemoglobin. Understanding the regulation of the human gamma-globin gene expression is a challenge for the treatment of thalassemia. A mouse model that facilitates high-throughput assays would simplify such studies. We have generated a transgenic dual reporter mouse model by tagging the gamma- and beta-globin genes with GFP and DsRed fluorescent proteins respectively in the endogenous human beta-globin locus. Erythroid cell lines derived from this mouse model were tested for their capacity to reactivate the gamma-globin gene. Here, we discuss the applications and limitations of this fluorescent reporter model to study the genetic basis of red blood cell disorders and the potential use of such model systems in high-throughput screens for hemoglobinopathies therapeutics.	[Papadopoulos, Petros; Gutierrez, Laura; van der Linden, Reinier; Kong-A-San, John; Maas, Alex; Drabek, Dubravka; Patrinos, George P.; Philipsen, Sjaak; Grosveld, Frank] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Patrinos, George P.] Univ Patras, Dept Pharm, Patras, Greece	Erasmus University Rotterdam; Erasmus MC; University of Patras	Grosveld, F (corresponding author), Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands.	f.grosveld@erasmusmc.nl	Papadopoulos, Petros/B-1913-2015; Gutiérrez, Laura/B-3780-2016; Gutiérrez, Laura/P-9367-2019	Papadopoulos, Petros/0000-0002-8342-329X; Gutiérrez, Laura/0000-0001-8443-900X; van der Linden, Reinier/0000-0001-7437-8901	NIH [5 RO1 HL 73455]; NWO-CW [700.55.006]; ZonMW DN [82-301]; NWO-VENI [863.09.012]; EMBO ASTF [15-2010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073455] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO-CW(Netherlands Organization for Scientific Research (NWO)); ZonMW DN; NWO-VENI(Netherlands Organization for Scientific Research (NWO)); EMBO ASTF(European Molecular Biology Organization (EMBO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH 5 RO1 HL 73455, NWO-CW 700.55.006, ZonMW DN 82-301, NWO-VENI 863.09.012, and EMBO ASTF 15-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzenani MK, 2011, MOL CELL BIOL, V31, P4119, DOI 10.1128/MCB.01304-10; BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; Chan KS, 2012, FASEB J; Chin J, 2009, EXP HEMATOL, V37, P1131, DOI 10.1016/j.exphem.2009.06.007; CONSTANTOULAKIS P, 1991, BLOOD, V77, P1326; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fraser ST, 2007, BLOOD, V109, P343, DOI 10.1182/blood-2006-03-006569; Fraser ST, 2010, METHOD ENZYMOL, V476, P403, DOI 10.1016/S0076-6879(10)76022-5; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Gutierrez L, 2005, EXP HEMATOL, V33, P1083, DOI 10.1016/j.exphem.2005.06.014; Haley JD, 2003, BIOCHEM PHARMACOL, V66, P1755, DOI 10.1016/S0006-2952(03)00542-2; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Heck S, 2003, BLOOD, V101, P903, DOI 10.1182/blood-2002-06-1861; Imam AMA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e65; Isern J, 2008, P NATL ACAD SCI USA, V105, P6662, DOI 10.1073/pnas.0802032105; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang J, 2006, BLOOD, V108, P1077, DOI 10.1182/blood-2006-01-008912; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Mankidy R, 2006, BLOOD, V108, P3179, DOI 10.1182/blood-2005-12-010934; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Rupon JW, 2006, P NATL ACAD SCI USA, V103, P6617, DOI 10.1073/pnas.0509322103; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; SAUVAGE C, 1993, BRIT J HAEMATOL, V84, P492, DOI 10.1111/j.1365-2141.1993.tb03106.x; Skarpidi E, 2000, BLOOD, V96, P321, DOI 10.1182/blood.V96.1.321.013k48_321_326; Spangrude GJ, 2006, STEM CELLS, V24, P2045, DOI 10.1634/stemcells.2006-0013; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Tewari R, 1996, DEVELOPMENT, V122, P3991; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; Vadolas J, 2002, BLOOD, V100, P4209, DOI 10.1182/blood-2001-12-0365; van Dijk TB, 2010, BLOOD, V116, P4349, DOI 10.1182/blood-2010-03-274399; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; Zhang CJ, 2010, J HEPATOL, V53, P889, DOI 10.1016/j.jhep.2010.05.012; ZIJLSTRA WG, 1987, COMP BIOCHEM PHYS B, V88, P251; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633; ZIJLSTRA WG, 1983, J APPL PHYSIOL, V54, P1287, DOI 10.1152/jappl.1983.54.5.1287	40	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51272	10.1371/journal.pone.0051272	http://dx.doi.org/10.1371/journal.pone.0051272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272095	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800037
J	Zhao, L; Hoi, SCH; Wong, LS; Hamp, T; Li, JY				Zhao, Liang; Hoi, Steven C. H.; Wong, Limsoon; Hamp, Tobias; Li, Jinyan			Structural and Functional Analysis of Multi-Interface Domains	PLOS ONE			English	Article							PROTEIN-STRUCTURE ALIGNMENT; SITES; PREDICTION; INTERFACES; COOPERATIVITY; COMPLEXES; CONSENSUS; FAMILIES; DATABASE; ANCHOR	A multi-interface domain is a domain that can shape multiple and distinctive binding sites to contact with many other domains, forming a hub in domain-domain interaction networks. The functions played by the multiple interfaces are usually different, but there is no strict bijection between the functions and interfaces as some subsets of the interfaces play the same function. This work applies graph theory and algorithms to discover fingerprints for the multiple interfaces of a domain and to establish associations between the interfaces and functions, based on a huge set of multi-interface proteins from PDB. We found that about 40% of proteins have the multi-interface property, however the involved multi-interface domains account for only a tiny fraction (1.8%) of the total number of domains. The interfaces of these domains are distinguishable in terms of their fingerprints, indicating the functional specificity of the multiple interfaces in a domain. Furthermore, we observed that both cooperative and distinctive structural patterns, which will be useful for protein engineering, exist in the multiple interfaces of a domain. Citation: Zhao L, Hoi SCH, Wong L, Hamp T, Li J (2012) Structural and Functional Analysis of Multi-Interface Domains. PLoS ONE 7(12): e50821. doi:10.1371/journal.pone.0050821	[Zhao, Liang; Hoi, Steven C. H.] Nanyang Technol Univ, Sch Comp Engn, Singapore, Singapore; [Wong, Limsoon] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore; [Hamp, Tobias] Tech Univ Munich, Munich, Germany; [Li, Jinyan] Univ Technol Sydney, Adv Analyt Inst, Sydney, NSW 2007, Australia	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Technical University of Munich; University of Technology Sydney	Hoi, SCH (corresponding author), Nanyang Technol Univ, Sch Comp Engn, Singapore, Singapore.	chhoi@ntu.edu.sg; Jinyan.Li@uts.edu.au	Wong, Limsoon/E-5033-2010; Wong, Limsoon/W-3611-2019; HOI, Steven C. H./A-3736-2011	Wong, Limsoon/0000-0003-1241-5441; Wong, Limsoon/0000-0003-1241-5441; Hoi, Steven/0000-0002-4584-3453; Li, Jinyan/0000-0003-1833-7413	Nanyang Technological University Tier-1 [RG66/07]	Nanyang Technological University Tier-1(Nanyang Technological University)	This work was supported in part by Nanyang Technological University Tier-1 grant RG66/07. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A. K., 2009, CELLULAR MOL IMMUNOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjorkholm P, 2009, BIOINFORMATICS, V25, P3020, DOI 10.1093/bioinformatics/btp522; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Cho KI, 2006, PROTEINS, V65, P593, DOI 10.1002/prot.21056; Crowley PB, 2008, BIOCHEMISTRY-US, V47, P6583, DOI 10.1021/bi800125h; Dasgupta B, 2011, J MOL BIOL, V411, P713, DOI 10.1016/j.jmb.2011.06.027; de Araujo AFP, 2005, PROTEIN PEPTIDE LETT, V12, P223, DOI 10.2174/0929866053587101; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Ferrante A, 2007, J IMMUNOL, V178, P7181, DOI 10.4049/jimmunol.178.11.7181; Greenbaum JA, 2007, J MOL RECOGNIT, V20, P75, DOI 10.1002/jmr.815; Guntas G, 2010, P NATL ACAD SCI USA, V107, P19296, DOI 10.1073/pnas.1006528107; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hu J, 2010, PROTEIN PEPTIDE LETT, V17, P1450, DOI 10.2174/0929866511009011450; Huan, 2004, P 8 ANN INT C RES CO, P308; Huan J, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P549; Huang J, 2008, P NATL ACAD SCI USA, V105, P6578, DOI 10.1073/pnas.0801097105; Itzhaki Z, 2010, BIOINFORMATICS, V26, P2564, DOI 10.1093/bioinformatics/btq495; Jambon M, 2003, PROTEINS, V52, P137, DOI 10.1002/prot.10339; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Kinjo AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031437; Kinjo AR, 2010, J MOL BIOL, V399, P526, DOI 10.1016/j.jmb.2010.04.028; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Li YL, 2005, STRUCTURE, V13, P297, DOI 10.1016/j.str.2004.12.012; Meinl T, 2006, ECEASST, V1; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Narayan V, 2011, J BIOL CHEM, V286, P14291, DOI 10.1074/jbc.M110.204602; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Qi Y, 2008, BIOINFORMATICS, V24, pI250, DOI 10.1093/bioinformatics/btn164; Schneidman-Duhovny D, 2008, NUCLEIC ACIDS RES, V36, pW223, DOI 10.1093/nar/gkn187; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Shulman-Peleg A, 2008, NUCLEIC ACIDS RES, V36, pW260, DOI 10.1093/nar/gkn185; Tropsha A, 2003, METHOD ENZYMOL, V374, P509, DOI 10.1016/S0076-6879(03)74022-1; Tyagi M, 2009, PROTEIN SCI, V18, P1674, DOI 10.1002/pro.181; Uno Takeaki, 2005, P 1 INT WORKSHOP OPE, P77, DOI DOI 10.1145/1133905.1133916; Vishveshwara S., 2002, J THEOR COMPUT CHEM, V1, P187, DOI DOI 10.1142/S0219633602000117; Wangikar PP, 2003, J MOL BIOL, V326, P955, DOI 10.1016/S0022-2836(02)01384-0; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x; Zhao L, 2009, IEEE INT C BIO BIO W, P163; Zhao L, 2011, IEEE ACM T COMPUT BI, V8, P1483, DOI 10.1109/TCBB.2011.49; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	54	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50821	10.1371/journal.pone.0050821	http://dx.doi.org/10.1371/journal.pone.0050821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272073	Green Published, gold			2022-12-25	WOS:000312386800017
J	Chambers, MC; Song, KH; Schneider, DS				Chambers, Moria C.; Song, Kyung Han; Schneider, David S.			Listeria monocytogenes Infection Causes Metabolic Shifts in Drosophila melanogaster	PLOS ONE			English	Article							IMMUNE FUNCTION; URATE OXIDASE; TRADE-OFFS; PROVIDES; DEFENSE; MODEL	Immunity and metabolism are intimately linked; manipulating metabolism, either through diet or genetics, has the power to alter survival during infection. However, despite metabolism's powerful ability to alter the course of infections, little is known about what being "sick'' means metabolically. Here we describe the metabolic changes occurring in a model system when Listeria monocytogenes causes a lethal infection in Drosophila melanogaster. L. monocytogenes infection alters energy metabolism; the flies gradually lose both of their energy stores, triglycerides and glycogen, and show decreases in both intermediate metabolites and enzyme message for the two main energy pathways, beta-oxidation and glycolysis. L. monocytogenes infection also causes enzymatic reduction in the anti-oxidant uric acid, and knocking out the enzyme uric oxidase has a complicated effect on immunity. Free amino acid levels also change during infection, including a drop in tyrosine levels which may be due to robust L. monocytogenes induced melanization.	[Chambers, Moria C.; Song, Kyung Han; Schneider, David S.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Schneider, DS (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	dschneider@stanford.edu		Chambers, Moria/0000-0002-2577-549X	National Institutes of Health Directors Pioneer Award [8DP1AT007753-02]; Ellison Medical Foundation; National Center for Complementary & Integrative Health [DP1AT007753] Funding Source: NIH RePORTER	National Institutes of Health Directors Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Directors Pioneer Award 8DP1AT007753-02 and a Senior Scholar in Aging Award from the Ellison Medical Foundation; http://www.ellisonfoundation.org/program/aging-senior-scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2010, ANIM BEHAV, V79, P3, DOI 10.1016/j.anbehav.2009.10.012; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Brown AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004490; Chambers MC, 2012, PLOS PATHOG IN PRESS; Cherry S, 2006, PLOS PATHOG, V2, P900, DOI 10.1371/journal.ppat.0020102; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; Il'yasova D, 2010, CANCER EPIDEM BIOMAR, V19, P1506, DOI 10.1158/1055-9965.EPI-10-0211; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Moser TS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002661; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; Opota O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002259; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; Sun Y, 2010, INFECT IMMUN, V78, P4667, DOI 10.1128/IAI.00546-10; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854	20	68	70	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50679	10.1371/journal.pone.0050679	http://dx.doi.org/10.1371/journal.pone.0050679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272066	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600013
J	Nury, C; Bregant, S; Czarny, B; Berthon, F; Cassar-Lajeunesse, E; Dive, V				Nury, Catherine; Bregant, Sarah; Czarny, Bertrand; Berthon, Fannely; Cassar-Lajeunesse, Evelyne; Dive, Vincent			Detection of Endogenous Matrix Metalloprotease-12 Active Form with a Novel Broad Spectrum Activity-based Probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOAFFINITY PROBE; PROTEIN; INHIBITORS; AFFINITY; CLONING; MMP-12; MMP12	Matrix metalloproteases (MMPs) have attracted considerable attention as critical mediators of pathological tissue remodeling processes. However it remains an unresolved challenge to detect their active forms in biological samples. To prove the efficacy of a recently developed MMP activity-based probe, we examined the content in MMP active forms of bronchoalveolar lavage fluids (BALf) from male C57BL/6 mice exposed to ultrafine carbon black nanoparticles, a model of chronic obstructive pulmonary disease. This probe was shown to label proteins, mostly expressed in BALf of mice exposed to nanoparticles. Using competition assays with a selective MMP-12 inhibitor as well as MMP-12knock-out mice, one of these proteins was identified as the active form of the catalytic domain of MMP-12. This new probe can detect the active form of MMP-12 down to a threshold of 1 fmol. Radioactive counting showed the concentration of the active form of MMP-12 to be around 1 fmol/mu l in BALf from nanoparticle-treated mice. A less sensitive probe would therefore not have detected MMP-12. As the probe can detect other MMPs in the femtomolar range, it is a potentially powerful tool for monitoring the levels of MMP active forms in various diseases.	[Nury, Catherine; Bregant, Sarah; Czarny, Bertrand; Berthon, Fannely; Cassar-Lajeunesse, Evelyne; Dive, Vincent] CE Saclay, CEA, IBiTec S, Serv Ingn Mol Prot SIMOPRO, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Dive, V (corresponding author), CE Saclay, CEA, IBiTec S, Serv Ingn Mol Prot SIMOPRO, Bat 152, F-91191 Gif Sur Yvette, France.	vincent.dive@cea.fr	Czarny, Bertrand/F-2001-2018; CZARNY, bertrand/AAP-6603-2020	Czarny, Bertrand/0000-0002-9586-0913; CZARNY, bertrand/0000-0002-9586-0913	Commissariat a l'Energie Atomique (CEA)	Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission)	This work was supported by funds from the Commissariat a l'Energie Atomique (CEA).	BANDA MJ, 1981, BIOCHEM J, V193, P589, DOI 10.1042/bj1930589; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bode W, 1996, ADV EXP MED BIOL, V389, P1; Bregant S, 2009, J PROTEOME RES, V8, P2484, DOI 10.1021/pr801069c; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Chan EWS, 2004, J AM CHEM SOC, V126, P14435, DOI 10.1021/ja047044i; Chang CC, 2011, INHAL TOXICOL, V23, P616, DOI 10.3109/08958378.2011.598965; Cobos-Correa A, 2009, NAT CHEM BIOL, V5, P628, DOI 10.1038/nchembio.196; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Dabert-Gay AS, 2008, J BIOL CHEM, V283, P31058, DOI 10.1074/jbc.M805795200; Dabert-Gay AS, 2009, BIOCONJUGATE CHEM, V20, P367, DOI 10.1021/bc800478b; David A, 2007, ANGEW CHEM INT EDIT, V46, P3275, DOI 10.1002/anie.200604408; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Deu E, 2012, NAT STRUCT MOL BIOL, V19, P9, DOI 10.1038/nsmb.2203; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Florea BI, 2010, CHEM BIOL, V17, P795, DOI 10.1016/j.chembiol.2010.05.027; Freije JR, 2003, J CHROMATOGR A, V1009, P155, DOI 10.1016/S0021-9673(03)00920-8; Freije R, 2008, J CHROMATOGR A, V1189, P417, DOI 10.1016/j.chroma.2007.10.059; Geurink PP, 2012, TOP CURR CHEM, V324, P85, DOI 10.1007/128_2011_286; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; Hesek D, 2006, CHEM BIOL, V13, P379, DOI 10.1016/j.chembiol.2006.01.012; HOROVITZ A, 1987, P NATL ACAD SCI USA, V84, P6654, DOI 10.1073/pnas.84.19.6654; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Jullien N, 2010, J MED CHEM, V53, P208, DOI 10.1021/jm9010803; Kessenbrock K, 2011, CURR PROTOC IMMUNOL, V14; Kleiner DE, 1993, CURR OPIN CELL BIOL, V5, P891, DOI 10.1016/0955-0674(93)90040-W; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; LaPan P, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-40; Leeuwenburgh MA, 2006, ORG LETT, V8, P1705, DOI 10.1021/ol060409e; Moellering RE, 2012, CHEM BIOL, V19, P11, DOI 10.1016/j.chembiol.2012.01.001; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nury C, 2013, CHEMBIOCHEM, V14, P107, DOI 10.1002/cbic.201200583; Ocana MF, 2010, ANAL BIOCHEM, V399, P202, DOI 10.1016/j.ab.2010.01.002; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Prely LM, 2012, J CHROMATOGR A, V1246, P103, DOI 10.1016/j.chroma.2012.02.076; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Yiotakis A, 2008, MOL ASPECTS MED, V29, P329, DOI 10.1016/j.mam.2008.06.001	51	7	8	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5636	5644		10.1074/jbc.M112.419499	http://dx.doi.org/10.1074/jbc.M112.419499			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271741	Green Published, hybrid			2022-12-25	WOS:000315342500037
J	Yan, WS; Chen, XF; Zhang, YH; Zhang, J; Jung, YS; Chen, XB				Yan, Wensheng; Chen, Xiufang; Zhang, Yanhong; Zhang, Jin; Jung, Yong-Sam; Chen, Xinbin			Arsenic Suppresses Cell Survival via Pirh2-mediated Proteasomal Degradation of Delta Np63 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; E3 UBIQUITIN LIGASE; P53 FAMILY; DEPENDENT DEGRADATION; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; P63 EXPRESSION; DIRECT TARGET; DNA-DAMAGE; IN-VIVO	Transcription factor p63, a member of the p53 family, shares a high degree of sequence similarity with p53. Because of transcription from two distinct promoters, the p63 gene encodes two isoforms, TAp63 and Delta Np63. Although TAp63 acts as a tumor suppressor, Delta Np63 functions as an oncogene and is often overexpressed in squamous cell carcinomas. Thus, therapeutic agents targeting Delta Np63 might be used to manage tumors that overexpress Delta Np63. Here we found that arsenic trioxide, a frontline agent for acute promyelocytic leukemia, inhibits Delta Np63 but not TAp63 expression in time-and dose-dependent manners. In addition, we found that arsenic trioxide decreases the stability of Delta Np63 protein via a proteasome-dependent pathway but has little effect on the level of Delta Np63 transcript. Furthermore, we found that arsenic trioxide activates the Pirh2 promoter and consequently induces Pirh2 expression. Consistent with this, we found that knockdown of Pirh2 inhibits, whereas ectopic expression of Pirh2 enhances, arsenic-induced degradation of Delta Np63 protein. Importantly, we found that knockdown of Delta Np63 sensitizes, whereas ectopic expression of Delta Np63 inhibits, growth suppression induced by arsenic. Together, these data suggest that arsenic degrades Delta Np63 protein at least in part via Pirh2-dependent proteolysis and that inhibition of Delta Np63 expression facilitates tumor cells to arsenic-induced death.	[Yan, Wensheng; Zhang, Yanhong; Zhang, Jin; Jung, Yong-Sam; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA; [Chen, Xiufang] Hosp Nantong Univ, Dept Hematol, Nantong 226001, Jiangsu, Peoples R China	University of California System; University of California Davis; Nantong University	Yan, WS (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	wyan@ucdavis.edu; xbchen@ucdavis.edu			National Institutes of Health [R01 CA102188]; NATIONAL CANCER INSTITUTE [R01CA123227, R01CA102188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA102188.	Barbieri CE, 2005, CANCER RES, V65, P2314, DOI 10.1158/0008-5472.CAN-04-3449; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Choi JY, 2007, BIOCHEM BIOPH RES CO, V352, P366, DOI 10.1016/j.bbrc.2006.11.036; Crook T, 2000, ONCOGENE, V19, P3439, DOI 10.1038/sj.onc.1203656; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Emadi A, 2010, BLOOD REV, V24, P191, DOI 10.1016/j.blre.2010.04.001; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hakem A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002360; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Jung Y. S., 2012, J INVEST DE IN PRESS; Jung YS, 2011, J BIOL CHEM, V286, P35388, DOI 10.1074/jbc.M111.261537; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; King KE, 2007, MOL CARCINOGEN, V46, P716, DOI 10.1002/mc.20337; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li XR, 2012, BIOCHEM BIOPH RES CO, V423, P338, DOI 10.1016/j.bbrc.2012.05.126; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; Mann KK, 2008, MOL CANCER THER, V7, P1680, DOI 10.1158/1535-7163.MCT-07-2164; Massion PP, 2003, CANCER RES, V63, P7113; Mitani Y, 2011, AM J PATHOL, V179, P391, DOI 10.1016/j.ajpath.2011.03.037; Mundt HM, 2010, BIOCHEM BIOPH RES CO, V396, P335, DOI 10.1016/j.bbrc.2010.04.093; Murata K, 2007, EXP MOL PATHOL, V83, P367, DOI 10.1016/j.yexmp.2007.03.006; Nonaka D, 2012, AM J SURG PATHOL, V36, P895, DOI 10.1097/PAS.0b013e3182498f2b; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rossi M, 2006, CELL CYCLE, V5, P1816, DOI 10.4161/cc.5.16.2861; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Shackelford D, 2006, CANCER RES, V66, P11360, DOI 10.1158/0008-5472.CAN-06-1774; Shen Y, 2001, LEUKEMIA, V15, P735, DOI 10.1038/sj.leu.2402106; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Wang XM, 2009, CANCER-AM CANCER SOC, V115, P4554, DOI 10.1002/cncr.24494; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Yan WS, 2007, CANCER RES, V67, P9117, DOI 10.1158/0008-5472.CAN-07-0996; Yan WS, 2011, J BIOL CHEM, V286, P17478, DOI 10.1074/jbc.M111.231639; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zangen R, 2005, CELL CYCLE, V4, P1313, DOI 10.4161/cc.4.10.2066; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107; Zhang QY, 2009, P NATL ACAD SCI USA, V106, P3378, DOI 10.1073/pnas.0813142106; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	52	15	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2907	2913		10.1074/jbc.M112.428607	http://dx.doi.org/10.1074/jbc.M112.428607			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23271742	Green Published, hybrid			2022-12-25	WOS:000314397900001
J	McLean, D; Cooke, MJ; Wang, YF; Green, D; Fraser, PE; St George-Hyslop, P; Shoichet, MS				McLean, Daniel; Cooke, Michael J.; Wang, Yuanfei; Green, David; Fraser, Paul E.; St George-Hyslop, Peter; Shoichet, Molly S.			Anti-Amyloid-beta-Mediated Positron Emission Tomography Imaging in Alzheimer's Disease Mouse Brains	PLOS ONE			English	Article							IN-VIVO; NANOPARTICLES; IMMUNIZATION; DEPOSITION; TRANSPORT; DELIVERY; BARRIER	Antibody-mediated imaging of amyloid beta (A beta) in Alzheimer's disease (AD) offers a promising strategy to detect and monitor specific A beta species, such as oligomers, that have important pathological and therapeutic relevance. The major current limitation of antibodies as a diagnostic and imaging device is poor blood-brain-barrier permeability. A classical anti-A beta antibody, 6E10, is modified with 10 kDa polyethylene glycol (PEG) and a positron emitting isotope, Copper-64 (t(1/2) = 12.7 h), and intravenously delivered to the TgCRND8 mouse model of Alzheimer's disease. Modification of 6E10 with PEG (6E10-PEG) increases accumulation of 6E10 in brain tissue in both TgCRND8 and wild type control animals. 6E10-PEG differentiates TgCRND8 animals from wild type controls using positron emission tomography (PET) and provides a framework for using antibodies to detect pathology using non-invasive medical imaging techniques.	[McLean, Daniel; Cooke, Michael J.; Wang, Yuanfei; Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [McLean, Daniel; Wang, Yuanfei; Shoichet, Molly S.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Green, David] Princess Margaret Hosp, Ctr Spatio & Temporal Targeting & Amplificat Radi, Toronto, ON M4X 1K9, Canada; [Fraser, Paul E.; St George-Hyslop, Peter] Univ Toronto, Dept Med Neurol, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Fraser, Paul E.; St George-Hyslop, Peter] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Shoichet, Molly S.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Cambridge; University of Toronto	Shoichet, MS (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	molly.shoichet@utoronto.ca			Firefly Foundation Grant; Canadian Institutes for Health Research [MOP-115056]; Natural Sciences and Engineering Research Council of Canada	Firefly Foundation Grant; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Work was funded by a Firefly Foundation Grant (to PSGH, PEF), Canadian Institutes for Health Research (MOP-115056; PEF) and the Natural Sciences and Engineering Research Council of Canada (to MSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beffert U, 1998, BRAIN RES REV, V27, P119, DOI 10.1016/S0165-0173(98)00008-3; Bilbul M, 2011, CAN J NEUROL SCI, V38, P580, DOI 10.1017/S0317167100012129; Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409; Boado RJ, 2007, BIOCONJUGATE CHEM, V18, P447, DOI 10.1021/bc060349x; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Bryan JN, 2011, CANCER BIOL THER, V11, P1001, DOI 10.4161/cbt.11.12.15528; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Frisoni GB, 2012, NEUROBIOL AGING, V33, P1021, DOI 10.1016/j.neurobiolaging.2010.09.007; Galvin JE, 2012, J AM BOARD FAM MED, V25, P367, DOI 10.3122/jabfm.2012.03.100181; Hampel H, 2011, PROG NEUROBIOL, V95, P718, DOI 10.1016/j.pneurobio.2011.11.008; Jordao JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010549; Kim HR, 2007, CELL MOL LIFE SCI, V64, P356, DOI 10.1007/s00018-007-6390-x; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Liu R, 2005, GENE THER, V12, P647, DOI 10.1038/sj.gt.3302445; McLean D, 2012, J CONTROL RELEASE, V159, P302, DOI 10.1016/j.jconrel.2011.12.036; Michaelis K, 2006, J PHARMACOL EXP THER, V317, P1246, DOI 10.1124/jpet.105.097139; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; PODUSLO JF, 1994, P NATL ACAD SCI USA, V91, P5705, DOI 10.1073/pnas.91.12.5705; Ramakrishnan M, 2008, PHARM RES-DORDR, V25, P1861, DOI 10.1007/s11095-008-9600-9; Reiman EM, 2012, NEUROIMAGE, V61, P505, DOI 10.1016/j.neuroimage.2011.11.075; Sair HI, 2004, NEURORADIOLOGY, V46, P93, DOI 10.1007/s00234-003-1034-9; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; SKARLATOS S, 1995, J DRUG TARGET, V3, P9, DOI 10.3109/10611869509015927; Tam JHK, 2012, CAN J NEUROL SCI, V39, P286, DOI 10.1017/S0317167100013408; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wang YF, 2011, J CONTROL RELEASE, V149, P225, DOI 10.1016/j.jconrel.2010.10.022; Wisniewski T, 2008, LANCET NEUROL, V7, P805, DOI 10.1016/S1474-4422(08)70170-4; Zhang Y, 2008, PHARM RES-DORD, V25, P400, DOI 10.1007/s11095-007-9357-6	31	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51958	10.1371/journal.pone.0051958	http://dx.doi.org/10.1371/journal.pone.0051958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284831	Green Submitted, Green Published, gold			2022-12-25	WOS:000313158800016
J	Morise, H; Miyazaki, E; Yoshimitsu, S; Eki, T				Morise, Hisashi; Miyazaki, Erika; Yoshimitsu, Shoko; Eki, Toshihiko			Profiling Nematode Communities in Unmanaged Flowerbed and Agricultural Field Soils in Japan by DNA Barcode Sequencing	PLOS ONE			English	Article							GEL-ELECTROPHORESIS DGGE; PHYLOGENETIC-RELATIONSHIPS; LIVING NEMATODES; BIODIVERSITY; EXTRACTION; INDICATORS; DIVERSITY; MONONCHIDA; MANAGEMENT; TILLAGE	Soil nematodes play crucial roles in the soil food web and are a suitable indicator for assessing soil environments and ecosystems. Previous nematode community analyses based on nematode morphology classification have been shown to be useful for assessing various soil environments. Here we have conducted DNA barcode analysis for soil nematode community analyses in Japanese soils. We isolated nematodes from two different environmental soils of an unmanaged flowerbed and an agricultural field using the improved flotation-sieving method. Small subunit (SSU) rDNA fragments were directly amplified from each of 68 (flowerbed samples) and 48 (field samples) isolated nematodes to determine the nucleotide sequence. Sixteen and thirteen operational taxonomic units (OTUs) were obtained by multiple sequence alignment from the flowerbed and agricultural field nematodes, respectively. All 29 SSU rDNA-derived OTUs (rOTUs) were further mapped onto a phylogenetic tree with 107 known nematode species. Interestingly, the two nematode communities examined were clearly distinct from each other in terms of trophic groups: Animal predators and plant feeders were markedly abundant in the flowerbed soils, in contrast, bacterial feeders were dominantly observed in the agricultural field soils. The data from the flowerbed nematodes suggests a possible food web among two different trophic nematode groups and plants (weeds) in the closed soil environment. Finally, DNA sequences derived from the mitochondrial cytochrome oxidase c subunit 1 (COI) gene were determined as a DNA barcode from 43 agricultural field soil nematodes. These nematodes were assigned to 13 rDNA-derived OTUs, but in the COI gene analysis were assigned to 23 COI gene-derived OTUs (cOTUs), indicating that COI gene-based barcoding may provide higher taxonomic resolution than conventional SSU rDNA-barcoding in soil nematode community analysis.	[Morise, Hisashi; Miyazaki, Erika; Yoshimitsu, Shoko; Eki, Toshihiko] Toyohashi Univ Technol, Dept Environm & Life Sci, Div Biosci & Biotechnol, Mol Genet Lab, Toyohashi, Aichi, Japan	Toyohashi University of Technology	Eki, T (corresponding author), Toyohashi Univ Technol, Dept Environm & Life Sci, Div Biosci & Biotechnol, Mol Genet Lab, Tempaku Cho, Toyohashi, Aichi, Japan.	eki@ens.tut.ac.jp			Toyohashi University of Technology	Toyohashi University of Technology	This work was supported in part by grants from the research program of Toyohashi University of Technology (to TE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abebe E, 2011, AFR J BIOTECHNOL, V10, P312; Baermann G., 1917, Geneeskundig Tijdschrift voor Nederlandsch-Indie Batavia, V57; BAIRD SM, 1984, J NEMATOL, V16, P379; Barthes BG, 2011, SOIL BIOL BIOCHEM, V43, P1649, DOI 10.1016/j.soilbio.2011.03.023; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Boag B, 1998, BIODIVERS CONSERV, V7, P617, DOI 10.1023/A:1008852301349; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Brown D.J.F., 1988, Nematologia Mediterranea, V16, P93; Carta LK, 2000, J NEMATOL, V32, P362; Coolen W.A, 1977, Nematologia Mediterranea, V5, P195; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; Eki T, 2011, ECOTOXICOLOGY GROBE, P1; Ferris H, 2004, APPL SOIL ECOL, V25, P19, DOI 10.1016/j.apsoil.2003.07.001; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Foucher ALJL, 2004, SOIL BIOL BIOCHEM, V36, P2027, DOI 10.1016/j.soilbio.2004.05.021; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Griffiths BS, 2006, APPL SOIL ECOL, V32, P325, DOI 10.1016/j.apsoil.2005.07.006; GRIFFITHS BS, 1994, SOIL USE MANAGE, V10, P20, DOI 10.1111/j.1475-2743.1994.tb00452.x; GRIFFITHS BS, 1990, NEMATOLOGICA, V36, P465, DOI 10.1163/002925990X00437; Hamilton HC, 2009, SOIL BIOL BIOCHEM, V41, P1311, DOI 10.1016/j.soilbio.2009.03.021; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heininger P, 2007, ENVIRON POLLUT, V146, P64, DOI 10.1016/j.envpol.2006.06.023; Holterman M, 2008, MOL PHYLOGENET EVOL, V48, P758, DOI 10.1016/j.ympev.2008.04.033; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Jairajpuri M.S., 1978, Nematologia Mediterranea, V6, P205; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang WJ, 2005, APPL SOIL ECOL, V29, P185, DOI 10.1016/j.apsoil.2004.10.004; MCSORLEY R, 1987, NEMATROPICA, V17, P147; McSorley R, 2004, APPL SOIL ECOL, V27, P55, DOI 10.1016/j.apsoil.2004.02.005; Nassonova E, 2010, PROTIST, V161, P102, DOI 10.1016/j.protis.2009.07.003; Neher DA, 2001, J NEMATOL, V33, P161; Neher DA, 2005, APPL SOIL ECOL, V30, P47, DOI 10.1016/j.apsoil.2005.01.002; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; Okada H, 2007, APPL SOIL ECOL, V35, P582, DOI 10.1016/j.apsoil.2006.09.008; Okada H, 2008, NEMATOLOGY, V10, P689, DOI 10.1163/156854108785787280; Olia M, 2009, NEMATOLOGY, V11, P337, DOI 10.1163/156854109X446935; Olia Majid, 2008, Japanese Journal of Nematology, V38, P57, DOI 10.3725/jjn.38.57; Oliveira CMG, 2004, J NEMATOL, V36, P153; Porazinska DL, 2010, MOL ECOL, V19, P5521, DOI 10.1111/j.1365-294X.2010.04891.x; Porazinska DL, 2010, MOL ECOL RESOUR, V10, P666, DOI 10.1111/j.1755-0998.2009.02819.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Powers TO, 2009, MOL ECOL, V18, P985, DOI 10.1111/j.1365-294X.2008.04075.x; PROCTER DLC, 1990, J NEMATOL, V22, P1; Ritz K, 1999, PLANT SOIL, V212, P1, DOI 10.1023/A:1004673027625; RODRIGUEZ-KABANA R, 1981, Nematropica, V11, P175; Sakai H, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.135.1716; Sochova I, 2006, ENVIRON INT, V32, P374, DOI 10.1016/j.envint.2005.08.031; Taylor HR, 2012, MOL ECOL RESOUR, V12, P377, DOI 10.1111/j.1755-0998.2012.03119.x; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Urzelai A, 2000, SCI TOTAL ENVIRON, V247, P253, DOI 10.1016/S0048-9697(99)00494-5; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vanreusel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012449; Waite IS, 2003, SOIL BIOL BIOCHEM, V35, P1165, DOI 10.1016/S0038-0717(03)00177-9; WARDLE DA, 1995, OIKOS, V73, P155, DOI 10.2307/3545904; Wu TH, 2009, SOIL BIOL BIOCHEM, V41, P849, DOI 10.1016/j.soilbio.2009.02.003; Yeates GW, 2003, BIOL FERT SOILS, V37, P199, DOI 10.1007/s00374-003-0586-5; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1997, PEDOBIOLOGIA, V41, P526; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X	61	29	31	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51785	10.1371/journal.pone.0051785	http://dx.doi.org/10.1371/journal.pone.0051785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284767	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500046
J	Schaffner, U; Alewell, C; Eschen, R; Matthies, D; Spiegelberger, T; Hegg, O				Schaffner, Urs; Alewell, Christine; Eschen, Rene; Matthies, Diethart; Spiegelberger, Thomas; Hegg, Otto			Calcium Induces Long-Term Legacy Effects in a Subalpine Ecosystem	PLOS ONE			English	Article							SPECIES COMPOSITION; GRASSLAND; CARBON; SOIL; BONFERRONI; DIVERSITY	Human activities have transformed a significant proportion of the world's land surface, with profound effects on ecosystem processes. Soil applications of macronutrients such as nitrate, phosphorus, potassium or calcium are routinely used in the management of croplands, grasslands and forests to improve plant health or increase productivity. However, while the effects of continuous fertilization and liming on terrestrial ecosystems are well documented, remarkably little is known about the legacy effect of historical fertilization and liming events in terrestrial ecosystems and of the mechanisms involved. Here, we show that more than 70 years after the last application of lime on a subalpine grassland, all major soil and plant calcium pools were still significantly larger in limed than in unlimed plots, and that the resulting shift in the soil calcium/aluminium ratio continues to affect ecosystem services such as primary production. The difference in the calcium content of the vegetation and the topmost 10 cm of the soil in limed vs. unlimed plots amounts to approximately 19.5 g m(-2), equivalent to 16.3% of the amount that was added to the plots some 70 years ago. In contrast, plots that were treated with nitrogen-phosphorus-potassium fertilizer in the 1930s did not differ from unfertilized plots in any of the soil and vegetation characteristics measured. Our findings suggest that the long-term legacy effect of historical liming is due to long-term storage of added calcium in stable soil pools, rather than a general increase in nutrient availability. Our results demonstrate that single applications of calcium in its carbonated form can profoundly and persistently alter ecosystem processes and services in mountain ecosystems.	[Schaffner, Urs; Eschen, Rene; Spiegelberger, Thomas] CABI, Delemont, Switzerland; [Alewell, Christine] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Matthies, Diethart] Univ Marburg, Dept Biol, Marburg, Germany; [Spiegelberger, Thomas] Inst Natl Rech Sci & Technol Environm & Agr, Ecosystemes Montagnards, St Martin Dheres, France; [Hegg, Otto] Univ Bern, Dept Biol, Bern, Switzerland	University of Basel; Philipps University Marburg; INRAE; University of Bern	Schaffner, U (corresponding author), CABI, Delemont, Switzerland.	U.Schaffner@cabi.org	Spiegelberger, Thomas/B-9513-2009; Alewell, Christine/K-5104-2016	Spiegelberger, Thomas/0000-0002-0979-1043; Alewell, Christine/0000-0001-9295-9806; Matthies, Diethart/0000-0003-2439-0501	Bristol Stiftung; Bristol Foundation	Bristol Stiftung; Bristol Foundation	The work was funded by the Bristol Stiftung (http://www.bristol-stiftung.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the Geschaftsleitung of the Alpengarten Schynige Platte for allowing us to work on the Ludi plots, Franz Conen and Heinz Hurlimann for technical support, Franz Conen and Richard Bardgett for valuable comments on an earlier version of the manuscript and the Bristol Foundation for financial support.	Alewell C, 2000, NATURE, V407, P856, DOI 10.1038/35038158; Blum JD, 2002, NATURE, V417, P729, DOI 10.1038/nature00793; Bossew P, 2004, J ENVIRON RADIOACTIV, V73, P87, DOI 10.1016/j.jenvrad.2003.08.004; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; CRONAN CS, 1995, J ENVIRON QUAL, V24, P209, DOI 10.2134/jeq1995.00472425002400020002x; Dahler W, 1993, GEOBOTANICA HELVETIC, V71, P1; DEANGELIS DL, 1989, AM NAT, V134, P778, DOI 10.1086/285011; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Folke C, 2002, AMBIO, V31, P437, DOI 10.1639/0044-7447(2002)031[0437:RASDBA]2.0.CO;2; Fornara DA, 2011, GLOBAL CHANGE BIOL, V17, P1925, DOI 10.1111/j.1365-2486.2010.02328.x; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Hamilton SK, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002738; HERBEN T, 1993, J VEG SCI, V4, P163, DOI 10.2307/3236101; Hrevusova Z, 2009, AGR ECOSYST ENVIRON, V130, P123, DOI 10.1016/j.agee.2008.12.008; Isselstein J, 2005, GRASSLAND SCI EUR, V10, P211; Jandl R, 2004, SOIL SCI SOC AM J, V68, P588, DOI 10.2136/sssaj2004.0588; Leifeld J, 2009, GLOBAL CHANGE BIOL, V15, P668, DOI 10.1111/j.1365-2486.2008.01782.x; Ludi W, 1959, VERSUCHE ALPWEIDENVE; McLaughlin SB, 1999, NEW PHYTOL, V142, P373, DOI 10.1046/j.1469-8137.1999.00420.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Pierik M, 2011, ECOLOGY, V92, P1393, DOI 10.1890/10-0210.1; Ray J. G., 2010, Journal of Agronomy, V9, P70, DOI 10.3923/ja.2010.70.74; RORISON IH, 1984, PLANT CELL ENVIRON, V7, P381, DOI 10.1111/j.1365-3040.1984.tb01427.x; Ross DS, 2008, EUR J SOIL SCI, V59, P1141, DOI 10.1111/j.1365-2389.2008.01069.x; Schaberg PG, 2001, ECOSYST HEALTH, V7, P214, DOI 10.1046/j.1526-0992.2001.01046.x; Schlesinger WH, 2003, TREATISE GEOCHEMISTR, V8; SHORTLE WC, 1988, SCIENCE, V240, P1017, DOI 10.1126/science.240.4855.1017; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Spiegelberger T, 2006, ECOLOGY, V87, P1939, DOI 10.1890/0012-9658(2006)87[1939:LEOSPI]2.0.CO;2; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TILMAN D, 1994, LONG-TERM EXPERIMENTS IN AGRICULTURAL AND ECOLOGICAL SCIENCES, P287; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; van Breemen N, 2000, GEODERMA, V94, P163, DOI 10.1016/S0016-7061(99)00050-6; Vanguelova EI, 2007, PLANT BIOSYST, V141, P460, DOI 10.1080/11263500701626192; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; West TO, 2005, AGR ECOSYST ENVIRON, V108, P145, DOI 10.1016/j.agee.2005.01.002; Whitehead D.C, 2000, NUTR ELEMENTS GRASSL	40	6	6	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51818	10.1371/journal.pone.0051818	http://dx.doi.org/10.1371/journal.pone.0051818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284779	gold, Green Published			2022-12-25	WOS:000312794500050
J	Wootton, JT				Wootton, J. Timothy			River Food Web Response to Large-Scale Riparian Zone Manipulations	PLOS ONE			English	Article							LARGE WOODY DEBRIS; SALMON ONCORHYNCHUS-KISUTCH; BRITISH-COLUMBIA; COHO SALMON; JUVENILE SALMONIDS; BENTHIC COMMUNITY; CARNATION CREEK; STREAM; ECOSYSTEM; USA	Conservation programs often focus on select species, leading to management plans based on the autecology of the focal species, but multiple ecosystem components can be affected both by the environmental factors impacting, and the management targeting, focal species. These broader effects can have indirect impacts on target species through the web of interactions within ecosystems. For example, human activity can strongly alter riparian vegetation, potentially impacting both economically-important salmonids and their associated river food web. In an Olympic Peninsula river, Washington state, USA, replicated large-scale riparian vegetation manipulations implemented with the long-term (>40 yr) goal of improving salmon habitat did not affect water temperature, nutrient limitation or habitat characteristics, but reduced canopy cover, causing reduced energy input via leaf litter, increased incident solar radiation (UV and PAR) and increased algal production compared to controls. In response, benthic algae, most insect taxa, and juvenile salmonids increased in manipulated areas. Stable isotope analysis revealed a predominant contribution of algal-derived energy to salmonid diets in manipulated reaches. The experiment demonstrates that riparian management targeting salmonids strongly affects river food webs via changes in the energy base, illustrates how species-based management strategies can have unanticipated indirect effects on the target species via the associated food web, and supports ecosystem-based management approaches for restoring depleted salmonid stocks.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	twootton@uchicago.edu	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344	Howard Hughes Foundation; National Science Foundation [DEB 93-17980, OCE 01-17801, OCE 04-52687, DEB 09-19420]; Andrew W. Mellon Foundation; Olympic Natural Resources Center; United States Environmental Protection Agency (University of Chicago Center for Integrating Statistics and the Environmental Sciences); Division Of Environmental Biology [0919420] Funding Source: National Science Foundation	Howard Hughes Foundation(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Andrew W. Mellon Foundation; Olympic Natural Resources Center; United States Environmental Protection Agency (University of Chicago Center for Integrating Statistics and the Environmental Sciences)(United States Environmental Protection Agency); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research was partially supported by grants from the Howard Hughes Foundation, National Science Foundation (DEB 93-17980, OCE 01-17801, OCE 04-52687, DEB 09-19420), Andrew W. Mellon Foundation, Olympic Natural Resources Center, and United States Environmental Protection Agency (University of Chicago Center for Integrating Statistics and the Environmental Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumsteiger J, 2005, T AM FISH SOC, V134, P829, DOI 10.1577/T04-114.1; BERG DR, 1995, ECOL APPL, V5, P87, DOI 10.2307/1942054; BILBY RE, 1992, CAN J FISH AQUAT SCI, V49, P540, DOI 10.1139/f92-064; Bilby RE, 1998, CAN J FISH AQUAT SCI, V55, P1909, DOI 10.1139/cjfas-55-8-1909; BOTHWELL ML, 1994, SCIENCE, V265, P97, DOI 10.1126/science.265.5168.97; Crowder LB, 2008, ANNU REV ECOL EVOL S, V39, P259, DOI 10.1146/annurev.ecolsys.39.110707.173406; EMLEN JM, 1990, CAN J FISH AQUAT SCI, V47, P1765, DOI 10.1139/f90-200; ESSEEN PA, 1994, BIOL CONSERV, V68, P19, DOI 10.1016/0006-3207(94)90542-8; FAUSCH KD, 1992, CAN J FISH AQUAT SCI, V49, P682, DOI 10.1139/f92-077; Findlay J.C., 1999, LIMNOL OCEANOGR, V44, P1198; Finlay JC, 2011, ECOLOGY, V92, P140, DOI 10.1890/09-2243.1; GIBEAU GG, 1989, J FRESHWATER ECOL, V5, P171, DOI 10.1080/02705060.1989.9665226; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Hartman G.F., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V223, P1; HARTMAN GF, 1987, CAN J FISH AQUAT SCI, V44, P262, DOI 10.1139/f87-035; HEIFETZ J, 1986, North American Journal of Fisheries Management, V6, P52, DOI 10.1577/1548-8659(1986)6<52:EOLOWH>2.0.CO;2; HOLTBY LB, 1988, CAN J FISH AQUAT SCI, V45, P502, DOI 10.1139/f88-060; Hyatt TL, 2001, ECOL APPL, V11, P191, DOI 10.1890/1051-0761(2001)011[0191:TRTOLW]2.0.CO;2; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Janisch JE, 2012, FOREST ECOL MANAG, V270, P302, DOI 10.1016/j.foreco.2011.12.035; JOHNSTON NT, 1990, CAN J FISH AQUAT SCI, V47, P862, DOI 10.1139/f90-099; Kareiva P, 2000, SCIENCE, V290, P977, DOI 10.1126/science.290.5493.977; Kiffney PM, 1997, J N AM BENTHOL SOC, V16, P520, DOI 10.2307/1468141; Kiffney PM, 2003, J APPL ECOL, V40, P1060, DOI 10.1111/j.1365-2664.2003.00855.x; LAJTHA K, 1994, STABLE ISOTOPES ECOL; LAMBERTI GA, 1985, FRESHWATER BIOL, V15, P21, DOI 10.1111/j.1365-2427.1985.tb00693.x; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Li Hiram W., 1996, P391; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; LIN BH, 1988, FISH B-NOAA, V86, P655; MacLeod NA, 1998, CAN J FISH AQUAT SCI, V55, P1919, DOI 10.1139/cjfas-55-8-1919; Mangel M, 2005, PHILOS T R SOC B, V360, P95, DOI 10.1098/rstb.2004.1571; Marks JC, 2000, OIKOS, V90, P20, DOI 10.1034/j.1600-0706.2000.900103.x; McHenry ML, 1998, CAN J FISH AQUAT SCI, V55, P1395, DOI 10.1139/cjfas-55-6-1395; Montgomery DR, 1996, NATURE, V381, P587, DOI 10.1038/381587a0; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Moring J.R., 1975, 9 OR DEP FISH WILDL; MURPHY ML, 1981, T AM FISH SOC, V110, P469, DOI 10.1577/1548-8659(1981)110<469:EOCMAA>2.0.CO;2; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Nickelson TE, 1998, CAN J FISH AQUAT SCI, V55, P2383, DOI 10.1139/cjfas-55-11-2383; PERRIN CJ, 1987, CAN J FISH AQUAT SCI, V44, P1247, DOI 10.1139/f87-147; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pollard W.R., 1997, FIELD IDENTIFICATION; RALPH SC, 1994, CAN J FISH AQUAT SCI, V51, P37, DOI 10.1139/f94-006; Roni P, 2002, N AM J FISH MANAGE, V22, P1, DOI 10.1577/1548-8675(2002)022&lt;0001:AROSRT&gt;2.0.CO;2; Roni P, 2001, CAN J FISH AQUAT SCI, V58, P282, DOI 10.1139/cjfas-58-2-282; Rosemond AD, 2000, CAN J FISH AQUAT SCI, V57, P66, DOI 10.1139/cjfas-57-1-66; Rosenfeld JS, 1997, ARCH HYDROBIOL, V139, P301; Sedell J. R., 1984, Verhandlungen der Internationalen Vereinigung fur Theoretische und Angewandte Limnologie, V22, P1828; SEDELL JR, 1990, ENVIRON MANAGE, V14, P711, DOI 10.1007/BF02394720; SLANEY PA, 1994, B MAR SCI, V55, P1160; TUCHMAN ML, 1980, HYDROBIOLOGIA, V75, P73, DOI 10.1007/BF00006564; UNESCO, 1994, PROT JOINT GLOB OC F, V29; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; WEBSTER JR, 1986, ANNU REV ECOL SYST, V17, P567, DOI 10.1146/annurev.es.17.110186.003031; Whitledge GW, 2000, HYDROBIOLOGIA, V437, P165, DOI 10.1023/A:1026559008308; Wigington PJ, 1998, J AM WATER RESOUR AS, V34, P1035, DOI 10.1111/j.1752-1688.1998.tb04152.x; Wilzbach MA, 2005, CAN J FISH AQUAT SCI, V62, P58, DOI 10.1139/F04-177; Wootton JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043561; WOOTTON JT, 1993, P NATL ACAD SCI USA, V90, P1384, DOI 10.1073/pnas.90.4.1384; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; Wydoski R.S., 1979, INLAND FISHES WASHIN; YEAKLEY JA, 1994, WATER AIR SOIL POLL, V77, P229, DOI 10.1007/BF00478421	65	30	31	0	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51839	10.1371/journal.pone.0051839	http://dx.doi.org/10.1371/journal.pone.0051839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284786	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500052
J	Nie, K; Qi, SX; Zhang, Y; Luo, L; Xie, Y; Yang, MJ; Zhang, Y; Li, J; Shen, HW; Li, Q; Ma, XJ				Nie, Kai; Qi, Shun-xiang; Zhang, Yong; Luo, Le; Xie, Yun; Yang, Meng-jie; Zhang, Yi; Li, Jin; Shen, Hongwei; Li, Qi; Ma, Xue-jun			Evaluation of a Direct Reverse Transcription Loop-Mediated Isothermal Amplification Method without RNA Extraction for the Detection of Human Enterovirus 71 Subgenotype C4 in Nasopharyngeal Swab Specimens	PLOS ONE			English	Article							HYDROXYNAPHTHOL BLUE-DYE; RAPID DETECTION; VISUAL DETECTION; CEREBROSPINAL-FLUID; RT-PCR; DNA; VIRUS; ASSAY; BLOOD; SERUM	Human enterovirus 71 (EV71) is the major causative agent of hand, foot, and mouth disease (HFMD) worldwide and has been associated with neurological complications which resulted in fatalities during recent outbreak in Asia pacific region. A direct reverse transcription loop-mediated isothermal amplification (direct RT-LAMP) assay using heat-treated samples without RNA extraction was developed and evaluated for the detection of EV71 subgenotype C4 in nasopharyngeal swab specimens. The analytical sensitivity and specificity of the direct RT-LAMP assay were examined. The detection limit of the direct RT-LAMP assays was 1.6 of a 50% tissue culture infective dose (TCID50) per reaction and no cross-reaction was observed with control viruses including Cosackievirus A (CVA) viruses (CVA2,4,5,7,9,10,14,16, and 24), Coxsackievirus B (CVB) viruses (CVB1,2,3,4, and 5) or ECHO viruses (ECHO3,6,11, and 19). The direct RT-LAMP assay was evaluated and compared to both RT-LAMP and quantitative real-time PCR (qRT-PCR) in detecting EV71 infection with 145 nasopharyngeal swab specimens. The clinical performance demonstrated the sensitivity and specificity of direct RT-LAMP was reported to be 90.3% and 100% respectively, compared to RT-LAMP, and 86.83% and 100% respectively, compared to qRT-PCR. These data demonstrated that the direct RT-LAMP assay can potentially be developed for the point of care screening of EV71 infection in China.	[Qi, Shun-xiang; Xie, Yun; Li, Qi] Ctr Dis Control & Prevent Hebei, Inst Viral Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China; [Nie, Kai; Zhang, Yong; Luo, Le; Yang, Meng-jie; Zhang, Yi; Li, Jin; Shen, Hongwei; Ma, Xue-jun] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Li, Q (corresponding author), Ctr Dis Control & Prevent Hebei, Inst Viral Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China.	liqinew@yahoo.com.cn; maxj2004@yahoo.com.cn	Nie, Kai/L-5389-2019	Zhang, Yong/0000-0002-2692-5437	China Mega-Project for Infectious Disease [2011ZX10004-001, 2012ZX10004-215]; State Key Laboratory for Genetic Engineering and Molecular Virology	China Mega-Project for Infectious Disease; State Key Laboratory for Genetic Engineering and Molecular Virology	This work was supported by the China Mega-Project for Infectious Disease (2011ZX10004-001, 2012ZX10004-215) and a research grant from the State Key Laboratory for Genetic Engineering and Molecular Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baethgen LF, 2003, J MED MICROBIOL, V52, P793, DOI 10.1099/jmm.0.05192-0; Bista BR, 2007, J CLIN MICROBIOL, V45, P1581, DOI 10.1128/JCM.01024-06; Cardoso MA, 2009, ZOONOSES PUBLIC HLTH, V56, P465, DOI 10.1111/j.1863-2378.2008.01199.x; Enomoto Y, 2005, J CLIN MICROBIOL, V43, P951, DOI 10.1128/JCM.43.2.951-955.2005; Fujimoto T, 2008, JPN J INFECT DIS, V61, P497; Haridas DV, 2010, J VIROL METHODS, V167, P61, DOI 10.1016/j.jviromet.2010.03.011; Ihira M, 2007, J CLIN VIROL, V39, P22, DOI 10.1016/j.jcv.2007.02.001; Ihira M, 2010, J VIROL METHODS, V167, P103, DOI 10.1016/j.jviromet.2010.01.025; Jiang T, 2011, J CLIN MICROBIOL, V49, P870, DOI 10.1128/JCM.02045-10; Kuan CP, 2010, J VIROL METHODS, V169, P61, DOI 10.1016/j.jviromet.2010.06.017; Luo L, 2011, J CLIN MICROBIOL, V49, P3545, DOI 10.1128/JCM.00930-11; Ma XJ, 2010, J VIROL METHODS, V167, P214, DOI 10.1016/j.jviromet.2010.03.027; Nakamichi K, 2011, JPN J INFECT DIS, V64, P211; Nemoto M, 2011, J VET MED SCI, V73, P1225, DOI 10.1292/jvms.11-0065; Nie K, 2011, J VIROL METHODS, V175, P283, DOI 10.1016/j.jviromet.2011.05.020; Nishimura N, 2010, J VIROL METHODS, V163, P282, DOI 10.1016/j.jviromet.2009.10.011; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; Poon LLM, 2006, CLIN CHEM, V52, P303; RUWAIDA ASA, 1976, EUR J APPL MICROBIOL, V2, P73, DOI 10.1007/BF00942349; Saitou Y, 2010, J VIROL METHODS, V168, P13, DOI 10.1016/j.jviromet.2010.04.008; Sarmiento PL, 2000, REV CUBANA MED TROP, V52, P15; Shi WF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-197; Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001; Victor ST, 2009, MOL DIAGN THER, V13, P383, DOI 10.2165/11317520-000000000-00000; Xia JF, 2011, DIAGN MICR INFEC DIS, V71, P244, DOI 10.1016/j.diagmicrobio.2011.07.014; Xiao XL, 2009, ARCH VIROL, V154, P121, DOI 10.1007/s00705-008-0266-8	27	34	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52486	10.1371/journal.pone.0052486	http://dx.doi.org/10.1371/journal.pone.0052486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272248	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300090
J	Sekiguchi, S; Kimura, K; Chiyo, T; Ohtsuki, T; Tobita, Y; Tokunaga, Y; Yasui, F; Tsukiyama-Kohara, K; Wakita, T; Tanaka, T; Miyasaka, M; Mizuno, K; Hayashi, Y; Hishima, T; Matsushima, K; Kohara, M				Sekiguchi, Satoshi; Kimura, Kiminori; Chiyo, Tomoko; Ohtsuki, Takahiro; Tobita, Yoshimi; Tokunaga, Yuko; Yasui, Fumihiko; Tsukiyama-Kohara, Kyoko; Wakita, Takaji; Tanaka, Toshiyuki; Miyasaka, Masayuki; Mizuno, Kyosuke; Hayashi, Yukiko; Hishima, Tsunekazu; Matsushima, Kouji; Kohara, Michinori			Immunization with a Recombinant Vaccinia Virus That Encodes Nonstructural Proteins of the Hepatitis C Virus Suppresses Viral Protein Levels in Mouse Liver	PLOS ONE			English	Article							TRANSGENIC MICE; STRUCTURAL PROTEINS; CRE/LOXP SYSTEM; IMMUNE-RESPONSE; CORE PROTEIN; SARS-COV; INFECTION; EXPRESSION; CHIMPANZEES; INTERFERON	Chronic hepatitis C, which is caused by infection with the hepatitis C virus (HCV), is a global health problem. Using a mouse model of hepatitis C, we examined the therapeutic effects of a recombinant vaccinia virus (rVV) that encodes an HCV protein. We generated immunocompetent mice that each expressed multiple HCV proteins via a Cre/loxP switching system and established several distinct attenuated rVV strains. The HCV core protein was expressed consistently in the liver after polyinosinic acid-polycytidylic acid injection, and these mice showed chronic hepatitis C-related pathological findings (hepatocyte abnormalities, accumulation of glycogen, steatosis), liver fibrosis, and hepatocellular carcinoma. Immunization with one rVV strain (rVV-N25), which encoded nonstructural HCV proteins, suppressed serum inflammatory cytokine levels and alleviated the symptoms of pathological chronic hepatitis C within 7 days after injection. Furthermore, HCV protein levels in liver tissue also decreased in a CD4 and CD8 T-cell-dependent manner. Consistent with these results, we showed that rVV-N25 immunization induced a robust CD8 T-cell immune response that was specific to the HCV nonstructural protein 2. We also demonstrated that the onset of chronic hepatitis in CN2-29((+/-))/MxCre((+/-)) mice was mainly attributable to inflammatory cytokines, (tumor necrosis factor) TNF-alpha and (interleukin) IL-6. Thus, our generated mice model should be useful for further investigation of the immunological processes associated with persistent expression of HCV proteins because these mice had not developed immune tolerance to the HCV antigen. In addition, we propose that rVV-N25 could be developed as an effective therapeutic vaccine.	[Sekiguchi, Satoshi; Chiyo, Tomoko; Ohtsuki, Takahiro; Tobita, Yoshimi; Tokunaga, Yuko; Yasui, Fumihiko; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Kimura, Kiminori] Tokyo Metropolitan Komagome Hosp, Div Hepatol, Bunkyo Ku, Tokyo, Japan; [Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Transboundary Anim Dis Ctr, Joint Fac Vet Med, Kagoshima 890, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo, Japan; [Tanaka, Toshiyuki] Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharm, Immunobiol Lab,Chuo Ku, Kobe, Hyogo, Japan; [Miyasaka, Masayuki] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Immunodynam, Suita, Osaka, Japan; [Mizuno, Kyosuke] Chemoserotherapeut Res Inst, Kumamoto, Japan; [Hayashi, Yukiko; Hishima, Tsunekazu] Tokyo Metropolitan Komagome Hosp, Dept Pathol, Bunkyo Ku, Tokyo, Japan; [Matsushima, Kouji] Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 113, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Kagoshima University; National Institute of Infectious Diseases (NIID); Immuno-Biological Laboratories Co. Ltd.; Osaka University; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; University of Tokyo	Kohara, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Bunkyo Ku, Tokyo 113, Japan.	kohara-mc@igakuken.or.jp	kimura, kiminori/H-6186-2019; Kimura, Kiminori/W-3108-2019; Miyasaka, Masayuki/AAM-6343-2020	kimura, kiminori/0000-0002-9352-4721; Kimura, Kiminori/0000-0002-9352-4721; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency of Japan; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency of Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency of Japan; and the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER MJ, 1995, SEMIN LIVER DIS, V15, P5, DOI 10.1055/s-2007-1007259; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Burkett MW, 2005, J IMMUNOTHER, V28, P396, DOI 10.1097/01.cji.0000165357.11548.6d; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; CHISARI FV, 1995, SPRINGER SEMIN IMMUN, V17, P261, DOI 10.1007/BF00196169; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Elmowalid GA, 2007, P NATL ACAD SCI USA, V104, P8427, DOI 10.1073/pnas.0702162104; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Humlova Z, 2002, J GEN VIROL, V83, P2821, DOI 10.1099/0022-1317-83-11-2821; Jasani B, 2009, VACCINE, V27, P3401, DOI 10.1016/j.vaccine.2009.01.071; Kawamura T, 1997, HEPATOLOGY, V25, P1014, DOI 10.1002/hep.510250437; Kitabatake M, 2007, VACCINE, V25, P630, DOI 10.1016/j.vaccine.2006.08.039; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Large MK, 1999, J IMMUNOL, V162, P931; Larrea E, 1996, HEPATOLOGY, V23, P210, DOI 10.1002/hep.510230203; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Machida K, 2001, J BIOL CHEM, V276, P12140, DOI 10.1074/jbc.M010137200; Malaguarnera M, 1997, INT J CLIN PHARM TH, V35, P385; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nishimura T, 2009, J BIOL CHEM, V284, P36442, DOI 10.1074/jbc.M109.043232; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pasquinelli C, 1997, HEPATOLOGY, V25, P719, DOI 10.1002/hep.510250338; Saito T, 1997, GASTROENTEROLOGY, V112, P1321, DOI 10.1016/S0016-5085(97)70146-X; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Satoi J, 2001, J VIROL, V75, P12121, DOI 10.1128/JVI.75.24.12121-12127.2001; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; SHIMIZU YK, 1993, P NATL ACAD SCI USA, V90, P6037, DOI 10.1073/pnas.90.13.6037; SUGIMOTO M, 1994, VACCINE, V12, P675, DOI 10.1016/0264-410X(94)90215-1; Tilg H, 2008, GUT, V57, P684, DOI 10.1136/gut.2006.117382; Tsukiyama-Kohara K, 2004, J BIOL CHEM, V279, P14531, DOI 10.1074/jbc.M312822200; Wakita T, 1998, J BIOL CHEM, V273, P9001, DOI 10.1074/jbc.273.15.9001; Wakita T, 2000, J MED VIROL, V62, P308, DOI 10.1002/1096-9071(200011)62:3<308::AID-JMV2>3.0.CO;2-6; Yasui F, 2008, J IMMUNOL, V181, P6337, DOI 10.4049/jimmunol.181.9.6337; Youn JW, 2008, J VIROL, V82, P10896, DOI 10.1128/JVI.01179-08; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	42	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51656	10.1371/journal.pone.0051656	http://dx.doi.org/10.1371/journal.pone.0051656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284733	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900038
J	Cao, SC; Li, BW; Yi, XJ; Chang, B; Zhu, BB; Lian, ZZ; Zhang, ZR; Zhao, G; Liu, HL; Zhang, H				Cao, Shicheng; Li, Bowen; Yi, Xuejie; Chang, Bo; Zhu, Beibei; Lian, Zhenzhen; Zhang, Zhaoran; Zhao, Gang; Liu, Huili; Zhang, He			Effects of Exercise on AMPK Signaling and Downstream Components to PI3K in Rat with Type 2 Diabetes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET; STREPTOZOTOCIN-TREATED RAT; INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; PHOSPHATIDYLINOSITOL 3-KINASE; MITOCHONDRIAL BIOGENESIS; ENDURANCE EXERCISE; GLUT4 TRAFFICKING	Exercise can increase skeletal muscle sensitivity to insulin, improve insulin resistance and regulate glucose homeostasis in rat models of type 2 diabetes. However, the potential mechanism remains poorly understood. In this study, we established a male Sprague-Dawley rat model of type 2 diabetes, with insulin resistance and beta cell dysfunction, which was induced by a high-fat diet and low-dose streptozotocin to replicate the pathogenesis and metabolic characteristics of type 2 diabetes in humans. We also investigated the possible mechanism by which chronic and acute exercise improves metabolism, and the phosphorylation and expression of components of AMP-activated protein kinase (AMPK) and downstream components of phosphatidylinositol 3-kinase (PI3K) signaling pathways in the soleus. As a result, blood glucose, triglyceride, total cholesterol, and free fatty acid were significantly increased, whereas insulin level progressively declined in diabetic rats. Interestingly, chronic and acute exercise reduced blood glucose, increased phosphorylation and expression of AMPK alpha 1/2 and the isoforms AMPK alpha 1 and AMPK alpha 2, and decreased phosphorylation and expression of AMPK substrate, acetyl CoA carboxylase (ACC). Chronic exercise upregulated phosphorylation and expression of AMPK upstream kinase, LKB1. But acute exercise only increased LKB1 expression. In particular, exercise reversed the changes in protein kinase C (PKC)zeta/lambda phosphorylation, and PKC zeta phosphorylation and expression. Additionally, exercise also increased protein kinase B (PKB)/Akt1, Akt2 and GLUT4 expression, but AS160 protein expression was unchanged. Chronic exercise elevated Akt (Thr(308)) and (Ser(473)) and AS160 phosphorylation. Finally, we found that exercise increased peroxisome proliferator-activated receptor-c coactivator 1 (PGC1) mRNA expression in the soleus of diabetic rats. These results indicate that both chronic and acute exercise influence the phosphorylation and expression of components of the AMPK and downstream to PIK3 (aPKC, Akt), and improve GLUT4 trafficking in skeletal muscle. These data help explain the mechanism how exercise regulates glucose homeostasis in diabetic rats.	[Cao, Shicheng; Li, Bowen; Lian, Zhenzhen; Zhang, Zhaoran; Zhao, Gang; Liu, Huili; Zhang, He] China Med Univ, Coll Basic Med Sci, Dept Sport Med, Shenyang, Liaoning Provin, Peoples R China; [Yi, Xuejie; Chang, Bo] Shenyang Sport Univ, Dept Exercise Sci, Shenyang, Liaoning Provin, Peoples R China; [Zhu, Beibei] Univ Kentucky, Dept Med, Div Endocrinol, Lexington, KY 40506 USA; [Zhu, Beibei] Univ Kentucky, Barnstable Brown Diabet & Obes Ctr, Lexington, KY USA	China Medical University; Shenyang Sport University; University of Kentucky; University of Kentucky	Cao, SC (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Sport Med, Shenyang, Liaoning Provin, Peoples R China.	caoshicheng@tom.com			National Natural Science Foundation of China [30971414]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (Grant No. 30971414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Braiman L, 2001, MOL CELL BIOL, V21, P7852, DOI 10.1128/MCB.21.22.7852-7861.2001; Brandt N, 2010, AM J PHYSIOL-ENDOC M, V299, pE215, DOI 10.1152/ajpendo.00098.2010; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Chibalin AV, 2000, P NATL ACAD SCI USA, V97, P38, DOI 10.1073/pnas.97.1.38; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; FOLLI F, 1992, J BIOL CHEM, V267, P22171; Frosig C, 2009, OBESITY, V17, pS15, DOI 10.1038/oby.2009.383; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; GOODYEAR LJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE987, DOI 10.1152/ajpendo.1995.268.5.E987; Hawley JA, 2008, ACTA PHYSIOL, V192, P127, DOI 10.1111/j.1748-1716.2007.01783.x; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; Herr HJ, 2005, J PHYSIOL-LONDON, V565, P627, DOI 10.1113/jphysiol.2005.086694; Hodgkinson CP, 2005, DIABETOLOGIA, V48, P1627, DOI 10.1007/s00125-005-1819-y; Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kanoh Y, 2003, ENDOCRINOLOGY, V144, P947, DOI 10.1210/en.2002-221017; Kanzaki M, 2004, J CELL BIOL, V164, P279, DOI 10.1083/jcb.200306152; Kim CH, 2000, AM J PHYSIOL-ENDOC M, V278, pE977, DOI 10.1152/ajpendo.2000.278.6.E977; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; KRAEGEN EW, 1989, AM J PHYSIOL, V256, pE242, DOI 10.1152/ajpendo.1989.256.2.E242; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavigne C, 2001, AM J PHYSIOL-ENDOC M, V281, pE62, DOI 10.1152/ajpendo.2001.281.1.E62; Lessard SJ, 2007, DIABETES, V56, P1856, DOI 10.2337/db06-1065; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Luciano E, 2002, EUR J ENDOCRINOL, V147, P149, DOI 10.1530/eje.0.1470149; Maarbjerg SJ, 2011, ACTA PHYSIOL, V202, P323, DOI 10.1111/j.1748-1716.2011.02267.x; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Richter EA, 2004, J PHYSIOL-LONDON, V560, P909, DOI 10.1113/jphysiol.2004.071373; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Sajan MP, 2010, AM J PHYSIOL-ENDOC M, V298, pE179, DOI 10.1152/ajpendo.00392.2009; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; SCOTT AM, 1981, DIABETOLOGIA, V21, P470; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Sriwijitkamol A, 2006, AM J PHYSIOL-ENDOC M, V290, pE925, DOI 10.1152/ajpendo.00429.2005; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Tanaka S, 2007, METABOLISM, V56, P1719, DOI 10.1016/j.metabol.2007.07.017; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; TREADWAY JL, 1989, AM J PHYSIOL, V256, pE138, DOI 10.1152/ajpendo.1989.256.1.E138; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wojtaszewski JFP, 2006, ESSAYS BIOCHEM, V42, P31, DOI 10.1042/bse0420031; Yaspelkis BB, 2007, AM J PHYSIOL-ENDOC M, V293, pE941, DOI 10.1152/ajpendo.00230.2007; Ye JM, 2006, DIABETES, V55, P2797, DOI 10.2337/db05-1315; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9; Zhang M, 2008, EXP DIABETES RES, DOI 10.1155/2008/704045	55	30	33	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51709	10.1371/journal.pone.0051709	http://dx.doi.org/10.1371/journal.pone.0051709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272147	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386600038
J	Eckert, T; Le, DTV; Link, S; Friedmann, L; Woehlke, G				Eckert, Thomas; Doan Tuong-Van Le; Link, Susanne; Friedmann, Lena; Woehlke, Guenther			Spastin's Microtubule-Binding Properties and Comparison to Katanin	PLOS ONE			English	Article							PARAPLEGIA PROTEIN; KINESIN ATPASE; MOTOR DOMAIN; TUBULIN; SITE; MECHANISM; SEVERS; NECK; PROCESSIVITY; RECOGNITION	Spastin and katanin are ring-shaped hexameric AAA ATPases that sever microtubules, and thus crucially depend on a physical interaction with microtubules. For the first time, we report here the microtubule binding properties of spastin at the single-molecule level, and compare them to katanin. Microscopic fluorescence assays showed that human spastin bound to microtubules by ionic interactions, and diffused along microtubules with a diffusion coefficient comparable to katanin. The microscopic measurement of landing and dissociation rates demonstrated the ionic character of the interaction, which could be mapped to a patch of three lysine residues outside of the catalytic domain of human spastin. This motif is not conserved in Drosophila spastin or katanin, which also bound by non-catalytic parts of the protein. The binding affinities of spastin and katanin were nucleotide-sensitive, with the lowest affinities under ADP,, the highest under ATP-gamma S conditions. These changes correlated with the formation of higher oligomeric states, as shown in biochemical experiments and electron microscopic images. Vice versa, the artificial dimerization of human spastin by addition of a coiled coil led to a constitutively active enzyme. These observations suggest that dimer formation is a crucial step in the formation of the active complex, and thus the severing process by spastin. Citation: Eckert T, Le DT-V, Link S, Friedmann L, Woehlke G (2012) Spastin's Microtubule-Binding Properties and Comparison to Katanin. PLoS ONE 7(12): e50161. doi:10.1371/journal.pone.0050161	[Eckert, Thomas; Doan Tuong-Van Le; Link, Susanne; Friedmann, Lena; Woehlke, Guenther] Tech Univ Munich, Dept Phys Biophys E22, D-8046 Garching, Germany	Technical University of Munich	Woehlke, G (corresponding author), Tech Univ Munich, Dept Phys Biophys E22, D-8046 Garching, Germany.	guenther.woehlke@mytum.de		Woehlke, Gunther/0000-0001-8462-9962	Deutsche Forschungsgemeinschaft [DFG WO 614/4-1, DFG SFB 863, B7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft: DFG WO 614/4-1; DFG SFB 863 project B7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Adio S, 2009, FEBS J, V276, P3641, DOI 10.1111/j.1742-4658.2009.07083.x; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bornschlogl T, 2009, P NATL ACAD SCI USA, V106, P6992, DOI 10.1073/pnas.0812620106; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Crevel I, 1999, EMBO J, V18, P5863, DOI 10.1093/emboj/18.21.5863; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Diaz-Valencia JD, 2011, BIOPHYS J, V100, P2440, DOI 10.1016/j.bpj.2011.03.062; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Ebbing B, 2008, HUM MOL GENET, V17, P1245, DOI 10.1093/hmg/ddn014; Eckert T, 2012, J BIOL CHEM; GILBERT SP, 1994, BIOCHEMISTRY-US, V33, P1951, DOI 10.1021/bi00173a044; Hahlen K, 2006, J BIOL CHEM, V281, P18868, DOI 10.1074/jbc.M508019200; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; HUANG TG, 1994, J BIOL CHEM, V269, P16493; HYMAN AA, 1991, J CELL SCI, P125; Iwaya N, 2010, J BIOL CHEM, V285, P16822, DOI 10.1074/jbc.M110.108365; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13242, DOI 10.1021/bi00040a040; MANDELKOW EM, 1985, J MOL BIOL, V185, P311, DOI 10.1016/0022-2836(85)90406-1; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Ramey VH, 2011, MOL BIOL CELL, V22, P457, DOI 10.1091/mbc.E10-10-0841; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Salinas S, 2005, J NEUROCHEM, V95, P1411, DOI 10.1111/j.1471-4159.2005.03472.x; Schilling J, 2004, REV SCI INSTRUM, V75, P2822, DOI 10.1063/1.1783598; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; Stoppin-Mellet V, 2007, PLANT PHYSIOL BIOCH, V45, P867, DOI 10.1016/j.plaphy.2007.09.005; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Taylor E.W., 1972, Muscle Biol, V1, P47; Verbrugge S, 2009, BIOPHYS J, V97, P173, DOI 10.1016/j.bpj.2009.02.073; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206	42	39	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50161	10.1371/journal.pone.0050161	http://dx.doi.org/10.1371/journal.pone.0050161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272056	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386600007
J	Whitley, E; Deary, IJ; Der, G; Batty, GD; Benzeval, M				Whitley, Elise; Deary, Ian J.; Der, Geoff; Batty, G. David; Benzeval, Michaela			Paternal Age in Relation to Offspring Intelligence in the West of Scotland Twenty-07 Prospective Cohort Study	PLOS ONE			English	Article							ALL-CAUSE-MORTALITY; REACTION-TIME; PARENTAL AGE; RISK; IQ; SCHIZOPHRENIA; HEALTH; YOUTH; DEATH; OLD	Background: The adverse effects of advancing maternal age on offspring's health and development are well understood. Much less is known about the impact of paternal age. Methods: We explored paternal age-offspring cognition associations in 772 participants from the West of Scotland Twenty-07 study. Offspring cognitive ability was assessed using Part 1 of the Alice Heim 4 (AH4) test of General Intelligence and by reaction time (RT). Results: There was no evidence of a parental age association with offspring RT. However, we observed an inverse U-shaped association between paternal age and offspring AH4 score with the lowest scores observed for the youngest and oldest fathers. Adjustment for parental education and socioeconomic status somewhat attenuated this association. Adjustment for number of, particularly older, siblings further reduced the scores of children of younger fathers and appeared to account for the lower offspring scores in the oldest paternal age group. Conclusion: We observed a paternal age association with AH4 but not RT, a measure of cognition largely independent of social and educational experiences. Factors such as parental education, socioeconomic status and number of, particularly older, siblings may play an important role in accounting for paternal age-AH4 associations. Future studies should include parental intelligence. Citation: Whitley E, Deary IJ, Der G, Batty GD, Benzeval M (2012) Paternal Age in Relation to Offspring Intelligence in the West of Scotland Twenty-07 Prospective Cohort Study. PLoS ONE 7(12): e52112. doi:10.1371/journal.pone.0052112	[Whitley, Elise; Der, Geoff; Benzeval, Michaela] MRC, CSO Social & Publ Hlth Serv Unit, Glasgow, Lanark, Scotland; [Deary, Ian J.; Batty, G. David] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England	University of Edinburgh; University of London; University College London	Whitley, E (corresponding author), MRC, CSO Social & Publ Hlth Serv Unit, Glasgow, Lanark, Scotland.	elise.whitley@bristol.ac.uk	Benzeval, Michaela/J-3163-2015; Batty, GD/Y-4401-2018; Deary, Ian J/C-6297-2009	Benzeval, Michaela/0000-0002-0372-2098; Batty, GD/0000-0003-1822-5753; Deary, Ian J/0000-0002-1733-263X; Whitley, Elise/0000-0002-0297-9078; Der, Geoff/0000-0002-8677-073X	UK Medical Research Council (MRC) [MC_US_A540_53462, MC_US_A540_5TK10, MC_US_A540_5TK30]; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; MRC; University of Edinburgh as part of the cross-council Lifelong Health and Wellbeing initiative; Medical Research Council [G0700704, MC_U130059823] Funding Source: researchfish; Chief Scientist Office [SPHSU2] Funding Source: researchfish; MRC [MC_U130059823, G0700704] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh as part of the cross-council Lifelong Health and Wellbeing initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The West of Scotland Twenty-07 Study is funded by the UK Medical Research Council (MRC) (MC_US_A540_53462). E Whitley, M Benzeval (MC_US_A540_5TK10) and G Der (MC_US_A540_5TK30) are funded by the MRC. The Centre for Cognitive Ageing and Cognitive Epidemiology is supported by the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council, the Economic and Social Research Council, the MRC, and the University of Edinburgh as part of the cross-council Lifelong Health and Wellbeing initiative. GD Batty is a Wellcome Trust Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Andersen AMN, 2004, AM J EPIDEMIOL, V160, P1214, DOI 10.1093/aje/kwh332; AUROUX M, 1983, TERATOLOGY, V27, P141, DOI 10.1002/tera.1420270202; AUROUX MR, 1989, HUM REPROD, V4, P794, DOI 10.1093/oxfordjournals.humrep.a136988; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Botting B, 2003, NATL STAT POPUL TREN, V100, P32; Bray I, 2006, J EPIDEMIOL COMMUN H, V60, P851, DOI 10.1136/jech.2005.045179; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Coleman DA, 2000, INT ST DEMOG, P29; Cox BD, 1993, HLTH LIFESTYLE SURVE; Deary IJ, 2010, PSYCHOL AGING, V25, P219, DOI 10.1037/a0017750; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/13825580590969235; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Deary IJ, 2006, HUMAN ABILITY GENETI; Der G, 2003, INTELLIGENCE, V31, P491, DOI 10.1016/S0160-2896(02)00189-7; Der G, 1998, COMP W SCOTLAND 2 07; Downey DB, 2001, AM PSYCHOL, V56, P497, DOI 10.1037//0003-066X.56.6-7.497; Edwards RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012157; El-Saadi O, 2004, SCHIZOPHR RES, V67, P227, DOI 10.1016/S0920-9964(03)00100-2; Heim A, 1970, MANUAL AII4 GROUP TE; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; Mathews T, 2009, DELAYED CHILDBEARING; Neiss M, 2002, J BIOSOC SCI, V34, P259, DOI 10.1017/S0021932002002596; ONS, 2009, PATT FATH ENGL WAL 1, P103; Perrin MC, 2007, SCHIZOPHRENIA BULL, V33, P1270, DOI 10.1093/schbul/sbm093; Powell B, 2006, SOC FORCES, V84, P1359, DOI 10.1353/sof.2006.0064; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Roberts J, 1974, VITAL HLTH STAT, V11, P1; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Schmidt L, 2012, HUM REPROD UPDATE, V18, P29, DOI 10.1093/humupd/dmr040; Shaw P, 2012, CEREB CORTEX, V22, P1256, DOI 10.1093/cercor/bhr194; Shipley BA, 2006, PSYCHOSOM MED, V68, P17, DOI 10.1097/01.psy.0000195867.66643.0f; Wohl M, 2007, EUR PSYCHIAT, V22, P22, DOI 10.1016/j.eurpsy.2006.08.007	37	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52112	10.1371/journal.pone.0052112	http://dx.doi.org/10.1371/journal.pone.0052112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AH	23272219	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000312386600055
J	Gupta, SK; Carmi, S; Ben-Asher, HW; Tkacz, ID; Naboishchikov, I; Michaeli, S				Gupta, Sachin Kumar; Carmi, Shai; Ben-Asher, Hiba Waldman; Tkacz, Itai Dov; Naboishchikov, Ilana; Michaeli, Shulamit			Basal Splicing Factors Regulate the Stability of Mature mRNAs in Trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS TBUBP1; ANALYSIS REVEALS; DOMAIN PROTEINS; WIDE ANALYSIS; SM PROTEINS; BRUCEI; IDENTIFICATION; EXPRESSION; NUCLEAR; INTERFERENCE	Gene expression in trypanosomes is mainly regulated post-transcriptionally. Genes are transcribed as polycistronic mRNAs that are dissected by the concerted action of trans-splicing and polyadenylation. In trans-splicing, a common exon, the spliced leader, is added to all mRNAs from a small RNA. In this study, we examined by microarray analysis the transcriptome following RNAi silencing of the basal splicing factors U2AF65, SF1, and U2AF35. The transcriptome data revealed correlations between the affected genes and their splicing and polyadenylation signaling properties, suggesting that differential binding of these factors to pre-mRNA regulates trans-splicing and hence expression of specific genes. Surprisingly, all these factors were shown to affect not only splicing but also mRNA stability. Affinity purification of SF1 and U2AF35 complexes supported their role in mRNA stability. U2AF35 but not SF1 was shown to bind to ribosomes. To examine the role of splicing factors in mRNA stability, mutations were introduced into the polypyrimidine tract located in the 3' UTR of a mini-gene, and the results demonstrate that U2AF65 binds to such a site and controls the mRNA stability. We propose that transcripts carrying splicing signals in their 3' UTR bind the splicing factors and control their stability.	[Michaeli, Shulamit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; Bar Ilan Univ, Adv Mat & Nanotechnol Inst, IL-52900 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Michaeli, S (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	shulamit.michaeli@biu.ac.il	Michaeli, Shulamit/AAC-8255-2022; Carmi, Shai/F-4817-2010	Carmi, Shai/0000-0002-0188-2610	Deutsche Forcshungsgemeinschaft via Deutsche-Israelische Projektkooperation; Israel Science Foundation	Deutsche Forcshungsgemeinschaft via Deutsche-Israelische Projektkooperation; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by the Deutsche Forcshungsgemeinschaft via Deutsche-Israelische Projektkooperation and the Israel Science Foundation.	AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; Alves LR, 2010, GENE, V452, P72, DOI 10.1016/j.gene.2009.12.009; Ambrosio DL, 2009, EUKARYOT CELL, V8, P990, DOI 10.1128/EC.00075-09; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Barth S, 2005, J BIOL CHEM, V280, P34558, DOI 10.1074/jbc.M503465200; Barth S, 2008, EUKARYOT CELL, V7, P86, DOI 10.1128/EC.00215-07; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Colasante C, 2007, MOL BIOCHEM PARASIT, V151, P193, DOI 10.1016/j.molbiopara.2006.11.003; Corioni M, 2011, NUCLEIC ACIDS RES, V39, P1868, DOI 10.1093/nar/gkq1042; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Droll D, 2010, FEBS LETT, V584, P1156, DOI 10.1016/j.febslet.2010.02.018; ELLIS JA, 1993, VET PARASITOL, V50, P143, DOI 10.1016/0304-4017(93)90015-F; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; Gunzl A, 2010, EUKARYOT CELL, V9, P1159, DOI 10.1128/EC.00113-10; Gupta SK, 2010, NUCLEIC ACIDS RES, V38, P7236, DOI 10.1093/nar/gkq599; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hartmann C, 2008, MOL BIOCHEM PARASIT, V157, P112, DOI 10.1016/j.molbiopara.2007.09.009; Hartmann C, 2007, EUKARYOT CELL, V6, P1964, DOI 10.1128/EC.00279-07; HUG M, 1994, MOL CELL BIOL, V14, P7428, DOI 10.1128/MCB.14.11.7428; Hury A, 2009, EUKARYOT CELL, V8, P56, DOI 10.1128/EC.00322-08; Ismaili N, 1999, MOL BIOCHEM PARASIT, V102, P103, DOI 10.1016/S0166-6851(99)00091-2; Ismaili N, 2000, MOL BIOCHEM PARASIT, V106, P109, DOI 10.1016/S0166-6851(99)00205-4; Jae N, 2010, EUKARYOT CELL, V9, P379, DOI 10.1128/EC.00353-09; Jensen BC, 2003, J BIOL CHEM, V278, P32204, DOI 10.1074/jbc.M304198200; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Kol G, 2005, HUM MOL GENET, V14, P1559, DOI 10.1093/hmg/ddi164; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Liang XH, 2006, MOL BIOCHEM PARASIT, V145, P29, DOI 10.1016/j.molbiopara.2005.09.004; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liang XH, 2001, J BIOL CHEM, V276, P40313, DOI 10.1074/jbc.M104488200; Mandelboim M, 2003, J BIOL CHEM, V278, P51469, DOI 10.1074/jbc.M308997200; Manful T, 2011, RNA, V17, P2039, DOI 10.1261/rna.2837311; Manger ID, 1998, MOL BIOCHEM PARASIT, V97, P1, DOI 10.1016/S0166-6851(98)00118-2; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; MICHAELI S, 1990, J BIOL CHEM, V265, P10582; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Palfi Z, 2005, NUCLEIC ACIDS RES, V33, P2493, DOI 10.1093/nar/gki548; Palfi Z, 2009, GENE DEV, V23, P1650, DOI 10.1101/gad.526109; Prohaska K, 2009, EUKARYOT CELL, V8, P77, DOI 10.1128/EC.00234-08; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Rino J, 2008, MOL CELL BIOL, V28, P3045, DOI 10.1128/MCB.02015-07; Ruan JP, 2007, MOL BIOCHEM PARASIT, V156, P246, DOI 10.1016/j.molbiopara.2007.09.001; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Siegel TN, 2005, MOL CELL BIOL, V25, P9586, DOI 10.1128/MCB.25.21.9586-9594.2005; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Tkacz ID, 2008, MOL BIOCHEM PARASIT, V160, P22, DOI 10.1016/j.molbiopara.2008.03.003; Tkacz ID, 2007, RNA, V13, P30, DOI 10.1261/rna.174307; Tkacz ID, 2010, J BIOL CHEM, V285, P27982, DOI 10.1074/jbc.M109.095349; VASSELLA E, 1994, NUCLEIC ACIDS RES, V22, P1359, DOI 10.1093/nar/22.8.1359; Vazquez M, 2003, MOL BIOCHEM PARASIT, V128, P77, DOI 10.1016/S0166-6851(03)00007-0; Vazquez MP, 2009, MOL BIOCHEM PARASIT, V164, P137, DOI 10.1016/j.molbiopara.2008.12.009; Wurst M, 2009, MOL BIOCHEM PARASIT, V163, P61, DOI 10.1016/j.molbiopara.2008.09.001; Xu YX, 2001, J BIOL CHEM, V276, P14289, DOI 10.1074/jbc.M007007200; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	74	26	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4991	5006		10.1074/jbc.M112.416578	http://dx.doi.org/10.1074/jbc.M112.416578			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283975	Green Published, hybrid			2022-12-25	WOS:000315340400046
J	Northey, JJ; Dong, ZF; Ngan, E; Kaplan, A; Hardy, WR; Pawson, T; Siegel, PM				Northey, Jason J.; Dong, Zhifeng; Ngan, Elaine; Kaplan, Andrew; Hardy, W. Rod; Pawson, Tony; Siegel, Peter M.			Distinct Phosphotyrosine-dependent Functions of the ShcA Adaptor Protein Are Required for Transforming Growth Factor beta (TGF beta)-induced Breast Cancer Cell Migration, Invasion, and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL-LIKE TRANSITION; TYROSINE PHOSPHORYLATION; TRANSGENIC MICE; PTB DOMAIN; KINASE; RECEPTOR; GRB2; INDUCTION; INTEGRIN; SITES	The ErbB2 and TGF beta signaling pathways cooperate to promote the migratory, invasive, and metastatic behavior of breast cancer cells. Wepreviously demonstrated that ShcA is necessary for these synergistic interactions. Through a structure/function approach, we now show that the phosphotyrosine-binding, but not the Src homology 2, domain of ShcA is required for TGF beta-induced migration and invasion of ErbB2-expressing breast cancer cells. We further demonstrate that the tyrosine phosphorylation sites within ShcA (Tyr(239)/Tyr(240) and Tyr(313)) transduce distinct and non-redundant signals that promote these TGF beta-mediated effects. We demonstrate that Grb2 is required specifically downstream of Tyr(313), whereas the Tyr(239)/Tyr(240) phosphorylation sites require the Crk adaptor proteins to augment TGF beta-induced migration and invasion. Furthermore, ShcA Tyr(313) phosphorylation enhances tumor cell survival, and ShcA Tyr(239)/Tyr(240) signaling promotes endothelial cell recruitment into ErbB2-expressing breast tumors in vivo, whereas all three ShcA tyrosine residues are required for efficient breast cancer metastasis to the lungs. Our data uncover a novel ShcA-dependent signaling axis downstream of TGF beta and ErbB2 that requires both the Grb2 and Crk adaptor proteins to increase the migratory and invasive properties of breast cancer cells. In addition, signaling downstream of specific ShcA tyrosine residues facilitates the survival, vascularization, and metastatic spread of breast tumors.	[Northey, Jason J.; Dong, Zhifeng; Ngan, Elaine; Kaplan, Andrew; Siegel, Peter M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Northey, Jason J.; Siegel, Peter M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Dong, Zhifeng; Ngan, Elaine; Siegel, Peter M.] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Kaplan, Andrew; Siegel, Peter M.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Hardy, W. Rod] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Pawson, Tony] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G IX5, Canada	McGill University; McGill University; McGill University; McGill University; University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Siegel, PM (corresponding author), McGill Univ, Goodman Canc Res Ctr, 1160 Pine Ave W,Rm 513, Montreal, PQ H3A 1A3, Canada.	peter.siegel@mcgill.ca	Northey, Jason/AAX-6365-2021; Pawson, Tony J/E-4578-2013	Northey, Jason/0000-0003-3115-2560	Association for International Cancer Research [11-0204]; Canadian Cancer Society Research Institute [2011-700790]; Research Institute of the McGill University Health Centre; Department of Medicine, McGill University; Fonds de recherche en sante du Quebec; United States Army Department of Defense Breast Cancer Research Program [W81XWH-11-1-0008]; Worldwide Cancer Research [11-0204] Funding Source: researchfish	Association for International Cancer Research; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Research Institute of the McGill University Health Centre; Department of Medicine, McGill University; Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); United States Army Department of Defense Breast Cancer Research Program; Worldwide Cancer Research	This work was supported in part by Association for International Cancer Research Grant 11-0204 and Canadian Cancer Society Research Institute Grant 2011-700790) ( to P. M. S.).; Supported by studentships from the Research Institute of the McGill University Health Centre and Department of Medicine, McGill University.; Supported by a studentship from the Fonds de recherche en sante du Quebec and currently holds a studentship from the United States Army Department of Defense Breast Cancer Research Program (Grant W81XWH-11-1-0008).	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cabodi S, 2010, FASEB J, V24, P3796, DOI 10.1096/fj.10-157347; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Chow A, 2011, J MAMMARY GLAND BIOL, V16, P81, DOI 10.1007/s10911-011-9206-4; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Davol PA, 2003, CANCER RES, V63, P6772; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Deshmukh L, 2010, J BIOL CHEM, V285, P34875, DOI 10.1074/jbc.M110.159087; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Fathers KE, 2010, AM J PATHOL, V176, P446, DOI 10.2353/ajpath.2010.090383; Frackelton AR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1631; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Giubellino A, 2007, CANCER RES, V67, P6012, DOI 10.1158/0008-5472.CAN-07-0022; Gotoh N, 1996, EMBO J, V15, P6197, DOI 10.1002/j.1460-2075.1996.tb01008.x; Gotoh N, 1997, MOL CELL BIOL, V17, P1824, DOI 10.1128/MCB.17.4.1824; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Hardy WR, 2007, SCIENCE, V317, P251, DOI 10.1126/science.1140114; Khoury H, 2001, ONCOGENE, V20, P788, DOI 10.1038/sj.onc.1204166; Lamorte L, 2002, MOL BIOL CELL, V13, P1449, DOI 10.1091/mbc.01-10-0477; Lamorte L, 2002, J BIOL CHEM, V277, P37904, DOI 10.1074/jbc.M201743200; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nakamura T, 2002, ONCOGENE, V21, P22, DOI 10.1038/sj.onc.1205019; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Rauh MJ, 1999, MOL CELL BIOL, V19, P8169; Rodrigues SP, 2005, MOL CANCER RES, V3, P183; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SALCINI AE, 1994, ONCOGENE, V9, P2827; Saucier C, 2004, P NATL ACAD SCI USA, V101, P2345, DOI 10.1073/pnas.0308065101; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Tornillo G, 2011, EUR J CELL BIOL, V90, P237, DOI 10.1016/j.ejcb.2010.09.002; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Ursini-Siegel J, 2010, CANCER RES, V70, P7776, DOI 10.1158/0008-5472.CAN-10-2229; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Zang XP, 2004, CLIN EXP METASTAS, V21, P437, DOI 10.1007/s10585-004-2051-8	50	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5210	5222		10.1074/jbc.M112.424804	http://dx.doi.org/10.1074/jbc.M112.424804			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23277357	Green Published, hybrid			2022-12-25	WOS:000315340400068
J	Li, SY; Du, MJ; Wan, YJ; Lan, B; Liu, YH; Yang, Y; Zhang, CZ; Cao, YJ				Li, Shi-Yang; Du, Ming-Juan; Wan, Ya-Juan; Lan, Bei; Liu, Yao-Hui; Yang, Yin; Zhang, Cui-Zhu; Cao, YouJia			The N-terminal 20-Amino Acid Region of Guanine Nucleotide Exchange Factor Vav1 Plays a Distinguished Role in T Cell Receptor-mediated Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; FAMILY PROTEINS; DEPENDENT TRANSCRIPTION; RHO-GTPASES; ACTIVATION; VISUALIZATION; LYMPHOCYTE; INHIBITION; CALMODULIN; REGULATORS	Vav1 is a guanine nucleotide exchange factor (GEF) specifically expressed in hematopoietic cells. It consists of multiple structural domains and plays important roles in T cell activation. The other highly conserved isoforms of Vav family, Vav2 and Vav3, are ubiquitously expressed in human tissues including lymphocytes. All three Vav proteins activate Rho family small GTPases, which are involved in a variety of biological processes during T cell activation. Intensive studies have demonstrated that Vav1 is indispensable for T cell receptor (TCR)-mediated signal transduction, whereas Vav2 and Vav3 function as GEFs that overlap with Vav1 on TCR-induced cytoskeleton reorganization. T cells lacking Vav1 exhibited severe defect in TCR-mediated calcium elevation, indicating that the co-existing Vav2 and Vav3 did not compensate Vav1 in calcium signaling. What is the functional particularity of Vav1 in lymphocytes? In this study, we identified the N-terminal 20 amino acids of Vav1 in the calponin homology (CH) domain to be essential for its interaction with calmodulin (CaM) that leads to TCR-induced calcium mobilization. Substitution of the 1-20 amino acids of Vav1 with those of Vav2 or Vav3 abolished the association with CaM, and the N-terminal mutations of Vav1 failed to potentiate normal TCR-induced calcium mobilization, that in turn, suspended nuclear factor of activated T cells (NFAT) activation and IL-2 production. This study highlights the importance of the N-terminal 20 aa of Vav1 for CaM binding, and provides new insights into the distinguished and irreplaceable role of Vav1 in T cell activation and signal transduction.	[Li, Shi-Yang; Du, Ming-Juan; Wan, Ya-Juan; Liu, Yao-Hui; Zhang, Cui-Zhu; Cao, YouJia] Nankai Univ, Minist Educ, Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China; [Lan, Bei; Yang, Yin; Zhang, Cui-Zhu; Cao, YouJia] Nankai Univ, State Key Lab, Med Chem Biol Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Cao, YJ (corresponding author), Mol Biol Inst Bldg,Rm 224,94 Weijin Rd, Tianjin 300071, Peoples R China.	caoyj@nankai.edu.cn			National Natural Science Foundation of China [81171556, 31270925]; Ministry of Science and Technology of China [2012CB917204]; Program of Introducing Talents of Discipline to Universities [B08011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China Grants 81171556 and 31270925 (to Y.C.), Ministry of Science and Technology of China Grant 2012CB917204 (to Y.C), and the Program of Introducing Talents of Discipline to Universities (B08011).	Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Billadeau DD, 2000, J EXP MED, V192, P381, DOI 10.1084/jem.192.3.381; Billadeau DD, 2000, J IMMUNOL, V164, P3971, DOI 10.4049/jimmunol.164.8.3971; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Charvet C, 2002, J BIOL CHEM, V277, P15376, DOI 10.1074/jbc.M111627200; Doody GM, 2000, EMBO J, V19, P6173, DOI 10.1093/emboj/19.22.6173; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; Groysman M, 2002, J BIOL CHEM, V277, P50121, DOI 10.1074/jbc.M204299200; Groysman M, 2000, FEBS LETT, V467, P75, DOI 10.1016/S0014-5793(00)01121-2; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kaminuma O, 2001, MOL CELL BIOL, V21, P3126, DOI 10.1128/MCB.21.9.3126-3136.2001; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Knyazhitsky M, 2012, J BIOL CHEM, V287, P19725, DOI 10.1074/jbc.M111.309799; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Miletic AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006599; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Saveliev A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000420; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Sylvain NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001178; Thalappilly S, 2010, ONCOGENE, V29, P2528, DOI 10.1038/onc.2010.1; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zakaria S, 2004, J EXP MED, V199, P429, DOI 10.1084/jem.20031228; Zhou Z, 2007, J BIOL CHEM, V282, P23737, DOI 10.1074/jbc.M702975200; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	39	12	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3777	3785		10.1074/jbc.M112.426221	http://dx.doi.org/10.1074/jbc.M112.426221			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23271736	Green Published, hybrid			2022-12-25	WOS:000314845000009
J	Lambert, SL; Yang, CF; Liu, Z; Sweetwood, R; Zhao, J; Cheng, LL; Jin, H; Woo, J				Lambert, Stacie L.; Yang, Chin-Fen; Liu, Zheng; Sweetwood, Rosemary; Zhao, Jackie; Cheng, Lily; Jin, Hong; Woo, Jennifer			Molecular and Cellular Response Profiles Induced by the TLR4 Agonist-Based Adjuvant Glucopyranosyl Lipid A	PLOS ONE			English	Article							ACTIVATION; CELLS	Background: Toll-like receptor (TLR) 4 agonists are known potent immunostimulatory compounds. These compounds can be formulated as part of novel adjuvants to enhance vaccine medicated immune responses. However, the contribution of the formulation to the innate in vivo activity of TLR4 agonist compounds is not well understood. Methodology and Principal Findings: We evaluated synthetic TLR4 agonist Glucopyranosyl Lipid A (GLA) for its effects on molecular and cellular innate immune responses in the murine model. Microarray techniques were used to compare the responses to GLA in an aqueous formulation or in an oil-in-water Stable Emulsion formulation (GLA-SE) versus either SE alone or the mineral salt aluminum hydroxide (alum) at the muscle injection site over multiple timepoints. In contrast to the minimal gene upregulation induced by SE and alum, both GLA and GLA-SE triggered MyD88- and TRIF-dependent gene expression. Genes for chemokines, cytokine receptors, signaling molecules, complement, and antigen presentation were also strongly upregulated by GLA and GLA-SE. These included chemokines for TH1-type T cells (CXCL9 and CXCL10) and mononuclear leukocytes (CCL2, CCL3) among others. GLA-SE induced stronger and more sustained gene upregulation than GLA in the muscle; GLA-SE induced genes were also detected in local draining lymph nodes and at lower levels in peripheral blood. Both GLA and GLA-SE resulted in increased cellular trafficking to the draining lymph nodes and upregulated MHC molecules and ICAM1 on local dendritic cells. GLA and GLA-SE transiently upregulated circulating MCP-1, TNF alpha, IFN gamma and IP-10 in blood. Conclusions/Significance: While GLA and GLA-SE activate a large number of shared innate genes and proteins, GLA-SE induces a quantitatively and qualitatively stronger response than GLA, SE or alum. The genes and proteins upregulated could be used to facilitate selection of appropriate adjuvant doses in vaccine formulations.	[Lambert, Stacie L.; Yang, Chin-Fen; Liu, Zheng; Sweetwood, Rosemary; Zhao, Jackie; Cheng, Lily; Jin, Hong; Woo, Jennifer] MedImmune LLC, Mountain View, CA USA	AstraZeneca; Medimmune	Jin, H (corresponding author), MedImmune LLC, Mountain View, CA USA.	jinh@medimmune.com; wooj@medimmune.com						Ahmed SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002302; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eskay R L, 1990, Adv Exp Med Biol, V274, P331; Fruh K, 1999, CURR OPIN IMMUNOL, V11, P76, DOI 10.1016/S0952-7915(99)80014-4; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Kang Suk-Jo, 2009, F1000 Biol Rep, V1, P15, DOI 10.3410/B1-15; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Marino M, 2011, GENE THER, V18, P109, DOI 10.1038/gt.2010.124; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238; Ramanathan S, 2008, ARCH IMMUNOL THER EX, V56, P311, DOI 10.1007/s00005-008-0033-2; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Ryman B E, 1978, Ann N Y Acad Sci, V308, P281, DOI 10.1111/j.1749-6632.1978.tb22031.x; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x	25	35	42	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51618	10.1371/journal.pone.0051618	http://dx.doi.org/10.1371/journal.pone.0051618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284726	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500013
J	Mostafavi, S; Goldenberg, A; Morris, Q				Mostafavi, Sara; Goldenberg, Anna; Morris, Quaid			Labeling Nodes Using Three Degrees of Propagation	PLOS ONE			English	Article							LANDSCAPE; NETWORK	The properties (or labels) of nodes in networks can often be predicted based on their proximity and their connections to other labeled nodes. So-called "label propagation algorithms" predict the labels of unlabeled nodes by propagating information about local label density iteratively through the network. These algorithms are fast, simple and scale to large networks but nonetheless regularly perform better than slower and much more complex algorithms on benchmark problems. We show here, however, that these algorithms have an intrinsic limitation that prevents them from adapting to some common patterns of network node labeling; we introduce a new algorithm, 3Prop, that retains all their advantages but is much more adaptive. As we show, 3Prop performs very well on node labeling problems ill-suited to label propagation, including predicting gene function in protein and genetic interaction networks and gender in friendship networks, and also performs slightly better on problems already well-suited to label propagation such as labeling blogs and patents based on their citation networks. 3Prop gains its adaptability by assigning separate weights to label information from different steps of the propagation. Surprisingly, we found that for many networks, the third iteration of label propagation receives a negative weight.	[Mostafavi, Sara] Stanford Univ, Dept Comp Sci, Palo Alto, CA 94304 USA; [Goldenberg, Anna] Univ Toronto, Sick Kids Res Inst, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Dept Comp Sci, Dept Mol Genet, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada	Stanford University; University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Mostafavi, S (corresponding author), Stanford Univ, Dept Comp Sci, Palo Alto, CA 94304 USA.	saram@cs.stanford.edu; quaid.morris@utoronto.ca	Morris, Quaid/ABE-8343-2020	Morris, Quaid/0000-0002-2760-6999; Mostafavi, Sara/0000-0003-4698-1177	NSERC operating grant	NSERC operating grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	SM, AG, and QM gratefully acknowledge the support from an NSERC operating grant to QM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, P WWW 2005 WORKSH WE; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bengio Y., 2006, SEMISUPERVISED LEARN, P193, DOI [10.7551/mitpress/9780262033589.003.0011, DOI 10.7551/MITPRESS/9780262033589.003.0011]; Bishop C.M., 2006, PATTERN RECOGNITION; Brun C, 2004, GENOME BIOL, V5; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Chung F. R. K., 1997, CBMS REGIONAL C SERI; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Davis J., 2006, P INT C MACH LEARN; Fowler J, 2008, BRIT MED J, V357, P370; Gallagher B., 2008, INT C KNOWL DISC DAT; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghahramani Z., 2003, INT C MACH LEARN, P912, DOI DOI 10.1/1/14/4312; Gillis J, 2010, MULTIFUNCTIONA UNPUB; Goh K, 2001, PHYS REV LETT, P87; Hall Bronwyn H., 2001, 8498 NBER; Haveliwala TH, 2002, P 11 INT WORLD WID W, P526; Hess DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000407; Kondor R, 2009, INT C MACH LEARN; Koutis I, 2010, FOCS; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lanckriet GRG, 2004, BIOINFORMATICS, V20, P2626, DOI 10.1093/bioinformatics/bth294; Lee I, 2011, GENOME RES; Leskovec J, 2006, PAC AS C KNOWL DISC; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Min R, 2009, LEARNING RANDOM WALK; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Newman M, 2006, P NATL ACAD SCI US; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Page L, 1999, PAGERANK CITATION RA; Park JY, 2007, P NATL ACAD SCI USA, V104, P17916, DOI 10.1073/pnas.0705081104; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Qi Y, 2008, GENOME RES, V18, P1991, DOI 10.1101/gr.077693.108; Richardson M, 2002, INT C KNOWL DISC DAT; Smola A, 2003, C LEARN THEOR COLT; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tong HH, 2008, KNOWL INF SYST, V14, P327, DOI 10.1007/s10115-007-0094-2; Traud A, 2008, 08090690 ARXIV; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang PI, 2010, J PROTEOMICS, V73, P2277, DOI 10.1016/j.jprot.2010.07.005; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weston J, 2004, P NATL ACAD SCI USA, V101, P6559, DOI 10.1073/pnas.0308067101; Zhou DY, 2004, ADV NEUR IN, V16, P321; Zhou X, P NATL ACAD SCI US, V99, P12783; Zhou X, 2011, INT C ART INT STAT A	47	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51947	10.1371/journal.pone.0051947	http://dx.doi.org/10.1371/journal.pone.0051947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284828	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500018
J	Betts, G; Poyntz, H; Stylianou, E; Reyes-Sandoval, A; Cottingham, M; Hill, A; McShane, H				Betts, Gareth; Poyntz, Hazel; Stylianou, Elena; Reyes-Sandoval, Arturo; Cottingham, Matthew; Hill, Adrian; McShane, Helen			Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection	PLOS ONE			English	Article							VACCINIA VIRUS ANKARA; PROTECTIVE EFFICACY; ENHANCED IMMUNOGENICITY; TUBERCULOSIS INFECTION; ADENOVIRUS VECTORS; T-CELLS; BCG; IMMUNITY; MICE; IMMUNIZATION	The Bacillus Calmette - Guerin (BCG) vaccine provides a critical but limited defense against Mycobacterium tuberculosis (M.tb). More than 60 years after the widespread introduction of BCG, there is an urgent need for a better vaccine. A large body of pre-clinical research continues to support ongoing clinical trials to assess whether viral vectors expressing M. tb antigens that are shared by BCG and M. tb, can be used alongside BCG to enhance protection. A major focus involves using multiple unique viral vectors to limit anti-vector immunity and thereby enhance responses to the insert antigen delivered. The successful introduction of viral vector vaccines to target M. tb and other pathogens will be reliant on reducing the costs when using multiple vectors and inhibiting the development of unwanted anti-vector responses that interfere with the response to insert antigen. This study examines methods to reduce the logistical costs of vaccination by mixing different viral vectors that share the same insert antigen in one vaccine; and whether combining different viral vectors reduces anti-vector immunity to improve immunogenicity to the insert antigen. Here we show that a homologous prime-boost regimen with a mixture of MVA (Modified Vaccinia virus Ankara) and Ad5 (human adenovirus type 5) vectors both expressing Ag85A in a single vaccine preparation is able to reduce anti-vector immunity, compared with a homologous prime-boost regimen with either vector alone. However, the level of immunogenicity induced by the homologous mixture remained comparable to that induced with single viral vectors and was less immunogenic than a heterologous Ad5 prime-MVA-boost regimen. These findings advance the understanding of how anti-vector immunity maybe reduced in viral vector vaccination regimens. Furthermore, an insight is provided to the impact on vaccine immunogenicity from altering vaccination methods to reduce the logistical demands of using separate vaccine preparations in the field.	[Betts, Gareth; Poyntz, Hazel; Stylianou, Elena; Reyes-Sandoval, Arturo; Cottingham, Matthew; Hill, Adrian; McShane, Helen] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Betts, Gareth] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; University of Oxford; Jenner Institute	Betts, G (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England.	Gareth.Betts@nds.ox.ac.uk	Reyes-Sandoval, Arturo/B-4264-2011	Cottingham, Matthew/0000-0003-0766-6465; McShane, Helen/0000-0002-2126-5142; Reyes-Sandoval, Arturo/0000-0002-2648-1696	NEWTBVAC (EC FP7); Wellcome Trust [WT076943MA, 097395]	NEWTBVAC (EC FP7); Wellcome Trust(Wellcome TrustEuropean Commission)	Funding was provided by NEWTBVAC (EC FP7). HM is a Wellcome Trust Senior Research Fellow (www.wellcome.ac.uk; WT076943MA). HM, AH and AR-S are Jenner Institute Investigators. AR-S is a Wellcome Trust Career Development Fellow (097395). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Caruso AM, 1999, J IMMUNOL, V162, P5407; Corbett EL, 1996, BRIT J HOSP MED, V56, P200; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; McCoy K, 2007, J VIROL, V81, P6594, DOI 10.1128/JVI.02497-06; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; McShane H, 2009, SWISS MED WKLY, V139, P156, DOI smw-12374; Oseroff C, 2005, P NATL ACAD SCI USA, V102, P13980, DOI 10.1073/pnas.0506768102; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; Reyes-Sandoval A, 2012, MOL THER, V20, P1633, DOI 10.1038/mt.2012.25; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Roederer M, 2011, CYTOMETRY A; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Schirmbeck R, 2008, MOL THER, V16, P1609, DOI 10.1038/mt.2008.141; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sousa AO, 2000, P NATL ACAD SCI USA, V97, P4204, DOI 10.1073/pnas.97.8.4204; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09	32	18	19	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e50447	10.1371/journal.pone.0050447	http://dx.doi.org/10.1371/journal.pone.0050447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284637	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800004
J	Abell, GCJ; Robert, SS; Frampton, DMF; Volkman, JK; Rizwi, F; Csontos, J; Bodrossy, L				Abell, Guy C. J.; Robert, Stan S.; Frampton, Dion M. F.; Volkman, John K.; Rizwi, Farhan; Csontos, Jozsef; Bodrossy, Levente			High-Throughput Analysis of Ammonia Oxidiser Community Composition via a Novel, amoA-Based Functional Gene Array	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DIAGNOSTIC MICROARRAY; OLIGONUCLEOTIDE MICROARRAYS; ENVIRONMENTAL GRADIENTS; BACTERIAL COMMUNITIES; NITROGEN-CYCLE; DIVERSITY; ARCHAEA; ESTUARY; SOIL	Advances in microbial ecology research are more often than not limited by the capabilities of available methodologies. Aerobic autotrophic nitrification is one of the most important and well studied microbiological processes in terrestrial and aquatic ecosystems. We have developed and validated a microbial diagnostic microarray based on the ammonia-monooxygenase subunit A (amoA) gene, enabling the in-depth analysis of the community structure of bacterial and archaeal ammonia oxidisers. The amoA microarray has been successfully applied to analyse nitrifier diversity in marine, estuarine, soil and wastewater treatment plant environments. The microarray has moderate costs for labour and consumables and enables the analysis of hundreds of environmental DNA or RNA samples per week per person. The array has been thoroughly validated with a range of individual and complex targets (amoA clones and environmental samples, respectively), combined with parallel analysis using traditional sequencing methods. The moderate cost and high throughput of the microarray makes it possible to adequately address broader questions of the ecology of microbial ammonia oxidation requiring high sample numbers and high resolution of the community composition.	[Abell, Guy C. J.; Robert, Stan S.; Frampton, Dion M. F.; Volkman, John K.; Rizwi, Farhan; Bodrossy, Levente] CSIRO Marine & Atmospher Res & Wealth Oceans Natl, Hobart, Tas, Australia; [Csontos, Jozsef] Budapest Univ Technol & Econ, Dept Phys Chem & Mat Sci, Budapest, Hungary	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Budapest University of Technology & Economics	Bodrossy, L (corresponding author), CSIRO Marine & Atmospher Res & Wealth Oceans Natl, Hobart, Tas, Australia.	lev.bodrossy@csiro.au	Csontos, Jozsef/H-5688-2012; Bodrossy, Levente/B-8054-2009; Frampton, Dion/D-3310-2012; Abell, Guy C J/A-1767-2010	Csontos, Jozsef/0000-0003-4732-9703; Bodrossy, Levente/0000-0001-6940-452X; 	Theme 'Our Resilient Coastal Australia' of the CSIRO Wealth from Oceans National Research Flagship	Theme 'Our Resilient Coastal Australia' of the CSIRO Wealth from Oceans National Research Flagship	The present work was funded by the Theme 'Our Resilient Coastal Australia' of the CSIRO Wealth from Oceans National Research Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell GCJ, 2005, FEMS MICROBIOL ECOL, V51, P265, DOI 10.1016/j.femsec.2004.09.001; Abell GCJ, 2011, FEMS MICROBIOL ECOL, V75, P111, DOI 10.1111/j.1574-6941.2010.00988.x; Abell GCJ, 2010, ISME J, V4, P286, DOI 10.1038/ismej.2009.105; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Bodrossy L, 2004, CURR OPIN MICROBIOL, V7, P245, DOI 10.1016/j.mib.2004.04.005; Bodrossy L, 2006, APPL ENVIRON MICROB, V72, P1672, DOI 10.1128/AEM.72.2.1672-1676.2006; Bodrossy L, 2003, ENVIRON MICROBIOL, V5, P566, DOI 10.1046/j.1462-2920.2003.00450.x; Bouskill N.J., 2011, ENV MICROBIOL; Cabezas A, 2009, APPL MICROBIOL BIOT, V84, P1191, DOI 10.1007/s00253-009-2138-x; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Casciotti KL, 2003, GEOMICROBIOL J, V20, P335, DOI 10.1080/01490450303895; Cebron A, 2003, APPL ENVIRON MICROB, V69, P7091, DOI 10.1128/AEM.69.12.7091-7100.2003; Chu HY, 2007, APPL ENVIRON MICROB, V73, P485, DOI 10.1128/AEM.01536-06; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Daebeler A, 2010, FRONTIERS MICROBIOLO, V3; Dang HY, 2008, MICROBIOL-SGM, V154, P2084, DOI 10.1099/mic.0.2007/013581-0; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; El Fantroussi S, 2003, APPL ENVIRON MICROB, V69, P2377, DOI 10.1128/AEM.69.4.2377-2382.2003; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2003, GEOBIOLOGY, V1, P129, DOI 10.1046/j.1472-4669.2003.00010.x; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; He Z, 2010, ISME J, DOI 101038/ismej201046; HOLMES AJ, 1995, FEMS MICROBIOL LETT, V132, P203, DOI 10.1016/0378-1097(95)00311-R; Horz HP, 2000, J MICROBIOL METH, V39, P197, DOI 10.1016/S0167-7012(99)00119-0; Jin T, 2010, APPL MICROBIOL BIOT, V87, P1167, DOI 10.1007/s00253-010-2595-2; Junier P, 2010, APPL MICROBIOL BIOT, V85, P425, DOI 10.1007/s00253-009-2228-9; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kumaresan D, 2011, RES MICROBIOL, V162, P1027, DOI 10.1016/j.resmic.2011.08.002; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mertens J, 2009, ISME J, V3, P916, DOI 10.1038/ismej.2009.39; Microarrays, 2003, BEGINNERS GUIDE MICR, P43; Moin NS, 2009, APPL ENVIRON MICROB, V75, P7461, DOI 10.1128/AEM.01001-09; Mosier AC, 2008, ENVIRON MICROBIOL, V10, P3002, DOI 10.1111/j.1462-2920.2008.01764.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nicolaisen MH, 2002, J MICROBIOL METH, V50, P189, DOI 10.1016/S0167-7012(02)00026-X; Onodera Y, 2010, MICROBES ENVIRON, V25, P28, DOI 10.1264/jsme2.ME09179; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Reed DW, 2010, APPL ENVIRON MICROB, V76, P2517, DOI 10.1128/AEM.02436-09; Ritz K, 2009, ECOL INDIC, V9, P1212, DOI 10.1016/j.ecolind.2009.02.009; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Sahan E, 2008, FEMS MICROBIOL ECOL, V64, P175, DOI 10.1111/j.1574-6941.2008.00462.x; Sanguin H, 2006, APPL ENVIRON MICROB, V72, P4302, DOI 10.1128/AEM.02686-05; Siljanen HMP, 2011, FEMS MICROBIOL ECOL, V75, P430, DOI 10.1111/j.1574-6941.2010.01015.x; STEHR G, 1995, FEMS MICROBIOL ECOL, V17, P177, DOI 10.1016/0168-6496(95)00022-3; Steward GF, 2004, APPL ENVIRON MICROB, V70, P1455, DOI 10.1128/AEM.70.3.1455-1465.2004; Stralis-Pavese N, 2004, ENVIRON MICROBIOL, V6, P347, DOI 10.1111/j.1462-2920.2004.00582.x; Stralis-Pavese N, 2011, NAT PROTOC, V6, P609, DOI 10.1038/nprot.2010.191; Tavormina PL, 2011, ENV MICROBIOL REP, V3, P91, DOI 10.1111/j.1758-2229.2010.00192.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Trias R, 2012, APPL ENVIRON MICROB, V78, P318, DOI 10.1128/AEM.05904-11; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward BB, 2007, ENVIRON MICROBIOL, V9, P2522, DOI 10.1111/j.1462-2920.2007.01371.x; Ye L, 2011, BIOTECHNOL BIOENG, V108, P2544, DOI 10.1002/bit.23211; Zhang L, 2006, MICROB ECOL; Zhang LM, 2009, FEMS MICROBIOL ECOL, V70, P208, DOI 10.1111/j.1574-6941.2009.00775.x	69	23	23	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51542	10.1371/journal.pone.0051542	http://dx.doi.org/10.1371/journal.pone.0051542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284709	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300030
J	Lucas, TM; Janaka, SK; Stephens, EB; Johnson, MC				Lucas, Tiffany M.; Janaka, Sanath K.; Stephens, Edward B.; Johnson, Marc C.			Vpu Downmodulates Two Distinct Targets, Tetherin and Gibbon Ape Leukemia Virus Envelope, through Shared Features in the Vpu Cytoplasmic Tail	PLOS ONE			English	Article							HIV-1 VPU; TRANSMEMBRANE DOMAIN; BETA-TRCP; CONFER SENSITIVITY; RAPID DEGRADATION; PARTICLE RELEASE; INHIBITS HIV-1; CELL-SURFACE; PROTEIN; CD4	During human immunodeficiency virus-1 (HIV-1) assembly, the host proteins CD4 (the HIV-1 receptor) and tetherin (an interferon stimulated anti-viral protein) both reduce viral fitness. The HIV-1 accessory gene Vpu counteracts both of these proteins, but it is thought to do so through two distinct mechanisms. Modulation of CD4 likely occurs through proteasomal degradation from the endoplasmic reticulum. The exact mechanism of tetherin modulation is less clear, with possible roles for degradation and alteration of protein transport to the plasma membrane. Most investigations of Vpu function have used different assays for CD4 and tetherin. In addition, many of these investigations used exogenously expressed Vpu, which could result in variable expression levels. Thus, few studies have investigated these two Vpu functions in parallel assays, making direct comparisons difficult. Here, we present results from a rapid assay used to simultaneously investigate Vpu-targeting of both tetherin and a viral glycoprotein, gibbon ape leukemia virus envelope (GaLV Env). We previously reported that Vpu modulates GaLV Env and prevents its incorporation into HIV-1 particles through a recognition motif similar to that found in CD4. Using this assay, we performed a comprehensive mutagenic scan of Vpu in its native proviral context to identify features required for both types of activity. We observed considerable overlap in the Vpu sequences required to modulate tetherin and GaLV Env. We found that features in the cytoplasmic tail of Vpu, specifically within the cytoplasmic tail hinge region, were required for modulation of both tetherin and GaLV Env. Interestingly, these same regions features have been determined to be critical for CD4 downmodulation. We also observed a role for the transmembrane domain in the restriction of tetherin, as previously reported, but not of GaLV Env. We propose that Vpu may target both proteins in a mechanistically similar manner, albeit in different cellular locations.	[Lucas, Tiffany M.; Janaka, Sanath K.; Johnson, Marc C.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher S Bond Life Sci Ctr, Columbia, MO 65212 USA; [Stephens, Edward B.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	University of Missouri System; University of Missouri Columbia; University of Kansas; University of Kansas Medical Center	Johnson, MC (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher S Bond Life Sci Ctr, Columbia, MO 65212 USA.	marcjohnson@missouri.edu	Janaka, Sanath Kumar/AAE-8500-2021	Janaka, Sanath Kumar/0000-0003-2341-1526	NIH-NIAID [R21 AI087448-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087448] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial aid for this study was funded by NIH-NIAID, in the form of a grant to M. C. J. (R21 AI087448-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binette J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-75; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; Bour S, 2003, MICROBES INFECT, V5, P1029, DOI 10.1016/S1286-4579(03)00191-6; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; CHEN MY, 1993, J VIROL, V67, P3877, DOI 10.1128/JVI.67.7.3877-3884.1993; Christodoulopoulos I, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-4; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Fujita K, 1997, J GEN VIROL, V78, P619, DOI 10.1099/0022-1317-78-3-619; Guatelli JC, 2009, CURR TOP MICROBIOL, V339, P27, DOI 10.1007/978-3-642-02175-6_2; Gustin JK, 2012, J BIOL CHEM, V287, P14837, DOI 10.1074/jbc.M112.349928; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hill MS, 2010, VIROLOGY, V397, P104, DOI 10.1016/j.virol.2009.10.048; Hout DR, 2005, VIROLOGY, V339, P56, DOI 10.1016/j.virol.2005.04.038; Hussain A, 2008, J VIROL, V82, P893, DOI 10.1128/JVI.01373-07; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Janaka SK, 2011, J VIROL, V85, P11945, DOI 10.1128/JVI.05171-11; Jorgenson RL, 2009, J VIROL, V83, P4060, DOI 10.1128/JVI.02425-08; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Kueck T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002609; Lewis BC, 2001, J VIROL, V75, P9339, DOI 10.1128/JVI.75.19.9339-9344.2001; Lucas TM, 2010, J VIROL, V84, P2666, DOI 10.1128/JVI.01562-09; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Nomaguchi M, 2008, MICROBES INFECT, V10, P960, DOI 10.1016/j.micinf.2008.07.006; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Ruiz A, 2008, VIROLOGY, V378, P58, DOI 10.1016/j.virol.2008.05.022; Ruiz A, 2010, CURR HIV RES, V8, P240, DOI 10.2174/157016210791111124; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; SCHUBERT U, 1994, J MOL BIOL, V236, P16, DOI 10.1006/jmbi.1994.1114; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Skasko M, 2012, J BIOL CHEM, V287, P58, DOI 10.1074/jbc.M111.296772; Skasko M, 2011, VIROLOGY, V411, P65, DOI 10.1016/j.virol.2010.12.038; Tiganos E, 1998, VIROLOGY, V251, P96, DOI 10.1006/viro.1998.9368; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vigan R, 2011, J VIROL, V85, P9737, DOI 10.1128/JVI.00479-11; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; Watanabe R, 2011, VIROLOGY, V417, P50, DOI 10.1016/j.virol.2011.05.006; WILLEY RL, 1994, J VIROL, V68, P1207, DOI 10.1128/JVI.68.2.1207-1212.1994; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992	55	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51741	10.1371/journal.pone.0051741	http://dx.doi.org/10.1371/journal.pone.0051741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284757	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300038
J	Bonte, B; Mathias, JD; Duboz, R				Bonte, Bruno; Mathias, Jean-Denis; Duboz, Raphael			Moment Approximation of Infection Dynamics in a Population of Moving Hosts	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; EPIDEMIOLOGIC MODELS; SCRAPIE EPIDEMIOLOGY; NETWORK STRUCTURE; TRANSMISSION; H5N1; CONTACT; PROPAGATION; PERSISTENCE; OUTBREAKS	The modelling of contact processes between hosts is of key importance in epidemiology. Current studies have mainly focused on networks with stationary structures, although we know these structures to be dynamic with continuous appearance and disappearance of links over time. In the case of moving individuals, the contact network cannot be established. Individual-based models (IBMs) can simulate the individual behaviours involved in the contact process. However, with very large populations, they can be hard to simulate and study due to the computational costs. We use the moment approximation (MA) method to approximate a stochastic IBM with an aggregated deterministic model. We illustrate the method with an application in animal epidemiology: the spread of the highly pathogenic virus H5N1 of avian influenza in a poultry flock. The MA method is explained in a didactic way so that it can be reused and extended. We compare the simulation results of three models: 1. an IBM, 2. a MA, and 3. a mean-field (MF). The results show a close agreement between the MA model and the IBM. They highlight the importance for the models to capture the displacement behaviours and the contact processes in the study of disease spread. We also illustrate an original way of using different models of the same system to learn more about the system itself, and about the representation we build of it. Citation: Bonte B, Mathias J-D, Duboz R (2012) Moment Approximation of Infection Dynamics in a Population of Moving Hosts. PLoS ONE 7(12): e51760. doi:10.1371/journal.pone.0051760	[Bonte, Bruno; Mathias, Jean-Denis] French Natl Res Inst Sci & Tech Environm & Agr IR, Lab Engn Complex Syst LISC, Aubiere, France; [Bonte, Bruno; Duboz, Raphael] French Ctr Int Cooperat Agr Res & Dev CIRAD, Anim & Integrated Risk Management AGIRs Res Unit, Montpellier, France; [Duboz, Raphael] Asian Inst Technol, Comp Sci & Informat Management CSIM Dept, Pathum Thani, Thailand	INRAE; CIRAD; Asian Institute of Technology	Mathias, JD (corresponding author), French Natl Res Inst Sci & Tech Environm & Agr IR, Lab Engn Complex Syst LISC, Aubiere, France.	jean-denis.mathias@irstea.fr	Bonté, Bruno/GNP-1909-2022; Mathias, Jean-Denis/R-5391-2016; Bonté, Bruno/GNP-4017-2022	Bonté, Bruno/0000-0002-7325-0495; Mathias, Jean-Denis/0000-0002-6172-9079; 				Amouroux E, 2008, LECT NOTES ARTIF INT, V5357, P26, DOI 10.1007/978-3-540-89674-6_6; Barthelemy M, 2005, J THEOR BIOL, V235, P275, DOI 10.1016/j.jtbi.2005.01.011; Bobashev Georgiy V., 2007, 2007 Winter Simulation Conference, P1532, DOI 10.1109/WSC.2007.4419767; Bolker BM, 1999, B MATH BIOL, V61, P849, DOI 10.1006/bulm.1999.0115; Bouma A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000281; Choisy M, 2007, ENCY INFECT DIS MODE; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Duboz R, 2010, ECOL MODEL, V221, P840, DOI 10.1016/j.ecolmodel.2009.11.023; Durand B, 2004, ECOL MODEL, V179, P515, DOI 10.1016/j.ecolmodel.2004.05.015; Eames KTD, 2009, EPIDEMICS-NETH, V1, P70, DOI 10.1016/j.epidem.2008.12.001; Filipe JAN, 2004, B MATH BIOL, V66, P373, DOI 10.1016/j.bulm.2003.09.002; Filipe JAN, 2001, B MATH BIOL, V63, P603, DOI 10.1006/bulm.2001.0234; Franc A, 2004, ECOL COMPLEX, V1, P49, DOI 10.1016/j.ecocom.2003.10.002; Fuentes MA, 1999, PHYSICA A, V267, P471, DOI 10.1016/S0378-4371(99)00027-8; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HENEBRY GM, 1995, ECOL MODEL, V82, P75, DOI 10.1016/0304-3800(94)00074-R; Horm VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034160; House T, 2011, J R SOC INTERFACE, V8, P67, DOI 10.1098/rsif.2010.0179; Keeling M, 2005, THEOR POPUL BIOL, V67, P1, DOI 10.1016/j.tpb.2004.08.002; Keeling M. J., 2007, MODELLING INFECT DIS; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kuperman MN, 1999, PHYSICA A, V272, P206, DOI 10.1016/S0378-4371(99)00284-8; Law R, 2003, ECOLOGY, V84, P252, DOI 10.1890/0012-9658(2003)084[0252:PGISAT]2.0.CO;2; Noordegraaf AV, 2003, EUR J OPER RES, V146, P433, DOI 10.1016/S0377-2217(02)00257-6; Pautasso M, 2008, ECOL COMPLEX, V5, P1, DOI 10.1016/j.ecocom.2007.07.001; Perkins SE, 2009, J ANIM ECOL, V78, P1015, DOI 10.1111/j.1365-2656.2009.01557.x; Sabatier P, 2004, ECOL MODEL, V180, P233, DOI 10.1016/j.ecolmodel.2004.05.012; Schimit PHT, 2009, ECOL MODEL, V220, P1034, DOI 10.1016/j.ecolmodel.2009.01.014; Shirley MDF, 2005, ECOL COMPLEX, V2, P287, DOI 10.1016/j.ecocom.2005.04.005; Thulke HH, 1999, ECOL MODEL, V117, P179, DOI 10.1016/S0304-3800(98)00198-7; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Tsukamoto K, 2007, AVIAN DIS, V51, P129, DOI 10.1637/0005-2086(2007)051[0129:IODHCO]2.0.CO;2; Turechek WW, 2001, ECOL MODEL, V144, P77, DOI 10.1016/S0304-3800(01)00350-7; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Walker P, 2012, J R SOC INTERFACE, V9, P1836, DOI 10.1098/rsif.2012.0022	36	4	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51760	10.1371/journal.pone.0051760	http://dx.doi.org/10.1371/journal.pone.0051760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272160	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300026
J	Raap, AK; Tafrechi, RSJ; van de Rijke, FM; Pyle, A; Wahlby, C; Szuhai, K; Ravelli, RBG; de Coo, RFM; Rajasimha, HK; Nilsson, M; Chinnery, PF; Samuels, DC; Janssen, GMC				Raap, Anton K.; Tafrechi, Roshan S. Jahangir; van de Rijke, Frans M.; Pyle, Angela; Waehlby, Carolina; Szuhai, Karoly; Ravelli, Raimond B. G.; de Coo, Rene F. M.; Rajasimha, Harsha K.; Nilsson, Mats; Chinnery, Patrick F.; Samuels, David C.; Janssen, George M. C.			Non-Random mtDNA Segregation Patterns Indicate a Metastable Heteroplasmic Segregation Unit in m.3243A > G Cybrid Cells	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DELETIONS; FUNCTIONAL-ORGANIZATION; TRNA(LEU(UUR)) MUTATION; GENETIC AUTONOMY; DEAFNESS MIDD; FIBER-FISH; MUTANT; EXPRESSION; NUCLEOIDS; REPLICATION	Many pathogenic mitochondrial DNA mutations are heteroplasmic, with a mixture of mutated and wild-type mtDNA present within individual cells. The severity and extent of the clinical phenotype is largely due to the distribution of mutated molecules between cells in different tissues, but mechanisms underpinning segregation are not fully understood. To facilitate mtDNA segregation studies we developed assays that measure m.3243A>G point mutation loads directly in hundreds of individual cells to determine the mechanisms of segregation over time. In the first study of this size, we observed a number of discrete shifts in cellular heteroplasmy between periods of stable heteroplasmy. The observed patterns could not be parsimoniously explained by random mitotic drift of individual mtDNAs. Instead, a genetically metastable, heteroplasmic mtDNA segregation unit provides the likely explanation, where stable heteroplasmy is maintained through the faithful replication of segregating units with a fixed wild-type/m.3243A>G mutant ratio, and shifts occur through the temporary disruption and re-organization of the segregation units. While the nature of the physical equivalent of the segregation unit remains uncertain, the factors regulating its organization are of major importance for the pathogenesis of mtDNA diseases.	[Raap, Anton K.; Tafrechi, Roshan S. Jahangir; van de Rijke, Frans M.; Szuhai, Karoly; Ravelli, Raimond B. G.; Janssen, George M. C.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Pyle, Angela; Chinnery, Patrick F.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Waehlby, Carolina] Broad Inst MIT & Harvard, Cambridge, MA USA; [Waehlby, Carolina] Uppsala Univ, Ctr Image Anal, Uppsala, Sweden; [de Coo, Rene F. M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Rajasimha, Harsha K.; Samuels, David C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Nilsson, Mats] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Newcastle University - UK; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Uppsala University; Erasmus University Rotterdam; Erasmus MC; Vanderbilt University; Uppsala University	Janssen, GMC (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	g.m.c.janssen@lumc.nl	Szuhai, Karoly/A-1100-2008; Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022	Szuhai, Karoly/0000-0002-1228-4245; Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Wahlby, Carolina/0000-0002-4139-7003; Chinnery, Patrick/0000-0002-7065-6617; Ravelli, Raimond/0000-0001-6056-5888; Raap, Anton Klaas/0000-0003-1483-7816; de Coo, Irenaeus/0000-0003-0533-7422	Wellcome Trust [096919] Funding Source: Medline; National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Allalou A, 2007, IMAGE ANAL LECT NOTE, V4522, P632; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; Chinnery PF, 2002, TRENDS GENET, V18, P173, DOI 10.1016/S0168-9525(01)02636-1; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901; El Meziane A, 1998, NAT GENET, V18, P350; Enriquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207; Enriquez JA, 2003, GENETICS MITOCHONDRI, P279; Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x; Florijn RJ, 1996, GENOMICS, V38, P277, DOI 10.1006/geno.1996.0629; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4; Janssen GMC, 2007, HUM MOL GENET, V16, P2472, DOI 10.1093/hmg/ddm203; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Knijnenburg J, 2005, AM J MED GENET A, V132A, P36, DOI 10.1002/ajmg.a.30378; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lehtinen SK, 2000, GENETICS, V154, P363; Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7; Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Szuhai K, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e13; Tafrechi RSJ, 2007, J HISTOCHEM CYTOCHEM, V55, P1159, DOI 10.1369/jhc.7A7282.2007; Tafrechi RSJ, 2005, MUTAT RES-FUND MOL M, V578, P43, DOI 10.1016/j.mrfmmm.2005.02.002; Takai D, 1999, J BIOL CHEM, V274, P11199, DOI 10.1074/jbc.274.16.11199; Tanke HJ, 1999, EUR J HUM GENET, V7, P2, DOI 10.1038/sj.ejhg.5200265; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Turner CJ, 2005, GENETICS, V170, P1879, DOI 10.1534/genetics.105.043653; van de Rijke FM, 2000, J HISTOCHEM CYTOCHEM, V48, P743, DOI 10.1177/002215540004800602; van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699	59	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52080	10.1371/journal.pone.0052080	http://dx.doi.org/10.1371/journal.pone.0052080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272214	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300060
J	Rahman, S; Czernik, PJ; Lu, YL; Lecka-Czernik, B				Rahman, Sima; Czernik, Piotr J.; Lu, Yalin; Lecka-Czernik, Beata			beta-Catenin Directly Sequesters Adipocytic and Insulin Sensitizing Activities but Not Osteoblastic Activity of PPAR gamma 2 in Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; INHIBITS ADIPOGENESIS; BONE-FORMATION; WNT; EXPRESSION; DIFFERENTIATION; LIGAND; MASS; PHOSPHORYLATION	Lineage allocation of the marrow mesenchymal stem cells (MSCs) to osteoblasts and adipocytes is dependent on both Wnt signaling and PPAR gamma 2 activity. Activation of PPAR gamma 2, an essential regulator of energy metabolism and insulin sensitivity, stimulates adipocyte and suppresses osteoblast differentiation and bone formation, and correlates with decreased bone mass and increased fracture rate. In contrast, activation of Wnt signaling promotes osteoblast differentiation, augments bone accrual and reduces total body fat. This study examined the cross-talk between PPAR gamma 2 and beta-catenin, a key mediator of canonical Wnt signaling, on MSC lineage determination. Rosiglitazone-activated PPAR gamma 2 induced rapid proteolytic degradation of beta-catenin, which was prevented by either inhibiting glycogen synthase kinase 3 beta (GSK3 beta) activity, or blocking pro-adipocytic activity of PPAR gamma 2 using selective antagonist GW9662 or mutation within PPAR gamma 2 protein. Stabilization of beta-catenin suppressed PPAR gamma 2 pro-adipocytic but not anti-osteoblastic activity. Moreover, beta-catenin stabilization decreased PPAR gamma 2-mediated insulin signaling as measured by insulin receptor and FoxO1 gene expression, and protein levels of phosphorylated Akt (pAkt). Cellular knockdown of beta-catenin with siRNA increased expression of adipocyte but did not affect osteoblast gene markers. Interestingly, the expression of Wnt10b was suppressed by anti-osteoblastic, but not by pro-adipocytic activity of PPAR gamma 2. Moreover, beta-catenin stabilization in the presence of activated PPAR gamma 2 did not restore Wnt10b expression indicating a dominant role of PPAR gamma 2 in negative regulation of pro-osteoblastic activity of Wnt signaling. In conclusion, beta-catenin and PPAR gamma 2 are in cross-talk which results in sequestration of pro-adipocytic and insulin sensitizing activity. The anti-osteoblastic activity of PPAR gamma 2 is independent of this interaction.	[Rahman, Sima; Czernik, Piotr J.; Lu, Yalin; Lecka-Czernik, Beata] Univ Toledo, Dept Orthopaed Surg, Coll Med, Toledo, OH 43606 USA; [Lecka-Czernik, Beata] Univ Toledo, Dept Physiol & Pharmacol, Coll Med, Toledo, OH 43606 USA; [Rahman, Sima; Lecka-Czernik, Beata] Univ Toledo, Ctr Diabet & Endocrine Res, Coll Med, Toledo, OH 43606 USA	University of Toledo; University of Toledo; University of Toledo	Lecka-Czernik, B (corresponding author), Univ Toledo, Dept Orthopaed Surg, Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	beata.leckaczernik@utoledo.edu			NIH/NIA [AG028935]; American Diabetes Association [1-09-RA95]; Amaranth Diabetes Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028935] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Diabetes Association(American Diabetes Association); Amaranth Diabetes Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by a grant from NIH/NIA AG028935, (www.nia.nih.gov) and American Diabetes Association grant 1-09-RA95 (www.diabetes.org) funded by Amaranth Diabetes Fund (www.amaranth.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Aslanidi G, 2007, AM J PHYSIOL-ENDOC M, V293, pE726, DOI 10.1152/ajpendo.00248.2007; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Bruedigam C, 2008, FEBS LETT, V582, P1618, DOI 10.1016/j.febslet.2008.04.012; Bruedigam C, 2010, STEM CELLS, V28, P916, DOI 10.1002/stem.405; Case N, 2011, J BIOL CHEM, V286, P39450, DOI 10.1074/jbc.M111.265330; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Cock TA, 2004, EMBO REP, V5, P1007, DOI 10.1038/sj.embor.7400254; Costa V, 2010, PPAR RES, V2010, DOI 10.1155/2010/409168; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Heikkinen S, 2007, BBA-MOL CELL BIOL L, V1771, P999, DOI 10.1016/j.bbalip.2007.03.006; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lazarenko OP, 2006, BONE, V38, P74, DOI 10.1016/j.bone.2005.07.008; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MARCUS SL, 1993, P NATL ACAD SCI USA, V90, P5723, DOI 10.1073/pnas.90.12.5723; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Rhee EJ, 2007, EXP MOL MED, V39, P696, DOI 10.1038/emm.2007.76; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720	49	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51746	10.1371/journal.pone.0051746	http://dx.doi.org/10.1371/journal.pone.0051746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272157	Green Submitted, gold, Green Published			2022-12-25	WOS:000312483300024
J	Zurovac, D; Larson, BA; Sudoi, RK; Snow, RW				Zurovac, Dejan; Larson, Bruce A.; Sudoi, Raymond K.; Snow, Robert W.			Costs and Cost-Effectiveness of a Mobile Phone Text-Message Reminder Programmes to Improve Health Workers' Adherence to Malaria Guidelines in Kenya	PLOS ONE			English	Article							MEDICINE RETAILERS; FACILITIES; QUALITY; MANAGEMENT	Background: Simple interventions for improving health workers' adherence to malaria case-management guidelines are urgently required across Africa. A recent trial in Kenya showed that text-message reminders sent to health workers' mobile phones improved management of pediatric outpatients by 25 percentage points. In this paper we examine costs and cost-effectiveness of this intervention. Methods/Findings: We evaluate costs and cost-effectiveness in 2010 USD under three implementation scenarios: (1) as implemented under study conditions in study areas; (2) if the intervention was routinely implemented by the Ministry of Health (MoH) in the same areas; and (3) if the intervention was scaled up nationally. Under study conditions, intervention costs were 19,342 USD, of which 45% were for developing and pretesting text-messages, 12% for developing text-message distribution system, 29% for collecting health workers' phone numbers, and 13% were costs of sending text-messages and monitoring of the system. If the intervention was implemented in the same areas by the MoH, the costs would be 28% lower (13,920 USD) due to lower costs of collecting health workers' numbers. The cost of national scale-up would be 97,350 USD, and the majority of these costs (66%) would be for sending text-messages. The cost per additional child correctly managed was 0.50 USD under study conditions, 0.36 USD if implemented by the MoH in the same area, and estimated at only 0.03 USD if implemented nationally. Even if the effect size was only 5% or the cost on the national scale was 400% higher than estimated, the cost per additional child correctly managed would be only 0.16 USD. Conclusions: A simple text-messaging intervention improving health worker adherence to malaria guidelines is effective and inexpensive. Further research is justified to optimize delivery of the intervention and expand targets beyond children and malaria disease.	[Zurovac, Dejan; Sudoi, Raymond K.; Snow, Robert W.] KEMRI Wellcome Trust Univ Oxford Collaborat Progr, Malaria Publ Hlth Cluster, Nairobi, Kenya; [Zurovac, Dejan; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Zurovac, Dejan; Larson, Bruce A.] Boston Univ, Dept Int Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA	University of Oxford; Boston University	Zurovac, D (corresponding author), KEMRI Wellcome Trust Univ Oxford Collaborat Progr, Malaria Publ Hlth Cluster, Nairobi, Kenya.	dzurovac@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; Larson, Bruce/0000-0002-9322-2387	Wellcome Trust, UK [084253]; Wellcome Trust [084253, 079080, 092654]	Wellcome Trust, UK(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Wellcome Trust, UK (#084253). RWS is supported by the Wellcome Trust as Principal Research Fellow [#079080]. DZ and RKS are supported by the Welcome Trust project grant [#084253]. All authors acknowledge support of the Wellcome Trust to the Kenyan Major Overseas Programme [#092654]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazin D., 2009, EC ANAL, V42, P7; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Goodman CA, 2006, HEALTH POLICY PLANN, V21, P275, DOI 10.1093/heapol/czl011; Jones COH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038636; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Mangham LJ, 2012, TROP MED INT HEALTH, V17, P330, DOI 10.1111/j.1365-3156.2011.02918.x; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Ministry of Health, 2009, TRAIN GUID 2006 NAT; Ministry of Health, 2008, NAT GUID DIAGN TREAT; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Thirumurthy H, 2012, B WORLD HEALTH ORGAN, V90, P390, DOI 10.2471/BLT.11.099317; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633; Zurovac D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001176; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	18	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52045	10.1371/journal.pone.0052045	http://dx.doi.org/10.1371/journal.pone.0052045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272206	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300052
J	Cheng, XF; Wang, S; Dai, X; Shi, CB; Wen, YF; Zhu, M; Zhan, SW; Meng, JH				Cheng, Xianfeng; Wang, Song; Dai, Xing; Shi, Chengbo; Wen, Yufeng; Zhu, Ming; Zhan, Shenwei; Meng, Jihong			Rabbit as a Novel Animal Model for Hepatitis E Virus Infection and Vaccine Evaluation	PLOS ONE			English	Article							CROSS-SPECIES INFECTION; CIS-REACTIVE ELEMENT; PATHOGENESIS; PIGS; IDENTIFICATION; REPLICATION; COUNTRIES; CHICKENS; PRIMATES; HEV	Background: The identification of hepatitis E virus (HEV) from rabbits motivated us to assess the possibility of using rabbits as a non-human primate animal model for HEV infection and vaccine evaluation. Methodology/Principal Findings: First, 75 rabbits were inoculated with seven strains of genotypes 1, 3, 4, and rabbit HEV, to determine the appropriate strain, administrative route and viral dosage. Second, 15 rabbits were randomly divided into three groups and vaccinated with 0 mu g (placebo), 10 mu g and 20 mu g of HEV candidate vaccine, HEV p179, respectively. After three doses of the vaccination, the rabbits were challenged with 3.3x10(5) genome equivalents of genotype 4 HEV strain H4-NJ703. The strain of genotype 1 HEV was not found to be infectious for rabbits. However, approximately 80% of the animals were infected by two rabbit HEV strains. All rabbits inoculated with a genotype 3 strain were seroconverted but did not show viremia or fecal viral shedding. Although two genotype 4 strains, H4-NJ153 and H4-NJ112, only resulted in part of rabbits infected, another strain of genotype 4, H4-NJ703, had an infection rate of 100% (five out of five) when administrated intravenously. However, only two out of fifteen rabbits showed virus excretion and seroconversion when inoculated orally with H4-NJ703 of three different dosages. In the vaccine evaluation study, rabbits vaccinated with 20 mg of the HEV p179 produced anti-HEV with titers of 1:10(4)-1:10(5) and were completely protected from infection. Rabbits vaccinated with 10 mg produced anti-HEV with titers of 1:10(3)-1:10(4) and were protected from hepatitis, but two out of the five rabbits showed virus shedding. Conclusions/Significance: Rabbits may be served as an alternative to the non-human primate models for HEV infection and vaccine evaluation when certain virus strains, appropriate viral dosages, and the intravenous route of inoculation are selected.	[Cheng, Xianfeng; Wang, Song; Meng, Jihong] Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Dai, Xing] Southeast Univ, Affiliated Zhongda Hosp, Sch Med, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Shi, Chengbo; Meng, Jihong] Changchun Inst Biol Prod Co Ltd, Changchun, Jilin, Peoples R China; [Wen, Yufeng] Wannan Med Coll, Dept Prevent Med, Wuhu, Anhui, Peoples R China; [Zhu, Ming; Zhan, Shenwei] Ctr Dis Control & Prevent Ma Anshan, Maanshan, Anhui, Peoples R China	Southeast University - China; Southeast University - China; Wannan Medical College	Meng, JH (corresponding author), Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China.	jihongmeng@163.com	Wang, Song/GRS-5358-2022	Wang, Song/0000-0001-7122-013X	National High Technology Research and Development Program of China ("863'' Program) [2006AA02A235]; Science and Technology Support Program of Jiangsu province, China [BE2009664]	National High Technology Research and Development Program of China ("863'' Program); Science and Technology Support Program of Jiangsu province, China	This work was supported by the National High Technology Research and Development Program of China ("863'' Program 2006AA02A235), and the Science and Technology Support Program of Jiangsu province, China (BE2009664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; Billam P, 2005, J VIROL, V79, P3429, DOI 10.1128/JVI.79.6.3429-3437.2005; Clemente-Casares P, 2003, EMERG INFECT DIS, V9, P448; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dong C, 2006, J CELL MOL IMMUNOL C, V22, P339; Dong C, 2007, VACCINE, V25, P1662, DOI 10.1016/j.vaccine.2006.11.001; Dong C, 2012, HEPATOLOGY, V55, P1324, DOI 10.1002/hep.25530; Emerson SU, 2001, P NATL ACAD SCI USA, V98, P15270, DOI 10.1073/pnas.251555098; Feagins AR, 2008, J MED VIROL, V80, P1379, DOI 10.1002/jmv.21223; Geng YS, 2011, INFECT GENET EVOL, V11, P476, DOI 10.1016/j.meegid.2010.12.012; Graff J, 2005, J VIROL, V79, P6680, DOI 10.1128/JVI.79.11.6680-6689.2005; Halbur PG, 2001, J CLIN MICROBIOL, V39, P918, DOI 10.1128/JCM.39.3.918-923.2001; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Huang F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-93; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Krawczynski K, 2011, VIRUS RES, V161, P78, DOI 10.1016/j.virusres.2011.03.007; Li SW, 2005, VACCINE, V23, P2893, DOI 10.1016/j.vaccine.2004.11.064; Ma HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009160; Maneerat Y, 1996, J MED VIROL, V48, P121; Meng JH, 2001, VIROLOGY, V288, P203, DOI 10.1006/viro.2001.1093; Meng XJ, 2010, J VIRAL HEPATITIS, V17, P153, DOI 10.1111/j.1365-2893.2009.01257.x; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Obriadina A, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS360, DOI 10.1046/j.1440-1746.17.s3.28.x; Pavio N, 2010, VET RES, V41, DOI 10.1051/vetres/2010018; Purcell R H, 2001, ILAR J, V42, P161; Purdy MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014376; TSAREV SA, 1993, J INFECT DIS, V167, P1302, DOI 10.1093/infdis/167.6.1302; Tsarev SA, 1997, VACCINE, V15, P1834, DOI 10.1016/S0264-410X(97)00145-X; van der Poel WHM, 2001, EMERG INFECT DIS, V7, P970, DOI 10.3201/eid0706.010608; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Yu C, 2010, J VIROL, V84, P11264, DOI 10.1128/JVI.01205-10; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	34	37	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51616	10.1371/journal.pone.0051616	http://dx.doi.org/10.1371/journal.pone.0051616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272124	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386600030
J	Jones, DK; Peters, CH; Allard, CR; Claydon, TW; Ruben, PC				Jones, David K.; Peters, Colin H.; Allard, Charlene R.; Claydon, Tom W.; Ruben, Peter C.			Proton Sensors in the Pore Domain of the Cardiac Voltage-gated Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE INACTIVATION; SLOW INACTIVATION; PERIODIC PARALYSIS; CRYSTAL-STRUCTURE; STRUCTURAL REARRANGEMENT; MOLECULAR DETERMINANTS; NA CHANNELS; OUTER RING; ACTIVATION; ACIDOSIS	Protons impart isoform-specific modulation of inactivation in neuronal, skeletal muscle, and cardiac voltage-gated sodium (Na-V) channels. Although the structural basis of proton block in Na(V)A channels has been well described, the amino acid residues responsible for the changes in Na-V kinetics during extracellular acidosis are as yet unknown. We expressed wild-type (WT) and two pore mutant constructs (H880Q and C373F) of the human cardiac Na-V channel, Na(V)1.5, in Xenopus oocytes. C373F and H880Q both attenuated proton block, abolished proton modulation of use-dependent inactivation, and altered pH modulation of the steady-state and kinetic parameters of slow inactivation. Additionally, C373F significantly reduced the maximum probability of use-dependent inactivation and slow inactivation, relative to WT. H880Q also significantly reduced the maximum probability of slow inactivation and shifted the voltage dependence of activation and fast inactivation to more positive potentials, relative to WT. These data suggest that Cys-373 and His880 in Na(V)1.5 are proton sensors for use-dependent and slow inactivation and have implications in isoform-specific modulation of Na-V channels.	[Jones, David K.; Peters, Colin H.; Allard, Charlene R.; Claydon, Tom W.; Ruben, Peter C.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Ruben, PC (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	pruben@sfu.ca	Jones, David K./AAX-1562-2020	Claydon, Tom/0000-0002-5143-7451; Jones, David/0000-0002-6762-5254	Natural Sciences and Engineering Research Council [611509, 611527]; Canadian Foundation for Innovation Leaders Opportunity Fund [17976]; Canadian Institutes for Health Research; Heart and Stroke Foundation of Canada New Investigator Award; Michael Smith Foundation for Health Research Career Scholar Award	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada New Investigator Award; Michael Smith Foundation for Health Research Career Scholar Award	This work was supported in part by Natural Sciences and Engineering Research Council Discovery Grants 611509 (to P. C. R.) and 611527 (to T. W. C.) and Canadian Foundation for Innovation Leaders Opportunity Fund Project 17976 (to T. W. C. and P. C. R.).; Supported by a Vanier Graduate Scholarship from the Canadian Institutes for Health Research.; Supported by a Heart and Stroke Foundation of Canada New Investigator Award and a Michael Smith Foundation for Health Research Career Scholar Award.	Antzelevitch C, 2004, CIRCULATION, V110, P904, DOI 10.1161/01.CIR.0000139333.83620.5D; Balser JR, 1996, J PHYSIOL-LONDON, V494, P431, DOI 10.1113/jphysiol.1996.sp021503; Bazett HC, 1920, J PHYSIOL-LONDON, V53, P320, DOI 10.1113/jphysiol.1920.sp001881; Bendahhou S, 2002, NEUROLOGY, V58, P1266, DOI 10.1212/WNL.58.8.1266; Bendahhou S, 1999, J NEUROSCI, V19, P4762; Capes DL, 2012, P NATL ACAD SCI USA, V109, P2648, DOI 10.1073/pnas.1115575109; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Claydon TW, 2002, AM J PHYSIOL-CELL PH, V283, pC1114, DOI 10.1152/ajpcell.00542.2001; Claydon TW, 2000, J PHYSIOL-LONDON, V526, P253, DOI 10.1111/j.1469-7793.2000.00253.x; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Cummins TR, 1996, BIOPHYS J, V71, P227, DOI 10.1016/S0006-3495(96)79219-6; Drummond GB, 2009, J PHYSIOL-LONDON, V587, P713, DOI 10.1113/jphysiol.2008.167387; Featherstone DE, 1996, BIOPHYS J, V71, P3098, DOI 10.1016/S0006-3495(96)79504-8; FLEIG A, 1994, PFLUG ARCH EUR J PHY, V427, P406, DOI 10.1007/BF00374254; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Hayward LJ, 1997, BIOPHYS J, V72, P1204, DOI 10.1016/S0006-3495(97)78768-X; Jensen MO, 2002, BIOPHYS J, V83, P98, DOI 10.1016/S0006-3495(02)75152-7; Jones DK, 2011, BIOPHYS J, V101, P2147, DOI 10.1016/j.bpj.2011.08.056; Kehl SJ, 2002, J PHYSIOL-LONDON, V541, P9, DOI 10.1113/jphysiol.2001.014456; Khan A, 2006, J PHYSIOL-LONDON, V576, P493, DOI 10.1113/jphysiol.2006.115659; Khan A, 2002, J PHYSIOL-LONDON, V543, P71, DOI 10.1113/jphysiol.2002.021014; Kuzmenkin A, 2002, BRAIN, V125, P835, DOI 10.1093/brain/awf071; Makita N, 1996, J NEUROSCI, V16, P7117; McCollum IJ, 2003, FEBS LETT, V552, P163, DOI 10.1016/S0014-5793(03)00912-8; Mitrovic N, 2000, J GEN PHYSIOL, V115, P707, DOI 10.1085/jgp.115.6.707; NGUYENTHI A, 1981, CAN J PHYSIOL PHARM, V59, P876, DOI 10.1139/y81-131; NODA M, 1993, ANN NY ACAD SCI, V707, P20, DOI 10.1111/j.1749-6632.1993.tb38039.x; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Ruben P.C., 2010, BIOPHYS J A, V111a; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Townsend C, 1997, J GEN PHYSIOL, V110, P23, DOI 10.1085/jgp.110.1.23; Vilin YY, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00109; Vilin YY, 2001, BIOPHYS J, V80, P2221, DOI 10.1016/S0006-3495(01)76195-4; Vilin YY, 2001, CELL BIOCHEM BIOPHYS, V35, P171, DOI 10.1385/CBB:35:2:171; Vilin YY, 1999, BIOPHYS J, V77, P1384, DOI 10.1016/S0006-3495(99)76987-0; Wang SY, 1997, BIOPHYS J, V72, P1633, DOI 10.1016/S0006-3495(97)78809-X; Xiong W, 2003, J GEN PHYSIOL, V122, P323, DOI 10.1085/jgp.200308881; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	43	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4782	4791		10.1074/jbc.M112.434266	http://dx.doi.org/10.1074/jbc.M112.434266			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283979	hybrid, Green Published			2022-12-25	WOS:000315340400027
J	Blount, RJ; Jarlsberg, LG; Daly, KR; Worodria, W; Davis, JL; Cattamanchi, A; Djawe, K; Andama, A; Koch, J; Walzer, PD; Huang, L				Blount, Robert J.; Jarlsberg, Leah G.; Daly, Kieran R.; Worodria, William; Davis, J. Lucian; Cattamanchi, Adithya; Djawe, Kpandja; Andama, Alfred; Koch, Judith; Walzer, Peter D.; Huang, Laurence		Int HIV-Associated Opportunistic P	Serologic Responses to Recombinant Pneumocystis jirovecii Major Surface Glycoprotein among Ugandan Patients with Respiratory Symptoms	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; IMMUNODEFICIENCY-VIRUS-INFECTION; B-CELLS; ANTIBODY-RESPONSE; HUMORAL IMMUNITY; CARINII INFECTION; IGG ANTIBODIES; TB SUSPECTS; EXPRESSION; ANTIGEN	Background: Little is known about the serologic responses to Pneumocystis jirovecii major surface glycoprotein (Msg) antigen in African cohorts, or the IgM responses to Msg in HIV-positive and HIV-negative persons with respiratory symptoms. Methods: We conducted a prospective study of 550 patients, both HIV-positive (n = 467) and HIV-negative (n = 83), hospitalized with cough >= 2 weeks in Kampala, Uganda, to evaluate the association between HIV status, CD4 cell count, and other clinical predictors and antibody responses to P. jirovecii. We utilized ELISA to measure the IgM and IgG serologic responses to three overlapping recombinant fragments that span the P. jirovecii major surface glycoprotein: MsgA (amino terminus), MsgB (middle portion) and MsgC1 (carboxyl terminus), and to three variations of MsgC1 (MsgC3, MsgC8 and MsgC9). Results: HIV-positive patients demonstrated significantly lower IgM antibody responses to MsgC1, MsgC3, MsgC8 and MsgC9 compared to HIV-negative patients. We found the same pattern of low IgM antibody responses to MsgC1, MsgC3, MsgC8 and MsgC9 among HIV-positive patients with a CD4 cell count <200 cells/mu l compared to those with a CD4 cell count >= 200 cells/mu l. HIV-positive patients on PCP prophylaxis had significantly lower IgM responses to MsgC3 and MsgC9, and lower IgG responses to MsgA, MsgC1, MsgC3, and MsgC8. In contrast, cigarette smoking was associated with increased IgM antibody responses to MsgC1 and MsgC3 but was not associated with IgG responses. We evaluated IgM and IgG as predictors of mortality. Lower IgM responses to MsgC3 and MsgC8 were both associated with increased in-hospital mortality. Conclusions: HIV infection and degree of immunosuppression are associated with reduced IgM responses to Msg. In addition, low IgM responses to MsgC3 and MsgC8 are associated with increased mortality.	[Blount, Robert J.; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Daly, Kieran R.; Koch, Judith; Walzer, Peter D.] Univ Cincinnati, Dept Internal Med, Div Infect Dis, Cincinnati, OH USA; [Daly, Kieran R.; Djawe, Kpandja; Koch, Judith; Walzer, Peter D.] Vet Adm Med Ctr, Cincinnati, OH 45220 USA; [Worodria, William; Davis, J. Lucian; Cattamanchi, Adithya; Andama, Alfred; Huang, Laurence] MU UCSF, Res Collaborat, Kampala, Uganda; [Worodria, William; Andama, Alfred] Mulago Hosp, Dept Med, Kampala, Uganda; [Djawe, Kpandja; Walzer, Peter D.] Univ Cincinnati, Dept Environm Hlth, Div Epidemiol & Biostat, Cincinnati, OH USA; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Mulago National Referral Hospital; University System of Ohio; University of Cincinnati; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Blount, RJ (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	robert.blount@ucsf.edu	Huang, Laurence/AAZ-7120-2021; Davis, J. Lucian/AAC-8376-2019; blount, robert/ABI-5978-2020; Huang, Laurence/AAE-1590-2019	Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; Blount, Robert/0000-0001-6177-7436; Jarlsberg, Leah/0000-0001-6548-6337	National Heart, Lung and Blood Institute (NHLBI) [K24HL087713, R01HL090335, K23HL094141]; National Institute of Allergy and Infectious Diseases (NIAID) [K23AI080147]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, T32HL007185, K23HL094141, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI080147] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Heart, Lung and Blood Institute (NHLBI) K24HL087713 (LH), R01HL090335 (LH), K23HL094141 (AC), and National Institute of Allergy and Infectious Diseases (NIAID) K23AI080147 (JLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447; ATZORI C, 1993, T ROY SOC TROP MED H, V87, P55, DOI 10.1016/0035-9203(93)90418-P; Bishop LR, 2003, J INFECT DIS, V187, P1844, DOI 10.1086/375354; BURNS SM, 1990, J INFECTION, V20, P33, DOI 10.1016/S0163-4453(90)92280-X; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Crothers K, 2011, CLIN VACCINE IMMUNOL, V18, P380, DOI 10.1128/CVI.00421-10; Crum-Cianflone NF, 2010, J INFECT DIS, V202, P1114, DOI 10.1086/656147; Daley CL, 1996, AM J RESP CRIT CARE, V154, P105, DOI 10.1164/ajrccm.154.1.8680664; Daly K, 2009, CLIN MICROBIOL INFEC, V15, P937, DOI 10.1111/j.1469-0691.2009.02716.x; Daly KR, 2006, CLIN VACCINE IMMUNOL, V13, P1071, DOI 10.1128/CVI.00140-06; Daly KR, 2006, EMERG INFECT DIS, V12, P1231, DOI 10.3201/eid1708.060230; Daly KR, 2004, EMERG INFECT DIS, V10, P848, DOI 10.3201/eid1005.030497; Daly KR, 2002, J INFECT DIS, V186, P644, DOI 10.1086/341565; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; Deok-Jong Yoo S, 2010, J ACQUIRED IMMUNE DE; Djawe K, 2010, INT J INFECT DIS IJI; Djawe K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014259; ELVIN K, 1994, SCAND J INFECT DIS, V26, P33, DOI 10.3109/00365549409008588; GARBE TR, 1994, INFECT IMMUN, V62, P3092, DOI 10.1128/IAI.62.8.3092-3101.1994; GIGLIOTTI F, 1988, J CLIN INVEST, V81, P1666, DOI 10.1172/JCI113503; Gigliotti F, 1996, INFECT IMMUN, V64, P1892, DOI 10.1128/IAI.64.6.1892-1899.1996; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; HOFMANN B, 1985, J INFECT DIS, V152, P838, DOI 10.1093/infdis/152.4.838; HOFMANN B, 1988, SCAND J INFECT DIS, V20, P389, DOI 10.3109/00365548809032473; JANOFF EN, 1988, J INFECT DIS, V158, P983, DOI 10.1093/infdis/158.5.983; JANOFF EN, 1993, J INFECT DIS, V167, P49, DOI 10.1093/infdis/167.1.49; JANOFF EN, 1988, J INFECT DIS, V157, P798, DOI 10.1093/infdis/157.4.798; KOVACS JA, 1993, J BIOL CHEM, V268, P6034; Kroon FP, 1997, CLIN INFECT DIS, V25, P600, DOI 10.1086/513750; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Laursen AL, 1998, SCAND J INFECT DIS, V30, P495, DOI 10.1080/00365549850161511; LUCAS S, 1989, AIDS, V3, P47, DOI 10.1097/00002030-198903010-00012; LUNDGREN B, 1993, SCAND J INFECT DIS, V25, P515, DOI 10.3109/00365549309008535; LUNDGREN B, 1992, J INFECT DIS, V165, P1151, DOI 10.1093/infdis/165.6.1151; MARTINEZMAZA O, 1987, J IMMUNOL, V138, P3720; Mei Q, 1998, INFECT IMMUN, V66, P4268; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Muller F, 1998, BLOOD, V92, P3721, DOI 10.1182/blood.V92.10.3721.422k11_3721_3729; Notermans DW, 2001, AIDS RES HUM RETROV, V17, P1003, DOI 10.1089/088922201300343681; PEGLOW SL, 1990, J INFECT DIS, V161, P296, DOI 10.1093/infdis/161.2.296; PERLMAN DM, 1988, ANN INTERN MED, V108, P540, DOI 10.7326/0003-4819-108-4-540; PIFER LLW, 1987, J CLIN MICROBIOL, V25, P991, DOI 10.1128/JCM.25.6.991-995.1987; SHIRAI A, 1992, J CLIN INVEST, V89, P561, DOI 10.1172/JCI115621; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; Stringer JR, 2007, J EUKARYOT MICROBIOL, V54, P8, DOI 10.1111/j.1550-7408.2006.00225.x; Stringer JR, 2001, INFECT IMMUN, V69, P627, DOI 10.1128/IAI.69.2.627-639.2001; Taylor SM, 2012, DIAGN MICR INFEC DIS, V72, P139, DOI 10.1016/j.diagmicrobio.2011.10.009; THEUS SA, 1995, J CLIN INVEST, V95, P2587, DOI 10.1172/JCI117960; Theus SA, 1998, VACCINE, V16, P1149, DOI 10.1016/S0264-410X(98)80113-8; Tipirneni R, 2009, EMERG INFECT DIS, V15, P1590, DOI 10.3201/eid1510.090207; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; van Oosterhout JJG, 2007, EMERG INFECT DIS, V13, P325, DOI 10.3201/eid1302.060462; Vargas SL, 2001, CLIN INFECT DIS, V32, P855, DOI 10.1086/319340; WABWIREMANGEN F, 1989, AM J TROP MED HYG, V41, P504, DOI 10.4269/ajtmh.1989.41.504; Walzer PD, 1999, CLIN DIAGN LAB IMMUN, V6, P149, DOI 10.1128/CDLI.6.2.149-155.1999; Walzer PD, 2009, J INFECT DIS, V199, P1335, DOI 10.1086/597803	61	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51545	10.1371/journal.pone.0051545	http://dx.doi.org/10.1371/journal.pone.0051545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284710	Green Published, gold			2022-12-25	WOS:000313158800012
J	Pavli, OI; Tampakaki, AP; Skaracis, GN				Pavli, Ourania I.; Tampakaki, Anastasia P.; Skaracis, George N.			High Level Resistance against Rhizomania Disease by Simultaneously Integrating Two Distinct Defense Mechanisms	PLOS ONE			English	Article							YELLOW-VEIN-VIRUS; SUGAR-BEET; MEDIATED RESISTANCE; BNYVV; PROTEIN; RICE; PATHOGENICITY; INFECTIONS; BREAKING; FRAGMENT	With the aim of achieving durable resistance against rhizomania disease of sugar beet, the employment of different sources of resistance to Beet necrotic yellow vein virus was pursued. To this purpose, Nicotiana benthamiana transgenic plants that simultaneously produce dsRNA originating from a conserved region of the BNYVV replicase gene and the HrpZ(Psph) protein in a secreted form (SP/HrpZ(Psph)) were produced. The integration and expression of both transgenes as well as proper production of the harpin protein were verified in all primary transformants and selfed progeny (T1, T2). Transgenic resistance was assessed by BNYVV-challenge inoculation on T2 progeny by scoring disease symptoms and DAS-ELISA at 20 and 30 dpi. Transgenic lines possessing single transformation events for both transgenes as well as wild type plants were included in inoculation experiments. Transgenic plants were highly resistant to virus infection, whereas in some cases immunity was achieved. In all cases, the resistant phenotype of transgenic plants carrying both transgenes was superior in comparison with the ones carrying a single transgene. Collectively, our findings demonstrate, for a first time, that the combination of two entirely different resistance mechanisms provide high level resistance or even immunity against the virus. Such a novel approach is anticipated to prevent a rapid virus adaptation that could potentially lead to the emergence of isolates with resistance breaking properties.	[Pavli, Ourania I.; Skaracis, George N.] Agr Univ Athens, Dept Crop Sci, Athens, Greece; [Tampakaki, Anastasia P.] Agr Univ Athens, Dept Agr Biotechnol, Athens, Greece	Agricultural University of Athens; Agricultural University of Athens	Pavli, OI (corresponding author), Agr Univ Athens, Dept Crop Sci, Athens, Greece.	raniapavli@yahoo.gr; gskaracis@aua.gr	Tampakaki, Anastasia/ABF-8966-2021	Tampakaki, Anastasia/0000-0003-4439-0920; Pavli, Ourania/0000-0002-5276-2184	Laboratory of Plant Breeding and Biometry; Laboratory of General and Agricultural Microbiology	Laboratory of Plant Breeding and Biometry; Laboratory of General and Agricultural Microbiology	The study was funded by the Laboratory of Plant Breeding and Biometry and the Laboratory of General and Agricultural Microbiology. No other funders supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Leal R, 2007, PHYTOPATHOLOGY, V97, P325, DOI 10.1094/PHYTO-97-3-0325; Acosta-Leal R, 2008, VIROLOGY, V376, P60, DOI 10.1016/j.virol.2008.03.008; Acosta-Leal R, 2010, PHYTOPATHOLOGY, V100, P127, DOI 10.1094/PHYTO-100-2-0127; Andika IB, 2005, MOL PLANT MICROBE IN, V18, P194, DOI 10.1094/MPMI-18-0194; Biancardi E, 2002, EUPHYTICA, V127, P383, DOI 10.1023/A:1020310718166; Casarini B, 1999, BARBABIETOLA NEGLI A, P273; Chen L, 2008, PHYTOPATHOLOGY, V98, P792, DOI 10.1094/PHYTO-98-7-0792; Chiba S, 2008, J GEN VIROL, V89, P1314, DOI 10.1099/vir.0.83624-0; Chiba S, 2011, MOL PLANT MICROBE IN, V24, P207, DOI 10.1094/MPMI-10-10-0241; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Dong HP, 2005, PLANTA, V221, P313, DOI 10.1007/s00425-004-1444-x; Fecker LF, 1997, ARCH VIROL, V142, P1857, DOI 10.1007/s007050050203; Grimmer MK, 2007, THEOR APPL GENET, V114, P1151, DOI 10.1007/s00122-007-0507-3; Heijbroek W, 1999, EUR J PLANT PATHOL, V105, P397, DOI 10.1023/A:1008705111232; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huo R, 2010, TRANSGENIC RES, V19, P841, DOI 10.1007/s11248-010-9365-x; Kiguchi T, 1996, J GEN VIROL, V77, P575, DOI 10.1099/0022-1317-77-4-575; Koenig R, 2009, J GEN VIROL, V90, P759, DOI 10.1099/vir.0.007112-0; KOENIG R, 1995, J GEN VIROL, V76, P2051, DOI 10.1099/0022-1317-76-8-2051; Koenig R, 1997, ARCH VIROL, V142, P1499, DOI 10.1007/s007050050176; Koenig R, 2000, ARCH VIROL, V145, P1561, DOI 10.1007/s007050070076; KRUSE M, 1994, J GEN VIROL, V75, P1835, DOI 10.1099/0022-1317-75-8-1835; Lennefors BL, 2006, MOL BREEDING, V18, P313, DOI 10.1007/s11032-006-9030-5; LEWELLEN RT, 1990, P 53 C IIRB, P79; Lewer R. P., 1987, Proceedings of the the Sixth Conference, Australian Association of Animal Breeding and Genetics, University of Western Australia, Perth, WA, Australia, 9-11 February 1987., P139; Mannerlof M, 1996, EUPHYTICA, V90, P293, DOI 10.1007/BF00027479; Oh CS, 2007, PLANT PHYSIOL, V145, P426, DOI 10.1104/pp.107.103432; Pavli O, 2011, EUR J PLANT PATHOL, V130, P133, DOI 10.1007/s10658-010-9639-4; Pavli OI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017306; Pavli OI, 2010, TRANSGENIC RES, V19, P915, DOI 10.1007/s11248-010-9364-y; Ren HY, 2006, ANN MICROBIOL, V56, P281, DOI 10.1007/BF03175019; Rush CM, 2006, PLANT DIS, V90, P4, DOI 10.1094/PD-90-0004; Rush CM, 2003, ANNU REV PHYTOPATHOL, V41, P567, DOI 10.1146/annurev.phyto.41.052002.095705; Schirmer A, 2005, J GEN VIROL, V86, P2897, DOI 10.1099/vir.0.81167-0; Scholten OE, 1996, EUPHYTICA, V91, P331, DOI 10.1007/BF00033095; Shao M, 2008, PLANT BIOTECHNOL J, V6, P73, DOI 10.1111/j.1467-7652.2007.00304.x; TAMADA T, 1989, J GEN VIROL, V70, P3399, DOI 10.1099/0022-1317-70-12-3399; Tamada T., 1996, Proceedings of the Third Symposium of the International Working Group on Plant Viruses with Fungal Vectors, West Park Conference Centre, Dundee, Scotland, 6-7 August, 1996, P49; Tamada T, 2002, P 5 S INT WORK GROUP, P13; Tamada T, 1999, ENCY VIROLOGY, P154; Tampakaki AP, 2000, MOL PLANT MICROBE IN, V13, P1366, DOI 10.1094/MPMI.2000.13.12.1366	41	1	1	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51414	10.1371/journal.pone.0051414	http://dx.doi.org/10.1371/journal.pone.0051414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284692	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500028
J	Zhang, H; Chen, YL; Chen, Y				Zhang, Hui; Chen, Yueling; Chen, Yong			Noise Propagation in Gene Regulation Networks Involving Interlinked Positive and Negative Feedback Loops	PLOS ONE			English	Article							CELL-CYCLE OSCILLATOR; MAP KINASE; MEMORY; FATE; DIFFERENTIATION; STOCHASTICITY; FLUCTUATIONS; VARIABILITY; SIMULATION; EXPRESSION	It is well known that noise is inevitable in gene regulatory networks due to the low-copy numbers of molecules and local environmental fluctuations. The prediction of noise effects is a key issue in ensuring reliable transmission of information. Interlinked positive and negative feedback loops are essential signal transduction motifs in biological networks. Positive feedback loops are generally believed to induce a switch-like behavior, whereas negative feedback loops are thought to suppress noise effects. Here, by using the signal sensitivity (susceptibility) and noise amplification to quantify noise propagation, we analyze an abstract model of the Myc/E2F/MiR-17-92 network that is composed of a coupling between the E2F/Myc positive feedback loop and the E2F/Myc/miR-17-92 negative feedback loop. The role of the feedback loop on noise effects is found to depend on the dynamic properties of the system. When the system is in monostability or bistability with high protein concentrations, noise is consistently suppressed. However, the negative feedback loop reduces this suppression ability (or improves the noise propagation) and enhances signal sensitivity. In the case of excitability, bistability, or monostability, noise is enhanced at low protein concentrations. The negative feedback loop reduces this noise enhancement as well as the signal sensitivity. In all cases, the positive feedback loop acts contrary to the negative feedback loop. We also found that increasing the time scale of the protein module or decreasing the noise autocorrelation time can enhance noise suppression; however, the systems sensitivity remains unchanged. Taken together, our results suggest that the negative/positive feedback mechanisms in coupled feedback loop dynamically buffer noise effects rather than only suppressing or amplifying the noise.	[Zhang, Hui; Chen, Yueling; Chen, Yong] Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China; [Chen, Yueling] Gansu Coll Tradit Chinese Med, Dept Phys, Lanzhou, Peoples R China; [Chen, Yong] Kings Coll London, Dept Math, London WC2R 2LS, England	Lanzhou University; Gansu University of Chinese Medicine; University of London; King's College London	Chen, Y (corresponding author), Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China.	ychen@lzu.edu.cn	Chen, Yong/B-9051-2008	Chen, Yong/0000-0003-2580-5895	National Natural Science Foundation of China [10975063]; Fundamental Research Funds for the Central Universities [lzujbky-2012-17]; Program for New Century Excellent Talents in University [NCET-11-0206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (Grants No. 10975063), the Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2012-17), and the Program for New Century Excellent Talents in University (Grant No. NCET-11-0206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 2001, J CELL SCI, V114, P257; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Cheng Z, 2008, FEBS LETT, V582, P3776, DOI 10.1016/j.febslet.2008.10.005; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; KASDIN NJ, 1995, J GUID CONTROL DYNAM, V18, P114, DOI 10.2514/3.56665; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; KEIZER J, 1995, MOL BIOL CELL, V6, P945, DOI 10.1091/mbc.6.8.945; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim D, 2007, BIOESSAYS, V29, P85, DOI 10.1002/bies.20511; Kim JR, 2008, BIOPHYS J, V94, P359, DOI 10.1529/biophysj.107.105106; KLOSEKDYGAS MM, 1988, SIAM J APPL MATH, V48, P425, DOI 10.1137/0148023; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Li Y, 2011, PLOS ONE, V6, DOI DOI 10.1371/journal.pone.0026302; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Ma J, 2008, CHAOS, V18, DOI 10.1063/1.3013178; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Papoulis A., 1991, PROBABILITY RANDOM V; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Pfeuty B, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046013; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; SINGH P, 1994, EMBO J, V13, P3329, DOI 10.1002/j.1460-2075.1994.tb06635.x; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218	70	28	28	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51840	10.1371/journal.pone.0051840	http://dx.doi.org/10.1371/journal.pone.0051840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284787	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500053
J	Pan, FG; Zhao, YY; Zhu, S; Sun, CJ; Lei, LC; Feng, X; Han, WY				Pan, Fengguang; Zhao, Yaya; Zhu, Seng; Sun, Changjiang; Lei, Liancheng; Feng, Xin; Han, Wen Yu			Different Transcriptional Profiles of RAW264.7 Infected with Mycobacterium tuberculosis H37Rv and BCG Identified via Deep Sequencing	PLOS ONE			English	Article							ACTIN-FILAMENT NETWORK; INNATE IMMUNITY; PATHOGENIC MYCOBACTERIA; MACROPHAGE RESPONSES; DEFENSE-MECHANISM; AUTOPHAGY; EXPRESSION; PHAGOSOMES; PATHWAYS; CELLS	Background: The Mycobacterium tuberculosis H37Rv and BCG effects on the host cell transcriptional profile consider a main research point. In the present study the transcriptome profiling analysis of RAW264.7 either infected with Mycobacterium tuberculosis H37Rv or BCG have been reported using Solexa/Illumina digital gene expression (DGE). Results: The DGE analysis showed 1,917 different expressed genes between the BCG and H37Rv group. In addition, approximately 5% of the transcripts appeared to be predicted genes that have never been described before. KEGG Orthology (KO) annotations showed more than 71% of these transcripts are possibly involved in approximately 210 known metabolic or signaling pathways. The gene of the 28 pathways about pathogen recognition receptors and Mycobacterium tuberculosis interaction with macrophages were analyzed using the CLUSTER 3.0 available, the Tree View tool and Gene Orthology (GO). Some genes were randomly selected to confirm their altered expression levels by quantitative real-time PCR (qRT-PCR). Conclusion: The present study used DGE from pathogen recognition receptors and Mycobacterium tuberculosis interaction with macrophages to understand the interplay between Mycobacterium tuberculosis and RAW264.7. Meanwhile find some important host protein which was affected by Mycobacterium tuberculosis to provide evidence for the further improvement of the present efficacy of existing Mycobacterium tuberculosis therapy and vaccine.	[Pan, Fengguang; Zhu, Seng; Sun, Changjiang; Lei, Liancheng; Feng, Xin; Han, Wen Yu] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China; [Pan, Fengguang; Zhao, Yaya] Jilin Univ, Lab Food Safety & Hyg Inspect, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University	Sun, CJ (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China.	schangjiang@126.com; jluhwy@sohu.com	SUN, CHANG/GXM-3680-2022	ZHAO, YAYA/0000-0001-6424-8687	National Science and Technology Major Project [2009ZX08009-163B]; National Natural Science Foundation of China [31101813]; Jilin Province Science and Technology Developing Project [20076013]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Province Science and Technology Developing Project	This work was supported by National Science and Technology Major Project (2009ZX08009-163B, http://www.nmp.gov.cn/), National Natural Science Foundation of China (Key Program, No. 31101813, http://www.nsfc.gov.cn) and Jilin Province Science and Technology Developing Project (20076013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Ansari MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022889; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chin MP, 2010, CHEM RES TOXICOL, V23, P778, DOI 10.1021/tx900415k; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; Coler RN, 2009, VACCINE, V27, P223, DOI 10.1016/j.vaccine.2008.10.056; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Friberg IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020070; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Guerin I, 2000, EUR J CELL BIOL, V79, P735, DOI 10.1078/0171-9335-00092; Guerin I, 2000, INFECT IMMUN, V68, P2655, DOI 10.1128/IAI.68.5.2655-2662.2000; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hestvik ALK, 2005, FEMS MICROBIOL REV, V29, P1041, DOI 10.1016/j.femsre.2005.04.013; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kissner TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015985; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Kozak RA, 2011, INFECT IMMUN, V79, P59, DOI 10.1128/IAI.00824-10; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Noel S, 2007, TOXICOLOGY, V239, P96, DOI 10.1016/j.tox.2007.06.098; Oliveira Helenice Bosco de, 2011, Rev Soc Bras Med Trop, V44, P627; Perskvist N, 2002, J CELL SCI, V115, P1321; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Sanarico N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/741051; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward SK, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00121; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x; Weigelt K, 2007, J LEUKOCYTE BIOL, V82, P1564, DOI 10.1189/jlb.0707447; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233	49	10	11	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51988	10.1371/journal.pone.0051988	http://dx.doi.org/10.1371/journal.pone.0051988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284841	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300068
J	Srikiatkhachorn, A; Wichit, S; Gibbons, RV; Green, S; Libraty, DH; Endy, TP; Ennis, FA; Kalayanarooj, S; Rothman, AL				Srikiatkhachorn, Anon; Wichit, Sineewanlaya; Gibbons, Robert V.; Green, Sharone; Libraty, Daniel H.; Endy, Timothy P.; Ennis, Francis A.; Kalayanarooj, Siripen; Rothman, Alan L.			Dengue Viral RNA Levels in Peripheral Blood Mononuclear Cells Are Associated with Disease Severity and Preexisting Dengue Immune Status	PLOS ONE			English	Article							VIRUS-INFECTION; CYTOKINE PRODUCTION; ANTIBODY; REPLICATION; ENHANCEMENT; LYMPHOCYTES; ACTIVATION; LEUKOCYTES; ILLNESS; HUMANS	Background: Infection with dengue viruses (DENV) causes a wide range of manifestations from asymptomatic infection to a febrile illness called dengue fever (DF), to dengue hemorrhagic fever (DHF). The in vivo targets of DENV and the relation between the viral burden in these cells and disease severity are not known. Method: The levels of positive and negative strand viral RNA in peripheral blood monocytes, T/NK cells, and B cells and in plasma of DF and DHF cases were measured by quantitative RT-PCR. Results: Positive strand viral RNA was detected in monocytes, T/NK cells and B cells with the highest amounts found in B cells. Viral RNA levels in CD14+ cells and plasma were significantly higher in DHF compared to DF, and in cases with a secondary infection compared to those undergoing a primary infection. The distribution of viral RNA among cell subpopulations was similar in DF and DHF cases. Small amounts of negative strand RNA were found in a few cases only. The severity of plasma leakage correlated with viral RNA levels in plasma and in CD14+ cells. Conclusions: B cells were the principal cells containing DENV RNA in peripheral blood, but overall there was little active DENV RNA replication detectable in peripheral blood mononuclear cells (PBMC). Secondary infection and DHF were associated with higher viral burden in PBMC populations, especially CD14+ monocytes, suggesting that viral infection of these cells may be involved in disease pathogenesis.	[Srikiatkhachorn, Anon; Green, Sharone; Libraty, Daniel H.; Ennis, Francis A.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Wichit, Sineewanlaya; Gibbons, Robert V.] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; [Endy, Timothy P.] SUNY Syracuse, Dept Med, Upstate Med Univ, Syracuse, NY USA; [Kalayanarooj, Siripen] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Rothman, Alan L.] Univ Rhode Isl, Inst Immunol & Informat, Providence, RI 02908 USA	University of Massachusetts System; University of Massachusetts Worcester; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Rhode Island	Srikiatkhachorn, A (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	anon.srikiatkhachorn@umassmed.edu		Rothman, Alan/0000-0002-4064-6848; Kalayanarooj, Siripen/0000-0002-3568-0929	National Institutes of Health [NIH-P01AI34533]; Military Infectious Disease Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319, P01AI034533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Military Infectious Disease Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant [NIH-P01AI34533] and the Military Infectious Disease Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baclig MO, 2010, SE ASIAN J TROP MED, V41, P1352; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; King Alan D., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P718; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002; Mentor NA, 1997, ACTA VIROL, V41, P175; Mota J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020762; Peyrefitte CN, 2003, J VIROL METHODS, V113, P19, DOI 10.1016/S0166-0934(03)00218-0; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; WATERMAN SH, 1985, AM J TROP MED HYG, V34, P380, DOI 10.4269/ajtmh.1985.34.380; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 1997, DENG HEM FEV DIAGN T, V2nd; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11	25	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51335	10.1371/journal.pone.0051335	http://dx.doi.org/10.1371/journal.pone.0051335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284680	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300018
J	Wahl, K; Rosenberg, W; Vaske, B; Manns, MP; Schulze-Osthoff, K; Bahr, MJ; Bantel, H				Wahl, Kristin; Rosenberg, William; Vaske, Bernhard; Manns, Michael P.; Schulze-Osthoff, Klaus; Bahr, Matthias J.; Bantel, Heike			Biopsy-Controlled Liver Fibrosis Staging Using the Enhanced Liver Fibrosis (ELF) Score Compared to Transient Elastography	PLOS ONE			English	Article							SERUM MARKERS; NONINVASIVE ASSESSMENT; STIFFNESS MEASUREMENT; HEPATITIS-C; CIRRHOSIS; DIAGNOSIS; CELLS; VARIABILITY; PERFORMANCE; REGRESSION	Background and Aims: Chronic liver diseases are characterized by inflammatory and fibrotic liver injuries that often result in liver cirrhosis with its associated complications such as portal hypertension and hepatocellular carcinoma. Liver biopsy still represents the reference standard for fibrosis staging, although transient elastography is increasingly used for non-invasive monitoring of fibrosis progression. However, this method is not generally available and is associated with technical limitations emphasizing the need for serological biomarkers staging of liver fibrosis. The enhanced liver fibrosis (ELF) score was shown to accurately predict significant liver fibrosis in different liver diseases, although extracellular matrix components detected by this score may not only mirror the extent of liver fibrosis but also inflammatory processes. Methods: In this prospective biopsy-controlled study we evaluated the utility of the ELF score in comparison to transient elastography to predict different stages of fibrosis in 102 patients with chronic liver diseases. Results: Both techniques revealed similar area under receiver operating characteristic curve values for prediction of advanced fibrosis stages. Compared to transient elastography, the ELF score showed a broader overlap between low and moderate fibrosis stages and a stronger correlation with inflammatory liver injury. Conclusions: Both the ELF score as well as transient elastography allowed for high quality fibrosis staging. However, the ELF score was less discriminative in low and moderate fibrosis stages and appeared more strongly influenced by inflammatory liver injury. This should be considered when making clinical interpretations on the basis of ELF score values.	[Wahl, Kristin; Manns, Michael P.; Bantel, Heike] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Rosenberg, William] UCL, Ctr Hepatol, Inst Liver & Digest Hlth, Div Med, London, England; [Vaske, Bernhard] Hannover Med Sch, Inst Biometry, D-3000 Hannover, Germany; [Schulze-Osthoff, Klaus] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Bahr, Matthias J.] Sana Kliniken, Lubeck, Germany	Hannover Medical School; University of London; University College London; Hannover Medical School; Eberhard Karls University of Tubingen	Bantel, H (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany.	Bantel.Heike@mh-hannover.de	Schulze-Osthoff, Klaus/N-9025-2013; Rosenberg, William/ABA-1071-2021	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Rosenberg, William/0000-0002-2732-2304; Bahr, Matthias J./0000-0001-6242-5299	Deutsche Forschungsgemeinschaft [SFB Transregio 77, SFB 685, BA 2092/9-1]; Siemens Healthcare Diagnostics Inc.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Siemens Healthcare Diagnostics Inc.	This study was supported by the Deutsche Forschungsgemeinschaft (SFB Transregio 77, SFB 685, BA 2092/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; WR is an inventor of the ELF test and has received support for research studies and speaking events from Siemens Healthcare Diagnostics Inc. The proprietary assays developed for the ELF test by Siemens Healthcare Diagnostics Inc. (Tarrytown, New York, United States of America) were used and analyses were performed on an Immuno-1 auto-analyser (Siemens Healthcare Diagnostics Inc., Tarrytown, New York, United States of America). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Afdhal NH, 2003, HEPATOLOGY, V37, P972, DOI 10.1053/jhep.2003.50223; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Cao Q, 2004, J BIOL CHEM, V279, P4292, DOI 10.1074/jbc.M308351200; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 1999, HEPATOLOGY, V30, P1529, DOI 10.1002/hep.510300624; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Crespo G, 2012, J HEPATOL, V57, P281, DOI 10.1016/j.jhep.2012.03.016; Dechene A, 2010, HEPATOLOGY, V52, P1008, DOI 10.1002/hep.23754; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kim BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041964; Kisseleva T, 2011, BEST PRACT RES CL GA, V25, P305, DOI 10.1016/j.bpg.2011.02.011; Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069; Lebensztejn DM, 2005, EUR J GASTROEN HEPAT, V17, P843, DOI 10.1097/00042737-200508000-00011; Lee MH, 2010, DIGEST DIS SCI, V55, P3552, DOI 10.1007/s10620-010-1219-0; Lichtinghagen R, 2004, EXPERT REV MOL DIAGN, V4, P715, DOI 10.1586/14737159.4.5.715; Lichtinghagen R, 2000, CLIN CHEM, V46, P183; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Mayo MJ, 2008, HEPATOLOGY, V48, P1549, DOI 10.1002/hep.22517; McHutchison JG, 2000, J GASTROEN HEPATOL, V15, P945, DOI 10.1046/j.1440-1746.2000.02233.x; Nahon P, 2008, J HEPATOL, V49, P1062, DOI 10.1016/j.jhep.2008.08.011; Nobili V, 2009, GASTROENTEROLOGY, V136, P160, DOI 10.1053/j.gastro.2008.09.013; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Parkes J, 2006, J HEPATOL, V44, P462, DOI 10.1016/j.jhep.2005.10.019; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; Sagir A, 2008, HEPATOLOGY, V47, P592, DOI 10.1002/hep.22056; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	48	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51906	10.1371/journal.pone.0051906	http://dx.doi.org/10.1371/journal.pone.0051906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284811	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300055
J	Yang, XF; Tan, MZ; Qiu, AQ				Yang, Xianfeng; Tan, Ming Zhen; Qiu, Anqi			CSF and Brain Structural Imaging Markers of the Alzheimer's Pathological Cascade	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; HIPPOCAMPAL ATROPHY; DISEASE; MRI; RECOMMENDATIONS; BIOMARKERS; DEMENTIA	Cerebral spinal fluid (CSF) and structural imaging markers are suggested as biomarkers amended to existing diagnostic criteria of mild cognitive impairment (MCI) and Alzheimer's disease (AD). But there is no clear instruction on which markers should be used at which stage of dementia. This study aimed to first investigate associations of the CSF markers as well as volumes and shapes of the hippocampus and lateral ventricles with MCI and AD at the baseline and secondly apply these baseline markers to predict MCI conversion in a two-year time using the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Our results suggested that the CSF markers, including A beta 42, t-tau, and p-tau, distinguished MCI or AD from NC, while the A beta 42 CSF marker contributed to the differentiation between MCI and AD. The hippocampal shapes performed better than the hippocampal volumes in classifying NC and MCI, NC and AD, as well as MCI and AD. Interestingly, the ventricular volumes were better than the ventricular shapes to distinguish MCI or AD from NC, while the ventricular shapes showed better accuracy than the ventricular volumes in classifying MCI and AD. As the CSF markers and the structural markers are complementary, the combination of them showed great improvements in the classification accuracies of MCI and AD. Moreover, the combination of these markers showed high sensitivity but low specificity for predicting conversion from MCI to AD in two years. Hence, it is feasible to employ a cross-sectional sample to investigate dynamic associations of the CSF and imaging markers with MCI and AD and to predict future MCI conversion. In particular, the volumetric information may be good for the early stage of AD, while morphological shapes should be considered as markers in the prediction of MCI conversion to AD together with the CSF markers.	[Yang, Xianfeng; Tan, Ming Zhen; Qiu, Anqi] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore; [Qiu, Anqi] Singapore Inst Clin Sci, Agcy Sci Technol & Res, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Qiu, AQ (corresponding author), Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore.	bieqa@nus.edu.sg	Qiu, Anqi/H-2267-2011	Qiu, Anqi/0000-0002-0215-6338	National Medical Research Council (NMRC/CG/NUHS/2010); Young Investigator Award at the National University of Singapore [NUSYIA FY10 P07]; National University of Singapore MOE AcRF	National Medical Research Council (NMRC/CG/NUHS/2010)(National Medical Research Council, Singapore); Young Investigator Award at the National University of Singapore(National University of Singapore); National University of Singapore MOE AcRF(Ministry of Education, SingaporeNational University of Singapore)	The work was supported by grants: a centre grant from the National Medical Research Council (NMRC/CG/NUHS/2010), the Young Investigator Award at the National University of Singapore (NUSYIA FY10 P07), and the National University of Singapore MOE AcRF Tier 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alves FD, 2008, PSYCHOPHARMACOL BULL, V41, P121; Apostolova LG, 2006, BRAIN, V129, P2867, DOI 10.1093/brain/awl274; Apostolova LG, 2006, ARCH NEUROL-CHICAGO, V63, P693, DOI 10.1001/archneur.63.5.693; Cardenas VA, 2003, NEUROBIOL AGING, V24, P537, DOI 10.1016/S0197-4580(02)00130-6; Chetelat G, 2002, NEUROREPORT, V13, P1939; Costafreda SG, 2011, NEUROIMAGE, V56, P212, DOI 10.1016/j.neuroimage.2011.01.050; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Ewers M, 2010, NEUROBIOL AGING; Ferrarini L, 2008, MAGN RESON MED, V59, P260, DOI 10.1002/mrm.21471; Ferrarini L, 2009, J ALZHEIMERS DIS, V17, P643, DOI 10.3233/JAD-2009-1082; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Kantarci K, 2009, NEUROLOGY, V72, P1519, DOI 10.1212/WNL.0b013e3181a2e864; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miller MI, 2009, NEUROIMAGE, V45, pS16, DOI 10.1016/j.neuroimage.2008.10.044; Qiu AQ, 2008, NEUROIMAGE, V42, P1430, DOI 10.1016/j.neuroimage.2008.04.257; Qiu A, 2008, NEUROIMAGE, V40, P68, DOI 10.1016/j.neuroimage.2007.11.041; Qiu AQ, 2010, IEEE T IMAGE PROCESS, V19, P1539, DOI 10.1109/TIP.2010.2042099; Qiu AQ, 2009, NEUROIMAGE, V45, P656, DOI 10.1016/j.neuroimage.2009.01.013; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vemuri P, 2010, NEUROLOGY, V75, P143, DOI 10.1212/WNL.0b013e3181e7ca82; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6; Westman E, 2012, NEUROIMAGE; Yang XF, 2011, NEUROIMAGE, V56, P149, DOI 10.1016/j.neuroimage.2011.01.069; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	35	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e47406	10.1371/journal.pone.0047406	http://dx.doi.org/10.1371/journal.pone.0047406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284610	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300003
J	Kweka, EJ; Zhou, GF; Munga, S; Lee, MC; Atieli, HE; Nyindo, M; Githeko, AK; Yan, GY				Kweka, Eliningaya J.; Zhou, Guofa; Munga, Stephen; Lee, Ming-Chieh; Atieli, Harrysone E.; Nyindo, Mramba; Githeko, Andrew K.; Yan, Guiyun			Anopheline Larval Habitats Seasonality and Species Distribution: A Prerequisite for Effective Targeted Larval Habitats Control Programmes	PLOS ONE			English	Article							WESTERN KENYA HIGHLANDS; GAMBIAE COMPLEX MOSQUITOS; INSECTICIDE-TREATED NETS; DAR-ES-SALAAM; RICE FIELDS; LAND-COVER; MALARIA TRANSMISSION; MICROBIAL LARVICIDES; USAMBARA MOUNTAINS; IMMATURE STAGES	Background: Larval control is of paramount importance in the reduction of malaria vector abundance and subsequent disease transmission reduction. Understanding larval habitat succession and its ecology in different land use managements and cropping systems can give an insight for effective larval source management practices. This study investigated larval habitat succession and ecological parameters which influence larval abundance in malaria epidemic prone areas of western Kenya. Methods and Findings: A total of 51 aquatic habitats positive for anopheline larvae were surveyed and visited once a week for a period of 85 weeks in succession. Habitats were selected and identified. Mosquito larval species, physico-chemical parameters, habitat size, grass cover, crop cycle and distance to nearest house were recorded. Polymerase chain reaction revealed that An. gambiae s.l was the most dominant vector species comprised of An. gambiae s.s (77.60%) and An.arabiensis (18.34%), the remaining 4.06% had no amplification by polymerase chain reaction. Physico-chemical parameters and habitat size significantly influenced abundance of An. gambiae s.s (P = 0.024) and An. arabiensis (P = 0.002) larvae. Further, larval species abundance was influenced by crop cycle (P <= 0.001), grass cover (P <= 0.001), while distance to nearest houses significantly influenced the abundance of mosquito species larvae (r = 0.920; P <= 0.001). The number of predator species influenced mosquito larval abundance in different habitat types. Crop weeding significantly influenced with the abundance of An. gambiae s.l (P <= 0.001) when preceded with fertilizer application. Significantly higher anopheline larval abundance was recorded in habitats in pasture compared to farmland (P = 0.002). When habitat stability and habitat types were considered, hoof print were the most productive followed by disused goldmines. Conclusion: These findings suggest that implementation of effective larval control programme should be targeted with larval habitats succession information when larval habitats are fewer and manageable. Crop cycles and distance from habitats to household should be considered as effective information in planning larval control.	[Kweka, Eliningaya J.; Munga, Stephen; Atieli, Harrysone E.; Githeko, Andrew K.] Kenya Govt Med Res Ctr, Climate & Human Hlth Res Unit, Kisumu, Kenya; [Kweka, Eliningaya J.; Nyindo, Mramba] Tumaini Univ Makumira, Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Zhou, Guofa; Lee, Ming-Chieh; Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA USA	Kenya Medical Research Institute; University of California System; University of California Irvine	Kweka, EJ (corresponding author), Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Mosquito Sect, Arusha, Tanzania.	pat.kweka@gmail.com	Lee, Ming-Chieh/ABE-8421-2021	Lee, Ming-Chieh/0000-0002-2462-6089; Kweka, Eliningaya/0000-0002-8891-758X	American National Institute of Health [D43 TW01505, R01 AI-50243]; FOGARTY INTERNATIONAL CENTER [D43TW001505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050243] Funding Source: NIH RePORTER	American National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received financial support from American National Institute of Health (D43 TW01505 and R01 AI-50243 to GY). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; ALATALO R, 1977, ECOLOGY, V58, P900, DOI 10.2307/1936226; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Baolin L, 1998, PARSITOL TODAY, V4, P328; Blaustein L, 2007, ANNU REV ENTOMOL, V52, P489, DOI 10.1146/annurev.ento.52.110405.091431; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bodker R, 2006, AM J TROP MED HYG, V74, P716; Chaki PP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-311; Chuma J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-144; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Gillies TM, 1987, ANOPHELES AFRICAN S; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Githeko A.K., 2001, GLOB CHANGE HUM HLTH, V2, P54, DOI [10.1023/A:1011943131643, DOI 10.1023/A:1011943131643]; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Himeidan YE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-234; Kebede A, 2005, AM J TROP MED HYG, V73, P676, DOI 10.4269/ajtmh.2005.73.676; KHAEMBA BM, 1994, E AFR MED J, V71, P159; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-128; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-110; Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9; Mala AO, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-25; MCCRAE AWR, 1984, ANN TROP MED PARASIT, V78, P307, DOI 10.1080/00034983.1984.11811821; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Minakawa N, 2005, J MED ENTOMOL, V42, P295, DOI 10.1603/0022-2585(2005)042[0295:RBOOAG]2.0.CO;2; Minakawa N, 2004, MED VET ENTOMOL, V18, P301, DOI 10.1111/j.0269-283X.2004.00503.x; Minakawa N, 2002, AM J TROP MED HYG, V67, P32, DOI 10.4269/ajtmh.2002.67.32; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Minakawa N, 2001, J MED ENTOMOL, V38, P388, DOI 10.1603/0022-2585-38.3.388; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; MOGI M, 1986, J MED ENTOMOL, V23, P244, DOI 10.1093/jmedent/23.3.244; Munga S, 2006, J MED ENTOMOL, V43, P221, DOI 10.1603/0022-2585(2006)043[0221:EOLCAP]2.0.CO;2; Munga S, 2006, AM J TROP MED HYG, V74, P69, DOI 10.4269/ajtmh.2006.74.69; Munga S, 2005, J MED ENTOMOL, V42, P993, DOI 10.1603/0022-2585(2005)042[0993:OSPAEH]2.0.CO;2; Munga S, 2007, J MED ENTOMOL, V44, P758, DOI 10.1603/0022-2585(2007)44[758:SOISOA]2.0.CO;2; Munga S, 2009, AM J TROP MED HYG, V81, P1079, DOI 10.4269/ajtmh.2009.09-0156; Mutero CM, 2000, ACTA TROP, V76, P253, DOI 10.1016/S0001-706X(00)00109-1; Mutero CM, 2004, ACTA TROP, V89, P187, DOI 10.1016/j.actatropica.2003.08.006; Mutuku FM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-19; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Muturi EJ, 2007, J MED ENTOMOL, V44, P336, DOI 10.1603/0022-2585(2007)44[336:MSSAPF]2.0.CO;2; Mwangangi J, 2006, J VECTOR ECOL, V31, P245, DOI 10.3376/1081-1710(2006)31[245:DOISOA]2.0.CO;2; Mwangangi JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-114; Mwangangi JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-228; Mwingira V S, 2009, Tanzan J Health Res, V11, P17; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Ndenga BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019473; Norris JL, 1998, ENVIRON ECOL STAT, V5, P391, DOI 10.1023/A:1009659922745; Paaijmans KP, 2008, INT J BIOMETEOROL, V52, P747, DOI 10.1007/s00484-008-0167-2; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Palmquist KR, 2008, ENVIRON TOXICOL CHEM, V27, P1728, DOI 10.1897/07-499.1; RAJENDRAN R, 1991, MED VET ENTOMOL, V5, P299, DOI 10.1111/j.1365-2915.1991.tb00556.x; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SERVICE MW, 1977, J MED ENTOMOL, V13, P535, DOI 10.1093/jmedent/13.4-5.535; Shililu J, 2003, J MED ENTOMOL, V40, P921, DOI 10.1603/0022-2585-40.6.921; Shililu JI, 1998, TROP MED INT HEALTH, V3, P706; Shililu J, 2007, AM J TROP MED HYG, V76, P103, DOI 10.4269/ajtmh.2007.76.103; Silberbush A, 2010, ECOL LETT, V13, P1129, DOI 10.1111/j.1461-0248.2010.01501.x; Tuno N, 2005, J MED ENTOMOL, V42, P270, DOI 10.1603/0022-2585(2005)042[0270:SOAGSS]2.0.CO;2; Victor TJ, 2000, MED VET ENTOMOL, V14, P361, DOI 10.1046/j.1365-2915.2000.00255.x; Wanjala CL, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-81; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Yakob L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006921; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450; Ye-Ebiyo Y, 2003, J MED ENTOMOL, V40, P860, DOI 10.1603/0022-2585-40.6.860; Ye-Ebiyo Y, 2003, AM J TROP MED HYG, V68, P748, DOI 10.4269/ajtmh.2003.68.748; Ye-Ebiyo Y, 2000, AM J TROP MED HYG, V63, P90, DOI 10.4269/ajtmh.2000.63.90; Zhou GF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-67	74	50	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52084	10.1371/journal.pone.0052084	http://dx.doi.org/10.1371/journal.pone.0052084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272215	Green Published, gold			2022-12-25	WOS:000312483300061
J	Apfelbeck, B; Kiefer, S; Mortega, KG; Goymann, W; Kipper, S				Apfelbeck, Beate; Kiefer, Sarah; Mortega, Kim G.; Goymann, Wolfgang; Kipper, Silke			Testosterone Affects Song Modulation during Simulated Territorial Intrusions in Male Black Redstarts (Phoenicurus ochruros)	PLOS ONE			English	Article							EXPERIMENTALLY ELEVATED TESTOSTERONE; ESTROGEN-RECEPTOR-ALPHA; MEDIAL PREOPTIC AREA; VOCAL PERFORMANCE; ZEBRA FINCH; PLASMA TESTOSTERONE; ANDROGEN RECEPTOR; SINGING BEHAVIOR; SEASONAL-CHANGES; FEMALE RESPONSE	Although it has been suggested that testosterone plays an important role in resource allocation for competitive behavior, details of the interplay between testosterone, territorial aggression and signal plasticity are largely unknown. Therefore, we investigated if testosterone acts specifically on signals that communicate the motivation or ability of individuals to engage in competitive situations in a natural context. We studied the black redstart, a territorial songbird species, during two different life-cycle stages, the early breeding phase in spring and the non-breeding phase in fall. Male territory holders were implanted with the androgen receptor blocker flutamide (Flut) and the aromatase inhibitor letrozole (Let) to inhibit the action of testosterone and its estrogenic metabolites. Controls received a placebo treatment. Three days after implantation birds were challenged with a simulated territorial intrusion (STI). Song was recorded before, during and after the challenge. In spring, both treatment groups increased the number of elements sung in parts of their song in response to the STI. However, Flut/Let-implanted males reacted to the STI with a decreased maximum acoustic frequency of one song part, while placebo-implanted males did not. Instead, placebo-implanted males sang the atonal part of their song with a broader frequency range. Furthermore, placebo-, but not Flut/Let-implanted males, sang shorter songs with shorter pauses between parts in the STIs. During simulated intrusions in fall, when testosterone levels are naturally low in this species, males of both treatment groups sang similar to Flut/Let-implanted males during breeding. The results suggest that song sung during a territorial encounter is of higher competitive value than song sung in an undisturbed situation and may, therefore, convey information about the motivation or quality of the territory holder. We conclude that testosterone facilitates context-dependent changes in song structures that may be honest signals of male quality in black redstarts.	[Apfelbeck, Beate; Goymann, Wolfgang] Max Planck Inst Ornithol, Abt Verhaltensneurobiol, Seewiesen, Germany; [Kiefer, Sarah; Mortega, Kim G.; Kipper, Silke] Free Univ Berlin, Inst Biol, AG Verhaltensbiol, Berlin, Germany; [Mortega, Kim G.] Univ Konstanz, Abt Ornithol, Constance, Germany	Max Planck Society; Free University of Berlin; University of Konstanz	Apfelbeck, B (corresponding author), Max Planck Inst Ornithol, Abt Verhaltensneurobiol, Seewiesen, Germany.	apfelbeck@orn.mpg.de	Goymann, Wolfgang/E-4854-2010	Goymann, Wolfgang/0000-0002-7553-5910; Apfelbeck, Beate/0000-0001-7605-7060; Mortega, Kim Geraldine/0000-0002-2645-6677	Max-Planck Gesellschaft; 'Berliner Programm' of the Freie Universitat Berlin	Max-Planck Gesellschaft(Max Planck Society); 'Berliner Programm' of the Freie Universitat Berlin	The study was kindly funded by the Max-Planck Gesellschaft and the 'Berliner Programm' of the Freie Universitat Berlin (research travel grants to S. Kiefer and KGM). Novartis kindly provided the authors with letrozole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; Apfelbeck B, 2011, HORM BEHAV, V60, P565, DOI 10.1016/j.yhbeh.2011.08.005; Apfelbeck B, 2011, P ROY SOC B-BIOL SCI, V278, P3233, DOI 10.1098/rspb.2011.0098; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Ballentine B, 2009, ANIM BEHAV, V77, P973, DOI 10.1016/j.anbehav.2008.12.027; Balthazart J, 1997, J STEROID BIOCHEM, V61, P323; Balthazart J, 2010, EUR J NEUROSCI, V32, P2116, DOI 10.1111/j.1460-9568.2010.07518.x; Bartsch C, 2012, ETHOLOGY, V118, P876, DOI 10.1111/j.1439-0310.2012.02081.x; Beckett MD, 2010, WILSON J ORNITHOL, V122, P655, DOI 10.1676/09-204.1; Bee MA, 1996, BEHAVIOUR, V133, P283, DOI 10.1163/156853996X00152; Boseret G, 2006, J NEUROBIOL, V66, P1044, DOI 10.1002/neu.20268; Botero CA, 2009, ANIM BEHAV, V77, P701, DOI 10.1016/j.anbehav.2008.11.020; Cheshenko K, 2008, GEN COMP ENDOCR, V155, P31, DOI 10.1016/j.ygcen.2007.03.005; Cucco M, 1999, CONDOR, V101, P689, DOI 10.2307/1370203; Cynx J, 2005, HORM BEHAV, V47, P446, DOI 10.1016/j.yhbeh.2004.11.018; DEWOLFE BB, 1974, BIRD BANDING, V45, P224, DOI 10.2307/4512046; Draganoiu T, 2006, J ORNITHOL, V147, P158; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; DuBois AL, 2011, BEHAV ECOL SOCIOBIOL, V65, P717, DOI 10.1007/s00265-010-1073-2; DuBois AL, 2009, BIOL LETTERS, V5, P163, DOI 10.1098/rsbl.2008.0626; Edler R, 2011, IBIS, V153, P46, DOI 10.1111/j.1474-919X.2010.01075.x; Fusani L, 2008, GEN COMP ENDOCR, V157, P249, DOI 10.1016/j.ygcen.2008.04.016; Gahr M, 1997, BRAIN RES BULL, V44, P509, DOI 10.1016/S0361-9230(97)00233-5; Galeotti P, 1997, ANIM BEHAV, V53, P687, DOI 10.1006/anbe.1996.0304; Garamszegi LZ, 2004, BEHAV ECOL, V15, P148, DOI 10.1093/beheco/arg108; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Goymann W, 2007, HORM BEHAV, V51, P463, DOI 10.1016/j.yhbeh.2007.01.007; Goymann W, 2009, GEN COMP ENDOCR, V163, P149, DOI 10.1016/j.ygcen.2008.11.027; Halupka K, 2006, BEHAVIOUR, V143, P1, DOI 10.1163/156853906775133614; Harding CF, 2004, ANN NY ACAD SCI, V1016, P524, DOI 10.1196/annals.1298.030; Hau M, 2000, GEN COMP ENDOCR, V117, P20, DOI 10.1006/gcen.1999.7390; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; Hoese WJ, 2000, J EXP BIOL, V203, P1845; Hurd PL, 2005, ANIM BEHAV, V70, P1155, DOI 10.1016/j.anbehav.2005.02.014; Illes AE, 2006, P ROY SOC B-BIOL SCI, V273, P1907, DOI 10.1098/rspb.2006.3535; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; Kipper S, 2010, ADV STUD BEHAV, V41, P77, DOI 10.1016/S0065-3454(10)41003-7; Kunc HP, 2006, ETHOLOGY, V112, P984, DOI 10.1111/j.1439-0310.2006.01254.x; LANDMANN A, 1995, ETHOL ECOL EVOL, V7, P147, DOI 10.1080/08927014.1995.9522962; Landmann A., 1996, HAUSROTSCHWANZ FELS; Landys MM, 2010, HORM BEHAV, V58, P317, DOI 10.1016/j.yhbeh.2010.02.013; Leitner S, 2001, HORM BEHAV, V40, P160, DOI 10.1006/hbeh.2001.1700; LOGAN CA, 1990, HORM BEHAV, V24, P568, DOI 10.1016/0018-506X(90)90042-V; LOGAN CA, 1984, J COMP PSYCHOL, V98, P3, DOI 10.1037/0735-7036.98.1.3; MONAGHAN E P, 1992, P261; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; Pasch B, 2011, HORM BEHAV, V59, P90, DOI 10.1016/j.yhbeh.2010.10.011; Podos J, 2009, ADV STUD BEHAV, V40, P159, DOI 10.1016/S0065-3454(09)40005-6; Price JJ, 2006, ANIM BEHAV, V71, P799, DOI 10.1016/j.anbehav.2005.05.025; R Development Core Team, 2009, R FDN STAT COMP; Riede T, 2010, BRAIN LANG, V115, P69, DOI 10.1016/j.bandl.2009.11.003; Riters LV, 2000, HORM BEHAV, V38, P250, DOI 10.1006/hbeh.2000.1623; Riters LV, 1999, HORM BEHAV, V36, P276, DOI 10.1006/hbeh.1999.1549; Ritschard M, 2011, PHYSIOL BEHAV, V102, P30, DOI 10.1016/j.physbeh.2010.10.005; Schlinger BA, 2006, J EXP ZOOL PART A, V305A, P743, DOI 10.1002/jez.a.303; SCHWABL H, 1992, ORNIS SCAND, V23, P271, DOI 10.2307/3676649; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Searcy WA, 2010, BEHAV ECOL SOCIOBIOL, V64, P1343, DOI 10.1007/s00265-010-0949-5; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; SILVERIN B, 1980, ANIM BEHAV, V28, P906, DOI 10.1016/S0003-3472(80)80152-7; Smith GT, 1997, J NEUROSCI, V17, P6001; Thompson CK, 2007, P NATL ACAD SCI USA, V104, P15520, DOI 10.1073/pnas.0707239104; Thompson CK, 2010, J COMP NEUROL, V518, P4760, DOI 10.1002/cne.22486; Vallet E, 1998, ANIM BEHAV, V55, P291, DOI 10.1006/anbe.1997.0631; Van Duyse E, 2005, HORM BEHAV, V48, P243, DOI 10.1016/j.yhbeh.2005.02.013; Veney SL, 2005, J COMP PHYSIOL A, V191, P97, DOI 10.1007/s00359-004-0577-5; Veney SL, 2004, GEN COMP ENDOCR, V136, P192, DOI 10.1016/j.ygcen.2003.12.017; Voigt C, 2008, HORM BEHAV, V54, P373, DOI 10.1016/j.yhbeh.2008.05.001; Wade J, 2000, J COMP NEUROL, V426, P154; WEATHERHEAD PJ, 1993, BEHAV ECOL SOCIOBIOL, V33, P13, DOI 10.1007/BF00164342; Weggler M, 2000, AUK, V117, P65, DOI 10.1642/0004-8038(2000)117[0065:RCOASI]2.0.CO;2; Weiss M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045057; Wingfield J.C., 2006, BIOL AGGRESSION, P179, DOI DOI 10.1093/ACPRO6OSO/9780195168261.0030008; WINGFIELD JC, 1994, HORM BEHAV, V28, P1, DOI 10.1006/hbeh.1994.1001; WINGFIELD JC, 1994, PSYCHONEUROENDOCRINO, V19, P709, DOI 10.1016/0306-4530(94)90052-3	76	24	24	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52009	10.1371/journal.pone.0052009	http://dx.doi.org/10.1371/journal.pone.0052009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284852	gold, Green Published, Green Accepted			2022-12-25	WOS:000312435900069
J	Rasmuson, A; Segerstrom, L; Nethander, M; Finnman, J; Elfman, LHM; Javanmardi, N; Nilsson, S; Johnsen, JI; Martinsson, T; Kogner, P				Rasmuson, Agnes; Segerstrom, Lova; Nethander, Maria; Finnman, Jennie; Elfman, Lotta H. M.; Javanmardi, Niloufar; Nilsson, Staffan; Johnsen, John Inge; Martinsson, Tommy; Kogner, Per			Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma	PLOS ONE			English	Article							N-MYC; MALIGNANT PROGRESSION; TRANSGENIC MODEL; AMPLIFICATION; EXPRESSION; INHIBITION; ONCOGENE; PROTEIN; TARGET; DNA	Background: The TH-MYCN transgenic neuroblastoma model, with targeted MYCN expression to the developing neural crest, has been used to study neuroblastoma development and evaluate novel targeted tumor therapies. Methods: We followed tumor development in 395 TH-MYCN (129X1/SvJ) mice (125 negative, 206 hemizygous and 64 homozygous mice) by abdominal palpations up to 40 weeks of age. DNA sequencing of MYCN in the original plasmid construct and mouse genomic DNA was done to verify the accuracy. Copy number analysis with Affymetrix(R) Mouse Diversity Genotyping Arrays was used to characterize acquired genetic aberrations. Results: DNA sequencing confirmed presence of human MYCN cDNA in genomic TH-MYCN DNA corresponding to the original plasmid construct. Tumor incidence and growth correlated significantly to transgene status with event-free survival for hemizygous mice at 50%, and 0% for homozygous mice. Hemizygous mice developed tumors at 5.6-19 weeks (median 9.1) and homozygous mice at 4.0-6.9 weeks (5.4). The mean treatment window, time from palpable tumor to sacrifice, for hemizygous and homozygous mice was 15 and 5.2 days, respectively. Hemizygous mice developing tumors as early as homozygous mice had a longer treatment window. Age at tumor development did not influence treatment window for hemizygous mice, whereas treatment window in homozygous mice decreased significantly with increasing age. Seven out of 10 analysed tumors had a flat DNA profile with neither segmental nor numerical chromosomal aberrations. Only three tumors from hemizygous mice showed acquired genetic features with one or more numerical aberrations. Of these, one event corresponded to gain on the mouse equivalent of human chromosome 17. Conclusion: Hemizygous and homozygous TH-MYCN mice have significantly different neuroblastoma incidence, tumor growth characteristics and treatment windows but overlap in age at tumor development making correct early genotyping essential to evaluate therapeutic interventions. Contrasting previous studies, our data show that TH-MYCN tumors have few genetic aberrations.	[Rasmuson, Agnes; Segerstrom, Lova; Elfman, Lotta H. M.; Johnsen, John Inge; Kogner, Per] Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Finnman, Jennie; Javanmardi, Niloufar; Martinsson, Tommy] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Clin Genet, Inst Biomed, Gothenburg, Sweden; [Nethander, Maria] Gothenburg Univ, Genom Core Facil, Gothenburg, Sweden; [Nilsson, Staffan] Chalmers, Dept Math Stat, S-41296 Gothenburg, Sweden	Karolinska Institutet; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; Chalmers University of Technology	Rasmuson, A (corresponding author), Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden.	Agnes.Rasmuson@ki.se; Per.Kogner@ki.se	Martinsson, Tommy/J-4140-2013	Martinsson, Tommy/0000-0002-9403-3123; Johnsen, John Inge/0000-0003-1277-812X; Kogner, Per/0000-0002-2202-9694; Nethander, Maria/0000-0003-3688-906X; Nilsson, Staffan/0000-0003-4748-0446	Swedish Children's Cancer Foundation; Swedish Cancer Society; Swedish Research Council; Robert Lundberg Memorial Foundation; ACT! thematic centre; Karolinska Institutet	Swedish Children's Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Robert Lundberg Memorial Foundation; ACT! thematic centre; Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Swedish Children's Cancer Foundation (http://www.barncancerfonden.se/), the Swedish Cancer Society (http://www.cancerfonden.se/), the Swedish Research Council (http://www.vr.se/), and the Robert Lundberg Memorial Foundation (http://www.ki.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to thank KIGene and Visual Sonics for expert assistance and advice in performing the sequencing and high-resolution ultrasound imaging, respectively. We acknowledge the support and collaboration within the ACT! thematic centre and the INTENT collaboration within the Karolinska Institutet.	Balamuth NJ, 2010, CANCER RES, V70, P2749, DOI 10.1158/0008-5472.CAN-09-3844; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Caren H, 2010, P NATL ACAD SCI USA, V107, P4323, DOI 10.1073/pnas.0910684107; Caren H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-353; Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; Chesler L, 2007, CANCER RES, V67, P9435, DOI 10.1158/0008-5472.CAN-07-1316; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Chesler L, 2011, SEMIN CANCER BIOL, V21, P245, DOI 10.1016/j.semcancer.2011.09.011; Hackett CS, 2003, CANCER RES, V63, P5266; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; Haraguchi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006902; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Johnsen J, 2009, APOPTOSIS, V14, P424, DOI 10.1007/s10495-009-0325-y; Morowitz MJ, 2005, CLIN CANCER RES, V11, P2680, DOI 10.1158/1078-0432.CCR-04-1917; Norris MD, 2000, MED PEDIATR ONCOL, V35, P585, DOI 10.1002/1096-911X(20001201)35:6<585::AID-MPO20>3.3.CO;2-G; RAMSAY G, 1986, MOL CELL BIOL, V6, P4450, DOI 10.1128/MCB.6.12.4450; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Weiss WA, 2000, CANCER RES, V60, P2483; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985	22	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51297	10.1371/journal.pone.0051297	http://dx.doi.org/10.1371/journal.pone.0051297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284678	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900019
J	Isaac, R; Boura-Halfon, S; Gurevitch, D; Shainskaya, A; Levkovitz, Y; Zick, Y				Isaac, Roi; Boura-Halfon, Sigalit; Gurevitch, Diana; Shainskaya, Alla; Levkovitz, Yechiel; Zick, Yehiel			Selective Serotonin Reuptake Inhibitors (SSRIs) Inhibit Insulin Secretion and Action in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; RECEPTOR SUBSTRATE 1; INDUCED APOPTOSIS; OXIDATIVE STRESS; ISLET CELLS; PHOSPHORYLATION; PROTEIN; ANTIDEPRESSANTS; KINASE; GLUCOSE	Selective serotonin reuptake inhibitors (SSRIs) are antidepressants used for the treatment of mood and anxiety disorders. Here, we demonstrate that incubation (2 h) of murine islets or Min6 beta cell line with the SSRIs paroxetine, fluoxetine, or sertraline inhibited insulin-induced Tyr phosphorylation of insulin receptor substrate (IRS)-2 protein and the activation of its downstream targets Akt and the ribosomal protein S6 kinase-1 (S6K1). Inhibition was dose-dependent with half-maximal effects at similar to 15-20 mu M. It correlated with a rapid dephosphorylation and activation of the IRS kinase GSK3 beta. Introduction of GSK3 beta siRNAs eliminated the inhibitory effects of the SSRIs. Inhibition of IRS-2 action by 30 mu M SSRI was associated with a marked inhibition of glucose-stimulated insulin secretion from murine and human pancreatic islets. Secretion induced by basic secretagogues (KCl and Arg) was not affected by these drugs. Prolonged treatment (16 h) of Min6 cells with sertraline resulted in the induction of inducible nitric oxide synthase; activation of endoplasmic reticulum stress, and the initiation of the unfolded protein response, manifested by enhanced transcription of ATF4 and C/EBP homologous protein. This triggered an apoptotic process, manifested by enhanced caspase 3/7 activity, which resulted in beta cell death. These findings implicate SSRIs as inhibitors of IRS protein function and insulin action through the activation of GSK3 beta. They further suggest that SSRIs inhibit insulin secretion; induce the unfolded protein response; activate an apoptotic process, and trigger beta cell death. Given that SSRIs promote insulin resistance while inhibiting insulin secretion, these drugs might accelerate the transition from an insulin-resistant state to overt diabetes.	[Isaac, Roi; Boura-Halfon, Sigalit; Gurevitch, Diana; Zick, Yehiel] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Shainskaya, Alla] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Isaac, Roi; Levkovitz, Yechiel] Tel Aviv Univ, Sackler Fac Med, Shalvata Mental Hlth Ctr, IL-6997801 Ramat Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine	Zick, Y (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	Yehiel.Zick@weizmann.ac.il	Zick, Yehiel/K-1479-2012		European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk program; Israel Science Foundation [759/09]; Mitchel Kaplan Fund	European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk program; Israel Science Foundation(Israel Science Foundation); Mitchel Kaplan Fund	This work was supported by research grants from the European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk program, The Israel Science Foundation (founded by the Israel Academy of Sciences and Humanities Grant 759/09), and the Mitchel Kaplan Fund.	ALTAMURA AC, 1994, CLIN PHARMACOKINET, V26, P201, DOI 10.2165/00003088-199426030-00004; Andersohn F, 2009, AM J PSYCHIAT, V166, P591, DOI 10.1176/appi.ajp.2008.08071065; Antoine MH, 2004, DIABETOLOGIA, V47, P909, DOI 10.1007/s00125-004-1384-9; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Beck A, 2011, DIABETOLOGIA, V54, P2845, DOI 10.1007/s00125-011-2277-3; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Boura-Halfon S, 2010, MOL ENDOCRINOL, V24, P2179, DOI 10.1210/me.2010-0072; Boura-Halfon S, 2009, VITAM HORM, V80, P313, DOI 10.1016/S0083-6729(08)00612-2; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Brown LC, 2008, DIABETES RES CLIN PR, V79, P61, DOI 10.1016/j.diabres.2007.07.009; Chou CT, 2007, TOXICOL APPL PHARM, V218, P265, DOI 10.1016/j.taap.2006.11.012; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; Fava M, 2000, J CLIN PSYCHIAT, V61, P863, DOI 10.4088/JCP.v61n1109; Fiory F, 2011, DIABETOLOGIA, V54, P2941, DOI 10.1007/s00125-011-2280-8; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; GarciaColunga J, 1997, P NATL ACAD SCI USA, V94, P2041, DOI 10.1073/pnas.94.5.2041; GRAM LF, 1994, NEW ENGL J MED, V331, P1354; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Himmerich H, 2004, J PSYCHIAT RES, V38, P485, DOI 10.1016/j.jpsychires.2004.02.002; Hiyama A, 2011, J CELL BIOCHEM, V112, P2974, DOI 10.1002/jcb.23217; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; HOWELL SL, 1984, DIABETOLOGIA, V26, P319; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322; Kellerer M, 1998, DIABETOLOGIA, V41, P833, DOI 10.1007/s001250050995; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Le Roith D, 2001, DIABETES CARE, V24, P588, DOI 10.2337/diacare.24.3.588; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Levkovitz Y, 2005, J MOL NEUROSCI, V27, P29, DOI 10.1385/JMN:27:1:029; Levkovitz Y, 2007, MOL CELL NEUROSCI, V36, P305, DOI 10.1016/j.mcn.2007.05.009; Liu YF, 2004, MOL CELL BIOL, V24, P9668, DOI 10.1128/MCB.24.21.9668-9681.2004; LUNDMARK J, 1989, ACTA PSYCHIAT SCAND, V80, P76, DOI 10.1111/j.1600-0447.1989.tb07177.x; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pancrazio JJ, 1998, J PHARMACOL EXP THER, V284, P208; Pariante CM, 2001, BRIT J PHARMACOL, V134, P1335, DOI 10.1038/sj.bjp.0704368; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; Preskorn SH, 1997, CLIN PHARMACOKINET, V32, P1, DOI 10.2165/00003088-199700321-00003; Raeder MB, 2006, J CLIN PSYCHIAT, V67, P1974, DOI 10.4088/JCP.v67n1219; Reaven G, 2005, CIRCULATION, V112, P3030, DOI 10.1161/CIRCULATIONAHA.105.504670; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SHARGILL NS, 1986, BIOCHEM BIOPH RES CO, V137, P286, DOI 10.1016/0006-291X(86)91208-8; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; STANTON T, 1993, BIOCHEM PHARMACOL, V45, P2352, DOI 10.1016/0006-2952(93)90211-E; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; Ungvari Z, 2000, J CARDIOVASC PHARM, V35, P849, DOI 10.1097/00005344-200006000-00004; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; YASUDA K, 1992, DIABETES, V41, P76, DOI 10.2337/diabetes.41.1.76; Yoshimura R, 2008, HUM PSYCHOPHARM CLIN, V23, P707, DOI 10.1002/hup.979	66	55	56	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5682	5693		10.1074/jbc.M112.408641	http://dx.doi.org/10.1074/jbc.M112.408641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23275337	Green Published, hybrid			2022-12-25	WOS:000315342500041
J	Moroz, NA; Novak, SM; Azevedo, R; Colpan, M; Uversky, VN; Gregorio, CC; Kostyukova, AS				Moroz, Natalia A.; Novak, Stefanie M.; Azevedo, Ricardo; Colpan, Mert; Uversky, Vladimir N.; Gregorio, Carol C.; Kostyukova, Alla S.			Alteration of Tropomyosin-binding Properties of Tropomodulin-1 Affects Its Capping Ability and Localization in Skeletal Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINUS; CIRCULAR-DICHROISM; STRIATED-MUSCLE; FILAMENT ARCHITECTURE; ACTIN POLYMERIZATION; ALPHA-TROPOMYOSIN; CARDIAC MYOCYTES; PROTEIN; MYOSIN; DYNAMICS	Tropomodulin (Tmod) is an actin-capping protein that binds to the two tropomyosins (TM) at the pointed end of the actin filament to prevent further actin polymerization and depolymerization. Therefore, understanding the role of Tmod is very important when studying actin filament dependent processes such as muscle contraction and intracellular transport. The capping ability of Tmod is highly influenced by TM and is 1000-fold greater in the presence of TM. There are four Tmod isoforms (Tmod1-4), three of which, Tmod1, Tmod3, and Tmod4, are expressed in skeletal muscles. The affinity of Tmod1 to skeletal striated TM (stTM) is higher than that of Tmod3 and Tmod4 to stTM. In this study, we tested mutations in the TM-binding sites of Tmod1, using circular dichroism (CD) and prediction analysis (PONDR). The mutations R11K, D12N, and Q144K were chosen because they decreased the affinity of Tmod1 to stTM, making it similar to that of affinity of Tmod3 and Tmod4 to stTM. Significant reduction of inhibition of actin pointed-end polymerization in the presence of stTM was shown for Tmod1 (R11K/D12N/Q144K) as compared with WT Tmod1. When GFP-Tmod1 and mutants were expressed in primary chicken skeletal myocytes, decreased assembly of Tmod1 mutants was revealed. This indicates a direct correlation between TM-binding and the actin-capping abilities of Tmod. Our data confirmed the hypothesis that assembly of Tmod at the pointed-end of the actin filament depends on its TM-binding affinity.	[Moroz, Natalia A.; Colpan, Mert; Kostyukova, Alla S.] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Novak, Stefanie M.; Gregorio, Carol C.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA; [Novak, Stefanie M.; Gregorio, Carol C.] Univ Arizona, Sarver Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Azevedo, Ricardo; Kostyukova, Alla S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia; [Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA	Washington State University; University of Arizona; University of Arizona; Rutgers State University New Brunswick; Rutgers State University Medical Center; Russian Academy of Sciences; State University System of Florida; University of South Florida	Kostyukova, AS (corresponding author), Washington State Univ, Voiland Sch Chem Engn & Bioengn, 118 Dana Hall,Spokane St, Pullman, WA 99164 USA.	alla.kostyukova@wsu.edu	Uversky, Vladimir N./F-4515-2011; Moroz, Natalia A/E-5287-2013	Uversky, Vladimir N./0000-0002-4037-5857; Moroz, Natalia A/0000-0001-5621-3898	National Institutes of Health [GM081688, HL083146, HL108625]; American Heart Association [11900038]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083146, R01HL081386, R01HL108625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM081688 (to A. S. K.) and HL083146 and HL108625 (to C. C. G.).; Supported by American Heart Association Grant 11900038.	Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FASMAN GD, 1989, TRENDS BIOCHEM SCI, V14, P295, DOI 10.1016/0968-0004(89)90068-6; Fischer RS, 2006, J BIOL CHEM, V281, P36454, DOI 10.1074/jbc.M606315200; Garner, 1999, Genome Inform Ser Workshop Genome Inform, V10, P41; GERHARD MD, 1985, J BIOL CHEM, V260, P3221; Gilbert R, 1996, J CELL SCI, V109, P101; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; Greenfield NJ, 1998, BIOCHEMISTRY-US, V37, P7834, DOI 10.1021/bi973167m; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Greenfield NJ, 2001, J MOL BIOL, V312, P833, DOI 10.1006/jmbi.2001.4982; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Greenfield Norma J, 2004, Methods Mol Biol, V261, P55; GREGORIO CC, 1995, NATURE, V377, P83, DOI 10.1038/377083a0; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Kostyukova A, 2000, EUR J BIOCHEM, V267, P6470, DOI 10.1046/j.1432-1327.2000.01738.x; Kostyukova AS, 2008, CELL MOL LIFE SCI, V65, P563, DOI 10.1007/s00018-007-7347-9; Kostyukova AS, 2007, J MOL BIOL, V372, P608, DOI 10.1016/j.jmb.2007.05.084; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2004, J BIOL CHEM, V279, P5066, DOI 10.1074/jbc.M311186200; Kostyukova AS, 2001, BIOPHYS J, V81, P345, DOI 10.1016/S0006-3495(01)75704-9; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Mudry RE, 2003, J CELL BIOL, V162, P1057, DOI 10.1083/jcb.200305031; NAWROTZKI R, 1995, J MUSCLE RES CELL M, V16, P45, DOI 10.1007/BF00125309; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Pappas CT, 2008, MOL BIOL CELL, V19, P1837, DOI 10.1091/mbc.E07-07-0690; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUNG LA, 1994, BIOCHEM BIOPH RES CO, V201, P627, DOI 10.1006/bbrc.1994.1747; Sussman MA, 1998, CIRC RES, V82, P94; Tsukada T, 2011, J BIOL CHEM, V286, P2194, DOI 10.1074/jbc.M110.186924; Uversky VN, 2011, J MOL RECOGNIT, V24, P647, DOI 10.1002/jmr.1093; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; Yamashiro S, 2010, J BIOL CHEM, V285, P33265, DOI 10.1074/jbc.M110.144873	41	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4899	4907		10.1074/jbc.M112.434522	http://dx.doi.org/10.1074/jbc.M112.434522			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23271735	hybrid, Green Published			2022-12-25	WOS:000315340400038
J	Chatterjee, D; Chaudhuri, K				Chatterjee, Debashree; Chaudhuri, Keya			Vibrio cholerae O395 Outer Membrane Vesicles Modulate Intestinal Epithelial Cells in a NOD1 Protein-dependent Manner and Induce Dendritic Cell-mediated Th2/Th17 Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; INFLAMMATORY MEDIATORS; PSEUDOMONAS-AERUGINOSA; ACTIVATION; INTERLEUKIN-17; IL-17; PEPTIDOGLYCAN; EXPRESSION; VIRULENCE	Like other Gram-negative pathogens, Vibrio cholerae, the causative agent of the diarrheal disease cholera, secretes outer membrane vesicles (OMVs). OMVs are complex entities composed of a subset of envelope lipid and protein components and play a role in the delivery of effector molecules to host cells. We previously showed that V. cholerae O395 cells secrete OMVs that are internalized by host cells, but their role in pathogenesis has not been well elucidated. In the present study, we evaluated the interaction of OMVs with intestinal epithelial cells. These vesicles induced expression of proinflammatory cytokines such as IL-8 and GM-CSF and chemokines such as CCL2, CCL20, and thymic stromal lymphopoietin in epithelial cells through activation of MAPK and NF-kappa B pathways in NOD1-dependent manner. Epithelial cells stimulated with OMVs activated dendritic cells (DCs) in a direct co-culture system. Activated DCs expressed high levels of co-stimulatory molecules; released inflammatory cytokines IL-1 beta, IL-6, TNF-alpha, and IL-23 and chemokines CCL22 and CCL17; and subsequently primed CD4(+) T cells leading to IL-4, IL-13, and IL-17 expression. These results suggest that V. cholerae O395 OMVs modulate the epithelial proinflammatory response and activate DCs, which promote T cell polarization toward an inflammatory Th2/Th17 response.	[Chatterjee, Debashree; Chaudhuri, Keya] Indian Inst Chem Biol, CSIR, Mol & Human Genet Div, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chaudhuri, K (corresponding author), Indian Inst Chem Biol, CSIR, Mol & Human Genet Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	keya.chaudhuri@gmail.com			Council of Scientific and Industrial Research (CSIR), Government of India; CSIR fellowship	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR fellowship(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by the Council of Scientific and Industrial Research (CSIR), Government of India.; Recipient of a CSIR fellowship.	Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Bandyopadhaya A, 2008, MICROB PATHOGENESIS, V44, P524, DOI 10.1016/j.micpath.2008.01.004; Bandyopadhaya A, 2007, INT J BIOCHEM CELL B, V39, P1863, DOI 10.1016/j.biocel.2007.05.005; Bandyopadhaya A, 2009, MOL IMMUNOL, V46, P1129, DOI 10.1016/j.molimm.2008.11.003; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Bettelli E, 2005, J EXP MED, V201, P169, DOI 10.1084/jem.20042279; Bhowmick S, 2012, INT J BIOCHEM CELL B, V44, P1779, DOI 10.1016/j.biocel.2012.06.030; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chatterjee D, 2011, FEBS LETT, V585, P1357, DOI 10.1016/j.febslet.2011.04.017; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gunn MD, 2003, SEMIN IMMUNOL, V15, P271, DOI 10.1016/j.smim.2003.08.004; Ismail S, 2003, INFECT IMMUN, V71, P5670, DOI 10.1128/IAI.71.10.5670-5675.2003; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kawaguchi M, 2004, J ALLERGY CLIN IMMUN, V114, P1265, DOI 10.1016/j.jaci.2004.10.019; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; Luzza F, 2000, J IMMUNOL, V165, P5332, DOI 10.4049/jimmunol.165.9.5332; Maeda S, 2001, J BIOL CHEM, V276, P44856, DOI 10.1074/jbc.M105381200; Matson JS, 2010, J BACTERIOL, V192, P2044, DOI 10.1128/JB.00023-10; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Naumann M, 2000, BIOCHEM PHARMACOL, V60, P1109, DOI 10.1016/S0006-2952(00)00390-7; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484; Qadri F, 2002, CLIN DIAGN LAB IMMUN, V9, P221, DOI 10.1128/CDLI.9.2.221-229.2002; Qadri F, 2004, GUT, V53, P62, DOI 10.1136/gut.53.1.62; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Sanchez J, 2005, CURR OPIN IMMUNOL, V17, P388, DOI 10.1016/j.coi.2005.06.007; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497	41	58	61	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4299	4309		10.1074/jbc.M112.408302	http://dx.doi.org/10.1074/jbc.M112.408302			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23275338	hybrid, Green Published			2022-12-25	WOS:000314845000058
J	Naito, M; Hirai, S; Mihara, M; Terayama, H; Hatayama, N; Hayashi, S; Matsushita, M; Itoh, M				Naito, Munekazu; Hirai, Shuichi; Mihara, Makoto; Terayama, Hayato; Hatayama, Naoyuki; Hayashi, Shogo; Matsushita, Masayuki; Itoh, Masahiro			Effect of a Magnetic Field on Drosophila under Supercooled Conditions	PLOS ONE			English	Article							PRESERVATION; CRYOPRESERVATION; EXPRESSION; EXPOSURE; LIVERS; CELLS	Under subzero degree conditions, free water contained in biological cells tends to freeze and then most living things die due to low temperatures. We examined the effect of a variable magnetic field on Drosophila under supercooled conditions (a state in which freezing is not caused even below the freezing point). Under such supercooled conditions with the magnetic field at 0 degrees C for 72 hours, -4 degrees C for 24 hours and -8 degrees C for 1 hour, the Drosophila all survived, while all conversely died under the supercooled conditions without the magnetic field. This result indicates a possibility that the magnetic field can reduce cell damage caused due to low temperatures in living things.	[Naito, Munekazu; Hirai, Shuichi; Terayama, Hayato; Hatayama, Naoyuki; Itoh, Masahiro] Tokyo Med Univ, Dept Anat, Tokyo, Japan; [Mihara, Makoto] Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Hayashi, Shogo] Aichi Med Univ, Med Educ Ctr, Sch Med, Aichi, Japan; [Matsushita, Masayuki] Univ Ryukyus, Nishihara, Okinawa 90301, Japan	Tokyo Medical University; University of Tokyo; Aichi Medical University; University of the Ryukyus	Hirai, S (corresponding author), Tokyo Med Univ, Dept Anat, Tokyo, Japan.	shinamon611@gmail.com	Hayashi, Shogo/K-7268-2015; HIRAI, SHUICHI/AAQ-6081-2020	Hayashi, Shogo/0000-0003-0302-7658; 	Ministry of Education, Science, Sports, and Culture, Japan	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for General Science Research from the Ministry of Education, Science, Sports, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSETT CAL, 1981, J BONE JOINT SURG AM, V63, P511, DOI 10.2106/00004623-198163040-00001; Belova N. A., 2010, Biofizika, V55, P657; Boyer BB, 1999, BIOSCIENCE, V49, P713, DOI 10.2307/1313595; Cho MH, 2012, NAT MAT IN PRESS; Delhaye C, 2012, J AM COLL CARDIOL, V59, P197, DOI 10.1016/j.jacc.2011.06.077; Feeney R E, 1978, Adv Protein Chem, V32, P191, DOI 10.1016/S0065-3233(08)60576-8; Gavish Z, 2008, REJUV RES, V11, P765, DOI 10.1089/rej.2008.0706; Iwasaka M, 2010, J APPL PHYS, V107, DOI 10.1063/1.3357348; Kostal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025025; McCann J, 1998, MUTAT RES-REV MUTAT, V411, P45, DOI 10.1016/S1383-5742(98)00006-4; Mevissen M, 1998, J TOXICOL ENV HEAL A, V53, P401; Monzen K, 2005, BIOCHEM BIOPH RES CO, V337, P534, DOI 10.1016/j.bbrc.2005.09.082; Nakagawa T, 2012, ACSC IN PRESS; OHTSU S, 1995, BIOCHEM BIOPH RES CO, V212, P104, DOI 10.1006/bbrc.1995.1942; Okamoto T, 2008, J HEART LUNG TRANSPL, V27, P1150, DOI 10.1016/j.healun.2008.07.008; Oshibuchi H, 1975, NIPPON GEKA GAKKAI Z, V76, P432; Silber SJ, 2012, MOL HUM REPROD, V18, P59, DOI 10.1093/molehr/gar082; Sputtek Andreas, 2007, Methods Mol Biol, V368, P283; Strachan LA, 2011, PHYSIOL BIOCHEM ZOOL, V84, P43, DOI 10.1086/657147; Takahashi T, 2001, TRANSPL P, V33, P916, DOI 10.1016/S0041-1345(00)02268-5; Valavanidis A, 2005, REDOX REP, V10, P37, DOI 10.1179/135100005X21606; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; Woods EJ, 2004, CRYOBIOLOGY, V48, P146, DOI 10.1016/j.cryobiol.2004.03.002; [No title captured]	24	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51902	10.1371/journal.pone.0051902	http://dx.doi.org/10.1371/journal.pone.0051902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284809	Green Submitted, gold, Green Published			2022-12-25	WOS:000313051500017
J	Murugan, S; Hung, HC				Murugan, Sujithkumar; Hung, Hui-Chih			Biophysical Characterization of the Dimer and Tetramer Interface Interactions of the Human Cytosolic Malic Enzyme	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; OXIDATIVE DECARBOXYLASES; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; TUMOR-CELLS; OBESE MICE; LIVER; PURIFICATION; EXPRESSION; IDENTIFICATION	The cytosolic NADP(+)-dependent malic enzyme (c-NADP-ME) has a dimer-dimer quaternary structure in which the dimer interface associates more tightly than the tetramer interface. In this study, the urea-induced unfolding process of the c-NADP-ME interface mutants was monitored using fluorescence and circular dichroism spectroscopy, analytical ultracentrifugation and enzyme activities. Here, we demonstrate the differential protein stability between dimer and tetramer interface interactions of human c-NADP-ME. Our data clearly demonstrate that the protein stability of c-NADP-ME is affected predominantly by disruptions at the dimer interface rather than at the tetramer interface. First, during thermal stability experiments, the melting temperatures of the wild-type and tetramer interface mutants are 8-10 degrees C higher than those of the dimer interface mutants. Second, during urea denaturation experiments, the thermodynamic parameters of the wild-type and tetramer interface mutants are almost identical. However, for the dimer interface mutants, the first transition of the urea unfolding curves shift towards a lower urea concentration, and the unfolding intermediate exist at a lower urea concentration. Third, for tetrameric WT c-NADP-ME, the enzyme is first dissociated from a tetramer to dimers before the 2 M urea treatment, and the dimers then dissociated into monomers before the 2.5 M urea treatment. With a dimeric tetramer interface mutant (H142A/D568A), the dimer completely dissociated into monomers after a 2.5 M urea treatment, while for a dimeric dimer interface mutant (H51A/D90A), the dimer completely dissociated into monomers after a 1.5 M urea treatment, indicating that the interactions of c-NADP-ME at the dimer interface are truly stronger than at the tetramer interface. Thus, this study provides a reasonable explanation for why malic enzymes need to assemble as a dimer of dimers.	[Murugan, Sujithkumar; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Hung, HC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/L-8061-2019; Hung, Hui-Chih/G-4485-2013	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council, Republic of China [NSC-101-2311-B-005-005-MY3]; Ministry of Education, Taiwan, Republic of China	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This work was supported by the National Science Council, Republic of China (NSC-101-2311-B-005-005-MY3 to H-CH) and in part by the Ministry of Education, Taiwan, Republic of China under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYALA A, 1986, FEBS LETT, V202, P102, DOI 10.1016/0014-5793(86)80657-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG GG, 1991, EUR J BIOCHEM, V202, P681, DOI 10.1111/j.1432-1033.1991.tb16423.x; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Cohen P T, 1972, Biochem Genet, V7, P303, DOI 10.1007/BF00484830; Coleman DE, 2002, BIOCHEMISTRY-US, V41, P6928, DOI 10.1021/bi0255120; CROZIER G, 1987, METABOLISM, V36, P807, DOI 10.1016/0026-0495(87)90122-3; Edens WA, 1997, BIOCHEMISTRY-US, V36, P1141, DOI 10.1021/bi962128s; FITCH WM, 1960, J BIOL CHEM, V235, P554; Frenkel R, 1975, Curr Top Cell Regul, V9, P157; Hsieh JY, 2009, J BIOL CHEM, V284, P18096, DOI 10.1074/jbc.M109.005082; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; HUUPPONEN R, 1989, DIABETES RES CLIN EX, V10, P143; KAM PL, 1988, MOL CELL BIOCHEM, V79, P171, DOI 10.1007/BF02424560; LOEBER G, 1994, BIOCHEM J, V304, P687, DOI 10.1042/bj3040687; LOEBER G, 1994, FEBS LETT, V344, P181, DOI 10.1016/0014-5793(94)00386-6; Pace C N, 1986, Methods Enzymol, V131, P266; POVEY S, 1975, ANN HUM GENET, V39, P203, DOI 10.1111/j.1469-1809.1975.tb00123.x; Rao GSJ, 2003, J BIOL CHEM, V278, P38051, DOI 10.1074/jbc.M305145200; Sanz N, 1997, BRIT J CANCER, V75, P487, DOI 10.1038/bjc.1997.85; SAUER LA, 1980, J BIOL CHEM, V255, P3844; SAUER LA, 1978, CANCER RES, V38, P1751; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Tao X, 2003, STRUCTURE, V11, P1141, DOI 10.1016/S0969-2126(03)00168-0; van Schothorst EM, 2006, OBESITY, V14, P974, DOI 10.1038/oby.2006.111; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Xu YW, 1999, STRUCT FOLD DES, V7, P877, DOI 10.1016/S0969-2126(99)80115-4; Yang ZR, 2000, NAT STRUCT BIOL, V7, P251; Yang ZR, 2002, PROTEIN SCI, V11, P332, DOI 10.1110/ps.38002; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8; YEN TT, 1976, HORM METAB RES, V8, P159, DOI 10.1055/s-0028-1093672; ZELEWSKI M, 1991, EUR J BIOCHEM, V201, P339, DOI 10.1111/j.1432-1033.1991.tb16291.x; Zhang YJ, 2006, BIOORG MED CHEM LETT, V16, P525, DOI 10.1016/j.bmcl.2005.10.065	34	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e50143	10.1371/journal.pone.0050143	http://dx.doi.org/10.1371/journal.pone.0050143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284632	Green Submitted, gold, Green Published			2022-12-25	WOS:000313158800003
J	Qiao, M; Jindrich, DL				Qiao, Mu; Jindrich, Devin L.			Task-Level Strategies for Human Sagittal-Plane Running Maneuvers Are Consistent with Robotic Control Policies	PLOS ONE			English	Article							DYNAMIC STABILITY; ROUGH TERRAIN; LEG STIFFNESS; LOCOMOTION; MUSCLE; TEMPLATES; MECHANICS; BALANCE; WALKING; ANCHORS	The strategies that humans use to control unsteady locomotion are not well understood. A "spring-mass" template comprised of a point mass bouncing on a sprung leg can approximate both center of mass movements and ground reaction forces during running in humans and other animals. Legged robots that operate as bouncing, "spring-mass" systems can maintain stable motion using relatively simple, distributed feedback rules. We tested whether the changes to sagittal-plane movements during five running tasks involving active changes to running height, speed, and orientation were consistent with the rules used by bouncing robots to maintain stability. Changes to running height were associated with changes to leg force but not stance duration. To change speed, humans primarily used a "pogo stick" strategy, where speed changes were associated with adjustments to fore-aft foot placement, and not a "unicycle" strategy involving systematic changes to stance leg hip moment. However, hip moments were related to changes to body orientation and angular speed. Hip moments could be described with first order proportional-derivative relationship to trunk pitch. Overall, the task-level strategies used for body control in humans were consistent with the strategies employed by bouncing robots. Identification of these behavioral strategies could lead to a better understanding of the sensorimotor mechanisms that allow for effective unsteady locomotion.	[Jindrich, Devin L.] Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92078 USA; [Qiao, Mu] Arizona State Univ, Kinesiol Program, Sch Nutr & Hlth Promot, Tempe, AZ USA	California State University System; California State University San Marcos; Arizona State University; Arizona State University-Tempe	Jindrich, DL (corresponding author), Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92078 USA.	djindrich@csusm.edu	Qiao, Mu/H-6877-2019	Qiao, Mu/0000-0002-7110-4830	Kinesiology Department, Arizona State University	Kinesiology Department, Arizona State University	This study was supported by the 2008 Douglas L. Conley Memorial Scholarship, Kinesiology Department, Arizona State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah ME, 2009, ROBOTICA, V27, P789, DOI 10.1017/S0263574708005134; ALEXANDER RM, 1991, J EXP BIOL, V160, P55; Biewener AA, 2007, J EXP BIOL, V210, P2949, DOI 10.1242/jeb.005801; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Blickhan R, 2007, PHILOS T R SOC A, V365, P199, DOI 10.1098/rsta.2006.1911; Bullimore SR, 2008, J THEOR BIOL, V250, P339, DOI 10.1016/j.jtbi.2007.09.038; Cavagna GA, 2009, P R SOC B, V276, P4279, DOI 10.1098/rspb.2009.1317; Cham JG, 2007, J DYN SYST-T ASME, V129, P275, DOI 10.1115/1.2718237; Cowan NJ, 2006, J EXP BIOL, V209, P1617, DOI 10.1242/jeb.02166; Daley MA, 2007, J EXP BIOL, V210, P383, DOI 10.1242/jeb.02668; Daley MA, 2006, J EXP BIOL, V209, P171, DOI 10.1242/jeb.01986; Daley MA, 2006, P NATL ACAD SCI USA, V103, P15681, DOI 10.1073/pnas.0601473103; DIETZ V, 1987, J PHYSIOL-LONDON, V386, P149, DOI 10.1113/jphysiol.1987.sp016527; Edgerton VR, 2009, EXERC SPORT SCI REV, V37, P171, DOI 10.1097/JES.0b013e3181b7b932; FARLEY CT, 1993, J EXP BIOL, V185, P71; Ferris DP, 1998, P ROY SOC B-BIOL SCI, V265, P989, DOI 10.1098/rspb.1998.0388; Full RJ, 2002, INTEGR COMP BIOL, V42, P149, DOI 10.1093/icb/42.1.149; Full RJ, 1999, J EXP BIOL, V202, P3325; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Grimmer S, 2008, J EXP BIOL, V211, P2989, DOI 10.1242/jeb.014357; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Hasan Z, 2005, J MOTOR BEHAV, V37, P484, DOI 10.3200/JMBR.37.6.484-493; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Huston RL, 1982, HUMAN BODY DYNAMICS, P203; Jindrich DL, 2009, CHAOS, V19, DOI 10.1063/1.3143031; Jindrich DL, 2002, J EXP BIOL, V205, P2803; Jindrich DL, 2006, J BIOMECH, V39, P1611, DOI 10.1016/j.jbiomech.2005.05.007; Keppel G, 2004, DESIGN ANAL RES HDB, P401; Khatib O, 2009, J PHYSIOL-PARIS, V103, P211, DOI 10.1016/j.jphysparis.2009.08.004; Kuo AD, 2010, PHYS THER, V90, P157, DOI 10.2522/ptj.20090125; Latash M.L., 2008, NEUROPHYSIOLOGICAL B, V3rd ed.; Lee J, 2008, IEEE T ROBOT, V24, P130, DOI 10.1109/TRO.2007.913981; McGowan CP, 2005, J EXP BIOL, V208, P2741, DOI 10.1242/jeb.01702; McGowan CP, 2012, J R SOC INTERFACE, V9, P1975, DOI 10.1098/rsif.2011.0877; Millard M, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000193; Muller R, 2010, HUM MOVEMENT SCI, V29, P578, DOI 10.1016/j.humov.2010.04.007; Pratt J., 2006, CAPTURE POINT STEP H, P200; RACK PMH, 1974, J PHYSIOL-LONDON, V240, P331, DOI 10.1113/jphysiol.1974.sp010613; Raibert MH., 1986, IEEE INTELL SYST APP, DOI [10.1109/MEX.1986.4307016, DOI 10.1109/MEX.1986.4307016]; Reisman DS, 2010, PHYS THER, V90, P187, DOI 10.2522/ptj.20090073; Ringrose R, 1997, IEEE INT CONF ROBOT, P487, DOI 10.1109/ROBOT.1997.620084; Ristroph L, 2010, P NATL ACAD SCI USA, V107, P4820, DOI 10.1073/pnas.1000615107; Roberts TJ, 2005, J EXP BIOL, V208, P1963, DOI 10.1242/jeb.01555; Rummel J, 2008, INT J ROBOT RES, V27, P919, DOI 10.1177/0278364908095136; Seyfarth A, 1999, J BIOMECH, V32, P1259, DOI 10.1016/S0021-9290(99)00137-2; Seyfarth A, 2003, J EXP BIOL, V206, P2547, DOI 10.1242/jeb.00463; Tresch MC, 2009, CURR OPIN NEUROBIOL, V19, P601, DOI 10.1016/j.conb.2009.09.002; Williams GN, 2001, J ORTHOP SPORT PHYS, V31, P546, DOI 10.2519/jospt.2001.31.10.546; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9	49	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51888	10.1371/journal.pone.0051888	http://dx.doi.org/10.1371/journal.pone.0051888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284804	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500062
J	Bedrosian, B; Craighead, D; Crandall, R				Bedrosian, Bryan; Craighead, Derek; Crandall, Ross			Lead Exposure in Bald Eagles from Big Game Hunting, the Continental Implications and Successful Mitigation Efforts	PLOS ONE			English	Article							CALIFORNIA CONDORS; AMMUNITION; GOLDEN; PERFORMANCE; HAZARDS	Studies suggest hunter discarded viscera of big game animals (i.e., offal) is a source of lead available to scavengers. We investigated the incidence of lead exposure in bald eagles in Wyoming during the big game hunting season, the influx of eagles into our study area during the hunt, the geographic origins of eagles exposed to lead, and the efficacy of using non-lead rifle ammunition to reduce lead in eagles. We tested 81 blood samples from bald eagles before, during and after the big game hunting seasons in 2005-2010, excluding 2008, and found eagles had significantly higher lead levels during the hunt. We found 24% of eagles tested had levels indicating at least clinical exposure (. 60 ug/dL) during the hunt while no birds did during the non-hunting seasons. We performed driving surveys from 2009-2010 to measure eagle abundance and found evidence to suggest that eagles are attracted to the study area during the hunt. We fitted 10 eagles with satellite transmitters captured during the hunt and all migrated south after the cessation of the hunt. One returned to our study area while the remaining nine traveled north to summer/breed in Canada. The following fall, 80% returned to our study area for the hunting season, indicating that offal provides a seasonal attractant for eagles. We fitted three local breeding eagles with satellite transmitters and none left their breeding territories to feed on offal during the hunt, indicating that lead ingestion may be affecting migrants to a greater degree. During the 2009 and 2010 hunting seasons we provided non-lead rifle ammunition to local hunters and recorded that 24% and 31% of successful hunters used non-lead ammunition, respectively. We found the use of non-lead ammunition significantly reduced lead exposure in eagles, suggesting this is a viable solution to reduce lead exposure in eagles.	[Bedrosian, Bryan; Craighead, Derek; Crandall, Ross] Craighead Beringia S, Kelly, WY USA		Bedrosian, B (corresponding author), Craighead Beringia S, Kelly, WY USA.	bryan@beringiasouth.org			1% for the Tetons; Engelhard Foundation; Community Foundation of Jackson Hole; Hewlett Foundation; Peregrine Fund; Packard Foundation	1% for the Tetons; Engelhard Foundation; Community Foundation of Jackson Hole; Hewlett Foundation; Peregrine Fund; Packard Foundation(The David & Lucile Packard Foundation)	Funding was provided by 1% for the Tetons, Engelhard Foundation, Community Foundation of Jackson Hole, the Hewlett Foundation, the Peregrine Fund, the Packard Foundation, R. and L. Haberfeld, Y. and M. Chouinard, A. and B. Hirschfield, H. Luther, G. Ordway, and P. Van Roijen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedrosian Bryan, 2007, Northwestern Naturalist, V88, P1, DOI 10.1898/1051-1733(2007)88[1:EOTFAT]2.0.CO;2; BORTOLOTTI GR, 1984, J FIELD ORNITHOL, V55, P54; Britten MW, 1999, J WILDLIFE MANAGE, V63, P1349, DOI 10.2307/3802854; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cade TJ, 2007, J WILDLIFE MANAGE, V71, P2125, DOI 10.2193/2007-084; CAIN S L, 1989, Journal of Raptor Research, V23, P10; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; CRAIG TH, 1990, WILSON BULL, V102, P130; Craighead D, 2008, P ING SPENT AMM IMPL, P202; Craighead D, 2008, J WILDLIFE MANAGE, V72, P240, DOI 10.2193/2007-120; Cruz-Martinez Luis, 2012, Human-Wildlife Interactions, V6, P94; Fisher IJ, 2006, BIOL CONSERV, V131, P421, DOI 10.1016/j.biocon.2006.02.018; Fry D.M., 2003, ASSESSMENT LEAD CONT; Fuller M.R., 1981, Studies in Avian Biology, P235; Grantham J, 2010, SO CENTRAL CAL UNPUB; Green RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004022; Harmata A. R., 1995, INTERMT J SCI, V1, P1; Harmata AR, 2011, J RAPTOR RES, V45, P119, DOI 10.3356/JRR-10-37.1; Harmata AR, 1992, BALD EAGLES GREATER; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017656; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015350; Knopper LD, 2006, J WILDLIFE MANAGE, V70, P295, DOI 10.2193/0022-541X(2006)70[295:COSRGS]2.0.CO;2; Kramer JL, 1997, J RAPTOR RES, V31, P327; Krone O., 2009, INGESTION LEAD SPENT; Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015; Longmire JL, 1988, GENOMICS, V2, P14, DOI 10.1016/0888-7543(88)90104-8; MCCOLLOUGH MA, 1989, WILSON BULL, V101, P1; Miller MJR, 1998, J WILDLIFE DIS, V34, P704, DOI 10.7589/0090-3558-34.4.704; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; Pain DJ, 1997, BIOL CONSERV, V81, P1, DOI 10.1016/S0006-3207(96)00132-2; Parish Christopher N., 2009, P259, DOI 10.4080/ilsa.2009.0217; Parish CN, 2007, CALIFORNIA CONDORS 2; PATTEE OH, 1990, CONDOR, V92, P931, DOI 10.2307/1368729; Pauli JN, 2007, J WILDLIFE MANAGE, V71, P103, DOI 10.2193/2005-620; RABINOWITZ MB, 1991, ENVIRON HEALTH PERSP, V91, P33, DOI 10.2307/3430979; Redig P, 2008, P ING SPENT AMM IMPL, P208; Redig PT, 1984, INVESTIGATION EFFECT; Seng PT, 2006, NONLEAD AMMUNITION P; Smith B., 2004, IMPERFECT PASTURE CE; Stauber E, 2010, J AVIAN MED SURG, V24, P279, DOI 10.1647/2009-006.1; Tranel Molly A., 2009, P318, DOI 10.4080/ilsa.2009.0307; Wayland M, 2003, J RAPTOR RES, V37, P8; Weisskopf MG, 2007, EPIDEMIOLOGY, V18, P59, DOI 10.1097/01.ede.0000248237.35363.29	45	46	46	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51978	10.1371/journal.pone.0051978	http://dx.doi.org/10.1371/journal.pone.0051978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284837	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300067
J	Bowers, JE; Nambeesan, S; Corbi, J; Barker, MS; Rieseberg, LH; Knapp, SJ; Burke, JM				Bowers, John E.; Nambeesan, Savithri; Corbi, Jonathan; Barker, Michael S.; Rieseberg, Loren H.; Knapp, Steven J.; Burke, John M.			Development of an Ultra-Dense Genetic Map of the Sunflower Genome Based on Single-Feature Polymorphisms	PLOS ONE			English	Article							CULTIVATED SUNFLOWER; RFLP MAP; IDENTIFICATION	The development of ultra-dense genetic maps has the potential to facilitate detailed comparative genomic analyses and whole genome sequence assemblies. Here we describe the use of a custom Affymetrix GeneChip containing nearly 2.4 million features (25 bp sequences) targeting 86,023 unigenes from sunflower (Helianthus annuus L.) and related species to test for single-feature polymorphisms (SFPs) in a recombinant inbred line (RIL) mapping population derived from a cross between confectionery and oilseed sunflower lines (RHA280xRHA801). We then employed an existing genetic map derived from this same population to rigorously filter out low quality data and place 67,486 features corresponding to 22,481 unigenes on the sunflower genetic map. The resulting map contains a substantial fraction of all sunflower genes and will thus facilitate a number of downstream applications, including genome assembly and the identification of candidate genes underlying QTL or traits of interest.	[Bowers, John E.; Nambeesan, Savithri; Corbi, Jonathan; Burke, John M.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Barker, Michael S.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Rieseberg, Loren H.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Rieseberg, Loren H.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Knapp, Steven J.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University of Arizona; University of British Columbia; Indiana University System; Indiana University Bloomington; University System of Georgia; University of Georgia	Burke, JM (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	jmburke@uga.edu	Burke, John M/A-3502-2013; Bowers, John/B-9245-2009; Barker, Mike/AAE-7891-2019; Bowers, John/AAD-7601-2019; Rieseberg, Loren H/B-3591-2013	Burke, John M/0000-0002-1412-5539; Bowers, John/0000-0001-8984-9796; Barker, Mike/0000-0001-7173-1319; Rieseberg, Loren H/0000-0002-2712-2417; Bowers, John/0000-0001-5693-2796	National Science Foundation Plant Genome Research Program [DBI-0820451]; Genome Canada; Genome British Columbia; INRA; Syngenta; Biogemma; Georgia Research Alliance	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Genome Canada(Genome Canada); Genome British Columbia; INRA; Syngenta(Syngenta); Biogemma; Georgia Research Alliance	This work was supported by funding from the National Science Foundation Plant Genome Research Program (DBI-0820451), Genome Canada, Genome British Columbia, INRA, Syngenta, Biogemma, and the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Barker MS, 2008, MOL BIOL EVOL, V25, P2445, DOI 10.1093/molbev/msn187; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bowers JE, 2012, G3-GENES GENOM GENET, V2, P721, DOI 10.1534/g3.112.002659; Burke JM, 2002, GENETICS, V161, P1257; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; FICK GN, 1974, CROP SCI, V14, P912, DOI 10.2135/cropsci1974.0011183X001400060061x; GARDINER JM, 1993, GENETICS, V134, P917; GENTZBITTEL L, 1995, THEOR APPL GENET, V90, P1079, DOI 10.1007/BF00222925; Lai Z, 2005, THEOR APPL GENET, V111, P1532, DOI 10.1007/s00122-005-0082-4; Mester D, 2003, GENETICS, V165, P2269; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Roath WW, 1981, CROP SCI, V21, P1; Tang S, 2002, THEOR APPL GENET, V105, P1124, DOI 10.1007/s00122-002-0989-y; Tang SX, 2006, CROP SCI, V46, P721, DOI 10.2135/cropsci2005.0006-7; Yu JK, 2003, CROP SCI, V43, P367, DOI 10.2135/cropsci2003.0367	17	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51360	10.1371/journal.pone.0051360	http://dx.doi.org/10.1371/journal.pone.0051360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284684	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300020
J	Ha, N; Polychronidou, M; Lohmann, I				Ha, Nati; Polychronidou, Maria; Lohmann, Ingrid			COPS: Detecting Co-Occurrence and Spatial Arrangement of Transcription Factor Binding Motifs in Genome-Wide Datasets	PLOS ONE			English	Article							REGULATORY CODE; DROSOPHILA; ENHANCERS; DORSAL; ORGANIZATION; SPECIFICITY; TWIST; INTEGRATION; NETWORKS; CLUSTERS	In multi-cellular organisms, spatiotemporal activity of cis-regulatory DNA elements depends on their occupancy by different transcription factors (TFs). In recent years, genome-wide ChIP-on-Chip, ChIP-Seq and DamID assays have been extensively used to unravel the combinatorial interaction of TFs with cis-regulatory modules (CRMs) in the genome. Even though genome-wide binding profiles are increasingly becoming available for different TFs, single TF binding profiles are in most cases not sufficient for dissecting complex regulatory networks. Thus, potent computational tools detecting statistically significant and biologically relevant TF-motif co-occurrences in genome-wide datasets are essential for analyzing context-dependent transcriptional regulation. We have developed COPS (Co-Occurrence Pattern Search), a new bioinformatics tool based on a combination of association rules and Markov chain models, which detects co-occurring TF binding sites (BSs) on genomic regions of interest. COPS scans DNA sequences for frequent motif patterns using a Frequent-Pattern tree based data mining approach, which allows efficient performance of the software with respect to both data structure and implementation speed, in particular when mining large datasets. Since transcriptional gene regulation very often relies on the formation of regulatory protein complexes mediated by closely adjoining TF binding sites on CRMs, COPS additionally detects preferred short distance between co-occurring TF motifs. The performance of our software with respect to biological significance was evaluated using three published datasets containing genomic regions that are independently bound by several TFs involved in a defined biological process. In sum, COPS is a fast, efficient and user-friendly tool mining statistically and biologically significant TFBS co-occurrences and therefore allows the identification of TFs that combinatorially regulate gene expression.	[Ha, Nati; Polychronidou, Maria; Lohmann, Ingrid] Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, Heidelberg & CellNetworks Cluster Excellence Germ, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Lohmann, I (corresponding author), Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, Heidelberg & CellNetworks Cluster Excellence Germ, Heidelberg, Germany.	ilohmann@flydev.org			Cluster of Excellence "Cellular Networks''	Cluster of Excellence "Cellular Networks''	Funding for this project provided by Cluster of Excellence "Cellular Networks''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1994, P 20 INT C VER LARG, P487; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arnone MI, 1997, DEVELOPMENT, V124, P1851; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Down TA, 2007, PLOS COMPUT BIOL, V3, P95, DOI 10.1371/journal.pcbi.0030007; Fakhouri WD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.97; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Ghazi A, 2000, NATURE, V408, P419, DOI 10.1038/35044174; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Han JW, 2007, DATA MIN KNOWL DISC, V15, P55, DOI 10.1007/s10618-006-0059-1; Han JW, 2000, SIGMOD RECORD, V29, P1; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jakobsen JS, 2007, GENE DEV, V21, P2448, DOI 10.1101/gad.437607; JUANG BH, 1985, IEEE T ACOUST SPEECH, V33, P1404, DOI 10.1109/TASSP.1985.1164727; Kolesov G, 2007, P NATL ACAD SCI USA, V104, P13948, DOI 10.1073/pnas.0700672104; Kulakovskiy I. V., 2011, Biophysics, V56, P114, DOI 10.1134/S0006350911010155; Kulakovskiy IV, 2011, BIOINFORMATICS, V27, P2621, DOI 10.1093/bioinformatics/btr453; Makeev VJ, 2003, NUCLEIC ACIDS RES, V31, P6016, DOI 10.1093/nar/gkg799; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Papatsenko D, 2009, NUCLEIC ACIDS RES, V37, P5665, DOI 10.1093/nar/gkp619; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Sandve GK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-527; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309; Stathopoulos A, 2002, DEVELOPMENT, V129, P3411; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; Sun H, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks237; Sun H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S30; SZYMANSKI P, 1995, EMBO J, V14, P2229, DOI 10.1002/j.1460-2075.1995.tb07217.x; Touzet H, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-15; Van Loo P, 2009, BRIEF BIOINFORM, V10, P509, DOI 10.1093/bib/bbp025; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	46	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52055	10.1371/journal.pone.0052055	http://dx.doi.org/10.1371/journal.pone.0052055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272209	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300055
J	Lipina, TV; Haque, FN; McGirr, A; Boutros, PC; Berger, T; Mak, TW; Roder, JC; Wong, AHC				Lipina, Tatiana V.; Haque, Fahmida Nipa; McGirr, Alexander; Boutros, Paul C.; Berger, Thorsten; Mak, Tak W.; Roder, John C.; Wong, Albert H. C.			Prophylactic Valproic Acid Treatment Prevents Schizophrenia-Related Behaviour in Disc1-L100P Mutant Mice	PLOS ONE			English	Article							PREPULSE INHIBITION; HISTONE DEACETYLASE; LATENT INHIBITION; MOOD STABILIZERS; INBRED STRAINS; LIPOCALIN 2; DISC1; ADULT; DISRUPTION; PROTEIN	Background: Schizophrenia is a neurodevelopmental disorder with onset early in adulthood. Disrupted-In-Schizophrenia-1 (DISC1) is a susceptibility gene for schizophrenia and other psychiatric disorders. Disc1-L100P mutant mice show behaviors relevant to schizophrenia at 12 weeks, but not at 8 weeks of age, and may be useful for investigating the onset of schizophrenia in early adulthood. Methods: We investigated whether early valproic acid treatment would prevent behavioral, cellular and gene expression abnormalities in Disc1-L100P mutants. Results: Valproic acid prevented hyperactivity and deficits in prepulse inhibition and latent inhibition in Disc1-L100P mice. Genome-wide transcription profiling identified Lcn2 (lipocalin2) transcripts as being elevated by the Disc1 mutation and corrected by valproate. Disc1-L100P mice also had increased glial cell numbers in the subventricular zone, which was normalized by valproate. Genetic deletion of Lcn2 normalized glial cell numbers and behavior in Disc1-L100P mutants. Conclusions: Pharmacological treatments are a feasible way of preventing abnormal behaviour in a genetic model of schizophrenia. Lcn2 is a potential novel drug target for early intervention in schizophrenia.	[Haque, Fahmida Nipa; Wong, Albert H. C.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Lipina, Tatiana V.; McGirr, Alexander; Roder, John C.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Berger, Thorsten; Mak, Tak W.] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, UHN, Toronto, ON M4X 1K9, Canada; [Roder, John C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Roder, John C.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; [Wong, Albert H. C.] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Wong, AHC (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON, Canada.	albert.wong@utoronto.ca	Lipina, Tatiana/G-9148-2014; Berger, Thorsten/J-7632-2012; Roder, John/G-6468-2013	McGirr, Alexander/0000-0002-8425-3958; Boutros, Paul/0000-0003-0553-7520; Wong, Albert/0000-0002-9753-3182	Canadian Institutes for Health Research (CIHR) [GMH79044]; NARSAD; OMHF Mid-career Investigator Fellowship	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NARSAD(NARSAD); OMHF Mid-career Investigator Fellowship	The study was supported by a Canadian Institutes for Health Research (CIHR) operating grant GMH79044 and a CIHR Clinician-Scientist Fellowship to AHCW, who also holds a NARSAD Independent Investigator Award and an OMHF Mid-career Investigator Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Ayhan Y, 2011, MOL PSYCHIATR, V16, P293, DOI 10.1038/mp.2009.144; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Bolton MM, 2009, CURR OPIN NEUROBIOL, V19, P491, DOI 10.1016/j.conb.2009.09.007; Boutros PC, 2005, BRIEFINGS B IN PRESS, V6; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Broome MR, 2005, SCHIZOPHR RES, V79, P23, DOI 10.1016/j.schres.2005.02.007; Brown SM, 2012, MOL PSYCHIATR, V17, P469, DOI 10.1038/mp.2011.27; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Cairns JM, 2008, BIOINFORMATICS, V24, P2921, DOI 10.1093/bioinformatics/btn557; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chateauvieux S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/479364; Choi J, 2011, J NEUROL SCI, V305, P28, DOI 10.1016/j.jns.2011.03.023; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Delcourt N, 2005, MOL CELL PROTEOMICS, V4, P1085, DOI 10.1074/mcp.M500040-MCP200; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Edwards D, 2003, BIOINFORMATICS, V19, P825, DOI 10.1093/bioinformatics/btg083; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Flood DG, 2009, PSYCHOPHARMACOLOGY, V205, P369, DOI 10.1007/s00213-009-1547-y; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kirkbride JB, 2011, SCHIZOPHRENIA BULL, V37, P262, DOI 10.1093/schbul/sbq120; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Lawrie SM, 2008, SCHIZOPHRENIA BULL, V34, P330, DOI 10.1093/schbul/sbm158; Lee FHF, 2011, J NEUROSCI, V31, P3197, DOI 10.1523/JNEUROSCI.4219-10.2011; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lin SM, 2008, NUCLEIC ACIDS RES, V11, P36; Lipina TV, 2010, GENES BRAIN BEHAV, V9, P777, DOI 10.1111/j.1601-183X.2010.00615.x; Lipina TV, 2011, SYNAPSE, V65, P234, DOI 10.1002/syn.20839; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marshall M, 2011, COCHRANE DB SYST REV, DOI [10.1093/schbul/sbr110, 10.1002/14651858.CD004718.pub3]; Monti Barbara, 2009, Curr Mol Pharmacol, V2, P95; Papaleo F, 2011, NEUROPHARMACOLOGY; Perucca E, 2011, LANCET NEUROL, V10, P446, DOI 10.1016/S1474-4422(11)70047-3; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Piontkewitz Y, 2011, SCHIZOPHRENIA BULL, V37, P1257, DOI 10.1093/schbul/sbq040; Porteous DJ, 2011, TRENDS MOL MED, V17, P699, DOI 10.1016/j.molmed.2011.09.002; Rodvold JJ, 2012, CANCER LETT, V316, P132, DOI 10.1016/j.canlet.2011.11.002; Schnieder TP, 2011, BIOL PSYCHIAT, V69, P134, DOI 10.1016/j.biopsych.2010.08.027; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Semeralul MO, 2006, J NEUROBIOL, V66, P1646, DOI 10.1002/neu.20302; Shoji Hirotaka, 2012, BMC Res Notes, V5, P108, DOI 10.1186/1756-0500-5-108; Tremolizzo L, 2005, BIOL PSYCHIAT, V57, P500, DOI 10.1016/j.biopsych.2004.11.046; Umeda K, 2006, EUR J PHARMACOL, V553, P157, DOI 10.1016/j.ejphar.2006.09.050; WALKER EF, 1994, SCHIZOPHRENIA BULL, V20, P441, DOI 10.1093/schbul/20.3.441; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Willott JF, 2003, BEHAV NEUROSCI, V117, P716, DOI 10.1037/0735-7044.117.4.716; Woods SW, 2009, SCHIZOPHRENIA BULL, V35, P894, DOI 10.1093/schbul/sbp027; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zuckerman L, 2003, PSYCHOPHARMACOLOGY, V169, P298, DOI 10.1007/s00213-003-1460-8; Zuckerman L, 2003, PSYCHOPHARMACOLOGY, V169, P308, DOI 10.1007/s00213-003-1461-7	58	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51562	10.1371/journal.pone.0051562	http://dx.doi.org/10.1371/journal.pone.0051562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272119	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300018
J	Redondo, N; Sanz, MA; Steinberger, J; Skern, T; Kusov, Y; Carrasco, L				Redondo, Natalia; Angel Sanz, Miguel; Steinberger, Jutta; Skern, Tim; Kusov, Yuri; Carrasco, Luis			Translation Directed by Hepatitis A Virus IRES in the Absence of Active eIF4F Complex and eIF2	PLOS ONE			English	Article							INITIATION-FACTOR 4G; CAP-INDEPENDENT TRANSLATION; RIBOSOME ENTRY SEGMENTS; DEPENDENT TRANSLATION; INTERNAL INITIATION; BINDING-PROTEIN; RNA HELICASE; PHOSPHORYLATION; SITE; REPLICATION	Translation directed by several picornavirus IRES elements can usually take place after cleavage of eIF4G by picornavirus proteases 2A(pro) or L-pro. The hepatitis A virus (HAV) IRES is thought to be an exception to this rule because it requires intact eIF4F complex for translation. In line with previous results we report that poliovirus (PV) 2A(pro) strongly blocks protein synthesis directed by HAV IRES. However, in contrast to previous findings we now demonstrate that eIF4G cleavage by foot-and-mouth disease virus (FMDV) L-pro strongly stimulates HAV IRES-driven translation. Thus, this is the first observation that 2A(pro) and L-pro exhibit opposite effects to what was previously thought to be the case in HAV IRES. This effect has been observed both in hamster BHK and human hepatoma Huh7 cells. In addition, this stimulation of translation is also observed in cell free systems after addition of purified L-pro. Notably, in presence of this FMDV protease, translation directed by HAV IRES takes place when eIF2 alpha has been inactivated by phosphorylation. Our present findings clearly demonstrate that protein synthesis directed by HAV IRES can occur when eIF4G has been cleaved and after inactivation of eIF2. Therefore, translation directed by HAV IRES without intact eIF4G and active eIF2 is similar to that observed with other picornavirus IRESs.	[Redondo, Natalia; Angel Sanz, Miguel; Carrasco, Luis] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Steinberger, Jutta; Skern, Tim] Med Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Kusov, Yuri] Med Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, D-23538 Lubeck, Germany; [Kusov, Yuri] Med Univ Lubeck, German Ctr Infect Res, D-23538 Lubeck, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Lubeck; German Center for Infection Research; University of Lubeck	Redondo, N (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	nsevillano@cbm.uam.es	sanz-gomez, miguel/Y-6244-2019; Skern, Tim/AAC-1732-2022; Sanz, Miguel A/H-1914-2015; Carrasco, Luis/E-2435-2012; Carrasco, Luis/H-3001-2017	sanz-gomez, miguel/0000-0002-5761-9010; Skern, Tim/0000-0001-8865-5500; Sanz, Miguel A/0000-0001-6573-883X; Carrasco, Luis/0000-0003-3833-8835; REDONDO, NATALIA/0000-0001-9356-8102	DGICYT (Direccion General de Investigacion Cientifica y Tecnica) [BFU2009-07352]; Fundacion Ramon Areces; FWF Austrian Science Fund [P24038]; Austrian Science Fund (FWF) [P 24038] Funding Source: researchfish	DGICYT (Direccion General de Investigacion Cientifica y Tecnica); Fundacion Ramon Areces; FWF Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by a DGICYT (Direccion General de Investigacion Cientifica y Tecnica) project BFU2009-07352. The Institutional Grant was awarded to the Centro de Biologia Molecular "Severo Ochoa'' (CSIC-UAM) by the Fundacion Ramon Areces. This project was funded by the FWF Austrian Science Fund, grant P24038, to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; Ali IK, 2001, J VIROL, V75, P7854, DOI 10.1128/JVI.75.17.7854-7863.2001; Ali IK, 2001, EMBO J, V20, P4233, DOI 10.1093/emboj/20.15.4233; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Sanz MA, 2010, J MOL BIOL, V402, P101, DOI 10.1016/j.jmb.2010.07.014; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; BARCO A, 1995, EMBO J, V14, P3349, DOI 10.1002/j.1460-2075.1995.tb07341.x; Belsham GJ, 2009, VIRUS RES, V139, P183, DOI 10.1016/j.virusres.2008.07.001; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Borman AM, 1997, VIROLOGY, V237, P129, DOI 10.1006/viro.1997.8761; BORMAN AM, 1995, NUCLEIC ACIDS RES, V23, P3656, DOI 10.1093/nar/23.18.3656; Borman AM, 2001, J VIROL, V75, P7864, DOI 10.1128/JVI.75.17.7864-7871.2001; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Castello A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/369648; Cordes S, 2008, BIOCHEM BIOPH RES CO, V368, P1014, DOI 10.1016/j.bbrc.2008.01.163; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; Gauss-Muller V, 2002, J GEN VIROL, V83, P2183, DOI 10.1099/0022-1317-83-9-2183; Junemann C, 2007, J BIOL CHEM, V282, P132, DOI 10.1074/jbc.M608750200; Kanda T, 2010, J VIRAL HEPATITIS, V17, P618, DOI 10.1111/j.1365-2893.2009.01221.x; KIRCHWEGER R, 1994, J VIROL, V68, P5677, DOI 10.1128/JVI.68.9.5677-5684.1994; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Lindqvist L, 2009, FUTURE MED CHEM, V1, P1709, DOI 10.4155/FMC.09.122; Lomakin IB, 2000, MOL CELL BIOL, V20, P6019, DOI 10.1128/MCB.20.16.6019-6029.2000; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Niepmann M, 2009, BBA-GENE REGUL MECH, V1789, P529, DOI 10.1016/j.bbagrm.2009.05.002; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Paulous S, 2003, NUCLEIC ACIDS RES, V31, P722, DOI 10.1093/nar/gkf695; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Redondo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025699; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Wehner KA, 2010, MOL CELL BIOL, V30, P2006, DOI 10.1128/MCB.01350-09; Welnowska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022230; WHETTER LE, 1994, J VIROL, V68, P5253, DOI 10.1128/JVI.68.8.5253-5263.1994; Zhang B, 2007, NUCLEIC ACIDS RES, V35, P5975, DOI 10.1093/nar/gkm645	38	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52065	10.1371/journal.pone.0052065	http://dx.doi.org/10.1371/journal.pone.0052065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272212	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300058
J	Hediger, MR; De Vico, L; Svendsen, A; Besenmatter, W; Jensen, JH				Hediger, Martin R.; De Vico, Luca; Svendsen, Allan; Besenmatter, Werner; Jensen, Jan H.			A Computational Methodology to Screen Activities of Enzyme Variants	PLOS ONE			English	Article							SEMIEMPIRICAL METHODS; PARAMETERS; MECHANISM; APPROXIMATIONS; OPTIMIZATION; CATALYSIS; ENERGY; AM1	We present a fast computational method to efficiently screen enzyme activity. In the presented method, the effect of mutations on the barrier height of an enzyme-catalysed reaction can be computed within 24 hours on roughly 10 processors. The methodology is based on the PM6 and MOZYME methods as implemented in MOPAC2009, and is tested on the first step of the amide hydrolysis reaction catalyzed by the Candida Antarctica lipase B (CalB) enzyme. The barrier heights are estimated using adiabatic mapping and shown to give barrier heights to within 3 kcal/mol of B3LYP/6-31G(d)//RHF/3-21G results for a small model system. Relatively strict convergence criteria (0.5 kcal/(mol angstrom)), long NDDO cutoff distances within the MOZYME method (15 angstrom) and single point evaluations using conventional PM6 are needed for reliable results. The generation of mutant structures and subsequent setup of the semiempirical calculations are automated so that the effect on barrier heights can be estimated for hundreds of mutants in a matter of weeks using high performance computing.	[Hediger, Martin R.; De Vico, Luca; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Svendsen, Allan; Besenmatter, Werner] Novozymes AS, Bagsvaerd, Denmark	University of Copenhagen; Novozymes	Jensen, JH (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	jhjensen@chem.ku.dk	Jensen, Jan Halborg/G-4338-2010; De Vico, Luca/D-2267-2009; De Vico, Luca/HFZ-7775-2022	Jensen, Jan Halborg/0000-0002-1465-1010; De Vico, Luca/0000-0002-2821-5711; De Vico, Luca/0000-0002-2821-5711	In Silico Rational Engineering of Novel Enzymes FP7 project	In Silico Rational Engineering of Novel Enzymes FP7 project	The authors acknowledge the In Silico Rational Engineering of Novel Enzymes FP7 project for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarsha M, 2010, J BIOL INORG CHEM, V15, P361, DOI 10.1007/s00775-009-0608-3; Claeyssens F, 2006, ANGEW CHEM, V118, P7010, DOI [10.1002/ange.200602711, DOI 10.1002/ANGE.200602711]; DEWAR MJS, 1977, J AM CHEM SOC, V99, P4899, DOI 10.1021/ja00457a004; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Friesner RA, 2005, ANNU REV PHYS CHEM, V56, P389, DOI 10.1146/annurev.physchem.55.091602.094410; Hermann JC, 2009, J PHYS CHEM A, V113, P11984, DOI 10.1021/jp9037254; Klamt A., 1993, J CHEM SOC P2, V2, P799, DOI DOI 10.1039/P29930000799; Li H, 2002, THEOR CHEM ACC, V107, P211, DOI 10.1007/s00214-001-0317-7; Noodleman L, 2004, CHEM REV, V104, P459, DOI 10.1021/cr020625a; Parks JM, 2009, J PHYS CHEM B, V113, P5217, DOI 10.1021/jp805137x; Pople JA., 1970, APPROXIMATE MOL ORBI; Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425; Schenker S, 2011, J CHEM THEORY COMPUT; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Stewart JJP, 2009, J MOL MODEL, V15, P765, DOI 10.1007/s00894-008-0420-y; STEWART JJP, 1990, J COMPUT AID MOL DES, V4, P1, DOI 10.1007/BF00128336; Stewart JJP, 1996, INT J QUANTUM CHEM, V58, P133, DOI 10.1002/(SICI)1097-461X(1996)58:2<133::AID-QUA2>3.0.CO;2-Z; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Syren PO, 2011, CHEMCATCHEM, V3, P853, DOI 10.1002/cctc.201000448; Tian L, 2009, J CHEM THEORY COMPUT, V5, P1421, DOI 10.1021/ct900040n; Uppenberg J, 1995, BIOCHEMISTRY-US, V34, P16838, DOI 10.1021/bi00051a035	26	12	13	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e49849	10.1371/journal.pone.0049849	http://dx.doi.org/10.1371/journal.pone.0049849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284627	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900004
J	Mendez-Villanueva, A; Edge, J; Suriano, R; Hamer, P; Bishop, D				Mendez-Villanueva, Alberto; Edge, Johann; Suriano, Rob; Hamer, Peter; Bishop, David			The Recovery of Repeated-Sprint Exercise Is Associated with PCr Resynthesis, while Muscle pH and EMG Amplitude Remain Depressed	PLOS ONE			English	Article							MAXIMAL VOLUNTARY CONTRACTIONS; INTERMITTENT CYCLING SPRINTS; SKELETAL-MUSCLE; POWER OUTPUT; SURFACE ELECTROMYOGRAM; NEUROMUSCULAR ACTIVITY; HIGH-INTENSITY; FATIGUE; METABOLISM; HUMANS	The physiological equivalents of power output maintenance and recovery during repeated-sprint exercise (RSE) remain to be fully elucidated. In an attempt to improve our understanding of the determinants of RSE performance we therefore aimed to determine its recovery following exhaustive exercise (which affected intramuscular and neural factors) concomitantly with those of intramuscular concentrations of adenosine triphosphate [ATP], phosphocreatine [PCr] and pH values and electromyography (EMG) activity (a proxy for net motor unit activity) changes. Eight young men performed 10, 6-s all-out sprints on a cycle ergometer, interspersed with 30 s of recovery, followed, after 6 min of passive recovery, by five 6-s sprints, again interspersed by 30 s of passive recovery. Biopsies of the vastus lateralis were obtained at rest, immediately after the first 10 sprints and after 6 min of recovery. EMG activity of the vastus lateralis was obtained from surface electrodes throughout exercise. Total work (TW), [ATP], [PCr], pH and EMG amplitude decreased significantly throughout the first ten sprints (P<0.05). After 6 min of recovery, TW during sprint 11 recovered to 86.3 +/- 7.7% of sprint 1. ATP and PCr were resynthesized to 92.6 +/- 6.0% and 85.3 +/- 10.3% of the resting value, respectively, but muscle pH and EMG amplitude remained depressed. PCr resynthesis was correlated with TW done in sprint 11 (r = 0.79, P<0.05) and TW done during sprints 11 to 15 (r = 0.67, P<0.05). There was a similar to 2-fold greater decrease in the TW/EMG ratio in the last five sprints (sprint 11 to 15) than in the first five sprints (sprint 1 to 5) resulting in a disproportionate decrease in mechanical power (i.e., TW) in relation to EMG. Thus, we conclude that the inability to produce power output during repeated sprints is mostly mediated by intramuscular fatigue signals probably related with the control of PCr metabolism.	[Mendez-Villanueva, Alberto] ASPIRE Acad Sports Excellence, Football Performance & Sci Dept, Doha, Qatar; [Mendez-Villanueva, Alberto; Edge, Johann; Suriano, Rob; Hamer, Peter; Bishop, David] Univ Western Australia, Sch Human Movement & Exercise Sci, Perth, WA 6009, Australia; [Hamer, Peter] Univ Notre Dame Australia, Sch Physiotherapy, Perth, WA, Australia; [Bishop, David] Victoria Univ, Sch Sport & Exercise Sci, ISEAL, Melbourne, Vic 8001, Australia	Aspire Academy for Sports Excellence; University of Western Australia; University of Notre Dame Australia; Victoria University	Mendez-Villanueva, A (corresponding author), ASPIRE Acad Sports Excellence, Football Performance & Sci Dept, Doha, Qatar.	amendezvillanueva@yahoo.com	Bishop, David John/X-9826-2019	Bishop, David John/0000-0002-6956-9188	Gatorade Sports Science Institute	Gatorade Sports Science Institute	This work was partly supported by a grant from the Gatorade Sports Science Institute to AMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akima H, 2005, INT J SPORTS MED, V26, P245, DOI 10.1055/s-2004-821000; Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; ARTHUR PG, 1995, ANAL BIOCHEM, V227, P281, DOI 10.1006/abio.1995.1281; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; Billaut F, 2006, INT J SPORTS MED, V27, P25, DOI 10.1055/s-2005-837488; Billaut F, 2005, NEUROSCI LETT, V380, P265, DOI 10.1016/j.neulet.2005.01.048; Bishop D, 2004, MED SCI SPORT EXER, V36, P807, DOI 10.1249/01.MSS.0000126392.20025.17; Bishop D, 2011, SPORTS MED, V41, P741, DOI 10.2165/11590560-000000000-00000; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; BOGDANIS GC, 1995, J PHYSIOL-LONDON, V482, P467, DOI 10.1113/jphysiol.1995.sp020533; Bogdanis GC, 1998, ACTA PHYSIOL SCAND, V163, P261, DOI 10.1046/j.1365-201x.1998.00378.x; Bruton JD, 1998, J APPL PHYSIOL, V85, P478, DOI 10.1152/jappl.1998.85.2.478; Day SJ, 2001, J NEUROPHYSIOL, V86, P2144, DOI 10.1152/jn.2001.86.5.2144; De Luca CJ, 1996, J NEUROPHYSIOL, V76, P1503, DOI 10.1152/jn.1996.76.3.1503; Deschenes MR, 2002, AM J PHYSIOL-REG I, V282, pR578, DOI 10.1152/ajpregu.00386.2001; Duchateau J, 2006, J APPL PHYSIOL, V101, P1766, DOI 10.1152/japplphysiol.00543.2006; Edge J, 2005, MED SCI SPORT EXER, V37, P1975, DOI 10.1249/01.mss.0000175855.35403.4c; ENOKA RM, 1992, MUSCLE NERVE, V15, P138, DOI 10.1002/mus.880150204; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; Fuglevand AJ, 2003, J PHYSIOL-LONDON, V549, P865, DOI 10.1113/jphysiol.2003.038836; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Gray SR, 2006, AM J PHYSIOL-REG I, V290, pR376, DOI 10.1152/ajpregu.00291.2005; Kalmar JM, 2006, J APPL PHYSIOL, V100, P1757, DOI 10.1152/japplphysiol.01347.2005; Karatzaferi C, 2001, PFLUG ARCH EUR J PHY, V442, P467, DOI 10.1007/s004240100552; Keenan KG, 2005, J APPL PHYSIOL, V98, P120, DOI 10.1152/japplphysiol.00894.2004; Kinugasa R, 2004, EUR J APPL PHYSIOL, V91, P230, DOI 10.1007/s00421-003-0970-8; Klein CS, 2001, NEUROSCI LETT, V316, P153, DOI 10.1016/S0304-3940(01)02389-8; Krustrup P, 2004, PFLUG ARCH EUR J PHY, V449, P56, DOI 10.1007/s00424-004-1304-3; Maxwell BF, 1998, EUR J APPL PHYSIOL O, V78, P346, DOI 10.1007/s004210050430; MCCARTNEY N, 1986, J APPL PHYSIOL, V60, P1164, DOI 10.1152/jappl.1986.60.4.1164; McGawley K, 2006, EUR J APPL PHYSIOL, V98, P383, DOI 10.1007/s00421-006-0284-8; McGawley K., 2008, COACHING SPORT SCI J, V3, P52; Mendez-Villanueva A, 2008, EUR J APPL PHYSIOL, V103, P411, DOI 10.1007/s00421-008-0723-9; Mendez-Villanueva A, 2007, MED SCI SPORT EXER, V39, P2219, DOI 10.1249/mss.0b013e31815669dc; Mendez-Villanueva A, 2007, J SCI MED SPORT, V10, P323, DOI 10.1016/j.jsams.2006.07.017; Parolin ML, 1999, AM J PHYSIOL-ENDOC M, V277, pE890, DOI 10.1152/ajpendo.1999.277.5.E890; Posterino GS, 2001, PFLUG ARCH EUR J PHY, V442, P197, DOI 10.1007/s004240100528; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; SAHLIN K, 1989, J APPL PHYSIOL, V67, P648, DOI 10.1152/jappl.1989.67.2.648; Sargeant AJ, 2007, EXP PHYSIOL, V92, P323, DOI 10.1113/expphysiol.2006.034322; Spencer M, 2005, SPORTS MED, V35, P1025, DOI 10.2165/00007256-200535120-00003; Spencer M, 2006, MED SCI SPORT EXER, V38, P1492, DOI 10.1249/01.mss.0000228944.62776.a7; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Thomas C, 2004, J APPL PHYSIOL, V97, P2132, DOI 10.1152/japplphysiol.00387.2004; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17; Zhang SJ, 2006, J PHYSIOL-LONDON, V572, P551, DOI 10.1113/jphysiol.2005.104521	49	69	69	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51977	10.1371/journal.pone.0051977	http://dx.doi.org/10.1371/journal.pone.0051977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284836	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000312435900067
J	Navarro-Gonzalez, N; Mentaberre, G; Porrero, CM; Serrano, E; Mateos, A; Lopez-Martin, JM; Lavin, S; Dominguez, L				Navarro-Gonzalez, Nora; Mentaberre, Gregorio; Porrero, Concepcion M.; Serrano, Emmanuel; Mateos, Ana; Lopez-Martin, Jose M.; Lavin, Santiago; Dominguez, Lucas			Effect of Cattle on Salmonella Carriage, Diversity and Antimicrobial Resistance in Free-Ranging Wild Boar (Sus scrofa) in Northeastern Spain	PLOS ONE			English	Article							INFECTIOUS-DISEASES; ESCHERICHIA-COLI; ENTERITIDIS; INTEGRONS; ENVIRONMENTS; TYPHIMURIUM; PREVALENCE; LIVESTOCK; OUTBREAK; VECTORS	Salmonella is distributed worldwide and is a pathogen of economic and public health importance. As a multi-host pathogen with a long environmental persistence, it is a suitable model for the study of wildlife-livestock interactions. In this work, we aim to explore the spill-over of Salmonella between free-ranging wild boar and livestock in a protected natural area in NE Spain and the presence of antimicrobial resistance. Salmonella prevalence, serotypes and diversity were compared between wild boars, sympatric cattle and wild boars from cattle-free areas. The effect of age, sex, cattle presence and cattle herd size on Salmonella probability of infection in wild boars was explored by means of Generalized Linear Models and a model selection based on the Akaike's Information Criterion. Prevalence was higher in wild boars co-habiting with cattle (35.67%, CI 95% 28.19-43.70) than in wild boar from cattle-free areas (17.54%, CI 95% 8.74-29.91). Probability of a wild boar being a Salmonella carrier increased with cattle herd size but decreased with the host age. Serotypes Meleagridis, Anatum and Othmarschen were isolated concurrently from cattle and sympatric wild boars. Apart from serotypes shared with cattle, wild boars appear to have their own serotypes, which are also found in wild boars from cattle-free areas (Enteritidis, Mikawasima, 4:b:- and 35:r:z35). Serotype richness (diversity) was higher in wild boars co-habiting with cattle, but evenness was not altered by the introduction of serotypes from cattle. The finding of a S. Mbandaka strain resistant to sulfamethoxazole, streptomycin and chloramphenicol and a S. Enteritidis strain resistant to ciprofloxacin and nalidixic acid in wild boars is cause for public health concern.	[Navarro-Gonzalez, Nora; Mentaberre, Gregorio; Serrano, Emmanuel; Lopez-Martin, Jose M.; Lavin, Santiago] UAB, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Barcelona, Spain; [Porrero, Concepcion M.; Mateos, Ana; Dominguez, Lucas] Univ Complutense UCM, Fac Vet Med, Ctr Vigilancia Sanitaria Vet VISAVET, Madrid, Spain; [Serrano, Emmanuel] Univ Lleida UdL, Dept Matemat, Lleida, Spain; [Lopez-Martin, Jose M.] Generalitat Catalunya, Direccio Gen Med Nat & Biodiversitat, Area Activitats Cineget, Barcelona, Spain	Autonomous University of Barcelona; Complutense University of Madrid; Universitat de Lleida	Navarro-Gonzalez, N (corresponding author), UAB, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Barcelona, Spain.	norit85@gmail.com	Navarro-Gonzalez, Nora/GYD-6516-2022; SERRANO-FERRON, Emmanuel/J-4489-2013; Martin, Josep Maria Lopez/H-8392-2015; Navarro-Gonzalez, Nora/N-9799-2017; Lavín, Santiago/L-5975-2014; Mentaberre, Gregorio A/H-4629-2015; Rodríguez, Lucas Domínguez/B-9668-2014; studies, IT VISAVET Account for bibliometric/C-3115-2014; Mentaberre, Gregorio/AAB-5912-2020	SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; Martin, Josep Maria Lopez/0000-0001-8162-3960; Navarro-Gonzalez, Nora/0000-0002-1878-1242; Lavín, Santiago/0000-0001-5655-588X; Mentaberre, Gregorio A/0000-0001-9542-7514; Rodríguez, Lucas Domínguez/0000-0001-8843-0010; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Mentaberre, Gregorio/0000-0001-9542-7514; MATEOS GARCIA, ANA ISABEL/0000-0002-5008-9053	Spanish Ministry of Science and Innovation [FAU2006-00011, FAU2008-00021]; Ministerio de Educacion (MEC, Spain); Catalan Science and Technology System (Spain); Comunidad de Madrid (Vigilancia Sanitaria) [S2009/AGR-1489]; Departament d'Agricultura, Ramaderia, Pesca, Alimentacio i Medi Natural of the Generalitat de Catalunya	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Educacion (MEC, Spain)(Spanish Government); Catalan Science and Technology System (Spain); Comunidad de Madrid (Vigilancia Sanitaria)(Comunidad de Madrid); Departament d'Agricultura, Ramaderia, Pesca, Alimentacio i Medi Natural of the Generalitat de Catalunya(Generalitat de Catalunya)	This work has been partially funded by the Spanish Ministry of Science and Innovation within the Program of Interaction between wild animals and livestock (FAU2006-00011 and FAU2008-00021). N. Navarro-Gonzalez was supported by the FPU programme of the Ministerio de Educacion (MEC, Spain) and E. Serrano by the Beatriu de Pinos programme (BP-DGR 2011) of the Catalan Science and Technology System (Spain). Phage Typing was performed in the Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain) within a collaborative project funded by the Comunidad de Madrid (Vigilancia Sanitaria, S2009/AGR-1489). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our gratitude to the Departament d'Agricultura, Ramaderia, Pesca, Alimentacio i Medi Natural of the Generalitat de Catalunya for supporting our research activity. We also are very grateful to the staff of the Natural Park and the National Game Reserve "Els Ports" for their big help in the sampling and the information about livestock, especially Xavier Olive and Josep Maria Forcadell.	Anderson DR, 2001, WILDLIFE SOC B, V29, P1260; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; [Anonymous], 2002, MODEL SELECTION MULT; Bohm M, 2007, VET J, V174, P260, DOI 10.1016/j.tvjl.2006.11.003; BOITANI L, 1992, ONGULES / UNGULATES 91, P419; Caleja C, 2011, INT MICROBIOL, V14, P19, DOI 10.2436/20.1501.01.131; Carlson JC, 2011, J APPL ECOL, V48, P479, DOI 10.1111/j.1365-2664.2010.01935.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davies RH, 2003, ENVIRON MICROBIOL, V5, P79, DOI 10.1046/j.1462-2920.2003.00387.x; Dolejska M, 2007, J APPL MICROBIOL, V103, P11, DOI 10.1111/j.1365-2672.2006.03241.x; EFSA, 2010, EFSA J, V8, P1309, DOI [10.2903/j.efsa.2010.1309, DOI 10.2903/J.EFSA.2010.1309]; European Environment Agency, 2007, 172007 EEA; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; FEDORKACRAY PJ, 1995, INFECT IMMUN, V63, P2658, DOI 10.1128/IAI.63.7.2658-2664.1995; Foley S L, 2008, J Anim Sci, V86, pE173; Garber L, 2003, AVIAN DIS, V47, P134, DOI 10.1637/0005-2086(2003)047[0134:SESEIT]2.0.CO;2; Glawischnig W, 2000, WIEN TIERARZTL MONAT, V87, P21; Gorski L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034722; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Gotelli NJ, ECOSIM 7 72 ACQ INT; Grimont P. A. D., 2007, ANTIGENIC FORMULAS S; Hilbert F, 2012, FOOD RES INT, V45, P603, DOI 10.1016/j.foodres.2011.08.015; Hudson P., 2002, ECOLOGY WILDLIFE DIS; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; International Organization for Standardization, 2007, 65792002 INT ORG STA; Johnson DH, 2002, J WILDLIFE MANAGE, V66, P272, DOI 10.2307/3803159; Lankau EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037302; Liebana E, 2003, J APPL MICROBIOL, V94, P1024, DOI 10.1046/j.1365-2672.2003.01924.x; Literak I, 2010, J APPL MICROBIOL, V108, P1702, DOI 10.1111/j.1365-2672.2009.04572.x; Meng XJ, 2009, PHILOS T R SOC B, V364, P2697, DOI 10.1098/rstb.2009.0086; Mentaberre G, ZOONOSES PU IN PRESS; Methner U, 2010, EUR J WILDLIFE RES, V56, P493, DOI 10.1007/s10344-009-0339-3; Millan J, 2004, REV SCI TECH OIE, V23, P905, DOI 10.20506/rst.23.3.1529; Murray C.J., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P765; Navarro-Gonzalez N, TRANSBOUND IN PRESS; Patton TG, 2009, VET MICROBIOL, V136, P285, DOI 10.1016/j.vetmic.2008.10.032; Paulsen P, 2012, FOOD RES INT, V45, P609, DOI 10.1016/j.foodres.2011.06.055; Perron GG, 2007, INFECT GENET EVOL, V7, P223, DOI 10.1016/j.meegid.2006.09.003; R Development Core Team, 2011, LANG ENV STAT COMP; Santos FBO, 2007, J APPL POULTRY RES, V16, P563, DOI 10.3382/japr.2006-00105; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Singer RS, 2009, J FOOD PROTECT, V72, P707, DOI 10.4315/0362-028X-72.4.707; Skov MN, 2008, J APPL MICROBIOL, V105, P1558, DOI 10.1111/j.1365-2672.2008.03914.x; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; Stevenson M, 2012, EPIR R PACK AN EP DA; Thulke HH, 2009, J WILDLIFE DIS, V45, P1089, DOI 10.7589/0090-3558-45.4.1089; Uzzau S, 2000, EPIDEMIOL INFECT, V125, P229, DOI 10.1017/S0950268899004379; VAV, 2005, RED VIG VET RES ANT; Vieira-Pinto M, 2011, FOODBORNE PATHOG DIS, V8, P739, DOI 10.1089/fpd.2010.0742; Wacheck S, 2010, FOODBORNE PATHOG DIS, V7, P307, DOI 10.1089/fpd.2009.0367; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Zuur AF, 2007, STAT BIOL HEALTH, P1; Zuur Alain F., 2009, P1	54	32	32	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51614	10.1371/journal.pone.0051614	http://dx.doi.org/10.1371/journal.pone.0051614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284725	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000312435900034
J	Vu, BV; Anthony, KL; Strych, U; Willson, RC				Vu, Binh V.; Anthony, Kim L.; Strych, Ulrich; Willson, Richard C.			Recovery of Small DNA Fragments from Serum Using Compaction Precipitation	PLOS ONE			English	Article							CIRCULATING DNA; SELECTIVE PRECIPITATION; CANCER-PATIENTS; PLASMA; QUANTIFICATION	Background: While most nucleic acids are intracellular, trace amounts of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), including micro RNAs, can also be found in peripheral blood. Many studies have suggested the potential utility of these circulating nucleic acids in prenatal diagnosis, early cancer detection, and the diagnosis of infectious diseases. However, DNA circulating in blood is usually present at very low concentrations (ng/ml), and is in the form of relatively small fragments (<1,000 bp), making its isolation challenging. Methods: Here we report an improved method for the isolation of small DNA fragments from serum using selective precipitation by quaternary ammonium compaction agents. A 151 bp fragment of double-stranded DNA from the Escherichia coli bacteriophage lambda served as the model DNA in our experiments. DNA was serially diluted in serum until undetectable by conventional polymerase chain reaction (PCR), before being enriched by compaction precipitation. Results: Starting with concentrations two to three orders of magnitude lower than the PCR-detectable level (0.01 ng/ml), we were able to enrich the DNA to a detectable level using a novel compaction precipitation protocol. The isolated DNA product after compaction precipitation was largely free of serum contaminants and was suitable for downstream applications. Conclusions: Using compaction precipitation, we were able to isolate and concentrate small DNA from serum, and increase the sensitivity of detection by more than four orders of magnitude. We were able to recover and detect very low levels (0.01 ng/ml) of a small DNA fragment in serum. In addition to being very sensitive, the method is fast, simple, inexpensive, and avoids the use of toxic chemicals.	[Vu, Binh V.; Anthony, Kim L.; Willson, Richard C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Strych, Ulrich; Willson, Richard C.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Willson, RC (corresponding author), Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA.	willson@uh.edu	Willson, richard/AAD-4832-2019	Strych, Ulrich/0000-0001-9455-7683	Welch Foundation	Welch Foundation(The Welch Foundation)	Funded by the Welch Foundation (http://www.welch1.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345; Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Anez-Lingerfelt M, 2009, ANAL BIOCHEM, V384, P79, DOI 10.1016/j.ab.2008.09.009; [Anonymous], 2010, CIRCULATING DNA PLAS; [Anonymous], 2009, QIAAMP CIRCULATING N; Gal S, 2004, BRIT J CANCER, V90, P1211, DOI 10.1038/sj.bjc.6601609; Goebel G, 2005, DIS MARKERS, V21, P105, DOI 10.1155/2005/218759; GOSULE LC, 1976, NATURE, V259, P333, DOI 10.1038/259333a0; Hahn SH, 2001, CLIN CHEM, V47, P1577; HOOPES BC, 1981, NUCLEIC ACIDS RES, V9, P5493, DOI 10.1093/nar/9.20.5493; Jung M, 2003, CLIN CHEM, V49, P1028, DOI 10.1373/49.6.1028; Kirsch C, 2008, ANN NY ACAD SCI, V1137, P135, DOI 10.1196/annals.1448.035; LEON SA, 1977, CANCER RES, V37, P646; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Mourich DV, 2003, J IMMUNOL METHODS, V274, P257, DOI 10.1016/S0022-1759(02)00516-1; Murphy JC, 1999, NAT BIOTECHNOL, V17, P822, DOI 10.1038/11777; RAZIN S, 1959, ARCH BIOCHEM BIOPHYS, V81, P36, DOI 10.1016/0003-9861(59)90173-0; Schmidt B, 2005, CLIN CHEM, V51, P1561, DOI 10.1373/clinchem.2005.051003; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; STROUN M, 1987, EUR J CANCER CLIN ON, V23, P707, DOI 10.1016/0277-5379(87)90266-5; Tamkovich SN, 2008, B EXP BIOL MED+, V146, P89, DOI 10.1007/s10517-008-0213-4	21	3	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51863	10.1371/journal.pone.0051863	http://dx.doi.org/10.1371/journal.pone.0051863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284792	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900059
J	Eriksson, EM; Keh, CE; Deeks, SG; Martin, JN; Hecht, FM; Nixon, DF				Eriksson, Emily M.; Keh, Chris E.; Deeks, Steven G.; Martin, Jeffrey N.; Hecht, Frederick M.; Nixon, Douglas F.			Differential Expression of CD96 Surface Molecule Represents CD8(+) T Cells with Dissimilar Effector Function during HIV-1 Infection	PLOS ONE			English	Article							VIRUS TYPE-1 INFECTION; IMMUNE ACTIVATION; NK-CELL; LYMPHOCYTE ACTIVATION; ADHESION MOLECULE; VIRAL SUPPRESSION; RESPONSES; PLASMA; DNAM-1; CD226	During HIV-1 infection, immune dysregulation and aberrant lymphocyte functions are well-established characteristics. Cell surface molecules are important for immunological functions and changes in expression can affect lymphocyte effector functions, thereby contributing to pathogenesis and disease progression. In this study we have focused on CD96, a member of the IgG superfamily receptors that have generated increasing recent interest due to their adhesive and co-stimulatory functions in addition to immunoregulatory capacity. CD96 is expressed by both T and NK cells. Although the function of CD96 is not completely elucidated, it has been shown to have adhesive functions and enhance cytotoxicity. Interestingly, CD96 may also have inhibitory functions due to its immunoreceptor tyrosine-based inhibitory motif (ITIM). The clinical significance of CD96 is still comparatively limited although it has been associated with chronic Hepatitis B infection and disease progression. CD96 has not previously been studied in the context of HIV-1 infection, but due to its potential importance in immune regulation and relevance to chronic disease, we examined CD96 expression in relation to HIV-1 pathogenesis. In a cross-sectional analysis, we investigated the CD8(+) T cell expression of CD96 in cohorts of untreated HIV-1 infected adults with high viral loads (non-controllers) and low viral loads ("elite'' controllers). We demonstrated that elite controllers have significantly higher CD96 mean fluorescence intensity on CD8(+) T cells compared to HIV-1 non-controllers and CD96 expression was positively associated with CD4(+) T cell counts. Functional assessment showed that CD8(+) T cells lacking CD96 expression represented a population that produced both perforin and IFN-gamma following stimulation. Furthermore, CD96 expression on CD8(+) T cells was decreased in presence of lipopolysaccharide in vitro. Overall, these findings indicate that down-regulation of CD96 is an important aspect of HIV-1 pathogenesis and differential expression is related to cell effector functions and HIV-1 disease course.	[Eriksson, Emily M.; Keh, Chris E.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Deeks, Steven G.; Hecht, Frederick M.] Univ Calif San Francisco, Dept Med, HIV AIDS Program, San Francisco, CA USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Eriksson, EM (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	eriksson@wehi.edu.au	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Eriksson, Emily/0000-0002-7851-973X; Hecht, Frederick/0000-0002-5782-1171	National Institutes of Health (NIH) [AI68498, 2T2AI060530-06]; NIAID [RO1 AI087145, K24AI069994]; UCSF CFAR [P30 AI27763]; UCSF CTSI [UL1 RR024131]; Cleveland Immunopathogenesis Consortium [AI 76174]; CFAR Network of Integrated Systems [R24 AI067039]; American-Scandinavian Foundation; NIH UCSF-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 AI27763]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI069994, T32AI060530, R24AI067039, R01AI087145, R01AI068498, P30AI027763, P01AI076174] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCSF CFAR; UCSF CTSI; Cleveland Immunopathogenesis Consortium; CFAR Network of Integrated Systems; American-Scandinavian Foundation; NIH UCSF-Gladstone Institute of Virology & Immunology Center for AIDS Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) grant AI68498. The SCOPE cohort was supported in part by the NIAID (RO1 AI087145, K24AI069994), the UCSF CFAR (P30 AI27763), the UCSF CTSI (UL1 RR024131), the Cleveland Immunopathogenesis Consortium (AI 76174) and CFAR Network of Integrated Systems (R24 AI067039). EME was supported by a fellowship from the American-Scandinavian Foundation and NIH UCSF-Gladstone Institute of Virology & Immunology Center for AIDS Research, P30 AI27763. CEK was supported by T32 translational HIV training grant from the NIH (2T2AI060530-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gong J, 2009, CLIN EXP IMMUNOL, V155, P207, DOI 10.1111/j.1365-2249.2008.03829.x; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Klingstrom J, 2006, AIDS, V20, P125, DOI 10.1097/01.aids.0000196170.57927.e1; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; O'Connell KA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-63; Onlamoon N, 2012, CYTOM PART B-CLIN CY, V82B, P35, DOI 10.1002/cyto.b.20616; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; RINALDO C, 1995, J VIROL, V69, P5838, DOI 10.1128/JVI.69.9.5838-5842.1995; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; TSUBOTA H, 1989, J EXP MED, V169, P1421, DOI 10.1084/jem.169.4.1421; WANG PL, 1992, J IMMUNOL, V148, P2600; Ye XH, 2006, VIRAL IMMUNOL, V19, P576, DOI 10.1089/vim.2006.19.576	31	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51696	10.1371/journal.pone.0051696	http://dx.doi.org/10.1371/journal.pone.0051696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272144	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600037
J	Li, YJ; Jiang, WQ; Rao, HL; Huang, JJ; Xia, Y; Huang, HQ; Lin, TY; Xia, ZJ; Li, S; Li, ZM				Li, Ya-Jun; Jiang, Wen-Qi; Rao, Hui-Lan; Huang, Jia-Jia; Xia, Yi; Huang, Hui-Qiang; Lin, Tong-Yu; Xia, Zhong-Jun; Li, Su; Li, Zhi-Ming			Expression of BAFF and BAFF-R in Follicular Lymphoma: Correlation with Clinicopathologic Characteristics and Survival Outcomes	PLOS ONE			English	Article							NECROSIS-FACTOR FAMILY; B-CELL LYMPHOMA; BLYS; TACI; APOPTOSIS; APRIL; ACTIVATION; STIMULATOR; RECEPTORS; FEATURES	Background: B-cell activation factor (BAFF) and BAFF-receptor (BAFF-R) play crucial roles in the viability and proliferation of malignant lymphoma cells. Limited information exists regarding expression profiles and the prognostic role of BAFF and BAFF-R in follicular lymphoma (FL). We sought to determine the expression profiles of BAFF and BAFF-R in FL and to evaluate the correlation of BAFF and BAFF-R expression with clinicopathologic characteristics and outcome of FL. Correlation between expression levels of BAFF detected by immunohistochemical (IHC) and serum levels of BAFF was also evaluated. Methods: Paraffin-embedded specimens from 115 patients were immunohistochemically examined for BAFF and BAFF-R expression. Expression levels were dichotomized into low versus high categories based on immunostaining intensity. The correlation of BAFF and BAFF-R expression with clinicopathologic characteristics and patient outcome was assessed. Serum levels of BAFF in 35 of the 115 patients with IHC data were measured by Enzyme-linked Immunosorbent assay (ELISA). Results: BAFF and BAFF-R were expressed in 88.7% (102/115) and 87.8% (101/115) of the cases, respectively. BAFF expression was significantly correlated with only one clinicopathologic feature: Ann Arbor stage. No significant correlation was found between expression levels of BAFF detected by IHC and serum levels of BAFF detected by ELISA. High expression of BAFF-R, but not BAFF, was significantly correlated with inferior progression-free survival (PFS; P = 0.013) and overall survival (OS; P = 0.03). High expression of BAFF-R, bulky disease, and elevated lactate dehydrogenase were correlated with inferior PFS and OS in multivariate analysis. A prognostic scoring system incorporating these 3 risk factors identified 3 distinct prognostic groups with 5-year PFS of 59.4%, 41.9%, and 10.7% and OS of 91.3%, 79.7%, and 45.8%, respectively. Conclusions: Most patients with FL variably express BAFF and BAFF-R. High expression of BAFF-R, but not BAFF, may be an independent risk factor for PFS and OS in FL.	[Li, Ya-Jun; Jiang, Wen-Qi; Rao, Hui-Lan; Huang, Jia-Jia; Xia, Yi; Huang, Hui-Qiang; Lin, Tong-Yu; Xia, Zhong-Jun; Li, Su; Li, Zhi-Ming] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Li, Ya-Jun; Jiang, Wen-Qi; Huang, Jia-Jia; Xia, Yi; Huang, Hui-Qiang; Lin, Tong-Yu; Li, Su; Li, Zhi-Ming] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Rao, Hui-Lan] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Zhong-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, ZM (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	lzmlzmlzm@yahoo.com	jiang, wen/GYI-9662-2022		National Natural Science Foundation of China [81071950]; Fundamental Research Funds for the Central Universities [10ykpy36]; National-Eleventh Five Technology Major Project [2008ZX09312-002, 2012ZX09301]; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National-Eleventh Five Technology Major Project; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	This work was supported by National Natural Science Foundation of China (81071950), Fundamental Research Funds for the Central Universities (10ykpy36), National-Eleventh Five Technology Major Project (2008ZX09312-002, 2012ZX09301), and Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Biagi JJ, 2002, BLOOD, V99, P4265, DOI 10.1182/blood.V99.12.4265; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Federico M, 2009, J CLIN ONCOL, V27, P4555, DOI 10.1200/JCO.2008.21.3991; Fu LC, 2006, BLOOD, V107, P4540, DOI 10.1182/blood-2005-10-4042; Fu LC, 2009, BLOOD, V113, P4627, DOI 10.1182/blood-2008-10-183467; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; He XH, 2012, CHIN J CANCER, V31, P306, DOI 10.5732/cjc.011.10420; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; Kim SJ, 2008, EUR J HAEMATOL, V81, P177, DOI 10.1111/j.1600-0609.2008.01099.x; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Moreaux J, 2004, BLOOD, V103, P3148, DOI 10.1182/blood-2003-06-1984; Nakamura N, 2005, VIRCHOWS ARCH, V447, P53, DOI 10.1007/s00428-005-1275-6; Novak AJ, 2004, BLOOD, V104, P2247, DOI 10.1182/blood-2004-02-0762; Novak AJ, 2002, BLOOD, V100, P2973, DOI 10.1182/blood-2002-02-0558; Oki Y, 2007, HAEMATOLOGICA, V92, P269, DOI 10.3324/haematol.10678; Parameswaran R, 2010, CANCER RES, V70, P4346, DOI 10.1158/0008-5472.CAN-10-0300; Paterson JC, 2006, HAEMATOLOGICA, V91, P772; Rodig SJ, 2005, HUM PATHOL, V36, P1113, DOI 10.1016/j.humpath.2005.08.005; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Song Yan, 2010, Chin J Cancer, V29, P781; Swerdlow E., 2008, WHO CLASSIFICATION T; Tecchio C, 2007, BRIT J HAEMATOL, V137, P553, DOI 10.1111/j.1365-2141.2007.06615.x; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wada K, 2009, HISTOPATHOLOGY, V54, P221, DOI 10.1111/j.1365-2559.2008.03203.x; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790	31	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50936	10.1371/journal.pone.0050936	http://dx.doi.org/10.1371/journal.pone.0050936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272079	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600015
J	Pradel, R; Choquet, R; Bechet, A				Pradel, Roger; Choquet, Remi; Bechet, Arnaud			Breeding Experience Might Be a Major Determinant of Breeding Probability in Long-Lived Species: The Case of the Greater Flamingo	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; REPRODUCTIVE SUCCESS; PHOENICOPTERUS-RUBER; MARKED ANIMALS; AGE; POPULATION; SURVIVAL; COSTS; HETEROGENEITY; PERFORMANCE	The probability of breeding is known to increase with age early in life in many long-lived species. This increase may be due to experience accumulated through past breeding attempts. Recent methodological advances allowing accounting for unobserved breeding episodes, we analyzed the encounter histories of 14716 greater flamingos over 25 years to get a detailed picture of the interactions of age and experience. Survival did not improve with experience, seemingly ruling out the selection hypothesis. Breeding probability varied within three levels of experience : no breeding experience, 1 experience, 2+ experiences. We fitted models with and without among-individual differences in breeding probabilities by including or not an additive individual random effect. Including the individual random effect improved the model fit less than including experience but the best model retained both. However, because modeling individual heterogeneity by means of an additive static individual random effect is currently criticized and may not be appropriate, we discuss the results with and without random effect. Without random effect, breeding probability of inexperienced birds was always > 3 times lower than that of same age experienced birds, and breeding probability increased more with one additional experience than with one additional year of age. With random effects, the advantage of experience was unequivocal only after age 9 while in young having > 1 experience was penalizing. Another pattern, that breeding probability of birds with < 2 experiences dropped after some age (8 without random effect; up to 11 with it), may point to differences in the timing of reproductive senescence or to the existence of a sensitive period for acquiring behavioral skills. Overall, the role of experience appears strong in this long-lived species. We argue that overlooking the role of experience may hamper detection of trade-offs and assessment of individual heterogeneity. However, manipulative experiments are desirable to confirm our finding. Citation: Pradel R, Choquet R, Bechet A (2012) Breeding Experience Might Be a Major Determinant of Breeding Probability in Long-Lived Species: The Case of the Greater Flamingo. PLoS ONE 7(12): e51016. doi:10.1371/journal.pone.0051016	[Pradel, Roger] CNRS, Ctr Ecol Fonct & Evolut, Roger Pradel Biostat & Populat Biol Grp, F-34033 Montpellier, France; [Choquet, Remi] CNRS, Ctr Ecol Fonct & Evolut, Remi Choquet Biostat & Populat Biol Grp, F-34033 Montpellier, France; [Bechet, Arnaud] Ctr Rech Tour Valat, Arnaud Bechet Populat Dynam Response Human Act, Arles, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Pradel, R (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, Roger Pradel Biostat & Populat Biol Grp, F-34033 Montpellier, France.	roger.pradel@cefe.cnrs.fr	Pradel, Roger/A-8666-2008; Béchet, Arnaud/AAA-4398-2021; Choquet, Remi/F-6462-2011	Pradel, Roger/0000-0002-2684-9251; Béchet, Arnaud/0000-0002-0330-6342; Choquet, Remi/0000-0003-0434-9085				Balkiz, 2006, THESIS U MONPELLIER; Balkiz O, 2010, J ANIM ECOL, V79, P1045, DOI 10.1111/j.1365-2656.2010.01721.x; Barbraud C, 2005, ECOLOGY, V86, P682, DOI 10.1890/04-0075; Beauplet G, 2006, OIKOS, V112, P430, DOI 10.1111/j.0030-1299.2006.14412.x; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Broussard DR, 2008, J MAMMAL, V89, P145, DOI 10.1644/06-MAMM-A-357.1; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Cam E, 1998, ECOLOGY, V79, P2917, DOI 10.1890/0012-9658(1998)079[2917:AANPPT]2.0.CO;2; Cam E, 2013, OIKOS, V122, P739, DOI 10.1111/j.1600-0706.2012.20532.x; Cezilly F, 1996, ECOLOGY, V77, P1143, DOI 10.2307/2265583; Cezilly F, 1997, IBIS, V139, P331, DOI 10.1111/j.1474-919X.1997.tb04632.x; Charlesworth B, 1994, CAMBRIDGE STUDIES MA, V2; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Chuei JY, 2007, ZOO BIOL, V26, P275, DOI 10.1002/zoo.20137; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; Desprez M, 2011, P ROY SOC B-BIOL SCI, V278, P3060, DOI 10.1098/rspb.2011.0189; Dugdale HL, 2011, MOL ECOL, V20, P3261, DOI 10.1111/j.1365-294X.2011.05167.x; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Gimenez O, 2010, ECOLOGY, V91, P951, DOI 10.1890/09-1903.1; GROOTHUIS T, 1992, ANIM BEHAV, V43, P1, DOI 10.1016/S0003-3472(05)80067-3; Hamel S, 2010, ECOL LETT, V13, P915, DOI 10.1111/j.1461-0248.2010.01478.x; HEPP GR, 1993, ECOLOGY, V74, P2027, DOI 10.2307/1940848; Johnson A, 2007, GREATER FLAMINGO; Kendall WL, 2002, ECOLOGY, V83, P3276; Kendall WL, 2001, BIOMETRICS, V57, P1113, DOI 10.1111/j.0006-341X.2001.01113.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lebreton JD, 2009, ADV ECOL RES, V41, P87, DOI 10.1016/S0065-2504(09)00403-6; Lee DE, 2011, J MAMMAL, V92, P517, DOI 10.1644/10-MAMM-A-042.1; Mauck RA, 2004, EVOLUTION, V58, P880, DOI 10.1554/03-147; Nevoux M, 2007, J ANIM ECOL, V76, P159, DOI 10.1111/j.1365-2656.2006.01191.x; Newton I, 1989, LIFETIME REPROD BIRD; NICHOLS JD, 1994, ECOLOGY, V75, P2052, DOI 10.2307/1941610; NOL E, 1987, J ANIM ECOL, V56, P301, DOI 10.2307/4816; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; Pike TW, 2006, P ROY SOC B-BIOL SCI, V273, P1093, DOI 10.1098/rspb.2005.3422; POLLOCK KH, 1981, BIOMETRICS, V37, P521, DOI 10.2307/2530565; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Pradel R, 1997, ECOLOGY, V78, P1431; Pyle P, 2001, J ANIM ECOL, V70, P1088, DOI 10.1046/j.0021-8790.2001.00567.x; Pyle P, 1997, BEHAV ECOL, V8, P140, DOI 10.1093/beheco/8.2.140; Reed E. T., 2004, Animal Biodiversity and Conservation, V27, P35; Rendon MA, 2001, BEHAV ECOL SOCIOBIOL, V50, P55, DOI 10.1007/s002650100326; Rivalan P, 2005, OECOLOGIA, V145, P564, DOI 10.1007/s00442-005-0159-4; Rouan L, 2009, J AGR BIOL ENVIR ST, V14, P338, DOI 10.1198/jabes.2009.06108; Sanz-Aguilar A, 2008, ECOLOGY, V89, P3195, DOI 10.1890/08-0431.1; Schmaltz L, 2011, J AVIAN BIOL, V42, P178, DOI 10.1111/j.1600-048X.2010.05112.x; Sedinger JS, 2001, J ANIM ECOL, V70, P798, DOI 10.1046/j.0021-8790.2001.00535.x; Stearns S.C., 1992, pi; Steiner UK, 2012, P NATL ACAD SCI USA, V109, P4684, DOI 10.1073/pnas.1018096109; Tavecchia G, 2005, J ANIM ECOL, V74, P201, DOI 10.1111/j.1365-2656.2005.00916.x; Tavecchia G, 2001, ECOLOGY, V82, P165, DOI 10.1890/0012-9658(2001)082[0165:SAARVI]2.0.CO;2; Tuljapurkar S, 2009, ECOL LETT, V12, P93, DOI 10.1111/j.1461-0248.2008.01262.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; WEIMERSKIRCH H, 1990, J ANIM ECOL, V59, P867, DOI 10.2307/5019; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson S, 2007, P ROY SOC B-BIOL SCI, V274, P2539, DOI 10.1098/rspb.2007.0643; WOOLLER RD, 1990, J ANIM ECOL, V59, P161, DOI 10.2307/5165; Wynne-Edwards VC, 1939, P ZOOL SOC LOND A-GE, V109, P127, DOI 10.1111/j.1096-3642.1939.tb03357.x	63	17	18	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51016	10.1371/journal.pone.0051016	http://dx.doi.org/10.1371/journal.pone.0051016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272085	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386600017
J	Thomson, RL; Tomas, G; Forsman, JT; Monkkonen, M				Thomson, Robert L.; Tomas, Gustavo; Forsman, Jukka T.; Monkkonen, Mikko			Manipulating Individual Decisions and Environmental Conditions Reveal Individual Quality in Decision-Making and Non-Lethal Costs of Predation Risk	PLOS ONE			English	Article							STRESS-PROTEIN-LEVELS; BREEDING HABITAT SELECTION; NEST-SITE SELECTION; CLUTCH SIZE; HSP70 EXPRESSION; PIED-FLYCATCHER; INFORMATION USE; HEAT-STRESS; BLUE TITS; EXPOSURE	Habitat selection is a crucial decision for any organism. Selecting a high quality site will positively impact survival and reproductive output. Predation risk is an important component of habitat quality that is known to impact reproductive success and individual condition. However, separating the breeding consequences of decision-making of wild animals from individual quality is difficult. Individuals face reproductive decisions that often vary with quality such that low quality individuals invest less. This reduced reproductive performance could appear a cost of increased risk but may simply reflect lower quality. Thus, teasing apart the effects of individual quality and the effect of predation risk is vital to understand the physiological and reproductive costs of predation risk alone on breeding animals. In this study we alter the actual territory location decisions of pied flycatchers by moving active nests relative to breeding sparrowhawks, the main predators of adult flycatchers. We experimentally measure the non-lethal effects of predation on adults and offspring while controlling for effects of parental quality, individual territory choice and initiation of breeding. We found that chicks from high predation risk nests (<50 m of hawk) were significantly smaller than chicks from low risk nests (>200 m from hawk). However, in contrast to correlative results, females in manipulated high risk nests did not suffer decreased body condition or increased stress response (HSP60 and HSP70). Our results suggest that territory location decisions relative to breeding avian predators cause spatial gradients in individual quality. Small adjustments in territory location decisions have crucial consequences and our results confirm non-lethal costs of predation risk that were expressed in terms of smaller offspring produced. However, females did not show costs in physiological condition which suggests that part of the costs incurred by adults exposed to predation risk are quality determined. Citation: Thomson RL, Tomas G, Forsman JT, Monkkonen M (2012) Manipulating Individual Decisions and Environmental Conditions Reveal Individual Quality in Decision-Making and Non-Lethal Costs of Predation Risk. PLoS ONE 7(12): e52226. doi:10.1371/journal.pone.0052226	[Thomson, Robert L.] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Tomas, Gustavo] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain; [Forsman, Jukka T.] Univ Oulu, Dept Biol, Oulu, Finland; [Monkkonen, Mikko] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland	University of Turku; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Oulu; University of Jyvaskyla	Thomson, RL (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	robtho@utu.fi	Thomson, Robert L/B-9637-2012; Forsman, Jukka/H-5345-2012; Tomas, Gustavo/J-7559-2012	Thomson, Robert L/0000-0002-6958-1259; Tomas, Gustavo/0000-0001-6701-2055; Monkkonen, Mikko/0000-0001-8897-3314	Oskar Oflund's foundation; Ella and Georg Ehrnrooth foundation; Academy of Finland [138049, 122665, 125720]; Programme Juan de la Cierva from Ministerio de Educacion y Ciencia; Ministerio de Educacion y Ciencia [BOS 2003-05724]	Oskar Oflund's foundation; Ella and Georg Ehrnrooth foundation; Academy of Finland(Academy of Finland); Programme Juan de la Cierva from Ministerio de Educacion y Ciencia; Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by: Oskar Oflund's foundation, Ella and Georg Ehrnrooth foundation and the Academy of Finland (project number 138049) to RT; Academy of Finland (project numbers: 122665 and 125720) to JF; Programme Juan de la Cierva and Grant BOS 2003-05724 from Ministerio de Educacion y Ciencia to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, EVOLUTION, V40, P574, DOI 10.1111/j.1558-5646.1986.tb00508.x; Arlt D, 2007, ECOLOGY, V88, P792, DOI 10.1890/06-0574; Blaustein L, 2004, OECOLOGIA, V138, P300, DOI 10.1007/s00442-003-1398-x; Buchanan KL, 2000, TRENDS ECOL EVOL, V15, P156, DOI 10.1016/S0169-5347(99)01812-1; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Doligez B, 2003, ECOLOGY, V84, P2582, DOI 10.1890/02-3116; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Fleshner M, 2004, PSYCHONEUROENDOCRINO, V29, P1142, DOI 10.1016/j.psyneuen.2004.01.007; Fontaine JJ, 2006, AM NAT, V168, P811, DOI 10.1086/508297; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; Fontaine JJ, 2011, CONDOR, V113, P825, DOI 10.1525/cond.2011.110027; Forsman JT, 2007, BEHAV ECOL, V18, P888, DOI 10.1093/beheco/arm048; Forstmeier W, 2004, OIKOS, V104, P487, DOI 10.1111/j.0030-1299.1999.12698.x; Herring G, 2007, THESCIENTIFICWORLDJO, V7, P1596, DOI 10.1100/tsw.2007.242; Huhta E, 1999, AUK, V116, P528, DOI 10.2307/4089385; Kessler A, 2002, ECOLOGY, V83, P2346, DOI 10.1890/0012-9658(2002)083[2346:MQSOOI]2.0.CO;2; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Kristensen TN, 2005, GENETICS, V171, P157, DOI 10.1534/genetics.104.039610; Kristensen TN, 2003, J GENET, V82, P89, DOI 10.1007/BF02715811; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; MARTIN TE, 1993, BIOSCIENCE, V43, P523, DOI 10.2307/1311947; Martinez-Padilla J, 2004, FUNCT ECOL, V18, P426, DOI 10.1111/j.0269-8463.2004.00874.x; Merino S, 1998, OECOLOGIA, V116, P343, DOI 10.1007/s004420050596; Merino S, 2002, ECOSCIENCE, V9, P300, DOI 10.1080/11956860.2002.11682716; Merino S, 2006, J ANIM ECOL, V75, P1147, DOI 10.1111/j.1365-2656.2006.01135.x; Monkkonen M, 2007, J ANIM ECOL, V76, P619, DOI 10.1111/j.1365-2656.2007.01233.x; Morosinotto C, 2010, J ANIM ECOL, V79, P327, DOI 10.1111/j.1365-2656.2009.01638.x; Pauwels K, 2005, J EVOLUTION BIOL, V18, P867, DOI 10.1111/j.1420-9101.2005.00890.x; PETTIFOR RA, 1988, NATURE, V336, P160, DOI 10.1038/336160a0; Resetarits WJ, 2005, ECOL LETT, V8, P480, DOI 10.1111/j.1461-0248.2005.00747.x; Scheuerlein A, 2001, P ROY SOC B-BIOL SCI, V268, P1575, DOI 10.1098/rspb.2001.1691; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; SIIKAMAKI P, 1995, ECOLOGY, V76, P308, DOI 10.2307/1940652; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Sorensen JG, 2011, CAN J ZOOL, V89, P1249, DOI 10.1139/Z11-105; Sorensen JG, 2004, J THERM BIOL, V29, P195, DOI 10.1016/j.jtherbio.2004.02.004; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Thomson RL, 2006, OIKOS, V113, P325, DOI 10.1111/j.2006.0030-1299.14376.x; Thomson RL, 2006, ECOGRAPHY, V29, P507; Thomson RL, 2011, ANIM BEHAV, V82, P1443, DOI 10.1016/j.anbehav.2011.09.029; Thomson RL, 2010, ECOLOGY, V91, P1832, DOI 10.1890/09-0989.1; Tomas G, 2005, ANN ZOOL FENN, V42, P45; Tomas G, 2004, J FIELD ORNITHOL, V75, P281, DOI 10.1648/0273-8570-75.3.281; Trnka A, 2011, ORNIS FENNICA, V88, P179; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668	51	9	9	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52226	10.1371/journal.pone.0052226	http://dx.doi.org/10.1371/journal.pone.0052226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272226	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386600057
J	Baron, JA; Laws, KM; Chen, JS; Culotta, VC				Baron, J. Allen; Laws, Kaitlin M.; Chen, Janice S.; Culotta, Valeria C.			Superoxide Triggers an Acid Burst in Saccharomyces cerevisiae to Condition the Environment of Glucose-starved Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; PLASMA-MEMBRANE; YEAST-CELLS; MITOCHONDRIAL DISEASE; MANGANESE; DISMUTASE; MUTATIONS; MUTANTS; GROWTH; SITE	Although yeast cells grown in abundant glucose tend to acidify their extracellular environment, they raise the pH of the environment when starved for glucose or when grown strictly with non-fermentable carbon sources. Following prolonged periods in this alkaline phase, Saccharomyces cerevisiae cells will switch to producing acid. The mechanisms and rationale for this "acid burst" were unknown. Herein we provide strong evidence for the role of mitochondrial superoxide in initiating the acid burst. Yeast mutants lacking the mitochondrial matrix superoxide dismutase (SOD2) enzyme, but not the cytosolic Cu,Zn-SOD1 enzyme, exhibited marked acceleration in production of acid on non-fermentable carbon sources. Acid production is also dramatically enhanced by the superoxide-producing agent, paraquat. Conversely, the acid burst is eliminated by boosting cellular levels of Mn-antioxidant mimics of SOD. We demonstrate that the acid burst is dependent on the mitochondrial aldehyde dehydrogenase Ald4p. Our data are consistent with a model in which mitochondrial superoxide damage to Fe-S enzymes in the tricarboxylic acid (TCA) cycle leads to acetate buildup by Ald4p. The resultant expulsion of acetate into the extracellular environment can provide a new carbon source to glucose-starved cells and enhance growth of yeast. By triggering production of organic acids, mitochondrial superoxide has the potential to promote cell population growth under nutrient depravation stress.	[Baron, J. Allen; Laws, Kaitlin M.; Chen, Janice S.; Culotta, Valeria C.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Culotta, VC (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	vculotta@jhsph.edu	Laws, Kaitlin Michelle/GPX-8412-2022	Chen, Janice/0000-0003-4797-3056; Baron, Allen/0000-0002-0593-3569; Laws, Kaitlin/0000-0003-4075-968X	National Institutes of Health [ES 08996, GM 50016]; Johns Hopkins University NIEHS, National Institutes of Health, center; National Institutes of Health NCI Training Grant [T32 CA009110]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008996, P30ES003819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050016, T32GM066698, R01GM050016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University NIEHS, National Institutes of Health, center; National Institutes of Health NCI Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES 08996 and GM 50016 (to V. C. C.) and the Johns Hopkins University NIEHS, National Institutes of Health, center.; Supported by National Institutes of Health NCI Training Grant T32 CA009110.	Ackrell B A, 1978, Methods Enzymol, V53, P466; Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Barnese K, 2012, P NATL ACAD SCI USA, V109, P6892, DOI 10.1073/pnas.1203051109; BLASZCZYNSKI M, 1985, ACTA MICROBIOL POL, V34, P243; Boubekeur S, 1999, J BIOL CHEM, V274, P21044, DOI 10.1074/jbc.274.30.21044; Burhans WC, 2009, CELL CYCLE, V8, P2300, DOI 10.4161/cc.8.14.8852; Burtner CR, 2011, CELL CYCLE, V10, P1385, DOI 10.4161/cc.10.9.15464; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Cap Michal, 2010, Commun Integr Biol, V3, P198; Cap M, 2009, J BIOL CHEM, V284, P32572, DOI 10.1074/jbc.M109.022871; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cocheme HM, 2009, METHOD ENZYMOL, V456, P395, DOI 10.1016/S0076-6879(08)04422-4; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Demir AB, 2010, BIOCHEM BIOPH RES CO, V400, P106, DOI 10.1016/j.bbrc.2010.08.019; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gleason JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024741; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; GUSKOVA RA, 1984, BIOCHIM BIOPHYS ACTA, V778, P579, DOI 10.1016/0005-2736(84)90409-7; Hayashi M, 1998, YEAST, V14, P905; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Jules M, 2004, APPL ENVIRON MICROB, V70, P2771, DOI 10.1128/AEM.70.5.2771-2778.2004; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Mbengue A, 2012, BRIT J HAEMATOL, V157, P171, DOI 10.1111/j.1365-2141.2012.09044.x; McCammon MT, 1996, GENETICS, V144, P57; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; MONK BC, 1991, J BACTERIOL, V173, P6826, DOI 10.1128/jb.173.21.6826-6836.1991; Navarro-Avino JP, 1999, YEAST, V15, P829, DOI 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Palkova Z, 2000, J CELL SCI, V113, P1923; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; Palkova Z, 2003, INT REV CYTOL, V225, P229, DOI 10.1016/S0074-7696(05)25006-4; Palkova Z, 2009, MOL MEMBR BIOL, V26, P228, DOI 10.1080/09687680902893130; Pedrajas JR, 1999, J BIOL CHEM, V274, P6366, DOI 10.1074/jbc.274.10.6366; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Reddi AR, 2011, GENETICS, V189, P1261, DOI 10.1534/genetics.111.134007; Reddi AR, 2009, FREE RADICAL BIO MED, V46, P154, DOI 10.1016/j.freeradbiomed.2008.09.032; Sanchez RJ, 2005, J BIOL INORG CHEM, V10, P913, DOI 10.1007/s00775-005-0044-y; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; SIGLER K, 1981, BIOCHIM BIOPHYS ACTA, V643, P583, DOI 10.1016/0005-2736(81)90354-0; SIKORSKI RS, 1989, GENETICS, V122, P19; Strain J, 1998, J BIOL CHEM, V273, P31138, DOI 10.1074/jbc.273.47.31138; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; SUMEGI B, 1992, BIOCHEMISTRY-US, V31, P8720, DOI 10.1021/bi00152a006; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Szeto SSW, 2010, J PROTEOME RES, V9, P6729, DOI 10.1021/pr100880y; VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995; VOGEL K, 1990, MOL MICROBIOL, V4, P2013, DOI 10.1111/j.1365-2958.1990.tb00560.x; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793	70	13	13	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4557	4566		10.1074/jbc.M112.409508	http://dx.doi.org/10.1074/jbc.M112.409508			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23281478	Green Published, hybrid			2022-12-25	WOS:000315340400006
J	Mondini, A; Sassone, F; Civello, DA; Garavaglia, ML; Bazzini, C; Rodighiero, S; Vezzoli, V; Conti, F; Torielli, L; Capasso, G; Paulmichl, M; Meyer, G				Mondini, Anna; Sassone, Francesca; Civello, Davide Antonio; Garavaglia, Maria Lisa; Bazzini, Claudia; Rodighiero, Simona; Vezzoli, Valeria; Conti, Fabio; Torielli, Lucia; Capasso, Giovanbattista; Paulmichl, Markus; Meyer, Giuliano			Hypertension-Linked Mutation of alpha-Adducin Increases CFTR Surface Expression and Activity in HEK and Cultured Rat Distal Convoluted Tubule Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SALT-SENSITIVE HYPERTENSION; SODIUM-CHANNEL ACTIVITY; EPITHELIAL NA+ CHANNEL; CYSTIC-FIBROSIS; PLASMA-MEMBRANE; BLOOD-PRESSURE; GENETIC-HYPERTENSION; CHLORIDE CHANNELS; CL-CHANNELS	The CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) activity and localization are influenced by the cytoskeleton, in particular by actin and its polymerization state. In this study we investigated whether the expression of the hypertensive mutations of alpha-adducin (G460W-S586C in humans, F316Y in rats), an actin capping protein, led to a functional modification of CFTR activity and surface expression. The experiments were performed on HEK293 T cells cotransfected with CFTR and the human wild type (WT) or G460W mutated alpha-adducin. In whole-cell patch-clamp experiments, both the CFTR chloride current and the slope of current activation after forskolin addition were significantly higher in HEK cells overexpressing the G460W adducin. A higher plasma membrane density of active CFTR channels was confirmed by cell-attached patch-clamp experiments, both in HEK cells and in cultured primary DCT cells, isolated from MHS (Milan Hypertensive Strain, a Wistar rat (Rattus norvegicus) hypertensive model carrying the F316Y adducin mutation), compared to MNS (Milan Normotensive Strain) rats. Western blot experiments demonstrated an increase of the plasma membrane CFTR protein expression, with a modification of the channel glycosylation state, in the presence of the mutated adducin. A higher retention of CFTR protein in the plasma membrane was confirmed both by FRAP (Fluorescence Recovery After Photobleaching) and photoactivation experiments. The present data indicate that in HEK cells and in isolated DCT cells the presence of the G460W-S586C hypertensive variant of adducin increases CFTR channel activity, possibly by altering its membrane turnover and inducing a retention of the channel in the plasmamembrane. Since CFTR is known to modulate the activity of many others transport systems, the increased surface expression of the channel could have consequences on the whole network of transport in kidney cells.	[Mondini, Anna; Sassone, Francesca; Civello, Davide Antonio; Garavaglia, Maria Lisa; Bazzini, Claudia; Vezzoli, Valeria; Meyer, Giuliano] Univ Milan, Dept Life Sci, Milan, Italy; [Rodighiero, Simona] Fdn Filarete, Milan, Italy; [Rodighiero, Simona] Prassis Res Inst, Sigma Tau, Settimo Mse, Italy; [Capasso, Giovanbattista] Univ Naples Federico II, Dept Internal Med, Naples, Italy; [Paulmichl, Markus] Paracelsus Med Univ, Inst Pharmacol & Toxicol, Salzburg, Austria	University of Milan; University of Naples Federico II; Paracelsus Private Medical University	Meyer, G (corresponding author), Univ Milan, Dept Life Sci, Milan, Italy.	giuliano.meyer@unimi.it	Garavaglia, Maria Lisa/AFV-3214-2022; Rodighiero, Simona/AAP-9816-2020; Meyer, Giuliano/G-8062-2011	Rodighiero, Simona/0000-0003-4236-7823; Vezzoli, Valeria/0000-0001-6396-7284; CIVELLO, DAVIDE ANTONIO/0000-0003-4133-8211; Capasso, Giovambattista/0000-0003-3469-8614; Mondini, Anna/0000-0002-3219-0684	Italian MIUR (Ministero Istruzione Universita Ricerca) [2008W5AZEC_002]	Italian MIUR (Ministero Istruzione Universita Ricerca)(Ministry of Education, Universities and Research (MIUR))	This paper was supported by grant #2008W5AZEC_002 (PRIN 2008; prin.miur.it) from the Italian MIUR (Ministero Istruzione Universita Ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EH, 1999, HYPERTENSION, V33, P1031, DOI 10.1161/01.HYP.33.4.1031; Ban H, 2007, GENE THER, V14, P1688, DOI 10.1038/sj.gt.3303032; Barriere H, 2004, J MEMBRANE BIOL, V198, P113, DOI 10.1007/s00232-004-0665-z; Bates IR, 2006, BIOPHYS J, V91, P1046, DOI 10.1529/biophysj.106.084830; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bernstein PL, 2011, SEMIN NEPHROL, V31, P475, DOI 10.1016/j.semnephrol.2011.09.002; BIANCHI G, 1975, CIRC RES, V36, P153, DOI 10.1161/01.RES.36.6.153; Bianchi G, 2005, AM J PHYSIOL-REG I, V289, pR1536, DOI 10.1152/ajpregu.00441.2005; BIANCHI G, 1994, P NATL ACAD SCI USA, V91, P3999, DOI 10.1073/pnas.91.9.3999; Cantiello HF, 2001, PFLUG ARCH EUR J PHY, V443, pS75; Capasso G, 2005, AM J PHYSIOL-RENAL, V288, pF1173, DOI 10.1152/ajprenal.00228.2004; Capasso G, 2008, AM J PHYSIOL-RENAL, V295, pF556, DOI 10.1152/ajprenal.00340.2007; Carmosino M, 2011, PFLUG ARCH EUR J PHY, V462, P281, DOI 10.1007/s00424-011-0967-9; Chang CT, 2005, J PHYSIOL-LONDON, V562, P271, DOI 10.1113/jphysiol.2004.077933; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Pinto ACOD, 2007, CELL PHYSIOL BIOCHEM, V20, P83, DOI 10.1159/000104156; Efendiev R, 2004, CIRC RES, V95, P1100, DOI 10.1161/01.RES.0000149570.20845.89; Ferrandi M, 1996, HYPERTENSION, V28, P1018, DOI 10.1161/01.HYP.28.6.1018; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Ferrandi M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001815; Ganeshan R, 2007, BBA-MOL CELL RES, V1773, P192, DOI 10.1016/j.bbamcr.2006.09.031; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Jin S, 2007, BIOPHYS J, V93, P1079, DOI 10.1529/biophysj.106.102244; Jouret F, 2011, METHODS MOL BIOL, V741, P285, DOI 10.1007/978-1-61779-117-8_19; Jouret F, 2009, PFLUG ARCH EUR J PHY, V457, P1227, DOI 10.1007/s00424-008-0594-2; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Kuhlman PA, 1996, J BIOL CHEM, V271, P7986, DOI 10.1074/jbc.271.14.7986; Kunzelmann K, 2003, PFLUG ARCH EUR J PHY, V445, P504, DOI 10.1007/s00424-002-0958-y; Kunzelmann K, 2002, CELL BIOCHEM BIOPHYS, V36, P209, DOI 10.1385/CBB:36:2-3:209; Lansdell KA, 1998, J PHYSIOL-LONDON, V508, P379, DOI 10.1111/j.1469-7793.1998.379bq.x; Lazrak A, 2011, AM J PHYSIOL-LUNG C, V301, pL557, DOI 10.1152/ajplung.00094.2011; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Li XL, 1998, J BIOL CHEM, V273, P19329, DOI 10.1074/jbc.273.30.19329; LIEBERMAN J, 1975, ANN INTERN MED, V82, P806, DOI 10.7326/0003-4819-82-6-806; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Lu M, 2010, P NATL ACAD SCI USA, V107, P6082, DOI 10.1073/pnas.0902661107; Luo TC, 2001, J VIROL, V75, P2488, DOI 10.1128/JVI.75.5.2488-2492.2001; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; MISCHE SM, 1987, J CELL BIOL, V105, P2837, DOI 10.1083/jcb.105.6.2837; Monterisi S, 2012, J CELL SCI; Morales MM, 2000, AN ACAD BRAS CIENC, V72, P399, DOI 10.1590/S0001-37652000000300013; Morales MM, 2001, PFLUG ARCH EUR J PHY, V443, P202, DOI 10.1007/s004240100671; Moscatelli A, 2007, J CELL SCI, V120, P3804, DOI 10.1242/jcs.012138; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; O'Riordan CR, 2000, GLYCOBIOLOGY, V10, P1225, DOI 10.1093/glycob/10.11.1225; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; Pera A, 2008, P NATL ACAD SCI USA, V105, P18608, DOI 10.1073/pnas.0805831105; Procino G, 2011, AM J HYPERTENS, V24, P822, DOI 10.1038/ajh.2011.47; Qualmann B, 2002, INT REV CYTOL, V220, P93; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; Scanlin TF, 2001, RESP RES, V2, P276, DOI 10.1186/rr69; Stanton BA, 1997, WIEN KLIN WOCHENSCHR, V109, P457; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Super M, 2004, HYPERTENSION, V44, P878, DOI 10.1161/01.HYP.0000145901.81989.46; Super M, 2000, LANCET, V355, P1840, DOI 10.1016/S0140-6736(00)02282-0; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Torielli L, 2008, AM J PHYSIOL-RENAL, V295, pF478, DOI 10.1152/ajprenal.90226.2008; Tripodi G, 1996, J CLIN INVEST, V97, P2815, DOI 10.1172/JCI118737; Vandewalle Alain, 2007, Chang Gung Med J, V30, P17; Veizis IE, 2007, PEDIATR NEPHROL, V22, P770, DOI 10.1007/s00467-006-0355-4; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Won S, 2011, FEBS LETT, V585, P2323, DOI 10.1016/j.febslet.2011.05.069; Xie Y, 2004, AM J PHYSIOL-RENAL, V287, pF722, DOI 10.1152/ajprenal.00135.2004	72	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52014	10.1371/journal.pone.0052014	http://dx.doi.org/10.1371/journal.pone.0052014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284854	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800023
J	Muxel, SM; Pires-Lapa, MA; Monteiro, AWA; Cecon, E; Tamura, EK; Floeter-Winter, LM; Markus, RP				Muxel, Sandra Marcia; Pires-Lapa, Marco Antonio; Arantes Monteiro, Alex Willian; Cecon, Erika; Tamura, Eduardo Koji; Floeter-Winter, Lucile Maria; Markus, Regina P.			NF-kappa B Drives the Synthesis of Melatonin in RAW 264.7 Macrophages by Inducing the Transcription of the Arylalkylamine-N-Acetyltransferase (AA-NAT) Gene	PLOS ONE			English	Article							PINEAL-GLAND; RESPONSE ELEMENT; C-REL; ACTIVATION; CELLS; EXPRESSION; RECEPTORS; ENDOCRINE; KB; INHIBITION	We demonstrate that during inflammatory responses the nuclear factor kappa B (NF-kappa B) induces the synthesis of melatonin by macrophages and that macrophage-synthesized melatonin modulates the function of these professional phagocytes in an autocrine manner. Expression of a DsRed2 fluorescent reporter driven by regions of the aa-nat promoter, that encodes the key enzyme involved in melatonin synthesis (arylalkylamine-N-acetyltransferase), containing one or two upstream kappa B binding sites in RAW 264.7 macrophage cell lines was repressed when NF-kappa B activity was inhibited by blocking its nuclear translocation or its DNA binding activity or by silencing the transcription of the RelA or c-Rel NF-kappa B subunits. Therefore, transcription of aa-nat driven by NF-kappa B dimers containing RelA or c-Rel subunits mediates pathogen-associated molecular patterns (PAMPs) or pro-inflammatory cytokine-induced melatonin synthesis in macrophages. Furthermore, melatonin acts in an autocrine manner to potentiate macrophage phagocytic activity, whereas luzindole, a competitive antagonist of melatonin receptors, decreases macrophage phagocytic activity. The opposing functions of NF-kappa B in the modulation of AA-NAT expression in pinealocytes and macrophages may represent the key mechanism for the switch in the source of melatonin from the pineal gland to immune-competent cells during the development of an inflammatory response.	[Muxel, Sandra Marcia; Pires-Lapa, Marco Antonio; Arantes Monteiro, Alex Willian; Cecon, Erika; Tamura, Eduardo Koji; Floeter-Winter, Lucile Maria; Markus, Regina P.] Univ Sao Paulo, Inst Biosci, Dept Physiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Markus, RP (corresponding author), Univ Sao Paulo, Inst Biosci, Dept Physiol, Sao Paulo, Brazil.	rpmarkus@usp.br	Tamura, Eduardo Koji/L-4360-2019; Markus, Regina P./AAC-1505-2021; Cecon, Erika/AAG-9413-2020; Markus, Regina P/K-2954-2012; Cecon, Erika/B-3444-2016; Cecon, Erika/F-9842-2014; Tamura, Eduardo Koji/F-7068-2012; Floeter-Winter, Lucile Maria/K-2618-2012; Muxel, Sandra/F-7464-2012; Floeter-Winter, Lucile Maria/AAE-7629-2019	Tamura, Eduardo Koji/0000-0002-6105-7452; Markus, Regina P./0000-0003-4606-6120; Cecon, Erika/0000-0003-2387-9313; Markus, Regina P/0000-0003-4606-6120; Cecon, Erika/0000-0003-2387-9313; Cecon, Erika/0000-0003-2387-9313; Tamura, Eduardo Koji/0000-0002-6105-7452; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Muxel, Sandra/0000-0003-0118-5361; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Lapa, Marco/0000-0003-4451-3169	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/7871-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 07/7871-6) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baler R, 1997, J BIOL CHEM, V272, P6979, DOI 10.1074/jbc.272.11.6979; Carrillo-Vico A, 2005, J CLIN ENDOCR METAB, V90, P992, DOI 10.1210/jc.2004-1429; CARVALHOSOUSA CE, 2011, FR ENDOCRINOL, V2, P1, DOI DOI 10.3389/FENDO.2011.00010; Cecon E, 2010, CHRONOBIOL INT, V27, P52, DOI 10.3109/07420521003661615; Cruz-Machado SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040142; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Fernandes PACM, 2006, J PINEAL RES, V41, P344, DOI 10.1111/j.1600-079X.2006.00373.x; Ferreira ZS, 2005, J PINEAL RES, V38, P182, DOI 10.1111/j.1600-079X.2004.00191.x; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilad E, 1998, FASEB J, V12, P685, DOI 10.1096/fasebj.12.9.685; Hardeland R, 2009, BIOFACTORS, V35, P183, DOI 10.1002/biof.23; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Huang DB, 2001, STRUCTURE, V9, P669, DOI 10.1016/S0969-2126(01)00635-9; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; Lotufo CMC, 2006, EUR J PHARMACOL, V534, P258, DOI 10.1016/j.ejphar.2006.01.050; Lotufo CMC, 2001, EUR J PHARMACOL, V430, P351, DOI 10.1016/S0014-2999(01)01369-3; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Majewski P, 2005, LIFE SCI, V76, P1907, DOI 10.1016/j.lfs.2004.04.062; Marcola M, 2012, J PINEAL RES; Markus RP, 2007, NEUROIMMUNOMODULAT, V14, P126, DOI 10.1159/000110635; Markus RP, 2011, ADV NEUROIMMUNE BIOL, V1, P95, DOI 10.3233/NIB-2011-009; Martins E, 2004, J LEUKOCYTE BIOL, V75, P1116, DOI 10.1189/jlb.1203614; Min KJ, 2012, J PINEAL RES, V52, P296, DOI 10.1111/j.1600-079X.2011.00943.x; Mohan N, 1995, BIOCHEM MOL BIOL INT, V37, P1063; Murakami Y, 2011, IN VIVO, V25, P641; Pontes GN, 2006, J PINEAL RES, V41, P136, DOI 10.1111/j.1600-079X.2006.00345.x; RALPH P, 1981, CANCER RES, V41, P3546; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Shi DB, 2012, J PINEAL RES, V53, P154, DOI 10.1111/j.1600-079X.2012.00982.x; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Shiu SY, 2012, J PINEAL RES; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; Skwarlo-Sonta K, 2003, CAN J PHYSIOL PHARM, V81, P342, DOI 10.1139/Y03-026; Tamura EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013958; Tan DX, 2007, J PINEAL RES, V43, P317, DOI 10.1111/j.1600-079X.2007.00513.x; Tan DX, 2010, BIOL REV, V85, P607, DOI 10.1111/j.1469-185X.2009.00118.x; VERWEIJ CL, 1991, J BIOL CHEM, V266, P14179; Xia MZ, 2012, J PINEAL RES	45	96	100	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52010	10.1371/journal.pone.0052010	http://dx.doi.org/10.1371/journal.pone.0052010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284853	Green Submitted, gold, Green Published			2022-12-25	WOS:000313158800022
J	Forrest, MD; Wall, MJ; Press, DA; Feng, JF				Forrest, Michael D.; Wall, Mark J.; Press, Daniel A.; Feng, Jianfeng			The Sodium-Potassium Pump Controls the Intrinsic Firing of the Cerebellar Purkinje Neuron	PLOS ONE			English	Article							ACTIVE MEMBRANE MODEL; CALCIUM EXCHANGE; ELECTROPHYSIOLOGICAL PROPERTIES; FUZZY SPACE; K+ CHANNELS; CELL SOMATA; ATPASE; MODULATION; SIMULATION; DENDRITES	In vitro, cerebellar Purkinje cells can intrinsically fire action potentials in a repeating trimodal or bimodal pattern. The trimodal pattern consists of tonic spiking, bursting, and quiescence. The bimodal pattern consists of tonic spiking and quiescence. It is unclear how these firing patterns are generated and what determines which firing pattern is selected. We have constructed a realistic biophysical Purkinje cell model that can replicate these patterns. In this model, Na+/K+ pump activity sets the Purkinje cell's operating mode. From rat cerebellar slices we present Purkinje whole cell recordings in the presence of ouabain, which irreversibly blocks the Na+/K+ pump. The model can replicate these recordings. We propose that Na+/K+ pump activity controls the intrinsic firing mode of cerbellar Purkinje cells.	[Forrest, Michael D.; Feng, Jianfeng] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Wall, Mark J.; Press, Daniel A.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Feng, Jianfeng] Fudan Univ, Computat Syst Biol Ctr, Shanghai 200433, Peoples R China	University of Warwick; University of Warwick; Fudan University	Forrest, MD (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	mikeforrest@hotmail.com		feng, jianfeng/0000-0002-9328-5732; Forrest, Michael/0000-0002-0648-7468; wall, mark/0000-0002-7014-1867	Medical Research Council (MRC) of the UK	Medical Research Council (MRC) of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Michael Forrest conducted the majority of this work and conducted it as a component of his Ph.D. research, which was funded by the Medical Research Council (MRC) of the UK, http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Amzica F, 2002, J NEUROSCI, V22, P1042, DOI 10.1523/JNEUROSCI.22-03-01042.2002; Arganda S, 2007, NAT NEUROSCI, V10, P1467, DOI 10.1038/nn1982; Baccus SA, 1998, P NATL ACAD SCI USA, V95, P8345, DOI 10.1073/pnas.95.14.8345; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; Blaustein MP, 2007, CIRC RES, V101, P959, DOI 10.1161/CIRCRESAHA.107.164459; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Brent R, 1976, NEW ALGORITHM MINIMI; Burke RE, 2000, J COMPUT NEUROSCI, V9, P31, DOI 10.1023/A:1008934327204; BUSH PC, 1993, J NEUROSCI METH, V46, P159, DOI 10.1016/0165-0270(93)90151-G; Canavier CC, 1999, J COMPUT NEUROSCI, V6, P49, DOI 10.1023/A:1008809000182; Cannon SC, 2004, NEURON, V43, P153, DOI 10.1016/j.neuron.2004.07.002; CHANG W, 1993, BRAIN RES, V614, P335, DOI 10.1016/0006-8993(93)91052-T; Colley B, 2004, RECEPTOR CHANNEL, V10, P25, DOI 10.1080/10606820490270870; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Delmas P, 2002, NEURON, V36, P787, DOI 10.1016/S0896-6273(02)01097-8; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P401, DOI 10.1152/jn.1994.71.1.401; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375, DOI 10.1152/jn.1994.71.1.375; Despa S, 2003, BIOPHYS J, V84, P4157, DOI 10.1016/S0006-3495(03)75140-6; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; Frohlich F, 2006, J NEUROSCI, V26, P6153, DOI 10.1523/JNEUROSCI.5509-05.2006; Genet S, 1997, PFLUG ARCH EUR J PHY, V434, P559, DOI 10.1007/s004240050436; Glitsch HG, 2001, PHYSIOL REV, V81, P1791, DOI 10.1152/physrev.2001.81.4.1791; GUSTAFSSON B, 1983, BRAIN RES, V275, P159, DOI 10.1016/0006-8993(83)90429-8; HEINEMANN U, 1977, BRAIN RES, V120, P231, DOI 10.1016/0006-8993(77)90903-9; HENKART M, 1976, J CELL BIOL, V70, P338, DOI 10.1083/jcb.70.2.338; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; Ito M, 1984, CEREBELLUM NEURAL CO; Johnston D., 1995, FDN CELLULAR NEUROPH; Kager H, 2007, J COMPUT NEUROSCI, V22, P105, DOI 10.1007/s10827-006-0001-y; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Komendantov AO, 2004, J NEUROPHYSIOL, V91, P346, DOI 10.1152/jn.00062.2003; LEDERER WJ, 1990, SCIENCE, V248, P283, DOI 10.1126/science.2326638; Lindblad DS, 1996, AM J PHYSIOL-HEART C, V271, pH1666, DOI 10.1152/ajpheart.1996.271.4.H1666; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; Mckay BE, 2007, J NEUROPHYSIOL, V97, P2590, DOI 10.1152/jn.00627.2006; Miyasho T, 2001, BRAIN RES, V891, P106, DOI 10.1016/S0006-8993(00)03206-6; MOODY WJ, 1974, EXP NEUROL, V42, P248, DOI 10.1016/0014-4886(74)90023-5; PHILIPSON KD, 1985, ANNU REV PHYSIOL, V47, P561; Prinz A., 2006, SCHOLARPEDIA, V2, P1903, DOI [10.4249/scholarpedia.l903, DOI 10.4249/SCHOLARPEDIA.1903]; Pulver SR, 2010, NAT NEUROSCI, V13, P53, DOI 10.1038/nn.2444; RAPP M, 1994, J PHYSIOL-LONDON, V474, P101, DOI 10.1113/jphysiol.1994.sp020006; Saraga F, 2003, J PHYSIOL-LONDON, V552, P673, DOI 10.1113/jphysiol.2003.046177; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sawczuk A, 1997, J NEUROPHYSIOL, V78, P2246, DOI 10.1152/jn.1997.78.5.2246; Scuri R, 2007, EUR J NEUROSCI, V25, P159, DOI 10.1111/j.1460-9568.2006.05257.x; Semb SO, 1996, ACTA PHYSIOL SCAND, V156, P213, DOI 10.1046/j.1365-201X.1996.211000.x; SHELTON DP, 1985, NEUROSCIENCE, V14, P111, DOI 10.1016/0306-4522(85)90168-X; Silverman BDZ, 2003, CARDIOVASC RES, V57, P1025, DOI 10.1016/S0008-6363(02)00645-4; Stryer L, 2002, BIOCHEMISTRY; Su Z, 1998, AM J PHYSIOL-HEART C, V275, pH1808, DOI 10.1152/ajpheart.1998.275.5.H1808; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Verdonck F, 2004, CELL CALCIUM, V35, P603, DOI 10.1016/j.ceca.2004.01.014; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; WENDTGALLITELLI MF, 1993, J PHYSIOL-LONDON, V472, P33, DOI 10.1113/jphysiol.1993.sp019934; Winklhofer A, 2003, NEUROPHARMACOLOGY, V44, P829, DOI 10.1016/S0028-3908(03)00070-4; WIT AL, 1981, CIRC RES, V49, P1029, DOI 10.1161/01.RES.49.4.1029; Womack M, 2002, J NEUROSCI, V22, P10603; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Womack MD, 2003, J NEUROSCI, V23, P2600; Zhang HY, 2012, CURR BIOL, V22, P526, DOI 10.1016/j.cub.2012.01.058	71	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51169	10.1371/journal.pone.0051169	http://dx.doi.org/10.1371/journal.pone.0051169			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284664	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500021
J	Fujiwara, T; Kubzansky, LD; Matsumoto, K; Kawachi, I				Fujiwara, Takeo; Kubzansky, Laura D.; Matsumoto, Kenji; Kawachi, Ichiro			The Association between Oxytocin and Social Capital	PLOS ONE			English	Article							SELF-RATED HEALTH; PLASMA OXYTOCIN; PARTICIPATION; NEIGHBORHOOD; TRUST; COMMUNITY; EMOTION; STRESS	Background: Oxytocin is known to be related to social behaviors, including trust. However, few studies have investigated the association between oxytocin levels and social capital. Thus, we tested the hypothesis that endogenous oxytocin levels are positively associated with social capital. We also considered whether the association differed across gender because previous studies have shown differential effects of OT on social behaviors depending on gender. Methods: We recruited a convenience sample of 50 women and 31 men in Japan via community sampling from whom we obtained urine sample with which to measure oxytocin levels. Individual-level cognitive social capital (social trust and mutual aid) and structural social capital (community participation) were assessed using a questionnaire. We used multivariate regression, adjusted for covariates (age, number of children, self-rated health, and education), and stratified by gender to consider associations between oxytocin and social capital. Results: Among women, oxytocin was inversely associated with social trust and mutual aid (p<0.05). However, women participating in only 1 organization in the community showed higher oxytocin than women who participated in either no organizations (p<0.05) or 2 or more organization (i.e. inverse-U shape association). Among men, no association was observed between oxytocin and either form of cognitive and structural social capital. Conclusion: Women who perceived low cognitive social capital showed higher oxytocin levels, while structural social capital showed inverse-U shape association with oxytocin. No association between oxytocin and social capital was found among men. Further study is needed to elucidate why oxytocin was inversely associated with cognitive social capital only among women.	[Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Kubzansky, Laura D.; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Cambridge, MA 02138 USA; [Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan	National Center for Child Health & Development - Japan; Harvard University; Harvard T.H. Chan School of Public Health; National Center for Child Health & Development - Japan	Fujiwara, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan.	fujiwara-tk@ncchd.go.jp			Research Development Grant for Child Health and Development from National Center for Child Health and Development [21 shi -10]	Research Development Grant for Child Health and Development from National Center for Child Health and Development	This research was supported by Research Development Grant for Child Health and Development from National Center for Child Health and Development (21 shi -10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICO JA, 1987, J CLIN ENDOCR METAB, V64, P340, DOI 10.1210/jcem-64-2-340; Aneshensel CS, 1996, J HEALTH SOC BEHAV, V37, P293, DOI 10.2307/2137258; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bolin K, 2003, SOC SCI MED, V56, P2379, DOI 10.1016/S0277-9536(02)00242-3; Carlson P, 2004, SOC SCI MED, V59, P1985, DOI 10.1016/j.socscimed.2004.03.003; CARTER CS, 1992, ANN NY ACAD SCI, V652, P204, DOI 10.1111/j.1749-6632.1992.tb34356.x; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ellaway A, 2001, URBAN STUD, V38, P2299, DOI 10.1080/00420980120087171; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Feldman R, 2011, DEVELOPMENTAL SCI, V14, P752, DOI 10.1111/j.1467-7687.2010.01021.x; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; Fujiwara T, J EPIDEMIOL IN PRESS; Fujiwara T, 2008, AM J PREV MED, V35, P139, DOI 10.1016/j.amepre.2008.04.015; Fujiwara T, 2012, ACTA MED OKAYAMA, V66, P343; Fukuyama F, 1995, TRUST SOCIAL VIRTURE; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Glei DA, 2012, SOC SCI MED; Gonzaga GC, 2006, EMOTION, V6, P163, DOI 10.1037/1528-3542.6.2.163; Grewen KM, 2005, PSYCHOSOM MED, V67, P531, DOI 10.1097/01.psy.0000170341.88395.47; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Heim C, 2009, MOL PSYCHIATR, V14, P954, DOI 10.1038/mp.2008.112; Hyyppa MT, 2003, HEALTH EDUC RES, V18, P770, DOI 10.1093/her/cyf044; Hyyppa MT, 2001, PREV MED, V32, P148, DOI 10.1006/pmed.2000.0782; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; KEVERNE EB, 1992, ANN NY ACAD SCI, V652, P83, DOI 10.1111/j.1749-6632.1992.tb34348.x; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lai JCL, 2012, SCI WORLD J, P1, DOI 10.1100/2012/929067; Lindstrom M, 2004, SOC SCI MED, V59, P595, DOI 10.1016/j.socscimed.2003.11.006; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; Lindstrom M, 2003, TOB CONTROL, V12, P274, DOI 10.1136/tc.12.3.274; McCulloch A, 2001, BRIT MED J, V323, P208, DOI 10.1136/bmj.323.7306.208; Mitchell C. U., 2002, CITY COMMUNITY, V1, P199, DOI DOI 10.1111/1540-6040.00017; Mitsui S, 2011, HORM BEHAV, V60, P239, DOI 10.1016/j.yhbeh.2011.05.012; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Oksanen T, 2012, J HYPERTENS, V30, P1129, DOI 10.1097/HJH.0b013e32835377ed; Rose R, 2000, SOC SCI MED, V51, P1421, DOI 10.1016/S0277-9536(00)00106-4; Steptoe A, 2001, ANN BEHAV MED, V23, P177, DOI 10.1207/S15324796ABM2303_5; Subramanian SV, 2002, J URBAN HEALTH, V79, pS21, DOI 10.1093/jurban/79.suppl_1.S21; Sudo T, 1978, Horumon To Rinsho, V26, P179; Taylor SE, 2006, PSYCHOSOM MED, V68, P238, DOI 10.1097/01.psy.0000203242.95990.74; Turner RA, 1999, PSYCHIATRY, V62, P97, DOI 10.1080/00332747.1999.11024859; Ueshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012135; Uphoff N, 1999, UNDERSTANDING SOCIAL, P215; Veenstra G, 2005, SOC SCI MED, V60, P2799, DOI 10.1016/j.socscimed.2004.11.013; Veenstra G, 2000, SOC SCI MED, V50, P619, DOI 10.1016/S0277-9536(99)00307-X; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Ziersch AM, 2004, J EPIDEMIOL COMMUN H, V58, P493, DOI 10.1136/jech.2003.009084	48	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52018	10.1371/journal.pone.0052018	http://dx.doi.org/10.1371/journal.pone.0052018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284856	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300069
J	Godsey, B; Heiser, D; Civin, C				Godsey, Brian; Heiser, Diane; Civin, Curt			Inferring MicroRNA Regulation of mRNA with Partially Ordered Samples of Paired Expression Data and Exogenous Prediction Algorithms	PLOS ONE			English	Article							GENE-EXPRESSION; DOWN-REGULATION; TARGETS; IDENTIFICATION; GENECODIS; MIRBASE	MicroRNAs (miRs) are known to play an important role in mRNA regulation, often by binding to complementary sequences in "target" mRNAs. Recently, several methods have been developed by which existing sequence-based target predictions can be combined with miR and mRNA expression data to infer true miR-mRNA targeting relationships. It has been shown that the combination of these two approaches gives more reliable results than either by itself. While a few such algorithms give excellent results, none fully addresses expression data sets with a natural ordering of the samples. If the samples in an experiment can be ordered or partially ordered by their expected similarity to one another, such as for time-series or studies of development processes, stages, or types, (e. g. cell type, disease, growth, aging), there are unique opportunities to infer miR-mRNA interactions that may be specific to the underlying processes, and existing methods do not exploit this. We propose an algorithm which specifically addresses [partially] ordered expression data and takes advantage of sample similarities based on the ordering structure. This is done within a Bayesian framework which specifies posterior distributions and therefore statistical significance for each model parameter and latent variable. We apply our model to a previously published expression data set of paired miR and mRNA arrays in five partially ordered conditions, with biological replicates, related to multiple myeloma, and we show how considering potential orderings can improve the inference of miR-mRNA interactions, as measured by existing knowledge about the involved transcripts.	[Godsey, Brian] Vienna Univ Technol, Dept Stat & Probabil, A-1040 Vienna, Austria; [Godsey, Brian] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Heiser, Diane] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Heiser, Diane; Civin, Curt] Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA; [Civin, Curt] Univ Maryland, Sch Med, Dept Physiol, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Civin, Curt] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA	Technische Universitat Wien; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Godsey, B (corresponding author), Vienna Univ Technol, Dept Stat & Probabil, A-1040 Vienna, Austria.	briangodsey@gmail.com		Pellegrini, Matteo/0000-0001-9355-9564	National Foundation for Cancer Research; National Institutes of Health [PO1CA70970, CA70970, DK080750]; Maryland Stem Cell Research Foundation/TEDCO [2007-MSCRFII-0114, 2008-MSCRF-303524, 2010-MSCRFII-0065]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA070970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080750] Funding Source: NIH RePORTER	National Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Foundation/TEDCO; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants to C.I.C. from the National Foundation for Cancer Research (Fellow Award), the National Institutes of Health (PO1CA70970, CA70970, and DK080750), and the Maryland Stem Cell Research Foundation/TEDCO (2007-MSCRFII-0114, 2008-MSCRF-303524, and 2010-MSCRFII-0065). Funding for open access charge: National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Beal M.J., 2003, VARIATIONAL ALGORITH; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen LJ, 2011, CANCER LETT, V309, P62, DOI 10.1016/j.canlet.2011.05.017; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Heuck C, 2012, CLIN CANC RES; Huang J C, 2008, Pac Symp Biocomput, P52; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jayaswal V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp153; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Jopling CL, 2006, COLD SH Q B, V71, P369; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Muniategui A, 2012, BRIEFINGS BIOINFORMA; Muniategui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030766; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; R Development Core Team, 2009, R FDN STAT COMP; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stingo FC, 2010, ANN APPL STAT, V4, P2024, DOI 10.1214/10-AOAS360; Teschendorff AE, 2005, BIOINFORMATICS, V21, P3025, DOI 10.1093/bioinformatics/bti466; Tokumoto M, 2011, J TOXICOL SCI, V36, P191, DOI 10.2131/jts.36.191; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Welling M, 2006, SIAM PROC S, P474; Winn JM, 2003, THESIS ST JOHNS COLL	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51480	10.1371/journal.pone.0051480	http://dx.doi.org/10.1371/journal.pone.0051480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284698	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300027
J	Slekovec, C; Plantin, J; Cholley, P; Thouverez, M; Talon, D; Bertrand, X; Hocquet, D				Slekovec, Celine; Plantin, Julie; Cholley, Pascal; Thouverez, Michelle; Talon, Daniel; Bertrand, Xavier; Hocquet, Didier			Tracking Down Antibiotic-Resistant Pseudomonas aeruginosa Isolates in a Wastewater Network	PLOS ONE			English	Article							EXTENDED-SPECTRUM OXACILLINASES; FIELD GEL-ELECTROPHORESIS; METALLO-BETA-LACTAMASE; STRAINS; INDUCTION; PATTERNS; REVEALS	The Pseudomonas aeruginosa-containing wastewater released by hospitals is treated by wastewater treatment plants (WWTPs), generating sludge, which is used as a fertilizer, and effluent, which is discharged into rivers. We evaluated the risk of dissemination of antibiotic-resistant P. aeruginosa (AR-PA) from the hospital to the environment via the wastewater network. Over a 10-week period, we sampled weekly 11 points (hospital and urban wastewater, untreated and treated water, sludge) of the wastewater network and the river upstream and downstream of the WWTP of a city in eastern France. We quantified the P. aeruginosa load by colony counting. We determined the susceptibility to 16 antibiotics of 225 isolates, which we sorted into three categories (wild-type, antibiotic-resistant and multidrug-resistant). Extended-spectrum beta-lactamases (ESBLs) and metallo-beta-lactamases (MBLs) were identified by gene sequencing. All non-wild-type isolates (n = 56) and a similar number of wild-type isolates (n = 54) were genotyped by pulsed-field gel electrophoresis and multilocus sequence typing. Almost all the samples (105/110, 95.5%) contained P. aeruginosa, with high loads in hospital wastewater and sludge (>= 3 x 10(6) CFU/l or/kg). Most of the multidrug-resistant isolates belonged to ST235, CC111 and ST395. They were found in hospital wastewater and some produced ESBLs such as PER-1 and MBLs such as IMP-29. The WWTP greatly reduced P. aeruginosa counts in effluent, but the P. aeruginosa load in the river was nonetheless higher downstream than upstream from the WWTP. We conclude that the antibiotic-resistant P. aeruginosa released by hospitals is found in the water downstream from the WWTP and in sludge, constituting a potential risk of environmental contamination.	[Slekovec, Celine; Plantin, Julie; Cholley, Pascal; Thouverez, Michelle; Talon, Daniel; Bertrand, Xavier; Hocquet, Didier] CHU Besancon, Serv Hyg Hosp, F-25030 Besancon, France; [Slekovec, Celine; Plantin, Julie; Cholley, Pascal; Thouverez, Michelle; Talon, Daniel; Bertrand, Xavier; Hocquet, Didier] Univ Franche Comte, Unite Mixte Rech Chronoenvironm 6249, F-25030 Besancon, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte	Hocquet, D (corresponding author), CHU Besancon, Serv Hyg Hosp, F-25030 Besancon, France.	dhocquet@univ-fcomte.fr	Bertrand, Xavier/AAK-3270-2021; Bertrand, Xavier/AAL-3809-2021; Hocquet, Didier/AAK-9107-2020	Bertrand, Xavier/0000-0002-8028-1396; Hocquet, Didier/0000-0002-4192-7238	University Hospital of Besancon	University Hospital of Besancon	The study was funded by the University Hospital of Besancon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BMR-Raisin network, 2010, MULT RES BACT SURV F; Cholley P, 2011, J CLIN MICROBIOL, V49, P2578, DOI 10.1128/JCM.00102-11; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hocquet D, 2003, ANTIMICROB AGENTS CH, V47, P1887, DOI 10.1128/AAC.47.6.1887-1894.2003; Hocquet D, 2007, ANTIMICROB AGENTS CH, V51, P3531, DOI 10.1128/AAC.00503-07; Hocquet D, 2011, J CLIN MICROBIOL, V49, P2262, DOI 10.1128/JCM.02585-10; Hocquet D, 2010, ANTIMICROB AGENTS CH, V54, P3512, DOI 10.1128/AAC.01646-09; Jeannot K, 2012, ANTIMICROB AGENTS CH, V56, P2187, DOI 10.1128/AAC.05838-11; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Khodursky AB, 1998, J BIOL CHEM, V273, P27668, DOI 10.1074/jbc.273.42.27668; LIAO XW, 1995, ANTIMICROB AGENTS CH, V39, P1871, DOI 10.1128/AAC.39.8.1871; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; MACH PA, 1982, APPL ENVIRON MICROB, V44, P1395, DOI 10.1128/AEM.44.6.1395-1403.1982; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Morita Y, 2003, J ANTIMICROB CHEMOTH, V51, P991, DOI 10.1093/jac/dkg173; Normark S, 1995, MICROB DRUG RESIST, V1, P111, DOI 10.1089/mdr.1995.1.111; Prado T, 2008, LETT APPL MICROBIOL, V46, P136, DOI 10.1111/j.1472-765X.2007.02275.x; Quinteira S, 2006, APPL ENVIRON MICROB, V72, P3743, DOI 10.1128/AEM.72.5.3743-3745.2006; Dinh QT, 2011, TALANTA, V85, P1238, DOI 10.1016/j.talanta.2011.05.013; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Schwartz T, 2006, FEMS MICROBIOL ECOL, V57, P158, DOI 10.1111/j.1574-6941.2006.00100.x; Scotta C, 2011, ANTIMICROB AGENTS CH, V55, P5376, DOI 10.1128/AAC.00716-11; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Talon D, 1996, J HOSP INFECT, V32, P135, DOI 10.1016/S0195-6701(96)90055-9; Tamtam F, 2009, ANAL BIOANAL CHEM, V393, P1709, DOI 10.1007/s00216-008-2576-9; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tumeo E, 2008, INT J HYG ENVIR HEAL, V211, P200, DOI 10.1016/j.ijheh.2007.02.010; Van Mansfeld R, 2009, J CLIN MICROBIOL, V47, P4096, DOI 10.1128/JCM.01462-09; Vettoretti L, 2009, EUR J CLIN MICROBIOL, V28, P1217, DOI 10.1007/s10096-009-0767-8; Yang CM, 2009, LETT APPL MICROBIOL, V48, P560, DOI 10.1111/j.1472-765X.2009.02572.x; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1273, DOI 10.1128/AAC.34.6.1273	32	62	62	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e49300	10.1371/journal.pone.0049300	http://dx.doi.org/10.1371/journal.pone.0049300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284623	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300007
J	Hoermann, S; Franz, EA; Regenbrecht, H				Hoermann, Simon; Franz, Elizabeth A.; Regenbrecht, Holger			Referred Sensations Elicited by Video-Mediated Mirroring of Hands	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; VISUAL FEEDBACK; SYNDROME TYPE-1; CORTICAL REORGANIZATION; VIRTUAL-REALITY; PHANTOM LIMBS; BOX THERAPY; INJURY; BRAIN; TOUCH	Humans readily perceive ownership of a limb even when it is artificially induced as in the case of using a mirror reflection. However, mirror reflections are very constrained perceptions which do not allow transformations and varied contexts as often occurs in real life. The extent to which perceived limb ownership occurs with video-mediated manipulations is not known, particularly given the perception would no longer be a precise copy (reflection) of a person's own limb. The present study directly compared referred sensations of the limbs with the use of a mirror reflection to those obtained with a new video-mediated setup to assess perceived ownership. Manipulations that could not be performed with a standard mirror reflection, such as reversal of the spatial positions of the limbs, were also investigated to examine how far the perceived ownership effects could be pushed. Across a series of experiments, data on the quality, intensity and location of referred sensations were collected and analyzed together with measures of hand ownership and participants' experience of the two setups. Results reveal that participants felt referred sensations in both the optical and the video-mediated setup, and that video-mediated manipulations of hand-position reversals produced equal to stronger effects of ownership compared with the mirror reflection. These findings open up new possibilities for scientific experimentation and therapy that are discussed in the paper.	[Hoermann, Simon; Regenbrecht, Holger] Univ Otago, Dept Informat Sci, Dunedin, New Zealand; [Franz, Elizabeth A.] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago; University of Otago	Hoermann, S (corresponding author), Univ Otago, Dept Informat Sci, Dunedin, New Zealand.	shoermann@infoscience.otago.ac.nz	Hoermann, Simon/AAT-2334-2021	Hoermann, Simon/0000-0002-4201-844X	University of Otago [106961.01.R.DL]	University of Otago	Parts of this research have been funded by a University of Otago Research Grant (106961.01.R.DL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acerra NE, 2005, NEUROLOGY, V65, P751, DOI 10.1212/01.wnl.0000178745.11996.8c; Altschuler EL, 1999, LANCET, V353, P2035, DOI 10.1016/S0140-6736(99)00920-4; Altschuler EL, 2008, SCAND J PLAST RECONS, V42, P110, DOI 10.1080/02844310701510355; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Durgin FH, 2007, PSYCHOL SCI, V18, P152, DOI 10.1111/j.1467-9280.2007.01865.x; Franz EA, 2004, EXP BRAIN RES, V157, P174, DOI 10.1007/s00221-004-1831-3; Franz EA, 2004, J MOTOR BEHAV, V36, P71, DOI 10.3200/JMBR.36.1.71-81; IJsselsteijn WA, 2006, PRESENCE-TELEOP VIRT, V15, P455, DOI 10.1162/pres.15.4.455; Karmarkar A, 2006, ANAESTHESIA, V61, P412, DOI 10.1111/j.1365-2044.2006.04605.x; Kraemer HH, 2008, EUR J PAIN, V12, P128, DOI 10.1016/j.ejpain.2007.02.005; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; McCabe CS, 2008, CURR PAIN HEADACHE R, V12, P103, DOI 10.1007/s11916-008-0020-7; McCabe CS, 2003, RHEUMATOLOGY, V42, P1067, DOI 10.1093/rheumatology/keg298; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; Moore CI, 2000, P NATL ACAD SCI USA, V97, P14703, DOI 10.1073/pnas.250348997; Moseley GL, 2004, PAIN, V108, P192, DOI 10.1016/j.pain.2004.01.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pescatore A, 2008, P 11 ANN INT WORKSH; Ramachandran VS, 2010, MED HYPOTHESES, V75, P495, DOI 10.1016/j.mehy.2010.07.003; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Regenbrecht HT, 2011, PRESENCE-TELEOP VIRT, V20, P559, DOI 10.1162/PRES_a_00082; Sathian K, 2000, NEUROLOGY, V54, P1866, DOI 10.1212/WNL.54.9.1866; Selles RW, 2008, J REHABIL MED, V40, P312, DOI 10.2340/16501977-0158; Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170; Takasugi J, 2011, PSYCHOL RES-PSYCH FO, V75, P54, DOI 10.1007/s00426-010-0287-2; Tichelaar YIGV, 2007, INT J REHABIL RES, V30, P181, DOI 10.1097/MRR.0b013e32813a2e4b; [No title captured]	30	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50942	10.1371/journal.pone.0050942	http://dx.doi.org/10.1371/journal.pone.0050942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272080	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300014
J	Reif, R; Qin, J; Shi, L; Dziennis, S; Zhi, ZW; Nuttall, AL; Wang, RK				Reif, Roberto; Qin, Jia; Shi, Lei; Dziennis, Suzan; Zhi, Zhongwei; Nuttall, Alfred L.; Wang, Ruikang K.			Monitoring Hypoxia Induced Changes in Cochlear Blood Flow and Hemoglobin Concentration Using a Combined Dual-Wavelength Laser Speckle Contrast Imaging and Doppler Optical Microangiography System	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; OXYGENATION; NOISE; MODEL; PERFUSION; VELOCITY	A synchronized dual-wavelength laser speckle contrast imaging (DWLSCI) system and a Doppler optical microangiography (DOMAG) system was developed to determine several ischemic parameters in the cochlea due to a systemic hypoxic challenge. DWLSCI can obtain two-dimensional data, and was used to determine the relative changes in cochlear blood flow, and change in the concentrations of oxyhemoglobin (HbO), deoxyhemoglobin (Hb) and total hemoglobin (HbT) in mice. DOMAG can obtain three-dimensional data, and was used to determine the changes in cochlear blood flow with single vessel resolution. It was demonstrated that during a hypoxic challenge there was an increase in the concentrations of Hb, a decrease in the concentrations of HbO and cochlear blood flow, and a slight decrease in the concentration of HbT. Also, the rate of change in the concentrations of Hb and HbO was quantified during and after the hypoxic challenge. The ability to simultaneously measure these ischemic parameters with high spatio-temporal resolution will allow the detailed quantitative analysis of several hearing disorders, and will be useful for diagnosing and developing treatments.	[Reif, Roberto; Qin, Jia; Shi, Lei; Dziennis, Suzan; Zhi, Zhongwei; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Sch Med, Oregon Hearing Res Ctr, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; Oregon Health & Science University	Wang, RK (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	wangrk@uw.edu	Wang, Ruikang/L-3889-2019; An, Lin/C-9923-2016; Zhi, Zhongwei/H-4175-2015	Wang, Ruikang/0000-0001-5169-8822; Zhi, Zhongwei/0000-0001-8995-7287	NIDCD [R01 DC010201, R01 DC000105, P30 DC005983]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010201, K23DC000105, P30DC005983, R01DC000105] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by research grants from the NIDCD R01 DC010201 (RKW), R01 DC000105 (ALN) and P30 DC005983 (ALN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; BONNER R, 1981, APPL OPTICS, V20, P2097, DOI 10.1364/AO.20.002097; Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359; Cantos R, 2000, P NATL ACAD SCI USA, V97, P11707, DOI 10.1073/pnas.97.22.11707; Cheng HY, 2008, OPT EXPRESS, V16, P10214, DOI 10.1364/OE.16.010214; Choudhury N, 2010, IEEE J SEL TOP QUANT, V16, P524, DOI 10.1109/JSTQE.2009.2032671; Du CW, 2005, J CEREBR BLOOD F MET, V25, P1078, DOI 10.1038/sj.jcbfm.9600102; Duncan DD, 2008, J OPT SOC AM A, V25, P2088, DOI 10.1364/JOSAA.25.002088; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; Dziennis S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106003; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI 10.2184/lsj.31.635; HAWKINS JE, 1971, ANN OTO RHINOL LARYN, V80, P903, DOI 10.1177/000348947108000617; HULTCRANTZ E, 1979, ARCH OTO-RHINO-LARYN, V224, P103, DOI 10.1007/BF00455231; HULTCRANTZ E, 1979, ACTA PHYSIOL SCAND, V106, P29, DOI 10.1111/j.1748-1716.1979.tb06366.x; Jero J, 2001, HEARING RES, V151, P106, DOI 10.1016/S0378-5955(00)00216-1; Jones PB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2950312; Kusaka T, 2003, OPT REV, V10, P466, DOI 10.1007/s10043-003-0466-0; Lamm K, 1996, Audiol Neurootol, V1, P148; Luo ZC, 2009, OPT LETT, V34, P1480, DOI 10.1364/OL.34.001480; MILLER JM, 1983, HEARING RES, V11, P385, DOI 10.1016/0378-5955(83)90069-2; MILLER JM, 1995, OTOLARYNG HEAD NECK, V112, P101, DOI 10.1016/S0194-5998(95)70308-X; Mom T, 2001, J ACOUST SOC AM, V110, P1477, DOI 10.1121/1.1390337; Mom T, 2005, FR ORL, V88, P81; NUTTALL AL, 1987, HEARING RES, V27, P111, DOI 10.1016/0378-5955(87)90012-8; Nuttall Alfred L., 1999, Noise Health, V2, P17; PERLMAN H B, 1959, Laryngoscope, V69, P591; PRAZMA J, 1983, ARCH OTOLARYNGOL, V109, P611; Qin J, 2012, OPT LETT, V37, P4005, DOI 10.1364/OL.37.004005; Qin J, 2012, BIOMED OPT EXPRESS, V3, P455, DOI 10.1364/BOE.3.000455; Ramirez-San-Juan JC, 2008, OPT EXPRESS, V16, P3197, DOI 10.1364/OE.16.003197; Ren TY, 1995, HEARING RES, V92, P30, DOI 10.1016/0378-5955(95)00192-1; Rosenberg M E, 1992, Br J Sports Med, V26, P161; SANTI PA, 1978, OTOLARYNG HEAD NECK, V86, P354, DOI 10.1177/019459987808600229; Shi XR, 2011, HEARING RES, V282, P10, DOI 10.1016/j.heares.2011.08.006; SINGH D, 1976, J LARYNGOL OTOL, V90, P1113, DOI 10.1017/S0022215100083201; Subhash HM, 2011, IEEE T MED IMAGING, V30, P224, DOI 10.1109/TMI.2010.2072934; THALMANN R, 1972, LARYNGOSCOPE, V82, P2249, DOI 10.1288/00005537-197212000-00013; THORNE PR, 1987, HEARING RES, V27, P1, DOI 10.1016/0378-5955(87)90021-9; Tominaga M, 2006, ACTA OTO-LARYNGOL, V126, P232, DOI 10.1080/00016480500316803; Wang RKK, 2010, IEEE J SEL TOP QUANT, V16, P545, DOI 10.1109/JSTQE.2009.2033609; Wang RK, 2009, OPT EXPRESS, V17, P8926, DOI 10.1364/OE.17.008926; Zhi ZW, 2011, BIOMED OPT EXPRESS, V2, P579, DOI 10.1364/BOE.2.000579	43	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52041	10.1371/journal.pone.0052041	http://dx.doi.org/10.1371/journal.pone.0052041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272205	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300051
J	Zhang, X; Ung, CY; Lam, SH; Ma, J; Chen, YZ; Zhang, LX; Gong, ZY; Li, BW				Zhang, Xun; Ung, Choong Yong; Lam, Siew Hong; Ma, Jing; Chen, Yu Zong; Zhang, Louxin; Gong, Zhiyuan; Li, Baowen			Toxicogenomic Analysis Suggests Chemical-Induced Sexual Dimorphism in the Expression of Metabolic Genes in Zebrafish Liver	PLOS ONE			English	Article							GENDER-DIFFERENCES; SPOTTED-MICROARRAY; ACID-METABOLISM; BRAIN; DIFFERENTIATION; TESTOSTERONE; HORMONES; DRUGS; MICE	Differential gene expression in two sexes is widespread throughout the animal kingdom, giving rise to sex-dimorphic gene activities and sex-dependent adaptability to environmental cues, diets, growth and development as well as susceptibility to diseases. Here, we present a study using a toxicogenomic approach to investigate metabolic genes that show sex-dimorphic expression in the zebrafish liver triggered by several chemicals. Our analysis revealed that, besides the known genes for xenobiotic metabolism, many functionally diverse metabolic genes, such as ELOVL fatty acid elongase, DNA-directed RNA polymerase, and hydroxysteroid dehydrogenase, were also sex-dimorphic in their response to chemical treatments. Moreover, sex-dimorphic responses were also observed at the pathway level. Pathways belonging to xenobiotic metabolism, lipid metabolism, and nucleotide metabolism were enriched with sex-dimorphically expressed genes. We also observed temporal differences of the sex-dimorphic responses, suggesting that both genes and pathways are differently correlated during different periods of chemical perturbation. The ubiquity of sex-dimorphic activities at different biological hierarchies indicate the importance and the need of considering the sex factor in many areas of biological researches, especially in toxicology and pathology.	[Zhang, Xun; Ma, Jing; Chen, Yu Zong; Zhang, Louxin; Gong, Zhiyuan; Li, Baowen] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Zhang, Xun; Ma, Jing; Chen, Yu Zong; Li, Baowen] Natl Univ Singapore, Ctr Computat Sci & Engn, Singapore 117548, Singapore; [Ung, Choong Yong; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Ung, Choong Yong; Zhang, Louxin] Natl Univ Singapore, Dept Math, Singapore 117548, Singapore; [Chen, Yu Zong] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Li, Baowen] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Zhang, X (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore.	g0801800@nus.edu.sg; dbsgzy@nus.edu.sg	Zhang, Louxin/M-4865-2016; Lam, Siew Hong/H-8483-2012; Gong, Zhiyuan/H-8794-2012; Li, Baowen/G-3003-2011	Zhang, Louxin/0000-0003-0260-824X; Gong, Zhiyuan/0000-0002-9660-5260; Li, Baowen/0000-0002-8728-520X; Chen, Yu Zong/0000-0002-5473-8022	Singapore National Research Foundation; Environment & Water Industry Programme Office (EWI) of the PUB [R-154-000-328-272]; Ministry of Education of Singapore [MOE2009-T2-2-064]	Singapore National Research Foundation(National Research Foundation, Singapore); Environment & Water Industry Programme Office (EWI) of the PUB; Ministry of Education of Singapore(Ministry of Education, Singapore)	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. CYU is currently supported by Ministry of Education of Singapore Grant MOE2009-T2-2-064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Bakker J, 2006, NAT NEUROSCI, V9, P220, DOI 10.1038/nn1624; BARDIN CW, 1981, SCIENCE, V211, P1285, DOI 10.1126/science.7010603; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; De Leon-Nava MA, 2009, J STEROID BIOCHEM, V113, P57, DOI 10.1016/j.jsbmb.2008.11.003; Decsi T, 2011, AM J CLIN NUTR, V94, p1914S, DOI 10.3945/ajcn.110.000893; Dennis C, 2004, NATURE, V427, P390, DOI 10.1038/427390a; Enserink M, 2005, SCIENCE, V308, P1578, DOI 10.1126/science.308.5728.1578; Gochfeld M, 2007, ENVIRON RES, V104, P4, DOI 10.1016/j.envres.2005.12.005; Han E, 2009, INT J OBESITY, V33, P249, DOI 10.1038/ijo.2008.193; Holden C, 2005, SCIENCE, V308, P1574, DOI 10.1126/science.308.5728.1574; Hollander M, 1973, NONPARAMETRIC STAT M; Horiuchi H, 2000, LIFE SCI, V66, P2051, DOI 10.1016/S0024-3205(00)00532-4; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam Siew Hong, 2009, V546, P175, DOI 10.1007/978-1-60327-977-2_12; Lam Siew Hong, 2009, V546, P197, DOI 10.1007/978-1-60327-977-2_13; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Mugford CA, 1998, DRUG METAB REV, V30, P441, DOI 10.3109/03602539808996322; Nicolson TJ, 2010, TRENDS PHARMACOL SCI, V31, P108, DOI 10.1016/j.tips.2009.12.001; NISHIDA Y, 1975, EXPERIENTIA, V31, P1134, DOI 10.1007/BF02326752; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Robison BD, 2008, COMP BIOCHEM PHYS D, V3, P141, DOI 10.1016/j.cbd.2008.01.001; Santos EM, 2008, COMP BIOCHEM PHYS A, V149, P314, DOI 10.1016/j.cbpa.2008.01.010; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Stromberg Anna, 2003, Eur J Cardiovasc Nurs, V2, P7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Waxman D J, 2000, Novartis Found Symp, V227, P61; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Waxman DJ., 2000, NOVART FDN SYMP, V227, P75; Woods SC, 2003, EXP BIOL MED, V228, P1175; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	42	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51971	10.1371/journal.pone.0051971	http://dx.doi.org/10.1371/journal.pone.0051971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272195	gold, Green Submitted, Green Published			2022-12-25	WOS:000312483300044
J	Spinelli, KJ; Gillespie, PG				Spinelli, Kateri J.; Gillespie, Peter G.			Monitoring Intracellular Calcium Ion Dynamics in Hair Cell Populations with Fluo-4 AM	PLOS ONE			English	Article							MECHANOTRANSDUCER CHANNEL; MECHANICAL TRANSDUCTION; MAMMALIAN COCHLEA; TURTLE; RESTORATION; ADAPTATION; CA2+; RAT	We optimized Fluo-4 AM loading of chicken cochlea to report hair-bundle Ca2+ signals in populations of hair cells. The bundle Ca2+ signal reported the physiological state of the bundle and cell; extruding cells had very high bundle Fluo-4 fluorescence, cells with intact bundles and tip links had intermediate fluorescence, and damaged cells with broken tip links had low fluorescence. Moreover, Fluo-4 fluorescence in the bundle correlated with Ca2+ entry through transduction channels; mechanically activating transduction channels increased the Fluo-4 signal, while breaking tip links with Ca2+ chelators or blocking Ca2+ entry through transduction channels each caused bundle and cell-body Fluo-4 fluorescence to decrease. These results show that when tip links break, bundle and soma Ca2+ decrease, which could serve to stimulate the hair cell's tip-link regeneration process. Measurement of bundle Ca2+ with Fluo-4 AM is therefore a simple method for assessing mechanotransduction in hair cells and permits an increased understanding of the interplay of tip links, transduction channels, and Ca2+ signaling in the hair cell.	[Gillespie, Peter G.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	gillespp@ohsu.edu		Spinelli, Kateri/0000-0002-6290-0886; Barr-Gillespie, Peter/0000-0002-9787-5860	National Institutes of Health [F31 DC10107, R01 DC002368, P30 DC005983]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R01DC002368, F31DC010107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants F31 DC10107 (to KJS), R01 DC002368 (to PGG), and P30 DC005983 (to PGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Auer M, 2008, JARO-J ASSOC RES OTO, V9, P215, DOI 10.1007/s10162-008-0114-2; Beurg M, 2010, J NEUROPHYSIOL, V104, P18, DOI 10.1152/jn.00019.2010; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Bortolozzi M, 2010, J BIOL CHEM, V285, P37693, DOI 10.1074/jbc.M110.170092; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Crumling MA, 2009, NEUROSCIENCE, V161, P1144, DOI 10.1016/j.neuroscience.2009.02.076; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; Frolenkov Gregory I., 2009, V493, P381, DOI 10.1007/978-1-59745-523-7_23; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Glowatzki E, 2008, CURR OPIN NEUROBIOL, V18, P389, DOI 10.1016/j.conb.2008.09.006; Griesinger CB, 2004, EUR J NEUROSCI, V20, P41, DOI 10.1111/j.0953-816X.2004.03452.x; Griesinger CB, 2002, J NEUROSCI, V22, P3939, DOI 10.1523/JNEUROSCI.22-10-03939.2002; Johnson SL, 2011, NEURON, V70, P1143, DOI 10.1016/j.neuron.2011.04.024; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; Meyers JR, 2003, J NEUROSCI, V23, P4054; Raybould NP, 2007, J PHYSIOL-LONDON, V579, P101, DOI 10.1113/jphysiol.2006.122929; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Spinelli KJ, 2012, P NATL ACAD SCI USA, V109, pE268, DOI 10.1073/pnas.1115866109; Yuan T, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3290799; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469	29	25	25	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51874	10.1371/journal.pone.0051874	http://dx.doi.org/10.1371/journal.pone.0051874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284798	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900061
J	Wallner, B; Fieder, M; Seidler, H				Wallner, Bernard; Fieder, Martin; Seidler, Horst			Ownership of Dwelling Affects the Sex Ratio at Birth in Uganda	PLOS ONE			English	Article							TRIVERS-WILLARD; MATERNAL AGE; MOTHERS; DETERMINANTS; ASSOCIATION; FERTILITY; POLYGYNY; PARITY; ORDER; TIME	Background: Socio-economic conditions can affect the secondary sex ratio in humans. Mothers under good environmental conditions are predicted to increase the birth rates of sons according to the Trivers-Willard hypothesis (TWH). This study analyzed the effects of ownership and non-ownership of dwellings on the sex ratio at birth (SRB) on a Ugandan sample. Methodology/Principal Findings: Our investigation included 438,640 mothers aged between 12 and 54 years. The overall average SRB was 0.5008. Mothers who live in owned dwellings gave increased births to sons (0.5019) compared to those who live in non-owned dwellings (0.458). Multivariate statistics revealed the strongest effects of dwelling ownership when controlling for demographic and social variables such as marital status, type of marriage, mothers' age, mothers' education, parity and others. Conclusions/Significance: The results are discussed in the framework of recent plausible models dealing with the adjustment of the sex ratio. We conclude that the aspect of dwelling status could represent an important socio-economic parameter in relation to SRB variations in humans if further studies are able to analyze it between different countries in a comparative way.	[Wallner, Bernard; Fieder, Martin; Seidler, Horst] Univ Vienna, Dept Anthropol, Vienna, Austria; [Wallner, Bernard] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Wallner, Bernard] Univ Vienna, Cognit Sci Res Platform, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna	Wallner, B (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.	bernard.wallner@univie.ac.at	Wallner, Bernard/B-1089-2009	wallner, bernard/0000-0002-1089-7443				Almond D, 2007, P ROY SOC B-BIOL SCI, V274, P2491, DOI 10.1098/rspb.2007.0524; Barber N, 2004, SOC BIOL, V51, P71; Cameron EZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004195; Catalano R, 2005, INT J EPIDEMIOL, V34, P944, DOI 10.1093/ije/dyi081; Catalano RA, 2003, HUM REPROD, V18, P1972, DOI 10.1093/humrep/deg370; ChaconPuignau GC, 1996, SOC BIOL, V43, P257; CHAHNAZARIAN A, 1988, SOC BIOL, V35, P214; ChartsBin statistics collector team, 2011, WORLDW HUM SEX RAT B; Curtis MA, 2010, SOC SCI MED, V71, P2049, DOI 10.1016/j.socscimed.2010.09.034; ERICKSON JD, 1976, ANN HUM GENET, V40, P205, DOI 10.1111/j.1469-1809.1976.tb00182.x; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Garenne M, 2008, HUM BIOL, V80, P473, DOI 10.3378/1534-6617-80.5.473; Garenne M, 2009, J BIOSOC SCI, V41, P399, DOI 10.1017/S0021932008003106; Gibson MA, 2003, P ROY SOC B-BIOL SCI, V270, pS108, DOI 10.1098/rsbl.2003.0031; Grant V. J., 2003, EVOL PSYCHOL, V1, P96, DOI [10.1177/147470490300100106, DOI 10.1177/147470490300100106, DOI 10.1177/]; Grant V. J., 1998, MATERNAL PERSONALITY; Grant VJ, 2011, ANIM BEHAV, V82, P893, DOI 10.1016/j.anbehav.2011.07.029; GUERRERO R, 1974, NEW ENGL J MED, V291, P1056, DOI 10.1056/NEJM197411142912004; Helle S, 2002, SCIENCE, V296, P1085, DOI 10.1126/science.1070106; Helle S, 2008, BIOL LETTERS, V4, P60, DOI 10.1098/rsbl.2007.0482; IMAIZUMI Y, 1979, ANN HUM GENET, V42, P457, DOI 10.1111/j.1469-1809.1979.tb00679.x; Jacobsen R, 1999, HUM REPROD, V14, P3120, DOI 10.1093/humrep/14.12.3120; JAMES WH, 1985, J BIOSOC SCI, V17, P47, DOI 10.1017/S0021932000015467; JAMES WH, 1987, HUM BIOL, V59, P721; James WH, 2001, HUM REPROD, V16, P2246, DOI 10.1093/humrep/16.10.2246; James WH, 2010, J BIOSOC SCI, V42, P587, DOI 10.1017/S002193201000012X; JOHNSON NE, 1984, J BIOSOC SCI, V16, P531, DOI 10.1017/S0021932000015352; Kulu H, 2007, DEMOGR RES, V17, P775, DOI 10.4054/DemRes.2007.17.26; Lazarus J, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P287, DOI 10.1017/CBO9780511542053.015; MACKEY WC, 1987, ETHOL SOCIOBIOL, V8, P49, DOI 10.1016/0162-3095(87)90057-4; Martina John F, 2008, Biodemography Soc Biol, V54, P141, DOI 10.1080/19485565.2008.9989139; Mulder CH, 2001, EUR J POPUL, V17, P137, DOI 10.1023/A:1010706308868; Norton HW, 1940, J HERED, V31, P29, DOI 10.1093/oxfordjournals.jhered.a104788; Owen D, 2003, ENDOCRINOLOGY, V144, P2775, DOI 10.1210/en.2002-0145; Pollet TV, 2009, BIOL LETTERS, V5, P765, DOI 10.1098/rsbl.2009.0394; Ruckstuhl KE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-269; Scahfer K, 1999, COLLEGIUM ANTROPOL, V23, P369; Stein AD, 2004, P ROY SOC B-BIOL SCI, V271, pS37, DOI 10.1098/rsbl.2003.0086; TEITELBAUM MS, 1971, J BIOSOC SCI, V3, P23, DOI 10.1017/S0021932000007793; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Wallner B, 2005, NEUROENDOCRINOL LETT, V26, P759; WHITING JWM, 1993, AM ANTHROPOL, V95, P435, DOI 10.1525/aa.1993.95.2.02a00090; Wilson K, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P48, DOI 10.1017/CBO9780511542053.004; ZALDIVAR ME, 1991, HUM ECOL, V19, P469, DOI 10.1007/BF00889791	44	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51463	10.1371/journal.pone.0051463	http://dx.doi.org/10.1371/journal.pone.0051463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055RZ	23284697	Green Submitted, gold, Green Published			2022-12-25	WOS:000312435900021
J	Misra, UK; Pizzo, SV				Misra, Uma K.; Pizzo, Salvatore V.			Receptor-Recognized alpha(2)-Macroglobulin Binds to Cell Surface-Associated GRP78 and Activates mTORC1 and mTORC2 Signaling in Prostate Cancer Cells	PLOS ONE			English	Article							CARBOXYL-TERMINAL DOMAIN; UNFOLDED PROTEIN RESPONSE; MAMMALIAN TARGET; RAPAMYCIN MTOR; GENE-EXPRESSION; KINASE B; AKT; PHOSPHORYLATION; LIGATION; RICTOR	Objective: Tetrameric alpha(2)-macroglobulin (alpha M-2), a plasma panproteinase inhibitor, is activated upon interaction with a proteinase, and undergoes a major conformational change exposing a receptor recognition site in each of its subunits. Activated alpha M-2 (alpha M-2*) binds to cancer cell surface GRP78 and triggers proliferative and antiapoptotic signaling. We have studied the role of alpha M-2* in the regulation of mTORC1 and TORC2 signaling in the growth of human prostate cancer cells. Methods: Employing immunoprecipitation techniques and Western blotting as well as kinase assays, activation of the mTORC1 and mTORC2 complexes, as well as down stream targets were studied. RNAi was also employed to silence expression of Raptor, Rictor, or GRP78 in parallel studies. Results: Stimulation of cells with alpha M-2* promotes phosphorylation of mTOR, TSC2, S6-Kinase, 4EBP, Akt(T308), and Akt(S473) in a concentration and time-dependent manner. Rheb, Raptor, and Rictor also increased. alpha M-2* treatment of cells elevated mTORC1 kinase activity as determined by kinase assays of mTOR or Raptor immunoprecipitates. mTORC1 activity was sensitive to LY294002 and rapamycin or transfection of cells with GRP78 dsRNA. Down regulation of Raptor expression by RNAi significantly reduced alpha M-2*-induced S6-Kinase phosphorylation at T389 and kinase activity in Raptor immunoprecipitates. alpha M-2*-treated cells demonstrate about a twofold increase in mTORC2 kinase activity as determined by kinase assay of Akt(S473) phosphorylation and levels of p-Akt (S473) in mTOR and Rictor immunoprecipitates. mTORC2 activity was sensitive to LY294002 and transfection of cells with GRP78 dsRNA, but insensitive to rapamycin. Down regulation of Rictor expression by RNAi significantly reduces alpha M-2*-induced phosphorylation of Akt(S473) phosphorylation in Rictor immunoprecipitates. Conclusion: Binding of alpha M-2* to prostate cancer cell surface GRP78 upregulates mTORC1 and mTORC2 activation and promotes protein synthesis in the prostate cancer cells.	[Misra, Uma K.; Pizzo, Salvatore V.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Pizzo, SV (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	salvatore.pizzo@duke.edu						Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Feldman ME, 2009, PLOS BIOL, P03781; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Liao YD, 2003, INT J CANCER, V107, P676, DOI 10.1002/ijc.11471; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2010, BIOCHEM BIOPH RES CO, V392, P538, DOI 10.1016/j.bbrc.2010.01.058; Misra UK, 2010, APOPTOSIS, V15, P173, DOI 10.1007/s10495-009-0430-y; Misra UK, 2009, J CELL BIOCHEM, V106, P381, DOI 10.1002/jcb.22016; Misra UK, 1998, BBA-MOL CELL RES, V1401, P121, DOI 10.1016/S0167-4889(97)00123-7; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J BIOL CHEM, V280, P38276, DOI 10.1074/jbc.M507332200; Misra UK, 2005, J IMMUNOL, V175, P2525, DOI 10.4049/jimmunol.175.4.2525; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2004, CELL SIGNAL, V16, P487, DOI 10.1016/j.cellsig.2003.09.010; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2002, J BIOL CHEM, V277, P36509, DOI 10.1074/jbc.M203543200; Misra UK, 2007, BIOCHEM BIOPH RES CO, V391, P272; Misra UK, 2012, J CELL BIOCHEM, V113, P1488, DOI 10.1002/jcb.24018; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2008, J CELL BIOCHEM, V104, P96, DOI 10.1002/jcb.21607; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Otto A, 1998, J UROLOGY, V159, P297, DOI 10.1016/S0022-5347(01)64085-0; PIZZO SV, 2006, HEMOSTASIS THROMBOSE, P395; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Smorenburg SM, 1996, HEPATOLOGY, V23, P560; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Wu S. M., 2000, HEMOSTASIS THROMBOSI, P367; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Yu H, 1999, J La State Med Soc, V151, P209; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	68	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51735	10.1371/journal.pone.0051735	http://dx.doi.org/10.1371/journal.pone.0051735			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272152	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800073
J	Ran, WQ; Higgs, PG				Ran, Wenqi; Higgs, Paul G.			Contributions of Speed and Accuracy to Translational Selection in Bacteria	PLOS ONE			English	Article							CODON USAGE BIAS; ESCHERICHIA-COLI; GENE-EXPRESSION; PROTEIN EXPRESSION; ADAPTATION INDEX; TRANSFER-RNAS; EVOLUTION; GENOME; GROWTH; YEAST	Among bacteria, we have previously shown that species that are capable of rapid growth have stronger selection on codon usage than slow growing species, and possess higher numbers of rRNA and tRNA genes. This suggests that fast-growers are adapted for fast protein synthesis. There is also considerable evidence that codon usage is influenced by accuracy of translation, and some authors have argued that accuracy is more important than speed. Here we compare the strength of the two effects by studying the codon usages in high and low expression genes and on conserved and variable sites within high expression genes. We introduce a simple statistical method that can be used to assess the significance and the strength of the two types of bias in the same sets of sequences. We compare our statistical measure of codon bias to the common used codon adaptation index, and show that the new measure is preferable for three reasons for the purposes of this analysis. Across a large sample of bacterial genomes, both effects from speed and accuracy are clearly visible, although the speed effect appears to be much stronger than the accuracy effect and is found to be significant in a larger proportion of genomes. It is also difficult to explain the correlation of codon bias in the high expression genes with growth rates and numbers of copies of tRNA and rRNA genes on the basis of selection for accuracy. Hence we conclude that selection for translational speed is a dominant effect in driving codon usage bias in fast-growing bacteria, with selection for accuracy playing a small supplementary role. Citation: Ran W, Higgs PG (2012) Contributions of Speed and Accuracy to Translational Selection in Bacteria. PLoS ONE 7(12): e51652. doi:10.1371/journal.pone. 0051652	[Ran, Wenqi; Higgs, Paul G.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Ran, Wenqi] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	McMaster University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Ran, WQ (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	wenqi.ran@nih.gov; higgsp@mcmaster.ca		Higgs, Paul/0000-0001-5220-9760	Natural Sciences and Engineering Research Council of Canada; Intramural Program of National Library of Medicine, National Center for Biotechnology Information, National Institutes of Health	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Intramural Program of National Library of Medicine, National Center for Biotechnology Information, National Institutes of Health	This work was supported by the Natural Sciences and Engineering Research Council of Canada. Wenqi Ran is supported by The Intramural Program of National Library of Medicine, National Center for Biotechnology Information, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1994, GENETICS, V136, P927; Akashi H, 2003, GENETICS, V164, P1291; BULMER M, 1991, GENETICS, V129, P897; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Higgs PG, 2008, MOL BIOL EVOL, V25, P2279, DOI 10.1093/molbev/msn173; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Kloster M, 2008, NUCLEIC ACIDS RES, V36, P3819, DOI 10.1093/nar/gkn288; KURLAND CG, 1991, FEBS LETT, V285, P165, DOI 10.1016/0014-5793(91)80797-7; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; Ran WQ, 2010, MOL BIOL EVOL, V27, P2129, DOI 10.1093/molbev/msq102; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Roth A, 2012, CODON EVOLUTION: MECHANISMS AND MODELS, P189; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Thomas SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002103; Wang R, 2005, GENOME RES, V15, P1118, DOI 10.1101/gr.3994105; Zhang Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-43	29	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51652	10.1371/journal.pone.0051652	http://dx.doi.org/10.1371/journal.pone.0051652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272132	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800060
J	Sonnewald, S; Priller, JPR; Schuster, J; Glickmann, E; Hajirezaei, MR; Siebig, S; Mudgett, MB; Sonnewald, U				Sonnewald, Sophia; Priller, Johannes P. R.; Schuster, Julia; Glickmann, Eric; Hajirezaei, Mohammed-Reza; Siebig, Stefan; Mudgett, Mary Beth; Sonnewald, Uwe			Regulation of Cell Wall-Bound Invertase in Pepper Leaves by Xanthomonas campestris pv. vesicatoria Type Three Effectors	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; PAMP-TRIGGERED IMMUNITY; IN-SOURCE LEAVES; POTATO-VIRUS-Y; III EFFECTORS; EXTRACELLULAR INVERTASE; SYMPTOM DEVELOPMENT; PRIMARY METABOLISM; SINK METABOLISM; INNATE IMMUNITY	Xanthomonas campestris pv. vesicatoria (Xcv) possess a type 3 secretion system (T3SS) to deliver effector proteins into its Solanaceous host plants. These proteins are involved in suppression of plant defense and in reprogramming of plant metabolism to favour bacterial propagation. There is increasing evidence that hexoses contribute to defense responses. They act as substrates for metabolic processes and as metabolic semaphores to regulate gene expression. Especially an increase in the apoplastic hexose-to-sucrose ratio has been suggested to strengthen plant defense. This shift is brought about by the activity of cell wall-bound invertase (cw-Inv). We examined the possibility that Xcv may employ type 3 effector (T3E) proteins to suppress cw-Inv activity during infection. Indeed, pepper leaves infected with a T3SS-deficient Xcv strain showed a higher level of cw-Inv mRNA and enzyme activity relative to Xcv wild type infected leaves. Higher cw-Inv activity was paralleled by an increase in hexoses and mRNA abundance for the pathogenesis-related gene PRQ. These results suggest that Xcv suppresses cw-Inv activity in a T3SS-dependent manner, most likely to prevent sugar-mediated defense signals. To identify Xcv T3Es that regulate cw-Inv activity, a screen was performed with eighteen Xcv strains, each deficient in an individual T3E. Seven Xcv T3E deletion strains caused a significant change in cw-Inv activity compared to Xcv wild type. Among them, Xcv lacking the xopB gene (Xcv Delta xopB) caused the most prominent increase in cw-Inv activity. Deletion of xopB increased the mRNA abundance of PRQ in Xcv Delta xopB-infected pepper leaves, but not of Pti5 and Acre31, two PAMP-triggered immunity markers. Inducible expression of XopB in transgenic tobacco inhibited Xcv-mediated induction of cw-Inv activity observed in wild type plants and resulted in severe developmental phenotypes. Together, these data suggest that XopB interferes with cw-Inv activity in planta to suppress sugar-enhanced defense responses during Xcv infection. Citation: Sonnewald S, Priller JPR, Schuster J, Glickmann E, Hajirezaei M-R, et al. (2012) Regulation of Cell Wall-Bound Invertase in Pepper Leaves by Xanthomonas campestris pv. vesicatoria Type Three Effectors. PLoS ONE 7(12): e51763. doi:10.1371/journal.pone.0051763	[Sonnewald, Sophia; Priller, Johannes P. R.; Schuster, Julia; Siebig, Stefan; Sonnewald, Uwe] Univ Erlangen Nurnberg, Lehrstuhl Biochem, D-91054 Erlangen, Germany; [Glickmann, Eric; Hajirezaei, Mohammed-Reza] Inst Pflanzengenet & Kulturpflanzenforsch, Gatersleben, Germany; [Mudgett, Mary Beth] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Erlangen Nuremberg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Stanford University	Sonnewald, S (corresponding author), Univ Erlangen Nurnberg, Lehrstuhl Biochem, D-91054 Erlangen, Germany.	ssonne@biologie.uni-erlangen.de	Sonnewald, Uwe/J-7875-2012	Sonnewald, Uwe/0000-0003-1835-5339; Priller, Josef/0000-0001-7596-0979	Deutsche Forschungsgemeinschaft in frame of the collaborative research centre "reprogramming of host cells by microbial effectors'' [SBF796]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068886] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft in frame of the collaborative research centre "reprogramming of host cells by microbial effectors''(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partly supported by a grant from the Deutsche Forschungsgemeinschaft in frame of the collaborative research centre "reprogramming of host cells by microbial effectors'' (SBF796) to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Bartetzko V, 2009, MOL PLANT MICROBE IN, V22, P655, DOI 10.1094/MPMI-22-6-0655; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Biemelt S, 2006, J PLANT PHYSIOL, V163, P307, DOI 10.1016/j.jplph.2005.10.011; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Bonfig KB, 2010, MOL PLANT, V3, P1037, DOI 10.1093/mp/ssq053; Brown I, 1995, MOL PLANT MICROBE IN, V8, P825, DOI 10.1094/MPMI-8-0825; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Buttner D, 2002, J BACTERIOL, V184, P2389, DOI 10.1128/JB.184.9.2389-2398.2002; Caddick MX, 1998, NAT BIOTECHNOL, V16, P177, DOI 10.1038/nbt0298-177; Canteros B, 1990, DIVERSITY PLASMIDS P; Chen S, 2003, PLANT J, V36, P731, DOI 10.1046/j.1365-313X.2003.01914.x; Chou HM, 2000, MOL PLANT PATHOL, V1, P99, DOI 10.1046/j.1364-3703.2000.00013.x; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Ehness R, 1997, PLANT CELL, V9, P1825; Erbs G, 2008, CHEM BIOL, V15, P438, DOI 10.1016/j.chembiol.2008.03.017; Essmann J, 2008, PLANT PHYSIOL, V147, P1288, DOI 10.1104/pp.108.121418; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Ferreira SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-93; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Godt DE, 1997, PLANT PHYSIOL, V115, P273, DOI 10.1104/pp.115.1.273; Hajirezaei MR, 2003, J EXP BOT, V54, P477, DOI 10.1093/jxb/erg040; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Herbers K, 2000, MOL PLANT PATHOL, V1, P51, DOI 10.1046/j.1364-3703.2000.00007.x; Herbers K, 1996, PLANT CELL, V8, P793, DOI 10.1105/tpc.8.5.793; Herbers K, 1996, FEBS LETT, V397, P239, DOI 10.1016/S0014-5793(96)01183-0; HOFGEN R, 1990, PLANT SCI, V66, P221, DOI 10.1016/0168-9452(90)90207-5; Hofius D, 2007, J VIROL, V81, P11870, DOI 10.1128/JVI.01525-07; HORSFALL J. G., 1957, Zeitschrift fur Pflanzenkrankheiten, Pflanzenpathologie und Pflanzenschutz, V64, P415; Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x; Huang LF, 2007, FUNCT PLANT BIOL, V34, P499, DOI 10.1071/FP06227; Huguet E, 1998, MOL MICROBIOL, V29, P1379, DOI 10.1046/j.1365-2958.1998.01019.x; JAKOBEK JL, 1993, PLANT CELL, V5, P57, DOI 10.1105/tpc.5.1.57; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Keshavarzi M, 2004, MOL PLANT MICROBE IN, V17, P805, DOI 10.1094/MPMI.2004.17.7.805; Kim JG, 2008, PLANT CELL, V20, P1915, DOI 10.1105/tpc.108.058529; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Kocal N, 2008, PLANT PHYSIOL, V148, P1523, DOI 10.1104/pp.108.127977; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Mason G, 2008, PLANT MOL BIOL REP, V26, P156, DOI 10.1007/s11105-008-0031-x; Metz M, 2005, PLANT J, V41, P801, DOI 10.1111/j.1365-313X.2005.02338.x; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Noel L, 2003, J BACTERIOL, V185, P7092, DOI 10.1128/JB.185.24.7092-7102.2003; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Rausch T, 2004, BBA-PROTEINS PROTEOM, V1696, P253, DOI 10.1016/j.bbapap.2003.09.017; Roden JA, 2004, P NATL ACAD SCI USA, V101, P16624, DOI 10.1073/pnas.0407383101; Rodriguez LM, 2010, XANTHOMONAS RESOURCE; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; ROSAHL S, 1987, EMBO J, V6, P1155, DOI 10.1002/j.1460-2075.1987.tb02348.x; Rossier O, 2000, MOL MICROBIOL, V38, P828, DOI 10.1046/j.1365-2958.2000.02173.x; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; Schulze S, 2012, NEW PHYTOL, V195, P894, DOI 10.1111/j.1469-8137.2012.04210.x; Seo Y.S., 2007, PLANT STRESS, V1, P42; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Stall R. E., 1995, PATHOGENESIS HOST SP, P167; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; Taylor KW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002768; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Thieme F, 2007, MOL PLANT MICROBE IN, V20, P1250, DOI 10.1094/MPMI-20-10-1250; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Zhao BY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002408	83	40	41	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51763	10.1371/journal.pone.0051763	http://dx.doi.org/10.1371/journal.pone.0051763			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272161	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800079
J	Weiss, RF; Miller, MG; Cronin, JF; Hensley, HH; Joshi, ID; Smith, MR				Weiss, Robert F.; Miller, Merlin G.; Cronin, John F.; Hensley, Harvey H.; Joshi, Indira D.; Smith, Mitchell R.			Parametric Model of Combination Therapy for Non-Hodgkin Lymphoma	PLOS ONE			English	Article							ANTISENSE OLIGONUCLEOTIDES COMPLEMENTARY; BCL-2/IMMUNOGLOBULIN FUSION TRANSCRIPT; IMMUNOGLOBULIN SEQUENCES; TREATMENT STRATEGIES; FOLLICULAR LYMPHOMA; APOPTOSIS; RITUXIMAB; EFFICACY; ANTIBODY	The development and clinical testing of drug combinations for the treatment of Non-Hodgkin Lymphoma (NHL) and other cancers has recently shown great promise. However, determining the optimum combination and its associated dosages for maximum efficacy and minimum side effects is still a challenge. This paper describes a parametric analysis of the dynamics of malignant B-cells and the effects of an anti-sense oligonucleotide targeted to BCL-2 (as-bcl-2), anti-CD-20 (rituximab) and their combination, for a SCID mouse human lymphoma xenograft model of NHL. Our parametric model is straightforward. Several mechanisms of malignant B-cell birth and death in the nodal micro-environment are simulated. Cell death is accelerated by hypoxia and starvation induced by tumor scale, by modification of anti-apoptosis with as-bcl-2, and by direct kill effects of rituximab (cell kill by cytotoxic immune cells is not included, due to the absence of an immune system in the corresponding experiments). We show that the cell population dynamics in the control animals are primarily determined by K*, the ratio of rate constants for malignant cell death, K-d, and cell birth, K-b. Tumor growth with independent treatments is reproduced by the model, and is used to predict their effect when administered in combination. Malignant cell lifetimes are derived to provide a quantitative comparison of the efficacy of these treatments. Future experimental and clinical applications of the model are discussed.	[Weiss, Robert F.; Miller, Merlin G.] Back Bay Biosci, Boston, MA USA; [Cronin, John F.] Phys Sci Inc, Comp Serv, Andover, MA 01810 USA; [Hensley, Harvey H.; Joshi, Indira D.; Smith, Mitchell R.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Physical Sciences Inc.; Fox Chase Cancer Center	Weiss, RF (corresponding author), Back Bay Biosci, Boston, MA USA.	RFDWeiss@gmail.com		Smith, Mitchell/0000-0003-1428-8765	National Cancer Institute [CA-006927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The following core facilities at Fox Chase Cancer Center contributed to this study: Laboratory Animal Facility and the Biological Imaging Facility, Small Animal Imaging Component, supported by grant CA-006927 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abes R, 2010, BLOOD, V116, P926, DOI 10.1182/blood-2009-10-248609; Ackler S, 2010, CANCER CHEMOTH PHARM, V66, P869, DOI 10.1007/s00280-009-1232-1; Cheson BD, 2011, BEST PRACT RES CL HA, V24, P305, DOI 10.1016/j.beha.2011.03.006; Collins-Burow B, 2007, EXPERT REV ANTICANC, V7, P257, DOI 10.1586/14737140.7.3.257; Mumenthaler SM, 2011, MOL PHARMACEUT, V8, P2069, DOI 10.1021/mp200270v; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Pollack A, 2012, NY TIMES; Smith MR, 2004, MOL CANCER THER, V3, P1693; Smith MR, 2001, CLIN CANCER RES, V7, P400; Smith MR, 2000, BRIT J HAEMATOL, V111, P1087, DOI 10.1046/j.1365-2141.2000.02431.x; Stolz C, 2008, BLOOD, V112, P3312, DOI 10.1182/blood-2007-11-124487; Tse C, 2008, ABT 263 POTENT ORALL; van Oers MHJ, 2011, BEST PRACT RES CL HA, V24, P187, DOI 10.1016/j.beha.2011.03.003	13	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51736	10.1371/journal.pone.0051736	http://dx.doi.org/10.1371/journal.pone.0051736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272153	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800074
J	Zhang, CZ; Liu, LL; Cai, MY; Pan, YH; Fu, J; Cao, Y; Yun, JP				Zhang, Chris Zhiyi; Liu, Lili; Cai, Muyan; Pan, Yinghua; Fu, Jia; Cao, Yun; Yun, Jingping			Low SIRT3 Expression Correlates with Poor Differentiation and Unfavorable Prognosis in Primary Hepatocellular Carcinoma	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; TUMOR-SUPPRESSOR; CELL-DEATH; DEACETYLATION; METABOLISM; DIAGNOSIS; BIOMARKER; SIRTUINS; PROTEIN; GROWTH	SIRT3, a mitochondrial sirtuin belonging to nicotinamide adenine nucleotide (NAD) dependent deacetylases, is implicated in metabolism, longevity and carcinogenesis. SIRT3 expression and its significance in hepatocellular carcinoma (HCC) remain largely unclear. In this study, we demonstrated that SIRT3 expression in HCC tissue was much lower than that in paracarcinoma tissue, at both mRNA and protein levels. The cutoff value for low SIRT3 expression in HCC was defined according to receiver operating characteristic curve (ROC) analysis. As disclosed by immunohistochemistry (IHC) results, low SIRT3 expression was present in 67.3% (167/248) of HCC cases. Furthermore, low expression of SIRT3 was significantly correlated to differentiation (P = 0.013), clinical stage (P = 0.005), serum AFP level (P<0.01), tumor multiplicity (P = 0.026) and relapse (P = 0.028). Moreover, Kaplan-Meier analysis indicated that low SIRT3 expression associated with unfavorable overall survival (P<0.01) and recurrence-free survival (P = 0.004). The prognostic impact of SIRT3 was further confirmed by stratified survival analysis. Importantly, multivariate analysis revealed that low SIRT3 expression was an independent poor prognostic marker for overall survival (Hazard Ratio (HR) 0.555, 95% confidence interval (95% CI) 0.344-0.897, P = 0.016). Collectively, we conclude that SIRT3 is decreased in HCC and is a novel unfavorable marker for prognosis of patients with this fatal disease.	[Zhang, Chris Zhiyi; Liu, Lili; Cai, Muyan; Fu, Jia; Cao, Yun; Yun, Jingping] Sun Yat Sen Univ, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Chris Zhiyi; Liu, Lili; Cai, Muyan; Fu, Jia; Cao, Yun; Yun, Jingping] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Yinghua] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol & Immunol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Yun, JP (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	yunjp@sysucc.org.cn	Zhang, Chris Zhiyi/F-9862-2013; Liu, Lili/HHC-6357-2022		National Natural Science Foundation of China [81172345]; China Postdoctoral Science Foundation [2012M511867]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (no. 81172345) and China Postdoctoral Science Foundation (no. 2012M511867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Alhazzazi TY, 2011, CANCER-AM CANCER SOC, V117, P1670, DOI 10.1002/cncr.25676; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cai MY, 2010, CANCER SCI, V101, P1543, DOI 10.1111/j.1349-7006.2010.01560.x; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; Erichsen R, 2008, EUR J GASTROEN HEPAT, V20, P104, DOI 10.1097/MEG.0b013e3282f17517; Fan ST, 2011, ANN SURG, V254, P569, DOI 10.1097/SLA.0b013e3182300a1d; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Huang C, 2012, CLIN CANCER RES, V18, P3042, DOI 10.1158/1078-0432.CCR-12-0183; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaseb AO, 2011, J CLIN ONCOL, V29, P3892, DOI 10.1200/JCO.2011.36.0636; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kozyreva ON, 2011, ONCOLOGIST, V16, P310, DOI 10.1634/theoncologist.2010-0223; Kyrylenko S, 2010, CURR MED CHEM, V17, P2921, DOI 10.2174/092986710792065009; Li SiDe, 2010, PLoS One, V5, pe10486, DOI 10.1371/journal.pone.0010486; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Marquardt JU, 2012, J HEPATOL, V56, P267, DOI 10.1016/j.jhep.2011.07.007; Nomura F, 2012, BIOCHEM BIOPH RES CO, V421, P837, DOI 10.1016/j.bbrc.2012.04.099; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Sceusi EL, 2011, HPB, V13, P369, DOI 10.1111/j.1477-2574.2011.00303.x; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Villalba JM, 2012, BIOFACTORS; Wang HN, 2012, ONCOL REP, V28, P311, DOI 10.3892/or.2012.1788; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Wu M, 2012, MED ONCOL; Xia L, 2012, HEPATOLOGY; Zhang CZY, 2012, HISTOPATHOLOGY, V60, P1114, DOI 10.1111/j.1365-2559.2011.04136.x; Zhang YY, 2012, BIOCHEM BIOPH RES CO, V423, P26, DOI 10.1016/j.bbrc.2012.05.053; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zlobec I, 2007, J CLIN PATHOL, V60, P1112, DOI 10.1136/jcp.2006.044537	45	57	60	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51703	10.1371/journal.pone.0051703	http://dx.doi.org/10.1371/journal.pone.0051703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272146	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800068
J	Nachat-Kappes, R; Pinel, A; Combe, K; Lamas, B; Farges, MC; Rossary, A; Goncalves-Mendes, N; Caldefie-Chezet, F; Vasson, MP; Basu, S				Nachat-Kappes, Rachida; Pinel, Alexandre; Combe, Kristell; Lamas, Bruno; Farges, Marie-Chantal; Rossary, Adrien; Goncalves-Mendes, Nicolas; Caldefie-Chezet, Florence; Vasson, Marie-Paule; Basu, Samar			Effects of Enriched Environment on COX-2, Leptin and Eicosanoids in a Mouse Model of Breast Cancer	PLOS ONE			English	Article							CATALYZED LIPID-PEROXIDATION; MAMMARY-GLAND; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; SOCIAL-ISOLATION; C57BL/6J MICE; GROWTH-FACTOR; TUMOR-GROWTH; LIFE STRESS; ADIPONECTIN	Cyclooxygenase-2 (COX-2) and adipokines have been implicated in breast cancer. This study investigated a possible link between COX-2 and adipokines in the development of mammary tumors. A model of environmental enrichment (EE), known to reduce tumor growth was used for a syngeneic murine model of mammary carcinoma. 3-week-old, female C57BL/6 mice were housed in standard environment (SE) or EE cages for 9 weeks and transplanted orthotopically with syngeneic EO771 adenocarcinoma cells into the right inguinal mammary fat pad. EE housing influenced mammary gland development with a decrease in COX-2 expressing cells and enhanced side-branching and advanced development of alveolar structures of the mammary gland. Tumor volume and weight were decreased in EE housed mice and were associated with a reduction in COX-2 and Ki67 levels, and an increase in caspase-3 levels. In tumors of SE mice, high COX-2 expression correlated with enhanced leptin detection. Non-tumor-bearing EE mice showed a significant increase in adiponectin levels but no change in those of leptin, F-2-isoprostanes, PGF(2 alpha), IL-6, TNF-alpha, PAI-1, and MCP-1 levels. Both tumor-bearing groups (SE and EE housing) had increased resistin, IL-6, TNF-alpha, PAI-1 and MCP-1 levels irrespective of the different housing environment demonstrating higher inflammatory response due to the presence of the tumor. This study demonstrates that EE housing influenced normal mammary gland development and inhibited mammary tumor growth resulting in a marked decrease in intratumoral COX-2 activity and an increase in the plasma ratio of adiponectin/leptin levels.	[Nachat-Kappes, Rachida; Pinel, Alexandre; Combe, Kristell; Lamas, Bruno; Farges, Marie-Chantal; Rossary, Adrien; Goncalves-Mendes, Nicolas; Caldefie-Chezet, Florence; Vasson, Marie-Paule; Basu, Samar] Univ Auvergne, Chaire Excellence Program, Equipe ECRIN,CLARA,CRNH Auvergne, Unite Nutr Humaine, Clermont Ferrand, France; [Nachat-Kappes, Rachida; Pinel, Alexandre; Combe, Kristell; Lamas, Bruno; Farges, Marie-Chantal; Rossary, Adrien; Goncalves-Mendes, Nicolas; Caldefie-Chezet, Florence; Vasson, Marie-Paule; Basu, Samar] CRNH Auvergne, INRA, UMR, UNH, Clermont Ferrand, France; [Vasson, Marie-Paule] Ctr Lutte Canc Jean Perrin, Unite Nutr, Clermont Ferrand, France; [Vasson, Marie-Paule] CHU Clermont Ferrand, Serv Nutr, Clermont Ferrand, France; [Basu, Samar] Uppsala Univ, Fac Med, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Universite Clermont Auvergne (UCA); INRAE; UNICANCER; Centre Jean Perrin; CHU Clermont Ferrand; Uppsala University	Basu, S (corresponding author), Univ Auvergne, Chaire Excellence Program, Equipe ECRIN,CLARA,CRNH Auvergne, Unite Nutr Humaine, Clermont Ferrand, France.	samar.basu@udamail.fr	Rossary, Adrien ad_ro/A-2863-2011; FLORENCE, CALDEFIE-CHEZET FCC/U-3378-2018; vasson, marie-paule/ABA-2486-2021	Nachat Kappes, Rachida/0000-0001-7523-3560; rossary, adrien/0000-0001-8311-2419; , blamas/0000-0002-7777-2127	Conseil Regional d'Auvergne; University d'Auvergne, Clermont-Ferrand	Conseil Regional d'Auvergne(Region Auvergne-Rhone-Alpes); University d'Auvergne, Clermont-Ferrand	This work was supported by grants from the Conseil Regional d'Auvergne and University d'Auvergne, Clermont-Ferrand, as a 'Chaire d'Excellence' Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Baroncelli L, 2010, CELL DEATH DIFFER, V17, P1092, DOI 10.1038/cdd.2009.193; Base S, 2011, PROSTAG LEUKOTR ESS, V84, P123, DOI 10.1016/j.plefa.2010.11.006; Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P319, DOI 10.1016/S0952-3278(98)90042-4; Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P347, DOI 10.1016/S0952-3278(98)90070-9; Basu S, 2012, ANTIOXIDANTS REDOX S; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; Basu S, 2007, MED RES REV, V27, P435, DOI 10.1002/med.20098; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Bechard A, 2011, J AM ASSOC LAB ANIM, V50, P171; Boyd AL, 2010, CANCER PREV RES, V3, P1398, DOI 10.1158/1940-6207.CAPR-10-0111; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Casadesus G, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-2; Chen HC, 2002, J LIPID RES, V43, P986; Chua ACL, 2010, DEVELOPMENT, V137, P4229, DOI 10.1242/dev.059261; Cleary Margot P, 2009, Front Biosci (Schol Ed), V1, P329, DOI 10.2741/e30; De Lorenzo MS, 2011, CARCINOGENESIS, V32, P1381, DOI 10.1093/carcin/bgr107; DUNHAM LJ, 1953, JNCI-J NATL CANCER I, V13, P1299; Eskelinen M, 2010, ANTICANCER RES, V30, P4303; Ewens A, 2005, ANTICANCER RES, V25, P3905; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Garonna E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018823; Gil A, 2011, INT J PEDIATR OBES, V6, P13, DOI 10.3109/17477166.2011.604326; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Gu JW, 2011, CANC BIOL THERAPY, P11; Hasen NS, 2010, CANCER PREV RES, V3, P620, DOI 10.1158/1940-6207.CAPR-09-0225; Hector J, 2007, HORM METAB RES, V39, P250, DOI 10.1055/s-2007-973075; Henry J, 2011, FASEB J, V25, P1567, DOI 10.1096/fj.10-168658; Howe LR, 2005, CANCER RES, V65, P10113, DOI 10.1158/0008-5472.CAN-05-1524; Howe LR, 2001, ENDOCR-RELAT CANCER, V8, P97, DOI 10.1677/erc.0.0080097; Hu X, 2002, J NATL CANCER I, V94, P1704, DOI 10.1093/jnci/94.22.1704; Hue-Beauvais C, 2011, DEV DYNAM, V240, P347, DOI 10.1002/dvdy.22536; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Jarde T, 2011, EUR J CANCER, V47, P33, DOI 10.1016/j.ejca.2010.09.005; Jeong YJ, 2011, J BREAST CANCER, V14, P96, DOI 10.4048/jbc.2011.14.2.96; Jonasson S, 2009, PROSTAG LEUKOTR ESS, V80, P1, DOI 10.1016/j.plefa.2008.10.001; Kamikawa A, 2009, DEV DYNAM, V238, P1092, DOI 10.1002/dvdy.21947; Lewis MT, 2009, J MAMMARY GLAND BIOL, V14, P365, DOI 10.1007/s10911-009-9162-4; Lin EJD, 2011, BEHAV BRAIN RES, V216, P349, DOI 10.1016/j.bbr.2010.08.019; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Liu SW, 2011, CRIT CARE MED, V39, P1935, DOI 10.1097/CCM.0b013e31821b85db; Macias H, 2011, DEV CELL, V20, P827, DOI 10.1016/j.devcel.2011.05.012; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Mauro L, 2007, CANCER RES, V67, P3412, DOI 10.1158/0008-5472.CAN-06-2890; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nkhata KJ, 2009, ONCOL REP, V21, P1611, DOI 10.3892/or_00000395; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ogunwobi O, 2006, ENDOCRINOLOGY, V147, P4505, DOI 10.1210/en.2006-0224; Polotsky VY, 2001, AM J RESP CRIT CARE, V164, P1470, DOI 10.1164/ajrccm.164.8.2101100; Raso GM, 2002, BRIT J PHARMACOL, V137, P799, DOI 10.1038/sj.bjp.0704903; Ruhl CE, 2001, AM J CLIN NUTR, V74, P295; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Schuler LA, 2010, CANCER PREV RES, V3, P1365, DOI 10.1158/1940-6207.CAPR-10-0238; Singh-Ranger G, 2008, BREAST CANCER RES TR, V109, P189, DOI 10.1007/s10549-007-9641-5; Solinas M, 2010, PROG NEUROBIOL, V92, P572, DOI 10.1016/j.pneurobio.2010.08.002; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Sztainberg Y, 2010, NAT PROTOC, V5, P1535, DOI 10.1038/nprot.2010.114; Tsai PP, 2002, LAB ANIM-UK, V36, P411, DOI 10.1258/002367702320389071; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Williams JB, 2009, CANCER PREV RES, V2, P850, DOI 10.1158/1940-6207.CAPR-08-0238; Wu KK, 1996, J LAB CLIN MED, V128, P242, DOI 10.1016/S0022-2143(96)90023-2; Zaias J, 2008, J AM ASSOC LAB ANIM, V47, P30; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	65	47	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51525	10.1371/journal.pone.0051525	http://dx.doi.org/10.1371/journal.pone.0051525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272114	Green Published, gold			2022-12-25	WOS:000312386600028
J	Sosunova, E; Sosunov, V; Epshtein, V; Nikiforov, V; Mustaev, A				Sosunova, Ekaterina; Sosunov, Vasily; Epshtein, Vitaly; Nikiforov, Vadim; Mustaev, Arkady			Control of Transcriptional Fidelity by Active Center Tuning as Derived from RNA Polymerase Endonuclease Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3.3 ANGSTROM RESOLUTION; II ELONGATION COMPLEX; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRIGGER LOOP; CATALYTIC RESIDUES; TERNARY COMPLEXES; CLEAVAGE FACTORS; MECHANISM	Precise transcription by cellular RNA polymerase requires the efficient removal of noncognate nucleotide residues that are occasionally incorporated. Mis-incorporation causes the transcription elongation complex to backtrack, releasing a single strand 3'-RNA segment bearing a noncognate residue, which is hydrolyzed by the active center that carries two Mg2+ ions. However, in most x-ray structures only one Mg2+ is present. This Mg2+ is tightly bound to the active center aspartates, creating an inactive stable state. The first residue of the single strand RNA segment in the backtracked transcription elongation complex strongly promotes transcript hydrolytic cleavage by establishing a network of interactions that force a shift of stably bound Mg2+ to release some of its aspartate coordination valences for binding to the second Mg2+ thus enabling catalysis. Such a rearrangement that we call active center tuning (ACT) occurs when all recognition contacts of the active center-bound RNA segment are established and verified by tolerance to stress. Transcription factor Gre builds on the ACT mechanism in the same reaction by increasing the retention of the second Mg2+ and by activating the attacking water, causing 3000-4000-fold reaction acceleration and strongly reinforcing proofreading. The unified mechanism for RNA synthesis and degradation by RNA polymerase predicts that ACT also executes NTP selection thereby contributing to high transcription fidelity.	[Sosunova, Ekaterina; Sosunov, Vasily; Epshtein, Vitaly; Nikiforov, Vadim; Mustaev, Arkady] Univ Med & Dent New Jersey, PHRI Ctr, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Nikiforov, Vadim] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rutgers State University New Brunswick; Rutgers State University Medical Center; Russian Academy of Sciences	Mustaev, A (corresponding author), Univ Med & Dent New Jersey, PHRI Ctr, New Jersey Med Sch, Dept Microbiol & Mol Genet, 225 Warren St, Newark, NJ 07103 USA.	mustaear@umdnj.edu			National Institutes of Health [RO1 GM-30717-21]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM-30717-21.	Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; HIGUCHI H, 1990, BIOCHEMISTRY-US, V29, P8747, DOI 10.1021/bi00489a035; HOARD DE, 1965, J AM CHEM SOC, V87, P1785, DOI 10.1021/ja01086a031; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; REINES D, 1992, J BIOL CHEM, V267, P15516; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; Sosunov V, 2005, NUCLEIC ACIDS RES, V33, P4202, DOI 10.1093/nar/gki688; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; SURRATT CK, 1991, P NATL ACAD SCI USA, V88, P7983, DOI 10.1073/pnas.88.18.7983; Svetlov V, 2004, J BIOL CHEM, V279, P38087, DOI 10.1074/jbc.C400316200; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Yuzenkova Y, 2010, P NATL ACAD SCI USA, V107, P10878, DOI 10.1073/pnas.0914424107; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732; Zhu R, 2008, THEOR CHEM ACC, V120, P479, DOI 10.1007/s00214-008-0440-9	43	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6688	6703		10.1074/jbc.M112.424002	http://dx.doi.org/10.1074/jbc.M112.424002			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23283976	hybrid, Green Published			2022-12-25	WOS:000315820700067
J	Dagil, R; O'Shea, C; Nykjaer, A; Bonvin, AMJJ; Kragelund, BB				Dagil, Robert; O'Shea, Charlotte; Nykjaer, Anders; Bonvin, Alexandre M. J. J.; Kragelund, Birthe B.			Gentamicin Binds to the Megalin Receptor as a Competitive Inhibitor Using the Common Ligand Binding Motif of Complement Type Repeats INSIGHT FROM THE NMR STRUCTURE OF THE 10TH COMPLEMENT TYPE REPEAT DOMAIN ALONE AND IN COMPLEX WITH GENTAMICIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; CYSTEINE-RICH; ULTRASTRUCTURAL-LOCALIZATION; AMINOGLYCOSIDE ANTIBIOTICS; INDUCED NEPHROTOXICITY; EXTRACELLULAR DOMAIN; RENAL ACCUMULATION; HEYMANN NEPHRITIS; STRUCTURAL BASIS; RAP COMPLEX	Gentamicin is an aminoglycoside widely used in treatments of, in particular, enterococcal, mycobacterial, and severe Gram-negative bacterial infections. Large doses of gentamicin cause nephrotoxicity and ototoxicity, entering the cell via the receptor megalin. Until now, no structural information has been available to describe the interaction with gentamicin in atomic detail, and neither have any three-dimensional structures of domains from the human megalin receptor been solved. To address this gap in our knowledge, we have solved the NMR structure of the 10th complement type repeat of human megalin and investigated its interaction with gentamicin. Using NMR titration data in HADDOCK, we have generated a three-dimensional model describing the complex between megalin and gentamicin. Gentamicin binds to megalin with low affinity and exploits the common ligand binding motif previously described (Jensen, G. A., Andersen, O. M., Bonvin, A. M., Bjerrum-Bohr, I., Etzerodt, M., Thogersen, H. C., O'Shea, C., Poulsen, F. M., and Kragelund, B. B. (2006) J. Mol. Biol. 362, 700-716) utilizing the indole side chain of Trp-1126 and the negatively charged residues Asp-1129, Asp-1131, and Asp-1133. Binding to megalin is highly similar to gentamicin binding to calreticulin. We discuss the impact of this novel insight for the future structure-based design of gentamicin antagonists.	[Dagil, Robert; O'Shea, Charlotte; Kragelund, Birthe B.] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen, Denmark; [Nykjaer, Anders] Univ Aarhus, Dept Biomed, Lundbeck Fdn Res Ctr MIND, DK-8000 Aarhus C, Denmark; [Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	University of Copenhagen; Aarhus University; Lundbeckfonden; Utrecht University	Kragelund, BB (corresponding author), Univ Copenhagen, Dept Biol, SBiNLab, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	bbk@bio.ku.dk	Bonvin, Alexandre M.J.J./A-5420-2009; Kragelund, Birthe/M-3927-2014	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Kragelund, Birthe/0000-0002-7454-1761; Dagil, Robert/0000-0002-5594-0716; Nykjaer, Anders/0000-0001-6422-6736	Oticon Foundation; European FP7 e-Infrastructure grant [261572]; national grid Initiative of Belgium via the Dutch BiG Grid project; national grid Initiative of Italy via the Dutch BiG Grid project; national grid Initiative of Germany via the Dutch BiG Grid project; national grid Initiative of the Netherlands via the Dutch BiG Grid project; Gisela project	Oticon Foundation; European FP7 e-Infrastructure grant; national grid Initiative of Belgium via the Dutch BiG Grid project; national grid Initiative of Italy via the Dutch BiG Grid project; national grid Initiative of Germany via the Dutch BiG Grid project; national grid Initiative of the Netherlands via the Dutch BiG Grid project; Gisela project	This work was supported by a grant from the Oticon Foundation.; We thank Line Hyltoft Kristensen, Simon Erlendsson, Kaare Teilum, and Johan G. Olsen for fruitful discussions and Kresten Lindorff-Larsen for help with the water refinements. Signe Sjorup and Michael Nielsen are thanked for their excellent technical assistance. The Worldwide e-infrastructure for NMR and structural biology (WeNMR) project (European FP7 e-Infrastructure grant, Contract 261572), supported by the national grid Initiatives of Belgium, Italy, Germany, the Netherlands (via the Dutch BiG Grid project), Portugal, the United Kingdom, South Africa, Taiwan, and the Latin America grid infrastructure via the Gisela project, is acknowledged for the use of web portals, computing, and storage facilities. We also thank the Danish Instrument Center at the Carlsberg Research Center for spectrometer time.	Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berjanskii M, 2012, J BIOMOL NMR, V53, P167, DOI 10.1007/s10858-012-9637-2; Blanchard SC, 1998, BIOCHEMISTRY-US, V37, P7716, DOI 10.1021/bi973125y; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; CHATELET F, 1986, AM J PATHOL, V122, P500; Chen LF, 2009, INFECT DIS CLIN N AM, V23, P1053, DOI 10.1016/j.idc.2009.06.004; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; CHRISTENSEN EI, 1992, J HISTOCHEM CYTOCHEM, V40, P1481, DOI 10.1177/40.10.1382088; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Gallagher H, 2004, BIOCHIMIE, V86, P179, DOI 10.1016/j.biochi.2004.03.001; Gettins PGW, 2012, BIOCHEM J, V443, P65, DOI 10.1042/BJ20111867; Guttman M, 2011, BIOCHEMISTRY-US, V50, P11001, DOI 10.1021/bi2014486; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Hariprasad G, 2012, J MOL MODEL, V18, P2645, DOI 10.1007/s00894-011-1289-8; Horibe T, 2004, BIOCHEM BIOPH RES CO, V323, P281, DOI 10.1016/j.bbrc.2004.08.099; Hsin K, 2008, J APPL CRYSTALLOGR, V41, P963, DOI 10.1107/S002188980802476X; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; Konig O, 2008, FASEB J, V22, P410, DOI 10.1096/fj.07-9171com; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Krzeminski M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-51; Lesniak W, 2003, CARBOHYD RES, V338, P2853, DOI 10.1016/j.carres.2003.08.005; Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337; Mizuta K, 1999, HEARING RES, V129, P83, DOI 10.1016/S0378-5955(98)00221-4; MOESTRUP SK, 1993, J BIOL CHEM, V268, P16564; Nabavi SF, 2012, FOOD FUNCT, V3, P28, DOI 10.1039/c1fo10173k; Nagai J, 2006, J CONTROL RELEASE, V112, P43, DOI 10.1016/j.jconrel.2006.01.003; Nagai J, 2002, J PHARM PHARMACOL, V54, P1491, DOI 10.1211/00223570272; Nagai J, 2001, AM J PHYSIOL-RENAL, V281, pF337, DOI 10.1152/ajprenal.2001.281.2.F337; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; Ojano-Dirain CP, 2012, LARYNGOSCOPE, V122, P2543, DOI 10.1002/lary.23593; Orlando RA, 1997, P NATL ACAD SCI USA, V94, P2368, DOI 10.1073/pnas.94.6.2368; Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Rybak MJ, 1999, ANTIMICROB AGENTS CH, V43, P1549, DOI 10.1128/AAC.43.7.1549; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Sandoval RM, 2004, AM J PHYSIOL-RENAL, V286, pF617, DOI 10.1152/ajprenal.00130.2003; Schmitz C, 2002, J BIOL CHEM, V277, P618, DOI 10.1074/jbc.M109959200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Takamoto K, 2005, BBA-GEN SUBJECTS, V1722, P247, DOI 10.1016/j.bbagen.2004.12.006; Takamoto K, 2003, BIOCHEM BIOPH RES CO, V308, P866, DOI 10.1016/S0006-291X(03)01502-X; Tauris J, 2009, AUDIOL NEURO-OTOL, V14, P267, DOI 10.1159/000199446; Turnidge J, 2003, INFECT DIS CLIN N AM, V17, P503, DOI 10.1016/S0891-5520(03)00057-6; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; VERPOOTEN GA, 1989, CLIN PHARMACOL THER, V45, P22, DOI 10.1038/clpt.1989.4; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Watanabe A, 2004, J CONTROL RELEASE, V95, P423, DOI 10.1016/j.jconrel.2003.12.005; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Wolf CA, 2007, J BIOMOL NMR, V37, P321, DOI 10.1007/s10858-006-9129-3; Wong CH, 1998, CHEM BIOL, V5, P397, DOI 10.1016/S1074-5521(98)90073-4; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02	70	38	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4424	4435		10.1074/jbc.M112.434159	http://dx.doi.org/10.1074/jbc.M112.434159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23275343	Green Published, hybrid			2022-12-25	WOS:000314845000069
J	Ouelaa, W; Ghouzali, I; Langlois, L; Fetissov, S; Dechelotte, P; Ducrotte, P; Leroi, AM; Gourcerol, G				Ouelaa, Wassila; Ghouzali, Ibtissem; Langlois, Ludovic; Fetissov, Serguei; Dechelotte, Pierre; Ducrotte, Philippe; Leroi, Anne Marie; Gourcerol, Guillaume			Gastric Electrical Stimulation Decreases Gastric Distension-Induced Central Nociception Response through Direct Action on Primary Afferents	PLOS ONE			English	Article							COLORECTAL DISTENSION; VISCERAL PAIN; NEURONS; GASTROPARESIS; ACTIVATION; MECHANISMS; OUTCOMES; STRESS	Background & Aims: Gastric electrical stimulation (GES) is an effective therapy to treat patients with chronic dyspepsia refractory to medical management. However, its mechanisms of action remain poorly understood. Methods: Gastric pain was induced by performing gastric distension (GD) in anesthetized rats. Pain response was monitored by measuring the pseudo-affective reflex (e.g., blood pressure variation), while neuronal activation was determined using c-fos immunochemistry in the central nervous system. Involvement of primary afferents was assessed by measuring phosphorylation of ERK1/2 in dorsal root ganglia. Results: GES decreased blood pressure variation induced by GD, and prevented GD-induced neuronal activation in the dorsal horn of the spinal cord (T9-T10), the nucleus of the solitary tract and in CRF neurons of the hypothalamic paraventricular nucleus. This effect remained unaltered within the spinal cord when sectioning the medulla at the T5 level. Furthermore, GES prevented GD-induced phosphorylation of ERK1/2 in dorsal root ganglia. Conclusions: GES decreases GD-induced pain and/or discomfort likely through a direct modulation of gastric spinal afferents reducing central processing of visceral nociception. Citation: Ouelaa W, Ghouzali I, Langlois L, Fetissov S, Dechelotte P, et al. (2012) Gastric Electrical Stimulation Decreases Gastric Distension-Induced Central Nociception Response through Direct Action on Primary Afferents. PLoS ONE 7(12): e47849. doi:10.1371/journal.pone.0047849	[Ouelaa, Wassila; Ghouzali, Ibtissem; Langlois, Ludovic; Fetissov, Serguei; Dechelotte, Pierre; Ducrotte, Philippe; Leroi, Anne Marie; Gourcerol, Guillaume] Univ Rouen, Nutr Gut & Brain Unit, ADEN INSERM U1073, Inst Biomed Res & Innovat, Rouen, France; [Dechelotte, Pierre; Ducrotte, Philippe; Leroi, Anne Marie; Gourcerol, Guillaume] Rouen Univ Hosp, Dept Nutr, Rouen, France; [Ducrotte, Philippe; Leroi, Anne Marie; Gourcerol, Guillaume] Rouen Univ Hosp, Dept Gastroenterol, Rouen, France; [Leroi, Anne Marie; Gourcerol, Guillaume] Rouen Univ Hosp, Dept Physiol, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen; CHU de Rouen	Gourcerol, G (corresponding author), Univ Rouen, Nutr Gut & Brain Unit, ADEN INSERM U1073, Inst Biomed Res & Innovat, Rouen, France.	Gourcerol.Guillaume@chu-rouen.fr	Fetissov, Sergueï O/H-6023-2016	Fetissov, Sergueï O/0000-0002-2491-4945; Gourcerol, Guillaume/0000-0001-8220-9155	University of Rouen, Institute for Research and Innovation in Biomedicine (IRIB); French Ministry of Health Grants for therapeutic innovation (STIC); French Society of Gastroenterology (SNFGE)	University of Rouen, Institute for Research and Innovation in Biomedicine (IRIB); French Ministry of Health Grants for therapeutic innovation (STIC); French Society of Gastroenterology (SNFGE)	This work was supported by the University of Rouen, Institute for Research and Innovation in Biomedicine (IRIB), by the French Ministry of Health Grants for therapeutic innovation (STIC). WO was the recipient of a fellowship from the French Society of Gastroenterology (SNFGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell T, 2003, JPEN-PARENTER ENTER, V27, P277, DOI 10.1177/0148607103027004277; Abell T, 2003, GASTROENTEROLOGY, V125, P421, DOI 10.1016/S0016-5085(03)00878-3; Chen JDZ, 2003, GASTROENTEROLOGY, V124, P401, DOI 10.1053/gast.2003.50048; Derrey S, 2011, NEUROSCIENCE, V195, P89, DOI 10.1016/j.neuroscience.2011.08.004; Erriquez J, 2009, CELL CALCIUM, V46, P197, DOI 10.1016/j.ceca.2009.07.003; Familoni BO, 1997, DIGEST DIS SCI, V42, P885, DOI 10.1023/A:1018852011857; Gallas S, 2011, EUR J NEUROSCI, V33, P276, DOI 10.1111/j.1460-9568.2010.07474.x; Gourcerol G, 2007, NEUROSCIENCE, V148, P775, DOI 10.1016/j.neuroscience.2007.07.001; Gourcerol G, 2007, EUR J GASTROEN HEPAT, V19, P29, DOI 10.1097/01.meg.0000250584.15490.b4; Gourcerol G, 2009, J AM COLL SURGEONS, V209, P215, DOI 10.1016/j.jamcollsurg.2009.04.009; Larauche M, 2008, AM J PHYSIOL-GASTR L, V294, pG1033, DOI 10.1152/ajpgi.00507.2007; Lin Z, 2006, NEUROGASTROENT MOTIL, V18, P18, DOI 10.1111/j.1365-2982.2005.00732.x; Lin Z, 2004, NEUROGASTROENT MOTIL, V16, P205, DOI 10.1111/j.1365-2982.2004.00503.x; Lin ZY, 2004, DIABETES CARE, V27, P1071, DOI 10.2337/diacare.27.5.1071; Marion R, 2006, INFECT IMMUN, V74, P4387, DOI 10.1128/IAI.02055-05; McCallum R, 2005, CLIN GASTROENTEROL H, V3, P49, DOI 10.1016/S1542-3565(04)00605-6; McCallum RW, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01389.x; McCallum RW, 2011, CLIN GASTROENTEROL H, V9, P314, DOI 10.1016/j.cgh.2010.12.013; Million M, 2006, GUT, V55, P172, DOI 10.1136/gut.2004.051391; NESS TJ, 1988, BRAIN RES, V450, P153, DOI 10.1016/0006-8993(88)91555-7; Peng YB, 2003, J NEUROSCI, V23, P4766; Reddymasu SC, 2010, DIGEST DIS SCI, V55, P983, DOI 10.1007/s10620-009-0818-0; Sakurai J, 2008, GASTROENTEROLOGY, V134, P1094, DOI 10.1053/j.gastro.2008.01.031; Stengel A, 2009, ANNU REV PHYSIOL, V71, P219, DOI 10.1146/annurev.physiol.010908.163221; Tache Yvette, 2009, Curr Gastroenterol Rep, V11, P270; Tang M, 2006, OBES SURG, V16, P344, DOI 10.1381/096089206776116372; Vergnano AM, 2008, ENDOCRINOLOGY, V149, P2306, DOI 10.1210/en.2007-1164	27	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e47849	10.1371/journal.pone.0047849	http://dx.doi.org/10.1371/journal.pone.0047849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284611	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500002
J	Chamorro-Garcia, R; Cervera, M; Arredondo, JJ				Chamorro-Garcia, Raquel; Cervera, Margarita; Arredondo, Juan J.			AF10 Plays a Key Role in the Survival of Uncommitted Hematopoietic Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; T(10-11) TRANSLOCATION; CALM/AF10 FUSION; SELF-RENEWAL; LINE; MLL; DIFFERENTIATION; TRANSFORMATION; GENES	Hematopoiesis is a complex process regulated by both cell intrinsic and cell extrinsic factors. Alterations in the expression of critical genes during hematopoiesis can modify the balance between stem cell differentiation and proliferation, and may ultimately give rise to leukemia and other diseases. AF10 is a transcription factor that has been implicated in the development of leukemia following chromosomal rearrangements between the AF10 gene and one of at least two other genes, MLL and CALM. The link between AF10 and leukemia, together with the known interactions between AF10 and hematopoietic regulators, suggests that AF10 may be important in hematopoiesis and in leukemic transformation. Here we show that AF10 is important for proper hematopoietic differentiation. The induction of hematopoietic differentiation in both human hematopoietic cell lines and murine total bone marrow cells triggers a decrease of AF10 mRNA and protein levels, particularly in stem cells and multipotent progenitors. Gain-and loss-of-function studies demonstrate that over-or under-expression of AF10 leads to apoptotic cell death in stem cells and multipotent progenitors. We conclude that AF10 plays a key role in the maintenance of multipotent hematopoietic cells.	Autonomous Univ Madrid, Consejo Super Invest Cient, Dept Bioquim, E-28049 Madrid, Spain; Autonomous Univ Madrid, Consejo Super Invest Cient, Inst Invest Biomed, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Chamorro-Garcia, R (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	rchamorr@uci.edu; juan.arredondo@uam.es	Arredondo, Juan/L-2404-2013	Arredondo, Juan/0000-0002-6784-0990	Autonomous University of Madrid-CAM [06/CSB/004, CCG06-UAM/BIO-0322]; Fundacion MMA	Autonomous University of Madrid-CAM; Fundacion MMA	Work supported by grants 06/CSB/004 and CCG06-UAM/BIO-0322 from The Autonomous University of Madrid-CAM and by Fundacion MMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2007, ADV EXP MED BIOL, V602, P61; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Bohlander SK, 2000, LEUKEMIA, V14, P93, DOI 10.1038/sj.leu.2401614; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; CHAPLIN T, 1995, BLOOD, V86, P2073, DOI 10.1182/blood.V86.6.2073.bloodjournal8662073; CHAPLIN T, 1995, BLOOD, V85, P1435, DOI 10.1182/blood.V85.6.1435.bloodjournal8561435; COLLINS SJ, 1987, BLOOD, V70, P1233; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Deshpande AJ, 2011, LEUKEMIA, V25, P1718, DOI 10.1038/leu.2011.153; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Felix CA, 1998, BBA-GENE STRUCT EXPR, V1400, P233, DOI 10.1016/S0167-4781(98)00139-0; Feng Y, 2010, BLOOD, V116, P4483, DOI 10.1182/blood-2010-03-276501; FitzGerald J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014714; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Forissier S, 2007, BIOL CELL, V99, P563, DOI 10.1042/BC20060131; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Greif PA, 2008, ONCOGENE, V27, P2886, DOI 10.1038/sj.onc.1210945; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Lessard J, 2003, EXP HEMATOL, V31, P567, DOI 10.1016/S0301-472X(03)00081-X; LONG MW, 1990, J CLIN INVEST, V85, P1072, DOI 10.1172/JCI114538; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Maguer-Satta W, 2004, MOL CELL ENDOCRINOL, V225, P109, DOI 10.1016/j.mce.2004.07.009; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; Mohan M, GENES DEV, V24, P574; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; You L, 2006, DRUG NEWS PERSPECT, V19, P27, DOI 10.1358/dnp.2006.19.1.965871; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	48	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51626	10.1371/journal.pone.0051626	http://dx.doi.org/10.1371/journal.pone.0051626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284727	Green Published, Green Accepted, gold			2022-12-25	WOS:000312694300033
J	Valdes-Mas, R; Bea, S; Puente, DA; Lopez-Otin, C; Puente, XS				Valdes-Mas, Rafael; Bea, Silvia; Puente, Diana A.; Lopez-Otin, Carlos; Puente, Xose S.			Estimation of Copy Number Alterations from Exome Sequencing Data	PLOS ONE			English	Article							FREQUENT MUTATION; HYBRID SELECTION; CANCER GENOME; IDENTIFICATION; DISCOVERY; VARIANTS; PATIENT	Exome sequencing constitutes an important technology for the study of human hereditary diseases and cancer. However, the ability of this approach to identify copy number alterations in primary tumor samples has not been fully addressed. Here we show that somatic copy number alterations can be reliably estimated using exome sequencing data through a strategy that we have termed exome2cnv. Using data from 86 paired normal and primary tumor samples, we identified losses and gains of complete chromosomes or large genomic regions, as well as smaller regions affecting a minimum of one gene. Comparison with high-resolution comparative genomic hybridization (CGH) arrays revealed a high sensitivity and a low number of false positives in the copy number estimation between both approaches. We explore the main factors affecting sensitivity and false positives with real data, and provide a side by side comparison with CGH arrays. Together, these results underscore the utility of exome sequencing to study cancer samples by allowing not only the identification of substitutions and indels, but also the accurate estimation of copy number alterations.	[Valdes-Mas, Rafael; Puente, Diana A.; Lopez-Otin, Carlos; Puente, Xose S.] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain; [Bea, Silvia] Hosp Clin Barcelona, Hematopathol Unit, IDIBAPS, Barcelona, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Puente, XS (corresponding author), Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain.	xspuente@uniovi.es	bea, silvia/K-7699-2014; Valdés-Mas, Rafael/AAC-2879-2021; Puente, Xosé S./ADB-0672-2022; López-Otín, Carlos/AAB-2106-2020	bea, silvia/0000-0001-7192-2385; Valdés-Mas, Rafael/0000-0002-0737-5425; Puente, Xosé S./0000-0001-9525-1483; López-Otín, Carlos/0000-0001-6964-1904; Wang, Pei/0000-0002-6890-6453	Ministerio de Ciencia e Innovacion-Spain; Fundacion "M.Botin"; European Union (FP7 MicroEnviMet); Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	Ministerio de Ciencia e Innovacion-Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion "M.Botin"; European Union (FP7 MicroEnviMet); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	This work was supported by grants from Ministerio de Ciencia e Innovacion-Spain, Fundacion "M.Botin", European Union (FP7 MicroEnviMet), Instituto de Salud Carlos III (ISCIII) and Red Tematica de Investigacion del Cancer (RTICC) del ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Link DC, 2011, JAMA-J AM MED ASSOC, V305, P1568, DOI 10.1001/jama.2011.473; Lonigro RJ, 2011, NEOPLASIA, V13, P1019, DOI 10.1593/neo.111252; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Merla G, 2010, HUM GENET, V128, P3, DOI 10.1007/s00439-010-0827-2; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Puente XS, 2011, AM J HUM GENET, V88, P650, DOI 10.1016/j.ajhg.2011.04.010; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033673, 10.1371/journal.pone.0041830]; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	42	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51422	10.1371/journal.pone.0051422	http://dx.doi.org/10.1371/journal.pone.0051422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284693	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300026
J	Sirakova, TD; Deb, C; Daniel, J; Singh, HD; Maamar, H; Dubey, VS; Kolattukudy, PE				Sirakova, Tatiana D.; Deb, Chirajyoti; Daniel, Jaiyanth; Singh, Harminder D.; Maamar, Hedia; Dubey, Vinod S.; Kolattukudy, Pappachan E.			Wax Ester Synthesis is Required for Mycobacterium tuberculosis to Enter In Vitro Dormancy	PLOS ONE			English	Article							ACYL-COA REDUCTASE; FATTY ALCOHOL; DIACYLGLYCEROL ACYLTRANSFERASES; GENE; TRIACYLGLYCEROL; PURIFICATION; EXPRESSION; STARVATION; ACIDS; BIOSYNTHESIS	Mycobacterium tuberculosis (Mtb) is known to produce wax esters (WE) when subjected to stress. However, nothing is known about the enzymes involved in biosynthesis of WE and their role in mycobacterial dormancy. We report that two putative Mtb fatty acyl-CoA reductase genes (fcr) expressed in E. coli display catalytic reduction of fatty acyl-CoA to fatty aldehyde and fatty alcohol. Both enzymes (FCR1/Rv3391) and FCR2/Rv1543) showed a requirement for NADPH as the reductant, a preference for oleoyl-CoA over saturated fatty acyl-CoA and were inhibited by thiol-directed reagents. We generated Mtb gene-knockout mutants for each reductase. Metabolic incorporation of C-14-oleate into fatty alcohols and WE was severely diminished in the mutants under dormancy-inducing stress conditions that are thought to be encountered by the pathogen in the host. The fatty acyl-CoA reductase activity in cell lysates of the mutants under nitric oxide stress was significantly reduced when compared with the wild type. Complementation restored the lost activity completely in the Delta fcr1 mutant and partially in the Delta fcr2 mutant. WE synthesis was inhibited in both Delta fcr mutants. The Dfcr mutants exhibited faster growth rates, an increased uptake of C-14-glycerol suggesting increased permeability of the cell wall, increased metabolic activity levels and impaired phenotypic antibiotic tolerance under dormancy-inducing combined multiple stress conditions. Complementation of the mutants did not restore the development of antibiotic tolerance to wild-type levels. Transcript analysis of Dfcr mutants showed upregulation of genes involved in energy generation and transcription, indicating the inability of the mutants to become dormant. Our results indicate that the fcr1 and fcr2 gene products are involved in WE synthesis under in vitro dormancy-inducing conditions and that WE play a critical role in reaching a dormant state. Drugs targeted against the Mtb reductases may inhibit its ability to go into dormancy and therefore increase susceptibility of Mtb to currently used antibiotics thereby enhancing clearance of the pathogen from patients. Citation: Sirakova TD, Deb C, Daniel J, Singh HD, Maamar H, et al. (2012) Wax Ester Synthesis is Required for Mycobacterium tuberculosis to Enter In Vitro Dormancy. PLoS ONE 7(12): e51641. doi:10.1371/journal.pone.0051641	[Sirakova, Tatiana D.; Deb, Chirajyoti; Daniel, Jaiyanth; Singh, Harminder D.; Maamar, Hedia; Dubey, Vinod S.; Kolattukudy, Pappachan E.] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Kolattukudy, PE (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	pk@mail.ucf.edu			National Institutes of Health [AI46582, AI35272]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046582, R01AI035272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI46582 and AI35272 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL VP, 1978, ARCH BIOCHEM BIOPHYS, V191, P452, DOI 10.1016/0003-9861(78)90384-3; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Asselineau J., 1966, BACTERIAL LIPIDS; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bates L, 2004, LANCET INFECT DIS, V4, P368, DOI 10.1016/S1473-3099(04)01047-3; Belisle ST, 1998, MYCOBACTERIA PROTOCO; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; BISHOP JE, 1981, J BIOL CHEM, V256, P9542; Buckner JS, 1976, CHEM BIOCH NATURAL W, P148; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hofvander P, 2011, FEBS LETT, V585, P3538, DOI 10.1016/j.febslet.2011.10.016; HUANG AHC, 1978, PLANT PHYSIOL, V61, P339, DOI 10.1104/pp.61.3.339; Ishige T, 2003, CURR OPIN MICROBIOL, V6, P244, DOI 10.1016/S1369-5274(03)00053-5; KOLATTUK.PE, 1970, BIOCHEMISTRY-US, V9, P1095, DOI 10.1021/bi00807a007; Kolattukudy P. E., 1980, The biochemistry of plants. A comprehensive treatise. Volume 4. Lipids: structure and function., P571; Kolattukudy P.E., 1976, CHEM BIOCH NATURAL W, P1; Kolattukudy P.E., 1976, CHEM BIOCH NATURAL W, P290; KOLATTUKUDY PE, 1986, J LIPID RES, V27, P404; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; MOORE C, 1982, ARCH BIOCHEM BIOPHYS, V214, P489, DOI 10.1016/0003-9861(82)90052-2; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; NYKA W, 1967, J BACTERIOL, V93, P1458, DOI 10.1128/JB.93.4.1458-1460.1967; NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974; OHLROGGE JB, 1978, LIPIDS, V13, P203, DOI 10.1007/BF02533401; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Sargent JR, 1976, MARINE WAXES, P50; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; Velayati AA, 2009, CHEMOTHERAPY, V55, P303, DOI 10.1159/000226425; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; Waltermann M, 2007, BIOCHIMIE, V89, P230, DOI 10.1016/j.biochi.2006.07.013; WANG L, 1972, BIOCHIM BIOPHYS ACTA, V260, P41; Willis RM, 2011, BIOCHEMISTRY-US, V50, P10550, DOI 10.1021/bi2008646	48	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51641	10.1371/journal.pone.0051641	http://dx.doi.org/10.1371/journal.pone.0051641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272127	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800058
J	Voxeur, A; Andre, A; Breton, C; Lerouge, P				Voxeur, Aline; Andre, Aurelie; Breton, Christelle; Lerouge, Patrice			Identification of Putative Rhamnogalacturonan-II Specific Glycosyltransferases in Arabidopsis Using a Combination of Bioinformatics Approaches	PLOS ONE			English	Article							3-DEOXY-D-MANNO-2-OCTULOSONIC ACID KDO; POLLEN-TUBE GROWTH; PLANT-CELL; PECTIC POLYSACCHARIDE; FUCOSYL-TRANSFERASE; CRYSTAL-STRUCTURE; PROTEIN; GENE; BIOSYNTHESIS; DATABASE	Rhamnogalacturonan-II (RG-II) is a complex plant cell wall polysaccharide that is composed of an a(1,4)-linked homogalacturonan backbone substituted with four side chains. It exists in the cell wall in the form of a dimer that is cross-linked by a borate di-ester. Despite its highly complex structure, RG-II is evolutionarily conserved in the plant kingdom suggesting that this polymer has fundamental functions in the primary wall organisation. In this study, we have set up a bioinformatics strategy aimed at identifying putative glycosyltransferases (GTs) involved in RG-II biosynthesis. This strategy is based on the selection of candidate genes encoding type II membrane proteins that are tightly coexpressed in both rice and Arabidopsis with previously characterised genes encoding enzymes involved in the synthesis of RG-II and exhibiting an up-regulation upon isoxaben treatment. This study results in the final selection of 26 putative Arabidopsis GTs, including 10 sequences already classified in the CAZy database. Among these CAZy sequences, the screening protocol allowed the selection of alpha-galacturonosyltransferases involved in the synthesis of alpha 4-GalA oligogalacturonides present in both homogalacturonans and RG-II, and two sialyltransferase-like sequences previously proposed to be involved in the transfer of Kdo and/or Dha on the pectic backbone of RG-II. In addition, 16 non-CAZy GT sequences were retrieved in the present study. Four of them exhibited a GT-A fold. The remaining sequences harbored a GT-B like fold and a fucosyltransferase signature. Based on homologies with glycosyltransferases of known functions, putative roles in the RG-II biosynthesis are proposed for some GT candidates. Citation: Voxeur A, Andre A, Breton C, Lerouge P (2012) Identification of Putative Rhamnogalacturonan-II Specific Glycosyltransferases in Arabidopsis Using a Combination of Bioinformatics Approaches. PLoS ONE 7(12): e51129. doi: 10.1371/journal.pone.0051129	[Voxeur, Aline; Andre, Aurelie; Lerouge, Patrice] Univ Rouen, Inst Rech & Innovat Biotechnol, EA 4358, Lab Glyco MEV, Mont St Aignan, France; [Breton, Christelle] Univ Grenoble 1, CERMAV CNRS, Grenoble, France	Universite de Rouen Normandie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lerouge, P (corresponding author), Univ Rouen, Inst Rech & Innovat Biotechnol, EA 4358, Lab Glyco MEV, Mont St Aignan, France.	patrice.lerouge@univ-rouen.fr	Voxeur, Aline/O-7149-2015	Voxeur, Aline/0000-0001-9452-6756	Universities of Grenoble 1; Rouen	Universities of Grenoble 1; Rouen	This research was supported by the Universities of Grenoble 1 and Rouen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JW, 2006, J BIOL CHEM, V281, P13708, DOI 10.1074/jbc.M512403200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atmodjo MA, 2011, P NATL ACAD SCI USA, V108, P20225, DOI 10.1073/pnas.1112816108; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Caffall KH, 2009, MOL PLANT, V2, P1000, DOI 10.1093/mp/ssp062; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cavalier DM, 2006, J BIOL CHEM, V281, P34197, DOI 10.1074/jbc.M606379200; Chazalet V, 2001, J BACTERIOL, V183, P7067, DOI 10.1128/JB.183.24.7067-7075.2001; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Delmas F, 2008, J EXP BOT, V59, P2639, DOI 10.1093/jxb/ern118; Deng Y, 2010, J INTEGR PLANT BIOL, V52, P829, DOI 10.1111/j.1744-7909.2010.00963.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Egelund J, 2004, PLANT PHYSIOL, V136, P2609, DOI 10.1104/pp.104.042978; Egelund J, 2006, PLANT CELL, V18, P2593, DOI 10.1105/tpc.105.036566; Egelund J, 2011, ANNU PLANT REV, V41, P213, DOI 10.1002/9781444391015.ch7; Eudes R, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-2; Fangel JU, 2011, PLANT SCI, V180, P470, DOI 10.1016/j.plantsci.2010.11.002; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Gilbert L, 2009, PLANT J, V60, P499, DOI 10.1111/j.1365-313X.2009.03972.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo HW, 2001, SCIENCE, V291, P487, DOI 10.1126/science.291.5503.487; Hansen SF, 2009, J PROTEOME RES, V8, P743, DOI 10.1021/pr800808m; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Imberty A, 2011, GLYCOSYLATION DIVERS, P25; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Kobayashi M, 2011, PLANT CELL PHYSIOL, V52, P1832, DOI 10.1093/pcp/pcr120; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lalanne E, 2004, GENETICS, V167, P1975, DOI 10.1534/genetics.104.030270; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Liu XL, 2011, PLANT J, V65, P647, DOI 10.1111/j.1365-313X.2010.04452.x; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Manfield IW, 2004, PLANT J, V40, P260, DOI 10.1111/j.1365-313X.2004.02208.x; Martinez-Duncker I, 2003, GLYCOBIOLOGY, V13, p1C, DOI 10.1093/glycob/cwg113; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Molhoj M, 2003, PLANT J, V35, P693, DOI 10.1046/j.1365-313X.2003.01841.x; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Obayashi T, 2010, J PLANT RES, V123, P311, DOI 10.1007/s10265-010-0333-6; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Oikawa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015481; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Parsons HT, 2012, PLANT PHYSIOL, V159, P12, DOI 10.1104/pp.111.193151; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Perez S, 2003, BIOCHIMIE, V85, P109, DOI 10.1016/S0300-9084(03)00053-1; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Reuhs BL, 2004, PLANTA, V219, P147, DOI 10.1007/s00425-004-1205-x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Seveno M, 2004, NAT BIOTECHNOL, V22, P1351, DOI 10.1038/nbt1104-1351; Seveno M, 2010, GLYCOBIOLOGY, V20, P617, DOI 10.1093/glycob/cwq011; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Suzuki N, 2010, J BIOL CHEM, V285, P5178, DOI 10.1074/jbc.M109.018663; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; Voxeur A, 2011, J BIOL CHEM, V286, P8014, DOI 10.1074/jbc.M110.198614; Yin Y, 2011, PLOS ONE, V11; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	76	14	50	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51129	10.1371/journal.pone.0051129	http://dx.doi.org/10.1371/journal.pone.0051129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272088	gold, Green Published			2022-12-25	WOS:000312386800027
J	Weng, CH; Hu, CC; Lin, JL; Lin-Tan, DT; Huang, WH; Hsu, CW; Yen, TH				Weng, Cheng-Hao; Hu, Ching-Chih; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Huang, Wen-Hung; Hsu, Ching-Wei; Yen, Tzung-Hai			Sequential Organ Failure Assessment Score Can Predict Mortality in Patients with Paraquat Intoxication	PLOS ONE			English	Article							PULSE THERAPY; ACUTE PHYSIOLOGY; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PLASMA; PROGNOSIS; MODERATE; SYSTEM	Introduction: Paraquat poisoning is characterized by multi-organ failure and pulmonary fibrosis with respiratory failure, resulting in high mortality and morbidity. The objective of this study was to identify predictors of mortality in cases of paraquat poisoning. Furthermore, we sought to determine the association between these parameters. Methods: A total of 187 patients were referred for management of intentional paraquat ingestion between January 2000 and December 2010. Demographic, clinical, and laboratory data were recorded. Sequential organ failure assessment (SOFA) and acute kidney injury network (AKIN) scores were collected, and predictors of mortality were analyzed. Results: Overall hospital mortality for the entire population was 54% (101/187). Using a multivariate logistic regression model, it was found that age, time to hospitalization, blood paraquat level, estimated glomerular filtration rate at admission (eGFR (first day)), and the SOFA(48-h) score, but not the AKIN(48-h) score, were significant predictors of mortality. For predicting the in-hospital mortality, SOFA(48-h) scores displayed a good area under the receiver operating characteristic curve (AUROC) (0.795 +/- 0.033, P<0.001). The cumulative survival rate differed significantly between patients with SOFA(48-h) scores <3 and those >= 3 (P<0.001). A modified SOFA (mSOFA) score was further developed by using the blood paraquat level, and this new score also demonstrated a better AUROC (0.848 +/- 0.029, P<0.001) than the original SOFA score. Finally, the cumulative survival rate also differed significantly between patients with mSOFA scores <4 and >= 4 (P<0.001). Conclusion: The analytical data demonstrate that SOFA and mSOFA scores, which are based on the extent of organ function or rate of organ failure, help to predict mortality after intentional paraquat poisoning.	[Weng, Cheng-Hao; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Huang, Wen-Hung; Hsu, Ching-Wei; Yen, Tzung-Hai] Chang Gung Mem Hosp, Dept Nephrol, Linkou Med Ctr, Taipei 10591, Taiwan; [Hu, Ching-Chih] Chang Gung Mem Hosp, Dept Hepatogastroenterol, Keelung, Taiwan; [Hu, Ching-Chih] Chang Gung Mem Hosp, Liver Res Unit, Keelung, Taiwan; [Weng, Cheng-Hao; Hu, Ching-Chih; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Huang, Wen-Hung; Hsu, Ching-Wei; Yen, Tzung-Hai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Yen, TH (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Linkou Med Ctr, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	m19570@adm.cgmh.org.tw	huang, wen/GXW-0661-2022; Yen, Tzung-Hai/AAQ-4525-2020	Yen, Tzung-Hai/0000-0002-0907-1505	Chang Gung Memorial Hospital	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Funding: Chang Gung Memorial Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan BSH, 1996, HUM EXP TOXICOL, V15, P949, DOI 10.1177/096032719601501202; Chan BSH, 1998, PHARMACOL THERAPEUT, V79, P193, DOI 10.1016/S0163-7258(98)00015-1; Chang MW, 2008, AM J MED SCI, V335, P451, DOI 10.1097/MAJ.0b013e318157cb6d; Cholongitas E, 2012, LIVER TRANSPLANT, V18, P405, DOI 10.1002/lt.23370; Craig DGN, 2011, ALIMENT PHARM THER, V34, P219, DOI 10.1111/j.1365-2036.2011.04687.x; HAMPSON ECGM, 1988, MED TOXICOL ADV DRUG, V3, P64, DOI 10.1007/BF03259932; Hsu HH, 2003, J TOXICOL-CLIN TOXIC, V41, P89, DOI 10.1081/CLT-120018278; Huang NC, 2006, CLIN TOXICOL, V44, P99, DOI 10.1080/15563650500514251; Jones AL, 1999, QJM-MON J ASSOC PHYS, V92, P573, DOI 10.1093/qjmed/92.10.573; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lin JL, 2011, INTENS CARE MED, V37, P1006, DOI 10.1007/s00134-010-2127-7; Lin JL, 1995, ARCH ENVIRON HEALTH, V50, P432, DOI 10.1080/00039896.1995.9935979; Lin JL, 1999, AM J RESP CRIT CARE, V159, P357, DOI 10.1164/ajrccm.159.2.9803089; Lin JL, 2006, CRIT CARE MED, V34, P368, DOI 10.1097/01.CCM.0000195013.47004.A8; Lin JL, 1996, THORAX, V51, P661, DOI 10.1136/thx.51.7.661; Lin NC, 2003, J TOXICOL-CLIN TOXIC, V41, P877, DOI 10.1081/CLT-120025356; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036576; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Min YG, 2011, CLIN TOXICOL, V49, P840, DOI 10.3109/15563650.2011.619137; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; PROUDFOOT AT, 1979, LANCET, V2, P330; SAWADA Y, 1988, LANCET, V1, P1333; SCHERRMANN JM, 1987, HUM TOXICOL, V6, P91, DOI 10.1177/096032718700600116; SELLERO IS, 1993, ANAL LETT, V26, P1891, DOI 10.1080/00032719308017438; SUZUKI K, 1989, HUM TOXICOL, V8, P33, DOI 10.1177/096032718900800106; SUZUKI K, 1991, HUM EXP TOXICOL, V10, P21, DOI 10.1177/096032719101000104; TALBOT AR, 1988, HUM TOXICOL, V7, P325, DOI 10.1177/096032718800700405; Tsai TY, 2011, HUM EXP TOXICOL, V30, P71, DOI 10.1177/0960327110368419; VALE JA, 1987, HUM TOXICOL, V6, P41, DOI 10.1177/096032718700600107; Yang CJ, 2012, LIVER INT, V32, P1400, DOI 10.1111/j.1478-3231.2012.02829.x; Yen TH, 2010, AM J EMERG MED, V28, P728, DOI 10.1016/j.ajem.2009.06.001	31	48	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51743	10.1371/journal.pone.0051743	http://dx.doi.org/10.1371/journal.pone.0051743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272154	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800075
J	Buffa, V; Klein, K; Fischetti, L; Shattock, RJ				Buffa, Viviana; Klein, Katja; Fischetti, Lucia; Shattock, Robin J.			Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice	PLOS ONE			English	Article							FEMALE GENITAL-TRACT; IMMUNE-RESPONSES; SUBLINGUAL IMMUNIZATION; VACCINE; ANTIBODIES; DELIVERY; CHITOSAN; IMMUNOTHERAPY; TOLERANCE; ANTIGENS	In the present study we investigate the impact of a range of TLR ligands and chitosan as potential adjuvants for different routes of mucosal immunisation (sublingual (SL), intranasal (IN), intravaginal (IVag) and a parenteral route (subcutaneous (SC)) in the murine model. We assess their ability to enhance antibody responses to HIV-1 CN54gp140 (gp140) and Tetanus toxoid (TT) in systemic and vaginal compartments. A number of trends were observed by route of administration. For non-adjuvanted antigen, SC>SL>IN immunisation with respect to systemic IgG responses, where endpoint titres were greater for TT than for gp140. In general, co-administration with adjuvants increased specific IgG responses where IN = SC>SL, while in the vaginal compartment IN>SL>SC for specific IgA. In contrast, for systemic and mucosal IgA responses to antigen alone SL>IN = SC. A number of adjuvants increased specific systemic IgA responses where in general IN>SL>SC immunisation, while for mucosal responses IN = SL>SC. In contrast, direct intravaginal immunisation failed to induce any detectable systemic or mucosal responses to gp140 even in the presence of adjuvant. However, significant systemic IgG responses to TT were induced by intravaginal immunisation with or without adjuvant, and detectable mucosal responses IgG and IgA were observed when TT was administered with FSL-1 or Poly I:C. Interestingly some TLRs displayed differential activity dependent upon the route of administration. MPLA (TLR4) suppressed systemic responses to SL immunisation while enhancing responses to IN or SC immunisation. CpG B enhanced SL and IN responses, while having little or no impact on SC immunisation. These data demonstrate important route, antigen and adjuvant effects that need to be considered in the design of mucosal vaccine strategies.	[Buffa, Viviana; Klein, Katja; Fischetti, Lucia; Shattock, Robin J.] St Georges Univ London, London, England	St Georges University London	Shattock, RJ (corresponding author), St Georges Univ London, London, England.	r.shattock@imperial.ac.uk			National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Division of AIDS (DAIDS); United States Department of Health and Human Services (HHS); Center for HIV/AIDS Vaccine Immunology (CHAVI) [U19 AI067854-05]; Dormeur Investment Service Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of AIDS (DAIDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Health and Human Services (HHS); Center for HIV/AIDS Vaccine Immunology (CHAVI); Dormeur Investment Service Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Division of AIDS (DAIDS), United States Department of Health and Human Services (HHS) and Center for HIV/AIDS Vaccine Immunology (CHAVI) # U19 AI067854-05. The authors gratefully acknowledge an equipment grant from Dormeur Investment Service Ltd. that provided funding to purchase the plate reader and washer used in these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca HC, 2009, EXPERT REV VACCINES, V8, P937, DOI [10.1586/erv.09.47, 10.1586/ERV.09.47]; Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Black CA, 2000, J IMMUNOL, V165, P5077, DOI 10.4049/jimmunol.165.9.5077; Chadwick S, 2009, EXPERT OPIN BIOL TH, V9, P427, DOI [10.1517/14712590902849224 , 10.1517/14712590902849224]; Cranage MP, 2010, MUCOSAL IMMUNOL, V3, P57, DOI 10.1038/mi.2009.110; Cranage MP, 2011, VACCINE, V29, P1421, DOI 10.1016/j.vaccine.2010.12.034; Cuburu N, 2009, J IMMUNOL, V183, P7851, DOI 10.4049/jimmunol.0803740; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hervouet C, 2010, VACCINE, V28, P5582, DOI 10.1016/j.vaccine.2010.06.033; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Huo ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033736; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kweon MN, 2011, CYTOKINE, V54, P1, DOI 10.1016/j.cyto.2010.12.014; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Levine MM, 2000, J PEDIATR GASTR NUTR, V31, P336, DOI 10.1097/00005176-200010000-00003; Mapletoft JW, 2010, CLIN VACCINE IMMUNOL, V17, P23, DOI 10.1128/CVI.00250-09; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McCluskie MJ, 2001, CRIT REV IMMUNOL, V21, P103; Mohanan D, 2010, J CONTROL RELEASE, V147, P342, DOI 10.1016/j.jconrel.2010.08.012; Naz RK, 2012, J REPROD IMMUNOL, V93, P1, DOI 10.1016/j.jri.2011.09.005; Negri DRM, 2010, VACCINE, V28, P4175, DOI 10.1016/j.vaccine.2010.04.013; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Novak N, 2008, TRENDS MOL MED, V14, P191, DOI 10.1016/j.molmed.2008.03.001; Pfaar O, 2011, INT ARCH ALLERGY IMM, V154, P336, DOI 10.1159/000321826; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Russell MW, 2002, AM J REPROD IMMUNOL, V47, P265, DOI 10.1034/j.1600-0897.2002.01099.x; Senti G, 2009, CURR OPIN ALLERGY CL, V9, P537, DOI 10.1097/ACI.0b013e3283310ff7; Staines NA, 1996, CLIN EXP IMMUNOL, V103, P368; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Sui YJ, 2010, P NATL ACAD SCI USA, V107, P9843, DOI 10.1073/pnas.0911932107; Tomai MA, 2007, EXPERT REV VACCINES, V6, P835, DOI 10.1586/14760584.6.5.835; van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5; Warshakoon HJ, 2009, HUM VACCINES, V5, P381, DOI 10.4161/hv.5.6.8175; Wegmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015861; Wright PF, 2011, AM J REPROD IMMUNOL, V65, P248, DOI 10.1111/j.1600-0897.2010.00954.x; Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034	41	48	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50529	10.1371/journal.pone.0050529	http://dx.doi.org/10.1371/journal.pone.0050529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272062	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600012
J	Qian, CP; Ma, JH; Zhang, PH; Luo, AT; Wang, C; Ren, ZQ; Kong, LH; Zhang, S; Wang, XJ; Wu, Y				Qian, Chunping; Ma, Jihua; Zhang, Peihua; Luo, Antao; Wang, Chao; Ren, Zhiqiang; Kong, Linghao; Zhang, Shuo; Wang, Xiaojing; Wu, Ying			Resveratrol Attenuates the Na+-Dependent Intracellular Ca2+ Overload by Inhibiting H2O2-Induced Increase in Late Sodium Current in Ventricular Myocytes	PLOS ONE			English	Article							SPIN-RESONANCE SPECTROSCOPY; FREE-RADICAL GENERATION; HYDROGEN-PEROXIDE; RED WINE; MYOCARDIAL-ISCHEMIA; THERAPEUTIC TARGET; REPERFUSION INJURY; CARDIAC MYOCYTES; OXIDATIVE STRESS; FRENCH PARADOX	Background/Aims: Resveratrol has been demonstrated to be protective in the cardiovascular system. The aim of this study was to assess the effects of resveratrol on hydrogen peroxide (H2O2)-induced increase in late sodium current (I-Na.L) which augmented the reverse Na+-Ca2+ exchanger current (I-NCX), and the diastolic intracellular Ca2+ concentration in ventricular myocytes. Methods: I-Na.L, I-NCX, L-type Ca2+ current (I-Ca.L) and intracellular Ca2+ properties were determined using whole-cell patch-clamp techniques and dual-excitation fluorescence photomultiplier system (IonOptix), respectively, in rabbit ventricular myocytes. Results: Resveratrol (10, 20, 40 and 80 mu M)decreased I-Na.L in myocytes both in the absence and presence of H2O2 (300 mu M) in a concentration dependent manner. Ranolazine (3-9 mu M) and tetrodotoxin (TTX, 4 mu M), I-Na.L inhibitors, decreased I-Na.L in cardiomyocytes in the presence of 300 mu M H2O2. H2O2 (300 mu M) increased the reverse I-NCX and this increase was significantly attenuated by either 20 mu M resveratrol or 4 mu M ranolazine or 4 mu M TTX. In addition, 10 mu M resveratrol and 2 mu M TTX significantly depressed the increase by 150 mu M H2O2 of the diastolic intracellular Ca2+ fura-2 fluorescence intensity (FFI), fura-fluorescence intensity change (Delta FFI), maximal velocity of intracellular Ca2+ transient rise and decay. As expected, 2 mu M TTX had no effect on I-Ca.L. Conclusion: Resveratrol protects the cardiomyocytes by inhibiting the H2O2-induced augmentation of I-Na.L and may contribute to the reduction of ischemia-induced lethal arrhythmias. Citation: Qian C, Ma J, Zhang P, Luo A, Wang C, et al. (2012) Resveratrol Attenuates the Na+-Dependent Intracellular Ca2+ Overload by Inhibiting H2O2-Induced Increase in Late Sodium Current in Ventricular Myocytes. PLoS ONE 7(12): e51358. doi:10.1371/journal.pone.0051358	[Qian, Chunping; Ma, Jihua; Zhang, Peihua; Luo, Antao; Wang, Chao; Ren, Zhiqiang; Kong, Linghao; Zhang, Shuo; Wang, Xiaojing; Wu, Ying] Wuhan Univ Sci & Technol, Coll Med, Cardioelectrophysiol Res Lab, Wuhan, Hubei, Peoples R China	Wuhan University of Science & Technology	Ma, JH (corresponding author), Wuhan Univ Sci & Technol, Coll Med, Cardioelectrophysiol Res Lab, Wuhan, Hubei, Peoples R China.	mjhua@wust.edu.cn			National Natural Science Foundation of China [81072637]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81072637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2004, CIRCULATION, V110, P904, DOI 10.1161/01.CIR.0000139333.83620.5D; ARROYO CM, 1987, FREE RADICAL BIO MED, V3, P313, DOI 10.1016/S0891-5849(87)80037-0; BAKER JE, 1988, P NATL ACAD SCI USA, V85, P2786, DOI 10.1073/pnas.85.8.2786; Barry WH, 2010, AM J PHYSIOL-HEART C, V298, pH102, DOI 10.1152/ajpheart.00316.2009; Belardinelli L, 2006, HEART, V92, P6, DOI 10.1136/hrt.2005.078790; BHATNAGAR A, 1990, CIRC RES, V67, P535, DOI 10.1161/01.RES.67.3.535; BOLLI R, 1988, J CLIN INVEST, V82, P476, DOI 10.1172/JCI113621; BORASO A, 1994, AM J PHYSIOL, V267, pH1010, DOI 10.1152/ajpheart.1994.267.3.H1010; Chen L, 2001, J CHROMATOGR A, V907, P343, DOI 10.1016/S0021-9673(00)00960-2; Constant J, 1997, CORONARY ARTERY DIS, V8, P645, DOI 10.1097/00019501-199710000-00007; Das DK, 1999, DRUG EXP CLIN RES, V25, P115; El-Ani D, 2011, LIFE SCI, V89, P7, DOI 10.1016/j.lfs.2011.04.017; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; GARLICK PB, 1987, CIRC RES, V61, P757, DOI 10.1161/01.RES.61.5.757; Hale SL, 2006, J PHARMACOL EXP THER, V318, P418, DOI 10.1124/jpet.106.103242; Harnmarstrom AKM, 2002, EUR BIOPHYS J BIOPHY, V31, P323, DOI 10.1007/s00249-002-0218-2; Hegyi B, 2012, PFLUG ARCH EUR J PHY, V464, P167, DOI 10.1007/s00424-012-1114-y; Hing LM, 2001, FREE RADICAL BIO MED, V30, P877, DOI 10.1016/S0891-5849(01)00474-9; Hung LM, 2000, CARDIOVASC RES, V47, P549, DOI 10.1016/S0008-6363(00)00102-4; JOSEPHSON RA, 1991, J BIOL CHEM, V266, P2354; Ju YK, 1996, J PHYSIOL-LONDON, V497, P337, DOI 10.1113/jphysiol.1996.sp021772; KIYOSUE T, 1989, CIRC RES, V64, P389, DOI 10.1161/01.RES.64.2.389; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Liu H, 2010, J CARDIOVASC PHARM, V55, P227, DOI 10.1097/FJC.0b013e3181cb599f; Liu Zheng, 2005, Shengli Xuebao, V57, P599; Luo AT, 2007, CELL PHYSIOL BIOCHEM, V19, P9, DOI 10.1159/000099188; Ma JH, 2005, ACTA PHARMACOL SIN, V26, P828, DOI 10.1111/j.1745-7254.2005.00154.x; Olas B, 2002, THROMB RES, V107, P141, DOI 10.1016/S0049-3848(02)00273-6; Parikh A, 2012, HEART RHYTHM, V9, P953, DOI 10.1016/j.hrthm.2012.01.010; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Richardt G, 1997, Z KARDIOL, V86, P23; Saint DA, 2008, BRIT J PHARMACOL, V153, P1133, DOI 10.1038/sj.bjp.0707492; Saint David A, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS96, DOI 10.1111/j.1540-8167.2006.00390.x; Sato H, 2009, ACTA PHARMACOL SIN, V30, P78, DOI 10.1038/aps.2008.4; Smith MA, 2003, J PHYSIOL-LONDON, V547, P417, DOI 10.1113/jphysiol.2002.034561; Song Y, 2006, J PHARMACOL EXP THER, V318, P214, DOI 10.1124/jpet.106.101832; Sossalla S, 2008, J MOL CELL CARDIOL, V45, P32, DOI 10.1016/j.yjmcc.2008.03.006; Sossalla S, 2012, PHARMACOL THERAPEUT, V133, P311, DOI 10.1016/j.pharmthera.2011.11.003; Sun LH, 2010, CELL PHYSIOL BIOCHEM, V26, P421, DOI 10.1159/000320584; Tang Q, 2012, PFLUG ARCH EUR J PHY, V463, P513, DOI 10.1007/s00424-011-1070-y; Undrovinas Albertas, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P348, DOI 10.2174/187152508785909447; Undrovinas Albertas I, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS169; Wagner S, 2003, CARDIOVASC RES, V60, P404, DOI 10.1016/j.cardiores.2003.08.006; Wallace CHR, 2006, BRIT J PHARMACOL, V149, P657, DOI 10.1038/sj.bjp.0706897; Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C; Wang WP, 2007, PFLUG ARCH EUR J PHY, V454, P461, DOI 10.1007/s00424-007-0219-1; Wasserstrom JA, 2009, J PHARMACOL EXP THER, V331, P382, DOI 10.1124/jpet.109.156471; Wood LG, 2010, ANTIOXID REDOX SIGN, V13, P1535, DOI 10.1089/ars.2009.3064; Yang KT, 2004, FASEB J, V18, P1442, DOI 10.1096/fj.03-1038fje; Zhang S, 2012, J CARDIOVASC PHARM; ZWEIER JL, 1988, J BIOL CHEM, V263, P1353	51	31	32	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51358	10.1371/journal.pone.0051358	http://dx.doi.org/10.1371/journal.pone.0051358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272101	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386600024
J	Mobashir, M; Schraven, B; Beyer, T				Mobashir, Mohammad; Schraven, Burkhart; Beyer, Tilo			Simulated Evolution of Signal Transduction Networks	PLOS ONE			English	Article							IN-SILICO EVOLUTION; KINASE CASCADE; ROBUSTNESS; ERK; DYNAMICS; PATHWAY; NOISE	Signal transduction is the process of routing information inside cells when receiving stimuli from their environment that modulate the behavior and function. In such biological processes, the receptors, after receiving the corresponding signals, activate a number of biomolecules which eventually transduce the signal to the nucleus. The main objective of our work is to develop a theoretical approach which will help to better understand the behavior of signal transduction networks due to changes in kinetic parameters and network topology. By using an evolutionary algorithm, we designed a mathematical model which performs basic signaling tasks similar to the signaling process of living cells. We use a simple dynamical model of signaling networks of interacting proteins and their complexes. We study the evolution of signaling networks described by mass-action kinetics. The fitness of the networks is determined by the number of signals detected out of a series of signals with varying strength. The mutations include changes in the reaction rate and network topology. We found that stronger interactions and addition of new nodes lead to improved evolved responses. The strength of the signal does not play any role in determining the response type. This model will help to understand the dynamic behavior of the proteins involved in signaling pathways. It will also help to understand the robustness of the kinetics of the output response upon changes in the rate of reactions and the topology of the network.	[Mobashir, Mohammad; Schraven, Burkhart; Beyer, Tilo] Otto von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Schraven, Burkhart] Helmholtz Ctr Infect Dis HZI, Dept Immune Control, Braunschweig, Germany	Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research	Mobashir, M (corresponding author), Otto von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany.	mohammad.mobashir@med.ovgu.de	Mobashir, Mohammad/ABC-2994-2021	Mobashir, Mohammad/0000-0002-5385-4048	German Ministry of Education and Research (BMBF FORSYS program) [0313922]; State of Sachsen-Anhalt (Dynamic Systems) [XD3639HP/0306]; European Union (SYBILLA) [HEALTH-F4-2008-201106]	German Ministry of Education and Research (BMBF FORSYS program)(Federal Ministry of Education & Research (BMBF)); State of Sachsen-Anhalt (Dynamic Systems); European Union (SYBILLA)(European Commission)	This work was supported in part by grants from the German Ministry of Education and Research (BMBF FORSYS program) [0313922], the State of Sachsen-Anhalt (Dynamic Systems) [XD3639HP/0306] and the European Union (SYBILLA) [HEALTH-F4-2008-201106]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2005, J CLIN ONCOL, V23, P5386, DOI 10.1200/JCO.2005.23.648; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bluthgen N, 2008, ESSAYS BIOCHEM, V45, P95, DOI 10.1042/BSE0450095; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Deckard A, 2004, CHEMBIOCHEM, V5, P1423, DOI 10.1002/cbic.200400178; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Ghiglione C, 2005, DEV BIOL, V99, P181; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Paladugu SR, 2006, IEE P SYST BIOL, V153, P223, DOI 10.1049/ip-syb:20050096; Papin JA, 2004, J THEOR BIOL, V227, P283, DOI 10.1016/j.jtbi.2003.11.016; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	28	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50905	10.1371/journal.pone.0050905	http://dx.doi.org/10.1371/journal.pone.0050905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23272078	Green Published, gold, Green Submitted			2022-12-25	WOS:000313236200047
J	Wu, FY; Peacock, SO; Rao, SY; Lemmon, SK; Burnstein, KL				Wu, Fayi; Peacock, Stephanie O.; Rao, Shuyun; Lemmon, Sandra K.; Burnstein, Kerry L.			Novel Interaction between the Co-chaperone Cdc37 and Rho GTPase Exchange Factor Vav3 Promotes Androgen Receptor Activity and Prostate Cancer Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-BINDING; PHASE-II TRIAL; TRANSCRIPTIONAL ACTIVITY; MOLECULAR CHAPERONE; AR COREGULATORS; CELL-LINE; HSP90; ACTIVATION; DOMAIN; IDENTIFICATION	Elevated androgen receptor (AR) activity in castration-resistant prostate cancer may occur through increased levels of AR co-activator proteins. Vav3, a guanine nucleotide exchange factor, is up-regulated following progression to castration resistance in preclinical models and is overexpressed in a significant number of human prostate cancers. Vav3 is a novel co-activator of the AR. We sought to identify Vav3 binding partners in an effort to understand the molecular mechanisms underlying Vav3 enhancement of AR activity and to identify new therapeutic targets. The cell division cycle 37 homolog (Cdc37), a protein kinase-specific co-chaperone for Hsp90, was identified as a Vav3 interacting protein by yeast two-hybrid screening. Vav3-Cdc37 interaction was confirmed by GST pulldown and, for native proteins, by co-immunoprecipitation experiments in prostate cancer cells. Cdc37 potentiated Vav3 co-activation of AR transcriptional activity and Vav3 enhancement of AR N-terminal-C-terminal interaction, which is essential for optimal receptor transcriptional activity. Cdc37 increased prostate cancer cell proliferation selectively in Vav3-expressing cells. Cdc37 did not affect Vav3 nucleotide exchange activity, Vav3 protein levels, or subcellular localization. Disruption of Vav3-Cdc37 interaction inhibited Vav3 enhancement of AR transcriptional activity and AR N-C interaction. Diminished Vav3-Cdc37 interaction also caused decreased prostate cancer cell proliferation selectively in Vav3-expressing cells. Taken together, we identified a novel Vav3 interacting protein that enhances Vav3 co-activation of AR and prostate cancer cell proliferation. Vav3-Cdc37 interaction may provide a new therapeutic target in prostate cancer.	[Wu, Fayi; Peacock, Stephanie O.; Rao, Shuyun; Lemmon, Sandra K.; Burnstein, Kerry L.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Burnstein, KL (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	kburnstein@med.miami.edu	Rao, Shuyun/AAE-9724-2019	Lemmon, Sandra/0000-0002-8022-130X	National Institutes of Health Grant [RO1CA132200]; Department of Defense Post-doctoral Grant [W81XWH-07-1-0151]; NATIONAL CANCER INSTITUTE [R01CA132200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG038275] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Post-doctoral Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA132200 (to K. L. B.).; Supported in part by Department of Defense Post-doctoral Grant W81XWH-07-1-0151.	Abbas-Terki T, 2000, FEBS LETT, V467, P111, DOI 10.1016/S0014-5793(00)01134-0; Askew EB, 2012, MOL CELL ENDOCRINOL, V348, P403, DOI 10.1016/j.mce.2011.03.026; Banach-Petrosky W, 2007, CANCER RES, V67, P9089, DOI 10.1158/0008-5472.CAN-07-2887; Bandhakavi S, 2003, J BIOL CHEM, V278, P2829, DOI 10.1074/jbc.M206662200; Berrevoets CA, 1998, MOL ENDOCRINOL, V12, P1172, DOI 10.1210/me.12.8.1172; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Colomba A, 2008, ONCOGENE, V27, P2728, DOI 10.1038/sj.onc.1210921; Dong ZY, 2006, MOL ENDOCRINOL, V20, P2315, DOI 10.1210/me.2006-0048; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gray PJ, 2007, CANCER RES, V67, P11942, DOI 10.1158/0008-5472.CAN-07-3162; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Heath EI, 2008, CLIN CANCER RES, V14, P7940, DOI 10.1158/1078-0432.CCR-08-0221; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Lee P, 2002, J CELL BIOL, V159, P1051, DOI 10.1083/jcb.200210121; Lin KT, 2012, CANCER RES, V72, P3000, DOI 10.1158/0008-5472.CAN-11-2502; Lin KY, 2012, MOL CANCER RES, V10, P750, DOI 10.1158/1541-7786.MCR-11-0598-T; Liu Y, 2008, CANCER RES, V68, P6396, DOI 10.1158/0008-5472.CAN-08-0645; Lyons LS, 2008, MOL ENDOCRINOL, V22, P597, DOI 10.1210/me.2007-0158; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Lyu J, 2009, J BIOL CHEM, V284, P12940, DOI 10.1074/jbc.M900207200; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Malanchuk OM, 2005, EXP ONCOL, V27, P186; Markus SM, 2002, MOL BIOL CELL, V13, P670, DOI 10.1091/mbc.01-10-0513; Marques RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013500; Miyata Y, 2005, MOL CELL BIOCHEM, V274, P171, DOI 10.1007/s11010-005-2949-8; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Oh WK, 2011, UROLOGY, V78, P626, DOI 10.1016/j.urology.2011.04.041; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Rao J, 2001, J BIOL CHEM, V276, P5814, DOI 10.1074/jbc.M007385200; Rao S, 2012, ONCOGENE, V31, P716, DOI 10.1038/onc.2011.273; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Rosenblatt AE, 2011, ENDOCR-RELAT CANCER, V18, P207, DOI 10.1677/ERC-10-0049; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Schmidt LJ, 2009, PROSTATE, V69, P1730, DOI 10.1002/pros.21022; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schutz AR, 1997, J CELL BIOL, V136, P969, DOI 10.1083/jcb.136.5.969; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Tatebe H, 2003, MOL CELL BIOL, V23, P5132, DOI 10.1128/MCB.23.15.5132-5142.2003; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang XT, 2002, J BIOL CHEM, V277, P24361, DOI 10.1074/jbc.M202198200; Yabana N, 2002, ONCOGENE, V21, P7720, DOI 10.1038/sj.onc.1205927; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zeng LY, 2000, MOL CELL BIOL, V20, P9212, DOI 10.1128/MCB.20.24.9212-9224.2000; Zhuang SH, 1998, ENDOCRINOLOGY, V139, P1197, DOI 10.1210/en.139.3.1197; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	59	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5463	5474		10.1074/jbc.M112.390963	http://dx.doi.org/10.1074/jbc.M112.390963			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23281476	hybrid, Green Published			2022-12-25	WOS:000315342500021
J	Del Re, DP; Yang, YF; Nakano, N; Cho, J; Zhai, PY; Yamamoto, T; Zhang, NL; Yabuta, N; Nojima, H; Pan, DJ; Sadoshima, J				Del Re, Dominic P.; Yang, Yanfei; Nakano, Noritsugu; Cho, Jaeyeaon; Zhai, Peiyong; Yamamoto, Takanobu; Zhang, Nailing; Yabuta, Norikazu; Nojima, Hiroshi; Pan, Duojia; Sadoshima, Junichi			Yes-associated Protein Isoform 1 (Yap1) Promotes Cardiomyocyte Survival and Growth to Protect against Myocardial Ischemic Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; HIPPO PATHWAY; MYOCYTE APOPTOSIS; HEART-FAILURE; PROLIFERATION; MST1; REGULATOR; HYPERTROPHY; LATS2	Yap1 is an important regulator of cardiomyocyte proliferation and embryonic heart development, yet the function of endogenous Yap1 in the adult heart remains unknown. We studied the role of Yap1 in maintaining basal cardiac function and in modulating injury after chronic myocardial infarction (MI). Cardiomyocyte-specific homozygous inactivation of Yap1 in the postnatal heart (Yap(F/F)Cre) elicited increased myocyte apoptosis and fibrosis, dilated cardiomyopathy, and premature death. Heterozygous deletion (Yap(+/F)Cre) did not cause an overt cardiac phenotype compared with Yap(F/F) control mice at base line. In response to stress (MI), nuclear Yap1 was found selectively in the border zone and not in the remote area of the heart. After chronic MI (28 days), Yap(+/F)Cre mice had significantly increased myocyte apoptosis and fibrosis, with attenuated compensatory cardiomyocyte hypertrophy, and further impaired function versus Yap(+/F) control mice. Studies in isolated cardiomyocytes demonstrated that Yap1 expression is sufficient to promote increased cell size and hypertrophic gene expression and protected cardiomyocytes against H2O2-induced cell death, whereas Yap1 depletion attenuated phenylephrine-induced hypertrophy and augmented apoptosis. Finally, we observed a significant decrease in cardiomyocyte proliferation in Yap(+/F)Cre hearts compared with Yap(+/F) controls after MI and demonstrated that Yap1 is sufficient to promote cardiomyocyte proliferation in isolated cardiomyocytes. Our findings suggest that Yap1 is critical for basal heart homeostasis and that Yap1 deficiency exacerbates injury in response to chronic MI.	[Del Re, Dominic P.; Yang, Yanfei; Nakano, Noritsugu; Cho, Jaeyeaon; Zhai, Peiyong; Yamamoto, Takanobu; Sadoshima, Junichi] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Del Re, Dominic P.; Yang, Yanfei; Nakano, Noritsugu; Cho, Jaeyeaon; Zhai, Peiyong; Yamamoto, Takanobu; Sadoshima, Junichi] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Zhang, Nailing; Pan, Duojia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21218 USA; [Zhang, Nailing; Pan, Duojia] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21218 USA; [Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Dept Mol Genet, Suita, Osaka 5650871, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Osaka University; Osaka University	Sadoshima, J (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, 185 S Orange Ave,MSB G-609, Newark, NJ 07103 USA.	sadoshju@umdnj.edu	yang, yanfei/GZK-2283-2022	Del Re, Dominic/0000-0002-5504-9114; Sadoshima, Junichi/0000-0003-3724-4132	National Institutes of Health [HL59139, HL67724, HL69020, HL91469, AG27211]; Fondation Leducq Transatlantic Network of Excellence; American Heart Association [11SDG7240067, 0930179N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067724, P01HL059139, R01HL112330, R01HL102738, R01HL091469, P01HL069020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027211, R21AG042678] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23370086] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	work was supported, in whole or in part, by National Institutes of Health Grants HL59139, HL67724, HL69020, HL91469, and AG27211 (United States Public Health Service). This work was also supported by the Fondation Leducq Transatlantic Network of Excellence (to J. S.).; Supported by American Heart Association Scientist Development Grants 11SDG7240067 and 0930179N.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; CONRAD CH, 1995, CIRCULATION, V91, P161, DOI 10.1161/01.CIR.91.1.161; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mani K, 2003, J AM COLL CARDIOL, V41, P761, DOI 10.1016/S0735-1097(02)02958-3; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Sciarretta S, 2012, CIRCULATION, V125, P1134, DOI 10.1161/CIRCULATIONAHA.111.078212; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Velagaleti RS, 2008, CIRCULATION, V118, P2057, DOI 10.1161/CIRCULATIONAHA.108.784215; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	30	166	170	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3977	3988		10.1074/jbc.M112.436311	http://dx.doi.org/10.1074/jbc.M112.436311			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23275380	Green Published, hybrid			2022-12-25	WOS:000314845000027
J	Bajaj, D; Batra, JK				Bajaj, Divya; Batra, Janendra K.			The C-Terminus of ClpC1 of Mycobacterium tuberculosis Is Crucial for Its Oligomerization and Function	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI; STRESS-RESPONSE; PROTEASE; VIRULENCE; CHAPERONE; DOMAINS; COMPLEX; PROTEOLYSIS; COMPETENCE	Mycobacterium tuberculosis ClpC1 is a member of the Hsp100/Clp AAA+ family of ATPases. The primary sequence of ClpC1 contains two N-terminal domains and two nucleotide binding domains (NBD). The second NBD has a long C-terminal subdomain containing several motifs important for substrate interaction. Generally, ClpC proteins are highly conserved, however presence of C-terminal domains of variable lengths is a remarkable difference in ClpC from different species. In this study, we constructed deletion mutants at the C-terminus of M. tuberculosis ClpC1 to determine its role in the structure and function of the protein. In addition, a deletion mutant having the two conserved N-terminal domains deleted was also constructed to investigate the role of these domains in M. tuberculosis ClpC1 function. The N-terminal domains were found to be dispensable for the formation of oligomeric structure, and ATPase and chaperone activities. However, deletions beyond a specific region in the C-terminus of the ClpC1 resulted in oligomerization defects and loss of chaperonic activity of the protein without affecting its ATPase activity. The truncated mutants, defective in oligomerization were also found to have lost the chaperonic activity, showing the formation of oligomer to be required for the chaperonic activity of M. tuberculosis ClpC1. The current study has identified a region in the C-terminus of M. tuberculosis ClpC1 which is essential for its oligomerization and in turn its function.	[Bajaj, Divya; Batra, Janendra K.] Natl Inst Immunol, Immunochem Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Batra, JK (corresponding author), Natl Inst Immunol, Immunochem Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	janendra@nii.res.in	Batra, Janendra/GWQ-8031-2022	Batra, Janendra/0000-0003-2206-3398	National Institute of Immunology; Department of Biotechnology, Government of India [BT-TF-10-BRB-2010]	National Institute of Immunology; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by core grants to the National Institute of Immunology and a grant No. BT-TF-10-BRB-2010 to JKB from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; Feldman DE, 2000, CURR OPIN STRUC BIOL, V10, P26, DOI 10.1016/S0959-440X(99)00044-5; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Kar NP, 2008, FEBS J, V275, P6149, DOI 10.1111/j.1742-4658.2008.06738.x; Kwon HY, 2004, INFECT IMMUN, V72, P5646, DOI 10.1128/IAI.72.10.5646-5653.2004; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Luong TT, 2011, J BACTERIOL, V193, P686, DOI 10.1128/JB.00987-10; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; de Oliveira NEM, 2011, MICROBIOL-SGM, V157, P656, DOI 10.1099/mic.0.041897-0; Neuwald AF, 1999, GENOME RES, V9, P27; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rouquette C, 1998, MOL MICROBIOL, V27, P1235, DOI 10.1046/j.1365-2958.1998.00775.x; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Stewart GR, 2001, NAT MED, V7, P732, DOI 10.1038/89113; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 2001, MOL MICROBIOL, V42, P717, DOI 10.1046/j.1365-2958.2001.02623.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076	33	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51261	10.1371/journal.pone.0051261	http://dx.doi.org/10.1371/journal.pone.0051261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284674	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500024
J	Montag, C; Brockmann, EM; Lehmann, A; Muller, DJ; Rujescu, D; Gallinat, J				Montag, Christiane; Brockmann, Eva-Maria; Lehmann, Anja; Mueller, Daniel J.; Rujescu, Dan; Gallinat, Juergen			Association between Oxytocin Receptor Gene Polymorphisms and Self-Rated 'Empathic Concern' in Schizophrenia	PLOS ONE			English	Article							HEALTHY CAUCASIAN ADULTS; EXTENDED LIMBIC SYSTEM; SOCIAL-BEHAVIOR; AFFILIATIVE BEHAVIOR; OXTR GENE; CENTRAL VASOPRESSIN; NEURAL CIRCUITRY; CENTRAL AMYGDALA; BRAIN OXYTOCIN; HUMANS	The nonapeptide oxytocin (OXT) and its receptor (OXTR) have been implicated in social cognition, empathy, emotion and stress regulation in humans. Previous studies reported associations between OXT and OXTR genetic polymorphisms and risk for disorders characterized by impaired socio-emotional functioning, such as schizophrenia and autism. Here we investigate the influence of two single nucleotide polymorphisms (SNPs) within the OXTR gene on a measure of socio-emotional functioning in schizophrenic patients. OXTR SNPs that were previously investigated in other studies were genotyped in 145 patients diagnosed with schizophrenia according to DSM-IV and 145 healthy controls matched for age and gender. The Interpersonal Reactivity Index (IRI) was used to assess cognitive ('perspective taking'), affective ('empathic concern') and self-related ('personal distress') dimensions of empathy. No group differences in genotype frequencies were observed. MANCOVA revealed a significant main (F [1,282] = 10.464; p < 0.01) and interaction effect (genotype by diagnosis: F [1,282] = 4.329; p < 0.05) of OXTR SNP rs2254298(A>GG) with 'empathic concern'. Within the schizophrenia group, linear regression analysis determined OXTR rs2254298 genotype, PANSS negative and general symptom score, and age of disease onset as being significantly associated with 'empathic concern'. OXTR rs2254298 significantly impacted PANSS general psychopathology scores. No associations were found for OXTR rs53576, IRI 'perspective taking' or 'personal distress' ratings. Our preliminary findings support hypotheses about an involvement of OXTR rs2254298 in emotional empathy in schizophrenic and healthy individuals, warranting independent replication.	[Montag, Christiane; Brockmann, Eva-Maria; Lehmann, Anja; Gallinat, Juergen] Charite, Dept Psychiat & Psychotherapy, Charite Campus Mitte, D-13353 Berlin, Germany; [Mueller, Daniel J.] Univ Toronto, Dept Psychiat, Neurogenet Sect, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Rujescu, Dan] Univ Munich, Dept Psychiat, D-8000 Munich, Germany; [Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, Halle, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Munich; Martin Luther University Halle Wittenberg	Montag, C (corresponding author), Charite, Dept Psychiat & Psychotherapy, Charite Campus Mitte, D-13353 Berlin, Germany.	christiane.montag@charite.de	Müller, Daniel J./L-4159-2016; Mueller, Daniel Josef/GVT-7899-2022; Rujescu, Dan/GRS-3875-2022	Müller, Daniel J./0000-0003-4978-4400; Mueller, Daniel Josef/0000-0003-4978-4400; Montag, Christiane/0000-0002-3307-276X	Canadian Institues of Health Research; Ontario Mental Health Foundation	Canadian Institues of Health Research; Ontario Mental Health Foundation	This work was supported by Canadian Institues of Health Research Michael Smith New Investigator Salary Prize for Research in Schizophrenia to DJM, and Ontario Mental Health Foundation New Investigator Fellowship to DJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Achim AM, 2011, PSYCHIAT RES, V190, P3, DOI 10.1016/j.psychres.2010.10.030; Averbeck BB, 2011, PSYCHOL MED, P1; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; Bartz JA, 2006, HORM BEHAV, V50, P518, DOI 10.1016/j.yhbeh.2006.06.018; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Bartz JA, 2010, P NATL ACAD SCI USA, V107, P21371, DOI 10.1073/pnas.1012669107; Bartz JA, 2010, PSYCHOL SCI, V21, P1426, DOI 10.1177/0956797610383439; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bora E, 2009, ACTA PSYCHIAT SCAND, V120, P253, DOI 10.1111/j.1600-0447.2009.01414.x; Brune M, 2007, SCHIZOPHR RES, V92, P151, DOI 10.1016/J.SCHRES.2007.01.006; Brune M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-38; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Buchheim A, 2009, PSYCHONEUROENDOCRINO, V34, P1417, DOI 10.1016/j.psyneuen.2009.04.002; BUJANOW W, 1974, CAN PSYCHIAT ASSOC J, V19, P323, DOI 10.1177/070674377401900323; Campbell DB, 2011, J NEURODEV DISORD, V3, P101, DOI 10.1007/s11689-010-9071-2; Campbell P, 2009, J COMP NEUROL, V516, P321, DOI 10.1002/cne.22116; Carter CS, 2007, BEHAV BRAIN RES, V176, P170, DOI 10.1016/j.bbr.2006.08.025; Chan RCK, 2010, PSYCHIAT RES, V178, P381, DOI 10.1016/j.psychres.2009.03.035; Chen FS, 2011, P NATL ACAD SCI USA, V108, P19937, DOI 10.1073/pnas.1113079108; Chen FS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00200; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; Cohen AS, 2010, SCHIZOPHRENIA BULL, V36, P143, DOI 10.1093/schbul/sbn061; Costa B, 2009, PSYCHONEUROENDOCRINO, V34, P1506, DOI 10.1016/j.psyneuen.2009.05.006; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Derntl B, 2012, SCHIZOPHR RES, V136, P70, DOI 10.1016/j.schres.2011.12.018; Derntl B, 2009, SCHIZOPHR RES, V108, P197, DOI 10.1016/j.schres.2008.11.009; Domes G, 2007, BIOL PSYCHIAT, V62, P1187, DOI 10.1016/j.biopsych.2007.03.025; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Feifel D, 1999, PSYCHOPHARMACOLOGY, V141, P93, DOI 10.1007/s002130050811; Feifel D, 2012, SCHIZOPHR RES, V139, P207, DOI 10.1016/j.schres.2012.05.018; Feifel D, 2010, BIOL PSYCHIAT, V68, P678, DOI 10.1016/j.biopsych.2010.04.039; Feldman R, 2012, BIOL PSYCHIAT, V72, P175, DOI 10.1016/j.biopsych.2011.12.025; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Frith CD, 2004, PSYCHOL MED, V34, P385, DOI 10.1017/S0033291703001326; Furman DJ, 2011, PSYCHONEUROENDOCRINO, V36, P891, DOI 10.1016/j.psyneuen.2010.12.004; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Goldman M, 2008, SCHIZOPHR RES, V98, P247, DOI 10.1016/j.schres.2007.09.019; Goldman MB, 2011, PSYCHOPHARMACOLOGY, V216, P101, DOI 10.1007/s00213-011-2193-8; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; HELMCHEN H, 1995, NERVENARZT, V66, P231; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Inoue H, 2010, BIOL PSYCHIAT, V68, P1066, DOI 10.1016/j.biopsych.2010.07.019; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Kawamura Y, 2010, J AFFECT DISORDERS, V127, P31, DOI 10.1016/j.jad.2010.04.014; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keri S, 2011, PHYSIOL BEHAV, V102, P221, DOI 10.1016/j.physbeh.2010.11.011; Keri S, 2009, COGN AFFECT BEHAV NE, V9, P237, DOI 10.3758/CABN.9.3.237; Keri S, 2009, SOC NEUROSCI-UK, V4, P287, DOI 10.1080/17470910802319710; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Kimura T, 2003, J MOL ENDOCRINOL, V30, P109, DOI 10.1677/jme.0.0300109; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kiss A, 2010, J NEUROSCI RES, V88, P677, DOI 10.1002/jnr.22226; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Kogan A, 2011, P NATL ACAD SCI USA, V108, P19189, DOI 10.1073/pnas.1112658108; Krueger F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00004; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee PR, 2007, BRAIN RES, V1156, P152, DOI 10.1016/j.brainres.2007.04.042; Lee PR, 2005, NEUROPSYCHOPHARMACOL, V30, P1883, DOI 10.1038/sj.npp.1300722; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Liu XX, 2010, J HUM GENET, V55, P137, DOI 10.1038/jhg.2009.140; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; MacDonald K, 2012, ACTA NEUROPSYCHIATR, V24, P130, DOI 10.1111/j.1601-5215.2011.00634.x; MacDonald K, 2010, HARVARD REV PSYCHIAT, V18, P1, DOI 10.3109/10673220903523615; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; Montag C, 2013, WORLD J BIOL PSYCHIA, V14, P500, DOI 10.3109/15622975.2012.677547; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Neumann ID, 2002, PROG BRAIN RES, V139, P147; Norman GJ, 2012, HORM BEHAV, V61, P134, DOI 10.1016/j.yhbeh.2011.11.006; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; PAULUS C, 1992, EMPATHIE KOMPETENZ A; Pedersen CA, 2011, SCHIZOPHR RES, V132, P50, DOI 10.1016/j.schres.2011.07.027; Petrovic P, 2008, J NEUROSCI, V28, P6607, DOI 10.1523/JNEUROSCI.4572-07.2008; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Riem MME, 2012, NEUROPSYCHOPHARMACOL, V37, P1257, DOI 10.1038/npp.2011.313; Riem MME, 2011, BIOL PSYCHIAT, V70, P291, DOI 10.1016/j.biopsych.2011.02.006; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Rosenfeld AJ, 2011, SCHIZOPHRENIA BULL, V37, P1077, DOI 10.1093/schbul/sbq015; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Rubin LH, 2011, SCHIZOPHR RES, V130, P266, DOI 10.1016/j.schres.2011.06.002; Ruble LH, 2010, SCHIZOPHR RES, V124, P13, DOI 10.1016/j.schres.2010.09.014; Sasayama D, 2012, SCHIZOPHR RES, V139, P201, DOI 10.1016/j.schres.2012.06.016; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Skuse DH, 2011, PEDIATR RES, V69, p85R, DOI 10.1203/PDR.0b013e318212f562; Skuse DH, 2009, TRENDS COGN SCI, V13, P27, DOI 10.1016/j.tics.2008.09.007; Smith MJ, 2012, SCHIZOPHR RES, V137, P196, DOI 10.1016/j.schres.2012.01.012; Souza RP, 2010, SCHIZOPHR RES, V121, P279, DOI 10.1016/j.schres.2010.04.019; Souza RP, 2010, INT J NEUROPSYCHOPH, V13, P793, DOI 10.1017/S1461145710000167; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Striepens N, 2011, FRONT NEUROENDOCRIN, V32, P426, DOI 10.1016/j.yfrne.2011.07.001; Tansey KE, 2010, NEUROSCI LETT, V474, P163, DOI 10.1016/j.neulet.2010.03.035; Teltsh O, 2012, INT J NEUROPSYCHOPH, V15, P309, DOI 10.1017/S1461145711001374; Thompson RJ, 2011, PSYCHONEUROENDOCRINO, V36, P144, DOI 10.1016/j.psyneuen.2010.07.003; Tomasino B, 2011, PSYCHOL MED, V41, P301, DOI 10.1017/S0033291710000875; Tost H, 2011, BIOL PSYCHIAT, V70, pE37, DOI 10.1016/j.biopsych.2011.06.034; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; UVNASMOBERG K, 1992, PSYCHOPHARMACOLOGY, V109, P473, DOI 10.1007/BF02247726; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Wermter AK, 2010, AM J MED GENET B, V153B, P629, DOI 10.1002/ajmg.b.31032; Wittchen H.U., 1997, SKID 1 SCID 2 STRUKT; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Yamasue H, 2011, BIOL PSYCHIAT, V70, pE41, DOI 10.1016/j.biopsych.2011.07.021; Ylisaukko-oja T, 2006, ANN NEUROL, V59, P145, DOI 10.1002/ana.20722; Yrigollen CM, 2008, BIOL PSYCHIAT, V63, P911, DOI 10.1016/j.biopsych.2007.11.015; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128	119	57	60	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51882	10.1371/journal.pone.0051882	http://dx.doi.org/10.1371/journal.pone.0051882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284802	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500061
J	Saxena, R; Ganguly, S; Chattopadhyay, A				Saxena, Roopali; Ganguly, Sourav; Chattopadhyay, Amitabha			Comparative Analysis of Calcium Spikes upon Activation of Serotonin(1A) and Purinergic Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CA2+ SIGNALS; CELLS; 5-HT1A-RECEPTORS; OSCILLATIONS; SPECIFICITY; EXPRESSION; DYNAMICS; KINETICS; DRUG	Calcium signaling represents one of the most important signaling cascades in cells and regulates diverse processes such as exocytosis, muscle contraction and relaxation, gene expression and cell growth. G protein-coupled receptors (GPCRs) are the most important family of receptors that activate calcium signaling. Since calcium signaling regulates a large number of physiological responses, it is intriguing that how changes in cytosolic calcium levels by a wide range of stimuli lead to signal-specific physiological responses in the cellular interior. In order to address this issue, we have analyzed temporal calcium profiles induced by two GPCRs, the serotonin(1A) and purinergic receptors. In this work, we have described a set of parameters for the analysis of calcium transients that could provide novel insight into mechanisms responsible for maintaining signal specificity by shaping calcium transients. An interesting feature of calcium signaling that has emerged from our analysis is that the profile of individual transients in a calcium response could play an important role in maintaining downstream signal specificity. In summary, our analysis offers a novel approach to identify differences in calcium response patterns induced by various stimuli.	[Saxena, Roopali; Ganguly, Sourav; Chattopadhyay, Amitabha] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chattopadhyay, A (corresponding author), Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India.	amit@ccmb.res.in	Ganguly, Sourav/A-8931-2011; Chattopadhyay, Amitabha/C-9882-2013	Ganguly, Sourav/0000-0003-1002-9002; 	Council of Scientific and Industrial Research, Govt. of India; Council of Scientific and Industrial Research	Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R.S. and S. G. thank the Council of Scientific and Industrial Research for the award of Senior Research Fellowships. A. C. is an Adjunct Professor at the Special Centre for Molecular Medicine of Jawaharlal Nehru University (New Delhi, India) and Indian Institute of Science Education and Research (Mohali, India), and Honorary Professor at the Jawaharlal Nehru Centre for Advanced Scientific Research (Bangalore, India). A. C. gratefully acknowledges J.C. Bose Fellowship (Department of Science and Technology, Govt. of India). We thank Nandini Rangaraj for valuable suggestions and technical help, and members of our laboratory for critically reading the manuscript.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cornelisse LN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001073; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; Dawson AP, 1997, CURR BIOL, V7, pR544, DOI 10.1016/S0960-9822(06)00277-6; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dupont G, 2007, INT REV CYTOL, V261, P193, DOI 10.1016/S0074-7696(07)61005-5; Heilker R, 2009, DRUG DISCOV TODAY, V14, P231, DOI 10.1016/j.drudis.2008.11.011; HOSEY MM, 1988, J MEMBRANE BIOL, V104, P81, DOI 10.1007/BF01870922; Iradale PA, 1993, BRIT J PHARMACOL, V110, P1305; James LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026889; Kiselyov K, 2003, CELL SIGNAL, V15, P243, DOI 10.1016/S0898-6568(02)00074-8; Lin SH, 2004, ANN MED, V36, P204, DOI 10.1080/07853890310024668; Marcet B, 2004, J PHARMACOL EXP THER, V309, P533, DOI 10.1124/jpet.103.063396; MILLARD PJ, 1988, P NATL ACAD SCI USA, V85, P1854, DOI 10.1073/pnas.85.6.1854; MINTA A, 1989, J BIOL CHEM, V264, P8171; Muller CP, 2007, PROG NEUROBIOL, V81, P133, DOI 10.1016/j.pneurobio.2007.01.001; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pucadyil TJ, 2005, CELL MOL NEUROBIOL, V25, P553, DOI 10.1007/s10571-005-3969-3; Ralevic V, 1998, PHARMACOL REV, V50, P413; RAYMOND JR, 1992, N-S ARCH PHARMACOL, V346, P127, DOI 10.1007/BF00165293; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	36	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51857	10.1371/journal.pone.0051857	http://dx.doi.org/10.1371/journal.pone.0051857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284790	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300051
J	Chen, YC; Yip, PK; Huang, YL; Sun, Y; Wen, LL; Chu, YM; Chen, TF				Chen, Yen-Ching; Yip, Ping-Keung; Huang, Yi-Ling; Sun, Yu; Wen, Li-Li; Chu, Yi-Min; Chen, Ta-Fu			Sequence Variants of Toll Like Receptor 4 and Late-Onset Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TLR4 POLYMORPHISMS; PROSTATE-CANCER; RISK; TOLL-LIKE-RECEPTOR-4; POPULATION; SUSCEPTIBILITY; HYPERTENSION; INFLAMMATION; AGREEMENT	Background: Toll like receptor 4 (TLR4) has been related to inflammation and beta-amyloid deposition in Alzheimer's disease (AD) brain. No study has explored the association between haplotype-tagging single nucleotide polymorphisms (htSNPs) of TLR4 and AD risk previously and ApoE e4 status alone showed low sensitivity in identifying late-onset AD (LOAD) patients. Methods: A total of 269 LOAD patients were recruited from three hospitals in northern Taiwan (2007-2010). Controls (n = 449) were recruited from elderly health checkup and volunteers of the hospital during the same period of time. Five common (frequency >= 5%) TLR4 htSNPs were selected to assess the association between TLR4 polymorphisms and the risk of LOAD in the Chinese ethnic population. Results: Homozygosity of TLR4 rs1927907 was significantly associated with an increased risk of LOAD [ TT vs. CC: adjusted odds ratio (AOR) = 2.45, 95% confidence interval (CI) = 1.30-4.64]. After stratification, the association increased further in ApoE e4 non-carriers (AOR = 3.07) and in hypertensive patients (AOR = 3.60). Haplotype GACGG was associated with a decreased risk of LOAD (1 vs. 0 copies: AOR = 0.59, 95% CI = 0.36-0.96; 2 vs. 0 copies: AOR = 0.31, 95% CI = 0.14-0.67) in ApoE e4 non-carriers. ApoE e4 status significantly modified this association (p(interaction) = 0.01). These associations remained significant after correction for multiple tests. Conclusions: Sequence variants of TLR4 were associated with an increased risk of LOAD, especially in ApoE e4 non-carriers and in hypertensive patients. The combination of TLR4 rs1927907 and ApoE e4 significantly increased the screening sensitivity in identifying LOAD patients from 0.4 to 0.7.	[Chen, Yen-Ching; Huang, Yi-Ling] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; [Yip, Ping-Keung] Cardinal Tien Hosp, Ctr Neurol Med, Taipei, Taiwan; [Sun, Yu] En Chu Kong Hosp, Dept Neurol, Taipei, Taiwan; [Yip, Ping-Keung] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Wen, Li-Li] En Chu Kong Hosp, Dept Lab Med, Taipei, Taiwan; [Chu, Yi-Min] Cardinal Tien Hosp, Dept Lab Med, Taipei, Taiwan; [Chen, Ta-Fu] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital	Chen, YC (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan.	karenchen@ntu.edu.tw	Huang, YiLing/ABH-8788-2020; Chen, Yen-Ching/D-1098-2010	Chen, Ta-Fu/0000-0003-1988-6924; Chen, Yen-Ching/0000-0002-8159-7202	National Science Council [96-2314-B-002-197, 97-2314-B-002-168-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	Funding for the study was provided by National Science Council grants 96-2314-B-002-197 and 97-2314-B-002-168-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Balistreri CR, 2008, CURR PHARM DESIGN, V14, P2672, DOI 10.2174/138161208786264089; Balistreri CR, 2011, MECH AGEING DEV, V132, P86, DOI 10.1016/j.mad.2010.12.005; Balistreri CR, 2009, J CLIN IMMUNOL, V29, P406, DOI 10.1007/s10875-009-9297-5; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Chapman J, 1996, NEUROLOGY, V46, P1484, DOI 10.1212/WNL.46.5.1484-a; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Eissler R, 2011, HYPERTENS RES, V34, P551, DOI 10.1038/hr.2010.270; El Fakiri F, 2007, J CLIN EPIDEMIOL, V60, P1271, DOI 10.1016/j.jclinepi.2007.02.014; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Fuh Jong-Ling, 2008, Acta Neurol Taiwan, V17, P153; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hajjar IM, 2008, AM J ALZHEIMERS DIS, V23, P77, DOI 10.1177/1533317507309803; Hang JQ, 2004, J ENDOTOXIN RES, V10, P238, DOI 10.1177/09680519040100040601; Harold D, 2009, NATURE GENETICS; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; HOLM S, 1979, SCAND J STAT, V6, P65; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Kamboh MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.45; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V59, P1; Lambert JC, 2009, NATURE GENETICS; Li NC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5465; Liao PY, 2010, BIOCHEM ENG J, V49, P149, DOI 10.1016/j.bej.2009.12.021; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Minoretti P, 2006, NEUROSCI LETT, V391, P147, DOI 10.1016/j.neulet.2005.08.047; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Roman Gustavo C, 2005, Cerebrovasc Dis, V20 Suppl 2, P91, DOI 10.1159/000089361; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; St Sauver JL, 2005, MAYO CLIN PROC, V80, P203; Stozicka Z, 2007, ACTA VIROL, V51, P205; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Streit WJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3423; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Udan MLD, 2008, J NEUROCHEM, V104, P524, DOI 10.1111/j.1471-4159.2007.05001.x; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Wang LZ, 2011, BRAIN RES, V1381, P202, DOI 10.1016/j.brainres.2011.01.007; Wang M, 2010, NEUROSCI LETT, V482, P260, DOI 10.1016/j.neulet.2010.07.051; Zheng SL, 2006, PROSTATE, V66, P1556, DOI 10.1002/pros.20496	47	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50771	10.1371/journal.pone.0050771	http://dx.doi.org/10.1371/journal.pone.0050771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272070	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300012
J	Han, ZC; Conley, SM; Makkia, R; Guo, JJ; Cooper, MJ; Naash, MI				Han, Zongchao; Conley, Shannon M.; Makkia, Rasha; Guo, Junjing; Cooper, Mark J.; Naash, Muna I.			Comparative Analysis of DNA Nanoparticles and AAVs for Ocular Gene Delivery	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS; IN-VIVO; OPTIC-NERVE; EXPRESSION; THERAPY; MOUSE; TRANSDUCTION; VECTORS; INTEGRATION; PROMOTER	Gene therapy is a critical tool for the treatment of monogenic retinal diseases. However, the limited vector capacity of the current benchmark delivery strategy, adeno-associated virus (AAV), makes development of larger capacity alternatives, such as compacted DNA nanoparticles (NPs), critical. Here we conduct a side-by-side comparison of self-complementary AAV and CK30PEG NPs using matched ITR plasmids. We report that although AAVs are more efficient per vector genome (vg) than NPs, NPs can drive gene expression on a comparable scale and longevity to AAV. We show that subretinally injected NPs do not leave the eye while some of the AAV-injected animals exhibited vector DNA and GFP expression in the visual pathways of the brain from PI-60 onward. As a result, these NPs have the potential to become a successful alternative for ocular gene therapy, especially for the multitude of genes too large for AAV vectors.	[Han, Zongchao; Conley, Shannon M.; Makkia, Rasha; Guo, Junjing; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Cooper, Mark J.] Copernicus Therapeut Inc, Cleveland, OH USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA.	Muna-Naash@ouhsc.edu		Han, Zongchao/0000-0002-1287-1810; Han, Zongchao/0000-0002-2019-395X	National Eye Institute [EY10609-MIN, EY018656-MIN, EY018512-SMC]; Foundation Fighting Blindness; Oklahoma Center for the Advancement of Science and Technology; state of Ohio Biomedical Research Commercialization Program; Dr. William "Bill'' W. Talley II Research Award; NATIONAL EYE INSTITUTE [R55EY010609, R56EY010609, R01EY018656, F32EY018512, R01EY010609] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Oklahoma Center for the Advancement of Science and Technology; state of Ohio Biomedical Research Commercialization Program; Dr. William "Bill'' W. Talley II Research Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by National Eye Institute (EY10609-MIN, EY018656-MIN, EY018512-SMC, http://www.nei.nih.gov/), the Foundation Fighting Blindness (MIN, http://www.blindness.org/), the Oklahoma Center for the Advancement of Science and Technology (ZH, SMC, and MIN, http://www.ok.gov/ocast/), the state of Ohio Biomedical Research Commercialization Program (MJC), and Dr. William "Bill'' W. Talley II Research Award ( ZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Amado D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000659; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Cai X, 2010, FASEB J, V24, P1178, DOI 10.1096/fj.09-139147; Cai X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005290; Chen X, 2008, MOL THER, V16, P333, DOI 10.1038/sj.mt.6300365; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dinculescu A, 2005, HUM GENE THER, V16, P649, DOI 10.1089/hum.2005.16.649; Ding XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007410; Donsante A, 2001, GENE THER, V8, P1343, DOI 10.1038/sj.gt.3301541; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Dudus L, 1999, VISION RES, V39, P2545, DOI 10.1016/S0042-6989(98)00308-3; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038; Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Glushakova LG, 2006, MOL VIS, V12, P298; Glushakova LG, 2006, INVEST OPHTH VIS SCI, V47, P3505, DOI 10.1167/iovs.05-1670; Gray SJ, 2011, HUM GENE THER, V22, P1143, DOI 10.1089/hum.2010.245; Guy J, 1999, ARCH OPHTHALMOL-CHIC, V117, P929; Han Z, 2008, MOL GENET METAB, V93, P381, DOI 10.1016/j.ymgme.2007.10.131; Han ZC, 2008, HUM GENE THER, V19, P267, DOI 10.1089/hum.2007.161; Han ZC, 2012, NANOMEDICINE-UK, V7, P521, DOI [10.2217/NNM.11.158, 10.2217/nnm.11.158]; Hasbrouck NC, 2008, GENE THER, V15, P870, DOI 10.1038/gt.2008.71; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hennig AK, 2003, J NEUROSCI, V23, P3302; Jacobson SG, 2006, HUM GENE THER, V17, P845, DOI 10.1089/hum.2006.17.845; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Koirala A, 2011, BIOMATERIALS, V32, P9483, DOI 10.1016/j.biomaterials.2011.08.062; Konstan MW, 2004, HUM GENE THER, V15, P1255, DOI 10.1089/hum.2004.15.1255; Lai Y, 2010, MOL THER, V18, P75, DOI 10.1038/mt.2009.256; Lei B, 2009, MOL VIS, V15, P1374; Liu G, 2003, J BIOL CHEM, V278, P32578, DOI 10.1074/jbc.M305776200; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Padegimas L, 2012, MOL THER, V20, P63, DOI 10.1038/mt.2011.196; Provost N, 2005, MOL THER, V11, P275, DOI 10.1016/j.ymthe.2004.09.022; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Rocha EM, 2011, INVEST OPHTH VIS SCI, V52, P9567, DOI 10.1167/iovs.11-8171; Sarra GM, 2001, HUM MOL GENET, V10, P2353, DOI 10.1093/hmg/10.21.2353; Shen WY, 2003, J GENE MED, V5, P576, DOI 10.1002/jgm.375; Voutetakis A, 2004, P NATL ACAD SCI USA, V101, P3053, DOI 10.1073/pnas.0400136101; Yang GS, 2002, J VIROL, V76, P7651, DOI 10.1128/JVI.76.15.7651-7660.2002; Yurek DM, 2011, MOL IMAGING, V10, P327, DOI 10.2310/7290.2010.00053; Ziady AG, 2003, MOL THER, V8, P936, DOI 10.1016/j.ymthe.2003.07.007; Ziady AG, 2003, MOL THER, V8, P948, DOI 10.1016/j.ymthe.2003.09.002	50	59	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52189	10.1371/journal.pone.0052189	http://dx.doi.org/10.1371/journal.pone.0052189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272225	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300069
J	Mendes, PAD; Thomsen, L				Mendes, Pedro A. de Jesus; Thomsen, Laurenz			Effects of Ocean Acidification on the Ballast of Surface Aggregates Sinking through the Twilight Zone	PLOS ONE			English	Article							BENTHIC BOUNDARY-LAYER; PRESSURE; CARBONATE; BACTERIA; SEAWATER	The dissolution of CaCO3 is one of the ways ocean acidification can, potentially, greatly affect the ballast of aggregates. A diminution of the ballast could reduce the settling speed of aggregates, resulting in a change in the carbon flux to the deep sea. This would mean lower amounts of more refractory organic matter reaching the ocean floor. This work aimed to determine the effect of ocean acidification on the ballast of sinking surface aggregates. Our hypothesis was that the decrease of pH will increase the dissolution of particulate inorganic carbon ballasting the aggregates, consequently reducing their settling velocity and increasing their residence time in the upper twilight zone. Using a new methodology for simulation of aggregate settling, our results suggest that future pCO(2) conditions can significantly change the ballast composition of sinking aggregates. The change in aggregate composition had an effect on the size distribution of the aggregates, with a shift to smaller aggregates. A change also occurred in the settling velocity of the particles, which would lead to a higher residence time in the water column, where they could be continuously degraded. In the environment, such an effect would result in a reduction of the carbon flux to the deep-sea. This reduction would impact those benthic communities, which rely on the vertical flow of carbon as primary source of energy.	[Mendes, Pedro A. de Jesus; Thomsen, Laurenz] Jacobs Univ Bremen gGmbH, OceanLab, Bremen, Germany	Jacobs University	Mendes, PAD (corresponding author), Jacobs Univ Bremen gGmbH, OceanLab, Bremen, Germany.	p.mendes@jacobs-university.de			German project Biological Impacts of Ocean ACIDification (BIOACID); Federal Ministry of Education and Research (BMBF) [FKZ 03F0608B]	German project Biological Impacts of Ocean ACIDification (BIOACID); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Support by the German project Biological Impacts of Ocean ACIDification (BIOACID), funded by the Federal Ministry of Education and Research (BMBF, FKZ 03F0608B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Balch WM, 2008, J PLANKTON RES, V30, P119, DOI 10.1093/plankt/fbm097; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; COOKE RC, 1980, GEOCHIM COSMOCHIM AC, V44, P1077, DOI 10.1016/0016-7037(80)90061-7; COOKE RC, 1977, MAR CHEM, V5, P75; DRAPEAU DT, 1994, LIMNOL OCEANOGR, V39, P723, DOI 10.4319/lo.1994.39.3.0723; Ehrhardt M, 1999, METHODS SEAWATER ANA, P437, DOI DOI 10.1002/9783527613984.CH17; Engel A, 2009, DEEP-SEA RES PT II, V56, P1396, DOI 10.1016/j.dsr2.2008.11.027; FRANKIGNOULLE M, 1994, LIMNOL OCEANOGR, V39, P458, DOI 10.4319/lo.1994.39.2.0458; Gattuso J, 2010, BIOGEOSCIENCE DISCUS, V6, P4413; Gattuso JP, 2009, BIOGEOSCIENCES, V6, P2121, DOI 10.5194/bg-6-2121-2009; GRAF G, 1992, OCEANOGR MAR BIOL, V30, P149; Hamm CE, 2002, LIMNOL OCEANOGR, V47, P1790, DOI 10.4319/lo.2002.47.6.1790; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Kiorboe T, 2001, MAR ECOL PROG SER, V211, P1, DOI 10.3354/meps211001; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Mendes PADJ, 2007, MAR GEOL, V246, P165, DOI 10.1016/j.margeo.2007.05.012; Passow U, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002579; Passow U, 2012, MAR CHEM, V128, P72, DOI 10.1016/j.marchem.2011.10.004; Ploug H, 1999, MAR ECOL PROG SER, V176, P279, DOI 10.3354/meps176279; PYTKOWICZ RM, 1963, DEEP-SEA RES, V10, P633, DOI 10.1016/0011-7471(63)90004-4; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Ritzrau W, 1997, J MARINE SYST, V10, P415, DOI 10.1016/S0924-7963(96)00073-5; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tamburini C, 2006, AQUAT MICROB ECOL, V43, P267, DOI 10.3354/ame043267; Thomsen L, 2000, DEEP-SEA RES PT I, V47, P1881, DOI 10.1016/S0967-0637(00)00003-0; Turley C, 2000, FEMS MICROBIOL ECOL, V33, P89, DOI 10.1111/j.1574-6941.2000.tb00731.x; TURLEY CM, 1993, DEEP-SEA RES PT I, V40, P2193; Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972; Wolf-Gladrow DA, 2001, CO2 SEAWATER EQUILIB, V65; Ziveri P, 2007, DEEP-SEA RES PT II, V54, P659, DOI 10.1016/j.dsr2.2007.01.006	35	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50865	10.1371/journal.pone.0050865	http://dx.doi.org/10.1371/journal.pone.0050865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272075	Green Accepted, gold, Green Published			2022-12-25	WOS:000312483300013
J	Weiland, T; Klein, K; Zimmermann, M; Speicher, T; Venturelli, S; Berger, A; Bantel, H; Konigsrainer, A; Schenk, M; Weiss, TS; Wendel, A; Schwab, M; Bitzer, M; Lauer, UM				Weiland, Timo; Klein, Kathrin; Zimmermann, Martina; Speicher, Tobias; Venturelli, Sascha; Berger, Alexander; Bantel, Heike; Koenigsrainer, Alfred; Schenk, Martin; Weiss, Thomas S.; Wendel, Albrecht; Schwab, Matthias; Bitzer, Michael; Lauer, Ulrich M.			Selective Protection of Human Liver Tissue in TNF-Targeting of Cancers of the Liver by Transient Depletion of Adenosine Triphosphate	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; ISOLATED HEPATIC PERFUSION; NECROSIS-FACTOR-ALPHA; PHASE-I; INTRAVENOUS FRUCTOSE; METABOLIC DEPLETION; TUMOR; APOPTOSIS; HEPATOCYTES; ATP	Background: Tumor necrosis factor alpha (TNF) is able to kill cancer cells via receptor-mediated cell death requiring adenosine triphosphate (ATP). Clinical usage of TNF so far is largely limited by its profound hepatotoxicity. Recently, it was found in the murine system that specific protection of hepatocytes against TNF's detrimental effects can be achieved by fructose-mediated ATP depletion therein. Before employing this quite attractive selection principle in a first clinical trial, we here comprehensively investigated the interdependence between ATP depletion and TNF hepatotoxicity in both in vitro and ex vivo experiments based on usage of primary patient tissue materials. Methods: Primary human hepatocytes, and both non-tumorous and tumorous patient-derived primary liver tissue slices were used to elucidate fructose-induced ATP depletion and TNF-induced cytotoxicity. Results: PHH as well as tissue slices prepared from non-malignant human liver specimen undergoing a fructose-mediated ATP depletion were both demonstrated to be protected against TNF-induced cell death. In contrast, due to tumor-specific overexpression of hexokinase II, which imposes a profound bypass on hepatocytic-specific fructose catabolism, this was not the case for human tumorous liver tissues. Conclusion: Normal human liver tissues can be protected transiently against TNF-induced cell death by systemic pretreatment with fructose used in non-toxic/physiologic concentrations. Selective TNF-targeting of primary and secondary tumors of the liver by transient and specific depletion of hepatocytic ATP opens up a new clinical avenue for the TNF-based treatment of liver cancers.	[Weiland, Timo; Zimmermann, Martina; Venturelli, Sascha; Berger, Alexander; Bitzer, Michael; Lauer, Ulrich M.] Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany; [Klein, Kathrin; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Speicher, Tobias] ETH, Dept Biol, Inst Cell Biol, Zurich, Switzerland; [Bantel, Heike] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Koenigsrainer, Alfred; Schenk, Martin] Univ Tubingen Hosp, Dept Gen Visceral & Transplant Surg, Tubingen, Germany; [Weiss, Thomas S.] Univ Hosp, Ctr Liver Cell Res, Regensburg, Germany; [Wendel, Albrecht] Univ Tubingen, Interfac Ctr Pharmacogen & Drug Res ICEPHA, D-72074 Tubingen, Germany; [Schwab, Matthias] Med Univ Hosp, Dept Clin Pharmacol, Inst Expt & Clin Pharmacol & Toxicol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Hannover Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Regensburg; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Lauer, UM (corresponding author), Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany.	ulrich.lauer@uni-tuebingen.de	Schwab, Matthias/ABH-7449-2020; Weiss, Thomas S./G-3989-2012	Weiss, Thomas S./0000-0003-0336-0581; Venturelli, Sascha/0000-0001-5585-6701	ICEPHA grant [2009-09]; Deutsche Forschungsgemeinschaft [SFB/TRR77]; Federal Ministry for Education and Research (BMBF) [0315755]; Robert Bosch Foundation, Stuttgart, Germany	ICEPHA grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Robert Bosch Foundation, Stuttgart, Germany	This work was supported by ICEPHA grant 2009-09, the Deutsche Forschungsgemeinschaft (SFB/TRR77), the Federal Ministry for Education and Research (BMBF, #0315755) and the Robert Bosch Foundation, Stuttgart, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HR, 1998, CLIN CANCER RES, V4, P2357; Boesch C, 1997, MAGN RESON IMAGING, V15, P1067, DOI 10.1016/S0730-725X(97)00163-X; BOESIGER P, 1994, PEDIATR RES, V36, P436, DOI 10.1203/00006450-199410000-00004; Christoforidis D, 2002, EUR J SURG ONCOL, V28, P875, DOI 10.1053/ejso.2002.1328; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; de Vries MR, 1998, RECENT RES CANCER, V147, P107; Hentze H, 2004, HEPATOLOGY, V39, P1311, DOI 10.1002/hep.20174; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Latta M, 2000, J EXP MED, V191, P1975, DOI 10.1084/jem.191.11.1975; LEIST M, 1994, J IMMUNOL, V153, P1778; LEJEUNE F, 1994, J CELL BIOCHEM, V56, P52, DOI 10.1002/jcb.240560110; LIENARD D, 1992, J CLIN ONCOL, V10, P52, DOI 10.1200/JCO.1992.10.1.52; OBERHAENSLI RD, 1986, BRIT J RADIOL, V59, P695, DOI 10.1259/0007-1285-59-703-695; SHERMAN ML, 1988, J CLIN ONCOL, V6, P344, DOI 10.1200/JCO.1988.6.2.344; Speicher T, 2012, J BIOL CHEM, V287, P1837, DOI 10.1074/jbc.M111.266742; Speicher T, 2010, J HEPATOL, V53, P896, DOI 10.1016/j.jhep.2010.05.024; SPRIGGS DR, 1988, J NATL CANCER I, V80, P1039, DOI 10.1093/jnci/80.13.1039; TERRIER F, 1989, RADIOLOGY, V171, P557, DOI 10.1148/radiology.171.2.2704824; Weinreich DM, 2002, SEMIN ONCOL, V29, P136, DOI 10.1053/sonc.2002.31681; WOODS HG, 1970, BIOCHEM J, V119, P501, DOI 10.1042/bj1190501; Zimmermann M, 2009, INT J ONCOL, V34, P1247, DOI 10.3892/ijo_00000253	21	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52496	10.1371/journal.pone.0052496	http://dx.doi.org/10.1371/journal.pone.0052496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272249	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300091
J	Gotoh, H; Ono, K; Nomura, T; Takebayashi, H; Harada, H; Nakamura, H; Ikenaka, K				Gotoh, Hitoshi; Ono, Katsuhiko; Nomura, Tadashi; Takebayashi, Hirohide; Harada, Hidekiyo; Nakamura, Harukazu; Ikenaka, Kazuhiro			Nkx2.2+Progenitors Generate Somatic Motoneurons in the Chick Spinal Cord	PLOS ONE			English	Article							MOTOR-NEURON DIVERSITY; TRANSCRIPTION FACTORS; PROGENITOR DISPERSAL; OLIG2; ORIGIN; IDENTITY; NKX2.2; OLIGODENDROCYTES; SPECIFICATION; PROTEINS	Heterogeneous classes of neurons are present in the spinal cord and are essential for its function. Expression patterns of transcription factors in neural progenitor cells determine neuron subtypes during development. Nkx2.2 is expressed in the progenitor cell pool located just ventrally to the Olig2-positive pool and is indispensable for V3 interneuron generation in the spinal cord and also for visceral motoneuron generation in the hindbrain. However, whether Nkx2.2-positive progenitor cells generate diverse classes of neuron is not fully understood. Using a chick lineage tracing method in a genetically-defined manner, we found that Nkx2.2-expressing progenitor cells differentiate into general visceral motoneurons as well as sim1-positive V3 interneurons. Surprisingly, we further observed that Nkx2.2-expressing progenitors differentiate into somatic motoneuron. Our findings suggest that the different classes of motoneurons are derived from more complex sources than were previously expected in the chick spinal cord.	[Gotoh, Hitoshi; Ono, Katsuhiko; Nomura, Tadashi] Kyoto Prefectural Univ Med, Dept Biol, Kyoto, Japan; [Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Nomura, Tadashi; Takebayashi, Hirohide] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan; [Harada, Hidekiyo; Nakamura, Harukazu] Tohoku Univ, Grad Sch Life Sci, Inst Dev Aging & Canc, Dept Mol Neurobiol, Sendai, Miyagi 980, Japan; [Ikenaka, Kazuhiro] Grad Univ Adv Studies Sokendai, Sch Life Sci, Dept Physiol Sci, Hayama, Kanagawa, Japan	Kyoto Prefectural University of Medicine; Niigata University; Japan Science & Technology Agency (JST); Tohoku University; Graduate University for Advanced Studies - Japan	Gotoh, H (corresponding author), Kyoto Prefectural Univ Med, Dept Biol, Kyoto, Japan.	hgotoh@koto.kpu-m.ac.jp; ikenaka@nips.ac.jp	Harada, Hidekiyo/X-2704-2019; Takebayashi, Hirohide/AAO-1693-2020	Harada, Hidekiyo/0000-0001-6758-4141; 	JSPS [22500295, 24657158]; MEXT [23523124]; Kyoto Prefectural University of Medicine; National Institute for Physiological Sciences; Astellas Foundation for Research on Metabolic Disorders; JST, PRESTO; Naito foundation	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto Prefectural University of Medicine; National Institute for Physiological Sciences(National Institutes of Natural Sciences (NINS) - JapanNational Institute for Physiological Sciences (NIPS)); Astellas Foundation for Research on Metabolic Disorders; JST, PRESTO(Japan Science & Technology Agency (JST)); Naito foundation(Naito Memorial Foundation)	This work was supported by Grant-in-Aid for Scientific Research (A) and (C)(22500295), for Challenging Exploratory Research (24657158) provided by JSPS, by Grant-in-Aid for Scientific Research on Innovative Areas (23523124) provided by MEXT, by Project Research Grants from Kyoto Prefectural University of Medicine, and by Cooperative Study Program of the National Institute for Physiological Sciences. TN was supported by Astellas Foundation for Research on Metabolic Disorders, and JST, PRESTO. HG was supported by the Naito foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalliu D, 2009, NEURON, V61, P708, DOI 10.1016/j.neuron.2008.12.026; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cajal Ramon y S, 1911, HISTOLOGY NERVOUS SY, VI; Clarke JDW, 1998, DEV DYNAM, V212, P14, DOI 10.1002/(SICI)1097-0177(199805)212:1<14::AID-AJA2>3.0.CO;2-5; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Erskine L, 1998, DEV BIOL, V199, P26, DOI 10.1006/dbio.1998.8912; Fu H, 2002, DEVELOPMENT, V129, P681; Gotoh H, 2011, DEV BIOL, V349, P504, DOI 10.1016/j.ydbio.2010.10.007; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; LEBER SM, 1995, J NEUROSCI, V15, P1236; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nanmoku K, 2003, DEV NEUROSCI-BASEL, V25, P152, DOI 10.1159/000072264; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; PRASAD A, 1991, J COMP NEUROL, V307, P237, DOI 10.1002/cne.903070207; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Soula C, 2001, DEVELOPMENT, V128, P1369; Sun T, 2003, J NEUROSCI, V23, P9547; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	32	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51581	10.1371/journal.pone.0051581	http://dx.doi.org/10.1371/journal.pone.0051581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284718	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900030
J	Zheng, YB; Xiao, YY; Tan, P; Zhang, Q; Xu, PL				Zheng, Yuan-Bin; Xiao, Ying-Ying; Tan, Peng; Zhang, Qing; Xu, Peilin			Live-Cell Visualization of Intracellular Interaction between a Nuclear Migration Protein (hNUDC) and the Thrombopoietin Receptor (Mpl)	PLOS ONE			English	Article							MOVEMENT PROTEIN; GENE NUDC; ASPERGILLUS-NIDULANS; EXTRACELLULAR DOMAIN; MOLECULAR-CLONING; HUMAN HOMOLOG; DYNEIN; LIS1; IDENTIFICATION; DIFFERENTIATION	We previously demonstrated that endogenous hNUDC and Mpl co-localized in the perinuclear and cytoplasmic regions of megakaryocyte cells by indirect immunofluorescence. We further reported that hNUDC accumulated in the Golgi when NIH 3T3 cells were transfected with an hNUDC expression vector alone. However, co-transfection with hNUDC and Mpl expression vectors caused both proteins to co-localize predominantly in the cytosol. These observations led us to hypothesize that a complex containing hNUDC and Mpl may alter hNUDC subcellular location and induce its secretion. In the present study, we test this hypothesis by employing bimolecular fluorescence complementation (BiFC) to detect and visualize the complex formation of hNUDC/Mpl in living cells. We further examined in detail the subcellular locations of the hNUDC/Mpl complex by co-transfection of BiFC chimeras with known subcellular markers. The distribution of hNUDC/Mpl in the endoplasmic reticulum (ER), Golgi and cell surface was determined. Furthermore, the N-terminal 159 amino acids of hNUDC, but not C-terminal half, bound to Mpl in vivo and exhibited a similar localization pattern to that of full-length hNUDC in Cos-1 cells. Adenovirus-mediated overexpression of hNUDC or its N-terminal 159 residues in a human megakaryocyte cell line (Dami) resulted in increased levels of hNUDC or hNUDC(1-159) secretion. In contrast, depletion of Mpl by transfecting Dami cells with adenovirus bearing Mpl-targeting siRNA significantly blocked hNUDC secretion. Thus, we provide the first evidence that the N-terminal region of hNUDC contains all of the necessary information to complex with Mpl and traffic through the secretory pathway.	[Zheng, Yuan-Bin; Xiao, Ying-Ying; Tan, Peng; Zhang, Qing; Xu, Peilin] Zhongshan Univ, Educ Minist, Key Lab Gene Engn, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, Q (corresponding author), Zhongshan Univ, Educ Minist, Key Lab Gene Engn, Guangzhou, Guangdong, Peoples R China.	lsszq@mail.sysu.edu.cn; xupeilin@hotmail.com	Tan, Peng/P-3856-2015; Tan, Peng/HGD-6812-2022; Tan, Peng/P-3825-2015; Tan, Peng/ABD-8190-2020	Tan, Peng/0000-0001-6992-9000; Tan, Peng/0000-0002-7005-1896; ZHANG, QING/0000-0003-3522-1471	National Natural Science Foundation of China [31271230, 30770923]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31271230 and 30770923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1996, EMBO J, V15, P6531, DOI 10.1002/j.1460-2075.1996.tb01044.x; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; Chen WM, 2010, J BIOL CHEM, V285, P26697, DOI 10.1074/jbc.M110.120956; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gocke CD, 2000, LEUKEMIA LYMPHOMA, V39, P447, DOI 10.3109/10428190009113375; Helmstaedt K, 2008, EUKARYOT CELL, V7, P1041, DOI 10.1128/EC.00071-07; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Karpova T., 2006, CURR PROTOC CYTOM, V35, P12; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; MASIBAY AS, 1993, J BIOL CHEM, V268, P9908; Matsumoto N, 1999, HUM GENET, V104, P498, DOI 10.1007/s004390050994; MEIER UT, 1992, CELL, V70, P127; Miller BA, 1999, EXP HEMATOL, V27, P742, DOI 10.1016/S0301-472X(98)00074-5; Morris SM, 1997, MOL ENDOCRINOL, V11, P229, DOI 10.1210/me.11.2.229; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; Pan RM, 2005, J CELL BIOCHEM, V96, P741, DOI 10.1002/jcb.20573; Pang SF, 2009, EXP CELL RES, V125, P1352; Riera J, 2007, FEBS LETT, V581, P3057, DOI 10.1016/j.febslet.2007.05.065; Riera J, 2009, CELL MOL LIFE SCI, V66, P2383, DOI 10.1007/s00018-009-0025-3; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; TANG BL, 1992, J BIOL CHEM, V267, P7072; Tang YS, 2008, LEUKEMIA, V22, P1018, DOI 10.1038/leu.2008.20; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; Wei MX, 2006, J CELL BIOCHEM, V98, P429, DOI 10.1002/jcb.20803; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; Zhang MY, 2002, EXP CELL RES, V273, P73, DOI 10.1006/excr.2001.5414; Zhang YP, 2007, EXP CELL RES, V313, P3210, DOI 10.1016/j.yexcr.2007.06.021; Zhou TH, 2006, P NATL ACAD SCI USA, V103, P9039, DOI 10.1073/pnas.0602916103; Zhu XJ, 2010, J BIOL CHEM, V285, P29903, DOI 10.1074/jbc.M110.105494	32	2	2	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51849	10.1371/journal.pone.0051849	http://dx.doi.org/10.1371/journal.pone.0051849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284788	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900058
J	Bushlin, I; Gupta, A; Stockton, SD; Miller, LK; Devi, LA				Bushlin, Ittai; Gupta, Achla; Stockton, Steven D., Jr.; Miller, Lydia K.; Devi, Lakshmi A.			Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; PERIPHERAL-NERVE INJURY; ANTIDEPRESSANT-LIKE; UP-REGULATION; PREFRONTAL CORTEX; SCIATIC-NERVE; SPINAL-CORD; MORPHINE ANALGESIA; TACTILE ALLODYNIA; CB1 RECEPTORS	The diversity of receptor signaling is increased by receptor heteromerization leading to dynamic regulation of receptor function. While a number of studies have demonstrated that family A G-protein-coupled receptors are capable of forming heteromers in vitro, the role of these heteromers in normal physiology and disease has been poorly explored. In this study, direct interactions between CB1 cannabinoid and delta opioid receptors in the brain were examined. Additionally, regulation of heteromer levels and signaling in a rodent model of neuropathic pain was explored. First we examined changes in the expression, function and interaction of these receptors in the cerebral cortex of rats with a peripheral nerve lesion that resulted in neuropathic pain. We found that, following the peripheral nerve lesion, the expression of both cannabinoid type 1 receptor (CB1R) and the delta opioid receptor (DOR) are increased in select brain regions. Concomitantly, an increase in CB1R activity and decrease in DOR activity was observed. We hypothesize that this decrease in DOR activity could be due to heteromeric interactions between these two receptors. Using a CB1R-DOR heteromer-specific antibody, we found increased levels of CB1R-DOR heteromer protein in the cortex of neuropathic animals. We subsequently examined the functionality of these heteromers by testing whether low, non-signaling doses of CB1R ligands influenced DOR signaling in the cortex. We found that, in cortical membranes from animals that experienced neuropathic pain, non-signaling doses of CB1R ligands significantly enhanced DOR activity. Moreover, this activity is selectively blocked by a heteromer-specific antibody. Together, these results demonstrate an important role for CB1R-DOR heteromers in altered cortical function of DOR during neuropathic pain. Moreover, they suggest the possibility that a novel heteromer-directed therapeutic strategy for enhancing DOR activity, could potentially be employed to reduce anxiety associated with chronic pain. Citation: Bushlin I, Gupta A, Stockton SD Jr, Miller LK, Devi LA (2012) Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain. PLoS ONE 7(12): e49789. doi:10.1371/journal.pone.0049789	[Bushlin, Ittai; Gupta, Achla; Stockton, Steven D., Jr.; Miller, Lydia K.; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Bushlin, Ittai; Stockton, Steven D., Jr.; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Bushlin, Ittai; Stockton, Steven D., Jr.; Devi, Lakshmi A.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Devi, LA (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	lakshmi.devi@mssm.edu	Devi P, Lakshmi/GXM-5982-2022	Devi P, Lakshmi/0000-0001-9274-4776	NIH [DA008863, DA019521, 1P50GM071558-01A27398]; Integrated Pharmacological Sciences Training Program [T32GM062754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754, P50GM071558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008863, R37DA008863, K05DA019521, R56DA008863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrated Pharmacological Sciences Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants DA008863, DA019521 to LAD and 1P50GM071558-01A27398 (Systems Biology Center of New York) to LAD. Ittai Bushlin was a trainee in the Integrated Pharmacological Sciences Training Program supported by grant T32GM062754. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Husn NS, 2007, BRIT J PHARMACOL, V151, P877, DOI 10.1038/sj.bjp.0707277; Bambico FR, 2007, J NEUROSCI, V27, P11700, DOI 10.1523/JNEUROSCI.1636-07.2007; BAUSCH SB, 1995, J CHEM NEUROANAT, V8, P175, DOI 10.1016/0891-0618(94)00044-T; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Berg KA, 2012, MOL PHARMACOL, V81, P264, DOI 10.1124/mol.111.072702; Berrendero F, 2003, EUR J NEUROSCI, V18, P2197, DOI 10.1046/j.1460-9568.2003.02951.x; Berrendero F, 2002, PSYCHOPHARMACOLOGY, V163, P111, DOI 10.1007/s00213-002-1144-9; BESSE D, 1992, NEUROSCIENCE, V50, P921, DOI 10.1016/0306-4522(92)90215-N; Bie BH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-37; Bushlin I, 2010, CURR OPIN PHARMACOL, V10, P80, DOI 10.1016/j.coph.2009.09.009; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chung JM, 2004, METH MOLEC MED, P35; Daniels DJ, 2005, P NATL ACAD SCI USA, V102, P19208, DOI 10.1073/pnas.0506627102; Datta S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-7; DEFONSECA FR, 1994, LIFE SCI, V54, P159, DOI 10.1016/0024-3205(94)00585-0; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dubois D, 2010, EUR J NEUROSCI, V32, P1921, DOI 10.1111/j.1460-9568.2010.07466.x; Ferre S, 2010, PROG MOL BIOL TRANSL, V91, P41, DOI 10.1016/S1877-1173(10)91002-8; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gomes I, 2012, METHODS ENZ IN PRESS; Gomes I, 2011, MOL PHARMACOL, V79, P1044, DOI 10.1124/mol.110.070847; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Gupta A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000807; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hohmann AG, 1999, BRAIN RES, V822, P17, DOI 10.1016/S0006-8993(98)01321-3; Holdridge SV, 2007, EUR J PAIN, V11, P685, DOI 10.1016/j.ejpain.2006.10.008; Hoot MR, 2010, BRAIN RES, V1339, P18, DOI 10.1016/j.brainres.2010.03.105; Hungund BL, 2004, MOL PSYCHIATR, V9, P184, DOI 10.1038/sj.mp.4001376; Jhaveri MD, 2006, J NEUROSCI, V26, P13318, DOI 10.1523/JNEUROSCI.3326-06.2006; Ji RR, 1995, J NEUROSCI, V15, P8156; Jutkiewicz EM, 2006, EUR J PHARMACOL, V531, P151, DOI 10.1016/j.ejphar.2005.12.002; Kabli N, 2007, PAIN, V127, P84, DOI 10.1016/j.pain.2006.08.003; Kathmann M, 2006, N-S ARCH PHARMACOL, V372, P354, DOI 10.1007/s00210-006-0033-x; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Knerlich-Lukoschus F, 2011, J NEUROTRAUM, V28, P619, DOI 10.1089/neu.2010.1652; Lazareno S, 1999, Methods Mol Biol, V106, P231; Li JL, 1996, NEUROSCI LETT, V214, P91, DOI 10.1016/0304-3940(96)12894-9; Lim G, 2003, PAIN, V105, P275, DOI 10.1016/S0304-3959(03)00242-2; Lim MP, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.52; Lin HC, 2009, CEREB CORTEX, V19, P165, DOI 10.1093/cercor/bhn075; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Maldonado R, 2003, EUR NEUROPSYCHOPHARM, V13, P401, DOI 10.1016/j.euroneuro.2003.08.001; Manzanares J, 1999, TRENDS PHARMACOL SCI, V20, P287, DOI 10.1016/S0165-6147(99)01339-5; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Narita M, 2006, J NEUROCHEM, V97, P1369, DOI 10.1111/j.1471-4159.2006.03824.x; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Obara I, 2009, PAIN, V141, P283, DOI 10.1016/j.pain.2008.12.006; Ozaki S, 2003, NEUROSCIENCE, V116, P89, DOI 10.1016/S0306-4522(02)00699-1; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Parolaro D, 2010, CURR DRUG TARGETS, V11, P393, DOI 10.2174/138945010790980367; Paszcuk AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024034; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Perrine SA, 2006, BRIT J PHARMACOL, V147, P864, DOI 10.1038/sj.bjp.0706686; Pertwee RG, 2005, AAPS J, V7, pE625, DOI 10.1208/aapsj070364; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Porreca F, 1998, BRAIN RES, V795, P197, DOI 10.1016/S0006-8993(98)00292-3; Puehler W, 2004, NEUROSCIENCE, V129, P473, DOI 10.1016/j.neuroscience.2004.06.086; Rashid MH, 2004, J PHARMACOL EXP THER, V309, P380, DOI 10.1124/jpet.103.060582; Rea K, 2007, BRIT J PHARMACOL, V152, P633, DOI 10.1038/sj.bjp.0707440; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Robertson B, 1999, EUR J PAIN, V3, P115, DOI 10.1053/eujp.1998.0104; Rozenfeld R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029239; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Saade NE, 2008, PROG NEUROBIOL, V86, P22, DOI 10.1016/j.pneurobio.2008.06.002; Saitoh A, 2005, PSYCHOPHARMACOLOGY, V182, P327, DOI 10.1007/s00213-005-0112-6; Saitoh A, 2004, J PHARMACOL SCI, V95, P374, DOI 10.1254/jphs.FPJ04014X; Saitoh A, 2011, BEHAV BRAIN RES, V223, P271, DOI 10.1016/j.bbr.2011.04.041; Salio C, 2002, NEUROSCIENCE, V110, P755, DOI 10.1016/S0306-4522(01)00584-X; Scott DA, 2004, PAIN, V109, P124, DOI 10.1016/j.pain.2004.01.020; Seifert F, 2009, CELL MOL LIFE SCI, V66, P375, DOI 10.1007/s00018-008-8428-0; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; STEVENS CW, 1991, PAIN, V46, P315, DOI 10.1016/0304-3959(91)90114-D; Stone LS, 2004, NEUROSCI LETT, V361, P208, DOI 10.1016/j.neulet.2003.12.067; Suzuki T, 2007, ANESTH ANALG, V104, P1570, DOI 10.1213/01.ane.0000261514.19946.66; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Truong W, 2003, ANN NEUROL, V53, P366, DOI 10.1002/ana.10465; Tseng TJ, 2008, NEUROSCIENCE, V156, P758, DOI 10.1016/j.neuroscience.2008.08.010; Uriguen L, 2005, EUR J NEUROSCI, V22, P2106, DOI 10.1111/j.1460-9568.2005.04372.x; Vinod KY, 2005, BIOL PSYCHIAT, V57, P480, DOI 10.1016/j.biopsych.2004.11.033; Walczak JS, 2005, NEUROSCIENCE, V132, P1093, DOI 10.1016/j.neuroscience.2005.02.010; Wang S, 2007, PAIN, V131, P96, DOI 10.1016/j.pain.2006.12.019; Wang ZJ, 2001, J NEUROSCI, V21, P1779, DOI 10.1523/JNEUROSCI.21-05-01779.2001; Welch SP, 2009, INT REV PSYCHIATR, V21, P143, DOI 10.1080/09540260902782794; Wilson-Poe AR, 2012, NEUROSCIENCE, V213, P191, DOI 10.1016/j.neuroscience.2012.03.038; Wu G, 2001, J NEUROSCI, V21; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	96	58	63	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e49789	10.1371/journal.pone.0049789	http://dx.doi.org/10.1371/journal.pone.0049789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272051	Green Submitted, gold, Green Published			2022-12-25	WOS:000312386800010
J	Monzo, C; Urbaneja, A; Ximenez-Embun, M; Garcia-Fernandez, J; Garcia, JL; Castanera, P				Monzo, Cesar; Urbaneja, Alberto; Ximenez-Embun, Miguel; Garcia-Fernandez, Julia; Luis Garcia, Jose; Castanera, Pedro			Selection of Ceratitis capitata (Diptera: Tephritidae) Specific Recombinant Monoclonal Phage Display Antibodies for Prey Detection Analysis	PLOS ONE			English	Article							PREDATION; GUT; LEPIDOPTERA; LIBRARIES; SPIDER; ELISA; ASSAY	Several recombinant antibodies against the Mediterranean fruit fly, Ceratitis capitata (Wiedemann) (Diptera: Tephritidae), one of the most important pests in agriculture worldwide, were selected for the first time from a commercial phage display library of human scFv antibodies. The specificity and sensitivity of the selected recombinant antibodies were compared with that of a rabbit polyclonal serum raised in parallel using a wide range of arthropod species as controls. The selected recombinant monoclonal antibodies had a similar or greater specificity when compared with classical monoclonal antibodies. The selected recombinant antibodies were successfully used to detect the target antigen in the gut of predators and the scFv antibodies were sequenced and compared. These results demonstrate the potential for recombinant scFv antibodies to be used as an alternative to the classical monoclonal antibodies or even molecular probes in the post-mortem analysis studies of generalist predators. Citation: Monzo C, Urbaneja A, Ximenez-Embun M, Garcia-Fernandez J, Garcia JL, et al. (2012) Selection of Ceratitis capitata (Diptera: Tephritidae) Specific Recombinant Monoclonal Phage Display Antibodies for Prey Detection Analysis. PLoS ONE 7(12): e51440. doi:10.1371/journal.pone.0051440	[Monzo, Cesar; Ximenez-Embun, Miguel; Garcia-Fernandez, Julia; Luis Garcia, Jose; Castanera, Pedro] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid, Spain; [Urbaneja, Alberto; Castanera, Pedro] Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, CSIC, Unidad Asociada Entomol IVIA CIB, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto Valenciano de Investigaciones Agrarias (IVIA)	Castanera, P (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid, Spain.	castan@cib.csic.es	Urbaneja, Alberto/C-9071-2011; Ximenez-Embun, Miguel/AAE-4290-2021; URBANEJA, ALBERTO/AAW-6198-2020; Monzo, C./O-5248-2019; castanera, pedro/G-2165-2015; Monzo, Cesar/L-7055-2014; Garcia Lopez, Jose Luis/G-9139-2015	Urbaneja, Alberto/0000-0001-5986-3685; Ximenez-Embun, Miguel/0000-0002-2137-7937; URBANEJA, ALBERTO/0000-0001-5986-3685; Monzo, C./0000-0003-3247-7412; Monzo, Cesar/0000-0003-3247-7412; Garcia-Fernandez, Julia/0000-0002-6937-6394; Garcia Lopez, Jose Luis/0000-0002-9238-2485	Comision Interministerial de Ciencia y Tecnologia (CICYT) [AGL2006-13346-C02-01]; Centro de Investigaciones Biologicas, CSIC	Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Centro de Investigaciones Biologicas, CSIC	This work was supported by grants from Comision Interministerial de Ciencia y Tecnologia (CICYT) (AGL2006-13346-C02-01). CM was recipient of a PhD grant from the Centro de Investigaciones Biologicas, CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAN N, 1994, P NATL ACAD SCI USA, V91, P1604, DOI 10.1073/pnas.91.5.1604; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P4457, DOI 10.1073/pnas.89.10.4457; BOREHAM PFL, 1978, B ENTOMOL RES, V68, P171, DOI 10.1017/S0007485300007264; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooke M. M., 1946, JOUR NATION MALARIA SOC, V5, P45; BUCHHOLZ U, 1994, BIOCHEM SYST ECOL, V22, P671, DOI 10.1016/0305-1978(94)90053-1; Cann A., 2005, PRINCIPLES MOL VIROL, V4th; Chen Y, 2000, MOL ECOL, V9, P1887, DOI 10.1046/j.1365-294x.2000.01100.x; GREENSTONE MH, 1989, ANN ENTOMOL SOC AM, V82, P45, DOI 10.1093/aesa/82.1.45; Greenstone MH, 1996, ECOLOGY AGR PESTS BI, P265; Hagler JR, 2005, BIOCONTROL SCI TECHN, V15, P321, DOI 10.1080/09583150500086474; Harlow E., 1988, ANTIBODIES LAB MANUA; Harwood JD, 2001, MOL ECOL, V10, P2049, DOI 10.1046/j.0962-1083.2001.01349.x; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Karu AE, 1995, ILAR J, V37, P3; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; LERNER RA, 1992, SCIENCE, V258, P1313, DOI 10.1126/science.1455226; Lim UT, 1994, ENVIRON ENTOMOL, V28, P1177; Malecki M, 2002, P NATL ACAD SCI USA, V99, P213, DOI 10.1073/pnas.261567298; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; MILLER MC, 1981, ANN ENTOMOL SOC AM, V74, P279, DOI 10.1093/aesa/74.3.279; Monzo C, 2010, B ENTOMOL RES, V100, P145, DOI 10.1017/S0007485309006920; Monzo C, 2009, BIOCONTROL, V54, P393, DOI 10.1007/s10526-008-9199-0; Nicholas K.B., 1997, EMBNEW NEWS, V4, P1; RAGSDALE DW, 1981, ENVIRON ENTOMOL, V10, P402, DOI 10.1093/ee/10.3.402; Schier R, 1996, J MOL BIOL, V263, P551, DOI 10.1006/jmbi.1996.0598; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Sigsgaard L, 2002, BIOCONTROL, V47, P151, DOI 10.1023/A:1014577114915; Staden R, 2003, STADEN PACKAGE 2003; SUNDERLAND KD, 1988, ANN APPL BIOL, V112, P201, DOI 10.1111/j.1744-7348.1988.tb02056.x; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Symondson WOC, 1996, SYST ASSOC, P323; Symondson WOC, 2000, MOL ECOL, V9, P1279, DOI 10.1046/j.1365-294x.2000.01006.x; Symondson WOC, 1999, INSECT BIOCHEM MOLEC, V29, P873, DOI 10.1016/S0965-1748(99)00063-6; Thomas RS, 2009, ECOL ENTOMOL, V34, P569, DOI 10.1111/j.1365-2311.2009.01104.x; Tijssen P., 1985, PRACTICE THEORY ENZY; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245	43	1	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51440	10.1371/journal.pone.0051440	http://dx.doi.org/10.1371/journal.pone.0051440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272105	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800045
J	Oz, S; Ivashko-Pachima, Y; Gozes, I				Oz, Saar; Ivashko-Pachima, Yanina; Gozes, Illana			The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; REDUCES TAU HYPERPHOSPHORYLATION; PROGRESSIVE SUPRANUCLEAR PALSY; III BETA-TUBULIN; ALZHEIMERS-DISEASE; NEURONAL DIFFERENTIATION; AXON FORMATION; DETYROSINATED MICROTUBULES; NEUROFIBRILLARY TANGLES; POLYADP-RIBOSYLATION	Microtubules (MTs), key cytoskeletal elements in living cells, are critical for axonal transport, synaptic transmission, and maintenance of neuronal morphology. NAP (NAPVSIPQ) is a neuroprotective peptide derived from the essential activity-dependent neuroprotective protein (ADNP). In Alzheimer's disease models, NAP protects against tauopathy and cognitive decline. Here, we show that NAP treatment significantly affected the alpha tubulin tyrosination cycle in the neuronal differentiation model, rat pheochromocytoma (PC12) and in rat cortical astrocytes. The effect on tubulin tyrosination/detyrosination was coupled to increased MT network area (measured in PC12 cells), which is directly related to neurite outgrowth. Tubulin beta3, a marker for neurite outgrowth/neuronal differentiation significantly increased after NAP treatment. In rat cortical neurons, NAP doubled the area of dynamic MT invasion (Tyr-tubulin) into the neuronal growth cone periphery. NAP was previously shown to protect against zinc-induced MT/neurite destruction and neuronal death, here, in PC12 cells, NAP treatment reversed zinc-decreased tau-tubulin-MT interaction and protected against death. NAP effects on the MT pool, coupled with increased tau engagement on compromised MTs imply an important role in neuronal plasticity, protecting against free tau accumulation leading to tauopathy. With tauopathy representing a major pathological hallmark in Alzheimer's disease and related disorders, the current findings provide a mechanistic basis for further development. NAP (davunetide) is in phase 2/3 clinical trial in progressive supranuclear palsy, a disease presenting MT deficiency and tau pathology. Citation: Oz S, Ivashko-Pachima Y, Gozes I (2012) The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities. PLoS ONE 7(12): e51458. doi:10.1371/journal.pone.0051458	[Oz, Saar; Ivashko-Pachima, Yanina; Gozes, Illana] Tel Aviv Univ, Adams Super Ctr Brain Studies, IL-69978 Tel Aviv, Israel; [Oz, Saar; Ivashko-Pachima, Yanina; Gozes, Illana] Tel Aviv Univ, Lily & Avraham Gildor Chair Invest Growth Factors, IL-69978 Tel Aviv, Israel; [Oz, Saar; Ivashko-Pachima, Yanina; Gozes, Illana] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, Elton Lab Neuroendocrinol, IL-69978 Tel Aviv, Israel; [Gozes, Illana] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Gozes, I (corresponding author), Tel Aviv Univ, Adams Super Ctr Brain Studies, IL-69978 Tel Aviv, Israel.	igozes@post.tau.ac.il	Oz, Saar/ABB-4496-2020	Oz, Saar/0000-0002-3377-0584; Ivashko-Pachima, Yanina/0000-0002-1773-7127	Allon Therapeutics Inc.; AMN Foundation; Montreal Circle of Canadian Friends of TAU (CFTAU); Oberfeld family; Adams family	Allon Therapeutics Inc.; AMN Foundation; Montreal Circle of Canadian Friends of TAU (CFTAU); Oberfeld family; Adams family	Funding was provided by Allon Therapeutics Inc., AMN Foundation, Montreal Circle of Canadian Friends of TAU (CFTAU), Joseph and Grace Alter, Barbara and Donald Seal, the Oberfeld family and the Adams family. Overall, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The valuable input and discussions of the Allon Therapeutics Science Team is appropriately acknowledged.; We would like to thank the Allon Therapeutics team including Drs. Michael Gold, Alistair Stewart, Bruce Morimoto, Jacqueline Tiong and Catherine Campbell for valuable input and discussions. We would like to thank Dr. Eliezer Giladi for help with biochemical analysis. This work is in partial fulfillment of the Ph.D. thesis requirements of Mr. Saar Oz and graduate thesis requirements of Mrs. Yanina Ivashko-Pachima. Professor Illana Gozes is the incumbent of the Lily and Avraham Gildor Chair for the Investigation of Growth Factors, and the Director of the Adams Super Center for Brain Studies, the Levie-Edersheim-Gitter Institute for Functional Brain Imaging and the Dr. Diana and Zelman Elton (Elbaum) Laboratory for Molecular Neuroendocrinology at Tel Aviv University. We thank AMN Foundation, Israel, Montreal Circle of Canadian Friends of TAU (CFTAU), Joseph and Grace Alter, Barbara and Donald Seal, the Oberfeld family and the Adams family for their support and encouragement.	Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; ARREGUI C, 1991, J NEUROSCI RES, V28, P171, DOI 10.1002/jnr.490280204; BAAS PW, 1993, J NEUROSCI, V13, P2177; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; BANCHER C, 1987, ACTA NEUROPATHOL, V74, P39, DOI 10.1007/BF00688336; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Boom A, 2009, BBA-MOL CELL RES, V1793, P1058, DOI 10.1016/j.bbamcr.2008.11.011; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; CHAUDHRY V, 1994, ANN NEUROL, V35, P304, DOI 10.1002/ana.410350310; Chen SZ, 2008, P NATL ACAD SCI USA, V105, P19962, DOI 10.1073/pnas.0807758105; Davis DA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000208; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Divinski I, 2004, J BIOL CHEM, V279, P28531, DOI 10.1074/jbc.M403197200; Divinski I, 2006, J NEUROCHEM, V98, P973, DOI 10.1111/j.1471-4159.2006.03936.x; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; Fukushima N, 2006, BRAIN RES, V1094, P65, DOI 10.1016/j.brainres.2006.04.007; GALLOWAY PG, 1988, NEUROSCI LETT, V91, P148, DOI 10.1016/0304-3940(88)90759-8; GARD DL, 1985, J CELL BIOL, V100, P764, DOI 10.1083/jcb.100.3.764; Goldberg S, 2009, J NEUROCHEM, V111, P72, DOI 10.1111/j.1471-4159.2009.06296.x; Gozes I, 1997, DEV BRAIN RES, V99, P167, DOI 10.1016/S0165-3806(96)00215-5; Gozes I, 2003, J MOL NEUROSCI, V20, P315, DOI 10.1385/JMN:20:3:315; GOZES I, 1981, NATURE, V294, P477, DOI 10.1038/294477a0; GOZES I, 1978, NATURE, V276, P411, DOI 10.1038/276411a0; Gozes I, 2007, CURR ALZHEIMER RES, V4, P507, DOI 10.2174/156720507783018208; Gozes I, 2009, CURR ALZHEIMER RES, V6, P455, DOI 10.2174/156720509789207895; Gozes Illana, 2006, Current Alzheimer Research, V3, P197; Guo JY, 2011, BRAIN RES, V1420, P8, DOI 10.1016/j.brainres.2011.08.066; Guo JY, 2010, CYTOSKELETON, V67, P431, DOI 10.1002/cm.20455; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Huang XD, 2000, J NUTR, V130, p1488S, DOI 10.1093/jn/130.5.1488S; Idan-Feldman A., 2012, INT J ALZHEIMERS DIS, V2012; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; JIANG YQ, 1992, J CELL SCI, V103, P643; Jouroukhin Y, 2012, J MOL NEUROSCI, V48, P597, DOI 10.1007/s12031-012-9882-6; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Lagreze WA, 2005, INVEST OPHTH VIS SCI, V46, P933, DOI 10.1167/iovs.04-0766; Lee G, 1998, J CELL SCI, V111, P3167; LETOURNEAU PC, 1984, J CELL BIOL, V98, P1355, DOI 10.1083/jcb.98.4.1355; LIPTON RB, 1989, NEUROLOGY, V39, P368, DOI 10.1212/WNL.39.3.368; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lotjonen J, 2011, NEUROIMAGE, V56, P185, DOI 10.1016/j.neuroimage.2011.01.062; Luduena RF, 1998, INT REV CYTOL, V178, P207; Mandel S, 2008, J MOL NEUROSCI, V35, P127, DOI 10.1007/s12031-007-9013-y; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; MANSFIELD SG, 1991, J NEUROCYTOL, V20, P654, DOI 10.1007/BF01187067; Matsuoka Y, 2008, J PHARMACOL EXP THER, V325, P146, DOI 10.1124/jpet.107.130526; Matsuoka Y, 2007, J MOL NEUROSCI, V31, P165, DOI 10.1385/JMN/31:02:165; Melli G, 2006, NEUROBIOL DIS, V24, P525, DOI 10.1016/j.nbd.2006.08.014; Merenlender-Wagner A, 2010, PEPTIDES, V31, P1368, DOI 10.1016/j.peptides.2010.04.011; Michaelis ML, 2002, J MOL NEUROSCI, V19, P289, DOI 10.1385/JMN:19:3:289; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Pascual M, 2007, J NEUROCHEM, V103, P557, DOI 10.1111/j.1471-4159.2007.04761.x; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Pontecorvo MJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt70; Raspaglio G, 2010, CANCER RES, V70, P5891, DOI 10.1158/0008-5472.CAN-09-4656; ROBSON SJ, 1989, CELL MOTIL CYTOSKEL, V12, P273, DOI 10.1002/cm.970120408; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; Sanchez-Martin FJ, 2010, BRAIN RES BULL, V81, P458, DOI 10.1016/j.brainresbull.2009.11.008; Saragoni L, 2000, NEUROCHEM RES, V25, P59, DOI 10.1023/A:1007587315630; Shea TB, 1999, BRAIN RES BULL, V48, P255, DOI 10.1016/S0361-9230(98)00019-7; Shemesh OA, 2011, NEUROBIOL DIS, V43, P163, DOI 10.1016/j.nbd.2011.03.008; Shiryaev N, 2011, CURR PHARM DESIGN, V17, P2603, DOI 10.2174/138161211797416093; Shiryaev N, 2009, NEUROBIOL DIS, V34, P381, DOI 10.1016/j.nbd.2009.02.011; Silva DFF, 2011, J ALZHEIMERS DIS, V26, P565, DOI 10.3233/JAD-2011-110423; Smith-Swintosky VL, 2005, J MOL NEUROSCI, V25, P225, DOI 10.1385/JMN:25:3:225; Smoter M, 2011, CANCER CHEMOTH PHARM, V68, P553, DOI 10.1007/s00280-011-1696-7; Sudo H, 2011, HUM MOL GENET, V20, P763, DOI 10.1093/hmg/ddq521; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Vassal E, 2006, J BIOMOL SCREEN, V11, P377, DOI 10.1177/1087057106286210; Visochek L, 2005, J NEUROSCI, V25, P7420, DOI 10.1523/JNEUROSCI.0333-05.2005; Vulih-Shultzman I, 2007, J PHARMACOL EXP THER, V323, P438, DOI 10.1124/jpet.107.129551; Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100; Yoshiyama Y, 2003, J NEUROSCI, V23, P10662; Zemlyak I, 2000, REGUL PEPTIDES, V96, P39, DOI 10.1016/S0167-0115(00)00198-1; Zemlyak I, 2009, J NEURAL TRANSM, V116, P1411, DOI 10.1007/s00702-009-0252-7; Zemlyak I, 2009, EUR J PHARMACOL, V618, P9, DOI 10.1016/j.ejphar.2009.07.013; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zia H, 1999, LIFE SCI, V66, P379	94	67	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51458	10.1371/journal.pone.0051458	http://dx.doi.org/10.1371/journal.pone.0051458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272107	Green Submitted, gold, Green Published			2022-12-25	WOS:000312386800046
J	Parenica, J; Nemec, P; Tomandl, J; Ondrasek, J; Pavkova-Goldbergova, M; Tretina, M; Jarkovsky, J; Littnerova, S; Poloczek, M; Pokorny, P; Spinar, J; Cermakova, Z; Miklik, R; Malik, P; Pes, O; Lipkova, J; Tomandlova, M; Kala, P				Parenica, Jiri; Nemec, Petr; Tomandl, Josef; Ondrasek, Jiri; Pavkova-Goldbergova, Monika; Tretina, Martin; Jarkovsky, Jiri; Littnerova, Simona; Poloczek, Martin; Pokorny, Petr; Spinar, Jindrich; Cermakova, Zdenka; Miklik, Roman; Malik, Petr; Pes, Ondrej; Lipkova, Jolana; Tomandlova, Marie; Kala, Petr			Prognostic Utility of Biomarkers in Predicting of One-Year Outcomes in Patients with Aortic Stenosis Treated with Transcatheter or Surgical Aortic Valve Implantation	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; REPLACEMENT; EUROSCORE; MORTALITY; PLASMA; SCORE	Objectives: The aim of the work was to find biomarkers identifying patients at high risk of adverse clinical outcomes after TAVI and SAVR in addition to currently used predictive model (EuroSCORE). Background: There is limited data about the role of biomarkers in predicting prognosis, especially when TAVI is available. Methods: The multi-biomarker sub-study included 42 consecutive high-risk patients (average age 82.0 years; logistic EuroSCORE 21.0%) allocated to TAVI transfemoral and transapical using the Edwards-Sapien valve (n = 29), or SAVR with the Edwards Perimount bioprosthesis (n = 13). Standardized endpoints were prospectively followed during the 12-month follow-up. Results: The clinical outcomes after both TAVI and SAVR were comparable. Malondialdehyde served as the best predictor of a combined endpoint at 1 year with AUC (ROC analysis) = 0.872 for TAVI group, resp. 0.765 (p<0.05) for both TAVI and SAVR groups. Increased levels of MDA, matrix metalloproteinase 2, tissue inhibitor of metalloproteinase (TIMP1), ferritin-reducing ability of plasma, homocysteine, cysteine and 8-hydroxy-2-deoxyguanosine were all predictors of the occurrence of combined safety endpoints at 30 days (AUC 0.750-0.948; p<0.05 for all). The addition of MDA to a currently used clinical model (EuroSCORE) significantly improved prediction of a combined safety endpoint at 30 days and a combined endpoint (0-365 days) by the net reclassification improvement (NRI) and the integrated discrimination improvement (IDI) (p<0.05). Cystatin C, glutathione, cysteinylglycine, asymmetric dimethylarginine, nitrite/nitrate and MMP9 did not prove to be significant. Total of 14.3% died during 1-year follow-up. Conclusion: We identified malondialdehyde, a marker of oxidative stress, as the most promising predictor of adverse outcomes during the 30-day and 1-year follow-up in high-risk patients with symptomatic, severe aortic stenosis treated with TAVI. The development of a clinical "TAVIscore" would be highly appreciated. Such dedicated scoring system would enable further testing of adjunctive value of various biomarkers. Citation: Parenica J, Nemec P, Tomandl J, Ondrasek J, Pavkova-Goldbergova M, et al. (2012) Prognostic Utility of Biomarkers in Predicting of One-Year Outcomes in Patients with Aortic Stenosis Treated with Transcatheter or Surgical Aortic Valve Implantation. PLoS ONE 7(12): e48851. doi:10.1371/journal.pone.0048851	[Parenica, Jiri; Poloczek, Martin; Spinar, Jindrich; Miklik, Roman; Kala, Petr] Univ Hosp Brno, Brno, Czech Republic; [Tomandl, Josef; Pes, Ondrej; Tomandlova, Marie] Masaryk Univ, Fac Med, Inst Biochem, Brno, Czech Republic; [Parenica, Jiri; Nemec, Petr; Spinar, Jindrich] Univ Hosp St Annes, Int Clin Res Ctr, Dept Cardiovasc Dis, Brno, Czech Republic; [Nemec, Petr; Ondrasek, Jiri; Tretina, Martin; Pokorny, Petr; Malik, Petr] Ctr Cardiovasc Surg & Transplantat, Brno, Czech Republic; [Pavkova-Goldbergova, Monika; Lipkova, Jolana] Masaryk Univ, Fac Med, Inst Pathol Physiol, Brno, Czech Republic; [Jarkovsky, Jiri] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic; [Cermakova, Zdenka] Fac Hosp Brno, Dept Biochem, Brno, Czech Republic; [Cermakova, Zdenka] Masaryk Univ, Inst Lab Methods, Brno, Czech Republic	University Hospital Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Institute of Biostatistics & Analyses; Masaryk University Brno; University Hospital Brno; Masaryk University Brno	Kala, P (corresponding author), Univ Hosp Brno, Brno, Czech Republic.	kalapetr@yahoo.com	Tomandl, Josef/B-7492-2009; Lipkova, Jolana/GRS-3000-2022; Tomandlova, Marie/E-3319-2012; Goldbergova, Monika Pavkova/G-3512-2013; Jarkovsky, Jiri/G-5494-2017	Tomandl, Josef/0000-0001-6554-3733; Tomandlova, Marie/0000-0003-2944-9605; Goldbergova, Monika Pavkova/0000-0002-3471-8702; Cermakova, Zdenka/0000-0002-0859-7409	European Regional Development Fund - Project of International Clinical Research Center; St.Anne's University Hospital Brno, Czech Republic [CZ.1.05/1.1.00/02.0123]; project (Ministry of Health, Czech Republic) for conceptual development of research organization (University Hospital Brno, Brno, Czech Republic) [65269705]	European Regional Development Fund - Project of International Clinical Research Center; St.Anne's University Hospital Brno, Czech Republic; project (Ministry of Health, Czech Republic) for conceptual development of research organization (University Hospital Brno, Brno, Czech Republic)	This work was supported by the European Regional Development Fund - Project of International Clinical Research Center, St.Anne's University Hospital Brno, Czech Republic (No. CZ.1.05/1.1.00/02.0123) and by the project (Ministry of Health, Czech Republic) for conceptual development of research organization 65269705 (University Hospital Brno, Brno, Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Dor I, 2011, CARDIOVASC REVASCULA, V12, P345, DOI 10.1016/j.carrev.2011.04.005; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Conradi L, 2012, J THORAC CARDIOV SUR, V143, P64, DOI 10.1016/j.jtcvs.2011.08.047; Cribier A, 2009, HERZ, V34, P347, DOI 10.1007/s00059-009-3264-z; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; Himbert D, 2009, J AM COLL CARDIOL, V54, P303, DOI 10.1016/j.jacc.2009.04.032; Kefer J, 2010, AM J CARDIOL, V106, P1782, DOI 10.1016/j.amjcard.2010.07.051; Khoschsorur GA, 2000, CHROMATOGRAPHIA, V52, P181, DOI 10.1007/BF02490453; Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406; Mack Michael J, 2011, Curr Cardiol Rep, V13, P107, DOI 10.1007/s11886-010-0167-9; Michel P, 2003, EUR J CARDIO-THORAC, V23, P684, DOI 10.1016/S1010-7940(03)00074-5; Nemec P, 2012, COR VASA, V54, pE76, DOI 10.1016/j.crvasa.2012.02.003; Nuis RJ, 2012, NETH HEART J, V20, P16, DOI 10.1007/s12471-011-0224-z; Pickering JW, 2012, CLIN J AM SOC NEPHRO, V7, P1355, DOI 10.2215/CJN.09590911; Pilgrim T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027556; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Sinning JM, 2010, JACC-CARDIOVASC INTE, V3, P1141, DOI 10.1016/j.jcin.2010.09.009; Solbiati M, 2011, INTERN EMERG MED, V6, P161, DOI 10.1007/s11739-011-0545-3; Spargias K, 2011, J INTERV CARDIOL, V24, P462, DOI 10.1111/j.1540-8183.2011.00654.x; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545; Velagaleti RS, 2010, ARTERIOSCL THROM VAS, V30, P2283, DOI 10.1161/ATVBAHA.110.208462; VESTER B, 1991, EUR J CLIN CHEM CLIN, V29, P549; Walther T, 2007, CIRCULATION, V116, pI240, DOI 10.1161/CIRCULATIONAHA.106.677237; Walther T, 2009, ANN THORAC SURG, V87, P276, DOI 10.1016/j.athoracsur.2008.08.017; Watanabe E, 2006, J CARD FAIL, V12, P527, DOI 10.1016/j.cardfail.2006.05.011; Zhou X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040424	26	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e48851	10.1371/journal.pone.0048851	http://dx.doi.org/10.1371/journal.pone.0048851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272045	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800004
J	Wostenberg, C; Lary, JW; Sahu, D; Acevedo, R; Quarles, KA; Cole, JL; Showalter, SA				Wostenberg, Christopher; Lary, Jeffrey W.; Sahu, Debashish; Acevedo, Roderico; Quarles, Kaycee A.; Cole, James L.; Showalter, Scott A.			The Role of Human Dicer-dsRBD in Processing Small Regulatory RNAs	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DSRNA-BINDING DOMAIN; PROTEIN INTERACTIONS; STRUCTURAL INSIGHTS; RIBONUCLEASE-III; MOLECULAR-BASIS; RECOGNITION; DYNAMICS; RELAXATION; MICRORNAS	One of the most exciting recent developments in RNA biology has been the discovery of small non-coding RNAs that affect gene expression through the RNA interference (RNAi) mechanism. Two major classes of RNAs involved in RNAi are small interfering RNA (siRNA) and microRNA (miRNA). Dicer, an RNase III enzyme, plays a central role in the RNAi pathway by cleaving precursors of both of these classes of RNAs to form mature siRNAs and miRNAs, which are then loaded into the RNA-induced silencing complex (RISC). miRNA and siRNA precursors are quite structurally distinct; miRNA precursors are short, imperfect hairpins while siRNA precursors are long, perfect duplexes. Nonetheless, Dicer is able to process both. Dicer, like the majority of RNase III enzymes, contains a dsRNA binding domain (dsRBD), but the data are sparse on the exact role this domain plays in the mechanism of Dicer binding and cleavage. To further explore the role of human Dicer-dsRBD in the RNAi pathway, we determined its binding affinity to various RNAs modeling both miRNA and siRNA precursors. Our study shows that Dicer-dsRBD is an avid binder of dsRNA, but its binding is only minimally influenced by a single-stranded - double-stranded junction caused by large terminal loops observed in miRNA precursors. Thus, the Dicer-dsRBD contributes directly to substrate binding but not to the mechanism of differentiating between pre-miRNA and pre-siRNA. In addition, NMR spin relaxation and MD simulations provide an overview of the role that dynamics contribute to the binding mechanism. We compare this current study with our previous studies of the dsRBDs from Drosha and DGCR8 to give a dynamic profile of dsRBDs in their apo-state and a mechanistic view of dsRNA binding by dsRBDs in general.	[Wostenberg, Christopher; Sahu, Debashish; Acevedo, Roderico; Quarles, Kaycee A.; Showalter, Scott A.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Wostenberg, Christopher; Sahu, Debashish; Acevedo, Roderico; Quarles, Kaycee A.; Showalter, Scott A.] Penn State Univ, Ctr RNA Mol Biol, University Pk, PA 16802 USA; [Lary, Jeffrey W.; Cole, James L.] Univ Connecticut, Natl Analyt Ultracentrifugat Facil, Storrs, CT USA; [Cole, James L.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Cole, James L.] Univ Connecticut, Dept Chem, Storrs, CT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Connecticut; University of Connecticut; University of Connecticut	Showalter, SA (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sas76@psu.edu	Showalter, Scott A/A-1655-2012; Sahu, Debashish/G-8325-2018	Showalter, Scott A/0000-0001-5179-032X; Sahu, Debashish/0000-0002-5890-813X	National Institutes of Health [R01-GM098451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health grant R01-GM098451 to Scott A. Showalter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Carlson CB, 2003, BIOPOLYMERS, V70, P86, DOI 10.1002/bip.10413; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dominguez C, 2011, PROG NUCL MAG RES SP, V58, P1, DOI 10.1016/j.pnmrs.2010.10.001; Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Ma E, 2012, J MOL BIOL; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Nicholson AW, 2011, NUCLEIC ACIDS MOL BI, V26, P269, DOI 10.1007/978-3-642-21078-5_11; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Prompers JJ, 2002, J AM CHEM SOC, V124, P4522, DOI 10.1021/ja012750u; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Showalter SA, 2007, J CHEM THEORY COMPUT, V3, P961, DOI 10.1021/ct7000045; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Song LP, 2011, PROTEIN CELL, V2, P273, DOI 10.1007/s13238-011-1037-y; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Ucci JW, 2007, BIOCHEMISTRY-US, V46, P55, DOI 10.1021/bi061531o; Ucci JW, 2004, BIOPHYS CHEM, V108, P127, DOI 10.1016/j.bpc.2003.10.033; van Rij RP, 2009, TRENDS MICROBIOL, V17, P163, DOI 10.1016/j.tim.2009.01.003; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang ZH, 2011, STRUCTURE, V19, P999, DOI 10.1016/j.str.2011.03.022; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; Wong CJ, 2011, METHOD ENZYMOL, P59, DOI 10.1016/B978-0-12-381268-1.00003-3; Wostenberg C, 2010, BIOCHEMISTRY-US, V49, P10728, DOI 10.1021/bi1015716; Wostenberg C, 2010, BIOPHYS J, V99, P248, DOI 10.1016/j.bpj.2010.04.010; Wu HH, 2004, P NATL ACAD SCI USA, V101, P8307, DOI 10.1073/pnas.0402627101; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	64	37	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51829	10.1371/journal.pone.0051829	http://dx.doi.org/10.1371/journal.pone.0051829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272173	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386600041
J	Yang, YL; Zhi, F; He, XZ; Moore, ML; Kang, XZ; Chao, DM; Wang, R; Kim, DH; Xia, Y				Yang, Yilin; Zhi, Feng; He, Xiaozhou; Moore, Meredith L.; Kang, Xuezhi; Chao, Dongman; Wang, Rong; Kim, Dong H.; Xia, Ying			delta-Opioid Receptor Activation and MicroRNA Expression of the Rat Cortex in Hypoxia	PLOS ONE			English	Article							NEUROPROTECTIVE ROLE; CORTICAL-NEURONS; K+ HOMEOSTASIS; NA+ CHANNELS; CELL-DEATH; INJURY; BRAIN; PROLIFERATION; ISCHEMIA; PROTECTS	Prolonged hypoxic/ischemic stress may cause cortical injury and clinically manifest as a neurological disability. Activation of the delta-opioid receptor (DOR) may induce cortical protection against hypoxic/ischemic insults. However, the mechanisms underlying DOR protection are not clearly understood. We have recently found that DOR activation modulates the expression of microRNAs (miRNAs) in the kidney exposed to hypoxia, suggesting that DOR protection may involve a miRNA mechanism. To determine if the miRNAs expressed in the cortex mediated DOR neuroprotection, we examined 19 miRNAs that were previously identified as hypoxia-and DOR-regulated miRNAs in the kidney, in the rat cortex treated with UFP-512, a potent and specific DOR agonist under hypoxic condition. Of the 19 miRNAs tested, 17 were significantly altered by hypoxia and/or DOR activation with the direction and amplitude varying depending on hypoxic duration and times of DOR treatment. Expression of several miRNAs such as miR-29b, -101b, -298, 324-3p, -347 and 466b was significantly depressed after 24 hours of hypoxia. Similar changes were seen in normoxic condition 24 hours after DOR activation with one-time treatment of UFP-512. In contrast, some miRNAs were more tolerant to hypoxic stress and showed significant reduction only with 5-day (e.g., miR-31 and -186) or 10-day (e. g., miR-29a, let-7f and -511) exposures. In addition, these miRNAs had differential responses to DOR activation. Other miRNAs like miRs-363* and -370 responded only to the combined exposure to hypoxia and DOR treatment, with a notable reduction of >70% in the 5-day group. These data suggest that cortical miRNAs are highly yet differentially sensitive to hypoxia. DOR activation can modify, enhance or resolve the changes in miRNAs that target HIF, ion transport, axonal guidance, free radical signaling, apoptosis and many other functions.	[Moore, Meredith L.; Chao, Dongman; Kim, Dong H.; Xia, Ying] Univ Texas Houston, Med Sch Houston, Houston, TX 77030 USA; [Yang, Yilin; Zhi, Feng; He, Xiaozhou; Wang, Rong] Soochow Univ, Clin Coll 3, Changzhou, Jiangsu, Peoples R China; [Kang, Xuezhi] Shanghai Res Ctr Acupuncture & Meridians, Shanghai, Peoples R China; [Chao, Dongman; Xia, Ying] Yale Univ, Sch Med, New Haven, CT USA	University of Texas System; University of Texas Health Science Center Houston; Soochow University - China; Yale University	Xia, Y (corresponding author), Univ Texas Houston, Med Sch Houston, Houston, TX 77030 USA.	Ying.Xia@UTH.TMC.edu	Kang, Xuezhi/L-6719-2016	Kang, Xuezhi/0000-0002-0582-2244; Kim, Dong/0000-0002-1523-6396	National Institutes of Health [HD-034852, AT-004422]; Vivian L. Smith Neurologic Foundation; National Science Foundation of China [31071046]; Changzhou Science Development Project [CS20102010]; Changzhou Health Bureau [ZD201007]; National Basic Research Project [09CB522901, 12CB518502]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vivian L. Smith Neurologic Foundation; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Science Development Project; Changzhou Health Bureau; National Basic Research Project(National Basic Research Program of China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by grants of National Institutes of Health (HD-034852; AT-004422), Vivian L. Smith Neurologic Foundation, National Science Foundation of China (31071046), Changzhou Science Development Project (CS20102010), Changzhou Health Bureau (ZD201007), and National Basic Research Project (09CB522901; 12CB518502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Borlongan CV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-31; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Chao D, 2009, CELL MOL LIFE SCI, V66, P1105, DOI 10.1007/s00018-009-8759-5; Chao DM, 2008, CEREB CORTEX, V18, P2217, DOI 10.1093/cercor/bhm247; Chao DM, 2007, J CELL PHYSIOL, V212, P60, DOI 10.1002/jcp.21000; Chao DM, 2007, J CEREBR BLOOD F MET, V27, P356, DOI 10.1038/sj.jcbfm.9600352; Chao DM, 2012, EXP NEUROL, V236, P228, DOI 10.1016/j.expneurol.2012.05.006; Chao DM, 2010, PROG NEUROBIOL, V90, P439, DOI 10.1016/j.pneurobio.2009.12.007; Charron C, 2008, PHYSIOL BEHAV, V93, P502, DOI 10.1016/j.physbeh.2007.10.015; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020; Dharap A, 2010, J NEUROCHEM, V113, P1685, DOI 10.1111/j.1471-4159.2010.06735.x; Feng YA, 2011, CHINESE J PHYSIOL, V54, P118, DOI 10.4077/CJP.2011.AMM047; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Horiuchi T, 2008, J ANESTH, V22, P32, DOI 10.1007/s00540-007-0576-0; Kang XZ, 2009, CELL MOL LIFE SCI, V66, P3505, DOI 10.1007/s00018-009-0136-x; Lim YJ, 2004, ANESTHESIOLOGY, V100, P562, DOI 10.1097/00000542-200403000-00015; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; Matsuo N, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-240; Narita M, 2006, J NEUROCHEM, V97, P1494, DOI 10.1111/j.1471-4159.2006.03849.x; Pamenter ME, 2008, J EXP BIOL, V211, P3512, DOI 10.1242/jeb.021949; Persson AI, 2003, MOL CELL NEUROSCI, V23, P360, DOI 10.1016/S1044-7431(03)00061-7; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Rao VLR, 2002, J NEUROCHEM, V83, P1072, DOI 10.1046/j.1471-4159.2002.01208.x; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; SHAHABI NA, 1995, ADV EXP MED BIOL, V373, P29; Shi GD, 2012, EXP BRAIN RES, V216, P225, DOI 10.1007/s00221-011-2925-3; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Wang SY, 2011, EUR J PHARMACOL, V658, P140, DOI 10.1016/j.ejphar.2011.02.006; White NMA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-65; Xia Y, 1999, NEUROSCIENCE, V94, P1231, DOI 10.1016/S0306-4522(99)00375-9; XIA Y, 1993, PEDIATR RES, V34, P634, DOI 10.1203/00006450-199311000-00015; XIA Y, 1995, BRAIN RES, V675, P224, DOI 10.1016/0006-8993(95)00079-6; Yang L, 2011, BRAIN RES, V1383, P307, DOI 10.1016/j.brainres.2011.01.083; Yang YL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-55; Zhang JH, 2006, STROKE, V37, P1094, DOI 10.1161/01.STR.0000206444.29930.18; Zhang JH, 2002, AM J PHYSIOL-CELL PH, V282, pC1225, DOI 10.1152/ajpcell.00226.2001; Zhang JH, 2000, BRAIN RES, V885, P143, DOI 10.1016/S0006-8993(00)02906-1; Zhu M, 2009, BRAIN RES, V1252, P183, DOI 10.1016/j.brainres.2008.11.030; Ziu MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014724	45	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51524	10.1371/journal.pone.0051524	http://dx.doi.org/10.1371/journal.pone.0051524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272113	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600027
J	Botelho, SC; Tatsuta, T; von Heijne, G; Kim, H				Botelho, Salome Calado; Tatsuta, Takashi; von Heijne, Gunnar; Kim, Hyun			Dislocation by the m-AAA Protease Increases the Threshold Hydrophobicity for Retention of Transmembrane Helices in the Inner Membrane of Yeast Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; RHOMBOID PROTEASE; SEQUENCE; MGM1; RECOGNITION; TRANSLOCON; MORPHOLOGY; INSERTION; PROTEINS	Sorting of mitochondrial inner membrane proteins is a complex process in which translocons and proteases function in a concerted way. Many inner membrane proteins insert into the membrane via the TIM23 translocon, and some are then further acted upon by the mitochondrial m-AAA protease, a molecular motor capable of dislocating proteins from the inner membrane. This raises the possibility that the threshold hydrophobicity for the retention of transmembrane segments in the inner membrane is different depending on whether they belong to membrane proteins that are m-AAA protease substrates or not. Here, using model transmembrane segments engineered into m-AAA protease-dependent proteins, we show that the threshold hydrophobicity for membrane retention measured in yeast cells in the absence of a functional m-AAA protease is markedly lower than that measured in its presence. Whether a given hydrophobic segment in a mitochondrial inner membrane protein will ultimately form a transmembrane helix may therefore depend on whether or not it will be exposed to the pulling force exerted by the m-AAA protease during biogenesis.	[Botelho, Salome Calado; von Heijne, Gunnar; Kim, Hyun] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Kim, Hyun] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, SE-17121 Stockholm, Sweden; [Tatsuta, Takashi] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Tatsuta, Takashi] Univ Cologne, Ctr Mol Med CMMC, D-50674 Cologne, Germany	Stockholm University; Seoul National University (SNU); Stockholm University; University of Cologne; University of Cologne	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se; joy@snu.ac.kr	von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569	Swedish Research Council; Swedish Cancer Foundation; Swedish Foundation for Strategic Research; European Research Council [ERC-2008-AdG 232648]; National Research Foundation of Korea [NRF0409-20100093, GRN-C00048]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/36107/2007]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Research Council(European Research Council (ERC)European Commission); National Research Foundation of Korea(National Research Foundation of Korea); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported in part by grants from the Swedish Research Council, the Swedish Cancer Foundation, and the Swedish Foundation for Strategic Research and European Research Council Grant ERC-2008-AdG 232648 (to G. v. H.) and by National Research Foundation of Korea Grants NRF0409-20100093 and GRN-C00048 (to H. K.).; Recipient of Graduate Student Fellowship SFRH/BD/36107/2007 from the Fundacao para a Ciencia e a Tecnologia, Portugal.	Arlt H, 1998, EMBO J, V17, P4837, DOI 10.1093/emboj/17.16.4837; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Bonn F, 2011, EMBO J, V30, P2545, DOI 10.1038/emboj.2011.169; Botelho SC, 2011, EMBO J, V30, P1003, DOI 10.1038/emboj.2011.29; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; FUKUHARA H, 1978, MOL GEN GENET, V162, P191, DOI 10.1007/BF00267876; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hessa T, 2009, J MOL BIOL, V386, P1222, DOI 10.1016/j.jmb.2009.01.027; Jiang H, 2006, J INORG BIOCHEM, V100, P1996, DOI 10.1016/j.jinorgbio.2006.07.017; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Osterberg M, 2011, FEBS LETT, V585, P1238, DOI 10.1016/j.febslet.2011.03.056; Schafer A, 2010, J MOL BIOL, V401, P182, DOI 10.1016/j.jmb.2010.06.014; SPEE JH, 1993, NUCLEIC ACIDS RES, V21, P777, DOI 10.1093/nar/21.3.777; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Tatsuta T, 2009, RES MICROBIOL, V160, P711, DOI 10.1016/j.resmic.2009.09.005; TAUER R, 1994, FEBS LETT, V353, P197, DOI 10.1016/0014-5793(94)01045-5; VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9; VONHEIJNE G, 1986, FEBS LETT, V198, P1, DOI 10.1016/0014-5793(86)81172-3	25	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4792	4798		10.1074/jbc.M112.430892	http://dx.doi.org/10.1074/jbc.M112.430892			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283966	Green Published, hybrid			2022-12-25	WOS:000315340400028
J	Chikka, MR; McCabe, DD; Tyra, HM; Rutkowski, DT				Chikka, Madhusudana R.; McCabe, Diane DeZwaan; Tyra, Heather M.; Rutkowski, D. Thomas			C/EBP Homologous Protein (CHOP) Contributes to Suppression of Metabolic Genes during Endoplasmic Reticulum Stress in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR CHOP; ER STRESS; MESSENGER-RNA; CELL-SURVIVAL; EXPRESSION; BINDING; BETA; INHIBITION; INDUCTION; GADD153	The unfolded protein response (UPR) senses stress in the endoplasmic reticulum (ER) and initiates signal transduction cascades that culminate in changes to gene regulation. Long recognized as a means for improving ER protein folding through up-regulation of ER chaperones, the UPR is increasingly recognized to play a role in the regulation of metabolic pathways. ER stress is clearly connected to altered metabolism in tissues such as the liver, but the mechanisms underlying this connection are only beginning to be elucidated. Here, working exclusively in vivo, we tested the hypothesis that the UPR-regulated CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP) participates in the transcriptional regulation of metabolism during hepatic ER stress. We found that metabolic dysregulation was associated with induction of eIF2 alpha signaling and CHOP up-regulation during challenge with tunicamycin or Velcade. CHOP was necessary for suppression of genes encoding the transcriptional master regulators of lipid metabolism: Cebpa, Ppara, and Srebf1. This action of CHOP required a contemporaneous CHOP-independent stress signal. CHOP bound directly to C/EBP-binding regions in the promoters of target genes, whereas binding of C/EBP alpha and C/EBP beta to the same regions was diminished during ER stress. Our results thus highlight a role for CHOP in the transcriptional regulation of metabolism.	[Chikka, Madhusudana R.; McCabe, Diane DeZwaan; Tyra, Heather M.; Rutkowski, D. Thomas] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Rutkowski, D. Thomas] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52246 USA	University of Iowa; University of Iowa	Rutkowski, DT (corresponding author), Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, 51 Newton Rd, Iowa City, IA 52246 USA.	thomas-rutkowski@uiowa.edu		Rutkowski, Thomas/0000-0001-6586-4449	National Institutes of Health from NIDDK [R01 DK084058]; Carver Medical Research Trust Initiative; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084058] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Carver Medical Research Trust Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK084058 from NIDDK (to D. T. R.). This work was also supported by the Carver Medical Research Trust Initiative.	Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Bek MF, 2006, AM J PATHOL, V168, P20, DOI 10.2353/ajpath.2006.040774; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Fawcett TW, 1996, J BIOL CHEM, V271, P14285, DOI 10.1074/jbc.271.24.14285; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Gao JH, 2011, CIRCULATION, V124, P830, DOI 10.1161/CIRCULATIONAHA.110.014050; Gow A, 2009, CURR OPIN NEUROBIOL, V19, P505, DOI 10.1016/j.conb.2009.08.007; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Ishikawa F, 2009, J BIOCHEM, V146, P123, DOI 10.1093/jb/mvp052; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Maris M, 2012, DIABETOLOGIA, V55, P1167, DOI 10.1007/s00125-011-2427-7; Oliveira SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006618; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Su QZ, 2009, HEPATOLOGY, V50, P77, DOI 10.1002/hep.22960; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tyra HM, 2012, MOL BIOL CELL, V23, P811, DOI 10.1091/mbc.E11-12-1011; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52	58	71	76	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4405	4415		10.1074/jbc.M112.432344	http://dx.doi.org/10.1074/jbc.M112.432344			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23281479	Green Published, hybrid			2022-12-25	WOS:000314845000067
J	Nakao, R; Ramstedt, M; Wai, SN; Uhlin, BE				Nakao, Ryoma; Ramstedt, Madeleine; Wai, Sun Nyunt; Uhlin, Bernt Eric			Enhanced Biofilm Formation by Escherichia coli LPS Mutants Defective in Hep Biosynthesis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA PAO1; O-ANTIGEN LIPOPOLYSACCHARIDE; NEGATIVE ANTIVIRULENCE DRUGS; EXTRACELLULAR DNA; PORPHYROMONAS-GINGIVALIS; SALMONELLA-TYPHIMURIUM; MONOCLONAL-ANTIBODY; MEMBRANE-VESICLES; IN-VIVO; CORE	Lipopolysaccharide (LPS) is the major component of the surface of Gram-negative bacteria and its polysaccharide portion is situated at the outermost region. We investigated the relationship between the polysaccharide portion of LPS and biofilm formation using a series of Escherichia coli mutants defective in genes earlier shown to affect the LPS sugar compositions. Biofilm formation by a deep rough LPS mutant, the hldE strain, was strongly enhanced in comparison with the parental strain and other LPS mutants. The hldE strain also showed a phenotype of increased auto-aggregation and stronger cell surface hydrophobicity compared to the wild-type. Similar results were obtained with another deep rough LPS mutant, the waaC strain whose LPS showed same molecular mass as that of the hldE strain. Confocal laser scanning microscopy (CLSM) analysis and biofilm formation assay using DNase I revealed that biofilm formation by the hldE strain was dependent on extracellular DNA. Furthermore, a loss of flagella and an increase in amount of outer membrane vesicles in case of the hldE strain were also observed by transmission electron microscopy and atomic force microscopy, respectively. In addition, we demonstrated that a mutation in the hldE locus, which alters the LPS structure, caused changes in both expression and properties of several surface bacterial factors involved in biofilm formation and virulence. We suggest that the implication of these results should be considered in the context of biofilm formation on abiotic surfaces, which is frequently associated with nosocominal infections such as the catheter-associated infections.	[Nakao, Ryoma; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, UCMR, Dept Mol Biol, Umea, Sweden; [Nakao, Ryoma; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, UCMR, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Ramstedt, Madeleine] Umea Univ, Dept Chem, Umea, Sweden; [Nakao, Ryoma] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan	Umea University; Umea University; Umea University; National Institute of Infectious Diseases (NIID)	Uhlin, BE (corresponding author), Umea Univ, UCMR, Dept Mol Biol, Umea, Sweden.	bernt.eric.uhlin@molbiol.umu.se	Uhlin, Bernt Eric/AAO-6292-2021; Ramstedt, Madeleine/E-7852-2011	Uhlin, Bernt Eric/0000-0002-2991-8072; Ramstedt, Madeleine/0000-0003-2646-8501; Wai, Sun Nyunt/0000-0003-4793-4671	Swedish Research Council; Naito Foundation; Waksman Foundation of Japan; Scandinavia-Japan Sasakawa Foundation; Curth Nilson Foundation for Scientific Research; Miyata Cardiac Research Promotion Foundation; JSPS KAKENHI [22791822]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Naito Foundation(Naito Memorial Foundation); Waksman Foundation of Japan(Waksman Foundation of Japan Inc.); Scandinavia-Japan Sasakawa Foundation; Curth Nilson Foundation for Scientific Research; Miyata Cardiac Research Promotion Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Swedish Research Council, The Naito Foundation, The Waksman Foundation of Japan, The Scandinavia-Japan Sasakawa Foundation, The Curth Nilson Foundation for Scientific Research, Miyata Cardiac Research Promotion Foundation, and JSPS KAKENHI (22791822). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; Bahrami S, 1997, CRIT CARE MED, V25, P1030, DOI 10.1097/00003246-199706000-00021; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Beloin C, 2006, J BACTERIOL, V188, P1316, DOI 10.1128/JB.188.4.1316-1331.2006; Bennett-Guerrero E, 2000, INFECT IMMUN, V68, P6202, DOI 10.1128/IAI.68.11.6202-6208.2000; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPRUBI S, 1993, FEMS MICROBIOL LETT, V111, P9; CAMPRUBI S, 1993, MICROB PATHOGENESIS, V14, P433, DOI 10.1006/mpat.1993.1042; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Desroy N, 2009, BIOORGAN MED CHEM, V17, P1276, DOI 10.1016/j.bmc.2008.12.021; DIPADOVA FE, 1993, INFECT IMMUN, V61, P3863, DOI 10.1128/IAI.61.9.3863-3872.1993; Dissanayake DRA, 2010, J MED MICROBIOL, V59, P100, DOI 10.1099/jmm.0.014720-0; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kaplan JB, 2012, MBIO, P3; Kong QK, 2011, INFECT IMMUN, V79, P4227, DOI 10.1128/IAI.05398-11; Lappann M, 2010, MOL MICROBIOL; Leone L, 2006, SURF INTERFACE ANAL, V38, P202, DOI 10.1002/sia.2184; Lindhout T, 2009, MICROBIOL-SGM, V155, P3449, DOI 10.1099/mic.0.030510-0; Moller AK, 2003, INFECT IMMUN, V71, P2142, DOI 10.1128/IAI.71.4.2142-2152.2003; Moreau F, 2008, BIOORG MED CHEM LETT, V18, P4022, DOI 10.1016/j.bmcl.2008.05.117; Muller-Loennies S, 2003, J BIOL CHEM, V278, P34090, DOI 10.1074/jbc.M303985200; Nagy G, 2005, FEMS MICROBIOL LETT, V244, P173, DOI 10.1016/j.femsle.2005.01.038; Nakao R, 2008, BIOCHEM BIOPH RES CO, V365, P784, DOI 10.1016/j.bbrc.2007.11.035; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; Nakao Ryoma, 2009, P129; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; NEVOLA JJ, 1987, INFECT IMMUN, V55, P2884, DOI 10.1128/IAI.55.12.2884-2890.1987; NEVOLA JJ, 1985, INFECT IMMUN, V50, P152, DOI 10.1128/IAI.50.1.152-159.1985; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pouttu R, 2001, J BACTERIOL, V183, P4727, DOI 10.1128/JB.183.16.4727-4736.2001; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramstedt M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209536; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; ROSENBERG M, 1991, J BACTERIOL, V173, P2581, DOI 10.1128/jb.173.8.2581-2589.1991; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sambrook J, 2001, MOL CLONING LAB MANU; Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513; Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06; Seper A, 2011, MOL MICROBIOL, V82, P1015, DOI 10.1111/j.1365-2958.2011.07867.x; Tetz VV, 2010, DNA CELL BIOL, V29, P399, DOI 10.1089/dna.2009.1011; Valvano MA, 2000, J BACTERIOL, V182, P488, DOI 10.1128/JB.182.2.488-497.2000; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Westerlund-Wikstrom B, 1997, PROTEIN ENG, V10, P1319, DOI 10.1093/protein/10.11.1319; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310	60	80	82	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51241	10.1371/journal.pone.0051241	http://dx.doi.org/10.1371/journal.pone.0051241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284671	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500008
J	Beebe, SJ; Chen, YJ; Sain, NM; Schoenbach, KH; Xiao, S				Beebe, Stephen J.; Chen, Yeong-Jer; Sain, Nova M.; Schoenbach, Karl H.; Xiao, Shu			Transient Features in Nanosecond Pulsed Electric Fields Differentially Modulate Mitochondria and Viability	PLOS ONE			English	Article							CELL-DEATH; MEMBRANE PERMEABILIZATION; CALCIUM UNIPORTER; ELECTROPORATION; APOPTOSIS; NECROSIS; INHIBITION; ACTIVATION; MECHANISMS; ABLATION	It is hypothesized that high frequency components of nanosecond pulsed electric fields (nsPEFs), determined by transient pulse features, are important for maximizing electric field interactions with intracellular structures. For monopolar square wave pulses, these transient features are determined by the rapid rise and fall of the pulsed electric fields. To determine effects on mitochondria membranes and plasma membranes, N1-S1 hepatocellular carcinoma cells were exposed to single 600 ns pulses with varying electric fields (0-80 kV/cm) and short (15 ns) or long (150 ns) rise and fall times. Plasma membrane effects were evaluated using Fluo-4 to determine calcium influx, the only measurable source of increases in intracellular calcium. Mitochondria membrane effects were evaluated using tetramethylrhodamine ethyl ester (TMRE) to determine mitochondria membrane potentials (DYm). Single pulses with short rise and fall times caused electric field-dependent increases in calcium influx, dissipation of DYm and cell death. Pulses with long rise and fall times exhibited electric field-dependent increases in calcium influx, but diminished effects on dissipation of DYm and viability. Results indicate that high frequency components have significant differential impact on mitochondria membranes, which determines cell death, but lesser variances on plasma membranes, which allows calcium influxes, a primary determinant for dissipation of DYm and cell death.	[Beebe, Stephen J.; Chen, Yeong-Jer; Sain, Nova M.; Schoenbach, Karl H.; Xiao, Shu] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA; [Schoenbach, Karl H.; Xiao, Shu] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA	Old Dominion University; Old Dominion University	Beebe, SJ (corresponding author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA.	sbeebe@odu.edu						Andre FM, 2010, BIOELECTROCHEMISTRY, V79, P95, DOI 10.1016/j.bioelechem.2009.12.007; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Beebe SJ, 2002, IEEE T PLASMA SCI, V30, P286, DOI 10.1109/TPS.2002.1003872; Bowman AM, 2010, J MEMBRANE BIOL, V236, P15, DOI 10.1007/s00232-010-9269-y; Buescher ES, 2004, IEEE T PLASMA SCI, V32, P1563, DOI 10.1109/TPS.2004.832643; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Eguchi Y, 1997, CANCER RES, V57, P1835; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Ford WE, 2010, ARCH BIOCHEM BIOPHYS, V497, P82, DOI 10.1016/j.abb.2010.03.008; Foster HR, 1995, HDB BIOL EFFECTS ELE; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V341, P1266, DOI 10.1016/j.bbrc.2006.01.094; Grimm S, 2012, BBA-MOL CELL RES, V1823, P327, DOI 10.1016/j.bbamcr.2011.11.018; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Long G., 2011, IEEE T BIOMED ENG, V99, P1; Napotnik TB, 2012, BIOELECTROMAGNETICS, V33, P257, DOI 10.1002/bem.20707; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Pakhomova ON, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017100; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71; Schoenbach KH., 2010, ADV ELECTROPORATION, P19; Stewart DA, 2004, IEEE T PLASMA SCI, V32, P1696, DOI 10.1109/TPS.2004.832639; Vernier PT, 2003, IEEE T DIELECT EL IN, V10, P795, DOI 10.1109/TDEI.2003.1237329; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Wang SF, 2009, BIOPHYS J, V96, P1640, DOI 10.1016/j.bpj.2008.11.011; Weaver JC, 2012, BIOELECTROCHEMISTRY, V87, P236, DOI 10.1016/j.bioelechem.2012.02.007; Weaver JC, 2003, IEEE T DIELECT EL IN, V10, P754, DOI 10.1109/TDEI.2003.1237325; White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200; Zhang J, 2008, ARCH BIOCHEM BIOPHYS, V471, P240, DOI 10.1016/j.abb.2007.12.009; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003	37	48	49	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51349	10.1371/journal.pone.0051349	http://dx.doi.org/10.1371/journal.pone.0051349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284682	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800009
J	Dixit, AK; Jayabaskaran, C				Dixit, Ajay Kumar; Jayabaskaran, Chelliah			Phospholipid Mediated Activation of Calcium Dependent Protein Kinase 1 (CaCDPK1) from Chickpea: A New Paradigm of Regulation	PLOS ONE			English	Article							SUCROSE SYNTHASE; SALT-STRESS; IN-VITRO; RESPONSES; PHOSPHORYLATION; GROWTH; PHOSPHATIDYLCHOLINE; IDENTIFICATION; EXPRESSION; TOLERANCE	Phospholipids, the major structural components of membranes, can also have functions in regulating signaling pathways in plants under biotic and abiotic stress. The effects of adding phospholipids on the activity of stress-induced calcium dependent protein kinase (CaCDPK1) from chickpea are reported here. Both autophosphorylation as well as phosphorylation of the added substrate were enhanced specifically by phosphatidylcholine and to a lesser extent by phosphatidic acid, but not by phosphatidylethanolamine. Diacylgylerol, the neutral lipid known to activate mammalian PKC, stimulated CaCDPK1 but at higher concentrations. Increase in V-max of the enzyme activity by these phospholipids significantly decreased the K-m indicating that phospholipids enhance the affinity towards its substrate. In the absence of calcium, addition of phospholipids had no effect on the negligible activity of the enzyme. Intrinsic fluorescence intensity of the CaCDPK1 protein was quenched on adding PA and PC. Higher binding affinity was found with PC (K-1/2 = 114 nM) compared to PA (K-1/2 = 335 nM). We also found that the concentration of PA increased in chickpea plants under salt stress. The stimulation by PA and PC suggests regulation of CaCDPK1 by these phospholipids during stress response.	[Dixit, Ajay Kumar; Jayabaskaran, Chelliah] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Jayabaskaran, C (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	cjb@biochem.iisc.ernet.in	Dixit, Ajay/AAH-7171-2021		Department of Sciences and Technology (DST), New Delhi, India [SR/SO/BB-07/2008/14.1.09]	Department of Sciences and Technology (DST), New Delhi, India	Financial supported provided by the Department of Sciences and Technology (DST), New Delhi, India (number SR/SO/BB-07/2008/14.1.09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Benetka W, 2008, CELL CYCLE, V7, P3709, DOI 10.4161/cc.7.23.7176; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coca M, 2010, PLANT J, V63, P526, DOI 10.1111/j.1365-313X.2010.04255.x; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; Darwish E, 2009, PLANT CELL PHYSIOL, V50, P986, DOI 10.1093/pcp/pcp051; Dixit AK, 2013, APPL MICROBIOL BIOT, V97, P3429, DOI 10.1007/s00253-012-4215-9; Farmer PK, 1999, BBA-PROTEIN STRUCT M, V1434, P6, DOI 10.1016/S0167-4838(99)00166-1; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; GUNDERSEN RE, 1987, J BIOL CHEM, V262, P4602; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HARPER JF, 1993, BIOCHEMISTRY-US, V32, P3282, DOI 10.1021/bi00064a010; Hwang I, 2000, P NATL ACAD SCI USA, V97, P6224, DOI 10.1073/pnas.97.11.6224; Ishida S, 2008, PLANT CELL, V20, P3273, DOI 10.1105/tpc.107.057489; Ivashuta S, 2005, PLANT CELL, V17, P2911, DOI 10.1105/tpc.105.035394; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Klimecka M, 2007, ACTA BIOCHIM POL, V54, P219, DOI 10.18388/abp.2007_3242; Klimecka M, 2011, ACTA BIOCHIM POL, V58, P589; Lee S, 2001, PLANT J, V26, P479, DOI 10.1046/j.1365-313x.2001.01037.x; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Mehlmer N, 2010, PLANT J, V63, P484, DOI 10.1111/j.1365-313X.2010.04257.x; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Nakai T, 1998, PLANT CELL PHYSIOL, V39, P1337, DOI 10.1093/oxfordjournals.pcp.a029339; Ogawa N, 1998, PLANT CELL PHYSIOL, V39, P1010, DOI 10.1093/oxfordjournals.pcp.a029297; Pical C, 1999, J BIOL CHEM, V274, P38232, DOI 10.1074/jbc.274.53.38232; Prakash SRS, 2006, J PLANT PHYSIOL, V163, P1135, DOI 10.1016/j.jplph.2006.04.002; Prakash SRS, 2006, J PLANT PHYSIOL, V163, P1083, DOI 10.1016/j.jplph.2006.04.005; Rietz S, 2010, MOL PLANT, V3, P524, DOI 10.1093/mp/ssp109; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; SCHALLER GE, 1992, BIOCHEMISTRY-US, V31, P1721, DOI 10.1021/bi00121a020; Sebastia CH, 2004, ARCH BIOCHEM BIOPHYS, V428, P81, DOI 10.1016/j.abb.2004.04.025; Szczegielniak J, 2005, PLANT PHYSIOL, V139, P1970, DOI 10.1104/pp.105.066472; Tasseva G, 2004, FEBS LETT, V566, P115, DOI 10.1016/j.febslet.2004.04.015; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang XQ, 1997, FEBS LETT, V410, P126, DOI 10.1016/S0014-5793(97)00537-1; ZHAO Y, 1994, MOL BIOCHEM PARASIT, V66, P329, DOI 10.1016/0166-6851(94)90159-7; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666	48	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51591	10.1371/journal.pone.0051591	http://dx.doi.org/10.1371/journal.pone.0051591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284721	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000312794500035
J	Kjellstrom, A; Edlund, H; Lembring, M; Ahlgren, V; Allen, M				Kjellstrom, Anna; Edlund, Hanna; Lembring, Maria; Ahlgren, Viktoria; Allen, Marie			An Analysis of the Alleged Skeletal Remains of Carin Goring	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; SEQUENCE; BONES; IDENTIFICATION; HYPEROSTOSIS; SURFACE; GENOME	In 1991, treasure hunters found skeletal remains in an area close to the destroyed country residence of former Nazi leader Hermann Goring in northeastern Berlin. The remains, which were believed to belong to Carin Goring, who was buried at the site, were examined to determine whether it was possible to make a positive identification. The anthropological analysis showed that the remains come from an adult woman. The DNA analysis of several bone elements showed female sex, and a reference sample from Carin's son revealed mtDNA sequences identical to the remains. The profile has one nucleotide difference from the Cambridge reference sequence ( rCRS), the common variant 263G. A database search resulted in a frequency of this mtDNA sequence of about 10% out of more than 7,000 European haplotypes. The mtDNA sequence found in the ulna, the cranium and the reference sample is, thus, very common among Europeans. Therefore, nuclear DNA analysis was attempted. The remains as well as a sample from Carin's son were successfully analysed for the three nuclear markers TH01, D7S820 and D8S1179. The nuclear DNA analysis of the two samples revealed one shared allele for each of the three markers, supporting a mother and son relationship. This genetic information together with anthropological and historical files provides an additional piece of circumstantial evidence in our efforts to identify the remains of Carin Goring.	[Edlund, Hanna; Lembring, Maria; Ahlgren, Viktoria; Allen, Marie] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Kjellstrom, Anna] Stockholm Univ, Dept Archaeol & Class Studies, Osteoarchaeol Res Lab, S-10691 Stockholm, Sweden	Uppsala University; Stockholm University	Allen, M (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	marie.allen@igp.uu.se	Kjellström, Anna/C-4343-2016	Kjellström, Anna/0000-0001-8964-3771	Beijer foundation; Carl Tryggers foundation; Kjell and Marta Beijer Foundation	Beijer foundation; Carl Tryggers foundation; Kjell and Marta Beijer Foundation	This work has been funded by The Beijer foundation and Carl Tryggers foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was generously supported by a grant from the Kjell and Marta Beijer Foundation. Likelihood ratios were kindly calculated by Dr. Andreas Tillmar at the National Board of Forensic Medicine in Linkoping.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Anton SC, 1997, AM J PHYS ANTHROPOL, V102, P111; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Bar W, 2000, INT J LEGAL MED, V113, P193, DOI 10.1007/s004140000149; Buchwald G., 2004, DECLINE TUBERCULOSIS; Buikstra JE, 1994, ARKANSAS ARCHEOLOGIC, V44; Chong VFH, 2002, AM J ROENTGENOL, V178, P717, DOI 10.2214/ajr.178.3.1780717; Coble MD, 2005, J FORENSIC SCI, V50, P43; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Divne AM, 2010, FORENSIC SCI INT-GEN, V4, P122, DOI 10.1016/j.fsigen.2009.07.004; Fontander B, 2009, CARIN GORING SKRIVER; France DL, 1998, FORENSIC OSTEOLOGY A, P163; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Hershkovitz I, 1999, AM J PHYS ANTHROPOL, V109, P303, DOI 10.1002/(SICI)1096-8644(199907)109:3<303::AID-AJPA3>3.0.CO;2-I; HOLLAND MM, 1993, J FORENSIC SCI, V38, P542; Irving D, 2002, GORING BIOGRAPHY; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; Manvell R, 1962, HERMANN GORING; Mays S, 2002, AM J PHYS ANTHROPOL, V119, P27, DOI 10.1002/ajpa.10099; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Nilsson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008986; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; ROBBINS SL, 1974, PATHOLOGIC BASIS DIS; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Stewart TD., 1979, ESSENTIALS FORENSIC; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Trotter M, 1952, AM J PHYS ANTHROP-NE, V10, P463, DOI 10.1002/ajpa.1330100407	29	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e44366	10.1371/journal.pone.0044366	http://dx.doi.org/10.1371/journal.pone.0044366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284605	Green Published, gold			2022-12-25	WOS:000312694300001
J	Makadi, L; Caldwell, MW; Osi, A				Makadi, Laszlo; Caldwell, Michael W.; Osi, Attila			The First Freshwater Mosasauroid (Upper Cretaceous, Hungary) and a New Clade of Basal Mosasauroids	PLOS ONE			English	Article							HUNGAROSAURUS-TORMAI; HALISAURUS; SQUAMATA; MOROCCO; LIZARD; DINOSAURIA; PHOSPHATES; PHYLOGENY; SPECIMEN; SLOVENIA	Mosasauroids are conventionally conceived of as gigantic, obligatorily aquatic marine lizards (1000s of specimens from marine deposited rocks) with a cosmopolitan distribution in the Late Cretaceous (90-65 million years ago [mya]) oceans and seas of the world. Here we report on the fossilized remains of numerous individuals (small juveniles to large adults) of a new taxon, Pannoniasaurus inexpectatus gen. et sp. nov. from the Csehbanya Formation, Hungary (Santonian, Upper Cretaceous, 85.3-83.5 mya) that represent the first known mosasauroid that lived in freshwater environments. Previous to this find, only one specimen of a marine mosasauroid, cf. Plioplatecarpus sp., is known from non-marine rocks in Western Canada. Pannoniasaurus inexpectatus gen. et sp. nov. uniquely possesses a plesiomorphic pelvic anatomy, a non-mosasauroid but pontosaur-like tail osteology, possibly limbs like a terrestrial lizard, and a flattened, crocodile-like skull. Cladistic analysis reconstructs P. inexpectatus in a new clade of mosasauroids: (Pannoniasaurus (Tethysaurus (Yaguarasaurus, Russellosaurus))). P. inexpectatus is part of a mixed terrestrial and freshwater faunal assemblage that includes fishes, amphibians turtles, terrestrial lizards, crocodiles, pterosaurs, dinosaurs and birds.	[Makadi, Laszlo] Hungarian Nat Hist Museum, Dept Geol & Paleontol, Budapest, Hungary; [Caldwell, Michael W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Osi, Attila] Eotvos Lorand Univ, Dept Phys & Appl Geol, MTA ELTE Lendulet Dinosaur Res Grp, Budapest, Hungary	University of Alberta; Eotvos Lorand University	Makadi, L (corresponding author), Hungarian Nat Hist Museum, Dept Geol & Paleontol, Budapest, Hungary.	iharkutia@yahoo.com	Ősi, Attila/K-2414-2018; Caldwell, Michael/A-2622-2014	Ősi, Attila/0000-0003-2967-997X; Caldwell, Michael/0000-0002-2377-3925	NSERC [238458-01]; University of Alberta, Chairs Research Allowance; OTKA [T-39045, PD-73021, NF-84193]; MTA-ELTE Lendulet (Dinosaur Research Group) [95102]; National Geographic Society; Jurassic Foundation; Hantken Foundation; Department of Geology and Paleontology, Hungarian Natural History Museum	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta, Chairs Research Allowance; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MTA-ELTE Lendulet (Dinosaur Research Group); National Geographic Society(National Geographic Society); Jurassic Foundation; Hantken Foundation; Department of Geology and Paleontology, Hungarian Natural History Museum	MWC was supported by an NSERC Discovery Grant (#238458-01) and a University of Alberta, Chairs Research Allowance. Fieldwork and the work of LM and AO were supported by the OTKA T-39045, PD-73021, NF-84193 grants; the MTA-ELTE Lendulet (Dinosaur Research Group, grant n. 95102); the National Geographic Society; the Jurassic Foundation, and the Hantken Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank N. Bardet, G. Bell, M. Polcyn, A. Palci, and T. Konishi for helpful discussions, providing literature and access to material. Members of the Iharkut Research Group, the staff of the Department of Paleontology, Eotvos University and the Department of Geology and Paleontology, Hungarian Natural History Museum, as well as the participants of the excavations are acknowledged for their support and help provided through the years. We are grateful to the Bakonyi Bauxitbanya Kft and the Geovol Kft for their assistance in the fieldworks. Nathalie Bardet and an anonymous reviewer are gratefully acknowledged for critically reading the manuscript and making useful suggestions that greatly improved our work.	Bardet N, 2005, ZOOL J LINN SOC-LOND, V143, P447, DOI 10.1111/j.1096-3642.2005.00152.x; Bardet N, 2003, CR PALEVOL, V2, P607, DOI 10.1016/j.crpv.2003.09.006; Bardet N, 2001, CR ACAD SCI II A, V332, P395, DOI 10.1016/S1251-8050(00)01486-5; Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; Bell Gorden L. Jr, 1997, P293, DOI 10.1016/B978-012155210-7/50017-X; Caldwell M.W., 2007, 2 MOS M ABSTR BOOKL, P10; Caldwell MW, 2007, J VERTEBR PALEONTOL, V27, P863, DOI 10.1671/0272-4634(2007)27[863:ANBMFT]2.0.CO;2; Caldwell Michael W., 2006, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V34, P1; Caldwell MW, 2012, B SOC GEOL FR, V183, P7, DOI 10.2113/gssgfbull.183.1.7; Caldwell MW, 2010, J VERTEBR PALEONTOL, V30, P747, DOI 10.1080/02724631003762963; Camp CL, 1923, B AM MUS NAT HIST, V48, P289; Carroll R.L., 1992, Journal of Vertebrate Paleontology, V12, P66; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Cuvier George, 1808, ANN MUSEUM HIST NATU, V12, P145; DEBRAGA M, 1993, EVOL BIOL, V27, P245; Dutchak AR, 2006, CAN J EARTH SCI, V43, P1821, DOI 10.1139/E06-086; Dutchak AR, 2005, NETH J GEOSCI, V84, P221, DOI 10.1017/S0016774600021004; Dyke GJ, 2010, GEOL J, V45, P434, DOI 10.1002/gj.1209; Estes R., 1983, ENCY PALEOHERPETOLOG; Evans SE, 2006, PALAEONTOLOGY, V49, P1143, DOI 10.1111/j.1475-4983.2006.00598.x; Haas J, 1977, STUDY MESOZOIC FORMA, V1975, P259; Haas J., 1992, CONTROLS DISTRIBUTIO, V267, P245; Holmes R, 1999, CAN J EARTH SCI, V36, P363, DOI 10.1139/e98-112; Holmes RB, 2000, J PALEONTOL, V74, P309, DOI 10.1666/0022-3360(2000)074<0309:APSOTB>2.0.CO;2; Houssaye A, 2011, GEOL MAG, V148, P237, DOI 10.1017/S0016756810000580; Jocha-Edelenyi E., 1988, ACTA GEOLOGICA HUNGA, V31, P19; Jocha-Edelenyi E., 1996, BASIC LITHOSTRATIGRA, P61; Knauer J, 1992, PALYNOSTRATIGRAPHIC, P463; Kocsis L, 2009, PALAEOGEOGR PALAEOCL, V280, P532, DOI 10.1016/j.palaeo.2009.07.009; Lindgren J, 2005, J PALEONTOL, V79, P763, DOI 10.1666/0022-3360(2005)079[0763:HSASMW]2.0.CO;2; Lindgren J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011998; Lingham-Soliar T, 2002, LETHAIA, V35, P187, DOI 10.1080/002411602320184033; LINGHAMSOLIAR T, 1991, PALAEONTOLOGY, V34, P653; Makadi Laszlo, 2006, Acta Geologica Hungarica, V49, P373, DOI 10.1556/AGeol.49.2006.4.5; Makadi Laszlo, 2006, Foldtani Kozlony, V136, P487; Mertens R, 1942, ABHANDLUNGEN SENCKEN, V465, P117; Norell M., 1992, AM MUS NOVIT, V3045, P1; Osi A, 2009, PALAEONTOL Z, V83, P227, DOI 10.1007/s12542-009-0017-5; Oppel M., 1811, ORDNUNGEN FAMILIEN G, p[i, 1], DOI DOI 10.5962/BHL.TITLE.4911; Osi A, 2005, ACTA PALAEONTOL POL, V50, P777; Osi A, 2005, J VERTEBR PALEONTOL, V25, P370, DOI 10.1671/0272-4634(2005)025[0370:HTANAD]2.0.CO;2; Osi A, 2009, CRETACEOUS SEDIMENTS, P51; Osi A, 2007, NEUES JAHRB GEOL P-A, V243, P169, DOI 10.1127/0077-7749/2007/0243-0169; Osi Attila, 2012, P532; Osi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044318; Osi A, 2010, CRETACEOUS RES, V31, P304, DOI 10.1016/j.cretres.2010.01.001; Osi A, 2010, NATURE, V465, P466, DOI 10.1038/nature09019; Paramo Maria Euridice, 1994, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V19, P63; Paramo-Fonseca Maria E., 2000, Historical Biology, V14, P121; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Polcyn MJ, 2005, NETH J GEOSCI, V84, P321, DOI 10.1017/S0016774600021107; Rabi M, 2012, GEOL MAG, V149, P662, DOI 10.1017/S0016756811000756; Rage J.-C., 1984, ENCY PALEOHERPETOLOG; Russell D. A., 1967, Bulletin of the Peabody Museum of Natural History, V23, P1; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Szantner F., 1984, FOLDTANI KOZLONY, V114, P19; Szentesi Z, 2010, NEUES JAHRB GEOL P-A, V256, P291, DOI 10.1127/0077-7749/2010/0054; Tuba Gy, 2006, FOLDTANI KOZLONY, V136, P1	58	49	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51781	10.1371/journal.pone.0051781	http://dx.doi.org/10.1371/journal.pone.0051781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284766	gold, Green Published, Green Accepted			2022-12-25	WOS:000312694300043
J	Oonincx, DGAB; de Boer, IJM				Oonincx, Dennis G. A. B.; de Boer, Imke J. M.			Environmental Impact of the Production of Mealworms as a Protein Source for Humans - A Life Cycle Assessment	PLOS ONE			English	Article							LIVESTOCK PRODUCTION; NUTRIENT COMPOSITION; CLIMATE-CHANGE; FOOD; INSECTS; ENERGY	The demand for animal protein is expected to rise by 70-80% between 2012 and 2050, while the current animal production sector already causes major environmental degradation. Edible insects are suggested as a more sustainable source of animal protein. However, few experimental data regarding environmental impact of insect production are available. Therefore, a lifecycle assessment for mealworm production was conducted, in which greenhouse gas production, energy use and land use were quantified and compared to conventional sources of animal protein. Production of one kg of edible protein from milk, chicken, pork or beef result in higher greenhouse gas emissions, require similar amounts of energy and require much more land. This study demonstrates that mealworms should be considered a more sustainable source of edible protein.	[Oonincx, Dennis G. A. B.] Wageningen Univ, Dept Plant Sci, Wageningen, Netherlands; [de Boer, Imke J. M.] Wageningen Univ, Anim Dept Anim Sci, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Oonincx, DGAB (corresponding author), Wageningen Univ, Dept Plant Sci, Wageningen, Netherlands.	dennis.oonincx@wur.nl	de Boer, Imke/P-7107-2014	de Boer, Imke/0000-0002-0675-7528; Oonincx, Dennis/0000-0002-6728-4859	Wageningen University, Wageningen, The Netherlands	Wageningen University, Wageningen, The Netherlands(Netherlands Government)	This study was directly funded by Wageningen University, Wageningen, The Netherlands (www.wur.nl) as part of a PhD program. Wageningen University had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, than can be expected with the academic supervision of a PhD candidate.	Barker D, 1998, ZOO BIOL, V17, P123, DOI 10.1002/(SICI)1098-2361(1998)17:2&lt;123::AID-ZOO7&gt;3.0.CO;2-B; Bernard JB., 1997, NUTR ADVIS GR HDB, V25, P7; Carlsson-Kanyama A, 1998, FOOD POLICY, V23, P277, DOI 10.1016/S0306-9192(98)00037-2; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; DeFoliart GR, 1997, ECOL FOOD NUTR, V36, P109, DOI 10.1080/03670244.1997.9991510; Ecoinvent Inventories SCfLC, 2004, EC DAT V1 1; FAO, 2007, MEAT PROC TECHN SMAL; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Friedrich U., 2004, BREEDING FOOD ANIMAL; Godfray HCJ, 2011, SCIENCE, V331, P1013, DOI 10.1126/science.1202899; Graham-Rowe D, 2011, NATURE, V474, pS6, DOI 10.1038/474S06a; Guinee J, 2001, INT J LIFE CYCLE ASS, V6, P255, DOI 10.1007/BF02978784; IPCC, 2007, CLIM CHANG 2007 PHYS; Luske B., 2009, MILIEUEFFECTEN DIERL; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Meijer-Rochow VB, 1975, SEARCH, V6, P261; Mercer CWL, 1997, ECOL FOOD NUTR, V36, P151, DOI 10.1080/03670244.1997.9991512; Oonincx DGAB, 2010, COMP BIOCHEM PHYS B, V156, P122, DOI 10.1016/j.cbpb.2010.02.008; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pelletier N, 2010, P NATL ACAD SCI USA, V107, P18371, DOI 10.1073/pnas.1004659107; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Ramos-Elorduy J, 2004, ECOLOGICAL IMPLICATIONS OF MINLIVESTOCK: POTENTIAL OF INSECTS RODENTS FROGS AND SNAILS, P263; Smil V, 2002, ENZYME MICROB TECH, V30, P305, DOI 10.1016/S0141-0229(01)00504-X; Steinfeld H., 2012, EXPL WORKSH SUST PRO; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Steinfeld H, 2010, P NATL ACAD SCI USA, V107, P18237, DOI 10.1073/pnas.1012541107; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; van Huis A., 2003, Insect Science and its Application, V23, P163; Wilkinson JM, 2011, ANIMAL, V5, P1014, DOI 10.1017/S175173111100005X; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475; WUR-Lifestock Research, 2012, LCI DAT CALC TOOL FE	33	373	385	10	258	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51145	10.1371/journal.pone.0051145	http://dx.doi.org/10.1371/journal.pone.0051145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284661	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300014
J	Patnaik, BB; Kim, DH; Oh, SH; Song, YS; Nguyen, DMC; Kim, JS; Jung, WJ; Saha, AK; Bindroo, BB; Han, YS				Patnaik, Bharat Bhusan; Kim, Dong Hyun; Oh, Seung Han; Song, Yong-Su; Nguyen Dang Minh Chanh; Kim, Jong Sun; Jung, Woo-Jin; Saha, Atul Kumar; Bindroo, Bharat Bhushan; Han, Yeon Soo			Molecular Cloning and Characterization of Novel Morus alba Germin-Like Protein Gene Which Encodes for a Silkworm Gut Digestion-Resistant Antimicrobial Protein	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; FUNCTIONALLY DIVERSE SUPERFAMILY; SWISS-MODEL REPOSITORY; SEED STORAGE PROTEINS; BOMBYX-MORI; OXALATE OXIDASE; ANTIVIRAL SUBSTANCE; SIGNAL PEPTIDES; PREDICTION; PURIFICATION	Background: Silkworm fecal matter is considered one of the richest sources of antimicrobial and antiviral protein (substances) and such economically feasible and eco-friendly proteins acting as secondary metabolites from the insect system can be explored for their practical utility in conferring broad spectrum disease resistance against pathogenic microbial specimens. Methodology/Principal Findings: Silkworm fecal matter extracts prepared in 0.02 M phosphate buffer saline (pH 7.4), at a temperature of 60 degrees C was subjected to 40% saturated ammonium sulphate precipitation and purified by gel-filtration chromatography (GFC). SDS-PAGE under denaturing conditions showed a single band at about 21.5 kDa. The peak fraction, thus obtained by GFC wastested for homogeneityusing C18reverse-phase high performance liquid chromatography (HPLC). The activity of the purified protein was tested against selected Gram +/- bacteria and phytopathogenic Fusarium species with concentration-dependent inhibitionrelationship. The purified bioactive protein was subjected to matrix-assisted laser desorption and ionization-time of flight mass spectrometry (MALDI-TOF-MS) and N-terminal sequencing by Edman degradation towards its identification. The N-terminal first 18 amino acid sequence following the predicted signal peptide showed homology to plant germin-like proteins (Glp). In order to characterize the full-length gene sequence in detail, the partial cDNA was cloned and sequenced using degenerate primers, followed by 5'- and 3'-rapid amplification of cDNA ends (RACE-PCR). The full-length cDNA sequence composed of 630 bp encoding 209 amino acids and corresponded to germin-like proteins (Glps) involved in plant development and defense. Conclusions/Significance: The study reports, characterization of novel Glpbelonging to subfamily 3 from M. alba by the purification of mature active protein from silkworm fecal matter. The N-terminal amino acid sequence of the purified protein was found similar to the deduced amino acid sequence (without the transit peptide sequence) of the full length cDNA from M. alba.	[Patnaik, Bharat Bhusan; Kim, Dong Hyun; Oh, Seung Han; Han, Yeon Soo] Chonnam Natl Univ, Div Plant Biotechnol, Coll Agr & Life Sci, Kwangju, South Korea; [Song, Yong-Su; Nguyen Dang Minh Chanh; Jung, Woo-Jin] Chonnam Natl Univ, Inst Environm Friendly Agr, Div Appl Biosci & Biotechnol, Kwangju, South Korea; [Kim, Jong Sun] Jeonnam Agr Res & Extens Serv, Inst Insect & Sericultural Res, Jangseong, South Korea; [Saha, Atul Kumar; Bindroo, Bharat Bhushan] Cent Silk Board Govt India, Cent Sericultural Res & Training Inst, Berhampur, W Bengal, India	Chonnam National University; Chonnam National University	Patnaik, BB (corresponding author), Chonnam Natl Univ, Div Plant Biotechnol, Coll Agr & Life Sci, Kwangju, South Korea.	drbharatbhusan4@gmail.com; hanys@chonnam.ac.kr	Patnaik, Bharat Bhusan/H-2973-2019; Patnaik, Bharat Bhusan/CAG-0338-2022	Patnaik, Bharat Bhusan/0000-0003-1383-6758; Patnaik, Bharat Bhusan/0000-0003-1383-6758; Lee, Yongseok/0000-0002-8687-589X	Korea Foundation for Advanced Studies through International Scholar Exchange Fellowship; Next-Generation Bio Green 21 Program of Rural Development Administration, Republic of Korea [PJ008186032012]	Korea Foundation for Advanced Studies through International Scholar Exchange Fellowship; Next-Generation Bio Green 21 Program of Rural Development Administration, Republic of Korea	The authors would like to acknowledge the following funding organizations for their support: 1) Korea Foundation for Advanced Studies through International Scholar Exchange Fellowship to first author (www.kfas.co.kr); 2) Next-Generation Bio Green 21 Program (No. PJ008186032012) of Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA K, 1962, J INSECT PATHOL, V4, P72; Amit Kumar, 2005, Pakistan Journal of Biological Sciences, V8, P190, DOI 10.3923/pjbs.2005.190.193; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; Carter C, 2000, J BIOL CHEM, V275, P36726, DOI 10.1074/jbc.M006461200; Chen H, 2007, PLANT PHYSIOL, V143, P1954, DOI 10.1104/pp.106.095588; Dae L, 2002, J PHOTOCHEM PHOTOBIO, V67, P149; Dunwell JM, 1998, J MOL EVOL, V46, P147, DOI 10.1007/PL00006289; El-Sharkawy I, 2010, J EXP BOT, V61, P1761, DOI 10.1093/jxb/erq043; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Evdokimov AG, 2001, J MOL BIOL, V305, P891, DOI 10.1006/jmbi.2000.4202; FINNEY D J, 1971, P333; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Godfrey D, 2007, MOL PLANT MICROBE IN, V20, P1112, DOI 10.1094/MPMI-20-9-1112; Harish BG, 2007, INT J BIOMED PHARM S, V1, P65; HAYASHIYA K, 1968, Japanese Journal of Applied Entomology and Zoology, V12, P189; HAYASHIYA K, 1978, ENTOMOL EXP APPL, V24, P428, DOI 10.1007/BF02385095; HEINTZEN C, 1994, PLANT PHYSIOL, V106, P905, DOI 10.1104/pp.106.3.905; Hiraki A, 2000, MICROBIOL IMMUNOL, V44, P669, DOI 10.1111/j.1348-0421.2000.tb02548.x; Hiraki A, 1997, BIOL PHARM BULL, V20, P547, DOI 10.1248/bpb.20.547; HIRAYAMA E, 1993, CELL STRUCT FUNCT, V18, P161, DOI 10.1247/csf.18.161; HOU RF, 1986, ENTOMOL EXP APPL, V42, P3, DOI 10.1007/BF00186151; Hwang JH, 2007, J MED FOOD, V10, P467, DOI 10.1089/jmf.2006.165; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Khuri S, 2001, MOL BIOL EVOL, V18, P593, DOI 10.1093/oxfordjournals.molbev.a003840; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Kim HJ, 2004, PLANTA, V218, P516, DOI 10.1007/s00425-003-1133-1; Knecht K, 2010, MOL PLANT MICROBE IN, V23, P446, DOI 10.1094/MPMI-23-4-0446; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laboure AM, 1999, FEBS LETT, V442, P123, DOI 10.1016/S0014-5793(98)01634-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakkappan V. J., 2007, Journal of Entomological Research, V31, P251; Lane BG, 2002, IUBMB LIFE, V53, P67, DOI 10.1080/15216540211474; Le Deunff E, 2004, PLANT J, V38, P421, DOI 10.1111/j.1365-313X.2004.02056.x; LEE M, 1990, Yonsei Medical Journal, V31, P339; Leon-Galvan F, 2011, INT J MOL SCI, V12, P7301, DOI 10.3390/ijms12117301; Lim DS, 2002, J PHOTOCH PHOTOBIO B, V67, P149, DOI 10.1016/S1011-1344(02)00318-4; Lippert D, 2007, PROTEOMICS, V7, P248, DOI 10.1002/pmic.200600525; Lou YG, 2006, PLANT PHYSIOL, V140, P1126, DOI 10.1104/PP.105.073700; Mahmood T, 2010, AFR J BIOTECHNOL, V9, P1871; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; Markert Y, 2001, PROTEIN ENG, V14, P791, DOI 10.1093/protein/14.10.791; Matti KM, 2009, PHOTOCH PHOTOBIO SCI, V8, P1364, DOI 10.1039/b904102h; Matti KM, 2010, BIOL PHARM BULL, V33, P1143, DOI 10.1248/bpb.33.1143; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; MUKAI JI, 1969, AGR BIOL CHEM TOKYO, V33, P125, DOI 10.1080/00021369.1969.10859288; Nakazawa H, 2004, VIROLOGY, V321, P154, DOI 10.1016/j.virol.2003.12.011; Neelagund S. E., 2007, Caspian Journal of Environmental Sciences, V5, P77; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NISHIKAWA K, 1986, BIOCHIM BIOPHYS ACTA, V871, P45, DOI 10.1016/0167-4838(86)90131-7; Ohmiya A, 1998, PLANT CELL PHYSIOL, V39, P492, DOI 10.1093/oxfordjournals.pcp.a029396; OHMIYA A, 1993, PLANT CELL PHYSIOL, V34, P177; Ono M, 1996, PLANT CELL PHYSIOL, V37, P855, DOI 10.1093/oxfordjournals.pcp.a029022; Pan HY, 2007, BIOCHEM BIOPH RES CO, V356, P925, DOI 10.1016/j.bbrc.2007.03.097; Pandian GN, 2010, J MEMBRANE BIOL, V237, P125, DOI 10.1007/s00232-010-9314-x; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Priyadharshini P., 2008, Current Biotica, V2, P181; Raghavendra R, 2012, APPL BIOCHEM BIOTECH, V167, P1002, DOI 10.1007/s12010-012-9588-9; Raghavendra R, 2009, INT J BIOMED PHARM S, V3, P74; Ravi Kumar S, 2009, INT J MED SCI, V1, P184; Smeath PHA, 1973, NUMERICAL TAXONOMY; Sobhani A, 2004, ACTA MED IRANICA, V42, P46; Staiger D, 1999, PLANT MOL BIOL, V40, P873, DOI 10.1023/A:1006278030024; Sunagar SG, 2008, PHOTOCHEM PHOTOBIOL, V84, P1440, DOI 10.1111/j.1751-1097.2008.00360.x; Suzuki K, 1936, B KYOTO SERICULT COL, V1, P225; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; UCHIDA Y, 1984, J INVERTEBR PATHOL, V43, P182, DOI 10.1016/0022-2011(84)90136-8; Vallelian-Bindschedler L, 1998, PLANT MOL BIOL, V37, P297, DOI 10.1023/A:1005982715972; Woo EJ, 1998, FEBS LETT, V437, P87, DOI 10.1016/S0014-5793(98)01203-4; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Xu JG, 2007, PESTIC BIOCHEM PHYS, V87, P220, DOI 10.1016/j.pestbp.2006.07.013; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190; Zhang ChuanXi, 2008, Entomological Research, V38, pS38, DOI 10.1111/j.1748-5967.2008.00173.x; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	84	6	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e50900	10.1371/journal.pone.0050900	http://dx.doi.org/10.1371/journal.pone.0050900			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284650	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300013
J	Qi, M; Chen, J; Sun, XX; Deng, XW; Niu, Y; Xie, P				Qi, Min; Chen, Jun; Sun, Xiaoxue; Deng, Xuwei; Niu, Yuan; Xie, Ping			Development of Models for Predicting the Predominant Taste and Odor Compounds in Taihu Lake, China	PLOS ONE			English	Article							PURGE-AND-TRAP; SOLID-PHASE MICROEXTRACTION; VOLATILE ORGANIC-COMPOUNDS; EARTHY-MUSTY ODORANTS; FENG-SHEN RESERVOIR; DRINKING-WATER; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; SOUTH TAIWAN; BY-PRODUCTS	Taste and odor (T&O) problems, which have adversely affected the quality of water supplied to millions of residents, have repeatedly occurred in Taihu Lake (e. g., a serious odor accident occurred in 2007). Because these accidents are difficult for water resource managers to forecast in a timely manner, there is an urgent need to develop optimum models to predict these T&O problems. For this purpose, various biotic and abiotic environmental parameters were monitored monthly for one year at 30 sites across Taihu Lake. This is the first investigation of this huge lake to sample T&O compounds at the whole-lake level. Certain phytoplankton taxa were important variables in the models; for instance, the concentrations of the particle-bound 2-methylisoborneol (p-MIB) were correlated with the presence of Oscillatoria, whereas those of the p-beta-cyclocitral and p-beta-ionone were correlated with Microcystis levels. Abiotic factors such as nitrogen (TN, TDN, NO3-N, and NO2-N), pH, DO, COND, COD and Chl-a also contributed significantly to the T&O predictive models. The dissolved (d) T&O compounds were related to both the algal biomass and to certain abiotic environmental factors, whereas the particle-bound (p) T&O compounds were more strongly related to the algal presence. We also tested the validity of these models using an independent data set that was previously collected from Taihu Lake in 2008. In comparing the concentrations of the T&O compounds observed in 2008 with those concentrations predicted from our models, we found that most of the predicted data points fell within the 90% confidence intervals of the observed values. This result supported the validity of these models in the studied system. These models, basing on easily collected environmental data, will be of practical value to the water resource managers of Taihu Lake for evaluating the probability of T&O accidents.	[Qi, Min; Chen, Jun; Sun, Xiaoxue; Deng, Xuwei; Niu, Yuan; Xie, Ping] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Hubei, Peoples R China; [Qi, Min; Sun, Xiaoxue] Huazhong Agr Univ, Coll Fisheries, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Huazhong Agricultural University	Xie, P (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Hubei, Peoples R China.	xieping@ihb.ac.cn	Xie, Ping/AAL-7532-2020		National Basic Research Program of China (973 Program) [2008CB418101]; State Key Laboratory of Freshwater Ecology and Biotechnology [2008FBZ01]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences)	This study was jointly supported by the National Basic Research Program of China (973 Program) (2008CB418101) [http://www.973.gov.cn/AreaAppl.aspx] and State Key Laboratory of Freshwater Ecology and Biotechnology (2008FBZ01) [http://eastlake.ihb.ac.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREAE MO, 1986, ROLE AIR SEA EXCHANG, P331, DOI DOI 10.1007/978-94-009-4738-2_14; BAUMANN FJ, 1974, ANAL CHEM, V46, P1336, DOI 10.1021/ac60345a039; Carmichael WW, 1997, ADV BOT RES, V27, P211; Chang DW, 2011, J HAZARD MATER, V185, P1214, DOI 10.1016/j.jhazmat.2010.10.033; Chen J, 2010, SCI TOTAL ENVIRON, V409, P314, DOI 10.1016/j.scitotenv.2010.10.010; Christensen VG, 2006, 2006509543 US GEOL S, P43; Deng XW, 2012, J CHROMATOGR A, V1219, P75, DOI 10.1016/j.chroma.2011.11.031; Deng XW, 2011, J CHROMATOGR A, V1218, P3791, DOI 10.1016/j.chroma.2011.04.041; Dzialowski AR, 2009, WATER RES, V43, P2829, DOI 10.1016/j.watres.2009.04.001; Filipiak W, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-113; GERBER NN, 1977, J CHEM ECOL, V3, P475, DOI 10.1007/BF00988190; Ginzburg B, 1998, ENVIRON SCI TECHNOL, V32, P2130, DOI 10.1021/es9709076; Grimm CC, 2001, J AGR FOOD CHEM, V49, P245, DOI 10.1021/jf0008902; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Harada KI, 2009, J CHEM ECOL, V35, P1295, DOI 10.1007/s10886-009-9706-5; Huang WJ, 2007, SCI TOTAL ENVIRON, V377, P214, DOI 10.1016/j.scitotenv.2007.01.075; HWANG CJ, 1984, ENVIRON SCI TECHNOL, V18, P535, DOI 10.1021/es00125a010; Ikawa M, 2001, HYDROBIOLOGIA, V443, P19, DOI 10.1023/A:1017535801766; Juttner F, 1984, APPL ENVIRON MICROB, V47, P4814; KARNES HT, 1991, PHARMACEUT RES, V8, P421, DOI 10.1023/A:1015882607690; Lara-Gonzalo A, 2008, TALANTA, V74, P1455, DOI 10.1016/j.talanta.2007.09.036; Li L, 2007, WATER SCI TECHNOL, V55, P43, DOI 10.2166/wst.2007.160; Li Lin, 2007, Acta Hydrobiologica Sinica, V31, P112; [李林 LI Lin], 2007, [中国给水排水, China Water & Wastewater], V23, P102; Lin TF, 2002, SCI TOTAL ENVIRON, V289, P225, DOI 10.1016/S0048-9697(01)01049-X; Lloyd SW, 1998, WATER RES, V32, P2140, DOI 10.1016/S0043-1354(97)00444-2; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Ma K, 2012, J SEP SCI, V35, P1494, DOI 10.1002/jssc.201200029; Mau DP, 2004, 2004504795 US GEOL S, P95; MCGUIRE MJ, 1981, J AM WATER WORKS ASS, V73, P530; Montenegro P, 2009, J WATER SUPPLY RES T, V58, P257, DOI 10.2166/aqua.2009.089; Nakanishi M, 1999, WATER SCI TECHNOL, V40, P179, DOI 10.2166/wst.1999.0293; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Peter A, 2009, WATER RES, V43, P2191, DOI 10.1016/j.watres.2009.02.016; Piriou P, 2009, J WATER SUPPLY RES T, V58, P532, DOI 10.2166/aqua.2009.124; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; SAS Institute, 2008, SAS STAT US GUID; Schellin M, 2006, J CHROMATOGR A, V1103, P211, DOI 10.1016/j.chroma.2005.11.010; Shen PP, 2003, ENVIRON INT, V29, P641, DOI 10.1016/S0160-4120(03)00047-3; Smith JL, 2008, AQUACULTURE, V280, P5, DOI 10.1016/j.aquaculture.2008.05.007; Smith VH, 2002, LAKE RESERV MANAGE, V18, P319, DOI 10.1080/07438140209353938; Sommerburg O, 2003, FREE RADICAL BIO MED, V35, P1480, DOI 10.1016/j.freeradbiomed.2003.08.020; STEFELS J, 1993, MAR ECOL PROG SER, V97, P11, DOI 10.3354/meps097011; Strickland J.D.H., 1968, PRACTICAL HDB SEAWAT, P311; Suffet IH, 1999, WATER SCI TECHNOL, V40, P1; SUGIURA N, 1994, HYDROBIOLOGIA, V288, P57, DOI 10.1007/BF00006806; SUGIURA N, 1987, ENVIRON TECHNOL LETT, V8, P95, DOI 10.1080/09593338709384467; Sugiura N, 1998, WATER RES, V32, P3549, DOI 10.1016/S0043-1354(98)00153-5; Sugiura Norio, 2004, Lakes & Reservoirs Research and Management, V9, P195, DOI 10.1111/j.1440-1770.2004.00246.x; Tao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032020; Tucker Craig S., 2000, Reviews in Fisheries Science, V8, P45, DOI 10.1080/10641260091129170; Tung SC, 2006, WA SCI TECHNOL, V6, P55, DOI 10.2166/ws.2006.050; Tung SC, 2004, WATER SCI TECHNOL, V49, P281, DOI 10.2166/wst.2004.0587; Tung SC, 2008, ENVIRON MONIT ASSESS, V145, P407, DOI 10.1007/s10661-007-0049-9; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; Watson SB, 2007, WATER SCI TECHNOL, V55, P1, DOI 10.2166/wst.2007.155; Watson SB, 2003, PHYCOLOGIA, V42, P332, DOI 10.2216/i0031-8884-42-4-332.1; Westerhoff P, 2005, WATER RES, V39, P4899, DOI 10.1016/j.watres.2005.06.038; Yang Liu, 2011, Hupo Kexue, V23, P605; Yang M, 2008, SCIENCE, V319, P158, DOI 10.1126/science.319.5860.158a; Ye C, 2011, J ENVIRON SCI, V23, P222, DOI 10.1016/S1001-0742(10)60396-8; Zhang KJ, 2012, SEP PURIF TECHNOL, V92, P93, DOI 10.1016/j.seppur.2011.10.031; Zimba PV, 2003, AQUACULTURE, V218, P81, DOI 10.1016/S0044-8486(02)00519-7	64	18	24	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51976	10.1371/journal.pone.0051976	http://dx.doi.org/10.1371/journal.pone.0051976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284835	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300066
J	Floyd, AM; Zhou, X; Evans, C; Rompala, OJ; Zhu, LX; Wang, MW; Chen, Y				Floyd, Anne M.; Zhou, Xu; Evans, Christopher; Rompala, Olivia J.; Zhu, Lingxiang; Wang, Mingwu; Chen, Yin			Mucin Deficiency Causes Functional and Structural Changes of the Ocular Surface	PLOS ONE			English	Article							DRY EYE; SJOGREN-SYNDROME; D-DOMAINS; EXPRESSION; MUC5AC; CORNEAL; GENES; MICE; CLASSIFICATION; EPITHELIUM	MUC5AC is the most abundant gel-forming mucin in the ocular system. However, the specific function is unknown. In the present study, a Muc5ac knockout (KO) mouse model was subject to various physiological measurements as compared to its wide-type (WT) control. Interestingly, when KO mice were compared to WT mice, the mean tear break up time (TBUT) values were significantly lower and corneal fluorescein staining scores were significantly higher. But the tear volume was not changed. Despite the lack of Muc5ac expression in the conjunctiva of KO mice, Muc5b expression was significantly increased in these mice. Corneal opacification, varying in location and severity, was found in a few KO mice but not in WT mice. The present results suggest a significant difference in the quality, but not the quantity, of tear fluid in the KO mice compared to WT mice. Dry eye disease is multifactorial and therefore further evaluation of the varying components of the tear film, lacrimal unit and corneal structure of these KO mice may help elucidate the role of mucins in dry eye disease. Because Muc5ac knockout mice have clinical features of dry eye, this mouse model will be extremely useful for further studies regarding the pathophysiology of the ocular surface in dry eye in humans.	[Floyd, Anne M.; Wang, Mingwu] Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, Tucson, AZ 85721 USA; [Floyd, Anne M.; Zhou, Xu; Rompala, Olivia J.; Zhu, Lingxiang; Chen, Yin] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Zhou, Xu] China Med Univ, Dept Ophthalmol, Affiliated Hosp 4, Shenyang, Peoples R China; [Evans, Christopher] Univ Colorado, Dept Med, Aurora, CO USA	University of Arizona; University of Arizona; China Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus	Wang, MW (corresponding author), Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, Tucson, AZ 85721 USA.	mingwuwang@hotmail.com; ychen@pharmacy.arizona.edu		Evans, Christopher/0000-0001-5600-7314	Arizona Biomedical Research Commission; NIH [RO1AI061695]; institutional Research to Prevent Blindness Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061695] Funding Source: NIH RePORTER	Arizona Biomedical Research Commission; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); institutional Research to Prevent Blindness Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by an Arizona Biomedical Research Commission grant, an NIH grant RO1AI061695, and an institutional Research to Prevent Blindness Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso P, 2002, INVEST OPHTH VIS SCI, V43, P1004; Bell SL, 1998, EUR J BIOCHEM, V253, P123, DOI 10.1046/j.1432-1327.1998.2530123.x; Copin MC, 2001, FRONT BIOSCI, V6, pD1264, DOI 10.2741/Copin; de Bolos C, 2001, FRONT BIOSCI-LANDMRK, V6, pD1256, DOI 10.2741/Bolos; Desseyn JL, 2000, MOL BIOL EVOL, V17, P1175, DOI 10.1093/oxfordjournals.molbev.a026400; Gipson IK, 2003, INT REV CYTOL, V231, P1, DOI 10.1016/S0074-7696(03)31001-0; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Gum JR, 1995, BIOCHEM SOC T, V23, P795, DOI 10.1042/bst0230795; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Katsumi A, 2000, J BIOL CHEM, V275, P25585, DOI 10.1074/jbc.M002654200; Zorzi GK, 2011, MOL PHARMACEUT, V8, P1783, DOI 10.1021/mp200155t; Lin ZR, 2011, MOL VIS, V17, P257; Mataftsi A, 2011, MOL VIS, V17, P1624; McKenzie RW, 2000, INVEST OPHTH VIS SCI, V41, P703; Moniaux N, 2001, FRONT BIOSCI-LANDMRK, V6, pD1192, DOI 10.2741/Moniaux; Nischal KK, 2007, EYE, V21, P1326, DOI 10.1038/sj.eye.6702840; Offner G D, 2000, Adv Dent Res, V14, P69; Pauly A, 2007, INVEST OPHTH VIS SCI, V48, P5473, DOI 10.1167/iovs.06-0728; Peral A, 2008, DRUG NEWS PERSPECT, V21, P166, DOI 10.1358/dnp.2008.21.3.1203413; Perez-Vilar J, 1998, J BIOL CHEM, V273, P34527, DOI 10.1074/jbc.273.51.34527; Perez-Vilar J, 1998, J BIOL CHEM, V273, P14442, DOI 10.1074/jbc.273.23.14442; Spurr-Michaud S, 2007, EXP EYE RES, V84, P939, DOI 10.1016/j.exer.2007.01.018; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; Tao SS, 2012, AM J RESP CELL MOL, V46, P660, DOI 10.1165/rcmb.2011-0340OC; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Van Seuningen I, 2001, FRONT BIOSCI-LANDMRK, V6, pD1216; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vemuganti GK, 2009, INT REV CEL MOL BIO, V275, P133, DOI 10.1016/S1937-6448(09)75005-1; Wang IJ, 2009, MOL VIS, V15, P108; Yu DF, 2008, EXP EYE RES, V86, P403, DOI 10.1016/j.exer.2007.11.013; Yu DF, 2011, AM J PHYSIOL-LUNG C, V301, pL31, DOI 10.1152/ajplung.00301.2010; Zhu LX, 2011, AM J RESP CELL MOL, V45, P348, DOI 10.1165/rcmb.2010-0312OC	32	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e50704	10.1371/journal.pone.0050704	http://dx.doi.org/10.1371/journal.pone.0050704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272068	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300011
J	Maresca, B; Cigliano, L; Spagnuolo, MS; Dal Piaz, F; Corsaro, MM; Balato, N; Nino, M; Balato, A; Ayala, F; Abrescia, P				Maresca, Bernardetta; Cigliano, Luisa; Spagnuolo, Maria Stefania; Dal Piaz, Fabrizio; Corsaro, Maria M.; Balato, Nicola; Nino, Massimiliano; Balato, Anna; Ayala, Fabio; Abrescia, Paolo			Differences between the Glycosylation Patterns of Haptoglobin Isolated from Skin Scales and Plasma of Psoriatic Patients	PLOS ONE			English	Article							CHOLESTEROL ACYLTRANSFERASE ACTIVITY; ACUTE-PHASE PROTEINS; SERUM GLYCOPROTEINS; OVARIAN-CANCER; EXPRESSION; GALECTIN-3; BINDING; CELLS; DISEASE; SITE	Improved diagnosis of psoriasis, by new biomarkers, is required for evaluating the progression rate of the disease and the response to treatment. Haptoglobin (Hpt), a glycoprotein secreted by hepatocytes and other types of cells including keratinocytes, was found with glycan changes in psoriasis and other diseases. We previously reported that Hpt isolated from plasma of psoriatic patients is more fucosylated than Hpt of healthy subjects. The aim of this study was to compare the glycosylation pattern of Hpt isolated from skin scales or plasma of patients with psoriasis with that of Hpt from cornified epidermal layer or plasma of healthy subjects. High performance liquid chromatography analysis of the glycans isolated from the protein backbone revealed that glycan patterns from skin and plasma of patients were similar, and mostly displayed quantitative rather than qualitative differences from normal pattern. Biotin-labeled lectins were used to evaluate quantitative differences in the glycoforms of Hpt from plasma and psoriatic skin scales. Hpt from skin and plasma of patients showed more fucosylated and branched glycans than Hpt from plasma of healthy subjects. Tryptic glycopeptides of Hpt were also analyzed by mass spectrometry, and a decreased amount of sialylated glycan chains was found in glycopeptides of skin Hpt, as compared with Hpt from plasma. High levels of glycans with fucosylated and tetra-antennary chains were detected on the peptide NLFLNHSENATAK from Hpt of psoriatic patients. Our data demonstrate that specific changes in glycan structures of Hpt, such as enhanced glycan branching and fucose content, are associated with psoriasis, and that differences between circulating and skin Hpt do exist. A lower extent of glycan fucosylation and branching was found in Hpt from plasma of patients in disease remission. Altered glycoforms might reflect changes of Hpt function in the skin, and could be used as markers of the disease.	[Maresca, Bernardetta; Cigliano, Luisa; Abrescia, Paolo] Univ Naples Federico II, Dipartimento Sci Biol, Naples, Italy; [Spagnuolo, Maria Stefania] CNR, Ist Sistema Prod Anim Ambiente Mediterraneo, I-80125 Naples, Italy; [Dal Piaz, Fabrizio] Univ Salerno, Dipartimento Sci Farmaceut & Biomed, I-84100 Salerno, Italy; [Corsaro, Maria M.] Complesso Univ MS Angelo, Dipartimento Chim Organ & Biochim, Univ Napoli Federico II, Naples, Italy; [Balato, Nicola; Nino, Massimiliano; Balato, Anna; Ayala, Fabio] Univ Naples Federico II, Dipartimento Patol Sistemat, Sez Dermatol, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); University of Salerno; University of Naples Federico II; University of Naples Federico II	Cigliano, L (corresponding author), Univ Naples Federico II, Dipartimento Sci Biol, Naples, Italy.	luisa.cigliano@unina.it	Dal Piaz, Fabrizio/D-1843-2010; Cigliano, Luisa/AEL-3260-2022; Corsaro, Maria Michela/T-6190-2019; Spagnuolo, Maria Stefania/B-7661-2015; Balato, Anna/K-5655-2016	Dal Piaz, Fabrizio/0000-0002-8643-5018; Corsaro, Maria Michela/0000-0002-6834-8682; Spagnuolo, Maria Stefania/0000-0001-6980-0661; Balato, Anna/0000-0001-5485-0172; Ayala, Fabio/0000-0002-2596-1268; Balato, Nicola/0000-0003-4871-2413	University of Naples Federico II [Ric. Dip. 10112/2010]	University of Naples Federico II	This work was supported by a research grant from the University of Naples Federico II (Ric. Dip. 10112/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Azuma Y, 2000, CLIN CHIM ACTA, V294, P93, DOI 10.1016/S0009-8981(99)00248-X; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Bresalier RS, 2004, GASTROENTEROLOGY, V127, P741, DOI 10.1053/j.gastro.2004.06.016; Carlsson MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026560; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Cigliano L, 2008, J EUR ACAD DERMATOL, V22, P417, DOI 10.1111/j.1468-3083.2007.02444.x; Cigliano L, 2003, ARCH BIOCHEM BIOPHYS, V416, P227, DOI 10.1016/S0003-9861(03)00318-7; Cigliano L, 2009, FEBS J, V276, P6158, DOI 10.1111/j.1742-4658.2009.07319.x; Comunale MA, 2006, J PROTEOME RES, V5, P308, DOI 10.1021/pr050328x; DArmiento J, 1997, GENE, V195, P19, DOI 10.1016/S0378-1119(97)00123-6; de Kleijn DPV, 2002, FASEB J, V16, P1123, DOI 10.1096/fj.02-0019fje; DOBROTINA NA, 1977, VOP MED KHIM, V23, P215; Dobryszycka W., 1997, J CLIN CHEM CLIN BIO, V35, P647; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Ferens-Sieczkowska M, 1999, GLYCOCONJUGATE J, V16, P573, DOI 10.1023/A:1007078114674; Fujimura T, 2008, INT J CANCER, V122, P39, DOI 10.1002/ijc.22958; Fukaya Y, 2008, J BIOL CHEM, V283, P18573, DOI 10.1074/jbc.M803115200; HANASAKI K, 1995, J BIOL CHEM, V270, P7543, DOI 10.1074/jbc.270.13.7543; He ZC, 2006, BIOCHEM BIOPH RES CO, V343, P496, DOI 10.1016/j.bbrc.2006.03.007; Ideo H, 2005, J BIOL CHEM, V280, P4730, DOI 10.1074/jbc.M410362200; Ishibashi Y, 2005, GLYCOCONJUGATE J, V22, P53, DOI 10.1007/s10719-005-0292-7; Kaartinen V, 1998, BIOCHIM BIOPHYS ACTA, V14, P345; KALMOVARIN N, 1991, INFLAMMATION, V15, P369, DOI 10.1007/BF00917353; Kossowska B, 2005, CLIN CHEM LAB MED, V43, P361, DOI 10.1515/CCLM.2005.066; KUROSKY A, 1980, P NATL ACAD SCI-BIOL, V77, P3388, DOI 10.1073/pnas.77.6.3388; Langlois MR, 1996, CLIN CHEM, V42, P1589; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; MANN AC, 1994, CLIN CHIM ACTA, V227, P69, DOI 10.1016/0009-8981(94)90136-8; Maresca B, 2010, BIOL CHEM, V391, P1429, DOI 10.1515/BC.2010.146; Nakano M, 2008, INT J CANCER, V122, P2301, DOI 10.1002/ijc.23364; NEMANSKY M, 1995, FEBS LETT, V363, P280, DOI 10.1016/0014-5793(95)00336-8; Park SY, 2012, INT J CANCER, V130, P2366, DOI 10.1002/ijc.26288; Piva M, 2002, GLYCOCONJUGATE J, V19, P33, DOI 10.1023/A:1022580813870; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Saegusa J, 2008, J INVEST DERMATOL, V128, P2403, DOI 10.1038/jid.2008.119; Saldova R, 2007, GLYCOBIOLOGY, V17, P1344, DOI 10.1093/glycob/cwm100; Spagnuolo MS, 2011, BIOL CHEM, V392, P371, DOI 10.1515/BC.2011.033; Spagnuolo MS, 2005, J BIOL CHEM, V280, P1193, DOI 10.1074/jbc.M411390200; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; THOMPSON S, 1992, CANCER LETT, V66, P43, DOI 10.1016/0304-3835(92)90278-4; THOMPSON S, 1993, CLIN CHIM ACTA, V220, P107, DOI 10.1016/0009-8981(93)90011-R; Varki A., 2009, ESSENTIALS GLYCOBIOL, P784; WADA T, 1970, J RETICULOENDOTH SOC, V8, P185; Wang H, 2005, BRIT J DERMATOL, V153, P894, DOI 10.1111/j.1365-2133.2005.06807.x; Xie Y, 2000, J DERMATOL SCI, V24, P25, DOI 10.1016/S0923-1811(00)00078-5; Yang FM, 2003, AM J PHYSIOL-LUNG C, V284, pL402, DOI 10.1152/ajplung.00115.2002	49	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52040	10.1371/journal.pone.0052040	http://dx.doi.org/10.1371/journal.pone.0052040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272204	Green Submitted, gold, Green Published			2022-12-25	WOS:000312483300050
J	Wang, YH; Li, XC; Zhu-Ge, Q; Jiang, X; Wang, WD; Fang, WP; Chen, X; Li, XH				Wang, Yu-Hua; Li, Xiao-Cheng; Zhu-Ge, Qiang; Jiang, Xin; Wang, Wei-Dong; Fang, Wan-Ping; Chen, Xuan; Li, Xing-Hui			Nitric Oxide Participates in Cold-Inhibited Camellia sinensis Pollen Germination and Tube Growth Partly via cGMP In Vitro	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENE-EXPRESSION; LOW-TEMPERATURE; ABIOTIC STRESS; ABSCISIC-ACID; SALT STRESS; PLANTS; TOLERANCE; TOBACCO; NO	Nitric oxide (NO) plays essential roles in many biotic and abiotic stresses in plant development procedures, including pollen tube growth. Here, effects of NO on cold stress inhibited pollen germination and tube growth in Camellia sinensis were investigated in vitro. The NO production, NO synthase (NOS)-like activity, cGMP content and proline (Pro) accumulation upon treatment with NO scavenger cPTIO, NOS inhibitor L-NNA, NO donor DEA NONOate, guanylate cyclase (GC) inhibitor ODQ or phosphodiesterase (PDE) inhibitor Viagra at 25 degrees C (control) or 4 degrees C were analyzed. Exposure to 4 degrees C for 2 h reduced pollen germination and tube growth along with increase of NOS-like activity, NO production and cGMP content in pollen tubes. DEA NONOate treatment inhibited pollen germination and tube growth in a dose-dependent manner under control and reinforced the inhibition under cold stress, during which NO production and cGMP content promoted in pollen tubes. L-NNA and cPTIO markedly reduced the generation of NO induced by cold or NO donor along with partly reverse of cold-or NO donor-inhibited pollen germination and tube growth. Furthermore, ODQ reduced the cGMP content under cold stress and NO donor treatment in pollen tubes. Meanwhile, ODQ disrupted the reinforcement of NO donor on the inhibition of pollen germination and tube growth under cold condition. Additionally, Pro accumulation of pollen tubes was reduced by ODQ compared with that receiving NO donor under cold or control condition. Effects of cPTIO and L-NNA in improving cold-treated pollen germination and pollen tube growth could be lowered by Viagra. Moreover, the inhibitory effects of cPTIO and L-NNA on Pro accumulation were partly reversed by Viagra. These data suggest that NO production from NOS-like enzyme reaction decreased the cold-responsive pollen germination, inhibited tube growth and reduced Pro accumulation, partly via cGMP signaling pathway in C. sinensis.	[Wang, Yu-Hua; Li, Xiao-Cheng; Jiang, Xin; Wang, Wei-Dong; Fang, Wan-Ping; Chen, Xuan; Li, Xing-Hui] Nanjing Agr Univ, Tea Sci Res Inst, Nanjing, Jiangsu, Peoples R China; [Zhu-Ge, Qiang] Nanjing Forestry Univ, Forest Resources & Environm Inst, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Forestry University	Li, XH (corresponding author), Nanjing Agr Univ, Tea Sci Res Inst, Nanjing, Jiangsu, Peoples R China.	lxh@njau.edu.cn			National Natural Science Foundation of China [31000315, 30972403]; Research Fund for the Doctoral Program of Higher Education of China [20090097120049]; China Postdoctoral Science Foundation [20100481158]; Open Project of Key Laboratory of Forest Genetics and Biotechnology (Nanjing Forestry University); Ministry of Education, China [FGB200904]; Natural Science Foundation of Jiangsu Province [BK2010451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Open Project of Key Laboratory of Forest Genetics and Biotechnology (Nanjing Forestry University); Ministry of Education, China(Ministry of Education, China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China (31000315, 30972403, http://www.nsfc.gov.cn/Portal0/default152.htm), Research Fund for the Doctoral Program of Higher Education of China (20090097120049, http://www.moe.edu.cn/), China Postdoctoral Science Foundation (20100481158, http://www.chinapostdoctor.org.cn/V3/Program/Main.aspx), Open Project of Key Laboratory of Forest Genetics and Biotechnology (Nanjing Forestry University), Ministry of Education, China (FGB200904, http://fgbio.njfu.edu.cn/), and Natural Science Foundation of Jiangsu Province (BK2010451, http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun E, 2010, CELL BIOL INT, V34, P469, DOI 10.1042/CBI20090417; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; Bouchard JN, 2008, PLANT CELL PHYSIOL, V49, P641, DOI 10.1093/pcp/pcn037; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantrel C, 2011, NEW PHYTOL, V189, P415, DOI 10.1111/j.1469-8137.2010.03500.x; Chinnusamy V, 2006, PHYSIOL PLANTARUM, V126, P52, DOI 10.1111/j.1399-3054.2006.00596.x; Corpas FJ, 2008, PLANT CELL PHYSIOL, V49, P1711, DOI 10.1093/pcp/pcn144; Corpas FJ, 2009, NEW PHYTOL, V184, P9, DOI 10.1111/j.1469-8137.2009.02989.x; Enrich MJD, 2000, ANAL BIOCHEM, V285, P105, DOI 10.1006/abio.2000.4731; Fan QJ, 2012, PLANT CELL REP, V31, P145, DOI 10.1007/s00299-011-1148-1; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Gupta KJ, 2011, NEW PHYTOL, V189, P360, DOI 10.1111/j.1469-8137.2010.03586.x; He JM, 2007, PHYSIOL PLANTARUM, V131, P273, DOI 10.1111/j.1399-3054.2007.00955.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Huang X, 2004, PLANTA, V218, P938, DOI 10.1007/s00425-003-1178-1; Khodakovskaya M, 2006, PLANTA, V223, P1090, DOI 10.1007/s00425-005-0161-4; Lee JY, 2003, PLANT PHYSIOL, V132, P517, DOI 10.1104/pp.103.020511; Liu YJ, 2010, PLANT PHYSIOL BIOCH, V48, P936, DOI 10.1016/j.plaphy.2010.09.001; Mur LAJ, 2011, PLANT SCI, V181, P509, DOI 10.1016/j.plantsci.2011.04.003; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; Newton RP, 2004, PHYTOCHEMISTRY, V65, P2423, DOI 10.1016/j.phytochem.2004.07.026; Pasqualini S, 2009, NEW PHYTOL, V181, P860, DOI 10.1111/j.1469-8137.2008.02711.x; Prado AM, 2004, DEVELOPMENT, V131, P2707, DOI 10.1242/dev.01153; Prado AM, 2008, MOL PLANT, V1, P703, DOI 10.1093/mp/ssn034; Reichler SA, 2009, J EXP BOT, V60, P2129, DOI 10.1093/jxb/erp091; Ruan HH, 2004, ACTA BOT SIN, V46, P1307; Rumer S, 2012, NITRIC OXIDE-BIOL CH, V27, P123, DOI 10.1016/j.niox.2012.05.007; Rumer S, 2009, PLANT SIGNAL BEHAV, V4, P853, DOI 10.1093/jxb/erp077; Sakaguchi M, 2007, J BIOCHEM, V141, P213, DOI 10.1093/jh/mvm025; Salmi ML, 2007, PLANT PHYSIOL, V144, P94, DOI 10.1104/pp.107.096131; SEKIYA J, 1988, AGR BIOL CHEM TOKYO, V52, P243; Shi HT, 2012, PLANT CELL PHYSIOL, V53, P344, DOI 10.1093/pcp/pcr181; Tossi V, 2022, NEW PHYTOL, DOI [10.1111/j.1469-8137.2008.02722.x, 10.1111/nph.17330]; Vyas D, 2005, PLANT PHYSIOL BIOCH, V43, P383, DOI 10.1016/j.plaphy.2005.02.016; Wang ML, 2004, PLANT CELL PHYSIOL, V45, P1519, DOI 10.1093/pcp/pch174; Wang YH, 2009, NEW PHYTOL, V182, P851, DOI 10.1111/j.1469-8137.2009.02820.x; Wilkins KA, 2011, PLANT PHYSIOL, V156, P404, DOI 10.1104/pp.110.167510; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Xu YC, 2004, PHYTOPATHOLOGY, V94, P402, DOI 10.1094/PHYTO.2004.94.4.402; Zhang LP, 2008, PLANT CELL PHYSIOL, V49, P411, DOI 10.1093/pcp/pcn017; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996	41	29	30	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52436	10.1371/journal.pone.0052436	http://dx.doi.org/10.1371/journal.pone.0052436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272244	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300086
J	Leistner, S; Benik, S; Laumeier, I; Ziegler, A; Nieweler, G; Nolte, CH; Heuschmann, PU; Audebert, HJ				Leistner, Stefanie; Benik, Steffen; Laumeier, Inga; Ziegler, Annerose; Nieweler, Gabriele; Nolte, Christian H.; Heuschmann, Peter U.; Audebert, Heinrich J.			Secondary Prevention after Minor Stroke and TIA - Usual Care and Development of a Support Program	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; EVENT RATES; CLINICAL-TRIAL; HYPERTENSION; DISEASE; ATHEROTHROMBOSIS; MULTIFACTORIAL	Background: Effective methods of secondary prevention after stroke or TIA are available but adherence to recommended evidence-based treatments is often poor. The study aimed to determine the quality of secondary prevention in usual care and to develop a stepwise modeled support program. Methods: Two consecutive cohorts of patients with acute minor stroke or TIA undergoing usual outpatient care versus a secondary prevention program were compared. Risk factor control and medication adherence were assessed in 6-month follow-ups (6M-FU). Usual care consisted of detailed information concerning vascular risk factor targets given at discharge and regular outpatient care by primary care physicians. The stepwise modeled support program additionally employed up to four outpatient appointments. A combination of educational and behavioral strategies was employed. Results: 168 patients in the observational cohort who stated their openness to participate in a prevention program (mean age 64.7 y, admission blood pressure (BP): 155/84 mmHg) and 173 patients participating in the support program (mean age 67.6 y, BP: 161/84 mmHg) were assessed at 6 months. Proportions of patients with BP according to guidelines were 50% in usual-care and 77% in the support program (p<0.01). LDL<100 mg/dl was measured in 62 versus 71% (p = 0.12). Proportions of patients who stopped smoking were 50 versus 79% (p<0.01). 72 versus 89% of patients with atrial fibrillation were on oral anticoagulation (p = 0.09). Conclusions: Risk factor control remains unsatisfactory in usual care. Targets of secondary prevention were met more often within the supported cohort. Effects on (cerebro-)vascular recurrence rates are going to be assessed in a multicenter randomized trial.	[Leistner, Stefanie; Benik, Steffen; Laumeier, Inga; Ziegler, Annerose; Nieweler, Gabriele; Nolte, Christian H.] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Heuschmann, Peter U.] Univ Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany; [Audebert, Heinrich J.] Charite Univ Med Berlin, Ctr Stroke Res, Dept Neurol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Leistner, S (corresponding author), Charite Univ Med Berlin, Dept Neurol, Berlin, Germany.	stefanie.leistner@charite.de	Nolte, Christian/AAA-2651-2022	Nolte, Christian/0000-0001-5577-1775; Audebert, Heinrich J./0000-0002-4785-0366	Lundbeck Pharma; Boehringer Ingelheim Pharma; Takeda Pharma; Sanofi Synthelabo; Bayer Vital; UCB Pharma; European Union; German Stroke Foundation; Stanley Thomas Johnson Foundation	Lundbeck Pharma(Lundbeck Corporation); Boehringer Ingelheim Pharma(Boehringer Ingelheim); Takeda Pharma(Takeda Pharmaceutical Company Ltd); Sanofi Synthelabo; Bayer Vital(Bayer AG); UCB Pharma(UCB Pharma SA); European Union(European Commission); German Stroke Foundation; Stanley Thomas Johnson Foundation	HJA received honoraria payment from Lundbeck Pharma, Boehringer Ingelheim Pharma, Takeda Pharma, Sanofi Synthelabo, Bayer Vital, UCB Pharma; Dr. C. H. Nolte from Boehringer Ingelheim Pharma, Takeda Pharma. PUH received research support from the European Union, the German Stroke Foundation, the Stanley Thomas Johnson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alberts MJ, 2009, EUR HEART J, V30, P2318, DOI 10.1093/eurheartj/ehp355; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bayerische Arbeitsgemeinschaft fur Qualitatssicherung in der stationaren Versorgung, 2010, JAHRESAUSWERTUNG MOD; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bushnell CD, 2011, NEUROLOGY, V77, P1182, DOI 10.1212/WNL.0b013e31822f0423; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Dart RA, 2003, CHEST, V123, P244, DOI 10.1378/chest.123.1.244; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Diener HCPN, 2008, PRIMAR UND SEKUNDARP; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Geschaftsstelle Qualitatssicherung Hessen, 2010, EXTERNE QUALITATSSIC; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Halkes PHA, 2006, LANCET, V367, P1665; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Heuschmann PU, 2011, NEUROLOGY, V76, P159, DOI 10.1212/WNL.0b013e318206ca1e; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Palanco MAM, 2007, MED CLIN-BARCELONA, V129, P241, DOI 10.1157/13108346; Rother J, 2008, CEREBROVASC DIS, V25, P366, DOI 10.1159/000120687; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Sacco RL, 1997, NEUROLOGY S4, V49, P39; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Vale MJ, 2003, ARCH INTERN MED, V163, P2775, DOI 10.1001/archinte.163.22.2775; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Zeymer U, 2008, DTSCH ARZTEBL INT, V105, P769, DOI 10.3238/arztebl.2008.0769	33	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e49985	10.1371/journal.pone.0049985	http://dx.doi.org/10.1371/journal.pone.0049985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284630	Green Submitted, gold, Green Published			2022-12-25	WOS:000312435900005
J	Zhang, BD; Asadi, S; Weng, ZY; Sismanopoulos, N; Theoharides, TC				Zhang, Bodi; Asadi, Shahrzad; Weng, Zuyi; Sismanopoulos, Nikolaos; Theoharides, Theoharis C.			Stimulated Human Mast Cells Secrete Mitochondrial Components That Have Autocrine and Paracrine Inflammatory Actions	PLOS ONE			English	Article							ACTIVATION; DNA; DISORDERS; MECHANISM; FISSION; AUTISM; DAMPS; ATP	Mast cells are hematopoietically-derived tissue immune cells that participate in acquired and innate immunity, as well as in inflammation through release of many chemokines and cytokines, especially in response to the pro-inflammatory peptide substance P (SP). Inflammation is critical in the pathogenesis of many diseases, but the trigger(s) is often unknown. We investigated if mast cell stimulation leads to secretion of mitochondrial components and whether these could elicit autocrine and/or paracrine inflammatory effects. Here we show that human LAD2 mast cells stimulated by IgE/anti-IgE or by the SP led to secretion of mitochondrial particles, mitochondrial (mt) mtDNA and ATP without cell death. Mitochondria purified fromLAD2 cells and, when mitochondria added to mast cells trigger degranulation and release of histamine, PGD(2), IL-8, TNF, and IL-1 beta. This stimulatory effect is partially inhibited by an ATP receptor antagonist and by DNAse. These results suggest that the mitochondrial protein fraction may also contribute. Purified mitochondria also stimulate IL-8 and vascular endothelial growth factor (VEGF) release from cultured human keratinocytes, and VEGF release from primary human microvascular endothelial cells. In order to investigate if mitochondrial components could be secreted in vivo, we injected rats intraperiotoneally (ip) with compound 48/80, which mimicks the action of SP. Peritoneal mast cells degranulated and mitochondrial particles were documented by transimission electron microscopy outside the cells. We also wished to investigate if mitochondrial components secreted locally could reach the systemic circulation. Administration ip of mtDNA isolated from LAD2 cells in rats was detected in their serum within 4 hr, indicating that extravascular mtDNA could enter the systemic circulation. Secretion of mitochondrial components from stimulated live mast cells may act as "autopathogens" contributing to the pathogenesis of inflammatory diseases and may be used as targets for novel treatments.	[Zhang, Bodi; Asadi, Shahrzad; Weng, Zuyi; Sismanopoulos, Nikolaos; Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Mol Immunopharm & Drug Discovery Lab, Boston, MA 02111 USA; [Zhang, Bodi; Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Zhang, Bodi; Weng, Zuyi; Theoharides, Theoharis C.] Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Asadi, Shahrzad; Theoharides, Theoharis C.] Tufts Med Ctr, Dept Pharm, Boston, MA USA; [Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Internal Med, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University; Tufts Medical Center; Tufts University	Theoharides, TC (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Mol Immunopharm & Drug Discovery Lab, Boston, MA 02111 USA.	theoharis.theoharides@tufts.edu	weng, zuyi/J-4147-2015; Zhang, Bodi/ABI-6738-2020		National Institutes of Health [R01 AR47652]; Safe Minds; Galenica, SA (Athens, Greece); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Safe Minds; Galenica, SA (Athens, Greece); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health grant R01 AR47652 and a grant from Safe Minds to TCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. A. S. Kirshenbaum (National Institutes of Health, Bethesda, MD) for the supply of LAD2 mast cells, Dr. A Slominski (University of Tennessee, TN) for the supply of HaCaT keratinocytes, Dr. Ira Herman (Tufts University) for the supply of HMVECs, and Sweden Orphan Biovitrum AB (Stockholm, Sweden) for their kind gift of rhSCF. We also thank Mr. Steven Punzell for his expert technical support. Bodi Zhang was supported by a graduate student fellowship from Galenica, SA (Athens, Greece).	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Angelidou A, 2011, J AUTISM DEV DISORD, V41, P1579, DOI 10.1007/s10803-010-1171-z; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bischoff SC, 2007, IMMUNOL REV, V217, P329, DOI 10.1111/j.1600-065X.2007.00523.x; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Castells M, 2011, AM J CLIN DERMATOL, V12, P259, DOI 10.2165/11588890-000000000-00000; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; JOHNSON RG, 1980, FEBS LETT, V120, P75, DOI 10.1016/0014-5793(80)81050-7; Kempuraj D, 1999, BLOOD, V93, P3338, DOI 10.1182/blood.V93.10.3338.410k05_3338_3346; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Lauritzen KH, 2010, MOL CELL BIOL, V30, P1357, DOI 10.1128/MCB.01149-09; Maintz L, 2011, ALLERGY, V66, P862, DOI 10.1111/j.1398-9995.2011.02550.x; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Olszewski MB, 2007, J IMMUNOL, V178, P5701, DOI 10.4049/jimmunol.178.9.5701; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Schaechter M, 2012, SCIENCE, V335, P32; Sismanopoulos N, 2012, PLOS ONE IN PRESS; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; Sudo N, 1996, J IMMUNOL, V156, P3970; Theoharides TC, 2006, ANN NY ACAD SCI, V1088, P78, DOI 10.1196/annals.1366.025; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Theoharides TC, 2009, INT J IMMUNOPATH PH, V22, P859, DOI 10.1177/039463200902200401; Theoharides TC, 2009, EXPERT OPIN PHARMACO, V10, P2127, DOI 10.1517/14656560903107789; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Valent P, 2012, INT ARCH ALLERGY IMM, V157, P215, DOI 10.1159/000328760; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; Weng Z, 2012, PLOS ONE IN PRESS; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhang B, 2012, INT ARCH AL IN PRESS; Zhang B, 2010, J IMMUNOL, V184, P11; Zhang BD, 2011, J ALLERGY CLIN IMMUN, V127, P1522, DOI 10.1016/j.jaci.2011.02.005; Zhang BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-80; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	41	69	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e49767	10.1371/journal.pone.0049767	http://dx.doi.org/10.1371/journal.pone.0049767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284625	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900003
J	Fehrholz, M; Bersani, I; Kramer, BW; Speer, CP; Kunzmann, S				Fehrholz, Markus; Bersani, Iliana; Kramer, Boris W.; Speer, Christian P.; Kunzmann, Steffen			Synergistic Effect of Caffeine and Glucocorticoids on Expression of Surfactant Protein B (SP-B) mRNA	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; THYROID TRANSCRIPTION FACTOR; HUMAN FETAL LUNG; GENE-EXPRESSION; IN-VITRO; II CELLS; BRONCHOPULMONARY DYSPLASIA; PROMOTER; RECEPTOR; THERAPY	Administration of glucocorticoids and caffeine is a common therapeutic intervention in the neonatal period, but possible interactions between these substances are still unclear. The present study investigated the effect of caffeine and different glucocorticoids on expression of surfactant protein (SP)-B, crucial for the physiological function of pulmonary surfactant. We measured expression levels of SP-B, various SP-B transcription factors including erythroblastic leukemia viral oncogene homolog 4 (ErbB4) and thyroid transcription factor-1 (TTF-1), as well as the glucocorticoid receptor (GR) after administering different doses of glucocorticoids, caffeine, cAMP, or the phosphodiesterase-4 inhibitor rolipram in the human airway epithelial cell line NCl-H441. Administration of dexamethasone (1 mu M) or caffeine (5 mM) stimulated SP-B mRNA expression with a maximal of 38.8 +/- 11.1-fold and 5.2 +/- 1.4-fold increase, respectively. Synergistic induction was achieved after co-administration of dexamethasone (1 mM) in combination with caffeine (10 mM) (206 +/- 59.7-fold increase, p<0.0001) or cAMP (1 mM) (213 +/- 11.1-fold increase, p = 0.0108). SP-B mRNA was synergistically induced also by administration of caffeine with hydrocortisone (87.9 +/- 39.0), prednisolone (154 +/- 66.8), and betamethasone (123 +/- 6.4). Rolipram also induced SP-B mRNA (64.9 +/- 21.0-fold increase). We detected a higher expression of ErbB4 and GR mRNA (7.0- and 1.7-fold increase, respectively), whereas TTF-1, Jun B, c-Jun, SP1, SP3, and HNF-3 alpha mRNA expression was predominantly unchanged. In accordance with mRNA data, mature SP-B was induced significantly by dexamethasone with caffeine (13.8 +/- 9.0-fold increase, p = 0.0134). We found a synergistic upregulation of SP-B mRNA expression induced by co-administration of various glucocorticoids and caffeine, achieved by accumulation of intracellular cAMP. This effect was mediated by a caffeine-dependent phosphodiesterase inhibition and by upregulation of both ErbB4 and the GR. These results suggested that caffeine is able to induce the expression of SP-transcription factors and affects the signaling pathways of glucocorticoids, amplifying their effects. Co-administration of caffeine and corticosteroids may therefore be of benefit in surfactant homeostasis.	[Fehrholz, Markus; Speer, Christian P.; Kunzmann, Steffen] Univ Wurzburg, Childrens Hosp, Wurzburg, Germany; [Bersani, Iliana] Univ Cattolica Sacro Cuore, A Gemelli Hosp, I-00168 Rome, Italy; [Kramer, Boris W.] Univ Hosp Maastricht, Dept Pediat, Maastricht, Netherlands	University of Wurzburg; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Maastricht University; Maastricht University Medical Centre (MUMC)	Fehrholz, M (corresponding author), Univ Wurzburg, Childrens Hosp, Wurzburg, Germany.	markus.fehrholz@uni-wuerzburg.de	BERSANI, ILIANA/AAC-9723-2022; Kramer, Boris/AAO-3183-2021		German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock Ian M, 2004, Proc Am Thorac Soc, V1, P247, DOI 10.1513/pats.200402-001MS; Alam MN, 2002, GENE, V282, P103, DOI 10.1016/S0378-1119(01)00844-7; Alcorn JL, 1997, AM J RESP CELL MOL, V17, P672, DOI 10.1165/ajrcmb.17.6.2858; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; BALLARD PL, 1991, ENDOCRINOLOGY, V128, P2916, DOI 10.1210/endo-128-6-2916; Barnes Peter J, 2005, Proc Am Thorac Soc, V2, P334, DOI 10.1513/pats.200504-024SR; Bates SR, 2002, AM J PHYSIOL-LUNG C, V282, pL267, DOI 10.1152/ajplung.00227.2001; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Berhane K, 2001, GENE, V268, P141, DOI 10.1016/S0378-1119(01)00417-6; Bersani I, 2012, EXPERT REV ANTI-INFE, V10, P573, DOI [10.1586/eri.12.34, 10.1586/ERI.12.34]; Boggaram V, 2003, FRONT BIOSCI-LANDMRK, V8, pD751, DOI 10.2741/1062; BOGGARAM V, 1991, MOL ENDOCRINOL, V5, P414, DOI 10.1210/mend-5-3-414; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; BROWER M, 1986, CANCER RES, V46, P798; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000; de Visser YP, 2012, AM J PHYSIOL-LUNG C, V302, P23; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; FLOROS J, 1991, AM J RESP CELL MOL, V4, P449, DOI 10.1165/ajrcmb/4.5.449; Focking M, 2005, BIOCHEM BIOPH RES CO, V337, P435, DOI 10.1016/j.bbrc.2005.09.067; FREY FJ, 1994, STEROIDS, V59, P74, DOI 10.1016/0039-128X(94)90079-5; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Gupta S, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/315642; HARRIS MC, 1983, J PEDIATR-US, V103, P303, DOI 10.1016/S0022-3476(83)80372-2; Henderson-Smart DJ, 2010, COCHRANE DATABASE SY, P8; Kolla V, 2007, AM J RESP CELL MOL, V36, P213, DOI 10.1165/rcmb.2006-0207OC; Lamontagne F, 2010, J CRIT CARE, V25, P420, DOI 10.1016/j.jcrc.2009.08.009; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LILEY HG, 1989, J CLIN INVEST, V83, P1191, DOI 10.1172/JCI114000; Liu W, 2010, BBA-MOL CELL RES, V1803, P832, DOI 10.1016/j.bbamcr.2010.03.003; Liu W, 2009, EXP LUNG RES, V35, P29, DOI 10.1080/01902140802395757; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losada A, 2000, ENDOCRINOLOGY, V141, P2166, DOI 10.1210/en.141.6.2166; MARGANA RK, 1995, AM J PHYSIOL-LUNG C, V268, pL481, DOI 10.1152/ajplung.1995.268.3.L481; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Mukwevho E, 2008, AM J PHYSIOL-ENDOC M, V294, P15; Ochs M, 2010, CELL PHYSIOL BIOCHEM, V25, P27, DOI 10.1159/000272061; OREILLY MA, 1991, AM J PHYSIOL, V260, pL37, DOI 10.1152/ajplung.1991.260.2.L37; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; PILOTMATIAS TJ, 1989, DNA-J MOLEC CELL BIO, V8, P75, DOI 10.1089/dna.1.1989.8.75; Roberts D, 2006, COCHRANE DATABASE SY, V19; Salinas D, 2003, AM J PHYSIOL-LUNG C, V285, pL1153, DOI 10.1152/ajplung.00084.2003; Sanz MJ, 2005, PHARMACOL THERAPEUT, V106, P269, DOI 10.1016/j.pharmthera.2004.12.001; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Schmidt B, 2008, NEONATOLOGY, V93, P284, DOI 10.1159/000121453; Speer CP, 2011, NEONATOLOGY, V99, P316, DOI 10.1159/000326619; SPEER CP, 1992, PEDIATRICS, V89, P13; Takahashi Y, 2011, AM J PHYSIOL-LUNG C, V300, pL453, DOI 10.1152/ajplung.00100.2010; Thomas W, 2008, NEONATOLOGY, V94, P150, DOI 10.1159/000143719; Tissing WJE, 2006, BLOOD, V108, P1045, DOI 10.1182/blood-2006-01-0261; Valdez RC, 2011, J PEDIATR-US, V158, P38, DOI 10.1016/j.jpeds.2010.06.051; Vidaeff A C, 2004, J Matern Fetal Neonatal Med, V15, P155, DOI 10.1080/14767050410001668248; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Whitsett JA, 1998, BBA-MOL BASIS DIS, V1408, P303, DOI 10.1016/S0925-4439(98)00076-3; Whitsett JA, 2006, PEDIATR CLIN N AM, V53, P873, DOI 10.1016/j.pcl.2006.08.009; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Woyda K, 2009, EUR RESPIR J, V33, P861, DOI 10.1183/09031936.00109008; Yan C, 1997, J BIOL CHEM, V272, P17327, DOI 10.1074/jbc.272.28.17327; Zscheppang K, 2007, AM J PHYSIOL-LUNG C, V293, pL429, DOI 10.1152/ajplung.00451.2006; Zscheppang K, 2011, AM J RESP CELL MOL, V45, P761, DOI 10.1165/rcmb.2010-0179OC	64	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51575	10.1371/journal.pone.0051575	http://dx.doi.org/10.1371/journal.pone.0051575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272120	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800054
J	Choumet, V; Attout, T; Chartier, L; Khun, H; Sautereau, J; Robbe-Vincent, A; Brey, P; Huerre, M; Bain, O				Choumet, Valerie; Attout, Tarik; Chartier, Loic; Khun, Huot; Sautereau, Jean; Robbe-Vincent, Annie; Brey, Paul; Huerre, Michel; Bain, Odile			Visualizing Non Infectious and Infectious Anopheles gambiae Blood Feedings in Naive and Saliva-Immunized Mice	PLOS ONE			English	Article							PLASMODIUM-BERGHEI SPOROZOITES; AEDES-AEGYPTI; MOSQUITO BITES; INFLAMMATORY RESPONSE; WUCHERERIA-BANCROFTI; CHEMOTACTIC FACTOR; DIPTERA-CULICIDAE; MALARIA PARASITES; ANTIBODY-RESPONSE; VECTOR	Background: Anopheles gambiae is a major vector of malaria and lymphatic filariasis. The arthropod-host interactions occurring at the skin interface are complex and dynamic. We used a global approach to describe the interaction between the mosquito (infected or uninfected) and the skin of mammals during blood feeding. Methods: Intravital video microscopy was used to characterize several features during blood feeding. The deposition and movement of Plasmodium berghei sporozoites in the dermis were also observed. We also used histological techniques to analyze the impact of infected and uninfected feedings on the skin cell response in naive mice. Results: The mouthparts were highly mobile within the skin during the probing phase. Probing time increased with mosquito age, with possible effects on pathogen transmission. Repletion was achieved by capillary feeding. The presence of sporozoites in the salivary glands modified the behavior of the mosquitoes, with infected females tending to probe more than uninfected females (86% versus 44%). A white area around the tip of the proboscis was observed when the mosquitoes fed on blood from the vessels of mice immunized with saliva. Mosquito feedings elicited an acute inflammatory response in naive mice that peaked three hours after the bite. Polynuclear and mast cells were associated with saliva deposits. We describe the first visualization of saliva in the skin by immunohistochemistry (IHC) with antibodies directed against saliva. Both saliva deposits and sporozoites were detected in the skin for up to 18 h after the bite. Conclusion: This study, in which we visualized the probing and engorgement phases of Anopheles gambiae blood meals, provides precise information about the behavior of the insect as a function of its infection status and the presence or absence of anti-saliva antibodies. It also provides insight into the possible consequences of the inflammatory reaction for blood feeding and pathogen transmission.	[Choumet, Valerie; Sautereau, Jean; Robbe-Vincent, Annie; Brey, Paul] Inst Pasteur, Unite Biochim & Biol Mol Insectes, Paris, France; [Attout, Tarik; Bain, Odile] Museum Natl Hist Nat, Unite Parasitol, UMR CNRS 7205, F-75231 Paris, France; [Chartier, Loic] Inst Pasteur, Unite Rech & Expertise Epidemiol Malad Emergentes, Paris, France; [Khun, Huot; Huerre, Michel] Inst Pasteur, Unite Rech & Expertise Histotechnol & Pathol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Choumet, V (corresponding author), Inst Pasteur, Unite Biochim & Biol Mol Insectes, Paris, France.	valerie.choumet@pasteur.fr						Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Anderson RA, 1999, P ROY SOC B-BIOL SCI, V266, P1729, DOI 10.1098/rspb.1999.0839; Beghdadi W, 2008, J EXP MED, V205, P395, DOI 10.1084/jem.20071548; BOS JD, 1986, IMMUNOL TODAY, V7, P235, DOI 10.1016/0167-5699(86)90111-8; BURKOT TR, 1990, PARASITOLOGY, V100, P369, DOI 10.1017/S003118200007863X; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Chadee DD, 1997, ANN TROP MED PARASIT, V91, P199, DOI 10.1080/00034983.1997.11813130; Chadee DD, 2002, J VECTOR ECOL, V27, P172; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Demeure CE, 2005, J IMMUNOL, V174, P3932, DOI 10.4049/jimmunol.174.7.3932; DIAGNE M, 1990, ANN PARASIT HUM COMP, V65, P193, DOI 10.1051/parasite/1990654193; Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06; GARCIA ES, 1994, EXP PARASITOL, V78, P287, DOI 10.1006/expr.1994.1030; Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038; GORDON R. M., 1939, ANN TROP MED AND PARASITOL, V33, P259; GRIFFITHS RB, 1952, ANN TROP MED PARASIT, V46, P311, DOI 10.1080/00034983.1952.11685536; Gueirard P, P NATL ACAD SCI US, V107, P18640; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Isawa H, 2007, INSECT BIOCHEM MOLEC, V37, P466, DOI 10.1016/j.ibmb.2007.02.002; Kebaier C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000399; Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358; Landau I., 2002, Parassitologia (Rome), V44, P111; Lardeux F, 1996, J MED ENTOMOL, V33, P516, DOI 10.1093/jmedent/33.4.516; Lefevre T, 2007, PROTEOMICS, V7, P1908, DOI 10.1002/pmic.200601021; Mahande A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-100; Mellor AL, 2006, IMMUNOL REV, V213, P5, DOI 10.1111/j.1600-065X.2006.00443.x; Metenou S, 2009, J IMMUNOL, V183, P916, DOI 10.4049/jimmunol.0900257; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Muturi EJ, 2008, PARASITOL RES, V102, P175, DOI 10.1007/s00436-007-0779-1; Natarajan R, 2001, CELL MICROBIOL, V3, P371, DOI 10.1046/j.1462-5822.2001.00117.x; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Owhashi M, 2001, PARASITOL RES, V87, P376, DOI 10.1007/s004360000355; Owhashi M, 2008, PARASITOL RES, V102, P357, DOI 10.1007/s00436-007-0769-3; PETIT G, 1985, ANN PARASIT HUM COMP, V60, P247, DOI 10.1051/parasite/1985603247; Pumpuni CB, 1997, J PARASITOL, V83, P652, DOI 10.2307/3284242; Qiu YT, 2011, MED VET ENTOMOL, V25, P247, DOI 10.1111/j.1365-2915.2010.00924.x; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; ROBINSON G. G., 1939, PARASITOLOGY, V31, P212, DOI 10.1017/S0031182000012774; Rosinski-Chupin I, 2007, CELL MICROBIOL, V9, P708, DOI 10.1111/j.1462-5822.2006.00822.x; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; ROSSIGNOL PA, 1985, P NATL ACAD SCI USA, V82, P7725, DOI 10.1073/pnas.82.22.7725; ROSSIGNOL PA, 1986, AM J TROP MED HYG, V35, P277, DOI 10.4269/ajtmh.1986.35.277; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; WEKESA JW, 1992, AM J TROP MED HYG, V47, P484, DOI 10.4269/ajtmh.1992.47.484; WILSON AB, 1965, INT ARCH ALLER A IMM, V26, P294, DOI 10.1159/000229580; Yamauchi LM, 2007, CELL MICROBIOL, V9, P1215, DOI 10.1111/j.1462-5822.2006.00861.x	55	61	61	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50464	10.1371/journal.pone.0050464	http://dx.doi.org/10.1371/journal.pone.0050464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272060	gold, Green Published			2022-12-25	WOS:000312386600011
J	Cortez, LM; Kumar, J; Renault, L; Young, HS; Sim, VL				Cortez, Leonardo M.; Kumar, Jitendra; Renault, Ludovic; Young, Howard S.; Sim, Valerie L.			Mouse Prion Protein Polymorphism Phe-108/Val-189 Affects the Kinetics of Fibril Formation and the Response to Seeding EVIDENCE FOR A TWO-STEP NUCLEATION POLYMERIZATION MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; INCUBATION PERIOD; AMYLOID FIBRILS; SCRAPIE; DISEASE; SHEEP; POLYMERIZATION; NUCLEATION; CONVERSION; MECHANISM	Prion diseases are fatal neurodegenerative disorders associated with the polymerization of the cellular form of prion protein (PrPC) into an amyloidogenic beta-sheet infectious form (PrPSc). The sequence of host PrP is the major determinant of host prion disease susceptibility. In mice, the presence of allele a (Prnp(a), encoding the polymorphism Leu-108/Thr-189) or b (Prnp(b), Phe-108/Val-189) is associated with short or long incubation times, respectively, following infection with PrPSc. The molecular bases linking PrP sequence, infection susceptibility, and convertibility of PrPC into PrPSc remain unclear. Here we show that recombinant PrPa and PrPb aggregate and respond to seeding differently in vitro. Our kinetic studies reveal differences during the nucleation phase of the aggregation process, where PrPb exhibits a longer lag phase that cannot be completely eliminated by seeding the reaction with preformed fibrils. Additionally, PrPb is more prone to propagate features of the seeds, as demonstrated by conformational stability and electron microscopy studies of the formed fibrils. We propose a model of polymerization to explain how the polymorphisms at positions 108 and 189 produce the phenotypes seen in vivo. This model also provides insight into phenomena such as species barrier and prion strain generation, two phenomena also influenced by the primary structure of PrP.	[Sim, Valerie L.] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada; [Renault, Ludovic; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada; [Sim, Valerie L.] Univ Alberta, Dept Med Neurol, Edmonton, AB T6G 2G3, Canada; [Sim, Valerie L.] Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2E1, Canada	University of Alberta; University of Alberta; National Research Council Canada; University of Alberta; University of Alberta; University of Alberta	Sim, VL (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, 204 BARB, Edmonton, AB T6G 2M8, Canada.	valerie.sim@ualberta.ca	Sim, Valerie/C-4137-2013	Sim, Valerie/0000-0002-0088-8666; Cortez, Leonardo/0000-0003-4080-8728; Young, Howard/0000-0002-5990-8422; Renault, Ludovic/0000-0001-6464-8808	Alberta Innovates Health Solutions	Alberta Innovates Health Solutions	This work was supported by Alberta Innovates Health Solutions (formerly Alberta Heritage Foundation for Medical Research).	Akhtar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028741; Alvarez-Martinez MT, 2011, BBA-PROTEINS PROTEOM, V1814, P1305, DOI 10.1016/j.bbapap.2011.05.016; Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; BARLOW RM, 1976, RES VET SCI, V21, P110, DOI 10.1016/S0034-5288(18)33406-4; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Chen SG, 2002, NEURON, V34, P854, DOI 10.1016/S0896-6273(02)00736-5; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Dima RI, 2004, P NATL ACAD SCI USA, V101, P15335, DOI 10.1073/pnas.0404235101; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Green KM, 2008, J GEN VIROL, V89, P598, DOI 10.1099/vir.0.83168-0; Hammarstrom P, 2010, BIOCHEMISTRY-US, V49, P6838, DOI 10.1021/bi100922r; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hill Andrew F., 2004, V11, P33; Houston F, 2003, NATURE, V423, P498, DOI 10.1038/423498a; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Julien O, 2011, BIOCHEMISTRY-US, V50, P7536, DOI 10.1021/bi200731e; Kirby L, 2010, BIOCHEMISTRY-US, V49, P1448, DOI 10.1021/bi901855z; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Lloyd SE, 2004, J GEN VIROL, V85, P2471, DOI 10.1099/vir.0.79889-0; Lloyd SE, 2004, MAMM GENOME, V15, P383, DOI 10.1007/s00335-004-3041-5; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Makarava N, 2007, J BIOL CHEM, V282, P36704, DOI 10.1074/jbc.M704926200; Moore RA, 2005, ARCH VIROL, P187; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Polano M, 2009, J MOL BIOL, V393, P1033, DOI 10.1016/j.jmb.2009.08.056; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Qi X, 2012, BIOCHEMISTRY-US, V51, P4600, DOI 10.1021/bi300201e; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Tizzano B, 2005, PROTEINS, V59, P72, DOI 10.1002/prot.20395; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	46	12	13	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4772	4781		10.1074/jbc.M112.414581	http://dx.doi.org/10.1074/jbc.M112.414581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283973	hybrid, Green Published			2022-12-25	WOS:000315340400026
J	Kearney, CJ; Sheridan, C; Cullen, SP; Tynan, GA; Logue, SE; Afonina, IS; Vucic, D; Lavelle, EC; Martin, SJ				Kearney, Conor J.; Sheridan, Clare; Cullen, Sean P.; Tynan, Graham A.; Logue, Susan E.; Afonina, Inna S.; Vucic, Domagoj; Lavelle, Ed C.; Martin, Seamus J.			Inhibitor of Apoptosis Proteins (IAPs) and Their Antagonists Regulate Spontaneous and Tumor Necrosis Factor (TNF)-induced Proinflammatory Cytokine and Chemokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; INDUCED CELL-DEATH; RHEUMATOID-ARTHRITIS; THERAPEUTIC TARGETS; TNF; ACTIVATION; CANCER; INFLAMMATION; CIAP1	Inhibitor of apoptosis proteins (IAPs) play a major role in determining whether cells undergo apoptosis in response to TNF as well as other stimuli. However, TNF is also highly proinflammatory through its ability to trigger the secretion of multiple inflammatory cytokines and chemokines, which is arguably the most important role of TNF in vivo. Indeed, deregulated production of TNF-induced cytokines is a major driver of inflammation in several autoimmune conditions such as rheumatoid arthritis. Here, we show that IAPs are required for the production of multiple TNF-induced proinflammatory mediators. Ablation or antagonism of IAPs potently suppressed TNF- or RIPK1-induced proinflammatory cytokine and chemokine production. Surprisingly, IAP antagonism also led to spontaneous production of chemokines, particularly RANTES, in vitro and in vivo. Thus, IAPs play a major role in influencing the production of multiple inflammatory mediators, arguing that these proteins are important regulators of inflammation in addition to apoptosis. Furthermore, small molecule IAP antagonists can modulate spontaneous as well as TNF-induced inflammatory responses, which may have implications for use of these agents in therapeutic settings.	[Kearney, Conor J.; Sheridan, Clare; Cullen, Sean P.; Logue, Susan E.; Afonina, Inna S.; Martin, Seamus J.] Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland; [Cullen, Sean P.; Tynan, Graham A.; Lavelle, Ed C.; Martin, Seamus J.] Trinity Coll Dublin, Immunobiol Res Ctr, Dublin 2, Ireland; [Tynan, Graham A.; Lavelle, Ed C.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Adjuvant Res Grp, Dublin 2, Ireland; [Vucic, Domagoj] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Roche Holding; Genentech	Martin, SJ (corresponding author), Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland.	martinsj@tcd.ie	Kearney, Conor/AAP-7860-2020; Lavelle, Ed/A-1716-2008; Logue, Susan/K-7748-2019; Afonina, Inna/AAM-8978-2020	Lavelle, Ed/0000-0002-3167-1080; Logue, Susan/0000-0001-7938-3558; Afonina, Inna/0000-0001-8894-5305; Martin, Seamus/0000-0002-8539-3143	Science Foundation Ireland [07/SRC/B1144, 08/IN.1/B2031]; Irish Research Council for Science, Engineering and Technology Postgraduate Studentship [RS/2010/2542]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering and Technology Postgraduate Studentship(Irish Research Council for Science, Engineering and Technology)	This work was supported by Strategic Research Cluster 07/SRC/B1144 and Principal Investigator 08/IN.1/B2031 Grants from Science Foundation Ireland.; Supported by an Irish Research Council for Science, Engineering and Technology Postgraduate Studentship (RS/2010/2542).	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Feldmann M, 2008, J CLIN INVEST, V118, P3533, DOI 10.1172/JCI37346; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Moulin M, 2012, EMBO J, V31, P1679, DOI 10.1038/emboj.2012.18; O'Riordan MXD, 2008, DEV CELL, V15, P497, DOI 10.1016/j.devcel.2008.09.012; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Scheinecker C, 2008, IMMUNITY, V28, P440, DOI 10.1016/j.immuni.2008.03.005; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	34	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4878	4890		10.1074/jbc.M112.422410	http://dx.doi.org/10.1074/jbc.M112.422410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23275336	Green Published, hybrid			2022-12-25	WOS:000315340400036
J	Yamashita-Sugahara, Y; Tokuzawa, Y; Nakachi, Y; Kanesaki-Yatsuka, Y; Matsumoto, M; Mizuno, Y; Okazaki, Y				Yamashita-Sugahara, Yzumi; Tokuzawa, Yoshimi; Nakachi, Yutaka; Kanesaki-Yatsuka, Yukiko; Matsumoto, Masahito; Mizuno, Yosuke; Okazaki, Yasushi			Fam57b ( Family with Sequence Similarity 57, Member B), a Novel Peroxisome Proliferator-activated Receptor gamma Target Gene That Regulates Adipogenesis through Ceramide Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; PPAR-GAMMA; 3T3-L1 ADIPOCYTES; ABDOMINAL OBESITY; EXPRESSION; INSULIN; DIFFERENTIATION; ACCUMULATION; SYSTEM; ALPHA	This report identifies a novel gene encoding Fam57b (family with sequence similarity 57, member B) as a novel peroxisome proliferator-activated receptor gamma (PPAR gamma)-responsive transmembrane gene that is related to obesity. The gene was identified based on an integrated bioinformatics analysis of the following three expression profiling data sets: adipocyte differentiation of mouse stromal cells (ST2 cells), adipose tissues from obesity mice, and siRNA-mediated knockdown of Ppar gamma using ST2 cells. Fam57b consists of three variants expressed from different promoters and contains a Tram-Lag1-CLN8 domain that is related to ceramide synthase. Reporter and ChIP assays showed that Fam57b variant 2 is a bona fide PPAR gamma target gene in ST2 cells. Fam57b was up-regulated during adipocyte differentiation, suggesting that FAM57B is involved in this process. Surprisingly, FAM57B overexpression inhibited adipogenesis, and siRNA-mediated knockdown promoted adipocyte differentiation. Analysis of the ceramide content by lipid assay found that ceramides were in fact augmented in FAM57B-overexpressing ST2 cells. We also confirmed that ceramide inhibits adipogenesis. Therefore, the aforementioned results of FAM57B overexpression and siRNA experiments are reconciled by ceramide synthesis. In summary, we present in vitro evidence showing that PPAR gamma regulates Fam57b transcription during the adipogenesis of ST2 cells. In addition, our results suggest that PPAR gamma activation contributes to the regulation of ceramide metabolism during adipogenesis via FAM57B.	[Yamashita-Sugahara, Yzumi; Tokuzawa, Yoshimi; Nakachi, Yutaka; Kanesaki-Yatsuka, Yukiko; Matsumoto, Masahito; Mizuno, Yosuke; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Funct Genom & Syst Med, Hidaka City, Saitama 3501241, Japan	Saitama Medical University	Okazaki, Y (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Div Funct Genom & Syst Med, 1397-1 Yamane, Hidaka City, Saitama 3501241, Japan.	okazaki@saitama-med.ac.jp	Nakachi, Yutaka/M-2446-2013; Matsumoto, Masahito/AGS-0755-2022	Nakachi, Yutaka/0000-0003-1964-2495; Okazaki, Yasushi/0000-0003-3241-5502	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for the "Genome Network Project" (to Y.O.) and "Support Project of Strategic Research Center in Private Universities" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to Saitama Medical University Research Center for Genomic Medicine).	Bonora E, 2008, G ITAL CARDIOL, V9, p40S, DOI 10.1714/669.7812; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi KM, 2011, BIOL PHARM BULL, V34, P912, DOI 10.1248/bpb.34.912; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Demiralp DO, 2008, CLIN APPL THROMB-HEM, V14, P438, DOI 10.1177/1076029607305081; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fiorito M, 2007, OBESITY, V15, P2889, DOI 10.1038/oby.2007.343; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Gray SL, 2005, BIOCHEM SOC T, V33, P1053, DOI 10.1042/BST0331053; Gulbins E, 2003, PHARMACOL RES, V47, P393, DOI 10.1016/S1043-6618(03)00052-5; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hutley L, 2005, AM J MED SCI, V330, P280, DOI 10.1097/00000441-200512000-00005; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nair S, 2005, DIABETOLOGIA, V48, P1784, DOI 10.1007/s00125-005-1868-2; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; Pan H, 2001, GENOMICS, V77, P58, DOI 10.1006/geno.2001.6614; Perry DK, 1998, BBA-MOL CELL BIOL L, V1436, P233, DOI 10.1016/S0005-2760(98)00145-3; Poll M, 2010, HAEMATOL-HEMATOL J, V95, P1832, DOI 10.3324/haematol.2010.027003; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Samad F, 2011, ADV EXP MED BIOL, V721, P67, DOI 10.1007/978-1-4614-0650-1_5; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Sprott KM, 2002, BIOCHEM J, V365, P181, DOI 10.1042/BJ20020215; Tokuzawa Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001019; Tomaru T, 2009, J BIOL CHEM, V284, P6116, DOI 10.1074/jbc.M808407200; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang BH, 2007, DNA SEQUENCE, V18, P92, DOI 10.1080/10425170601060947; Wang Jiao-Li, 2011, Zhonghua Jie He He Hu Xi Za Zhi, V34, P433; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Xu F, 2010, APPL BIOCHEM BIOTECH, V160, P197, DOI 10.1007/s12010-008-8505-8; Xu LB, 2012, NEUROBIOL DIS, V45, P923, DOI 10.1016/j.nbd.2011.12.011; Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008	55	21	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4522	4537		10.1074/jbc.M112.440792	http://dx.doi.org/10.1074/jbc.M112.440792			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23275342	Green Published, hybrid			2022-12-25	WOS:000315340400003
J	Ndirangu, J; Viljoen, J; Bland, RM; Danaviah, S; Thorne, C; Van de Perre, P; Newell, ML				Ndirangu, James; Viljoen, Johannes; Bland, Ruth M.; Danaviah, Siva; Thorne, Claire; Van de Perre, Philippe; Newell, Marie-Louise			Cell-Free (RNA) and Cell-Associated (DNA) HIV-1 and Postnatal Transmission through Breastfeeding	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; TYPE-1 RNA; NEVIRAPINE PROPHYLAXIS; VERTICAL TRANSMISSION; HIV-1-INFECTED WOMEN; INFECTED MOTHERS; P24 ANTIGEN; MILK CELLS	Introduction: Transmission through breastfeeding remains important for mother-to-child transmission (MTCT) in resource-limited settings. We quantify the relationship between cell-free (RNA) and cell-associated (DNA) shedding of HIV-1 virus in breastmilk and the risk of postnatal HIV-1 transmission in the first 6 months postpartum. Materials and Methods: Thirty-six HIV-positive mothers who transmitted HIV-1 by breastfeeding were matched to 36 non-transmitting HIV-1 infected mothers in a case-control study nested in a cohort of HIV-infected women. RNA and DNA were quantified in the same breastmilk sample taken at 6 weeks and 6 months. Cox regression analysis assessed the association between cell-free and cell-associated virus levels and risk of postnatal HIV-1 transmission. Results: There were higher median levels of cell-free than cell-associated HIV-1 virus (per ml) in breastmilk at 6 weeks and 6 months. Multivariably, adjusting for antenatal CD4 count and maternal plasma viral load, at 6 weeks, each 10-fold increase in cell-free or cell-associated levels (per ml) was significantly associated with HIV-1 transmission but stronger for cell-associated than cell-free levels [2.47 (95% CI 1.33-4.59) vs. aHR 1.52 (95% CI, 1.17-1.96), respectively]. At 6 months, cell-free and cell-associated levels (per ml) in breastmilk remained significantly associated with HIV-1 transmission but was stronger for cell-free than cell-associated levels [aHR 2.53 (95% CI 1.64-3.92) vs. 1.73 (95% CI 0.94-3.19), respectively]. Conclusions: The findings suggest that cell-associated virus level (per ml) is more important for early postpartum HIV-1 transmission (at 6 weeks) than cell-free virus. As cell-associated virus levels have been consistently detected in breastmilk despite antiretroviral therapy, this highlights a potential challenge for resource-limited settings to achieve the UNAIDS goal for 2015 of eliminating vertical transmission. More studies would further knowledge on mechanisms of HIV-1 transmission and help develop more effective drugs during lactation.	[Ndirangu, James; Viljoen, Johannes; Bland, Ruth M.; Danaviah, Siva; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Bland, Ruth M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland; [Thorne, Claire; Newell, Marie-Louise] UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Van de Perre, Philippe] INSERM U, Montpellier, France; [Van de Perre, Philippe] Univ Montpellier, F-34059 Montpellier, France; [Van de Perre, Philippe] CHU Montpellier, Dept Bacteriol Virol, Montpellier, France; [Van de Perre, Philippe] CHU Montpellier, Dept Med Informat, Montpellier, France	University of Kwazulu Natal; University of Glasgow; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Ndirangu, J (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa.	jndirangu@africacentre.ac.za; jviljoen@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019; Van de Perre, Philippe/B-9692-2008; Thorne, Claire/C-5943-2008	Newell, Marie-Louise/0000-0002-1074-7699; Van de Perre, Philippe/0000-0002-3912-0427; Thorne, Claire/0000-0003-0389-1956; Bland, Ruth/0000-0003-1675-9268; Ndirangu, James/0000-0002-2768-5631	Wellcome Trust; University of KwaZulu-Natal [050524];  [UK 063009/Z/00/2]; Medical Research Council [G0400546, G0400546B] Funding Source: researchfish; MRC [G0400546] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); University of KwaZulu-Natal; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust core grant to the Africa Centre for Health and Population Studies, University of KwaZulu-Natal (050524); and an additional grant to the Vertical Transmission Study (UK 063009/Z/00/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, KWAZULU NAT PROV DEP; Antinori A, 2005, CLIN INFECT DIS, V41, P1787, DOI 10.1086/498310; Ayouba A, 2003, AM J TROP MED HYG, V69, P447, DOI 10.4269/ajtmh.2003.69.447; Becquart P, 2002, VIROLOGY, V300, P109, DOI 10.1006/viro.2002.1537; Bennetto-Hood C, 2007, CLIN INFECT DIS, V45, P391, DOI 10.1086/519427; Bland RM, 2007, CLIN INFECT DIS, V45, P1502, DOI 10.1086/523320; Bland RM, 2010, INT J EPIDEMIOL, V39, P351, DOI 10.1093/ije/dyp165; Cassol S, 1997, J CLIN MICROBIOL, V35, P2795, DOI 10.1128/JCM.35.11.2795-2801.1997; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chege D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013077; Chung MH, 2005, AIDS, V19, P1415, DOI 10.1097/01.aids.0000181013.70008.4d; Chung MH, 2008, ANTIVIR THER, V13, P799; Chung MH, 2007, JAIDS-J ACQ IMM DEF, V46, P472, DOI 10.1097/QAI.0b013e3181594c1c; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Department of Health, 2010, CLIN GUID PMTCT PREV; Gantt S, 2008, AIDS, V22, P1453, DOI 10.1097/QAD.0b013e32830184f2; Ghosh MK, 2003, J CLIN MICROBIOL, V41, P2465, DOI 10.1128/JCM.41.6.2465-2470.2003; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; GOLDMAN AS, 1982, J PEDIATR-US, V100, P563, DOI 10.1016/S0022-3476(82)80753-1; Guay LA, 1996, PEDIATRICS, V98, P438; Gupta A, 2011, J INFECT DIS, V203, P358, DOI [10.1093/infdis/jiq064, 10.1093/jinfdis/jiq064]; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; John-Stewart G, 2004, JAIDS-J ACQ IMM DEF, V35, P196, DOI 10.1097/00126334-200402010-00015; Khamduang W, 2011, JAIDS-J ACQ IMM DEF, V58, P188, DOI [10.1097/QAI.0B013E31822D0433, 10.1097/QAI.0b013e31822d0433]; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Koulinska IN, 2006, JAIDS-J ACQ IMM DEF, V41, P93, DOI 10.1097/01.qai.0000179424.19413.24; Lehman DA, 2008, AIDS, V22, P1475, DOI 10.1097/QAD.0b013e328302cc11; Lewis P, 1998, J INFECT DIS, V177, P34, DOI 10.1086/513816; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mmiro FA, 2009, JAIDS-J ACQ IMM DEF, V52, P32, DOI 10.1097/QAI.0b013e3181afd352; NDUATI RW, 1995, J INFECT DIS, V172, P1461, DOI 10.1093/infdis/172.6.1461; Neveu D, 2011, CLIN INFECT DIS, V52, P819, DOI 10.1093/cid/ciq203; NEWELL ML, 1992, LANCET, V339, P1007; Newell ML, 2003, T ROY SOC TROP MED H, V97, P22, DOI 10.1016/S0035-9203(03)90009-5; Pillay K, 2000, J ACQ IMMUN DEF SYND, V24, P330, DOI 10.1097/00126334-200008010-00006; Richardson BA, 2003, J INFECT DIS, V187, P736, DOI 10.1086/374272; Rouet F, 2007, JAIDS-J ACQ IMM DEF, V45, P380, DOI 10.1097/QAI.0b013e3180640cf5; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; RUFF AJ, 1994, J ACQ IMMUN DEF SYND, V7, P68; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Semrau K, 2008, JAIDS-J ACQ IMM DEF, V47, P320, DOI 10.1097/QAI.0b013e31815e7436; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shapiro RL, 2005, J INFECT DIS, V192, P713, DOI 10.1086/432489; Slyker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029777; Tasker S, 2010, J MED MICROBIOL, V59, P1285, DOI 10.1099/jmm.0.021691-0; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; UNAIDS, 2011, GLOB REP UNAIDS REP; UNAIDS, 2010, GETT ZER 2011 2015 S; Valea D, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-34; Van de Perre P, 1999, AIDS, V13, P1133, DOI 10.1097/00002030-199906180-00018; VANDEPERRE P, 1993, LANCET, V341, P914, DOI 10.1016/0140-6736(93)91210-D; WHO, 2010, WHO ANT DRUGS TREAT; Willumsen JF, 2001, AIDS, V15, P1896, DOI 10.1097/00002030-200109280-00026	57	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51493	10.1371/journal.pone.0051493	http://dx.doi.org/10.1371/journal.pone.0051493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284701	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500012
J	Gonzalez-Recio, O; Ugarte, E; Bach, A				Gonzalez-Recio, Oscar; Ugarte, Eva; Bach, Alex			Trans-Generational Effect of Maternal Lactation during Pregnancy: A Holstein Cow Model	PLOS ONE			English	Article							BODY CONDITION SCORE; FEMALE FERTILITY; MILK-YIELD; SELECTION; NUTRITION; TRAITS; HEALTH; PERFORMANCE; PREDICTION; DISEASE	Epigenetic regulation in mammals begins in the first stages of embryogenesis. This prenatal programming determines, in part, phenotype expression in adult life. Some species, particularly dairy cattle, are conceived during the maternal lactation, which is a period of large energy and nutrient needs. Under these circumstances, embryo and fetal development compete for nutrients with the mammary gland, which may affect prenatal programming and predetermine phenotype at adulthood. Data from a specialized dairy breed were used to determine the transgenerational effect when embryo development coincides with maternal lactation. Longitudinal phenotypic data for milk yield (kg), ratio of fat-protein content in milk during first lactation, and lifespan (d) from 40,065 cows were adjusted for environmental and genetic effects using a Bayesian framework. Then, the effect of different maternal circumstances was determined on the residuals. The maternal-related circumstances were 1) presence of lactation, 2) maternal milk yield level, and 3) occurrence of mastitis during embryogenesis. Females born to mothers that were lactating while pregnant produced 52 kg (MonteCarlo standard error; MCs.e. = 0.009) less milk, lived 16 d (MCs.e. = 0.002) shorter and were metabolically less efficient (+0.42% milk fat/protein ratio; MCs.e.<0.001) than females whose fetal life developed in the absence of maternal lactation. The greater the maternal milk yield during embryogenesis, the larger the negative effects of prenatal programming, precluding the offspring born to the most productive cows to fully express their potential additive genetic merit during their adult life. Our data provide substantial evidence of transgenerational effect when pregnancy and lactation coincide. Although this effect is relatively low, it should not be ignored when formulating rations for lactating and pregnant cows. Furthermore, breeding, replacement, and management strategies should also take into account whether the individuals were conceived during maternal lactation because, otherwise, their performance may deviate from what it could be expected.	[Gonzalez-Recio, Oscar] INIA, Dept Mejora Genet Anim, Madrid, Spain; [Ugarte, Eva] NEIKER TECNALIA, Araba, Spain; [Bach, Alex] ICREA, Barcelona, Spain; [Bach, Alex] IRTA, Dept Ruminant Prod, Caldes De Montbui, Spain	ICREA; IRTA	Gonzalez-Recio, O (corresponding author), INIA, Dept Mejora Genet Anim, Madrid, Spain.	gonzalez.oscar@inia.es	Ugarte, Eva/D-9598-2019; Gonzalez-Recio, Oscar/C-8553-2016	Gonzalez-Recio, Oscar/0000-0002-9106-4063; Bach, Alex/0000-0001-6804-2002	ICREA Funding Source: Custom	ICREA(ICREA)		Bach A, 2012, J ANIM SCI, V90, P1835, DOI 10.2527/jas.2011-4516; Banos G, 2007, J DAIRY SCI, V90, P3490, DOI 10.3168/jds.2006-809; BARKER DJP, 1992, P NUTR SOC, V51, P135, DOI 10.1079/PNS19920023; Bascom SS, 1998, J DAIRY SCI, V81, P2299, DOI 10.3168/jds.S0022-0302(98)75810-2; Bell CG, 2010, BRIEF FUNCT GENOMICS, V9, P477, DOI 10.1093/bfgp/elq026; Berry DP, 2008, J DAIRY SCI, V91, P329, DOI 10.3168/jds.2007-0438; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Burdge GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028282; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Funston RN, 2010, J ANIM SCI, V88, pE205, DOI 10.2527/jas.2009-2351; Geyer CJ, 1992, STAT SCI, V7, P473, DOI [10.1214/ss/1177011137, DOI 10.1214/SS/1177011137]; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gonzalez-Recio O, 2006, J DAIRY SCI, V89, P4438, DOI 10.3168/jds.S0022-0302(06)72492-4; Gonzalez-Recio O, 2005, J DAIRY SCI, V88, P783, DOI 10.3168/jds.S0022-0302(05)72742-9; Gonzalez-Recio O, 2004, J DAIRY SCI, V87, P3053, DOI 10.3168/jds.S0022-0302(04)73438-4; Gonzalez-Recio Oscar, 2012, Frontiers in Genetics, V2, P106, DOI 10.3389/fgene.2011.00106; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; HENDERSON CR, 1976, BIOMETRICS, V32, P69, DOI 10.2307/2529339; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; JONES WP, 1994, J DAIRY SCI, V77, P3137, DOI 10.3168/jds.S0022-0302(94)77257-X; Kossaibati MA, 1997, VET J, V154, P41, DOI 10.1016/S1090-0233(05)80007-3; Nijland MJ, 2008, CURR OPIN OBSTET GYN, V20, P132, DOI 10.1097/GCO.0b013e3282f76753; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauw WM, 1998, LIVEST PROD SCI, V56, P15, DOI 10.1016/S0301-6226(98)00147-X; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Robinson JJ, 1999, ANIM SCI, V68, P315, DOI 10.1017/S1357729800050323; Roxstrom A, 2002, LIVEST PROD SCI, V74, P125, DOI 10.1016/S0301-6226(01)00300-1; SORENSEN DA, 2002, LIKELIHOOD BAYESIAN, P588; Veerkamp RF, 2001, J DAIRY SCI, V84, P2327, DOI 10.3168/jds.S0022-0302(01)74681-4; Vollema AR, 1996, J DAIRY SCI, V79, P2261, DOI 10.3168/jds.S0022-0302(96)76603-1; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Zwald NR, 2004, J DAIRY SCI, V87, P4287, DOI 10.3168/jds.S0022-0302(04)73573-0	33	59	60	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51816	10.1371/journal.pone.0051816	http://dx.doi.org/10.1371/journal.pone.0051816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284777	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500048
J	Mondal, S; Martinson, JA; Ghosh, S; Watson, R; Pahan, K				Mondal, Susanta; Martinson, Jeffrey A.; Ghosh, Supurna; Watson, Richard; Pahan, Kalipada			Protection of Tregs, Suppression of Th1 and Th17 Cells, and Amelioration of Experimental Allergic Encephalomyelitis by a Physically-Modified Saline	PLOS ONE			English	Article							REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INHIBITS ADOPTIVE TRANSFER; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; NITRIC-OXIDE; IL-12P40 HOMODIMER; SODIUM BENZOATE; CUTTING EDGE; FOXP3	In multiple sclerosis (MS) and other autoimmune diseases, the autoreactive T cells overcome the resistance provided by the regulatory T cells (Tregs) due to a decrease in the number of Foxp3-expressing Tregs. Therefore, upregulation and/or maintenance of Tregs during an autoimmune insult may have therapeutic efficacy in autoimmune diseases. Although several immunomodulatory drugs and molecules are available, most present significant side effects over long-term use. Here we have undertaken an innovative approach to upregulate Tregs and achieve immunomodulation. RNS60 is a 0.9% saline solution generated by subjecting normal saline to Taylor-Couette-Poiseuille (TCP) flow under elevated oxygen pressure. RNS60, but not NS (normal saline), RNS10.3 (TCP-modified saline without excess oxygen) and PNS60 (saline containing excess oxygen without TCP modification), was found to upregulate Foxp3 and enrich Tregs in MBP-primed T cells. Moreover, RNS60, but not NS, RNS10.3 and PNS60, inhibited the production of nitric oxide (NO) and the expression of iNOS in MBP-primed splenocytes. Incubation of the cells with an NO donor abrogated the RNS60-mediated upregulation of Foxp3. These results suggest that RNS60 boosts Tregs via suppression of NO production. Consistent to the suppressive activity of Tregs towards autoreactive T cells, RNS60, but not NS, RNS10.3, or PNS60, suppressed the differentiation of Th17 and Th1 cells and shifted the balance towards a Th2 response. Finally, RNS60 treatment exhibited immunomodulation and ameliorated adoptive transfer of experimental allergic encephalomyelitis, an animal model of MS, via Tregs. These results describe a novel immunomodulatory property of RNS60 and suggest its exploration for therapeutic intervention in MS and other autoimmune disorders.	[Mondal, Susanta; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Martinson, Jeffrey A.] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Ghosh, Supurna; Watson, Richard] Revalesio Corp, Tacoma, WA USA	Rush University; Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			Revalesio Corporation	Revalesio Corporation	This work was supported by Revalesio Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskar S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-3; Brahmachari S, 2007, J IMMUNOL, V179, P275, DOI 10.4049/jimmunol.179.1.275; Brahmachari S, 2010, J IMMUNOL, V184, P1799, DOI 10.4049/jimmunol.0804394; Brahmachari S, 2009, J IMMUNOL, V183, P2045, DOI 10.4049/jimmunol.0800276; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; Dasgupta S, 2003, J BIOL CHEM, V278, P22424, DOI 10.1074/jbc.M301789200; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kuerten S, 2011, J INTERF CYTOK RES, V31, P907, DOI 10.1089/jir.2011.0072; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; McKee AS, 2004, J IMMUNOL, V173, P1224, DOI 10.4049/jimmunol.173.2.1224; Miller A, 1997, SOUTH MED J, V90, P367, DOI 10.1097/00007611-199704000-00001; Mondal S, 2009, J IMMUNOL, V182, P5013, DOI 10.4049/jimmunol.0801734; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Pahan K, 2011, IMMUNOPHARM IMMUNOT, V33, P586, DOI 10.3109/08923973.2011.561861; Pahan K, 2010, J NEUROIMMUNE PHARM, V5, P165, DOI 10.1007/s11481-010-9219-6; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Rapoport N, 2007, JNCI-J NATL CANCER I, V99, P1095, DOI 10.1093/jnci/djm043; Reddy J, 2005, J IMMUNOL, V175, P5591, DOI 10.4049/jimmunol.175.9.5591; Sabatino JJ, 2010, J NEUROIMMUNE PHARM, V5, P176, DOI 10.1007/s11481-009-9181-3; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Schrempf W, 2007, AUTOIMMUN REV, V6, P469, DOI 10.1016/j.autrev.2007.02.003; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Sinha S, 2010, J NEUROIMMUNE PHARM, V5, P231, DOI 10.1007/s11481-009-9175-1; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Xu DM, 2003, J IMMUNOL, V170, P394, DOI 10.4049/jimmunol.170.1.394; Zhu JF, 2010, IMMUNITY, V32, P11, DOI 10.1016/j.immuni.2010.01.001; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	41	45	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51869	10.1371/journal.pone.0051869	http://dx.doi.org/10.1371/journal.pone.0051869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284794	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500056
J	Scheer, JM; Sandoval, W; Elliott, JM; Shao, L; Luis, E; Lewin-Koh, SC; Schaefer, G; Vandlen, R				Scheer, Justin M.; Sandoval, Wendy; Elliott, J. Michael; Shao, Lily; Luis, Elizabeth; Lewin-Koh, Sock-Cheng; Schaefer, Gabriele; Vandlen, Richard			Reorienting the Fab Domains of Trastuzumab Results in Potent HER2 Activators	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODY; BISPECIFIC ANTIBODIES; STRUCTURAL-ANALYSIS; THERAPEUTIC INDEX; ESCHERICHIA-COLI; CANCER-THERAPY; BREAST-CANCER; KINASE DOMAIN; COMPLEX	The structure of the Fab region of antibodies is critical to their function. By introducing single cysteine substitutions into various positions of the heavy and light chains of the Fab region of trastuzumab, a potent antagonist of HER2, and using thiol chemistry to link the different Fabs together, we produced a variety of monospecific F(ab')(2)-like molecules with activities spanning from activation to inhibition of breast tumor cell growth. These isomers (or bis-Fabs) of trastuzumab, with varying relative spatial arrangements between the Fv-regions, were able to either promote or inhibit cell-signaling activities through the PI3K/AKT and MAPK pathways. A quantitative phosphorylation mapping of HER2 indicated that the agonistic isomers produced a distinct phosphorylation pattern associated with activation. This study suggests that antibody geometric isomers, found both in nature and during synthetic antibody development, can have profoundly different biological activities independent of their affinities for their target molecules.	[Scheer, Justin M.; Sandoval, Wendy; Elliott, J. Michael; Luis, Elizabeth; Vandlen, Richard] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Shao, Lily; Schaefer, Gabriele] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Lewin-Koh, Sock-Cheng] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Scheer, JM (corresponding author), Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA.	scheer.justin@gene.com		Schaefer, Gabriele/0000-0001-9727-3555				[Anonymous], 2006, SAS MIXED MODELS; Carter P, 2000, Breast Dis, V11, P103; CARTER P, 1992, BIO-TECHNOL, V10, P163, DOI 10.1038/nbt0292-163; Chames P, 2009, IDRUGS, V12, P276; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Dornan D, 2009, BLOOD, V114, P2721, DOI 10.1182/blood-2009-02-205500; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; HORGAN C, 1993, J IMMUNOL, V150, P5400; Jackson JG, 2004, CANCER RES, V64, P2601, DOI 10.1158/0008-5472.CAN-03-3106; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Junutula JR, 2008, J IMMUNOL METHODS, V332, P41, DOI 10.1016/j.jim.2007.12.011; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kontermann RE, 2005, ACTA PHARMACOL SIN, V26, P1, DOI 10.1111/j.1745-7254.2005.00008.x; Kruser TJ, 2010, EXP CELL RES, V316, P1083, DOI 10.1016/j.yexcr.2010.01.009; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Liu YD, 2008, J BIOL CHEM, V283, P29266, DOI 10.1074/jbc.M804787200; Montgomery D., 2001, DESIGN ANAL EXPT, V5th; Patel D, 2009, INT J ONCOL, V34, P25, DOI 10.3892/ijo_00000125; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; SMIGEL MD, 1981, INT J BIOMED COMPUT, V12, P189, DOI 10.1016/0020-7101(81)90009-X; STANCOVSKI I, 1991, P NATL ACAD SCI USA, V88, P8691, DOI 10.1073/pnas.88.19.8691; Takai N, 2005, CANCER-AM CANCER SOC, V104, P2701, DOI 10.1002/cncr.21533; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yip YL, 2003, INT J CANCER, V104, P303, DOI 10.1002/ijc.10951; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	33	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51817	10.1371/journal.pone.0051817	http://dx.doi.org/10.1371/journal.pone.0051817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284778	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500049
J	Dimitri, N				Dimitri, Nicola			R&D Incentives for Neglected Diseases	PLOS ONE			English	Article								Neglected diseases are typically characterized as those for which adequate drug treatment is lacking, and the potential return on effort in research and development (R&D), to produce new therapies, is too small for companies to invest significant resources in the field. In recent years various incentives schemes to stimulate R&D by pharmaceutical firms have been considered. Broadly speaking, these can be classified either as 'push' or 'pull' programs. Hybrid options, that include push and pull incentives, have also become increasingly popular. Supporters and critics of these various incentive schemes have argued in favor of their relative merits and limitations, although the view that no mechanism is a perfect fit for all situations appears to be widely held. For this reason, the debate on the advantages and disadvantages of different approaches has been important for policy decisions, but is dispersed in a variety of sources. With this in mind, the aim of this paper is to contribute to the understanding of the economic determinants behind R&D investments for neglected diseases by comparing the relative strength of different incentive schemes within a simple economic model, based on the assumption of profit maximizing firms. The analysis suggests that co-funded push programs are generally more efficient than pure pull programs. However, by setting appropriate intermediate goals hybrid incentive schemes could further improve efficiency.	[Dimitri, Nicola] Univ Siena, Dept Polit Econ & Stat, I-53100 Siena, Italy; [Dimitri, Nicola] Maastricht Sch Management, Holland, MI USA; [Dimitri, Nicola] IMT Lucca, Lucca, Italy	University of Siena; IMT School for Advanced Studies Lucca	Dimitri, N (corresponding author), Univ Siena, Dept Polit Econ & Stat, Via Laterina 8, I-53100 Siena, Italy.	dimitri@unisi.it						Acemoglu D, 2004, Q J ECON, V119, P1049, DOI 10.1162/0033553041502144; [Anonymous], 2007, OECD HIGH LEV FOR ME; Danzon PM, 2007, NATURE, V449, P176, DOI 10.1038/449176a; Glennerster R., 2006, INNOVATIONS TECHNOLO, V1, P67, DOI [10.1162/itgg.2006.1.1.67, DOI 10.1162/ITGG.2006.1.1.67]; Herrling P, 2008, MAKING DRUGS ACCESSI, P5; Herrling PL, 2009, NAT REV DRUG DISCOV, V8, P91, DOI 10.1038/nrd2818; Konrad K. A., 2009, STRATEGY DYNAMICS CO; Kremer M, 2006, STRONG MED; Love J, 2007, BIG IDEA PRIZES STIM; Maurer S, 2005, DESIGNING COST EFFEC; Maurer SM, 2006, B WORLD HEALTH ORGAN, V84, P376, DOI 10.2471/BLT.06.029835; Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302; Nature Outlook, 2007, NEGLECTED DIS, V449, P157; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Price Waterhouse Coopers, 2007, PHARM 2020 VIS WHICH; Ropars AL, 2005, NEW LANDSCAPE NEGLEC; WHO, 2012, RES DEV MEET HLTH NE	18	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e50835	10.1371/journal.pone.0050835	http://dx.doi.org/10.1371/journal.pone.0050835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284648	Green Submitted, gold, Green Published			2022-12-25	WOS:000312694300012
J	Fleming, JM; Shabir, S; Varley, CL; Kirkwood, LA; White, A; Holder, J; Trejdosiewicz, LK; Southgate, J				Fleming, Jonathan M.; Shabir, Saqib; Varley, Claire L.; Kirkwood, Lisa A.; White, Angela; Holder, Julie; Trejdosiewicz, Ludwik K.; Southgate, Jennifer			Differentiation-Associated Reprogramming of the Transforming Growth Factor beta Receptor Pathway Establishes the Circuitry for Epithelial Autocrine/Paracrine Repair	PLOS ONE			English	Article							HUMAN UROTHELIAL CELLS; UROPLAKIN GENE-EXPRESSION; TGF-BETA; IN-VITRO; URINARY-BLADDER; PPAR-GAMMA; PROLIFERATION	Transforming growth factor (TGF) beta has diverse and sometimes paradoxical effects on cell proliferation and differentiation, presumably reflecting a fundamental but incompletely-understood role in regulating tissue homeostasis. It is generally considered that downstream activity is modulated at the ligand: receptor axis, but microarray analysis of proliferative versus differentiating normal human bladder epithelial cell cultures identified unexpected transcriptional changes in key components of the canonical TGF beta R/activin signalling pathway associated with cytodifferentiation. Changes included upregulation of the transcriptional modulator SMAD3 and downregulation of inhibitory modulators SMURF2 and SMAD7. Functional analysis of the signalling pathway revealed that non-differentiated normal human urothelial cells responded in paracrine mode to TGF beta by growth inhibition, and that exogenous TGF beta inhibited rather than promoted differentiation. By contrast, in differentiated cell cultures, SMAD3 was activated upon scratch-wounding and was involved in promoting tissue repair. Exogenous TGF beta enhanced the repair and resulted in hyperplastic scarring, indicating a feedback loop implicit in an autocrine pathway. Thus, the machinery for autocrine activation of the SMAD3-mediated TGF beta R pathway is established during urothelial differentiation, but signalling occurs only in response to a trigger, such as wounding. Our study demonstrates that the circuitry of the TGF beta R pathway is defined transcriptionally within a tissue-specific differentiation programme. The findings provide evidence for re-evaluating the role of TGF beta R signalling in epithelial homeostasis as an autocrine-regulated pathway that suppresses differentiation and promotes tissue repair. This provides a new paradigm to help unravel the apparently diverse and paradoxical effect of TGF beta signalling on cell proliferation and differentiation.	[Fleming, Jonathan M.; Shabir, Saqib; Varley, Claire L.; Kirkwood, Lisa A.; Trejdosiewicz, Ludwik K.; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England; [White, Angela; Holder, Julie] GlaxoSmithKline R&D, Ware, Herts, England	University of York - UK; GlaxoSmithKline	Southgate, J (corresponding author), Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.	jennifer.southgate@york.ac.uk	Southgate, Jennifer/AAJ-9089-2021	Southgate, Jennifer/0000-0002-0135-480X; Tang, Yaoliang/0000-0002-8372-1545	Biotechnology & Biological Sciences Research Council; GlaxoSmithKline; York Against Cancer	Biotechnology & Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); York Against Cancer	JMF was in receipt of a Biotechnology & Biological Sciences Research Council Industrial CASE studentship with GlaxoSmithKline. JS holds a research chair supported by York Against Cancer. AW and JH are employees of GlaxoSmithKline. The funders did not control the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOMBARA C, 1992, J CELL PHYSIOL, V153, P30, DOI 10.1002/jcp.1041530106; Booth C, 2002, J PATHOL, V198, P359, DOI 10.1002/path.1214; Cross WR, 2005, AM J PHYSIOL-RENAL, V289, pF459, DOI 10.1152/ajprenal.00040.2005; DEBOER WI, 1994, EXP CELL RES, V214, P510, DOI 10.1006/excr.1994.1288; Gaja L, 2012, CURR PHARM DES; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Herrera RE, 1996, MOL BIOL CELL, V7, P1335, DOI 10.1091/mbc.7.9.1335; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Lobban ED, 1998, AM J PATHOL, V153, P1957, DOI 10.1016/S0002-9440(10)65709-4; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Masters, 2003, CULTURE EPITHELIAL C, V8, P381, DOI DOI 10.1002/0471221201.CH12; Olsburgh J, 2003, J PATHOL, V199, P41, DOI 10.1002/path.1252; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; SHINAR DM, 1990, ENDOCRINOLOGY, V126, P3153, DOI 10.1210/endo-126-6-3153; Sillett HK, 2001, IMMUNOLOGY, V102, P310, DOI 10.1046/j.1365-2567.2001.01185.x; SOUTHGATE J, 1994, LAB INVEST, V71, P583; SOUTHGATE J, 1995, CELL ADHES COMMUN, V3, P231, DOI 10.3109/15419069509081289; Southgate J, 2007, BJU INT, V99, P1506, DOI 10.1111/j.1464-410X.2007.06795.x; Sun TT, 1999, ADV EXP MED BIOL, V462, P7; Varley C, 2005, EXP CELL RES, V306, P216, DOI 10.1016/j.yexcr.2005.02.004; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; Varley CL, 2004, AM J PATHOL, V164, P1789, DOI 10.1016/S0002-9440(10)63737-6; Varley CL, 2006, J CELL PHYSIOL, V208, P407, DOI 10.1002/jcp.20676; Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang J, 2002, CANCER RES, V62, P3743; Zi ZK, 2012, FEBS LETT, V586, P1921, DOI 10.1016/j.febslet.2012.03.063	28	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51404	10.1371/journal.pone.0051404	http://dx.doi.org/10.1371/journal.pone.0051404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284691	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300025
J	Aluru, SV; Agarwal, S; Srinivasan, B; Iyer, GK; Rajappa, SM; Tatu, U; Padmanabhan, P; Subramanian, N; Narayanasamy, A				Aluru, Saijyothi Venkata; Agarwal, Shweta; Srinivasan, Bhaskar; Iyer, Geetha Krishnan; Rajappa, Sivakumar M.; Tatu, Utpal; Padmanabhan, Prema; Subramanian, Nirmala; Narayanasamy, Angayarkanni			Lacrimal Proline Rich 4 (LPRR4) Protein in the Tear Fluid Is a Potential Biomarker of Dry Eye Syndrome	PLOS ONE			English	Article							OCULAR SURFACE; SECRETORY IGA; PATTERNS; LACRITIN; DISEASE	Dry eye syndrome (DES) is a complex, multifactorial, immune-associated disorder of the tear and ocular surface. DES with a high prevalence world over needs identification of potential biomarkers so as to understand not only the disease mechanism but also to identify drug targets. In this study we looked for differentially expressed proteins in tear samples of DES to arrive at characteristic biomarkers. As part of a prospective case-control study, tear specimen were collected using Schirmer strips from 129 dry eye cases and 73 age matched controls. 2D electrophoresis (2DE) and Differential gel electrophoresis (DIGE) was done to identify differentially expressed proteins. One of the differentially expressed protein in DES is lacrimal proline rich 4 protein (LPRR4). LPRR4 protein expression was quantified by enzyme immune sorbent assay (ELISA). LPRR4 was down regulated significantly in all types of dry eye cases, correlating with the disease severity as measured by clinical investigations. Further characterization of the protein is required to assess its therapeutic potential in DES.	[Aluru, Saijyothi Venkata; Narayanasamy, Angayarkanni] Sankara Nethralaya, Biochem & Cell Biol Dept, Vis Res Fdn, Madras, Tamil Nadu, India; [Agarwal, Shweta; Srinivasan, Bhaskar; Iyer, Geetha Krishnan; Padmanabhan, Prema] Sankara Nethralaya, Ocular Surface Clin, Med Res Fdn, Madras, Tamil Nadu, India; [Rajappa, Sivakumar M.] Cerebrovasc & Vasculitis Res Fdn, Madras, Tamil Nadu, India; [Tatu, Utpal] Indian Inst Sci IISc, Dept Biochem, Bangalore, Karnataka, India; [Subramanian, Nirmala] Sankara Nethralaya, Med Res Fdn, Oculoplasty Dept, Madras, Tamil Nadu, India	Indian Institute of Science (IISC) - Bangalore	Narayanasamy, A (corresponding author), Sankara Nethralaya, Biochem & Cell Biol Dept, Vis Res Fdn, Madras, Tamil Nadu, India.	drak@snmail.org	Iyer, Geetha/GZA-6085-2022; Narayanasamy, Angayarkanni/ABD-8584-2020	Iyer, Geetha/0000-0002-7903-9500; Tatu, Utpal/0000-0003-0404-8872	Department of Biotechnology (DBT), India [BT/PR/0412/Med/30/82/2008]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work is funded by Department of Biotechnology (DBT), No. BT/PR/0412/Med/30/82/2008, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthi S, 2008, MOL VIS, V14, P500; Assouti M, 2006, BBA-MOL BASIS DIS, V1762, P54, DOI 10.1016/j.bbadis.2005.09.005; Baldini C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-188; BENNICK A, 1971, BIOCHEM J, V123, P455, DOI 10.1042/bj1230455; Boehm N, 2011, INVEST OPHTH VIS SCI, V52, P7725, DOI 10.1167/iovs.11-7266; CARLSON DM, 1993, CRIT REV ORAL BIOL M, V4, P495, DOI 10.1177/10454411930040033401; Choy CKM, 2001, INVEST OPHTH VIS SCI, V42, P3130; DICKINSON DP, 1995, INVEST OPHTH VIS SCI, V36, P2020; Fung KYC, 2004, PROTEOMICS, V4, P3953, DOI 10.1002/pmic.200300849; Galor A, 2011, AM J OPHTHALMOL, V152, P377, DOI 10.1016/j.ajo.2011.02.026; Graham Joanna E, 2007, Invest Ophthalmol Vis Sci, V48, P5616; Gupta N, 2010, ANN TROP MED PARASIT, V104, P247, DOI 10.1179/136485910X12647085215859; Ham BM, 2007, ANAL BIOANAL CHEM, V387, P889, DOI 10.1007/s00216-006-1018-9; HAY DI, 1988, BIOCHEM J, V255, P15, DOI 10.1042/bj2550015; Herber S, 2001, ELECTROPHORESIS, V22, P1838, DOI 10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7; Hjelmervik TOR, 2009, ORAL DIS, V15, P342, DOI 10.1111/j.1601-0825.2009.01531.x; HOLLY FJ, 1977, SURV OPHTHALMOL, V22, P69, DOI 10.1016/0039-6257(77)90087-X; Hoshino Mai, 2006, Nippon Ganka Gakkai Zasshi, V110, P276; Jeong JH, 2011, CORNEA; Kawai S, 2002, ANN CLIN BIOCHEM, V39, P56, DOI 10.1258/0004563021901748; Knop E, 2003, OPHTHALMOLOGE, V100, P917, DOI 10.1007/s00347-003-0935-7; Knop E, 2008, INVEST OPHTH VIS SCI, V49, P2322, DOI 10.1167/iovs.07-0691; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; Lehrer RI, 1998, FEBS LETT, V432, P163, DOI 10.1016/S0014-5793(98)00852-7; Lembach M, 2001, CURR EYE RES, V22, P286, DOI 10.1076/ceyr.22.4.286.5502; Lemp MA, 2007, OCUL SURF, V5, P75; McKown RL, 2009, EXP EYE RES, V88, P848, DOI 10.1016/j.exer.2008.09.002; MORENO EC, 1982, J BIOL CHEM, V257, P2981; OPPENHEIM FG, 1971, BIOCHEMISTRY-US, V10, P4233, DOI 10.1021/bi00799a013; Redl B, 2000, BBA-PROTEIN STRUCT M, V1482, P241, DOI 10.1016/S0167-4838(00)00142-4; Saijyothi AV, 2010, ELECTROPHORESIS, V31, P3420, DOI 10.1002/elps.201000271; Samudre S, 2011, INVEST OPHTH VIS SCI, V52, P6265, DOI 10.1167/iovs.10-6220; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Tervo T, 1997, EXP EYE RES, V64, P501, DOI 10.1006/exer.1996.0226; Tomosugi N, 2005, J PROTEOME RES, V4, P820, DOI 10.1021/pr0497576; Tsai PS, 2006, BRIT J OPHTHALMOL, V90, P372, DOI 10.1136/bjo.2005.080846; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4; Vesaluoma M, 1997, CURR EYE RES, V16, P19, DOI 10.1076/ceyr.16.1.19.5119; WARNER TF, 1988, MED HYPOTHESES, V26, P99, DOI 10.1016/0306-9877(88)90060-6; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wong TT, 2011, INVEST OPHTH VIS SCI; Zhou L, 2003, RAPID COMMUN MASS SP, V17, P401, DOI 10.1002/rcm.925	43	47	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51979	10.1371/journal.pone.0051979	http://dx.doi.org/10.1371/journal.pone.0051979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272196	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000312483300045
J	Cruz, MC; Souza-Melo, N; da Silva, CV; DaRocha, WD; Bahia, D; Araujo, PR; Teixeira, SR; Mortara, RA				Cruz, Mario C.; Souza-Melo, Normanda; da Silva, Claudio Vieira; DaRocha, Wanderson Duarte; Bahia, Diana; Araujo, Patricia R.; Teixeira, Santuza R.; Mortara, Renato A.			Trypanosoma cruzi: Role of delta-Amastin on Extracellular Amastigote Cell Invasion and Differentiation	PLOS ONE			English	Article							FAMILY ENCODING AMASTIN; GENE FAMILY; VIRULENCE EVOLUTION; SURFACE-PROTEINS; PARASITE; INFECTION; BINDING; CHAGAS; TRYPOMASTIGOTES; IDENTIFICATION	Trypanosoma cruzi is a protozoan parasite that comprises different phylogenetic groups and is the causative agent of Chagas' disease. Different T. cruzi strains present differences in infectivity in in vitro and in vivo experimental models, which are likely related to the expression of different virulence factors. Amastin is a surface glycoprotein abundantly expressed on the intracellular mammalian amastigote form of the parasite. In this study, we showed that a highly infective strain (G strain) of extracellular amastigote (EA) invasive forms expressed reduced RNA levels of amastin compared to a less infective strain (CL). The treatment of HeLa cells with recombinant delta-amastin reduced infectivity of EA forms. However, the ectopic expression of delta-amastin accelerated amastigote differentiation into trypomastigotes. Corroborating the virulence behavior in association with amastin expression, the EAs overexpressing amastin were precociously and robustly observed in the liver of susceptible mouse strains (A/JUnib), whereas parasitemia was never detected in in vivo assays. This is the first report on the regulatory role of amastin in the course of both in vitro and in vivo T. cruzi infection. Citation: Cruz MC, Souza- Melo N, da Silva CV, DaRocha WD, Bahia D, et al. (2012) Trypanosoma cruzi: Role of delta-Amastin on Extracellular Amastigote Cell Invasion and Differentiation. PLoS ONE 7(12): e51804. doi:10.1371/journal.pone.0051804	[Cruz, Mario C.; Bahia, Diana; Mortara, Renato A.] Escola Paulista Med UNIFESP, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Souza-Melo, Normanda; DaRocha, Wanderson Duarte] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil; [da Silva, Claudio Vieira] Univ Fed Uberlandia, Disciplina Imunol, Inst Ciencias Biomed, BR-38400 Uberlandia, MG, Brazil; [Araujo, Patricia R.; Teixeira, Santuza R.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Parana; Universidade Federal de Uberlandia; Universidade Federal de Minas Gerais	Mortara, RA (corresponding author), Escola Paulista Med UNIFESP, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.	ramortara@unifesp.br	Mortara, Renato A./C-1864-2012; DaRocha, Wanderson Duarte/AAB-9319-2021; da Silva, Claudio Vieira/AAK-1485-2021; DaRocha, Wanderson/A-8918-2013; Bahia, Diana/W-3974-2019	Mortara, Renato A./0000-0002-2311-8349; DaRocha, Wanderson Duarte/0000-0002-8722-5143; da Silva, Claudio Vieira/0000-0002-5052-3139; DaRocha, Wanderson/0000-0002-8722-5143; 	FAPESP [2006/61450-0, 2011/51475-3, 07/50551-2]; CNPq fellowships; Fundacao Araucaria; CAPES/Reuni; PPSUS/MS; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); CAPES/Reuni(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PPSUS/MS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by FAPESP (grants 2006/61450-0 and 2011/51475-3); RAM and ST are recipients of CNPq fellowships; DB is supported by FAPESP (07/50551-2) and is a CNPq fellow. WDDR and NSM were supported by Fundacao Araucaria, CAPES/Reuni, PPSUS/MS and CNPq and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Araujo PR, 2011, PARASITOL INT, V60, P161, DOI 10.1016/j.parint.2011.01.006; Azizi H, 2009, PARASITOLOGY, V136, P723, DOI 10.1017/S0031182009005873; BEHBEHANI K, 1973, PARASITOLOGY, V66, P343, DOI 10.1017/S0031182000045273; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; Burleigh BA, 1998, CURR OPIN MICROBIOL, V1, P461, DOI 10.1016/S1369-5274(98)80066-0; Cerqueira GC, 2008, MOL BIOCHEM PARASIT, V157, P65, DOI 10.1016/j.molbiopara.2007.10.002; Claser C, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-68; da Costa SCG, 2002, HISTOL HISTOPATHOL, V17, P837, DOI 10.14670/HH-17.837; da Silva CV, 2009, MICROBES INFECT, V11, P563, DOI 10.1016/j.micinf.2009.03.007; da Silva CV, 2006, MICROBES INFECT, V8, P2120, DOI 10.1016/j.micinf.2006.03.016; DaRocha WD, 2004, PARASITOL RES, V92, P113, DOI 10.1007/s00436-003-1004-5; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Fernandes AB, 2004, MICROBES INFECT, V6, P460, DOI 10.1016/j.micinf.2004.01.009; Fernandes AB, 2006, PARASITOL RES, V100, P59, DOI 10.1007/s00436-006-0236-6; Fernandes MC, 2007, INT J PARASITOL, V37, P1431, DOI 10.1016/j.ijpara.2007.04.025; Jackson AP, 2010, MOL BIOL EVOL, V27, P33, DOI 10.1093/molbev/msp214; KAHN S, 1995, J EXP MED, V182, P1243, DOI 10.1084/jem.182.5.1243; LEY V, 1988, J EXP MED, V168, P649, DOI 10.1084/jem.168.2.649; Lima FM, 2010, NEW BIOTECHNOL, V27, P837, DOI 10.1016/j.nbt.2010.02.003; Mackinnon MJ, 2008, VACCINE, V26, pC42, DOI 10.1016/j.vaccine.2008.04.012; Maeda FY, 2011, ACTA TROP, V120, P231, DOI 10.1016/j.actatropica.2011.09.001; MCDANIEL JP, 1993, MOL BIOCHEM PARASIT, V57, P213, DOI 10.1016/0166-6851(93)90197-6; Moore DD, 1995, GLOB MOB SURV; Mortara RA, 2005, AN ACAD BRAS CIENC, V77, P77, DOI 10.1590/S0001-37652005000100006; MORTARA RA, 1991, EXP PARASITOL, V73, P1, DOI 10.1016/0014-4894(91)90002-E; Mortara Renato A., 2008, V47, P101; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Neira I, 2002, INT J PARASITOL, V32, P405, DOI 10.1016/S0020-7519(02)00004-8; NOGUEIRA N, 1976, J EXP MED, V143, P1402, DOI 10.1084/jem.143.6.1402; Rafati S, 2006, CLIN VACCINE IMMUNOL, V13, P1104, DOI 10.1128/CVI.00188-06; Rochette A, 2005, MOL BIOCHEM PARASIT, V140, P205, DOI 10.1016/j.molbiopara.2005.01.006; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Rodrigues AA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001598; Salotra P, 2006, MICROBES INFECT, V8, P637, DOI 10.1016/j.micinf.2005.08.018; Santos MAM, 1997, MOL BIOCHEM PARASIT, V86, P1, DOI 10.1016/S0166-6851(96)02840-X; Staquicini DI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000613; Stecconi-Silva RB, 2003, MEM I OSWALDO CRUZ, V98, P953, DOI 10.1590/S0074-02762003000700016; Stober CB, 2006, VACCINE, V24, P2602, DOI 10.1016/j.vaccine.2005.12.012; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737; Wu Y, 2000, MOL BIOCHEM PARASIT, V110, P345, DOI 10.1016/S0166-6851(00)00290-5; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; Yoshida Nobuko, 2008, V47, P82	47	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51804	10.1371/journal.pone.0051804	http://dx.doi.org/10.1371/journal.pone.0051804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272170	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300030
J	Liboska, R; Ligasova, A; Strunin, D; Rosenberg, I; Koberna, K				Liboska, Radek; Ligasova, Anna; Strunin, Dmytro; Rosenberg, Ivan; Koberna, Karel			Most Anti-BrdU Antibodies React with 2 '-Deoxy-5-Ethynyluridine - The Method for the Effective Suppression of This Cross-Reactivity	PLOS ONE			English	Article							DNA-REPLICATION; NUCLEAR-ORGANIZATION; MAMMALIAN-CELLS; S-PHASE	5-Bromo-2'-deoxyuridine (BrdU) and 2'-deoxy-5-ethynyluridine (EdU) are widely used as markers of replicated DNA. While BrdU is detected using antibodies, the click reaction typically with fluorescent azido-dyes is used for EdU localisation. We have performed an analysis of ten samples of antibodies against BrdU with respect to their reactivity with EdU. Except for one sample all the others evinced reactivity with EdU. A high level of EdU persists in nuclear DNA even after the reaction of EdU with fluorescent azido-dyes if the common concentration of dye is used. Although a ten-time increase of azido-dye concentration resulted in a decrease of the signal provided by anti-BrdU antibodies, it also resulted in a substantial increase of the non-specific signal. We have shown that this unwanted reactivity is effectively suppressed by non-fluorescent azido molecules. In this respect, we have tested two protocols of the simultaneous localisation of incorporated BrdU and EdU. They differ in the mechanism of the revelation of incorporated BrdU for the reaction with antibodies. The first one was based on the use of hydrochloric acid, the second one on the incubation of samples with copper(I) ions. The use of hydrochloric acid resulted in a significant increase of the non-specific signal. In the case of the second method, no such effect was observed.	[Ligasova, Anna; Strunin, Dmytro; Koberna, Karel] ASCR, Inst Biophys, Dept Mol Cytol & Cytometry, Vvi, Brno, Czech Republic; [Liboska, Radek; Rosenberg, Ivan] ASCR, Oligonucleotide Grp, Inst Organ Chem & Biochem, Vvi, Prague, Czech Republic; [Ligasova, Anna; Strunin, Dmytro; Koberna, Karel] ASCR, Dept RNA Biol, Inst Mol Genet, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Ligasova, A (corresponding author), ASCR, Inst Biophys, Dept Mol Cytol & Cytometry, Vvi, Brno, Czech Republic.	ligasova@gmail.com	Liboska, Radek/I-5715-2014; KOBERNA, Karel/G-5551-2019; Rosenberg, Ivan/G-5602-2014; Ligasová, Anna/P-5460-2015	KOBERNA, Karel/0000-0002-7375-4298; Ligasová, Anna/0000-0002-1564-3768	Czech Science Foundation [204/09/0973, P302/12/G157]; Grant Agency of the Academy of Sciences of the Czech Republic [KAN 200520801, AV0Z50520514, AV0Z50040702]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic)	This work has been supported by the Czech Science Foundation (204/09/0973, P302/12/G157) and the Grant Agency of the Academy of Sciences of the Czech Republic (KAN 200520801, AV0Z50520514 and AV0Z50040702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; BARR PJ, 1981, J MED CHEM, V24, P1385, DOI 10.1021/jm00144a003; BEHRENS CH, 1985, J ORG CHEM, V50, P5696, DOI 10.1021/jo00350a051; Bradford JA, 2011, CURR PROTOC CYTOM, V55, P1; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Ligasova A, 2012, PLOS ONE IN PRESS; Ligasova A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq619; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Qu DZ, 2011, ANAL BIOCHEM, V417, P112, DOI 10.1016/j.ab.2011.05.037; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Stanojcic S, 2008, MOL CELL BIOL, V28, P5265, DOI 10.1128/MCB.00181-08; Wu JC, 2010, J ORG CHEM, V75, P8604, DOI 10.1021/jo1019267	16	42	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51679	10.1371/journal.pone.0051679	http://dx.doi.org/10.1371/journal.pone.0051679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272138	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300023
J	Wang, YJ; van der Walt, A; Paine, M; Klistorner, A; Butzkueven, H; Egan, GF; Kilpatrick, TJ; Kolbe, SC				Wang, Yejun; van der Walt, Anneke; Paine, Mark; Klistorner, Alexander; Butzkueven, Helmut; Egan, Gary F.; Kilpatrick, Trevor J.; Kolbe, Scott C.			Optic Nerve Magnetisation Transfer Ratio after Acute Optic Neuritis Predicts Axonal and Visual Outcomes	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS BRAIN; CONTRAST LETTER ACUITY; COHERENCE TOMOGRAPHY; DYSFUNCTION; LESIONS; MYELIN; MRI	Magnetisation transfer ratio (MTR) can reveal the degree of proton exchange between free water and macromolecules and was suggested to be pathological informative. We aimed to investigate changes in optic nerve MTR over 12 months following acute optic neuritis (ON) and to determine whether MTR measurements can predict clinical and paraclinical outcomes at 6 and 12 months. Thirty-seven patients with acute ON were studied within 2 weeks of presentation and at 1, 3, 6 and 12 months. Assessments included optic nerve MTR, retinal nerve fibre layer (RNFL) thickness, multifocal visual evoked potential (mfVEP) amplitude and latency and high (100%) and low (2.5%) contrast letter acuity. Eleven healthy controls were scanned twice four weeks apart for comparison with patients. Patient unaffected optic nerve MTR did not significantly differ from controls at any time-point. Compared to the unaffected nerve, affected optic nerve MTR was significantly reduced at 3 months (mean percentage interocular difference = -9.24%, p = 0.01), 6 months (mean = -12.48%, p<0.0001) and 12 months (mean = -7.61%, p = 0.003). Greater reduction in MTR at 3 months in patients was associated with subsequent loss of high contrast letter acuity at 6 (rho = 0.60, p = 0.0003) and 12 (rho = 0.44, p = 0.009) months, low contrast letter acuity at 6 (rho = 0.35, p = 0.047) months, and RNFL thinning at 12 (rho = 0.35, p = 0.044) months. Stratification of individual patient MTR time courses based on flux over 12 months (stable, putative remyelination and putative degeneration) predicted RNFL thinning at 12 months (F-2,F-32 = 3.59, p = 0.02). In conclusion, these findings indicate that MTR flux after acute ON is predictive of axonal degeneration and visual disability outcomes.	[Wang, Yejun; van der Walt, Anneke; Kilpatrick, Trevor J.; Kolbe, Scott C.] Univ Melbourne, Ctr Neurosci Res, Parkville, Vic 3052, Australia; [Butzkueven, Helmut] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia; [van der Walt, Anneke; Butzkueven, Helmut; Kilpatrick, Trevor J.] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia; [Paine, Mark] Royal Victoria Eye & Ear Hosp, Melbourne, Vic, Australia; [Klistorner, Alexander] Sydney Eye Hosp, Sydney, NSW, Australia; [Egan, Gary F.] Monash Univ, Clayton, Vic, Australia	University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Royal Victorian Eye & Ear Hospital; Monash University	Kolbe, SC (corresponding author), Univ Melbourne, Ctr Neurosci Res, Parkville, Vic 3052, Australia.	kolbes@unimelb.edu.au	Egan, Gary F./A-1381-2013	Butzkueven, Helmut/0000-0003-3940-8727; Klistorner, Alexander/0000-0003-0361-6399; Egan, Gary/0000-0002-3186-4026; Kilpatrick, Trevor/0000-0003-3999-085X; Kolbe, Scott/0000-0003-4685-1380	National MS Society [RG4211A4/2]; National Health and Medical Research Council of Australia [628415]; Bayer Australia; Biogen Idec; Merck Serono; GlaxoSmithKline; Sanofi Aventis; Novartis; Bayer Schering pharma	National MS Society(National Multiple Sclerosis Society); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Bayer Australia; Biogen Idec(Biogen); Merck Serono(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Sanofi Aventis(Sanofi-Aventis); Novartis(Novartis); Bayer Schering pharma(Bayer AG)	This research was supported by the National MS Society (grant RG4211A4/2#) and the National Health and Medical Research Council of Australia (grant 628415). The authors received small unrestricted grants from Bayer Australia, Biogen Idec, Merck Serono and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. van der Walt has received travel support from Bayer Australia and Sanofi Aventis. She has received unrestricted grants from Bayer Asutralia and Biogen Idec. Dr. Klistorner is supported by an unrestricted grant from Biogen Idec. Dr. Butzkueven has served on scientific advisory boards for Biogen Idec, Novartis and Sanofi-Aventis and has received conference travel support from Novartis, Biogen Idec and Sanofi Aventis. He serves on steering committees for trials conducted by Merck Serono, Biogen Idec and Novartis. Dr. Butzkueven has received research support from Merck Serono, Novartis and Biogen Idec in his capacity as honorary chair of the MSBase Foundation. Dr. Kilpatrick has served on scientific advisory boards for GlaxoSmithKline, Neurosciences Victoria and the Victorian Neurotrauma Initiative; has received funding for travel from Bayer Schering pharma, Sanofi Aventis and Merck Serono; served on the editorial board of Therapeutic Advances in Neurological Disorders; is listed as an inventor on patents re: HIV test kit method for detecting anti-HIV-1 antibodies in saliva; A method of modulating cell survival and reagents useful for the same; Methods for the treatment and prophylaxis of demyelinating disease; and Method of treatment in the field of inflammatory neurodegeneration; and receives research support from Bayer Schering Pharma, Biogen IDEC. Dr. Egan serves on an ARC college of experts panel for which he receives personal compensation, he is a member of the Neurosciences Victoria scientific advisory board; he has received travel expenses and/or honoraria for lectures or educational activities not funded by industry; he is an associate editor of Human Brain Mapping, he serves on the editorial boards of Neuroimage and the Journal of Imaging Technology.	Baier ML, 2005, NEUROLOGY, V64, P992, DOI 10.1212/01.WNL.0000154521.40686.63; Balcer LJ, 2003, NEUROLOGY, V61, P1367, DOI 10.1212/01.WNL.0000094315.19931.90; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; Fraser CL, 2006, OPHTHALMOLOGY, V113, P315, DOI 10.1016/j.ophtha.2005.10.017; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; HALLIDAY AM, 1972, LANCET, V1, P982; Hickman SJ, 2004, BRAIN, V127, P692, DOI 10.1093/brain/awh076; Klistorner A, 2011, NEUROIMAGE, V56, P21, DOI 10.1016/j.neuroimage.2011.02.041; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Klistorner A, 2007, INVEST OPHTH VIS SCI, V48, P4549, DOI 10.1167/iovs.07-0381; Klistorner A, 2009, DOC OPHTHALMOL, V118, P129, DOI 10.1007/s10633-008-9147-4; Kolappan M, 2009, J NEUROL, V256, P305, DOI 10.1007/s00415-009-0123-z; Melzi L, 2007, MULT SCLER, V13, P265, DOI 10.1177/1352458506071212; O'Riordan JI, 1998, BRAIN, V121, P495, DOI 10.1093/brain/121.3.495; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; REGAN D, 1977, BRAIN, V100, P563, DOI 10.1093/brain/100.3.563; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Schmierer K, 2007, J MAGN RESON IMAGING, V26, P41, DOI 10.1002/jmri.20984; THORPE JW, 1995, J NEUROL NEUROSUR PS, V59, P487, DOI 10.1136/jnnp.59.5.487; Trip S, 2007, MULT SCLER J, V13, P875, DOI 10.1177/1352458507076952; Trip SA, 2006, NEUROIMAGE, V31, P286, DOI 10.1016/j.neuroimage.2005.11.051; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113	28	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52291	10.1371/journal.pone.0052291	http://dx.doi.org/10.1371/journal.pone.0052291			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272235	Green Published, gold			2022-12-25	WOS:000312483300077
J	Ichise, T; Yoshida, N; Ichise, H				Ichise, Taeko; Yoshida, Nobuaki; Ichise, Hirotake			Ras/MAPK Signaling Modulates VEGFR-3 Expression through Ets-Mediated p300 Recruitment and Histone Acetylation on the Vegfr3 Gene in Lymphatic Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-C; TRANSCRIPTION FACTORS; KAPOSI-SARCOMA; MOUSE EMBRYOS; PROX1; LYMPHANGIOGENESIS; KINASE; PHOSPHORYLATION; ANGIOGENESIS; INFLAMMATION	Modulation of VEGFR-3 expression is important for altering lymphatic endothelial cell (LEC) characteristics during the lymphangiogenic processes that occur under developmental, physiological, and pathological conditions. However, the mechanisms underlying the modulation of Vegfr3 gene expression remain largely unknown. Using genetically engineered mice and LECs, we demonstrated previously that Ras signaling is involved not only in VEGFR-3-induced signal transduction but also in Vegfr3 gene expression. Here, we investigated the roles of the transcription factor Ets and the histone acetyltransferase p300 in LECs in Ras-mediated transcriptional regulation of Vegfr3. Ras activates Ets proteins via MAPK-induced phosphorylation. Ets knockdown, similar to Ras knockdown, resulted in a decrease in both Vegfr3 transcript levels and acetylated histone H3 on the Vegfr3 gene. Vegfr3 knockdown results in altered LEC phenotypes, such as aberrant cell proliferation and network formation, and Ets knockdown led to milder but similar phenotypic changes. We identified evolutionarily conserved, non-coding regulatory elements within the Vegfr3 gene that harbor Ets-binding motifs and have enhancer activities in LECs. Chromatin immunoprecipitation (ChIP) assays revealed that acetylated histone H3 on the regulatory elements of the Vegfr3 gene was decreased following Ras and Ets knockdown, and that activated Ets proteins, together with p300, were associated with these regulatory elements, consistent with a reduction in Vegfr3 gene expression in p300-knockdown LECs. Our findings demonstrate a link between Ras signaling and Ets- and p300-mediated transcriptional regulation of Vegfr3, and provide a potential mechanism by which VEGFR-3 expression levels may be modulated during lymphangiogenesis.	[Ichise, Taeko; Yoshida, Nobuaki; Ichise, Hirotake] Univ Tokyo, Lab Dev Genet, Ctr Expt Med & Syst Biol, Inst Med Sci,Minato Ku, Tokyo, Japan	University of Tokyo	Ichise, H (corresponding author), Univ Tokyo, Lab Dev Genet, Ctr Expt Med & Syst Biol, Inst Med Sci,Minato Ku, Tokyo, Japan.	h-ichise@ims.u-tokyo.ac.jp	Ichise, Hirotake/V-3536-2019	Ichise, Hirotake/0000-0002-3424-6637; Ichise, Taeko/0000-0002-1441-1463	Japan Society for the Promotion of Science; "Center of Education and Research for the Advanced Genome-Based Medicine - For personalized medicine and the control of worldwide infectious diseases'', MEXT, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); "Center of Education and Research for the Advanced Genome-Based Medicine - For personalized medicine and the control of worldwide infectious diseases'', MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Japan Society for the Promotion of Science (to TI. and HI) and in part by the Global COE Program "Center of Education and Research for the Advanced Genome-Based Medicine - For personalized medicine and the control of worldwide infectious diseases'', MEXT, Japan (to NY and HI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Chen L, 2010, J CELL BIOL, V189, P417, DOI 10.1083/jcb.200912037; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Haiko P, 2008, MOL CELL BIOL, V28, P4843, DOI 10.1128/MCB.02214-07; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hong YK, 2004, NAT GENET, V36, P683, DOI 10.1038/ng1383; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Huang HY, 2001, LAB INVEST, V81, P1729, DOI 10.1038/labinvest.3780386; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Iljin K, 2001, FASEB J, V15, P1028, DOI 10.1096/fj.00-0383com; Jones D, 2012, ARTERIOSCL THROM VAS, V32, P633, DOI 10.1161/ATVBAHA.111.243576; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Lapinski PE, 2012, J CLIN INVEST, V122, P733, DOI 10.1172/JCI46116; Lee S, 2009, BLOOD, V113, P1856, DOI 10.1182/blood-2008-03-145789; Meadows SM, 2011, SEMIN CELL DEV BIOL, V22, P976, DOI 10.1016/j.semcdb.2011.09.009; Mishima K, 2007, MOL BIOL CELL, V18, P1421, DOI 10.1091/mbc.E06-09-0780; Nelson ML, 2010, P NATL ACAD SCI USA, V107, P10026, DOI 10.1073/pnas.0915137107; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pan MR, 2009, J CELL SCI, V122, P3358, DOI 10.1242/jcs.050005; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Pytowski B, 2005, JNCI-J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003; Shawber CJ, 2007, J CLIN INVEST, V117, P3369, DOI 10.1172/JCI24311; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Yamaguchi T, 2008, FEBS J, V275, P1988, DOI 10.1111/j.1742-4658.2008.06353.x; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yoshimatsu Y, 2011, J CELL SCI, V124, P2753, DOI 10.1242/jcs.083998; Zhang LQ, 2010, CELL RES, V20, P1319, DOI 10.1038/cr.2010.116	42	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51639	10.1371/journal.pone.0051639	http://dx.doi.org/10.1371/journal.pone.0051639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284731	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900037
J	Saha, RK; Karmakar, S; Roy, M				Saha, Ratan K.; Karmakar, Subhajit; Roy, Madhusudan			Computational Investigation on the Photoacoustics of Malaria Infected Red Blood Cells	PLOS ONE			English	Article							HEMOZOIN PRODUCTION; DIAGNOSIS	A computer simulation study on the possibility of using photoacoustic (PA) technique to differentiate intraerythrocytic stages of malarial parasite is reported. This parasite during its development substantially converts hemoglobin into hemozoin. This conversion is expected to alter the cellular absorption leading to changes in the PA emission of a red blood cell (RBC) at certain incident optical wavelengths. The PA signals from blood samples corresponding to ring, trophozoite and schizont stages were computed and compared with that of normal blood. A Monte Carlo algorithm was implemented generating random locations of RBCs in 3D to simulate blood samples. The average PA amplitude for wide bandwidth signals decreases for 434 nm incident radiation, but increases for 700 nm as the parasite matures. The spectral power at 7.5 MHz for the blood sample at the schizont stage compared to the normal blood is nearly reduced by 6 dB and enhanced by 22 dB at those incident wavelengths, respectively. Bandlimited signals for transducers of 15 and 50 MHz center frequencies were studied and found to exhibit similar characteristics. The presence of hemozoin inside the cells was examined and an excellent estimation was made. The simulation results suggest that intraerythrocytic stages of malarial parasite may be assessed using the PA technique. Citation: Saha RK, Karmakar S, Roy M (2012) Computational Investigation on the Photoacoustics of Malaria Infected Red Blood Cells. PLoS ONE 7(12): e51774. doi:10.1371/journal.pone.0051774	[Saha, Ratan K.] Saha Inst Nucl Phys, Ratan K Saha Appl Mat Sci Div, Kolkata, W Bengal, India; [Karmakar, Subhajit] Saha Inst Nucl Phys, Subhajit Karmakar Appl Nucl Phys Div, Kolkata, W Bengal, India; [Roy, Madhusudan] Saha Inst Nucl Phys, Madhusudan Roy Appl Mat Sci Div, Kolkata, W Bengal, India	Saha Institute of Nuclear Physics; Saha Institute of Nuclear Physics; Saha Institute of Nuclear Physics	Saha, RK (corresponding author), Saha Inst Nucl Phys, Ratan K Saha Appl Mat Sci Div, Kolkata, W Bengal, India.	ratank.saha@saha.ac.in						BALASUBRAMANIAN D, 1984, SCIENCE, V223, P828, DOI 10.1126/science.6695185; BALASUBRAMANIAN D, 1983, BIOSCIENCE REP, V3, P981, DOI 10.1007/BF01121025; Belisle JM, 2008, BIOPHYS J, V94, pL26, DOI 10.1529/biophysj.107.125443; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; BERRYMAN JG, 1983, PHYS REV A, V27, P1053, DOI 10.1103/PhysRevA.27.1053; Bracewell RN, 2003, FOURIER TRANSFORM IT, P329; Diebold GJ, 2009, OPT SCI ENG-CRC, V144, P3; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; FITCH CD, 1987, J BIOL CHEM, V262, P15552; Fox S. I., 2008, HUMAN PHYSL, P388; HINRICHSEN EL, 1990, PHYS REV A, V41, P4199, DOI 10.1103/PhysRevA.41.4199; Hysi E, 2012, BIOMED OPT EXPRESS, V3, P2326, DOI 10.1364/BOE.3.002326; Ishimaru A, 1978, WAVE PROPAGATION SCA, P69; JODREY WS, 1985, PHYS REV A, V32, P2347, DOI 10.1103/PhysRevA.32.2347; Makler MT, 1998, ANN TROP MED PARASIT, V92, P419, DOI 10.1080/00034989859401; MURRAY CK, 2009, INTERDISCIP PERSPECT; Newman DM, 2008, BIOPHYS J, V95, P994, DOI 10.1529/biophysj.107.128140; NORRIS CL, 1993, BIOPHYS J, V65, P1660, DOI 10.1016/S0006-3495(93)81223-2; ORJIH AU, 1993, BIOCHIM BIOPHYS ACTA, V1157, P270, DOI 10.1016/0304-4165(93)90109-L; Orjih AU, 2001, EXP BIOL MED, V226, P746, DOI 10.1177/153537020222600806; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; Prahl S., TABULATED DATA VARIO; Saha RK, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.055002; Saha RK, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3655355; Saha RK, 2011, IEEE T ULTRASON FERR, V58, P2118, DOI 10.1109/TUFFC.2011.2061; Saha RK, 2011, J ACOUST SOC AM, V129, P2935, DOI 10.1121/1.3570946; Saha RK, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061919; Samson EB, 2012, J OPTICS-UK, V14, DOI 10.1088/2040-8978/14/6/065302; SHUNG KK, 1984, J ACOUST SOC AM, V75, P1265, DOI 10.1121/1.390733; Shung KK, 1993, ULTRASOUND SCATTERIN, P1; Szabo TL, 2004, DIAGNOSTIC ULTRASOUN, P97; Toubal M, 1999, PHYS MED BIOL, V44, P1277, DOI 10.1088/0031-9155/44/5/313; Wang LV, 2008, MED PHYS, V35, P5758, DOI 10.1118/1.3013698; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	36	22	24	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51774	10.1371/journal.pone.0051774	http://dx.doi.org/10.1371/journal.pone.0051774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272166	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800082
J	Bao, B; Ali, S; Ahmad, A; Azmi, AS; Li, YW; Banerjee, S; Kong, DJ; Sethi, S; Aboukameel, A; Padhye, SB; Sarkar, FH				Bao, Bin; Ali, Shadan; Ahmad, Aamir; Azmi, Asfar S.; Li, Yiwei; Banerjee, Sanjeev; Kong, Dejuan; Sethi, Seema; Aboukameel, Amro; Padhye, Subhash B.; Sarkar, Fazlul H.			Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment	PLOS ONE			English	Article							PROSTATE-CANCER; STEM-CELLS; DRUG-RESISTANCE; CLINICAL-TRIALS; TUMOR HYPOXIA; ANALOG CDF; CURCUMIN; MICRORNAS; GROWTH; INTERLEUKIN-6	Hypoxia is known to play critical roles in cell survival, angiogenesis, tumor invasion, and metastasis. Hypoxia mediated overexpression of hypoxia-inducible factor (HIF) has been shown to be associated with therapeutic resistance, and contributes to poor prognosis of cancer patients. Emerging evidence suggest that hypoxia and HIF pathways contributes to the acquisition of epithelial-to-mesenchymal transition (EMT), maintenance of cancer stem cell (CSC) functions, and also maintains the vicious cycle of inflammation-all which lead to therapeutic resistance. However, the precise molecular mechanism(s) by which hypoxia/HIF drives these events are not fully understood. Here, we show, for the first time, that hypoxia leads to increased expression of VEGF, IL-6, and CSC signature genes Nanog, Oct4 and EZH2 consistent with increased cell migration/invasion and angiogenesis, and the formation of pancreatospheres, concomitant with increased expression of miR-21 and miR-210 in human pancreatic cancer (PC) cells. The treatment of PC cells with CDF, a novel synthetic compound inhibited the production of VEGF and IL-6, and down-regulated the expression of Nanog, Oct4, EZH2 mRNAs, as well as miR-21 and miR-210 under hypoxia. CDF also led to decreased cell migration/invasion, angiogenesis, and formation of pancreatospheres under hypoxia. Moreover, CDF decreased gene expression of miR-21, miR-210, IL-6, HIF-1 alpha, VEGF, and CSC signatures in vivo in a mouse orthotopic model of human PC. Collectively, these results suggest that the anti-tumor activity of CDF is in part mediated through deregulation of tumor hypoxic pathways, and thus CDF could become a novel, and effective anti-tumor agent for PC therapy. Citation: Bao B, Ali S, Ahmad A, Azmi AS, Li Y, et al. (2012) Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment. PLoS ONE 7(12): e50165. doi:10.1371/journal.pone.0050165	[Bao, Bin; Ahmad, Aamir; Azmi, Asfar S.; Li, Yiwei; Banerjee, Sanjeev; Kong, Dejuan; Sethi, Seema; Aboukameel, Amro; Sarkar, Fazlul H.] Wayne State Univ, Karmanos Canc Inst, Dept Pathol, Detroit, MI 48202 USA; [Ali, Shadan; Sarkar, Fazlul H.] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI USA; [Padhye, Subhash B.] Abeda Inamdar Senior Coll Arts Sci & Commerce, MCE Soc, ISTRA, Dept Chem, Pune, Maharashtra, India	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Sarkar, FH (corresponding author), Wayne State Univ, Karmanos Canc Inst, Dept Pathol, Detroit, MI 48202 USA.	fsarkar@med.wayne.edu	Ahmad, Aamir/E-8747-2010	Ahmad, Aamir/0000-0003-1784-5723; AZMI, ASFAR/0000-0003-1178-9505	National Cancer Institute, National Institutes of Health [R01CA131151, R01CA132794, R01CA154321]; Department of Defense Exploration-Hypothesis Development Award [PC101482]; NATIONAL CANCER INSTITUTE [P30CA022453, R01CA131151, R01CA132794, R01CA154321, R01CA140314] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Exploration-Hypothesis Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute, National Institutes of Health grants R01CA131151, R01CA132794 and R01CA154321 awarded to FHS, and Department of Defense Exploration-Hypothesis Development Award PC101482 awarded to Bin Bao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Bao B, 2012, CANC PREV RES PHILA; Bao B, 2012, BIOCH BIOPHYS ACTA; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Conze D, 2001, CANCER RES, V61, P8851; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jubb AM, 2010, J CELL MOL MED, V14, P18, DOI 10.1111/j.1582-4934.2009.00944.x; Kondo S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-268; Kong D, 2008, CANCER RES, V68, P1927, DOI 10.1158/0008-5472.CAN-07-3241; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, CELL CYCLE, V6, P1426; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; MOULDER JE, 1987, CANCER METAST REV, V5, P313, DOI 10.1007/BF00055376; Mukherjee PK, 2011, PHYTOMEDICINE, V19, P64, DOI 10.1016/j.phymed.2011.10.003; Narayan S, 2004, J MOL HISTOL, V35, P301, DOI 10.1023/B:HIJO.0000032361.98815.bb; Nie Y, 2011, INT J BIOL SCI, V7, P762, DOI 10.7150/ijbs.7.762; Nilsson CL, 2010, J PROTEOME RES, V9, P430, DOI 10.1021/pr9007927; Padhye S, 2010, MINI-REV MED CHEM, V10, P372, DOI 10.2174/138955710791330891; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004; Pocock R, 2011, PFLUG ARCH EUR J PHY, V461, P307, DOI 10.1007/s00424-010-0910-5; Quero L, 2011, RADIOTHER ONCOL; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Sarkar FH, 2010, CURR PHARM DESIGN, V16, P1801, DOI 10.2174/138161210791208956; Sarkar FH, 2009, CANCER TREAT REV, V35, P597, DOI 10.1016/j.ctrv.2009.07.001; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wang ZW, 2008, LIFE SCI, V83, P293, DOI 10.1016/j.lfs.2008.06.017; Wang ZW, 2011, J CELL BIOCHEM, V112, P78, DOI 10.1002/jcb.22770; Yi H, 2012, KOREAN J PHYSIOL PHA, V16, P11, DOI 10.4196/kjpp.2012.16.1.11	50	114	118	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50165	10.1371/journal.pone.0050165	http://dx.doi.org/10.1371/journal.pone.0050165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272057	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386600008
J	Fanin, N; Barantal, S; Fromin, N; Schimann, H; Schevin, P; Hattenschwiler, S				Fanin, Nicolas; Barantal, Sandra; Fromin, Nathalie; Schimann, Heidy; Schevin, Patrick; Haettenschwiler, Stephan			Distinct Microbial Limitations in Litter and Underlying Soil Revealed by Carbon and Nutrient Fertilization in a Tropical Rainforest	PLOS ONE			English	Article							PHOSPHORUS LIMITATION; NITROGEN ADDITIONS; TEMPERATURE SENSITIVITY; COMMUNITY COMPOSITION; ELEVATED CO2; DECOMPOSITION; RESPIRATION; ECOSYSTEM; CLIMATE; DIVERSITY	Human-caused alterations of the carbon and nutrient cycles are expected to impact tropical ecosystems in the near future. Here we evaluated how a combined change in carbon (C), nitrogen (N) and phosphorus (P) availability affects soil and litter microbial respiration and litter decomposition in an undisturbed Amazonian rainforest in French Guiana. In a fully factorial C (as cellulose), N (as urea), and P (as phosphate) fertilization experiment we analyzed a total of 540 litterbag-soil pairs after a 158-day exposure in the field. Rates of substrate-induced respiration (SIR) measured in litter and litter mass loss were similarly affected by fertilization showing the strongest stimulation when N and P were added simultaneously. The stimulating NP effect on litter SIR increased considerably with increasing initial dissolved organic carbon (DOC) concentrations in litter, suggesting that the combined availability of N, P, and a labile C source has a particularly strong effect on microbial activity. Cellulose fertilization, however, did not further stimulate the NP effect. In contrast to litter SIR and litter mass loss, soil SIR was reduced with N fertilization and showed only a positive effect in response to P fertilization that was further enhanced with additional C fertilization. Our data suggest that increased nutrient enrichment in the studied Amazonian rainforest can considerably change microbial activity and litter decomposition, and that these effects differ between the litter layer and the underlying soil. Any resulting change in relative C and nutrient fluxes between the litter layer and the soil can have important consequences for biogeochemical cycles in tropical forest ecosystems. Citation: Fanin N, Barantal S, Fromin N, Schimann H, Schevin P, et al. (2012) Distinct Microbial Limitations in Litter and Underlying Soil Revealed by Carbon and Nutrient Fertilization in a Tropical Rainforest. PLoS ONE 7(12): e49990. doi: 10.1371/journal.pone.0049990	[Fanin, Nicolas; Barantal, Sandra; Fromin, Nathalie; Schevin, Patrick; Haettenschwiler, Stephan] CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France; [Schimann, Heidy] UMR Ecol Forets Guyane EcoFoG, Kourou, French Guiana; [Fanin, Nicolas] Univ Montpellier 2, Montpellier, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Universite de Montpellier	Fromin, N (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France.	nathalie.fromin@cefe.cnrs.fr	Schimann, Heidy/AAN-5252-2020; Fanin, Nicolas/H-5501-2019	Schimann, Heidy/0000-0002-9139-920X; Fanin, Nicolas/0000-0003-4195-855X; Fromin, Nathalie/0000-0003-3752-7503	CNRS "PIR Amazonie II"; CNRS "EC2CO"; French Research and Education Ministry; University of Montpellier II	CNRS "PIR Amazonie II"; CNRS "EC2CO"; French Research and Education Ministry; University of Montpellier II	This research was funded through CNRS "PIR Amazonie II" and "EC2CO" grants. N. Fanin received a Ph. D. grant from the French Research and Education Ministry and from the University of Montpellier II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barantal S, 2012, ECOSYSTEMS, V15, P1039, DOI 10.1007/s10021-012-9564-9; Bates D., 2010, LINEAR MIXED MODEL I; BEARE MH, 1990, SOIL BIOL BIOCHEM, V22, P585, DOI 10.1016/0038-0717(90)90002-H; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; Brown ALP, 2009, MICROB ECOL, V57, P14, DOI 10.1007/s00248-008-9461-0; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Chambers JQ, 2004, ECOL APPL, V14, pS72; Cherif M, 2009, P ROY SOC B-BIOL SCI, V276, P487, DOI 10.1098/rspb.2008.0560; Cleveland CC, 2006, ECOLOGY, V87, P492, DOI 10.1890/05-0525; Cleveland CC, 2002, ECOSYSTEMS, V5, P680, DOI 10.1007/s10021-002-0202-9; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Coq S, 2010, ECOLOGY, V91, P2080, DOI 10.1890/09-1076.1; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Cusack DF, 2011, BIOGEOCHEMISTRY, V104, P203, DOI 10.1007/s10533-010-9496-4; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; Cusack DF, 2010, GLOBAL CHANGE BIOL, V16, P2555, DOI 10.1111/j.1365-2486.2009.02131.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Angelis P, 2000, PLANT SOIL, V224, P31, DOI 10.1023/A:1004790328560; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; ENRIQUEZ S, 1993, OECOLOGIA, V94, P457, DOI 10.1007/BF00566960; Epron D, 2004, FOREST ECOL MANAG, V202, P149, DOI 10.1016/j.foreco.2004.07.019; Fanin N, 2011, SOIL BIOL BIOCHEM, V43, P1014, DOI 10.1016/j.soilbio.2011.01.018; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P2636, DOI 10.1111/j.1365-2486.2012.02719.x; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; GALLARDO A, 1994, SOIL BIOL BIOCHEM, V26, P1409, DOI 10.1016/0038-0717(94)90225-9; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gnankambary Z, 2008, SOIL BIOL BIOCHEM, V40, P350, DOI 10.1016/j.soilbio.2007.08.015; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; Gourlet-Fleury S, 2000, FOREST ECOL MANAG, V131, P269, DOI 10.1016/S0378-1127(99)00212-1; Grace J., 2001, TERRESTRIAL GLOBAL P, P401; Hattenschwiler S, 2008, NEW PHYTOL, V179, P165, DOI 10.1111/j.1469-8137.2008.02438.x; Hattenschwiler S, 2011, NEW PHYTOL, V189, P950, DOI 10.1111/j.1469-8137.2010.03483.x; Hattenschwiler S, 2010, J ECOL, V98, P754, DOI 10.1111/j.1365-2745.2010.01671.x; Hattenschwiler S, 2004, GLOBAL CHANGE BIOL, V10, P1899, DOI 10.1111/j.1365-2486.2004.00856.x; Henry HAL, 2005, OECOLOGIA, V142, P465, DOI 10.1007/s00442-004-1713-1; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; Ilstedt U, 2005, SOIL BIOL BIOCHEM, V37, P1407, DOI 10.1016/j.soilbio.2005.01.002; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Joergensen RG, 1999, SOIL BIOL BIOCHEM, V31, P859, DOI 10.1016/S0038-0717(98)00185-0; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; KORNER C, 1994, OECOLOGIA, V99, P343, DOI 10.1007/BF00627748; Krashevska V, 2010, OIKOS, V119, P1020, DOI 10.1111/j.1600-0706.2009.18169.x; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; McGlynn TP, 2007, BIOTROPICA, V39, P50, DOI 10.1111/j.1744-7429.2006.00241.x; Milcu A, 2011, ECOSYSTEMS, V14, P710, DOI 10.1007/s10021-011-9440-z; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Okin GS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002145; Orwin KH, 2006, ECOLOGY, V87, P580, DOI 10.1890/05-0383; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Pinheiro J., 2011, PACKAGE R SOFTWARE S, P21; Priess JA, 2001, SOIL BIOL BIOCHEM, V33, P503, DOI 10.1016/S0038-0717(00)00191-7; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; Reed SC, 2011, BIOGEOCHEMISTRY, V106, P323, DOI 10.1007/s10533-010-9522-6; Roy J, 2005, NATO SCI S SS IV EAR, V55, P337; Sayer EJ, 2010, SOIL BIOL BIOCHEM, V42, P347, DOI 10.1016/j.soilbio.2009.11.014; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schreeg L, 2012, ECOLOGY IN PRESS; Silver WL, 2005, GLOBAL CHANGE BIOL, V11, P290, DOI 10.1111/j.1365-2486.2005.00903.x; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Talbot JM, 2012, ECOLOGY, V93, P345, DOI 10.1890/11-0843.1; Townsend AR, 2008, TRENDS ECOL EVOL, V23, P424, DOI 10.1016/j.tree.2008.04.009; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Townsend AR, 2011, FRONT ECOL ENVIRON, V9, P9, DOI 10.1890/100047; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Ushio M, 2008, SOIL BIOL BIOCHEM, V40, P2699, DOI 10.1016/j.soilbio.2008.06.023; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wieder WR, 2009, ECOLOGY, V90, P3333, DOI 10.1890/08-2294.1; Yang XD, 2009, SOIL BIOL BIOCHEM, V41, P910, DOI 10.1016/j.soilbio.2008.12.028; Yuste JC, 2005, TREE PHYSIOL, V25, P609, DOI 10.1093/treephys/25.5.609	82	38	38	6	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e49990	10.1371/journal.pone.0049990	http://dx.doi.org/10.1371/journal.pone.0049990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272052	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386600005
J	Jin, L; Zhang, MW; Ma, JD; Zhang, J; Zhou, CW; Liu, YK; Wang, T; Jiang, AA; Chen, L; Wang, JY; Jiang, ZR; Zhu, L; Shuai, SR; Li, RQ; Li, MZ; Li, XW				Jin, Long; Zhang, Mingwang; Ma, Jideng; Zhang, Jie; Zhou, Chaowei; Liu, Yingkai; Wang, Tao; Jiang, An-an; Chen, Lei; Wang, Jinyong; Jiang, Zhongrong; Zhu, Li; Shuai, Surong; Li, Ruiqiang; Li, Mingzhou; Li, Xuewei			Mitochondrial DNA Evidence Indicates the Local Origin of Domestic Pigs in the Upstream Region of the Yangtze River	PLOS ONE			English	Article							MULTIPLE MATERNAL ORIGINS; PHYLOGEOGRAPHIC STRUCTURE; WILD BOARS; DIVERSITY	Previous studies have indicated two main domestic pig dispersal routes in East Asia: one is from the Mekong region, through the upstream region of the Yangtze River (URYZ) to the middle and upstream regions of the Yellow River, the other is from the middle and downstream regions of the Yangtze River to the downstream region of the Yellow River, and then to northeast China. The URYZ was regarded as a passageway of the former dispersal route; however, this assumption remains to be further investigated. We therefore analyzed the hypervariable segements of mitochondrial DNA from 513 individual pigs mainly from Sichuan and the Tibet highlands and 1,394 publicly available sequences from domestic pigs and wild boars across Asia. From the phylogenetic tree, most of the samples fell into a mixed group that was difficult to distinguish by breed or geography. The total network analysis showed that the URYZ pigs possessed a dominant position in haplogroup A and domestic pigs shared the same core haplotype with the local wild boars, suggesting that pigs in group A were most likely derived from the URYZ pool. In addition, a region-wise network analysis determined that URYZ contains 42 haplotypes of which 22 are unique indicating the high diversity in this region. In conclusion, our findings confirmed that pigs from the URYZ were domesticated in situ. Citation: Jin L, Zhang M, Ma J, Zhang J, Zhou C, et al. (2012) Mitochondrial DNA Evidence Indicates the Local Origin of Domestic Pigs in the Upstream Region of the Yangtze River. PLoS ONE 7(12): e51649. doi:10.1371/journal.pone.0051649	[Jin, Long; Zhang, Mingwang; Ma, Jideng; Zhang, Jie; Zhou, Chaowei; Liu, Yingkai; Wang, Tao; Jiang, An-an; Zhu, Li; Shuai, Surong; Li, Mingzhou] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Jiang, Zhongrong] Anim Husb Inst Ganze Tibetan Autonomous Prefectur, Kangding, Sichuan, Peoples R China; [Li, Ruiqiang; Li, Mingzhou] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Li, Ruiqiang; Li, Mingzhou] Peking Univ, Peking Tsinghua Ctr Life Sci, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China	Sichuan Agricultural University; Peking University; Peking University	Li, MZ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China.	mingzhou.li@163.com; xuewei.li@sicau.edu.cn		Li, Mingzhou/0000-0001-8681-7684	Specialized Research Fund of Ministry of Agriculture of China [NYCYTX-009]; Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province [2011YZGG15]; International Science & Technology Cooperation Program of China [2011DFB30340]; National Special Foundation for Transgenic Species of China [2011ZX08006-003]; National Natural Science Foundation of China [30901024]; Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences	Specialized Research Fund of Ministry of Agriculture of China; Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province; International Science & Technology Cooperation Program of China; National Special Foundation for Transgenic Species of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences	This work was supported by grants from the Specialized Research Fund of Ministry of Agriculture of China (NYCYTX-009), the Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province (2011YZGG15), the International Science & Technology Cooperation Program of China (2011DFB30340) and the National Special Foundation for Transgenic Species of China (2011ZX08006-003) to X.L., the National Natural Science Foundation of China (30901024) and the Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences to M.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	B?k?nyi S., 1974, HIST DOMESTIC MAMMAL; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; CLUTTONBROCK J, 1987, NATURAL HIST DOMESTI, P70; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Giuffra E, 2000, GENETICS, V154, P1785; Jing Y, 2002, ANTIQUITY, V76, P724, DOI 10.1017/S0003598X00091171; Jing Y, 2008, ANTIQUITY, V82, P351, DOI 10.1017/S0003598X0009685X; Lai SJ, 2007, ANIM GENET, V38, P77, DOI 10.1111/j.1365-2052.2007.01555.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YP, 2009, J ANIM BREED GENET, V126, P80, DOI 10.1111/j.1439-0388.2008.00737.x; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Lum JK, 2006, P NATL ACAD SCI USA, V103, P17190, DOI 10.1073/pnas.0608220103; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Scandura M, 2011, MAMMAL REV, V41, P125, DOI 10.1111/j.1365-2907.2010.00182.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wei DY, 1982, ARCHAEOLOGY, V2, P181; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245; Yang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028215	32	19	22	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51649	10.1371/journal.pone.0051649	http://dx.doi.org/10.1371/journal.pone.0051649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272130	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386600033
J	Macdonald, IK; Murray, A; Healey, GF; Parsy-Kowalska, CB; Allen, J; McElveen, J; Robertson, C; Sewell, HF; Chapman, CJ; Robertson, JFR				Macdonald, Isabel K.; Murray, Andrea; Healey, Graham F.; Parsy-Kowalska, Celine B.; Allen, Jared; McElveen, Jane; Robertson, Chris; Sewell, Herbert F.; Chapman, Caroline J.; Robertson, John F. R.			Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT (R)-Lung Test	PLOS ONE			English	Article							ALPHA-ENOLASE; AUTOANTIBODY TEST; LUNG-CANCER; EXPRESSION; PROTEIN; CYTOKERATIN-20; IDENTIFICATION; VALIDATION; CELLS; MYC	Background: The National Lung Screening Trial showed that CT screening for lung cancer led to a 20% reduction in mortality. However, CT screening has a number of disadvantages including low specificity. A validated autoantibody assay is available commercially (EarlyCDT (R)-Lung) to aid in the early detection of lung cancer and risk stratification in patients with pulmonary nodules detected by CT. Recent advances in high throughput (HTP) cloning and expression methods have been developed into a discovery pipeline to identify biomarkers that detect autoantibodies. The aim of this study was to demonstrate the successful clinical application of this strategy to add to the EarlyCDT-Lung panel in order to improve its sensitivity and specificity (and hence positive predictive value, (PPV)). Methods and Findings: Serum from two matched independent cohorts of lung cancer patients were used (n = 100 and n = 165). Sixty nine proteins were initially screened on an abridged HTP version of the autoantibody ELISA using protein prepared on small scale by a HTP expression and purification screen. Promising leads were produced in shake flask culture and tested on the full assay. These results were analyzed in combination with those from the EarlyCDT-Lung panel in order to provide a set of re-optimized cut-offs. Five proteins that still displayed cancer/normal differentiation were tested for reproducibility and validation on a second batch of protein and a separate patient cohort. Addition of these proteins resulted in an improvement in the sensitivity and specificity of the test from 38% and 86% to 49% and 93% respectively (PPV improvement from 1 in 16 to 1 in 7). Conclusion: This is a practical example of the value of investing resources to develop a HTP technology. Such technology may lead to improvement in the clinical utility of the EarlyCDT-Lung test, and so further aid the early detection of lung cancer. Citation: Macdonald IK, Murray A, Healey GF, Parsy-Kowalska CB, Allen J, et al. (2012) Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT (R)-Lung Test. PLoS ONE 7(12): e51002. doi:10.1371/journal.pone.0051002	[Macdonald, Isabel K.; Murray, Andrea; Healey, Graham F.; Parsy-Kowalska, Celine B.; Allen, Jared; McElveen, Jane; Sewell, Herbert F.; Chapman, Caroline J.; Robertson, John F. R.] Oncimmune Ltd, City Hosp Nottingham, Nottingham, England; [Robertson, Chris] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Sewell, Herbert F.; Chapman, Caroline J.; Robertson, John F. R.] Univ Nottingham, Ctr Excellence Autoimmun Canc, Nottingham NG7 2RD, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Strathclyde; University of Nottingham	Macdonald, IK (corresponding author), Oncimmune Ltd, City Hosp Nottingham, Nottingham, England.	Isabel.Macdonald@nottingham.ac.uk		Allen, Jared/0000-0002-4061-3704	Oncimmune	Oncimmune	This work was funded by Oncimmune. The funders had no role to play in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BALDWIN RW, 1966, INT J CANCER, V1, P257, DOI 10.1002/ijc.2910010305; Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Canelle L, 2005, J IMMUNOL METHODS, V299, P77, DOI 10.1016/j.jim.2005.01.015; Chapman CJ, 2012, TUMOR BIOL      0411; Desmetz C, 2011, J CELL MOL MED, V15, P2013, DOI 10.1111/j.1582-4934.2011.01355.x; Geyer C, 1999, MARKOV CHAIN MONTE C, P241; HEMBROUGH TA, 1995, J CELL SCI, V108, P1071; Ingvarsson S, 1990, Semin Cancer Biol, V1, P359; Jett JR, 2011, J THORAC ONCOL, V6, pS1387; Krause P, 2003, J IMMUNOL METHODS, V283, P261, DOI 10.1016/j.jim.2003.09.014; Lam S, 2011, CANCER PREV RES, V4, P1126, DOI 10.1158/1940-6207.CAPR-10-0328; Lee KH, 2003, ARTHRITIS RHEUM, V48, P2025, DOI 10.1002/art.11074; Leong AS-Y, 2003, MANUAL DIAGNOSTIC CY, P177; Macdonald IK, 2012, DEV VALIDATION HIGH; MOLL R, 1993, DIFFERENTIATION, V53, P75, DOI 10.1111/j.1432-0436.1993.tb00648.x; MOLL R, 1992, AM J PATHOL, V140, P427; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; Moriya T, 2006, MED MOL MORPHOL, V39, P8, DOI 10.1007/s00795-006-0309-8; Murray A, 2010, ANN ONCOL, V21, P1687, DOI 10.1093/annonc/mdp606; Nahm DH, 2006, J ALLERGY CLIN IMMUN, V118, P376, DOI 10.1016/j.jaci.2006.04.002; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Parsy CB, 2007, J CHROMATOGR B, V853, P314, DOI 10.1016/j.jchromb.2007.03.046; ROBERTSON NG, 1991, NUCLEIC ACIDS RES, V19, P3129, DOI 10.1093/nar/19.11.3129; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; van Klaveren R J, 2009, Eur J Cancer, V45 Suppl 1, P375, DOI 10.1016/S0959-8049(09)70054-1; Yoneda M, 2007, J NEUROIMMUNOL, V185, P195, DOI 10.1016/j.jneuroim.2007.01.018	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51002	10.1371/journal.pone.0051002	http://dx.doi.org/10.1371/journal.pone.0051002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272083	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600016
J	Choudhury, KR; Raychaudhuri, S; Bhattacharyya, NP				Choudhury, Kamalika Roy; Raychaudhuri, Swasti; Bhattacharyya, Nitai P.			Identification of HYPK-Interacting Proteins Reveals Involvement of HYPK in Regulating Cell Growth, Cell Cycle, Unfolded Protein Response and Cell Death	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; HUNTINGTONS-DISEASE; MOLECULAR CHAPERONES; EMBRYONIC LETHALITY; COMPLEX; AGGREGATION; APOPTOSIS; DISORDER; NETWORK; REPEAT	Huntingtin Yeast Two-Hybrid Protein K (HYPK) is an intrinsically unstructured huntingtin (HTT)-interacting protein with chaperone-like activity. To obtain more information about the function(s) of the protein, we identified 27 novel interacting partners of HYPK by pull-down assay coupled with mass spectrometry and, further, 9 proteins were identified by co-localization and co-immunoprecipitation (co-IP) assays. In neuronal cells, (EEF1A1 and HSPA1A), (HTT and LMNB2) and (TP53 and RELA) were identified in complex with HYPK in different experiments. Various Gene Ontology (GO) terms for biological processes, like protein folding (GO: 0006457), response to unfolded protein (GO: 0006986), cell cycle arrest (GO: 0007050), anti-apoptosis (GO: 0006916) and regulation of transcription (GO: 0006355) were significantly enriched with the HYPK-interacting proteins. Cell growth and the ability to refold heat-denatured reporter luciferase were decreased, but cytotoxicity was increased in neuronal cells where HYPK was knocked-down using HYPK antisense DNA construct. The proportion of cells in different phases of cell cycle was also altered in cells with reduced levels of HYPK. These results show that HYPK is involved in several biological processes, possibly through interaction with its partners.	[Choudhury, Kamalika Roy; Raychaudhuri, Swasti; Bhattacharyya, Nitai P.] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India	Saha Institute of Nuclear Physics	Bhattacharyya, NP (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India.	nitai_sinp@yahoo.com	Raychaudhuri, Swasti/AAZ-2748-2020	Roy Choudhury, Kamalika/0000-0003-1298-9875	Department of Atomic Energy (DAE), Govt. of India	Department of Atomic Energy (DAE), Govt. of India(Department of Atomic Energy (DAE))	The Department of Atomic Energy (DAE), Govt. of India, funded this work as Institutional grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza A, 2003, J BIOL CHEM, V278, P27844, DOI 10.1074/jbc.M304522200; Arnesen T, 2010, MOL CELL BIOL, V30, P1898, DOI 10.1128/MCB.01199-09; Bao J, 1996, P NATL ACAD SCI USA, V93, P5037, DOI 10.1073/pnas.93.10.5037; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Bhattacharya D, 2010, PROTEOM CLIN APPL, V4, P480, DOI 10.1002/prca.200900073; Bhattacharyya NP, 2011, HUNTINGTIN INTERACTI, P39; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Ghose J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023837; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hegyi H, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-65; Helmbrecht K, 2000, CELL PROLIFERAT, V33, P341, DOI 10.1046/j.1365-2184.2000.00189.x; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Lane L, 2012, NUCLEIC ACIDS RES, V40, pD76, DOI 10.1093/nar/gkr1179; Majumder P, 2007, CELL MOL NEUROBIOL, V27, P1127, DOI 10.1007/s10571-007-9220-7; Mitsui K, 2002, J NEUROSCI, V22, P9267; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Novoselova TV, 2005, J NEUROCHEM, V94, P597, DOI 10.1111/j.1471-4159.2005.03119.x; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Raychaudhuri S, 2008, PROTEINS, V71, P1686, DOI 10.1002/prot.21856; Raychaudhuri S, 2008, HUM MOL GENET, V17, P240, DOI 10.1093/hmg/ddm301; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wu SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040727; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	40	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51415	10.1371/journal.pone.0051415	http://dx.doi.org/10.1371/journal.pone.0051415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23272104	gold, Green Submitted, Green Published			2022-12-25	WOS:000312201900083
J	O'Meara, JA; Lemke, CT; Godbout, C; Kukolj, G; Lagace, L; Moreau, B; Thibeault, D; White, PW; Llinas-Brunet, M				O'Meara, Jeff A.; Lemke, Christopher T.; Godbout, Cedrickx; Kukolj, George; Lagace, Lisette; Moreau, Benoit; Thibeault, Diane; White, Peter W.; Llinas-Brunet, Montse			Molecular Mechanism by Which a Potent Hepatitis C Virus NS3-NS4A Protease Inhibitor Overcomes Emergence of Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NS3 PROTEASE; PRECLINICAL PROFILE; BILN-2061; BINDING; TMC435; DOMAIN	Although optimizing the resistance profile of an inhibitor can be challenging, it is potentially important for improving the long term effectiveness of antiviral therapy. This work describes our rational approach toward the identification of a macrocyclic acylsulfonamide that is a potent inhibitor of the NS3-NS4A proteases of all hepatitis C virus genotypes and of a panel of genotype 1-resistant variants. The enhanced potency of this compound versus variants D168V and R155K facilitated x-ray determination of the inhibitor-variant complexes. In turn, these structural studies revealed a complex molecular basis of resistance and rationalized how such compounds are able to circumvent these mechanisms.	[O'Meara, Jeff A.; Lemke, Christopher T.; Godbout, Cedrickx; Kukolj, George; Lagace, Lisette; Moreau, Benoit; Thibeault, Diane; White, Peter W.; Llinas-Brunet, Montse] Boehringer Ingelheim Canada Ltd, Res & Dev, Laval, PQ H7S 2G5, Canada	Boehringer Ingelheim	O'Meara, JA (corresponding author), Boehringer Ingelheim Canada Ltd, Res & Dev, Laval, PQ H7S 2G5, Canada.	RESGeneral.lav@boehringer-ingelheim.com	Moreau, Benoit/J-4335-2015	Moreau, Benoit/0000-0003-1591-2312				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berger K., 2012, REV ANTIVIRAL THERAP, V6, P29; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cummings MD, 2010, ANGEW CHEM INT EDIT, V49, P1652, DOI 10.1002/anie.200906696; Di Marco S, 2000, J BIOL CHEM, V275, P7152, DOI 10.1074/jbc.275.10.7152; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hinrichsen H, 2004, GASTROENTEROLOGY, V127, P1347, DOI 10.1053/j.gastro.2004.08.002; IRVINE GB, 1990, ANAL BIOCHEM, V185, P304, DOI 10.1016/0003-2697(90)90298-N; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Lagace L, 2012, ANTIMICROB AGENTS CH, V56, P569, DOI 10.1128/AAC.05166-11; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lemke CT, 2011, J BIOL CHEM, V286, P11434, DOI 10.1074/jbc.M110.211417; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lin TI, 2009, ANTIMICROB AGENTS CH, V53, P1377, DOI 10.1128/AAC.01058-08; Llinas-Brunet M., 2011, U.S. Patent WO, Patent No. [2011/063502 A1, 2011063502]; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; Massariol MJ, 2010, BIOCHEM BIOPH RES CO, V391, P692, DOI 10.1016/j.bbrc.2009.11.122; Mehellou Y, 2010, J MED CHEM, V53, P521, DOI 10.1021/jm900492g; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Muzammil S, 2007, J VIROL, V81, P5144, DOI 10.1128/JVI.02706-06; Nalam MNL, 2010, J VIROL, V84, P5368, DOI 10.1128/JVI.02531-09; Ohtaka H, 2005, PROG BIOPHYS MOL BIO, V88, P193, DOI 10.1016/j.pbiomolbio.2004.07.005; Ozer N, 2010, BIOPHYS J, V99, P1650, DOI 10.1016/j.bpj.2010.06.064; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Romano KP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002832; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Tanwar S, 2012, EXPERT OPIN INV DRUG, V21, P1193, DOI 10.1517/13543784.2012.690392; Thibeault D, 2004, J VIROL, V78, P7352, DOI 10.1128/JVI.78.14.7352-7359.2004; Thibeault D, 2009, BIOCHEMISTRY-US, V48, P744, DOI 10.1021/bi801931e; Tsantrizos YS, 2003, ANGEW CHEM INT EDIT, V42, P1355, DOI 10.1002/anie.200390347; White PW, 2010, ANTIMICROB AGENTS CH, V54, P4611, DOI 10.1128/AAC.00787-10; Yee NK, 2006, J ORG CHEM, V71, P7133, DOI 10.1021/jo060285j	39	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5673	5681		10.1074/jbc.M112.439455	http://dx.doi.org/10.1074/jbc.M112.439455			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23271737	Green Published, hybrid			2022-12-25	WOS:000315342500040
J	Zigdon, H; Kogot-Levin, A; Park, JW; Goldschmidt, R; Kelly, S; Merrill, AH; Scherz, A; Pewzner-Jung, Y; Saada, A; Futerman, AH				Zigdon, Hila; Kogot-Levin, Aviram; Park, Joo-Won; Goldschmidt, Ruth; Kelly, Samuel; Merrill, Alfred H., Jr.; Scherz, Avigdor; Pewzner-Jung, Yael; Saada, Ann; Futerman, Anthony H.			Ablation of Ceramide Synthase 2 Causes Chronic Oxidative Stress Due to Disruption of the Mitochondrial Respiratory Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; QUANTITATIVE-ANALYSIS; LIVER; SPHINGOLIPIDS; METABOLISM; COMPLEX; GENERATION; INHIBITION; APOPTOSIS; SPECIFICITY	Ceramide is a key intermediate in the pathway of sphingolipid biosynthesis and is an important intracellular messenger. We recently generated a ceramide synthase 2 (CerS2) null mouse that cannot synthesize very long acyl chain (C22-C24) ceramides. This mouse displays severe and progressive hepatopathy. Significant changes were observed in the sphingolipid profile of CerS2 null mouse liver, including elevated C16-ceramide and sphinganine levels in liver and in isolated mitochondrial fractions. Because ceramide may be involved in reactive oxygen species (ROS) formation, we examined whether ROS generation was affected in CerS2 null mice. Levels of a number of antioxidant enzymes were elevated, as were lipid peroxidation, protein nitrosylation, and ROS. ROS were generated from mitochondria due to impaired complex IV activity. C16-ceramide, sphingosine, and sphinganine directly inhibited complex IV activity in isolated mitochondria and in mitoplasts, whereas other ceramide species, sphingomyelin, and diacylglycerol were without effect. A fluorescent analog of sphinganine accumulated in mitochondria. Heart mitochondria did not display a substantial alteration in the sphingolipid profile or in complex IV activity. We suggest that C16-ceramide and/or sphinganine induce ROS formation through the modulation of mitochondrial complex IV activity, resulting in chronic oxidative stress. These results are of relevance for understanding modulation of ROS signaling by sphingolipids.	[Zigdon, Hila; Park, Joo-Won; Pewzner-Jung, Yael; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Goldschmidt, Ruth; Scherz, Avigdor] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Kogot-Levin, Aviram; Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Dept Genet & Metab Dis, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Weizmann Institute of Science; Weizmann Institute of Science; Hebrew University of Jerusalem; Hadassah University Medical Center; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	Saada, Ann/J-6864-2017; Pewzner, Faivish/I-6225-2017	Saada, Ann/0000-0003-2951-0656; Pewzner, Faivish/0000-0002-7490-8121; Merrill, Alfred/0000-0002-6673-968X; Futerman, Anthony/0000-0003-0013-0115	National Institutes of Health [GM076217]; Israel Science Foundation [0888/11]; Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217. This work was also supported by the Israel Science Foundation (0888/11) and the Minerva Foundation.	Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Ben-David O, 2011, J BIOL CHEM, V286, P30022, DOI 10.1074/jbc.M111.261206; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Esposti MD, 2002, METHODS, V26, P335, DOI 10.1016/S1046-2023(02)00039-7; Flock G, 2007, DIABETES, V56, P3006, DOI 10.2337/db07-0697; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hardman MJ, 2008, ENDOCRINOLOGY, V149, P551, DOI 10.1210/en.2007-1042; HASINOFF BB, 1989, BIOCHEM J, V258, P101, DOI 10.1042/bj2580101; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; HOFF HF, 1993, J LIPID RES, V34, P1209; Idkowiak-Baldys J, 2010, BIOCHEM J, V427, P265, DOI 10.1042/BJ20091589; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Kim HJ, 2012, J LIPID RES, V53, P1701, DOI 10.1194/jlr.D025627; Kroesen BJ, 2003, J BIOL CHEM, V278, P14723, DOI 10.1074/jbc.M210756200; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Laskin JD, 2010, ANN NY ACAD SCI, V1203, P92, DOI 10.1111/j.1749-6632.2010.05605.x; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Li X, 2010, CELL PHYSIOL BIOCHEM, V26, P41, DOI 10.1159/000315104; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mansat-De Mas V, 1999, MOL PHARMACOL, V56, P867, DOI 10.1124/mol.56.5.867; Mattson MP, 2009, EXP GERONTOL, V44, P625, DOI 10.1016/j.exger.2009.07.003; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Novgorodov SA, 2011, J BIOL CHEM, V286, P25352, DOI 10.1074/jbc.M110.214866; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; Park J. W., 2012, HEPATOLOGY IN PRESS; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Preethy CP, 2012, J PHARMACOL PHARMACO, V3, P26, DOI 10.4103/0976-500X.92500; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shimeno H, 1998, LIPIDS, V33, P601, DOI 10.1007/s11745-998-0246-2; Silva LC, 2012, J LIPID RES, V53, P430, DOI 10.1194/jlr.M022715; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Sullards M C, 2001, Sci STKE, V2001, ppl1; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Voss KA, 2006, TOXICOL SCI, V89, P108, DOI 10.1093/toxsci/kfj019; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Won JS, 2006, FREE RADICAL BIO MED, V40, P1875, DOI 10.1016/j.freeradbiomed.2006.01.035; Yurlova L, 2011, BIOPHYS J, V101, P2713, DOI 10.1016/j.bpj.2011.10.026; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	59	135	142	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4947	4956		10.1074/jbc.M112.402719	http://dx.doi.org/10.1074/jbc.M112.402719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283968	Green Published, hybrid			2022-12-25	WOS:000315340400042
J	Wu, XL; Hernandez-Enriquez, B; Banas, M; Xu, R; Sesti, F				Wu, Xilong; Hernandez-Enriquez, Berenice; Banas, Michelle; Xu, Robin; Sesti, Federico			Molecular Mechanisms Underlying the Apoptotic Effect of KCNB1 K+ Channel Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; TYROSINE KINASE; KV2.1 CHANNEL; LIPID RAFTS; SRC; PHOSPHORYLATION; ENDOCYTOSIS; ACTIVATION; RECEPTOR; DYNAMIN	Potassium (K+) channels are targets of reactive oxygen species in the aging nervous system. KCNB1 (formerly Kv2.1), a voltage-gated K+ channel abundantly expressed in the cortex and hippocampus, is oxidized in the brains of aging mice and of the triple transgenic 3xTg-AD mouse model of Alzheimer's disease. KCNB1 oxidation acts to enhance apoptosis in mammalian cell lines, whereas a KCNB1 variant resistant to oxidative modification, C73A-KCNB1, is cytoprotective. Here we investigated the molecular mechanisms through which oxidized KCNB1 channels promote apoptosis. Biochemical evidence showed that oxidized KCNB1 channels, which form oligomers held together by disulfide bridges involving Cys-73, accumulated in the plasma membrane as a result of defective endocytosis. In contrast, C73A-mutant channels, which do not oligomerize, were normally internalized. KCNB1 channels localize in lipid rafts, and their internalization was dynamin 2-dependent. Accordingly, cholesterol supplementation reduced apoptosis promoted by oxidation of KCNB1. In contrast, cholesterol depletion exacerbated apoptotic death in a KCNB1-independent fashion. Inhibition of raft-associating c-Src tyrosine kinase and downstream JNK kinase by pharmacological and molecular means suppressed the pro-apoptotic effect of KCNB1 oxidation. Together, these data suggest that the accumulation of KCNB1 oligomers in the membrane disrupts planar lipid raft integrity and causes apoptosis via activating the c-Src/JNK signaling pathway.	[Wu, Xilong; Hernandez-Enriquez, Berenice; Banas, Michelle; Xu, Robin; Sesti, Federico] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sesti, F (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 683 Hoes Ln W, Piscataway, NJ 08854 USA.	sestife@umdnj.edu			National Science Foundation [0842708, 1026958]; American Heart Association [09GRNT2250529]; RISE Research in Science and Engineering Rutgers-University of Medicine and Dentistry of New Jersey joint program	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); RISE Research in Science and Engineering Rutgers-University of Medicine and Dentistry of New Jersey joint program	This work was supported by National Science Foundation Grants 0842708 and 1026958 and an American Heart Association Grant 09GRNT2250529 (to F. S.). This work was also supported by the RISE Research in Science and Engineering Rutgers-University of Medicine and Dentistry of New Jersey joint program (to M. B.).	ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; Cai SQ, 2009, NAT NEUROSCI, V12, P611, DOI 10.1038/nn.2291; Catarzi S, 2005, BBA-MOL CELL RES, V1745, P166, DOI 10.1016/j.bbamcr.2005.03.004; Cotella D, 2012, J NEUROSCI, V32, P4133, DOI 10.1523/JNEUROSCI.6153-11.2012; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Morgan MJ, 2007, ANTIOXID REDOX SIGN, V9, P1471, DOI 10.1089/ars.2007.1658; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Pal S, 2003, J NEUROSCI, V23, P4798; Pal SK, 2006, CELL DEATH DIFFER, V13, P661, DOI 10.1038/sj.cdd.4401792; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; Sesti F, 2010, TRENDS CELL BIOL, V20, P45, DOI 10.1016/j.tcb.2009.09.008; Sobko A, 1998, EMBO J, V17, P4723, DOI 10.1093/emboj/17.16.4723; Song MY, 2012, J PROTEOME RES, V11, P1018, DOI 10.1021/pr200770v; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Suprynowicz FA, 2002, ONCOGENE, V21, P1695, DOI 10.1038/sj.onc.1205223; Tiran Z, 2003, J BIOL CHEM, V278, P17509, DOI 10.1074/jbc.M212766200; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Xu XH, 2009, CARDIOVASC RES, V82, P430, DOI 10.1093/cvr/cvp047	24	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4128	4134		10.1074/jbc.M112.440933	http://dx.doi.org/10.1074/jbc.M112.440933			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23275378	Green Published, hybrid			2022-12-25	WOS:000314845000041
J	Yu, ML; Liu, CH; Huang, CF; Tseng, TC; Huang, JF; Dai, CY; Lin, ZY; Chen, SC; Wang, LY; Juo, SHH; Chuang, WL; Kao, JH				Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng			Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; INTERLEUKIN-28B GENETIC-VARIANTS; EARLY IDENTIFICATION; IL28B POLYMORPHISM; VIRAL KINETICS; INTERFERON; ASSOCIATION; INFECTION; THERAPY; MULTICENTER	Background: The current stopping rule for peginterferon/ribavirin therapy in hepatitis C virus genotype-1 (HCV-1) patients is based on an early virological response (EVR, defined as >2 log(10) viral reduction at treatment week 12). We aimed to explore rapid stopping rules at week 4. Methods: We randomly allocated 528 HCV-1 patients into training and validation sets (at a 1: 2 ratio). The interleukin-28B rs8099917 genotypes and on-treatment virological responses were evaluated to determine the negative predictive value (NPV) for achieving a sustained virological response (SVR, defined as undetectable HCV RNA 24 weeks after end-of-treatment). The study was approved by the ethics committees of the participating hospitals. All of the patients gave written informed consent before enrollment. Results: A poor week 4 response (W4R), defined as a HCV RNA reduction of <1 log(10) IU/mL at week 4 or a week 4 HCV RNA. 10,000 IU/mL with interleukin-28B non-TT genotype, had the highest NPV (95%). In the complete sample, poor W4R could identify 43.4% (59/136) of the non-responders, with an NPV of 95% and a false negative rate of only 0.8% (3/396). The multivariate analysis revealed that a poor W4R was the most important negative predictor (odds ratio/95% confidence intervals: 49.01/13.70-175.37), followed by the lack of an EVR. In addition to HCV RNA <1 log(10) IU/mL reduction, using the criteria of HCV RNA >10,000 IU/mL/non-TT genotype helped identifying an additional one-third of non-SVR patients at W4. Using the strategy of sequential rapid stopping rule strategy could identify 53.7% (73/136) of the non-responders (43.4% at week 4 and an addition 11.3% at week 12), as compared to 40.4% for the classical week-12 early stopping rule. Conclusions: Sequential rapid stopping rules using on-treatment virological responses and interleukin-28B genotype can rapidly identify additional peginterferon/ribavirin non-responders.	[Yu, Ming-Lung; Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Yu, Ming-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Yu, Ming-Lung; Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Juo, Suh-Hang Hank; Chuang, Wan-Long] Kaohsiung Med Univ, Hepatitis Res Ctr, Coll Med, Fac Internal Med, Kaohsiung, Taiwan; [Liu, Chen-Hua; Kao, Jia-Horng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Liu, Chen-Hua; Kao, Jia-Horng] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; [Liu, Chen-Hua; Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Tseng, Tai-Chung] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, Taipei, Taiwan; [Huang, Jee-Fu] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Neurol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Buddhist Tzu Chi General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Kao, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	fish6069@gmail.com	Kao, Jia-Horng/AAB-8947-2019; Liu, Chen-Hua/F-6608-2018; Yu, Ming-Lung/AAZ-4306-2020; Chuang, Wan-Long/ABF-7427-2021; Huang, Jee-Fu/AAX-4622-2020	Kao, Jia-Horng/0000-0002-2442-7952; Liu, Chen-Hua/0000-0003-3622-9707; Yu, Ming-Lung/0000-0001-8145-1900; Chuang, Wan-Long/0000-0002-2376-421X; Huang, Jee-Fu/0000-0002-2752-7051	Kaohsiung Medical University Hospital [KMUH100-9I02]; National Science Council, Taiwan [NSC 100-2314-B-037 -014 -MY2]	Kaohsiung Medical University Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the Kaohsiung Medical University Hospital (KMUH100-9I02) and a grant from the National Science Council, Taiwan (NSC 100-2314-B-037 -014 -MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochud PY, 2011, J HEPATOL, V55, P980, DOI 10.1016/j.jhep.2011.01.050; Chayama K, 2011, HEPATOLOGY, V54, p1428A; Ciesla A, 2012, WORLD J GASTROENTERO, V18, P4892, DOI 10.3748/wjg.v18.i35.4892; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; El-Awady MK, 2012, HEPAT MON, V12, P271, DOI 10.5812/hepatmon.835; Eurich D, 2011, LIVER TRANSPLANT, V17, P289, DOI 10.1002/lt.22235; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Graziadei IW, 2012, LIVER TRANSPLANT, V18, P671, DOI 10.1002/lt.23402; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Huang CF, 2012, J HEPATOL, V56, P34, DOI 10.1016/j.jhep.2011.03.029; Huang CF, 2010, J GASTROEN HEPATOL, V25, P758, DOI 10.1111/j.1440-1746.2009.06148.x; Huang CF, 2010, J INFECT DIS, V201, P751, DOI 10.1086/650470; Huang JF, 2007, ALIMENT PHARM THER, V25, P1029, DOI 10.1111/j.1365-2036.2007.03297.x; Ito K, 2011, J CLIN MICROBIOL, V49, P1853, DOI 10.1128/JCM.02139-10; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jensen DM, 2006, HEPATOLOGY, V43, P954, DOI 10.1002/hep.21159; Liu CH, 2012, ANTIVIR THE IN PRESS; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Lopez-Rodriguez R, 2011, CLIN PHARMACOL THER, V90, P712, DOI 10.1038/clpt.2011.189; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mangia A, 2011, HEPATOLOGY, V54, P772, DOI 10.1002/hep.24458; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; Ogawa E, 2012, J HEPATOL, V57, P534, DOI 10.1016/j.jhep.2012.04.027; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Reau N, 2011, AM J GASTROENTEROL, V106, P452, DOI 10.1038/ajg.2010.424; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319; Yu ML, 2006, ANTIVIR THER, V11, P985; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Zeuzem S, 2001, GASTROENTEROLOGY, V120, P1438, DOI 10.1053/gast.2001.24006	36	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52048	10.1371/journal.pone.0052048	http://dx.doi.org/10.1371/journal.pone.0052048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284866	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800025
J	Couteau, C; Chauvet, C; Paparis, E; Coiffard, L				Couteau, Celine; Chauvet, Catherine; Paparis, Eva; Coiffard, Laurence			UV Filters, Ingredients with a Recognized Anti-Inflammatory Effect	PLOS ONE			English	Article							IN-VITRO; BENZIMIDAZOLE DERIVATIVES; PROTECTION FACTORS; INHIBITORS; ANALOGS; CYCLOOXYGENASE; INFLAMMATION; SELECTIVITY; KETOPROFEN; AGENTS	Background: To explain observed differences during SPF determination using either an in vivo or in vitro method, we hypothesized on the presence of ingredients having anti-inflammatory properties. Methodology/Principal Findings: To research our hypothesis, we studied the 21 UV filters both available on the market and authorized by European regulations and subjected these filters to the phorbol-myristate-acetate test using mice. We then catalogued the 13 filters demonstrating a significant anti-inflammatory effect with edema inhibition percentages of more than 70%. The filters are: diethylhexyl butamido triazone (92%), benzophenone-5 and titanium dioxide (90%), benzophenone-3 (83%), octocrylene and isoamyl p-methoxycinnamate (82%), PEG-25 PABA and homosalate (80%), octyl triazone and phenylbenzimidazole sulfonic acid (78%), octyl dimethyl PABA (75%), bis-ethylhexyloxyphenol methoxyphenyl triazine and diethylamino hydroxybenzoyl hexylbenzoate (70%). These filters were tested at various concentrations, including their maximum authorized dose. We detected a dose-response relationship. Conclusions/Significance: The anti-inflammatory effect of a sunscreen ingredient may affect the in vivo SPF value. Citation: Couteau C, Chauvet C, Paparis E, Coiffard L (2012) UV Filters, Ingredients with a Recognized Anti-Inflammatory Effect. PLoS ONE 7(12): e46187. doi:10.1371/journal.pone.0046187	[Couteau, Celine; Paparis, Eva; Coiffard, Laurence] Univ Nantes, Nantes Atlantic Univ, MMS, EA 2160,FR CNRS 3473,Fac Pharm, Nantes, France; [Chauvet, Catherine] Univ Nantes, Nantes Atlantic Univ, Pharmacochem Dept, Fac Pharm,IICiMed UPRES EA 1155, Nantes, France	Nantes Universite; Nantes Universite	Coiffard, L (corresponding author), Univ Nantes, Nantes Atlantic Univ, MMS, EA 2160,FR CNRS 3473,Fac Pharm, Nantes, France.	laurence.coiffard@univ-nantes.fr						Alaric J, 2011, BIOORGAN MED CHEM, V21, P4633; Bendova H, 2007, TOXICOL IN VITRO, V21, P1268, DOI 10.1016/j.tiv.2007.08.022; Breteche A, 2002, J ENZYM INHIB MED CH, V17, P415, DOI 10.1080/1475636021000005695; CARLSON RP, 1985, AGENTS ACTIONS, V17, P197, DOI 10.1007/BF01966592; Collin X, 2001, J PHARM PHARMACOL, V53, P417, DOI 10.1211/0022357011775505; Couteau C, 2007, PHARMAZIE, V62, P449, DOI 10.1691/ph.2007.6.6247; Couteau C, 2007, J PHARMACEUT BIOMED, V44, P270, DOI 10.1016/j.jpba.2007.01.052; DIFFEY BL, 1989, J SOC COSMET CHEM, V40, P127; Doiron J, 2009, BIOORG MED CHEM LETT, V19, P1118, DOI 10.1016/j.bmcl.2008.12.108; Fu Y, 2004, BIOCHEM BIOPH RES CO, V322, P263, DOI 10.1016/j.bbrc.2004.07.094; Garoli D, 2009, J DERMATOL SCI, V56, P89, DOI 10.1016/j.jdermsci.2009.07.015; Isbrucker RA, 2006, REGUL TOXICOL PHARM, V46, P167, DOI 10.1016/j.yrtph.2006.06.002; Khanum SA, 2004, BIOORG CHEM, V32, P211, DOI 10.1016/j.bioorg.2004.04.003; LAZER ES, 1987, J MED CHEM, V30, P726, DOI 10.1021/jm00387a026; Leite GD, 2011, FITOTERAPIA, V82, P208, DOI 10.1016/j.fitote.2010.09.012; Lopez-Rodriguez ML, 1999, J MED CHEM, V42, P5020, DOI 10.1021/jm991076c; McKay DL, 2006, PHYTOTHER RES, V20, P519, DOI 10.1002/ptr.1900; Mirzoeva OK, 1996, PROSTAG LEUKOTR ESS, V55, P441, DOI 10.1016/S0952-3278(96)90129-5; Moyal D, 2000, PHOTODERMATOL PHOTO, V16, P245, DOI 10.1034/j.1600-0781.2000.160602.x; Ottosen ER, 2003, J MED CHEM, V46, P5651, DOI 10.1021/jm030851s; Palomer A, 2000, J MED CHEM, V43, P2280, DOI 10.1021/jm9906217; Palomer A, 2002, BIOORG MED CHEM LETT, V12, P533, DOI 10.1016/S0960-894X(01)00800-9; Schulze R., 1956, PARFUM KOSMET, V37, P310; Touaibia M, 2009, MINI REVIEWS IN MEDI, V11, P695; Venu TD, 2007, BIOORGAN MED CHEM, V15, P3505, DOI 10.1016/j.bmc.2007.02.051; Zhang B, 2006, EUR J PHARMACOL, V530, P166, DOI 10.1016/j.ejphar.2005.11.030	26	26	28	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e46187	10.1371/journal.pone.0046187	http://dx.doi.org/10.1371/journal.pone.0046187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284607	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500001
J	Knol, AC; Nguyen, JM; Pandolfino, MC; Quereux, G; Brocard, A; Peuvrel, L; Saint-Jean, M; Saiagh, S; Khammari, A; Dreno, B				Knol, Anne-Chantal; Nguyen, Jean-Michel; Pandolfino, Marie-Christine; Quereux, Gaelle; Brocard, Anabelle; Peuvrel, Lucie; Saint-Jean, Melanie; Saiagh, Soraya; Khammari, Amir; Dreno, Brigitte			Tissue Biomarkers in Melanoma Patients Treated with TIL	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; STAGE-III MELANOMA; METASTATIC MELANOMA; ADOPTIVE TRANSFER; CLINICAL ACTIVITY; ADJUVANT THERAPY; REACTIVE TIL; PHASE-II; T-CELLS; IMMUNOTHERAPY	While treating stage III melanoma patients with autologous therapeutic TIL in an adjuvant setting, we previously reported a significant benefit of treatment on both progression-free survival and overall survival in patients with only one invaded lymph node (early stage III) compared to patients with more than one invaded lymph nodes (advanced stage III). In this context, in order to understand the difference of activity of TIL therapy according to the progression of the illness at stage III, the first objective of the present study was to determine potential differences in the characteristics of TIL populations obtained from an early stage III and a more advanced stage III when tumor burden is more important. The second objective was to determine possible differences in tissue expression level of several molecules involved in interactions between tumor cells and T cells between early and advanced stage III considering that the tumor microenvironment of invaded lymph nodes could become more tolerant with the progression of the disease. A total of 47 samples of melanoma invaded LN from stage IIIb (AJCC 2007) melanoma patients treated with TIL plus IL-2 were included in this study. We confirmed that both PFS and OS were significantly associated to the presence of tumor-reactive T-cells among TIL injected to the patients and that these tumor reactive T cells were more frequently observed at the early stage III. Moreover, while analyzing the expression of 17 markers on 34/47 tumor specimens using immunohistochemistry, we identified that 3 tissue markers involved in interactions between melanoma cells and T cells have a significant difference of expression between early and advanced stage III: MHC class I, adhesion molecule ICAM-1 and the co-stimulation molecule LFA-3 had a significantly weaker expression in melanoma tissue specimens from advanced stage III. In addition, the expression of the alpha chain of the IL-2 receptor (CD25) and the nuclear transcription factor Foxp3 was significantly increased in the melanoma tissue specimens from advanced stage III. Our results suggest differences in the immunological status of the tumor microenvironment between early and advanced stage III, which could explain the difference in clinical response to TIL infusion in an adjuvant setting between early and advanced stage III.	[Knol, Anne-Chantal; Nguyen, Jean-Michel; Pandolfino, Marie-Christine; Quereux, Gaelle; Brocard, Anabelle; Peuvrel, Lucie; Saint-Jean, Melanie; Khammari, Amir; Dreno, Brigitte] INSERM, CRCNA, U892, Nantes, France; [Quereux, Gaelle; Brocard, Anabelle; Peuvrel, Lucie; Saint-Jean, Melanie; Khammari, Amir; Dreno, Brigitte] Unite Cancerodermatol CIC Biotherapie INSERM 0503, Nantes, France; [Pandolfino, Marie-Christine; Saiagh, Soraya; Dreno, Brigitte] Unite Therapie Cellulaire & Genique, Nantes, France; [Nguyen, Jean-Michel] Hop St Jacques, PIMESP SEB, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Dreno, B (corresponding author), INSERM, CRCNA, U892, Nantes, France.	brigitte.dreno@wanadoo.fr	KNOL, Anne Chantal C/K-7974-2015	KNOL, Anne Chantal C/0000-0003-4011-5008; Peuvrel, Lucie/0000-0002-4347-915X	la Ligue Nationale contre le cancer; la Societe Francaise de Dermatologie; l'Association Francaise contre les Myopathies; European Program "Cancer Immunotherapy"	la Ligue Nationale contre le cancer(Ligue nationale contre le cancer); la Societe Francaise de Dermatologie; l'Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); European Program "Cancer Immunotherapy"	This work was supported by grants from "la Ligue Nationale contre le cancer", from "la Societe Francaise de Dermatologie", from "l'Association Francaise contre les Myopathies" and from the European Program "Cancer Immunotherapy". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berd David, 2004, Expert Rev Vaccines, V3, P521, DOI 10.1586/14760584.3.5.521; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Carretero R, 2012, INT J CANCER, V131, P387, DOI 10.1002/ijc.26471; Chebassier N, 2004, EXP DERMATOL, V13, P484, DOI 10.1111/j.0906-6705.2004.00197.x; Dreno B, 2002, CANCER IMMUNOL IMMUN, V51, P539, DOI 10.1007/s00262-002-0315-1; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Garrido F, 2010, INT J CANCER, V127, P249, DOI 10.1002/ijc.25270; GERVOIS N, 1990, EUR J IMMUNOL, V20, P825, DOI 10.1002/eji.1830200417; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; JOTEREAU F, 1991, J IMMUNOTHER, V10, P405, DOI 10.1097/00002371-199112000-00003; Jotereau F, 2003, B CANCER, V90, P583; JUNG T, 1993, J IMMUNOL METHODS, V159, P197, DOI 10.1016/0022-1759(93)90158-4; Khammari A, 2007, CANCER IMMUNOL IMMUN, V56, P1853, DOI 10.1007/s00262-007-0340-1; Knol AC, 2011, EXP DERMATOL, V20, P430, DOI 10.1111/j.1600-0625.2011.01260.x; Labarriere N, 2002, CANCER IMMUNOL IMMUN, V51, P532, DOI 10.1007/s00262-002-0313-3; Pandolfino MC, 2010, CYTOTECHNOLOGY, V62, P403, DOI 10.1007/s10616-010-9286-9; Pandolfino MC, 2001, CANCER IMMUNOL IMMUN, V50, P134, DOI 10.1007/PL00006683; Quereux G, 2007, EUR J DERMATOL, V17, P295, DOI 10.1684/ejd.2009.0203; Ribas A, 2009, CLIN CANCER RES, V15, P390, DOI 10.1158/1078-0432.CCR-08-0783; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Somasundaram R, 2002, CANCER RES, V62, P5267; Terabe M, 2004, CURR OPIN IMMUNOL, V16, P157, DOI 10.1016/j.coi.2004.01.010; Yuan JD, 2011, CANCER IMMUNOL IMMUN, V60, P1137, DOI 10.1007/s00262-011-1011-9	27	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e48729	10.1371/journal.pone.0048729	http://dx.doi.org/10.1371/journal.pone.0048729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284620	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500007
J	Nelissen, J; Nuyts, K; De Zotti, M; Lavigne, R; Lamberigts, C; De Borggraeve, WM				Nelissen, Jo; Nuyts, Koen; De Zotti, Marta; Lavigne, Rob; Lamberigts, Chris; De Borggraeve, Wim M.			Total Synthesis of Septocylindrin B and C-Terminus Modified Analogues	PLOS ONE			English	Article							ELUCIDATION; PEPTAIBOLS; PEPTIDES	The total synthesis is reported of the peptaibol Septocylindrin B which is related to the well documented channel forming peptaibol antibiotic Alamethicin. Several analogues were synthesized with a modified C-terminus, to investigate the SAR of the terminal residue Phaol. All these peptides were tested for their membrane perturbation properties by fluorescent dye leakage assay and for their antibacterial activity.	[Nelissen, Jo; Nuyts, Koen; De Borggraeve, Wim M.] Katholieke Univ Leuven, Dept Chem, B-3001 Heverlee, Belgium; [De Zotti, Marta] Univ Padua, Dept Chem, Padua, Italy; [Lavigne, Rob; Lamberigts, Chris] Katholieke Univ Leuven, Biosyst Dept, Lab Gene Technol, B-3001 Heverlee, Belgium	KU Leuven; University of Padua; KU Leuven	De Borggraeve, WM (corresponding author), Katholieke Univ Leuven, Dept Chem, B-3001 Heverlee, Belgium.	Wim.DeBorggraeve@chem.kuleuven.be	De Zotti, Marta/A-3265-2014; Nuyts, Koen/L-9930-2017; De Borggraeve, Wim/AGE-5612-2022	De Zotti, Marta/0000-0002-3302-6499; Nuyts, Koen/0000-0003-0387-9965; De Borggraeve, Wim/0000-0001-7813-6192; Lamberigts, Chris/0000-0002-7484-0059; Lavigne, Rob/0000-0001-7377-1314	Institute for the Promotion of Innovation through Science and Technology in Flanders (Belgium, I.W.T.); KU Leuven [OT/11/047/TBA]; IOF Knowledge Platform grant of the KU Leuven [IOF/KP/09/003]; FWO Vlaanderen [G.0599.11]	Institute for the Promotion of Innovation through Science and Technology in Flanders (Belgium, I.W.T.)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven(KU Leuven); IOF Knowledge Platform grant of the KU Leuven; FWO Vlaanderen(FWO)	JN thanks the Institute for the Promotion of Innovation through Science and Technology in Flanders (Belgium, I.W.T., www.iwt.be) for financial support. KN thanks KU Leuven for financial support (Project OT/11/047/TBA). CL is supported by the IOF Knowledge Platform grant ("Functional peptidomics" IOF/KP/09/003) of the KU Leuven. This work was also partly supported by a grant of the FWO Vlaanderen (G.0599.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyes SGB, 2007, INT J ANTIMICROB AG, V29, pS43, DOI 10.1016/S0924-8579(07)72177-5; Crisma M, 2007, ANGEW CHEM INT EDIT, V46, P2047, DOI 10.1002/anie.200604417; Kastin AJ, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, pXXXIX, DOI 10.1016/B978-012369442-3/50002-7; Kaul R, 2004, TETRAHEDRON LETT, V69, P6131; KUMAZAWA S, 1994, J ANTIBIOT, V47, P1136, DOI 10.7164/antibiotics.47.1136; Mattheus W, 2010, CHEM BIOL, V17, P149, DOI 10.1016/j.chembiol.2010.01.014; Navath RS, 2006, TETRAHEDRON LETT, V47, P389, DOI 10.1016/j.tetlet.2005.11.003; Nelissen J, 2011, J PEPT SCI, V17, P527, DOI 10.1002/psc.1362; Peggion C, 2004, BIOPOLYMERS, V76, P485, DOI 10.1002/bip.20161; Peggion C, 2007, EUR J BIOCHEM, V4, P1183; Stella L, 2007, CHEM BIODIVERS, V4, P1299, DOI 10.1002/cbdv.200790111; Summers MY, 2007, J NAT PROD, V70, P391, DOI 10.1021/np060571q; Theis C, 2008, CHEM BIODIVERS, V5, P2337, DOI 10.1002/cbdv.200890200; Toniolo C., 2009, PEPTAIBIOTICS	14	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51708	10.1371/journal.pone.0051708	http://dx.doi.org/10.1371/journal.pone.0051708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284749	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500041
J	Norrelgen, F; Lilja, A; Ingvar, M; Gisselgard, J; Fransson, P				Norrelgen, Fritjof; Lilja, Anders; Ingvar, Martin; Gisselgard, Jens; Fransson, Peter			Language Lateralization in Children Aged 10 to 11 Years: A Combined fMRI and Dichotic Listening Study	PLOS ONE			English	Article							CONSONANT-VOWEL SYLLABLES; WADA TEST; BRAIN ACTIVATION; FUNCTIONAL MRI; INTRASUBJECT REPRODUCIBILITY; EPILEPSY; DOMINANCE; COMPREHENSION; PARADIGM; ADULTS	Objective: The aims of this study were to develop and assess a method to map language networks in children with two auditory fMRI protocols in combination with a dichotic listening task (DL). The method is intended for pediatric patients prior to epilepsy surgery. To evaluate the potential clinical usefulness of the method we first wanted to assess data from a group of healthy children. Methods: In a first step language test materials were developed, intended for subsequent implementation in fMRI protocols. An evaluation of this material was done in 30 children with typical development, 10 from the 1st, 4th and the 7th grade, respectively. The language test material was then adapted and implemented in two fMRI protocols intended to target frontal and posterior language networks. In a second step language lateralization was assessed in 17 typical 10-11 year olds with fMRI and DL. To reach a conclusion about language lateralization, firstly, quantitative analyses of the index data from the two fMRI tasks and the index data from the DL task were done separately. In a second step a set of criteria were applied to these results to reach a conclusion about language lateralization. The steps of these analyses are described in detail. Results: The behavioral assessment of the language test material showed that it was well suited for typical children. The results of the language lateralization assessments, based on fMRI data and DL data, showed that for 15 of the 17 subjects (88%) a conclusion could be reached about hemispheric language dominance. In 2 cases (12%) DL provided critical data. Conclusions: The employment of DL combined with language mapping using fMRI for assessing hemispheric language dominance is novel and it was deemed valuable since it provided additional information compared to the results gained from each method individually.	[Norrelgen, Fritjof; Ingvar, Martin; Fransson, Peter] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Norrelgen, Fritjof] Karolinska Univ Hosp, Dept Speech & Language Pathol, Stockholm, Sweden; [Lilja, Anders] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden; [Gisselgard, Jens] Stavanger Univ Hosp, Div Psychiat, Reg Ctr Clin Res Psychosis, Stavanger, Norway	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Stavanger University Hospital	Norrelgen, F (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	fritjof.norrelgen@karolinska.se	Fransson, Peter/M-5679-2014	Fransson, Peter/0000-0002-1305-9875; Ingvar, Martin/0000-0002-9041-5714; Norrelgen, Fritjof/0000-0003-3363-0925	Stockholm County Council; Karolinska Institutet	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	Financial support was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2003, NEUROLOGY, V60, P1598, DOI 10.1212/01.WNL.0000059865.32155.86; Arora J, 2009, EPILEPSIA, V50, P2225, DOI 10.1111/j.1528-1167.2009.02136.x; Binder JR, 2011, EPILEPSY BEHAV, V20, P214, DOI 10.1016/j.yebeh.2010.08.004; Binder JR, 1996, NEUROLOGY, V46, P978, DOI 10.1212/WNL.46.4.978; Bishop D., 2009, TROG 2 TEST RECEPTIO; Bishop D. V. M, 2003, TEST RECEPTION GRAMM; Byars AW, 2002, J CHILD NEUROL, V17, P885, DOI 10.1177/08830738020170122201; Dragovic M, 2004, LATERALITY, V9, P411, DOI 10.1080/13576500342000248; Fernandez G, 2003, NEUROLOGY, V60, P969, DOI 10.1212/01.WNL.0000049934.34209.2E; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gaillard WD, 2004, NEUROLOGY, V63, P1403, DOI 10.1212/01.wnl.0000141852.65175.a7; Gaillard WD, 2003, HUM BRAIN MAPP, V18, P176, DOI 10.1002/hbm.10091; Gaillard WD, 2002, NEUROLOGY, V59, P256, DOI 10.1212/WNL.59.2.256; Gaillard WD, 2001, NEUROLOGY, V57, P47, DOI 10.1212/WNL.57.1.47; Hammeke T A, 2000, Adv Neurol, V83, P221; Harrington GS, 2006, AM J NEURORADIOL, V27, P938; Holland SK, 2007, INT J AUDIOL, V46, P533, DOI 10.1080/14992020701448994; Hugdahl K, 1999, NEUROPSYCHOLOGIA, V37, P431, DOI 10.1016/S0028-3932(98)00101-8; Hugdahl K, 1997, ARCH NEUROL-CHICAGO, V54, P1494, DOI 10.1001/archneur.1997.00550240046011; Hugdahl K, 1997, J CLIN EXP NEUROPSYC, V19, P667, DOI 10.1080/01688639708403752; HUGDAHL K, 1986, CORTEX, V22, P417, DOI 10.1016/S0010-9452(86)80005-3; Hugdahl K, 2001, DEV NEUROPSYCHOL, V20, P445, DOI 10.1207/S15326942DN2001_8; HUGDAHL K, 1989, NEUROPSYCHOLOGIA, V27, P999, DOI 10.1016/0028-3932(89)90075-4; HUGDAHL K, 1987, J CLIN EXP NEUROPSYC, V9, P631, DOI 10.1080/01688638708405207; Hugdahl K, 1994, DIKOTISK LYSSNING ME; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Lidzba K, 2011, BRAIN LANG, V119, P6, DOI 10.1016/j.bandl.2011.02.003; Loddenkemper T, 2008, EPILEPSY BEHAV, V13, P551, DOI 10.1016/j.yebeh.2008.05.014; Medina LS, 2004, RADIOLOGY, V230, P49, DOI 10.1148/radiol.2301021122; O'Shaughnessy ES, 2008, J CHILD NEUROL, V23, P791, DOI 10.1177/0883073807313047; Pellock JM, 2004, NEUROLOGY, V62, pS17, DOI 10.1212/WNL.62.5_suppl_2.S17; Roder B, 2002, NEUROIMAGE, V15, P1003, DOI 10.1006/nimg.2001.1026; Rutten GJM, 2002, NEUROIMAGE, V17, P447, DOI 10.1006/nimg.2002.1196; Rydberg S, 1974, MANUAL SPIQ SNABBT P; SCHACHTER SC, 1993, ANN NY ACAD SCI, V682, P402, DOI 10.1111/j.1749-6632.1993.tb23006.x; Sharan A, 2011, EPILEPSY BEHAV, V20, P209, DOI 10.1016/j.yebeh.2010.11.013; Shurtleff H, 2010, J NEUROSURG-PEDIATR, V5, P500, DOI 10.3171/2009.11.PEDS09248; Spanaki Marianna V., 2001, Epilepsia, V42, P78; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Spritzer SD, 2012, NEUROLOGIST, V18, P329, DOI 10.1097/NRL.0b013e31826ac675; Swanson SJ, 2007, NEUROPSYCHOL REV, V17, P491, DOI 10.1007/s11065-007-9050-x; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; van den Noort M, 2008, NEUROIMAGE, V40, P902, DOI 10.1016/j.neuroimage.2007.11.051; Wada J, 2007, J NEUROSURG, V106, P1117, DOI 10.3171/jns.2007.106.6.1117; Wang YY, 2012, BRAIN RES, V1447, P79, DOI 10.1016/j.brainres.2012.02.001; Wellmer J, 2009, EPILEPSIA, V50, P2213, DOI 10.1111/j.1528-1167.2009.02102.x; Wiig E.H., 1989, TEST LANGUAGE COMPET; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wood AG, 2004, NEUROLOGY, V63, P1035, DOI 10.1212/01.WNL.0000140707.61952.CA	49	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51872	10.1371/journal.pone.0051872	http://dx.doi.org/10.1371/journal.pone.0051872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284796	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500057
J	Bhattacharyya, M; Upadhyay, R; Vishveshwara, S				Bhattacharyya, Moitrayee; Upadhyay, Roopali; Vishveshwara, Saraswathi			Interaction Signatures Stabilizing the NAD(P)-Binding Rossmann Fold: A Structure Network Approach	PLOS ONE			English	Article							PROTEIN-STRUCTURE; EVOLUTION; SEQUENCE; FAMILIES; NUMBER	The fidelity of the folding pathways being encoded in the amino acid sequence is met with challenge in instances where proteins with no sequence homology, performing different functions and no apparent evolutionary linkage, adopt a similar fold. The problem stated otherwise is that a limited fold space is available to a repertoire of diverse sequences. The key question is what factors lead to the formation of a fold from diverse sequences. Here, with the NAD(P)-binding Rossmann fold domains as a case study and using the concepts of network theory, we have unveiled the consensus structural features that drive the formation of this fold. We have proposed a graph theoretic formalism to capture the structural details in terms of the conserved atomic interactions in global milieu, and hence extract the essential topological features from diverse sequences. A unified mathematical representation of the different structures together with a judicious concoction of several network parameters enabled us to probe into the structural features driving the adoption of the NAD(P)-binding Rossmann fold. The atomic interactions at key positions seem to be better conserved in proteins, as compared to the residues participating in these interactions. We propose a "spatial motif" and several "fold specific hot spots" that form the signature structural blueprints of the NAD(P)-binding Rossmann fold domain. Excellent agreement of our data with previous experimental and theoretical studies validates the robustness and validity of the approach. Additionally, comparison of our results with statistical coupling analysis (SCA) provides further support. The methodology proposed here is general and can be applied to similar problems of interest.	[Bhattacharyya, Moitrayee; Upadhyay, Roopali; Vishveshwara, Saraswathi] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Vishveshwara, S (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	sv@mbu.iisc.ernet.in			Department of Science and Technology for Mathematical Biology, Government of India [DSTO773]; Council for Scientific and Industrial Research (CSIR)	Department of Science and Technology for Mathematical Biology, Government of India(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	The support from the Department of Science and Technology for Mathematical Biology (DSTO773), Government of India, is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MB and SV thank the Council for Scientific and Industrial Research (CSIR) for senior research fellowship and emeritus professorship respectively. We also thank Prof. Rama Ranganathan for providing the SCA codes.	Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bhattacharyya M, 2010, PROTEINS, V78, P506, DOI 10.1002/prot.22573; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Choi IG, 2006, P NATL ACAD SCI USA, V103, P14056, DOI 10.1073/pnas.0606239103; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Deb D, 2009, BIOPHYS J, V97, P1787, DOI 10.1016/j.bpj.2009.07.016; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hoang TX, 2004, P NATL ACAD SCI USA, V101, P7960, DOI 10.1073/pnas.0402525101; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Lee D, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-2; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; LopezHernandez E, 1996, FOLD DES, V1, P43, DOI 10.1016/S1359-0278(96)00011-9; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Raimondi F, 2012, J BIOMOL STRUCT DYN, P1; Redfern OC, 2008, CURR OPIN STRUC BIOL, V18, P394, DOI 10.1016/j.sbi.2008.05.007; Rose GD, 2006, P NATL ACAD SCI USA, V103, P16623, DOI 10.1073/pnas.0606843103; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Soundararajan V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009391; Sukhwal A, 2011, ACTA CRYSTALLOGR D, V67, P429, DOI 10.1107/S0907444911007062; Taylor WR, 2007, CURR OPIN STRUC BIOL, V17, P354, DOI 10.1016/j.sbi.2007.06.002; Vijayabaskar MS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002505; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wolf YI, 2000, J MOL BIOL, V299, P897, DOI 10.1006/jmbi.2000.3786; Worth CL, 2009, NAT REV MOL CELL BIO, V10, P709, DOI 10.1038/nrm2762; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P1029, DOI 10.1073/pnas.0407152101	42	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51676	10.1371/journal.pone.0051676	http://dx.doi.org/10.1371/journal.pone.0051676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284738	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000312435900041
J	Kaminski, KP; Petersen, AH; Sonderkaer, M; Pedersen, LH; Pedersen, H; Feder, C; Nielsen, KL				Kaminski, Kacper Piotr; Petersen, Annabeth Hogh; Sonderkaer, Mads; Pedersen, Lars Haastrup; Pedersen, Henrik; Feder, Christian; Nielsen, Kare L.			Transcriptome Analysis Suggests That Starch Synthesis May Proceed via Multiple Metabolic Routes in High Yielding Potato Cultivars	PLOS ONE			English	Article							ANTISENSE REPRESSION; PHOSPHOGLUCOMUTASE; CARBON; PLANTS	Background: Glucose-6-phosphate is imported into the amyloplast of potato tubers and thought to constitute the precursor for starch synthesis in potato tubers. However, recently it was shown that glucose-1-phosphate can also be imported into the amyloplast and incorporated into starch via an ATP independent mechanism under special conditions. Nonetheless, glucose-6-phosphate is believed to be the quantitatively important precursor for starch synthesis in potato. Principal Finding: Potato tubers of the high yielding cv Kuras had low gene expression of plastidial phophoglucomutase (PGM) and normal levels of transcripts for other enzymes involved in starch metabolism in comparison with medium and low yielding cultivars as determined by DeepSAGE transcriptome profiling. The decrease in PGM activity in Kuras was confirmed by measuring the enzyme activity from potato tuber extracts. Contrary to expectations, this combination lead to a higher level of intracellular glucose-1-phosphate (G1P) in Kuras suggesting that G1P is directly imported into plastids and can be quantitatively important for starch synthesis under normal conditions in high yielding cultivars. Significance: This could open entirely new possibilities for metabolic engineering of the starch metabolism in potato via the so far uncharacterized G1P transporter. The perspectives are to increase yield and space efficiency of this important crop. In the light of the increasing demands imposed on agriculture to support a growing global population this presents an exciting new possibility.	[Kaminski, Kacper Piotr] Aarhus Univ, Dept Agroecol, Aarhus, Denmark; [Kaminski, Kacper Piotr; Petersen, Annabeth Hogh; Sonderkaer, Mads; Pedersen, Lars Haastrup; Nielsen, Kare L.] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Pedersen, Henrik] AKV Langholt Amba, Langholt, Denmark; [Feder, Christian] KMC, Brande, Denmark	Aarhus University; Aalborg University	Nielsen, KL (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark.	kln@bio.aau.dk	Nielsen, Kåre Lehmann L/A-1181-2013	Nielsen, Kåre Lehmann L/0000-0002-5598-4401; Sonderkaer, Mads/0000-0002-9309-7459	Danish Strategic Research Council [2101-07-0116]	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Danish Strategic Research Council (grant no 2101-07-0116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernie AR, 2002, PLANT PHYSIOL BIOCH, V40, P921, DOI 10.1016/S0981-9428(02)01457-2; Fernie AR, 2002, PLANTA, V214, P510, DOI 10.1007/s004250100644; Fettke J, 2010, NEW PHYTOL, V185, P663, DOI 10.1111/j.1469-8137.2009.03126.x; Geigenberger P, 2001, PLANT PHYSIOL, V125, P1667, DOI 10.1104/pp.125.4.1667; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Jeong JS, 2007, J CHROMATOGR A, V1164, P167, DOI 10.1016/j.chroma.2007.07.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lytovchenko A, 2007, CURR OPIN PLANT BIOL, V10, P227, DOI 10.1016/j.pbi.2007.04.002; Nielsen Kare Lehmann, 2008, V387, P81; Nielsen KL, 2008, NEXT GENERATION SEQU, P229; Regierer B, 2002, NAT BIOTECHNOL, V20, P1256, DOI 10.1038/nbt760; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; Streb S, 2009, PLANT PHYSIOL, V151, P1769, DOI 10.1104/pp.109.144931; Sweetlove LJ, 1999, PLANTA, V209, P330, DOI 10.1007/s004250050640; Tauberger E, 2000, PLANT J, V23, P43, DOI 10.1046/j.1365-313x.2000.00783.x; Tjaden J, 1998, PLANT J, V16, P531, DOI 10.1046/j.1365-313X.1998.00317.x; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	18	17	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51248	10.1371/journal.pone.0051248	http://dx.doi.org/10.1371/journal.pone.0051248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V30PH	23284672	Green Submitted, Green Published, gold			2022-12-25	WOS:000208827400001
J	Rhedin, S; Hamrin, J; Naucler, P; Bennet, R; Rotzen-Ostlund, M; Farnert, A; Eriksson, M				Rhedin, Samuel; Hamrin, Johan; Naucler, Pontus; Bennet, Rutger; Rotzen-Ostlund, Maria; Farnert, Anna; Eriksson, Margareta			Respiratory Viruses in Hospitalized Children with Influenza-Like Illness during the H1n1 2009 Pandemic in Sweden	PLOS ONE			English	Article							A H1N1; RHINOVIRUS; INFECTIONS; SYMPTOMS	Background: The swine-origin influenza A(H1N1)pdm09 pandemic of 2009 had a slower spread in Europe than expected. The human rhinovirus (HRV) has been suggested to have delayed the pandemic through viral interference. The importance of co-infections over time during the pandemic and in terms of severity of the disease needs to be assessed. Objective: The aim of this study was to investigate respiratory viruses and specifically the presence of co-infections with influenza A(H1N1) pdm09 (H1N1) in hospitalized children during the H1N1 pandemic. A secondary aim was to investigate if co-infections were associated with severity of disease. Methods: A retrospective study was performed on 502 children with influenza-like illness admitted to inpatient care at a pediatric hospital in Stockholm, Sweden during the 6 months spanning the H1N1 pandemic in 2009. Respiratory samples were analyzed for a panel of 16 viruses by real-time polymerase chain reaction. Results: One or more viruses were detected in 61.6% of the samples. Of these, 85.4% were single infections and 14.6% co-infections (2-4 viruses). The number of co-infections increased throughout the study period. H1N1 was found in 83 (16.5%) children and of these 12 (14.5%) were co-infections. HRV and H1N1 circulated to a large extent at the same time and 6.0% of the H1N1-positive children were also positive for HRV. There was no correlation between co-infections and severity of disease in children with H1N1. Conclusions: Viral co-infections were relatively common in H1N1 infected hospitalized children and need to be considered when estimating morbidity attributed to H1N1. Population-based longitudinal studies with repeated sampling are needed to improve the understanding of the importance of co-infections and viral interference. Citation: Rhedin S, Hamrin J, Naucler P, Bennet R, Rotzen-Ostlund M, et al. (2012) Respiratory Viruses in Hospitalized Children with Influenza-Like Illness during the H1n1 2009 Pandemic in Sweden. PLoS ONE 7(12): e51491. doi:10.1371/journal.pone.0051491	[Rhedin, Samuel; Farnert, Anna] Karolinska Univ Hosp, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden; [Hamrin, Johan; Bennet, Rutger; Eriksson, Margareta] Karolinska Univ Hosp, Dept Women & Child Hlth, Stockholm, Sweden; [Hamrin, Johan; Bennet, Rutger; Eriksson, Margareta] Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Naucler, Pontus] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Naucler, Pontus; Farnert, Anna] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Rotzen-Ostlund, Maria] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Rhedin, S (corresponding author), Karolinska Univ Hosp, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden.	samuel.rhedin@ki.se; johan.hamrin@karolinska.se	Bennet, Rutger/AAC-1255-2019; Arthur Rhedin, Samuel/H-4653-2019	Bennet, Rutger/0000-0003-0105-1865; Arthur Rhedin, Samuel/0000-0001-5798-2875; Farnert, Anna/0000-0001-7583-282X				Anestad G, 2011, MED HYPOTHESES, V77, P1132, DOI 10.1016/j.mehy.2011.09.021; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307; DaPalma T, 2010, VIRUS RES, V149, P1, DOI 10.1016/j.virusres.2010.01.002; Dawood FS, 2011, NEW ENGL J MED, V360, P2605; Esper FP, 2011, J INFECTION, V63, P260, DOI 10.1016/j.jinf.2011.04.004; Falagas ME, 2010, EUR J CLIN MICROBIOL, V29, P1327, DOI 10.1007/s10096-010-1002-3; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; Guan Y, 2010, PROTEIN CELL, V1, P9, DOI 10.1007/s13238-010-0008-z; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Kling S, 2005, CLIN EXP ALLERGY, V35, P672, DOI 10.1111/j.1365-2222.2005.02244.x; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Linde A, 2009, EURO SURVEILL, V40; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Nisii C, 2010, J CLIN MICROBIOL, V48, P3383, DOI 10.1128/JCM.01179-10; Ortqvist A, 2011, CLIN INFECT DIS, V52, P1203, DOI 10.1093/cid/cir182; Statistics Sweden, 2009, POP MUN MAR STAT AG; Swedish Institute for Communicable Disease Control, 2010, INFL VECK 1 4 1 10 1; Tanner H, 2012, EUR J CLIN MICROBIOL, V31, P3001, DOI 10.1007/s10096-012-1653-3; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; WAGNER RR, 1960, BACTERIOL REV, V24, P151, DOI 10.1128/MMBR.24.1.151-166.1960; Wang JH, 2009, LARYNGOSCOPE, V119, P1406, DOI 10.1002/lary.20498; Wright PF, 2007, J CLIN MICROBIOL, V45, P2126, DOI 10.1128/JCM.02553-06; Yang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045807	27	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51491	10.1371/journal.pone.0051491	http://dx.doi.org/10.1371/journal.pone.0051491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272110	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386800048
J	Hayashi, K; Morita, T				Hayashi, Ken'ichiro; Morita, Tsuyoshi			Differences in the Nuclear Export Mechanism between Myocardin and Myocardin-related Transcription Factor A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; MUSCLE GENE-EXPRESSION; MEGAKARYOBLASTIC LEUKEMIA; ACTIN; SRF; COACTIVATOR; LOCALIZATION; PROTEINS; COFACTOR; IMPORT	Myocardin (Mycd), a key factor in smooth muscle cell differentiation, is constitutively located in the nucleus, whereas myocardin-related transcription factors A and B (MRTF-A/B) reside mostly in the cytoplasm and translocate to the nucleus in a Rho-dependent manner. Here, we investigated the nuclear export of Mycd family members. They possess two leucine-rich sequences: L1 in the N terminus and L2 in the Gln-rich domain. Although L2 (but not L1) served as a CRM1-binding site for Mycd, CRM1-mediated nuclear export did not affect its subcellular localization. Serum response factor (SRF) competitively inhibited Mycd/CRM1 interaction. Furthermore, such interaction was autonomously inhibited. The N terminus of Mycd bound intramolecularly to Mycd, resulting in masking L2. In contrast, the CRM1-binding affinity of MRTF-A was much higher than that of Mycd because both L1 and L2 of MRTF-A served as functional CRM1-binding sites, and the autoinhibition observed in the Mycd/CRM1 interaction was absent in the MRTF-A/CRM1 interaction. Additionally, because the SRF-binding affinity of MRTF-A was lower than that of Mycd, the inhibitory effect of SRF on the MRTF-A/CRM1 interaction was weak. Thus, MRTF-A is much more likely to be exported from the nucleus. These differences could be the reason for the distinct subcellular localization of Mycd and MRTF-A.	[Hayashi, Ken'ichiro; Morita, Tsuyoshi] Osaka Univ, Grad Sch Med, Dept Neurosci D13, Suita, Osaka 5650871, Japan	Osaka University	Hayashi, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci D13, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	khayashi@nbiochem.med.osaka-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [23590332]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 23590332 from the Ministry of Education, Science, Sports and Culture of Japan ( to K. H.).	Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hieda M, 1999, J CELL BIOL, V144, P645, DOI 10.1083/jcb.144.4.645; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Moroianu J, 1998, J CELL BIOCHEM, V70, P231; Mouilleron S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001750; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Nakamura S, 2010, J BIOL CHEM, V285, P37314, DOI 10.1074/jbc.M110.180786; Nakielny S, 1997, CURR OPIN CELL BIOL, V9, P420, DOI 10.1016/S0955-0674(97)80016-6; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ransom JF, 2008, J BIOL CHEM, V283, P35845, DOI 10.1074/jbc.M805909200; Settleman J, 2003, MOL CELL, V11, P1121, DOI 10.1016/S1097-2765(03)00189-8; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425	30	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5743	5755		10.1074/jbc.M112.408120	http://dx.doi.org/10.1074/jbc.M112.408120			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23283978	Green Published, hybrid			2022-12-25	WOS:000315342500046
J	Harper, KN; Fyumagwa, RD; Hoare, R; Wambura, PN; Coppenhaver, DH; Sapolsky, RM; Alberts, SC; Tung, J; Rogers, J; Kilewo, M; Batamuzi, EK; Leendertz, FH; Armelagos, GJ; Knauf, S				Harper, Kristin N.; Fyumagwa, Robert D.; Hoare, Richard; Wambura, Philemon N.; Coppenhaver, Dorian H.; Sapolsky, Robert M.; Alberts, Susan C.; Tung, Jenny; Rogers, Jeffrey; Kilewo, Morris; Batamuzi, Emmanuel K.; Leendertz, Fabian H.; Armelagos, George J.; Knauf, Sascha			Treponema pallidum Infection in the Wild Baboons of East Africa: Distribution and Genetic Characterization of the Strains Responsible	PLOS ONE			English	Article							SEQUENCE CONSERVATION; YAWS; POPULATION; SYPHILIS; DISEASE	It has been known for decades that wild baboons are naturally infected with Treponema pallidum, the bacterium that causes the diseases syphilis (subsp.pallidum), yaws (subsp.pertenue), and bejel (subsp.endemicum) in humans. Recently, a form of T. pallidum infection associated with severe genital lesions has been described in wild baboons at Lake Manyara National Park in Tanzania. In this study, we investigated ten additional sites in Tanzania and Kenya using a combination of macroscopic observation and serology, in order to determine whether the infection was present in each area. In addition, we obtained genetic sequence data from six polymorphic regions using T. pallidum strains collected from baboons at two different Tanzanian sites. We report that lesions consistent with T. pallidum infection were present at four of the five Tanzanian sites examined, and serology was used to confirm treponemal infection at three of these. By contrast, no signs of treponemal infection were observed at the six Kenyan sites, and serology indicated T. pallidum was present at only one of them. A survey of sexually mature baboons at Lake Manyara National Park in 2006 carried out as part of this study indicated that roughly ten percent displayed T. pallidum-associated lesions severe enough to cause major structural damage to the genitalia. Finally, we found that T. pallidum strains from Lake Manyara National Park and Serengeti National Park were genetically distinct, and a phylogeny suggested that baboon strains may have diverged prior to the clade containing human strains. We conclude that T. pallidum infection associated with genital lesions appears to be common in the wild baboons of the regions studied in Tanzania. Further study is needed to elucidate the infection's transmission mode, its associated morbidity and mortality, and the relationship between baboon and human strains.	[Harper, Kristin N.] Columbia Univ, Med Ctr, Dept Environm Hlth Sci, New York, NY 10027 USA; [Fyumagwa, Robert D.; Hoare, Richard] Tanzania Wildlife Res Inst, Wildlife Vet Program, Arusha, Tanzania; [Wambura, Philemon N.] Sokoine Univ Agr, Fac Vet Med, Dept Vet Microbiol & Parasitol, Morogoro, Tanzania; [Coppenhaver, Dorian H.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Sapolsky, Robert M.] Stanford Univ, Stanford, CA 94305 USA; [Sapolsky, Robert M.; Alberts, Susan C.] Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya; [Alberts, Susan C.] Duke Univ, Dept Biol, Durham, NC USA; [Tung, Jenny] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Tung, Jenny] Duke Univ, Populat Res Inst, Durham, NC USA; [Rogers, Jeffrey] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Kilewo, Morris] Tanzania Natl Pk, Dept Ecol, Arusha, Tanzania; [Batamuzi, Emmanuel K.] Sokoine Univ Agr, Dept Vet Surg & Theriogenol, Morogoro, Tanzania; [Leendertz, Fabian H.] Robert Koch Inst, Res Grp Emerging Zoonoses, Berlin, Germany; [Armelagos, George J.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Knauf, Sascha] Leibniz Inst Primate Res, German Primate Ctr, Pathol Unit, Gottingen, Germany	Columbia University; Sokoine University of Agriculture; University of Texas System; University of Texas Medical Branch Galveston; Stanford University; Duke University; Duke University; Duke University; Baylor College of Medicine; Sokoine University of Agriculture; Robert Koch Institute; Emory University; Deutsches Primatenzentrum (DPZ)	Harper, KN (corresponding author), Columbia Univ, Med Ctr, Dept Environm Hlth Sci, New York, NY 10027 USA.	kh2383@columbia.edu	Knauf, Sascha/F-1661-2017; Leendertz, Fabian Hubertus/H-8902-2019	Knauf, Sascha/0000-0001-5744-4946; 	National Science Foundation [0622399]; Wenner-Gren Foundation; The Messerli Foundation of Switzerland; Robert Wood Johnson Health & Society Scholar; Howard Hughes Medical Institute; German Academic Exchange Program [D/06/43974]; Christian Vogel Fond; World Association of Zoos and Aquariums [07002]; University of Leipzig; Justis Liebig University; Wuppertal Zoo; German Primate Centre; Robert-Koch-Institute; Scil Animal Care Company; Telinject Inc.; Translogistic Inc.;  [5-R25-CA 094061]; NATIONAL CANCER INSTITUTE [R25CA094061] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; The Messerli Foundation of Switzerland; Robert Wood Johnson Health & Society Scholar; Howard Hughes Medical Institute(Howard Hughes Medical Institute); German Academic Exchange Program(Deutscher Akademischer Austausch Dienst (DAAD)); Christian Vogel Fond; World Association of Zoos and Aquariums; University of Leipzig; Justis Liebig University; Wuppertal Zoo; German Primate Centre; Robert-Koch-Institute; Scil Animal Care Company; Telinject Inc.; Translogistic Inc.; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by dissertation improvement grants from the National Science Foundation (Award Number 0622399) and the Wenner-Gren Foundation to KNH as well as by The Messerli Foundation of Switzerland. KNH was a Cancer Epidemiology Training Fellow (5-R25-CA 094061), a Robert Wood Johnson Health & Society Scholar, and a Howard Hughes Medical Institute Pre-doctoral Fellow at the time of this work. SK received support from the German Academic Exchange Program (grant No. D/06/43974), the Christian Vogel Fond 2006, World Association of Zoos and Aquariums (project No. 07002), University of Leipzig, Justis Liebig University, and the Wuppertal Zoo. The German Primate Centre, Robert-Koch-Institute, Scil Animal Care Company, Telinject Inc., and Translogistic Inc. also supported analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project received support from the Scil Animal Care Company, Telinject Inc., and Translogistic Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baylet R, 1971, Bull Soc Pathol Exot Filiales, V64, P842; Baylet R, 1971, Bull Soc Pathol Exot Filiales, V64, P836; Cameron CE, 1999, INFECT IMMUN, V67, P3168, DOI 10.1128/IAI.67.6.3168-3170.1999; Cameron CE, 2000, J INFECT DIS, V181, P1401, DOI 10.1086/315399; Cejkova D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001471; Centurion-Lara A, 1998, J INFECT DIS, V177, P1036, DOI 10.1086/515247; Centurion-Lara A, 2006, J CLIN MICROBIOL, V44, P3377, DOI 10.1128/JCM.00784-06; Charpentier MJE, 2012, MOL ECOL, V21, P715, DOI 10.1111/j.1365-294X.2011.05302.x; Cousins D., 1972, International Zoo Yearbook, V12, P211, DOI 10.1111/j.1748-1090.1972.tb02330.x; FELSENFELD O, 1971, FOLIA PRIMATOL, V16, P294, DOI 10.1159/000155411; FRIBOURG-BLANC A, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P54; Fribourg-Blanc A, 1969, Primates Med, V3, P113; FRIBOURGBLANC A, 1972, B SOC FR DERMATOL SY, V79, P454; Gray RR, 2006, MOL BIOL EVOL, V23, P2220, DOI 10.1093/molbev/msl092; Hackett C.J., 1953, B WORLD HEALTH ORGAN, V8, P127; Harper KN, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000148; Izard J, 1999, J BACTERIOL, V181, P6739, DOI 10.1128/JB.181.21.6739-6746.1999; KARESH W, 2000, CANOPEE, V18, P16; Knauf S, 2012, VET PATHOL, V49, P292, DOI 10.1177/0300985811402839; Kuhn U, 1970, TREPONEMATOSES, V3, P71; Levrero F, 2007, AM J PHYS ANTHROPOL, V132, P568, DOI 10.1002/ajpa.20560; Lovell NC, 2000, PRIMATES, V41, P275, DOI 10.1007/BF02557597; Maurice J, 2012, LANCET, V379, P1377, DOI 10.1016/S0140-6736(12)60581-9; Mlengeya T. D. K., 2004, DISTRIBUTION PATTERN; MOLLARET H H, 1967, Medecine d'Afrique Noire, V14, P397; NOORDHOEK GT, 1990, INFECT IMMUN, V58, P2011, DOI 10.1128/IAI.58.6.2011-2013.1990; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Smajs D, 2012, INFECT GENET EVOL, V12, P191, DOI 10.1016/j.meegid.2011.12.001; Smajs D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020415; SMITH JL, 1971, BRIT J VENER DIS, V47, P226; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wallis J, 1999, INT J PRIMATOL, V20, P803, DOI 10.1023/A:1020879700286	33	40	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e50882	10.1371/journal.pone.0050882	http://dx.doi.org/10.1371/journal.pone.0050882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284649	Green Published, gold			2022-12-25	WOS:000312794500017
J	Liu, O; Jia, LX; Liu, XX; Wang, YL; Wang, XL; Qin, YW; Du, J; Zhang, HJ				Liu, Ou; Jia, Lixin; Liu, Xiaoxi; Wang, Yueli; Wang, Xiaolong; Qin, Yanwen; Du, Jie; Zhang, Hongjia			Clopidogrel, a Platelet P2Y12 Receptor Inhibitor, Reduces Vascular Inflammation and Angiotensin II Induced-Abdominal Aortic Aneurysm Progression	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; WALL STRESS; MATRIX METALLOPROTEINASES; EXPRESSION; ATHEROSCLEROSIS; TRANSPLANTS; DISSECTION; THROMBUS; RUPTURE; DISEASE	Medial degeneration and inflammation are features of abdominal aortic aneurysms (AAAs). However, the early inflammatory event initiating aneurysm formation remains to be identified. Activated platelets release abundant proinflammatory cytokines and are involved in initial inflammation in various vascular diseases. We investigated the role of platelets in progression of AAA in vivo and in vitro. Histological studies of tissues of patients with AAA revealed that the number of platelets was increased in aneurysm sites along with the increased infiltration of T lymphocytes and augmented angiogenesis. In a murine model of AAA, apolipoprotein E-knockout mice infused with 1,000 ng/kg/min angiotensin II, treatment with clopidogrel, an inhibitor of platelets, significantly suppressed aneurysm formation (47% decrease, P<0.05). The clopidogrel also suppressed changes in aortic expansion, elastic lamina degradation and inflammatory cytokine expression. Moreover, the infiltration of macrophages and production of matrix metalloproteinases (MMPs) were also significantly reduced by clopidogrel treatment. In vitro incubation of macrophages with isolated platelets stimulated MMP activity by 45%. These results demonstrate a critical role for platelets in vascular inflammation and AAA progression.	[Liu, Ou; Jia, Lixin; Liu, Xiaoxi; Wang, Yueli; Qin, Yanwen; Du, Jie; Zhang, Hongjia] Capital Med Univ, Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China; [Liu, Ou; Jia, Lixin; Liu, Xiaoxi; Wang, Yueli; Qin, Yanwen; Du, Jie; Zhang, Hongjia] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Liu, Ou; Liu, Xiaoxi; Wang, Xiaolong; Zhang, Hongjia] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiovasc Surg, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Du, J (corresponding author), Capital Med Univ, Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China.	jdu@bcm.edu; zhanghongjia722@hotmail.com	Liu, Ou/O-1168-2016; Qin, Yanwen/AAM-6961-2020	Qin, Yanwen/0000-0002-5185-9726	National Natural Science Foundation of China [81170283, 30872536, 81070251]; Beijing Natural Science Foundation [7112041]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1074]; International Science & Technology Cooperation Program of China [2010DFB30040]; Program for New Century Excellent Talents in University [NCET-11-0899]; Scientific Research Common Program of Beijing Municipal Commission of Education [SQKM201210025017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); International Science & Technology Cooperation Program of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Research Common Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	This study was supported by grants from the National Natural Science Foundation of China (81170283, 30872536, and 81070251), Beijing Natural Science Foundation (7112041), Program for Changjiang Scholars and Innovative Research Team in University (IRT1074), International Science & Technology Cooperation Program of China (2010DFB30040), Program for New Century Excellent Talents in University (NCET-11-0899), and Scientific Research Common Program of Beijing Municipal Commission of Education (SQKM201210025017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; BRADBURY AW, 1995, J VASC SURG, V21, P484, DOI 10.1016/S0741-5214(95)70291-1; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Chen XL, 1998, CIRC RES, V83, P952; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; Dai JP, 2009, J VASC SURG, V49, P719, DOI 10.1016/j.jvs.2008.09.057; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; FOUSER LS, 1980, AM J CLIN PATHOL, V74, P701; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Gresele P, 1998, J CLIN INVEST, V101, P667, DOI 10.1172/JCI575; Hans SS, 2005, J VASC SURG, V41, P584, DOI 10.1016/j.jvs.2005.01.004; Hao L, 2006, ARTERIOSCL THROM VAS, V26, P819, DOI 10.1161/01.ATV.0000204344.90301.7c; HARA K, 1991, INT J CARDIOL, V32, P231, DOI 10.1016/0167-5273(91)90330-R; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Herbert JM, 2004, EXPERT OPIN INV DRUG, V13, P457, DOI 10.1517/13543784.13.5.457; Kajimoto K, 2009, ATHEROSCLEROSIS, V206, P505, DOI 10.1016/j.atherosclerosis.2009.03.028; KAMP TJ, 1994, AM HEART J, V128, P1234, DOI 10.1016/0002-8703(94)90756-0; Kantelhardt Sven R, 2003, Cardiol Rev, V11, P240, DOI 10.1097/01.CRD.0000078443.08887.28; Kintscher U, 2002, CIRC RES, V91, pE35, DOI 10.1161/01.RES.0000046017.96083.34; Kirk AD, 2009, AM J TRANSPLANT, V9, P14, DOI 10.1111/j.1600-6143.2008.02473.x; Ko HM, 2005, FEBS LETT, V579, P6451, DOI 10.1016/j.febslet.2005.10.027; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Krettek A, 2003, ARTERIOSCL THROM VAS, V23, P582, DOI 10.1161/01.ATV.0000064372.78561.A5; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; Lehoux S, 2004, CIRCULATION, V109, P1041, DOI 10.1161/01.CIR.0000115521.95662.7A; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Patel SR, 2009, J CLIN INVEST, V119, P2787, DOI 10.1172/JCI39590; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Risinger GM, 2006, J BIOL CHEM, V281, P25915, DOI 10.1074/jbc.M513513200; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Satta J, 1996, J VASC SURG, V23, P737, DOI 10.1016/S0741-5214(96)80062-0; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; Thompson RW, 2002, NEW ENGL J MED, V346, P1484, DOI 10.1056/NEJM200205093461910; Truijers M, 2007, EUR J VASC ENDOVASC, V33, P401, DOI 10.1016/j.ejvs.2006.10.009; Venkatasubramaniam AK, 2004, EUR J VASC ENDOVASC, V28, P168, DOI 10.1016/j.ejvs.2004.03.029; Weyrich A, 2007, CURR PHARM DESIGN, V13, P1685, DOI 10.2174/138161207780831374; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zhao LZ, 2009, J NEUROSCI, V29, P3603, DOI 10.1523/JNEUROSCI.5302-08.2009	47	49	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51707	10.1371/journal.pone.0051707	http://dx.doi.org/10.1371/journal.pone.0051707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284748	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500040
J	Takizawa, H; Hiroi, N; Funahashi, A				Takizawa, Hiromu; Hiroi, Noriko; Funahashi, Akira			Mathematical Modeling of Sustainable Synaptogenesis by Repetitive Stimuli Suggests Signaling Mechanisms In Vivo	PLOS ONE			English	Article							LONG-TERM POTENTIATION; LASTING SYNAPTIC ENHANCEMENT; LATE-PHASE LTP; PROTEIN-SYNTHESIS; DENDRITIC SPINE; DENTATE GYRUS; ACTIN POLYMERIZATION; POSTSYNAPTIC DENSITY; HIPPOCAMPAL-NEURONS; MESSENGER-RNA	The mechanisms of long-term synaptic maintenance are a key component to understanding the mechanism of long-term memory. From biological experiments, a hypothesis arose that repetitive stimuli with appropriate intervals are essential to maintain new synapses for periods of longer than a few days. We successfully reproduce the time-course of relative numbers of synapses with our mathematical model in the same conditions as biological experiments, which used Adenosine-3', 5'-cyclic monophosphorothioate, Sp-isomer (Sp-cAMPS) as external stimuli. We also reproduce synaptic maintenance responsiveness to intervals of Sp-cAMPS treatment accompanied by PKA activation. The model suggests a possible mechanism of sustainable synaptogenesis which consists of two steps. First, the signal transduction from an external stimulus triggers the synthesis of a new signaling protein. Second, the new signaling protein is required for the next signal transduction with the same stimuli. As a result, the network component is modified from the first network, and a different signal is transferred which triggers the synthesis of another new signaling molecule. We refer to this hypothetical mechanism as network succession. We build our model on the basis of two hypotheses: (1) a multi-step network succession induces downregulation of SSH and COFILIN gene expression, which triggers the production of stable F-actin; (2) the formation of a complex of stable F-actin with Drebrin at PSD is the critical mechanism to achieve long-term synaptic maintenance. Our simulation shows that a three-step network succession is sufficient to reproduce sustainable synapses for a period longer than 14 days. When we change the network structure to a single step network, the model fails to follow the exact condition of repetitive signals to reproduce a sufficient number of synapses. Another advantage of the three-step network succession is that this system indicates a greater tolerance of parameter changes than the single step network.	[Takizawa, Hiromu; Hiroi, Noriko; Funahashi, Akira] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan	Keio University	Hiroi, N (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan.	hiroi@bio.keio.ac.jp	Hiroi, Noriko/D-2467-2014; Funahashi, Akira/C-4923-2014; Hiroi, Noriko/AAE-2657-2019	Hiroi, Noriko/0000-0002-0214-373X; Funahashi, Akira/0000-0003-0605-239X; Hiroi, Noriko/0000-0002-0214-373X	Japan Society for the Promotion of Science (JSPS); KAKENHI [22710221]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research, KAKENHI 22710221 (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay SM, 2004, EUR J NEUROSCI, V20, P2671, DOI 10.1111/j.1460-9568.2004.03725.x; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Aslam N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.38; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bhalla US, 2002, METHOD ENZYMOL, V345, P3; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Breindl C, 2010, POSTPRINT SERIES STU, V2009-42, P1; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Dailey ME, 1996, J NEUROSCI, V16, P2983; de Lecea L, 1998, J NEUROSCI RES, V53, P269, DOI 10.1002/(SICI)1097-4547(19980801)53:3<269::AID-JNR1>3.0.CO;2-8; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Fiala JC, 1998, J NEUROSCI, V18, P8900; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hu NW, 2003, J NEUROPHYSIOL, V89, P2354, DOI 10.1152/jn.01027.2002; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Johnson OL, 2004, BRAIN RES, V996, P89, DOI 10.1016/j.brainres.2003.10.011; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kawaai K, 2010, J NEUROSCI RES, V88, P2911, DOI 10.1002/jnr.22457; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kubota Y, 2001, J COMPUT NEUROSCI, V11, P263, DOI 10.1023/A:1013727331979; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Moodie S., 2011, NAT PREC, DOI [10.1038/npre.2011.3721.4, DOI 10.1038/NPRE.2011.3721.4]; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Ostroff LE, 2010, P NATL ACAD SCI USA, V107, P9418, DOI 10.1073/pnas.0913384107; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Takahashi H, 2003, J NEUROSCI, V23, P6586; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Taniguchi N, 2006, NEUROSCI LETT, V406, P38, DOI 10.1016/j.neulet.2006.06.071; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tominaga-Yoshino K, 2002, NEUROSCI RES, V44, P357, DOI 10.1016/S0168-0102(02)00155-4; Tominaga-Yoshino K, 2008, HIPPOCAMPUS, V18, P281, DOI 10.1002/hipo.20391; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; WALSH DA, 1971, J BIOL CHEM, V246, P1977; Yamamoto M, 2005, BRAIN RES, V1042, P6, DOI 10.1016/j.brainres.2005.01.102; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	84	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51000	10.1371/journal.pone.0051000	http://dx.doi.org/10.1371/journal.pone.0051000			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284653	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500018
J	Albi, E; Curcio, F; Spelat, R; Lazzarini, A; Lazzarini, R; Cataldi, S; Loreti, E; Ferri, I; Ambesi-Impiombato, FS				Albi, Elisabetta; Curcio, Francesco; Spelat, Renza; Lazzarini, Andrea; Lazzarini, Remo; Cataldi, Samuela; Loreti, Elisabetta; Ferri, Ivana; Ambesi-Impiombato, Francesco Saverio			Loss of Parafollicular Cells during Gravitational Changes (Microgravity, Hypergravity) and the Secret Effect of Pleiotrophin	PLOS ONE			English	Article							THYROID C-CELLS; FOLLICULAR CELLS; IN-VITRO; RATS; HYPOTHYROIDISM; EXPRESSION; RECEPTOR; MODELS; GLAND	It is generally known that bone loss is one of the most important complications for astronauts who are exposed to long-term microgravity in space. Changes in blood flow, systemic hormones, and locally produced factors were indicated as important elements contributing to the response of osteoblastic cells to loading, but research in this field still has many questions. Here, the possible biological involvement of thyroid C cells is being investigated. The paper is a comparison between a case of a wild type single mouse and a over-expressing pleiotrophin single mouse exposed to hypogravity conditions during the first animal experiment of long stay in International Space Station (91 days) and three similar mice exposed to hypergravity (2Gs) conditions. We provide evidence that both microgravity and hypergravity induce similar loss of C cells with reduction of calcitonin production. Pleiotrophin over-expression result in some protection against negative effects of gravity change. Potential implication of the gravity mechanic forces in the regulation of bone homeostasis via thyroid equilibrium is discussed.	[Albi, Elisabetta; Lazzarini, Andrea] Ctr Ric Anal Biochim Specialist, Lab Nucl Lipid BioPathol, Perugia, Italy; [Curcio, Francesco; Spelat, Renza; Lazzarini, Andrea; Lazzarini, Remo; Cataldi, Samuela; Ambesi-Impiombato, Francesco Saverio] Univ Udine, Dept Clin & Biol Sci, I-33100 Udine, Italy; [Loreti, Elisabetta; Ferri, Ivana] Univ Perugia, Inst Pathol Anat & Histol, I-06100 Perugia, Italy	University of Udine; University of Perugia	Albi, E (corresponding author), Ctr Ric Anal Biochim Specialist, Lab Nucl Lipid BioPathol, Perugia, Italy.	elisabetta.albi@yahoo.com	Spelat, Renza/AAZ-2980-2021; Curcio, Francesco/K-4669-2014; Albi, Elisabetta/K-3369-2016	Spelat, Renza/0000-0001-5794-8976; Albi, Elisabetta/0000-0002-5745-5343; CURCIO, Francesco/0000-0002-9070-4807	Italian Space Agenzy	Italian Space Agenzy	Italian Space Agenzy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHREN B, 1991, ACTA ENDOCRINOL-COP, V124, P225, DOI 10.1530/acta.0.1240225; Albi E, 2012, ARCH BIOCHEM BIOPHYS, V518, P16, DOI 10.1016/j.abb.2011.12.001; Carmeliet G, 2001, CRIT REV EUKAR GENE, V11, P131; Dadan J, 2001, FOLIA HISTOCHEM CYTO, V39, P189; Dai KS, 2009, THROMB HAEMOSTASIS, V101, P902, DOI 10.1160/TH08-11-0750; De Miguel M, 2005, HISTOL HISTOPATHOL, V20, P713, DOI 10.14670/HH-20.713; Esenyel M, 2012, RHEUMATOL INT, V28; Giangregorio L, 2002, SPORTS MED, V32, P459, DOI 10.2165/00007256-200232070-00005; Gorgiladze G I, 2011, Aviakosm Ekolog Med, V45, P28; Heer M, 2002, NUTRITION, V18, P853, DOI 10.1016/S0899-9007(02)00905-X; Heer M, 1999, Eur J Med Res, V4, P357; KALISNIK M, 1988, AM J ANAT, V183, P148, DOI 10.1002/aja.1001830205; Klein-Nulend J, 2003, ADV SPACE RES-SERIES, V32, P1551, DOI 10.1016/S0273-1177(03)90395-4; Loomer PM, 2001, CRIT REV ORAL BIOL M, V12, P252, DOI 10.1177/10454411010120030401; Manzano AI, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-105; Martin-Lacave I, 2009, J ANAT, V214, P301, DOI 10.1111/j.1469-7580.2008.01044.x; Martinez DA, 1998, AVIAT SPACE ENVIR MD, V69, pA17; Masini MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035418; Morillo-Bernal J, 2009, J ANAT, V215, P150, DOI 10.1111/j.1469-7580.2009.01095.x; SAWICKI B, 1995, ACTA HISTOCHEM, V97, P389, DOI 10.1016/S0065-1281(11)80064-4; Tare RS, 2002, J BONE MINER RES, V17, P2009, DOI 10.1359/jbmr.2002.17.11.2009; Tavella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033179; Usenko VS, 1999, ANAT REC, V256, P7; Zbucki RL, 2007, FOLIA HISTOCHEM CYTO, V45, P115	24	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e48518	10.1371/journal.pone.0048518	http://dx.doi.org/10.1371/journal.pone.0048518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284618	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300005
J	Calverley, M; Erickson, S; Read, AJ; Harmsen, AG				Calverley, Matthew; Erickson, Sara; Read, Amanda J.; Harmsen, Allen G.			Resident Alveolar Macrophages Are Susceptible to and Permissive of Coxiella burnetii Infection	PLOS ONE			English	Article							INFLAMMATORY DENDRITIC CELLS; Q-FEVER; FUNCTIONAL-CHARACTERIZATION; CHEMOKINE RECEPTOR; MICE; MONOCYTES; LUNG; RESPONSES; KINETICS; ANTIGEN	Coxiella burnetii, the causative agent of Q fever, is a zoonotic disease with potentially life-threatening complications in humans. Inhalation of low doses of Coxiella bacteria can result in infection of the host alveolar macrophage (AM). However, it is not known whether a subset of AMs within the heterogeneous population of macrophages in the infected lung is particularly susceptible to infection. We have found that lower doses of both phase I and phase II Nine Mile C. burnetii multiply and are less readily cleared from the lungs of mice compared to higher infectious doses. We have additionally identified AM resident within the lung prior to and shortly following infection, opposed to newly recruited monocytes entering the lung during infection, as being most susceptible to infection. These resident cells remain infected up to twelve days after the onset of infection, serving as a permissive niche for the maintenance of bacterial infection. A subset of infected resident AMs undergo a distinguishing phenotypic change during the progression of infection exhibiting an increase in surface integrin CD11b expression and continued expression of the surface integrin CD11c. The low rate of phase I and II Nine Mile C. burnetii growth in murine lungs may be a direct result of the limited size of the susceptible resident AM cell population.	[Calverley, Matthew; Erickson, Sara; Harmsen, Allen G.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Read, Amanda J.] Univ Texas San Antonio, Off Senior Associate Vice President Res, San Antonio, TX USA	Montana State University System; Montana State University Bozeman; University of Texas System; University of Texas at San Antonio (UTSA)	Harmsen, AG (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	aharmsen@montana.edu			National Institutes of Health/Rocky Mountain Regional Center of Excellence [U54-AI06535]; NIH/COBRE [P20GM103500]; INBRE-BRIN [P20GM103474]; Montana State University Agricultural Station; MJ Murdock Charitable Trust; National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NIH/NIAID [F31AI081492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI081492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103500, P20GM103474] Funding Source: NIH RePORTER	National Institutes of Health/Rocky Mountain Regional Center of Excellence; NIH/COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INBRE-BRIN(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Montana State University Agricultural Station; MJ Murdock Charitable Trust; National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NIH/NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/Rocky Mountain Regional Center of Excellence GRANT# U54-AI06535, NIH/COBRE GRANT#P20GM103500 and INBRE-BRIN GRANT# P20GM103474. Additional support was provided through The Montana State University Agricultural Station and the MJ Murdock Charitable Trust. This research was also supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award F31AI081492 from the NIH/NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh M, 2003, INFECT IMMUN, V71, P4717, DOI 10.1128/IAI.71.8.4717-4723.2003; BARBOSA IL, 1991, CLIN EXP IMMUNOL, V86, P173; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Burges A, 1997, Eur J Med Res, V2, P149; Chen L, 2000, CLIN EXP IMMUNOL, V120, P125, DOI 10.1046/j.1365-2249.2000.01196.x; Chen L, 2001, EUR J IMMUNOL, V31, P265, DOI 10.1002/1521-4141(200101)31:1<265::AID-IMMU265>3.3.CO;2-C; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1; da Silva MF, 2011, IMMUNOBIOLOGY, V216, P821, DOI 10.1016/j.imbio.2010.12.002; Davidson BA, 2005, EXP LUNG RES, V31, P323, DOI 10.1080/01902140590918524; Delsing CE, 2011, ADV EXP MED BIOL, V719, P133, DOI 10.1007/978-1-4614-0204-6_12; Denison AM, 2007, FEMS MICROBIOL LETT, V267, P102, DOI 10.1111/j.1574-6968.2006.00544.x; DUDLEY D, 1989, BIOCHEM BIOPH RES CO, V160, P346, DOI 10.1016/0006-291X(89)91662-8; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Gama JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002503; Garn H, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-4; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Goto Y, 2003, AM J PHYSIOL-CELL PH, V285, pC253, DOI 10.1152/ajpcell.00035.2003; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Jager C, 1998, EPIDEMIOL INFECT, V120, P157, DOI 10.1017/S0950268897008510; Jiang-Shieh YF, 2010, J ANAT, V216, P407, DOI 10.1111/j.1469-7580.2009.01190.x; KHAVKIN T, 1988, INFECT IMMUN, V56, P1792, DOI 10.1128/IAI.56.7.1792-1799.1988; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; LEHNERT BE, 1986, J LEUKOCYTE BIOL, V39, P285, DOI 10.1002/jlb.39.3.285; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; Mishra MK, 2012, AM J PATHOL, V181, P642, DOI 10.1016/j.ajpath.2012.05.011; Padigel UM, 2006, INFECT IMMUN, V74, P3232, DOI 10.1128/IAI.02067-05; Read AJ, 2010, INFECT IMMUN, V78, P3019, DOI 10.1128/IAI.00101-10; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Russell-Lodrigue KE, 2006, INFECT IMMUN, V74, P6085, DOI 10.1128/IAI.00763-06; Russell-Lodrigue KE, 2009, INFECT IMMUN, V77, P5640, DOI 10.1128/IAI.00851-09; Schreiber HA, 2011, J CLIN INVEST, V121, P3902, DOI 10.1172/JCI45113; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; STEIN A, 1993, MICROB PATHOGENESIS, V15, P177, DOI 10.1006/mpat.1993.1068; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Waag DM, 2007, VACCINE, V25, P7288, DOI 10.1016/j.vaccine.2007.08.002; Zamboni DS, 2004, INFECT IMMUN, V72, P2395, DOI 10.1128/IAI.72.4.2395-2399.2004	39	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51941	10.1371/journal.pone.0051941	http://dx.doi.org/10.1371/journal.pone.0051941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284825	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300064
J	Elser, JA; Margulies, KB				Elser, Jeremy A.; Margulies, Kenneth B.			Hybrid Mathematical Model of Cardiomyocyte Turnover in the Adult Human Heart	PLOS ONE			English	Article							AGING HUMAN HEART; HYPERTROPHY; APOPTOSIS; RENEWAL; NUCLEI; PLOIDY; LEVEL	Rationale: The capacity for cardiomyocyte regeneration in the healthy adult human heart is fundamentally relevant for both myocardial homeostasis and cardiomyopathy therapeutics. However, estimates of cardiomyocyte turnover rates conflict greatly, with a study employing C14 pulse-chase methodology concluding 1% annual turnover in youth declining to 0.5% with aging and another using cell population dynamics indicating substantial, age-increasing turnover (4% increasing to 20%). Objective: Create a hybrid mathematical model to critically examine rates of cardiomyocyte turnover derived from alternative methodologies. Methods and Results: Examined in isolation, the cell population analysis exhibited severe sensitivity to a stem cell expansion exponent (20% variation causing 2-fold turnover change) and apoptosis rate. Similarly, the pulse-chase model was acutely sensitive to assumptions of instantaneous incorporation of atmospheric C14 into the body (4-fold impact on turnover in young subjects) while numerical restrictions precluded otherwise viable solutions. Incorporating considerations of primary variable sensitivity and controversial model assumptions, an unbiased numerical solver identified a scenario of significant, age-increasing turnover (4-6% increasing to 15-22% with age) that was compatible with data from both studies, provided that successive generations of cardiomyocytes experienced higher attrition rates than predecessors. Conclusions: Assignment of histologically-observed stem/progenitor cells into discrete regenerative phenotypes in the cell population model strongly influenced turnover dynamics without being directly testable. Alternatively, C14 trafficking assumptions and restrictive models in the pulse-chase model artificially eliminated high-turnover solutions. Nevertheless, discrepancies among recent cell turnover estimates can be explained and reconciled. The hybrid mathematical model provided herein permits further examination of these and forthcoming datasets.	[Margulies, Kenneth B.] Univ Penn, Sch Med, Dept Internal Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Elser, Jeremy A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Margulies, KB (corresponding author), Univ Penn, Sch Med, Dept Internal Med, Cardiovasc Inst, Philadelphia, PA 19104 USA.	ken.margulies@uphs.upenn.edu			American Heart Association; National Institutes of Health [R01HL089847]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089847] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by American Heart Association Pre-doctoral Fellowship to JAE and National Institutes of Health R01HL089847 to KBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler C P, 1975, Recent Adv Stud Cardiac Struct Metab, V8, P373; Adler CP, 1991, DEV REGENERATIVE POT, P13; Bayes-Genis A, 2002, CARDIOVASC RES, V56, P404, DOI 10.1016/S0008-6363(02)00597-7; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BRODSKY VY, 1994, VIRCHOWS ARCH, V424, P429; BROECKER WS, 1959, SCIENCE, V130, P331, DOI 10.1126/science.130.3371.331-a; Herget GW, 1997, CARDIOVASC RES, V36, P45, DOI 10.1016/S0008-6363(97)00140-5; Kajstura J, 2012, CIRC RES, V110, pE19, DOI 10.1161/CIRCRESAHA.111.259721; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; Levin I, 2008, SCI TOTAL ENVIRON, V391, P211, DOI 10.1016/j.scitotenv.2007.10.019; Mallat Z, 2001, J GERONTOL A-BIOL, V56, pM719, DOI 10.1093/gerona/56.11.M719; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Parmacek MS, 2009, NEW ENGL J MED, V361, P86, DOI 10.1056/NEJMcibr0903347; Porrello E, 2012, CIRC RES, V107, P1292; Rupp S, 2008, EUR HEART J, V29, P1867, DOI 10.1093/eurheartj/ehn223; Scudamore CL, 2010, COMP CLIN PATHOL, V20, P95; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; TAKAMATSU T, 1983, HISTOCHEMISTRY, V77, P485, DOI 10.1007/BF00495803; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51683	10.1371/journal.pone.0051683	http://dx.doi.org/10.1371/journal.pone.0051683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284740	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300036
J	Garcia, M; Bellosillo, B; Sanchez-Gonzalez, B; Garcia-Payarols, F; Seoane, A; Ferrer, AM; Gimeno, E; Barranco, LE; Torner, A; Sole, F; Besses, C; Serrano, S; Salar, A				Garcia, Mar; Bellosillo, Beatriz; Sanchez-Gonzalez, Blanca; Garcia-Payarols, Francesc; Seoane, Agustin; Maria Ferrer, Ana; Gimeno, Eva; Eugenio Barranco, Luis; Torner, Ariadna; Sole, Francesc; Besses, Carles; Serrano, Sergi; Salar, Antonio			Study of Regulatory T-Cells in Patients with Gastric Malt Lymphoma: Influence on Treatment Response and Outcome	PLOS ONE			English	Article							FOLLICULAR LYMPHOMA; INDEPENDENT PREDICTOR; HIGH NUMBERS; TISSUE; SURVIVAL; MICROENVIRONMENT; CHEMOTHERAPY; FLUDARABINE; EXPRESSION; PROGNOSIS	Purpose: FOXP3+ regulatory T cells (Treg) play an essential role in modulating host responses to tumors and infections. The role of these cells in the pathogenesis of MALT lymphomas remains unknown. The aims of the study were to quantify the number of infiltrating FOXP3+ and CD3+ cells in patients with gastric MALT lymphoma at diagnosis and to study kinetics of these cells and CD20+ tumor cells after treatment and during long-term follow-up. Methods: FOXP3+, CD3+ and CD20+ cells were analyzed by immunohistochemistry and the number of cells was quantified using a micrometric ocular. Samples of 35 patients with gastric MALT lymphoma at diagnosis and after treatment were included. Diagnostic samples were compared to 19 cases of chronic gastritis and diffuse large B-cell lymphoma (DLBCL) of the stomach. Results: The median number of FOXP3+ infiltrating cells was higher (27 cells/cm(2)) in gastric MALT patients than in DLBCL (10 cells; p = 0.162) but similar to chronic gastritis (20 cells; p = 0.605). No characteristic or specific distribution pattern of infiltrating FOXP3+ cells was found. Gastric MALT lymphoma patients responding to bacterial eradication therapy had higher number of FOXP3+ cells at study entry. Kinetics of both infiltrating FOXP3+ cells and tumor CD20+ cells were strongly dependent on the treatment administered. Discussion: Gastric MALT lymphomas have a number of Treg cells more similar to chronic gastritis than to DLBCL. Patients with higher number of tumor infiltrating FOXP3+ cells at study entry seem to have better response to antibiotics. Kinetics of Treg and tumor cells are influenced by type of treatment.	[Garcia, Mar; Bellosillo, Beatriz; Maria Ferrer, Ana; Torner, Ariadna; Sole, Francesc; Serrano, Sergi] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Sanchez-Gonzalez, Blanca; Garcia-Payarols, Francesc; Gimeno, Eva; Besses, Carles; Salar, Antonio] Hosp del Mar, Dept Hematol, Barcelona, Spain; [Seoane, Agustin; Eugenio Barranco, Luis] Hosp del Mar, Dept Gastroenterol, Barcelona, Spain; [Garcia, Mar; Bellosillo, Beatriz; Sanchez-Gonzalez, Blanca; Garcia-Payarols, Francesc; Seoane, Agustin; Maria Ferrer, Ana; Gimeno, Eva; Eugenio Barranco, Luis; Torner, Ariadna; Sole, Francesc; Besses, Carles; Serrano, Sergi; Salar, Antonio] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Garcia, M (corresponding author), Hosp del Mar, Dept Pathol, Barcelona, Spain.	94972@parcdesalutmar.cat	Garcia, Mar/GOG-9086-2022; Solé, Francesc/K-8373-2012; Barranco Priego, Luis/AFV-2437-2022	Garcia, Mar/0000-0003-2078-8205; Solé, Francesc/0000-0002-3251-2161; Barranco Priego, Luis/0000-0002-7352-7415; Ana, Ferrer/0000-0002-3381-9472; Seoane Urgorri, Agustin/0000-0001-8023-4445; Salar, Antonio/0000-0002-4652-4825	Instituto de Salud Carlos III, Spanish Ministry of Science and Technology [FIS-FEDER 07/0586]	Instituto de Salud Carlos III, Spanish Ministry of Science and Technology(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work received grant support from Instituto de Salud Carlos III, Spanish Ministry of Science and Technology grant (FIS-FEDER 07/0586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Alvaro T, 2006, J CLIN ONCOL, V24, P5350, DOI 10.1200/JCO.2006.06.4766; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; Cavalli F, 2001, MALT LYMPHOMAS HEMAT, P241; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Copie-Bergman C, 2003, GUT, V52, P1656, DOI 10.1136/gut.52.11.1656; Craig VJ, 2010, LEUKEMIA, V24, P1186, DOI 10.1038/leu.2010.76; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; de Boer JP, 2011, LEUKEMIA LYMPHOMA, V52, P2262, DOI 10.3109/10428194.2011.607527; de Jong D, 2009, HAEMATOL-HEMATOL J, V94, P70, DOI 10.3324/haematol.13574; Farinha P, 2010, BLOOD, V115, P289, DOI 10.1182/blood-2009-07-235598; Gjerdrum LM, 2007, LEUKEMIA, V21, P2512, DOI 10.1038/sj.leu.2404913; Glas AM, 2007, J CLIN ONCOL, V25, P390, DOI 10.1200/JCO.2006.06.1648; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Isaacson P.G., 2008, WHO CLASSIFICATION T, V4th, P214; Jiang H, 2006, NEW ENGL J MED, V354, P1166, DOI 10.1056/NEJMra055446; Kim WY, 2009, ANN ONCOL, V20, P1688, DOI 10.1093/annonc/mdp056; Lee AM, 2006, J CLIN ONCOL, V24, P5052, DOI 10.1200/JCO.2006.06.4642; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Mittal S, 2008, BLOOD, V111, P5359, DOI 10.1182/blood-2007-08-105395; ROHATINER A, 1994, ANN ONCOL, V5, P397, DOI 10.1093/oxfordjournals.annonc.a058869; Ruskone -Fourmestraux A, 2011, GUT, V60, P747, DOI 10.1136/gut.2010.224949; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salar A, 2005, J CLIN ONCOL, V23, P7361, DOI 10.1200/JCO.2005.02.6138; Salar A, 2009, CANCER, V115, P5210, DOI 10.1002/cncr.24605; Santon A, 2008, LEUKEMIA LYMPHOMA, V49, P1516, DOI 10.1080/10428190802210692; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Yang ZZ, 2007, BLOOD, V110, P2537, DOI 10.1182/blood-2007-03-082578	30	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51681	10.1371/journal.pone.0051681	http://dx.doi.org/10.1371/journal.pone.0051681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284739	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300035
J	Ozersky, T; Evans, DO; Barton, DR				Ozersky, Ted; Evans, David O.; Barton, David R.			Invasive Mussels Alter the Littoral Food Web of a Large Lake: Stable Isotopes Reveal Drastic Shifts in Sources and Flow of Energy	PLOS ONE			English	Article							BENTHIC INVERTEBRATES; DREISSENA-POLYMORPHA; ZEBRA MUSSELS; TROPHIC POSITION; PHOSPHORUS; CARBON; ALGAE; RATIOS; GROWTH; PRESERVATION	We investigated how establishment of invasive dreissenid mussels impacted the structure and energy sources of the littoral benthic food web of a large temperate lake. We combined information about pre- and postdreissenid abundance, biomass, and secondary production of the littoral benthos with results of carbon and nitrogen stable isotope analysis of archival (predreissenid) and recent (postdreissenid) samples of all common benthic taxa. This approach enabled us to determine the importance of benthic and sestonic carbon to the littoral food web before, and more than a decade after dreissenid establishment. Long term dreissenid presence was associated with a 32-fold increase in abundance, 6-fold increase in biomass, and 14-fold increase in secondary production of the littoral benthos. Dreissenids comprised a large portion of the post-invasion benthos, making up 13, 38, and 56% of total abundance, biomass, and secondary production, respectively. The predreissenid food web was supported primarily by benthic primary production, while sestonic material was relatively more important to the postdreissenid food web. The absolute importance of both sestonic material and benthic primary production to the littoral benthos increased considerably following dreissenid establishment. Our results show drastic alterations to food web structure and suggest that dreissenid mussels redirect energy and material from the water column to the littoral benthos both through biodeposition of sestonic material as well as stimulation of benthic primary production.	[Ozersky, Ted; Evans, David O.] Trent Univ, Ontario Minist Nat Resources, Peterborough, ON K9J 7B8, Canada; [Barton, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	Ministry of Natural Resources & Forestry; Trent University; University of Waterloo	Ozersky, T (corresponding author), Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA.	tozersky@gmail.com			Environment Canada; Ontario Ministry of Natural Resources	Environment Canada(CGIAR); Ontario Ministry of Natural Resources	Lake Simcoe Clean Up Fund grant from Environment Canada to the authors, and research funding to DOE from Ontario Ministry of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON D R, 1978, Journal of Great Lakes Research, V4, P27; Beekey MA, 2004, OECOLOGIA, V141, P164, DOI 10.1007/s00442-004-1632-1; BENKE AC, 1993, PROC INT ASSOC THEOR, V25, P15; Botts PS, 1996, J N AM BENTHOL SOC, V15, P179, DOI 10.2307/1467947; BRUNER KA, 1994, J GREAT LAKES RES, V20, P735, DOI 10.1016/S0380-1330(94)71191-6; Campbell LM, 2009, J GREAT LAKES RES, V35, P224, DOI 10.1016/j.jglr.2009.02.002; Eimers MC, 2005, J GREAT LAKES RES, V31, P322; Evans DO, 2011, J GREAT LAKES RES, V37, P36, DOI 10.1016/j.jglr.2011.04.002; Evans DO, 1996, CAN J FISH AQUAT SCI, V53, P194, DOI 10.1139/cjfas-53-S1-194; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Garton DW, 2005, CAN J FISH AQUAT SCI, V62, P1119, DOI 10.1139/F05-025; Gergs R, 2011, BIOL INVASIONS, V13, P2727, DOI 10.1007/s10530-011-9943-8; Gergs R, 2009, FRESHWATER BIOL, V54, P1379, DOI 10.1111/j.1365-2427.2009.02188.x; Gorokhova E, 2005, OECOLOGIA, V143, P251, DOI 10.1007/s00442-004-1791-0; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Hecky RE, 2004, CAN J FISH AQUAT SCI, V61, P1285, DOI 10.1139/F04-065; Hershey AE, 2006, LIMNOL OCEANOGR, V51, P177, DOI 10.4319/lo.2006.51.1.0177; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; Hill WR, 2008, LIMNOL OCEANOGR, V53, P1217, DOI 10.4319/lo.2008.53.4.1217; Hiriart-Baer VP, 2011, J GREAT LAKES RES, V37, P764, DOI 10.1016/j.jglr.2011.08.014; IZVEKOVA E I, 1972, Polskie Archiwum Hydrobiologii, V19, P203; Korinkova Tereza, 2011, Malacologica Bohemoslovaca, V10, P1; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; Limen H, 2005, J GREAT LAKES RES, V31, P97, DOI 10.1016/S0380-1330(05)70241-0; Lombardo P, 2002, ARCH HYDROBIOL, V155, P667; Lorrain A, 2003, ANAL CHIM ACTA, V491, P125, DOI 10.1016/S0003-2670(03)00815-8; MacLeod NA, 1998, CAN J FISH AQUAT SCI, V55, P1919, DOI 10.1139/cjfas-55-8-1919; Malkin SY, 2008, LIMNOL OCEANOGR, V53, P1111, DOI 10.4319/lo.2008.53.3.1111; Mayer CM, 2002, J N AM BENTHOL SOC, V21, P616, DOI 10.2307/1468434; MERRITT R. W., 1996, INTRO AQUATIC INSECT; Mills EL, 2003, CAN J FISH AQUAT SCI, V60, P471, DOI 10.1139/F03-033; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mitchell MJ, 1996, CAN J FISH AQUAT SCI, V53, P1445, DOI 10.1139/cjfas-53-6-1445; MORIN A, 1992, CAN J FISH AQUAT SCI, V49, P532, DOI 10.1139/f92-063; Morrison HA, 1998, ENVIRON SCI TECHNOL, V32, P3862, DOI 10.1021/es980434i; MURVOSH CM, 1971, ECOL MONOGR, V41, P79, DOI 10.2307/1942436; Nilsson E, 2012, FRESHWATER BIOL, V57, P10, DOI 10.1111/j.1365-2427.2011.02688.x; Ozersky T, 2011, J N AM BENTHOL SOC, V30, P913, DOI 10.1899/10-122.1; Ozersky T, 2009, J GREAT LAKES RES, V35, P321, DOI 10.1016/j.jglr.2009.05.001; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Rennie MD, 2012, CAN J ZOOL, V90, P1320, DOI 10.1139/z2012-101; Rennie MD, 2009, OECOLOGIA, V159, P789, DOI 10.1007/s00442-008-1271-z; STANCZYKOWSKA A, 1993, HYDROBIOLOGIA, V251, P73, DOI 10.1007/BF00007167; Stewart TW, 1998, J N AM BENTHOL SOC, V17, P81, DOI 10.2307/1468053; Strayer DL, 2010, FRESHWATER BIOL, V55, P152, DOI 10.1111/j.1365-2427.2009.02380.x; Vadeboncoeur Y, 2002, BIOSCIENCE, V52, P44, DOI 10.1641/0006-3568(2002)052[0044:PTLBTR]2.0.CO;2; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Ward JM, 2007, DIVERS DISTRIB, V13, P155, DOI 10.1111/j.1472-4642.2007.00336.x; Winter JG, 2011, J GREAT LAKES RES, V37, P63, DOI 10.1016/j.jglr.2010.05.002; Young JD, 2011, J GREAT LAKES RES, V37, P7, DOI 10.1016/j.jglr.2010.12.008	53	36	38	1	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51249	10.1371/journal.pone.0051249	http://dx.doi.org/10.1371/journal.pone.0051249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284673	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900017
J	Xiang, XY; Deng, ZB; Zhuang, XY; Ju, SW; Mu, JY; Jiang, H; Zhang, LF; Yan, J; Miller, D; Zhang, HG				Xiang, Xiaoyu; Deng, ZhongBin; Zhuang, Xiaoying; Ju, Songwen; Mu, Jingyao; Jiang, Hong; Zhang, Lifeng; Yan, Jun; Miller, Donald; Zhang, Huang-Ge			Grhl2 Determines the Epithelial Phenotype of Breast Cancers and Promotes Tumor Progression	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; E-CADHERIN; METASTASIS; DISSEMINATION; CELLS; REGULATOR; STATES	Until now the essential transcription factor that determines the epithelial phenotype of breast cancer has not been identified and its role in epithelial-to-mesenchymal transition (EMT) and tumor progression remain unclear. Here, by analyzing large expression profiles of human breast cancer cells, we found an extraordinary correlation between the expression of Grainyhead transcription factor Grhl2 and epithelial marker E-cadherin. Knockdown of Grhl2 expression by shRNA in human mammary epithelial cell MCF10A leads to down-regulation of E-cadherin and EMT. Grhl2 is down-regulated in disseminated cancer cells that have undergone EMT, and over-expression of Grhl2 is sufficient to induce epithelial gene expression. Large clinical datasets reveal that expression of Grhl2 is significantly associated with poor relapse free survival and increased risk of metastasis in breast cancer patients. In mouse models, over-expression of Grhl2 significantly promotes tumor growth and metastasis. Further testing of several Grhl2 regulated genes leads to the same conclusions that the tumorigenic and metastatic potentials of tumor cells are linked to epithelial phenotype but not mesenchymal phenotype. In conclusion, our findings indicate that Grhl2 plays an essential role in the determination of epithelial phenotype of breast cancers, EMT and tumor progression.	[Zhang, Huang-Ge] Louisville Vet Adm, Med Ctr, Louisville, KY USA; [Xiang, Xiaoyu; Deng, ZhongBin; Zhuang, Xiaoying; Ju, Songwen; Mu, Jingyao; Jiang, Hong; Zhang, Lifeng; Miller, Donald; Zhang, Huang-Ge] Univ Louisville, Brown Canc Ctr, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Yan, Jun] Univ Louisville, Brown Canc Ctr, Dept Med, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Zhang, HG (corresponding author), Louisville Vet Adm, Med Ctr, Louisville, KY USA.	H0Zhan17@louisville.edu	Yan, Jun/A-8988-2008	Miller, Donald/0000-0002-7881-8801	National Institutes of Health (NIH) [RO1CA137037, RO1CA116092]; Louisville Veterans Administration Medical Center (VAMC) Merit Review Grants; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA116092, R01CA137037] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisville Veterans Administration Medical Center (VAMC) Merit Review Grants; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (NIH) (RO1CA137037 and RO1CA116092); the Louisville Veterans Administration Medical Center (VAMC) Merit Review Grants (H.-G.Z.); and a grant from the Susan G. Komen Breast Cancer Foundation. The authors thank Dr. Jerald Ainsworth for editorial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chiu HS, 2010, DEV BIOL, V344, P1071, DOI 10.1016/j.ydbio.2010.05.495; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Filant J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097089; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hajra KM, 2002, CANCER RES, V62, P1613; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Korpal M, 2011, NAT MED ADV; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pyrgaki C, 2011, DEV BIOL, V353, P38, DOI 10.1016/j.ydbio.2011.02.027; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu ZQ, 2008, DEV BIOL, V319, P56, DOI 10.1016/j.ydbio.2008.04.001	41	67	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e50781	10.1371/journal.pone.0050781	http://dx.doi.org/10.1371/journal.pone.0050781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284647	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900009
J	Wong, LP				Wong, Li Ping			Qualitative Inquiry into Premarital Sexual Behaviours and Contraceptive Use among Multiethnic Young Women: Implications for Education and Future Research	PLOS ONE			English	Article							RISK BEHAVIOR; ADOLESCENTS; ATTITUDES; PARENT; INTERVENTIONS; ACCULTURATION; COMMUNICATION; ASSOCIATIONS; RELIGIOSITY; INTERCOURSE	Background: This study was a qualitative investigation into sexual attitudes and behaviours, and contraceptive use among Malaysian youth, based on constructs from the health belief model, theory of reasoned action, and problem behaviour theory. Methods: A total of 34 focus group discussions with 185 participants were conducted among the Malay (35%), Chinese (34%), and Indian (31%) young females between November, 2010 and April, 2011. The participants were secondary school students and university undergraduates from Selangor and the Federal Territory of Kuala Lumpur. Results: The study found a lack of knowledge about sexual issues and contraception among the participants. Many engaged in unprotected sexual intercourse and relied on periodic abstinence, natural methods, and traditional folk pregnancy preventive practices. The findings also revealed numerous categories of factors influencing sexual attitudes and behaviours: ethnic group and religion, level of religiosity, peer pressure and norms, and parental monitoring. With regard to condom use, factors such as embarrassment about condom acquisition, low perceived susceptibility to sexually transmitted infections (STIs), and perceived efficacy of traditional and folk methods of contraception, were uncovered from the discussions. Conclusion: This study underscores the importance of development of culturally specific interventions that address the identified promoting factors of premarital sex. Behavioral interventions to promote condom use should increase awareness about condom effectiveness against not only unwanted pregnancies but also STIs. Citation: Wong LP (2012) Qualitative Inquiry into Premarital Sexual Behaviours and Contraceptive Use among Multiethnic Young Women: Implications for Education and Future Research. PLoS ONE 7(12): e51745. doi:10.1371/journal.pone.0051745	[Wong, Li Ping] Univ Malaya, Dept Social & Prevent Med, Ctr Populat Hlth CePH, Kuala Lumpur, Malaysia; [Wong, Li Ping] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr Univ Malaya, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Wong, LP (corresponding author), Univ Malaya, Dept Social & Prevent Med, Ctr Populat Hlth CePH, Kuala Lumpur, Malaysia.	wonglp@ummc.edu.my	WONG, LI PING/B-2782-2010	WONG, LI PING/0000-0002-0107-0532	University Malaya (High Impact Research Grant) [UM.C/625/1/HIR/034]	University Malaya (High Impact Research Grant)	This study was funded by University Malaya (High Impact Research Grant UM.C/625/1/HIR/034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckwith Jessica, 2006, Mcgill J Med, V9, P119; Brotto LA, 2005, ARCH SEX BEHAV, V34, P613, DOI 10.1007/s10508-005-7909-6; Browning CR, 2005, AM SOCIOL REV, V70, P758, DOI 10.1177/000312240507000502; Doswell Willa M, 2011, J Pediatr Nurs, V26, pe45, DOI 10.1016/j.pedn.2011.03.007; Downing J, 2011, HEALTH EDUC RES, V26, P808, DOI 10.1093/her/cyr019; ERICKSEN KP, 1994, FAM PLANN PERSPECT, V26, P257, DOI 10.2307/2135891; Fishbein M., 1975, BELIEF ATTITUDE INTE; Forehand R, 2005, PERSPECT SEX REPRO H, V37, P13, DOI 10.1363/3701305; Frost JJ, 2008, PERSPECT SEX REPRO H, V40, P94, DOI 10.1363/4009408; Gillmore MR, 2002, J MARRIAGE FAM, V64, P885, DOI 10.1111/j.1741-3737.2002.00885.x; Glynn JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022840; GORGEN R, 1993, STUD FAMILY PLANN, V24, P283, DOI 10.2307/2939222; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Greenhalgh T, 1997, BMJ-BRIT MED J, V315, P740, DOI 10.1136/bmj.315.7110.740; Guzman BL, 2003, J COMMUNITY APPL SOC, V13, P269, DOI 10.1002/casp.735; Hahm HC, 2006, PERSPECT SEX REPRO H, V38, P28, DOI 10.1363/3802806; HEROLD ES, 1983, J SCHOOL HEALTH, V53, P19, DOI 10.1111/j.1746-1561.1983.tb04047.x; Holtzman D, 1995, FAM PLANN PERSPECT, V27, P235, DOI 10.2307/2136175; Huang M.S.L., 1999, CASE STUDY MALAYSIA; Jan JM, 2005, NATL STUDY REPROD RI; Janz NK, 2002, HLTH BEHAV HLTH ED T, P45, DOI DOI 10.1177/109019819101800409; Jessor R., 1977, PROBLEM BEHAV PSYCHO; Kotchick BA, 2001, CLIN PSYCHOL REV, V21, P493, DOI 10.1016/S0272-7358(99)00070-7; Larkins SL, 2007, MED J AUSTRALIA, V186, P513, DOI 10.5694/j.1326-5377.2007.tb01025.x; Lee L. K., 2006, SMJ Singapore Medical Journal, V47, P476; Lefkowitz ES, 2004, J SEX RES, V41, P150, DOI 10.1080/00224490409552223; LEIBLUM S., 2003, SEX RELATSH THER, V18, P473, DOI [10.1080/14681990310001609813, DOI 10.1080/14681990310001609813]; Madkour AS, 2010, J ADOLESCENT HEALTH, V47, P389, DOI 10.1016/j.jadohealth.2010.02.008; METZLER CW, 1994, J BEHAV MED, V17, P419, DOI 10.1007/BF01858012; Miller BC, 2002, J SEX RES, V39, P22, DOI 10.1080/00224490209552115; Miller L, 2002, J ADOLESCENT HEALTH, V31, P401, DOI 10.1016/S1054-139X(02)00403-2; Modeste N N, 1993, Int Q Community Health Educ, V14, P273, DOI 10.2190/1W2E-MXYX-GUGT-FYPR; Mohammodi MR, 2006, INT FAM PLAN PERSPEC, V32, P35, DOI 10.1363/3203506; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Noar SM, 2008, AIDS BEHAV, V12, P335, DOI 10.1007/s10461-007-9313-9; Pedlow CT, 2004, ANN BEHAV MED, V27, P172, DOI 10.1207/s15324796abm2703_5; Reid AE, 2011, PSYCHOL HEALTH, V26, P1499, DOI 10.1080/08870446.2011.572259; Romer D, 1999, ARCH PEDIAT ADOL MED, V153, P1055, DOI 10.1001/archpedi.153.10.1055; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; SHEERAN P, 1993, EUR J SOC PSYCHOL, V23, P39, DOI 10.1002/ejsp.2420230104; Strecher VJ, 1997, HLTH BEHAV HLTH ED T, P113, DOI DOI 10.1111/J.1365-2648.2010.05450.X; Tapia-Aguirre V, 2004, ARCH MED RES, V35, P334, DOI 10.1016/j.arcmed.2004.05.002; Turnbull T, 2008, HEALTH EDUC J, V67, P182, DOI 10.1177/0017896908094636; Wallace SA, 2008, AIDS EDUC PREV, V20, P360, DOI 10.1521/aeap.2008.20.4.360; Whitaker DJ, 2000, J ADOLESCENT RES, V15, P251, DOI 10.1177/0743558400152004; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; World Health Organization, 2007, SEX REPR HLTH AD YOU	47	21	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51745	10.1371/journal.pone.0051745	http://dx.doi.org/10.1371/journal.pone.0051745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23272156	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386800077
J	Kalle, M; Papareddy, P; Kasetty, G; Morgelin, M; van der Plas, MJA; Rydengard, V; Malmsten, M; Albiger, B; Schmidtchen, A				Kalle, Martina; Papareddy, Praveen; Kasetty, Gopinath; Morgelin, Matthias; van der Plas, Mariena J. A.; Rydengard, Victoria; Malmsten, Martin; Albiger, Barbara; Schmidtchen, Artur			Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; TISSUE FACTOR; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; SEPTIC SHOCK; INFECTIONS; LL-37; PATHOPHYSIOLOGY; PROTEINASES; MECHANISMS	Gram-negative sepsis is accompanied by a disproportionate innate immune response and excessive coagulation mainly induced by endotoxins released from bacteria. Due to rising antibiotic resistance and current lack of other effective treatments there is an urgent need for new therapies. We here present a new treatment concept for sepsis and endotoxin-mediated shock, based on host defense peptides from the C-terminal part of human thrombin, found to have a broad and inhibitory effect on multiple sepsis pathologies. Thus, the peptides abrogate pro-inflammatory cytokine responses to endotoxin in vitro and in vivo. Furthermore, they interfere with coagulation by modulating contact activation and tissue factor-mediated clotting in vitro, leading to normalization of coagulation responses in vivo, a previously unknown function of host defense peptides. In a mouse model of Pseudomonas aeruginosa sepsis, the peptide GKY25, while mediating a modest antimicrobial effect, significantly inhibited the pro-inflammatory response, decreased fibrin deposition and leakage in the lungs, as well as reduced mortality. Taken together, the capacity of such thrombin-derived peptides to simultaneously modulate bacterial levels, pro-inflammatory responses, and coagulation, renders them attractive therapeutic candidates for the treatment of invasive infections and sepsis. Citation: Kalle M, Papareddy P, Kasetty G, Morgelin M, van der Plas MJA, et al. (2012) Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis. PLoS ONE 7(12): e51313. doi:10.1371/journal.pone.0051313	[Kalle, Martina; Papareddy, Praveen; Kasetty, Gopinath; van der Plas, Mariena J. A.; Rydengard, Victoria; Albiger, Barbara; Schmidtchen, Artur] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Malmsten, Martin] Uppsala Univ, Dept Pharm, Uppsala, Sweden; [Albiger, Barbara] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden	Lund University; Lund University; Uppsala University; European Centre for Disease Prevention & Control	Kalle, M (corresponding author), Lund Univ, Biomed Ctr, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden.	martina.kalle@med.lu.se	van der Plas, Mariena/GYV-3702-2022; Schmidtchen, Artur/F-9507-2015	Malmsten, Martin/0000-0003-0046-5599; Papareddy, Praveen/0000-0002-3872-478X; van der Plas, Mariena/0000-0002-3233-2881	Swedish Research Council [2009-3378, 2009-3009)]; Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation; Crafoord Foundation; Osterlund Foundation; Kock Foundation; XImmune AB; Swedish Government Funds for Clinical Research (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Crafoord Foundation; Osterlund Foundation; Kock Foundation; XImmune AB; Swedish Government Funds for Clinical Research (ALF)	This work was supported by grants from the Swedish Research Council (projects 2009-3378 and 2009-3009), the Welander-Finsen, Knut and Alice Wallenberg, Crafoord, Osterlund, and Kock Foundations, XImmune AB, and the Swedish Government Funds for Clinical Research (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, CRIT CARE MED, V28, pS31, DOI 10.1097/00003246-200009001-00007; Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Brown KL, 2007, TRENDS IMMUNOL, V28, P260, DOI 10.1016/j.it.2007.04.005; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Castellino FJ, 2011, BLOOD, V117, P283, DOI 10.1182/blood-2010-07-299057; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; de Jong HK, 2010, J INNATE IMMUN, V2, P422, DOI 10.1159/000316286; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dellinger RP, 2008, J CRIT CARE, V23, P493, DOI 10.1016/j.jcrc.2007.12.022; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Hirsch T, 2008, SHOCK, V30, P117, DOI 10.1097/SHK.0b013e318160de11; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kasetty G, 2011, J INNATE IMMUN, V3, P471, DOI 10.1159/000327016; Kasetty G, 2011, ANTIMICROB AGENTS CH, V55, P2880, DOI 10.1128/AAC.01515-10; Kohler Thilo, 2009, Rev Med Suisse, V5, P732; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lee K. H., 1993, Singapore Medical Journal, V34, P245; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Levi M, 2011, BLOOD REV, V25, P33, DOI 10.1016/j.blre.2010.09.002; Lolis E, 2003, NAT REV DRUG DISCOV, V2, P635, DOI 10.1038/nrd1153; Mackman N, 2006, BLOOD CELL MOL DIS, V36, P104, DOI 10.1016/j.bcmd.2005.12.008; Marshall JC, 2010, CONTRIB NEPHROL, V167, P1, DOI 10.1159/000315914; MESZAROS K, 1994, BLOOD, V83, P2516; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; Oehmcke S, 2009, BLOOD, V114, P444, DOI 10.1182/blood-2008-10-182527; Osterud B, 2010, THROMB RES, V125, pS31, DOI 10.1016/j.thromres.2010.01.032; Page MGP, 2009, CURR OPIN PHARMACOL, V9, P558, DOI 10.1016/j.coph.2009.08.006; Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Pawlinski R, 2004, BLOOD, V103, P1342, DOI 10.1182/blood-2003-09-3051; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Schmidtchen A, 2009, J BIOL CHEM, V284, P17584, DOI 10.1074/jbc.M109.011650; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Semple F, 2011, EUR J IMMUNOL, V41, P3291, DOI 10.1002/eji.201141648; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; van Delden C, 2007, INT J ANTIMICROB AG, V30, pS71, DOI 10.1016/j.ijantimicag.2007.06.015; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Yeaman MR, 2006, CURR TOP MICROBIOL, V306, P111; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U	51	55	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51313	10.1371/journal.pone.0051313	http://dx.doi.org/10.1371/journal.pone.0051313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272096	Green Submitted, Green Published, gold			2022-12-25	WOS:000312386600022
J	Tumwebaze, H; Tumwesigye, E; Baeten, JM; Kurth, AE; Revall, J; Murnane, PM; Chang, LW; Celum, C				Tumwebaze, Henry; Tumwesigye, Elioda; Baeten, Jared M.; Kurth, Ann E.; Revall, Jennifer; Murnane, Pamela M.; Chang, Larry W.; Celum, Connie			Household-Based HIV Counseling and Testing as a Platform for Referral to HIV Care and Medical Male Circumcision in Uganda: A Pilot Evaluation	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTION; INTERVENTION; PREVENTION; DISTRICT; AFRICA; ADULTS	Background: Combination HIV prevention initiatives incorporate evidence-based, biomedical and behavioral interventions appropriate and acceptable to specific populations, aiming to significantly reduce population-level HIV incidence. Knowledge of HIV serostatus is key to linkages to HIV care and prevention. Household-based HIV counseling and testing (HBCT) can achieve high HIV testing rates. We evaluated HBCT as a platform for delivery of combination HIV prevention services in sub-Saharan Africa. Methods: We conducted HBCT in a semi-urban area in southwestern Uganda. All adults received standard HIV prevention messaging. Real-time electronic data collection included a brief risk assessment and prevention triage algorithm for referrals of HIV seropositive persons to HIV care and uncircumcised HIV seronegative men with multiple sex partners to male circumcision. Monthly follow-up visits for 3 months were conducted to promote uptake of HIV care and male circumcision. Results: 855 households received HBCT; 1587 of 1941 (81.8%) adults were present at the HBCT visit, 1557 (98.1% of those present) were tested and received HIV results, of whom, 46.5% were men. A total of 152 (9.8%) were HIV seropositive, for whom the median CD4 count was 456 cells/mu L, and 50.7% were newly-identified as HIV seropositive. Three months after HBCT, 88.5% of HIV seropositive persons had attended an HIV care clinic; among those with CD4 counts < 250 cells/mu L, 71.4% initiated antiretroviral therapy. Among 123 HIV seronegative men with an HIV+ partner or multiple partners, 62.0% were circumcised by month 3. Conclusions: HBCT achieves high levels of knowledge of HIV serostatus and is an effective platform for identifying at-risk persons and achieving higher uptake of HIV prevention and care services through referrals and targeted follow-up than has been accomplished through other single focus strategies. Citation: Tumwebaze H, Tumwesigye E, Baeten JM, Kurth AE, Revall J, et al. (2012) Household-Based HIV Counseling and Testing as a Platform for Referral to HIV Care and Medical Male Circumcision in Uganda: A Pilot Evaluation. PLoS ONE 7(12): e51620. doi:10.1371/journal.pone.0051620	[Baeten, Jared M.; Revall, Jennifer; Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Tumwebaze, Henry; Tumwesigye, Elioda] Integrated Community Based Initiat, Kabwohe, Uganda; [Baeten, Jared M.; Celum, Connie] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Baeten, Jared M.; Murnane, Pamela M.; Celum, Connie] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Kurth, Ann E.] NYU, Coll Nursing, New York, NY USA; [Chang, Larry W.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Chang, Larry W.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; New York University; Johns Hopkins University; Johns Hopkins University	Celum, C (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	ccelum@uw.edu	Kurth, Ann E/A-1615-2013		United States National Institutes of Health [R01 AI083034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083034] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was received from the United States National Institutes of Health (R01 AI083034). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2012, 19 INT AIDS C AIDS 2; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bollinger RC, 2011, INFECT DIS CLIN N AM, V25, P385, DOI 10.1016/j.idc.2011.02.006; Cherutich P, 2010, 17 C RETR OPP INF CR; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Curran K, CURR HIV AI IN PRESS; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; Dalal W, 2012, J ACQUIRED IMMUNE DI; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Gray R, 2012, 19 C RETR OPP INF CR; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Medley A, 2012, AIDS BEHAV; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Molesworth AM, 2010, JAIDS-J ACQ IMM DEF, V55, P625, DOI 10.1097/QAI.0b013e3181f98628; Mugglin C, 2012, 19 C RETR OPP INF CR; Nuwaha F, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17423; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sabapathy K, 2012, 19 INT AIDS C AIDS 2; Sekandi JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-730; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Tabana H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-73; Tanser F, 2012, 19 C RETR OPP INF CR; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; UNAIDS, 2012, JC2215E UNAIDS; Van Rooyen H, 2012, 19 C RETR OPP INF CR; Wachira J, 2012, CLIN INFECT DIS, V54, P275, DOI 10.1093/cid/cir789; World Health Organization, 2012, GUID OR PREEXP PROPH	29	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51620	10.1371/journal.pone.0051620	http://dx.doi.org/10.1371/journal.pone.0051620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272125	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600031
J	Vela, L; Gonzalo, O; Naval, J; Marzo, I				Vela, Laura; Gonzalo, Oscar; Naval, Javier; Marzo, Isabel			Direct Interaction of Bax and Bak Proteins with Bcl-2 Homology Domain 3 (BH3)-only Proteins in Living Cells Revealed by Fluorescence Complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC ACTIVITY; BH3 DOMAINS; FAMILY; ACTIVATION; PUMA; BIM; BINDING; MCL-1; VISUALIZATION; ABSENCE	The key event in the mitochondrial pathway of apoptosis is the activation of Bax and Bak by BH3-only proteins through a molecular mechanism that is still a matter of debate. Here we studied interactions among anti-and proapoptotic proteins of the Bcl-2 family in living cells by using bimolecular fluorescence complementation analysis. Our results indicate that the antiapoptotic proteins Mcl-1 and Bcl-xL bind preferably to the BH3-only proteins Bim, PUMA, and Noxa but can also bind to Bak and Bax. We also found a direct interaction between Bim, PUMA, or Noxa with either Bax or Bak during apoptosis induction. In HeLa cells, interaction of Bim with Bax occurs in cytosol, and then Bim-Bax complexes translocate to mitochondria. Complexes of either PUMA or Noxa with Bax or Bak were always detected at mitochondria. Overexpression of Bcl-xL or Mcl-1 delayed Bim/Bax translocation to mitochondria. These results reveal the ability of main BH3-only proteins to directly activate Bax and Bak in living cells and suggest that a complex network of interactions regulate the function of Bcl-2 family members during apoptosis.	[Vela, Laura; Gonzalo, Oscar; Naval, Javier; Marzo, Isabel] Univ Zaragoza, Fac Ciencias, Dept Biochem Mol & Cell Biol, Zaragoza 5009, Spain	University of Zaragoza	Marzo, I (corresponding author), Univ Zaragoza, Fac Sci, Dept Biochem Mol & Cell Biol, E-50009 Zaragoza, Spain.	imarzo@unizar.es	Marzo, Isabel/E-6918-2016	Marzo, Isabel/0000-0002-2315-9079	Ministerio de Ciencia e Innovacion [SAF2007-60748, SAF2010-14920]; Red Tematica de Investigacion Cooperativa en Cancer-Instituto de Salud Carlos III [RD06/0020]; Gobierno de Aragon/Fondo Social Europeo Grant [B16]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red Tematica de Investigacion Cooperativa en Cancer-Instituto de Salud Carlos III(Instituto de Salud Carlos III); Gobierno de Aragon/Fondo Social Europeo Grant	This study was supported by Ministerio de Ciencia e Innovacion Grants SAF2007-60748, SAF2010-14920, and Red Tematica de Investigacion Cooperativa en Cancer-Instituto de Salud Carlos III Grant RD06/0020, and Gobierno de Aragon/Fondo Social Europeo Grant B16.	Aranovich A, 2012, MOL CELL, V45, P754, DOI 10.1016/j.molcel.2012.01.030; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Ding JZ, 2010, J BIOL CHEM, V285, P28749, DOI 10.1074/jbc.M110.148361; Du H, 2011, J BIOL CHEM, V286, P491, DOI 10.1074/jbc.M110.167148; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Germain M, 2008, J BIOL CHEM, V283, P6384, DOI 10.1074/jbc.M707762200; Hoetelmans RWM, 2000, CELL DEATH DIFFER, V7, P384, DOI 10.1038/sj.cdd.4400664; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lopez-Royuela N, 2010, BIOCHEM PHARMACOL, V79, P1746, DOI 10.1016/j.bcp.2010.02.010; Lopez-Royuela N, 2010, BBA-MOL CELL RES, V1803, P311, DOI 10.1016/j.bbamcr.2009.11.004; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pang YP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00257; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Villunger A, 2011, CELL DEATH DIFFER, V18, P1545, DOI 10.1038/cdd.2011.100; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wong C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.28; Yee KS, 2008, APOPTOSIS, V13, P87, DOI 10.1007/s10495-007-0140-2; Yivgi-Ohana N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.47; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	49	62	64	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4935	4946		10.1074/jbc.M112.422204	http://dx.doi.org/10.1074/jbc.M112.422204			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283967	Green Published, hybrid			2022-12-25	WOS:000315340400041
J	Wilkins, HM; Kirchhof, D; Manning, E; Joseph, JW; Linseman, DA				Wilkins, Heather M.; Kirchhof, Danielle; Manning, Evan; Joseph, Jamie W.; Linseman, Daniel A.			Mitochondrial Glutathione Transport Is a Key Determinant of Neuronal Susceptibility to Oxidative and Nitrosative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICARBOXYLATE CARRIER; CELL-DEATH; PARKINSONS-DISEASE; BRAIN MITOCHONDRIA; DYSFUNCTION; BCL-2; APOPTOSIS; DEPLETION; ASTROCYTES; INDUCTION	Mitochondrial oxidative stress significantly contributes to the underlying pathology of several devastating neurodegenerative disorders. Mitochondria are highly sensitive to the damaging effects of reactive oxygen and nitrogen species; therefore, these organelles are equipped with a number of free radical scavenging systems. In particular, the mitochondrial glutathione (GSH) pool is a critical antioxidant reserve that is derived entirely from the larger cytosolic pool via facilitated transport. The mechanism of mitochondrial GSH transport has not been extensively studied in the brain. However, the dicarboxylate (DIC) and 2-oxoglutarate (OGC) carriers localized to the inner mitochondrial membrane have been established as GSH transporters in liver and kidney. Here, we investigated the role of these carriers in protecting neurons from oxidative and nitrosative stress. Immunoblot analysis of DIC and OGC in primary cultures of rat cerebellar granule neurons (CGNs) and cerebellar astrocytes showed differential expression of these carriers, with CGNs expressing only DIC and astrocytes expressing both DIC and OGC. Consistent with these findings, butylmalonate specifically reduced mitochondrial GSH in CGNs, whereas both butylmalonate and phenylsuccinate diminished mitochondrial GSH in astrocytes. Moreover, preincubation with butylmalonate but not phenylsuccinate significantly enhanced susceptibility of CGNs to oxidative and nitrosative stressors. This increased vulnerability was largely prevented by incubation with cell-permeable GSH monoethylester but not malate. Finally, knockdown of DIC with adenoviral siRNA also rendered CGNs more susceptible to oxidative stress. These findings demonstrate that maintenance of the mitochondrial GSH pool via sustained mitochondrial GSH transport is essential to protect neurons from oxidative and nitrosative stress.	[Wilkins, Heather M.; Kirchhof, Danielle; Manning, Evan; Linseman, Daniel A.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Wilkins, Heather M.; Kirchhof, Danielle; Manning, Evan; Linseman, Daniel A.] Univ Denver, Eleanor Roosevelt Inst, Denver, CO 80208 USA; [Joseph, Jamie W.] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada; [Linseman, Daniel A.] Vet Affairs Med Ctr, Res Serv, Denver, CO 80220 USA; [Linseman, Daniel A.] Univ Colorado Denver, Div Clin Pharmacol & Toxicol, Dept Med, Aurora, CO 80045 USA; [Linseman, Daniel A.] Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA	University of Denver; University of Denver; University of Waterloo; US Department of Veterans Affairs; Veterans Health Administration (VHA); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Linseman, DA (corresponding author), Univ Denver, Dept Biol Sci, 2199 S Univ Blvd, Denver, CO 80208 USA.	daniel.linseman@du.edu	Linseman, Daniel/L-3846-2019	Wilkins, Heather/0000-0003-4563-4544	National Institutes of Health [R01 NS062766]; Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062766] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS062766 (to D. A. L.). This work was also supported by a Merit Review grant from the Department of Veterans Affairs (to D. A. L.).	Andreassen OA, 2000, ANN NEUROL, V47, P447, DOI 10.1002/1531-8249(200004)47:4<447::AID-ANA7>3.3.CO;2-I; Arthur CR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-37; Babu GN, 2008, NEUROCHEM INT, V52, P1284, DOI 10.1016/j.neuint.2008.01.009; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Chen ZF, 1998, J PHARMACOL EXP THER, V285, P608; Chen ZF, 2000, ARCH BIOCHEM BIOPHYS, V373, P193, DOI 10.1006/abbi.1999.1527; Chi L, 2007, NEUROSCIENCE, V144, P991, DOI 10.1016/j.neuroscience.2006.09.064; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Eckert A, 2003, BIOCHEM PHARMACOL, V66, P1627, DOI 10.1016/S0006-2952(03)00534-3; Flanagan SW, 2002, J NEUROCHEM, V81, P170, DOI 10.1046/j.1471-4159.2002.00812.x; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; HUANG JA, 1995, BRAIN RES, V680, P16, DOI 10.1016/0006-8993(95)00209-9; Huypens P, 2011, DIABETOLOGIA, V54, P135, DOI 10.1007/s00125-010-1923-5; Isobe C, 2010, NEUROSCI LETT, V469, P159, DOI 10.1016/j.neulet.2009.11.065; Kajimoto K, 2005, MOL GENET METAB, V85, P46, DOI 10.1016/j.ymgme.2005.01.006; Kamga CK, 2010, AM J PHYSIOL-CELL PH, V299, pC497, DOI 10.1152/ajpcell.00058.2010; Lash LH, 2006, CHEM-BIOL INTERACT, V163, P54, DOI 10.1016/j.cbi.2006.03.001; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Merad-Boudia M, 1998, BIOCHEM PHARMACOL, V56, P645, DOI 10.1016/S0006-2952(97)00647-3; Mizuarai S, 2005, J BIOL CHEM, V280, P32434, DOI 10.1074/jbc.M503152200; Mu XJ, 1996, ANN NEUROL, V40, P379, DOI 10.1002/ana.410400307; Muratai T, 2008, FREE RADICAL RES, V42, P221, DOI 10.1080/10715760701877262; Muyderman H, 2007, J NEUROCHEM, V102, P1369, DOI 10.1111/j.1471-4159.2007.04641.x; PALMIERI F, 1971, EUR J BIOCHEM, V22, P66, DOI 10.1111/j.1432-1033.1971.tb01515.x; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pedrini S, 2010, HUM MOL GENET, V19, P2974, DOI 10.1093/hmg/ddq202; PERRY TL, 1986, NEUROSCI LETT, V67, P269, DOI 10.1016/0304-3940(86)90320-4; RAVINDRANATH V, 1989, NEUROSCI LETT, V101, P187, DOI 10.1016/0304-3940(89)90528-4; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Vargas MR, 2011, NEUROBIOL DIS, V43, P543, DOI 10.1016/j.nbd.2011.04.025; Wadey AL, 2009, J NEUROCHEM, V109, P101, DOI 10.1111/j.1471-4159.2009.05936.x; Wilkins HM, 2012, FREE RADICAL BIO MED, V52, P410, DOI 10.1016/j.freeradbiomed.2011.10.495; Wullner U, 1999, BRAIN RES, V826, P53, DOI 10.1016/S0006-8993(99)01228-7; Zimmermann AK, 2005, J NEUROCHEM, V94, P22, DOI 10.1111/j.1471-4159.2005.03156.x; Zimmermann AK, 2007, J BIOL CHEM, V282, P29296, DOI 10.1074/jbc.M702853200; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	41	38	38	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5091	5101		10.1074/jbc.M112.405738	http://dx.doi.org/10.1074/jbc.M112.405738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283974	hybrid, Green Published			2022-12-25	WOS:000315340400057
J	Sproviero, D; Julien, S; Burford, B; Taylor-Papadimitriou, J; Burchell, JM				Sproviero, Daisy; Julien, Sylvain; Burford, Brian; Taylor-Papadimitriou, Joyce; Burchell, Joy M.			Cyclooxygenase-2 Enzyme Induces the Expression of the alpha-2,3-Sialyltransferase-3 (ST3Gal-I) in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL MATURATION; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; UP-REGULATION; GLYCOSYLATION; GLYCOSYLTRANSFERASES; METASTASIS; EP4; ANGIOGENESIS; ACTIVATION	Aberrant glycosylation is a common feature of malignant change. Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the core 2-based glycans observed in normal mammary epithelium cells. This has been shown, in part, to be due to changes in the expression of glycosyltransferases, including the up-regulation of some sialyltransferases. Using the breast cancer cell line T47D, we have shown that PGE2, one of the final products of the cyclooxygenase-2 (COX-2) pathway, can induce the mRNA expression of the sialyltransferase alpha-2,3-sialyltransferase-3 (ST3Gal-I), resulting in increased sialyltransferase activity, demonstrated by a reduction in PNA lectin staining. Induction of COX-2 in the MDA-MB- 231 breast cancer cell line also results in the increased expression of ST3Gal-I, leading to increased sialylation of the substrate of ST3Gal-I, core 1 Gal beta 1,3GalNAc. This effect on sialylation could be reversed by the selective COX-2 inhibitor celecoxib. The use of siRNA to knock down COX-2 and overexpression of COX-2 in MDA-MD-231 cells confirmed the involvement of COX-2 in the up-regulation of ST3Gal-I. Moreover, analysis of the expression of ST3Gal-I and COX-2 by 74 primary breast cancers showed a significant correlation between the two enzymes. COX-2 expression has been associated with a number of tumors, including breast cancer, where its expression is associated with poor prognoses. Thus, these results suggest the intriguing possibility that some of the malignant characteristics associated with COX-2 expression may be via the influence that COX-2 exerts on the glycosylation of tumor cells.	[Sproviero, Daisy; Julien, Sylvain; Burford, Brian; Taylor-Papadimitriou, Joyce; Burchell, Joy M.] Kings Coll London, Breast Canc Biol Lab, Guys Hosp, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Burchell, JM (corresponding author), Kings Coll London, Breast Canc Biol Lab, Guys Hosp, 3rd Floor, London SE1 9RT, England.	joy.burchell@kcl.ac.uk	Sproviero, Daisy/AAB-8752-2019; Sproviero, Daisy/GSN-0961-2022	Sproviero, Daisy/0000-0001-5061-683X; Burchell, Joy/0000-0003-0413-3823	Breast Cancer Campaign [2008NovPhD28]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's; St Thomas' National Health Service Foundation Trust and King's College London; Experimental Cancer Medicine Centre at King's College London	Breast Cancer Campaign; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's(National Institute for Health Research (NIHR)); St Thomas' National Health Service Foundation Trust and King's College London; Experimental Cancer Medicine Centre at King's College London	This work was supported by Grant 2008NovPhD28 from the Breast Cancer Campaign and supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service Foundation Trust and King's College London. This work was also supported by the Experimental Cancer Medicine Centre at King's College London.	Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Boland GP, 2004, BRIT J CANCER, V90, P423, DOI 10.1038/sj.bjc.6601534; BOURIN MC, 1982, CARCINOGENESIS, V3, P671, DOI 10.1093/carcin/3.6.671; BROCKHAUSEN I, 1995, EUR J BIOCHEM, V233, P607, DOI 10.1111/j.1432-1033.1995.607_2.x; Brunner C, 2000, J IMMUNOL, V165, P6278, DOI 10.4049/jimmunol.165.11.6278; Burchell J, 1999, GLYCOBIOLOGY, V9, P1307, DOI 10.1093/glycob/9.12.1307; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Costa C, 2002, J CLIN PATHOL, V55, P429, DOI 10.1136/jcp.55.6.429; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; Davies G, 2003, CLIN CANCER RES, V9, P2651; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Eltze E, 2005, INT J ONCOL, V26, P1525; FITZPATRICK FA, 1980, PROSTAGLANDINS, V19, P917, DOI 10.1016/0090-6980(80)90126-4; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Higai K, 2006, BIOL PHARM BULL, V29, P2372, DOI 10.1248/bpb.29.2372; Julien S, 2007, J IMMUNOL, V179, P5701, DOI 10.4049/jimmunol.179.9.5701; Julien S, 2011, CANCER RES, V71, P7683, DOI 10.1158/0008-5472.CAN-11-1139; Kudo T, 1998, LAB INVEST, V78, P797; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Legler DF, 2006, J IMMUNOL, V176, P966, DOI 10.4049/jimmunol.176.2.966; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Mungul A, 2004, INT J ONCOL, V25, P937; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Nishigaki N, 1996, MOL PHARMACOL, V50, P1031; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ono M, 2003, GLYCOCONJUGATE J, V20, P71, DOI 10.1023/B:GLYC.0000018019.22070.7d; Pan MR, 2008, J BIOL CHEM, V283, P11155, DOI 10.1074/jbc.M710038200; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Potapenko IO, 2010, MOL ONCOL, V4, P98, DOI 10.1016/j.molonc.2009.12.001; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Ristimaki A, 2002, CANCER RES, V62, P632; Son SW, 2011, BIOCHEM BIOPH RES CO, V414, P159, DOI 10.1016/j.bbrc.2011.09.043; Stasinopoulos I, 2007, MOL CANCER RES, V5, P435, DOI 10.1158/1541-7786.MCR-07-0010; Subbaramaiah K, 2008, J BIOL CHEM, V283, P3433, DOI 10.1074/jbc.M705409200; Takkouche B, 2008, JNCI-J NATL CANCER I, V100, P1439, DOI 10.1093/jnci/djn324; Taniguchi A, 2001, GLYCOBIOLOGY, V11, P241, DOI 10.1093/glycob/11.3.241; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; Videira PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-357	40	20	21	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44490	44497		10.1074/jbc.M112.427827	http://dx.doi.org/10.1074/jbc.M112.427827			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23275522	Green Published, Bronze			2022-12-25	WOS:000312938600045
J	Woodward, LJ; Clark, CAC; Bora, S; Inder, TE				Woodward, Lianne J.; Clark, Caron A. C.; Bora, Samudragupta; Inder, Terrie E.			Neonatal White Matter Abnormalities an Important Predictor of Neurocognitive Outcome for Very Preterm Children	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; EXECUTIVE FUNCTION; PREMATURE-INFANT; BEHAVIORAL OUTCOMES; PRESCHOOL-CHILDREN; BAYLEY SCALES; BORN PRETERM; BRAIN-INJURY; SCHOOL-AGE; ADOLESCENTS	Background: Cerebral white matter abnormalities on term MRI are a strong predictor of motor disability in children born very preterm. However, their contribution to cognitive impairment is less certain. Objective: Examine relationships between the presence and severity of cerebral white matter abnormalities on neonatal MRI and a range of neurocognitive outcomes assessed at ages 4 and 6 years. Design/Methods: The study sample consisted of a regionally representative cohort of 104 very preterm (<= 32 weeks gestation) infants born from 1998-2000 and a comparison group of 107 full-term infants. At term equivalent, all preterm infants underwent a structural MRI scan that was analyzed qualitatively for the presence and severity of cerebral white matter abnormalities, including cysts, signal abnormalities, loss of white matter volume, ventriculomegaly, and corpus callosal thinning/myelination. At corrected ages 4 and 6 years, all children underwent a comprehensive neurodevelopmental assessment that included measures of general intellectual ability, language development, and executive functioning. Results: At 4 and 6 years, very preterm children without cerebral white matter abnormalities showed no apparent neurocognitive impairments relative to their full-term peers on any of the domain specific measures of intelligence, language, and executive functioning. In contrast, children born very preterm with mild and moderate-to-severe white matter abnormalities were characterized by performance impairments across all measures and time points, with more severe cerebral abnormalities being associated with increased risks of cognitive impairment. These associations persisted after adjustment for gender, neonatal medical risk factors, and family social risk. Conclusions: Findings highlight the importance of cerebral white matter connectivity for later intact cognitive functioning amongst children born very preterm. Preterm born children without cerebral white matter abnormalities on their term MRI appear to be spared many of the cognitive impairments commonly associated with preterm birth. Further follow-up will be important to assess whether this finding persists into the school years.	[Woodward, Lianne J.; Bora, Samudragupta] Univ Canterbury, Dept Psychol, Canterbury Child Dev Res Grp, Christchurch 1, New Zealand; [Woodward, Lianne J.] New Zealand Brain Res Inst, Christchurch, New Zealand; [Clark, Caron A. C.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Inder, Terrie E.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Inder, Terrie E.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Inder, Terrie E.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA	University of Canterbury; University of Oregon; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Woodward, LJ (corresponding author), Univ Canterbury, Dept Psychol, Canterbury Child Dev Res Grp, Christchurch 1, New Zealand.	lianne.woodward@canterbury.ac.nz		Clark, Caron/0000-0002-9907-0548	New Zealand Health Research Council of New Zealand [03/196]; Neurological Foundation of New Zealand [0227PG]; Canterbury Medical Research Foundation [05/01]	New Zealand Health Research Council of New Zealand; Neurological Foundation of New Zealand; Canterbury Medical Research Foundation	Funding for this study was provided by the following funding organizations: the New Zealand Health Research Council of New Zealand (ref no: 03/196) (URL: http://www.hrc.govt.nz/); the Neurological Foundation of New Zealand (ref no. 0227PG) (URL: http://www.neurological.org.nz/) and Canterbury Medical Research Foundation (ref. no. 05/01) (URL: http://www.cmrf.org.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; Baron IS, 2010, NEUROPSYCHOL REV, V20, P430, DOI 10.1007/s11065-010-9132-z; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Boardman J P, 2007, Minerva Pediatr, V59, P349; Cheong JLY, 2009, AM J NEURORADIOL, V30, P623, DOI 10.3174/ajnr.A1399; Conners C., 2001, CONNERS KIDDIE CONTI; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Espy KA, 1997, DEV NEUROPSYCHOL, V13, P495, DOI 10.1080/87565649709540690; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Heron M, 2010, PEDIATRICS, V125, P4, DOI 10.1542/peds.2009-2416; HUGHES C, 1993, DEV PSYCHOL, V29, P498, DOI 10.1037/0012-1649.29.3.498; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Inder TE, 2003, AM J NEURORADIOL, V24, P805; Inder TE, 2003, J PEDIATR-US, V143, P171, DOI 10.1067/S0022-3476(03)00357-3; Iwata S, 2012, PEDIATRICS, V129, pE1138, DOI 10.1542/peds.2011-1735; Jacques S, 2001, DEV NEUROPSYCHOL, V20, P573, DOI 10.1207/875656401753549807; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2007, SEMIN FETAL NEONAT M, V12, P363, DOI 10.1016/j.siny.2007.05.004; Korkman M., 2007, NEPSY 2, V2nd; Larroque B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021361; Litt J, 2005, J LEARN DISABIL-US, V38, P130, DOI 10.1177/00222194050380020301; LOBELLO SG, 1991, J SCHOOL PSYCHOL, V29, P229, DOI 10.1016/0022-4405(91)90004-B; Marlow N, 2004, ARCH DIS CHILD-FETAL, V89, pF224, DOI 10.1136/adc.2002.019752; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Moore T, 2012, J PEDIATR-US, V160, P553, DOI 10.1016/j.jpeds.2011.09.047; Morrow CE, 2004, J PEDIATR PSYCHOL, V29, P543, DOI 10.1093/jpepsy/jsh056; Myers E, 2009, CLIN PERINATOL, V36, P773, DOI 10.1016/j.clp.2009.07.008; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Pritchard VE, 2009, EARLY HUM DEV, V85, P215, DOI 10.1016/j.earlhumdev.2008.10.004; Roberts G, 2010, ARCH DIS CHILD, V95, P786, DOI 10.1136/adc.2009.160283; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Spittle AJ, 2011, DEV MED CHILD NEUROL, V53, P1000, DOI 10.1111/j.1469-8749.2011.04095.x; Taylor HG, 2011, DEV NEUROPSYCHOL, V36, P96, DOI 10.1080/87565641.2011.540544; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 2014, WECHSLER PRESCHOOL P; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Wiig E., 1992, CLIN EVALUATION LANG; Williams J, 2010, DEV MED CHILD NEUROL, V52, P232, DOI 10.1111/j.1469-8749.2009.03544.x; Wocadlo C, 2006, EARLY HUM DEV, V82, P29, DOI 10.1016/j.earlhumdev.2005.06.005; WOLKE D, 1994, EUR J PEDIATR, V153, P906, DOI 10.1007/s004310050239; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T; Woodward LJ, 2009, ARCH DIS CHILD-FETAL, V94, pF339, DOI 10.1136/adc.2008.146282; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Woodward LJ, 2011, DEV NEUROPSYCHOL, V36, P22, DOI 10.1080/87565641.2011.540530	50	182	185	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51879	10.1371/journal.pone.0051879	http://dx.doi.org/10.1371/journal.pone.0051879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284800	Green Published, gold			2022-12-25	WOS:000313051500016
J	Leach, S; Clements, JD; Kaim, J; Lundgren, A				Leach, Susannah; Clements, John D.; Kaim, Joanna; Lundgren, Anna			The Adjuvant Double Mutant Escherichia coli Heat Labile Toxin Enhances IL-17A Production in Human T Cells Specific for Bacterial Vaccine Antigens	PLOS ONE			English	Article							HUMAN TH17 CELLS; HELPER-CELLS; T(H)17 CELLS; TGF-BETA; RESPONSES; ENTEROTOXIN; CYTOKINE; COLONIZATION; EXPRESSION; DISTINCT	The strong adjuvant activity and low enterotoxicity of the novel mucosal adjuvant double mutant Escherichia coli heat labile toxin, LT(R192G/L211A) or dmLT, demonstrated in mice, makes this molecule a promising adjuvant candidate. However, little is known about the mechanisms responsible for the adjuvant effect of dmLT or whether dmLT also has an adjuvant function in humans. We investigated the effect of dmLT on human T cell responses to different bacterial vaccine antigens: the mycobacterial purified protein derivative (PPD) antigen, tested in individuals previously vaccinated with Bacillus Calmette-Guerin, the LT binding subunit (LTB), evaluated in subjects immunised with oral inactivated whole cell vaccines against enterotoxigenic Escherichia coli, and Streptococcus pneumoniae whole cell vaccine antigens, tested in subjects naturally exposed to pneumococci. We found that dmLT enhanced the production of IL-17A by peripheral blood mononuclear cells in response to all antigens tested. dmLT had comparable effects on IL-17A responses to PPD as the single mutant LT(R192G) adjuvant, which has demonstrated clinical adjuvant activity in humans. Neutralisation of IL-1 beta and IL-23, but not IL-6, suppressed the IL-17A-enhancing effect of dmLT. Furthermore, CD4+ T cells produced higher levels of IL-17A when stimulated with monocytes pulsed with PPD and dmLT compared to PPD alone, supporting an important role of antigen presenting cells in enhancing IL-17A responses. dmLT also potentiated mitogen-induced IL-17A and IL-13 production. However, dmLT had variable influences on IFN-gamma responses to the different stimuli tested. Our demonstration of a potent ability of dmLT to enhance human Th17 type T cell responses to bacterial vaccine antigens encourages further evaluation of the adjuvant function of dmLT in humans.	[Leach, Susannah; Kaim, Joanna; Lundgren, Anna] Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg Univ Vaccine Res Inst GUVAX, Gothenburg, Sweden; [Clements, John D.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	University of Gothenburg; Tulane University	Lundgren, A (corresponding author), Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg Univ Vaccine Res Inst GUVAX, Gothenburg, Sweden.	anna.lundgren@microbio.gu.se	Leach, Susannah/ABA-6448-2020	Leach, Susannah/0000-0002-9614-2753	Goteborg Medical Society; Adlerbertska Forskningsstiftelsen; Wilhelm och Martina Lundgren Vetenskapsfond	Goteborg Medical Society; Adlerbertska Forskningsstiftelsen; Wilhelm och Martina Lundgren Vetenskapsfond	This study was supported by grants from The Goteborg Medical Society (http://www.goteborgslakaresallskap.se), Adlerbertska Forskningsstiftelsen (http://www.gu.se/forskning/stipendier/gustipendier/adlerbertska_forskningsstiftelsen), and Wilhelm och Martina Lundgren Vetenskapsfond (http://www.wmlundgren.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2011, CYTOKINE, V56, P112, DOI 10.1016/j.cyto.2011.06.009; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; CROFT M, 1994, J IMMUNOL, V152, P2675; DANIS VA, 1990, CLIN EXP IMMUNOL, V80, P435; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kotloff KL, 2001, INFECT IMMUN, V69, P3581, DOI 10.1128/IAI.69.6.3581-3590.2001; Lalor MK, 2010, VACCINE, V28, P1635, DOI 10.1016/j.vaccine.2009.11.004; Lebens M, 1996, INFECT IMMUN, V64, P2144, DOI 10.1128/IAI.64.6.2144-2150.1996; Lee WW, 2010, BLOOD, V115, P530, DOI 10.1182/blood-2009-08-236521; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lu YJ, 2010, CLIN VACCINE IMMUNOL, V17, P1005, DOI 10.1128/CVI.00036-10; Lundgren A, 2012, VACCINE, V30, P3897, DOI 10.1016/j.vaccine.2012.03.082; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Malley R, 2001, INFECT IMMUN, V69, P4870, DOI 10.1128/IAI.69.8.4870-4873.2001; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Norton EB, 2012, INFECT IMMUN; Norton EB, 2011, CLIN VACCINE IMMUNOL, V18, P546, DOI 10.1128/CVI.00538-10; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ryan EJ, 2000, J IMMUNOL, V165, P5750, DOI 10.4049/jimmunol.165.10.5750; Scott DA, 1997, J INFECT DIS, V176, pS183, DOI 10.1086/513791; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Summerton NA, 2010, VACCINE, V28, P1404, DOI 10.1016/j.vaccine.2009.10.147; SVENNERHOLM AM, 1978, CURR MICROBIOL, V1, P19, DOI 10.1007/BF02601701; Takagi R, 2008, J IMMUNOL, V181, P186, DOI 10.4049/jimmunol.181.1.186; Tobias J, 2010, VACCINE, V28, P6977, DOI 10.1016/j.vaccine.2010.08.047; Tribble DR, 2008, CAMPYLOBACTER, 3RD EDITION, P429; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	41	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51718	10.1371/journal.pone.0051718	http://dx.doi.org/10.1371/journal.pone.0051718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284753	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500043
J	Andrew, AS; Hu, T; Gu, J; Gui, J; Ye, YQ; Marsit, CJ; Kelsey, KT; Schned, AR; Tanyos, SA; Pendleton, EM; Mason, RA; Morlock, EV; Zens, MS; Li, ZZ; Moore, JH; Wu, XF; Karagas, MR				Andrew, Angeline S.; Hu, Ting; Gu, Jian; Gui, Jiang; Ye, Yuanqing; Marsit, Carmen J.; Kelsey, Karl T.; Schned, Alan R.; Tanyos, Sam A.; Pendleton, Eben M.; Mason, Rebecca A.; Morlock, Elaine V.; Zens, Michael S.; Li, Zhongze; Moore, Jason H.; Wu, Xifeng; Karagas, Margaret R.			HSD3B and Gene-Gene Interactions in a Pathway-Based Analysis of Genetic Susceptibility to Bladder Cancer	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; CONFERS SUSCEPTIBILITY; METABOLISM GENES; DNA-REPAIR; ASSOCIATION; RISK; TUMOR; POLYMORPHISMS; PROGRESSION; MECHANISMS	Bladder cancer is the 4th most common cancer among men in the U.S. We analyzed variant genotypes hypothesized to modify major biological processes involved in bladder carcinogenesis, including hormone regulation, apoptosis, DNA repair, immune surveillance, metabolism, proliferation, and telomere maintenance. Logistic regression was used to assess the relationship between genetic variation affecting these processes and susceptibility in 563 genotyped urothelial cell carcinoma cases and 863 controls enrolled in a case-control study of incident bladder cancer conducted in New Hampshire, U.S. We evaluated gene-gene interactions using Multifactor Dimensionality Reduction (MDR) and Statistical Epistasis Network analysis. The 3'UTR flanking variant form of the hormone regulation gene HSD3B2 was associated with increased bladder cancer risk in the New Hampshire population (adjusted OR 1.85 95%CI 1.31-2.62). This finding was successfully replicated in the Texas Bladder Cancer Study with 957 controls, 497 cases (adjusted OR 3.66 95%CI 1.06-12.63). The effect of this prevalent SNP was stronger among males (OR 2.13 95%CI 1.40-3.25) than females (OR 1.56 95%CI 0.83-2.95), (SNP-gender interaction P = 0.048). We also identified a SNP-SNP interaction between T-cell activation related genes GATA3 and CD81 (interaction P = 0.0003). The fact that bladder cancer incidence is 3-4 times higher in males suggests the involvement of hormone levels. This biologic process-based analysis suggests candidate susceptibility markers and supports the theory that disrupted hormone regulation plays a role in bladder carcinogenesis.	[Andrew, Angeline S.; Hu, Ting; Gui, Jiang; Marsit, Carmen J.; Schned, Alan R.; Tanyos, Sam A.; Pendleton, Eben M.; Mason, Rebecca A.; Morlock, Elaine V.; Zens, Michael S.; Li, Zhongze; Moore, Jason H.; Karagas, Margaret R.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA; [Gu, Jian; Ye, Yuanqing; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Kelsey, Karl T.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Kelsey, Karl T.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Dartmouth College; Norris Cotton Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Brown University; Brown University	Andrew, AS (corresponding author), Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA.	Angeline.Andrew@dartmouth.edu	Gu, Jian/Q-4780-2018; Moore, Jason H./AAV-9645-2021; Kelsey, Karl T/I-1252-2014	Gu, Jian/0000-0003-3499-0973; Moore, Jason H./0000-0002-5015-1099; Marsit, Carmen/0000-0003-4566-150X	National Cancer Institute [CA102327, CA121382, CA099500, CA82354, CA57494, CA078609, U01 CA 127615, R01 CA 74880, P50 CA 91846, R01 CA 131335]; National Institute of Environmental Health Sciences [ES00002, 5 P42 ES05947, ES07373]; National Center for Research Resources [RR028309, RR018787, RR024475]; National Institutes of Health [LM009012]; National Institute of General Medical Sciences [GM103534]; UT MD Anderson Cancer Center Research Trust; NATIONAL CANCER INSTITUTE [U01CA127615, P30CA016672, R01CA057494, R01CA078609, P30CA023108, R01CA131335, R01CA082354, R03CA099500, P50CA091846, R03CA121382, R01CA074880, K07CA102327] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024475, P20RR018787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005947, P30ES000002, P42ES007373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UT MD Anderson Cancer Center Research Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding in part for Dartmouth's research from National Cancer Institute (http://cancer.gov/) grant numbers CA102327, CA121382, CA099500, CA82354, CA57494, and CA078609; the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) grant numbers ES00002, 5 P42 ES05947, and ES07373; the National Center for Research Resources (http://www.ncrr.nih.gov) grant numbers RR028309, RR018787 and RR024475; National Institutes of Health (http://nih.gov/) grant number LM009012; and National Institute of General Medical Sciences GM103534. Funding in part for MD Anderson Cancer Center's research from National Cancer Institute (http://cancer.gov/) grant numbers U01 CA 127615, R01 CA 74880, P50 CA 91846, and R01 CA 131335 and from the UT MD Anderson Cancer Center Research Trust (http://www.mdanderson.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AS, 2009, HUM GENET, V125, P527, DOI 10.1007/s00439-009-0645-6; Bartsch H, 1999, CANCER DETECT PREV, V23, P445, DOI 10.1046/j.1525-1500.1999.99055.x; Beuten J, 2009, CANCER EPIDEM BIOMAR, V18, P1869, DOI 10.1158/1055-9965.EPI-09-0076; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; CANTOR KP, 1992, CANCER CAUSE CONTROL, V3, P57, DOI 10.1007/BF00051913; CARTWRIGHT RA, 1979, BRIT MED J, V2, P798, DOI 10.1136/bmj.2.6193.798-b; Chang BL, 2002, CANCER RES, V62, P1784; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; D'Amico F, 2007, PHARMACOGENOMICS, V8, P645, DOI 10.2217/14622416.8.6.645; de Visser KE, 2008, CANCER IMMUNOL IMMUN, V57, P1531, DOI 10.1007/s00262-008-0501-x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dietrich K, 2011, EUR J CANCER, V47, P592, DOI 10.1016/j.ejca.2010.10.007; Fortuny Joan, 2007, BMC Urol, V7, P13, DOI 10.1186/1471-2490-7-13; Garcia-Closas M, 2007, CANCER EPIDEM BIOMAR, V16, P2269, DOI 10.1158/1055-9965.EPI-07-0449; Greene CS, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-5; Groth A, 2011, J INNATE IMMUN, V3, P344, DOI 10.1159/000327014; Hahn Lance W, 2004, In Silico Biol, V4, P183; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Higgins JPT, 2007, AM J SURG PATHOL, V31, P673, DOI 10.1097/01.pas.0000213438.01278.5f; Hu T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-364; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; KANTOR AF, 1985, INT J CANCER, V35, P703, DOI 10.1002/ijc.2910350602; Karagas MR, 1998, ENVIRON HEALTH PERSP, V106, P1047, DOI 10.1289/ehp.98106s41047; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Neslund-Dudas C, 2007, PROSTATE, V67, P1654, DOI 10.1002/pros.20625; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Simons MP, 2007, IMMUNOL RES, V39, P79, DOI 10.1007/s12026-007-0084-1; Stern MC, 2009, CANCER RES, V69, P6857, DOI 10.1158/0008-5472.CAN-09-1091; SULLIVAN JW, 1982, J UROLOGY, V128, P281, DOI 10.1016/S0022-5347(17)52886-4; VanCompernolle SE, 2001, EUR J IMMUNOL, V31, P823, DOI 10.1002/1521-4141(200103)31:3<823::AID-IMMU823>3.3.CO;2-4; Wang L, 2007, J STEROID BIOCHEM, V107, P88, DOI 10.1016/j.jsbmb.2007.03.037; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421	43	74	75	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51301	10.1371/journal.pone.0051301	http://dx.doi.org/10.1371/journal.pone.0051301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284679	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300017
J	Byun, J; Kim, BT; Kim, YT; Jiao, ZX; Hur, EM; Zhou, FQ				Byun, Justin; Kim, Bo Taek; Kim, Yun Tai; Jiao, Zhongxian; Hur, Eun-Mi; Zhou, Feng-Quan			Slit2 Inactivates GSK3 beta to Signal Neurite Outgrowth Inhibition	PLOS ONE			English	Article							AXON GUIDANCE; GROWTH CONE; CANCER PROGRESSION; NEURONAL POLARITY; ROBO PATHWAY; ANGIOGENESIS; RECEPTORS; MIDLINE; ROLES; GENE	Slit molecules comprise one of the four canonical families of axon guidance cues that steer the growth cone in the developing nervous system. Apart from their role in axon pathfinding, emerging lines of evidence suggest that a wide range of cellular processes are regulated by Slit, ranging from branch formation and fasciculation during neurite outgrowth to tumor progression and to angiogenesis. However, the molecular and cellular mechanisms downstream of Slit remain largely unknown, in part, because of a lack of a readily manipulatable system that produces easily identifiable traits in response to Slit. The present study demonstrates the feasibility of using the cell line CAD as an assay system to dissect the signaling pathways triggered by Slit. Here, we show that CAD cells express receptors for Slit (Robo1 and Robo2) and that CAD cells respond to nanomolar concentrations of Slit2 by markedly decelerating the rate of process extension. Using this system, we reveal that Slit2 inactivates GSK3 beta and that inhibition of GSK3 beta is required for Slit2 to inhibit process outgrowth. Furthermore, we show that Slit2 induces GSK3 beta phosphorylation and inhibits neurite outgrowth in adult dorsal root ganglion neurons, validating Slit2 signaling in primary neurons. Given that CAD cells can be conveniently manipulated using standard molecular biological methods and that the process extension phenotype regulated by Slit2 can be readily traced and quantified, the use of a cell line CAD will facilitate the identification of downstream effectors and elucidation of signaling cascade triggered by Slit.	[Byun, Justin; Kim, Bo Taek; Kim, Yun Tai; Jiao, Zhongxian; Hur, Eun-Mi; Zhou, Feng-Quan] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA; [Zhou, Feng-Quan] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Kim, Yun Tai] Korea Food Res Inst, Songnam, South Korea; [Hur, Eun-Mi] Korea Inst Sci & Technol, Brain Sci Inst, Seoul, South Korea	Johns Hopkins University; Johns Hopkins University; Korea Food Research Institute (KFRI); Korea Institute of Science & Technology (KIST)	Hur, EM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA.	ehur@kist.re.kr; fzhou4@jhmi.edu	Hur, Eun Mi/AAU-4906-2021; Zhou, Fengquan/X-5782-2019	Zhou, Fengquan/0000-0002-1525-9969; Byun, Justin/0000-0002-7953-8238	National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institutes of Health [R01NS064288]; Craig H. Neilsen Foundation; Korea Institute of Science and Technology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064288] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Craig H. Neilsen Foundation; Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Alliance for Research on Schizophrenia and Depression (NARSAD), National Institutes of Health grant R01NS064288, the Craig H. Neilsen Foundation and Intramural funding from Korea Institute of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews WD, 2007, J ANAT, V211, P188, DOI 10.1111/j.1469-7580.2007.00750.x; Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chedotal A, 2007, ADV EXP MED BIOL, V621, P65, DOI 10.1007/978-0-387-76715-4_5; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Dallol A, 2002, CANCER RES, V62, P5874; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Hartigan JA, 2001, BIOCHEM BIOPH RES CO, V284, P485, DOI 10.1006/bbrc.2001.4986; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Hur EM, 2011, GENE DEV, V25, P1968, DOI 10.1101/gad.17015911; Hur EM, 2011, P NATL ACAD SCI USA, V108, P5057, DOI 10.1073/pnas.1011258108; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jaworski A, 2012, NAT NEUROSCI, V15, P367, DOI 10.1038/nn.3037; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; McGrath LM, 2006, TRENDS MOL MED, V12, P333, DOI 10.1016/j.molmed.2006.05.007; Narayan G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-16; Nugent AA, 2012, CURR OPIN NEUROBIOL; Pujic Z, 2008, J NEUROSCI METH, V170, P220, DOI 10.1016/j.jneumeth.2008.01.014; Qi YP, 1997, J NEUROSCI, V17, P1217; SURI C, 1993, J NEUROSCI, V13, P1280; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Ye BQ, 2010, J IMMUNOL, V185, P6294, DOI 10.4049/jimmunol.1001648; Yeo SY, 2004, MECH DEVELOP, V121, P315, DOI 10.1016/j.mod.2004.03.006; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Yuasa-Kawada J, 2009, P NATL ACAD SCI USA, V106, P14530, DOI 10.1073/pnas.0801262106; Zhou FQ, 2006, J CELL SCI, V119, P2787, DOI 10.1242/jcs.03016	44	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51895	10.1371/journal.pone.0051895	http://dx.doi.org/10.1371/journal.pone.0051895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284807	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300052
J	Konarzewski, TK; Murray, BR; Godfree, RC				Konarzewski, Tara K.; Murray, Brad R.; Godfree, Robert C.			Rapid Development of Adaptive, Climate-Driven Clinal Variation in Seed Mass in the Invasive Annual Forb Echium plantagineum L.	PLOS ONE			English	Article							LOCAL ADAPTATION; SIZE VARIATION; GENETIC DIFFERENTIATION; PHENOTYPIC PLASTICITY; LATITUDINAL VARIATION; PLANT-POPULATIONS; FLOWERING TIME; EVOLUTION; RANGE; PATTERNS	We examined adaptive clinal variation in seed mass among populations of an invasive annual species, Echium plantagineum, in response to climatic selection. We collected seeds from 34 field populations from a 1,000 km long temperature and rainfall gradient across the species' introduced range in south-eastern Australia. Seeds were germinated, grown to reproductive age under common glasshouse conditions, and progeny seeds were harvested and weighed. Analyses showed that seed mass was significantly related to climatic factors, with populations sourced from hotter, more arid sites producing heavier seeds than populations from cooler and wetter sites. Seed mass was not related to edaphic factors. We also found that seed mass was significantly related to both longitude and latitude with each degree of longitude west and latitude north increasing seed mass by around 2.5% and 4% on average. There was little evidence that within-population or between-population variation in seed mass varied in a systematic manner across the study region. Our findings provide compelling evidence for development of a strong cline in seed mass across the geographic range of a widespread and highly successful invasive annual forb. Since large seed mass is known to provide reproductive assurance for plants in arid environments, our results support the hypothesis that the fitness and range potential of invasive species can increase as a result of genetic divergence of populations along broad climatic gradients. In E. plantagineum population-level differentiation has occurred in 150 years or less, indicating that the adaptation process can be rapid.	[Konarzewski, Tara K.; Godfree, Robert C.] CSIRO, Plant Ind, Canberra, ACT, Australia; [Konarzewski, Tara K.; Murray, Brad R.] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Technology Sydney	Godfree, RC (corresponding author), CSIRO, Plant Ind, Canberra, ACT, Australia.	Robert.Godfree@csiro.au		Murray, Brad/0000-0002-4734-5976	University of Technology Sydney; CSIRO Climate Adaptation Flagship; CSIRO Plant Industry	University of Technology Sydney; CSIRO Climate Adaptation Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Plant Industry(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	Funders were University of Technology Sydney (www.uts.edu.au), CSIRO Climate Adaptation Flagship (http://www.csiro.au/Organisation-Structure/Flagships/Climate-Adaptation-Flagship/ClimateAdaptationFlagshipOverview.aspx) and CSIRO Plant Industry (http://www.csiro.au/Organisation-Structure/Divisions/Plant-Industry.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZEN MA, 1992, CAN J BOT, V70, P1218, DOI 10.1139/b92-153; Alexander JM, 2012, J ECOL, V100, P771, DOI 10.1111/j.1365-2745.2011.01951.x; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Blood K., 2001, ENV WEEDS FIELD GUID; Bone E, 2001, GENETICA, V112, P165, DOI 10.1023/A:1013378014069; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Boulli A, 2001, EUPHYTICA, V119, P309, DOI 10.1023/A:1017571904517; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; BROWN AHD, 1983, AUST J BIOL SCI, V36, P503, DOI 10.1071/BI9830503; Buckley YM, 2003, ECOLOGY, V84, P1434, DOI 10.1890/0012-9658(2003)084[1434:AIBAGS]2.0.CO;2; BURDON JJ, 1986, AUST J BIOL SCI, V39, P369, DOI 10.1071/BI9860369; Carter J, 2009, PALGR STUD ORAL HIST, P1, DOI 10.1017/CBO9780511575679.004; Colautti RI, 2010, P ROY SOC B-BIOL SCI, V277, P1799, DOI 10.1098/rspb.2009.2231; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Daws MI, 2007, S AFR J BOT, V73, P138, DOI 10.1016/j.sajb.2006.09.003; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DUMAS JB, 1981, ANN CHIM, V47, P195; Dytham C., 2011, CHOOSING USING STAT; Ebeling SK, 2011, J PLANT ECOL-UK, V4, P209, DOI 10.1093/jpe/rtr007; Etterson JR, 2004, EVOLUTION, V58, P1446, DOI 10.1111/j.0014-3820.2004.tb01726.x; Etterson JR, 2008, BOTANY, V86, P91, DOI 10.1139/B07-115; Fenner M, 2001, NEW ZEAL J ECOL, V25, P95; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Friedman JM, 2008, EVOL APPL, V1, P598, DOI 10.1111/j.1752-4571.2008.00044.x; Grigulis K, 2001, J APPL ECOL, V38, P281, DOI 10.1046/j.1365-2664.2001.00587.x; Guo QF, 2000, ECOLOGY, V81, P2149, DOI 10.1890/0012-9658(2000)081[2149:COSSOP]2.0.CO;2; Hinz HL, 2004, WEED TECHNOL, V18, P1533, DOI 10.1614/0890-037X(2004)018[1533:CIPFTN]2.0.CO;2; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; HURKA H, 1979, BIOL ZBL, V98, P699; Jeffrey SJ, 2001, ENVIRON MODELL SOFTW, V16, P309, DOI 10.1016/S1364-8152(01)00008-1; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kollmann J, 2004, DIVERS DISTRIB, V10, P377, DOI 10.1111/j.1366-9516.2004.00126.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leger EA, 2007, J EVOLUTION BIOL, V20, P1090, DOI 10.1111/j.1420-9101.2006.01292.x; LEISHMAN MR, 1994, J ECOL, V82, P249, DOI 10.2307/2261293; Leishman MR., 2000, SEEDS ECOLOGY REGENE, V2nd edition; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Lioubimtseva E, 2004, ENVIRON MANAGE, V33, P5388; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Maron JL, 2007, EVOLUTION, V61, P1912, DOI 10.1111/j.1558-5646.2007.00153.x; Mason RAB, 2008, GLOBAL ECOL BIOGEOGR, V17, P633, DOI 10.1111/j.1466-8238.2008.00402.x; Mealor BA, 2007, OIKOS, V116, P1493, DOI 10.1111/j.0030-1299.2007.15781.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Moles AT, 2007, GLOBAL ECOL BIOGEOGR, V16, P109, DOI 10.1111/j.1466-8238.2006.00259.x; Moles AT, 2005, P NATL ACAD SCI USA, V102, P10540, DOI 10.1073/pnas.0501473102; Montague JL, 2008, J EVOLUTION BIOL, V21, P234, DOI 10.1111/j.1420-9101.2007.01456.x; Monty A, 2009, J EVOLUTION BIOL, V22, P917, DOI 10.1111/j.1420-9101.2009.01728.x; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; Murray BR, 2004, J BIOGEOGR, V31, P379, DOI 10.1046/j.0305-0270.2003.00993.x; Murray BR, 2003, AUST J BOT, V51, P47, DOI 10.1071/BT02069; Muyt A, 2001, BUSH INVADERS S E AU; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Petanidou T, 2012, PERSPECT PLANT ECOL, V14, P3, DOI 10.1016/j.ppees.2011.08.003; Phillips PC, 1996, EVOLUTION, V50, P1334, DOI [10.2307/2410673, 10.1111/j.1558-5646.1996.tb02373.x]; Piggin C. M., 1995, BIOL AUSTR WEEDS, V1, P87; PIGGIN CM, 1976, WEED RES, V16, P337, DOI 10.1111/j.1365-3180.1976.tb00423.x; PIGGIN CM, 1982, J AUST I AGR SCI, V48, P3; RASMUSSON EM, 1968, MON WEATHER REV, V96, P720, DOI 10.1175/1520-0493(1968)096<0720:AWVTAT>2.0.CO;2; RAYMENT GE, 1992, AUSTR LAB HDB SOILS; Rees M, 1996, PHILOS T R SOC B, V351, P1299, DOI 10.1098/rstb.1996.0113; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Ridley CE, 2010, EVOL APPL, V3, P64, DOI 10.1111/j.1752-4571.2009.00099.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Scott BJ, 2000, AUST J EXP AGR, V40, P1173, DOI 10.1071/EA00014; Shea K, 2000, OECOLOGIA, V124, P615, DOI 10.1007/s004420000425; SNAYDON RW, 1982, EVOLUTION, V36, P289, DOI [10.2307/2408047, 10.1111/j.1558-5646.1982.tb05044.x]; Sokal RR., 1995, INTRO BIOSTATISTICS; STAMP NE, 1990, AM J BOT, V77, P874, DOI 10.2307/2444503; Telenius A, 1999, PLANT BIOLOGY, V1, P585, DOI 10.1111/j.1438-8677.1999.tb00788.x; Thackway R., 1995, INTERIM BIOGEOGRAPHI; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Tukey JW., 1953, PROBLEM MULTIPLE COM; Vaughton G, 1998, J ECOL, V86, P563, DOI 10.1046/j.1365-2745.1998.00279.x; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; WINN AA, 1993, OECOLOGIA, V93, P55, DOI 10.1007/BF00321191	82	22	27	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e49000	10.1371/journal.pone.0049000	http://dx.doi.org/10.1371/journal.pone.0049000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284621	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300006
J	Van Gramberg, JL; de Veer, MJ; O'Hehir, RE; Meeusen, ENT; Bischof, RJ				Van Gramberg, Jenna L.; de Veer, Michael J.; O'Hehir, Robyn E.; Meeusen, Els N. T.; Bischof, Robert J.			Induction of Allergic Responses to Peanut Allergen in Sheep	PLOS ONE			English	Article							ARA-H-I; ANAPHYLACTIC REACTIONS; ATOPIC-DERMATITIS; CROSS-REACTIVITY; FOOD ALLERGY; MODEL; IDENTIFICATION; ANTIBODIES; IMMUNOTHERAPY; CHALLENGE	Peanut allergy is the leading cause of deaths due to food-induced anaphylaxis but despite continued research, there are currently no specific treatments available. Challenge testing is limited in patients due to the high risk of adverse reactions, emphasising the need for an appropriate animal model. In the present study we examine the induction of allergic responses in a sheep model for peanut allergy. Sheep were sensitised with peanut (PN) extract and in separate injections with ovalbumin (OVA) or house dust mite (HDM) extract. Serum PN-specific IgE responses were detected in 40-50% of immunised sheep, while only 10% (1 of 10 sheep) showed detectable OVA-specific IgE. All PN-allergic sheep tested showed an Ara h 1-specific IgE response, while four out of five allergic sheep showed an Ara h 2-specific IgE response. Animals with high serum IgE levels to HDM were also PN IgE-positive. Of the PN-sensitised animals with high PN-specific IgE, 80% also showed an immediate hypersensitivity reaction following an intradermal PN injection. This new large animal model of peanut allergy may provide a useful tool for future investigations of allergen-associated immune mechanisms and specific immunotherapy.	[Van Gramberg, Jenna L.; de Veer, Michael J.; Meeusen, Els N. T.; Bischof, Robert J.] Monash Univ, Dept Physiol, Biotechnol Res Labs, Clayton, Vic 3168, Australia; [O'Hehir, Robyn E.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; [O'Hehir, Robyn E.] Monash Univ, Melbourne, Vic 3004, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; Monash University	Bischof, RJ (corresponding author), Monash Univ, Dept Physiol, Biotechnol Res Labs, Clayton, Vic 3168, Australia.	rob.bischof@monash.edu	O'Hehir, Robyn E/H-3627-2011	O'Hehir, Robyn E/0000-0002-3489-7595; Meeusen, Els/0000-0003-1239-6287; Bischof, Robert/0000-0002-6649-9612	Australian Research Council (ARC)	Australian Research Council (ARC)(Australian Research Council)	This work was supported by a grant from the Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Bischof RJ, 2003, CLIN EXP ALLERGY, V33, P367, DOI 10.1046/j.1365-2222.2003.01534.x; Bischof RJ, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-16; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Breiteneder H, 2005, BIOTECHNOL ADV, V23, P395, DOI 10.1016/j.biotechadv.2005.05.004; BURKS AW, 1992, J ALLERGY CLIN IMMUN, V90, P962, DOI 10.1016/0091-6749(92)90469-I; BURKS AW, 1991, J ALLERGY CLIN IMMUN, V88, P172, DOI 10.1016/0091-6749(91)90325-I; BURKS AW, 1995, J CLIN INVEST, V96, P1715, DOI 10.1172/JCI118216; Comeau MR, 2010, MUCOSAL IMMUNOL, V3, P138, DOI 10.1038/mi.2009.134; De Jong EC, 1998, CLIN EXP ALLERGY, V28, P743, DOI 10.1046/j.1365-2222.1998.00301.x; de Leon MP, 2007, MOL IMMUNOL, V44, P463, DOI 10.1016/j.molimm.2006.02.016; de Leon Maria P., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000208; de Leon MP, 2003, CLIN EXP ALLERGY, V33, P1273, DOI 10.1046/j.1365-2222.2003.01761.x; Ermel RW, 1997, LAB ANIM SCI, V47, P40; Fischer R, 2005, AM J PATHOL, V167, P1621, DOI 10.1016/S0002-9440(10)61246-1; Gillman A, 2010, CLIN EXP ALLERGY, V40, P1295, DOI 10.1111/j.1365-2222.2010.03528.x; Helm RM, 2002, J ALLERGY CLIN IMMUN, V109, P136, DOI 10.1067/mai.2002.120551; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Koppelman SJ, 2004, CLIN EXP ALLERGY, V34, P583, DOI 10.1111/j.1365-2222.2004.1923.x; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lack G, 1997, J ALLERGY CLIN IMMUN, V99, P530, DOI 10.1016/S0091-6749(97)70081-2; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; LOZA C, 1995, CLIN EXP ALLERGY, V25, P493, DOI 10.1111/j.1365-2222.1995.tb01086.x; Meeusen EN, 2009, DRUG DISCOV TODAY DI, V6, P101, DOI [DOI 10.1016/J.DDM0D.2009.12.002, 10.1016/j.ddmod.2009.12.002]; Morafo V, 2003, J ALLERGY CLIN IMMUN, V111, P1122, DOI 10.1067/mai.2003.1463; Morar N, 2006, J ALLERGY CLIN IMMUN, V118, P24, DOI 10.1016/j.jaci.2006.03.037; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Otsu K, 2011, DISCOV MED, V12, P319; Palmer GW, 2005, CLIN IMMUNOL, V115, P302, DOI 10.1016/j.clim.2005.02.011; Prickett SR, 2011, J ALLERGY CLIN IMMUN, V127, P608, DOI 10.1016/j.jaci.2010.09.027; Prioult G, 2005, IMMUNOL REV, V206, P204, DOI 10.1111/j.0105-2896.2005.00277.x; Pumphrey RSH, 2000, CLIN EXP ALLERGY, V30, P1144, DOI 10.1046/j.1365-2222.2000.00864.x; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Shaw RJ, 1997, VET IMMUNOL IMMUNOP, V57, P253, DOI 10.1016/S0165-2427(97)00010-X; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P881, DOI 10.1067/mai.2001.118515; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Teuber SS, 2002, J ALLERGY CLIN IMMUN, V110, P921, DOI 10.1067/mai.2002.130056; Valenta R, 2004, ADV IMMUNOL, V82, P105, DOI 10.1016/S0065-2776(04)82003-0; Wang JL, 2007, CLIN EXP ALLERGY, V37, P651, DOI 10.1111/j.1365-2222.2007.02682.x	41	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51386	10.1371/journal.pone.0051386	http://dx.doi.org/10.1371/journal.pone.0051386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284686	Green Submitted, Green Published, gold			2022-12-25	WOS:000312694300022
J	Kang, CB; Bharatham, N; Chia, J; Mu, YG; Baek, K; Yoon, HS				Kang, CongBao; Bharatham, Nagakumar; Chia, Joel; Mu, Yuguang; Baek, Kwanghee; Yoon, Ho Sup			The Natively Disordered Loop of Bcl-2 Undergoes Phosphorylation-Dependent Conformational Change and Interacts with Pin1	PLOS ONE			English	Article							SUBSTRATE; DOMAIN; RECOGNITION; DETERMINANTS; DEGRADATION; CALCINEURIN; MECHANISMS; SIMULATION; REGULATORS; APOPTOSIS	Bcl-2 plays a central role in the regulation of apoptosis. Structural studies of Bcl-2 revealed the presence of a flexible and natively disordered loop that bridges the Bcl-2 homology motifs, BH3 and BH4. This loop is phosphorylated on multiple sites in response to a variety of external stimuli, including the microtubule-targeting drugs, paclitaxel and colchicine. Currently, the underlying molecular mechanism of Bcl-2 phosphorylation and its biological significance remain elusive. In this study, we investigated the molecular characteristics of this anti-apoptotic protein. To this end, we generated synthetic peptides derived from the Bcl-2 loop, and multiple Bcl-2 loop truncation mutants that include the phosphorylation sites. Our results demonstrate that S87 in the flexible loop of Bcl-2 is the primary phosphorylation site for JNK and ERK2, suggesting some sequence or structural specificity for the phosphorylation by these kinases. Our NMR studies and molecular dynamics simulation studies support indicate that phosphorylation of S87 induces a conformational change in the peptide. Finally, we show that the phosphorylated peptides of the Bcl-2 loop can bind Pin1, further substantiating the phosphorylation-mediated conformation change of Bcl-2.	[Kang, CongBao; Bharatham, Nagakumar; Chia, Joel; Mu, Yuguang; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore, Singapore; [Kang, CongBao] Agcy Sci Technol & Res, Ctr Expt Therapeut, Singapore, Singapore; [Baek, Kwanghee; Yoon, Ho Sup] Kyung Hee Univ, Coll Life Sci, Dept Genet Engn, Yongin, Gyeonggi Do, South Korea	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Kyung Hee University	Kang, CB (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore, Singapore.	cbkang@etc.a-star.edu.sg; hsyoon@ntu.edu.sg	Yoon, Ho Sup/A-2193-2011; Kang, Congbao/AAP-7572-2020; Baek, Kwanghee/N-2760-2018	Yoon, Ho Sup/0000-0002-8243-3904; Kang, Congbao/0000-0002-9886-9374; Baek, Kwanghee/0000-0002-1364-1355	Ministry of Health Singapore [NMRC/1177/2008]; Nanyang Technological University [URC/RG65/06]; A*STAR Investigatorship	Ministry of Health Singapore(Ministry of Health-Singapore); Nanyang Technological University(Nanyang Technological University); A*STAR Investigatorship(Agency for Science Technology & Research (A*STAR))	This work was supported by Ministry of Health Singapore Grant NMRC/1177/2008. Financial support from Nanyang Technological University (URC/RG65/06) to Yuguang Mu is also acknowledged. CK appreciate the support from A*STAR Investigatorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboule N, 2005, CELL CYCLE, V4, P590; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Bayer E, 2003, J BIOL CHEM, V278, P26183, DOI 10.1074/jbc.M300721200; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Brichese L, 2004, CELL CYCLE, V3, P1312, DOI 10.4161/cc.3.10.1166; CIECHANOVER A, 1994, FASEB J, V8, P182, DOI 10.1096/fasebj.8.2.8119489; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Huang STJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0852com; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kang CB, 2005, FEBS LETT, V579, P1469, DOI 10.1016/j.febslet.2005.01.053; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Kim S, 2001, BIOCHEMISTRY-US, V40, P6776, DOI 10.1021/bi002700m; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Pathan N, 2001, NEOPLASIA, V3, P550, DOI 10.1038/sj.neo.7900213; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Shen TY, 2001, J AM CHEM SOC, V123, P9107, DOI 10.1021/ja010190t; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; Smet C, 2005, J MED CHEM, V48, P4815, DOI 10.1021/jm0500119; Tamura Y, 2004, FEBS LETT, V569, P249, DOI 10.1016/j.febslet.2004.06.003; Tholey A, 1999, BIOPHYS J, V76, P76, DOI 10.1016/S0006-3495(99)77179-1; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Weiwad M, 2004, J MOL BIOL, V339, P635, DOI 10.1016/j.jmb.2004.02.021; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200; Wong SE, 2005, J PHYS CHEM B, V109, P5249, DOI 10.1021/jp046333q; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200	38	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52047	10.1371/journal.pone.0052047	http://dx.doi.org/10.1371/journal.pone.0052047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272207	Green Published, gold			2022-12-25	WOS:000312483300053
J	Parnmen, S; Rangsiruji, A; Mongkolsuk, P; Boonpragob, K; Nutakki, A; Lumbsch, HT				Parnmen, Sittiporn; Rangsiruji, Achariya; Mongkolsuk, Pachara; Boonpragob, Kansri; Nutakki, Aparna; Lumbsch, H. Thorsten			Using Phylogenetic and Coalescent Methods to Understand the Species Diversity in the Cladia aggregata Complex (Ascomycota, Lecanorales)	PLOS ONE			English	Article							LICHEN-FORMING FUNGI; MOLECULAR PHYLOGENY; MORPHOLOGICAL CHARACTERS; GENEALOGICAL APPROACH; MAXIMUM-LIKELIHOOD; PARMELIOID LICHENS; BAYESIAN-INFERENCE; GROUP CLADONIACEAE; CRYPTIC DIVERSITY; PARMELIACEAE	The Cladia aggregata complex is one of the phenotypically most variable groups in lichenized fungi, making species determination difficult and resulting in different classifications accepting between one to eight species. Multi-locus DNA sequence data provide an avenue to test species delimitation scenarios using genealogical and coalescent methods, employing gene and species trees. Here we tested species delimitation in the complex using molecular data of four loci (nuITS and IGS rDNA, protein-coding GAPDH and Mcm-7), including 474 newly generated sequences. Using a combination of ML and Bayesian gene tree topologies, species tree inferences, coalescent-based species delimitation, and examination of phenotypic variation we assessed the circumscription of lineages. We propose that results from our analyses support a 12 species delimitation scenario, suggesting that there is a high level of species diversity in the complex. Morphological and chemical characters often do not characterize lineages but show some degree of plasticity within at least some of the clades. However, clades can often be characterized by a combination of several phenotypical characters. In contrast to the amount of homoplasy in the morphological characters, the data set exhibits some geographical patterns with putative species having distribution patterns, such as austral, Australasian or being endemic to Australia, New Zealand or Tasmania.	[Parnmen, Sittiporn; Lumbsch, H. Thorsten] Field Museum, Dept Bot, Chicago, IL USA; [Parnmen, Sittiporn; Rangsiruji, Achariya] Srinakharinwirot Univ, Dept Biol, Bangkok, Thailand; [Parnmen, Sittiporn; Mongkolsuk, Pachara; Boonpragob, Kansri] Ramkhamhang Univ, Dept Biol, Bangkok, Thailand; [Nutakki, Aparna] Univ Chicago, Dept Biol Sci, Chicago, IL 60637 USA	Field Museum of Natural History (Chicago); Srinakharinwirot University; Ramkhamhaeng University; University of Chicago	Lumbsch, HT (corresponding author), Field Museum, Dept Bot, Chicago, IL USA.	tlumbsch@fieldmuseum.org	Parnmen, Sittiporn/B-9203-2014	Parnmen, Sittiporn/0000-0002-0116-9436	Scholarship of The Field Museum; Graduate Fund of the Faculty of Science, Srinakharinwirot University; National Research Council of Thailand	Scholarship of The Field Museum; Graduate Fund of the Faculty of Science, Srinakharinwirot University; National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was financially supported by a Scholarship of The Field Museum, the Graduate Fund of the Faculty of Science, Srinakharinwirot University and the National Research Council of Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHTI T, 1982, LICHENOLOGIST, V14, P105, DOI 10.1017/S0024282982000255; AHTI T., 2000, FLORA NEOTROPICA MON, V78, P1; Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Articus K, 2002, MYCOL RES, V106, P412, DOI 10.1017/S0953756202005786; Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; Birky CW, 2011, ZOOL J LINN SOC-LOND, V161, P723, DOI 10.1111/j.1096-3642.2010.00674.x; Blanco O, 2004, TAXON, V53, P959, DOI 10.2307/4135563; Blanco O, 2004, MYCOL RES, V108, P873, DOI 10.1017/S0953756204000723; Buschbom J, 2006, MOL BIOL EVOL, V23, P574, DOI 10.1093/molbev/msj063; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Molina MC, 2011, ORG DIVERS EVOL, V11, P331, DOI 10.1007/s13127-011-0060-4; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Cracraft J., 1983, Current Ornithology, V1, P159; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Cubero OF, 2004, MYCOL RES, V108, P498, DOI 10.1017/s095375620400975x; CULBERSON CF, 1983, BIOCHEM SYST ECOL, V11, P77, DOI 10.1016/0305-1978(83)90003-0; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Molina MD, 2011, LICHENOLOGIST, V43, P585, DOI 10.1017/S0024282911000521; Dettman JR, 2003, EVOLUTION, V57, P2721; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Divakar PK, 2005, LICHENOLOGIST, V37, P55, DOI 10.1017/S0024282904014586; Divakar PK, 2005, LICHENOLOGIST, V37, P37, DOI 10.1017/S0024282904014641; Divakar PK, 2006, MOL PHYLOGENET EVOL, V40, P448, DOI 10.1016/j.ympev.2006.03.024; Divakar PK, 2010, FUNGAL DIVERS, V42, P47, DOI 10.1007/s13225-010-0027-3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elix JA, 2009, SYST BIODIVERS, V7, P479, DOI 10.1017/S1477200009990223; FEIGE GB, 1993, J CHROMATOGR, V646, P417, DOI 10.1016/0021-9673(93)83356-W; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Mendoza F, 2011, MOL ECOL, V20, P1208, DOI 10.1111/j.1365-294X.2010.04993.x; Filson R.B., 1981, J HATTORI BOT LAB, V49, P1; Filson R.B., 1992, FLORA AUSTR, V54, P101; FILSON RB, 1978, LICHENOLOGIST, V10, P13, DOI 10.1017/S0024282978000043; Fontaneto D, 2011, HYDROBIOLOGIA, V662, P27, DOI 10.1007/s10750-010-0481-7; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Galloway, 1985, SCH PERSISTENT ABSEN; GALLOWAY DJ, 1977, NOVA HEDWIGIA, V28, P475; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gattolliat JL, 2010, J N AM BENTHOL SOC, V29, P1042, DOI 10.1899/09-119.1; Goffinet B, 2003, BRYOLOGIST, V106, P349, DOI 10.1639/01; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hodkinson BP, 2011, BIBL LICHENOL, V106, P115; Hognabba F, 2003, CLADISTICS, V19, P224, DOI 10.1016/S0748-3007(03)00028-8; Hognabba F, 2006, MYCOL RES, V110, P1080, DOI 10.1016/j.mycres.2006.04.013; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jahns HM, 1973, HERZOGIA, V2, P437; Jahns HM, 1970, NOVA HEDWIGIA, V20, P1; JAHNS M, 1995, ANN BOT FENN, V32, P35; KANTVILAS G, 1987, MYCOTAXON, V29, P199; Kantvilas G, 1995, LICHENOLOGIST, V27, P433, DOI 10.1016/S0024-2829(95)80004-2; Kantvilas Gintaras, 1999, Muelleria, V12, P135; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Kroken S, 2001, MYCOLOGIA, V93, P38, DOI 10.2307/3761604; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Lamb IM, 1972, OCCASIONAL PAPERS FA, V4, P1; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V60, P317, DOI 10.1016/j.ympev.2011.05.012; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V59, P587, DOI 10.1016/j.ympev.2011.03.020; Lorion J, 2010, MOL PHYLOGENET EVOL, V57, P71, DOI 10.1016/j.ympev.2010.05.027; Lucentini L, 2011, HYDROBIOLOGIA, V673, P215, DOI 10.1007/s10750-011-0778-1; Lucking R, 2008, SYST BIODIVERS, V6, P31, DOI 10.1017/S1477200007002629; Lumbsch H. T., 2007, MYCONET, V13, P1, DOI DOI 10.3158/1557.1; Lumbsch HT, 2008, AUST SYST BOT, V21, P217, DOI 10.1071/SB07049; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lumbsch HT, 2010, AUST SYST BOT, V23, P239, DOI 10.1071/SB10010; Lumbsch H. Thorsten, 2002, P281; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Maddison WP, 2009, MESQUITE MODULAR SYS; Mayr E., 1963, ANIMAL SPECIES EVOLU, pxiv; McCune B, 2009, BRYOLOGIST, V112, P94, DOI 10.1639/0007-2745-112.1.94; McDonald T, 2003, BRYOLOGIST, V106, P61, DOI 10.1639/0007-2745(2003)106[0061:TLGSIT]2.0.CO;2; Miralles A, 2011, ZOOL SCR, V40, P16, DOI 10.1111/j.1463-6409.2010.00453.x; Molina MD, 2004, LICHENOLOGIST, V36, P37, DOI 10.1017/S0024282904013933; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Myllys L, 2002, LICHENOLOGIST, V34, P237, DOI 10.1006/lich.2002.0390; Myllys L, 2011, LICHENOLOGIST, V43, P617, DOI 10.1017/S0024282911000132; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Nelsen MP, 2009, BRYOLOGIST, V112, P42, DOI 10.1639/0007-2745-112.1.42; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Otalora MAG, 2010, AM J BOT, V97, P216, DOI 10.3732/ajb.0900064; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2006, USE R, P8; Parnmen S, 2012, LICHENOLOGIST, V44, P297, DOI 10.1017/S0024282911000715; Parnmen S, 2010, TAXON, V59, P841, DOI 10.1002/tax.593013; Pecchia S, 2004, MYCOPATHOLOGIA, V157, P317, DOI 10.1023/B:MYCO.0000024185.66158.7e; Pino-Bodas R, 2012, LICHENOLOGIST, V44, P121, DOI 10.1017/S002428291100065X; Pino-Bodas R, 2011, ORG DIVERS EVOL, V11, P343, DOI 10.1007/s13127-011-0062-2; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pons J, 2011, MOL PHYLOGENET EVOL, V59, P251, DOI 10.1016/j.ympev.2011.02.013; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Printzen C, 2003, MOL ECOL, V12, P1473, DOI 10.1046/j.1365-294X.2003.01812.x; Printzen C, 2002, LICHENOLOGIST, V34, P101, DOI 10.1006/lich.2002.0381; Purvis O. W., 1997, V54, P109; Ruprecht U, 2010, ANTARCT SCI, V22, P727, DOI 10.1017/S0954102010000477; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schmitt I, 2004, MOL PHYLOGENET EVOL, V33, P43, DOI 10.1016/j.ympev.2004.04.014; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Spribille T, 2011, MOL PHYLOGENET EVOL, V59, P603, DOI 10.1016/j.ympev.2011.03.021; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stenroos SK, 1998, AM J BOT, V85, P1548, DOI 10.2307/2446481; Tehler A, 2001, LICHENOLOGIST, V33, P403, DOI 10.1006/lich.2001.0342; Tehler A, 2007, CLADISTICS, V23, P432, DOI 10.1111/j.1096-0031.2007.00156.x; Thell A., 2009, BIBLIOTHECA LICHENOL, V99, P393; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Velmala S, 2009, LICHENOLOGIST, V41, P231, DOI 10.1017/S0024282909008573; Verdon D, 1986, BRUNONIA, V9, P193, DOI DOI 10.1071/BRU9860193; Vondrak J, 2009, LICHENOLOGIST, V41, P571, DOI 10.1017/S0024282909008317; Vuataz L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019728; Wedin M, 1999, MYCOL RES, V103, P1131, DOI 10.1017/S0953756298008223; Wedin M, 2009, CLADISTICS, V25, P161, DOI 10.1111/j.1096-0031.2009.00240.x; White F.J., 1985, BRIT LICHEN SOC, V57, P1; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wirtz N, 2008, MYCOL RES, V112, P472, DOI 10.1016/j.mycres.2007.05.006; Wirtz N, 2012, ORG DIVERS EVOL, V12, P17, DOI 10.1007/s13127-011-0066-y; Zhou QM, 2006, J HATTORI BOT LAB, P871	123	51	52	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52245	10.1371/journal.pone.0052245	http://dx.doi.org/10.1371/journal.pone.0052245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272229	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300072
J	Yang, J; Chen, JY; Yan, JY; Zhang, LP; Chen, G; He, LQ; Wang, YL				Yang, Jun; Chen, Jiyuan; Yan, Jingyin; Zhang, Liping; Chen, Gang; He, Liqun; Wang, Yanlin			Effect of Interleukin 6 Deficiency on Renal Interstitial Fibrosis	PLOS ONE			English	Article							EXPERIMENTAL GLOMERULONEPHRITIS; CIRCULATING FIBROCYTES; PERIPHERAL-BLOOD; T-CELLS; MYOFIBROBLASTS; DISEASE; DIFFERENTIATION; PROGRESSION; INFLAMMATION; FIBROBLAST	Our recent studies have shown that bone marrow-derived fibroblast precursors contribute significantly to the pathogenesis of renal fibrosis. However, the molecular mechanisms underlying the recruitment and activation of bone marrow-derived fibroblast precursors are incompletely understood. We found that interleukin 6 was induced in the kidney in a murine model of renal fibrosis induced by unilateral ureteral obstruction. Therefore, we investigated if interleukin 6 play a role in the recruitment and maturation of bone marrow-derived fibroblast precursors in the kidney during the development of renal fibrosis. Wild-type and interleukin 6 knockout mice were subjected to unilateral obstructive injury for up to two weeks. Interleukin 6 knockout mice accumulated similar number of bone marrow-derived fibroblast precursors and myofibroblasts in the kidney in response to obstructive injury compared to wild-type mice. Furthermore, IL-6 knockout mice expressed comparable alpha-SMA in the obstructed kidney compared to wild-type mice. Moreover, targeted disruption of Interleukin 6 did not affect gene expression of profibrotic chemokine and cytokines in the obstructed kidney. Finally, there were no significant differences in renal interstitial fibrosis or expression of extracellular matrix proteins between wild-type and interleukin 6 knockout mice following obstructive injury. Our results indicate that interleukin 6 does not play a significant role in the recruitment of bone marrow-derived fibroblast precursors and the development of renal fibrosis. Citation: Yang J, Chen J, Yan J, Zhang L, Chen G, et al. (2012) Effect of Interleukin 6 Deficiency on Renal Interstitial Fibrosis. PLoS ONE 7(12): e52415. doi:10.1371/journal.pone.0052415	[Yang, Jun; Chen, Jiyuan; Yan, Jingyin; Zhang, Liping; Wang, Yanlin] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Yang, Jun] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, Wuhan 430074, Hubei, Peoples R China; [Chen, Gang; He, Liqun] Shuguang Hosp, Dept Nephrol, Shanghai, Peoples R China	Baylor College of Medicine; Huazhong University of Science & Technology	Wang, YL (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA.	yanlinw@bcm.edu			NIH [K08HL092958, R01DK095835]; AHA grant [BGIA7840054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL092958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095835] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants - K08HL092958 and R01DK095835, an AHA grant - BGIA7840054, and a grant from Dr. and Mrs. Harold Selzman (to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; CHEEVER AW, 1994, J IMMUNOL, V153, P753; Chen G, 2011, J AM SOC NEPHROL, V22, P1876, DOI 10.1681/ASN.2010080881; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Finkelman FD, 1999, CURR OPIN IMMUNOL, V11, P420, DOI 10.1016/S0952-7915(99)80070-3; Gadient RA, 1999, STEM CELLS, V17, P127, DOI 10.1002/stem.170127; Garcia GE, 2007, AM J PATHOL, V170, P1485, DOI 10.2353/ajpath.2007.060065; Grimm PC, 2001, NEW ENGL J MED, V345, P93, DOI 10.1056/NEJM200107123450203; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Kielar ML, 2005, J AM SOC NEPHROL, V16, P3315, DOI 10.1681/asn.2003090757; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Li JH, 2007, STEM CELLS, V25, P697, DOI 10.1634/stemcells.2006-0133; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0; Nath KA, 1998, KIDNEY INT, V54, P992, DOI 10.1046/j.1523-1755.1998.00079.x; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Neilson EG, 2006, NAT CLIN PRACT NEPHR, V2, P101, DOI 10.1038/ncpneph0093; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Pecoits R, 2003, NEPHROL DIAL TRANSPL, V18, P1042, DOI 10.1093/ndt/gfg111; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Roberts ISD, 1997, J CLIN PATHOL, V50, P123, DOI 10.1136/jcp.50.2.123; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Strutz F, 2006, NEPHROL DIAL TRANSPL, V21, P3368, DOI 10.1093/ndt/gfl199; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; ZHANG G, 1995, EXP NEPHROL, V3, P308; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275	38	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52415	10.1371/journal.pone.0052415	http://dx.doi.org/10.1371/journal.pone.0052415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272241	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300083
J	Fuxjager, MJ; Barske, J; Du, SM; Day, LB; Schlinger, BA				Fuxjager, Matthew J.; Barske, Julia; Du, Sienmi; Day, Lainy B.; Schlinger, Barney A.			Androgens Regulate Gene Expression in Avian Skeletal Muscles	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; SPEED VIDEO ANALYSIS; ESTROGEN-RECEPTOR; STEROID-RECEPTORS; RELAXATION SPEED; SEX STEROIDS; IGF-I; TESTOSTERONE; MYOSTATIN; COURTSHIP	Circulating androgens in adult reproductively active male vertebrates influence a diversity of organ systems and thus are considered costly. Recently, we obtained evidence that androgen receptors (AR) are expressed in several skeletal muscles of three passeriform birds, the golden-collared manakin (Manacus vitellinus), zebra finch (Taenopygia guttata), and ochrebellied flycatcher (Mionectes oleagieus). Because skeletal muscles that control wing movement make up the bulk of a bird's body mass, evidence for widespread effects of androgen action on these muscles would greatly expand the functional impact of androgens beyond their well-characterized effects on relatively discrete targets throughout the avian body. To investigate this issue, we use quantitative PCR (qPCR) to determine if androgens alter gene mRNA expression patterns in wing musculature of wild golden-collared manakins and captive zebra finches. In manakins, the androgen testosterone (T) up-regulated expression of parvalbumin (PV) and insulin-like growth factor I (IGF-I), two genes whose products enhance cellular Ca2+ cycling and hypertrophy of skeletal muscle fibers. In T-treated zebra finches, the anti-androgen flutamide blunted PV and IGF-I expression. These results suggest that certain transcriptional effects of androgen action via AR are conserved in passerine skeletal muscle tissue. When we examined wing muscles of manakins, zebra finches and ochrebellied flycatchers, we found that expression of PV and IGF-I varied across species and in a manner consistent with a function for AR-dependent gene regulation. Together, these findings imply that androgens have the potential to act on avian muscle in a way that may enhance the physicality required for successful reproduction.	[Fuxjager, Matthew J.; Du, Sienmi; Schlinger, Barney A.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Barske, Julia; Schlinger, Barney A.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Fuxjager, Matthew J.; Du, Sienmi; Schlinger, Barney A.] Univ Calif Los Angeles, Brain Res Inst, Neuroendocrinol Lab, Los Angeles, CA 90024 USA; [Day, Lainy B.] Univ Mississippi, Dept Biol, University, MS 38677 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Mississippi	Fuxjager, MJ (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	mfoxhunter@gmail.com		Day, Lainy/0000-0002-9122-3044	National Institutes of Health [T32 HD007228]; National Science Foundation [IOS 0646459]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065823] Funding Source: NIH RePORTER; Direct For Biological Sciences [1122180] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	M.J.F. was supported in part by National Institutes of Health training grant T32 HD007228 awarded to the Laboratory of Neuroendocrinology at UCLA. The research was funded by National Science Foundation grant IOS 0646459 (to BAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; Ball GF, 2003, ANN NY ACAD SCI, V1007, P211, DOI 10.1196/annals.1286.021; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Barske J, 2011, P ROY SOC B-BIOL SCI, V278, P3523, DOI 10.1098/rspb.2011.0382; Bostwick KS, 2010, P R SOC B, V277, P835, DOI 10.1098/rspb.2009.1576; Bostwick KS, 2003, J EXP BIOL, V206, P3693, DOI 10.1242/jeb.00598; BRANTLEY RK, 1993, J MORPHOL, V216, P305, DOI 10.1002/jmor.1052160306; Buttemer WA, 2008, COMP BIOCHEM PHYS A, V150, P204, DOI 10.1016/j.cbpa.2006.06.047; Canoine V, 2007, DEV NEUROBIOL, V67, P57, DOI 10.1002/dneu.20296; Casto JM, 2001, AM NAT, V157, P408, DOI 10.1086/319318; CELIO MR, 1982, NATURE, V297, P504, DOI 10.1038/297504a0; Chapman F.M., 1935, B AM MUS NAT HIST, V68, P472; Chappell MA, 1997, BEHAVIOUR, V134, P511, DOI 10.1163/156853997X00502; Clark CJ, 2011, SCIENCE, V333, P1430, DOI 10.1126/science.1205222; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; CREWS D, 1986, SCIENCE, V231, P121, DOI 10.1126/science.3941893; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; Day LB, 2007, HORM BEHAV, V51, P69, DOI 10.1016/j.yhbeh.2006.08.006; Day LB, 2006, HORM BEHAV, V49, P223, DOI 10.1016/j.yhbeh.2005.07.006; Duffy DL, 2000, BEHAV ECOL, V11, P654, DOI 10.1093/beheco/11.6.654; Feng NY, 2010, ENDOCRINOLOGY, V151, P1042, DOI 10.1210/en.2009-0901; Fusani L, 2007, ETHOLOGY, V113, P964, DOI 10.1111/j.1439-0310.2007.01395.x; Fusani L, 2007, HORM BEHAV, V51, P62, DOI 10.1016/j.yhbeh.2006.08.005; Fuxjager MJ, 2012, ENDOCRINOLOGY, V153, P3780, DOI 10.1210/en.2012-1313; Goymann W, 2007, HORM BEHAV, V51, P463, DOI 10.1016/j.yhbeh.2007.01.007; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Gu Z, 2004, ANIM GENET, V35, P470, DOI 10.1111/j.1365-2052.2004.01194.x; Guernec A, 2004, DOMEST ANIM ENDOCRIN, V26, P143, DOI 10.1016/j.domaniend.2003.10.001; HARTMAN FRANK A., 1961, SMITHSONIAN MISC COLL, V143, P1; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; HEDENSTROM A, 1992, P ROY SOC B-BIOL SCI, V247, P183, DOI 10.1098/rspb.1992.0026; HEGNER RE, 1987, AUK, V104, P462, DOI 10.2307/4087545; HEIZMANN CW, 1982, P NATL ACAD SCI-BIOL, V79, P7243, DOI 10.1073/pnas.79.23.7243; Hirschenhauser K, 2003, HORM BEHAV, V43, P508, DOI 10.1016/S0018-506X(03)00027-8; HOU TT, 1991, J PHYSIOL-LONDON, V441, P285, DOI 10.1113/jphysiol.1991.sp018752; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; KREBS HA, 1950, BIOCHIM BIOPHYS ACTA, V4, P249, DOI 10.1016/0006-3002(50)90032-1; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Larsen ON, 2002, J EXP BIOL, V205, P25; Leska A, 2012, GEN COMP ENDOCR, V179, P63, DOI 10.1016/j.ygcen.2012.07.026; MARDEN JH, 1987, J EXP BIOL, V130, P235; Matheny RW, 2011, ENDOCRINOLOGY, V152, P1923, DOI 10.1210/en.2010-1279; McGraw KJ, 2007, BIOL LETTERS, V3, P375, DOI 10.1098/rsbl.2007.0190; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; Mendler L, 2007, BIOCHEM BIOPH RES CO, V361, P237, DOI 10.1016/j.bbrc.2007.07.023; Metzdorf R, 1999, J COMP NEUROL, V407, P115; Mosler S, 2012, ARCH TOXICOL, V86, P109, DOI 10.1007/s00204-011-0740-z; Mozdziak PE, 1998, J APPL PHYSIOL, V84, P1359, DOI 10.1152/jappl.1998.84.4.1359; MUNTENER M, 1995, P NATL ACAD SCI USA, V92, P6504, DOI 10.1073/pnas.92.14.6504; Noriega NC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-47; ORING LEWIS W., 1964, AUK, V81, P83; Price ER, 2011, J EXP BIOL, V214, P2823, DOI 10.1242/jeb.057620; RAND MN, 1992, J NEUROBIOL, V23, P17, DOI 10.1002/neu.480230104; REGNIER M, 1993, J PHYSIOL-LONDON, V461, P565, DOI 10.1113/jphysiol.1993.sp019529; REGNIER M, 1993, J NEUROBIOL, V24, P1215, DOI 10.1002/neu.480240908; RUBINSTEIN NA, 1983, EXP NEUROL, V82, P424, DOI 10.1016/0014-4886(83)90414-4; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Schlinger BA, 2008, GEN COMP ENDOCR, V157, P254, DOI 10.1016/j.ygcen.2008.05.015; Schultz JD, 2001, J COMP PHYSIOL A, V187, P677; Serra C, 2011, ENDOCRINOLOGY, V152, P193, DOI 10.1210/en.2010-0802; Seward DJ, 2001, AM J PHYSIOL-CELL PH, V280, pC408, DOI 10.1152/ajpcell.2001.280.2.C408; Sibley CG, 1990, DISTRIBUTION TAXONOM; Singh R, 2003, ENDOCRINOLOGY, V144, P5081, DOI 10.1210/en.2003-0741; Swanson DL, 2009, PHYSL BIOCH ZOOL, V82; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; TOBIAS ML, 1993, J NEUROSCI, V13, P324; Tomaszycki ML, 2006, HORM BEHAV, V50, P141, DOI 10.1016/j.yhbeh.2006.02.005; Tramontin AD, 2003, J NEUROBIOL, V57, P130, DOI 10.1002/neu.10263; Veney SL, 2004, GEN COMP ENDOCR, V136, P192, DOI 10.1016/j.ygcen.2003.12.017; VORNBERGER W, 1994, ENDOCRINOLOGY, V134, P2307, DOI 10.1210/en.134.5.2307; Wade J, 2000, J COMP NEUROL, V426, P154; Wainman P, 1941, ENDOCRINOLOGY, V29, P975, DOI 10.1210/endo-29-6-975; WESTCOTT DA, 1994, CONDOR, V96, P672, DOI 10.2307/1369470; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wood RI, 1999, J NEUROBIOL, V39, P359, DOI 10.1002/(SICI)1097-4695(19990605)39:3<359::AID-NEU3>3.0.CO;2-W; Wyce A, 2010, MOL ENDOCRINOL, V24, P1665, DOI 10.1210/me.2010-0138; Yoshioka M, 2006, J MOL ENDOCRINOL, V36, P247, DOI 10.1677/jme.1.01964; ZOPPI S, 1988, J STEROID BIOCHEM, V31, P677, DOI 10.1016/0022-4731(88)90018-0	78	39	39	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51482	10.1371/journal.pone.0051482	http://dx.doi.org/10.1371/journal.pone.0051482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284699	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900022
J	Glennie, SJ; Banda, D; Mulwafu, W; Nkhata, R; Williams, NA; Heyderman, RS				Glennie, Sarah J.; Banda, Dominic; Mulwafu, Wakisa; Nkhata, Rose; Williams, Neil A.; Heyderman, Robert S.			Regulation of Naturally Acquired Mucosal Immunity to Streptococcus pneumoniae in Healthy Malawian Adults and Children	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; PNEUMOCOCCAL CARRIAGE; CELL MEMORY; COLONIZATION; PROTECTION; ANTIBODIES; ANTIGENS	Worldwide, invasive pneumococcal disease caused by Streptococcus pneumoniae is most common in young children. In adults, disease rates decline following intermittent colonization and the acquisition of naturally acquired immunity. We characterized mucosal and systemic pneumococcal-specific T-cell responses in African children and adults who contend with intense rates of colonization, up to 100% and 60% respectively. We find most Malawian children have high pneumococcal-specific T-cell responses in tonsil tissue and peripheral blood. In addition, frequent commensalism generates CD25(hi) (Tregs) which modulate mucosal pneumococcal-specific T-cell responses in some children and >= 50% of adults. We propose that immune regulation may prolong pneumococcal colonization and predispose vulnerable individuals to disease.	[Glennie, Sarah J.; Banda, Dominic; Nkhata, Rose; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Glennie, Sarah J.; Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England; [Mulwafu, Wakisa] Univ Malawi, Coll Med, Dept Surg, Blantyre, Malawi; [Williams, Neil A.] Univ Bristol, Sch Med Sci, Bristol BS8 1TD, Avon, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Bristol	Glennie, SJ (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	sarah.glennie@liverpool.ac.uk		Heyderman, Robert/0000-0003-4573-449X	Wellcome Trust (United Kingdom) [083603/A/07/Z, 084679/Z/08/Z]	Wellcome Trust (United Kingdom)(Wellcome Trust)	This work was supported by a grant to NAW and RSH by the Wellcome Trust "083603/A/07/Z" (United Kingdom), a core programme grant to RSH by the Wellcome Trust "084679/Z/08/Z" (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195; Davenport V, 2008, J INFECT DIS, V198, P731, DOI 10.1086/590669; Davenport V, 2007, CELL MICROBIOL, V9, P1050, DOI 10.1111/j.1462-5822.2006.00851.x; Ferreira DM, 2011, TRENDS MICROBIOL, V19, P464, DOI 10.1016/j.tim.2011.06.003; French N, N ENGL J MED, V362, P812; Glennie SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025610; Glennie SJ, 2010, TRENDS MICROBIOL, V18, P487, DOI 10.1016/j.tim.2010.08.002; Iwajomo OH, 2011, J INFECT DIS, V204, P534, DOI 10.1093/infdis/jir316; Jambo KC, 2011, THORAX, V66, P375, DOI 10.1136/thx.2010.153825; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; Mureithi MW, 2009, J INFECT DIS, V200, P783, DOI 10.1086/605023; Pido-Lopez J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002396; Trzcinski K, 2005, INFECT IMMUN, V73, P7043, DOI 10.1128/IAI.73.10.7043-7046.2005; Whitney CG, 2002, PEDIATR INFECT DIS J, V21, P961, DOI 10.1097/00006454-200210000-00016; Zhang QB, 2002, INFECT IMMUN, V70, P5363, DOI 10.1128/IAI.70.10.5363-5369.2002; Zhang QB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002175	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51425	10.1371/journal.pone.0051425	http://dx.doi.org/10.1371/journal.pone.0051425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284694	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000312435900020
J	Carlson, JE; Holsinger, KE				Carlson, Jane E.; Holsinger, Kent E.			Developmental Plasticity in Protea as an Evolutionary Response to Environmental Clines in the Cape Floristic Region	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; ECOLOGICAL SPECIATION; BIODIVERSITY HOTSPOT; NATURAL-SELECTION; PLANT; ADAPTATION; DIVERSITY; TRAITS; DIFFERENTIATION; EXPRESSION	Local adaptation along steep environmental gradients likely contributes to plant diversity in the Cape Region of South Africa, yet existing analyses of trait divergence are limited to static measurements of functional traits rather than trajectories of individual development. We explore whether five taxa of evergreen shrubs (Protea section Exsertae) differ in their developmental trajectories and capacity for plasticity using two environmentally-distinct common gardens in South Africa. We measured seedlings in the summer-dry season and winter-wet season of each of two consecutive years to characterize ontogeny and plasticity within years, as same-age leaf cohorts mature, and between years, i.e., from leaf one cohort to the next. We compared patterns of development between gardens to assess whether trait trajectories are programmed versus plastic and examined whether developmental differences covaried with characteristics of a seedling's home environment. We detected plasticity in developmental trajectories for leaf area, stomatal size, stomatal pore index, and to a limited extent specific leaf area, but not for stomatal density. We showed that the species growing in the harshest environments exhibits both the smallest increase in leaf area between years and the least change in SLA and photosynthetic rates as leaves age within years. These results show that within this clade, species have diverged in developmental trajectories and plasticity as well as in mean trait values. Some of these differences may be associated with adaptation to cold and drought stress within an environmentally-complex region. Citation: Carlson JE, Holsinger KE (2012) Developmental Plasticity in Protea as an Evolutionary Response to Environmental Clines in the Cape Floristic Region. PLoS ONE 7(12): e52035. doi:10.1371/journal.pone.0052035	[Carlson, Jane E.; Holsinger, Kent E.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA	University of Connecticut	Holsinger, KE (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA.	kent.holsinger@uconn.edu	Holsinger, Kent/A-7435-2009	Holsinger, Kent/0000-0003-4312-3804; , Jane/0000-0003-2902-6055	United States National Science Foundation [DEB-0716622, DEB-1046328]; Direct For Biological Sciences [1046328] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the United States National Science Foundation: DEB-0716622 and DEB-1046328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2008, J ECOL, V96, P536, DOI 10.1111/j.1365-2745.2008.01365.x; Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767; [Anonymous], 2006, SAS MIXED MODELS; ANTONOVICS J., 1971, Advances in Ecological Research, V7, P1, DOI 10.1016/S0065-2504(08)60202-0; Bell DL, 1999, AM J BOT, V86, P807, DOI 10.2307/2656702; Bukhov NG, 2004, CHLOROPHYLL FLUORESC; Carlson JE, 2011, EVOLUTION, V65, P108, DOI 10.1111/j.1558-5646.2010.01131.x; Carlson JE, 2010, AM J BOT, V97, P934, DOI 10.3732/ajb.0900348; Clausen J D, 1940, USITC PUBL; COOK SA, 1968, EVOLUTION, V22, P496, DOI 10.1111/j.1558-5646.1968.tb03988.x; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2002, DIVERS DISTRIB, V8; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DIGGLE PK, 1994, AM J BOT, V81, P1354, DOI 10.2307/2445411; Diggle PK, 2002, EVOL ECOL, V16, P267, DOI 10.1023/A:1019680527788; Distler T, 2009, ANN MO BOT GARD, V96, P470, DOI 10.3417/2008034; Dunlap JM, 2001, CAN J BOT, V79, P528, DOI 10.1139/cjb-79-5-528; Edwards EJ, 2006, NEW PHYTOL, V172, P479, DOI 10.1111/j.1469-8137.2006.01850.x; Ellis AG, 2006, J ECOL, V94, P322, DOI 10.1111/j.1365-2745.2005.01074.x; FENSTER CB, 1991, EVOLUTION, V45, P398, DOI 10.1111/j.1558-5646.1991.tb04413.x; Forster MA, 2009, ANN BOT-LONDON, V103, P95, DOI 10.1093/aob/mcn210; Forsyth GG, 2007, CSIRNREECOER20070118; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Friar EA, 2006, EVOLUTION, V60, P1777; Geber MA, 2003, INTERNATIONAL JOURNA, V164; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gianoli E, 2005, EVOL ECOL, V19, P603, DOI 10.1007/s10682-005-2220-5; Goldblatt P., 2000, CAPE PLANTS A CONSPE; GOLIBER TE, 1990, AM J BOT, V77, P399, DOI 10.2307/2444726; Grime J. P., 1979, Plant strategies and vegetation processes.; Heschel MS, 2001, INT J PLANT SCI, V162, P1253, DOI 10.1086/322951; Jones C. S., 2001, B SOC ARGENT BOT, V36, P171; JONES CS, 1993, AM J BOT, V80, P778, DOI 10.2307/2445598; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Latimer AM, 2009, OECOLOGIA, V160, P151, DOI 10.1007/s00442-009-1275-3; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Linder HP, 2005, TRENDS PLANT SCI, V10, P536, DOI 10.1016/j.tplants.2005.09.006; Maherali H, 2009, NEW PHYTOL, V183, P908, DOI 10.1111/j.1469-8137.2009.02845.x; Maron JL, 2007, EVOLUTION, V61, P1912, DOI 10.1111/j.1558-5646.2007.00153.x; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Paakkonen E, 1998, ANN BOT-LONDON, V82, P49, DOI 10.1006/anbo.1998.0656; Picotte JJ, 2007, OECOLOGIA, V153, P821, DOI 10.1007/s00442-007-0794-z; Prunier R, JOURNAL OF EVOLUTION; Prunier R, 2010, MOL ECOL, V19, P3968, DOI 10.1111/j.1365-294X.2010.04779.x; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Rebelo AG, 2004, PROTEA ATLAS PROJECT; Reich PB, 2003, INT J PLANT SCI, V164, pS143, DOI 10.1086/374368; Reynoso-Castillo GA, 2001, ACTA HORT ISHS, V545, P245; RICHARDSON DM, 1990, S AFR J BOT, V56, P214, DOI 10.1016/S0254-6299(16)31089-4; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; SAS Institute Inc, 2008, SAS STAT 9 2 USERS G; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Saville DJ, 2003, CAN J EXP PSYCHOL, V57, P167, DOI 10.1037/h0087423; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schnitzler J, 2011, SYST BIOL, V60, P343, DOI 10.1093/sysbio/syr006; Schulze R.E., 2007, 1489106 WRC; Stock W. D., 1997, P376; Sultan SE, 2003, EVOL DEV, V5, P25, DOI 10.1046/j.1525-142X.2003.03005.x; SULTAN SE, 1992, EVOL TREND PLANT, V6, P61; Valente LM, 2010, EVOLUTION, V64, P745, DOI 10.1111/j.1558-5646.2009.00856.x; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Verboom GA, 2004, AM J BOT, V91, P1364, DOI 10.3732/ajb.91.9.1364; WATSON MA, 1995, TRENDS ECOL EVOL, V10, P474; West-Eberhard Mary Jane, 2003, pi; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Yuan Y, 2000, PROCEEDINGS OF THE 2	72	9	10	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52035	10.1371/journal.pone.0052035	http://dx.doi.org/10.1371/journal.pone.0052035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272203	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386600054
J	Gebremedhin, S; Enquselassie, F; Umeta, M				Gebremedhin, Samson; Enquselassie, Fikre; Umeta, Melaku			Independent and Joint Effects of Prenatal Zinc and Vitamin A Deficiencies on Birthweight in Rural Sidama, Southern Ethiopia: Prospective Cohort Study	PLOS ONE			English	Article							INTRAUTERINE GROWTH; ANTENATAL CARE; CORD SERUM; MALNUTRITION; ASSOCIATION	Background: The effects of prenatal Zinc Deficiency (ZD) and Vitamin A Deficiency (VAD) on birthweight are controversial and their interaction has not been investigated. Objective: To assess the independent and interaction effects of prenatal zinc and vitamin A deficiencies on birthweight in rural Sidama, Southern Ethiopia. Methodology: A community-based prospective cohort study design was employed. Six hundred fifty pregnant women in their second or third trimester were randomly selected and their serum zinc and retinol concentrations were determined. About 575 subjects were successfully followed until delivery and birthweight was measured within 72 hours after delivery. The association between the exposures and birthweight was examined using log-binomial and liner regression analyses. Potential interaction between ZD and VAD was examined using Synergy Index (SI). Results: The mean birthweight (6 standard deviation) was 2896 g (6423). About 16.5% (95% CI: 13.5-19.6%) of the babies had Low Birthweight (LBW). Prenatal ZD and VAD were not significantly associated to LBW with Adjusted Relative Risk (ARR) of 1.25 (95 CI: 0.86-1.82) and 1.27 (95% CI: 0.86-1.87), respectively. Stratified analysis on the basis of gestational trimester showed that the occurrence of the deficiencies neither in the second nor third trimester were associated to LBW. The deficiencies did not show synergetic interaction in causing LBW [SI = 1.04 (95% CI: 0.17-6.28)]. Important risk factors of LBW were maternal illiteracy [RR = 1.80 (95% CI: 1.11-2.93)], female sex of the newborn [RR = 1.79 (95% CI: 1.19-2.67)], primiparity [RR = 1.16 (95% CI: 1.02-1.35)], short maternal stature [RR = 1.63 (95% CI: 1.06-2.51)] and maternal thinness [ RR = 1.52 (95% CI: 1.03-2.25)]. In the linear regression model, elevated CRP was also negatively associated to birthweight. Conclusion: LBW is of public health significance in the locality. The study did not witness any independent or interaction effect of prenatal ZD and VAD on birthweight. Citation: Gebremedhin S, Enquselassie F, Umeta M (2012) Independent and Joint Effects of Prenatal Zinc and Vitamin A Deficiencies on Birthweight in Rural Sidama, Southern Ethiopia: Prospective Cohort Study. PLoS ONE 7(12):e50213. doi:10.1371/journal.pone.0050213	[Gebremedhin, Samson] Hawassa Univ, Coll Agr, Hawassa, Ethiopia; [Enquselassie, Fikre] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Umeta, Melaku] Univ Addis Ababa, Sch Med, Addis Ababa, Ethiopia	Hawassa University; Addis Ababa University; Addis Ababa University	Gebremedhin, S (corresponding author), Hawassa Univ, Coll Agr, Hawassa, Ethiopia.	samsongmgs@yahoo.com	Gebremedhin, Samson/O-2121-2019	Gebremedhin, Samson/0000-0002-7838-2470	Addis Ababa University, School of Public Health	Addis Ababa University, School of Public Health	The study was funded by Addis Ababa University, School of Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Ammar C., 2009, ENCY WOMENS HLTH; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Asefa M, 2004, ETHIOP J HLTH SCI, V14, P13; Barua D, 2009, BANGLADESH J CHILD H, V33, P46; Broek NV, 2010, VITAMIN A SUPPLEMENT, DOI [10.1002/14651858.CD008666.pub2, DOI 10.1002/14651858.CD008666.PUB2]; CoriaSoto IL, 1996, INT J QUAL HEALTH C, V8, P13, DOI 10.1093/intqhc/8.1.13; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Enquoselassie F., 2000, Ethiopian Journal of Health Development, V14, P169; Feleke Y, 1999, E AFR MED J, V76, P468; FerroLuzzi A, 1996, BRIT J NUTR, V75, P3, DOI 10.1079/BJN19960105; Gazala E, 2003, EARLY HUM DEV, V71, P19, DOI 10.1016/S0378-3782(02)00096-8; Gebremariam A, 2005, East Afr Med J, V82, P554; Gebremedhin S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-898; GHEBREMESKEL K, 1994, EARLY HUM DEV, V39, P177, DOI 10.1016/0378-3782(94)90196-1; HIGASHI A, 1988, J PEDIATR GASTR NUTR, V7, P430, DOI 10.1097/00005176-198805000-00020; Hirve S S, 1994, Indian Pediatr, V31, P1221; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Institute of Health Economics, 2001, DET PREV LOW BIRTHW; International Zinc Nutrition Consultative Group, 2007, ASS POP ZINC STAT SE; Khatun S, 2008, J BIOSOC SCI, V40, P321, DOI 10.1017/S0021932007002532; King JC, 2000, AM J CLIN NUTR, V71, p1334S, DOI 10.1093/ajcn/71.5.1334s; KIRKSEY A, 1994, AM J CLIN NUTR, V60, P782, DOI 10.1093/ajcn/60.5.782; Mohanty C, 2006, J TROP PEDIATRICS, V52, P24, DOI 10.1093/tropej/fmi059; Mori R, 2012, ZINC SUPPLEMENTATION, DOI [10.1002/14651858.CD000230.pub4, DOI 10.1002/14651858.CD000230.PUB4]; NEEL NR, 1990, EUR J CLIN NUTR, V44, P207; NEGGERS YH, 1990, AM J CLIN NUTR, V51, P678, DOI 10.1093/ajcn/51.4.678; Nekatibeb Gezahegn, 2007, Ethiop Med J, V45, P195; ORC Macro, 2006, ETH DEM HLTH SURV 20; ORC Macro Central Statistical Agency, 2001, ETH DEM HLTH SURV 20; Pojda J, 2000, 18 ACCSCN; Prasad M, 2002, J Obstet Gynaecol, V22, P513, DOI 10.1080/0144361021000003654; Rah JH, 2006, CHANGE MATERNAL MIDU; Ricalde AE, 1998, REV SAUDE PUBL, V32, P112, DOI 10.1590/S0034-89101998000200002; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Sommer A, 2002, J NUTR, V132, p2845S, DOI 10.1093/jn/132.9.2845S; Tamura T, 1997, ACTA OBSTET GYN SCAN, V76, P63; Tema T, 2006, East Afr Med J, V83, P366; Teshome D, 2006, Cent Afr J Med, V52, P8; United Nations Children's Fund and World Health Organization, 2004, LOW BIRTHW COUNTR RE	41	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50213	10.1371/journal.pone.0050213	http://dx.doi.org/10.1371/journal.pone.0050213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AH	23272058	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600009
J	Naumova, EA; Sandulescu, T; Al Khatib, P; Thie, M; Lee, WK; Zimmer, S; Arnold, WH				Naumova, Ella A.; Sandulescu, Tudor; Al Khatib, Philipp; Thie, Michael; Lee, Wing-Kee; Zimmer, Stefan; Arnold, Wolfgang H.			Acute Short-Term Mental Stress Does Not Influence Salivary Flow Rate Dynamics	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ALPHA-AMYLASE; PSYCHOLOGICAL STRESS; SUCROSE CLEARANCE; CORTISOL; ANXIETY; IMPACT; ADULTS	Background: Results of studies that address the influence of stress on salivary flow rate and composition are controversial. The aim of this study was to reveal the influence of stress vulnerability and different phases of stress reactivity on the unstimulated and stimulated salivary flow rate. We examined that acute mental stress does not change the salivary flow rate. In addition, we also examined the salivary cortisol and protein level in relation to acute mental stress stimuli. Methods: Saliva of male subjects was collected for five minutes before, immediately, 10, 30 and 120 min after toothbrushing. Before toothbrushing, the subjects were exposed to acute stress in the form of a 2 min public speech. Salivary flow rate and total protein was measured. The physiological stress marker cortisol was analyzed using enzyme-linked immunosorbent assay. To determine the subjects' psychological stress reaction, the State-Trait-Anxiety Inventory State questionnaire (STAI) data were obtained. The subjects were divided into stress subgroup (S1) (psychological reactivity), stress subgroup (S2) (psychological and physiological reactivity) and a control group. The area under the curve for salivarycortisol concentration and STAI-State scores were calculated. All data underwent statistical analysis using one-way analysis of variance. Results: Immediately after stress exposure, all participants exhibited a psychological stress reaction. Stress exposure did not change the salivary flow rate. Only 69% of the subjects continued to display a physiological stress reaction 20 minutes after the public talk. There was no significant change in the salivary flow rate during the psychological and the physiological stress reaction phases relative to the baseline. Conclusions: Acute stress has no impact on the salivary flow rate; however, there may be other responses through salivary proteins that are increased with the acute stress stimuli. Future studies are needed to examine specific proteins and their possible roles in acute stress responses. Citation: Naumova EA, Sandulescu T, Al Khatib P, Thie M, Lee W-K, et al. (2012) Acute Short-Term Mental Stress Does Not Influence Salivary Flow Rate Dynamics. PLoS ONE 7(12): e51323. doi:10.1371/journal.pone.0051323	[Naumova, Ella A.; Sandulescu, Tudor; Al Khatib, Philipp; Zimmer, Stefan; Arnold, Wolfgang H.] Univ Witten Herdecke, Fac Hlth, Sch Dent, Witten, Germany; [Thie, Michael] Univ Duisburg Essen, Inst Pathol & Neuropathol, Essen, Germany; [Lee, Wing-Kee] Univ Witten Herdecke, Inst Physiol & Pathophysiol, Ctr Biomed Educ & Res, Witten, Germany	Witten Herdecke University; University of Duisburg Essen; Witten Herdecke University	Arnold, WH (corresponding author), Univ Witten Herdecke, Fac Hlth, Sch Dent, Witten, Germany.	wolfgang.arnold@uni-wh.de		Lee, Wing-Kee/0000-0002-7352-4679	Deutsche Gesellschaft fur Zahnerhaltung	Deutsche Gesellschaft fur Zahnerhaltung	This study was supported by Deutsche Gesellschaft fur Zahnerhaltung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balodis IM, 2010, PSYCHONEUROENDOCRINO, V35, P1363, DOI 10.1016/j.psyneuen.2010.03.011; BASS C C, 1954, J La State Med Soc, V106, P57; BAUM BJ, 1993, ANN NY ACAD SCI, V694, P17; Beltzer EK, 2010, PHYSIOL BEHAV, V101, P289, DOI 10.1016/j.physbeh.2010.05.016; Bjorntorp P, 2001, Lakartidningen, V98, P5458; Bosch JA, 2003, PSYCHOSOM MED, V65, P245, DOI 10.1097/01.PSY.0000058376.50240.2D; Bosch JA, 1996, PSYCHOSOM MED, V58, P374, DOI 10.1097/00006842-199607000-00010; Boudarene M, 2002, ENCEPHALE, V28, P139; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861; Elishoov H, 2005, Refuat Hapeh Vehashinayim (1993), V22, P44; ELISHOOV H, 2005, REFUAT HAPEH VEHASHI, V22, P86; Flink Hakan, 2007, Swed Dent J Suppl, P3; Gibbons CJ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-82; Hansen AM, 2008, SCAND J CLIN LAB INV, V68, P448, DOI 10.1080/00365510701819127; Herrmann-Lingen C., 2005, HADS D HOSP ANXIETY; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; King JA, 2000, BEHAV MED, V26, P67, DOI 10.1080/08964280009595753; King Shirley L, 2002, Biol Res Nurs, V4, P92, DOI 10.1177/1099800402238334; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; Kreher DA, 2012, BEHAV NEUROSCI, V126, P157, DOI 10.1037/a0026654; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; LAGERLOF F, 1994, CARIES RES, V28, P348, DOI 10.1159/000262000; Laux L., 1981, DAS STATE TRAIT ANGS; Lenander-Lumikari M, 2000, Adv Dent Res, V14, P40; MIURA H, 1991, J DENT, V19, P189, DOI 10.1016/0300-5712(91)90016-R; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Paris JJ, 2010, HORM BEHAV, V57, P35, DOI 10.1016/j.yhbeh.2009.06.003; Pawlak CR, 1999, BRAIN BEHAV IMMUN, V13, P287, DOI 10.1006/brbi.1999.0553; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Shigeyama C, 2008, ORAL SURG ORAL MED O, V106, P833, DOI 10.1016/j.tripleo.2008.07.005; Siedek V, 2008, MMW Fortschr Med, V150, P31; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Takai N, 2004, ARCH ORAL BIOL, V49, P963, DOI 10.1016/j.archoralbio.2004.06.007; Tornhage CJ, 2009, NEUROIMMUNOMODULAT, V16, P284, DOI 10.1159/000216186	36	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51323	10.1371/journal.pone.0051323	http://dx.doi.org/10.1371/journal.pone.0051323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AH	23272098	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386600023
J	Tol, MB; Deluz, C; Hassaine, G; Graff, A; Stahlberg, H; Vogel, H				Tol, Menno B.; Deluz, Cedric; Hassaine, Gherici; Graff, Alexandra; Stahlberg, Henning; Vogel, Horst			Thermal Unfolding of a Mammalian Pentameric Ligand-gated Ion Channel Proceeds at Consecutive, Distinct Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; BLUE NATIVE ELECTROPHORESIS; SEROTONIN 5-HT3 RECEPTOR; NONIONIC SURFACTANTS; CIRCULAR-DICHROISM; PROTEIN-STABILITY; MEMBRANE; BINDING; TORPEDO; THERMOSTABILITY	Pentameric ligand-gated ion channels (LGICs) play an important role in fast synaptic signal transduction. Binding of agonists to the beta-sheet-structured extracellular domain opens an ion channel in the transmembrane alpha-helical region of the LGIC. How the structurally distinct and distant domains are functionally coupled for such central transmembrane signaling processes remains an open question. To obtain detailed information about the stability of and the coupling between these different functional domains, we analyzed the thermal unfolding of a homopentameric LGIC, the 5-hydroxytryptamine receptor (ligand binding, secondary structure, accessibility of Trp and Cys residues, and aggregation), in plasma membranes as well as during detergent extraction, purification, and reconstitution into artificial lipid bilayers. We found a large loss in thermostability correlating with the loss of the lipid bilayer during membrane solubilization and purification. Thermal unfolding of the 5-hydroxytryptamine receptor occurred in consecutive steps at distinct protein locations. A loss of ligand binding was detected first, followed by formation of different transient low oligomeric states of receptor pentamers, followed by partial unfolding of helical parts of the protein, which finally lead to the formation receptor aggregates. Structural destabilization of the receptor in detergents could be partially reversed by reconstituting the receptor into lipid bilayers. Our results are important because they quantify the stability of LGICs during detergent extraction and purification and can be used to create stabilized receptor proteins for structural and functional studies.	[Tol, Menno B.; Deluz, Cedric; Hassaine, Gherici; Vogel, Horst] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, CH-1015 Lausanne, Switzerland; [Graff, Alexandra; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, CH-4085 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Basel	Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol Lausanne, LCPPM, Stn 6, CH-1015 Lausanne, Switzerland.	horst.vogel@epfl.ch	Stahlberg, Henning/H-1868-2011; Vogel, Horst/AAJ-5490-2021	Stahlberg, Henning/0000-0002-1185-4592; 	European Community's Seventh Framework Program [211800]; Swiss National Science Foundation [31003A-118148]; Ecole Polytechnique Federale de Lausanne	European Community's Seventh Framework Program(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne	This work was supported by the European Community's Seventh Framework Program FP7/2007-2013 under Grant 211800, the Swiss National Science Foundation (the SystemsX program and SNF Grant 31003A-118148), and internal funds of the Ecole Polytechnique Federale de Lausanne.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; ARTIGUES A, 1987, ARCH BIOCHEM BIOPHYS, V258, P33, DOI 10.1016/0003-9861(87)90319-5; Asmar-Rovira GA, 2008, J MEMBRANE BIOL, V223, P13, DOI 10.1007/s00232-008-9107-7; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bowie JU, 2001, CURR OPIN STRUC BIOL, V11, P397, DOI 10.1016/S0959-440X(00)00223-2; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chen ML, 2007, CHEM RES CHINESE U, V23, P715, DOI 10.1016/S1005-9040(07)60156-1; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; Dellisanti CD, 2011, J BIOL CHEM, V286, P3658, DOI 10.1074/jbc.M110.156851; Derewenda ZS, 2010, ACTA CRYSTALLOGR D, V66, P604, DOI 10.1107/S090744491000644X; Frauenfelder H, 2006, P NATL ACAD SCI USA, V103, P15469, DOI 10.1073/pnas.0607168103; FRAUENFELDER H, 1987, BIOCHEMISTRY-US, V26, P254, DOI 10.1021/bi00375a035; Garriga P, 1996, P NATL ACAD SCI USA, V93, P4560, DOI 10.1073/pnas.93.10.4560; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W; Harris NJ, 2012, BBA-BIOMEMBRANES, V1818, P1055, DOI 10.1016/j.bbamem.2011.11.006; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Heyden M, 2012, SOFT MATTER, V8, P7742, DOI 10.1039/c2sm25402f; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; Hong H, 2009, METHOD ENZYMOL, V455, P213, DOI 10.1016/S0076-6879(08)04208-0; Hovius R, 1998, J NEUROCHEM, V70, P824; Jenney FE, 2008, EXTREMOPHILES, V12, P39, DOI 10.1007/s00792-007-0087-9; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Machu TK, 2011, PHARMACOL THERAPEUT, V130, P338, DOI 10.1016/j.pharmthera.2011.02.003; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Maksay G, 1996, J NEUROCHEM, V67, P407; Mancusso R, 2011, METHODS, V55, P324, DOI 10.1016/j.ymeth.2011.07.008; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; O'Malley MA, 2010, BIOCHEMISTRY-US, V49, P9181, DOI 10.1021/bi101155r; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; PEREZRAMIREZ B, 1994, MOL CELL BIOCHEM, V132, P91, DOI 10.1007/BF00926917; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Purohit P, 2010, J GEN PHYSIOL, V135, P321, DOI 10.1085/jgp.200910384; Quirk PL, 2004, J NEUROSCI RES, V77, P498, DOI 10.1002/jnr.20185; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rees DC, 2001, PROTEIN SCI, V10, P1187, DOI 10.1110/ps.180101; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schlinkmann KM, 2012, J MOL BIOL, V422, P414, DOI 10.1016/j.jmb.2012.05.039; Schreiter C, 2003, J BIOL CHEM, V278, P22709, DOI 10.1074/jbc.M301801200; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Sharma KS, 2003, COLLOID SURFACE A, V219, P67, DOI 10.1016/S0927-7757(03)00012-8; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; Tairi AP, 1998, BIOCHEMISTRY-US, V37, P15850, DOI 10.1021/bi981812z; Tate CG, 2010, METHODS MOL BIOL, V601, P187, DOI 10.1007/978-1-60761-344-2_12; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Tsetlin V, 2011, J NEUROCHEM, V116, P734, DOI 10.1111/j.1471-4159.2010.07060.x; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VOGEL H, 1988, P NATL ACAD SCI USA, V85, P5067, DOI 10.1073/pnas.85.14.5067; VOGEL H, 1987, BIOCHEMISTRY-US, V26, P4562, DOI 10.1021/bi00388a060; Walstab J, 2010, PHARMACOL THERAPEUT, V128, P146, DOI 10.1016/j.pharmthera.2010.07.001; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Yeh AP, 2006, ACTA CRYSTALLOGR D, V62, P451, DOI 10.1107/S0907444906005233; Zelent B, 1998, BIOPHYS CHEM, V73, P53, DOI 10.1016/S0301-4622(98)00137-9	69	15	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5756	5769		10.1074/jbc.M112.422287	http://dx.doi.org/10.1074/jbc.M112.422287			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23275379	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000315342500047
J	Shi, J; Koteiche, HA; McDonald, ET; Fox, TL; Stewart, PL; Mchaourab, HS				Shi, Jian; Koteiche, Hanane A.; McDonald, Ezelle T.; Fox, Tara L.; Stewart, Phoebe L.; Mchaourab, Hassane S.			Cryoelectron Microscopy Analysis of Small Heat Shock Protein 16.5 (Hsp16.5) Complexes with T4 Lysozyme Reveals the Structural Basis of Multimode Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; CHAPERONE ACTIVITY; MISSENSE MUTATION; 2-MODE BINDING; MECHANISM; SUBSTRATE; DOMAIN; DETERMINANTS; DISSOCIATION; POLYDISPERSITY	Small heat shock proteins (sHSPs) are ubiquitous chaperones that bind and sequester non-native proteins preventing their aggregation. Despite extensive studies of sHSPs chaperone activity, the location of the bound substrate within the sHSP oligomer has not been determined. In this paper, we used cryoelectron microscopy (cryoEM) to visualize destabilized mutants of T4 lysozyme (T4L) bound to engineered variants of the small heat shock protein Hsp16.5. In contrast to wild type Hsp16.5, binding of T4L to these variants does not induce oligomer heterogeneity enabling cryoEM analysis of the complexes. CryoEM image reconstruction reveals the sequestration of T4L in the interior of the Hsp16.5 oligomer primarily interacting with the buried N-terminal domain but also tethered by contacts with the alpha-crystallin domain shell. Analysis of Hsp16.5-WT/T4L complexes uncovers oligomer expansion as a requirement for high affinity binding. In contrast, a low affinity mode of binding is found to involve T4L binding on the outer surface of the oligomer bridging the formation of large complexes of Hsp16.5. These mechanistic principles were validated by cryoEM analysis of an expanded variant of Hsp16.5 in complex with T4L and Hsp16.5-R107G, which is equivalent to a mutant of human alpha B-crystallin linked to cardiomyopathy. In both cases, high affinity binding is found to involve conformational changes in the N-terminal region consistent with a central role of this region in substrate recognition.	[Shi, Jian; Koteiche, Hanane A.; McDonald, Ezelle T.; Fox, Tara L.; Stewart, Phoebe L.; Mchaourab, Hassane S.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Stewart, PL (corresponding author), Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Dept Pharmacol, Cleveland, OH 44106 USA.	pls47@case.edu; hassane.mchaourab@vanderbilt.edu			National Institutes of Health from NEI [EY12018]; NATIONAL EYE INSTITUTE [R01EY012018, R29EY012018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EY12018 from the NEI (to H. S. M.).	Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Berengian AR, 1997, BIOCHEMISTRY-US, V36, P9951, DOI 10.1021/bi9712347; Bova MP, 2002, J BIOL CHEM, V277, P38468, DOI 10.1074/jbc.M205594200; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; Cheng GL, 2008, J BIOL CHEM, V283, P26634, DOI 10.1074/jbc.M802946200; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; Claxton DP, 2008, J MOL BIOL, V375, P1026, DOI 10.1016/j.jmb.2007.11.014; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Graw J, 2001, INVEST OPHTH VIS SCI, V42, P2909; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Kim DR, 2003, BIOCHEM BIOPH RES CO, V307, P991, DOI 10.1016/S0006-291X(03)01302-0; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kim R, 2003, P NATL ACAD SCI USA, V100, P8151, DOI 10.1073/pnas.1032940100; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Koteiche HA, 2005, STRUCTURE, V13, P1165, DOI 10.1016/j.str.2005.05.006; Koteiche HA, 1999, J MOL BIOL, V294, P561, DOI 10.1006/jmbi.1999.3242; Koteiche HA, 2002, FEBS LETT, V519, P16, DOI 10.1016/S0014-5793(02)02688-1; Koteiche HA, 2006, J BIOL CHEM, V281, P14273, DOI 10.1074/jbc.M512938200; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mansoor SE, 1999, BIOCHEMISTRY-US, V38, P16383, DOI 10.1021/bi991331v; McDonald ET, 2012, BIOCHEMISTRY-US, V51, P1257, DOI 10.1021/bi2017624; Mchaourab HS, 2012, BIOCHEMISTRY-US, V51, P5105, DOI 10.1021/bi300525x; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; MCHAOURAB HS, 1993, BIOCHEMISTRY-US, V32, P11895, DOI 10.1021/bi00095a019; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mchaourab HS, 2002, J BIOL CHEM, V277, P40557, DOI 10.1074/jbc.M206250200; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sathish HA, 2004, J BIOL CHEM, V279, P16425, DOI 10.1074/jbc.M313402200; Sathish HA, 2003, J BIOL CHEM, V278, P44214, DOI 10.1074/jbc.M307578200; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Shi J, 2006, J BIOL CHEM, V281, P40420, DOI 10.1074/jbc.M608322200; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Treweek TM, 2000, BBA-PROTEIN STRUCT M, V1481, P175, DOI 10.1016/S0167-4838(00)00109-6; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	55	29	31	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4819	4830		10.1074/jbc.M112.388132	http://dx.doi.org/10.1074/jbc.M112.388132			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23277356	hybrid, Green Published			2022-12-25	WOS:000315340400031
J	Li, S; Zhou, QB; He, H; Zhao, YH; Liu, ZH				Li, Sheng; Zhou, Qibing; He, Huan; Zhao, Yahui; Liu, Zhihua			Peroxisome Proliferator-activated Receptor gamma Agonists Induce Cell Cycle Arrest through Transcriptional Regulation of Kruppel-like Factor 4 (KLF4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; PPAR-GAMMA; LIGAND TROGLITAZONE; TUMOR-SUPPRESSOR; DOWN-REGULATION; INHIBIT GROWTH; BREAST-CANCER; IN-VITRO; EXPRESSION; APOPTOSIS	Peroxisome proliferator-activated receptor gamma(PPAR gamma), a sub-group of ligand-activated nuclear receptors, plays critical roles in cell cycle regulation, differentiation, apoptosis, and invasion. PPAR gamma is involved in tumorigenesis and is a potent target for cancer therapy. PPAR gamma transactivation of KLF4 has been demonstrated in various studies; however, how PPAR gamma regulates KLF4 expression is not clear. In this study, we reveal that PPAR gamma regulates the expression of KLF4 by binding directly to the PPAR response element (PPRE) within the KLF4 promoter. The PPRE resides at - 1657 to - 1669 bp upstream of the KLF4 ATG codon, which is essential for the transactivation of troglitazone-induced KLF4 expression. Furthermore, we found that stable silencing of KLF4 obviously suppressed the G(1)/S arrest and anti-proliferation effects induced by PPAR gamma ligands. Taken together, our data indicate that up-regulation of KLF4 upon PPAR gamma activation is mediated through the PPRE in the KLF4 promoter, thus providing further insights into the PPAR gamma signal transduction pathway as well as a novel cancer therapeutic strategy.	Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, ZH (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn		Zhao, Yahui/0000-0002-9613-1384; Li, Sheng/0000-0001-8080-9712	National Basic Research Program of China [2011CB504205]; National Natural Science Foundation of China [81130043, 81021061]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2011CB504205 and National Natural Science Foundation of China Grants 81130043 and 81021061.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Burstein HJ, 2003, BREAST CANCER RES TR, V79, P391, DOI 10.1023/A:1024038127156; Cekanova M, 2010, EUR J PHARMACOL, V637, P30, DOI 10.1016/j.ejphar.2010.03.055; Chen ZY, 2005, MOL PHARMACOL, V68, P1203, DOI 10.1124/mol.105.014944; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Guan HF, 2010, BLOOD, V116, P1469, DOI 10.1182/blood-2009-12-256446; Hu WX, 2009, CLIN CANCER RES, V15, P5688, DOI 10.1158/1078-0432.CCR-09-0310; Itami A, 2001, INT J CANCER, V94, P370, DOI 10.1002/ijc.1488; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Kubota T, 1998, CANCER RES, V58, P3344; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Ming M, 2006, WORLD J GASTROENTERO, V12, P7263, DOI 10.3748/wjg.v12.i45.7263; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Ohta K, 2001, J CLIN ENDOCR METAB, V86, P2170, DOI 10.1210/jc.86.5.2170; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Papi A, 2010, CANCER LETT, V297, P65, DOI 10.1016/j.canlet.2010.04.026; Rageul J, 2009, INT J CANCER, V125, P2802, DOI 10.1002/ijc.24683; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Takahashi N, 1999, FEBS LETT, V455, P135, DOI 10.1016/S0014-5793(99)00871-6; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Toyota M, 2002, LIFE SCI, V70, P1565, DOI 10.1016/S0024-3205(01)01524-7; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Wang N, 2002, WORLD J GASTROENTERO, V8, P966, DOI 10.3748/wjg.v8.i6.966; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345	33	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4076	4084		10.1074/jbc.M111.317487	http://dx.doi.org/10.1074/jbc.M111.317487			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23275339	Green Published, hybrid			2022-12-25	WOS:000314845000036
J	Lin, MH; Hsu, FF; Miner, JH				Lin, Meei-Hua; Hsu, Fong-Fu; Miner, Jeffrey H.			Requirement of Fatty Acid Transport Protein 4 for Development, Maturation, and Function of Sebaceous Glands in a Mouse Model of Ichthyosis Prematurity Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA SYNTHETASE; MEIBOMIAN GLANDS; ECTODERMAL DYSPLASIA; TARGETED DISRUPTION; WRINKLE-FREE; MICE; SKIN; LIPIDS; FATP4; GENE	Fatty acid transport protein 4 (FATP4) is one of a family of six transmembrane proteins that facilitate long-and very long-chain fatty acid uptake. FATP4 is expressed in several tissues, including skin. Mutations in human SLC27A4, which encodes FATP4, cause ichthyosis prematurity syndrome, characterized by a thick desquamating epidermis and premature birth. Mice lacking FATP4, which genetically model the human disease, are born with tight, thick skin and a defective skin barrier; they die neonatally due to dehydration and restricted movements. Both the skin phenotype and the lethality are rescued by transgene expression of FATP4 in suprabasal keratinocytes. Sebaceous glands in Fatp4 null skin grafted onto nude mice were found to be dystrophic and enwrapped by thick layers of epithelial cells. Consistent with these results, transgene-rescued Fatp4 null mice showed a subnormal level of FATP4 expression in sebocytes and exhibited abnormal development of both sebaceous glands and meibomian glands, specialized sebaceous glands of the eyelids. Sebum from these mice contained a reduced level of type II diester wax, a major mouse sebum lipid species, and showed perturbations in mass spectrometric profiles of diester wax and cholesteryl ester species. In addition, these mice showed an impaired ability to repel water and regulate body temperature after water immersion. Taken together, our results suggest that FATP4 plays crucial roles in the development and maturation of both sebaceous and meibomian glands, as well as in the formation and composition of sebum, likely by regulating the trafficking of fatty acids necessary for proper synthesis of sebum lipids.	[Lin, Meei-Hua; Miner, Jeffrey H.] Washington Univ, Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA; [Hsu, Fong-Fu] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Miner, Jeffrey H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Miner, JH (corresponding author), Box 8126,660 S Euclid Ave, St Louis, MO 63110 USA.	minerj@wustl.edu		Hsu, Fong-Fu/0000-0001-5368-0183	National Institutes of Health [R01AR049269, P30DK056341, P41RR00954, P60DK020579, P30DK079333, P01HL029594, C06RR015502]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015502, P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK079333, P30DK056341, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR049269 (to J. H. M.), P30DK056341, P41RR00954, P60DK020579, P30DK079333, P01HL029594, and C06RR015502.	Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Cheng YS, 2011, LIPIDS, V46, P95, DOI 10.1007/s11745-010-3494-0; Cui CY, 2005, AM J PATHOL, V167, P89, DOI 10.1016/S0002-9440(10)62956-2; ENOCH HG, 1978, BIOCHEMISTRY-US, V17, P4927, DOI 10.1021/bi00616a011; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Gu LH, 2008, AM J PATHOL, V173, P752, DOI 10.2353/ajpath.2008.071089; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Herrmann T, 2005, J INVEST DERMATOL, V125, P1228, DOI 10.1111/j.0022-202X.2005.23972.x; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; House JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009837; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; JESTER JV, 1989, INVEST OPHTH VIS SCI, V30, P936; Kenchegowda D, 2011, DEV BIOL, V356, P5, DOI 10.1016/j.ydbio.2011.05.005; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Lee L, 2007, J INVEST DERMATOL, V127, P16, DOI 10.1038/sj.jid.5700511; Lin MH, 2010, DEV BIOL, V344, P707, DOI 10.1016/j.ydbio.2010.05.503; MACALA LJ, 1983, J LIPID RES, V24, P1243; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Moulson CL, 2007, J BIOL CHEM, V282, P15912, DOI 10.1074/jbc.M701779200; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; Naito A, 2002, P NATL ACAD SCI USA, V99, P8766, DOI 10.1073/pnas.132636999; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; NICOLAIDES N, 1970, LIPIDS, V5, P299, DOI 10.1007/BF02531461; Nien CJ, 2010, MOL VIS, V16, P1132; Obata H, 2002, CORNEA, V21, pS70, DOI 10.1097/01.ico.0000263122.45898.09; Patel Sejal, 2001, Journal of Insect Science (Tucson), V1, P1; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; Reneerkens J, 2005, J EXP BIOL, V208, P4199, DOI 10.1242/jeb.01872; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Schmuth M, 2005, J INVEST DERMATOL, V125, P1174, DOI 10.1111/j.0022-202X.2005.23934.x; Senba Y, 2009, BRIT J DERMATOL, V160, P454, DOI 10.1111/j.1365-2133.2008.08964.x; Sobol Maria, 2011, BMC Res Notes, V4, P90, DOI 10.1186/1756-0500-4-90; STEWART ME, 1991, ADV LIPID RES, V24, P263; THODY AJ, 1989, PHYSIOL REV, V69, P383, DOI 10.1152/physrev.1989.69.2.383; Tsau C, 2011, DEVELOPMENT, V138, P3307, DOI 10.1242/dev.066241; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; White CR, 1996, CUTANEOUS MED SURG, P3; WILKINSON DI, 1966, J INVEST DERMATOL, V47, P449, DOI 10.1038/jid.1966.168; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446; Zouboulis CC, 2003, J INVEST DERMATOL, V120, pXIV, DOI 10.1046/j.1523-1747.2003.12263.x	43	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					3964	3976		10.1074/jbc.M112.416990	http://dx.doi.org/10.1074/jbc.M112.416990			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23271751	Green Published, hybrid			2022-12-25	WOS:000314845000026
J	Degaki, KY; Chen, ZL; Yamada, AT; Croy, BA				Degaki, Karina Y.; Chen, Zhilin; Yamada, Aureo T.; Croy, B. Anne			Delta-Like Ligand (DLL)1 Expression in Early Mouse Decidua and Its Localization to Uterine Natural Killer Cells	PLOS ONE			English	Article							INTERFERON-GAMMA CONTRIBUTES; GENE-EXPRESSION; NK CELLS; DECIDUALIZATION; DIFFERENTIATION; IMPLANTATION; ANGIOGENESIS; RECEPTOR; UTERUS; NOTCH1	Uterine vascular changes, critical for pregnancy success, occur at each implant site during endometrial decidualization. Mesometrial decidualization recruits high numbers of angiogenic, uterine Natural Killer (uNK) cells that trigger midpregnancy spiral arterial remodeling. We postulated that uNK cells contribute to early decidual angiogenesis as endothelial-cell extrinsic sources of Delta-like ligand 1 (DLL1), a molecule that induces endothelial tip cell differentiation and orthogonal vascular growth in other tissues. Virgin uteri expressed Dll1 mesometrially and anti-mesometrially and relative expression increased in both anatomic regions as pregnancy progressed. Analyses of transcripts from gd10.5 uNK cells flow sorted on the basis of expression of Dolichos biflorus agglutinin (DBA) lectin revealed that DBA+ but not DBA- uNK cells expressed Dll1. Immunostaining at gd4.5 found DLL1-expressing cells rare. At gd6.5, DBA+ uNK cells at all stages of maturation expressed DLL1. By gd10.5, DLL1 immunoreactivity was strongly expressed by some but not all DBA+ uNK cells and more weakly by DBA- cells. DLL1+ cells were mesometrially stratified and concentrated within central decidua basalis. Our data suggest that uNK cells have the potential to induce endothelial tip cell differentiation and to promote non-planar vascular growth within early decidua basalis.	[Degaki, Karina Y.; Chen, Zhilin; Croy, B. Anne] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Degaki, Karina Y.; Yamada, Aureo T.] Univ Campinas UNICAMP, Inst Biol, Sao Paulo, Brazil	Queens University - Canada; Universidade de Sao Paulo; Universidade Estadual de Campinas	Croy, BA (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	croya@queensu.ca	Yamada, Aureo T/F-7752-2012	Yamada, Aureo T/0000-0003-3620-9685	Natural Sciences and Engineering Research Council, Canada; Canadian Institutes for Health Research; Canada Research Chairs Program; Canada Foundation for Innovation; CAPES (Brazil); Foreign Affairs and International Trade Canada	Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foreign Affairs and International Trade Canada	These studies were supported by awards from the Natural Sciences and Engineering Research Council, Canada, the Canadian Institutes for Health Research, the Canada Research Chairs Program, the Canada Foundation for Innovation, Foreign Affairs and International Trade Canada and CAPES (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar Y, 2012, ENDOCRINOLOGY, V153, P2884, DOI 10.1210/en.2011-2122; Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; Ashkar AA, 1999, BIOL REPROD, V61, P493, DOI 10.1095/biolreprod61.2.493; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Bany BM, 2012, REPRODUCTION, V143, P359, DOI 10.1530/REP-11-0325; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; Beck RC, 2009, BIOL BLOOD MARROW TR, V15, P1026, DOI 10.1016/j.bbmt.2009.06.002; Bondarenko GI, 2012, AM J REPROD IMMUNOL, V68, P309, DOI 10.1111/j.1600-0897.2012.01174.x; Carr DB, 2009, HYPERTENS PREGNANCY, V28, P42, DOI 10.1080/10641950802132803; Chen ZL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102293; Cherrier M, 2012, CURR OPIN IMMUNOL, V24, P277, DOI 10.1016/j.coi.2012.03.011; Croy BA, 2006, IMMUNOL REV, V214, P161; Croy BA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102830; Das A, 2009, P NATL ACAD SCI USA, V106, P12542, DOI 10.1073/pnas.0901647106; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Dimitriadis E, 2010, INT J DEV BIOL, V54, P313, DOI 10.1387/ijdb.082772ed; Greenwood JD, 2000, PLACENTA, V21, P693, DOI 10.1053/plac.2000.0556; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kubota Y, 2008, J CLIN INVEST, V118, P2393, DOI 10.1172/JCI34882; Kume T, 2012, ADV EXP MED BIOL, V727, P210, DOI 10.1007/978-1-4614-0899-4_16; Laranjeiro R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034553; Lima PDA, 2012, J LEUKOCYTE BIOL, V92, P195, DOI 10.1189/jlb.0312136; Manaster I, 2010, J REPROD IMMUNOL, V84, P1, DOI 10.1016/j.jri.2009.10.009; Matsumoto H, 2002, J BIOL CHEM, V277, P29260, DOI 10.1074/jbc.M203996200; Mazella J, 2008, ENDOCRINOLOGY, V149, P15, DOI 10.1210/en.2007-0477; Mikhailik A, 2009, BIOCHEM BIOPH RES CO, V388, P479, DOI 10.1016/j.bbrc.2009.07.037; Napp LC, 2012, CIRC RES, V110, P530, DOI 10.1161/CIRCRESAHA.111.263319; Paffaro VA, 2003, PLACENTA, V24, P479, DOI 10.1053/plac.2002.0919; Plaisier M, 2011, BEST PRACT RES CL OB, V25, P259, DOI 10.1016/j.bpobgyn.2010.10.011; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; STEWART CL, 1994, ANN NY ACAD SCI, V734, P157, DOI 10.1111/j.1749-6632.1994.tb21743.x; Tayade C, 2007, J IMMUNOL, V178, P4267, DOI 10.4049/jimmunol.178.7.4267; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wang CL, 2003, MICROSC RES TECHNIQ, V60, P420, DOI 10.1002/jemt.10280; Yadi H, 2008, J IMMUNOL, V181, P6140, DOI 10.4049/jimmunol.181.9.6140; Yinon Y, 2010, CIRCULATION, V122, P1846, DOI 10.1161/CIRCULATIONAHA.110.948455; Zhang JH, 2009, PLACENTA, V30, P968, DOI 10.1016/j.placenta.2009.08.011; Zhang J, 2008, BIOL REPROD, V79, P450, DOI 10.1095/biolreprod.108.067975; Zhang JH, 2012, J LEUKOCYTE BIOL, V91, P417, DOI 10.1189/jlb.1011501	45	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52037	10.1371/journal.pone.0052037	http://dx.doi.org/10.1371/journal.pone.0052037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284862	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500022
J	Isendahl, J; Turlej-Rogacka, A; Manjuba, C; Rodrigues, A; Giske, CG; Naucler, P				Isendahl, Joakim; Turlej-Rogacka, Agata; Manjuba, Cristovao; Rodrigues, Amabelia; Giske, Christian G.; Naucler, Pontus			Fecal Carriage of ESBL-Producing E. coli and K. pneumoniae in Children in Guinea-Bissau: A Hospital-Based Cross-Sectional Study	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ESCHERICHIA-COLI; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; QUINOLONE RESISTANCE; RAPID DETECTION; ENTEROBACTERIACEAE; EPIDEMIOLOGY; INFECTIONS; PREVALENCE	Background: In recent years, the world has seen a surge in extended-spectrum beta-lactamase (ESBL)-producing bacteria. However, data on the dissemination of ESBL-producing Enterobacteriaceae in the community from systematically enrolled study subjects in Africa remains limited. To determine the prevalence, phenotypic resistance patterns and genetic characteristics of ESBL-producing E. coli and K. pneumoniae in fecal carriage and to analyze associated risk factors in children attending a pediatric emergency department in Guinea-Bissau. Methodology/Principal Findings: From June to September 2010, children <5 years of age with fever or tachycardia attending a pediatric emergency ward during the day was screened for ESBL carriage in feces. Socio-demographic and health seeking behavior data was collected. Antibiotic susceptibility was tested with VITEK2 and EUCAST disk diffusion method, molecular characterization of ESBL-encoding genes was performed with multiplex PCR and clonal relatedness was established by automated rep-PCR. Of 408 enrolled children 133 (32.6%) were ESBL carriers. In total, 83 E. coli and 91 K. pneumoniae ESBL-producing isolates were obtained. Nearly all isolates were multidrug-resistant. Co-resistance to ciprofloxacin, trimethoprim-sulfamethoxazole and aminoglycosides was common. Of the isolates, 38.5% were co-resistant to these classes plus extended-spectrum cephalosporins, which infers resistance to all easily available antibiotic agents for treatment of gram-negative sepsis in Guinea-Bissau. The predominant resistance-encoding gene subgroup was bla(CTX-M-1) and epidemiologic typing showed that the bacterial ESBL population was highly diverse both for E. coli and K. pneumoniae. Bed sharing with another child <5 years of age was a risk factor for ESBL carriage, indicating crowding as a potential risk factor for transmission of ESBL- producing bacteria. Conclusions/Significance: Prevalence of ESBL- producing bacteria in this population was high and clonally diverse. This is alarming considering the limited diagnostic and treatment possibilities in Guinea-Bissau and other resource-poor countries.	[Isendahl, Joakim; Turlej-Rogacka, Agata; Giske, Christian G.; Naucler, Pontus] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Turlej-Rogacka, Agata; Giske, Christian G.] Karolinska Inst, Dept Clin Microbiol, Stockholm, Sweden; [Manjuba, Cristovao] Hosp Nacl Simao Mendes, Dept Pediat, Bissau, Guinea Bissau; [Rodrigues, Amabelia] Inst Nacl Saude Publ, Bissau, Guinea Bissau; [Naucler, Pontus] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Isendahl, J (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	joakim.isendahl@ki.se		Isendahl, Joakim/0000-0002-0544-4343	Swedish Institute of Development Cooperation (SIDA)	Swedish Institute of Development Cooperation (SIDA)	This study was funded by a grant from the Swedish Institute of Development Cooperation (SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriatahina T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-204; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Bogaerts P, 2011, ANTIMICROB AGENTS CH, V55, P4457, DOI 10.1128/AAC.00353-11; Brolund A, 2010, J MICROBIOL METH, V83, P224, DOI 10.1016/j.mimet.2010.09.004; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Dromigny JA, 2005, J ANTIMICROB CHEMOTH, V56, P236, DOI 10.1093/jac/dki158; European Committee on Antimicrobial Susceptibility Testing, 2012, BREAKP TABL INT MICS; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Freeman JT, 2012, INT J INFECT DIS, V16, pE371, DOI 10.1016/j.ijid.2012.01.008; Herindrainy P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022738; Kariuki S, 2001, CURR OPIN INFECT DIS, V14, P579, DOI 10.1097/00001432-200110000-00012; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Livermore DM, 2008, CLIN MICROBIOL INFEC, V14, P3, DOI 10.1111/j.1469-0691.2007.01857.x; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Lonchel CM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-53; Luvsansharav UO, 2012, J ANTIMICROB CHEMOTH, V67, P1769, DOI 10.1093/jac/dks118; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mammeri H, 2005, ANTIMICROB AGENTS CH, V49, P71, DOI 10.1128/AAC.49.1.71-76.2005; Mora A, 2011, INT J ANTIMICROB AG, V37, P16, DOI 10.1016/j.ijantimicag.2010.09.012; Mshana SE, 2011, CLIN MICROBIOL INFEC, V17, P1279, DOI 10.1111/j.1469-0691.2011.03518.x; Namboodiri SS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-44; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Peirano G, 2011, DIAGN MICR INFEC DIS, V69, P449, DOI 10.1016/j.diagmicrobio.2010.11.011; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rahman EMA, 2011, J INVEST MED, V59, P1284, DOI 10.2130/JIM.0b013e318238748e; Reglier-Poupet H, 2008, J MED MICROBIOL, V57, P310, DOI 10.1099/jmm.0.47625-0; Rodriguez-Bano J, 2008, J ANTIMICROB CHEMOTH, V62, P1142, DOI 10.1093/jac/dkn293; Sanders CC, 2000, J CLIN MICROBIOL, V38, P570, DOI 10.1128/JCM.38.2.570-574.2000; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Tumbarello M, 2008, ANTIMICROB AGENTS CH, V52, P3244, DOI 10.1128/AAC.00063-08; United Nations Department of Economic and Social Affairs Statistics Division, 2012, WORLD STAT POCK 20 5, V36, P87; Weisenberg SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045141; Wickramasinghe NH, 2012, J ANTIMICROB CHEMOTH, V67, P1108, DOI 10.1093/jac/dks018; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522	37	63	65	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51981	10.1371/journal.pone.0051981	http://dx.doi.org/10.1371/journal.pone.0051981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284838	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500071
J	Shen, M; Wu, RX; Zhao, L; Li, J; Guo, HT; Fan, R; Cui, Y; Wang, YM; Yue, SQ; Pei, JM				Shen, Min; Wu, Rui-Xin; Zhao, Lei; Li, Juan; Guo, Hai-Tao; Fan, Rong; Cui, Yan; Wang, Yue-Min; Yue, Shu-Qiang; Pei, Jian-Ming			Resveratrol Attenuates Ischemia/Reperfusion Injury in Neonatal Cardiomyocytes and Its Underlying Mechanism	PLOS ONE			English	Article							PROTEIN-KINASE-C; CELL-DEATH; REPERFUSION INJURY; INFARCT SIZE; APOPTOSIS; SIRT1; MITOCHONDRIA; PATHOGENESIS; PHYTOALEXIN; INHIBITION	This study was designed to investigate whether Resveratrol (Res) could be a prophylactic factor in the prevention of I/R injury and to shed light on its underlying mechanism. Primary culture of neonatal rat cardiomyocytes were randomly distributed into three groups: the normal group (cultured cardiomyocytes were in normal conditions), the I/R group (cultured cardiomyocytes were subjected to 2 h simulated ischemia followed by 4 h reperfusion), and the Res+I/R group (100 mmol/L Res was administered before cardiomyocytes were subjected to 2 h simulated ischemia followed by 4 h reperfusion). To test the extent of cardiomyocyte injury, several indices were detected including cell viability, LDH activity, Na+-K+-ATPase and Ca2+-ATPase activity. To test apoptotic cell death, caspase-3 activity and the expression of Bcl-2/Bax were detected. To explore the underlying mechanism, several inhibitors, intracellular calcium, SOD activity and MDA content were used to identify some key molecules involved. Res increased cell viability, Na+-K+-ATPase and Ca2+-ATPase activity, Bcl-2 expression, and SOD level. While LDH activity, capase-3 activity, Bax expression, intracellular calcium and MDA content were decreased by Res. And the effect of Res was blocked completely by either L-NAME (an eNOS inhibitor) or MB (a cGMP inhibitor), and partly by either DS (a PKC inhibitor) or Glybenclamide (a K-ATP inhibitor). Our results suggest that Res attenuates I/R injury in cardiomyocytes by preventing cell apoptosis, decreasing LDH release and increasing ATPase activity. NO, cGMP, PKC and K-ATP may play an important role in the protective role of Res. Moreover, Res enhances the capacity of anti-oxygen free radical and alleviates intracellular calcium overload in cardiomyocytes.	[Yue, Shu-Qiang] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary & Pancreas Surg, Xian 710032, Peoples R China; [Shen, Min; Wu, Rui-Xin; Zhao, Lei; Li, Juan; Guo, Hai-Tao; Fan, Rong; Wang, Yue-Min; Pei, Jian-Ming] Fourth Mil Med Univ, Natl Key Discipline Cell Biol, Dept Physiol, Xian 710032, Peoples R China; [Shen, Min] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Cui, Yan] Fourth Mil Med Univ, Dept Clin Nursing, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yue, SQ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary & Pancreas Surg, Xian 710032, Peoples R China.	blanker36@163.com; jmpei8@fmmu.edu.cn	Zhao, Lei/AAF-3066-2020	Zhao, Lei/0000-0003-1263-1742	National Natural Science Foundation of China (NSFC) [30971060, 81270402, 30900535, 31100827]; Shanxi Province [2010K01-195, 2011JM4001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanxi Province	This work was supported by grants (NOs. 30971060, 81270402, 30900535, 31100827) from the National Natural Science Foundation of China (NSFC) and grants from Shanxi Province (NOs. 2010K01-195, 2011JM4001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaq F, 2003, TOXICOL APPL PHARM, V186, P28, DOI 10.1016/S0041-008X(02)00014-5; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Aluyen Julia Khristine, 2012, Journal of Dietary Supplements, V9, P45, DOI 10.3109/19390211.2011.650842; Athar M, 2007, TOXICOL APPL PHARM, V224, P274, DOI 10.1016/j.taap.2006.12.025; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Cain BS, 1999, J SURG RES, V81, P249, DOI 10.1006/jsre.1998.5508; Chakrabarty SP, 2011, CURR MOL MED, V11, P709; Chan CC, 2011, MOL NUTR FOOD RES, V55, P1841, DOI 10.1002/mnfr.201100374; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Golstein P, 1997, SCIENCE, V275, P1081, DOI 10.1126/science.275.5303.1081; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Kajstura J, 1996, LAB INVEST, V74, P86; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Lee M, 2003, GENE THER, V10, P1535, DOI 10.1038/sj.gt.3302034; Li F, 2012, CURR PHARM DESIGN, V18, P27, DOI 10.2174/138161212798919075; Liu YG, 1996, CIRC RES, V78, P443, DOI 10.1161/01.RES.78.3.443; Lopez-Miranda V, 2012, REV NEUROLOGIA, V54, P349, DOI 10.33588/rn.5406.2011611; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Ong ET, 2011, TOXICOL APPL PHARM, V256, P198, DOI 10.1016/j.taap.2011.08.013; Penumathsa SV, 2007, J MOL CELL CARDIOL, V42, P508, DOI 10.1016/j.yjmcc.2006.10.018; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Piotrowska H, 2012, TOXICOL APPL PHARM, V263, P53, DOI 10.1016/j.taap.2012.05.023; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Rabkin SW, 2000, EUR J PHARMACOL, V388, P209, DOI 10.1016/S0014-2999(99)00880-8; Rahal K, 2012, INFLAMM BOWEL DIS, V18, P613, DOI 10.1002/ibd.21843; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Rush JWE, 2007, EXP BIOL MED, V232, P814; Sehirli O, 2007, TOXICOL APPL PHARM, V222, P33, DOI 10.1016/j.taap.2007.03.025; Stricker SA, 1999, MICROSC RES TECHNIQ, V46, P356, DOI 10.1002/(SICI)1097-0029(19990915)46:6<356::AID-JEMT4>3.0.CO;2-6; Tanno M, 2000, J CARDIOVASC PHARM, V35, P345, DOI 10.1097/00005344-200003000-00001; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Wallerath T, 2005, NITRIC OXIDE-BIOL CH, V12, P97, DOI 10.1016/j.niox.2004.12.004; WATERS DD, 1977, AM J CARDIOL, V39, P537, DOI 10.1016/S0002-9149(77)80163-X; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zhang C, 2012, INT J MOL MED, V29, P557, DOI 10.3892/ijmm.2012.885	45	49	55	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51223	10.1371/journal.pone.0051223	http://dx.doi.org/10.1371/journal.pone.0051223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284668	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500023
J	Wang, ZX; Zhang, LJ; Guha, G; Li, S; Kyrylkova, K; Kioussi, C; Leid, M; Ganguli-Indra, G; Indra, AK				Wang, Zhixing; Zhang, Ling-juan; Guha, Gunjan; Li, Shan; Kyrylkova, Kateryna; Kioussi, Chrissa; Leid, Mark; Ganguli-Indra, Gitali; Indra, Arup K.			Selective Ablation of Ctip2/Bcl11b in Epidermal Keratinocytes Triggers Atopic Dermatitis-Like Skin Inflammatory Responses in Adult Mice	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; RETINOID-X-RECEPTOR; NF-KAPPA-B; BARRIER FUNCTION; TRANSCRIPTIONAL REPRESSION; MOUSE KERATINOCYTES; TSLP EXPRESSION; T-LYMPHOCYTES; NURD COMPLEX; RXR-ALPHA	Background: Ctip2 is crucial for epidermal homeostasis and protective barrier formation in developing mouse embryos. Selective ablation of Ctip2 in epidermis leads to increased transepidermal water loss (TEWL), impaired epidermal proliferation, terminal differentiation, as well as altered lipid composition during development. However, little is known about the role of Ctip2 in skin homeostasis in adult mice. Methodology/Principal Findings: To study the role of Ctip2 in adult skin homeostasis, we utilized Ctip2(ep2/2) mouse model in which Ctip2 is selectively deleted in epidermal keratinocytes. Measurement of TEWL, followed by histological, immunohistochemical, and RT-qPCR analyses revealed an important role of Ctip2 in barrier maintenance and in regulating adult skin homeostasis. We demonstrated that keratinocytic ablation of Ctip2 leads to atopic dermatitis (AD)-like skin inflammation, characterized by alopecia, pruritus and scaling, as well as extensive infiltration of immune cells including T lymphocytes, mast cells, and eosinophils. We observed increased expression of T-helper 2 (Th2)-type cytokines and chemokines in the mutant skin, as well as systemic immune responses that share similarity with human AD patients. Furthermore, we discovered that thymic stromal lymphopoietin (TSLP) expression was significantly upregulated in the mutant epidermis as early as postnatal day 1 and ChIP assay revealed that TSLP is likely a direct transcriptional target of Ctip2 in epidermal keratinocytes. Conclusions/Significance: Our data demonstrated a cell-autonomous role of Ctip2 in barrier maintenance and epidermal homeostasis in adult mice skin. We discovered a crucial non-cell autonomous role of keratinocytic Ctip2 in suppressing skin inflammatory responses by regulating the expression of Th2-type cytokines. It is likely that the epidermal hyperproliferation in the Ctip2-lacking epidermis may be secondary to the compensatory response of the adult epidermis that is defective in barrier functions. Our results establish an initiating role of epidermal TSLP in AD pathogenesis via a novel repressive regulatory mechanism enforced by Ctip2.	[Wang, Zhixing; Zhang, Ling-juan; Guha, Gunjan; Li, Shan; Kyrylkova, Kateryna; Kioussi, Chrissa; Leid, Mark; Ganguli-Indra, Gitali; Indra, Arup K.] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Kioussi, Chrissa; Leid, Mark; Ganguli-Indra, Gitali; Indra, Arup K.] Oregon State Univ, Mol Cell Biol Program, Corvallis, OR 97331 USA; [Leid, Mark; Indra, Arup K.] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA; [Indra, Arup K.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA	Oregon State University; Oregon State University; Oregon State University; Oregon Health & Science University	Indra, AK (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	arup.indra@oregonstate.edu	Guha, Gunjan/D-8197-2011; Zhang, Lingjuan/K-3080-2017; Indra, Arup/AAG-2376-2019; Indra, Gitali/G-2963-2016; Zhang, Ling-juan/V-6141-2019	Guha, Gunjan/0000-0002-9224-0241; Zhang, Lingjuan/0000-0001-6937-4578; Indra, Arup/0000-0001-6137-7555; Zhang, Ling-juan/0000-0001-6937-4578; Kioussi, Chrissa/0000-0001-8226-9908	National Institutes of Health [5R01AR056008-03]; Oregon Health and Science University Medical Research Foundation grant; National Institute of Environmental Health Sciences center [ES00210]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health and Science University Medical Research Foundation grant; National Institute of Environmental Health Sciences center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	These studies were supported by grant 5R01AR056008-03 (AI) from the National Institutes of Health, an Oregon Health and Science University Medical Research Foundation grant (AI), and a National Institute of Environmental Health Sciences center grant (ES00210) to Environmental Health Sciences Center, Oregon State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Argmann Carmen A, 2006, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29a03s75; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Biedermann T, 2004, J INVEST DERM SYMP P, V9, P5, DOI 10.1111/j.1087-0024.2004.00829.x; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Brandt E, 2011, J CLIN CELLULAR IMMU; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Comeau MR, 2010, MUCOSAL IMMUNOL, V3, P138, DOI 10.1038/mi.2009.134; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Dubrac S, 2010, IMMUNOL CELL BIOL, V88, P400, DOI 10.1038/icb.2010.33; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Ganguli-Indra G, 2009, EXP DERMATOL, V18, P994, DOI 10.1111/j.1600-0625.2009.00876.x; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Hyter S, 2010, PIGM CELL MELANOMA R, V23, P635, DOI 10.1111/j.1755-148X.2010.00732.x; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Indra AK, 2005, DEV BIOL, V285, P28, DOI 10.1016/j.ydbio.2005.05.043; Jakasa I, 2011, J INVEST DERMATOL, V131, P540, DOI 10.1038/jid.2010.307; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Kastner P, 2010, EUR J IMMUNOL, V40, P2143, DOI 10.1002/eji.200940258; Lee HC, 2008, J IMMUNOL, V181, P5189, DOI 10.4049/jimmunol.181.8.5189; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Liang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029999; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Liu YJ, 2009, ADV IMMUNOL, V101, P1, DOI 10.1016/S0065-2776(08)01001-8; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Nakayama T, 2004, J VIROL, V78, P1665, DOI 10.1128/JVI.78.4.1665-1674.2004; Novak N, 2011, CURR OPIN IMMUNOL, V23, P778, DOI 10.1016/j.coi.2011.09.007; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; PROKSCH E, 1991, J CLIN INVEST, V87, P1668, DOI 10.1172/JCI115183; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Scharschmidt TC, 2008, J INVEST DERMATOL, V128, P1061, DOI 10.1038/sj.jid.5701201; Sebastian Katrin, 2008, Cell Commun Signal, V6, P5, DOI 10.1186/1478-811X-6-5; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Soumelis V, 2002, NATURE IMMUNOLOGY; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Takai T, 2012, ALLERGOL INT, V61, P3, DOI 10.2332/allergolint.11-RAI-0395; Tasian SK, 2012, BLOOD, V120, P833, DOI 10.1182/blood-2011-12-389932; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; VANVLIET E, 1993, INT ARCH ALLERGY IMM, V101, P392, DOI 10.1159/000236482; Wang ZX, 2011, J INVEST DERMATOL, V131, P177, DOI 10.1038/jid.2010.290; Wong CK, 2010, AM J RESP CELL MOL, V43, P305, DOI 10.1165/rcmb.2009-0168OC; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang LJ, 2012, J CELL SCI, V125, P5733, DOI 10.1242/jcs.108969; Zhang LJ, 2012, J BIOL CHEM, V287, P26971, DOI 10.1074/jbc.M112.344176; Ziegler SF, 2010, CURR OPIN IMMUNOL, V22, P795, DOI 10.1016/j.coi.2010.10.020; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	62	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51262	10.1371/journal.pone.0051262	http://dx.doi.org/10.1371/journal.pone.0051262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284675	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500025
J	Miotto, P; Forti, F; Ambrosi, A; Pellin, D; Veiga, DF; Balazsi, G; Gennaro, ML; Di Serio, C; Ghisotti, D; Cirillo, DM				Miotto, Paolo; Forti, Francesca; Ambrosi, Alessandro; Pellin, Danilo; Veiga, Diogo F.; Balazsi, Gabor; Gennaro, Maria L.; Di Serio, Clelia; Ghisotti, Daniela; Cirillo, Daniela M.			Genome-Wide Discovery of Small RNAs in Mycobacterium tuberculosis	PLOS ONE			English	Article							ANAEROBIC NITRATE REDUCTASE; REGULATORY RNAS; NONCODING RNAS; BOVIS BCG; GENE-EXPRESSION; IDENTIFICATION; TRANSCRIPTION; VIRULENCE; BACTERIA; DISRUPTION	Only few small RNAs (sRNAs) have been characterized in Mycobacterium tuberculosis and their role in regulatory networks is still poorly understood. Here we report a genome-wide characterization of sRNAs in M. tuberculosis integrating experimental and computational analyses. Global RNA-seq analysis of exponentially growing cultures of M. tuberculosis H37Rv had previously identified 1373 sRNA species. In the present report we show that 258 (19%) of these were also identified by microarray expression. This set included 22 intergenic sRNAs, 84 sRNAs mapping within 5'/3' UTRs, and 152 antisense sRNAs. Analysis of promoter and terminator consensus sequences identified sigma A promoter consensus sequences for 121 sRNAs (47%), terminator consensus motifs for 22 sRNAs (8.5%), and both motifs for 35 sRNAs (14%). Additionally, 20/23 candidates were visualized by Northern blot analysis and 59 end mapping by primer extension confirmed the RNA-seq data. We also used a computational approach utilizing functional enrichment to identify the pathways targeted by sRNA regulation. We found that antisense sRNAs preferentially regulated transcription of membrane-bound proteins. Genes putatively regulated by novel cis-encoded sRNAs were enriched for two-component systems and for functional pathways involved in hydrogen transport on the membrane.	[Miotto, Paolo; Cirillo, Daniela M.] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Forti, Francesca; Ghisotti, Daniela] Univ Milan, Dipartimento BioSci, Milan, Italy; [Ambrosi, Alessandro; Pellin, Danilo; Di Serio, Clelia] Univ Vita Salute San Raffaele, Univ Stat Ctr Biomed Sci, Milan, Italy; [Veiga, Diogo F.; Balazsi, Gabor] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Gennaro, Maria L.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; University of Texas System; UTMD Anderson Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Cirillo, DM (corresponding author), Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy.	cirillo.daniela@hsr.it	ambrosi, alessandro/H-4424-2011; Miotto, Paolo/E-3940-2017; Cirillo, Daniela Maria/AAB-3646-2019; Veiga, Diogo Troggian/J-9279-2019; Di Serio, Clelia/AAO-5494-2020; GHISOTTI, DANIELA ERICA/B-7732-2017	ambrosi, alessandro/0000-0003-1976-5663; Miotto, Paolo/0000-0003-4610-2427; Cirillo, Daniela Maria/0000-0001-6415-1535; Veiga, Diogo Troggian/0000-0002-4018-5375; GHISOTTI, DANIELA ERICA/0000-0003-2924-5303; Balazsi, Gabor/0000-0002-6865-5818; Gennaro, Maria Laura/0000-0003-4801-3567; DI SERIO, Mariaclelia Stefania/0000-0001-6385-6058	European Community [FP7-223681]; European Society of Clinical Microbiology and Infectious Diseases	European Community(European Commission); European Society of Clinical Microbiology and Infectious Diseases	This work was partially supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement FP7-223681 to DMC and from the European Society of Clinical Microbiology and Infectious Diseases Research Grant 2011 to PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Atun R, 2010, LANCET, V376, P940, DOI 10.1016/S0140-6736(10)61428-6; Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; BOORSTEIN WR, 1989, METHOD ENZYMOL, V180, P347; COATES ARM, 1993, MOL MICROBIOL, V8, P787, DOI 10.1111/j.1365-2958.1993.tb01624.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DEHO G, 1992, MOL MICROBIOL, V6, P3415, DOI 10.1111/j.1365-2958.1992.tb02209.x; DiChiara JM, 2010, NUCLEIC ACIDS RES, V38, P4067, DOI 10.1093/nar/gkq101; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Dudoit S., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1040; Ewann F, 2002, INFECT IMMUN, V70, P2256, DOI 10.1128/IAI.70.5.2256-2263.2002; Fritz C, 2002, INFECT IMMUN, V70, P286, DOI 10.1128/IAI.70.1.286-291.2002; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, P5845, DOI 10.1093/nar/gkr168; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gopel Y, 2012, CURR OPIN MICROBIOL, V15, P132, DOI 10.1016/j.mib.2011.12.001; Gonzalez-Y-Merchand JA, 1998, J BACTERIOL, V180, P5756, DOI 10.1128/JB.180.21.5756-5761.1998; GonzalezyMerchand JA, 1996, MICROBIOL-UK, V142, P667, DOI 10.1099/13500872-142-3-667; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Grundy FJ, 2006, CRIT REV BIOCHEM MOL, V41, P329, DOI 10.1080/10409230600914294; HOLM S, 1979, SCAND J STAT, V6, P65; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irnov AK, 2006, COLD SH Q B, V71, P239, DOI 10.1101/sqb.2006.71.021; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee HJ, 2012, FEMS MICROBIOL LETT, V326, P131, DOI 10.1111/j.1574-6968.2011.02441.x; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Mitra A, 2008, TUBERCULOSIS, V88, P566, DOI 10.1016/j.tube.2008.06.004; Mitra A, 2011, NUCLEIC ACIDS RES, V39, pD129, DOI 10.1093/nar/gkq971; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P20130, DOI 10.1073/pnas.1112724108; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Peirs P, 2005, INFECT IMMUN, V73, P1898, DOI 10.1128/IAI.73.3.1898-1902.2005; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Sachdeva P, 2010, FEBS J, V277, P605, DOI 10.1111/j.1742-4658.2009.07479.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shinhara A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-428; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Vanzembergh F, 2010, TUBERCULOSIS, V90, P338, DOI 10.1016/j.tube.2010.09.004; Verma A, 1999, J BACTERIOL, V181, P4326, DOI 10.1128/JB.181.14.4326-4333.1999; Viegas SC, 2008, RNA BIOL, V5, P230, DOI 10.4161/rna.6915; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; Wendisch V., 2007, MICROBIOLOGY MONOGRA, P129, DOI DOI 10.1007/7171_2006_070; Wolfe LM, 2010, J PROTEOME RES, V9, P5816, DOI 10.1021/pr1005873; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Zhou YX, 2011, J CELL PHYSIOL, V226, P968, DOI 10.1002/jcp.22483; Zvi A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-18	65	52	55	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51950	10.1371/journal.pone.0051950	http://dx.doi.org/10.1371/journal.pone.0051950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284830	Green Published, gold			2022-12-25	WOS:000312694300065
J	Abraham, S; Pahwa, R; Ye, CT; Choi, JG; Pahwa, S; Jaggaiahgari, S; Raut, A; Chen, SP; Manjunath, N; Shankar, P				Abraham, Sojan; Pahwa, Rajendra; Ye, Chunting; Choi, Jang-gi; Pahwa, Savita; Jaggaiahgari, Shashidhar; Raut, Ashwin; Chen, Shuiping; Manjunath, N.; Shankar, Premlata			Long-Term Engraftment of Human Natural T Regulatory Cells in NOD/SCID IL2r gamma c(null) Mice by Expression of Human IL-2	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; IN-VIVO; MOUSE; PREVENT; SCURFY; MODEL	Regulatory T cells are essential to maintain immune homeostasis and prevent autoimmunity. Therapy with in vitro expanded human nT(Regs) is being tested to prevent graft versus host disease, which is a major cause for morbidity and mortality associated with hematopoietic stem cell transplantation. Their usefulness in therapy will depend on their capacity to survive, migrate appropriately and retain suppressive activity when introduced into a transplant recipient. The lack of a suitable animal model for studying the in vivo reconstitutive capability of human nT(Regs) is a major impediment for investigating the behavior of adoptively transferred nT(Regs) in vivo. We show that injection of a plasmid encoding human IL-2 is necessary and sufficient for long term engraftment of in vitro expanded nT(Regs) in NOD-SCID IL2r gamma c(null) mice. We also demonstrate that these in vivo reconstituted T-Regs traffic to different organs of the body and retain suppressive function. Finally, in an IL-2 accelerated GVHD model, we show that these in vivo reconstituted T-Regs are capable of preventing severe xenogenic response of human PBMCs. Thus, this novel 'hu-T-Reg mouse' model offers a pre-clinical platform to study the in vivo function and stability of human nT(Regs) and their ability to modulate autoimmune diseases and GVHD.	[Abraham, Sojan; Ye, Chunting; Choi, Jang-gi; Raut, Ashwin; Chen, Shuiping; Manjunath, N.; Shankar, Premlata] Texas Tech Univ Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis Res, Paul L Foster Sch Med, El Paso, TX USA; [Pahwa, Rajendra; Jaggaiahgari, Shashidhar] Max Healthcare Super Specialty Hosp, Saket New Delhi, India; [Pahwa, Rajendra; Jaggaiahgari, Shashidhar] Max Res Inst 1, Saket New Delhi, India; [Pahwa, Savita] Univ Miami, Leonard M Miller Sch Med, Dev Ctr AIDS Res Microbiol & Immunol, Miami, FL USA	Texas Tech University System; Texas Tech University Health Science Center; University of Miami	Shankar, P (corresponding author), Texas Tech Univ Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis Res, Paul L Foster Sch Med, El Paso, TX USA.	Premlata.shankar@ttuhsc.edu	Pahwa, Savita/AAA-4900-2019; Choi, Jang-gi/AAP-6339-2020	Pahwa, Savita/0000-0002-4470-4216; Raut, Ashwin/0000-0002-4978-901X; Jaggaiahgari, Shashidhar/0000-0001-7318-3942	National Institutes of Health [RO1 AI071882, R01 AI084795]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071882, P30AI073961, R01AI084795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health RO1 AI071882 and R01 AI084795 to Premlata Shankar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluestone JA, 2008, J CLIN IMMUNOL, V28, P677, DOI 10.1007/s10875-008-9242-z; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Brusko Todd M, 2007, Immunol Invest, V36, P607, DOI 10.1080/08820130701790368; Cao TH, 2009, CELL IMMUNOL, V258, P65, DOI 10.1016/j.cellimm.2009.03.013; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; DONOHUE JH, 1983, J IMMUNOL, V130, P2203; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Ferrara JLM, 1996, STEM CELLS, V14, P473, DOI 10.1002/stem.140473; Hippen KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001809; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Leveque L, 2009, J IMMUNOTHER, V32, P101, DOI 10.1097/CJI.0b013e318195b59e; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; Pahwa R, 2010, J IMMUNOL METHODS, V363, P67, DOI 10.1016/j.jim.2010.10.006; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Scheffold A, 2005, EUR J IMMUNOL, V35, P1336, DOI 10.1002/eji.200425887; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51832	10.1371/journal.pone.0051832	http://dx.doi.org/10.1371/journal.pone.0051832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272176	gold, Green Submitted, Green Published			2022-12-25	WOS:000312483300033
J	Martin, FL; Sangaralingham, SJ; Huntley, BK; McKie, PM; Ichiki, T; Chen, HH; Korinek, J; Harders, GE; Burnett, JC				Martin, Fernando L.; Sangaralingham, S. Jeson; Huntley, Brenda K.; McKie, Paul M.; Ichiki, Tomoko; Chen, Horng H.; Korinek, Josef; Harders, Gerald E.; Burnett, John C., Jr.			CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart	PLOS ONE			English	Article							NATRIURETIC PEPTIDE RECEPTOR; ANGIOTENSIN-ALDOSTERONE SYSTEM; CARDIAC FIBROBLASTS; MYOCYTE APOPTOSIS; GENE-EXPRESSION; FIBROSIS; EXCRETION; FAMILY; CNP	Natriuretic peptides (NPs) are cardioprotective through the activation of guanylyl cyclase (GC) receptors A and B. CD-NP, also known as cenderitide, is a novel engineered NP that was designed to uniquely serve as a first-in-class dual GC receptor agonist. Recognizing the aldosterone suppressing actions of GC-A activation and the potent inhibitory actions on collagen synthesis and fibroblast proliferation through GC-B activation, the current study was designed to establish the anti-fibrotic actions of CD-NP, administered subcutaneously, in an experimental rat model of early cardiac fibrosis induced by unilateral nephrectomy (UNX). Our results demonstrate that a two week subcutaneous infusion of CD-NP significantly suppresses left ventricular fibrosis and circulating aldosterone, while preserving both systolic and diastolic function, in UNX rats compared to vehicle treated UNX rats. Additionally we also confirmed, in vitro, that CD-NP significantly generates the second messenger, cGMP, through both the GC-A and GC-B receptors. Taken together, this novel dual GC receptor activator may represent an innovative anti-fibrotic therapeutic agent. Citation: Martin FL, Sangaralingham SJ, Huntley BK, McKie PM, Ichiki T, et al. (2012) CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart. PLoS ONE 7(12): e52422. doi:10.1371/journal.pone.0052422	[Martin, Fernando L.; Sangaralingham, S. Jeson; Huntley, Brenda K.; McKie, Paul M.; Ichiki, Tomoko; Chen, Horng H.; Korinek, Josef; Harders, Gerald E.; Burnett, John C., Jr.] Mayo Clin, Cardiorenal Res Lab, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Sangaralingham, SJ (corresponding author), Mayo Clin, Cardiorenal Res Lab, Div Cardiovasc Dis, Rochester, MN 55905 USA.	sangaralingham.jeson@mayo.edu	Korinek, Josef/C-9936-2016	Korinek, Josef/0000-0002-4712-4444	National Institutes of Health [RO1 HL36634, R01 HL83231, PO1 HL76611]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076611, R01HL083231, R01HL036634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (RO1 HL36634, R01 HL83231 and PO1 HL76611) and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brilla CG, 2000, CARDIOVASC RES, V47, P1, DOI 10.1016/S0008-6363(00)00092-4; Burniston JG, 2005, J MOL CELL CARDIOL, V39, P395, DOI 10.1016/j.yjmcc.2005.04.001; Dickey DM, 2011, J MOL CELL CARDIOL, V51, P67, DOI 10.1016/j.yjmcc.2011.03.013; Dickey DM, 2008, J BIOL CHEM, V283, P35003, DOI 10.1074/jbc.M804538200; Doyle DD, 2002, AM J PHYSIOL-HEART C, V282, pH2117, DOI 10.1152/ajpheart.00988.2001; Horio T, 2003, ENDOCRINOLOGY, V144, P2279, DOI 10.1210/en.2003-0128; Hu P, 2012, PEPTIDES, V37, P98, DOI 10.1016/j.peptides.2012.06.009; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; KENNY AJ, 1993, BIOCHEM J, V291, P83, DOI 10.1042/bj2910083; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; Lee CYW, 2009, J CLIN PHARMACOL, V49, P668, DOI 10.1177/0091270009336233; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; Mano A, 2004, CIRCULATION, V110, P317, DOI 10.1161/01.CIR.0000135599.33787.CA; Martin FL, 2012, AM J PHYSIOL-REG I, V302, pR292, DOI 10.1152/ajpregu.00194.2011; MAYES D, 1970, J CLIN ENDOCR METAB, V30, P682, DOI 10.1210/jcem-30-5-682; Murakami S, 2004, AM J PHYSIOL-LUNG C, V287, pL1172, DOI 10.1152/ajplung.00087.2004; Peltonen TO, 2007, CIRCULATION, V116, P1283, DOI 10.1161/CIRCULATIONAHA.106.685743; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Sangaralingham SJ, 2012, CIRC-CARDIOVASC IMAG, V5, P518, DOI 10.1161/CIRCIMAGING.112.973057; Sangaralingham SJ, 2011, AM J PHYSIOL-RENAL, V301, pF943, DOI 10.1152/ajprenal.00170.2011; Sangaralingham SJ, 2011, HYPERTENSION, V57, P201, DOI 10.1161/HYPERTENSIONAHA.110.160796; SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928; Socki T, 2005, J AM COLL CARDIOL, V45, P608, DOI 10.1016/j.jacc.2004.10.067; Steiner A L, 1970, Adv Biochem Psychopharmacol, V3, P89; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; Surendran K, 2003, AM J PHYSIOL-RENAL, V284, pF653, DOI 10.1152/ajprenal.00343.2002; Tsuruda T, 2002, CIRC RES, V91, P1127, DOI 10.1161/01.RES.0000046234.73401.70; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; Young MJ, 2008, CURR OPIN NEPHROL HY, V17, P174, DOI 10.1097/MNH.0b013e3282f56854	32	44	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52422	10.1371/journal.pone.0052422	http://dx.doi.org/10.1371/journal.pone.0052422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272242	gold, Green Submitted, Green Published			2022-12-25	WOS:000312483300084
J	Wang, Y; Loers, G; Pan, HC; Gouveia, R; Zhao, WJ; Shen, YQ; Kleene, R; Costa, J; Schachner, M				Wang, Yan; Loers, Gabriele; Pan, Hong-Chao; Gouveia, Ricardo; Zhao, Wei-Jiang; Shen, Yan-Qin; Kleene, Ralf; Costa, Julia; Schachner, Melitta			Antibody Fragments Directed against Different Portions of the Human Neural Cell Adhesion Molecule L1 Act as Inhibitors or Activators of L1 Function	PLOS ONE			English	Article							NEURITE OUTGROWTH; N-CAM; IMMUNOGLOBULIN SUPERFAMILY; RECOGNITION MOLECULES; STRUCTURAL-ANALYSIS; NERVOUS-SYSTEM; DOMAINS; EXPRESSION; SURFACE; PROLIFERATION	The neural cell adhesion molecule L1 plays important roles in neuronal migration and survival, neuritogenesis and synaptogenesis. L1 has also been found in tumors of different origins, with levels of L1 expression correlating positively with the metastatic potential of tumors. To select antibodies targeting the varied functions of L1, we screened the Tomlinson library of recombinant human antibody fragments to identify antibodies binding to recombinant human L1 protein comprising the entire extracellular domain of human L1. We obtained four L1 binding single-chain variable fragment antibodies (scFvs), named I4, I6, I13, and I27 and showed by enzyme-linked immunosorbent assay (ELISA) that scFvs I4 and I6 have high affinity to the immunoglobulin-like (Ig) domains 1-4 of L1, while scFvs I13 and I27 bind strongly to the fibronectin type III homologous (Fn) domains 1-3 of L1. Application of scFvs I4 and I6 to human SK-N-SH neuroblastoma cells reduced proliferation and transmigration of these cells. Treatment of SK-N-SH cells with scFvs I13 and I27 enhanced cell proliferation and migration, neurite outgrowth, and protected against the toxic effects of H2O2 by increasing the ratio of Bcl-2/Bax. In addition, scFvs I4 and I6 inhibited and scFvs I13 and I27 promoted phosphorylation of src and Erk. Our findings indicate that scFvs reacting with the immunoglobulin-like domains 1-4 inhibit L1 functions, whereas scFvs interacting with the fibronectin type III domains 1-3 trigger L1 functions of cultured neuroblastoma cells. Citation: Wang Y, Loers G, Pan H-C, Gouveia R, Zhao W-J, et al. (2012) Antibody Fragments Directed against Different Portions of the Human Neural Cell Adhesion Molecule L1 Act as Inhibitors or Activators of L1 Function. PLoS ONE 7(12): e52404. doi:10.1371/journal.pone.0052404	[Wang, Yan; Pan, Hong-Chao; Zhao, Wei-Jiang; Shen, Yan-Qin; Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Guangdong, Peoples R China; [Loers, Gabriele; Kleene, Ralf] Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Hamburg, Germany; [Gouveia, Ricardo; Costa, Julia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	Shantou University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidade Nova de Lisboa; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, M (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Guangdong, Peoples R China.	schachner@stu.edu.cn	Costa, Júlia C/B-7131-2008; Wang, Yan/AAJ-1575-2020	Costa, Júlia C/0000-0001-7782-6319; Zhao, Wei-jiang/0000-0002-6556-2827; Gouveia, Ricardo/0000-0002-2968-1298	Li Ka Shing Shantou University Foundation; Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-NEU/100724/2008]	Li Ka Shing Shantou University Foundation; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by the Li Ka Shing Shantou University Foundation (to MS) and the Fundacao para a Ciencia e Tecnologia, Portugal (project PTDC/SAU-NEU/100724/2008 to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL F, 1993, J NEUROSCI, V13, P4764; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Blaess S, 1998, J NEUROCHEM, V71, P2615, DOI 10.1046/j.1471-4159.1998.71062615.x; Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Dong L, 2003, MOL CELL NEUROSCI, V22, P234, DOI 10.1016/S1044-7431(02)00033-7; Drescher B, 1996, EUR J NEUROSCI, V8, P2467, DOI 10.1111/j.1460-9568.1996.tb01541.x; Eteshola E, 2010, J IMMUNOL METHODS, V358, P104, DOI 10.1016/j.jim.2010.04.003; FAISSNER A, 1984, DEV BRAIN RES, V15, P69, DOI 10.1016/0165-3806(84)90141-X; FISCHER G, 1986, J NEUROSCI, V6, P605; Fransen E, 1996, AM J MED GENET, V64, P73, DOI 10.1002/(SICI)1096-8628(19960712)64:1<73::AID-AJMG11>3.0.CO;2-P; Gouveia R, 2012, BBA-GEN SUBJECTS, V1820, P2007, DOI 10.1016/j.bbagen.2012.09.004; Gouveia R, 2010, J BIOTECHNOL, V145, P130, DOI 10.1016/j.jbiotec.2009.10.018; Gouveia RM, 2008, J BIOL CHEM, V283, P28038, DOI 10.1074/jbc.M804991200; Guseva D, 2011, EXP NEUROL, V229, P339, DOI 10.1016/j.expneurol.2011.02.018; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; Hall H, 2000, J NEUROCHEM, V75, P336, DOI 10.1046/j.1471-4159.2000.0750336.x; Hall Heike, 2004, Angiogenesis, V7, P213, DOI 10.1007/s10456-004-1328-5; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; Hoefnagel CA, 2011, EUR J NUCL MED, V38, P359; Islam R, 2004, MOL BIOL CELL, V15, P2003, DOI 10.1091/mbc.e03-05-0333; Itoh K, 2005, MOL CELL NEUROSCI, V30, P624, DOI 10.1016/j.mcn.2005.06.012; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; Kamiguchi H, 1997, J NEUROSCI RES, V49, P1, DOI 10.1002/(SICI)1097-4547(19970701)49:1<1::AID-JNR1>3.0.CO;2-H; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Kurumaji A, 2001, AM J MED GENET, V105, P99; Lee ES, 2012, EXP MOL MED, V44, P293, DOI 10.3858/emm.2012.44.4.027; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; Min JK, 2010, CLIN CANCER RES, V16, P3571, DOI 10.1158/1078-0432.CCR-09-3075; Miyahara R, 2001, J SURG ONCOL, V77, P49, DOI 10.1002/jso.1065; Montgomery AMP, 1996, J CELL BIOL, V132, P475, DOI 10.1083/jcb.132.3.475; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Pavlou O, 2002, MOL CELL NEUROSCI, V20, P367, DOI 10.1006/mcne.2002.1105; POLTORAK M, 1995, EXP NEUROL, V131, P266, DOI 10.1016/0014-4886(95)90048-9; RATHJEN FG, 1984, EMBO J, V3, P1; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schmid RS, 2000, J NEUROSCI, V20, P4177; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; Siesser PF, 2009, CELL ADHES MIGR, V3, P275, DOI 10.4161/cam.3.3.8689; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; TimorTritsch IE, 1996, PRENATAL DIAG, V16, P543, DOI 10.1002/(SICI)1097-0223(199606)16:6<543::AID-PD878>3.0.CO;2-I; Wei CH, 2011, FEBS LETT, V585, P153, DOI 10.1016/j.febslet.2010.11.028; Wolterink S, 2010, CANCER RES, V70, P2504, DOI 10.1158/0008-5472.CAN-09-3730; WOOD PM, 1990, J NEUROSCI, V10, P3635; Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277	54	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52404	10.1371/journal.pone.0052404	http://dx.doi.org/10.1371/journal.pone.0052404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272240	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300082
J	Wu, H; Tao, N; Liu, XM; Li, X; Tang, J; Ma, CW; Xu, XF; Shao, HT; Hou, BD; Wang, H; Qin, ZH				Wu, Hao; Tao, Ning; Liu, Xiaoman; Li, Xiao; Tang, Jian; Ma, Chungwah; Xu, Xiaofei; Shao, Haitao; Hou, Baidong; Wang, Hui; Qin, Zhihai			Polysaccharide from Lentinus edodes Inhibits the Immunosuppressive Function of Myeloid-Derived Suppressor Cells	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; IMMUNE-RESPONSES; CANCER-PATIENTS; DIFFERENTIATION; INTERLEUKIN-4; POLARIZATION; EXPANSION; IMPROVES; MICE	Reversing the function of immune suppressor cells may improve the efficacy of cancer therapy. Here, we have isolated a novel polysaccharide MPSSS (577.2 Kd) from Lentinus edodes and examined its effects on differentiation and function of myeloid-derived suppressor cells (MDSCs). MPSSS is composed of glucose (75.0%), galactose (11.7%), mannose (7.8%), and xylose (0.4%). In vivo, it inhibits the growth of McgR32 tumor cells, which is correlated with a reduced percentage of MDSCs in peripheral blood. In vitro, it induces both morphological and biophysical changes in MDSCs. Importantly, MPSSS up-regulates MHC II and F4/80 expression on MDSCs, and reverses their inhibition effect on CD4(+) T cells in a dose-dependent manner. The mechanism study shows that MPSSS may stimulate MDSCs through a MyD88 dependent NF-kappa B signaling pathway. Together, we demonstrated for the first time that MPSSS stimulates the differentiation of MDSCs and reverses its immunosuppressive functions, shedding new light on developing novel anti-cancer strategies by targeting MDSCs.	[Shao, Haitao; Hou, Baidong] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Wu, Hao; Wang, Hui] Xinxiang Med Univ, Xinxiang, Peoples R China; [Tao, Ning; Liu, Xiaoman; Li, Xiao; Qin, Zhihai] Chinese Acad Sci, Inst Biophys, Prot & Peptide Pharmaceut Lab, Beijing 100080, Peoples R China; [Tang, Jian; Ma, Chungwah; Xu, Xiaofei] Infinitus China Co Ltd, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Xinxiang Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Hou, BD (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	baidong_hou@ibp.ac.cn; wanghui@xxmu.edu.cn; zhihai@ibp.ac.cn	Tao, Ning/AAK-7068-2021	Tao, Ning/0000-0002-0021-4995; wu, hao/0000-0002-6713-7752; Wang, Hui/0000-0002-2454-3814; Hou, Baidong/0000-0002-0892-0181; Qin, Zhihai/0000-0001-9793-7964	Plan for Scientific Innovation Talent of Henan Province [104200510001]; National Natural Science Foundation of China [31071261]	Plan for Scientific Innovation Talent of Henan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by Plan for Scientific Innovation Talent of Henan Province (104200510001), and the National Natural Science Foundation of China (31071261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; CHICHARA G, 1969, NATURE, V222, P687, DOI 10.1038/222687a0; CHIHARA G, 1970, CANCER RES, V30, P2776; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; HAMURO J, 1980, IMMUNOLOGY, V39, P551; Jiang J, 2010, GENE THER, V17, P991, DOI 10.1038/gt.2010.54; Jung HY, 2011, FOOD HYDROCOLLOID, V25, P1291, DOI 10.1016/j.foodhyd.2010.12.002; Kusmartsev S, 2003, CANCER RES, V63, P4441; LADANYI A, 1993, CANCER IMMUNOL IMMUN, V36, P123, DOI 10.1007/BF01754412; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Li Xiao-bing, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P363, DOI 10.3736/jcim20100411; Li ZG, 2008, CANCER RES, V68, P8687, DOI 10.1158/0008-5472.CAN-08-0449; Li ZG, 2009, CELL MOL IMMUNOL, V6, P415, DOI 10.1038/cmi.2009.53; MAEDA YY, 1973, INT J CANCER, V11, P153, DOI 10.1002/ijc.2910110118; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Mirza N, 2006, CANCER RES, V66, P9299, DOI 10.1158/0008-5472.CAN-06-1690; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; PETER G, 1988, IMMUNOPHARM IMMUNOT, V10, P157; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Wang ZB, 2010, J IMMUNOTHER, V33, P167, DOI 10.1097/CJI.0b013e3181bed2ba; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Zhang YY, 2011, FOOD HYDROCOLLOID, V25, P196, DOI 10.1016/j.foodhyd.2010.02.001	27	32	36	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51751	10.1371/journal.pone.0051751	http://dx.doi.org/10.1371/journal.pone.0051751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272159	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300025
J	Lee, CM; Mudaliar, MAV; Haggart, DR; Wolf, CR; Miele, G; Vass, JK; Higham, DJ; Crowther, D				Lee, Clare M.; Mudaliar, Manikhandan A. V.; Haggart, D. R.; Wolf, C. Roland; Miele, Gino; Vass, J. Keith; Higham, Desmond J.; Crowther, Daniel			Simultaneous Non-Negative Matrix Factorization for Multiple Large Scale Gene Expression Datasets in Toxicology	PLOS ONE			English	Article							BILE-ACIDS; MUSCLE-CONTRACTION; MICROARRAY DATA; DISEASE; DISCOVERY; TROPONIN; RECEPTOR; INHIBITION; ENHANCER; COMPLEX	Non-negative matrix factorization is a useful tool for reducing the dimension of large datasets. This work considers simultaneous non-negative matrix factorization of multiple sources of data. In particular, we perform the first study that involves more than two datasets. We discuss the algorithmic issues required to convert the approach into a practical computational tool and apply the technique to new gene expression data quantifying the molecular changes in four tissue types due to different dosages of an experimental panPPAR agonist in mouse. This study is of interest in toxicology because, whilst PPARs form potential therapeutic targets for diabetes, it is known that they can induce serious side-effects. Our results show that the practical simultaneous non-negative matrix factorization developed here can add value to the data analysis. In particular, we find that factorizing the data as a single object allows us to distinguish between the four tissue types, but does not correctly reproduce the known dosage level groups. Applying our new approach, which treats the four tissue types as providing distinct, but related, datasets, we find that the dosage level groups are respected. The new algorithm then provides separate gene list orderings that can be studied for each tissue type, and compared with the ordering arising from the single factorization. We find that many of our conclusions can be corroborated with known biological behaviour, and others offer new insights into the toxicological effects. Overall, the algorithm shows promise for early detection of toxicity in the drug discovery process. Citation: Lee CM, Mudaliar MAV, Haggart DR, Wolf CR, Miele G, et al. (2012) Simultaneous Non-Negative Matrix Factorization for Multiple Large Scale Gene Expression Datasets in Toxicology. PLoS ONE 7(12): e48238. doi:10.1371/journal.pone.0048238	[Lee, Clare M.; Vass, J. Keith; Higham, Desmond J.] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Mudaliar, Manikhandan A. V.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Wolf, C. Roland] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Wolf, C. Roland] CXR Biosci Ltd, Dundee, Scotland; [Haggart, D. R.; Miele, Gino] Epsistem Ltd, Manchester, Lancs, England; [Crowther, Daniel] Sanofi, Frankfurt, Germany	University of Strathclyde; University of Glasgow; University of Dundee; Sanofi-Aventis	Higham, DJ (corresponding author), Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland.	d.j.higham@strath.ac.uk	Mudaliar, Manikhandan/K-1377-2014	Mudaliar, Manikhandan/0000-0003-1482-840X	Translational Medicine Research Collaboration; Scottish Enterprise; Pfizer; EPSRC [EP/E49370/1]; Knowledge Transfer Account of the University of Strathclyde; DTI grant "New serum Biomarkers for Preclinical and Clinical Drug Safety Assessment"; Engineering and Physical Sciences Research Council of the UK under their Fundamentals of Complexity Science call; Leverhulme Trust; TMRC; Cancer Research UK [10822] Funding Source: researchfish	Translational Medicine Research Collaboration; Scottish Enterprise; Pfizer(Pfizer); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Knowledge Transfer Account of the University of Strathclyde; DTI grant "New serum Biomarkers for Preclinical and Clinical Drug Safety Assessment"; Engineering and Physical Sciences Research Council of the UK under their Fundamentals of Complexity Science call(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); TMRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	This work was supported by the Translational Medicine Research Collaboration-a consortium made up of the Universities of Aberdeen, Dundee, Edinburgh and Glasgow, the four associated NHS Health Boards (Grampian, Tayside, Lothian and Greater Glasgow & Clyde), Scottish Enterprise and Pfizer, by EPSRC Grant EP/E49370/1, by the Knowledge Transfer Account of the University of Strathclyde and by the 2007 DTI grant "New serum Biomarkers for Preclinical and Clinical Drug Safety Assessment". CML and DJH were supported by the Engineering and Physical Sciences Research Council of the UK, under their Fundamentals of Complexity Science call. DJH was funded by a Fellowship from the Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DC was employed by Pfizer and legacy company Wyeth during the course of this work and is now employed by Sanofi. GM was employed by Pfizer and legacy company Wyeth during the course of this work and is now employed by Epistem. CRW is employed by CXR. Pfizer agreed to the publication of this manuscript. MM, DRH and JKV were funded through the TMRC. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, CURR CARDIO RISK REP, V4, P142; Artis DR, 2009, P NATL ACAD SCI USA, V106, P262, DOI 10.1073/pnas.0811325106; Badea Liviu, 2007, 2007 International Conference on Bioinformatics & Computational Biology (BIOCOMP'07), P127; Badea Liviu, 2008, Pac Symp Biocomput, P267; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carmona-Saez P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-78; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Florvall G, 2006, J GERONTOL A-BIOL, V61, P1262, DOI 10.1093/gerona/61.12.1262; Fogel P, 2007, BIOINFORMATICS, V23, P44, DOI 10.1093/bioinformatics/btl550; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Gao Y, 2005, BIOINFORMATICS, V21, P3970, DOI 10.1093/bioinformatics/bti653; Gervois P, 2001, J BIOL CHEM, V276, P33471, DOI 10.1074/jbc.M102839200; Guo Y, 2007, TOXICOL SCI, V96, P294, DOI 10.1093/toxsci/kfm009; Hall R., 2001, PRINCIPLES METHODS T; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jones D, 2010, NAT REV DRUG DISCOV, V9, P668, DOI 10.1038/nrd3271; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Matsukuma KE, 2006, J LIPID RES, V47, P2754, DOI 10.1194/jlr.M600342-JLR200; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Oldgren J, 2003, EUR HEART J, V24, P86, DOI 10.1016/S0195-668X(02)00312-3; PARMACEK MS, 1990, J BIOL CHEM, V265, P15970; Pascual-Montano A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-366; Perry SV, 2003, J MUSCLE RES CELL M, V24, P593; Redwood City CISI, 2011, ING ING PATHW AN VER; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Scotti E, 2007, CELL MOL LIFE SCI, V64, P2477, DOI 10.1007/s00018-007-7280-y; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	37	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e48238	10.1371/journal.pone.0048238	http://dx.doi.org/10.1371/journal.pone.0048238			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272042	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000312386800003
J	Tsao, KC; Tu, CF; Lee, SJ; Yang, RB				Tsao, Ku-Chi; Tu, Cheng-Fen; Lee, Shyh-Jye; Yang, Ruey-Bing			Zebrafish scube1 (Signal Peptide-CUB (Complement Protein C1r/C1s, Uegf, and Bmp1)-EGF (Epidermal Growth Factor) Domain-containing Protein 1) Is Involved in Primitive Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE GLYCOPROTEIN; FUNCTIONAL-ANALYSIS; GENE; BMP; ERYTHROPOIESIS; EXPRESSION; SCUBE2; BLOOD; IDENTIFICATION; TRANSCRIPTION	scube1 (signal peptide-CUB (complement protein C1r/C1s, Uegf, and Bmp1)-EGF domain-containing protein 1), the founding member of a novel secreted and cell surface SCUBE protein family, is expressed predominantly in various developing tissues in mice. However, its function in primitive hematopoiesis remains unknown. In this study, we identified and characterized zebrafish scube1 and analyzed its function by injecting antisense morpholino-oligonucleotide into embryos. Whole-mount in situ hybridization revealed that zebrafish scube1 mRNA is maternally expressed and widely distributed during early embryonic development. Knockdown of scube1 by morpholino-oligonucleotide down-regulated the expression of marker genes associated with early primitive hematopoietic precursors (scl) and erythroid (gata1 and hbbe1), as well as early (pu.1) and late (mpo and l-plastin) myelomonocytic lineages. However, the expression of an early endothelial marker fli1a and vascular morphogenesis appeared normal in scube1 morphants. Overexpression of bone morphogenetic protein (bmp) rescued the expression of scl in the posterior lateral mesoderm during early primitive hematopoiesis in scube1 morphants. Biochemical and molecular analysis revealed that Scube1 could be a BMP co-receptor to augment BMP signaling. Our results suggest that scube1 is critical for and functions at the top of the regulatory hierarchy of primitive hematopoiesis by modulating BMP activity during zebrafish embryogenesis.	[Tsao, Ku-Chi; Tu, Cheng-Fen; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Tu, Cheng-Fen; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taiwan Int Grad Program, Program Mol Med, Taipei 11529, Taiwan; [Tu, Cheng-Fen; Yang, Ruey-Bing] Natl Yang Ming Univ, Sch Med, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Yang, Ruey-Bing] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 11221, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10617, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University	Yang, RB (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	rbyang@ibms.sinica.edu.tw	Lee, Shyh-Jye/C-6092-2008; Yang, Ruey-Bing/O-1494-2018	Lee, Shyh-Jye/0000-0001-8452-9152; Yang, Ruey-Bing/0000-0003-3017-3714; Tu, Cheng-Fen/0000-0003-3624-7884	National Science Council [NSC 99-2311-B-001-022-MY3, NSC-98-2311-B-002-006-MY3, 101-2321-B-001-026, 101-2321-B-400-014]; National Taiwan University [NTU CESRP-10R70602A5, NTU ERP-10R80600]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by National Science Council Grant NSC 99-2311-B-001-022-MY3 (to R.-B. Y.) and by National Science Council Grant NSC-98-2311-B-002-006-MY3 and National Taiwan University Grants NTU CESRP-10R70602A5 and NTU ERP-10R80600 (to S.-J. L.).; We thank the Zebrafish International Resource Center (ZIRC), Taiwan Zebrafish Core Facility at Academia Sinica (supported by grant 101-2321-B-001-026 from the National Science Council), and Taiwan Zebrafish Core Facility at NTHU/NHRI (supported by grant 101-2321-B-400-014 from the National Science Council) for providing AB, Tg(kdr:EGFP), Tg(gata1:dsRed) fish lines, and some ISH probes used in this study.	Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Blank U, 2011, LEUKEMIA, V25, P1379, DOI 10.1038/leu.2011.95; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Chiang PM, 2011, DEVELOPMENT, V138, P2833, DOI 10.1242/dev.061440; Ciau-Uitz A, 2010, INT J DEV BIOL, V54, P1139, DOI 10.1387/ijdb.093055ac; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Grimmond S, 2001, MECH DEVELOP, V102, P209, DOI 10.1016/S0925-4773(00)00586-4; Gupta S, 2006, DEVELOPMENT, V133, P2177, DOI 10.1242/dev.02386; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hogan BM, 2006, CURR BIOL, V16, P506, DOI 10.1016/j.cub.2006.01.047; Hollway GE, 2006, DEV BIOL, V294, P104, DOI 10.1016/j.ydbio.2006.02.032; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Johnson JLFA, 2012, DEV BIOL, V368, P193, DOI 10.1016/j.ydbio.2012.05.007; Kawakami A, 2005, CURR BIOL, V15, P480, DOI 10.1016/j.cub.2005.02.018; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Lin YC, 2011, J BIOL CHEM, V286, P27039, DOI 10.1074/jbc.M111.244418; Marom K, 2005, DEV BIOL, V282, P442, DOI 10.1016/j.ydbio.2005.03.024; McReynolds LJ, 2007, BLOOD, V110, P3881, DOI 10.1182/blood-2007-04-085753; McReynolds LJ, 2008, EXP HEMATOL, V36, P1604, DOI 10.1016/j.exphem.2008.08.005; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Prince VE, 1998, DEVELOPMENT, V125, P393; Quinkertz A, 1999, DEV GENES EVOL, V209, P126, DOI 10.1007/s004270050235; Schmerer M, 2003, BLOOD, V102, P3196, DOI 10.1182/blood-2003-04-1094; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Tsai MT, 2009, BIOCHEM J, V422, P119, DOI 10.1042/BJ20090341; Tu CF, 2008, J BIOL CHEM, V283, P12478, DOI 10.1074/jbc.M705872200; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Walmsley M, 2002, DEVELOPMENT, V129, P5683, DOI 10.1242/dev.00169; Woods IG, 2005, PLOS BIOL, V3, P476, DOI 10.1371/journal.pbio.0030066; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Xavier GM, 2009, J EXP ZOOL PART B, V312B, P518, DOI 10.1002/jez.b.21260; Xavier GM, 2010, GENESIS, V48, P684, DOI 10.1002/dvg.20678; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200	50	16	17	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5017	5026		10.1074/jbc.M112.375196	http://dx.doi.org/10.1074/jbc.M112.375196			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23271740	Green Published, hybrid			2022-12-25	WOS:000315340400048
J	Li, CH; Li, Z; Li, Y; Zhou, J; Zhang, CD; Su, XR; Li, TW				Li, Chenghua; Li, Zhen; Li, Ye; Zhou, Jun; Zhang, Chundan; Su, Xiurong; Li, Taiwu			A Ferritin from Dendrorhynchus zhejiangensis with Heavy Metals Detoxification Activity	PLOS ONE			English	Article							HORSE-SPLEEN FERRITIN; ION BINDING; IRON; EXPRESSION; HOMOLOG	Ferritin, an iron homeostasis protein, has important functions in transition and storage of toxic metal ions. In this study, the full-length cDNA of ferritin was isolated from Dendrorhynchus zhejiangensis by cDNA library and RACE approaches. The higher similarity and conserved motifs for ferritin were also identified in worm counterparts, indicating that it belonged to a new member of ferritin family. The temporal expression of worm ferritin in haemocytes was analyzed by RT-PCR, and revealed the ferritin could be induced by Cd2+, Pb2+ and Fe2+. The heavy metal binding activity of recombinant ferritin was further elucidated by atomic force microscopy (AFM). It was observed that the ferritin protein could form a chain of beads with different size against three metals exposure, and the largest one with 35 similar to 40 nm in height was identified in the Cd2+ challenge group. Our results indicated that worm ferritin was a promising candidate for heavy metals detoxification.	[Li, Chenghua; Li, Zhen; Li, Ye; Zhou, Jun; Zhang, Chundan; Su, Xiurong] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China; [Li, Taiwu] Ningbo City Coll Vocat Technol, Ningbo, Zhejiang, Peoples R China	Ningbo University; Ningbo City College of Vocational Technology	Su, XR (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.	suxiurong@gmail.com	Li, Chenghua/L-9825-2019	Li, Chenghua/0000-0003-2978-8762	National Natural Science Foundation [41176123, 31272637]; Natural Science Foundation of Zhejiang Province [Y3100480]; KC Wong Magna Fund at Ningbo University	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); KC Wong Magna Fund at Ningbo University	This work was financially supported by the National Natural Science Foundation (No. 41176123 and No31272637), the Natural Science Foundation of Zhejiang Province (No. Y3100480), and KC Wong Magna Fund at Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Georgieva T, 2002, INSECT BIOCHEM MOLEC, V32, P295, DOI 10.1016/S0965-1748(01)00090-X; Haikarainen T, 2011, J MOL BIOL, V405, P448, DOI 10.1016/j.jmb.2010.10.058; HAINFELD JF, 1992, P NATL ACAD SCI USA, V89, P11064, DOI 10.1073/pnas.89.22.11064; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Huang H, 2000, ACTA BIOPHYSICA SINI, V16, P39; Jin CH, 2011, DEV COMP IMMUNOL, V35, P745, DOI 10.1016/j.dci.2011.02.006; Jung JH, 2011, J MAGN MAGN MATER, V323, P3077, DOI 10.1016/j.jmmm.2011.06.060; Khare G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018570; Li CH, 2011, FISH SHELLFISH IMMUN, V30, P1147, DOI 10.1016/j.fsi.2011.02.017; Li M, 2008, COMP BIOCHEM PHYS B, V150, P263, DOI 10.1016/j.cbpb.2008.03.014; Margarita EA, 2011, BIOORGAN MED CHEM, V19, P534; MELDRUM FC, 1995, J INORG BIOCHEM, V58, P59, DOI 10.1016/0162-0134(94)00037-B; PEAD S, 1995, J INORG BIOCHEM, V59, P15, DOI 10.1016/0162-0134(94)00050-K; Qiu GF, 2008, COMP BIOCHEM PHYS B, V150, P320, DOI 10.1016/j.cbpb.2008.03.016; Stephanie LD, 2009, ANAL BIOANAL CHEM, V394, P215; Su XR, 2009, FISH SHELLFISH IMMUN, V27, P466, DOI 10.1016/j.fsi.2009.06.014; Zhang JH, 2009, CHINESE SCI BULL, V54, P723, DOI 10.1007/s11434-008-0544-6; Zheng WJ, 2010, COMP BIOCHEM PHYS B, V156, P222, DOI 10.1016/j.cbpb.2010.03.012; Zhu B, 2011, FISH SHELLFISH IMMUN, V31, P453, DOI 10.1016/j.fsi.2011.06.020; Zoysa D, 2007, FISH SHELLFISH IMMUN, V23, P624	21	9	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51428	10.1371/journal.pone.0051428	http://dx.doi.org/10.1371/journal.pone.0051428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284696	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500010
J	Bi, CWC; Xu, L; Tian, XY; Liu, J; Zheng, KYZ; Lau, CW; Lau, DTW; Choi, RCY; Dong, TTX; Huang, Y; Tsim, KWK				Bi, Cathy W. C.; Xu, Li; Tian, Xiao Yu; Liu, Jian; Zheng, Ken Y. Z.; Lau, Chi Wai; Lau, David T. W.; Choi, Roy C. Y.; Dong, Tina T. X.; Huang, Yu; Tsim, Karl W. K.			Fo Shou San, an Ancient Chinese Herbal Decoction, Protects Endothelial Function through Increasing Endothelial Nitric Oxide Synthase Activity	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; FERULIC ACID; ANGELICAE SINENSIS; GINSENOSIDE RB1; REACTIVE OXYGEN; NADPH OXIDASE; CELLS; DYSFUNCTION; HOMOCYSTEINE; ACTIVATION	Fo Shou San (FSS) is an ancient herbal decoction comprised of Chuanxiong Rhizoma (CR; Chuanxiong) and Angelicae Sinensis Radix (ASR; Danggui) in a ratio of 2:3. Previous studies indicate that FSS promotes blood circulation and dissipates blood stasis, thus which is being used widely to treat vascular diseases. Here, we aim to determine the cellular mechanism for the vascular benefit of FSS. The treatment of FSS reversed homocysteine-induced impairment of acetylcholine (ACh)-evoked endothelium-dependent relaxation in aortic rings, isolated from rats. Like radical oxygen species (ROS) scavenger tempol, FSS attenuated homocysteine-stimulated ROS generation in cultured human umbilical vein endothelial cells (HUVECs), and it also stimulated the production of nitric oxide (NO) as measured by fluorescence dye and biochemical assay. In addition, the phosphorylation levels of both Akt kinase and endothelial NO synthases (eNOS) were markedly increased by FSS treatment, which was abolished by an Akt inhibitor triciribine. Likewise, triciribine reversed FSS-induced NO production in HUVECs. Finally, FSS elevated intracellular Ca2+ levels in HUVECs, and the Ca2+ chelator BAPTA-AM inhibited the FSS-stimulated eNOS phosphorylation. The present results show that this ancient herbal decoction benefits endothelial function through increased activity of Akt kinase and eNOS; this effect is causally via a rise of intracellular Ca2+ and a reduction of ROS.	[Bi, Cathy W. C.; Xu, Li; Zheng, Ken Y. Z.; Lau, David T. W.; Choi, Roy C. Y.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Bi, Cathy W. C.; Xu, Li; Zheng, Ken Y. Z.; Lau, David T. W.; Choi, Roy C. Y.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Tian, Xiao Yu; Liu, Jian; Lau, Chi Wai; Huang, Yu] Chinese Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Inst Hlth Sci, Inst Vasc Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese University of Hong Kong	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk	Huang, Yu/K-2866-2017; Tian, Xiao Yu/P-1092-2016	Huang, Yu/0000-0002-1277-6784; Tian, Xiao Yu/0000-0003-3472-9898; Lau, Tai Wai David/0000-0002-3443-1808; Tsim, Karl/0000-0003-4808-1674; Liu, Jian/0000-0001-9719-2923	Research Grants Council of Hong Kong [N_HKUST629/07, 662608, 662911, 661110]; Croucher Foundation [CAS-CF07/08.SC03]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Croucher Foundation	This research was supported by grants from Research Grants Council of Hong Kong (N_HKUST629/07, 662608, 662911 to KWKT; 661110 to DTWL), Croucher Foundation (CAS-CF07/08.SC03) to KWKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Berndt N, 2010, CELL DEATH DIFFER, V17, P1795, DOI 10.1038/cdd.2010.63; Bi CWC, 2012, PLANTA MED, V78, P122, DOI 10.1055/s-0031-1280356; Bi CWC, 2010, PLANTA MED, V76, P1525, DOI 10.1055/s-0029-1241003; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Chan WK, 2000, CARDIOVASC RES, V46, P180, DOI 10.1016/S0008-6363(99)00423-X; Chen ZY, 1998, LIFE SCI, V63, P1983, DOI 10.1016/S0024-3205(98)00476-7; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Hasin T, 2011, BASIC RES CARDIOL, V106, P175, DOI 10.1007/s00395-010-0145-9; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; Higashi Y, 2002, AM J HYPERTENS, V15, P326, DOI 10.1016/S0895-7061(01)02317-2; Hink U, 2001, CIRC RES, V88, pE14; Hu QH, 2000, J BIOL CHEM, V275, P15749, DOI 10.1074/jbc.M000381200; Huang Y, 1999, BBA-GEN SUBJECTS, V1427, P322, DOI 10.1016/S0304-4165(99)00034-3; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Lan TH, 2011, BIOCHEM PHARMACOL, V82, P148, DOI 10.1016/j.bcp.2011.04.001; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Leber A, 1999, J BIOL CHEM, V274, P37658, DOI 10.1074/jbc.274.53.37658; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Leung KW, 2007, FEBS LETT, V581, P2423, DOI 10.1016/j.febslet.2007.04.055; Li JM, 2001, CARDIOVASC RES, V52, P477, DOI 10.1016/S0008-6363(01)00407-2; Li YB, 1998, J BIOL CHEM, V273, P2015, DOI 10.1074/jbc.273.4.2015; Ma ZC, 2010, BIOL PHARM BULL, V33, P29, DOI 10.1248/bpb.33.29; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Moens AL, 2008, CIRCULATION, V117, P1810, DOI 10.1161/CIRCULATIONAHA.107.725481; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Ohashi R, 2006, J SURG RES, V133, P89, DOI 10.1016/j.jss.2005.09.016; Shao M.L., 2010, PHARMACOPOEIA PEOP 1, P144; Stanger O, 2003, CLIN CHEM LAB MED, V41, P1444, DOI 10.1515/CCLM.2003.222; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Suzuki A, 2002, AM J HYPERTENS, V15, P351, DOI 10.1016/S0895-7061(01)02337-8; Suzuki A, 2007, AM J HYPERTENS, V20, P508, DOI 10.1016/j.amjhyper.2006.11.008; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Tang EHC, 2007, BRIT J PHARMACOL, V151, P15, DOI 10.1038/sj.bjp.0707190; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wang BH, 2004, J CARDIOVASC PHARM, V43, P549, DOI 10.1097/00005344-200404000-00010; Wong WT, 2011, CELL METAB, V14, P104, DOI 10.1016/j.cmet.2011.05.009; Wong WT, 2010, J CARDIOVASC PHARM, V55, P300, DOI 10.1097/FJC.0b013e3181d7671c; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	41	30	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51670	10.1371/journal.pone.0051670	http://dx.doi.org/10.1371/journal.pone.0051670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284736	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800013
J	Racke, FK; Baird, M; Barth, RF; Huo, TY; Yang, WL; Gupta, N; Weldon, M; Rutledge, H				Racke, Frederick K.; Baird, Maureen; Barth, Rolf F.; Huo, Tianyao; Yang, Weilian; Gupta, Nilendu; Weldon, Michael; Rutledge, Heather			Unique In Vitro and In Vivo Thrombopoietic Activities of Ingenol 3,20 Dibenzoate, A Ca++-Independent Protein Kinase C Isoform Agonist	PLOS ONE			English	Article							HUMAN MEGAKARYOCYTE GROWTH; ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTORS FLI-1; HUMAN BONE-MARROW; DOUBLE-BLIND; PHORBOL DIESTERS; PROGENITOR CELLS; FACTOR EKLF; K562 CELLS; DIFFERENTIATION	Thrombopoiesis following severe bone marrow injury frequently is delayed, thereby resulting in life-threatening thrombocytopenia for which there are limited treatment options. The reasons for these delays in recovery are not well understood. Protein kinase C (PKC) agonists promote megakaryocyte differentiation in leukemia cell lines and primary cells. However, little is known about the megakaryopoietic effects of PKC agonists on primary CD34+ cells grown in culture or in vivo. Here we present evidence that the novel PKC isoform-selective agonist 3,20 ingenol dibenzoate (IDB) potently stimulates early megakaryopoiesis of human CD34+ cells. In contrast, broad spectrum PKC agonists failed to do so. In vivo, a single intraperitoneal injection of IDB selectively increased platelets in mice without affecting hemoglobin or white counts. Finally, IDB strongly mitigated radiation-induced thrombocytopenia, even when administered 24 hours after irradiation. Our data demonstrate that novel PKC isoform agonists such as IDB may represent a unique therapeutic strategy for accelerating the recovery of platelet counts following severe marrow injury.	[Racke, Frederick K.; Baird, Maureen; Barth, Rolf F.; Huo, Tianyao; Yang, Weilian; Rutledge, Heather] Ohio State Univ, Dept Pathol, Sch Med, Columbus, OH 43210 USA; [Gupta, Nilendu; Weldon, Michael] Ohio State Univ, Sch Med, Dept Radiat Oncol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Racke, FK (corresponding author), Quest Diagnost, Capistrano, CA USA.	frederick.k.racke@questdiagnostics.com	Gupta, Nilendu/E-3171-2011	Gupta, Nilendu/0000-0003-0461-0570	Department of Pathology, The Ohio State University, Columbus, Ohio	Department of Pathology, The Ohio State University, Columbus, Ohio	Internal funds for this work were provided by the Department of Pathology, The Ohio State University, Columbus, Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Archimbaud E, 1999, BLOOD, V94, P3694, DOI 10.1182/blood.V94.11.3694.423k18_3694_3701; Baatout S, 1998, HEMATOL CELL THER, V40, P33; BARTLEY TD, 1994, CELL, V77, P1117, DOI 10.1016/0092-8674(94)90450-2; Bassini A, 1999, BLOOD, V93, P1178, DOI 10.1182/blood.V93.4.1178.404k28_1178_1188; Bouilloux F, 2008, BLOOD, V112, P576, DOI 10.1182/blood-2007-07-098996; Cejas PJ, 2005, J BIOL CHEM, V280, P28412, DOI 10.1074/jbc.M500345200; Clay D, 2001, BLOOD, V97, P1982, DOI 10.1182/blood.V97.7.1982; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DESAUVAGE FJ, 1994, NATURE, V369, P533, DOI 10.1038/369533a0; DRACHMAN JG, 1995, J BIOL CHEM, V270, P4979, DOI 10.1074/jbc.270.10.4979; Geissler K, 2003, ANN HEMATOL, V82, P677, DOI 10.1007/s00277-003-0737-7; Gobbi G, 2007, STEM CELLS, V25, P2322, DOI 10.1634/stemcells.2006-0839; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Hilton DJ, 2009, BLOOD; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Kaushansky K, 2000, LEUKEMIA, V14, P505, DOI 10.1038/sj.leu.2401620; Kruse EA, 2009, P NATL ACAD SCI USA, V106, P13814, DOI 10.1073/pnas.0906556106; LeNaour F, 1997, LEUKEMIA, V11, P1290, DOI 10.1038/sj.leu.2400721; LONG MW, 1984, J CLIN INVEST, V74, P1686, DOI 10.1172/JCI111585; LONG MW, 1985, J CLIN INVEST, V76, P431, DOI 10.1172/JCI111990; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; McCullough J, 2000, SEMIN HEMATOL, V37, P3, DOI 10.1016/S0037-1963(00)90047-7; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Myklebust JH, 2000, BLOOD, V95, P510, DOI 10.1182/blood.V95.2.510; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; PERKINS AC, 1995, NATURE, V375, P318; Pierce A, 1998, J CELL BIOL, V140, P1511, DOI 10.1083/jcb.140.6.1511; Racke F, 2004, ASH ANN M, V104, P1607; Racke FK, 1997, J BIOL CHEM, V272, P23366, DOI 10.1074/jbc.272.37.23366; Racke FK, 2001, J BIOL CHEM, V276, P522, DOI 10.1074/jbc.M005236200; Saito H, 1997, BAILLIERE CLIN HAEM, V10, P47, DOI 10.1016/S0950-3536(97)80050-9; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Schiffer CA, 2000, BLOOD, V95, P2530, DOI 10.1182/blood.V95.8.2530.008k31_2530_2535; St Louis DC, 1999, J IMMUNOL, V162, P3237; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Tallack MR, 2010, HAEMATOL-HEMATOL J, V95, P144, DOI 10.3324/haematol.2009.010017; Tewari R, 1998, EMBO J, V17, P2334, DOI 10.1093/emboj/17.8.2334; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Vitale M, 2006, EUR J HISTOCHEM, V50, P15; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947	45	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51059	10.1371/journal.pone.0051059	http://dx.doi.org/10.1371/journal.pone.0051059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284657	gold, Green Submitted, Green Published			2022-12-25	WOS:000313158800007
J	Mateus, R; Pereira, T; Sousa, S; de Lima, JE; Pascoal, S; Saude, L; Jacinto, A				Mateus, Rita; Pereira, Telmo; Sousa, Sara; de Lima, Joana Esteves; Pascoal, Susana; Saude, Leonor; Jacinto, Antonio			In Vivo Cell and Tissue Dynamics Underlying Zebrafish Fin Fold Regeneration	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; BLASTEMA FORMATION; GENE-EXPRESSION; FUSION PROTEIN; MORPHOGENESIS; DEDIFFERENTIATION; PROLIFERATION; MIGRATION; FILAMENTS	Background: Zebrafish (Danio rerio) has a remarkable capacity to regenerate many organs and tissues. During larval stages the fin fold allows the possibility of performing long time-lapse imaging making this system very appealing to study the relationships between tissue movements, cell migration and proliferation necessary for the regeneration process. Results: Through the combined use of transgenic fluorescently-labeled animals and confocal microscopy imaging, we characterized in vivo the complete fin fold regeneration process. We show, for the first time, that there is an increase in the global rate of epidermal growth as a response to tissue loss. Also enhanced significantly is cell proliferation, which upon amputation happens in a broad area concerning the amputation level and not in a blastema-restricted way. This reveals a striking difference with regard to the adult fin regeneration system. Finally, an accumulation of migratory, shape-changing fibroblasts occurs proximally to the wound area, resembling a blastemal-like structure, which may act as a signaling center for the regeneration process to proceed. Conclusions: These findings provide a novel in vivo description of fundamental mechanisms occurring during the fin fold regeneration process, thereby contributing to a better knowledge of this regenerative system and to reveal variations in the epimorphic regeneration field.	[Mateus, Rita; Pereira, Telmo; Sousa, Sara; de Lima, Joana Esteves; Pascoal, Susana; Saude, Leonor; Jacinto, Antonio] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal; [Sousa, Sara] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Programme Expt Biol & Biomed PDBEB 5, Coimbra, Portugal; [Mateus, Rita; Pereira, Telmo; Saude, Leonor; Jacinto, Antonio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Mateus, Rita; Pereira, Telmo; Jacinto, Antonio] Fac Ciencias Med, Ctr Estudos Doencas Cron, Lisbon, Portugal	Universidade de Lisboa; Universidade de Coimbra; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa	Jacinto, A (corresponding author), Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal.	antonio.jacinto@fcm.unl.pt	Mateus, Rita/V-6535-2019; Saúde, Leonor/D-2720-2012; Jacinto, Antonio/F-5729-2013; Mateus, Rita/GSN-1922-2022	Mateus, Rita/0000-0002-6023-3880; Saúde, Leonor/0000-0001-5933-8872; Jacinto, Antonio/0000-0002-4193-6089; Esteves de Lima, Joana/0000-0002-5497-5669; Sousa, Sara/0000-0001-5479-0325; Pascoal, Susana/0000-0002-2294-8084; Pereira, Telmo/0000-0002-6903-9187	Fundacao para a Ciencia e Tecnologia (FCT), Portugal; FCT; European Research Council [2007-StG-208631]	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	RM, TP and SS receive PhD grants from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. SP receives a post-doctoral grant from FCT. The research presented in this manuscript was partially funded by an European Research Council Starting Grant (2007-StG-208631). The funders had no role in study design; data collection, analysis, and interpretation; decision to publish, or preparation of the manuscript.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Campbell LJ, 2008, CELL MOL LIFE SCI, V65, P73, DOI 10.1007/s00018-007-7433-z; Campbell LJ, 2011, DEV DYNAM, V240, P1826, DOI 10.1002/dvdy.22669; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; DANE PJ, 1985, J EMBRYOL EXP MORPH, V87, P145; Danjo Y, 1998, J CELL SCI, V111, P3323; Duran I, 2011, DEV BIOL, V354, P160, DOI 10.1016/j.ydbio.2011.03.014; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Feitosa NM, 2012, DEV BIOL, V369, P235, DOI 10.1016/j.ydbio.2012.06.023; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Ishida T, 2010, DEV BIOL, V340, P468, DOI 10.1016/j.ydbio.2010.01.036; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Kawakami A, 2010, DEV GROWTH DIFFER, V52, P77, DOI 10.1111/j.1440-169X.2009.01138.x; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lee Y, 2009, DEV BIOL, V331, P270, DOI 10.1016/j.ydbio.2009.05.545; MacManus CF, 2006, WOUND REPAIR REGEN, V14, P61, DOI 10.1111/j.1524-475X.2005.00089.x; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Morgan TH, 1901, SCIENCE, V14, P235, DOI 10.1126/science.14.346.235; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Pittlik S, 2012, DEV DYNAM, V241, P1205, DOI 10.1002/dvdy.23805; Quesada-Hernandez E, 2010, CURR BIOL, V20, P1966, DOI 10.1016/j.cub.2010.10.009; Santos-Ruiz L, 2002, DEV DYNAM, V223, P262, DOI 10.1002/dvdy.10055; Sepich DS, 2011, DEVELOPMENT, V138, P543, DOI 10.1242/dev.053959; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Sousa S, 2011, DEVELOPMENT, V138, P3897, DOI 10.1242/dev.064717; Sugiyama M, 2009, P NATL ACAD SCI USA, V106, P20812, DOI 10.1073/pnas.0906464106; WOOD A, 1984, J CELL SCI, V66, P205; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Zhang JX, 2010, PROCEEDINGS OF THE 1ST INTERNATIONAL CONFERENCE ON SUSTAINABLE CONSTRUCTION & RISK MANAGEMENT, VOLS I AND II, P1; Zigman M, 2011, CURR BIOL, V21, P79, DOI 10.1016/j.cub.2010.12.005	38	36	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51766	10.1371/journal.pone.0051766	http://dx.doi.org/10.1371/journal.pone.0051766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284763	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500044
J	Meihls, LN; Higdon, ML; Ellersieck, MR; Tabashnik, BE; Hibbard, BE				Meihls, Lisa N.; Higdon, Matthew L.; Ellersieck, Mark R.; Tabashnik, Bruce E.; Hibbard, Bruce E.			Greenhouse-Selected Resistance to Cry3Bb1-Producing Corn in Three Western Corn Rootworm Populations	PLOS ONE			English	Article							VIRGIFERA-VIRGIFERA COLEOPTERA; FIELD-EVOLVED RESISTANCE; TO-PLANT MOVEMENT; INSECT RESISTANCE; TRANSGENIC CORN; BACILLUS-THURINGIENSIS; FITNESS COSTS; BT MAIZE; LABORATORY COLONIES; LARVAE COLEOPTERA	Transgenic corn producing the Bacillus thuringiensis (Bt) toxin Cry3Bb1 has been useful for controlling western corn rootworm, Diabrotica virgifera virgifera LeConte, one of the most economically important crop pests in the United States. However, rapid evolution of resistance by this beetle to Bt corn producing Cry3Bb1 has been reported previously from the laboratory, greenhouse, and field. Here we selected in the greenhouse for resistance to Cry3Bb1 corn in three colonies of WCR derived from Kansas, Minnesota, and Wisconsin, respectively. Three generations of rearing on Cry3Bb1 corn significantly increased larval survival on Cry3Bb1 corn, resulting in similar survival in the greenhouse for selected colonies on Cry3Bb1 corn and isoline corn that does not produce Bt toxin. After four to seven generations of rearing on Cry3Bb1 corn, survival in the field on Cry3Bb1 corn relative to isoline corn more than doubled for selected colonies (72%) compared with control colonies (33%). For both selected and control colonies, survival in the field was significantly lower on Cry3Bb1 corn than on isoline corn. On isoline corn, most fitness components were similar for selected colonies and control colonies. However, fecundity was significantly lower for selected colonies than control colonies, indicating a fitness cost associated with resistance. The rapid evolution of resistance by western corn rootworm to Bt corn reported here and previously underlines the importance of effective resistance management for this pest.	[Meihls, Lisa N.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Higdon, Matthew L.; Hibbard, Bruce E.] ARS, USDA, Plant Genet Res Unit, Columbia, MO USA; [Ellersieck, Mark R.] Univ Missouri Columbia, Dept Stat, Columbia, MO USA; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Arizona	Meihls, LN (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	lnm2m9@mail.missouri.edu		Hibbard, Bruce/0000-0001-8067-4416	Biotechnology Risk Assessment Program from USDA National Institute of Food and Agriculture [2006-33522-17716]; USDA-ARS; University of Missouri-Division of Plant Sciences	Biotechnology Risk Assessment Program from USDA National Institute of Food and Agriculture; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); University of Missouri-Division of Plant Sciences	This research was supported, in part, by Biotechnology Risk Assessment Program Grant no. 2006-33522-17716 from the USDA National Institute of Food and Agriculture, USDA-ARS, and the University of Missouri-Division of Plant Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyokhin A, 2011, NAT BIOTECHNOL, V29, P577, DOI 10.1038/nbt.1911; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; BRANSON TF, 1976, ENTOMOL EXP APPL, V19, P148, DOI 10.1007/BF00345776; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Clark TL, 2012, J APPL ENTOMOL, V136, P721, DOI 10.1111/j.1439-0418.2012.01709.x; Crowder DW, 2006, J ECON ENTOMOL, V99, P899, DOI 10.1603/0022-0493-99.3.899; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Environmental Protection Agency, 2011, BIOP REG ACT DOC BT1; Environmental Protection Agency, 2007, PEST FACT SHEET MOD; Environmental Protection Agency, 2009, PEST FACT SHEET MON; Environmental Protection Agency, 2005, EPA PUBL; Environmental Protection Agency, 2011, 2009 RES MON REV CRY; Environmental Protection Agency, 2011, BIOP REG ACT DOC MON; Environmental Protection Agency, 2005, FED REGISTER, V70, P17323; Environmental Protection Agency, 2010, BIOP REG ACT DOC OPT; Gassmann Aaron J, 2012, GM Crops Food, V3, P235, DOI 10.4161/gmcr.20744; Gassmann AJ, 2012, J INVERTEBR PATHOL, V110, P287, DOI 10.1016/j.jip.2012.04.006; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 2006, J ECON ENTOMOL, V99, P2091, DOI 10.1603/0022-0493-99.6.2091; Gray ME, 2012, B U ILLINOIS EXTENSI, V20; Hibbard BE, 2005, J ECON ENTOMOL, V98, P1126, DOI 10.1603/0022-0493-98.4.1126; Hibbard BE, 2004, J ECON ENTOMOL, V97, P871, DOI 10.1603/0022-0493(2004)097[0871:ROEDOE]2.0.CO;2; Jackson J.J., 1985, P237; JACKSON JJ, 1988, ENVIRON ENTOMOL, V17, P166, DOI 10.1093/ee/17.2.166; Kang J, 2009, J ECON ENTOMOL, V102, P2096, DOI 10.1603/029.102.0612; Kim KS, 2007, ENVIRON ENTOMOL, V36, P637, DOI 10.1603/0046-225X(2007)36[637:GDILCO]2.0.CO;2; KIRK VM, 1968, J ECON ENTOMOL, V61, P1322, DOI 10.1093/jee/61.5.1322; Kruger M, 2012, J APPL ENTOMOL, V136, P38, DOI 10.1111/j.1439-0418.2011.01616.x; Lefko SA, 2008, J APPL ENTOMOL, V132, P189, DOI 10.1111/j.1439-0418.2008.01279.x; LUTTRELL RG, 2004, 2004 BELTW COTT C SA, P1373; Malaeb ZA, 1997, ENVIRON MONIT ASSESS, V47, P255, DOI 10.1023/A:1005798521296; Meihls LN, 2011, J ECON ENTOMOL, V104, P1045, DOI 10.1603/EC10320; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Monsanto, 2009, MONS BIOT TRAIT ACR; Murphy AF, 2010, J ECON ENTOMOL, V103, P147, DOI 10.1603/EC09156; Oleson JD, 2005, J ECON ENTOMOL, V98, P1, DOI 10.1603/0022-0493-98.1.1; Onstad DW, 2010, J ECON ENTOMOL, V103, P849, DOI 10.1603/EC09199; Onstad DW, 2001, J ECON ENTOMOL, V94, P529, DOI 10.1603/0022-0493-94.2.529; Oswald KJ, 2012, J APPL ENTOMOL, V136, P730, DOI 10.1111/j.1439-0418.2012.01704.x; Oswald KJ, 2011, J ECON ENTOMOL, V104, P1038, DOI 10.1603/EC10312; Oyediran IO, 2005, J ECON ENTOMOL, V98, P1679, DOI 10.1603/0022-0493-98.5.1679; Petzold-Maxwell JL, 2012, J ECON ENTOMOL, V105, P1407, DOI 10.1603/EC11425; Porter P, 2012, COMMUNICATION   0305; Ritchie W. W., 1992, 48 COOP EXT SERV; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; SAS, 2004, SAS VERS 931; SCHAAFSMA AW, 1991, CAN ENTOMOL, V123, P1183, DOI 10.4039/Ent1231183-6; Snedecor G.W., 1989, AMES IOWA STATE U PR; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2012, J ECON ENTOMOL, V105, P767, DOI 10.1603/EC12080; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Tabashnik BE, 2008, P NATL ACAD SCI USA, V105, P19029, DOI 10.1073/pnas.0810763106; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Zhao JZ, 2005, P NATL ACAD SCI USA, V102, P8426, DOI 10.1073/pnas.0409324102	59	44	44	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51055	10.1371/journal.pone.0051055	http://dx.doi.org/10.1371/journal.pone.0051055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284656	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500020
J	Cheeseman, MT; Vowell, K; Hough, TA; Jones, L; Pathak, P; Tyrer, HE; Kelly, M; Cox, R; Warren, MV; Peters, J				Cheeseman, Michael T.; Vowell, Kate; Hough, Tertius A.; Jones, Lynn; Pathak, Paras; Tyrer, Hayley E.; Kelly, Michelle; Cox, Roger; Warren, Madhuri V.; Peters, Jo			A Mouse Model for Osseous Heteroplasia	PLOS ONE			English	Article							ALBRIGHT-HEREDITARY-OSTEODYSTROPHY; PROTEIN ALPHA-SUBUNIT; STIMULATORY G-PROTEIN; PSEUDOHYPOPARATHYROIDISM TYPE 1A; IMPRINTING CONTROL REGION; G(S)ALPHA GENE GNAS1; HETEROTOPIC OSSIFICATION; INACTIVATING MUTATIONS; EXTRASKELETAL OSSIFICATION; HORMONE RESISTANCE	GNAS/Gnas encodes G(s)alpha that is mainly biallelically expressed but shows imprinted expression in some tissues. In Albright Hereditary Osteodystrophy (AHO) heterozygous loss of function mutations of GNAS can result in ectopic ossification that tends to be superficial and attributable to haploinsufficiency of biallelically expressed G(s)alpha. Oed-Sml is a point missense mutation in exon 6 of the orthologous mouse locus Gnas. We report here both the late onset ossification and occurrence of benign cutaneous fibroepithelial polyps in Oed-Sml. These phenotypes are seen on both maternal and paternal inheritance of the mutant allele and are therefore due to an effect on biallelically expressed G(s)alpha. The ossification is confined to subcutaneous tissues and so resembles the ossification observed with AHO. Our mouse model is the first with both subcutaneous ossification and fibroepithelial polyps related to G(s)alpha deficiency. It is also the first mouse model described with a clinically relevant phenotype associated with a point mutation in G(s)alpha and may be useful in investigations of the mechanisms of heterotopic bone formation. Together with earlier results, our findings indicate that G(s)alpha signalling pathways play a vital role in repressing ectopic bone formation.	[Cheeseman, Michael T.; Tyrer, Hayley E.; Kelly, Michelle; Cox, Roger; Peters, Jo] Med Res Council Harwell, Mammalian Genet Unit, Harwell, Oxon, England; [Cheeseman, Michael T.; Vowell, Kate; Hough, Tertius A.; Jones, Lynn; Pathak, Paras] Med Res Council Harwell, Mary Lyon Ctr, Harwell, Oxon, England; [Warren, Madhuri V.] Pathol Diagnost Ltd, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Cheeseman, MT (corresponding author), Med Res Council Harwell, Mammalian Genet Unit, Harwell, Oxon, England.	m.cheeseman@har.mrc.ac.uk		Cox, Roger/0000-0001-7170-5014; Tyrer, Hayley/0000-0002-4447-828X	Medical Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969] Funding Source: researchfish; Medical Research Council [MC_U142636336, MC_UP_1502/1, MC_U142670371] Funding Source: researchfish; BBSRC [BBS/E/D/20251969] Funding Source: UKRI; MRC [MC_UP_1502/1, MC_U142670371, MC_U142636336] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All co-authors with the exception of MVM are core funded by the Medical Research Council. (www.mrc.ac.uk/). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbite NS, 2008, AM J MED GENET A, V146A, P1788, DOI 10.1002/ajmg.a.32346; Ahmed SF, 1998, CLIN ENDOCRINOL, V49, P525, DOI 10.1046/j.1365-2265.1998.00572.x; Ahrens W, 2001, J CLIN ENDOCR METAB, V86, P4630, DOI 10.1210/jc.86.10.4630; Aldred MA, 2000, HUM MUTAT, V16, P183, DOI 10.1002/1098-1004(200009)16:3<183::AID-HUMU1>3.0.CO;2-L; Alvarez F, 2010, J EUR ACAD DERMATOL, V24, P974, DOI 10.1111/j.1468-3083.2009.03539.x; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; Bastepe M, 2005, HORM RES, V63, P65, DOI 10.1159/000083895; Burtis CA, 2005, TIETZ TXB CLIN CHEM; Castrop H, 2007, CELL TISSUE RES, V330, P487, DOI 10.1007/s00441-007-0491-6; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; CRAWFORD JA, 1993, J BIOL CHEM, V268, P9879; DAVIES SJ, 1993, J MED GENET, V30, P101, DOI 10.1136/jmg.30.2.101; de Sanctis L, 2004, J CLIN ENDOCR METAB, V89, P1650, DOI 10.1210/jc.2003-030850; Eddy MC, 2000, J BONE MINER RES, V15, P2074, DOI 10.1359/jbmr.2000.15.11.2074; Faust RA, 2003, AM J MED GENET A, V118A, P71, DOI 10.1002/ajmg.a.10170; Frohlich LF, 2010, P NATL ACAD SCI USA, V107, P9275, DOI 10.1073/pnas.0910224107; Garavelli Livia, 2005, Acta Biomed, V76, P45; Gelfand IM, 2006, J PEDIATR-US, V149, P877, DOI 10.1016/j.jpeds.2006.08.050; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hudson J, 2000, J MED GENET, V37, pS79, DOI 10.1136/jmg.37.11.e35; Huso DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021755; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Kacerovska D, 2008, AM J DERMATOPATH, V30, P417, DOI 10.1097/DAD.0b013e318180ec0e; KAPLAN FS, 1994, J BONE JOINT SURG AM, V76A, P425, DOI 10.2106/00004623-199403000-00013; Kelly ML, 2009, INT J OBESITY, V33, P507, DOI 10.1038/ijo.2009.30; Klagge A, 2010, EXP CLIN ENDOCR DIAB, V118, P586, DOI 10.1055/s-0029-1237708; Klemke M, 2000, J BIOL CHEM, V275, P33633, DOI 10.1074/jbc.M006594200; Lebrun M, 2010, J CLIN ENDOCR METAB, V95, P3028, DOI 10.1210/jc.2009-1451; Linglart A, 2002, J CLIN ENDOCR METAB, V87, P189, DOI 10.1210/jc.87.1.189; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Long DN, 2007, J CLIN ENDOCR METAB, V92, P1073, DOI 10.1210/jc.2006-1497; McKee PH, 2006, PATHOLOGY SKIN CLIN; Nwosu BU, 2009, NAT REV ENDOCRINOL, V5, P345, DOI 10.1038/nrendo.2009.81; Pasolli HA, 2000, J BIOL CHEM, V275, P33622, DOI 10.1074/jbc.M001335200; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Peters J, 2007, EPIGENETICS, V2, P207, DOI 10.4161/epi.2.4.5380; Pignolo RJ, 2011, J BONE MINER RES, V26, P2647, DOI 10.1002/jbmr.481; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Plagge A, 2005, MOL CELL BIOL, V25, P3019, DOI 10.1128/MCB.25.8.3019-3026.2005; Pohlenz J, 2003, EUR J ENDOCRINOL, V148, P463, DOI 10.1530/eje.0.1480463; Riepe FG, 2005, EUR J ENDOCRINOL, V152, P515, DOI 10.1530/eje.1.01879; Sakamoto A, 2009, ENDOCR RES, V34, P1, DOI 10.1080/07435800902841280; SCHWINDINGER WF, 1994, J BIOL CHEM, V269, P25387; Shapira H, 1996, HUM GENET, V97, P73; Shore EM, 2002, NEW ENGL J MED, V346, P99, DOI 10.1056/NEJMoa011262; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Warner DR, 1998, J BIOL CHEM, V273, P23976, DOI 10.1074/jbc.273.37.23976; Warner DR, 1997, MOL ENDOCRINOL, V11, P1718, DOI 10.1210/me.11.11.1718; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; WEINSTEIN LS, 1990, P NATL ACAD SCI USA, V87, P8287, DOI 10.1073/pnas.87.21.8287; WEINSTEIN LS, 1992, GENOMICS, V13, P1319, DOI 10.1016/0888-7543(92)90056-X; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; WILSON LC, 1994, J MED GENET, V31, P779, DOI 10.1136/jmg.31.10.779; WILSON LC, 1994, J MED GENET, V31, P835, DOI 10.1136/jmg.31.11.835; Xie T, 2006, J BIOL CHEM, V281, P18989, DOI 10.1074/jbc.M511752200; Yeh GL, 2000, J BONE MINER RES, V15, P2063, DOI 10.1359/jbmr.2000.15.11.2063; Yu DW, 1999, J CLIN ENDOCR METAB, V84, P3254, DOI 10.1210/jc.84.9.3254; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	65	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51835	10.1371/journal.pone.0051835	http://dx.doi.org/10.1371/journal.pone.0051835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284784	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000312694300050
J	Decker, WK; Shah, N; Xing, DX; Lapushin, R; Li, SF; Robinson, SN; Yang, H; Parmar, S; Halpert, MM; Keating, MJ; Gribben, JG; Molldrem, JJ; Shpall, EJ; Wierda, WG				Decker, William K.; Shah, Nina; Xing, Dongxia; Lapushin, Ruth; Li, Sufang; Robinson, Simon N.; Yang, Hong; Parmar, Simrit; Halpert, Matthew M.; Keating, Michael J.; Gribben, John G.; Molldrem, Jeffrey J.; Shpall, Elizabeth J.; Wierda, William G.			Generation of Functional CLL-Specific Cord Blood CTL Using CD40-Ligated CLL APC	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; IMMUNOLOGICAL SYNAPSE FORMATION; GRAFT-VERSUS-LEUKEMIA; ALLOREACTIVE T-CELLS; CLASS-I; B-CLL; THERAPY; IMMUNODEFICIENCY; IMMUNOTHERAPY	Though remissions have been observed following allo-HSCT for the treatment of CLL, many CLL patients are ineligible for transplant due to the lack of HLA-compatible donors. The use of umbilical cord blood (UCB) permits transplantation of many patients who lack HLA-compatible donors due to reduced requirements for stringent HLA matching between graft and recipient; however, disease relapse remains a concern with this modality. The generation of CLL-specific CTL from UCB T-cells, primed and expanded against the leukemic clone, might enhance the GVL effect and improve outcomes with UCB transplantation. Here we report the generation of functional, CLL-specific CTL using CD40-ligated CLL cells to prime partially-HLA matched UCB T-cells. Functionality and specificity were demonstrated by immune synapse assay, IFN-gamma ELISpot, multi-parametric intracellular cytokine flow cytometry, and Cr-51 release assay. The use of patient-specific, non-CLL controls demonstrated the generation of both alloantigen and CLL-specific responses. Subsequently, we developed a clinically-applicable procedure permitting separation of alloreactive CTL from leukemia-specific CTL. Leukemia-specific CTL were able to mediate in vivo killing of CLL in humanized mice without concurrent or subsequent development of xenoGVHD. Our results demonstrate that generation of CLL-specific effectors from UCB is feasible and practical, and the results support further exploration of this strategy as a treatment modality for CLL.	[Decker, William K.; Halpert, Matthew M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Shah, Nina; Xing, Dongxia; Li, Sufang; Robinson, Simon N.; Yang, Hong; Parmar, Simrit; Molldrem, Jeffrey J.; Shpall, Elizabeth J.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Lapushin, Ruth; Keating, Michael J.; Wierda, William G.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Gribben, John G.] Barts & London Queen Marys Sch Med & Dent, Inst Canc, London, England	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of London; Queen Mary University London	Decker, WK (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	decker@bcm.edu		Shiku, Hiroshi/0000-0002-0362-755X	CLL Global Alliance; NATIONAL CANCER INSTITUTE [P50CA100632, P01CA081534] Funding Source: NIH RePORTER	CLL Global Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant from the CLL Global Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Bagnara D, 2011, BLOOD, V117, P5463, DOI 10.1182/blood-2010-12-324210; Ben-Bassat I, 2007, BONE MARROW TRANSPL, V39, P441, DOI 10.1038/sj.bmt.1705619; Chen JZ, 2008, CANCER BIOL THER, V7, P174, DOI 10.4161/cbt.7.2.5262; Decker WK, 2006, VACCINE, V24, P3203, DOI 10.1016/j.vaccine.2006.01.029; Dilloo D, 1997, BLOOD, V90, P1927, DOI 10.1182/blood.V90.5.1927; Gribben JG, 2005, BLOOD, V106, P4389, DOI 10.1182/blood-2005-05-1778; Gribben JG, 2009, BIOL BLOOD MARROW TR, V15, P53, DOI 10.1016/j.bbmt.2008.10.022; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Hamblin AD, 2008, BRIT MED BULL, V87, P49, DOI 10.1093/bmb/ldn034; Hoogendoorn M, 2004, LEUKEMIA, V18, P1278, DOI 10.1038/sj.leu.2403358; Hus I, 2005, LEUKEMIA, V19, P1621, DOI 10.1038/sj.leu.2403860; Kater AP, 2004, BRIT J HAEMATOL, V126, P512, DOI 10.1111/j.1365-2141.2004.05070.x; Kater AP, 2007, BLOOD, V110, P2811, DOI 10.1182/blood-2007-01-068932; Kato K, 1998, J CLIN INVEST, V101, P1133, DOI 10.1172/JCI1472; Khouri IF, 2004, EXP HEMATOL, V32, P28, DOI 10.1016/j.exphem.2003.09.021; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; Le Dieu R, 2006, SEMIN ONCOL, V33, P220, DOI 10.1053/j.seminoncol.2005.12.012; Martins SLR, 2004, BLOOD, V104, P3429, DOI 10.1182/blood-2004-05-1918; Mavroudis DA, 1998, BRIT J HAEMATOL, V101, P565; Mayr C, 2005, BLOOD, V106, P3223, DOI 10.1182/blood-2005-04-1742; McClune BL, 2012, BRIT J HAEMATOL, V156, P273, DOI 10.1111/j.1365-2141.2011.08842.x; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Miscia S, 1999, J IMMUNOL, V163, P2416; Mous R, 2006, LEUKEMIA, V20, P1096, DOI 10.1038/sj.leu.2404185; Nabhan C, 2008, LEUKEMIA RES, V32, P679, DOI 10.1016/j.leukres.2007.11.002; Nishida T, 2009, CLIN CANCER RES, V15, P4759, DOI 10.1158/1078-0432.CCR-09-0199; Parmar S, 2006, CYTOTHERAPY, V8, P149, DOI 10.1080/14653240600620812; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Ramsay AG, 2008, BLOOD, V112, p2333a; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Ritgen M, 2008, LEUKEMIA, V22, P1377, DOI 10.1038/leu.2008.96; Rodrigues CA, 2009, J CLIN ONCOL, V27, P256, DOI 10.1200/JCO.2007.15.8865; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; Samarasinghe S, 2010, BLOOD, V115, P396, DOI 10.1182/blood-2009-08-235895; Schmidt SM, 2003, BLOOD, V102, P571, DOI 10.1182/blood-2002-08-2554; Shah N, 2011, LEUKEMIA, V25, P1036, DOI 10.1038/leu.2011.30; Trojan A, 2000, NAT MED, V6, P667, DOI 10.1038/76243; Wierda WG, 2000, BLOOD, V96, P2917; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015; Xing DX, 2010, J IMMUNOTHER, V33, P684, DOI 10.1097/CJI.0b013e3181e475e9	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51390	10.1371/journal.pone.0051390	http://dx.doi.org/10.1371/journal.pone.0051390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284688	Green Published, gold			2022-12-25	WOS:000312694300024
J	Kennedy, DM; Stanton, JAL; Garcia, JA; Mason, C; Rand, CJ; Kieser, JA; Tompkins, GR				Kennedy, Darnell M.; Stanton, Jo-Ann L.; Garcia, Jose A.; Mason, Chris; Rand, Christy J.; Kieser, Jules A.; Tompkins, Geoffrey R.			Microbial Analysis of Bite Marks by Sequence Comparison of Streptococcal DNA	PLOS ONE			English	Article							VIRIDANS GROUP STREPTOCOCCI; INTERGENIC SPACER REGION; PHYLOGENETIC-RELATIONSHIPS; ORAL STREPTOCOCCI; IDENTIFICATION; MITIS; DIVERSITY; BITEMARKS; LOCATION; DYNAMICS	Bite mark injuries often feature in violent crimes. Conventional morphometric methods for the forensic analysis of bite marks involve elements of subjective interpretation that threaten the credibility of this field. Human DNA recovered from bite marks has the highest evidentiary value, however recovery can be compromised by salivary components. This study assessed the feasibility of matching bacterial DNA sequences amplified from experimental bite marks to those obtained from the teeth responsible, with the aim of evaluating the capability of three genomic regions of streptococcal DNA to discriminate between participant samples. Bite mark and teeth swabs were collected from 16 participants. Bacterial DNA was extracted to provide the template for PCR primers specific for streptococcal 16S ribosomal RNA (16S rRNA) gene, 16S-23S intergenic spacer (ITS) and RNA polymerase beta subunit (rpoB). High throughput sequencing (GS FLX 454), followed by stringent quality filtering, generated reads from bite marks for comparison to those generated from teeth samples. For all three regions, the greatest overlaps of identical reads were between bite mark samples and the corresponding teeth samples. The average proportions of reads identical between bite mark and corresponding teeth samples were 0.31, 0.41 and 0.31, and for non-corresponding samples were 0.11, 0.20 and 0.016, for 16S rRNA, ITS and rpoB, respectively. The probabilities of correctly distinguishing matching and non-matching teeth samples were 0.92 for ITS, 0.99 for 16S rRNA and 1.0 for rpoB. These findings strongly support the tenet that bacterial DNA amplified from bite marks and teeth can provide corroborating information in the identification of assailants.	[Kennedy, Darnell M.; Kieser, Jules A.; Tompkins, Geoffrey R.] Univ Otago, Sch Dent, Sir John Walsh Res Inst, Dunedin, New Zealand; [Kennedy, Darnell M.; Stanton, Jo-Ann L.; Mason, Chris; Rand, Christy J.] Univ Otago, Dept Anat, Dunedin, New Zealand; [Garcia, Jose A.] Univ Otago, Dept Preventat & Social Med, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Tompkins, GR (corresponding author), Univ Otago, Sch Dent, Sir John Walsh Res Inst, Dunedin, New Zealand.	geoffrey.tompkins@otago.ac.nz	Stanton, Jo-Ann L/C-6621-2009; Athens, Josie/Q-7172-2018	Stanton, Jo-Ann L/0000-0001-8139-4694; Athens, Josie/0000-0002-9897-0683; Rand, Christy/0000-0003-1617-6089	New Zealand Dental Research Foundation, Ministry of Science and Innovation; New Economy Research Fund [UOOX0809]	New Zealand Dental Research Foundation, Ministry of Science and Innovation; New Economy Research Fund	Funding came from the New Zealand Dental Research Foundation, Ministry of Science and Innovation and the New Economy Research Fund (UOOX0809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Al-Talabani N, 2006, J FORENSIC SCI, V51, P1372, DOI 10.1111/j.1556-4029.2006.00265.x; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Bek-Thomsen M, 2008, INFECT IMMUN, V76, P1889, DOI 10.1128/IAI.01511-07; Borgula L M, 2003, J Forensic Odontostomatol, V21, P23; Chen CC, 2004, J CLIN MICROBIOL, V42, P2651, DOI 10.1128/JCM.42.6.2651-2657.2004; Clement JG, 2010, FORENSIC SCI INT, V201, P33, DOI 10.1016/j.forsciint.2010.03.006; Dekio I, 2005, J MED MICROBIOL, V54, P1231, DOI 10.1099/jmm.0.46075-0; Drancourt M, 2004, J CLIN MICROBIOL, V42, P497, DOI 10.1128/JCM.42.2.497-504.2004; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Ellner PD, 2006, BIOMEDICAL SCI EXPER; Fitzsimmons S, 1996, CLIN DIAGN LAB IMMUN, V3, P517, DOI 10.1128/CDLI.3.5.517-522.1996; Freeman AJ, 2005, J FORENSIC SCI, V50, P1436; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Glazunova OO, 2009, INT J SYST EVOL MICR, V59, P2317, DOI 10.1099/ijs.0.005488-0; Hardie JM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P76, DOI 10.1007/0-387-30744-3_2; Hassan AA, 2003, SYST APPL MICROBIOL, V26, P97, DOI 10.1078/072320203322337371; Herschaft EE, 2007, MANUAL FORENSIC ODON; Hohwy J, 2001, INFECT IMMUN, V69, P6055, DOI 10.1128/IAI.69.10.6055-6063.2001; Hoshino T, 2005, PEDIATR DENT J, V15, P185, DOI 10.1016/S0917-2394(05)70051-3; Hsu L, 2012, CURR MICROBIOL, V65, P207, DOI 10.1007/s00284-012-0148-x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Innings A, 2005, J CLIN MICROBIOL, V43, P5983, DOI 10.1128/JCM.43.12.5983-5991.2005; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Kieser J, 2005, FOREN PATHOL REV, V3, P157, DOI 10.1007/978-1-59259-910-3_4; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Kirkwood B. R., 2003, MED STAT; Marsh P, 1999, ORAL MICROBIOLOGY, V4th; Mercer DK, 1999, APPL ENVIRON MICROB, V65, P6; Mora D, 2003, MICROBIOL-SGM, V149, P807, DOI 10.1099/mic.0.25925-0; NADANO D, 1993, CLIN CHEM, V39, P448; National Academy of Sciences, 2009, STRENGTHENING FORENS; NYVAD B, 1987, SCAND J DENT RES, V95, P369; PEARCE C, 1995, J MED MICROBIOL, V42, P67, DOI 10.1099/00222615-42-1-67; Plourd GJ, 2009, P AM ACAD FORENSIC S, P257; Pretty IA, 2001, SCI JUSTICE, V41, P85, DOI 10.1016/S1355-0306(01)71859-X; Pretty IA, 2000, J FORENSIC SCI, V45, P812; Pretty IA, 2005, FORENSIC SCI SER D, P547; Pretty IA, 2006, FORENSIC SCI INT, V159, pS110, DOI 10.1016/j.forsciint.2006.02.033; Pretty IA, 2010, FORENSIC SCI INT, V201, P38, DOI 10.1016/j.forsciint.2010.04.004; Rahimi M, 2005, J APPL MICROBIOL, V99, P1265, DOI 10.1111/j.1365-2672.2005.02703.x; ROTHWELL BR, 1995, J AM DENT ASSOC, V126, P223, DOI 10.14219/jada.archive.1995.0149; RUDNEY JD, 1994, J CLIN MICROBIOL, V32, P437, DOI 10.1128/JCM.32.2.437-443.1994; Rudney JD, 2003, ARCH ORAL BIOL, V48, P475, DOI 10.1016/S0003-9969(03)00043-8; SOCRANSKY SS, 1977, J PERIODONTAL RES, V12, P90, DOI 10.1111/j.1600-0765.1977.tb00112.x; Tapp J, 2003, INT J SYST EVOL MICR, V53, P1861, DOI 10.1099/ijs.0.02639-0; TENJO E, 1993, ELECTROPHORESIS, V14, P1042, DOI 10.1002/elps.11501401166; Truong TL, 2000, J MED MICROBIOL, V49, P63, DOI 10.1099/0022-1317-49-1-63; Whiley RA, 1998, ORAL MICROBIOL IMMUN, V13, P195, DOI 10.1111/j.1399-302X.1998.tb00698.x; Wisplinghoff H, 1999, J CLIN MICROBIOL, V37, P1876, DOI 10.1128/JCM.37.6.1876-1880.1999	51	7	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51757	10.1371/journal.pone.0051757	http://dx.doi.org/10.1371/journal.pone.0051757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284761	Green Submitted, Green Published, gold			2022-12-25	WOS:000312694300041
J	Li, A; Song, TL; Wang, F; Liu, DY; Fan, ZP; Zhang, CM; He, JQ; Wang, SL				Li, Ang; Song, Tieli; Wang, Fu; Liu, Dayong; Fan, Zhipeng; Zhang, Chunmei; He, Junqi; Wang, Songlin			MicroRNAome and Expression Profile of Developing Tooth Germ in Miniature Pigs	PLOS ONE			English	Article							GENE-EXPRESSION; MODEL; DIFFERENTIATION; IDENTIFICATION; TRANSCRIPTOME; MORPHOGENESIS; PREDICTION; DISCOVERY; ABUNDANCE; IDENTITY	MicroRNAs (miRNAs) play important roles in the regulation of rodent tooth development, but little is known about their role in tooth development in large mammals. We identified 637 unique miRNA sequences in a large-scale screen for miRNA expression profiles in the developing lower deciduous molars of miniature pigs (Sus scrofa) using Illumina Solexa deep sequencing. These candidate miRNAs and another 105 known Sus scrofa miRNAs were included in the custom-designed microarray and used to analyze the miRNA expression profile in the bud, cap, early bell, and late bell stages of tooth development. Microarray analysis revealed 166 transcripts that were differentially expressed in the four stages. Bioinformatic analysis identified 18 key miRNAs, including let-7f, miR-128, miR-200b, and miR-200c, that might play key roles in tooth development. Taken together, our results not only identified the specific microRNAome and expression profile in developing lower deciduous molars of the miniature pig, but they also provided useful information for investigating the molecular mechanism of tooth development in the miniature pig.	[Li, Ang; Song, Tieli; Wang, Fu; Liu, Dayong; Fan, Zhipeng; Zhang, Chunmei; Wang, Songlin] Capital Med Univ, Sch Stomatol, Mol Lab Gene Therapy & Tooth Regenerat, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Beijing, Peoples R China; [He, Junqi; Wang, Songlin] Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Wang, SL (corresponding author), Capital Med Univ, Sch Stomatol, Mol Lab Gene Therapy & Tooth Regenerat, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Beijing, Peoples R China.	slwang@ccmu.edu.cn	Liu, Dayong/E-3440-2018; Wang, Fu/P-9950-2019; Liu, Dayong/AAT-9061-2021; Liu, Dayong/AAG-4081-2020; Li, Ang/AAV-6381-2021	Liu, Dayong/0000-0001-8511-2658; Wang, Fu/0000-0001-9615-1038; Liu, Dayong/0000-0001-8511-2658; 	Beijing Municipal Committee for Science and Technology [Z121100005212004]; National Basic Research Program of China [2010CB944801]; Beijing Municipality [PHR20090510, PXM 2009-014226-074691, PXM2011-014226-07-000066]	Beijing Municipal Committee for Science and Technology; National Basic Research Program of China(National Basic Research Program of China); Beijing Municipality	This work was supported by the research grants from Beijing Municipal Committee for Science and Technology (No. Z121100005212004) to S.W., National Basic Research Program of China (No. 2010CB944801) to S.W., Beijing Municipality (PHR20090510, PXM 2009-014226-074691 and PXM2011-014226-07-000066) to S.W. and Z.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BIVIN WS, 1976, J DENT RES, V55, P591, DOI 10.1177/00220345760550040701; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Caton J, 2009, J ANAT, V214, P502, DOI 10.1111/j.1469-7580.2008.01014.x; Chai Y, 1999, MECH DEVELOP, V86, P63, DOI 10.1016/S0925-4773(99)00112-4; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-240; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Gu YR, 2011, ANIM SCI J, V82, P722, DOI 10.1111/j.1740-0929.2011.00908.x; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Jevnaker AM, 2008, ARCH ORAL BIOL, V53, P629, DOI 10.1016/j.archoralbio.2008.01.014; Jheon AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024536; Kapadia H, 2007, ORTHOD CRANIOFAC RES, V10, P236; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Sehic A, 2011, PHYSIOL GENOMICS, V43, P488, DOI 10.1152/physiolgenomics.00248.2010; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shi Y, 2009, SCI CHINA SER C, V52, P205, DOI 10.1007/s11427-009-0040-5; Stembirek J, 2010, EUR J ORAL SCI, V118, P547, DOI 10.1111/j.1600-0722.2010.00772.x; Teferedegne B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014416; Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhao SH, 2006, MAMM GENOME, V17, P777, DOI 10.1007/s00335-005-0155-3	33	21	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52256	10.1371/journal.pone.0052256	http://dx.doi.org/10.1371/journal.pone.0052256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272230	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300073
J	Ma, JY; Sun, W; Liu, XN; Chen, FH				Ma, Jian-Ying; Sun, Wei; Liu, Xiao-Ning; Chen, Fa-Hu			Variation in the Stable Carbon and Nitrogen Isotope Composition of Plants and Soil along a Precipitation Gradient in Northern China	PLOS ONE			English	Article							N-15 NATURAL-ABUNDANCE; RAINFALL GRADIENT; MYCORRHIZAL FUNGI; C-4 PLANTS; DISCRIMINATION; DELTA-C-13; PATTERNS; FRACTIONATION; AVAILABILITY; VEGETATION	Water availability is the most influential factor affecting plant carbon (delta C-13) and nitrogen (delta N-15) isotope composition in arid and semi-arid environments. However, there are potential differences among locations and/or species in the sensitivity of plant delta C-13 and delta N-15 to variation in precipitation, which are important for using stable isotope signatures to extract paleo-vegetation and paleo-climate information. We measured delta C-13 and delta N-15 of plant and soil organic matter (SOM) samples collected from 64 locations across a precipitation gradient with an isotherm in northern China. delta C-13 and delta N-15 for both C-3 and C-4 plants decreased significantly with increasing mean annual precipitation (MAP). The sensitivity of delta C-13 to MAP in C-3 plants (-0.6 +/- 0.07 parts per thousand/100 mm) was twice as high as that in C-4 plants (-0.3 +/- 0.08 parts per thousand/100 mm). Species differences in the sensitivity of plant delta C-13 and delta N-15 to MAP were not observed among three main dominant plants. SOM became depleted in C-13 with increasing MAP, while no significant correlations existed between delta N-15 of SOM and MAP. We conclude that water availability is the primary environmental factor controlling the variability of plant delta C-13 and delta N-15 and soil delta C-13 in the studied arid and semi-arid regions. Carbon isotope composition is useful for tracing environmental precipitation changes. Plant nitrogen isotope composition can reflect relative openness of ecosystem nitrogen cycling.	[Sun, Wei] NE Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Peoples R China; [Ma, Jian-Ying; Liu, Xiao-Ning] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Ma, Jian-Ying; Chen, Fa-Hu] Lanzhou Univ, Key Lab Western Chinas Environm Syst, Minist Educ, Lanzhou 730000, Peoples R China	Northeast Normal University - China; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Lanzhou University	Sun, W (corresponding author), NE Normal Univ, Inst Grassland Sci, Key Lab Vegetat Ecol, Minist Educ, Changchun, Peoples R China.	sunwei@nenu.edu.cn	Fahu, Chen/B-2788-2011	Chen, Fahu/0000-0002-8874-1035	National Basic Research Program of China [2009CB825101, 2009CB421306]; National Natural Science Foundation of China [41071032, 31270445]; Talents Foundation of Cold and Arid Regions Environmental and Engineering Research Institute; West Light Foundation of the Chinese Academy of Science	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talents Foundation of Cold and Arid Regions Environmental and Engineering Research Institute; West Light Foundation of the Chinese Academy of Science(Chinese Academy of Sciences)	This research was supported by National Basic Research Program of China (2009CB825101 and 2009CB421306), National Natural Science Foundation of China (41071032, 31270445), Talents Foundation of Cold and Arid Regions Environmental and Engineering Research Institute (2011) and West Light Foundation of the Chinese Academy of Science (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; AMUNDSON R, 1994, J ARID ENVIRON, V28, P265, DOI 10.1016/S0140-1963(05)80048-5; Anderson JE, 1996, AUST J PLANT PHYSIOL, V23, P311, DOI 10.1071/PP9960311; Aranibar JN, 2008, J ARID ENVIRON, V72, P326, DOI 10.1016/j.jaridenv.2007.06.007; Aranibar JN, 2004, GLOBAL CHANGE BIOL, V10, P359, DOI 10.1111/j.1365-2486.2003.00698.x; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; BALESDENT J, 1993, ECOLOGY, V74, P1713, DOI 10.2307/1939930; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Ding Y., 1993, SPRINGER NETHERLANDS, DOI DOI 10.1007/978-94-015-8302-2; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1983, AUST J PLANT PHYSIOL, V10, P205, DOI 10.1071/PP9830205; Handley LL, 1999, AUST J PLANT PHYSIOL, V26, P185, DOI 10.1071/PP98146; HANDLEY LL, 1992, PLANT CELL ENVIRON, V15, P965, DOI 10.1111/j.1365-3040.1992.tb01650.x; Hartman G, 2010, OECOLOGIA, V162, P837, DOI 10.1007/s00442-009-1514-7; HATTERSLEY PW, 1982, AUST J PLANT PHYSIOL, V9, P139, DOI 10.1071/PP9820139; Hobbie EA, 2003, NEW PHYTOL, V157, P115, DOI 10.1046/j.1469-8137.2003.00657.x; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Kitayama K, 2001, PLANT SOIL, V229, P203, DOI 10.1023/A:1004853915544; Korol RL, 1999, TREE PHYSIOL, V19, P551; Liu WG, 2009, CHINESE SCI BULL, V54, P272, DOI 10.1007/s11434-008-0442-y; Liu WG, 2005, GLOBAL CHANGE BIOL, V11, P1094, DOI 10.1111/j.1365-2486.2005.00969.x; Ma JY, 2007, J ARID ENVIRON, V69, P365, DOI 10.1016/j.jaridenv.2006.11.002; Midwood AJ, 1998, SOIL BIOL BIOCHEM, V30, P1301, DOI 10.1016/S0038-0717(98)00030-3; Miller JM, 2001, FUNCT ECOL, V15, P222, DOI 10.1046/j.1365-2435.2001.00508.x; Neff JC, 2003, FRONT ECOL ENVIRON, V1, P205, DOI 10.1890/1540-9295(2003)001[0205:BITCDO]2.0.CO;2; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Robinson D, 1998, PLANTA, V205, P397, DOI 10.1007/s004250050336; Schulze ED, 1998, AUST J PLANT PHYSIOL, V25, P413, DOI 10.1071/PP97113; SPEAR RW, 1994, ECOL MONOGR, V64, P85, DOI 10.2307/2937056; STEWART GR, 1995, AUST J PLANT PHYSIOL, V22, P51, DOI 10.1071/PP9950051; Swap RJ, 2004, GLOBAL CHANGE BIOL, V10, P350, DOI 10.1111/j.1365-2486.2003.00702.x; Van de Water PK, 2002, OECOLOGIA, V132, P332, DOI 10.1007/s00442-002-0973-x; Wang GA, 2005, PHYSIOL PLANTARUM, V125, P74, DOI 10.1111/j.1399-3054.2005.00549.x; Wang T, 2003, DESERT DESERTIFICATI; Williams DG, 2001, NEW PHYTOL, V150, P285, DOI 10.1046/j.1469-8137.2001.00093.x; Wittmer MHOM, 2010, GLOBAL CHANGE BIOL, V16, P605, DOI 10.1111/j.1365-2486.2009.02033.x	41	47	56	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51894	10.1371/journal.pone.0051894	http://dx.doi.org/10.1371/journal.pone.0051894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272186	gold, Green Submitted, Green Published			2022-12-25	WOS:000312483300040
J	Simoes, P; Calabria, G; Picao-Osorio, J; Balanya, J; Pascual, M				Simoes, Pedro; Calabria, Gemma; Picao-Osorio, Joao; Balanya, Joan; Pascual, Marta			The Genetic Content of Chromosomal Inversions across a Wide Latitudinal Gradient	PLOS ONE			English	Article							DROSOPHILA-SUBOBSCURA; LINKAGE DISEQUILIBRIUM; NUCLEOTIDE VARIABILITY; NATURAL-POPULATIONS; POLYMORPHISM; SELECTION; MELANOGASTER; RECOMBINATION; ARRANGEMENTS; SUBDIVISION	There is increasing evidence regarding the role of chromosomal inversions in relevant biological processes such as local adaptation and speciation. A classic example of the adaptive role of chromosomal polymorphisms is given by the clines of inversion frequencies in Drosophila subobscura, repeatable across continents. Nevertheless, not much is known about the molecular variation associated with these polymorphisms. We characterized the genetic content of ca. 600 individuals from nine European populations following a latitudinal gradient by analysing 19 microsatellite loci from two autosomes (J and U) and the sex chromosome (A), taking into account their chromosomal inversions. Our results clearly demonstrate the molecular genetic uniformity within a given chromosomal inversion across a large latitudinal gradient, particularly from Groningen (Netherlands) in the north to Malaga (Spain) in the south, experiencing highly diverse environmental conditions. This low genetic differentiation within the same gene arrangement across the nine European populations is consistent with the local adaptation hypothesis for th evolutionof chromosomal polymorphisms. We also show the effective role of chromosomal inversions in maintaining different genetic pools within these inverted genomic regions even in the presence of high gene flow. Inversions represent thus an important barrier to gene flux and can help maintain specific allelic combinations with positive effects on fitness. Consistent patterns of microsatellite allele-inversion linkage disequilibrium particularly in loci within inversions were also observed. Finally, we identified areas within inversions presenting clinal variation that might be under selection.	[Simoes, Pedro; Calabria, Gemma; Picao-Osorio, Joao; Balanya, Joan; Pascual, Marta] Univ Barcelona, Fac Biol, Dept Genet, Grp Biol Evolutiva IRBio, Barcelona, Spain; [Picao-Osorio, Joao] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Barcelona; University of Sussex	Simoes, P (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	pmsimoes@fc.ul.pt	Pascual, Marta/ABG-3782-2020; /A-8683-2008; Pascual, Marta/M-7626-2015; Simões, Pedro/F-7220-2015	Pascual, Marta/0000-0002-6189-0612; /0000-0002-8236-4101; Pascual, Marta/0000-0002-6189-0612; Simões, Pedro/0000-0002-4253-1200	Ministerio de Ciencia y Tecnologia (MCYT, Spain) [CGL2006-13423-C02-02, CTM2010-22218-C02-02]; Fundacao para Ciencia e a Tecnologia (Portugal) [SFRH/BPD/36829/2007]; Ministerio de Educacion y Ciencia (Spain) [BES-2007-15096]; Generalitat de Catalunya [2009SGR-636]	Ministerio de Ciencia y Tecnologia (MCYT, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacao para Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	Research was founded by projects CGL2006-13423-C02-02 and CTM2010-22218-C02-02 from the Ministerio de Ciencia y Tecnologia (MCYT, Spain). Pedro Simoes had a Post-Doctoral grant (SFRH/BPD/36829/2007) from Fundacao para Ciencia e a Tecnologia (Portugal). Gemma Calabria had a FPI doctoral grant (BES-2007-15096) from Ministerio de Educacion y Ciencia (Spain). Authors are part of the research group 2009SGR-636 from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; [Anonymous], 1992, DROSOPHILA INVERSION; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Balanya J, 2004, J ZOOL SYST EVOL RES, V42, P191, DOI 10.1111/j.1439-0469.2004.00274.x; Balanya J, 2003, EVOLUTION, V57, P1837; Balanya J, 2009, HEREDITY, V103, P364, DOI 10.1038/hdy.2009.86; Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Barker JSF, 2011, J EVOLUTION BIOL, V24, P430, DOI 10.1111/j.1420-9101.2010.02180.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; CHARLESWORTH B, 1979, GENETICS, V92, P983; DOBZHANSKY T, 1950, GENETICS, V35, P288; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feder JL, 2011, EVOLUTION, V65, P2157, DOI 10.1111/j.1558-5646.2011.01321.x; Frydenberg J, 2003, MOL ECOL, V12, P2025, DOI 10.1046/j.1365-294X.2002.01882.x; Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227; Gockel J, 2001, GENETICS, V158, P319; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guerrero RF, 2012, PHILOS T R SOC B, V367, P430, DOI 10.1098/rstb.2011.0246; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hoffmann AA, 2007, GENETICA, V129, P133, DOI 10.1007/s10709-006-9010-z; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Kennington WJ, 2006, GENETICS, V172, P1655, DOI 10.1534/genetics.105.053173; Kennington WJ, 2003, GENETICS, V165, P667; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kirkpatrick M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000501; KOSKE T, 1954, J GENET, V52, P521, DOI 10.1007/BF02985076; Krimbas CB., 1993, DROSOPHILA SUBOBSCUR; KUNZEMUHL E, 1958, CHROMOSOMA, V9, P559; Laayouni H, 2003, MOL BIOL EVOL, V20, P931, DOI 10.1093/molbev/msg099; LATORRE A, 1992, HEREDITY, V68, P15, DOI 10.1038/hdy.1992.2; LEWONTIN RC, 1964, GENETICS, V49, P49; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LOUKAS M, 1979, GENETICS, V93, P497; MAINX F, 1953, Z INDUKT ABSTAMM VER, V85, P354, DOI 10.1007/BF00309673; McAllister BF, 2002, GENOME, V45, P13, DOI 10.1139/g01-112; McGaugh SE, 2012, PHILOS T R SOC B, V367, P422, DOI 10.1098/rstb.2011.0250; Muller H. J., 1940, The New Systematics Oxford, V1940, P185; Munte A, 2005, GENETICS, V169, P1573, DOI 10.1534/genetics.104.032748; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Navarro A, 1997, GENETICS, V146, P695; Navarro A, 2000, GENETICS, V155, P685; Nobrega C, 2008, MOL BIOL EVOL, V25, P1534, DOI 10.1093/molbev/msn100; Noor MAF, 2000, EVOLUTION, V54, P696, DOI 10.1111/j.0014-3820.2000.tb00071.x; OHTA T, 1982, P NATL ACAD SCI-BIOL, V79, P1940, DOI 10.1073/pnas.79.6.1940; Pascual M, 2000, MOL BIOL EVOL, V17, P1259, DOI 10.1093/oxfordjournals.molbev.a026409; Pascual M, 1997, J ZOOL SYST EVOL RES, V35, P159; Pascual M, 2001, MOL BIOL EVOL, V18, P731, DOI 10.1093/oxfordjournals.molbev.a003855; Pegueroles C, 2010, J EVOLUTION BIOL, V23, P2709, DOI 10.1111/j.1420-9101.2010.02136.x; PREVOSTI A, 1988, P NATL ACAD SCI USA, V85, P5597, DOI 10.1073/pnas.85.15.5597; RodriguezTrelles F, 1996, GENETICS, V142, P179; ROZAS J, 1995, J EVOLUTION BIOL, V8, P355, DOI 10.1046/j.1420-9101.1995.8030355.x; Santos J, 2010, CHROMOSOME RES, V18, P213, DOI 10.1007/s10577-010-9112-4; Santos M, 2009, GENETICS, V181, P803, DOI 10.1534/genetics.108.097857; Schaeffer SW, 2008, EVOLUTION, V62, P3082, DOI 10.1111/j.1558-5646.2008.00504.x; Schaeffer SW, 2005, GENETICS, V171, P1729, DOI 10.1534/genetics.105.041947; Schaeffer SW, 2003, P NATL ACAD SCI USA, V100, P8319, DOI 10.1073/pnas.1432900100; SLATKIN M, 1995, GENETICS, V139, P457; Umina PA, 2006, GENET RES, V87, P13, DOI 10.1017/S0016672306007919; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217	63	18	19	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51625	10.1371/journal.pone.0051625	http://dx.doi.org/10.1371/journal.pone.0051625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272126	gold, Green Submitted, Green Published			2022-12-25	WOS:000312483300019
J	Dessombz, A; Meria, P; Bazin, D; Daudon, M				Dessombz, Arnaud; Meria, Paul; Bazin, Dominique; Daudon, Michel			Prostatic Stones: Evidence of a Specific Chemistry Related to Infection and Presence of Bacterial Imprints	PLOS ONE			English	Article							CALCIUM-PHOSPHATE; INFLAMMATION; SPECTROSCOPY; WHITLOCKITE; IMMUNITY; CRYSTAL; CALCULI	Prostatic stones are a common condition in older men in industrialized countries. However, aging appears not to be the unique pathogenesis of these calcifications. Our morpho-constitutional investigation of 23 stone samples suggested that infection has a significant role in the lithogenic process of prostate calcifications, even without detection of infection by clinical investigation. Most stones (83%) showed bacterial imprints and/or chemical composition, suggestive of a long-term infection process. Chronic infection may induce persistent inflammation of the tissue and secondarily, a cancerization process within a few years. Thus, the discovery of prostate calcifications by computerized tomodensitometry, for example, might warrant further investigation and management to search for chronic infection of the prostate gland.	[Dessombz, Arnaud; Bazin, Dominique] Univ Paris 11, CNRS, Phys Solides Lab, F-91405 Orsay, France; [Meria, Paul; Bazin, Dominique] Hop St Louis, AP HP, Serv Urol, Paris, France; [Bazin, Dominique] Univ Paris 06, CNRS, Coll France, Lab Chim Mat Condense Paris, Paris, France; [Daudon, Michel] Hop Tenon, AP HP, Serv Explorat Fonctionnelles, F-75970 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Dessombz, A (corresponding author), Univ Paris 11, CNRS, Phys Solides Lab, F-91405 Orsay, France.	arnaud.dessombz@u-psud.fr	Dessombz, Arnaud/B-7149-2016; , Bazin/C-6306-2014	Dessombz, Arnaud/0000-0002-6610-4879; , Bazin/0000-0002-5112-9061	physic and chemistry institutes of CNRS (Centre National de la Recherche Scientifique); Agence Nationale de la Recheche contract [ANR-09-BLAN-0120-02]	physic and chemistry institutes of CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recheche contract(French National Research Agency (ANR))	This work was supported by the physic and chemistry institutes of CNRS (Centre National de la Recherche Scientifique) and by an Agence Nationale de la Recheche contract (grant number: ANR-09-BLAN-0120-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All the supporters have no commercial interests.	Alcaraz A, 2009, EUR UROL, V55, P864, DOI 10.1016/j.eururo.2008.11.011; Bazin D, 2012, CHEM REV, V112, P5092, DOI 10.1021/cr200068d; Bazin D, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/38/383001; Bazin D, 2012, UROLOGY, V79, P786, DOI 10.1016/j.urology.2011.08.054; Carpentier X, 2009, UROLOGY, V73, P968, DOI 10.1016/j.urology.2008.12.049; Daudon M, 2008, NEW ENGL J MED, V359, P100, DOI 10.1056/NEJMc0800990; Dessombz A, 2011, PROG UROL, V21, P940, DOI 10.1016/j.purol.2011.04.003; Dessombz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028007; Dorfmuller P, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/685926; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; Estepa L, 1997, BIOSPECTROSCOPY, V3, P347, DOI 10.1002/(SICI)1520-6343(1997)3:5<347::AID-BSPY3>3.0.CO;2-#; Freeman-Cook L, 2005, STAPHYLOCOCCUS AUREU; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hsu THS, 2011, UROL RES, V39, P165, DOI 10.1007/s00240-010-0316-z; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; KATO H, 1987, J UROLOGY, V138, P154, DOI 10.1016/S0022-5347(17)43031-X; Kopans D, 2011, BREAST J, V17, P638, DOI 10.1111/j.1524-4741.2011.01152.x; Lagier R, 2003, PATHOL RES PRACT, V199, P329, DOI 10.1078/0344-0338-00425; Li C, 2003, J BIOMED MATER RES A, V64A, P197, DOI 10.1002/jbm.a.10320; Maurice-Estepa L, 1999, SCAND J UROL NEPHROL, V33, P299, DOI 10.1080/003655999750017365; MCLAUGHLIN JK, 1984, JNCI-J NATL CANCER I, V72, P275; Meares EM, 1974, LAB DIAGN CLIN MANAG, V4, P560; MENDELSOHN R, 1989, CALCIFIED TISSUE INT, V44, P20, DOI 10.1007/BF02556236; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Parker AS, 2004, AM J EPIDEMIOL, V159, P42, DOI 10.1093/aje/kwh014; Quy-Dao N, 1997, INFRARED RAMAN SPECT; REID JD, 1993, ATHEROSCLEROSIS, V101, P213, DOI 10.1016/0021-9150(93)90118-E; Sfanos KS, 2009, P NATL ACAD SCI USA, V106, P3443, DOI 10.1073/pnas.0810473106; SONDERGAARD G, 1987, ACTA PATH MICRO IM A, V95, P141; SUTOR DJ, 1974, BRIT J UROL, V46, P533, DOI 10.1111/j.1464-410X.1974.tb03852.x	32	58	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51691	10.1371/journal.pone.0051691	http://dx.doi.org/10.1371/journal.pone.0051691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272143	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386600036
J	Pomeroy, E; Stock, JT; Stanojevic, S; Miranda, JJ; Cole, TJ; Wells, JCK				Pomeroy, Emma; Stock, Jay T.; Stanojevic, Sanja; Jaime Miranda, J.; Cole, Tim J.; Wells, Jonathan C. K.			Trade-Offs in Relative Limb Length among Peruvian Children: Extending the Thrifty Phenotype Hypothesis to Limb Proportions	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; GUANGZHOU-BIOBANK COHORT; CORONARY HEART-DISEASE; BODY-MASS INDEX; LEG LENGTH; HIGH-ALTITUDE; CHILDHOOD CONDITIONS; HYPOXIC ENVIRONMENT; GENETIC ADMIXTURE; ADOLESCENT GROWTH	Background and Methods: Both the concept of 'brain-sparing' growth and associations between relative lower limb length, childhood environment and adult disease risk are well established. Furthermore, tibia length is suggested to be particularly plastic under conditions of environmental stress. The mechanisms responsible are uncertain, but three hypotheses may be relevant. The 'thrifty phenotype' assumes that some components of growth are selectively sacrificed to preserve more critical outcomes, like the brain. The 'distal blood flow' hypothesis assumes that blood nutrients decline with distance from the heart, and hence may affect limbs in relation to basic body geometry. Temperature adaptation predicts a gradient of decreased size along the limbs reflecting decreasing tissue temperature/blood flow. We examined these questions by comparing the size of body segments among Peruvian children born and raised in differentially stressful environments. In a cross-sectional sample of children aged 6 months to 14 years (n = 447) we measured head circumference, head-trunk height, total upper and lower limb lengths, and zeugopod (ulna and tibia) and autopod (hand and foot) lengths. Results: Highland children (exposed to greater stress) had significantly shorter limbs and zeugopod and autopod elements than lowland children, while differences in head-trunk height were smaller. Zeugopod elements appeared most sensitive to environmental conditions, as they were relatively shorter among highland children than their respective autopod elements. Discussion: The results suggest that functional traits (hand, foot, and head) may be partially protected at the expense of the tibia and ulna. The results do not fit the predictions of the distal blood flow and temperature adaptation models as explanations for relative limb segment growth under stress conditions. Rather, our data support the extension of the thrifty phenotype hypothesis to limb growth, and suggest that certain elements of limb growth may be sacrificed under tough conditions to buffer more functional traits.	[Pomeroy, Emma; Stock, Jay T.] Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, Cambridge, England; [Stanojevic, Sanja] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Sch Med, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru; [Cole, Tim J.; Wells, Jonathan C. K.] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London, England	University of Cambridge; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of London; University College London	Pomeroy, E (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, Cambridge, England.	emma.pomeroy@cantab.net	Stanojevic, Sanja/A-4243-2010; Cole, Tim J/B-7883-2008; Wells, Jonathan/A-4604-2009; Stock, Jay T/B-6453-2011	Cole, Tim J/0000-0001-5711-8200; Wells, Jonathan/0000-0003-0411-8025; Stock, Jay T/0000-0003-0147-8631; Stanojevic, Sanja/0000-0001-7931-8051; Miranda, J. Jaime/0000-0002-4738-5468; Pomeroy, Emma/0000-0001-6251-2165	Arts and Humanities Research Council (UK); University of Cambridge Centre for Latin American Studies Abbey-Santander Travel Grants; National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]; Medical Research Council [G0700961]; MRC [G0700961, MR/J004839/1] Funding Source: UKRI; Medical Research Council [MR/J004839/1] Funding Source: researchfish	Arts and Humanities Research Council (UK)(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); University of Cambridge Centre for Latin American Studies Abbey-Santander Travel Grants; National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	EP received Ph.D. funding from the Arts and Humanities Research Council (UK), and fieldwork grants from the University of Cambridge Centre for Latin American Studies Abbey-Santander Travel Grants. JJM is with the CRONICAS Center of Excellence in Chronic Diseases at the Universidad Peruana Cayetano Heredia which is funded by the National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract number HHSN268200900033C. TJC is funded by Medical Research Council grant G0700961. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 1877, RADICAL REV, V1, P108, DOI DOI 10.1038/SCIENTIFICAMERICAN05251907-26247SUPP; Antonow-Schlorke I, 2011, P NATL ACAD SCI USA, V108, P3011, DOI 10.1073/pnas.1009838108; Auerbach BM, 2011, AM J PHYS ANTHROPOL, V144, P382, DOI 10.1002/ajpa.21418; Bailey SM, 2007, AM J HUM BIOL, V19, P662, DOI 10.1002/ajhb.20667; Baker J, 2010, AM J HUM BIOL, V22, P206, DOI 10.1002/ajhb.20979; Barbiro-Michaely E, 2007, MED SCI MONITOR, V13, pBR211; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barker DJP, 1998, MOTHERS BABIES DIS L; Bergmann C, 1847, GOTTINGER STUDIEN, V1, P595; Bigham AW, 2008, HIGH ALT MED BIOL, V9, P167, DOI 10.1089/ham.2007.1066; Bogin B, 2003, COMP BIOCHEM PHYS A, V136, P71, DOI 10.1016/S1095-6433(02)00294-5; Bogin B, 2001, PERSPECTIVES IN HUMAN GROWTH, DEVELOPMENT AND MATURATION, P205; Bogin B, 2008, INT J EPIDEMIOL, V37, P201, DOI 10.1093/ije/dym254; Bogin B, 2010, INT J ENV RES PUB HE, V7, P1047, DOI 10.3390/ijerph7031047; BROOKE OG, 1984, EARLY HUM DEV, V10, P85, DOI 10.1016/0378-3782(84)90114-2; Brutsaert TD, 2005, AM J PHYSIOL-REG I, V289, pR225, DOI 10.1152/ajpregu.00105.2005; Brutsaert TD, 2004, AM J PHYS ANTHROPOL, V123, P390, DOI 10.1002/ajpa.10319; Brutsaert TD, 2003, J APPL PHYSIOL, V95, P519, DOI 10.1152/japplphysiol.01088.2002; Burrage DM, 2009, J PHYSIOL-LONDON, V587, P611, DOI 10.1113/jphysiol.2008.165944; Cameron N, 2004, METHODS HUMAN GROWTH, P68; Cole, 2010, LMSCHARTMAKER PROGRA; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Coly AN, 2006, J NUTR, V136, P2412, DOI 10.1093/jn/136.9.2412; Eveleth PB, 1990, WORLDWIDE VARIATION; Feldesman MR, 1996, AM J PHYS ANTHROPOL, V100, P207; Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Fok TF, 2006, BIOL NEONATE, V89, P25, DOI 10.1159/000088195; FREYRE EA, 1988, J ADOLESCENT HEALTH, V9, P144, DOI 10.1016/0197-0070(88)90061-7; Frisancho A. R, 2008, ANTHROPOMETRIC STAND; Frisancho AR, 2007, AM J HUM BIOL, V19, P703, DOI 10.1002/ajhb.20676; Frisancho AR, 1976, MAN ANDES MULTIDISCI, P180; Giussani DA, 2005, PEDIATR RES, V58, P179, DOI 10.1203/01.PDR.0000169999.66157.C0; Giussani DA, 2011, P NATL ACAD SCI USA, V108, P2641, DOI 10.1073/pnas.1019726108; Goldbourt U, 2002, STROKE, V33, P743, DOI 10.1161/hs0302.103814; Greksa LP, 2006, HIGH ALT MED BIOL, V7, P116, DOI 10.1089/ham.2006.7.116; Gunnell D, 2003, J EPIDEMIOL COMMUN H, V57, P141, DOI 10.1136/jech.57.2.141; Gunnell DJ, 1998, PAEDIATR PERINAT EP, V12, P96, DOI 10.1046/j.1365-3016.1998.0120s1096.x; HAAS JD, 1977, HUM BIOL, V49, P611; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Holliday TW, 2001, AM J PHYS ANTHROPOL, V116, P26, DOI 10.1002/ajpa.1098; [INEI ICF Macro/MEASURE DHS], 2010, PER ENC DEM SAL FAM; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Jantz LM, 1999, AM J PHYS ANTHROPOL, V110, P57, DOI 10.1002/(SICI)1096-8644(199909)110:1<57::AID-AJPA5>3.0.CO;2-1; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Kinra S, 2011, INT J EPIDEMIOL, V40, P1022, DOI 10.1093/ije/dyr074; Krampl E, 2000, ULTRASOUND OBST GYN, V16, P9, DOI 10.1046/j.1469-0705.2000.00156.x; Lampl M, 2005, AM J HUM BIOL, V17, P66, DOI 10.1002/ajhb.20094; Lampl M, 2003, AM J HUM BIOL, V15, P667, DOI 10.1002/ajhb.10204; Lampl M, 2003, A J HUM BIOL, V15; Lausent-Herrera I, 2009, J CHIN OVERSEAS, V5, P115, DOI 10.1163/179325409X434522; Leary S, 2006, ACTA OBSTET GYN SCAN, V85, P1080, DOI 10.1080/00016340600697447; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; MARTORELL R, 1988, HUM BIOL, V60, P205; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; McClung J., 1969, EFFECTS HIGH ALTITUD; Miranda JJ, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-23; Miranda JJ, 2009, THESIS LONDON SCH HY; MUELLER WH, 1980, HUM BIOL, V52, P529; MUELLER WH, 1978, ANN HUM BIOL, V5, P329, DOI 10.1080/03014467800002981; Mulder ALM, 1998, J PHYSIOL-LONDON, V508, P281, DOI 10.1111/j.1469-7793.1998.281br.x; Niermeyer S, 2009, ARCH DIS CHILD, V94, P806, DOI 10.1136/adc.2008.141838; Palomino H, 1978, AM J PHYS ANTHROPOL, V50, P39; POWERS WF, 1977, ACTA PAEDIATR SCAND, V66, P205, DOI 10.1111/j.1651-2227.1977.tb07834.x; Rivera-Ch Maria, 2008, International Journal of Environment and Health, V2, P92, DOI 10.1504/IJENVH.2008.018675; Roberts D. F., 1978, CLIMATE HUMAN VARIAB; Rolian C, 2008, EVOL DEV, V10, P15, DOI 10.1111/j.1525-142X.2008.00211.x; Rolian C, 2009, EVOL BIOL, V36, P100, DOI 10.1007/s11692-009-9049-8; Samaras TT, 2007, HUMAN BODY SIZE LAWS; Sanchez E, 2010, ARTHRITIS RHEUM-US, V62, P3722, DOI 10.1002/art.27753; Sanna E, 2000, AM J HUM BIOL, V12, P782, DOI 10.1002/1520-6300(200011/12)12:6<782::AID-AJHB6>3.0.CO;2-L; Santos JL, 2001, NUTRITION, V17, P305, DOI 10.1016/S0899-9007(00)00551-7; SATYANARAYANA K, 1989, ANN HUM BIOL, V16, P289, DOI 10.1080/03014468900000422; Schooling CM, 2008, J EPIDEMIOL COMMUN H, V62, P607, DOI 10.1136/jech.2007.065003; Schooling CM, 2008, J EPIDEMIOL COMMUN H, V62, P160, DOI 10.1136/jech.2006.058917; Schooling CM, 2007, AM J PUBLIC HEALTH, V97, P1834, DOI 10.2105/AJPH.2006.088096; Serrat MA, 2007, THESIS KENT STATE U; Serrat MA, 2008, P NATL ACAD SCI USA, V105, P19348, DOI 10.1073/pnas.0803319105; Stanojevic S, 2009, AM J RESP CRIT CARE, V180, P547, DOI 10.1164/rccm.200903-0323OC; STECKEL RH, 1987, ANN HUM BIOL, V14, P111, DOI 10.1080/03014468700006852; Stinson S, 2009, AM J HUM BIOL, V21, P606, DOI 10.1002/ajhb.20918; Stockard CR, 1921, AM J ANAT, V28, P115, DOI 10.1002/aja.1000280202; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; TANNER JM, 1982, ANN HUM BIOL, V9, P411, DOI 10.1080/03014468200005951; Tanner JM, 1969, HUMAN BIOL GUIDE FIE; Udjus LG, 1964, ANTHROPOMETRICAL CHA; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Webb E, 2008, J EPIDEMIOL COMMUN H, V62, P351, DOI 10.1136/jech.2006.056457; Wells JCK, 2007, YEARB PHYS ANTHROPOL, V50, P191, DOI 10.1002/ajpa.20735; Wells JCK, 2012, AM J HUM BIOL, V24, P261, DOI 10.1002/ajhb.22253; Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100; Whitley E, 2010, J EPIDEMIOL COMMUNIT, V24, P24; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Williams SJ, 2005, AM J PHYSIOL-REG I, V288, pR360, DOI 10.1152/ajpregu.00178.2004; World Medical Association, 2008, WMA DECL HELS ETH PR; Young NM, 2005, EVOLUTION, V59, P2691; Zamudio S, 2007, AM J PATHOL, V170, P2171, DOI 10.2353/ajpath.2007.061185	99	78	80	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51795	10.1371/journal.pone.0051795	http://dx.doi.org/10.1371/journal.pone.0051795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AH	23272169	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386600040
J	Bullwinkle, TJ; Zou, SB; Rajkovic, A; Hersch, SJ; Elgamal, S; Robinson, N; Smil, D; Bolshan, Y; Navarre, WW; Ibba, M				Bullwinkle, Tammy J.; Zou, S. Betty; Rajkovic, Andrei; Hersch, Steven J.; Elgamal, Sara; Robinson, Nathaniel; Smil, David; Bolshan, Yuri; Navarre, William Wiley; Ibba, Michael			(R)-beta-Lysine-modified Elongation Factor P Functions in Translation Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-EF-P; TRANSFER-RNA; PEPTIDE-BOND; POSTTRANSLATIONAL MODIFICATION; GENE; RIBOSOME; PARALOG; POXA; SITE	Post-translational modification of bacterial elongation factor P (EF-P) with (R)-beta-lysine at a conserved lysine residue activates the protein in vivo and increases puromycin reactivity of the ribosome in vitro. The additional hydroxylation of EF-P at the same lysine residue by the YfcM protein has also recently been described. The roles of modified and unmodified EF-P during different steps in translation, and how this correlates to its physiological role in the cell, have recently been linked to the synthesis of polyproline stretches in proteins. Polysome analysis indicated that EF-P functions in translation elongation, rather than initiation as proposed previously. This was further supported by the inability of EF-P to enhance the rate of formation of fMet-Lys or fMet-Phe, indicating that the role of EF-P is not to specifically stimulate formation of the first peptide bond. Investigation of hydroxyl-(beta)-lysyl-EF-P showed 30% increased puromycin reactivity but no differences in dipeptide synthesis rates when compared with the beta-lysylated form. Unlike disruption of the other genes required for EF-P modification, deletion of yfcM had no phenotypic consequences in Salmonella. Taken together, our findings indicate that EF-P functions in translation elongation, a role critically dependent on post-translational beta-lysylation but not hydroxylation.	[Bullwinkle, Tammy J.; Elgamal, Sara; Robinson, Nathaniel; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Rajkovic, Andrei; Ibba, Michael] Ohio State Univ, Mol Cell & Dev Biol Program, Columbus, OH 43210 USA; [Zou, S. Betty; Hersch, Steven J.; Navarre, William Wiley] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Smil, David; Bolshan, Yuri] Univ Toronto, Struct Genom Consortium, Toronto, ON M5S 1A8, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Toronto; University of Toronto; Structural Genomics Consortium	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu	Elgamal, Sara/GQH-4293-2022	Robinson, Nathaniel/0000-0003-1020-5440; Elgamal, Sara/0000-0003-2274-9891; Hersch, Steven/0000-0001-6186-0133; Navarre, William/0000-0002-9293-9220; Smil, David/0000-0002-6232-6087	National Institutes of Health [GM 65183]; Vanier Canada Graduate Scholarships; Canada Institutes for Health Research [MOP-86683, MSH-87729]; Natural Sciences and Engineering Research Council of Canada [RGPIN 386286-10]; Canadian Institutes for Health Research; Genome Canada; Canadian Foundation for Innovation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Wellcome Trust; AbbVie; Eli Lilly Canada; GlaxoSmithKline; Novartis; Pfizer; Takeda; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanier Canada Graduate Scholarships; Canada Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); AbbVie(AbbVie); Eli Lilly Canada(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 65183.; Funded by Vanier Canada Graduate Scholarships.; Supported by an Operating Grant and a New Investigator Award from the Canada Institutes for Health Research (MOP-86683 and MSH-87729) and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN 386286-10).; We thank Dr. Kurt Fredrick and the members of the Fredrick laboratory for helpful advice and discussions as well as strains for the initiation factors. The Structural Genomics Consortium is a registered charity (Number 1097737) that receives funds from the Canadian Institutes for Health Research, Genome Canada, the Canadian Foundation for Innovation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, the Wellcome Trust, AbbVie, Eli Lilly Canada, GlaxoSmithKline, Novartis, Pfizer, and Takeda.	Aoki H, 1997, BIOCHIMIE, V79, P7, DOI 10.1016/S0300-9084(97)87619-5; AOKI H, 1991, NUCLEIC ACIDS RES, V19, P6215, DOI 10.1093/nar/19.22.6215; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Beringer M, 2007, BIOL CHEM, V388, P687, DOI 10.1515/BC.2007.077; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Dale T, 2009, NUCLEIC ACIDS RES, V37, P1202, DOI 10.1093/nar/gkn1040; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; GANOZA MC, 1985, EUR J BIOCHEM, V146, P287, DOI 10.1111/j.1432-1033.1985.tb08651.x; Ganoza MC, 2000, BIOL CHEM, V381, P553, DOI 10.1515/BC.2000.071; Gilreath MS, 2011, FEBS LETT, V585, P3284, DOI 10.1016/j.febslet.2011.09.008; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Levengood J, 2004, J BIOL CHEM, V279, P17707, DOI 10.1074/jbc.M313665200; Ling J, 2007, RNA, V13, P1881, DOI 10.1261/rna.684107; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; McGarry KG, 2005, MOL CELL, V20, P613, DOI 10.1016/j.molcel.2005.10.007; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Swaney S, 2006, J BIOMOL SCREEN, V11, P736, DOI 10.1177/1087057106291634; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Walker SE, 2008, METHODS, V44, P81, DOI 10.1016/j.ymeth.2007.09.003; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	33	38	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4416	4423		10.1074/jbc.M112.438879	http://dx.doi.org/10.1074/jbc.M112.438879			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23277358	Green Published, hybrid			2022-12-25	WOS:000314845000068
J	Riley, L; Zhou, H; Lange, K; Sinsheimer, JS; Sehl, ME				Riley, Lindsay; Zhou, Hua; Lange, Kenneth; Sinsheimer, Janet S.; Sehl, Mary E.			Determining Duration of HER2-Targeted Therapy Using Stem Cell Extinction Models	PLOS ONE			English	Article							BREAST-CANCER; HER2; TRASTUZUMAB; TUMORIGENESIS; NUMBER	Introduction: Trastuzumab dramatically improves survival in breast cancer patients whose tumor overexpresses HER2. A subpopulation of cells in human breast tumors has been identified with characteristics of cancer stem cells. These breast cancer stem-like cells (BCSCs) rely on HER2 signaling for self-renewal, suggesting that HER2-targeted therapy targets BCSCs even when the bulk of the tumor does not overexpress HER2. In order to guide clinical trials examining HER2-targeted therapy in the adjuvant setting, we propose a mathematical model to examine BCSC population dynamics and predict optimal duration of therapy. Methods: Varying the susceptibility of BCSCs to HER2-targeted therapy, we quantify the average time to extinction of BCSCs. We expand our model using stochastic simulation to include the partially differentiated tumor cells (TCs) that represent bulk tumor population and examine effects of plasticity on required duration of therapy. Results: Lower susceptibility of BCSCs and increased rates of dedifferentiation entail longer extinction times, indicating a need for prolonged administration of HER2-targeted therapy. We predict that even when therapy does not appreciably reduce tumor size in the advanced cancer setting, it will eventually eradicate the tumor in the adjuvant setting as long as there is at least a modest effect on BCSCs. Conclusions: We anticipate that our results will inform clinical trials of targeted therapies in planning the duration of therapy needed to eradicate BCSCs. Our predictions also address safety, as longer duration of therapy entails a greater potential impact on normal stem cells that may also be susceptible to stem cell-targeted therapies.	[Sehl, Mary E.] Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Riley, Lindsay; Lange, Kenneth; Sinsheimer, Janet S.] Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA; [Zhou, Hua] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Lange, Kenneth; Sinsheimer, Janet S.] Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA USA; [Lange, Kenneth] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA; [Sinsheimer, Janet S.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; North Carolina State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sehl, ME (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA.	msehl@mednet.ucla.edu		Zhou, Hua/0000-0003-1320-7118	NCATS UCLA CTSI Grant [KL2TR000122]; USPHS [GM53275, MH59490]; NIH service award [GM008185]; Career Development Award from the ASCO Cancer Foundation; Breast Cancer Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000122] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275, T32GM008185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER	NCATS UCLA CTSI Grant; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH service award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award from the ASCO Cancer Foundation; Breast Cancer Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research is supported in part by NCATS UCLA CTSI Grant KL2TR000122, USPHS grants GM53275 and MH59490 and NIH service award GM008185, and by a Career Development Award from the ASCO Cancer Foundation and the Breast Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ashkenazi R, 2008, NEOPLASIA, V10, P1170, DOI 10.1593/neo.08572; Ashkenazi R, 2007, STEM CELL REV, V3, P176, DOI 10.1007/s12015-007-0026-2; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Ferguson T. S., 1996, COURSE LARGE SAMPLE; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; McDermott SP, 2010, MOL ONCOL, V4, P404, DOI 10.1016/j.molonc.2010.06.005; MEYSKENS FL, 1984, CANCER RES, V44, P271; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; NORTON L, 1988, CANCER RES, V48, P7067; Padhani AR, 2001, BRIT J RADIOL, V74, P983, DOI 10.1259/bjr.74.887.740983; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Redana S, 2007, ANN ONCOL, V18, P43; Sehl M, 2011, MATH BIOSCI, V234, P132, DOI 10.1016/j.mbs.2011.09.005; Sehl M, 2009, J COMPUT BIOL, V16, P1195, DOI 10.1089/cmb.2008.0249; Sehl ME, 2009, CANCER RES, V69, P9481, DOI 10.1158/0008-5472.CAN-09-2070; Slamon D, 2005, BREAST CANCER RES TR, V94, pS5; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sottoriva A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001132; TOMITA K, 1979, CANCER RES, V39, P4407; Wicha MS, 2009, BREAST, V18, pS56, DOI 10.1016/S0960-9776(09)70274-7; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	29	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e46613	10.1371/journal.pone.0046613	http://dx.doi.org/10.1371/journal.pone.0046613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284608	gold, Green Published			2022-12-25	WOS:000313051500002
J	Hennebry, SC; Sait, LC; Mantena, R; Humphrey, TJ; Yang, J; Scott, T; Kupz, A; Richardson, SJ; Strugnell, RA				Hennebry, Sarah C.; Sait, Leanne C.; Mantena, Raju; Humphrey, Thomas J.; Yang, Ji; Scott, Timothy; Kupz, Andreas; Richardson, Samantha J.; Strugnell, Richard A.			Salmonella Typhimurium's Transthyretin-Like Protein Is a Host-Specific Factor Important in Fecal Survival in Chickens	PLOS ONE			English	Article							URIC-ACID; ESCHERICHIA-COLI; EVOLUTION; TRANSCRIPTION; OXIDATION; 5-HYDROXYISOURATE; ALLANTOIN; XANTHINE; NITROGEN; PRODUCT	The transthyretin-like protein (TLP) from Salmonella enterica subspecies I is a periplasmic protein with high level structural similarity to a protein found in mammals and fish. In humans, the protein homologue, transthyretin, binds and carries retinol and thyroxine, and a series of other, unrelated aromatic compounds. Here we show that the amino acid sequence of the TLP from different species, subspecies and serovars of the Salmonella genus is highly conserved and demonstrate that the TLP gene is constitutively expressed in S. Typhimurium and that copper and other divalent metal ions severely inhibit enzyme activity of the TLP, a cyclic amidohydrolase that hydrolyses 5-hydroxyisourate (5-HIU). In order to determine the in vivo role of the S. Typhimurium TLP, we constructed a strain of mouse-virulent S. Typhimurium SL1344 bearing a mutation in the TLP gene (SL1344 DyedX). We assessed the virulence of this strain via oral inoculation of mice and chickens. Whilst SL1344 DyedX induced a systemic infection in both organisms, the bacterial load detected in the faeces of infected chickens was significantly reduced when compared to the load of S. Typhimurium SL1344. These data demonstrate that the TLP gene is required for survival of S. Typhimurium in a high uric acid environment such as chicken faeces, and that metabolic traits of Salmonellae in natural and contrived hosts may be fundamentally different. Our data also highlight the importance of using appropriate animal models for the study of bacterial pathogenesis especially where host-specific virulence factors or traits are the subject of the study.	[Hennebry, Sarah C.; Richardson, Samantha J.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Sait, Leanne C.; Humphrey, Thomas J.] Univ Bristol, Dept Vet Clin Sci, Bristol, Avon, England; [Hennebry, Sarah C.; Mantena, Raju; Yang, Ji; Scott, Timothy; Kupz, Andreas; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Richardson, Samantha J.] RMIT Univ, Sch Med Sci, Bundoora, Vic, Australia	University of Melbourne; University of Bristol; University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Hennebry, SC (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia.	rastru@unimelb.edu.au	Kupz, Andreas/J-3844-2014	Kupz, Andreas/0000-0002-9259-7873; Scott, Timothy/0000-0001-7042-8609; Strugnell, Richard/0000-0003-0614-5641; Richardson, Samantha/0000-0002-1708-9430; Humphrey, Tom/0000-0001-7965-8988	NHMRC (National Health and Medical Research Council) of Australia	NHMRC (National Health and Medical Research Council) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the NHMRC (National Health and Medical Research Council) of Australia under Project and Program Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM., 1988, CURRENT PROTOCOLS MO; BARROW PA, 1987, RES VET SCI, V42, P194, DOI 10.1016/S0034-5288(18)30685-4; BARROW PA, 1988, AVIAN PATHOL, V17, P571, DOI 10.1080/03079458808436478; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BRAUN EJ, 1989, J EXP ZOOL, P70, DOI 10.1002/jez.1402520512; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; EITEMAN MA, 1994, FRESEN J ANAL CHEM, V348, P680, DOI 10.1007/BF00325572; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; Gowrishankar J, 1998, J BACTERIOL, V180, P6743, DOI 10.1128/JB.180.24.6743-6748.1998; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Hennebry SC, 2006, PROTEINS, V64, P1024, DOI 10.1002/prot.21033; Hennebry SC, 2006, J MOL BIOL, V359, P1389, DOI 10.1016/j.jmb.2006.04.057; Hennebry SC, 2009, FEBS J, V276, P5367, DOI 10.1111/j.1742-4658.2009.07246.x; Hennebry SC, 2009, RECENT ADV TRANSTHYR; HUDSON GS, 1984, J MOL BIOL, V180, P1023, DOI 10.1016/0022-2836(84)90269-9; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; Kim GJ, 1998, BIOCHEM J, V330, P295, DOI 10.1042/bj3300295; Lee Y, 2005, FEBS LETT, V579, P4769, DOI 10.1016/j.febslet.2005.07.056; Lundberg E, 2006, J STRUCT BIOL, V155, P445, DOI 10.1016/j.jsb.2006.04.002; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller TM, 1974, EXPT MOL GENETICS; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Richardson SJ, 2007, INT REV CYTOL, V258, P137, DOI 10.1016/S0074-7696(07)58003-4; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Samocha-Bonet D, 2005, J INORG BIOCHEM, V99, P1963, DOI 10.1016/j.jinorgbio.2005.06.006; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Schultz AC, 2001, J BACTERIOL, V183, P3293, DOI 10.1128/JB.183.11.3293-3302.2001; Simoyi MF, 2003, COMP BIOCHEM PHYS B, V135, P325, DOI 10.1016/S1096-4959(03)00086-1; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wilkinson SP, 2004, J BIOL CHEM, V279, P51442, DOI 10.1074/jbc.M405586200; Xi HL, 2000, J BACTERIOL, V182, P5332, DOI 10.1128/JB.182.19.5332-5341.2000; Zanotti G, 2006, J MOL BIOL, V363, P1, DOI 10.1016/j.jmb.2006.07.079	35	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e46675	10.1371/journal.pone.0046675	http://dx.doi.org/10.1371/journal.pone.0046675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284609	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000313158800001
J	Fernandez, DC; Pasquini, LA; Dorfman, D; Marcos, HJA; Rosenstein, RE				Fernandez, Diego C.; Pasquini, Laura A.; Dorfman, Damian; Aldana Marcos, Hernan J.; Rosenstein, Ruth E.			Ischemic Conditioning Protects from Axoglial Alterations of the Optic Pathway Induced by Experimental Diabetes in Rats	PLOS ONE			English	Article							VISUAL-EVOKED-POTENTIALS; CONTRAST SENSITIVITY; PATTERN ELECTRORETINOGRAM; DISTAL AXONOPATHY; NEURONAL DEATH; DEGENERATION; RETINOPATHY; GLUTAMATE; RETINA	Diabetic retinopathy is a leading cause of blindness. Visual function disorders have been demonstrated in diabetics even before the onset of retinopathy. At early stages of experimental diabetes, axoglial alterations occur at the distal portion of the optic nerve. Although ischemic conditioning can protect neurons and synaptic terminals against ischemic damage, there is no information on its ability to protect axons. We analyzed the effect of ischemic conditioning on the early axoglial alterations in the distal portion of the optic nerve induced by experimental diabetes. Diabetes was induced in Wistar rats by an intraperitoneal injection of streptozotocin. Retinal ischemia was induced by increasing intraocular pressure to 120 mm Hg for 5 min; this maneuver started 3 days after streptozotocin injection and was weekly repeated in one eye, while the contralateral eye was submitted to a sham procedure. The application of ischemia pulses prevented a deficit in the anterograde transport from the retina to the superior colliculus, as well as an increase in astrocyte reactivity, ultraestructural myelin alterations, and altered morphology of oligodendrocyte lineage in the optic nerve distal portion at early stages of experimental diabetes. Ischemia tolerance prevented a significant decrease of retinal glutamine synthetase activity induced by diabetes. These results suggest that early vision loss in diabetes could be abated by ischemic conditioning which preserved axonal function and structure.	[Fernandez, Diego C.; Dorfman, Damian; Rosenstein, Ruth E.] Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med,CEFyBO,CONICET, Buenos Aires, DF, Argentina; [Fernandez, Diego C.; Aldana Marcos, Hernan J.] Univ Moron, Histol Lab, Sch Med, Buenos Aires, DF, Argentina; [Pasquini, Laura A.] Univ Buenos Aires, CONICET, Dept Biol Chem, Buenos Aires, DF, Argentina; [Pasquini, Laura A.] Univ Buenos Aires, CONICET, Inst Chem & Biol Physicochem, IQUIFIB,Sch Pharm & Biochem, Buenos Aires, DF, Argentina; [Aldana Marcos, Hernan J.] Univ Belgrano, Histol Lab, Sch Sci, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Rosenstein, RE (corresponding author), Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med,CEFyBO,CONICET, Buenos Aires, DF, Argentina.	ruthr@fmed.uba.ar	Pasquini, Laura/ABD-8106-2021	Fernandez, Diego Carlos/0000-0002-4363-1318	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1623]; University of Buenos Aires [M062]; CONICET, Argentina [PIP 1911]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); University of Buenos Aires(University of Buenos Aires); CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 1623); The University of Buenos Aires (M062); CONICET, (PIP 1911) Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; BLOODWORTH JMB, 1962, DIABETES, V11, P1; BRESNICK GH, 1986, ARCH OPHTHALMOL-CHIC, V104, P989; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; DELLASALA S, 1985, BRIT J OPHTHALMOL, V69, P136, DOI 10.1136/bjo.69.2.136; Deng J, 2000, Yan Ke Xue Bao, V16, P199; FALSINI B, 1989, DOC OPHTHALMOL, V73, P193, DOI 10.1007/BF00155037; Fernandez DC, 2012, AM J PATHOL, V180, P303, DOI 10.1016/j.ajpath.2011.09.018; Fernandez DC, 2011, AM J PATHOL, V178, P2264, DOI 10.1016/j.ajpath.2011.01.040; Fernandez DC, 2009, J NEUROCHEM, V111, P488, DOI 10.1111/j.1471-4159.2009.06334.x; Fernandez DC, 2009, INVEST OPHTH VIS SCI, V50, P3922, DOI 10.1167/iovs.08-3344; Georgakopoulos CD, 2011, J PEDIAT OPHTH STRAB, V48, P92, DOI 10.3928/01913913-20100420-02; GHAFOUR IM, 1982, BRIT J OPHTHALMOL, V66, P492, DOI 10.1136/bjo.66.8.492; Hogins J, 2011, NEUROBIOL DIS, V43, P516, DOI 10.1016/j.nbd.2011.05.005; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Lieth E, 1998, DIABETES, V47, P815, DOI 10.2337/diabetes.47.5.815; Lu MJ, 2007, EXP DIABETES RES, DOI 10.1155/2007/39765; Marcos HJA, 1996, BIOCELL, V20, P265; MARTINELLI V, 1992, ACTA DIABETOL, V29, P34, DOI 10.1007/BF00572827; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pignataro Giuseppe, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P1; PRAGER TC, 1990, AM J OPHTHALMOL, V109, P279, DOI 10.1016/S0002-9394(14)74550-7; Roth S, 1998, INVEST OPHTH VIS SCI, V39, P777; SOKOL S, 1985, ARCH OPHTHALMOL-CHIC, V103, P51; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tanaka K, 2000, NEUROSCI RES, V37, P15, DOI 10.1016/S0168-0102(00)00104-8; Uberall MA, 1996, NEUROPEDIATRICS, V27, P88, DOI 10.1055/s-2007-973755; Verrotti A, 2000, DEV MED CHILD NEUROL, V42, P240, DOI 10.1017/S0012162200000414; Villarroel M, 2010, WORLD J DIABETES, V1, P57, DOI 10.4239/wjd.v1.i2.57; Whitmire W, 2011, MOL VIS, V17, P300; Wolff BE, 2010, DOC OPHTHALMOL, V121, P189, DOI 10.1007/s10633-010-9245-y; Yu XH, 2009, EXP EYE RES, V89, P967, DOI 10.1016/j.exer.2009.08.006; Zeng KH, 2010, MOL CELL NEUROSCI, V45, P192, DOI 10.1016/j.mcn.2010.06.010; Zhang WQ, 2011, J CLIN NEUROSCI, V18, P685, DOI 10.1016/j.jocn.2010.08.027	40	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51966	10.1371/journal.pone.0051966	http://dx.doi.org/10.1371/journal.pone.0051966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284834	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500070
J	Kallendrusch, S; Hobusch, C; Ehrlich, A; Nowicki, M; Ziebell, S; Bechmann, I; Geisslinger, G; Koch, M; Dehghani, F				Kallendrusch, Sonja; Hobusch, Constance; Ehrlich, Angela; Nowicki, Marcin; Ziebell, Simone; Bechmann, Ingo; Geisslinger, Gerd; Koch, Marco; Dehghani, Faramarz			Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage	PLOS ONE			English	Article							HIPPOCAMPAL SLICE CULTURES; CANNABINOID RECEPTOR CB1; FOCAL CEREBRAL-ISCHEMIA; KNOCK-OUT MICE; MONOACYLGLYCEROL LIPASE; ENDOCANNABINOID SYSTEM; INTERNATIONAL UNION; DIRECT SUPPRESSION; DENTATE GYRUS; BRAIN-INJURY	Background: The endocannabinoid 2-arachidonoyl glycerol (2-AG) acts as a retrograde messenger and modulates synaptic signaling e. g. in the hippocampus. 2-AG also exerts neuroprotective effects under pathological situations. To better understand the mechanism beyond physiological signaling we used Organotypic Entorhino-Hippocampal Slice Cultures (OHSC) and investigated the temporal regulation of 2-AG in different cell subsets during excitotoxic lesion and dendritic lesion of long range projections in the enthorhinal cortex (EC), dentate gyrus (DG) and the cornu ammonis region 1 (CA1). Results: 2-AG levels were elevated 24 h after excitotoxic lesion in CA1 and DG (but not EC) and 24 h after perforant pathway transection (PPT) in the DG only. After PPT diacylglycerol lipase alpha (DAGL) protein, the synthesizing enzyme of 2-AG was decreased when Dagl mRNA expression and 2-AG levels were enhanced. In contrast to DAGL, the 2-AG hydrolyzing enzyme monoacylglycerol lipase (MAGL) showed no alterations in total protein and mRNA expression after PPT in OHSC. MAGL immunoreaction underwent a redistribution after PPT and excitotoxic lesion since MAGL IR disappeared in astrocytes of lesioned OHSC. DAGL and MAGL immunoreactions were not detectable in microglia at all investigated time points. Thus, induction of the neuroprotective endocannabinoid 2-AG might be generally accomplished by down-regulation of MAGL in astrocytes after neuronal lesions. Conclusion: Increase in 2-AG levels during secondary neuronal damage reflects a general neuroprotective mechanism since it occurred independently in both different lesion models. This intrinsic up-regulation of 2-AG is synergistically controlled by DAGL and MAGL in neurons and astrocytes and thus represents a protective system for neurons that is involved in dendritic reorganisation.	[Kallendrusch, Sonja; Hobusch, Constance; Ehrlich, Angela; Nowicki, Marcin; Bechmann, Ingo; Koch, Marco; Dehghani, Faramarz] Univ Leipzig, Inst Anat, Leipzig, Germany; [Kallendrusch, Sonja] Lipid Signaling Forschungszentrum Frankfurt, Frankfurt, Germany; [Ziebell, Simone; Geisslinger, Gerd] Goethe Univ Frankfurt, Inst Pharmakol, Frankfurt, Germany; [Dehghani, Faramarz] Univ Halle Wittenberg, Inst Anat & Zellbiol, Halle, Germany	Leipzig University; Goethe University Frankfurt; Martin Luther University Halle Wittenberg	Dehghani, F (corresponding author), Univ Leipzig, Inst Anat, Leipzig, Germany.	Faramarz.Dehghani@medizin.uni-halle.de	Kallendrusch, Sonja/AAV-7179-2020; Kallendrusch, Sonja/ABG-1789-2021	Kallendrusch, Sonja/0000-0003-2474-8307	BMBF project Tierversuchsersatzmethoden; Lipid Signaling Forschungszentrum Frankfurt (LiFF)	BMBF project Tierversuchsersatzmethoden; Lipid Signaling Forschungszentrum Frankfurt (LiFF)	This study was supported by the BMBF project Tierversuchsersatzmethoden and by the Lipid Signaling Forschungszentrum Frankfurt (LiFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Casteels C, 2011, EXP NEUROL, V229, P440, DOI 10.1016/j.expneurol.2011.03.014; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Degn M, 2007, J NEUROCHEM, V103, P1907, DOI 10.1111/j.1471-4159.2007.04892.x; Del Turco Domenico, 2007, V399, P55, DOI 10.1007/978-1-59745-504-6_5; Deller T, 1997, ANN ANAT, V179, P501, DOI 10.1016/S0940-9602(97)80003-9; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dittel BN, 2008, BRIT J PHARMACOL, V153, P271, DOI 10.1038/sj.bjp.0707493; Fernandez-Ruiz J, 2008, MOL CELL ENDOCRINOL, V286, pS91, DOI 10.1016/j.mce.2008.01.001; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Frotscher M, 1997, TRENDS NEUROSCI, V20, P218, DOI 10.1016/S0166-2236(96)01018-1; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gomez O, 2010, GLIA, V58, P1913, DOI 10.1002/glia.21061; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Kallendrusch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033537; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Koch M, 2011, NEUROTOX RES, V19, P330, DOI 10.1007/s12640-010-9166-2; Kovac AD, 2004, BRAIN PATHOL, V14, P249; Kreutz S, 2007, EXP NEUROL, V203, P246, DOI 10.1016/j.expneurol.2006.08.010; Kristensen BW, 2001, BRAIN RES, V917, P21, DOI 10.1016/S0006-8993(01)02900-6; Ludanyi A, 2011, NEUROSCIENCE, V174, P50, DOI 10.1016/j.neuroscience.2010.10.062; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Marsicano G, 2002, J NEUROCHEM, V80, P448, DOI 10.1046/j.0022-3042.2001.00716.x; McPartland JM, 2007, GENE, V397, P126, DOI 10.1016/j.gene.2007.04.017; Milton NGN, 2002, NEUROSCI LETT, V332, P127, DOI 10.1016/S0304-3940(02)00936-9; Mulder J, 2011, BRAIN, V134, P1041, DOI 10.1093/brain/awr046; Nagayama T, 1999, J NEUROSCI, V19, P2987; Pan B, 2011, J NEUROSCI, V31, P13420, DOI 10.1523/JNEUROSCI.2075-11.2011; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pisani V, 2011, MOVEMENT DISORD, V26, P216, DOI 10.1002/mds.23457; Ramirez JJ, 2001, RESTOR NEUROL NEUROS, V19, P237; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Straiker A, 2011, BRIT J PHARMACOL, V164, P1672, DOI 10.1111/j.1476-5381.2011.01486.x; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Uchigashima M, 2011, J NEUROSCI, V31, P7700, DOI 10.1523/JNEUROSCI.5665-10.2011; van der Stelt M, 2005, NEUROMOL MED, V7, P37, DOI 10.1385/NMM:7:1-2:037; van der Stelt M, 2001, J NEUROSCI, V21, P6475, DOI 10.1523/JNEUROSCI.21-17-06475.2001; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wickliffe K, 2009, CHEM REV, V109, P1537, DOI 10.1021/cr800414e; Witting A, 2006, P NATL ACAD SCI USA, V103, P6362, DOI 10.1073/pnas.0510418103; Yazaki M, 2012, MOL BIOL CELL, V23, P12, DOI 10.1091/mbc.E11-07-0623; Yin H, 2010, J BIOL CHEM, V285, P13580, DOI 10.1074/jbc.M109.046359; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Zajicek JP, 2011, CNS DRUGS, V25, P187, DOI 10.2165/11539000-000000000-00000; Zhao Y, 2010, J CARDIOVASC PHARM, V55, P292, DOI 10.1097/FJC.0b013e3181d2644d	64	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51208	10.1371/journal.pone.0051208	http://dx.doi.org/10.1371/journal.pone.0051208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284665	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500022
J	Kriegl, L; Jung, A; Horst, D; Rizzani, A; Jackstadt, R; Hermeking, H; Gallmeier, E; Gerbes, AL; Kirchner, T; Goke, B; De Toni, EN				Kriegl, Lydia; Jung, Andreas; Horst, David; Rizzani, Antonia; Jackstadt, Rene; Hermeking, Heiko; Gallmeier, Eike; Gerbes, Alexander L.; Kirchner, Thomas; Goeke, Burkhard; De Toni, Enrico N.			Microsatellite Instability, KRAS Mutations and Cellular Distribution of TRAIL-Receptors in Early Stage Colorectal Cancer	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; NATURAL-KILLER-CELLS; HEPATOCELLULAR-CARCINOMA; COLON-CANCER; TUMOR-DEVELOPMENT; DEATH-RECEPTORS; PROGNOSTIC-SIGNIFICANCE; ADJUVANT THERAPY; PLUS IRINOTECAN; MISMATCH REPAIR	Background: The fact that the receptors for the TNF-related apoptosis inducing ligand (TRAIL) are almost invariably expressed in colorectal cancer (CRC) represents the rationale for the employment of TRAIL-receptors targeting compounds for the therapy of patients affected by this tumor. Yet, first reports on the use of these bioactive agents provided disappointing results. We therefore hypothesized that loss of membrane-bound TRAIL-R might be a feature of some CRC and that the evaluation of membrane staining rather than that of the overall expression of TRAIL-R might predict the response to TRAIL-R targeting compounds in this tumor. Aim and Methods: Thus, we evaluated the immunofluorescence pattern of TRAIL-receptors and E-cadherin to assess the fraction of membrane-bound TRAIL-receptors in 231 selected patients with early-stage CRC undergoing surgical treatment only. Moreover, we investigated whether membrane staining for TRAIL-receptors as well as the presence of KRAS mutations or of microsatellite instability (MSI) had an effect on survival and thus a prognostic effect. Results: As expected, almost all CRC samples stained positive for TRAIL-R1 and 2. Instead, membrane staining for these receptors was positive in only 71% and 16% of samples respectively. No correlation between KRAS mutation status or MSI-phenotype and prognosis could be detected. TRAIL-R1 staining intensity correlated with survival in univariate analysis, but only membranous staining of TRAIL-R1 and TRAIL-R2 on cell membranes was an independent predictor of survival (cox multivariate analysis: TRAIL-R1: p = 0.019, RR 2.06[1.12-3.77]; TRAIL-R2: p = 0.033, RR 3.63[1.11-11.84]). Conclusions: In contrast to the current assumptions, loss of membrane staining for TRAIL-receptors is a common feature of early stage CRC which supersedes the prognostic significance of their staining intensity. Failure to achieve therapeutic effects in recent clinical trials using TRAIL-receptors targeting compounds might be due to insufficient selection of patients bearing tumors with membrane-bound TRAIL-receptors.	[Rizzani, Antonia; Gallmeier, Eike; Gerbes, Alexander L.; Goeke, Burkhard; De Toni, Enrico N.] Univ Munich, Univ Hosp Grosshadern, Dept Med 2, Munich, Germany; [Kriegl, Lydia; Jung, Andreas; Horst, David; Jackstadt, Rene; Hermeking, Heiko; Kirchner, Thomas] Univ Munich, Inst Pathol, D-8000 Munich, Germany	University of Munich; University of Munich	De Toni, EN (corresponding author), Univ Munich, Univ Hosp Grosshadern, Dept Med 2, Munich, Germany.	enrico.detoni@med.uni-muenchen.de	De Toni, Enrico N/C-6496-2008		Deutsche Forschungsgemeinschaft (DFG) [DFG TO 605/2-1]; Else Kroner-Fresenius Stiftung [2011_A226]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) with the grant DFG TO 605/2-1 to EDT and by the Else Kroner-Fresenius Stiftung with the grant 2011_A226 to EDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2009, J PATHOL, V219, P435, DOI 10.1002/path.2625; Bavi P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-203; Boland CR, 1998, CANCER RES, V58, P5248; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; De Toni EN, 2008, CLIN CANCER RES, V14, P4713, DOI 10.1158/1078-0432.CCR-07-5019; Deschoolmeester V, 2008, J MOL DIAGN, V10, P154, DOI 10.2353/jmoldx.2008.070087; Elias A, 2009, CLIN CANCER RES, V15, P5457, DOI 10.1158/1078-0432.CCR-09-1125; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Jaitner S, 2012, CELL CYCLE, V11, P3331, DOI 10.4161/cc.21790; Jeng YM, 2002, CANCER LETT, V181, P205, DOI 10.1016/S0304-3835(02)00051-4; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kriegl L, 2010, CLIN CANCER RES, V16, P5529, DOI 10.1158/1078-0432.CCR-09-3403; McCarthy MM, 2005, CLIN CANCER RES, V11, P5188, DOI 10.1158/1078-0432.CCR-05-0158; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Niemoller O, 2009, RESULTS PROBL CELL D, V49, P219, DOI 10.1007/400_2009_17; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ohira M, 2006, TRANSPLANTATION, V82, P1712, DOI 10.1097/01.tp.0000250935.41034.2d; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Poehlmann A, 2007, PATHOL RES PRACT, V203, P489, DOI 10.1016/j.prp.2007.06.001; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Schulze-Bergkamen H, 2009, GUT, V58, P1010, DOI 10.1136/gut.2008.164350; Shin MS, 2001, CANCER RES, V61, P4942; Sinicrope FA, 2011, JNCI-J NATL CANCER I, V103, P863, DOI 10.1093/jnci/djr153; SOBIN LH, 2010, TMN CLASSIFICATION M; Soria JC, 2010, J CLIN ONCOL, V28, P1527, DOI 10.1200/JCO.2009.25.4847; Strater J, 2002, CLIN CANCER RES, V8, P3734; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Trarbach T, 2010, BRIT J CANCER, V102, P506, DOI 10.1038/sj.bjc.6605507; Ullenhag GJ, 2007, CLIN CANCER RES, V13, P5070, DOI 10.1158/1078-0432.CCR-06-2547; van Geelen CM, 2006, J CLIN ONCOL, V24, P4998, DOI 10.1200/JCO.2006.06.8809; Van Geelen CMM, 2004, DRUG RESIST UPDATE, V7, P345, DOI 10.1016/j.drup.2004.11.002; Walczak H, 2006, APOPTOSIS CANC THERA, P31; Yamamoto T, 2004, CLIN CANCER RES, V10, P7884, DOI 10.1158/1078-0432.CCR-04-0794; Yue HH, 2005, CELL DEATH DIFFER, V12, P94, DOI 10.1038/sj.cdd.4401523; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	40	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51654	10.1371/journal.pone.0051654	http://dx.doi.org/10.1371/journal.pone.0051654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284732	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500037
J	Balam, S; Romero, JF; Bongfen, SE; Guillaume, P; Corradin, G				Balam, Saidou; Romero, Jackeline F.; Bongfen, Silayuv E.; Guillaume, Philippe; Corradin, Giampietro			CSP-A Model for In Vivo Presentation of Plasmodium berghei Sporozoite Antigens by Hepatocytes	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN; INFECTED HEPATOCYTES; T-CELLS; KUPFFER CELLS; LIVER STAGES; MALARIA; INTERFERON; PROTECTION; DEFICIENT; RESPONSES	One target of protective immunity against the Plasmodium liver stage in BALB/c mice is represented by the circumsporozoite protein (CSP), and mainly involves its recognition by IFN-gamma producing specific CD8+T-cells. In a previous in vitro study we showed that primary hepatocytes from BALB/c mice process Plasmodium berghei (Pb) CSP (PbCSP) and present CSP-derived peptides to specific H-2k(d) restricted CD8+T-cells with subsequent killing of the presenting cells. We now extend these observations to an in vivo infection model in which infected hepatocytes and antigen specific T-cell clones are transferred into recipient mice inducing protection from sporozoite (SPZ) challenge. In addition, using a similar protocol, we suggest the capacity of hepatocytes in priming of naive T-cells to provide protection, as further confirmed by induction of protection after depletion of cross-presenting dendritic cells (DCs) by cytochrome c (cyt c) treatment or using traversal deficient parasites. Our results clearly show that hepatocytes present Plasmodium CSP to specific-primed CD8+T-cells, and could also prime naive T-cells, leading to protection from infection. These results could contribute to a better understanding of liver stage immune response and design of malaria vaccines.	[Balam, Saidou; Romero, Jackeline F.; Bongfen, Silayuv E.; Corradin, Giampietro] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Guillaume, Philippe] Univ Lausanne, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland	University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne	Corradin, G (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	giampietro.corradin@unil.ch		BALAM, Dr Saidou/0000-0002-7178-7758				Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; Bongfen SE, 2008, PARASITE IMMUNOL, V30, P375, DOI 10.1111/j.1365-3024.2008.01032.x; Bongfen SE, 2007, J IMMUNOL, V178, P7054, DOI 10.4049/jimmunol.178.11.7054; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chattopadhyay R, 2011, J BIOL CHEM, V286, P26396, DOI 10.1074/jbc.M111.240879; Chefalo PJ, 2003, J IMMUNOL, V170, P5825, DOI 10.4049/jimmunol.170.12.5825; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; Crispe IN, 2006, IMMUNOL REV, V213, P101, DOI 10.1111/j.1600-065X.2006.00435.x; Douradinha Bruno, 2011, J Immune Based Ther Vaccines, V9, P6, DOI 10.1186/1476-8518-9-6; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Leiriao P, 2005, J INFECT DIS, V191, P1576, DOI 10.1086/429635; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; LUESCHER IF, 1995, IMMUNITY, V3, P51, DOI 10.1016/1074-7613(95)90158-2; Mehal WZ, 2001, J IMMUNOL, V167, P667, DOI 10.4049/jimmunol.167.2.667; MEIS JFGM, 1983, PARASITOLOGY, V86, P231, DOI 10.1017/S003118200005040X; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Renia L, 2006, J INFECT DIS, V193, P163, DOI 10.1086/498536; RENIA L, 1994, IMMUNOLOGY, V82, P164; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SEGUIN MC, 1989, J IMMUNOL, V143, P1716; Torgler R, 2008, J IMMUNOL, V180, P3990, DOI 10.4049/jimmunol.180.6.3990; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Voza T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-362	30	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51875	10.1371/journal.pone.0051875	http://dx.doi.org/10.1371/journal.pone.0051875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272182	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300037
J	Man, SL; Petersen, I; Thompson, M; Nazareth, I				Man, Shuk-Li; Petersen, Irene; Thompson, Mary; Nazareth, Irwin			Antiepileptic Drugs during Pregnancy in Primary Care: A UK Population Based Study	PLOS ONE			English	Article							BIPOLAR DISORDER; EPILEPSY; WOMEN; RISK	Objective: Antiepileptic drugs (AEDs) are commonly prescribed for epilepsy and bipolar disorder but little is known about their use in pregnancy. We examined secular trends in AED prescribing in pregnancy and pregnancy as a determinant for stopping AED prescribing. Methods: We identified 174,055 pregnancies from The Health Improvement Network UK primary care database. Secular trends in AED prescribing during pregnancy were examined between 1994 and 2009. We used Cox's regression analyses to compare time to discontinuation of AED prescriptions between pregnant and non-pregnant women and to identify predictors of discontinuation of AEDs in pregnancy. Results: Prescribing of carbamazepine and sodium valproate have declined since 1994 despite being the most commonly prescribed AEDs in pregnancy up to 2004. Prescribing of lamotrigine in pregnancy has steadily increased and has been the most popular AED prescribed in pregnancy since 2004. Pregnant women with epilepsy were twice as likely to stop receiving AEDs (Hazard Ratio (HR) 2.00, 95% Confidence Interval (CI) 1.62-2.47) when compared to non-pregnant women and for women with bipolar disorder this was even higher (HR 3.07, 95% CI 2.04-4.62). For pregnant women with epilepsy, those receiving AEDs less regularly before pregnancy were more likely to stop receiving AEDs in pregnancy. Conclusions: Lamotrigine has been increasingly prescribed in pregnancy over older AEDs namely carbamazepine and sodium valproate. Pregnancy is a strong determinant for the discontinuation of AED prescribing particularly for women with bipolar disorder. Citation: Man S-L, Petersen I, Thompson M, Nazareth I (2012) Antiepileptic Drugs during Pregnancy in Primary Care: A UK Population Based Study. PLoS ONE 7(12): e52339. doi:10.1371/journal.pone.0052339	[Man, Shuk-Li; Petersen, Irene; Nazareth, Irwin] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Thompson, Mary] Cegedim Strateg Data Med Res UK, London, England	University of London; University College London	Man, SL (corresponding author), UCL, Res Dept Primary Care & Populat Hlth, London, England.	shuk-li.man.10@ucl.ac.uk	Petersen, Irene/C-5702-2009	Petersen, Irene/0000-0002-0037-7524; Nazareth, Irwin/0000-0003-2146-9628	Medical Research Council UK; Cegedim Strategic Data; Cegedim Strategic Data Medical Research UK; MRC [G0601726] Funding Source: UKRI; Medical Research Council [1029459, G0601726] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cegedim Strategic Data; Cegedim Strategic Data Medical Research UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is funded by the Medical Research Council UK and Cegedim Strategic Data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Shuk-Li Man's PhD is largely funded by the Medical Research Council, UK, but the authors also receive commercial funding for this research from Cegedim Strategic Data Medical Research UK, and Dr. Mary Thompson is also employed by Cegedim Strategic Data Medical Research UK. The authors declare that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; Battino D, 2009, EPILEPSIA, V50, P2305, DOI 10.1111/j.1528-1167.2009.02093.x; Bengt K, 2005, REPROD TOXICOL, V8, P203, DOI [10.1016/0890-6238(94)90003-5, DOI 10.1016/0890-6238(94)90003-5]; Bourke Alison, 2004, Inform Prim Care, V12, P171; British Medical Association and Royal Pharmaceutical Society, 2011, BRIT NAT FORM 62; CLAYTONSMITH J, 1995, J MED GENET, V32, P724, DOI 10.1136/jmg.32.9.724; Crawford P, 2003, SEIZURE-EUR J EPILEP, V12, P502, DOI 10.1016/S1059-1311(03)00085-2; Einarson A, 2001, J PSYCHIATR NEUROSCI, V26, P44; Hayes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028725; Holmes LB, 2008, NEUROLOGY, V70, P2152, DOI 10.1212/01.wnl.0000304343.45104.d6; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; Jentink J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6581; Jones I, 2005, BRIT J PSYCHIAT, V186, P453, DOI 10.1192/bjp.186.6.453; Jones I, 2001, AM J PSYCHIAT, V158, P913, DOI 10.1176/appi.ajp.158.6.913; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Mawer G, 2010, SEIZURE-EUR J EPILEP, V19, P112, DOI 10.1016/j.seizure.2009.11.008; Meador Kimford J, 2009, Epilepsy Behav, V15, P339, DOI 10.1016/j.yebeh.2009.04.026; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; National Institute for Clinical Excellence (Great Britain), 2012, EP DIAGN MAN EP AD C; National Institute for Health and Clinical Excellence, 2006, BIP DIS MAN BIP DIS; Nordeng H, 2010, EUR J CLIN PHARMACOL, V66, P207, DOI 10.1007/s00228-009-0744-2; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; The NHS Information Centre PaPCS, 2011, PRESCR COMPL REV PRO; Townsend P., 1986, INEQUALITIES HLTH NO; Vajda FJE, 2010, ACTA NEUROL SCAND, V121, P89, DOI 10.1111/j.1600-0404.2009.01260.x; Vajda FJE, 2006, EUR J NEUROL, V13, P645, DOI 10.1111/j.1468-1331.2006.01359.x; Viguera AC, 2007, AM J PSYCHIAT, V164, P1817, DOI 10.1176/appi.ajp.2007.06101639; WATERS CH, 1994, ARCH NEUROL-CHICAGO, V51, P250, DOI 10.1001/archneur.1994.00540150044014	29	43	43	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52339	10.1371/journal.pone.0052339	http://dx.doi.org/10.1371/journal.pone.0052339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272239	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300081
J	Shang, K; Bai, YP; Wang, C; Wang, Z; Gu, HY; Du, X; Zhou, XY; Zheng, CL; Chi, YY; Mukaida, N; Li, YY				Shang, Kun; Bai, Yu-Pan; Wang, Chen; Wang, Zhen; Gu, Hong-Yu; Du, Xiang; Zhou, Xiao-Yan; Zheng, Chun-Lei; Chi, Ya-Yun; Mukaida, Naofumi; Li, Ying-Yi			Crucial Involvement of Tumor-Associated Neutrophils in the Regulation of Chronic Colitis-Associated Carcinogenesis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; INFILTRATING NEUTROPHILS; COLORECTAL NEOPLASIA; PROGNOSTIC-FACTORS; ANGIOGENIC SWITCH; CELL CARCINOMA; CXC CHEMOKINES; COLON-CANCER; MOUSE MODEL	Ulcerative colitis (UC) is a major form of chronic inflammation that can frequently progress to colon cancer. Several studies have demonstrated massive infiltration of neutrophils and macrophages into the lamina propria and submucosa in the progression of UC-associated colon carcinogenesis. Macrophages contribute to the development of colitis-associated colon cancer (CAC). However, the role of neutrophils is not well understood. To better understand the involvement of tumor-associated neutrophils (TANs) in the regulation of CAC, we used a mouse CAC model produced by administering azoxymethane (AOM), followed by repeated dextran sulfate sodium (DSS) ingestion. This causes severe colonic inflammation and subsequent development of multiple tumors in mice colon. We observed that colorectal mucosal inflammation became increasingly severe with AOM and DSS treatment. Macrophages infiltrated the lamina propria and submucosa, together with a marked increase in neutrophil infiltration. The chemokine CXCL2 increased in the lamina propria and submucosal regions of the colons of the treated mice, together with the infiltration of neutrophils expressing CXCR2, a specific receptor for CXCL2. This process was followed by neoplastic transformation. After AOM and DSS treatment, the mice showed enhanced production of metalloproteinase (MMP)-9 and neutrophil elastase (NE), accompanied by excessive vessel generation and cell proliferation. Moreover, CXCL2 promoted neutrophil recruitment and induced neutrophils to express MMP-9 and NE in vitro. Furthermore, administration of neutrophil-neutralizing antibodies after the last DSS cycle markedly reduced the number and size of tumors and decreased the expression of CXCR2, CXCL2, MMP-9, and NE. These observations indicate a crucial role for TANs in the initiation and progression of CAC and suggest that the CXCL2-CXCR2 axis might be useful in reducing the risk of UC-associated colon cancer.	[Shang, Kun; Bai, Yu-Pan; Wang, Chen; Wang, Zhen; Gu, Hong-Yu; Du, Xiang; Zhou, Xiao-Yan; Zheng, Chun-Lei; Chi, Ya-Yun; Li, Ying-Yi] Fudan Univ, Canc Res Lab, Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Mukaida, Naofumi; Li, Ying-Yi] Kanazawa Univ, Canc Res Inst, Canc Microenvironm Res Program, Div Mol Bioregulat, Kanazawa, Ishikawa 920, Japan	Fudan University; Kanazawa University	Li, YY (corresponding author), Fudan Univ, Canc Res Lab, Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China.	liyingyi@fudan.edu.cn	Mukaida, Naofumi/D-7623-2011	Mukaida, Naofumi/0000-0002-4193-1851	National Science Foundation of China (NSFC) [30973476]; Shanghai Pujiang Program [10PJ1402100]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This study supported by funding from The National Science Foundation of China (NSFC) (30973476) and Shanghai Pujiang Program (10PJ1402100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bellocq A, 1998, AM J PATHOL, V152, P83; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Ding PR, 2010, INT J COLORECTAL DIS, V25, P1427, DOI 10.1007/s00384-010-1052-0; DOBBINS WO, 1984, ANNU REV MED, V35, P33, DOI 10.1146/annurev.me.35.020184.000341; Donskov F, 2006, J CLIN ONCOL, V24, P1997, DOI 10.1200/JCO.2005.03.9594; Fossati G, 1999, ACTA NEUROPATHOL, V98, P349, DOI 10.1007/s004010051093; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Hannelien V, 2012, BBA-REV CANCER, V1825, P117, DOI 10.1016/j.bbcan.2011.10.008; Houghton AM, 2010, CELL CYCLE, V9, P1732, DOI 10.4161/cc.9.9.11297; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Kostadinova FI, 2010, J LEUKOCYTE BIOL, V88, P133, DOI 10.1189/jlb.1109768; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Lu PR, 2008, J IMMUNOL, V180, P4283, DOI 10.4049/jimmunol.180.6.4283; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Michael M, 2006, CLIN COLORECTAL CANC, V6, P297, DOI 10.3816/CCC.2006.n.048; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mukaida N, 2012, EXP CELL RES, V318, P95, DOI 10.1016/j.yexcr.2011.10.012; Nickkho-Amiry M, 2012, MOL CANCER RES, V10, P441, DOI 10.1158/1541-7786.MCR-11-0233; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Okayasu I, 2002, J GASTROEN HEPATOL, V17, P1078, DOI 10.1046/j.1440-1746.2002.02853.x; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; OWEN CA, 1994, AM J PHYSIOL-LUNG C, V267, pL775, DOI 10.1152/ajplung.1994.267.6.L775; Paesmans M, 2000, CANCER, V89, P523, DOI 10.1002/1097-0142(20000801)89:3<523::AID-CNCR7>3.0.CO;2-6; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Popivanova BK, 2009, CANCER RES, V69, P7884, DOI 10.1158/0008-5472.CAN-09-1451; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Reid MD, 2011, MODERN PATHOL, V24, P1612, DOI 10.1038/modpathol.2011.113; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Schmidt H, 2007, J CLIN ONCOL, V25, P1562, DOI 10.1200/JCO.2006.09.0274; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stolfi C, 2011, J EXP MED, V208, P2279, DOI 10.1084/jem.20111106; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Terkeltaub R, 1998, ARTHRITIS RHEUM, V41, P900, DOI 10.1002/1529-0131(199805)41:5<900::AID-ART18>3.0.CO;2-K; Trellakis S, 2011, INT J IMMUNOPATH PH, V24, P683, DOI 10.1177/039463201102400314; Ullman T, 2003, GASTROENTEROLOGY, V125, P1311, DOI 10.1016/j.gastro.2003.08.023; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wislez M, 2003, CANCER RES, V63, P1405; Wu YN, 2012, J BIOL CHEM, V287, P5744, DOI 10.1074/jbc.M111.315762	57	100	105	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51848	10.1371/journal.pone.0051848	http://dx.doi.org/10.1371/journal.pone.0051848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272179	Green Submitted, gold, Green Published			2022-12-25	WOS:000312483300035
J	Haanes, KA; Schwab, A; Novak, I				Haanes, Kristian A.; Schwab, Albrecht; Novak, Ivana			The P2X7 Receptor Supports Both Life and Death in Fibrogenic Pancreatic Stellate Cells	PLOS ONE			English	Article							FUNCTIONAL EVIDENCE; ATP; ACTIVATION; RELEASE; PROLIFERATION; CULTURE; MODEL	The pancreatic stellate cells (PSCs) have complex roles in pancreas, including tissue repair and fibrosis. PSCs surround ATP releasing exocrine cells, but little is known about purinergic receptors and their function in PSCs. Our aim was to resolve whether PSCs express the multifunctional P2X7 receptor and elucidate how it regulates PSC viability. The number of PSCs isolated from wild type (WT) mice was 50% higher than those from the Pfizer P2X7 receptor knock out (KO) mice. The P2X7 receptor protein and mRNA of all known isoforms were expressed in WT PSCs, while KO PSCs only expressed truncated versions of the receptor. In culture, the proliferation rate of the KO PSCs was significantly lower. Inclusion of apyrase reduced the proliferation rate in both WT and KO PSCs, indicating importance of endogenous ATP. Exogenous ATP had a two-sided effect. Proliferation of both WT and KO cells was stimulated with ATP in a concentration-dependent manner with a maximum effect at 100 mu ZM. At high ATP concentration (5 mM), WT PSCs, but not the KO PSCs died. The intracellular Ca2+ signals and proliferation rate induced by micromolar ATP concentrations were inhibited by the allosteric P2X7 receptor inhibitor az10606120. The P2X7 receptor-pore inhibitor A438079 partially prevented cell death induced by millimolar ATP concentrations. This study shows that ATP and P2X7 receptors are important regulators of PSC proliferation and death, and therefore might be potential targets for treatments of pancreatic fibrosis and cancer.	[Haanes, Kristian A.; Novak, Ivana] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Schwab, Albrecht] Univ Munster, Inst Physiol 2, Munster, Germany	University of Copenhagen; University of Munster	Novak, I (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	inovak@bio.ku.dk	Haanes, Kristian Agmund/I-5881-2013; Novak, Ivana/M-2791-2014	Haanes, Kristian Agmund/0000-0001-5182-8957; Novak, Ivana/0000-0002-8917-8010	Danish Council for Independent Research \ Natural Sciences; Lundbeck Foundation; Novo Nordisk Foundation; Carlsberg Foundation; FP7 Marie Curie Initial Training Network "IonTraC"; Lundbeck Foundation [R17-2007-1366] Funding Source: researchfish	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); FP7 Marie Curie Initial Training Network "IonTraC"; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Council for Independent Research vertical bar Natural Sciences, the Lundbeck Foundation, the Novo Nordisk Foundation, the Carlsberg Foundation and FP7 Marie Curie Initial Training Network "IonTraC". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi Elena, 2005, Purinergic Signal, V1, P219, DOI 10.1007/s11302-005-6322-x; Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Amstrup J, 2003, BIOCHEM J, V374, P51, DOI 10.1042/BJ20030585; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Bianchi BR, 1999, EUR J PHARMACOL, V376, P127, DOI 10.1016/S0014-2999(99)00350-7; Burnstock G, 2012, J ENDOCRINOL, V213, P123, DOI 10.1530/JOE-11-0434; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Costa HM, 2011, PURINERG SIGNAL, V7, P7, DOI 10.1007/s11302-011-9215-1; Dalskov SM, 2005, NEUROCHEM INT, V46, P489, DOI 10.1016/j.neuint.2004.11.010; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Ferrari D, 1997, J IMMUNOL, V159, P1451; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Glas R, 2009, DIABETOLOGIA, V52, P1579, DOI 10.1007/s00125-009-1349-0; Haanes KA, 2010, BIOCHEM J, V429, P303, DOI 10.1042/BJ20091337; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Hennigs JK, 2011, PANCREAS, V40, P740, DOI 10.1097/MPA.0b013e31821b5b68; Hoque R, 2011, GASTROENTEROLOGY, V141, P358, DOI 10.1053/j.gastro.2011.03.041; Jaster R, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-26; Jun DJ, 2007, J BIOL CHEM, V282, P37350, DOI 10.1074/jbc.M707915200; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Klapperstuck M, 2001, J PHYSIOL-LONDON, V534, P25, DOI 10.1111/j.1469-7793.2001.00025.x; Kunzli BM, 2008, GASTROENTEROLOGY, V134, P292, DOI 10.1053/j.gastro.2007.10.030; Kunzli BM, 2007, AM J PHYSIOL-GASTR L, V292, pG223, DOI 10.1152/ajpgi.00259.2006; Lenertz LY, 2011, IMMUNOL RES, V50, P22, DOI 10.1007/s12026-011-8203-4; Masin M, 2011, BRIT J PHARMACOL, V165, P978; Michel AD, 2007, BRIT J PHARMACOL, V151, P84, DOI 10.1038/sj.bjp.0707196; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Novak I, 2008, PURINERG SIGNAL, V4, P237, DOI 10.1007/s11302-007-9087-6; Obermuller S, 2005, J CELL SCI, V118, P4271, DOI 10.1242/jcs.02549; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; RUOSLAHTI E, 1984, CANCER METAST REV, V3, P43, DOI 10.1007/BF00047692; Schulze-Lohoff E, 1998, AM J PHYSIOL-RENAL, V275, pF962, DOI 10.1152/ajprenal.1998.275.6.F962; Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Won JH, 2011, MOL BIOL CELL, V22, P421, DOI 10.1091/mbc.E10-10-0807; Xu C, 2009, AM J PHYSIOL-RENAL, V296, pF1464, DOI 10.1152/ajprenal.90542.2008; Zimmermann A, 2002, GUT, V51, P574, DOI 10.1136/gut.51.4.574	44	50	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51164	10.1371/journal.pone.0051164	http://dx.doi.org/10.1371/journal.pone.0051164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284663	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900014
J	Liang, J; Li, YP; Zhou, N; Teng, F; Zhao, J; Zou, CY; Qi, L				Liang, Jun; Li, Yanping; Zhou, Na; Teng, Fei; Zhao, Jing; Zou, Caiyan; Qi, Lu			Synergistic Effects of Serum Uric Acid and Cardiometabolic Risk Factors on Early Stage Atherosclerosis: The Cardiometabolic Risk in Chinese Study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; LOW-GRADE INFLAMMATION; HEART-RATE; ARTERIAL STIFFNESS; CARDIOVASCULAR-DISEASE; ALL-CAUSE; MORTALITY; EVENTS; MARKER; MEN	Objective: To comprehensively examine the associations of serum uric acid (SUA) with central and peripheral arterial stiffness in Chinese adults, and particularly assess the interactions between SUA and other cardiometabolic risk factors. Methods: The study included 3,772 Chinese men and women with carotid radial pulse wave velocity (crPWV), carotid femoral PWV (cfPWV), carotid artery dorsalis pedis PWV (cdPWV) and SUA measured. Results: After adjustment for age, sex, and BMI, the levels of SUA were significantly associated with increasing trend of cfPWV, crPWV and cdPWV (P for trend <0.0001). Further adjustment for heart rate (HR), blood pressure (BP) and lipids attenuated the associations with crPWV and cdPWV to be non-significant (P = 0.1, P = 0.099 respectively), but the association between SUV and cfPWV remained significant (P = 0.004). We found significant interactions between SUA and HR or BP in relation to cfPWV (P for interaction = 0.03, 0.003 respectively). The associations between SUA and cfPWV were more evident among individuals with higher HR or normal BP than those with lower HR or hypertension. Conclusions: SUA was associated with elevated aortic arterial stiffness in Chinese adults, independent of conventional cardiovascular risk factors. BP and HR might modify the deleterious effects of SUA.	[Liang, Jun; Teng, Fei; Zhao, Jing; Zou, Caiyan] Southeast Univ, Affiliated Hosp, Xuzhou Med Coll, Xuzhou Clin Sch,Cent Hosp Xuzhou,Dept Endocrinol, Xuzhou, Jiangsu, Peoples R China; [Liang, Jun; Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Li, Yanping; Qi, Lu] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Li, Yanping; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Zhou, Na] Oriental Peoples Hosp Xuzhou, Xuzhou, Jiangsu, Peoples R China	Southeast University - China; Xuzhou Medical University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Liang, J (corresponding author), Southeast Univ, Affiliated Hosp, Xuzhou Med Coll, Xuzhou Clin Sch,Cent Hosp Xuzhou,Dept Endocrinol, Xuzhou, Jiangsu, Peoples R China.	mwlj521@163.com; nhlqi@channing.harvard.edu	Li, Yanping/H-6437-2011	Li, Yanping/0000-0002-0412-2748	National Heart, Lung, and Blood Institute [HL071981]; Boston Obesity Nutrition Research Center [DK46200]; American Heart Association Scientist Development Award [0730094N]; Xuzhou medical leading talent grant; Xuzhou Science and Technology Board Foundation [XF11C067]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071981] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston Obesity Nutrition Research Center; American Heart Association Scientist Development Award(American Heart Association); Xuzhou medical leading talent grant; Xuzhou Science and Technology Board Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Lu Qi was supported by grants from the National Heart, Lung, and Blood Institute (HL071981), the Boston Obesity Nutrition Research Center (DK46200), and the American Heart Association Scientist Development Award (0730094N). Dr. Jun Liang was supported by Xuzhou medical leading talent grant & Xuzhou Science and Technology Board Foundation grant (XF11C067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; Chen JH, 2009, ARTHRIT RHEUM-ARTHR, V61, P225, DOI 10.1002/art.24164; Forman JP, 2009, ARCH INTERN MED, V169, P155, DOI 10.1001/archinternmed.2008.521; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; Group K.W., 2002, AM J KIDNEY DIS, V39, pS46, DOI DOI 10.1053/AJKD.2002.30943; Hakoda M, 2005, J RHEUMATOL, V32, P906; Ishizaka N, 2007, ATHEROSCLEROSIS, V192, P131, DOI 10.1016/j.atherosclerosis.2006.04.016; Krantz MJ, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-15; Lanza GA, 2006, ADV CARDIOL, V43, P1, DOI 10.1159/000095401; Liang J, 2009, J HYPERTENS, V27, P1761, DOI 10.1097/HJH.0b013e32832e0b44; Lin Y, 2011, J ENDOCRINOL INVEST; Mankovsky B, 2010, DIABETES METAB SYND, V4, P176, DOI 10.1016/j.dsx.2010.07.010; Meisinger C, 2008, ARTERIOSCL THROM VAS, V28, P1186, DOI 10.1161/ATVBAHA.107.160184; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Neogi T, 2009, J RHEUMATOL, V36, P378, DOI 10.3899/jrheum.080646; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; Palatini P, 2007, DRUGS, V67, P3, DOI 10.2165/00003495-200767002-00002; Palatini P, 2006, J HYPERTENS, V24, P1873, DOI 10.1097/01.hjh.0000242413.96277.5b; Shen L, 2011, CEREBROVASC DIS, V32, P16, DOI 10.1159/000330316; Sugawara J, 2005, J HUM HYPERTENS, V19, P401, DOI 10.1038/sj.jhh.1001838; Sulikowska B, 2012, KIDNEY BLOOD PRESS R, V35, P161, DOI 10.1159/000330717; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Teng Fei, 2010, J HUMAN HYPERTENSION, V12, P31; Tomiyama H, 2007, HYPERTENS RES, V30, P417, DOI 10.1291/hypres.30.417; Tomiyama H, 2010, J HYPERTENS, V28, P687, DOI 10.1097/HJH.0b013e3283369fe8; Tsioufis C, 2011, J HUM HYPERTENS, V25, P554, DOI 10.1038/jhh.2010.98; Tsioufis C, 2007, EUR HEART J, V28, P1162, DOI 10.1093/eurheartj/ehm089	28	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51101	10.1371/journal.pone.0051101	http://dx.doi.org/10.1371/journal.pone.0051101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284659	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900011
J	Reyes-Bermudez, A; Miller, DJ; Sprungala, S				Reyes-Bermudez, Alejandro; Miller, David J.; Sprungala, Susanne			The Neuronal Calcium Sensor Protein Acrocalcin: A Potential Target of Calmodulin Regulation during Development in the Coral Acropora millepora	PLOS ONE			English	Article							REEF CORALS; POCILLOPORA-DAMICORNIS; BINDING PROTEINS; PLANULA LARVA; PHOSPHORYLATION; LOCALIZATION; RECOGNITION; EXPRESSION; MECHANISM; RESPONSES	To understand the calcium-mediated signalling pathways underlying settlement and metamorphosis in the Scleractinian coral Acropora millepora, a predicted protein set derived from larval cDNAs was scanned for the presence of EF-hand domains (Pfam Id: PF00036). This approach led to the identification of a canonical calmodulin (AmCaM) protein and an uncharacterised member of the Neuronal Calcium Sensor (NCS) family of proteins known here as Acrocalcin (AmAC). While AmCaM transcripts were present throughout development, AmAC transcripts were not detected prior to gastrulation, after which relatively constant mRNA levels were detected until metamorphosis and settlement. The AmAC protein contains an internal CaM-binding site and was shown to interact in vitro with AmCaM. These results are consistent with the idea that AmAC is a target of AmCaM in vivo, suggesting that this interaction may regulate calcium-dependent processes during the development of Acropora millepora.	[Reyes-Bermudez, Alejandro; Miller, David J.; Sprungala, Susanne] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Reyes-Bermudez, Alejandro; Miller, David J.; Sprungala, Susanne] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia; [Reyes-Bermudez, Alejandro] Okinawa Inst Sci & Technol, Okinawa, Japan	James Cook University; James Cook University; Okinawa Institute of Science & Technology Graduate University	Sprungala, S (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	susanne.sprungala@jcu.edu.au		Reyes-Bermudez, Alejandro/0000-0002-4588-3770; Miller, David/0000-0003-0291-9531	School of Pharmacy and Molecular Sciences, James Cook University; ARC Centre of Excellence for Coral Reef Studies	School of Pharmacy and Molecular Sciences, James Cook University; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	The work was supported by the School of Pharmacy and Molecular Sciences, James Cook University and the ARC Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Amici M, 2009, BIOCHEM SOC T, V37, P1359, DOI 10.1042/BST0371359; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Ball EE, 2002, INT J DEV BIOL, V46, P671; Ball EE, 2000, P 9 INT COR REEFS S, P395; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carafoli E, 1999, BIOCHEM BIOPH RES CO, V266, P624, DOI 10.1006/bbrc.1999.1879; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Chen IP, 2009, MAR BIOTECHNOL, V11, P141, DOI 10.1007/s10126-008-9129-2; Clode PL, 2004, TISSUE CELL, V36, P379, DOI 10.1016/j.tice.2004.06.005; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034; DECASTRO E, 1995, BIOCHEM BIOPH RES CO, V216, P133, DOI 10.1006/bbrc.1995.2601; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Gunderson L, 2007, CURR BIOL, V17, pR27, DOI 10.1016/j.cub.2006.11.034; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Hayward DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026411; Hayward DC, 2001, DEV GENES EVOL, V211, P10; Hilfiker S, 2003, BIOCHEM SOC T, V31, P828, DOI 10.1042/BST0310828; Ishida H, 2002, BIOCHEMISTRY-US, V41, P15536, DOI 10.1021/bi020330r; Ivings L, 2002, BIOCHEM J, V363, P599, DOI 10.1042/0264-6021:3630599; Jamieson G A Jr, 1980, Ann N Y Acad Sci, V356, P1, DOI 10.1111/j.1749-6632.1980.tb29593.x; Lab I, 2002, CALM TARG DAT; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; Morita M, 2009, MAR BIOTECHNOL, V11, P118, DOI 10.1007/s10126-008-9127-4; Morse ANC, 1996, BIOL BULL, V191, P149, DOI 10.2307/1542917; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; O'Donnell SE, 2011, PROTEINS, V79, P765, DOI 10.1002/prot.22917; O'Donnell SE, 2009, METHOD ENZYMOL, V466, P503, DOI 10.1016/S0076-6879(09)66021-3; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reyes-Bermudez A, 2009, MAR GENOM, V2, P149, DOI 10.1016/j.margen.2009.07.002; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; VANDERMEULEN JH, 1973, MAR BIOL, V23, P47, DOI 10.1007/BF00394111; VANDERMEULEN JH, 1974, MAR BIOL, V27, P239, DOI 10.1007/BF00391949; VANDERMEULEN JH, 1975, MAR BIOL, V31, P69, DOI 10.1007/BF00390649; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; WALLACE RW, 1982, J BIOL CHEM, V257, P1845; Weiss JL, 2010, CELL MOL NEUROBIOL, V30, P1283, DOI 10.1007/s10571-010-9588-7; Yuasa HJ, 2001, GENE, V279, P205, DOI 10.1016/S0378-1119(01)00755-7; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010	55	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51689	10.1371/journal.pone.0051689	http://dx.doi.org/10.1371/journal.pone.0051689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284743	Green Published, Green Accepted, gold			2022-12-25	WOS:000312435900044
J	Kazma, R; Mefford, JA; Cheng, I; Plummer, SJ; Levin, AM; Rybicki, BA; Casey, G; Witte, JS				Kazma, Remi; Mefford, Joel A.; Cheng, Iona; Plummer, Sarah J.; Levin, Albert M.; Rybicki, Benjamin A.; Casey, Graham; Witte, John S.			Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk	PLOS ONE			English	Article							SCAVENGER RECEPTOR-1 GENE; COMMON SEQUENCE VARIANTS; RNASEL GENE; COX-2 GENE; ALPHA GENE; CYCLOOXYGENASE-2; EXPRESSION; SUSCEPTIBILITY; POLYMORPHISM; MUTATIONS	Prostate cancer is the most frequent and second most lethal cancer in men in the United States. Innate immunity and inflammation may increase the risk of prostate cancer. To determine the role of innate immunity and inflammation in advanced prostate cancer, we investigated the association of 320 single nucleotide polymorphisms, located in 46 genes involved in this pathway, with disease risk using 494 cases with advanced disease and 536 controls from Cleveland, Ohio. Taken together, the whole pathway was associated with advanced prostate cancer risk (P = 0.02). Two sub-pathways (intracellular antiviral molecules and extracellular pattern recognition) and four genes in these sub-pathways (TLR1, TLR6, OAS1, and OAS2) were nominally associated with advanced prostate cancer risk and harbor several SNPs nominally associated with advanced prostate cancer risk. Our results suggest that the innate immunity and inflammation pathway may play a modest role in the etiology of advanced prostate cancer through multiple small effects. Citation: Kazma R, Mefford JA, Cheng I, Plummer SJ, Levin AM, et al. (2012) Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk. PLoS ONE 7(12): e51680. doi: 10.1371/journal.pone.0051680	[Kazma, Remi; Mefford, Joel A.; Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kazma, Remi; Mefford, Joel A.; Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Cheng, Iona] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Plummer, Sarah J.; Casey, Graham] Univ So Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Levin, Albert M.; Rybicki, Benjamin A.] Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cancer Research Center of Hawaii; University of Hawaii System; University of Southern California; Henry Ford Health System; Henry Ford Hospital	Witte, JS (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	wittej@humgen.ucsf.edu	Rybicki, Benjamin/L-4614-2019	Rybicki, Benjamin/0000-0003-3190-3467	National Institutes of Health [R01CA88164, U01CA127298, R25CA112355]; NATIONAL CANCER INSTITUTE [R25CA112355, U01CA127298, R01CA088164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [Grant numbers: R01CA88164, U01CA127298, and R25CA112355 to R.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER LH, 1981, J UROLOGY, V125, P370, DOI 10.1016/S0022-5347(17)55039-9; Casey Graham, 2002, Nature Genetics, V32, P581, DOI 10.1038/ng1021; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Cheng I, 2007, BRIT J CANCER, V97, P557, DOI 10.1038/sj.bjc.6603874; Cheng I, 2010, CANCER EPIDEM BIOMAR, V19, P2124, DOI 10.1158/1055-9965.EPI-10-0268; Cohen BL, 2006, INT J CANCER, V119, P1082, DOI 10.1002/ijc.21749; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Visser KE, 2005, CANCER IMMUNOL IMMUN, V54, P1143, DOI 10.1007/s00262-005-0702-5; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Grinstein S, 2002, CANCER RES, V62, P4876; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardin J, 2011, NUTR CANCER, V63, P860, DOI 10.1080/01635581.2011.582224; Hayes RB, 2000, BRIT J CANCER, V82, P718, DOI 10.1054/bjoc.1999.0986; Hedelin M, 2007, INT J CANCER, V120, P398, DOI 10.1002/ijc.22319; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman LJ, 2004, J INFECT DIS, V189, P15, DOI 10.1086/380568; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaushal N, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P443, DOI 10.1007/978-1-4614-1025-6_35; Kirschenbaum A, 2000, UROLOGY, V56, P671, DOI 10.1016/S0090-4295(00)00674-9; Lee JC, 2003, J UROLOGY, V169, P584, DOI 10.1016/S0022-5347(05)63958-4; Lee LM, 2001, ANTICANCER RES, V21, P1291; Lindmark F, 2004, JNCI-J NATL CANCER I, V96, P1248, DOI 10.1093/jnci/djh227; Lindmark F, 2005, BRIT J CANCER, V93, P493, DOI 10.1038/sj.bjc.6602729; Lindmark F, 2004, PROSTATE, V59, P132, DOI 10.1002/pros.10367; Liu X, 2006, AM J EPIDEMIOL, V164, P984, DOI 10.1093/aje/kwj294; Loza MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001035; Mandal S, 2011, CANCER-AM CANCER SOC, V117, P5509, DOI 10.1002/cncr.26219; McCarron SL, 2002, CANCER RES, V62, P3369; Miller DC, 2003, CANCER RES, V63, P3486; Molinaro RJ, 2006, NUCLEIC ACIDS RES, V34, P6684, DOI 10.1093/nar/gkl968; Nakazato H, 2003, BRIT J CANCER, V89, P691, DOI 10.1038/sj.bjc.6601075; Noonan-Wheeler FC, 2006, PROSTATE, V66, P49, DOI 10.1002/pros.20320; Oh BR, 2000, J UROLOGY, V163, P1584, DOI 10.1016/S0022-5347(05)67683-5; Panguluri RCK, 2004, CARCINOGENESIS, V25, P961, DOI 10.1093/carcin/bgh100; Platz Elizabeth A., 2004, Journal of Urology, V171, pS36, DOI 10.1097/01.ju.0000108131.43160.77; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Core Team, 2021, R LANG ENV STAT COMP; Reese AC, 2009, J NUTRIGENET NUTRIGE, V2, P149, DOI 10.1159/000235565; Rennert H, 2005, CANCER EPIDEM BIOMAR, V14, P949, DOI 10.1158/1055-9965.EPI-04-0637; Rennert H, 2002, AM J HUM GENET, V71, P981, DOI 10.1086/342775; Rossi PG, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-71, 10.1186/1471-2407-9-69]; Rybicki BA, 2006, CANCER DETECT PREV, V30, P412, DOI 10.1016/j.cdp.2006.09.004; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Seppala EH, 2003, CLIN CANCER RES, V9, P5252; Shahedi K, 2006, INT J CANCER, V119, P668, DOI 10.1002/ijc.21864; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Sun JL, 2005, JNCI-J NATL CANCER I, V97, P525, DOI 10.1093/jnci/dji070; Sun JL, 2006, PROSTATE, V66, P728, DOI 10.1002/pros.20396; Taylor ML, 2005, FAM MED, V37, P506; Wang L, 2002, AM J HUM GENET, V71, P116, DOI 10.1086/341281; Wang WZ, 2005, CLIN CANCER RES, V11, P3250, DOI 10.1158/1078-0432.CCR-04-2405; Wu HC, 2004, UROL INT, V73, P41, DOI 10.1159/000078803; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Xu JF, 2005, CANCER EPIDEM BIOMAR, V14, P2563, DOI 10.1158/1055-9965.EPI-05-0356; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Xu JF, 2003, AM J HUM GENET, V72, P208, DOI 10.1086/345802; Zha S, 2001, CANCER RES, V61, P8617; Zheng SL, 2006, PROSTATE, V66, P1556, DOI 10.1002/pros.20496; Zheng SL, 2004, CANCER RES, V64, P2918, DOI 10.1158/0008-5472.CAN-03-3280	63	43	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51680	10.1371/journal.pone.0051680	http://dx.doi.org/10.1371/journal.pone.0051680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272139	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800063
J	Luna, C; Li, GR; Huang, JY; Qiu, JM; Wu, J; Yuan, F; Epstein, DL; Gonzalez, P				Luna, Coralia; Li, Guorong; Huang, Jianyong; Qiu, Jianming; Wu, Jing; Yuan, Fan; Epstein, David L.; Gonzalez, Pedro			Regulation of Trabecular Meshwork Cell Contraction and Intraocular Pressure by miR-200c	PLOS ONE			English	Article							MUSCLE-ACTIN EXPRESSION; HUMOR OUTFLOW FACILITY; GROWTH-FACTOR-BETA; SMALL NONCODING RNAS; OPEN-ANGLE GLAUCOMA; AQUEOUS-HUMOR; CILIARY MUSCLE; TRACTION FORCE; INHIBITOR Y-27632; CORNEAL INJURY	Lowering intraocular pressure (IOP) delays or prevents the loss of vision in primary open-angle glaucoma (POAG) patients with high IOP and in those with normal tension glaucoma showing progression. Abundant evidence demonstrates that inhibition of contractile machinery of the trabecular meshwork cells is an effective method to lower IOP. However, the mechanisms involved in the regulation of trabecular contraction are not well understood. Although microRNAs have been shown to play important roles in the regulation of multiple cellular functions, little is known about their potential involvement in the regulation of IOP. Here, we showed that miR-200c is a direct postranscriptional inhibitor of genes relevant to the physiologic regulation of TM cell contraction including the validated targets Zinc finger E-box binding homeobox 1 and 2 (ZEB1 and ZEB2), and formin homology 2 domain containing 1 (FHOD1), as well as three novel targets: lysophosphatidic acid receptor 1 (LPAR1/EDG2), endothelin A receptor (ETAR), and RhoA kinase (RHOA). Consistently, transfection of TM cells with miR-200c resulted in strong inhibition of contraction in collagen populated gels as well as decreased cell traction forces exerted by individual TM cells. Finally, delivery of miR-200c to the anterior chamber of living rat eyes resulted in a significant decrease in IOP, while inhibition of miR-200c using an adenoviral vector expressing a molecular sponge led to a significant increase in IOP. These results demonstrate for the first time the ability of a miRNA to regulate trabecular contraction and modulate IOP in vivo, making miR-200c a worthy candidate for exploring ways to alter trabecular contractility with therapeutic purposes in glaucoma.	[Luna, Coralia; Li, Guorong; Qiu, Jianming; Wu, Jing; Epstein, David L.; Gonzalez, Pedro] Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA; [Huang, Jianyong; Yuan, Fan] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University; Duke University	Gonzalez, P (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.	gonza012@mc.duke.edu	Yuan, Fan/A-1287-2011		NEI [EY01894, EY016228, EY05722]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY016228, P30EY005722, R01EY001894] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI EY01894, NEI EY016228, NEI EY05722, and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arend KO, 2005, KLIN MONATSBL AUGENH, V222, P807, DOI 10.1055/s-2005-858210; Bollinger KE, 2011, INVEST OPHTH VIS SCI, V52, P8287, DOI 10.1167/iovs.11-8218; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; COUSINS SW, 1991, INVEST OPHTH VIS SCI, V32, P2201; Dai ZK, 2010, PEDIATR PULM, V45, P1076, DOI 10.1002/ppul.21290; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Epstein DL, 1999, INVEST OPHTH VIS SCI, V40, P74; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Gautreau Z., 2006, CHARACTERIZING VISCO; Ghanem AA, 2011, OPHTHALMIC RES, V46, P98, DOI 10.1159/000323584; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grise F, 2012, HEPATOLOGY; Guzey M, 2001, EYE, V15, P781, DOI 10.1038/eye.2001.249; Hayasaka K, 1998, LIFE SCI, V63, P1089, DOI 10.1016/S0024-3205(98)00205-7; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Holley CL, 2011, CARDIOVASC DRUG THER, V25, P151, DOI 10.1007/s10557-011-6290-z; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Huang JY, 2012, CELL MOL BIOENG, V5, P205, DOI 10.1007/s12195-012-0224-0; Huang JY, 2009, J THEOR BIOL, V259, P811, DOI 10.1016/j.jtbi.2009.05.005; Huang JY, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/3/035101; Huang JY, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118767; HUNT RC, 1994, INVEST OPHTH VIS SCI, V35, P955; Iwabe S, 2010, CURR EYE RES, V35, P287, DOI 10.3109/02713680903545315; Iyer P, 2011, ARVO M APR 22 2011 F, V52, P2070; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kallberg ME, 2002, J GLAUCOMA, V11, P105; Krauss AHP, 1997, EXP EYE RES, V64, P447, DOI 10.1006/exer.1996.0224; Kumar J, 2011, J CELL BIOCHEM, V112, P600, DOI 10.1002/jcb.22950; Last JA, 2011, INVEST OPHTH VIS SCI, V52, P2147, DOI 10.1167/iovs.10-6342; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Liliom K, 1998, AM J PHYSIOL-CELL PH, V274, pC1065, DOI 10.1152/ajpcell.1998.274.4.C1065; Loser P, 1998, J VIROL, V72, P180; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; Mansouri K, 2012, SWISS MED WKLY, V142, DOI DOI 10.4414/smw.2012.13545; Mettu PS, 2004, INVEST OPHTH VIS SCI, V45, P2263, DOI 10.1167/iovs.03-0960; MOSES RA, 1977, SURV OPHTHALMOL, V22, P88, DOI 10.1016/0039-6257(77)90088-1; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Nobe H, 2003, AM J PHYSIOL-CELL PH, V284, pC599, DOI 10.1152/ajpcell.00188.2002; Noske W, 1997, GRAEF ARCH CLIN EXP, V235, P551, DOI 10.1007/BF00947082; O'Reilly S, 2011, INVEST OPHTH VIS SCI, V52, P7316, DOI 10.1167/iovs.10-6692; Pattabiraman PP, 2010, AM J PHYSIOL-CELL PH, V298, pC749, DOI 10.1152/ajpcell.00317.2009; Rao PV, 2005, EXP EYE RES, V80, P197, DOI 10.1016/j.exer.2004.08.029; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Rao VP, 2007, BIODRUGS, V21, P167, DOI 10.2165/00063030-200721030-00004; Rosenthal R, 2011, BRIT J PHARMACOL, V162, P806, DOI 10.1111/j.1476-5381.2010.01103.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5240, DOI 10.1167/iovs.11-7287; Shahar I, 1999, INT J IMMUNOPHARMACO, V21, P759, DOI 10.1016/S0192-0561(99)00056-9; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Shoshani YZ, 2012, CURR EYE RES, V37, P1, DOI 10.3109/02713683.2011.622849; STAMER WD, 1995, CURR EYE RES, V14, P611, DOI 10.3109/02713689508998409; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Syriani E, 2009, INVEST OPHTH VIS SCI, V50, P3833, DOI 10.1167/iovs.08-2924; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Tamm ER, 1996, EXP EYE RES, V62, P389, DOI 10.1006/exer.1996.0044; Tamm ER, 2007, SURV OPHTHALMOL, V52, pS101, DOI 10.1016/j.survophthal.2007.08.002; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tanihara H, 2008, ARCH OPHTHALMOL-CHIC, V126, P309, DOI 10.1001/archophthalmol.2007.76; Thieme H, 2000, INVEST OPHTH VIS SCI, V41, P4240; Tian B, 2009, EXP EYE RES, V88, P713, DOI 10.1016/j.exer.2008.08.008; Tian BH, 2005, EXP EYE RES, V80, P215, DOI 10.1016/j.exer.2004.09.002; Tokumura A, 2012, PROSTAG OTH LIPID M, V97, P83, DOI 10.1016/j.prostaglandins.2012.01.003; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Trivedi RH, 2011, J OCUL PHARMACOL TH, V27, P477, DOI 10.1089/jop.2010.0100; Von Zee CL, 2012, INVEST OPHTHALMOL VI; Watsky MA, 2000, ANN NY ACAD SCI, V905, P142; Wiederholt M, 1996, GER J OPHTHALMOL, V5, P146; WIEDERHOLT M, 1994, INVEST OPHTH VIS SCI, V35, P2515; Wiederholt M, 1998, INVEST OPHTH VIS SCI, V39, P1012; Wierzbowska J, 2010, MED SCI MONITOR, V16, pRA252; Yao J, 2002, J AM SOC NEPHROL, V13, P2018, DOI 10.1097/01.ASN.0000023436.71816.56; Yorio T, 2002, J GLAUCOMA, V11, P259, DOI 10.1097/00061198-200206000-00016; Yu M, 2008, J OCUL PHARMACOL TH, V24, P373, DOI 10.1089/jop.2008.0029; Zhang M, 2005, INVEST OPHTH VIS SCI, V46, P4130, DOI 10.1167/iovs.05-0164	78	63	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51688	10.1371/journal.pone.0051688	http://dx.doi.org/10.1371/journal.pone.0051688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272142	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386800066
J	Schrago, CG; Menezes, AN; Moreira, MAM; Pissinatti, A; Seuanez, HN				Schrago, Carlos G.; Menezes, Albert N.; Moreira, Miguel A. M.; Pissinatti, Alcides; Seuanez, Hector N.			Chronology of Deep Nodes in the Neotropical Primate Phylogeny: Insights from Mitochondrial Genomes	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; DIVERGENCE TIMES; MOLECULAR CLOCK; DIVERSIFICATION; BIOGEOGRAPHY; ACCURATE; RODENTS; MIOCENE	The evolution of Neotropical Primates (NP) is permeated by factors associated with the pattern of diversification and the biogeography of the major lineages. These questions can be better understood by providing a robust estimate of the chronological scenario of NP evolution, a reason why molecular dating methods have been widely applied. One aspect of especial interest is the timing of diversification of the major NP lineages (pitheciids, atelids and cebids), which may have resulted from rapid episodes of adaptive radiation, a question that requires NP divergence time estimates with accurate statistical certainty. In this study, we evaluated the primate timescale focused on the age of nodes of NP radiation. We investigated the performance of complete primate mitochondrial genomes as traditional molecular markers of primate evolution and further including original mitochondrial data from the endangered muriqui, Brachyteles arachnoides (Accession No. JX262672). Comparisons of the age estimates at NP nodes based on mitochondrial genomes with those obtained from a nuclear supermatrix showed similar degrees of uncertainty. Further molecular data and more informative calibration priors are required for a more precise understanding of the early NP diversification.	[Schrago, Carlos G.; Seuanez, Hector N.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Menezes, Albert N.; Moreira, Miguel A. M.; Seuanez, Hector N.] Inst Nacl Canc, Genet Program, Rio De Janeiro, Brazil; [Pissinatti, Alcides] Ctr Primatol Rio de Janeiro, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca)	Seuanez, HN (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.	genetics@inca.gov.br	Moreira, Miguel/AAN-7405-2020; Ferreira, Miguel/HHZ-6251-2022; Schrago, Carlos/E-4612-2012	Schrago, Carlos/0000-0001-6257-8906	Brazilian Research Council-CNPq grant [308147/2009-0]; Rio de Janeiro State Science Foundation-FAPERJ grants [110.028/2011, 111.831/2011]; CNPq [303306/2010-6]; FAPERJ [E-26/103.012/2011]	Brazilian Research Council-CNPq grant; Rio de Janeiro State Science Foundation-FAPERJ grants; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	CGS was funded by the Brazilian Research Council-CNPq grant 308147/2009-0 and the Rio de Janeiro State Science Foundation-FAPERJ grants 110.028/2011 and 111.831/2011. HNS was funded by CNPq grant 303306/2010-6 and FAPERJ grant E-26/103.012/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests	Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Chaimanee Y, 2003, NATURE, V422, P61, DOI 10.1038/nature01449; Chatterjee HJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-259; de Oliveira FB, 2008, S AM PRIMATES DEV PR; Gebo DL, 1997, SCIENCE, V276, P401, DOI 10.1126/science.276.5311.401; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Hodgson JA, 2009, P NATL ACAD SCI USA, V106, P5534, DOI 10.1073/pnas.0810346106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; Loss-Oliveira L, 2012, EVOL BIOINFORM, V8, P127, DOI 10.4137/EBO.S9008; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Ruff C, 2010, J HUM EVOL, V58, P166, DOI 10.1016/j.jhevol.2009.10.003; Schneider H, 2012, ZOOL SCR, V41, P1, DOI 10.1111/j.1463-6409.2011.00502.x; Schrago CG, 2007, AM J PHYS ANTHROPOL, V132, P344, DOI 10.1002/ajpa.20459; Seiffert ER, 2007, AM J PRIMATOL, V69, P27, DOI 10.1002/ajp.20324; Simons EL, 1996, AM J PHYS ANTHROPOL, V100, P261, DOI 10.1002/(SICI)1096-8644(199606)100:2<261::AID-AJPA7>3.0.CO;2-#; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Tabuce R, 2004, J HUM EVOL, V47, P305, DOI 10.1016/j.jhevol.2004.08.005; van Roosmalen Marc G.M., 2002, Neotropical Primates, V10, P1; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	26	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51699	10.1371/journal.pone.0051699	http://dx.doi.org/10.1371/journal.pone.0051699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272145	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800067
J	Prota, LFM; Cebotaru, L; Cheng, J; Wright, J; Vij, N; Morales, MM; Guggino, WB				Prota, Luiz Felipe M.; Cebotaru, Liudmila; Cheng, Jie; Wright, Jerry; Vij, Neeraj; Morales, Marcelo M.; Guggino, William B.			Dexamethasone Regulates CFTR Expression in Calu-3 Cells with the Involvement of Chaperones HSP70 and HSP90	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; FLUID TRANSPORT; DEGRADATION; LUNG; TRAFFICKING; SECRETION; PROTEIN; ENAC; DELTA-F508-CFTR	Background: Dexamethasone is widely used for pulmonary exacerbation in patients with cystic fibrosis, however, not much is known about the effects of glucocorticoids on the wild-type cystic fibrosis channel transmembrane regulator (CFTR). Our aim was to determine the effects of dexamethasone treatment on wild-type CFTR expression. Methods and Results: Dose-response (1 nM to 10 mM) and time course (3 to 48 h) curves were generated for dexamethasone for mRNA expression in Calu-3 cells using a real-time PCR. Within 24 h, dexamethasone (10 nM) showed a 0.3-fold decrease in CFTR mRNA expression, and a 3.2-fold increase in alpha ENaC mRNA expression compared with control groups. Dexamethasone (10 nM) induced a 1.97-fold increase in the total protein of wild-type CFTR, confirmed by inhibition by mifepristone. To access surface protein expression, biotinylation followed by Western blotting showed that dexamethasone treatment led to a 2.35-fold increase in the amount of CFTR in the cell surface compared with the untreated control groups. Once protein translation was inhibited with cycloheximide, dexamethasone could not increase the amount of CFTR protein. Protein stability was assessed by inhibition of protein synthesis with cycloheximide (50 mu g/ml) at different times in cells treated with dexamethasone and in untreated cells. Dexamethasone did not alter the degradation of wild-type CFTR. Assessment of the B band of CFTR within 15 min of metabolic pulse labeling showed a 1.5-fold increase in CFTR protein after treatment with dexamethasone for 24 h. Chaperone 90 (HSP90) binding to CFTR increased 1.55-fold after treatment with dexamethasone for 24 h, whereas chaperone 70 (HSP70) binding decreased 0.30 fold in an immunoprecipitation assay. Conclusion: Mature wild-type CFTR protein is regulated by dexamethasone post transcription, involving cotranslational mechanisms with HSP90 and HSP70, which enhances maturation and expression of wild-type CFTR. Citation: Prota LFM, Cebotaru L, Cheng J, Wright J, Vij N, et al. (2012) Dexamethasone Regulates CFTR Expression in Calu-3 Cells with the Involvement of Chaperones HSP70 and HSP90. PLoS ONE 7(12): e47405. doi: 10.1371/journal.pone.0047405	[Prota, Luiz Felipe M.; Morales, Marcelo M.] Univ Fed Rio de Janeiro, Lab Cellular & Mol Physiol, Rio De Janeiro, Brazil; [Prota, Luiz Felipe M.; Cebotaru, Liudmila; Cheng, Jie; Wright, Jerry; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Vij, Neeraj] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Morales, Marcelo M.] Johns Hopkins Univ, Sch Med, Inst Nanobiotechnol, Baltimore, MD USA	Universidade Federal do Rio de Janeiro; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Morales, MM (corresponding author), Univ Fed Rio de Janeiro, Lab Cellular & Mol Physiol, Rio De Janeiro, Brazil.	mmorales@biof.ufrj.br			Cystic Fibrosis Foundation; National Institutes of Health [CFFT GUGGINO5X0, NIH P01:DK72084]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funding that has supported this work is from the Cystic Fibrosis Foundation and the National Institutes of Health, respectively, CFFT GUGGINO5X0 and NIH P01:DK72084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Blouquit S, 2006, AM J RESP CRIT CARE, V174, P299, DOI 10.1164/rccm.200506-987OC; Bradbury Neil A., 1999, Physiological Reviews, V79, pS175; Broackes-Carter FC, 2002, HUM MOL GENET, V11, P125, DOI 10.1093/hmg/11.2.125; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; CYR DM, 1992, J BIOL CHEM, V267, P20927; ENGELHARDT JF, 1994, J CLIN INVEST, V93, P737, DOI 10.1172/JCI117028; Foster KA, 2000, INT J PHARMACEUT, V208, P1, DOI 10.1016/S0378-5173(00)00452-X; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Husted RF, 2007, AM J PHYSIOL-RENAL, V293, pF813, DOI 10.1152/ajprenal.00225.2007; Itani OA, 2002, AM J PHYSIOL-LUNG C, V282, pL631, DOI 10.1152/ajplung.00085.2001; Konstas AA, 2002, J BIOL CHEM, V277, P25377, DOI 10.1074/jbc.M201925200; Kulaksiz H, 2001, HISTOCHEM CELL BIOL, V115, P131, DOI 10.1007/s004180000244; Lindert J, 2007, AM J RESP CELL MOL, V36, P688, DOI 10.1165/rcmb.2006-0347OC; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; McCarthy VA, 2005, PEDIATR PULM, V40, P1, DOI 10.1002/ppul.20199; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Pawliczak R, 2005, PHYSIOL GENOMICS, V23, P28, DOI 10.1152/physiolgenomics.00011.2005; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Rossi L, 2004, BLOOD CELL MOL DIS, V33, P57, DOI 10.1016/j.bcmd.2004.04.004; Rubenstein RC, 2011, AM J PHYSIOL-LUNG C, V300, pL88, DOI 10.1152/ajplung.00142.2010; Sayegh R, 1999, J BIOL CHEM, V274, P12431, DOI 10.1074/jbc.274.18.12431; Sloane PA, 2010, CURR OPIN PULM MED, V16, P591, DOI 10.1097/MCP.0b013e32833f1d00; TOMASHEFSKI JF, 1989, AM J CLIN PATHOL, V91, P522, DOI 10.1093/ajcp/91.5.522; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vankeerberghen Anne, 2002, J Cyst Fibros, V1, P13, DOI 10.1016/S1569-1993(01)00003-0; WARD CL, 1994, J BIOL CHEM, V269, P25710; Xu M, 1998, J BIOL CHEM, V273, P13918, DOI 10.1074/jbc.273.22.13918; Yang CL, 2007, BIOCHEM BIOPH RES CO, V353, P535, DOI 10.1016/j.bbrc.2006.11.151; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	35	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e47405	10.1371/journal.pone.0047405	http://dx.doi.org/10.1371/journal.pone.0047405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272037	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600001
J	Swensen, JP; Dollar, AM				Swensen, John P.; Dollar, Aaron M.			The Connectedness of Packed Circles and Spheres with Application to Conductive Cellular Materials	PLOS ONE			English	Article							PACKING	In this paper, we examine the static connectivity of 2D and 3D arrays of spherical cells with conductive paths, and the associated power dissipation in the individual cells. Herein, we use the term "cellular material" to describe the ensemble of many cells, in contrast to the more traditional use of the term for foams and honeycomb materials. Using a numerical analytical approach from highly parallel resistor arrays, we examine the cells and ensemble structures in terms of their connectivity, defined as the number of cells that are dissipating power, as well as the redundancy and robustness to localized cell failure. We examine how the connectivity changes with the geometry of the conductive cell surface area, and in particular, the percentage of the cell half that is conductive and makes contact with neighboring cells. We find that the best connectivity exists when the conductive surface of the cell is approximately 80% of the hemisphere surface, addressing the tradeoff of maximizing contact with neighboring cells while minimizing shorts in the structure. In terms of robustness, the results show that, for the proposed circular and spherical cell design, the connectivity is a nearly linear function of the number of disconnects, indicating that there is not a catastrophic effect of isolated cell failures. In terms of structure size, the connectivity appears to plateau at around 60% for the planar structures and around 50% for the cubic structures of around 500 cells or greater with random cell orientation.	[Swensen, John P.; Dollar, Aaron M.] Yale Univ, Sch Engn & Appl Sci, New Haven, CT 06520 USA	Yale University	Swensen, JP (corresponding author), Yale Univ, Sch Engn & Appl Sci, New Haven, CT 06520 USA.	john.swensen@yale.edu	Swensen, John/AAC-8194-2020	Swensen, John/0000-0003-4562-6309; Dollar, Aaron/0000-0002-2409-4668	United States Air Force Office of Scientific Research [FA9550-11-1-0093]	United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research was funded by the United States Air Force Office of Scientific Research under Grant #FA9550-11-1-0093. The URL of the granting agency is http://www.wpafb.af.mil/afrl/afosr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amengual A, 2000, AM J PHYS, V68, P175, DOI 10.1119/1.19396; Ashwin SS, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061307; Barooah P, 2007, IEEE CONTR SYST MAG, V27, P57, DOI 10.1109/MCS.2007.384125; Blair D. L., 2001, PHYS REV E, V63; Christodoulou L, 2003, JOM-J MIN MET MAT S, V55, P39, DOI 10.1007/s11837-003-0008-z; Clusel M, 2009, NATURE, V460, P611, DOI 10.1038/nature08158; Gao GJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061303; Gilpin K, 2010, IEEE INT CONF ROBOT, P2485, DOI 10.1109/ROBOT.2010.5509817; Hawkes E, 2010, P NATL ACAD SCI USA, V107, P12441, DOI 10.1073/pnas.0914069107; Holm R., 1967, ELECT CONTACTS THEOR, DOI 10.1007/978-3-662-06688-1; Johnson K. L., 1987, CONTACT MECH, DOI [10.1201/ b17588-12, DOI 10.1201/B17588-12]; Jones W, 1985, THEORETICAL SOLID ST, V1; Mehrabian AR, 2011, J FRANKLIN I, V348, P12, DOI 10.1016/j.jfranklin.2009.02.006; Pouliquen O, 1997, PHYS REV LETT, V79, P3640, DOI 10.1103/PhysRevLett.79.3640; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Torquato S, 2000, PHYS REV LETT, V84, P2064, DOI 10.1103/PhysRevLett.84.2064; Torquato S, 2010, REV MOD PHYS, V82, P2633, DOI 10.1103/RevModPhys.82.2633; VENEZIAN G, 1994, AM J PHYS, V62, P1000, DOI 10.1119/1.17696; Vitelli V, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021301; Wu FY, 2004, J PHYS A-MATH GEN, V37, P6653, DOI 10.1088/0305-4470/37/26/004; Xu N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.038001	21	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51695	10.1371/journal.pone.0051695	http://dx.doi.org/10.1371/journal.pone.0051695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284746	Green Published, gold			2022-12-25	WOS:000312794500039
J	Hjelm, B; Forsstrom, B; Lofblom, J; Rockberg, J; Uhlen, M				Hjelm, Barbara; Forsstrom, Bjorn; Lofblom, John; Rockberg, Johan; Uhlen, Mathias			Parallel Immunizations of Rabbits Using the Same Antigen Yield Antibodies with Similar, but Not Identical, Epitopes	PLOS ONE			English	Article							AFFINITY REAGENTS; HUMAN PROTEOME; AMINO-ACID; PREDICTION; DISPLAY; GENERATION; PEPTIDE; ATLAS; MODEL	A problem for the generation of polyclonal antibodies is the potential difficulties for obtaining a renewable resource due to batch-to-batch variations when the same antigen is immunized into several separate animals. Here, we have investigated this issue by determining the epitopes of antibodies generated from parallel immunizations of rabbits with recombinant antigens corresponding to ten human protein targets. The epitopes were mapped by both a suspension bead array approach using overlapping synthetic 15-mer peptides and a bacterial display approach using expression of random fragments of the antigen on the surface of bacteria. Both methods determined antibody binding with the aid of fluorescent-based analysis. In addition, one polyclonal antibody was fractionated by peptide-specific affinity capture for in-depth comparison of epitopes. The results show that the same antigen immunized in several rabbits yields polyclonal antibodies with similar epitopes, but with larger differences in the relative amounts of antibodies to the different epitopes. In some cases, unique epitopes were observed for one of the immunizations. The results suggest that polyclonal antibodies generated by repeated immunizations do not display an identical epitope pattern, although many of the epitopes are similar.	[Hjelm, Barbara; Forsstrom, Bjorn; Lofblom, John; Rockberg, Johan; Uhlen, Mathias] Royal Inst Technol, Sch Biotechnol, AlbaNova Univ Ctr, Stockholm, Sweden; [Uhlen, Mathias] Royal Inst Technol, Sci Life Lab, Stockholm, Sweden	Royal Institute of Technology; Royal Institute of Technology	Uhlen, M (corresponding author), Royal Inst Technol, Sch Biotechnol, AlbaNova Univ Ctr, Stockholm, Sweden.	mathias.uhlen@scilifelab.se	Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021	Uhlen, Mathias/0000-0002-4858-8056; Lofblom, John/0000-0001-9423-0541	Knut and Alice Wallenberg Foundation; Swedish Research Council; VINNOVA ProNova center grant	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA ProNova center grant(Vinnova)	This work was supported by grants from the Knut and Alice Wallenberg Foundation, Swedish Research Council and the VINNOVA ProNova center grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; GEYSEN HM, 1987, SCIENCE, V235, P1184, DOI 10.1126/science.3823878; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Gloriam DE, 2010, MOL CELL PROTEOMICS, V9, P1, DOI 10.1074/mcp.M900185-MCP200; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hjelm B, 2011, PROTEIN SCI, V20, P1824, DOI 10.1002/pro.716; Hjelm B, 2010, NEW BIOTECHNOL, V27, P129, DOI 10.1016/j.nbt.2009.11.001; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; John SH, 2006, DRUG DISCOV TODAY, V11, P655; Kiermer V, 2008, NAT METHODS, V5, P860, DOI 10.1038/nmeth1008-860; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larsson K, 2009, J IMMUNOL METHODS, V342, P20, DOI 10.1016/j.jim.2008.11.013; Lofblom J, 2007, J APPL MICROBIOL, V102, P736, DOI 10.1111/j.1365-2672.2006.03127.x; Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002; Nilsson P, 2005, PROTEOMICS, V5, P4327, DOI 10.1002/pmic.200500072; Partidos CD, 1997, J GEN VIROL, V78, P3227, DOI 10.1099/0022-1317-78-12-3227; Petersen G, 1995, MOL GEN GENET, V249, P425, DOI 10.1007/BF00287104; Rockberg J, 2009, PROTEIN SCI, V18, P2346, DOI 10.1002/pro.245; Rockberg J, 2008, NAT METHODS, V5, P1039, DOI 10.1038/nmeth.1272; Ton L, 2007, TRENDS BIOTECHNOL, V25, P390; Uhlen M, 2008, NAT METHODS, V5, P854, DOI 10.1038/nmeth1008-854; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; WANG LF, 1995, J IMMUNOL METHODS, V178, P1, DOI 10.1016/0022-1759(94)00235-O	28	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e45817	10.1371/journal.pone.0045817	http://dx.doi.org/10.1371/journal.pone.0045817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284606	gold, Green Submitted, Green Published			2022-12-25	WOS:000312694300002
J	Sanggaard, KW; Danielsen, CC; Wogensen, L; Vinding, MS; Rydtoft, LM; Mortensen, MB; Karring, H; Nielsen, NC; Wang, T; Thogersen, IB; Enghild, JJ				Sanggaard, Kristian W.; Danielsen, Carl Chr.; Wogensen, Lise; Vinding, Mads S.; Rydtoft, Louise M.; Mortensen, Martin B.; Karring, Henrik; Nielsen, Niels Chr.; Wang, Tobias; Thogersen, Ida B.; Enghild, Jan J.			Unique Structural Features Facilitate Lizard Tail Autotomy	PLOS ONE			English	Article							FIBRILLAR ADHESIVE MICROSTRUCTURE; COLLAGENOUS TISSUE; CAUDAL AUTOTOMY; ECHINODERMATA; REGENERATION; OPHIUROIDEA; PEPTIDES; MOVEMENT; PROTEINS; OSIRIX	Autotomy refers to the voluntary shedding of a body part; a renowned example is tail loss among lizards as a response to attempted predation. Although many aspects of lizard tail autotomy have been studied, the detailed morphology and mechanism remains unclear. In the present study, we showed that tail shedding by the Tokay gecko (Gekko gecko) and the associated extracellular matrix (ECM) rupture were independent of proteolysis. Instead, lizard caudal autotomy relied on biological adhesion facilitated by surface microstructures. Results based on bio-imaging techniques demonstrated that the tail of Gekko gecko was pre-severed at distinct sites and that its structural integrity depended on the adhesion between these segments.	[Sanggaard, Kristian W.; Thogersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct inSPIN, Interdiciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Danielsen, Carl Chr.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Wogensen, Lise] Aarhus Univ, Dept Clin Med, Res Lab Biochem Pathol, Aarhus, Denmark; [Vinding, Mads S.; Nielsen, Niels Chr.] Aarhus Univ, Dept Chem, Ctr Insoluble Prot Structures inSPIN, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Rydtoft, Louise M.] Aarhus Univ, Dept Clin Med, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Mortensen, Martin B.] Aarhus Univ, Dept Clin Med, Dept Thorac & Cardiovasc Surg, Aarhus, Denmark; [Karring, Henrik] Univ So Denmark, Fac Engn, Inst Chem Engn Biotechnol & Environm Technol, Odense, Denmark; [Wang, Tobias] Aarhus Univ, Dept Biosci Zoophysiol, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of Southern Denmark; Aarhus University	Enghild, JJ (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct inSPIN, Interdiciplinary Nanosci Ctr iNANO, Aarhus, Denmark.	jje@mb.au.dk	Wang, Tobias/I-7946-2013; Vinding, Mads S./AAN-4915-2020	Wang, Tobias/0000-0002-4350-3682; Vinding, Mads S./0000-0002-0149-583X; Nielsen, Niels Chr./0000-0003-2978-4366; Karring, Henrik/0000-0002-4672-1503; Enghild, Jan Johannes/0000-0001-9292-9172; Mortensen, Martin Bodtker/0000-0003-2693-4154	Danish Council for Strategic Research, Programme Commission on Health, Food and Welfare [09-067076, NOVENIA]; Danish National Research Foundation, Centers of Excellence (inSPIN)	Danish Council for Strategic Research, Programme Commission on Health, Food and Welfare; Danish National Research Foundation, Centers of Excellence (inSPIN)	This work is supported by the Danish Council for Strategic Research (http://en.fi.dk/councils-commissions/the-danish-council-for-strategic-research), Programme Commission on Health, Food and Welfare (grant 09-067076, NOVENIA), and by the Danish National Research Foundation (http://www.dg.dk/en/), Centers of Excellence (inSPIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD EN, 1984, J NAT HIST, V18, P127, DOI 10.1080/00222938400770131; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; Bellairs AdA, 1985, AUTOTOMY REGENERATIO, P310; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Carbone G, 2011, SOFT MATTER, V7, P5545, DOI 10.1039/c0sm01482f; Cheung E, 2009, LANGMUIR, V25, P6613, DOI 10.1021/la900997p; CLARK DR, 1971, J EXP ZOOL, V176, P295, DOI 10.1002/jez.1401760305; Clause AR, 2006, J EXP ZOOL PART A, V305A, P965, DOI 10.1002/jez.a.346; DIAL BE, 1983, SCIENCE, V219, P391, DOI 10.1126/science.219.4583.391; DOBSON WE, 1985, J EXP MAR BIOL ECOL, V94, P223, DOI 10.1016/0022-0981(85)90060-7; Gorb S, 2007, J R SOC INTERFACE, V4, P271, DOI 10.1098/rsif.2006.0164; Higham TE, 2010, BIOL LETTERS, V6, P70, DOI 10.1098/rsbl.2009.0577; Maughan DW, 2005, MOL CELL PROTEOMICS, V4, P1541, DOI 10.1074/mcp.M500053-MCP200; Rosset A, 2004, INT CONGR SER, V1268, P1247, DOI 10.1016/j.ics.2004.03.048; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Seidler J, 2010, PROTEOMICS, V10, P634, DOI 10.1002/pmic.200900459; Sheppard L., 1972, British J Herpet, V4, P276; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Varenberg M, 2008, J R SOC INTERFACE, V5, P785, DOI 10.1098/rsif.2007.1201; Wang DX, 2004, RAPID COMMUN MASS SP, V18, P96, DOI 10.1002/rcm.1289; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; WILKIE IC, 1979, CELL TISSUE RES, V197, P515; Wilkie IC, 2005, PROG MOLEC, V39, P221; WILKIE IC, 1993, NATURE, V366, P519, DOI 10.1038/366519a0; Wilkie IC, 2001, MICROSC RES TECHNIQ, V55, P369, DOI 10.1002/jemt.1185	27	26	27	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51803	10.1371/journal.pone.0051803	http://dx.doi.org/10.1371/journal.pone.0051803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284771	Green Published, gold			2022-12-25	WOS:000312694300044
J	Tang, XY; Jing, LF; Chen, J				Tang, Xinyan; Jing, Liufang; Chen, Jun			Changes in the Molecular Phenotype of Nucleus Pulposus Cells with Intervertebral Disc Aging	PLOS ONE			English	Article							PROTEIN GENE-EXPRESSION; GROWTH-FACTOR-I; LOW-BACK-PAIN; PROTEOGLYCAN SYNTHESIS; IMMUNOGLOBULIN SUPERFAMILY; DIFFERENTIAL EXPRESSION; EXTRACELLULAR-MATRIX; NOTOCHORDAL CELLS; ANNULUS FIBROSUS; CARTILAGE CELLS	Intervertebral disc (IVD) disorder and age-related degeneration are believed to contribute to low back pain. Cell-based therapies represent a promising strategy to treat disc degeneration; however, the cellular and molecular characteristics of disc cells during IVD maturation and aging still remain poorly defined. This study investigated novel molecular markers and their age-related changes in the rat IVD. Affymetrix cDNA microarray analysis was conducted to identify a new set of genes characterizing immature nucleus pulposus (NP) cells. Among these markers, select neuronal-related proteins (Basp1, Ncdn and Nrp-1), transcriptional factor (Brachyury T), and cell surface receptors (CD24, CD90, CD155 and CD221) were confirmed by real-time PCR and immunohistochemical (IHC) staining for differential expression between IVD tissue regions and among various ages (1, 12 and 21 months). NP cells generally possessed higher levels of mRNA or protein expression for all aforementioned markers, with the exception of CD90 in anulus fibrosus (AF) cells. In addition, CD protein (CD24 and CD90) and Brachyury (T) expression in immature disc cells were also confirmed via flow cytometry. Similar to IHC staining, results revealed a higher percentage of immature NP cells expressing CD24 and Brachyury, while higher percentage of immature AF cells was stained positively for CD90. Altogether, this study identifies that tissue-specific gene expression and age-related differential expression of the above markers do exist in immature and aged disc cells. These age-related phenotype changes provide a new insight for a molecular profile that may be used to characterize NP cells for developing cell-based regenerative therapy for IVD regeneration.	[Chen, Jun] Duke Univ, Med Ctr, Dept Orthoped Surg, Durham, NC 27710 USA; [Tang, Xinyan; Jing, Liufang] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University; Duke University	Chen, J (corresponding author), Duke Univ, Med Ctr, Dept Orthoped Surg, Durham, NC 27710 USA.	junchen@duke.edu			NIH [AR057410, AR047442, EB002263]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057410, R01AR047442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002263] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported by the following NIH grants: AR057410, AR047442 and EB002263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Baer AE, 2001, J ORTHOPAED RES, V19, P2, DOI 10.1016/S0736-0266(00)00003-6; Bayliss MT, 1992, LUMBAR SPINE BACK PA, P111; Biyani A, 2004, J AM ACAD ORTHOP SUR, V12, P106, DOI 10.5435/00124635-200403000-00006; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108; Boyd LM, 2004, SPINE, V29, P2217, DOI 10.1097/01.brs.0000142747.90488.1d; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Chen J, 2002, BIOCHEM BIOPH RES CO, V293, P932, DOI 10.1016/S0006-291X(02)00314-5; Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x; Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Dateki M, 2004, NEUROSCI LETT, V356, P107, DOI 10.1016/j.neulet.2003.11.026; Escalante NK, 2011, ARTERIOSCL THROM VAS, V31, P1177, DOI 10.1161/ATVBAHA.111.224162; Fleming A, 2001, J ANAT, V199, P177, DOI 10.1017/S0021878201008044; Fujisawa H, 1998, CURR OPIN NEUROBIOL, V8, P587, DOI 10.1016/S0959-4388(98)80085-8; Fujita N, 2005, BIOCHEM BIOPH RES CO, V338, P1890, DOI 10.1016/j.bbrc.2005.10.166; Gabr MA, 2011, J ORTHOP RES, V29, P1, DOI 10.1002/jor.21206; Gilchrist CL, 2011, EUR CELLS MATER, V21, P523, DOI 10.22203/eCM.v021a39; Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170; Gilson A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2931; Goodfellow SJ, 2011, BIOCHEM J, V435, P113, DOI 10.1042/BJ20101734; Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001; Gruber HE, 2000, SPINE, V25, P2153, DOI 10.1097/00007632-200009010-00002; Guilak F, 1999, SPINE, V24, P2475, DOI 10.1097/00007632-199912010-00009; Hartl M, 2009, P NATL ACAD SCI USA, V106, P5604, DOI 10.1073/pnas.0812101106; Hayes AJ, 2001, MATRIX BIOL, V20, P107, DOI 10.1016/S0945-053X(01)00125-1; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402; Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x; Iino S, 1999, NEUROSCIENCE, V91, P1435, DOI 10.1016/S0306-4522(98)00701-5; Istvanffy R, 2004, DEV GENES EVOL, V214, P206, DOI 10.1007/s00427-004-0396-2; Jing LF, 2012, J ORTHOP RES, V30, P1923, DOI 10.1002/jor.22158; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kim KW, 2003, SPINE, V28, P982, DOI 10.1097/00007632-200305150-00005; KISPERT A, 1993, EMBO J, V12, P4898, DOI 10.1002/j.1460-2075.1993.tb06179.x; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Lange R, 2001, VIROLOGY, V285, P218, DOI 10.1006/viro.2001.0943; Le Maitre CL, 2005, J PATHOL, V207, P445, DOI 10.1002/path.1862; Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Mochizuki R, 1999, BBA-GENE STRUCT EXPR, V1446, P397, DOI 10.1016/S0167-4781(99)00120-7; Nakamura Y, 2006, BRIT J DERMATOL, V154, P1062, DOI 10.1111/j.1365-2133.2006.07209.x; Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; OEGEMA TR, 1993, CLIN SPORT MED, V12, P419; Okuda S, 2001, SPINE, V26, P2421, DOI 10.1097/00007632-200111150-00005; Osada R, 1996, J ORTHOP RES, V14, P690, DOI 10.1002/jor.1100140503; PEARCE RH, 1987, J ORTHOP RES, V5, P198, DOI 10.1002/jor.1100050206; POSTACCHINI F, 1984, SPINE, V9, P596, DOI 10.1097/00007632-198409000-00010; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6; ROBERTS S, 1991, SPINE, V16, P1030, DOI 10.1097/00007632-199109000-00003; RUFAI A, 1995, ANAT EMBRYOL, V192, P53; Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Sebastine IM, 2007, P ANN INT IEEE EMBS, P6401; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Stevens JW, 2000, DEV DYNAM, V219, P381, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1060>3.0.CO;2-P; TAYLOR JR, 1988, BIOL INTERVERTEBRAL, P39; THOMPSON JP, 1991, SPINE, V16, P253, DOI 10.1097/00007632-199103000-00001; Tolofari SK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2898; TROUT JJ, 1982, ANAT REC, V204, P307, DOI 10.1002/ar.1092040403; TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Xu ZW, 2010, CELL MOL IMMUNOL, V7, P11, DOI 10.1038/cmi.2009.108; Yu J, 2002, J ANAT, V201, P465, DOI 10.1046/j.1469-7580.2002.00111.x; Zakharov VV, 2003, BBA-GEN SUBJECTS, V1622, P14, DOI 10.1016/S0304-4165(03)00099-0; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001	74	73	79	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52020	10.1371/journal.pone.0052020	http://dx.doi.org/10.1371/journal.pone.0052020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284858	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300070
J	Gu, LB; Kitamura, M				Gu, Liubao; Kitamura, Masanori			Sensitive Detection and Monitoring of Senescence-Associated Secretory Phenotype by SASP-RAP Assay	PLOS ONE			English	Article							CELLULAR SENESCENCE; GENE-EXPRESSION; ER STRESS; CANCER; INHIBITOR; CLONING; DRESSA; CELLS	Senescence-associated secretory phenotype (SASP) is characterized by abundant secretion of various proteins in senescent cells and implicated in tumor progression and inflammatory responses. However, the profile of secreted proteins in SASP is different from cell type to cell type, and currently, universal markers for SASP have not been reported. In the present investigation, we show that SASP-responsive alkaline phosphatase (SASP-RAP) serves as a sensitive, general and convenient marker for SASP. Etoposide-treated cells exhibited a senescent phenotype characterized by senile morphology, positive staining for senescence-associated beta-galactosidase, growth arrest and induction of p53 and p21(WAF1/CIP1). In SASP-RAP-transfected cells, exposure to etoposide increased secretion of SASP-RAP time-dependently. The kinetics of secretion was closely correlated with that of activation of the p21(WAF1/CIP1) promoter and the p16(INK4a) promoter. The enhanced secretion of SASP-RAP by senescence was also observed in cells treated with other senescence inducers such as trichostatin A, doxorubicin and 4-phenylbutylic acid. The induction of SASP-RAP by senescence was similarly observed in natural replicative senescence. To confirm selectivity of the SASP-RAP response, cells were treated with senescence-related and unrelated stimuli (IL-1 beta, LPS, TNF-alpha and TGF-beta), and induction of senescence markers and activity of SASP-RAP were evaluated in parallel. Unlike etoposide, senescence-unrelated stimuli did not induce p53 and p21(WAF1/CIP1), and it was correlated with lack of induction of SASP-RAP. In contrast, senescence-unrelated stimuli up-regulated conventional indicators for SASP, e.g., MMP-3, IL-6 and TIMP, without induction of senescence. SASP-RAP thus serves as a selective, convenient and general marker for detection and monitoring of SASP during cellular senescence.	[Gu, Liubao; Kitamura, Masanori] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Gu, Liubao] Jiangsu Prov Inst Geriatr, Diabet Care & Res Ctr, Nanjing, Jiangsu, Peoples R China	University of Yamanashi	Kitamura, M (corresponding author), Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	masanori@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [20390235]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (20390235) to M. Kitamura (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; CULLEN BR, 1992, METHOD ENZYMOL, V216, P362; Demarchi F, 2010, CELL CYCLE, V9, P755, DOI 10.4161/cc.9.4.10637; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hiramatsu N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl515; HUPPI K, 1994, ONCOGENE, V9, P3017; Johno H, 2010, APPL BIOCHEM BIOTECH, V162, P1529, DOI 10.1007/s12010-010-8934-z; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kasai A, 2005, ANAL BIOCHEM, V337, P84, DOI 10.1016/j.ab.2004.10.004; Kasai A, 2004, ANAL BIOCHEM, V335, P73, DOI 10.1016/j.ab.2004.08.017; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kitamura M, 2011, CELL DEATH DIFFER, V18, P1876, DOI 10.1038/cdd.2011.63; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Kurihara Y, 2002, BIOL PHARM BULL, V25, P1272, DOI 10.1248/bpb.25.1272; Leontieva OV, 2010, AGING-US, V2, P924, DOI 10.18632/aging.100265; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; Matsumoto N, 2000, BIOORG MED CHEM LETT, V10, P865, DOI 10.1016/S0960-894X(00)00114-1; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Narita M, 2007, BRIT J CANCER, V96, P686, DOI 10.1038/sj.bjc.6603636; Ogryzko VV, 1996, MOL CELL BIOL, V16, P5210; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Qiu Z, 2009, IMMUNOBIOLOGY, V214, P835, DOI 10.1016/j.imbio.2009.06.007; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Shin DM, 2011, GERONTOLOGY, V57, P76, DOI 10.1159/000281882; Tominaga K, 1997, MOL IMMUNOL, V34, P1147, DOI 10.1016/S0161-5890(97)00145-4; VANSNICK J, 1988, EUR J IMMUNOL, V18, P193; WILSON VL, 1983, SCIENCE, V220, P1054	40	15	15	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52305	10.1371/journal.pone.0052305	http://dx.doi.org/10.1371/journal.pone.0052305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272236	Green Submitted, Green Published, gold			2022-12-25	WOS:000312483300078
J	Liang, YL; Zhang, ZH; Liu, XJ; Liu, XQ; Tao, L; Zhang, YF; Wang, H; Zhang, C; Chen, X; Xu, DX				Liang, Ying-Li; Zhang, Zhi-Hui; Liu, Xiao-Jing; Liu, Xiao-Qian; Tao, Li; Zhang, Ye-Fa; Wang, Hua; Zhang, Cheng; Chen, Xi; Xu, De-Xiang			Melatonin Protects against Apoptosis-Inducing Factor (AIF)-Dependent Cell Death during Acetaminophen-Induced Acute Liver Failure	PLOS ONE			English	Article							MITOCHONDRIAL OXIDANT STRESS; FULMINANT HEPATIC-FAILURE; ANTIOXIDANT ENZYMES; DNA FRAGMENTATION; BAX TRANSLOCATION; OXIDATIVE STRESS; INJURY; MICE; HEPATOTOXICITY; PHOSPHORYLATION	Acetaminophen (APAP) overdose is the most frequent cause of acute liver failure and is primarily caused by cytochrome P450 (CYP) 2E1-driven conversion of APAP into hepatotoxic metabolites. Several reports showed that melatonin attenuated APAP-induced acute liver failure. Nevertheless, the exact mechanism remains obscure. In the present study, we investigated the effects of melatonin on apoptosis-inducing factor (AIF)-dependent cell death in APAP-induced acute liver failure. Mice were intraperitoneally (i.p.) injected with different doses of melatonin (1.25, 5, 20 mg/kg) 30 min before APAP (300 mg/kg, i.p.). As expected, melatonin significantly alleviated APAP-induced cell death, as determined by TdT-mediated dUTP-biotin nick end labeling (TUNEL) assay. Further analysis showed that melatonin significantly attenuated APAP-induced activation of the serine/threonine kinase receptor interacting protein 1 (RIP1). In addition, melatonin inhibited APAP-induced hepatic c-Jun N-terminal kinase (JNK) phosphorylation and mitochondrial Bax translocation. Correspondingly, melatonin inhibited APAP-induced translocation of AIF from mitochondria to nuclei. Interestingly, no changes were induced by melatonin on hepatic CYP2E1 expression. In addition, melatonin had little effect on APAP-induced hepatic glutathione (GSH) depletion. In conclusion, melatonin protects against AIF-dependent cell death during APAP-induced acute liver failure through its direct inhibition of hepatic RIP1 and subsequent JNK phosphorylation and mitochondrial Bax translocation.	[Liu, Xiao-Jing; Tao, Li; Chen, Xi; Xu, De-Xiang] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China; [Liang, Ying-Li; Zhang, Zhi-Hui; Liu, Xiao-Jing; Liu, Xiao-Qian; Zhang, Ye-Fa; Wang, Hua; Zhang, Cheng; Xu, De-Xiang] Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Chen, X (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China.	chenxi402@yahoo.com.cn; xudex@126.com	zhang, zh/GWV-4677-2022; wang, hua/E-5028-2013		National Natural Science Foundation of China [30371667, 30572223, 30973544, 81172711, 81001480]; Natural Science Foundation of Anhui province [090413142, 1208085QH143]; University Excellence Young Talent Fund of Educational Commission of Anhui Province [2011SQRL058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui province(Natural Science Foundation of Anhui Province); University Excellence Young Talent Fund of Educational Commission of Anhui Province	This project was supported by National Natural Science Foundation of China (30371667, 30572223, 30973544, 81172711, 81001480), Natural Science Foundation of Anhui province (090413142, 1208085QH143) and the University Excellence Young Talent Fund of Educational Commission of Anhui Province (2011SQRL058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Bajt ML, 2008, J PHARMACOL EXP THER, V324, P8, DOI 10.1124/jpet.107.129445; Bajt ML, 2006, TOXICOL SCI, V94, P217, DOI 10.1093/toxsci/kfl077; Bajt ML, 2011, TOXICOL SCI, V122, P598, DOI 10.1093/toxsci/kfr116; BARLOWWALDEN LR, 1995, NEUROCHEM INT, V26, P497, DOI 10.1016/0197-0186(94)00154-M; Carbajo-Pescador S, 2011, J PINEAL RES, V51, P463, DOI 10.1111/j.1600-079X.2011.00910.x; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Crespo I, 2010, J PINEAL RES, V49, P193, DOI 10.1111/j.1600-079X.2010.00787.x; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Ghosh J, 2010, FREE RADICAL BIO MED, V48, P535, DOI 10.1016/j.freeradbiomed.2009.11.023; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Hardeland R, 2009, J PINEAL RES, V47, P109, DOI 10.1111/j.1600-079X.2009.00701.x; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Ji YL, 2012, J PINEAL RES, V52, P71, DOI 10.1111/j.1600-079X.2011.00921.x; Johnson C, 2008, BIOL REPROD, V79, P806, DOI 10.1095/biolreprod.108.068833; Kang JW, 2011, J PINEAL RES, V50, P403, DOI 10.1111/j.1600-079X.2011.00858.x; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim SH, 2008, J PINEAL RES, V44, P165, DOI 10.1111/j.1600-079X.2007.00504.x; Kitagawa A, 2012, J PINEAL RES, V52, P403, DOI 10.1111/j.1600-079X.2011.00955.x; Koh PO, 2011, J PINEAL RES, V51, P214, DOI 10.1111/j.1600-079X.2011.00879.x; Latchoumycandane C, 2007, HEPATOLOGY, V45, P412, DOI 10.1002/hep.21475; Liang R, 2009, J PINEAL RES, V46, P8, DOI 10.1111/j.1600-079X.2008.00596.x; Martin-Renedo J, 2008, J PINEAL RES, V45, P532, DOI 10.1111/j.1600-079X.2008.00641.x; Matsura T, 2006, J PINEAL RES, V41, P211, DOI 10.1111/j.1600-079X.2006.00356.x; Mauriz JL, 2007, J PINEAL RES, V42, P222, DOI 10.1111/j.1600-079X.2006.00409.x; Molpeceres V, 2007, J GERONTOL A-BIOL, V62, P687, DOI 10.1093/gerona/62.7.687; Ramachandran A, 2011, TOXICOL APPL PHARM, V251, P226, DOI 10.1016/j.taap.2011.01.004; Ressmeyer AR, 2003, REDOX REP, V8, P205, DOI 10.1179/135100003225002709; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Sainz RM, 2003, CELL MOL LIFE SCI, V60, P1407, DOI 10.1007/s00018-003-2319-1; Saito C, 2010, TOXICOL APPL PHARM, V246, P8, DOI 10.1016/j.taap.2010.04.015; Sener G, 2003, J PINEAL RES, V35, P61, DOI 10.1034/j.1600-079X.2003.00050.x; Singhal NK, 2011, J PINEAL RES, V50, P97, DOI 10.1111/j.1600-079X.2010.00819.x; Tahan V, 2009, J PINEAL RES, V46, P401, DOI 10.1111/j.1600-079X.2009.00676.x; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Tunon MJ, 2011, J PINEAL RES, V50, P38, DOI 10.1111/j.1600-079X.2010.00807.x; Vera Y, 2004, BIOL REPROD, V70, P1534, DOI 10.1095/biolreprod.103.024661; Wang H, 2007, TOXICOLOGY, V237, P49, DOI 10.1016/j.tox.2007.04.021; Wang H, 2011, J PINEAL RES, V50, P418, DOI 10.1111/j.1600-079X.2011.00860.x; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200	45	26	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51911	10.1371/journal.pone.0051911	http://dx.doi.org/10.1371/journal.pone.0051911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272189	Green Published, Green Submitted, gold			2022-12-25	WOS:000312483300041
J	Tomasetti, M; Nocchi, L; Neuzil, J; Goodwin, J; Nguyen, M; Dong, LF; Manzella, N; Staffolani, S; Milanese, C; Garrone, B; Alleva, R; Borghi, B; Santarelli, L; Guerrieri, R				Tomasetti, Marco; Nocchi, Linda; Neuzil, Jiri; Goodwin, Jacob; Maria Nguyen; Dong, Lanfeng; Manzella, Nicola; Staffolani, Sara; Milanese, Claudio; Garrone, Beatrice; Alleva, Renata; Borghi, Battista; Santarelli, Lory; Guerrieri, Roberto			Alpha-Tocopheryl Succinate Inhibits Autophagic Survival of Prostate Cancer Cells Induced by Vitamin K3 and Ascorbate to Trigger Cell Death	PLOS ONE			English	Article							MEDIATED PROGRAMMED NECROSIS; RESPIRATORY COMPLEX-II; MITOCHONDRIAL AIF; INDUCED APOPTOSIS; CYTOTOXICITY; ACTIVATION; INDUCTION; MECHANISM; EFFECTOR; GROWTH	Background: The redox-silent vitamin E analog alpha-tocopheryl succinate (alpha-TOS) was found to synergistically cooperate with vitamin K3 (VK3) plus ascorbic acid (AA) in the induction of cancer cell-selective apoptosis via a caspase-independent pathway. Here we investigated the molecular mechanism(s) underlying cell death induced in prostate cancer cells by alpha-TOS, VK3 and AA, and the potential use of targeted drug combination in the treatment of prostate cancer. Methodology/Principal Findings: The generation of ROS, cellular response to oxidative stress, and autophagy were investigated in PC3 prostate cancer cells by using drugs at sub-toxic doses. We evaluated whether PARP1-mediated apoptosis-inducing factor (AIF) release plays a role in apoptosis induced by the combination of the agents. Next, the effect of the combination of alpha-TOS, VK3 and AA on tumor growth was examined in nude mice. VK3 plus AA induced early ROS formation associated with induction of autophagy in response to oxidative stress, which was reduced by alpha-TOS, preventing the formation of autophagosomes. alpha-TOS induced mitochondrial destabilization leading to the release of AIF. Translocation of AIF from mitochondria to the nucleus, a result of the combinatorial treatment, was mediated by PARP1 activation. The inhibition of AIF as well as of PARP1 efficiently attenuated apoptosis triggered by the drug combination. Using a mouse model of prostate cancer, the combination of alpha-TOS, VK3 and AA was more efficient in tumor suppression than when the drugs were given separately, without deleterious side effects. Conclusions/Significance: alpha-TOS, a mitochondria-targeting apoptotic agent, switches at sub-apoptotic doses from autophagy-dependent survival of cancer cells to their demise by promoting the induction of apoptosis. Given the grim prognosis for cancer patients, this finding is of potential clinical relevance.	[Tomasetti, Marco; Nocchi, Linda; Manzella, Nicola; Staffolani, Sara; Santarelli, Lory] Polytechn Univ Marche, Dept Mol & Clin Sci, Ancona, Italy; [Neuzil, Jiri; Goodwin, Jacob; Maria Nguyen; Dong, Lanfeng] Griffith Univ, Apoptosis Res Grp, Sch Med Sci, Southport, Qld 4215, Australia; [Neuzil, Jiri; Goodwin, Jacob; Maria Nguyen; Dong, Lanfeng] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia; [Neuzil, Jiri] Acad Sci Czech Republ, Mol Therapy Grp, Inst Biotechnol, Prague, Czech Republic; [Milanese, Claudio; Garrone, Beatrice] Angelini Res, Rome, Italy; [Alleva, Renata; Borghi, Battista] IRCCS Orthopaed Inst Rizzoli, Dept Anesthesiol, Res Unit, Bologna, Italy; [Guerrieri, Roberto] Univ Bologna, ARCES, Bologna, Italy	Marche Polytechnic University; Griffith University; Griffith University; Menzies Health Institute Queensland; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; University of Bologna	Tomasetti, M (corresponding author), Polytechn Univ Marche, Dept Mol & Clin Sci, Ancona, Italy.	m.tomasetti@univpm.it	Santarelli, Lory/AAU-4494-2020; Neuzil, Jiri/H-7204-2014; DONG, LANFENG/S-8805-2019	Neuzil, Jiri/0000-0002-2478-2460; Nocchi, Linda/0000-0002-2113-9031; Goodwin, Jacob/0000-0002-3834-3071; Dong, Lanfeng/0000-0002-9857-6352; santarelli, lory/0000-0003-1015-7098	Prostate Cancer Foundation of Australia; Polytechnic University of Marche	Prostate Cancer Foundation of Australia; Polytechnic University of Marche	This work was supported in part by a grant from the Prostate Cancer Foundation of Australia to JN, and the additional part by the Research funding of Polytechnic University of Marche. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck R, 2011, INVEST NEW DRUG, V29, P891, DOI 10.1007/s10637-010-9441-3; Biasutto L, 2010, MITOCHONDRION, V10, P670, DOI 10.1016/j.mito.2010.06.004; Blenn C, 2011, CELL MOL LIFE SCI, V68, P1455, DOI 10.1007/s00018-010-0533-1; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chen P, 2012, ANTI-CANCER DRUG, V23, P437, DOI 10.1097/CAD.0b013e32834fd01f; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Dong LF, 2009, CLIN CANCER RES, V15, P1593, DOI 10.1158/1078-0432.CCR-08-2439; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Esposti MD, 2002, METHODS, V26, P335, DOI 10.1016/S1046-2023(02)00039-7; Gilloteaux J, 2010, ULTRASTRUCT PATHOL, V34, P140, DOI 10.3109/01913121003662304; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Kang YH, 2004, INT J CANCER, V112, P385, DOI 10.1002/ijc.20424; Kassouf W, 2006, J UROLOGY, V176, P1642, DOI 10.1016/j.juro.2006.06.042; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Neuzil H, 2002, BIOCHEM BIOPH RES CO, V293, P1309, DOI 10.1016/S0006-291X(02)00358-3; Neuzil J, 2006, FEBS LETT, V580, P5125, DOI 10.1016/j.febslet.2006.05.072; Nocchi L, 2011, J BIOL CHEM, V286, P19478, DOI 10.1074/jbc.M110.217331; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Ogawa M, 2007, INT J ONCOL, V31, P323; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Paglin S, 2001, CANCER RES, V61, P439; Prochazka L, 2010, APOPTOSIS, V15, P782, DOI 10.1007/s10495-010-0482-z; Ralph SJ, 2010, MOL ASPECTS MED, V31, P29, DOI 10.1016/j.mam.2009.12.006; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Sasaki R, 2008, CANCER SCI, V99, P1040, DOI 10.1111/j.1349-7006.2008.00771.x; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tareen Basir, 2008, Int J Med Sci, V5, P62; Tomasetti M, 2010, BRIT J CANCER, V102, P1224, DOI 10.1038/sj.bjc.6605617; Valis K, 2011, CANCER RES, V71, P946, DOI 10.1158/0008-5472.CAN-10-2203; Verrax F, 2005, FREE RADICAL RES, V39, P649, DOI 10.1080/10715760500097906; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Weber T, 2003, BIOCHEMISTRY-US, V42, P4277, DOI 10.1021/bi020527j; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu WP, 2003, CANCER RES, V63, P2483; Zhang WW, 2012, CELL SIGNAL, V24, P1037, DOI 10.1016/j.cellsig.2011.12.025	47	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52263	10.1371/journal.pone.0052263	http://dx.doi.org/10.1371/journal.pone.0052263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272231	gold, Green Submitted, Green Published			2022-12-25	WOS:000312483300074
J	Kammula, EC; Motter, J; Gorgels, A; Jonas, E; Hoffmann, S; Willbold, D				Kammula, Ellen C.; Moetter, Jessica; Gorgels, Alexandra; Jonas, Esther; Hoffmann, Silke; Willbold, Dieter			Brain Transcriptome-Wide Screen for HIV-1 Nef Protein Interaction Partners Reveals Various Membrane-Associated Proteins	PLOS ONE			English	Article							CD4 CYTOPLASMIC DOMAIN; VIRUS TYPE-1 NEF; ENDOPLASMIC-RETICULUM; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; INFECTED PATIENTS; DILEUCINE MOTIF; T-CELLS; EXPRESSION; BINDING	HIV-1 Nef protein contributes essentially to the pathology of AIDS by a variety of protein-protein-interactions within the host cell. The versatile functionality of Nef is partially attributed to different conformational states and posttranslational modifications, such as myristoylation. Up to now, many interaction partners of Nef have been identified using classical yeast two-hybrid screens. Such screens rely on transcriptional activation of reporter genes in the nucleus to detect interactions. Thus, the identification of Nef interaction partners that are integral membrane proteins, membrane-associated proteins or other proteins that do not translocate into the nucleus is hampered. In the present study, a split-ubiquitin based yeast two-hybrid screen was used to identify novel membrane-localized interaction partners of Nef. More than 80% of the hereby identified interaction partners of Nef are transmembrane proteins. The identified hits are GPM6B, GPM6A, BAP31, TSPAN7, CYB5B, CD320/TCblR, VSIG4, PMEPA1, OCIAD1, ITGB1, CHN1, PH4, CLDN10, HSPA9, APR-3, PEBP1 and B3GNT, which are involved in diverse cellular processes like signaling, apoptosis, neurogenesis, cell adhesion and protein trafficking or quality control. For a subfraction of the hereby identified proteins we present data supporting their direct interaction with HIV-1 Nef. We discuss the results with respect to many phenotypes observed in HIV infected cells and patients. The identified Nef interaction partners may help to further elucidate the molecular basis of HIV-related diseases.	[Kammula, Ellen C.; Moetter, Jessica; Gorgels, Alexandra; Hoffmann, Silke; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Kammula, Ellen C.; Moetter, Jessica; Jonas, Esther; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Willbold, D (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany.	d.willbold@fz-juelich.de	Willbold, Dieter/A-6280-2013; Hoffmann, Silke/H-5059-2013	Willbold, Dieter/0000-0002-0065-7366; Hoffmann, Silke/0000-0003-1414-8957	Prasidentenfond der Helmholtzgemeinschaft (HGF, Virtual Institute of Structural Biology)	Prasidentenfond der Helmholtzgemeinschaft (HGF, Virtual Institute of Structural Biology)	This work was supported by a grant from the Prasidentenfond der Helmholtzgemeinschaft (HGF, Virtual Institute of Structural Biology) to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Ances BM, 2008, INT REV PSYCHIATR, V20, P89, DOI 10.1080/09540260701877670; Andras IE, 2011, METHODS MOL BIOL, V762, P355, DOI 10.1007/978-1-61779-185-7_26; Baur AS, 2011, TRENDS MICROBIOL, V19, P435, DOI 10.1016/j.tim.2011.06.002; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Cettomai D, 2009, ARCH NEUROL-CHICAGO, V66, P255, DOI 10.1001/archneurol.2008.557; Charfi C, 2011, BLOOD, V117, P1899, DOI 10.1182/blood-2010-10-311001; Cheung ST, 2005, CLIN CANCER RES, V11, P551; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Drabek K, 2011, J BONE MINER RES, V26, P2045, DOI 10.1002/jbmr.435; Fernandez ME, 2010, J NEUROSCI RES, V88, P1298, DOI 10.1002/jnr.22298; Fjorback AW, 2009, J MOL NEUROSCI, V37, P191, DOI 10.1007/s12031-008-9092-4; Foster JL, 2011, J NEUROIMMUNE PHARM, V6, P230, DOI 10.1007/s11481-011-9262-y; Fukushi M, 1999, FEBS LETT, V442, P83, DOI 10.1016/S0014-5793(98)01631-7; Gallina A, 2001, VIROLOGY, V283, P7, DOI 10.1006/viro.2001.0855; Geiger R, 2011, NAT CELL BIOL, V13, P1305, DOI 10.1038/ncb2339; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hoffmann S, 2007, BIOL CHEM, V388, P181, DOI 10.1515/BC.2007.020; Horberg MA, 2008, JAIDS-J ACQ IMM DEF, V47, P384, DOI 10.1097/QAI.0b013e318160d53e; Huang GW, 2011, J CANCER RES CLIN, V137, P1213, DOI 10.1007/s00432-011-0987-z; Hult B, 2008, INT REV PSYCHIATR, V20, P3, DOI 10.1080/09540260701862086; Ip YC, 2007, MOL CANCER THER, V6, P2858, DOI 10.1158/1535-7163.MCT-07-0453; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jia X, 2012, NATURE STRUCTURAL MO; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kasper MR, 2005, J BIOL CHEM, V280, P12840, DOI 10.1074/jbc.M413538200; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kwak YT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-77; Ladasky JJ, 2006, J IMMUNOL, V177, P6172, DOI 10.4049/jimmunol.177.9.6172; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Lamers SL, 2010, CURR HIV RES, V8, P638, DOI 10.2174/157016210794088209; Lanzafame M, 2009, Infez Med, V17, P35; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2000, J EXP MED, V191, P1077, DOI 10.1084/jem.191.6.1077; Liu YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024477; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Mobius W, 2008, NEURON GLIA BIOL, V4, P111, DOI 10.1017/S1740925X0900009X; Mukerji J, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-33; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Preusser A, 2002, BIOCHEM BIOPH RES CO, V292, P734, DOI 10.1006/bbrc.2002.6700; Preusser A, 2001, J VIROL, V75, P3960, DOI 10.1128/JVI.75.8.3960-3964.2001; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Regan JA, 2008, J VIROL, V82, P10042, DOI 10.1128/JVI.01240-08; Reggiori F, 2011, VIRUSES-BASEL, V3, P1610, DOI 10.3390/v3091610; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Rossi F, 1997, VIROLOGY, V237, P33, DOI 10.1006/viro.1997.8752; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Shelton MN, 2012, J VIROL, V86, P406, DOI 10.1128/JVI.05720-11; Tokarev Andrey, 2011, Cell Logist, V1, P90; Tran T, 2005, BIOCHEMISTRY-US, V44, P15042, DOI 10.1021/bi051403k; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Watanabe W, 1997, BIOCHEM BIOPH RES CO, V238, P234, DOI 10.1006/bbrc.1997.7217; Werner H, 2001, MOL CELL NEUROSCI, V18, P593, DOI 10.1006/mcne.2001.1044; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8; Wonderlich ER, 2011, IMMUNOL RES, V50, P228, DOI 10.1007/s12026-011-8220-3; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Yi L, 2010, J BIOL CHEM, V285, P30884, DOI 10.1074/jbc.M110.135947; Zhang YN, 2006, IMMUNOL RES, V35, P151, DOI 10.1385/IR:35:1:151; Zheng JY, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-79; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	71	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51578	10.1371/journal.pone.0051578	http://dx.doi.org/10.1371/journal.pone.0051578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284715	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900027
J	Sakamuri, SSVP; Sukapaka, M; Prathipati, VK; Nemani, H; Putcha, UK; Pothana, S; Koppala, SR; Ponday, LRK; Acharya, V; Veetill, GN; Ayyalasomayajula, V				Sakamuri, Siva Sankara Vara Prasad; Sukapaka, Mahesh; Prathipati, Vijay Kumar; Nemani, Harishankar; Putcha, Uday Kumar; Pothana, Shailaja; Koppala, Swarupa Rani; Ponday, Lakshmi Raj Kumar; Acharya, Vani; Veetill, Giridharan Nappan; Ayyalasomayajula, Vajreswari			Carbenoxolone Treatment Ameliorated Metabolic Syndrome in WNIN/Ob Obese Rats, but Induced Severe Fat Loss and Glucose Intolerance in Lean Rats	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; ADIPOSE-TISSUE; INSULIN SENSITIVITY; ZUCKER RATS; 11BETA-HYDROXYSTEROID DEHYDROGENASE; SELECTIVE-INHIBITION; HYPERGLYCEMIC MICE; VISCERAL OBESITY; MESSENGER-RNA; RESISTANCE	Background: 11beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) regulates local glucocorticoid action in tissues by catalysing conversion of inactive glucocorticoids to active glucocorticoids. 11 beta-HSD1 inhibition ameliorates obesity and associated co-morbidities. Here, we tested the effect of 11 beta-HSD inhibitor, carbenoxolone (CBX) on obesity and associated comorbidities in obese rats of WNIN/Ob strain, a new animal model for genetic obesity. Methodology/Principal Findings: Subcutaneous injection of CBX (50 mg/kg body weight) or volume-matched vehicle was given once daily for four weeks to three month-old WNIN/Ob lean and obese rats (n = 6 for each phenotype and for each treatment). Body composition, plasma lipids and hormones were assayed. Hepatic steatosis, adipose tissue morphology, inflammation and fibrosis were also studied. Insulin resistance and glucose intolerance were determined along with tissue glycogen content. Gene expressions were determined in liver and adipose tissue. CBX significantly inhibited 11 beta-HSD1 activity in liver and adipose tissue of WNIN/Ob lean and obese rats. CBX significantly decreased body fat percentage, hypertriglyceridemia, hypercholesterolemia, insulin resistance in obese rats. CBX ameliorated hepatic steatosis, adipocyte hypertrophy, adipose tissue inflammation and fibrosis in obese rats. Tissue glycogen content was significantly decreased by CBX in liver and adipose tissue of obese rats. Severe fat loss and glucose-intolerance were observed in lean rats after CBX treatment. Conclusions/Significance: We conclude that 11 beta-HSD1 inhibition by CBX decreases obesity and associated co-morbidities in WNIN/Ob obese rats. Our study supports the hypothesis that inhibition of 11 beta-HSD1 is a key strategy to treat metabolic syndrome. Severe fat loss and glucose-intolerance by CBX treatment in lean rats suggest that chronic 11 beta-HSD1 inhibition may lead to insulin resistance in normal conditions.	[Sakamuri, Siva Sankara Vara Prasad; Prathipati, Vijay Kumar; Koppala, Swarupa Rani; Ponday, Lakshmi Raj Kumar; Acharya, Vani; Ayyalasomayajula, Vajreswari] Indian Council Med Res, Natl Inst Nutr, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India; [Sukapaka, Mahesh; Nemani, Harishankar; Pothana, Shailaja; Veetill, Giridharan Nappan] Indian Council Med Res, Natl Ctr Lab Anim Sci, Dept Anim Physiol, Hyderabad 500007, Andhra Pradesh, India; [Putcha, Uday Kumar] Indian Council Med Res, Natl Inst Nutr, Dept Pathol, Hyderabad 500007, Andhra Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Indian Council of Medical Research (ICMR); ICMR - National Animal Resource Facility for Biomedical Research (NARFBR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Ayyalasomayajula, V (corresponding author), Indian Council Med Res, Natl Inst Nutr, Dept Biochem, Jamai Osmania Po, Hyderabad 500007, Andhra Pradesh, India.	vaj_lipidresearch@yahoo.com		Sakamuri, Siva Sankara Vara Prasad/0000-0003-3569-9985	Council of Scientific and Industrial Research (CSIR), India	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	We are grateful to Dr. B. Sesikeran, Director, of the Institute for constant encouragement during the conduct of the study. SSSVP thanks the Council of Scientific and Industrial Research (CSIR), India for the award of a research fellowship to carry out this work. SSSVP thanks Ms. M. V. Surekha and Mr. P. Srinivas for helping in histopathology-studies. SSSVP thanks Mr. Venu for helping in animal experiment & Mr. Murali for helping in western blotting.	Alberts P, 2003, ENDOCRINOLOGY, V144, P4755, DOI 10.1210/en.2003-0344; Alberts P, 2002, DIABETOLOGIA, V45, P1528, DOI 10.1007/s00125-002-0959-6; Andrews RC, 2003, J CLIN ENDOCR METAB, V88, P285, DOI 10.1210/jc.2002-021194; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; Berthiaume M, 2007, ENDOCRINOLOGY, V148, P2391, DOI 10.1210/en.2006-1199; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; ElHadri K, 1997, BIOCHEM J, V323, P359, DOI 10.1042/bj3230359; Farb MG, 2011, J AM COLL CARDIOL, V58, P232, DOI 10.1016/j.jacc.2011.01.051; FOLCH J, 1957, J BIOL CHEM, V226, P497; Giridharan N., 1996, Scandinavian Journal of Laboratory Animal Science, V23, P131; HAUNER H, 1987, J CLIN ENDOCR METAB, V64, P832, DOI 10.1210/jcem-64-4-832; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Jeyakumar SM, 2007, OBESITY, V15, P322, DOI 10.1038/oby.2007.534; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1227, DOI 10.1152/ajpendo.00344.2005; KOUBI H, 1991, CAN J PHYSIOL PHARM, V69, P841, DOI 10.1139/y91-127; Liu J, 2011, ENDOCR J, V58, P199, DOI 10.1507/endocrj.K10E-318; Livingstone DEW, 2003, J PHARMACOL EXP THER, V305, P167, DOI 10.1124/jpet.102.044842; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Muller C, 1997, DIABETOLOGIA, V40, P463, DOI 10.1007/s001250050701; Nuotio-Antar AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1517, DOI 10.1152/ajpendo.00522.2007; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-132; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Seckl JR, 2004, RECENT PROG HORM RES, V59, P359, DOI 10.1210/rp.59.1.359; Silver DL, 1999, J BIOL CHEM, V274, P4140, DOI 10.1074/jbc.274.7.4140; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Venu L, 2004, DIABETOLOGIA, V47, P1493, DOI 10.1007/s00125-004-1506-4; Wamil M, 2011, DIABETES, V60, P1158, DOI 10.2337/db10-0830; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Xue B, 2007, J BIOL CHEM, V282, P23829, DOI 10.1074/jbc.M609680200	38	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e50216	10.1371/journal.pone.0050216	http://dx.doi.org/10.1371/journal.pone.0050216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284633	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900006
J	Wei, W; Lampe, L; Park, S; Vangara, BS; Waldo, GS; Cabantous, S; Subaran, SS; Yang, DM; Lakatta, EG; Lin, L				Wei, Wen; Lampe, Leonie; Park, Sungha; Vangara, Bhavana S.; Waldo, Geoffrey S.; Cabantous, Stephanie; Subaran, Sarah S.; Yang, Dongmei; Lakatta, Edward G.; Lin, Li			Disulfide Bonds within the C2 Domain of RAGE Play Key Roles in Its Dimerization and Biogenesis	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INFLAMMATORY CELL RECRUITMENT; PEPTIDE-N-GLYCANASE; ENDOPLASMIC-RETICULUM; PATTERN-RECOGNITION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; IMMUNE-RESPONSES; ENDPRODUCTS RAGE; REDOX REGULATION	Background: The receptor for advanced glycation end products (RAGE) on the cell surface transmits inflammatory signals. A member of the immunoglobulin superfamily, RAGE possesses the V, C1, and C2 ectodomains that collectively constitute the receptor's extracellular structure. However, the molecular mechanism of RAGE biogenesis remains unclear, impeding efforts to control RAGE signaling through cellular regulation. Methodology and Result: We used co-immunoprecipitation and crossing-linking to study RAGE oligomerization and found that RAGE forms dimer-based oligomers. Via non-reducing SDS-polyacrylamide gel electrophoresis and mutagenesis, we found that cysteines 259 and 301 within the C2 domain form intermolecular disulfide bonds. Using a modified tripartite split GFP complementation strategy and confocal microscopy, we also found that RAGE dimerization occurs in the endoplasmic reticulum (ER), and that RAGE mutant molecules without the double disulfide bridges are unstable, and are subjected to the ER-associated degradation. Conclusion: Disulfide bond-mediated RAGE dimerization in the ER is the critical step of RAGE biogenesis. Without formation of intermolecular disulfide bonds in the C2 region, RAGE fails to reach cell surface. Significance: This is the first report of RAGE intermolecular disulfide bond.	[Wei, Wen; Lampe, Leonie; Park, Sungha; Vangara, Bhavana S.; Subaran, Sarah S.; Yang, Dongmei; Lakatta, Edward G.; Lin, Li] Natl Inst Aging, Cardiovasc Sci Lab, Baltimore, MD USA; [Waldo, Geoffrey S.; Cabantous, Stephanie] Los Alamos Natl Lab, Biosci Lab, Los Alamos, NM USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); United States Department of Energy (DOE); Los Alamos National Laboratory	Lin, L (corresponding author), Natl Inst Aging, Cardiovasc Sci Lab, Baltimore, MD USA.	linli@mail.nih.gov	Cabantous, Stephanie/AAB-5113-2020; Cabantous, Stephanie/M-3282-2014; Lakatta, Edward G/AAL-1447-2020	Cabantous, Stephanie/0000-0002-8406-9421; Cabantous, Stephanie/0000-0002-8406-9421; Lakatta, Edward/0000-0002-4772-0035	National Institutes of Health, National Institute on Aging; NIH [RO1CA94102]; NIH Protein Structure Initiative [U54 GM074946-01US]; Oak Ridge Institute for Science and Education's Research Associates Program at the NIH; Roland Ernst Foundation; Korea Research Foundation [KRF-2009-013-E00008]; NIH, NIA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000796] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Ridge Institute for Science and Education's Research Associates Program at the NIH; Roland Ernst Foundation; Korea Research Foundation(National Research Foundation of Korea); NIH, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute on Aging (L. Lin and EGL), the NIH grant RO1CA94102 (L. Lin), and the NIH Protein Structure Initiative (U54 GM074946-01US, "Integrated Center for Structure and Function Innovation") (GSW and SC). WW and DY were supported in part by the Oak Ridge Institute for Science and Education's Research Associates Program at the NIH; L. Lampe was supported in part by the Roland Ernst Foundation; SP was supported in part by the Korea Research Foundation grant (KRF-2009-013-E00008; BV was supported by 2009 and 2010 Summer Student Internship Program of NIH, NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, J NEUROCHEM, V92, P255, DOI 10.1111/j.1471-4159.2004.02864.x; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen VM, 2006, J THROMB HAEMOST, V4, P2533, DOI 10.1111/j.1538-7836.2006.02236.x; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; He M, 2011, EMBO REP, V12, P358, DOI 10.1038/embor.2011.28; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Janssen-Heininger YM, ANN N Y ACAD SCI, V1203, P23; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Kinnula VL, 2007, CURR MED CHEM, V14, P213, DOI 10.2174/092986707779313345; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Lin L, 2006, CELL MOL IMMUNOL, V3, P351; Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315; Matthias LJ, 2003, ANTIOXID REDOX SIGN, V5, P133, DOI 10.1089/152308603321223621; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Pang J, 2009, PROTEIN SCI, V18, P1261, DOI 10.1002/pro.136; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Thornalley PJ, 2005, ANN NY ACAD SCI, V1043, P111, DOI 10.1196/annals.1333.014; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2007, CURR MOL MED, V7, P699; Yan SF, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S146239940900101X; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	45	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e50736	10.1371/journal.pone.0050736	http://dx.doi.org/10.1371/journal.pone.0050736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284645	Green Submitted, gold, Green Published			2022-12-25	WOS:000312435900008
J	Diguisto, C; Le Ray, C; Maillard, F; Khoshnood, B; Verspyck, E; Perrotin, F; Goffinet, F				Diguisto, Caroline; Le Ray, Camille; Maillard, Francoise; Khoshnood, Babak; Verspyck, Eric; Perrotin, Franck; Goffinet, Francois		EVAPRIMA Grp	Individual and Organisational Determinants Associated with Maintenance Tocolysis in the Management of Preterm Labour: A Multilevel Analysis	PLOS ONE			English	Article							ORAL TERBUTALINE; CONTROLLED-TRIAL; CLINICAL-TRIAL; NIFEDIPINE; EFFICACY; DELIVERY; PLACEBO; BIRTH	Background: Clinical guidelines do not recommend maintenance tocolysis for the management of preterm labour. The French national survey EVAPRIMA revealed it was administered to more than 50% of women hospitalised for preterm labour. Our aim was to identify the individual and organisational determinants associated with maintenance tocolysis. Methods: The study was a secondary analysis of the prospective population-based EVAPRIMA study database. Population study included every women hospitalised for preterm labour and at risk of receiving maintenance tocolysis, over a one month period, in 99 randomly selected French maternity units. Main outcome was the prescription of maintenance tocolysis. The association between maintenance tocolysis and individual (maternal or obstetrical) and organisational determinants were evaluated with multilevel analysis. Results: Of the 531 women included, 68.9% (95% CI 0.65-0.73) received maintenance tocolysis. The only individual factor associated with maintenance tocolysis was gestational age at admission; the rate of maintenance tocolysis was higher among women hospitalised before 32 weeks of gestation. The significantly different rates between maternity units demonstrated the existence of a maternity unit effect. Maintenance tocolysis was also associated with organisational determinants and was more frequent in level 1 (ORa = 6.54[2.21-19.40]) and level 2 maternity units (ORa = 3.68[1.28-10.59]), in units with less than 1500 deliveries/year (ORa = 5.27[4.43-19.44]), and in specific areas of France. Conclusion: A maternity unit effect, explained partly by the organisational characteristics of the units, plays a major role in the practice of maintenance tocolysis. Widespread dissemination of these results might improve adherence to clinical guidelines.	[Diguisto, Caroline; Le Ray, Camille; Maillard, Francoise; Khoshnood, Babak; Goffinet, Francois] Univ Paris 06, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, INSERM, UMR S953, Paris, France; [Le Ray, Camille; Goffinet, Francois] Univ Paris 05, Assistance Publ Hop Paris, Cochin St Vincent de Paul Hosp, Dept Obstet & Gynaecol, Paris, France; [Verspyck, Eric] Univ Hosp Rouen, Dept Obstet & Gynaecol, Rouen, France; [Diguisto, Caroline; Perrotin, Franck] Univ Tours, Univ Hosp Tours, Dept Obstet & Gynaecol, Tours, France; [Le Ray, Camille; Goffinet, Francois] Premup Fdn, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU de Rouen; CHU Tours; Universite de Tours; UDICE-French Research Universities; Universite Paris Cite	Diguisto, C (corresponding author), Univ Paris 06, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, INSERM, UMR S953, Paris, France.	carolinediguisto@gmail.com	Khoshnood, Babak/N-9096-2017; Perrotin, Franck/AAL-8833-2021	Perrotin, Franck/0000-0001-9694-6658; GOFFINET, Francois/0000-0001-9643-0299; Le Ray, Camille/0000-0003-0891-1063; Khoshnood, Babak/0000-0002-4031-4915	Ferring Company	Ferring Company(Ferring Pharmaceuticals)	The EVAPRIMA survey was supported by the Ferring Company. The funders had no role in the study design, data collection, data interpretation or the writing of the report.	Blondel B, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P373; Carr DB, 1999, AM J OBSTET GYNECOL, V181, P822, DOI 10.1016/S0002-9378(99)70308-X; D'Ercole C, 2002, J GYNECOL OBST BIO R, V31, pS84; Dodd JM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003927.pub2; Gaunekar NN, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004071; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Gyetvai K, 1999, OBSTET GYNECOL, V94, P869, DOI 10.1016/S0029-7844(99)00329-4; HOW HY, 1995, AM J OBSTET GYNECOL, V173, P1518, DOI 10.1016/0002-9378(95)90642-8; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Lewis R, 1996, AM J OBSTET GYNECOL, V175, P834, DOI 10.1016/S0002-9378(96)80008-1; Lyell DJ, 2008, OBSTET GYNECOL, V112, P1221, DOI 10.1097/AOG.0b013e31818d8386; Nanda K, 2002, COCHRANE DB SYST REV; Papatsonis D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005938.pub2; Parant O, 2008, BJOG-INT J OBSTET GY, V115, P1538, DOI 10.1111/j.1471-0528.2008.01929.x; PARILLA BV, 1993, AM J OBSTET GYNECOL, V169, P965, DOI 10.1016/0002-9378(93)90036-I; RCOG, 2002, CLIN GUID B; RICCI JM, 1991, AM J OBSTET GYNECOL, V165, P603, DOI 10.1016/0002-9378(91)90293-Z; Roos C, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-42; Saillour-Glenisson F, 2008, REV EPIDEMIOL SANTE, V56, pS207, DOI 10.1016/j.respe.2008.04.006; Sanchez-Ramos L, 1999, AM J OBSTET GYNECOL, V181, P484, DOI 10.1016/S0002-9378(99)70582-X; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Valenzuela GJ, 2000, AM J OBSTET GYNECOL, V182, P1184, DOI 10.1067/mob.2000.105816; Veatch RM, 2000, JAMA-J AM MED ASSOC, V283, P1685, DOI 10.1001/jama.283.13.1685	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e50788	10.1371/journal.pone.0050788	http://dx.doi.org/10.1371/journal.pone.0050788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272071	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386600014
J	Sheth, S; Jajoo, S; Kaur, T; Mukherjea, D; Sheehan, K; Rybak, LP; Ramkumar, V				Sheth, Sandeep; Jajoo, Sarvesh; Kaur, Tejbeer; Mukherjea, Debashree; Sheehan, Kelly; Rybak, Leonard P.; Ramkumar, Vickram			Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway	PLOS ONE			English	Article							NEGATIVE FEEDBACK; SUPPRESSOR PDCD4; TGF-BETA; FACTOR I; MICRORNA-21; EXPRESSION; MIR-21; APOPTOSIS; INVASION; GENE	The consumption of foods containing resveratrol produces significant health benefits. Resveratrol inhibits cancer by reducing cell proliferation and metastasis and by inducing apoptosis. These actions could be explained by its ability to inhibit (ERK-1/2), Akt and suppressing the levels of estrogen and insulin growth factor -1 (IGF-1) receptor. How these processes are manifested into the antitumor actions of resveratrol is not clear. Using microarray studies, we show that resveratrol reduced the expression of various prostate-tumor associated microRNAs (miRs) including miR-21 in androgen-receptor negative and highly aggressive human prostate cancer cells, PC-3M-MM2. This effect of resveratrol was associated with reduced cell viability, migration and invasiveness. Additionally, resveratrol increased the expression of tumor suppressors, PDCD4 and maspin, which are negatively regulated by miR-21. Short interfering (si) RNA against PDCD4 attenuated resveratrol's effect on prostate cancer cells, and similar effects were observed following over expression of miR-21 with pre-miR-21 oligonucleotides. PC-3M-MM2 cells also exhibited high levels of phospho-Akt (pAkt), which were reduced by both resveratrol and LY294002 (a PI3-kinase inhibitor). MiR-21 expression in these cells appeared to be dependent on Akt, as LY294002 reduced the levels of miR-21 along with a concurrent increase in PDCD4 expression. These in vitro findings were further corroborated in a severe combined immunodeficient (SCID) mouse xenograft model of prostate cancer. Oral administration of resveratrol not only inhibited the tumor growth but also decreased the incidence and number of metastatic lung lesions. These tumor- and metastatic-suppressive effects of resveratrol were associated with reduced miR-21 and pAkt, and elevated PDCD4 levels. Similar anti-tumor effects of resveratrol were observed in DU145 and LNCaP prostate cancer cells which were associated with suppression of Akt and PDCD4, but independent of miR-21. These data suggest that resveratrol's anti-tumor actions in prostate cancer could be explained, in part, through inhibition of Akt/miR-21 signaling pathway. Citation: Sheth S, Jajoo S, Kaur T, Mukherjea D, Sheehan K, et al. (2012) Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway. PLoS ONE 7(12): e51655. doi:10.1371/journal.pone.0051655	[Sheth, Sandeep; Jajoo, Sarvesh; Kaur, Tejbeer; Ramkumar, Vickram] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; [Mukherjea, Debashree; Sheehan, Kelly; Rybak, Leonard P.] So Illinois Univ, Sch Med, Dept Surg, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Ramkumar, V (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	vramkumar@siumed.edu	Mukherjea, Debashree/AAR-5651-2020; Kaur, Tejbeer/AAG-1992-2019; Sheth, Sandeep/B-7839-2015	Kaur, Tejbeer/0000-0003-3626-2670; Sheth, Sandeep/0000-0001-6570-8120	NIH Grant [R15CA135494]; SIU School of Medicine Cancer Center Grant; SIU School of Medicine Excellence in Academic Medicine Award; US Department of Defense Grant [PC100127]; NATIONAL CANCER INSTITUTE [R15CA135494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002396, R03DC011621] Funding Source: NIH RePORTER	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SIU School of Medicine Cancer Center Grant; SIU School of Medicine Excellence in Academic Medicine Award; US Department of Defense Grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by NIH Grant (R15CA135494), SIU School of Medicine Cancer Center Grant and SIU School of Medicine Excellence in Academic Medicine Award to VR. SJ was supported by the US Department of Defense Grant (PC100127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2000, MOL CARCINOGEN, V28, P129, DOI 10.1002/1098-2744(200007)28:3&lt;129::AID-MC1&gt;3.0.CO;2-0; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Barrack ER, 1997, PROSTATE, V31, P61; Bishayee A, 2009, CANCER PREV RES, V2, P409, DOI 10.1158/1940-6207.CAPR-08-0160; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bowers JL, 2000, ENDOCRINOLOGY, V141, P3657, DOI 10.1210/en.141.10.3657; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; DELWORTH MG, 1995, INT J ONCOL, V6, P293; Dorrie J, 2001, CANCER RES, V61, P4731; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Harper CE, 2007, CARCINOGENESIS, V28, P1946, DOI 10.1093/carcin/bgm144; Himpe E, 2011, GROWTH HORM IGF RES, V21, P252, DOI 10.1016/j.ghir.2011.07.001; Jajoo S, 2006, J PHARMACOL EXP THER, V317, P1, DOI 10.1124/jpet.105.096255; Jajoo S, 2009, NEOPLASIA, V11, P1132, DOI 10.1593/neo.09744; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kaur T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.63; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Levi F, 2005, EUR J CANCER PREV, V14, P139, DOI 10.1097/00008469-200504000-00009; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Li YW, 2010, PHARM RES-DORDR, V27, P1027, DOI 10.1007/s11095-010-0105-y; Liu J, 2011, INT J ORAL SCI, V3, P165, DOI 10.4248/IJOS11063; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; MAXWELL S, 1994, LANCET, V344, P193, DOI 10.1016/S0140-6736(94)92795-2; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mocellin S, 2009, MINI-REV MED CHEM, V9, P70, DOI 10.2174/138955709787001802; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Qin WM, 2009, ACTA BIOCH BIOPH SIN, V41, P618, DOI 10.1093/abbs/gmp049; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Ruan WF, 1999, ENDOCRINOLOGY, V140, P1984, DOI 10.1210/en.140.5.1984; Sayed D, 2010, J BIOL CHEM, V285, P20281, DOI 10.1074/jbc.M110.109207; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sgambato A, 2001, MUTAT RES-GEN TOX EN, V496, P171, DOI 10.1016/S1383-5718(01)00232-7; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Tili E, 2010, BIOCHEM PHARMACOL, V80, P2057, DOI 10.1016/j.bcp.2010.07.003; Torring N, 1997, J UROLOGY, V158, P222, DOI 10.1097/00005392-199707000-00075; van der Fits L, 2011, J INVEST DERMATOL, V131, P762, DOI 10.1038/jid.2010.349; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wei N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030311; Wolk A, 1998, J NATL CANCER I, V90, P911, DOI 10.1093/jnci/90.12.911; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yu W, 2012, J CELL BIOCHEM, V113, P752, DOI 10.1002/jcb.23431; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	57	149	159	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51655	10.1371/journal.pone.0051655	http://dx.doi.org/10.1371/journal.pone.0051655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272133	gold, Green Published, Green Submitted			2022-12-25	WOS:000312386600034
J	Liu, Q; Zhou, H; Zhang, K; Shi, XX; Fan, W; Zhu, RX; Yu, PS; Cao, ZW				Liu, Qi; Zhou, Han; Zhang, Kui; Shi, Xiaoxiao; Fan, Wei; Zhu, Ruixin; Yu, Philip S.; Cao, Zhiwei			In Silico Target-Specific siRNA Design Based on Domain Transfer in Heterogeneous Data	PLOS ONE			English	Article							RNA-INTERFERENCE; EXPRESSION; SELECTION; MICRORNA	RNA interference via exogenous small interference RNAs (siRNA) is a powerful tool in gene function study and disease treatment. Designing efficient and specific siRNA on target gene remains the key issue in RNAi. Although various in silico models have been proposed for rational siRNA design, most of them focus on the efficiencies of selected siRNAs, while limited effort has been made to improve their specificities targeted on specific mRNAs, which is related to reducing off-target effects (OTEs) in RNAi. In our study, we propose for the first time that the enhancement of target specificity of siRNA design can be achieved computationally by domain transfer in heterogeneous data sources from different siRNA targets. A transfer learning based method i.e., heterogeneous regression (HEGS) is presented for target-specific siRNA efficacy modeling and feature selection. Based on the model, (1) the target regression model can be built by extracting information from related data in other targets/experiments, thus increasing the target specificity in siRNA design with the help of information from siRNAs binding to other homologous genes, and (2) the potential features correlated to the current siRNA design can be identified even when there is lack of experimental validated siRNA affinity data on this target. In summary, our findings present useful instructions for a better target-specific siRNA design, with potential applications in genome-wide high-throughput screening of effective siRNA, and will provide further insights on the mechanism of RNAi.	[Liu, Qi; Zhou, Han; Zhang, Kui; Zhu, Ruixin; Cao, Zhiwei] Tongji Univ, Dept Bioinformat, Shanghai 200092, Peoples R China; [Shi, Xiaoxiao; Yu, Philip S.] Univ Illinois, Dept Comp Sci, Chicago, IL 60680 USA; [Fan, Wei] IBM Thomas J Watson Res Ctr, New York, NY USA	Tongji University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; International Business Machines (IBM)	Yu, PS (corresponding author), Univ Illinois, Dept Comp Sci, Chicago, IL 60680 USA.	psyu@uic.edu; zwcao@tongji.edu.cn	, 金石为开/AFU-9737-2022; Shi, Xiaoxiao/D-6554-2014	Shi, Xiaoxiao/0000-0002-1746-2792; Zhu, Ruixin/0000-0002-5070-6453	National Natural Science Foundation of China [30976611, 31100956, 61173117]; Shanghai Pujiang Talents Funding [11PJ1407400]; Doctoral Program of Higher Education of China [20100072110008, 20100072120050, 20110072120048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Talents Funding; Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	1. National Natural Science Foundation of China (Grant No. 30976611, Grant No. 31100956 and Grant No. 61173117) (http://www.nsfc.gov.cn/), 2. Shanghai Pujiang Talents Funding (Grant No. 11PJ1407400) (http://www.stcsm.gov.cn/), 3. Doctoral Program of Higher Education of China (20100072110008, 20100072120050, 20110072120048) (http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Klingelhoefer JW, 2009, BIOINFORMATICS, V25, P1594, DOI 10.1093/bioinformatics/btp284; Larsson E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.89; Li W, 2007, CELL MOL LIFE SCI, V64, P1785, DOI 10.1007/s00018-007-7057-3; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037879; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-181; Mahanthappa N, 2005, PHARMACOGENOMICS, V6, P879, DOI 10.2217/14622416.6.8.879; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Patzel V, 2005, NAT BIOTECHNOL, V23, P1440, DOI 10.1038/nbt1151; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saetrom P, 2004, BIOCHEM BIOPH RES CO, V321, P247, DOI 10.1016/j.bbrc.2004.06.116; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Shi X., 2010, P 2010 SIAM INT C DA, P814; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Weinheim HKVC, 1994, J MED CHEM, V37, P2481; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Zhong EH, 2010, LECT NOTES ARTIF INT, V6323, P547, DOI 10.1007/978-3-642-15939-8_35	30	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e50697	10.1371/journal.pone.0050697	http://dx.doi.org/10.1371/journal.pone.0050697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284642	gold, Green Published, Green Submitted			2022-12-25	WOS:000313158800005
J	Aillet, F; Lopitz-Otsoa, F; Egana, I; Hjerpe, R; Fraser, P; Hay, RT; Rodriguez, MS; Lang, V				Aillet, Fabienne; Lopitz-Otsoa, Fernando; Egana, Isabel; Hjerpe, Roland; Fraser, Paul; Hay, Ron T.; Rodriguez, Manuel S.; Lang, Valerie			Heterologous SUMO-2/3-Ubiquitin Chains Optimize I kappa B alpha Degradation and NF-kappa B Activity	PLOS ONE			English	Article							SUMO-1 MODIFICATION; UBIQUITIN CHAINS; ACTIVATION; BINDING; IDENTIFICATION; NEDDYLATION; SUMOYLATION; NEDD8; NEMO; PHOSPHORYLATION	The NF-kappa B pathway is regulated by SUMOylation at least at three levels: the inhibitory molecule I kappa B alpha, the IKK subunit gamma/NEMO and the p52 precursor p100. Here we investigate the role of SUMO-2/3 in the degradation of I kappa B alpha and activation of NF-kappa B mediated by TNF alpha. We found that under conditions of deficient SUMOylation, an important delay in both TNF alpha-mediated proteolysis of I kappa B alpha and NF-kappa B dependent transcription occurs. In vitro and ex vivo approaches, including the use of ubiquitin-traps (TUBEs), revealed the formation of chains on I kappa B alpha containing SUMO-2/3 and ubiquitin after TNF alpha stimulation. The integration of SUMO-2/3 appears to promote the formation of ubiquitin chains on I kappa B alpha after activation of the TNF alpha signalling pathway. Furthermore, heterologous chains of SUMO-2/3 and ubiquitin promote a more efficient degradation of I kappa B alpha by the 26S proteasome in vitro compared to chains of either SUMO-2/3 or ubiquitin alone. Consistently, Ubc9 silencing reduced the capture of I kappa B alpha modified with SUMO-ubiquitin hybrid chains that display a defective proteasome-mediated degradation. Thus, hybrid SUMO-2/3-ubiquitin chains increase the susceptibility of modified I kappa B alpha to the action of 26S proteasome, contributing to the optimal control of NF-kappa B activity after TNF alpha-stimulation.	[Aillet, Fabienne; Lopitz-Otsoa, Fernando; Egana, Isabel; Hjerpe, Roland; Rodriguez, Manuel S.; Lang, Valerie] CIBERehd, CIC bioGUNE, Prote Unit, Derio, Bizkaia, Spain; [Aillet, Fabienne; Rodriguez, Manuel S.] Inbiomed, Ubiquitylat & Canc Mol Biol Lab, San Sebastian, Gipuzkoa, Spain; [Fraser, Paul] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 1A1, Canada; [Fraser, Paul] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; [Hay, Ron T.] Univ Dundee, Sch Life Sci, Interdisciplinary Res Ctr, Dundee, Scotland	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; University of Toronto; University of Toronto; University of Dundee	Rodriguez, MS (corresponding author), Inbiomed, Ubiquitylat & Canc Mol Biol Lab, San Sebastian, Gipuzkoa, Spain.	msrodriguez@inbiomed.org	Lopitz-Otsoa, Fernando/A-1966-2017; RODRIGUEZ, Manuel S./D-5439-2018	Lopitz-Otsoa, Fernando/0000-0001-8452-6939; 	Ramon y Cajal Program; Ministerio de Educacion y Ciencia [BFU2008-01108/BMC, BFU2006-12991]; Fondo de Investigaciones Sanitarias (FIS) CIBERhed; Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia Country; Canadian Institutes for Health Research (CIHR); Alzheimer Society of Ontario	Ramon y Cajal Program(Spanish Government); Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigaciones Sanitarias (FIS) CIBERhed(Instituto de Salud Carlos III); Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia Country; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Ontario	This work was funded by the Ramon y Cajal Program, Ministerio de Educacion y Ciencia grant (BFU2008-01108/BMC) and (BFU2006-12991), Fondo de Investigaciones Sanitarias (FIS) CIBERhed, Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2005/2006) and from the Innovation Technology Department of the Bizkaia Country. PF is funded by Canadian Institutes for Health Research (CIHR) and Alzheimer Society of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aad G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.041805; Aillet F, 2012, METHODS MOL BIOL, V832, P173, DOI 10.1007/978-1-61779-474-2_12; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Coux O, 1998, J BIOL CHEM, V273, P8820, DOI 10.1074/jbc.273.15.8820; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; Da Silva-Ferrada E, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/875148; Da Silva-Ferrada E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025397; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Dorval V, 2007, BIOCHEM J, V404, P309, DOI 10.1042/BJ20061451; Gareau JR, 2012, J BIOL CHEM, V287, P4740, DOI 10.1074/jbc.M111.321141; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hjerpe R, 2012, J MOL BIOL, V421, P27, DOI 10.1016/j.jmb.2012.05.013; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kim EM, 2011, MOL IMMUNOL, V48, P2189, DOI 10.1016/j.molimm.2011.05.002; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; Lang V, 2008, BIOCHEM SOC T, V36, P853, DOI 10.1042/BST0360853; Leidecker O, 2012, CELL CYCLE, V11, P1142, DOI 10.4161/cc.11.6.19559; Liu Q, 2009, J BIOL CHEM, V284, P13686, DOI 10.1074/jbc.M809275200; Mabb AM, 2007, CELL MOL LIFE SCI, V64, P1979, DOI 10.1007/s00018-007-7005-2; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rodriguez MS, 1996, ONCOGENE, V12, P2425; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Roff M, 1996, J BIOL CHEM, V271, P7844, DOI 10.1074/jbc.271.13.7844; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Shimada K, 2008, BONE, V42, P886, DOI 10.1016/j.bone.2008.01.009; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vatsyayan J, 2008, EMBO REP, V9, P885, DOI 10.1038/embor.2008.122; Vertegaal ACO, 2011, CHEM REV, V111, P7923, DOI 10.1021/cr200187e; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158	50	45	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51672	10.1371/journal.pone.0051672	http://dx.doi.org/10.1371/journal.pone.0051672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284737	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500038
J	Nicholson, JD; Puche, AC; Guo, Y; Weinreich, D; Slater, BJ; Bernstein, SL				Nicholson, James D.; Puche, Adam C.; Guo, Yan; Weinreich, Daniel; Slater, Bernard J.; Bernstein, Steven L.			PGJ(2) Provides Prolonged CNS Stroke Protection by Reducing White Matter Edema	PLOS ONE			English	Article							ISCHEMIC OPTIC NEUROPATHY; ACTIVATED RECEPTOR-GAMMA; 15D-PROSTAGLANDIN J(2); PRIMATE MODEL; CELL-DEATH; BRAIN; RAT; APOPTOSIS; NEUROPROTECTION; INJURY	Few clinically effective approaches reduce CNS-white matter injury. After early in-vivo white matter infarct, NFkB-driven pro-inflammatory signals can amplify a relatively small amount of vascular damage, resulting in progressive endothelial dysfunction to create a severe ischemic lesion. This process can be minimized by 15-deoxy-Delta(12,14)-prostaglandin J2 (PGJ(2)), an analog of the metabolically active PGD(2) metabolite. We evaluated PGJ(2)'s effects and mechanisms using rodent anterior ischemic optic neuropathy (rAION); an in vivo white matter ischemia model. PGJ(2) administration systemically administered either acutely or 5 hours post-insult results in significant neuroprotection, with stereologic evaluation showing improved neuronal survival 30 days post-infarct. Quantitative capillary vascular analysis reveals that PGJ(2) improves perfusion at 1 day post-infarct by reducing tissue edema. Our results suggest that PGJ2 acts by reducing NFkB signaling through preventing p65 nuclear localization and inhibiting inflammatory gene expression. Importantly, PGJ(2) showed no in vivo toxicity structurally as measured by optic nerve (ON) myelin thickness, functionally by ON-compound action potentials, on a cellular basis by oligodendrocyte precursor survival or changes in ON-myelin gene expression. PGJ(2) may be a clinically useful neuroprotective agent for ON and other CNS infarcts involving white matter, with mechanisms of action enabling effective treatment beyond the currently considered maximal time for intervention.	[Nicholson, James D.; Guo, Yan; Slater, Bernard J.; Bernstein, Steven L.] Univ Maryland, Baltimore Sch Med, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA; [Puche, Adam C.; Bernstein, Steven L.] Univ Maryland, Baltimore Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Weinreich, Daniel] Univ Maryland, Baltimore Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bernstein, SL (corresponding author), Univ Maryland, Baltimore Sch Med, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA.	slbernst@umaryland.edu		Slater, Bernard/0000-0001-6895-137X	NIH from NEI [RO1-EY015304, RO1-EY019529]; NATIONAL EYE INSTITUTE [R01EY019529, R01EY015304] Funding Source: NIH RePORTER	NIH from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH grants RO1-EY015304 and RO1-EY019529 from the NEI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JJ, 2007, MOL IMMUNOL, V44, P123, DOI 10.1016/j.molimm.2006.07.287; Arnold AC, 2003, J NEURO-OPHTHALMOL, V23, P157, DOI 10.1097/00041327-200306000-00012; Bernstein SL, 2003, INVEST OPHTH VIS SCI, V44, P4153, DOI 10.1167/iovs.03-0274; Bosomtwi A, 2011, BRAIN RES, V1381, P217, DOI 10.1016/j.brainres.2011.01.009; Bristow MS, 2005, J CEREBR BLOOD F MET, V25, P1280, DOI 10.1038/sj.jcbfm.9600135; Campbell SJ, 2007, J NEUROCHEM, V103, P2245, DOI 10.1111/j.1471-4159.2007.04928.x; Chen CS, 2008, INVEST OPHTH VIS SCI, V49, P2985, DOI 10.1167/iovs.07-1651; Cho WH, 2006, NEUROCHEM RES, V31, P1247, DOI 10.1007/s11064-006-9157-0; Dickstein JB, 2011, AM J PHYSL; Donnan GA, 2008, STROKE, V39, P242, DOI 10.1161/STROKEAHA.107.493296; Farkas RH, 2001, INT OPHTHALMOL CLIN, V41, P111, DOI 10.1097/00004397-200101000-00011; Garcia-Bueno B, 2005, PSYCHOPHARMACOLOGY, V180, P513, DOI 10.1007/s00213-005-2195-5; Genovese T, 2008, SHOCK, V30, P142, DOI 10.1097/SHK.0b013e31815dd381; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Gur RC, 1999, J NEUROSCI, V19, P4065; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kim GS, 2011, J CEREB BLOOD FLOW M, P1; Kunte H, 2007, STROKE, V38, P2526, DOI 10.1161/STROKEAHA.107.482216; LEE HB, 1985, J NUCL MED, V26, P72; Li ZM, 2004, J NEUROSCI RES, V78, P824, DOI 10.1002/jnr.20346; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Lin TN, 2006, ARTERIOSCL THROM VAS, V26, P481, DOI 10.1161/01.ATV.0000201933.53964.5b; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Morris DC, 2000, BRAIN RES, V876, P31, DOI 10.1016/S0006-8993(00)02543-9; Morrison JC, 1999, INVEST OPHTH VIS SCI, V40, P1702; Ou ZS, 2006, BRAIN RES, V1096, P196, DOI 10.1016/j.brainres.2006.04.062; Pereira MP, 2006, J CEREBR BLOOD F MET, V26, P218, DOI 10.1038/sj.jcbfm.9600182; Salgado C, 2011, ARCH OPHTHALMOL-CHIC, V129, P1583, DOI 10.1001/archophthalmol.2011.351; Sasaguri T, 2004, CURR VASC PHARMACOL, V2, P103, DOI 10.2174/1570161043476384; Schmitz C, 2000, J CHEM NEUROANAT, V20, P93, DOI 10.1016/S0891-0618(00)00066-1; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Slater BJ, 2008, INVEST OPHTH VIS SCI, V49, P3671, DOI 10.1167/iovs.07-0504; Taniike M, 2002, J NEUROSCI, V22, P4885, DOI 10.1523/JNEUROSCI.22-12-04885.2002; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1240, DOI 10.2174/156802609789869619; Witt KA, 2005, J NEUROCHEM, V92, P203, DOI 10.1111/j.1471-4159.2004.02871.x; Xiang ZM, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-18; Zhang C, 2009, BRAIN RES, V1264, P67, DOI 10.1016/j.brainres.2008.12.075; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	42	24	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e50021	10.1371/journal.pone.0050021	http://dx.doi.org/10.1371/journal.pone.0050021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284631	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500011
J	Perez-Pepe, M; Slomiansky, V; Loschi, M; Luchelli, L; Neme, M; Thomas, MG; Boccaccio, GL				Perez-Pepe, Marcelo; Slomiansky, Victoria; Loschi, Mariela; Luchelli, Luciana; Neme, Maximiliano; Gabriela Thomas, Maria; Lidia Boccaccio, Graciela			BUHO: A MATLAB Script for the Study of Stress Granules and Processing Bodies by High-Throughput Image Analysis	PLOS ONE			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC GRANULES; DNA-REPLICATION; UV-IRRADIATION; LIVING CELLS; P-BODIES; TRANSLATION; DYNAMICS; SITES	The spontaneous and reversible formation of foci and filaments that contain proteins involved in different metabolic processes is common in both the nucleus and the cytoplasm. Stress granules (SGs) and processing bodies (PBs) belong to a novel family of cellular structures collectively known as mRNA silencing foci that harbour repressed mRNAs and their associated proteins. SGs and PBs are highly dynamic and they form upon stress and dissolve thus releasing the repressed mRNAs according to changes in cell physiology. In addition, aggregates containing abnormal proteins are frequent in neurodegenerative disorders. In spite of the growing relevance of these supramolecular aggregates to diverse cellular functions a reliable automated tool for their systematic analysis is lacking. Here we report a MATLAB Script termed BUHO for the high-throughput image analysis of cellular foci. We used BUHO to assess the number, size and distribution of distinct objects with minimal deviation from manually obtained parameters. BUHO successfully addressed the induction of both SGs and PBs in mammalian and insect cells exposed to different stress stimuli. We also used BUHO to assess the dynamics of specific mRNA-silencing foci termed Smaug 1 foci (S-foci) in primary neurons upon synaptic stimulation. Finally, we used BUHO to analyze the role of candidate genes on SG formation in an RNAi-based experiment. We found that FAK56D, GCN2 and PP1 govern SG formation. The role of PP1 is conserved in mammalian cells as judged by the effect of the PP1 inhibitor salubrinal, and involves dephosphorylation of the translation factor eIF2a. All these experiments were analyzed manually and by BUHO and the results differed in less than 5% of the average value. The automated analysis by this user-friendly method will allow high-throughput image processing in short times by providing a robust, flexible and reliable alternative to the laborious and sometimes unfeasible visual scrutiny.	[Perez-Pepe, Marcelo; Slomiansky, Victoria; Loschi, Mariela; Luchelli, Luciana; Neme, Maximiliano; Gabriela Thomas, Maria; Lidia Boccaccio, Graciela] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Perez-Pepe, Marcelo; Slomiansky, Victoria; Loschi, Mariela; Luchelli, Luciana; Gabriela Thomas, Maria; Lidia Boccaccio, Graciela] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [Slomiansky, Victoria; Loschi, Mariela; Luchelli, Luciana; Lidia Boccaccio, Graciela] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Boccaccio, GL (corresponding author), Fdn Inst Leloir, Buenos Aires, DF, Argentina.	gboccaccio@leloir.org.ar		Perez-Pepe, Marcelo/0000-0002-5712-0973	University of Buenos Aires, Argentina [UBACyT X311]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) [PIP 6173]; Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina [PICT 38006, PICT 1965]	University of Buenos Aires, Argentina(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina(ANPCyT)	This work was supported by the following grants UBACyT X311 from University of Buenos Aires, Argentina; PIP 6173 from Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET); PICT 38006 and PICT 1965 from Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; Andersen PL, 2011, MOL BIOL CELL, V22, P2373, DOI 10.1091/mbc.E10-12-0938; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Baez MV, 2005, J BIOL CHEM, V280, P43131, DOI 10.1074/jbc.M508374200; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Campbell SG, 2005, J CELL BIOL, V170, P925, DOI 10.1083/jcb.200503162; Campbell SG, 2006, CELL CYCLE, V5, P678, DOI 10.4161/cc.5.7.2607; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; DORMANN D, 2010, EMBO J; Thomas MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036447; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Thomas MG, 2009, J CELL SCI, V122, P563, DOI 10.1242/jcs.038208; Gaillard H, 2008, MOL BIOL CELL, V19, P4980, DOI 10.1091/mbc.E08-02-0193; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Kedersha N, 2008, METHOD ENZYMOL, V448, P521, DOI 10.1016/S0076-6879(08)02626-8; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Moreno JA, 2012, NATURE; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Pascual M, 2012, COMMUNICATI IN PRESS, V5, P4; Raaben M, 2007, CELL MICROBIOL, V9, P2218, DOI 10.1111/j.1462-5822.2007.00951.x; Solomon DA, 2004, J CELL BIOL, V166, P455, DOI 10.1083/jcb.200312048; Soria G, 2008, J CELL SCI, V121, P3271, DOI 10.1242/jcs.027730; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Taylor EJ, 2010, MOL BIOL CELL, V21, P2202, DOI 10.1091/mbc.E09-11-0962; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Tsai NP, 2008, EMBO J, V27, P715, DOI 10.1038/emboj.2008.19; Baez MV, 2011, J CELL BIOL, V195, P1141, DOI 10.1083/jcb.201108159; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; White JP, 2012, TRENDS MICROBIOL	40	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51495	10.1371/journal.pone.0051495	http://dx.doi.org/10.1371/journal.pone.0051495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284702	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500030
J	Samy, RP; Rajendran, P; Li, F; Anandi, NM; Stiles, BG; Ignacimuthu, S; Sethi, G; Chow, VTK				Samy, Ramar Perumal; Rajendran, Peramaiyan; Li, Feng; Anandi, Narayana Moorthy; Stiles, Bradley G.; Ignacimuthu, Savarimuthu; Sethi, Gautam; Chow, Vincent T. K.			Identification of a Novel Calotropis procera Protein That Can Suppress Tumor Growth in Breast Cancer through the Suppression of NF-kappa B Pathway	PLOS ONE			English	Article							BRCA1/2 MUTATION CARRIERS; S-TRANSFERASE EXPRESSION; CULEX-QUINQUEFASCIATUS; MAMMOGRAPHIC DENSITY; MAMMARY-TUMORS; PLANT-EXTRACTS; RATS; CELLS; RISK; APOPTOSIS	Breast cancer is the most common cancer among women. To date, improvements in hormonal and cytotoxic therapies have not yet led to a sustained remission or cure. In the present study, we investigated the in vitro and in vivo antitumor activities of a novel Calotropis procera protein (CP-P) isolated from root bark. CP-P protein inhibited the proliferation and induced apoptosis of breast cancer cells through the suppression of nuclear factor kappaB (NF-kB) activation. CP-P, when administered individually or in combination with cyclophosphamide (CYC, 0.2 mg/kg) to rats with 7, 12-dimethyl benz(a) anthracene (DMBA)-induced breast cancer decreased tumor volume significantly without affecting the body weight. To elucidate the anticancer mechanism of CP-P, antioxidant activities such as superoxide dismutase (SOD), catalase (CAT), glutathione-s-transferase (GST) and non-enzymatic antioxidant - reduced glutathione (GSH), vitamin E and C generation in the breast were analyzed by various assays. SOD, CAT, GST, GSH, vitamin E and C levels were high in combination-treated groups (CP-P+CYC) versus the CYC alone-treated groups. Also, the combination was more effective in down-regulating the expression of NF-kB-regulated gene products (cyclin D1 and Bcl-2) in breast tumor tissues. Our findings indicate that CP-P possesses significant antitumor activity comparable to a commonly used anticancer drug, cyclophosphamide, and may form the basis of a novel therapy for breast cancer.	[Samy, Ramar Perumal; Anandi, Narayana Moorthy; Chow, Vincent T. K.] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol,Infect Dis Programme, Singapore 117548, Singapore; [Rajendran, Peramaiyan; Li, Feng; Sethi, Gautam] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol,Clin Res Ctr, Singapore 117548, Singapore; [Ignacimuthu, Savarimuthu] Loyola Coll, Entomol Res Inst, Chennai, Tamil Nadu, India; [Stiles, Bradley G.] USA, Integrated Toxicol Div, Med Res Inst Infect Dis, Ft Detrick, MD USA; [Stiles, Bradley G.] Wilson Coll, Chambersburg, PA USA	National University of Singapore; National University of Singapore; Loyola College - Chennai	Samy, RP (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol,Infect Dis Programme, Singapore 117548, Singapore.	rperumalsamy@yahoo.co.uk	Ignacimuthu, S/ABH-3983-2020; R., Ponalagusamy/B-5250-2014; Rajendran, Peramaiyan/I-3877-2012; Sethi, Gautam/F-2372-2011; Rajendran, Peramaiyan/K-3287-2019	Ignacimuthu, S/0000-0002-8467-789X; R., Ponalagusamy/0000-0002-9868-3764; Rajendran, Peramaiyan/0000-0001-6354-4388; Sethi, Gautam/0000-0002-8677-8475; Chow, Vincent/0000-0003-2634-6213	Council of Scientific and Industrial Research [2000-CSIR]; Extramural Research Division, Government of India, New Delhi; NUS Academic Research Fund (ARF)	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Extramural Research Division, Government of India, New Delhi; NUS Academic Research Fund (ARF)	The authors acknowledge the Council of Scientific and Industrial Research (2000-CSIR), Extramural Research Division, Government of India, New Delhi for the award of Research Associate (RA) to first author and financial assistance to carry out this work. The work was also supported in part by the grants from NUS Academic Research Fund (ARF) to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, BREAST CANCER RES TR, V122, P579, DOI 10.1007/s10549-009-0704-7; Akinmoladun AC, 2010, J MED FOOD, V13, P444, DOI 10.1089/jmf.2008.0292; Ali NOM, 2010, EUR REV MED PHARMACO, V14, P925; Andrieu N, 2006, J CLIN ONCOL, V24, P3361, DOI 10.1200/JCO.2005.03.3126; Badami S, 2003, PHYTOTHER RES, V17, P1001, DOI 10.1002/ptr.1229; Ballard-Barbash R, 2010, ENERG BALANCE CANCER, V1, P1, DOI 10.1007/978-1-4419-5515-9_1; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunello A, 2008, RECENT PAT ANTI-CANC, V3, P187, DOI 10.2174/157489208786242313; Buchholz TA, 2005, CLIN CANCER RES, V11, P8398, DOI 10.1158/1078-0432.CCR-05-0885; Circosta C, 2001, FARMACO, V56, P373, DOI 10.1016/S0014-827X(01)01089-8; Clarkson RWE, 2000, J BIOL CHEM, V275, P12737, DOI 10.1074/jbc.275.17.12737; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; de Lima JM, 2011, TOXICON, V57, P183, DOI 10.1016/j.toxicon.2010.11.007; Dieye A M, 1993, Dakar Med, V38, P69; Flom JD, 2009, BREAST CANC IN PRESS; FORSTROM JW, 1978, BIOCHEMISTRY-US, V17, P2639, DOI 10.1021/bi00606a028; Gierach GL, 2010, BREAST CANCER RES TR, V123, P245, DOI 10.1007/s10549-010-0749-7; Greenlee H, 2009, BREAST CANC IN PRESS; Guo SQ, 2005, J NUTR, V135, p2978S, DOI 10.1093/jn/135.12.2978S; Gupta S, 2005, THERIOGENOLOGY, V64, P1273, DOI 10.1016/j.theriogenology.2005.03.008; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hasan S. Z., 2009, Biological Forum, V1, P12; Heusinger K, 2011, EUR J CANCER PREV, V20, P1, DOI 10.1097/CEJ.0b013e328341e2ce; Jain PK, 1985, J RES AYUR SIDHA, V6, P88; Jeune MAL, 2005, J MED FOOD, V8, P469, DOI 10.1089/jmf.2005.8.469; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Kamath JV, 2002, FITOTERAPIA, V73, P111, DOI 10.1016/S0367-326X(02)00005-9; Kelemen LE, 2008, AM J EPIDEMIOL, V167, P1027, DOI 10.1093/aje/kwn063; Khalili-Azad T, 2009, NEOPLASMA, V56, P22, DOI 10.4149/neo_2009_01_22; Kumar Nagi B, 2005, Cancer Control, V12, P149; Kumar VL, 2011, PHYTOTHER RES; Latiff AA, 2010, CLIN TER, V161, P359; Li F, 2010, BRIT J PHARMACOL, V161, P541, DOI 10.1111/j.1476-5381.2010.00874.x; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Lima JV, 2010, J ETHNOPHARMACOL, V129, P327, DOI 10.1016/j.jep.2010.03.038; Lin YL, 2008, PHYTOTHER RES, V22, P1440, DOI 10.1002/ptr.2439; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Magalhaes HIF, 2010, AN ACAD BRAS CIENC, V82, P407, DOI 10.1590/S0001-37652010000200017; Maier CM, 2002, NEUROSCIENTIST, V8, P323, DOI 10.1177/107385840200800408; Malejka-Giganti D, 2005, CANCER DETECT PREV, V29, P338, DOI 10.1016/j.cdp.2005.01.005; Matthew KM, 1981, FLORA TAMIL NADU CAR, V1, P469; Morsy Tosson A., 2001, Journal of the Egyptian Society of Parasitology, V31, P107; MOSSA JS, 1991, AM J CHINESE MED, V19, P223, DOI 10.1142/S0192415X91000302; Moustafa AMY, 2010, PHARM BIOL, V48, P1080, DOI 10.3109/13880200903490513; Muraina IA, 2010, PHARM BIOL, V48, P1103, DOI 10.3109/13880200903505633; Murti Y, 2010, Int J Ayurveda Res, V1, P14, DOI 10.4103/0974-7788.59938; Narod SA, 2006, LANCET ONCOL, V7, P402, DOI 10.1016/S1470-2045(06)70624-6; Oliveira JS, 2010, N-S ARCH PHARMACOL, V382, P139, DOI 10.1007/s00210-010-0525-6; Omaye ST, 1979, VITAMINS COENZYMES M, V62, P3; Pandey M., 2011, J PHARMACOGN PHYTOTH, V3, P113; Perumal Samy R, 2007, NATURE P; Prasad G., 1985, J NATL MED ASSOC, V27, P7; Rishton GM, 2008, AM J CARDIOL, V101, p43D, DOI 10.1016/j.amjcard.2008.02.007; Roomi MW, 2005, BREAST CANCER RES, V7, pR291, DOI 10.1186/bcr989; Sagiv SK, 2009, ENVIRON RES, V109, P287, DOI 10.1016/j.envres.2008.11.005; Samy RP, 2008, J CELL PHYSIOL, V216, P54, DOI 10.1002/jcp.21373; Samy RP, 2006, CHEM-BIOL INTERACT, V164, P1, DOI 10.1016/j.cbi.2006.08.018; Schmidt B, 2008, METABOLISM, V57, pS3, DOI 10.1016/j.metabol.2008.03.001; Sethi G, 2006, J BIOL CHEM, V281, P23425, DOI 10.1074/jbc.M602627200; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; Shahi M, 2010, J VECTOR DIS, V47, P185; Shanmugam MK, 2011, J MOL MED, V89, P713, DOI 10.1007/s00109-011-0746-2; Souza DP, 2011, PLANTA; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; Steiner C, 2007, CARCINOGENESIS, V28, P738, DOI 10.1093/carcin/bgl180; de Freitas CDT, 2011, PLANT PHYSIOL BIOCH, V49, P738, DOI 10.1016/j.plaphy.2011.01.027; TERRIER P, 1990, AM J PATHOL, V137, P845; Tikoo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-107; Tour N, 2011, J NAT MED-TOKYO, V65, P598, DOI 10.1007/s11418-011-0522-1; Vachon CM, 2007, CANCER EPIDEM BIOMAR, V16, P921, DOI 10.1158/1055-9965.EPI-06-1047; Valderrama B, 2002, CHEM BIOL, V9, P555, DOI 10.1016/S1074-5521(02)00149-7; Vecanova J, 2011, BRATISL MED J, V112, P67; Verma R., 2010, ETHNOBOT LEAFLETS, V14, P721; Xiang YJ, 2009, NATURE METHODS, V6, P1	75	26	30	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e48514	10.1371/journal.pone.0048514	http://dx.doi.org/10.1371/journal.pone.0048514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284617	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500006
J	Amici, F; Barney, B; Johnson, VE; Call, J; Aureli, F				Amici, Federica; Barney, Bradley; Johnson, Valen E.; Call, Josep; Aureli, Filippo			A Modular Mind? A Test Using Individual Data from Seven Primate Species	PLOS ONE			English	Article							GENERAL COGNITIVE-ABILITY; HETEROGENEOUS STOCK MICE; FISSION-FUSION DYNAMICS; APES PAN-TROGLODYTES; INHIBITORY CONTROL; GREAT APES; BAYESIAN-ANALYSIS; GORILLA-GORILLA; PONGO-PYGMAEUS; INTELLIGENCE	It has long been debated whether the mind consists of specialized and independently evolving modules, or whether and to what extent a general factor accounts for the variance in performance across different cognitive domains. In this study, we used a hierarchical Bayesian model to re-analyse individual level data collected on seven primate species (chimpanzees, bonobos, orangutans, gorillas, spider monkeys, brown capuchin monkeys and long-tailed macaques) across 17 tasks within four domains (inhibition, memory, transposition and support). Our modelling approach evidenced the existence of both a domain-specific factor and a species factor, each accounting for the same amount (17%) of the observed variance. In contrast, inter-individual differences played a minimal role. These results support the hypothesis that the mind of primates is (at least partially) modular, with domain-specific cognitive skills undergoing different evolutionary pressures in different species in response to specific ecological and social demands.	[Amici, Federica; Call, Josep] Max Planck Inst Evolutionary Anthropol, Dept Comparat & Dev Psychol, Leipzig, Germany; [Barney, Bradley] Kennesaw State Univ, Dept Math & Stat, Kennesaw, GA USA; [Johnson, Valen E.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Aureli, Filippo] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico; [Aureli, Filippo] Liverpool John Moores Univ, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England	Max Planck Society; University System of Georgia; Kennesaw State University; University of Texas System; UTMD Anderson Cancer Center; Universidad Veracruzana; Liverpool John Moores University	Amici, F (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Comparat & Dev Psychol, Leipzig, Germany.	abbepu@yahoo.it	; Amici, Federica/F-8996-2016	Call Balaguer, Josep/0000-0002-8597-8336; Aureli, Filippo/0000-0002-0671-013X; Amici, Federica/0000-0003-3539-1067	SEDSU [012-984 NESTPathfinder]; INCORE [043318]; European Community; Humboldt Research Fellowship for Postdoctoral Researchers [1138999]	SEDSU; INCORE(European Commission); European Community(European Commission); Humboldt Research Fellowship for Postdoctoral Researchers	Data collection was funded by a SEDSU project (contract number 012-984 NESTPathfinder) and supported by an INCORE project (contract number 043318), both funded by the European Community's Sixth Framework Programme (FP6/2002-2006). This work was written while Federica Amici held a Humboldt Research Fellowship for Postdoctoral Researchers (Humboldt ID number: 1138999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; Amici F, 2010, AM J PHYS ANTHROPOL, V143, P188, DOI 10.1002/ajpa.21305; ANDERSON B, 1993, NEUROSCI LETT, V153, P98, DOI 10.1016/0304-3940(93)90086-Z; Anderson Britt, 2000, Novartis Foundation Symposium, V233, P79, DOI 10.1002/0470870850.ch5; Atkinson R. C., 1968, PSYCHOL LEARN MOTIVA, V2, P89, DOI 10.1016/S0079-7421(08)60422-3; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Banerjee K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005883; Barkow J. H., 1992, ADAPTED MIND EVOLUTI, Patent No. [2201.07245, 220107245]; Barney, 2011, THESIS; Barrett L, 2003, TRENDS COGN SCI, V7, P494, DOI 10.1016/j.tics.2003.09.005; Barth J, 2006, J EXP PSYCHOL ANIM B, V32, P239, DOI 10.1037/0097-7403.32.3.239; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Barton Robert, 1999, P167, DOI 10.1017/CBO9780511542466.010; Boogert NJ, 2011, ANIM BEHAV, V81, P1209, DOI 10.1016/j.anbehav.2011.03.004; Carruthers P, 2003, MIND LANG, V18, P502, DOI 10.1111/1468-0017.00240; Chandra SBC, 2000, J COMP PSYCHOL, V114, P86, DOI 10.1037//0735-7036.114.1.86; Colom R, 2006, NEUROIMAGE, V31, P1359, DOI 10.1016/j.neuroimage.2006.01.006; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Crinella FM, 1995, INTELLIGENCE, V21, P225, DOI 10.1016/0160-2896(95)90027-6; de Winter W, 2001, NATURE, V409, P710, DOI 10.1038/35055547; Deaner R. O., 2006, EVOL PSYCHOL, V4, DOI [10.1177/147470490600400114, DOI 10.1177/147470490600400114]; Deaner RO, 2000, BRAIN BEHAV EVOLUT, V55, P44, DOI 10.1159/000006641; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Fodor J. A, 1983, MODULARITY MIND; Gallistel C.Randy., 2000, NEW COGNITIVE NEUROS, V2nd ed., P1179; GALLISTEL R, 1990, ORG LEARNING; Galsworthy MJ, 2005, BEHAV GENET, V35, P675, DOI 10.1007/s10519-005-3423-9; Galsworthy MJ, 2002, GENES BRAIN BEHAV, V1, P88, DOI 10.1034/j.1601-183X.2002.10204.x; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Harlow HF, 1934, J COMP PSYCHOL, V18, P423, DOI 10.1037/h0073305; Herrmann E, 2008, J COMP PSYCHOL, V122, P220, DOI 10.1037/0735-7036.122.2.220; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; Herrmann E, 2010, PSYCHOL SCI, V21, P102, DOI 10.1177/0956797609356511; Jensen A.R., 1998, G FACTOR SCI MENTAL; JENSEN AR, 1993, CURRENT DIRECTIONS P, V2, P53, DOI DOI 10.1111/1467-8721.EP10770697; Johnson VE, 2007, BAYESIAN ANAL, V2, P719, DOI 10.1214/07-BA229; Johnson VE, 2002, J AM STAT ASSOC, V97, P8, DOI 10.1198/016214502753479185; Keagy J, 2011, ANIM BEHAV, V81, P1063, DOI 10.1016/j.anbehav.2011.02.018; Kolata S, 2005, NEUROBIOL LEARN MEM, V84, P241, DOI 10.1016/j.nlm.2005.07.006; Kolata S, 2008, INTELLIGENCE, V36, P619, DOI 10.1016/j.intell.2007.12.001; Kralik JD, 2005, J COMP PSYCHOL, V119, P78, DOI 10.1037/0735-7036.119.1.78; Kralik JD, 2002, J COMP PSYCHOL, V116, P39, DOI 10.1037//0735-7036.116.1.39; Lee JJ, 2007, INTELLIGENCE, V35, P253, DOI 10.1016/j.intell.2006.08.003; Locurto C, 2003, GENES BRAIN BEHAV, V2, P40, DOI 10.1034/j.1601-183X.2003.00006.x; Locurto C, 1998, J COMP PSYCHOL, V112, P344, DOI 10.1037/0735-7036.112.4.344; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; MacLullich AMJ, 2002, NEUROLOGY, V59, P169, DOI 10.1212/WNL.59.2.169; Matzel LD, 2003, J NEUROSCI, V23, P6423; Matzel LD, 2006, NEUROBIOL LEARN MEM, V86, P228, DOI 10.1016/j.nlm.2006.03.004; Pennington BF, 2000, J COGNITIVE NEUROSCI, V12, P223, DOI 10.1162/089892900561850; Pinker S., 1997, MIND WORKS; Plomin R, 2001, NAT REV NEUROSCI, V2, P136, DOI 10.1038/35053584; Reader SM, 2011, PHILOS T R SOC B, V366, P1017, DOI 10.1098/rstb.2010.0342; REGOLIN L, 1994, ANIM BEHAV, V47, P123, DOI 10.1006/anbe.1994.1014; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; Schmitt V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032024; Semendeferi K, 1997, J HUM EVOL, V32, P375, DOI 10.1006/jhev.1996.0099; Semendeferi Katerina, 1999, P70, DOI 10.1017/CBO9780511542305.004; Shettleworth S. J., 2009, COGNITION EVOLUTION; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Sperber D., 1996, EXPLAINING CULTURE; Sprague J. M., 1976, PROGR PSYCHOBIOLOGY, V6, P245; Tomasello M, 1997, PRIMATE COGNITION; Van Schaik CP, 2003, ANIMAL SOCIAL COMPLEXITY, P5; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; WILLERMAN L, 1987, PERS INDIV DIFFER, V8, P943, DOI 10.1016/0191-8869(87)90145-0; Yuan Y, 2012, BIOMETRICS, V68, P156, DOI 10.1111/j.1541-0420.2011.01668.x; [No title captured]	69	38	38	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51918	10.1371/journal.pone.0051918	http://dx.doi.org/10.1371/journal.pone.0051918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284816	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300056
J	Khan, I; Kumar, N; Pant, I; Narra, S; Kondaiah, P				Khan, Imran; Kumar, Neeraj; Pant, Ila; Narra, Sivakrishna; Kondaiah, Paturu			Activation of TGF-beta Pathway by Areca Nut Constituents: A Possible Cause of Oral Submucous Fibrosis	PLOS ONE			English	Article							LYSYL OXIDASE; PATHOGENESIS; EXPRESSION	Oral submucous fibrosis (OSF) is a chronic inflammatory disease characterized by the accumulation of excess collagen, and areca nut chewing has been proposed as an important etiological factor for disease manifestation. Activation of transforming growth factor-beta signaling has been postulated as the main causative event for increased collagen production in OSF. Oral epithelium plays important roles in OSF, and arecoline has been shown to induce TGF-beta in epithelial cells. In an attempt to understand the role of areca nut constituents in the manifestation of OSF, we studied the global gene expression profile in epithelial cells (HaCaT) following treatment with areca nut water extract or TGF-beta. Interestingly, 64% of the differentially regulated genes by areca nut water extract matches with the TGF-beta induced gene expression profile. Out of these, expression of 57% of genes was compromised in the presence of ALK5 (T beta RI) inhibitor and 7% were independently induced by areca nut, highlighting the importance of TGF-beta in areca nut actions. Areca nut water extract treatment induced p-SMAD2 and TGF-beta downstream targets in HaCaT cells but not in human gingival fibroblast cells (hGF), suggesting epithelial cells could be the source of TGF-beta in promoting OSF. Water extract of areca nut consists of polyphenols and alkaloids. Both polyphenol and alkaloid fractions of areca nut were able to induce TGF-beta signaling and its downstream targets. Also, SMAD-2 was phosphorylated following treatment of HaCaT cells by Catechin, Tannin and alkaloids namely Arecoline, Arecaidine and Guvacine. Moreover, both polyphenols and alkaloids induced TGF-beta 2 and THBS1 (activator of latent TGF-beta) in HaCaT cells suggesting areca nut mediated activation of p-SMAD2 involves up-regulation and activation of TGF-beta. These data suggest a major causative role for TGF-beta that is induced by areca nut in OSF progression.	[Khan, Imran; Kumar, Neeraj; Pant, Ila; Narra, Sivakrishna; Kondaiah, Paturu] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Kondaiah, P (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	paturu@mrdg.iisc.ernet.in	khan, imran/K-9921-2013; Pant, Ila/AAG-9501-2020	khan, imran/0000-0001-6888-7347; Pant, Ila/0000-0003-0517-6542; sivakrishna, Narra/0000-0002-2254-0935	Department of Science and Technology (DST), Government of India; DST (Fund for Improvement of Science and Technology); Council of Scientific and Industrial Research, New Delhi	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); DST (Fund for Improvement of Science and Technology); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge Department of Science and Technology (DST), Government of India, for funding this study and Infrastructural support from DST (Fund for Improvement of Science and Technology) and University Grants Commission, Government of India, to the Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science. IK is recipient of a fellowship from Council of Scientific and Industrial Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Haque MF, 2000, J ORAL PATHOL MED, V29, P123, DOI 10.1034/j.1600-0714.2000.290304.x; HARVEY W, 1986, ARCH ORAL BIOL, V31, P45, DOI 10.1016/0003-9969(86)90112-3; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V85, P1; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JENG JH, 1994, J DENT RES, V73, P1043, DOI 10.1177/00220345940730050501; Khan I, 2011, GROWTH FACTORS, V29, P119, DOI 10.3109/08977194.2011.582839; Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188; Le PV, 1996, ORAL SURG ORAL MED O, V81, P148, DOI 10.1016/S1079-2104(96)80404-5; Moutasim KA, 2011, J PATHOL, V223, P366, DOI 10.1002/path.2786; Nigam M, 2008, LIFE SCI, V82, P577, DOI 10.1016/j.lfs.2007.11.028; Perera MWS, 2007, J ORAL PATHOL MED, V36, P273, DOI 10.1111/j.1600-0714.2007.00523.x; Rajalalitha P, 2005, J ORAL PATHOL MED, V34, P321, DOI 10.1111/j.1600-0714.2005.00325.x; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Shanley CJ, 1997, J VASC SURG, V25, P446, DOI 10.1016/S0741-5214(97)70254-4; SINOR PN, 1990, J ORAL PATHOL MED, V19, P94, DOI 10.1111/j.1600-0714.1990.tb00804.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Thangjam GS, 2009, J PERIODONTAL RES, V44, P736, DOI 10.1111/j.1600-0765.2008.01185.x; Thangjam GS, 2009, J DENT RES, V88, P170, DOI 10.1177/0022034508329633; Tilakaratne WM, 2006, ORAL ONCOL, V42, P561, DOI 10.1016/j.oraloncology.2005.08.005; Trivedy C, 1999, J ORAL PATHOL MED, V28, P246; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	25	72	72	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51806	10.1371/journal.pone.0051806	http://dx.doi.org/10.1371/journal.pone.0051806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284772	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000312694300045
J	Mirpuri, J; Sotnikov, I; Myers, L; Denning, TL; Yarovinsky, F; Parkos, CA; Denning, PW; Louis, NA				Mirpuri, Julie; Sotnikov, Ilya; Myers, Loren; Denning, Timothy L.; Yarovinsky, Felix; Parkos, Charles A.; Denning, Patricia W.; Louis, Nancy A.			Lactobacillus rhamnosus (LGG) Regulates IL-10 Signaling in the Developing Murine Colon through Upregulation of the IL-10R2 Receptor Subunit	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL NECROTIZING ENTEROCOLITIS; MACROPHAGE INFLAMMATORY PROTEIN-2; INTESTINAL EPITHELIAL-CELLS; GUANYLATE-BINDING PROTEIN-1; IFN-ALPHA-A; EXPERIMENTAL COLITIS; GENE-EXPRESSION; HUMAN-MILK	The intestinal microflora is critical for normal development, with aberrant colonization increasing the risk for necrotizing enterocolitis (NEC). In contrast, probiotic bacteria have been shown to decrease its incidence. Multiple pro-and anti-inflammatory cytokines have been identified as markers of intestinal inflammation, both in human patients with NEC and in models of immature intestine. Specifically, IL-10 signaling attenuates intestinal responses to gut dysbiosis, and disruption of this pathway exacerbates inflammation in murine models of NEC. However, the effects of probiotics on IL-10 and its signaling pathway, remain poorly defined. Real-time PCR profiling revealed developmental regulation of MIP-2, TNF-alpha, IL-12, IL-10 and the IL-10R2 subunit of the IL-10 receptor in immature murine colon, while the expression of IL-6 and IL-18 was independent of postnatal age. Enteral administration of the probiotic Lactobacillus rhamnosus GG (LGG) down-regulated the expression of TNF-alpha and MIP-2 and yet failed to alter IL-10 mRNA and protein expression. LGG did however induce mRNA expression of the IL-10R2 subunit of the IL-10 receptor. IL-10 receptor activation has been associated with signal transducer and activator of transcription (STAT) 3-dependent induction of members of the suppressors of cytokine signaling (SOCS) family. In 2 week-old mice, LGG also induced STAT3 phosphorylation, increased colonic expression of SOCS-3, and attenuated colonic production of MIP-2 and TNF-alpha. These LGG-dependent changes in phosphoSTAT3, SOCS3, MIP-2 and TNF-alpha were all inhibited by antibody-mediated blockade of the IL-10 receptor. Thus LGG decreased baseline proinflammatory cytokine expression in the developing colon through upregulation of IL-10 receptor-mediated signaling, most likely due to the combined induction of phospho-STAT3 and SOCS3. Furthermore, LGG-dependent increases in IL-10R2 were associated with reductions in TNF-alpha, MIP-2 and disease severity in a murine model of intestinal injury in the immature colon.	[Mirpuri, Julie; Sotnikov, Ilya; Myers, Loren; Denning, Timothy L.; Denning, Patricia W.; Louis, Nancy A.] Emory Univ, Dept Pediat, Div Neonatal Perinatal Med, Atlanta, GA 30322 USA; [Mirpuri, Julie] Univ Texas SW, Dept Pediat, Dallas, TX USA; [Denning, Timothy L.; Parkos, Charles A.] Emory Univ, Dept Pathol & Lab Med, Epithelial Pathobiol Unit, Atlanta, GA 30322 USA; [Yarovinsky, Felix] Univ Texas SW, Dept Immunol, Dallas, TX USA	Emory University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mirpuri, J (corresponding author), Emory Univ, Dept Pediat, Div Neonatal Perinatal Med, Atlanta, GA 30322 USA.	julie.mirpuri@utsouthwestern.edu; nlouis@emory.edu	Denning, Patricia W/G-4485-2011; Louis, Nancy/G-5163-2011; Denning, Timothy/F-2271-2011	Louis, Nancy/0000-0001-7092-8136; Denning, Timothy/0000-0002-1072-7444; Yarovinsky, Felix/0000-0001-5825-8002; Sotnikov, ILya/0000-0001-9968-2803; Mirpuri, Julie/0000-0003-4255-3474	National Institutes of Health [DK62007, K12 HD 068369, R03DK076613, R01HD059122, AA01787001, AI083554, DK79392, DK 063399]; Crohn's and Colitis Foundation of America; Emory Egleston Children's Research Center; Children's Medical Center Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068369, R01HD059122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK076613, R01DK079392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Emory Egleston Children's Research Center; Children's Medical Center Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK62007 (N.A.L), K12 HD 068369 (J.M.), R03DK076613 & R01HD059122 (P. W. D.); AA01787001 & AI083554 (T. L. D); DK79392 (C. A. P.); DK 063399 (C. A. P., N.A.L, P. W. D., and T. L. D.). Additional support came from a Career Development Award from the Crohn's and Colitis Foundation of America, an Emory Egleston Children's Research Center seed grant (T. L. D.) and a Children's Medical Center Foundation Grant (J.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisu M, 2003, EUR J PEDIATR SURG, V13, P319, DOI 10.1055/s-2003-43580; AlFaleh K, 2011, COCHRANE DB SYST REV, DOI [10.1097/AOG.0b013e3181726f2f, 10.1002/14651858.CD005496.pub3]; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Bahjat KS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000568; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Butel MJ, 1998, J MED MICROBIOL, V47, P391, DOI 10.1099/00222615-47-5-391; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Chiu BC, 2007, AM J PATHOL, V171, P829, DOI 10.2353/ajpath.2007.061122; Chokshi NK, 2008, J AM COLL SURGEONS, V207, pS14, DOI 10.1016/j.jamcollsurg.2008.06.013; Claud EC, 2003, PEDIATR RES, V53, P419, DOI 10.1203/01.PDR.0000050141.73528.AD; Dani C, 2002, BIOL NEONATE, V82, P103, DOI 10.1159/000063096; De Groote MA, 2005, PEDIATR INFECT DIS J, V24, P278, DOI 10.1097/01.inf.0000154588.79356.e6; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Denning TL, 2000, INT IMMUNOL, V12, P133, DOI 10.1093/intimm/12.2.133; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Emami CN, 2012, AM J SURG, V203, P428, DOI 10.1016/j.amjsurg.2011.08.016; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Fituch CC, 2004, ACTA PAEDIATR, V93, P1496, DOI 10.1080/08035250410022314; Ford H, 1997, J PEDIATR SURG, V32, P275, DOI 10.1016/S0022-3468(97)90194-9; Frost BL, 2008, SEMIN PERINATOL, V32, P100, DOI 10.1053/j.semperi.2008.01.001; GAROFALO R, 1995, PEDIATR RES, V37, P444, DOI 10.1203/00006450-199504000-00010; GREIG PC, 1995, AM J OBSTET GYNECOL, V173, P1223, DOI 10.1016/0002-9378(95)91358-0; Halpern MD, 2006, AM J PHYSIOL-GASTR L, V290, pG757, DOI 10.1152/ajpgi.00408.2005; Halpern MD, 2002, PEDIATR RES, V51, P733, DOI 10.1023/01.PDR.0000017480.64723.56; Han XB, 2004, AM J PHYSIOL-GASTR L, V287, pG1220, DOI 10.1152/ajpgi.00231.2004; HARRIS MC, 1994, J PEDIATR-US, V124, P105, DOI 10.1016/S0022-3476(94)70264-0; Hobbie S, 1997, J IMMUNOL, V159, P5550; Hoyos A B, 1999, Int J Infect Dis, V3, P197, DOI 10.1016/S1201-9712(99)90024-3; HSUEH W, 1987, FASEB J, V1, P403, DOI 10.1096/fasebj.1.5.3678700; HUANG L, 1994, IMMUNOLOGY, V83, P65; Hunter CJ, 2009, INFECT IMMUN, V77, P1031, DOI 10.1128/IAI.01192-08; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; KASAMA T, 1995, J CLIN INVEST, V95, P2868, DOI 10.1172/JCI117993; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Kopydlowski KM, 1999, J IMMUNOL, V163, P1537; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lee J, 2006, ANN NY ACAD SCI, V1072, P351, DOI 10.1196/annals.1326.022; Li N, 2009, PEDIATR RES, V66, P203, DOI 10.1203/PDR.0b013e3181aabd4f; Liedel JL, 2011, PEDIATR RES, V69, P395, DOI 10.1203/PDR.0b013e3182114ec9; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Lin PW, 2009, FREE RADICAL BIO MED, V47, P1205, DOI 10.1016/j.freeradbiomed.2009.07.033; LIU Y, 1994, J IMMUNOL, V152, P1821; Louis NA, 2008, J IMMUNOL, V180, P4246, DOI 10.4049/jimmunol.180.6.4246; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Madsen KL, 2002, INFLAMM BOWEL DIS, V8, P390, DOI 10.1097/00054725-200211000-00003; Maheshwari A, 2010, GASTROENTEROLOGY; MALEFYT RD, 1991, J EXP MED, V174, P1209; McInnes IB, 2000, IMMUNOL TODAY, V21, P312, DOI 10.1016/S0167-5699(00)01648-0; Mirpuri J, 2010, J IMMUNOL, V184, P7186, DOI 10.4049/jimmunol.0903116; MORECROFT J, 1994, ACTA PAEDIATR, V83, P18, DOI 10.1111/j.1651-2227.1994.tb13235.x; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Ren Y, 2005, HISTOPATHOLOGY, V46, P659, DOI 10.1111/j.1365-2559.2005.02159.x; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Schnoor M, 2009, MUCOSAL IMMUNOL, V2, P33, DOI 10.1038/mi.2008.62; Smallie T, 2010, J EXP MED, V207, P2081, DOI 10.1084/jem.20100414; STANDIFORD TJ, 1995, J IMMUNOL, V155, P2222; SUN X, 1994, GUT, V35, P215, DOI 10.1136/gut.35.2.215; Sun XM, 1997, AM J PHYSIOL-GASTR L, V273, pG56, DOI 10.1152/ajpgi.1997.273.1.G56; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; TAN XD, 1993, AM J PATHOL, V142, P1858; Waeytens A, 2008, INFLAMM BOWEL DIS, V14, P471, DOI 10.1002/ibd.20346; Weitkamp J.H., 2012, GUT; Zein E F, 2008, Ann Biol Clin (Paris), V66, P195, DOI 10.1684/abc.2008.0210	73	39	41	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51955	10.1371/journal.pone.0051955	http://dx.doi.org/10.1371/journal.pone.0051955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272193	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300042
J	Weber, SS; Parente, AFA; Borges, CL; Parente, JA; Bailao, AM; Soares, CMD				Weber, Simone Schneider; Alves Parente, Ana Flavia; Borges, Clayton Luiz; Parente, Juliana Alves; Bailao, Alexandre Melo; de Almeida Soares, Celia Maria			Analysis of the Secretomes of Paracoccidioides Mycelia and Yeast Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; HISTOPLASMA-CAPSULATUM; MACROPHAGE FUNCTIONS; PROTEIN SECRETION; POSTTRANSLATIONAL MODIFICATIONS; EXTRACELLULAR VESICLES; ASPERGILLUS-FUMIGATUS; PROTEOMIC ANALYSIS; CANDIDA-GLABRATA	Paracoccidioides, a complex of several phylogenetic species, is the causative agent of paracoccidioidomycosis. The ability of pathogenic fungi to develop a multifaceted response to the wide variety of stressors found in the host environment is important for virulence and pathogenesis. Extracellular proteins represent key mediators of the host-parasite interaction. To analyze the expression profile of the proteins secreted by Paracoccidioides, Pb01 mycelia and yeast cells, we used a proteomics approach combining two-dimensional electrophoresis with matrix-assisted laser desorption ionization quadrupole time-of-flight mass spectrometry (MALDI-Q-TOF MS/MS). From three biological replicates, 356 and 388 spots were detected, in mycelium and yeast cell secretomes, respectively. In this study, 160 non-redundant proteins/isoforms were indentified, including 30 and 24 proteins preferentially secreted in mycelia and yeast cells, respectively. In silico analyses revealed that 65% of the identified proteins/isoforms were secreted primarily via non-conventional pathways. We also investigated the influence of protein export inhibition in the phagocytosis of Paracoccidioides by macrophages. The addition of Brefeldin A to the culture medium significantly decreased the production of secreted proteins by both Paracoccidioides and internalized yeast cells by macrophages. In contrast, the addition of concentrated culture supernatant to the co-cultivation significantly increased the number of internalized yeast cells by macrophages. Importantly, the proteins detected in the fungal secretome were also identified within macrophages. These results indicate that Paracoccidioides extracellular proteins are important for the fungal interaction with the host.	[Weber, Simone Schneider; Alves Parente, Ana Flavia; Borges, Clayton Luiz; Parente, Juliana Alves; Bailao, Alexandre Melo; de Almeida Soares, Celia Maria] Univ Fed Goias, Inst Ciencias Biol, Mol Biol Lab, Goiania, Go, Brazil	Universidade Federal de Goias	Soares, CMD (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Mol Biol Lab, Goiania, Go, Brazil.	cmasoares@gmail.com	BORGES, CLAYTON LUIZ/GQB-5595-2022; Bailao, Alexandre Melo/H-1272-2013; Soares, Celia/N-6395-2014	Bailao, Alexandre Melo/0000-0001-7754-4047; Weber, Simone/0000-0002-4181-142X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [558923/2009-7, 563398/2010-5, 477962/2010-6, 473277/2011-5]; Financiadora de Estudos e Projetos (FINEP) [0107055200]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [PNPD 024979/09-5]; Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG); CNPq PhD fellowship	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); CNPq PhD fellowship	This work performed at Universidade Federal de Goias was supported by the following grants: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (558923/2009-7, 563398/2010-5, 477962/2010-6 and 473277/2011-5), Financiadora de Estudos e Projetos (FINEP) (0107055200), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (PNPD 024979/09-5) and Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG). SSW is the recipient of a CNPq PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Almeida SR, 1998, MED MYCOL, V36, P405, DOI 10.1080/02681219880000641; Bailao AM, 2007, FEMS IMMUNOL MED MIC, V51, P43, DOI 10.1111/j.1574-695X.2007.00277.x; Barbosa MS, 2006, INFECT IMMUN, V74, P382, DOI 10.1128/IAI.74.1.382-389.2006; Beck MR, 2009, MOL MICROBIOL, V72, P344, DOI 10.1111/j.1365-2958.2009.06647.x; Bonin-Debs AL, 2004, EXPERT OPIN BIOL TH, V4, P551, DOI 10.1517/eobt.4.4.551.29788; Borges CL, 2010, FEMS YEAST RES, V10, P104, DOI 10.1111/j.1567-1364.2009.00594.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckova M, 2010, CURR MICROBIOL, V61, P241, DOI 10.1007/s00284-010-9601-x; Carrero LL, 2008, FUNGAL GENET BIOL, V45, P605, DOI 10.1016/j.fgb.2008.02.002; Choi J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-105; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; Tacco BACD, 2009, MED MYCOL, V47, P845, DOI 10.3109/13693780802695512; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; EISSENBERG LG, 1993, J EXP MED, V177, P1605, DOI 10.1084/jem.177.6.1605; Fernandez-Arenas E, 2009, CELL MICROBIOL, V11, P560, DOI 10.1111/j.1462-5822.2008.01274.x; Fortier AH, 2006, CURRENT PROTOCOLS IM, P11; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hassani K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018724; HAYES JD, 1995, FREE RADICAL RES, V22, P193, DOI 10.3109/10715769509147539; Herbert B, 2001, ELECTROPHORESIS, V22, P2046, DOI 10.1002/1522-2683(200106)22:10<2046::AID-ELPS2046>3.0.CO;2-C; Holbrook ED, 2008, CURR OPIN MICROBIOL, V11, P318, DOI 10.1016/j.mib.2008.05.010; Holbrook ED, 2011, J PROTEOME RES, V10, P1929, DOI 10.1021/pr1011697; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Konno AYC, 2009, MICROBES INFECT, V11, P92, DOI 10.1016/j.micinf.2008.10.011; Lacaz C, 1994, PARACOCCIDIOIDOMYCOS, P1; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MORGAN A, 1992, BIOCHEM J, V286, P807, DOI 10.1042/bj2860807; Murad AM, 2011, J SEP SCI, V34, P2618, DOI 10.1002/jssc.201100238; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; Nosanchuk Joshua D, 2008, Commun Integr Biol, V1, P37; Oliveira DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011113; Oliveira DL, 2010, INFECT IMMUN, V78, P1601, DOI 10.1128/IAI.01171-09; Parente AFA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022810; Parente JA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-292; Pereira LA, 2007, FEMS YEAST RES, V7, P1381, DOI 10.1111/j.1567-1364.2007.00292.x; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; Ramana J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009695; Ranganathan S, 2009, GENOME MED, V1, DOI 10.1186/gm113; RESTREPO A, 2005, PRINCIPLES PRACTICE, P3062; Rezende TCV, 2011, J PROTEOMICS, V75, P572, DOI 10.1016/j.jprot.2011.08.020; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Roth D, 1999, FEBS LETT, V460, P411, DOI 10.1016/S0014-5793(99)01383-6; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Sambrook J, 2001, MOL CLONING LAB MANU; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Seider K, 2011, J IMMUNOL, V187, P3072, DOI 10.4049/jimmunol.1003730; Chaves DFS, 2009, J PROTEOMICS, V73, P50, DOI 10.1016/j.jprot.2009.07.012; Seo J, 2004, J BIOCHEM MOL BIOL, V37, P35; Shah P, 2009, J PROTEOME RES, V8, P1123, DOI 10.1021/pr8003002; Shaw MM, 2003, PROTEOMICS, V3, P1408, DOI 10.1002/pmic.200300471; Silverman JM, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00026; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Teutschbein J, 2010, J PROTEOME RES, V9, P3427, DOI 10.1021/pr9010684; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Vaejo MC, 2012, J PROTEOME RES, V11, P1676, DOI 10.1021/pr200872s; Vallejo MC, 2011, EUKARYOT CELL, V10, P343, DOI 10.1128/EC.00227-10; Waditee-Sirisattha R, 2012, FEMS MICROBIOL LETT; Wartenberg D, 2011, INT J MED MICROBIOL, V301, P602, DOI 10.1016/j.ijmm.2011.04.016; Yang H, 2006, ONCOGENE, V25, P4585, DOI 10.1038/sj.onc.1209481; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713; Zhu K, 2005, ANAL CHEM, V77, P2745, DOI 10.1021/ac048494w	76	41	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52470	10.1371/journal.pone.0052470	http://dx.doi.org/10.1371/journal.pone.0052470			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272246	Green Published, gold, Green Submitted			2022-12-25	WOS:000312483300088
J	Barua, D; Goldstein, B				Barua, Dipak; Goldstein, Byron			A Mechanistic Model of Early Fc epsilon RI Signaling: Lipid Rafts and the Question of Protection from Dephosphorylation	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; DETERGENT-RESISTANT MEMBRANES; HIGH-AFFINITY RECEPTOR; CELL ANTIGEN RECEPTOR; RBL-2H3 MAST-CELLS; PLASMA-MEMBRANE; IGE RECEPTOR; LYN KINASE; HEMATOPOIETIC-CELLS; MOLECULAR-DYNAMICS	We present a model of the early events in mast cell signaling mediated by Fc epsilon RI where the plasma membrane is composed of many small ordered lipid domains (rafts), surrounded by a non-order region of lipids consisting of the remaining plasma membrane. The model treats the rafts as transient structures that constantly form and breakup, but that maintain a fixed average number per cell. The rafts have a high propensity for harboring Lyn kinase, aggregated, but not unaggregated receptors, and the linker for the activation of T cells (LAT). Phosphatase activity in the rafts is substantially reduced compared to the nonraft region. We use the model to analyze published experiments on the rat basophilic leukemia (RBL)-2H3 cell line that seem to contradict the notion that rafts offer protection. In these experiments IgE was cross-linked with a multivalent antigen and then excess monovalent hapten was added to break-up cross-links. The dephosphorylation of the unaggregated receptor (nonraft associated) and of LAT (raft associated) were then monitored in time and found to decay at similar rates, leading to the conclusion that rafts offer no protection from dephosphorylation. In the model, because the rafts are transient, a protein that is protected while in a raft will be subject to dephosphorylation when the raft breaks up and the protein finds itself in the nonraft region of the membrane. We show that the model is consistent with the receptor and LAT dephosphorylation experiments while still allowing rafts to enhance signaling by providing substantial protection from phosphatases.	[Barua, Dipak; Goldstein, Byron] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Div Theoret, Los Alamos, NM USA; [Barua, Dipak] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Goldstein, B (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Div Theoret, Los Alamos, NM USA.	bxg@lanl.gov		Barua, Dipak/0000-0001-8394-1233	National Institute of General Medical Sciences of the National Institutes of Health [R37-GM035556]; Department of Energy [DE-AC52-06NA25396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035556] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number R37-GM035556 and the Department of Energy through contract DE-AC52-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026; Arudchandran R, 2000, J EXP MED, V191, P47, DOI 10.1084/jem.191.1.47; Babiychuk EB, 2002, FASEB J, V16, DOI 10.1096/fj.02-0070com; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Das R, 2008, BIOPHYS J, V94, P4996, DOI 10.1529/biophysj.107.105502; Davey AM, 2007, BIOPHYS J, V92, P343, DOI 10.1529/biophysj.106.088815; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Elson EL, 2010, ANNU REV BIOPHYS, V39, P207, DOI 10.1146/annurev.biophys.093008.131238; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Faeder JR, 2003, J IMMUNOL, V170, P3769, DOI 10.4049/jimmunol.170.7.3769; Fan J, 2010, FEBS LETT, V584, P1678, DOI 10.1016/j.febslet.2009.10.051; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Ge MT, 2003, BIOPHYS J, V85, P1278, DOI 10.1016/S0006-3495(03)74563-9; Gidwani A, 2001, BIOCHEMISTRY-US, V40, P12422, DOI 10.1021/bi010496c; GOLDSTEIN B, 1984, BIOPHYS J, V46, P573, DOI 10.1016/S0006-3495(84)84056-4; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; Holowka D, 2005, BBA-MOL CELL RES, V1746, P252, DOI 10.1016/j.bbamcr.2005.06.007; Holowka D, 2001, SEMIN IMMUNOL, V13, P99, DOI 10.1006/smim.2000.0301; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Karpen HE, 2001, J BIOL CHEM, V276, P19503, DOI 10.1074/jbc.M010832200; Katagiri YU, 2001, MICROBIOL IMMUNOL, V45, P1; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LIU FT, 1980, J IMMUNOL, V124, P2728; Mao SY, 1997, J BIOL CHEM, V272, P14067, DOI 10.1074/jbc.272.22.14067; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Peirce M, 2000, J BIOL CHEM, V275, P34976, DOI 10.1074/jbc.M005819200; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; Pyenta PS, 2001, BIOPHYS J, V80, P2120, DOI 10.1016/S0006-3495(01)76185-1; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Saitoh S, 2003, J EXP MED, V198, P831, DOI 10.1084/jem.20030574; Sengupta P, 2007, SEMIN CELL DEV BIOL, V18, P583, DOI 10.1016/j.semcdb.2007.07.010; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SOTIRELLIS N, 1995, J BIOL CHEM, V270, P29773; Tanimura N, 2003, J CELL BIOL, V160, P125, DOI 10.1083/jcb.200207096; THOMAS JL, 1994, J CELL BIOL, V125, P795, DOI 10.1083/jcb.125.4.795; Tolar P, 2004, EUR J IMMUNOL, V34, P1136, DOI 10.1002/eji.200324505; Torigoe C, 1997, P NATL ACAD SCI USA, V94, P1372, DOI 10.1073/pnas.94.4.1372; Wilson BS, 2002, MOL IMMUNOL, V38, P1259, DOI 10.1016/S0161-5890(02)00073-1; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Wofsy C, 1997, J IMMUNOL, V159, P5984; Wofsy C, 1999, P NATL ACAD SCI USA, V96, P8615, DOI 10.1073/pnas.96.15.8615; Young RM, 2005, J BIOL CHEM, V280, P1230, DOI 10.1074/jbc.M408339200; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	68	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51669	10.1371/journal.pone.0051669	http://dx.doi.org/10.1371/journal.pone.0051669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284735	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900040
J	Eddison, M; Belay, AT; Sokolowski, MB; Heberlein, U				Eddison, Mark; Belay, Amsale T.; Sokolowski, Marla B.; Heberlein, Ulrike			A Genetic Screen for Olfactory Habituation Mutations in Drosophila: Analysis of Novel Foraging Alleles and an Underlying Neural Circuit	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; GILL-WITHDRAWAL REFLEX; SUCROSE RESPONSIVENESS; MYELINATED AXONS; MUSHROOM BODIES; ANTENNAL LOBE; BINGE ETHANOL; GAIN-CONTROL; CGMP; APLYSIA	Habituation is a form of non-associative learning that enables animals to reduce their reaction to repeated harmless stimuli. When exposed to ethanol vapor, Drosophila show an olfactory-mediated startle response characterized by a transient increase in locomotor activity. Upon repeated exposures, this olfactory startle attenuates with the characteristics of habituation. Here we describe the results of a genetic screen to identify olfactory startle habituation (OSH) mutants. One mutation is a transcript specific allele of foraging (for) encoding a cGMP-dependent kinase. We show this allele of for reduces expression of a for-T1 isoform expressed in the head and functions normally to inhibit OSH. We localize for-T1 function to a limited set of neurons that include olfactory receptor neurons (ORNs) and the mushroom body (MB). Overexpression of for-T1 in ORNs inhibits OSH, an effect also seen upon synaptic silencing of the ORNs; for-T1 may therefore function in ORNs to decrease synaptic release upon repeated exposure to ethanol vapor. Overall, this work contributes to our understanding of the genes and neurons underlying olfactory habituation in Drosophila.	[Eddison, Mark; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Belay, Amsale T.; Sokolowski, Marla B.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of California System; University of California San Francisco; University of Toronto	Eddison, M (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	mark.eddison@ucsf.edu		Eddison, Mark/0000-0003-0280-8137; Sokolowski, Marla/0000-0002-7462-8007	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism; Wheeler Center; Canadian Institute for Health Research of Canada (CIHR); Natural Sciences and Engineering Council of Canada; CIHR; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Wheeler Center; Canadian Institute for Health Research of Canada (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research was supported by the National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism(UH) and the Wheeler Center (to ME). This work was also supported by grants from the Canadian Institute for Health Research of Canada (CIHR) (to MBS), the Natural Sciences and Engineering Council of Canada (to MBS) and a CIHR training grant (to ATB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo SF, 2007, LEARN MEMORY, V14, P376, DOI 10.1101/lm.566007; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Banerjee S, 2008, J NEUROSCI RES, V86, P1189, DOI 10.1002/jnr.21574; Belay AT, 2007, J COMP NEUROL, V504, P570, DOI 10.1002/cne.21466; Best AR, 2005, J NEUROSCI, V25, P2513, DOI 10.1523/JNEUROSCI.5298-04.2005; Bhat MA, 2003, CURR OPIN NEUROBIOL, V13, P552, DOI 10.1016/j.conb.2003.09.004; BRAND AH, 1993, DEVELOPMENT, V118, P401; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; Cho W, 2004, GENES BRAIN BEHAV, V3, P127, DOI 10.1111/j.1601-183x.2004.00061.x; Christoffersen GRJ, 1997, PROG NEUROBIOL, V53, P45, DOI 10.1016/S0301-0082(97)00031-2; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; Davies SA, 2006, CELL SIGNAL, V18, P409, DOI 10.1016/j.cellsig.2005.08.011; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Engel JE, 2000, LEARN MEMORY, V7, P341, DOI 10.1101/lm.31600; Fitzpatrick MJ, 2004, INTEGR COMP BIOL, V44, P28, DOI 10.1093/icb/44.1.28; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; GEYER MA, 1982, PSYCHOPHYSIOLOGY, V19, P1, DOI 10.1111/j.1469-8986.1982.tb02589.x; Glanzman DL, 2009, NEUROBIOL LEARN MEM, V92, P147, DOI 10.1016/j.nlm.2009.03.005; Gover TD, 2009, NEUROBIOL LEARN MEM, V92, P155, DOI 10.1016/j.nlm.2009.03.006; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; HOYLE G, 1952, NATURE, V169, P281, DOI 10.1038/169281a0; Hunt PS, 2004, NEUROTOXICOL TERATOL, V26, P451, DOI 10.1016/j.ntt.2004.01.003; KORPI ER, 1994, ALCOHOL ALCOHOLISM, V29, P115; Kroner C, 1996, EUR J BIOCHEM, V236, P632, DOI 10.1111/j.1432-1033.1996.00632.x; KUPFERMANN I, 1970, SCIENCE, V167, P1743, DOI 10.1126/science.167.3926.1743; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Larkin Aoife, 2010, Learn Mem, V17, P645, DOI 10.1101/lm.1839010; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Martin JR, 1998, LEARN MEMORY, V5, P179; Massa J, 2012, J ATTEN DISORD, V16, P553, DOI 10.1177/1087054711423621; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; McCann C, 2011, P NATL ACAD SCI USA, V108, pE655, DOI 10.1073/pnas.1107198108; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Moon C, 1998, J NEUROSCI, V18, P3195; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P906, DOI 10.1016/j.jaac.2010.06.007; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; ORNITZ EM, 1993, J AUTISM DEV DISORD, V23, P619, DOI 10.1007/BF01046105; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PINSKER H, 1970, SCIENCE, V167, P1740, DOI 10.1126/science.167.3926.1740; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Renger JJ, 1999, J NEUROSCI, V19; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Scheiner R, 2004, LEARN MEMORY, V11, P303, DOI 10.1101/lm.71604; Schulte J, 2003, J CELL BIOL, V161, P991, DOI 10.1083/jcb.200303192; Sharma P, 2009, J NEUROSCI METH, V182, P43, DOI 10.1016/j.jneumeth.2009.05.024; Sudhakaran IP, 2012, J NEUROSCI, V32, P7225, DOI 10.1523/JNEUROSCI.1099-12.2012; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thompson RF, 2009, NEUROBIOL LEARN MEM, V92, P127, DOI 10.1016/j.nlm.2008.07.011; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2012, DEV NEUROBIOL, V72, P87, DOI 10.1002/dneu.20936; Wilson DA, 2008, J NEUROPHYSIOL, V100, P2, DOI 10.1152/jn.90479.2008; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wolf FW, 2007, P NATL ACAD SCI USA, V104, P4653, DOI 10.1073/pnas.0700493104; Wolf FW, 2002, J NEUROSCI, V22, P11035; Xue J, 2004, BIOCHEM J, V381, P753, DOI 10.1042/BJ20040455; Xue J, 2000, J BIOL CHEM, V275, P10047, DOI 10.1074/jbc.275.14.10047; Yao X., 2007, V179, P527; Zhang YW, 2007, J NEUROSCI, V27, P10878, DOI 10.1523/JNEUROSCI.0034-07.2007	65	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51684	10.1371/journal.pone.0051684	http://dx.doi.org/10.1371/journal.pone.0051684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284741	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900042
J	Moore, JAY; Bellchambers, LM; Depczynski, MR; Evans, RD; Evans, SN; Field, SN; Friedman, KJ; Gilmour, JP; Holmes, TH; Middlebrook, R; Radford, BT; Ridgway, T; Shedrawi, G; Taylor, H; Thomson, DP; Wilson, SK				Moore, James A. Y.; Bellchambers, Lynda M.; Depczynski, Martial R.; Evans, Richard D.; Evans, Scott N.; Field, Stuart N.; Friedman, Kim J.; Gilmour, James P.; Holmes, Thomas H.; Middlebrook, Rachael; Radford, Ben T.; Ridgway, Tyrone; Shedrawi, George; Taylor, Heather; Thomson, Damian P.; Wilson, Shaun K.			Unprecedented Mass Bleaching and Loss of Coral across 12 degrees of Latitude in Western Australia in 2010-11	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; INDIAN-OCEAN; MORTALITY; THRESHOLDS; IMPACTS; FUTURE; RESILIENCE; ISLAND; CONSERVATION	Background: Globally, coral bleaching has been responsible for a significant decline in both coral cover and diversity over the past two decades. During the summer of 2010-11, anomalous large-scale ocean warming induced unprecedented levels of coral bleaching accompanied by substantial storminess across more than 12 degrees of latitude and 1200 kilometers of coastline in Western Australia (WA). Methodology/Principal Findings: Extreme La-Nina conditions caused extensive warming of waters and drove considerable storminess and cyclonic activity across WA from October 2010 to May 2011. Satellite-derived sea surface temperature measurements recorded anomalies of up to 5 degrees C above long-term averages. Benthic surveys quantified the extent of bleaching at 10 locations across four regions from tropical to temperate waters. Bleaching was recorded in all locations across regions and ranged between 17% (+/- 5.5) in the temperate Perth region, to 95% (+/- 3.5) in the Exmouth Gulf of the tropical Ningaloo region. Coincident with high levels of bleaching, three cyclones passed in close proximity to study locations around the time of peak temperatures. Follow-up surveys revealed spatial heterogeneity in coral cover change with four of ten locations recording significant loss of coral cover. Relative decreases ranged between 22%-83.9% of total coral cover, with the greatest losses in the Exmouth Gulf. Conclusions/Significance: The anomalous thermal stress of 2010-11 induced mass bleaching of corals along central and southern WA coral reefs. Significant coral bleaching was observed at multiple locations across the tropical-temperate divide spanning more than 1200 km of coastline. Resultant spatially patchy loss of coral cover under widespread and high levels of bleaching and cyclonic activity, suggests a degree of resilience for WA coral communities. However, the spatial extent of bleaching casts some doubt over hypotheses suggesting that future impacts to coral reefs under forecast warming regimes may in part be mitigated by southern thermal refugia.	[Moore, James A. Y.; Evans, Richard D.; Field, Stuart N.; Friedman, Kim J.; Holmes, Thomas H.; Shedrawi, George; Wilson, Shaun K.] Dept Environm & Conservat, Marine Sci Program, Kensington, NSW, Australia; [Bellchambers, Lynda M.; Evans, Scott N.] Dept Fisheries WA, Biodivers & Biosecur Branch, Hillarys, WA, Australia; [Depczynski, Martial R.; Gilmour, James P.; Radford, Ben T.; Ridgway, Tyrone] Australian Inst Marine Sci, Crawley, WA, Australia; [Evans, Richard D.; Field, Stuart N.; Friedman, Kim J.; Gilmour, James P.; Holmes, Thomas H.; Radford, Ben T.; Ridgway, Tyrone; Wilson, Shaun K.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Middlebrook, Rachael] Dept Environm & Conservat, Pilbara Reg Serv, Karratha, NSW, Australia; [Taylor, Heather] Dept Environm & Conservat, Pilbara Reg Serv, Exmouth, NSW, Australia; [Thomson, Damian P.] CSIRO, Marine & Atmospher Res, Floreat, WA, Australia	Australian Institute of Marine Science; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Moore, JAY (corresponding author), Dept Environm & Conservat, Marine Sci Program, Kensington, NSW, Australia.	james.moore@dec.wa.gov.au	Thomson, Damian P/C-3047-2014; Evans, Richard D/K-5779-2013; Moore, James/K-3698-2013; Middlebrook, Rachael/AAM-6912-2021; Evans, Richard D./O-3559-2019; depczynski, martial/B-7689-2008; Wilson, Shaun/K-8597-2019	Moore, James/0000-0003-4641-8667; Evans, Richard D./0000-0003-4364-4810; depczynski, martial/0000-0001-8723-0076; Wilson, Shaun/0000-0002-4590-0948; Shedrawi, George/0000-0002-4507-7293; Thomson, Damian/0000-0001-5485-1562	Department of Environment and Conservation WA; Department of Fisheries WA; Australian Institute of Marine Science; Western Australian Marine Science Institution; Commonwealth Scientific and Industrial Research Organisation	Department of Environment and Conservation WA; Department of Fisheries WA; Australian Institute of Marine Science; Western Australian Marine Science Institution; Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This study was funded by the Department of Environment and Conservation WA, the Department of Fisheries WA, the Australian Institute of Marine Science, the Western Australian Marine Science Institution and the Commonwealth Scientific and Industrial Research Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043878; Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Baird A., 1999, REEF RES, V9, P6; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Berkelmans R, 2002, MAR ECOL PROG SER, V229, P73, DOI 10.3354/meps229073; Berkelmans R., 2009, V205, P103; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Celliers L, 2002, MAR POLLUT BULL, V44, P1380, DOI 10.1016/S0025-326X(02)00302-8; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; DONE TJ, 1992, CONT SHELF RES, V12, P859, DOI 10.1016/0278-4343(92)90048-O; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner Simon D., 2009, V205, P159; Eakin C. M., 2009, V205, P41; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Fisher R, 2011, CONSERV LETT, V4, P64, DOI 10.1111/j.1755-263X.2010.00146.x; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Glynn P.W., 1990, Elsevier Oceanography Series, V52, P55; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; GOREAU TJ, 1994, AMBIO, V23, P176; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Halford AR, 2009, GLOBAL CHANGE BIOL, V15, P3031, DOI 10.1111/j.1365-2486.2009.01972.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harrison PL, 2011, CORAL REEFS, V30, P775, DOI 10.1007/s00338-011-0778-7; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hill JJ, 2004, METHODS ECOLOGICAL M; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoeke RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018038; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kleypas JA, 1999, AM ZOOL, V39, P146; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Liu G, 2006, P 10 INT COR REEF S; Liu G, 2008, P 11 INT COR REEF S, P951; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Masiri I, 2008, INT J REMOTE SENS, V29, P4443, DOI 10.1080/01431160801930255; Maynard JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032175; McClanahan TR, 2007, CORAL REEFS, V26, P695, DOI 10.1007/s00338-006-0193-7; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Michael KJ, 2012, MAR FRESHWATER RES, V63, P142, DOI 10.1071/MF11106; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Morton B, 2002, J MOLLUS STUD, V68, P217, DOI 10.1093/mollus/68.3.217; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Oliver J. K., 2009, V205, P21; Pearce AF, 2012, J MAR SYST; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Smith LD, 2008, CORAL REEFS, V27, P197, DOI 10.1007/s00338-007-0311-1; Spillman CM, 2009, CORAL REEFS, V28, P197, DOI 10.1007/s00338-008-0438-8; Taylor J. G., 1999, Journal of the Royal Society of Western Australia, V82, P57; Thomson DP, 2011, CORAL REEFS, V30, P1107, DOI 10.1007/s00338-011-0811-x; Thomson DP, 2010, CORAL REEFS, V29, P923, DOI 10.1007/s00338-010-0650-1; Trapon Melanie L., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/807625; Veron J.E.N., 1988, HERMATYPIC CORALS W; Veron John E.N., 2011, Diversity, V3, P262; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; West J, 2003, COMMENTARY, V115, P17; Weymouth GT, 2001, AUST METEOROL MAG, V50, P263; Wilkinson C, 1999, AMBIO, V28, P188; Wilkinson C, 2008, STATUS CORAL REEFS W; Williams EH, 1990, ATOLL RES B, P330, DOI DOI 10.5479/SI.00775630.335.1; Woo M, 2006, CONT SHELF RES, V26, P132, DOI 10.1016/j.csr.2005.07.007; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	83	82	83	0	175	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51807	10.1371/journal.pone.0051807	http://dx.doi.org/10.1371/journal.pone.0051807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284773	gold, Green Submitted, Green Published			2022-12-25	WOS:000312435900055
J	Ting, CH; Wen, HL; Liu, HC; Hsieh-Li, HM; Li, H; Lin-Chao, S				Ting, Chen-Hung; Wen, Hsin-Lan; Liu, Hui-Chun; Hsieh-Li, Hsiu-Mei; Li, Hung; Lin-Chao, Sue			The Spinal Muscular Atrophy Disease Protein SMN Is Linked to the Golgi Network	PLOS ONE			English	Article							SURVIVAL MOTOR-NEURON; DETERMINING GENE-PRODUCT; ACTIN MESSENGER-RNA; SINGLE NUCLEOTIDE; GROWTH CONES; IN-VITRO; COMPLEX; LOCALIZATION; TRANSPORT; AXONS	Proximal spinal muscular atrophy (SMA) is a neurodegenerative disorder caused by deficiency of the ubiquitous Survival of Motor Neuron (SMN) protein. SMN has been shown to be transported in granules along the axon and moved through cytoskeletal elements. However, the role and nature of SMN granules are still not well characterized. Here, using immunocytochemical methods and time-lapse studies we show that SMN granules colocalize with the Golgi apparatus in motor neuron-like NSC34 cells. Electron microscopy clearly revealed that SMN granules are transported into the Golgi stack and aggregate in the trans-Golgi apparatus. SMN granules are characterized as either coated or un-coated and behave like regulated secretory granules. Treatment of cells with monensin to disrupt Golgi-mediated granule secretion decreased SMN expression in neurites and caused growth cone defects similar to those seen in SMN knockdown cells. Knockdown of Cop-alpha, the protein that coats vesicles transporting proteins between the Golgi compartments, caused SMN granule accumulation in the Golgi apparatus. In addition to the well-studied role of SMN in small nuclear ribonucleoprotein (SnRNP) assembly, this work links SMN granules with the Golgi network and thus sheds light on Golgi-mediated SMN granule transport.	[Ting, Chen-Hung; Wen, Hsin-Lan; Liu, Hui-Chun; Li, Hung; Lin-Chao, Sue] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Liu, Hui-Chun] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hsieh-Li, Hsiu-Mei] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Taiwan Normal University	Ting, CH (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	koichiting@gmail.com; mbsue@gate.sinica.edu.tw	Lin-Chao, Sue/AAZ-8246-2021; Lin-Chao, Sue/AGI-2030-2022	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304; Ting, Chen-Hung/0000-0002-6093-0600	National Science Council, Taiwan [NSC100-2321-B-001-008]; Academia Sinica [AS034006, AS022323]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by the research grant NSC100-2321-B-001-008 from the National Science Council, Taiwan (http://web1.nsc.gov.tw) and Academia Sinica (AS034006 and AS022323; http://www.sinica.edu.tw/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Elsner M, 2003, MOL MEMBR BIOL, V20, P221, DOI 10.1080/0968768031000114024; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Gavrilov DK, 1998, NAT GENET, V20, P230, DOI 10.1038/3030; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hubers L, 2011, HUM MOL GENET, V20, P553, DOI 10.1093/hmg/ddq500; Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Matusica D, 2008, J NEUROSCI RES, V86, P553, DOI 10.1002/jnr.21507; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Peter CJ, 2011, HUM MOL GENET, V20, P1701, DOI 10.1093/hmg/ddr046; Piazzon N, 2008, J BIOL CHEM, V283, P5598, DOI 10.1074/jbc.M707304200; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Setola V, 2007, P NATL ACAD SCI USA, V104, P1959, DOI 10.1073/pnas.0610660104; Taylor JE, 1998, EUR J HUM GENET, V6, P467, DOI 10.1038/sj.ejhg.5200210; Ting CH, 2007, HUM MOL GENET, V16, P499, DOI 10.1093/hmg/ddl482; Todd AG, 2010, J MOL BIOL, V401, P681, DOI 10.1016/j.jmb.2010.06.058; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Wen HL, 2010, HUM MOL GENET, V19, P1766, DOI 10.1093/hmg/ddq058; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang HL, 2007, J NEUROSCI RES, V85, P2657, DOI 10.1002/jnr.21308; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	36	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51826	10.1371/journal.pone.0051826	http://dx.doi.org/10.1371/journal.pone.0051826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284781	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900056
J	Rodriguez, MC; Viadas, C; Seoane, A; Sangari, FJ; Lopez-Goni, I; Garcia-Lobo, JM				Cruz Rodriguez, Maria; Viadas, Cristina; Seoane, Asuncion; Javier Sangari, Felix; Lopez-Goni, Ignacio; Maria Garcia-Lobo, Juan			Evaluation of the Effects of Erythritol on Gene Expression in Brucella abortus	PLOS ONE			English	Article							B19 VACCINE STRAIN; 2,3-DIHYDROXYBENZOIC ACID; RNA-SEQ; METABOLISM; VIRULENCE; CATABOLISM; OPERON; IDENTIFICATION; SIDEROPHORE; ADAPTATION	Bacteria of the genus Brucella have the unusual capability to catabolize erythritol and this property has been associated with their virulence mainly because of the presence of erythritol in bovine foetal tissues and because the attenuated S19 vaccine strain is the only Brucella strain unable to oxydize erythritol. In this work we have analyzed the transcriptional changes produced in Brucella by erythritol by means of two high throughput approaches: RNA hybridization against a microarray containing most of Brucella ORF's constructed from the Brucella ORFeome and next generation sequencing of Brucella mRNA in an Illumina GAIIx platform. The results obtained showed the overexpression of a group of genes, many of them in a single cluster around the ery operon, able to co-ordinately mediate the transport and degradation of erythritol into three carbon atoms intermediates that will be then converted into fructose-6P (F6P) by gluconeogenesis. Other induced genes participating in the nonoxidative branch of the pentose phosphate shunt and the TCA may collaborate with the ery genes to conform an efficient degradation of sugars by this route. On the other hand, several routes of amino acid and nucleotide biosynthesis are up-regulated whilst amino acid transport and catabolism genes are down-regulated. These results corroborate previous descriptions indicating that in the presence of erythritol, this sugar was used preferentially over other compounds and provides a neat explanation of the the reported stimulation of growth induced by erythritol. Citation: Rodriguez MC, Viadas C, Seoane A, Sangari FJ, Lopez-Goni I, et al. (2012) Evaluation of the Effects of Erythritol on Gene Expression in Brucella abortus. PLoS ONE 7(12): e50876. doi:10.1371/journal.pone.0050876	[Cruz Rodriguez, Maria; Seoane, Asuncion; Javier Sangari, Felix; Maria Garcia-Lobo, Juan] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Dept Biol Mol,SODERCAN, E-39005 Santander, Cantabria, Spain; [Viadas, Cristina; Lopez-Goni, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Navarra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of Navarra	Sangari, FJ (corresponding author), Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Dept Biol Mol,SODERCAN, E-39005 Santander, Cantabria, Spain.	sangarif@unican.es; jmglobo@unican.es	Lobo, Juan M Garcia/K-2727-2014; Sangari, Félix J/K-9104-2014; Rodriguez, Maria-Cruz/K-6533-2014; López-Goñi, Ignacio/K-2572-2017	Lobo, Juan M Garcia/0000-0002-9187-0671; Sangari, Félix J/0000-0002-3298-6076; Rodriguez, Maria-Cruz/0000-0001-6778-1663; López-Goñi, Ignacio/0000-0002-3873-8743	Ministerio de Ciencia y Tecnologia of Spain [BIO2005-04985, AGL2008-04514, BIO2007-63656, BFU2011-25658]; Instituto de Salud Carlos III [PI050894]; Gobierno Vasco; Fundacion Marques de Valdecilla-IFIMAV	Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Gobierno Vasco(Basque Government); Fundacion Marques de Valdecilla-IFIMAV	This work was supported by the Ministerio de Ciencia y Tecnologia of Spain (BIO2005-04985 and AGL2008-04514 to ILG, and BIO2007-63656 and BFU2011-25658 to FJS) and Instituto de Salud Carlos III (PI050894 to JMG-L). Fellowships support to CV from the Gobierno Vasco and to MCR from Fundacion Marques de Valdecilla-IFIMAV are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2008, PROTEOMICS, V8, P3862, DOI 10.1002/pmic.200800026; ANDERSON JD, 1965, J GEN MICROBIOL, V38, P109, DOI 10.1099/00221287-38-1-109; Barbier T, 2011, FEBS LETT, V585, P2929, DOI 10.1016/j.febslet.2011.08.011; Bellaire BH, 2003, INFECT IMMUN, V71, P1794, DOI 10.1128/IAI.71.4.1794-1803.2003; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Burkhardt S, 2005, INFECT IMMUN, V73, P6782, DOI 10.1128/IAI.73.10.6782-6790.2005; Carrero MIG, 2002, MICROBIOL-SGM, V148, P353, DOI 10.1099/00221287-148-2-353; Crasta OR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002193; Delrue RM, 2004, FEMS MICROBIOL LETT, V231, P1, DOI 10.1016/S0378-1097(03)00963-7; Dozot M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012679; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Eskra L, 2001, INFECT IMMUN, V69, P7736, DOI 10.1128/IAI.69.12.7736-7742.2001; Eskra L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031747; Essenberg RC, 2002, VET MICROBIOL, V90, P249, DOI 10.1016/S0378-1135(02)00212-2; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Hernandez-Castro R, 2003, MICROBIOL-SGM, V149, P3185, DOI 10.1099/mic.0.26678-0; Jain N, 2011, FEMS MICROBIOL LETT, V316, P1, DOI 10.1111/j.1574-6968.2010.02186.x; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lillo AM, 2003, BIOORG MED CHEM LETT, V13, P737, DOI 10.1016/S0960-894X(02)01032-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPEZGONI I, 1992, INFECT IMMUN, V60, P4496; MEYER ME, 1966, J BACTERIOL, V92, P584, DOI 10.1128/JB.92.3.584-588.1966; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Poysti NJ, 2007, J BACTERIOL, V189, P3445, DOI 10.1128/JB.01707-06; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SANGARI FJ, 1994, FEMS MICROBIOL LETT, V121, P337, DOI 10.1111/j.1574-6968.1994.tb07123.x; Sangari FJ, 1998, VACCINE, V16, P1640, DOI 10.1016/S0264-410X(98)00063-2; SANGARI FJ, 1994, VACCINE, V12, P435, DOI 10.1016/0264-410X(94)90121-X; Sangari FJ, 2000, MICROBIOL-UK, V146, P487, DOI 10.1099/00221287-146-2-487; Simon R, 2007, CANCER INFORM, V3, P11; SMITH H, 1962, NATURE, V193, P47, DOI 10.1038/193047a0; SPERRY JF, 1975, J BACTERIOL, V121, P619, DOI 10.1128/JB.121.2.619-630.1975; Sun YH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00047; Trant CGMC, 2010, INFECT IMMUN, V78, P2283, DOI 10.1128/IAI.01433-09; Viadas C, 2009, MICROB PATHOGENESIS, V47, P189, DOI 10.1016/j.micpath.2009.06.002; Viadas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010216; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yost CK, 2006, MICROBIOL-SGM, V152, P2061, DOI 10.1099/mic.0.28938-0	41	14	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50876	10.1371/journal.pone.0050876	http://dx.doi.org/10.1371/journal.pone.0050876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272076	Green Published, gold			2022-12-25	WOS:000312386800019
J	Champagne, E; Tremblay, JP; Cote, SD				Champagne, Emilie; Tremblay, Jean-Pierre; Cote, Steeve D.			Tolerance of an Expanding Subarctic Shrub, Betula glandulosa, to Simulated Caribou Browsing	PLOS ONE			English	Article							PUBESCENS SSP TORTUOSA; PLANT TOLERANCE; MOUNTAIN BIRCH; HERBIVORY; RESPONSES; GROWTH; TUNDRA; OVERCOMPENSATION; AVAILABILITY; CONSEQUENCES	Densification of the shrub layer has been reported in many subarctic regions, raising questions about the implication for large herbivores and their resources. Shrubs can tolerate browsing and their level of tolerance could be affected by browsing and soils productivity, eventually modifying resource availability for the caribou. Our objective was to assess the compensatory growth potential of a subarctic shrub, Betula glandulosa Michx., in relation with caribou browsing and nutriment availability for the plants. We used a simulated browsing (0, 25 and 75% of available shoots) and nitrogen-fertilisation (0 and 10 g m 22) experiment to test two main hypotheses linking tolerance to resource availability, the Compensatory Continuum Hypothesis and the Growth Rate Hypothesis as well as the predictions from the Limiting Resource Model. We seek to explicitly integrate the relative browsing pressure in our predictions since the amount of tissues removed could affect the capacity of long-lived plants to compensate. Birches fully compensated for moderate browsing with an overall leaf biomass similar to unbrowsed birches but undercompensated under heavy browsing pressure. The main mechanism explaining compensation appears to be the conversion of short shoots into long shoots. The leaf area increased under heavy browsing pressure but only led to undercompensation. Fertilisation for two consecutive years did not influence the response of birch, thus we conclude that our results support the LRM hypothesis of equal tolerance under both high and low nitrogen availability. Our results highlight that the potential for compensatory growth in dwarf birch is surpassed under heavy browsing pressure independently of the fertilisation regime. In the context of the worldwide decline in caribou herds, the reduction in browsing pressure could act synergistically with global climate change to promote the current shrub expansion reported in subarctic regions. Citation: Champagne E, Tremblay J-P, Cote SD (2012) Tolerance of an Expanding Subarctic Shrub, Betula glandulosa, to Simulated Caribou Browsing. PLoS ONE 7(12): e51940. doi: 10.1371/journal.pone.0051940	[Champagne, Emilie; Tremblay, Jean-Pierre; Cote, Steeve D.] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Champagne, Emilie; Tremblay, Jean-Pierre; Cote, Steeve D.] Univ Laval, Ctr Etud Nord, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Tremblay, JP (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	jean-pierre.tremblay@bio.ulaval.ca	Champagne, Emilie/I-4364-2019	Champagne, Emilie/0000-0003-1550-2735; Tremblay, Jean-Pierre/0000-0003-0978-529X	Natural Sciences and Engineering Research Council of Canada; Association of Canadian Universities for Northern Studies; Beverly and Qamarniqjuak management board; NSERC; Ressources naturelles et Faune Quebec; ArcticNet; Fonds de recherche sur la nature et les technologies du Gouvernement du Quebec; Hydro Quebec; Xstrata Nickel; Federation des pourvoiries du Quebec inc.; Federation quebecoise des chasseurs et pecheurs; First Air; Makivik Corporation; CARMA; International Polar Year; Canada Foundation for Innovation; Institute for Environmental Monitoring and Research; Fondation de la Faune du Quebec; Ouranos; Canadian Wildlife Federation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Association of Canadian Universities for Northern Studies; Beverly and Qamarniqjuak management board; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ressources naturelles et Faune Quebec; ArcticNet; Fonds de recherche sur la nature et les technologies du Gouvernement du Quebec; Hydro Quebec; Xstrata Nickel; Federation des pourvoiries du Quebec inc.; Federation quebecoise des chasseurs et pecheurs; First Air; Makivik Corporation; CARMA; International Polar Year; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Institute for Environmental Monitoring and Research; Fondation de la Faune du Quebec; Ouranos; Canadian Wildlife Federation	E.C. received scholarships from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/), Association of Canadian Universities for Northern Studies (http://www.acuns.ca/) and the Beverly and Qamarniqjuak management board (http://www.arctic-caribou.com/). This project is part of the Caribou Ungava research program (http://www.caribou-ungava.ulaval.ca/en/accueil/) funded by NSERC, Ressources naturelles et Faune Quebec, ArcticNet, Fonds de recherche sur la nature et les technologies du Gouvernement du Quebec, Hydro Quebec, Xstrata Nickel, Federation des pourvoiries du Quebec inc., Federation quebecoise des chasseurs et pecheurs, First Air, Makivik Corporation, CARMA, International Polar Year, Canada Foundation for Innovation, Institute for Environmental Monitoring and Research, Fondation de la Faune du Quebec, Ouranos, and the Canadian Wildlife Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare their commercial funders as a competing interest. This project is part of the Caribou Ungava research program (http://www.caribou-ungava.ulaval.ca/en/accueil/) funded by NSERC, Ressources naturelles et Faune Quebec, ArcticNet, Fonds de recherche sur la nature et les technologies du Gouvernement du Quebec, Hydro Quebec, Xstrata Nickel, Federation des pourvoiries du Quebec inc., Federation quebecoise des chasseurs et pecheurs, First Air, Makivik Corporation, CARMA, International Polar Year, Canada Foundation for Innovation, Institute for Environmental Monitoring and Research, Fondation de la Faune du Quebec, Ouranos, and the Canadian Wildlife Federation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aerts R, 2009, FUNCT ECOL, V23, P680, DOI 10.1111/j.1365-2435.2009.01566.x; Allard M., 1987, G OG PHYS QUATER, V41, P141, DOI [10.7202/032671ar, DOI 10.7202/032671AR]; ALWARD RD, 1993, OECOLOGIA, V95, P358, DOI 10.1007/BF00320989; Banta JA, 2010, OIKOS, V119, P359, DOI 10.1111/j.1600-0706.2009.17726.x; Baraza E, 2010, ECOSCIENCE, V17, P156, DOI 10.2980/17-2-3286; Barry KM, 2012, TREE PHYSIOL, V32, P24, DOI 10.1093/treephys/tpr128; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; BERGERUD AT, 1972, J WILDLIFE MANAGE, V36, P913, DOI 10.2307/3799448; Bergstrom Roger, 2003, Journal for Nature Conservation (Jena), V10, P203, DOI 10.1078/1617-1381-00020; Brathen KA, 2004, J VEG SCI, V15, P653, DOI 10.1111/j.1654-1103.2004.tb02307.x; Bret-Harte MS, 2001, ECOLOGY, V82, P18, DOI 10.1890/0012-9658(2001)082[0018:DPABNT]2.0.CO;2; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; CRETE M, 1990, ARCTIC, V43, P60; DANELL K, 1994, J MAMMAL, V75, P833, DOI 10.2307/1382465; DANELL K, 1989, OIKOS, V55, P11, DOI 10.2307/3565866; DeGroot WJ, 1997, J ECOL, V85, P241, DOI 10.2307/2960655; Diamond D, 1992, 13107062D LECH INSTR; Federer W.T., 2007, VARIATIONS SPLIT PLO; Gerhart KL, 1996, CAN J ZOOL, V74, P136, DOI 10.1139/z96-018; Gornall JL, 2009, OECOLOGIA, V161, P747, DOI 10.1007/s00442-009-1427-5; Gough L, 2007, OIKOS, V116, P407, DOI 10.1111/j.0030-1299.2007.15449.x; Guillet C, 2006, OIKOS, V113, P33, DOI 10.1111/j.0030-1299.2006.13545.x; Haukioja E, 2000, EVOL ECOL, V14, P551, DOI 10.1023/A:1011091606022; HAUKIOJA E, 1990, OECOLOGIA, V82, P238, DOI 10.1007/BF00323540; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; HERMANUTZ LA, 1989, AM J BOT, V76, P755, DOI 10.2307/2444422; Hester A. J., 2006, LARGE HERBIVORE ECOL, P97; Hester AJ, 2000, FORESTRY, V73, P381, DOI 10.1093/forestry/73.4.381; HILBERT DW, 1981, OECOLOGIA, V51, P14, DOI 10.1007/BF00344645; Hobbie SE, 2005, J ECOL, V93, P770, DOI 10.1111/j.1365-2745.2005.01006.x; Ishihara M, 2004, CAN J BOT, V82, P1393, DOI [10.1139/b04-099, 10.1139/B04-099]; JONASSON S, 1988, OIKOS, V52, P101, DOI 10.2307/3565988; Kaitaniemi P, 1999, ECOLOGY, V80, P524, DOI 10.1890/0012-9658(1999)080[0524:EOCDOG]2.0.CO;2; LEHTILA K, 1994, ECOLOGY, V75, P945, DOI 10.2307/1939418; Lehtila K, 2000, OIKOS, V90, P160, DOI 10.1034/j.1600-0706.2000.900116.x; Littell R. C., 2006, SAS SYSTEM MIXED MOD; MAILLETTE L, 1982, J APPL ECOL, V19, P203, DOI 10.2307/2403005; Manseau M, 1996, RELATION RECIPROQUE; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; MAYCOCK PF, 1966, ARCTIC, V19, P114; Melnychuk MC, 2005, CAN J BOT, V83, P399, DOI [10.1139/B05-013, 10.1139/b05-013]; MRN, 2002, CART GEOL QUEB; Nadelhoffer K.J., 1992, ARCTIC ECOSYSTEMS CH, P281, DOI DOI 10.1016/B978-0-12-168250-7.50019-5; Naito AT, 2011, PROG PHYS GEOG, V35, P423, DOI 10.1177/0309133311403538; Pajunen AM, 2009, ARCT ANTARCT ALP RES, V41, P478, DOI 10.1657/1938-4246-41.4.478; Palacio S, 2008, FUNCT ECOL, V22, P808, DOI 10.1111/j.1365-2435.2008.01433.x; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Persson IL, 2007, OIKOS, V116, P1639, DOI [10.1111/j.2007.0030-1299.15946.x, 10.1111/j.0030-1299.2007.15946.x]; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Ropars P, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015501; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; [SAS I Institute S], 2008, SAS WIND V9 2; [SAS I Institute S], 2008, LSMEANS STAT; [SAS I Institute S], 2008, GLIMMIX PROC; SENN J, 1994, FUNCT ECOL, V8, P494, DOI 10.2307/2390074; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Tremblay B, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035501; van der Wal R, 2006, OIKOS, V114, P177, DOI 10.1111/j.2006.0030-1299.14264.x; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wise MJ, 2008, AM NAT, V172, P635, DOI 10.1086/591691; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wise MJ, 2005, OIKOS, V109, P417, DOI 10.1111/j.0030-1299.2005.13878.x	64	11	11	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51940	10.1371/journal.pone.0051940	http://dx.doi.org/10.1371/journal.pone.0051940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272191	gold, Green Published			2022-12-25	WOS:000312386600050
J	Foutz, TJ; Ackermann, DM; Kilgore, KL; McIntyre, CC				Foutz, Thomas J.; Ackermann, D. Michael, Jr.; Kilgore, Kevin L.; McIntyre, Cameron C.			Energy Efficient Neural Stimulation: Coupling Circuit Design and Membrane Biophysics	PLOS ONE			English	Article							SPINAL-CORD STIMULATION; DEEP-BRAIN-STIMULATION; ELECTRICAL-STIMULATION; NERVE; ELECTRODES; FIBERS; MODEL	The delivery of therapeutic levels of electrical current to neural tissue is a well-established treatment for numerous indications such as Parkinson's disease and chronic pain. While the neuromodulation medical device industry has experienced steady clinical growth over the last two decades, much of the core technology underlying implanted pulse generators remain unchanged. In this study we propose some new methods for achieving increased energy-efficiency during neural stimulation. The first method exploits the biophysical features of excitable tissue through the use of a centered-triangular stimulation waveform. Neural activation with this waveform is achieved with a statistically significant reduction in energy compared to traditional rectangular waveforms. The second method demonstrates energy savings that could be achieved by advanced circuitry design. We show that the traditional practice of using a fixed compliance voltage for constant-current stimulation results in substantial energy loss. A portion of this energy can be recuperated by adjusting the compliance voltage to real-time requirements. Lastly, we demonstrate the potential impact of axon fiber diameter on defining the energy-optimal pulse-width for stimulation. When designing implantable pulse generators for energy efficiency, we propose that the future combination of a variable compliance system, a centered-triangular stimulus waveform, and an axon diameter specific stimulation pulse-width has great potential to reduce energy consumption and prolong battery life in neuromodulation devices. Citation: Foutz TJ, Ackermann DM Jr, Kilgore KL, McIntyre CC (2012) Energy Efficient Neural Stimulation: Coupling Circuit Design and Membrane Biophysics. PLoS ONE 7(12): e51901. doi:10.1371/journal.pone.0051901	[Foutz, Thomas J.; Ackermann, D. Michael, Jr.; Kilgore, Kevin L.; McIntyre, Cameron C.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Foutz, Thomas J.; McIntyre, Cameron C.] Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA; [Ackermann, D. Michael, Jr.; Kilgore, Kevin L.] MetroHlth Med Ctr, Cleveland, OH USA; [Ackermann, D. Michael, Jr.] Stanford Univ, Palo Alto, CA 94304 USA; [Kilgore, Kevin L.; McIntyre, Cameron C.] Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH USA	Case Western Reserve University; Cleveland Clinic Foundation; MetroHealth System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	McIntyre, CC (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	mcintyc@ccf.org	Foutz, Tom/AHE-3189-2022	Foutz, Tom/0000-0002-0114-0019; Kilgore, Kevin/0000-0002-2642-9855	National Institutes of Health [R01 NS047388, R01 EB002091]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health R01 NS047388, R01 EB002091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann DM, 2009, IEEE T NEUR SYS REH, V17, P469, DOI 10.1109/TNSRE.2009.2034069; Carnevale N.T., 2009, NEURON BOOK, V1st; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Foldes EL, 2011, J NEUROSCI METH, V196, P31, DOI 10.1016/j.jneumeth.2010.12.020; Foutz TJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066008; Haefner PA, 2011, US Patent, Patent No. [8,014,866, 8014866]; HARRISON LM, 1975, EXP NEUROL, V47, P364, DOI 10.1016/0014-4886(75)90266-6; Holsheimer J, 2002, NEUROMODULATION, V5, P25, DOI 10.1046/j.1525-1403.2002._2005.x; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Mogyoros I, 1996, BRAIN, V119, P439, DOI 10.1093/brain/119.2.439; MORTIMER JT, 1970, J NEUROSURG, V32, P553, DOI 10.3171/jns.1970.32.5.0553; NORTH RB, 1993, NEUROSURGERY, V32, P384, DOI 10.1227/00006123-199303000-00008; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Peckham PH, 2009, IMPLANTABLE NEURAL S; Sahin M, 2007, J NEURAL ENG, V4, P227, DOI 10.1088/1741-2560/4/3/008; SHANNON RV, 1992, IEEE T BIO-MED ENG, V39, P424, DOI 10.1109/10.126616; Shepherd Robert K, 2006, Adv Otorhinolaryngol, V64, P186, DOI 10.1159/000094652; Shi JW, 2012, US Patent, Patent No. [8,175,719, 8175719]; Wongsarnpigoon A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046009	21	23	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51901	10.1371/journal.pone.0051901	http://dx.doi.org/10.1371/journal.pone.0051901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272188	Green Published, gold, Green Submitted			2022-12-25	WOS:000312386600048
J	Chen, L; Liu, WQ; Lei, JH; Guan, F; Li, MJ; Song, WJ; Li, YL; Wang, T				Chen, Lin; Liu, Wen-qi; Lei, Jia-hui; Guan, Fei; Li, Man-jun; Song, Wen-jian; Li, Yong-long; Wang, Ting			Chronic Schistosoma japonicum Infection Reduces Immune Response to Vaccine against Hepatitis B in Mice	PLOS ONE			English	Article							PROTECTIVE EFFICACY; MANSONI INFECTION; IMMUNOGENICITY; METAANALYSIS; ACTIVATION; ANTIBODIES; CHILDREN; INFANTS	Background: Hepatitis B and schistosomiasis are most prevalent in Africa and Asia, and co-infections of both are frequent in these areas. The immunomodulation reported to be induced by schistosome infections might restrict immune control of hepatitis B virus (HBV) leading to more severe viral infection. Vaccination is the most effective measure to control and prevent HBV infection, but there is evidence for a reduced immune response to the vaccine in patients with chronic schistosomiasis japonica. Methodology/Principal Findings: In this paper, we demonstrate in a mouse model that a chronic Schistosoma japonicum infection can inhibit the immune response to hepatitis B vaccine (HBV vaccine) and lead to lower production of anti-HBs antibodies, interferon-gamma (IFN-gamma) and interleukin-2 (IL-2). After deworming with Praziquantel (PZQ), the level of anti-HBs antibodies gradually increased and the Th2-biased profile slowly tapered. At 16 weeks after deworming, the levels of anti-HBs antibodies and Th1/Th2 cytokines returned to the normal levels. Conclusions/Significance: The results suggest that the preexisting Th2-dominated immune profile in the host infected with the parasite may down-regulate levels of anti-HBs antibodies and Th1 cytokines. To improve the efficacy of HBV vaccination in schistosome infected humans it may be valuable to treat them with praziquantel (PZQ) some time prior to HBV vaccination. Citation: Chen L, Liu W-q, Lei J-h, Guan F, Li M-j, et al. (2012) Chronic Schistosoma japonicum Infection Reduces Immune Response to Vaccine against Hepatitis B in Mice. PLoS ONE 7(12): e51512. doi:10.1371/journal.pone.0051512	[Chen, Lin; Liu, Wen-qi; Lei, Jia-hui; Guan, Fei; Li, Man-jun; Li, Yong-long; Wang, Ting] Huazhong Univ Sci & Technol, Dept Parasitol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chen, Lin] Jianghan Univ, Wuhan Inst Biomed Sci, Wuhan, Peoples R China; [Song, Wen-jian] Jianghan Univ, Dept Parasitol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Jianghan University; Jianghan University	Wang, T (corresponding author), Huazhong Univ Sci & Technol, Dept Parasitol, Tongji Med Coll, Wuhan 430074, Peoples R China.	wangting139@mail.hust.edu.cn	Lei, Jiahui/HGV-0100-2022	LI, MANJUN/0000-0002-5296-7614	National Nature and Science Foundation of China [81000738]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the National Nature and Science Foundation of China (project grant 81000738). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Bocher WO, 2000, HEPATOLOGY, V31, P480, DOI 10.1002/hep.510310231; Borkow G, 2006, PARASITE IMMUNOL, V28, P605, DOI 10.1111/j.1365-3024.2006.00918.x; Borkow G, 2002, CLIN DIAGN LAB IMMUN, V9, P505, DOI 10.1128/CDLI.9.3.505-507.2002; Borkow G, 2000, J CLIN INVEST, V106, P1053, DOI 10.1172/JCI10182; Bundy D, 2000, PARASITOL TODAY, V16, P273, DOI 10.1016/S0169-4758(00)01689-6; Cioli D, 2003, PARASITOL RES, V90, pS3, DOI 10.1007/s00436-002-0751-z; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; Cooper PJ, 2000, J INFECT DIS, V182, P1199, DOI 10.1086/315837; Elias D, 2005, VACCINE, V23, P1326, DOI 10.1016/j.vaccine.2004.09.038; Eren R, 1998, IMMUNOLOGY, V93, P154; GHAFFAR YA, 1989, LANCET, V2, P272; GHAFFAR YA, 1990, AM J TROP MED HYG, V43, P516, DOI 10.4269/ajtmh.1990.43.516; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guan you-gen, 2008, CHINESE J CHILD HLTH, V16, P494; JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263, DOI 10.1093/oxfordjournals.aje.a121457; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Lanata CF, 1996, J INFECT DIS, V174, P268, DOI 10.1093/infdis/174.2.268; McClary H, 2000, J EXP MED, V192, P289, DOI 10.1084/jem.192.2.289; Michel ML, 2010, PATHOL BIOL, V58, P288, DOI 10.1016/j.patbio.2010.01.006; Muniz-Junqueira M I, 1996, Rev Soc Bras Med Trop, V29, P441, DOI 10.1590/S0037-86821996000500006; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Sabin EA, 1996, J INFECT DIS, V173, P269, DOI 10.1093/infdis/173.1.269; SAMUEL D, 1993, NEW ENGL J MED, V329, P1842, DOI 10.1056/NEJM199312163292503; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Sjogren MH, 2005, AM J MED, V118, P34, DOI 10.1016/j.amjmed.2005.07.012; Song Wen-Jian, 2005, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V23, P163; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stewart GR, 1999, CLIN EXP IMMUNOL, V117, P517; SUTTER RW, 1991, LANCET, V338, P715, DOI 10.1016/0140-6736(91)91442-W; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; WAINWRIGHT RB, 1989, JAMA-J AM MED ASSOC, V261, P2362, DOI 10.1001/jama.261.16.2362; Wu G.L., 2005, HUMAN PARASITOLOGY, V3rd ed.; Zai XJ, 2002, RAILWAY MED J, V30, P63; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	36	27	27	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51512	10.1371/journal.pone.0051512	http://dx.doi.org/10.1371/journal.pone.0051512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272112	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386800050
J	Hou, TT; Zhang, X; Xu, JJ; Jian, CS; Huang, ZL; Ye, T; Hu, KP; Zheng, M; Gao, F; Wang, XH; Cheng, HP				Hou, Tingting; Zhang, Xing; Xu, Jiejia; Jian, Chongshu; Huang, Zhanglong; Ye, Tao; Hu, Keping; Zheng, Ming; Gao, Feng; Wang, Xianhua; Cheng, Heping			Synergistic Triggering of Superoxide Flashes by Mitochondrial Ca2+ Uniport and Basal Reactive Oxygen Species Elevation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CA-2&-INDUCED MEMBRANE TRANSITION; OXIDATIVE-STRESS; CYCLOPHILIN-D; CA-2+-DEPENDENT PORE; ISOLATED HEPATOCYTES; CELL-DEATH; TRANSIENT; METABOLISM; COMPONENT	Mitochondrial superoxide flashes reflect a quantal, bursting mode of reactive oxygen species (ROS) production that arises from stochastic, transient opening of the mitochondrial permeability transition pore (mPTP) in many types of cells and in living animals. However, the regulatory mechanisms and the exact nature of the flash-coupled mPTP remain poorly understood. Here we demonstrate a profound synergistic effect between mitochondrial Ca2+ uniport and elevated basal ROS production in triggering superoxide flashes in intact cells. Hyperosmotic stress potently augmented the flash activity while simultaneously elevating mitochondrial Ca2+ and ROS. Blocking mitochondrial Ca2+ transport by knockdown of MICU1 or MCU, newly identified components of the mitochondrial Ca2+ uniporter, or scavenging mitochondrial basal ROS markedly diminished the flash response. More importantly, whereas elevating Ca2+ or ROS production alone was inefficacious in triggering the flashes, concurrent physiological Ca2+ and ROS elevation served as the most powerful flash activator, increasing the flash incidence by an order of magnitude. Functionally, superoxide flashes in response to hyperosmotic stress participated in the activation of JNK and p38. Thus, physiological levels of mitochondrial Ca2+ and ROS synergistically regulate stochastic mPTP opening and quantal ROS production in intact cells, marking the flash as a coincidence detector of mitochondrial Ca2+ and ROS signals.	[Hou, Tingting; Xu, Jiejia; Jian, Chongshu; Huang, Zhanglong; Zheng, Ming; Wang, Xianhua; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Zhang, Xing; Gao, Feng] Fourth Mil Med Univ, Dept Physiol, Xian 710023, Peoples R China; [Ye, Tao] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Hu, Keping] Chinese Acad Med Sci, Inst Med Plant Dev, Res Ctr Pharmacol & Toxicol, Beijing 100094, Peoples R China; [Hu, Keping] Peking Union Med Coll, Beijing 100094, Peoples R China	Peking University; Air Force Military Medical University; Hong Kong Polytechnic University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, XH (corresponding author), Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	xianhua@pku.edu.cn	Gao, Feng/X-4385-2019; Zhang, Xing/ACQ-5035-2022; cheng, heping/A-7299-2011; Ye，PhD，FRSC, Tao/ABB-8698-2020; Heping, Cheng/AAE-2680-2019	Ye，PhD，FRSC, Tao/0000-0002-2780-9761; Heping, Cheng/0000-0002-9604-6702; Xu, Jiejia/0000-0003-3885-3546; Hahn, Michael/0000-0003-2136-5191; Knox, John Paul/0000-0002-9231-6891	National Basic Research Program of China [2011CB809102]; National Science Foundation of China [31221002, 31130067, 31123004, 30900264]; BBSRC [BB/E015190/1] Funding Source: UKRI	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Basic Research Program of China Grant 2011CB809102 and National Science Foundation of China Grants 31221002, 31130067, 31123004, and 30900264.	ALNASSER I, 1986, BIOCHEM J, V239, P19, DOI 10.1042/bj2390019; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 2007, NOVART FDN SYMP, V287, P164; Bernardi Paolo, 2007, Novartis Found Symp, V287, P157; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chiong M, 2010, APOPTOSIS, V15, P887, DOI 10.1007/s10495-010-0505-9; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; CROMPTON M, 1988, BIOCHEM J, V255, P357; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Huang ZL, 2011, FREE RADICAL BIO MED, V51, P1937, DOI 10.1016/j.freeradbiomed.2011.08.024; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Korge P, 2011, J BIOL CHEM, V286, P34851, DOI 10.1074/jbc.M111.239921; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Pastor MM, 2009, J BIOL CHEM, V284, P30307, DOI 10.1074/jbc.M109.050682; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; POWIS G, 1981, MOL PHARMACOL, V20, P387; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; THOR H, 1982, J BIOL CHEM, V257, P2419; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XH, 2012, J MOL CELL CARDIOL, V52, P940, DOI 10.1016/j.yjmcc.2012.02.007; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Wright AR, 1998, PHARMACOL THERAPEUT, V80, P89, DOI 10.1016/S0163-7258(98)00025-4; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	54	80	85	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4602	4612		10.1074/jbc.M112.398297	http://dx.doi.org/10.1074/jbc.M112.398297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23283965	Green Published, hybrid			2022-12-25	WOS:000315340400010
J	Long, LE; Chesworth, R; Huang, XF; Wong, A; Spiro, A; McGregor, IS; Arnold, JC; Karl, T				Long, Leonora E.; Chesworth, Rose; Huang, Xu-Feng; Wong, Alexander; Spiro, Adena; McGregor, Iain S.; Arnold, Jonathon C.; Karl, Tim			Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; PREPULSE INHIBITION; SOCIAL-INTERACTION; BASE-LINE; RECEPTORS; DELTA(9)-TETRAHYDROCANNABINOL; DELTA-9-TETRAHYDROCANNABINOL; GENE; RAT; BEHAVIOR	The cannabis constituent cannabidiol (CBD) possesses anxiolytic and antipsychotic properties. We have previously shown that transmembrane domain neuregulin 1 mutant (Nrg1 TM HET) mice display altered neurobehavioural responses to the main psychoactive constituent of cannabis, Delta(9)-tetrahydrocannabinol. Here we investigated whether Nrg1 TM HET mice respond differently to CBD and whether CBD reverses schizophrenia-related phenotypes expressed by these mice. Adult male Nrg1 TM HET and wild type-like littermates (WT) received vehicle or CBD (1, 50 or 100 mg/kg i.p.) for 21 days. During treatment and 48 h after withdrawal we measured behaviour, whole blood CBD concentrations and autoradiographic receptor binding. Nrg1 HET mice displayed locomotor hyperactivity, PPI deficits and reduced 5-HT2A receptor binding density in the substantia nigra, but these phenotypes were not reversed by CBD. However, long-term CBD (50 and 100 mg/kg) selectively enhanced social interaction in Nrg1 TM HET mice. Furthermore, acute CBD (100 mg/kg) selectively increased PPI in Nrg1 TM HET mice, although tolerance to this effect was manifest upon repeated CBD administration. Long-term CBD (50 mg/kg) also selectively increased GABA(A) receptor binding in the granular retrosplenial cortex in Nrg1 TM HET mice and reduced 5-HT2A binding in the substantia nigra in WT mice. Nrg1 appears necessary for CBD-induced anxiolysis since only WT mice developed decreased anxiety-related behaviour with repeated CBD treatment. Altered pharmacokinetics in mutant mice could not explain our findings since no genotype differences existed in CBD blood concentrations. Here we demonstrate that Nrg1 modulates acute and long-term neurobehavioural effects of CBD, which does not reverse the schizophrenia-relevant phenotypes.	[Long, Leonora E.; Chesworth, Rose; Huang, Xu-Feng; Arnold, Jonathon C.; Karl, Tim] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Long, Leonora E.; Chesworth, Rose; Karl, Tim] Neurosci Res Australia, Randwick, NSW, Australia; [Long, Leonora E.; Karl, Tim] Univ New S Wales, Sydney, NSW, Australia; [Huang, Xu-Feng] Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW, Australia; [Wong, Alexander; Spiro, Adena; Arnold, Jonathon C.] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia; [McGregor, Iain S.; Arnold, Jonathon C.] Brain & Mind Res Inst, Sydney, NSW, Australia; [McGregor, Iain S.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Wollongong; University of Sydney; University of Sydney; University of Sydney	Long, LE (corresponding author), Schizophrenia Res Inst, Darlinghurst, NSW, Australia.	jonathon.arnold@sydney.edu.au; t.karl@neura.edu.au	Huang, Xu-Feng/D-6053-2013; Huang, Xu-Feng/H-7408-2015; Karl, Tim/E-2088-2011; Wong, Alexander/GZM-2929-2022; Arnold, Jonathon C/ACF-5231-2022; Long, Leonora/D-2576-2010	Huang, Xu-Feng/0000-0002-5895-2253; Huang, Xu-Feng/0000-0002-5895-2253; Karl, Tim/0000-0001-9904-8482; Wong, Alexander/0000-0002-5295-2797; Long, Leonora/0000-0002-1759-4138; mcgregor, iain/0000-0002-9307-7159; Chesworth, Rose/0000-0002-3758-9598; Arnold, Jonathon/0000-0002-0159-9997	National Health and Medical Research Council (NHMRC) [493301, 568752]; Schizophrenia Research Institute; NSW Health; Baxter Charitable Foundation; Alma Hazel Eddy Trust; National Alliance for Research on Schizophrenia and Depression	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute; NSW Health; Baxter Charitable Foundation; Alma Hazel Eddy Trust; National Alliance for Research on Schizophrenia and Depression(NARSAD)	This work was supported by the National Health and Medical Research Council (NHMRC, project grant 493301) and by the Schizophrenia Research Institute, utilising infrastructure funding from NSW Health, the Baxter Charitable Foundation and the Alma Hazel Eddy Trust. TK is funded by a NHMRC career development award (568752). TK and JCA are also supported by the National Alliance for Research on Schizophrenia and Depression (Young Investigator Awards). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert L, 2006, GENES BRAIN BEHAV, V5, P423, DOI 10.1111/j.1601-183X.2005.00178.x; Bergamaschi MM, 2011, NEUROPSYCHOPHARMACOL, V36, P1219, DOI 10.1038/npp.2011.6; Bhattacharyya S, 2010, NEUROPSYCHOPHARMACOL, V35, P764, DOI 10.1038/npp.2009.184; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Boucher AA, 2007, NEUROSCIENCE, V149, P861, DOI 10.1016/j.neuroscience.2007.08.020; Boucher AA, 2007, PSYCHOPHARMACOLOGY, V192, P325, DOI 10.1007/s00213-007-0721-3; Boucher AA, 2011, INT J NEUROPSYCHOPH, V14, P631, DOI 10.1017/S146114571000091X; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Campos AC, 2008, PSYCHOPHARMACOLOGY, V199, P223, DOI 10.1007/s00213-008-1168-x; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Cato MA, 2004, J COGNITIVE NEUROSCI, V16, P167, DOI 10.1162/089892904322984481; CORBETT R, 1991, PSYCHOPHARMACOLOGY, V104, P312, DOI 10.1007/BF02246029; Crippa JAD, 2004, NEUROPSYCHOPHARMACOL, V29, P417, DOI 10.1038/sj.npp.1300340; Dean B, 2008, SCHIZOPHR RES, V99, P341, DOI 10.1016/j.schres.2007.10.013; Deiana S, 2012, PSYCHOPHARMACOLOGY, V219, P859, DOI 10.1007/s00213-011-2415-0; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Deng C, 2006, EXP BRAIN RES, V168, P587, DOI 10.1007/s00221-005-0290-9; Deng Chao, 2007, Neurosci Bull, V23, P341, DOI 10.1007/s12264-007-0051-9; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; El-Alfy AT, 2010, PHARMACOL BIOCHEM BE, V95, P434, DOI 10.1016/j.pbb.2010.03.004; Ellenbroek BA, 2000, BEHAV PHARMACOL, V11, P223, DOI 10.1097/00008877-200006000-00006; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; Frisher M, 2005, J EPIDEMIOL COMMUN H, V59, P847, DOI 10.1136/jech.2004.030833; Fusar-Poli P, 2009, ARCH GEN PSYCHIAT, V66, P95, DOI 10.1001/archgenpsychiatry.2008.519; Geyer MA, 2003, CURR PROTOC NEUROSCI; Gomes FV, 2011, PSYCHOPHARMACOLOGY, V213, P465, DOI 10.1007/s00213-010-2036-z; Gunasekaran N, 2009, BRIT J PHARMACOL, V158, P1330, DOI 10.1111/j.1476-5381.2009.00399.x; Gururajan A, 2011, BEHAV BRAIN RES, V222, P299, DOI 10.1016/j.bbr.2011.03.053; Han M, 2009, NEUROSCIENCE, V164, P1754, DOI 10.1016/j.neuroscience.2009.09.041; Kang K, 2009, PROG NEURO-PSYCHOPH, V33, P867, DOI 10.1016/j.pnpbp.2009.04.010; Karl T, 2007, GENES BRAIN BEHAV, V6, P677, DOI 10.1111/j.1601-183X.2006.00298.x; Karl T, 2011, BEHAV BRAIN RES, V223, P336, DOI 10.1016/j.bbr.2011.04.051; Karschner EL, 2010, ANAL BIOANAL CHEM, V397, P603, DOI 10.1007/s00216-010-3599-6; Keene CS, 2008, BEHAV NEUROSCI, V122, P1070, DOI 10.1037/a0012895; Klein C, 2011, PSYCHOPHARM IN PRESS; Koethe D, 2009, PSYCHOPHARMACOLOGY, V206, P551, DOI 10.1007/s00213-009-1591-7; Koethe D, 2009, BRIT J PSYCHIAT, V194, P371, DOI 10.1192/bjp.bp.108.053843; KREUZ DS, 1973, SCIENCE, V179, P391, DOI 10.1126/science.179.4071.391; Long LE, 2006, NEUROPSYCHOPHARMACOL, V31, P795, DOI 10.1038/sj.npp.1300838; Long LE, 2010, INT J NEUROPSYCHOPH, V13, P861, DOI 10.1017/S1461145709990605; Long LE, 2010, PSYCHOPHARMACOLOGY, V211, P277, DOI 10.1007/s00213-010-1896-6; Malone DT, 2009, PHARMACOL BIOCHEM BE, V93, P91, DOI 10.1016/j.pbb.2009.04.010; MARTIN WR, 1963, PSYCHOPHARMACOLOGIA, V4, P247, DOI 10.1007/BF00408180; McLaren J, 2008, ADDICTION, V103, P1100, DOI 10.1111/j.1360-0443.2008.02230.x; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Moreira FA, 2005, EUR J PHARMACOL, V512, P199, DOI 10.1016/j.ejphar.2005.02.040; Moreira FA, 2006, PROG NEURO-PSYCHOPH, V30, P1466, DOI 10.1016/j.pnpbp.2006.06.004; Nadulski T, 2005, J ANAL TOXICOL, V29, P782, DOI 10.1093/jat/29.8.782; Newell KA, 2007, J NEURAL TRANSM, V114, P995, DOI 10.1007/s00702-007-0668-x; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; O'Tuathaigh CMP, 2008, PROG NEURO-PSYCHOPH, V32, P462, DOI 10.1016/j.pnpbp.2007.09.018; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Petitet F, 1998, LIFE SCI, V63, pPL1, DOI 10.1016/S0024-3205(98)00238-0; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Porras G, 2002, NEUROPSYCHOPHARMACOL, V26, P311, DOI 10.1016/S0893-133X(01)00333-5; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; SCHMIDT CJ, 1992, EUR J PHARMACOL, V223, P65, DOI 10.1016/0014-2999(92)90819-P; Schwarcz G, 2009, J CLIN PSYCHOPHARM, V29, P255, DOI 10.1097/JCP.0b013e3181a6bc3b; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; van den Buuse M, 2009, INT J NEUROPSYCHOPH, V12, P1383, DOI 10.1017/S1461145709000388; Yee BK, 2004, NEUROPSYCHOPHARMACOL, V29, P1865, DOI 10.1038/sj.npp.1300480; Zanelati TV, 2010, BRIT J PHARMACOL, V159, P122, DOI 10.1111/j.1476-5381.2009.00521.x; Zuardi AW, 2006, J PSYCHOPHARMACOL, V20, P683, DOI 10.1177/0269881106060967; ZUARDI AW, 1982, PSYCHOPHARMACOLOGY, V76, P245, DOI 10.1007/BF00432554	68	73	74	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34129	10.1371/journal.pone.0034129	http://dx.doi.org/10.1371/journal.pone.0034129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509273	gold, Green Published, Green Submitted			2022-12-25	WOS:000304805900013
J	Chen, LF; Chen, HP; Huang, YS; Huang, KY; Chou, P; Lee, CC				Chen, Li-Fu; Chen, Hsin-Pai; Huang, Yung-Sung; Huang, Kuang-Yung; Chou, Pesus; Lee, Ching-Chih			Pneumococcal Pneumonia and the Risk of Stroke: A Population-Based Follow-Up Study	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; MYOCARDIAL-INFARCTION; DISEASE; ATHEROSCLEROSIS; VACCINATION	Background: To investigate the risk of developing stroke in patients hospitalized following a diagnosis of pneumococcal pneumonia. Methods: The study cohorts comprised of patients hospitalized with a principal diagnosis of pneumococcal pneumonia (n = 745), with a random sampling of control individuals in 2004 (n = 1490). The Cox proportional hazard model was used to compare the stroke-free survival rate between the cohorts after adjusting for possible confounding and risk factors for a two-year follow up. Instrumental variable analysis (IVA) was used to address potential biases associated with measured and unmeasured confounding variables. Results: Of the 153 patients with stroke, 80 (10.7%) were from the pneumococcal pneumonia cohort, and 73 (4.9%) were from the control group. The risk of stroke was 3.65 times higher (95% confidence interval, 2.25-5.90; P<0.001) in patients with pneumococcal pneumonia after adjusting for patient characteristics, co-morbidities, geographic region, urbanization level of residence, and socioeconomic status during the first year. IVA showed an additional 14% risk of stroke for pneumococcal pneumonia patients (odds ratio = 1.14; 95% CI, 1.02-1.26, P = 0.032). Conclusions: Patients with pneumococcal pneumonia carry an increased risk for stroke than the general population. Further studies are warranted for developing better diagnostic and follow-up strategies for patients with increased risk.	[Chen, Li-Fu] Natl Yang Ming Univ Hosp, Dept Emergency Med, Ilan, Taiwan; [Chen, Hsin-Pai] Natl Yang Ming Univ Hosp, Dept Internal Med, Ilan, Taiwan; [Huang, Yung-Sung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Neurol, Chiayi, Taiwan; [Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Clin Epidemiol & Biostat, Chiayi, Taiwan; [Huang, Kuang-Yung; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, CC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan.	hematcd@hotmail.com	Lei, Jiahui/HGV-0100-2022	LI, MANJUN/0000-0002-5296-7614				Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Elkind MSV, 2010, STROKE, V41, pE117, DOI 10.1161/STROKEAHA.109.571299; Gross PL, 2000, SEMIN THROMB HEMOST, V26, P463, DOI 10.1055/s-2000-13202; Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Lamontagne F, 2008, CAN MED ASSOC J, V179, P773, DOI 10.1503/cmaj.070221; Libby P, 1997, CIRCULATION, V96, P4095; Mendall MA, 1997, HEART, V78, P273, DOI 10.1136/hrt.78.3.273; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Smieja M, 2003, CIRCULATION, V107, P251, DOI 10.1161/01.CIR.0000044940.65226.1F; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Zysk G, 2001, INFECT IMMUN, V69, P845, DOI 10.1128/IAI.69.2.845-852.2001	15	27	27	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51452	10.1371/journal.pone.0051452	http://dx.doi.org/10.1371/journal.pone.0051452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23272112	gold, Green Submitted, Green Published			2022-12-25	WOS:000313236200111
J	Zhao, MR; Wang, C; Zhang, CL; Wen, YZ; Liu, WP				Zhao, Meirong; Wang, Cui; Zhang, Chunlong; Wen, Yuezhong; Liu, Weiping			Enantioselective Cytotoxicity Profile of o,p '-DDT in PC 12 Cells	PLOS ONE			English	Article							DDT INDUCES APOPTOSIS; IN-VITRO; ORGANOCHLORINE PESTICIDES; OXIDATIVE STRESS; INSECTICIDE ACETOFENATE; NEUROBLASTOMA-CELLS; ESTROGENIC ACTIVITY; MONONUCLEAR-CELLS; RISK-ASSESSMENT; EXPRESSION	Background: The continued uses of dichlordiphenyltrichloroethane (DDT) for indoor vector control in some developing countries have recently fueled intensive debates toward the global ban of this persistent legacy contaminant. Current approaches for ecological and health risk assessment has ignored the chiral nature of DDT. In this study by employing an array of cytotoxicity related endpoints, we investigated the enantioselective cytotoxicity of o,p'-DDT. Principal Findings: we demonstrated for the first time that R-(2)-o,p'-DDT caused more neuron cell death by inducing more severe oxidative stress, which selectively imbalanced the transcription of stress-related genes (SOD1, SOD2, HSP70) and enzyme (superoxide dismutase and lactate dehydrogenase) activities, and greater cellular apoptosis compared to its enantiomer S-(+)-o,p'-DDT at the level comparable to malaria area exposure (parts per million). We further elucidated enantioselective modes of action using microarray combined with enzyme-linked immunosorbent assay. The enantioselective apoptosis might involve three signaling pathways via caspase 3, tumor protein 53 (p53) and NFkB. Conclusions: Based on DDT stereochemistry and results reported for other chiral pesticides, our results pointed to the same directional enantioselectivity of chiral DDT toward mammalian cells. We proposed that risk assessment on DDT should consider the enantiomer ratio and enantioselectivities.	[Zhao, Meirong; Wang, Cui] Zhejiang Univ Technol, Res Ctr Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Chunlong] Univ Houston Clear Lake City, Houston, TX 77058 USA; [Wen, Yuezhong; Liu, Weiping] Zhejiang Univ, Inst Environm Sci, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University of Technology; University of Houston System; University of Houston; University of Houston Clear Lake; Zhejiang University	Zhao, MR (corresponding author), Zhejiang Univ Technol, Res Ctr Environm Sci, Hangzhou, Zhejiang, Peoples R China.	Wliu@zju.edu.cn	Zhang, Chunlong/N-2564-2014; Liu, Weiping/E-9208-2010; Wen, Yue/GYQ-5844-2022; wen, Yuezhong/A-7651-2011; Zhao, Meirong/E-9679-2014	Zhang, Chunlong/0000-0003-4782-5424; Liu, Weiping/0000-0002-1173-892X; Zhao, Meirong/0000-0003-3132-9223; Zhang, Chun-Lei/0000-0003-1296-1370; zhen, xuechu/0000-0001-7458-2566	National Basic Research Program of China [2009CB421603]; National Natural Science Foundations of China [21077094, 20837002]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2009CB421603) and the National Natural Science Foundations of China (21077094,20837002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria-Torres JA, 2009, TOXICOL IN VITRO, V23, P1000, DOI 10.1016/j.tiv.2009.06.021; Anantharam V, 2007, NEUROCHEM INT, V50, P834, DOI 10.1016/j.neuint.2007.02.003; Bagchi D, 1995, TOXICOLOGY, V104, P129, DOI 10.1016/0300-483X(95)03156-A; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Bollimuntha S, 2005, J BIOL CHEM, V280, P2132, DOI 10.1074/jbc.M407384200; Bosma H, 2000, LANCET, V356, P912, DOI 10.1016/S0140-6736(00)02685-4; BUSER HR, 1995, ANAL CHEM, V67, P2691, DOI 10.1021/ac00111a030; Carlson K, 2000, TOXICOL APPL PHARM, V168, P102, DOI 10.1006/taap.2000.8997; Cohn BA, 2007, ENVIRON HEALTH PERSP, V115, P1406, DOI 10.1289/ehp.10260; de Joode BV, 2001, LANCET, V357, P1014, DOI 10.1016/S0140-6736(00)04249-5; Ennaceur S, 2008, ENVIRON RES, V108, P86, DOI 10.1016/j.envres.2008.05.005; Ennaceur S, 2010, INT J ENVIRON AN CH, V90, P821, DOI 10.1080/03067311003778615; Forsyth D J, 1973, Arch Environ Contam Toxicol, V1, P1, DOI 10.1007/BF02030141; Frigo DE, 2005, TOXICOL LETT, V155, P227, DOI 10.1016/j.toxlet.2004.09.008; Hemish J, 2003, J BIOL CHEM, V278, P42321, DOI 10.1074/jbc.M308192200; Hoekstra PF, 2001, TOXICOL LETT, V125, P75, DOI 10.1016/S0378-4274(01)00410-6; Hu F, 2010, ENVIRON TOXICOL CHEM, V29, P683, DOI 10.1002/etc.73; Jia Z, 2007, FREE RADICAL BIO MED, V42, P288, DOI 10.1016/j.freeradbiomed.2006.10.047; Kedziora-Kornatowska KZ, 2000, IUBMB LIFE, V49, P303; Kurt-Karakus PB, 2007, ENVIRON SCI TECHNOL, V41, P4965, DOI 10.1021/es0620787; Lascombe I, 2000, ENVIRON HEALTH PERSP, V108, P621, DOI 10.2307/3434882; Leber ER, 1994, PATTYS IND HYGIENE B, V2, P1503; Li L, 2010, J ENVIRON SCI-CHINA, V22, P1980, DOI 10.1016/S1001-0742(09)60349-1; Liu HG, 2010, TOXICOLOGY, V276, P115, DOI 10.1016/j.tox.2010.07.018; Liu HG, 2008, TOXICOLOGY, V253, P89, DOI 10.1016/j.tox.2008.08.015; Liu WP, 2005, P NATL ACAD SCI USA, V102, P701, DOI 10.1073/pnas.0408847102; Lu XT, 2011, ENVIRON TOXICOL, V26, P271, DOI 10.1002/tox.20553; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MCBLAIN WA, 1987, LIFE SCI, V40, P215, DOI 10.1016/0024-3205(87)90361-4; MCBLAIN WA, 1977, CAN J ZOOL, V55, P562, DOI 10.1139/z77-071; Moran JM, 2008, J TOXICOL ENV HEAL A, V71, P1457, DOI 10.1080/15287390802329364; OEHME M, 1994, HRC-J HIGH RES CHROM, V17, P583; Perez-Maldonado IN, 2004, ENVIRON RES, V94, P38, DOI 10.1016/S0013-9351(03)00112-9; Qian HF, 2009, CHEMOSPHERE, V76, P885, DOI 10.1016/j.chemosphere.2009.05.009; Qiu XH, 2004, ENVIRON SCI TECHNOL, V38, P1368, DOI 10.1021/es035052d; Rohrdanz E, 1998, FREE RADICAL BIO MED, V24, P27, DOI 10.1016/S0891-5849(97)00159-7; Shi YQ, 2010, TOXICOL LETT, V193, P79, DOI 10.1016/j.toxlet.2009.12.008; Shinomiya N, 2003, TOXICOL LETT, V137, P175, DOI 10.1016/S0378-4274(02)00401-0; Slater AFG, 1995, TOXICOL LETT, V82-3, P149, DOI 10.1016/0378-4274(95)03474-9; Song Y, 2008, TOXICOLOGY, V253, P53, DOI 10.1016/j.tox.2008.08.013; Stanley Jacob K., 2009, Integrated Environmental Assessment and Management, V5, P364, DOI 10.1897/IEAM_2008-076.1; Stemmler I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041340; Tebourbi O, 1998, B ENVIRON CONTAM TOX, V61, P216, DOI 10.1007/s001289900751; UNEP, 2002, STOCKH CONV PERS ORG; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; Van Dyk JC, 2010, SCI TOTAL ENVIRON, V408, P2745, DOI 10.1016/j.scitotenv.2010.03.002; Wang C, 2010, CHIRALITY, V22, P612, DOI 10.1002/chir.20800; Wang LM, 2009, ENVIRON TOXICOL CHEM, V28, P1, DOI 10.1897/08-055.1; Xu C, 2008, CHEM RES TOXICOL, V21, P1050, DOI 10.1021/tx8000016; Yang HY, 2010, CHEMOSPHERE, V80, P652, DOI 10.1016/j.chemosphere.2010.04.052; Zhao MR, 2008, ENVIRON TOXICOL CHEM, V27, P1194, DOI 10.1897/07-482.1; Zhao MR, 2010, ENVIRON POLLUT, V158, P1968, DOI 10.1016/j.envpol.2009.10.027; Zhao MR, 2009, ENVIRON TOXICOL CHEM, V28, P578, DOI 10.1897/08-246.1	54	45	46	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43823	10.1371/journal.pone.0043823	http://dx.doi.org/10.1371/journal.pone.0043823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937105	gold, Green Published, Green Submitted			2022-12-25	WOS:000308225500107
J	Li, RG; Gao, S; Hernandez, AG; Wechter, WP; Fei, ZJ; Ling, KS				Li, Rugang; Gao, Shan; Hernandez, Alvaro G.; Wechter, W. Patrick; Fei, Zhangjun; Ling, Kai-Shu			Deep Sequencing of Small RNAs in Tomato for Virus and Viroid Identification and Strain Differentiation	PLOS ONE			English	Article							PEPINO-MOSAIC-VIRUS; 1ST REPORT; GREENHOUSE TOMATOES; NATURAL INFECTION; DISCOVERY; ALIGNMENT; EVOLUTION; PATHOGEN; INSIGHTS; REVEALS	Small RNAs (sRNA), including microRNAs (miRNA) and small interfering RNAs (siRNA), are produced abundantly in plants and animals and function in regulating gene expression or in defense against virus or viroid infection. Analysis of siRNA profiles upon virus infection in plant may allow for virus identification, strain differentiation, and de novo assembly of virus genomes. In the present study, four suspected virus-infected tomato samples collected in the U. S. and Mexico were used for sRNA library construction and deep sequencing. Each library generated between 5-7 million sRNA reads, of which more than 90% were from the tomato genome. Upon in-silico subtraction of the tomato sRNAs, the remaining highly enriched, virus-like siRNA pools were assembled with or without reference virus or viroid genomes. A complete genome was assembled for Potato spindle tuber viroid (PSTVd) using siRNA alone. In addition, a near complete virus genome (98%) also was assembled for Pepino mosaic virus (PepMV). A common mixed infection of two strains of PepMV (EU and US1), which shared 82% of genome nucleotide sequence identity, also could be differentially assembled into their respective genomes. Using de novo assembly, a novel potyvirus with less than 60% overall genome nucleotide sequence identity to other known viruses was discovered and its full genome sequence obtained. Taken together, these data suggest that the sRNA deep sequencing technology will likely become an efficient and powerful generic tool for virus identification in plants and animals.	[Li, Rugang; Wechter, W. Patrick; Ling, Kai-Shu] ARS, US Vegetable Lab, USDA, Charleston, SC USA; [Gao, Shan; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Hernandez, Alvaro G.] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL USA; [Fei, Zhangjun] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Li, RG (corresponding author), ARS, US Vegetable Lab, USDA, Charleston, SC USA.	zf25@Cornell.edu; kai.ling@ars.usda.gov	Li, Cong-jun/J-8572-2014; Fei, Zhangjun/H-5152-2012; Ling, Kai-Shu/ABE-9461-2020; Li, Weizhong/A-9735-2008; Khafipour, Ehsan/E-4140-2016	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403; Li, Rugang/0000-0001-6514-496X; Khafipour, Ehsan/0000-0003-4673-7633; Fei, Zhangjun/0000-0001-9684-1450; Li, Ru/0000-0001-7332-7790	U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative [SCRI-600-25320]; National Science Foundation [IOS-1110080]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by a grant from the U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative (SCRI-600-25320) to KSL and by National Science Foundation (IOS-1110080) to ZF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bao Y, 2008, ENCY VIROLOGY, V5, P342; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Cotillon AC, 2002, ARCH VIROL, V147, P2231, DOI 10.1007/s00705-002-0873-8; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hanssen IM, 2010, MOL PLANT MICROBE IN, V23, P539, DOI 10.1094/MPMI-23-5-0539; Hanssen IM, 2010, MOL PLANT PATHOL, V11, P179, DOI 10.1111/j.1364-3703.2009.00600.x; Isakov O, 2011, BIOINFORMATICS, V27, P2027, DOI 10.1093/bioinformatics/btr349; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; JONES RAC, 1980, ANN APPL BIOL, V94, P61, DOI 10.1111/j.1744-7348.1980.tb03896.x; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ling KS, 2010, PLANT DIS, V94, P1376, DOI 10.1094/PDIS-07-10-0516; Ling KS, 2009, PLANT DIS, V93, P1216, DOI 10.1094/PDIS-93-11-1216A; Ling KS, 2009, PLANT DIS, V93, P1075, DOI 10.1094/PDIS-93-10-1075B; Ling KS, 2009, PLANT DIS, V93, P839, DOI 10.1094/PDIS-93-8-0839B; Ling KS, 2007, VIRUS GENES, V34, P1, DOI 10.1007/s11262-006-0003-x; Ling KS, 2008, PLANT DIS, V92, P1683, DOI 10.1094/PDIS-92-12-1683; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Maroon-Lango CJ, 2005, ARCH VIROL, V150, P1187, DOI 10.1007/s00705-005-0495-z; Martin R, 2007, VIROLOGY, V367, P135, DOI 10.1016/j.virol.2007.05.011; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Navarro B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007686; The Tomato Genome Consortium, 2012, NATURE IN PRESS; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Vlugt R A A, 2000, Plant Dis, V84, P103, DOI 10.1094/PDIS.2000.84.1.103C; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wu QF, 2012, P NATL ACAD SCI USA, V109, P3938, DOI 10.1073/pnas.1117815109; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	279	296	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37127	10.1371/journal.pone.0037127	http://dx.doi.org/10.1371/journal.pone.0037127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623984	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343500061
J	Li, RW; Wu, ST; Baldwin, RL; Li, WZ; Li, CJ				Li, Robert W.; Wu, Sitao; Baldwin, Ransom L.; Li, Weizhong; Li, Congjun			Perturbation Dynamics of the Rumen Microbiota in Response to Exogenous Butyrate	PLOS ONE			English	Article							VOLATILE FATTY-ACIDS; HUMAN GUT; BUTYRIVIBRIO-FIBRISOLVENS; RUMINAL BUTYRATE; RESISTANT STARCH; LARGE-INTESTINE; FAST PROGRAM; DAIRY-COWS; MILK-YIELD; METABOLISM	The capacity of the rumen microbiota to produce volatile fatty acids (VFAs) has important implications in animal well-being and production. We investigated temporal changes of the rumen microbiota in response to butyrate infusion using pyrosequencing of the 16S rRNA gene. Twenty one phyla were identified in the rumen microbiota of dairy cows. The rumen microbiota harbored 54.5 +/- 6.1 genera (mean +/- SD) and 127.3 +/- 4.4 operational taxonomic units (OTUs), respectively. However, the core microbiome comprised of 26 genera and 82 OTUs. Butyrate infusion altered molar percentages of 3 major VFAs. Butyrate perturbation had a profound impact on the rumen microbial composition. A 72 h-infusion led to a significant change in the numbers of sequence reads derived from 4 phyla, including 2 most abundant phyla, Bacteroidetes and Firmicutes. As many as 19 genera and 43 OTUs were significantly impacted by butyrate infusion. Elevated butyrate levels in the rumen seemingly had a stimulating effect on butyrate-producing bacteria populations. The resilience of the rumen microbial ecosystem was evident as the abundance of the microorganisms returned to their pre-disturbed status after infusion withdrawal. Our findings provide insight into perturbation dynamics of the rumen microbial ecosystem and should guide efforts in formulating optimal uses of probiotic bacteria treating human diseases.	[Li, Robert W.; Baldwin, Ransom L.; Li, Congjun] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA	United States Department of Agriculture (USDA); University of California System; University of California San Diego	Li, RW (corresponding author), ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA.	robert.li@ars.usda.gov	Li, Cong-jun/J-8572-2014; Fei, Zhangjun/H-5152-2012; Ling, Kai-Shu/ABE-9461-2020; Li, Weizhong/A-9735-2008; Khafipour, Ehsan/E-4140-2016	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403; Li, Rugang/0000-0001-6514-496X; Khafipour, Ehsan/0000-0003-4673-7633; Fei, Zhangjun/0000-0001-9684-1450; Li, Ru/0000-0001-7332-7790	National Center for Research Resources (NCRR) [R01RR025030]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	SW and WL are supported by Award Number R01RR025030 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or the National Institutes of Health. SW and WL are supported by Award Number R01RR025030 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; HUHTANEN P, 1993, J DAIRY SCI, V76, P1114, DOI 10.3168/jds.S0022-0302(93)77440-8; Kristensen NB, 2004, J ANIM SCI, V82, P2033; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Li CJ, 2008, GENE REGUL SYST BIO, V2, P113; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez S, 2003, J ANIM SCI, V81, P2609; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Miettinen H, 1996, J DAIRY SCI, V79, P851, DOI 10.3168/jds.S0022-0302(96)76434-2; Mrazek J, 2006, FOLIA MICROBIOL, V51, P294, DOI 10.1007/BF02931817; Niu BF, 2011, BIOINFORMATICS, V27, P1704, DOI 10.1093/bioinformatics/btr252; Ohkawara S, 2005, J NUTR, V135, P2878, DOI 10.1093/jn/135.12.2878; Ohkawara S, 2006, CLIN VACCINE IMMUNOL, V13, P1231, DOI 10.1128/CVI.00267-06; Pitt RE, 1996, J ANIM SCI, V74, P226; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sato T, 2008, FEMS MICROBIOL ECOL, V66, P528, DOI 10.1111/j.1574-6941.2008.00528.x; Silvi S, 1999, J APPL MICROBIOL, V86, P521, DOI 10.1046/j.1365-2672.1999.00696.x; STORRY JE, 1966, BRIT J NUTR, V20, P217, DOI 10.1079/BJN19660023; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015	35	279	296	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29392	10.1371/journal.pone.0029392	http://dx.doi.org/10.1371/journal.pone.0029392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22623984	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100009
J	Wang, LH; Lv, XJ; Zhai, YG; Fu, SH; Wang, D; Rayner, S; Tang, Q; Liang, GD				Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Wang, David; Rayner, Simon; Tang, Qing; Liang, Guodong			Genomic Characterization of a Novel Virus of the Family Tymoviridae Isolated from Mosquitoes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; YELLOW-MOSAIC-VIRUS; MINUS-STRAND SYNTHESIS; RNA; GENUS; ORGANIZATION; INITIATION; MEMBER; LINE	Background: The family Tymoviridae comprises three plant virus genera, including Tymovirus, Marafivirus, and Maculavirus, which are found in most parts of the world and cause severe agricultural losses. We describe a putatively novel member of the family Tymoviridae, which is isolated from mosquitoes (Culex spp.), referred to as CuTLV. Methods and Results: The CuTLV was isolated by cell culture, which replicates and causes cytopathic effects in Aedes albopictus C6/36 cells, but not in mammalian BHK-21 or Vero cells. The complete 6471 nucleotide sequence of CuTLV was determined. The genome of CuTLV is predicted to contain three open reading frames (ORFs). The largest ORF1 is 5307 nucleotides (nt) in length and encodes a putative polypeptide of 1769 amino acids (aa), which contains the conserved motifs for the methyltransferase (MTR), Tymovirus endopeptidase (PRO), helicase (HEL), and RNA-dependent RNA polymerase (RdRp) of the replication-associated proteins (RPs) of positive-stranded RNA viruses. In contrast, the ORF1 sequence does not contain the so-called "tymobox'' or "marafibox'', the conserved subgenomic RNA promoter present in all tymoviruses or marafiviruses, respectively. ORF2 and ORF3 putatively encode a 248-aa coat protein (CP) and a proline-rich 149-aa polypeptide. The whole genomic nucleotide identity of CuTLV with other members of family Tymoviridae ranged from 46.2% (ChiYMV) to 52.4% (GFkV). Phylogenetic analysis based on the putative RP and CP genes of CuTLV demonstrated that the virus is most closely related to viruses in the genus Maculavirus. Conclusions: The CuTLV is a novel virus related to members of the family Tymoviridae, with molecular characters that are distinct from those of tymoviruses, marafiviruses, and other maculaviruses or macula-like viruses. This is the first report of the isolation of a Tymoviridae-like virus from mosquitoes. Further investigations are required to clarify the origin, replication strategy, and the public health or agricultural importance of the CuTLV.	[Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Tang, Qing; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, David] Washington Univ, St Louis, MO USA; [Rayner, Simon] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Beijing 100864, Hubei, Peoples R China	Chinese Center for Disease Control & Prevention; Washington University (WUSTL); Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, LH (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	Ministry of Science and Technology, People's Republic of China [2003BA712A08-01, 2011CB504702]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control	Funding was provided by the Ministry of Science and Technology, People's Republic of China (no. 2003BA712A08-01 and 2011CB504702); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabdullah A, 2010, VIRUS RES, V152, P10, DOI 10.1016/j.virusres.2010.05.010; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; DING S, 1990, NUCLEIC ACIDS RES, V18, P1181, DOI 10.1093/nar/18.5.1181; Dreher TW, 2004, MOL PLANT PATHOL, V5, P367, DOI 10.1111/j.1364-3703.2004.00236.X; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Hammond RW, 2001, VIROLOGY, V282, P338, DOI 10.1006/viro.2001.0859; Hellendoorn K, 1996, NUCLEIC ACIDS RES, V24, P4910, DOI 10.1093/nar/24.24.4910; Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7; Iwanaga M, 2012, J VIROL METHODS, V179, P316, DOI 10.1016/j.jviromet.2011.11.016; Izadpanah K, 2002, VIRUS GENES, V24, P131, DOI 10.1023/A:1014516515454; Jakubiec A, 2007, J VIROL, V81, P11402, DOI 10.1128/JVI.01428-07; Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005; King AMQ, 2011, 9 INT COMM TAX VIR, P944; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang GD, 2000, J GEN VIROL, V81, P1347, DOI 10.1099/0022-1317-81-5-1347; Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martelli GP, 2002, ARCH VIROL, V147, P1837, DOI 10.1007/s007050200045; Martelli GP, 2002, ARCH VIROL, V147, P1847, DOI 10.1007/s007050200046; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x; Sabanadzovic S, 2001, J GEN VIROL, V82, P2009, DOI 10.1099/0022-1317-82-8-2009; Sabanadzovic S, 2009, ARCH VIROL, V154, P1729, DOI 10.1007/s00705-009-0510-x; Singh RN, 1998, RNA, V4, P1083, DOI 10.1017/S1355838298980694; Stephan D, 2008, VIRUS GENES, V36, P231, DOI 10.1007/s11262-007-0181-1; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39845	10.1371/journal.pone.0039845	http://dx.doi.org/10.1371/journal.pone.0039845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	23272162	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950200014
J	Wang, L; Si, WN; Yao, YF; Tian, DC; Araki, H; Yang, SH				Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai			Genome-Wide Survey of Pseudogenes in 80 Fully Resequenced Arabidopsis thaliana Accessions	PLOS ONE			English	Article							PROCESSED PSEUDOGENES; GENETIC DIVERSITY; DNA; ASSOCIATION; POLYMORPHISMS; EVOLUTIONARY; ANNOTATION; MECHANISMS; RESISTANCE; PATTERNS	Pseudogenes (Psi s), including processed and non-processed Psi s, are ubiquitous genetic elements derived from originally functional genes in all studied genomes within the three kingdoms of life. However, systematic surveys of non-processed Psi s utilizing genomic information from multiple samples within a species are still rare. Here a systematic comparative analysis was conducted of Psi s within 80 fully re-sequenced Arabidopsis thaliana accessions, and 7546 genes, representing similar to 28% of the genomic annotated open reading frames (ORFs), were found with disruptive mutations in at least one accession. The distribution of these Psi s on chromosomes showed a significantly negative correlation between Psi s/ORFs and their local gene densities, suggesting a higher proportion of Psi s in gene desert regions, e. g. near centromeres. On the other hand, compared with the non-Psi loci, even the intact coding sequences (CDSs) in the Psi loci were found to have shorter CDS length, fewer exon number and lower GC content. In addition, a significant functional bias against the null hypothesis was detected in the Psi s mainly involved in responses to environmental stimuli and biotic stress as reported, suggesting that they are likely important for adaptive evolution to rapidly changing environments by pseudogenization to accumulate successive mutations.	[Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Araki, Hitoshi] Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Switzerland	Nanjing University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Araki, H (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	Hitoshi.Araki@eawag.ch; sihaiyang@nju.edu.cn	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	National Natural Science Foundation of China [30970198, J1103512]; NSFC of Jiangsu province [BK2011015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC of Jiangsu province	This work was supported by National Natural Science Foundation of China (30970198 and J1103512) and NSFC of Jiangsu province (BK2011015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benovoy D, 2006, J MOL EVOL, V62, P511, DOI 10.1007/s00239-005-0045-z; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Du JC, 2008, GENE, V426, P1, DOI 10.1016/j.gene.2008.09.003; Freeling M, 2012, CURR OPIN PLANT BIOL, V15, P131, DOI 10.1016/j.pbi.2012.01.015; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Khachane AN, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-38; Lafontaine I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-260; Laitinen RAE, 2010, PLANT PHYSIOL, V153, P652, DOI 10.1104/pp.110.156448; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Sen K, 2010, FEBS LETT, V584, P4015, DOI 10.1016/j.febslet.2010.08.012; TAJIMA F, 1989, GENETICS, V123, P585; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yang LA, 2011, MOL BIOL EVOL, V28, P1193, DOI 10.1093/molbev/msq298; Yang S, 2012, P NATL ACAD SCI USA; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Zhang YL, 2009, J MOL EVOL, V68, P393, DOI 10.1007/s00239-009-9217-6; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; Zou C, 2009, PLANT PHYSIOL, V151, P3, DOI 10.1104/pp.109.140632	43	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51769	10.1371/journal.pone.0051769	http://dx.doi.org/10.1371/journal.pone.0051769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272162	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600039
